PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Demery, JA; Pedraza, O; Hanlon, RE				Demery, JA; Pedraza, O; Hanlon, RE			Differential profiles of verbal learning in traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							SUBGROUPS; SUBTYPES	Several recent investigations have utilized cluster analytic procedures to elucidate profiles of verbal learning on the California Verbal Learning Test following traumatic brain injury (TBI). Although the results of these studies have contributed to our understanding of verbal learning following TBI, limitations in sample composition and methodology render the results difficult to evaluate. The current study provides an analysis of verbal learning clusters in the most comprehensive sample (n=160) of TBI patients reported thus far. Results obtained from multiple hierarchical agglomerative clustering procedures suggested the presence of two distinct clusters, the first consisting of performance patterns falling within normal limits and the second consisting of moderate-to-severe impairment. Two iterative partitioning analyses further suggested a reliable solution with better-than-chance agreement (kappa coefficients >.85, p<.001). Thus, it is concluded that a two-cluster classification solution provides a parsimonious understanding of verbal learning profiles after TBI.	Univ Florida, Hlth Sci Ctr, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA; Northwestern Univ, Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA		Demery, JA (corresponding author), Univ Florida, Hlth Sci Ctr, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA.						American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Blashfield R.K., 1984, CLUSTER ANAL; Blashfield R. K., 1988, HDB MULTIVARIATE EXP, P447, DOI DOI 10.1007/978-1-4613-0893-5_14; Bonafina MA, 2000, J LEARN DISABIL-US, V33, P297, DOI 10.1177/002221940003300307; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; DELIS D, 1987, CALIFORNIA VERBAL LE; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; Everitt B. S., 1993, CLUSTER ANAL; Fisher NJ, 1996, J CLIN EXP NEUROPSYC, V18, P349, DOI 10.1080/01688639608408993; FLETCHER JM, 1988, HDB NEUROPSYCHOLOGY, V1, P83; Fridlund A, 1987, CVLT RES EDITION ADM; Hair J.H., 2000, READING UNDERSTANDIN, P147, DOI DOI 10.5860/CHOICE.38-5067; Hamsher K., 1989, MULTILINGUAL APHASIA; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; KAPLAN E, 1983, BOSTON NAMING; KUIPER FK, 1975, BIOMETRICS, V31, P777, DOI 10.2307/2529565; MILLIGAN GW, 1980, PSYCHOMETRIKA, V45, P325, DOI 10.1007/BF02293907; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; MOJENA R, 1977, COMPUT J, V20, P359, DOI 10.1093/comjnl/20.4.359; Morris RD, 1998, J EDUC PSYCHOL, V90, P347, DOI 10.1037/0022-0663.90.3.347; MORRIS RD, 1988, J CLIN EXP NEUROPSYC, V10, P640, DOI 10.1080/01688638808402801; Reitan RM, 1985, HALSTEADREITAN NEURO; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; TEASDALE G, 1974, LANCET, V2, P81; van Gorp W. G., 1993, NEUROPSYCHOLOGY, V7, P62, DOI DOI 10.1037/0894-4105.7.1.62; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925	33	14	14	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	SEP	2002	24	6					818	827		10.1076/jcen.24.6.818.8400			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	611UM	WOS:000179036200010	12424655				2022-02-06	
J	Greve, KW; Love, JM; Sherwin, E; Mathias, CW; Houston, RJ; Brennan, A				Greve, KW; Love, JM; Sherwin, E; Mathias, CW; Houston, RJ; Brennan, A			Temporal stability of the Wisconsin Card Sorting Test in a chronic traumatic brain injury sample	ASSESSMENT			English	Article						WCST; reliability; psychometrics; assessment; neuropsychology	RELIABILITY	The aim of the present study was to investigate the temporal stability of the Wisconsin Card Sorting Test (WCST) in a clinical population with documented brain pathology, stable cognitive deficits, and for whom repeated testing is common: chronic severe traumatic brain injury (TBI). Participants were 34 patients at least 1 year postsevere TBI living at a large residential rehabilitation facility. The WCST was administered in standard fashion with both the standard and 64-card versions scored. All derived scores with norms were examined. Results indicated acceptable temporal stability of most scores for both the standard and short WCST, although the stability of the WCST-64 was poorer than for the standard WCST Three sets of significant change indices are provided for clinical use.	Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA; Georgia So Univ, Statesboro, GA 30460 USA; Univ New Orleans, New Orleans, LA 70148 USA		Greve, KW (corresponding author), Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu		Mathias, Charles/0000-0003-1902-673X			*AM PSYCH ASS, 1992, AM PSYCH, V0047, P01597, DOI DOI 10.1037/0003-066X.47.12.1597; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; BEDARD MA, 1991, J CLIN EXP NEUROPSYC, V13, P950, DOI 10.1080/01688639108405110; BUTLER M, 1991, PROF PSYCHOL-RES PR, V22, P510, DOI 10.1037/0735-7028.22.6.510; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Greve KW, 2001, CLIN NEUROPSYCHOL, V15, P228, DOI 10.1076/clin.15.2.228.1901; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton R., 2000, WISCONSIN CARD SORTI; Heaton R.K., 2000, WCST 64 COMPUTER VER; Heaton RK, 1999, WISCONSIN CARD SORTI; Ingram F, 1999, BRIT J CLIN PSYCHOL, V38, P209, DOI 10.1348/014466599162764; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kirk R. E., 1999, STAT INTRO, V4th; Lord F. M., 1968, STAT THEORIES MENTAL; MATARAZZO JD, 1984, J CLIN NEUROPSYCHOL, V6, P351, DOI 10.1080/01688638408401227; NAEGELE B, 1995, SLEEP, V18, P43; Paolo A. M., 1996, ASSESSMENT, V3, P137, DOI [10.1177/107319119600300205, DOI 10.1177/107319119600300205]; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tate RL, 1998, CLIN NEUROPSYCHOL, V12, P348, DOI 10.1076/clin.12.3.348.1988	21	14	14	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	SEP	2002	9	3					271	277		10.1177/1073191102009003006			7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	588YL	WOS:000177729800006	12216784				2022-02-06	
J	Powell, EC; Jovtis, E; Tanz, RR				Powell, EC; Jovtis, E; Tanz, RR			Incidence and description of high chair-related injuries to children	AMBULATORY PEDIATRICS			English	Article; Proceedings Paper	41st Annual Meeting of the Ambulatory-Pediatrics-Association	MAY   02, 2001	BALTIMORE, MARYLAND	Ambulatory Pediat Assoc		falls; high chair; infant; injury		Study Objective.-To describe the incidence, circumstances. and types (of high chair-related injuries among, US children. Design.-Retrospective review of data for children 3 bears old and younger iron) the National Electronic Injury Surveillance System of the US Consumer Product Safety Commission for 1994-98. Results.-There were an estimated 40650 hi,, h chair-related injuries (951,1 confidence interval [Cl]. 32657-48643) to children 3 years old and younger treated in hospital emergency department,, in the LIS during the 5-year study period, An estimated 5231 injuries (13%) were related to use of an attachable high chair (including booster,eats). and an estimated 4067 10%) were related to the use of a youth chair. The annual rate Of injury among, children less than or equal to3 years old was 5.3 per 10000. The mean age was 10 months (median. 1 year): 56% were boys. Nienty-four percent of injuries resulted from a fall from the chair. Most injuries involved the head (44%) or face (39%). Injury diagnoses included contusions or abrasions (36%), lacerations (25%). closed head injury (21%) and fractures (8%). Two percent of injured children, an estimated 941 (95% Cl. 399-1487). were admitted to the hospital during the study period, an annual admission rate of 0.1 per 10000. There were no significant differences between attachable high chairs, youth chairs, and high chairs in anatomic sites of injury. injury diagnosis, or frequency I of hospital admission. Conclusions.-Injuries related to high chairs are common. particularly anion, children in the first year of life. They often result front falls from the chair. The data suggest that restraint use would prevent most of these injuries.	Childrens Mem Hosp, Div Pediat Emergency Med, Chicago, IL 60614 USA; Childrens Mem Hosp, Div Gen Acad Pediat, Chicago, IL 60614 USA; Northwestern Univ, Sch Med, Dept Pediat, Chicago, IL 60611 USA		Powell, EC (corresponding author), Childrens Mem Hosp, Div Pediat Emergency Med, Box 62,2300 Childrens Plaza, Chicago, IL 60614 USA.			Powell, Elizabeth/0000-0003-3147-9889			*CPSC, 2000, COSC ANN REC REP HIG; Mayr JM, 1999, ACTA PAEDIATR, V88, P319, DOI 10.1080/08035259950170105; Smith GA, 1996, PEDIATRICS, V97, P161; TINSWORTH DK, 2001, COMMUNICATION   0504; *US CONS PROD SAF, 1994, NAT EL INJ SURV SYST; *US CONS PROD SAF, 1993, EXPL SHEET NEISS EST; *US CONS PROD SAF, 1998, NAT EL INJ SURV SYST; *US CONS PROD SAF, 1996, CONSUMER PROD SAFETY, V1, P4; *US CONS PROD SAF, 2000, NURS PROD REP; *US CONS PROD SAF, 1986, US CONS PROD SAF COM; WATSON WL, 1993, J PAEDIATR CHILD H, V29, P228, DOI 10.1111/j.1440-1754.1993.tb00493.x	11	14	16	0	4	AMBULATORY PEDIATRIC ASSOC	MCLEAN	6728 OLD MCLEAN VILLAGE DR, MCLEAN, VA 22101-3906 USA	1530-1567			AMBUL PEDIATR	Ambul. Pediatr.	JUL-AUG	2002	2	4					276	278		10.1367/1539-4409(2002)002<0276:IADOHC>2.0.CO;2			3	Pediatrics	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	577LP	WOS:000177062600007	12135401				2022-02-06	
J	Alderson, AL; Novack, TA				Alderson, AL; Novack, TA			Measuring recovery of orientation during acute rehabilitation for traumatic brain injury: Value and expectations of recovery	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							POSTTRAUMATIC AMNESIA; GALVESTON ORIENTATION; COGNITIVE ORIENTATION; HEAD-INJURY; SCALE; LOG	Objectives: To further evaluate the use of the orientation log (O-Log) in an acute rehabilitation program for adults with traumatic brain injury (TBI), specifically focusing on prediction of rehabilitation outcome, possible use of the O-Log to promote recovery, and development of templates of orientation recovery. Design: Stepwise discriminant function analysis was used in one study and ANOVA based on between-groups comparisons in another. Confidence intervals were established in the third study. Setting: Acute rehabilitation hospital. Patients: Samples were taken from an overall pool of 389 subjects with predominantly severe TBI based on Glasgow Coma Scale score. Results: A combination of initial O-Log performance, time since injury; and number of O-Log assessments correctly predicted resolution of disorientation for 76% of the sample. Individuals attaining orientation before discharge achieved higher discharge scores on functional measures. Administration of the O-Log 3 versus 5 times a week did not result in more rapid resolution of disorientation. A similar pattern of steady improvement in orientation was evident for mild-moderate and severe injury cases across 10 administrations. Conclusions: Recovery of orientation provides important information about recovery following TBI and is predictive of rehabilitation outcome. More frequent administration of a formal orientation measure does not seem to expedite the recovery of orientation, which on average seems to progress at a steady pace in a rehabilitation setting regardless of the time since injury or severity of injury:	Shepherd Ctr, Inpatient Neuropsychol Acquired Brain Injury Prog, Atlanta, GA 30309 USA; Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL USA		Alderson, AL (corresponding author), Shepherd Ctr, Inpatient Neuropsychol Acquired Brain Injury Prog, 2020 Peachtree Rd NW, Atlanta, GA 30309 USA.				NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD07420] Funding Source: Medline		Ahmed S, 2000, BRAIN INJURY, V14, P765; BODE RK, 2000, J HEAD TRAUMA REHAB, V15, P1; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Dowler RN, 2000, BRAIN INJURY, V14, P117, DOI 10.1080/026990500120781; Gronwall D, 1989, MILD HEAD INJURY, P153; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jain N, 2000, CLIN NEUROPSYCHOL, V14, P13, DOI 10.1076/1385-4046(200002)14:1;1-8;FT013; Keith R A, 1987, Adv Clin Rehabil, V1, P6; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	14	14	14	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	2002	17	3					210	219		10.1097/00001199-200206000-00003			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	552WE	WOS:000175642400003	12086575				2022-02-06	
J	Singh, S; Salib, RJ; Oates, J				Singh, S; Salib, RJ; Oates, J			Traumatic fracture of the stapes suprastructure following minor head injury	JOURNAL OF LARYNGOLOGY AND OTOLOGY			English	Article						head injuries, closed; ear, middle; stapes; fracture; ossicular prosthesis	SIGN	Traumatic fracture of the stapes occurs rarely following head injury. Ossicular dislocation is more commonly encountered. When present, stapes fractures are usually associated with an underlying temporal bone fracture. A higher incidence has been reported in childhood, possibly because of the greater flexibility of the skull in this age group. This report highlights the fact that these fractures can be associated with a relatively minor head injury. This possibility should be kept in mind when evaluating patients, especially children, who have a persistent conductive deafness of more than 30 dB with an intact tympanic membrane following any form of head injury. An exploratory tympanotomy with appropriate ossicular reconstruction, as described in this case, can yield excellent results.	Queens Hosp, Dept Otolaryngol Head & Neck Surg, Burton Upon Trent, Staffs, England		Salib, RJ (corresponding author), 3 Stephenson Way,Hedge End, Southampton SO30 2WR, Hants, England.						Demaldent J E, 1984, Ann Otolaryngol Chir Cervicofac, V101, P467; DOES IES, 1965, ARCHIV OTOLARYNGOL, V82, P331; ELBROND O, 1960, ACTA OTOLARYNGOL, V51, P469; HAMMOND VT, 1980, J LARYNGOL OTOL, V94, P117, DOI 10.1017/S0022215100088551; HOUGH JVD, 1968, LARYNGOSCOPE, V78, P899, DOI 10.1288/00005537-196806000-00003; Li STT, 2000, AM J ROENTGENOL, V174, P1296, DOI 10.2214/ajr.174.5.1741296; LOURENCO MTC, 1995, AM J OTOL, V16, P387; MAFEE MF, 1984, AM J OTOL, V5, P374; Meriot P, 1997, RADIOGRAPHICS, V17, P1445, DOI 10.1148/radiographics.17.6.9397457; Swartz JD, 1998, RADIOL CLIN N AM, V36, P819, DOI 10.1016/S0033-8389(05)70066-X	10	14	16	0	3	HEADLEY BROTHERS LTD	ASHFORD	INVICTA PRESS, ASHFORD TN24 8HH, KENT, ENGLAND	0022-2151			J LARYNGOL OTOL	J. Laryngol. Otol.	JUN	2002	116	6					457	459		10.1258/0022215021911068			3	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	579CU	WOS:000177159500013	12385361				2022-02-06	
J	Elgafy, H; Ebraheim, NA; Shaheen, PE; Yeasting, RA				Elgafy, H; Ebraheim, NA; Shaheen, PE; Yeasting, RA			Extensor hallucis longus innervation - An anatomic study	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article								Thirty legs from skeletally mature embalmed cadavers were dissected to define the most common pattern and the variants of innervation of the extensor hallucis longus muscle and its clinical significance. Twenty-seven muscles had only one innervating branch (90%). Only three muscles had two innervating branches (10%). Twenty-one of the branches entered the muscles from the fibular side (63.6%), six entered the muscles from the tibial side (18.2%), and six entered the muscles from the anterior edge (18.2%). The branches innervating the extensor hallucis longus from the fibular side had a closer relation with the fibular periosteum than those entering the muscle from the tibial side or the anterior edge. The mean length of these branches between their points of origin and entry in the extensor hallucis longus was 5.0 +/- 1.5 cm. The high risk zone for the iatrogenic injury to the muscular branch of the extensor hallucis longus was located between 5.9 +/- 1.7 and 10.9 +/- 1.7 cm inferior to the most distal palpable point of the fibular head. The current study confirmed that the extensor hallucis longus was supplied mostly by one nerve that usually entered the muscle from the fibular side and had a close relation to the fibular periosteum in the dangerous zone.	Med Coll Ohio, Dept Orthopaed Surg, Toledo, OH 43614 USA; Med Coll Ohio, Dept Anat, Toledo, OH 43614 USA		Ebraheim, NA (corresponding author), Med Coll Ohio, Dept Orthopaed Surg, Dowling Hall 3065 Arlington Ave, Toledo, OH 43614 USA.						Aydogdu S, 1996, Acta Orthop Belg, V62, P156; GARLAND DE, 1979, CLIN ORTHOP RELAT R, P169; GIBSON MJ, 1986, J BONE JOINT SURG BR, V68, P471, DOI 10.1302/0301-620X.68B3.3733817; KIRGIS A, 1992, J BONE JOINT SURG AM, V74A, P1180, DOI 10.2106/00004623-199274080-00007; Loredo R, 1998, J COMPUT ASSIST TOMO, V22, P925, DOI 10.1097/00004728-199811000-00017; NAUMANN T, 1987, ORTHOP PRAX, V23, P466; PIGOTT T J D, 1991, British Journal of Neurosurgery, V5, P7, DOI 10.3109/02688699108998440; ROMANES GJ, 1972, PERIPHERAL NERVOUS S, P766; Satku K, 1992, Ann Acad Med Singap, V21, P222; STITGEN SH, 1992, CLIN ORTHOP RELAT R, P134; WILLIAMS PL, 1989, COMMON PERONEAL NERV, P1148	11	14	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	MAY	2002		398					245	251					7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	549FJ	WOS:000175433600035	11964657				2022-02-06	
J	Beers, SR; De Bellis, MD				Beers, SR; De Bellis, MD			Outcomes of child abuse	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NONACCIDENTAL HEAD-INJURY; SEXUAL-ABUSE; INFANTS; DIAGNOSIS	The rate of intentional injury to younger children has increased over the past decade. This article discusses the outcomes of inflicted traumatic brain injury during infancy and early childhood. We discuss both the short and long term effects of injury. A post-traumatic stress disorder model is proposed as a way of integrating both physical and psychological effects of trauma occurring in younger children, We discuss results of studies that suggest that there may be a synergistic interaction between sequelae of inflicted traumatic brain injury and physiological changes associated with chronic stress.	Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dev Traumatol Neuroimaging Lab, Pittsburgh, PA 15213 USA		Beers, SR (corresponding author), Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dept Psychiat, 3811 OHara St, Pittsburgh, PA 15213 USA.	beerssr@msx.upmc.edu			NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [5 K08 MHO 1324-02] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH001324] Funding Source: NIH RePORTER		American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Beers SR, 2002, AM J PSYCHIAT, V159, P483, DOI 10.1176/appi.ajp.159.3.483; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; *COMM CHILD AB NEG, 1993, AM ACAD PEDIAT, V92, P872; Conway EE, 1998, PEDIATR ANN, V27, P677, DOI 10.3928/0090-4481-19981001-11; De Bellis MD, 2000, AM J PSYCHIAT, V157, P1175, DOI 10.1176/appi.ajp.157.7.1175; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Bellis MD, 2001, DEV PSYCHOPATHOL, V13, P539, DOI 10.1017/S0954579401003078; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; Dubner AE, 1999, J CONSULT CLIN PSYCH, V67, P367, DOI 10.1037/0022-006X.67.3.367; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; FAMULARO R, 1994, CHILD ABUSE NEGLECT, V18, P27, DOI 10.1016/0145-2134(94)90093-0; Fulton D R, 2000, Crit Care Nurs Q, V23, P43; GREEN A, 1985, CHILDREN TRAUMATIZED; Hersen M, 1997, HDB PREVENTION TREAT, P455; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; *NAT RES OCUNC, 1993, UND AB NEGL; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; PRICHARD JW, 1996, MR SPECTROSCOPY CLIN, P1; PYNOOS RS, 1985, WITNESSING ACTS PERS; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; SBALCHIERO J, 2000, ANN EMERG MED, V36, pS48; SCHEERINGA MS, 1995, J AM ACAD CHILD PSY, V34, P191, DOI 10.1097/00004583-199502000-00014; Sedlak A.J, 1996, 3 NATL INCIDENCE STU; Shin LM, 1999, AM J PSYCHIAT, V156, P575; SINAL SH, 1987, SOUTHERN MED J, V80, P1505, DOI 10.1097/00007611-198712000-00006; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; U.S. DEP'T OF HEALTH & HUMAN SERVS, 1998, CHILD MALTR 1996 REP; *US DEP HHS, 1999, CHLD MALTR 1997 REP	38	14	14	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	APR	2002	13	2					235	+	PII S1042-3680(01)00003-1	10.1016/S1042-3680(01)00003-1			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	573HM	WOS:000176823500009	12391707				2022-02-06	
J	Eng, JJ; Rowe, SJ; McLaren, LM				Eng, JJ; Rowe, SJ; McLaren, LM			Mobility status during inpatient rehabilitation: A comparison of patients with stroke and traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; outcome assessment (health care); rehabilitation	OUTCOMES; LENGTH; STAY; POSTSTROKE; AGE; DISABILITY; PREDICTION; RECOVERY; CHARGES; MOTOR	Objectives: To compare the mobility status (admission and discharge status, change in status) between patients with stroke and traumatic brain injury (TBI) during inpatient rehabilitation and to determine the relationship between mobility status and outcome variables including length of stay (LOS). Design: Prospective study. Setting: Free-standing tertiary rehabilitation center. Participants: A total of 210 patients with stroke (n = 136) and TBI (n = 74) consecutively admitted for inpatient rehabilitation. Interventions: Not applicable. Main Outcome Measures: Clinical Outcome Variable Scale (COVS), a 13-item scale of mobility status (measured on admission and discharge from inpatient rehabilitation), and rehabilitation LOS. Results: With age and time since injury controlled in the model, the TBI group showed a significantly higher mobility status on admission and discharge over the stroke group, but the change (improvement) in mobility status did not differ. The admission mobility status accounted for 61% and 60% of variability of the discharge mobility status for the stroke and TBI groups, respectively. The admission mobility status accounted for 40% and 50% of the variability in rehabilitation LOS for the stroke and TBI groups, respectively. Either the admission mobility status or the physical therapist's prediction of the discharge status could be used to determine the actual discharge mobility status, although the physical therapist's predictions were more accurate than using a statistical model. Conclusions: The TBI group showed a higher mobility status at admission and discharge from inpatient rehabilitation than the stroke group; however, the rate of improvement (improvement in mobility status per day) did not differ between groups. Admission mobility status using the COVS was an excellent predictor of discharge mobility status and rehabilitation LOS in stroke and TBI patients.	Univ British Columbia, Sch Rehabil Sci, Vancouver, BC VT6 2B5, Canada; Gf Strong Rehab Ctr, Rehabil Res Lab, Vancouver, BC, Canada; Gf Strong Rehab Ctr, Acquired Brain Injury Program, Vancouver, BC, Canada		Eng, JJ (corresponding author), Univ British Columbia, Sch Rehabil Sci, T325-2211 Wesbrook Mall, Vancouver, BC VT6 2B5, Canada.			Eng, Janice/0000-0002-2093-0788	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [57862] Funding Source: Medline		Brock K, 1997, J Qual Clin Pract, V17, P37; Brosseau L, 1996, AM J PHYS MED REHAB, V75, P422, DOI 10.1097/00002060-199611000-00005; Brosseau L, 1996, AM J PHYS MED REHAB, V75, P431, DOI 10.1097/00002060-199611000-00006; CAREY RG, 1988, ARCH PHYS MED REHAB, V69, P337; CHAE J, 1995, AM J PHYS MED REHAB, V74, P218, DOI 10.1097/00002060-199505000-00007; CHANG WC, 1995, ARCH PHYS MED REHAB, V76, P934, DOI 10.1016/S0003-9993(95)80070-0; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Duncan P, 1989, DUKE MOBILITY SKILLS; Franchignoni F, 1998, Ann Ist Super Sanita, V34, P463; Freeman JA, 1996, DISABIL REHABIL, V18, P106, DOI 10.3109/09638289609166025; GRANGER CV, 1992, STROKE, V23, P978, DOI 10.1161/01.STR.23.7.978; Harvey RL, 1998, ARCH PHYS MED REHAB, V79, P1349, DOI 10.1016/S0003-9993(98)90226-X; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; HEINEMANN AW, 1987, ARCH NEUROL-CHICAGO, V44, P167; Heinemann AW, 1990, J NEUROL REHABIL, V4, P27; HERTANU JS, 1984, ARCH PHYS MED REHAB, V65, P505; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; *I REH RES DEV, 1999, COVS PHYS CLIN OUTC; JONGBLOED L, 1986, STROKE, V17, P765, DOI 10.1161/01.STR.17.4.765; JONGBLOED L, 1988, CAN J REHABIL, V2, P87; Juneja G, 1998, AM J PHYS MED REHAB, V77, P388, DOI 10.1097/00002060-199809000-00005; KALRA L, 1994, STROKE, V25, P346, DOI 10.1161/01.STR.25.2.346; Kleinbaum DG, 1998, APPL REGRESSION ANAL, V3rd; KORNERBITENSKY N, 1989, ARCH PHYS MED REHAB, V70, P95; MAYO NE, 1991, AM J PHYS MED REHAB, V70, P5, DOI 10.1097/00002060-199102000-00003; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; NAKAYAMA H, 1994, STROKE, V25, P808, DOI 10.1161/01.STR.25.4.808; Prudham D, 1981, Age Ageing, V10, P141; Reeder KP, 1996, J HEAD TRAUMA REHAB, V11, P22, DOI 10.1097/00001199-199606000-00006; Sakari-Rantala R, 1998, SCAND J REHABIL MED, V30, P121; SEABY L, 1989, Physiotherapy Canada, V41, P264; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; STINEMAN MG, 1994, MED CARE, V32, P366, DOI 10.1097/00005650-199404000-00005; STINEMAN MG, 1990, ARCH PHYS MED REHAB, V71, P881; TAPPING C, 1981, ASSESSMENT QUALITY C, V2; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; Wade D T, 1987, Int Rehabil Med, V8, P129; WRIGHT BD, 1989, ARCH PHYS MED REHAB, V70, P857	39	14	14	0	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2002	83	4					483	490		10.1053/apmr.2002.31203			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	538DF	WOS:000174798300007	11932849	Green Accepted			2022-02-06	
J	Ruppel, RA; Clark, RSB; Bayir, H; Satchell, MA; Kochanek, PM				Ruppel, RA; Clark, RSB; Bayir, H; Satchell, MA; Kochanek, PM			Critical mechanisms of secondary damage after inflicted head injury in infants and children	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article							TRAUMATIC BRAIN INJURY; METHYL-D-ASPARTATE; CEREBRAL BLOOD-FLOW; CENTRAL NERVOUS-SYSTEM; PROGRAMMED CELL-DEATH; TUMOR-NECROSIS-FACTOR; SHAKEN BABY SYNDROME; NEONATAL RAT-BRAIN; CEREBROSPINAL-FLUID; QUINOLINIC ACID	A number of critical mechanisms are involved in the pathophysiology of inflicted head injury. Excitotoxicity, oxidative stress, inflammation, programmed cell death, and mediators of blood flow and metabolism all contribute to secondary injury after abusive head trauma. These mechanisms are reviewed and the implications for clinical practice discussed.	Univ Pittsburgh, Sch Med, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15260 USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Ctr Injury Control & Res, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15213 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Anesthesiol & Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@anes.upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30318, T32-NS07485-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, P20NS030318, P01NS030318] Funding Source: NIH RePORTER		Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bayir H, 2000, CRIT CARE MED, V28, pA52; BAYIR H, 2001, SOC NEUR ABSTR, V27; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Bell MJ, 2001, CRIT CARE MED, V29, P399, DOI 10.1097/00003246-200102000-00033; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bergeron M, 2000, ANN NEUROL, V48, P285, DOI 10.1002/1531-8249(200009)48:3<285::AID-ANA2>3.3.CO;2-#; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; Cheema ZF, 1999, J NEUROSCI, V19, P1754; Chen J, 1997, NEUROLOGY, V48, P306, DOI 10.1212/WNL.48.2.306; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Clark RSB, 1997, NEUROSURGERY, V41, P1284, DOI 10.1097/00006123-199712000-00010; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Currie RW, 2000, BRAIN RES, V863, P169, DOI 10.1016/S0006-8993(00)02133-8; Duhaime A.C., 1993, J NEUROTRAUM, V10, pS59; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; GIDDAY JM, 1994, NEUROSCI LETT, V168, P221, DOI 10.1016/0304-3940(94)90455-3; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Gorgias N, 1996, BRAIN RES, V714, P215, DOI 10.1016/0006-8993(95)01548-5; Goss JR, 1997, EXP NEUROL, V146, P291, DOI 10.1006/exnr.1997.6515; Han YY, 1999, CRIT CARE MED, V27, pA75, DOI 10.1097/00003246-199912001-00184; HEURTEAUX C, 1995, P NATL ACAD SCI USA, V92, P4666, DOI 10.1073/pnas.92.10.4666; HEYES MP, 1993, BIOCHEM SOC T, V21, P83, DOI 10.1042/bst0210083; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Janesko K. L., 2000, Journal of Neurotrauma, V17, P956; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Jones NM, 2001, J CEREBR BLOOD F MET, V21, P1105, DOI 10.1097/00004647-200109000-00008; KATO H, 1992, NEUROSCI LETT, V139, P118, DOI 10.1016/0304-3940(92)90871-4; KATO N, 1993, P NATL ACAD SCI USA, V90, P7114, DOI 10.1073/pnas.90.15.7114; KITAGAWA K, 1990, BRAIN RES, V528, P21, DOI 10.1016/0006-8993(90)90189-I; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; KOCHANEK PM, 2001, TRAUMATIC CNS INJURY, P251; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; MARINI AM, 1992, P NATL ACAD SCI USA, V89, P6555, DOI 10.1073/pnas.89.14.6555; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; Perez-Pinzon MA, 1999, NEUROREPORT, V10, P2951, DOI 10.1097/00001756-199909290-00014; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; PorteraCailliau C, 1997, J COMP NEUROL, V378, P70; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; ROBERTSON CL, 1999, J NEUROTRAUM, V16, P975; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Ruppel RA, 1999, CRIT CARE MED, V27, pA76, DOI 10.1097/00003246-199912001-00188; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; SANCHEZRODRIGUEZ VF, 1995, AM J FOREN MED PATH, V16, P210, DOI 10.1097/00000433-199509000-00004; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Smith SL, 1998, J NEUROTRAUM, V15, P693, DOI 10.1089/neu.1998.15.693; Smith SL, 1998, J NEUROTRAUM, V15, P707, DOI 10.1089/neu.1998.15.707; SPECTOR R, 1984, FED PROC, V43, P196; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; Xiao F, 2000, NEUROSCI LETT, V285, P5, DOI 10.1016/S0304-3940(00)00997-6; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538; Zhong J, 1996, MOL PHARMACOL, V50, P631	86	14	14	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	APR	2002	13	2					169	+	PII S1042-3680(01)00005-5	10.1016/S1042-3680(01)00005-5			19	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	573HM	WOS:000176823500004	12391702				2022-02-06	
J	Schlund, MW				Schlund, MW			The effects of brain injury on choice and sensitivity to remote consequences: deficits in discriminating response-consequence relations	BRAIN INJURY			English	Article							ANTICIPATORY BEHAVIOR DEFICITS; CLOSED-HEAD-INJURY; PREFRONTAL CORTEX; LESIONS; DAMAGE	Primary objective: One characteristic of some decision-making deficits is a failure to respond adaptively to consequences that follow choices. This investigation examined the sensitivity of choice to remote consequences with a high overall reinforcement rate and proximal consequences with a low overall reinforcement rate. Methods: Three control and three subjects with brain injury made repeated choices between two reinforcement schedules: a fixed time schedule (FT) that delayed reinforcement by 12 seconds, and a progressive time schedule (PT) that progressively increased reinforcement delay by 2 seconds with each consecutive choice and reset to 0 seconds with each choice of the fixed schedule. Switching to the FT schedule at PT 6 seconds maximized overall reinforcement rate. Results: Subjects with brain injury were less sensitive to contingencies and earned less reinforcement relative to controls because switching occurred at lengthy PT delays (delays far exceeding 6 seconds). Conclusions: Some deficits in decision-making and adaptation following injury may reflect a reduction in sensitivity to contingencies.	Kennedy Krieger Inst, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA		Schlund, MW (corresponding author), Kennedy Krieger Inst, 333 Cassell Dr,Triad Technol Bldg Suite 4200, Baltimore, MD 21224 USA.	schlund@kennedykrieger.org					Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BLEIBERG J, 1985, INT J CLIN NEUROPSYC, V7, P153; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; FINDLEY JD, 1958, J EXP ANAL BEHAV, V1, P123, DOI 10.1901/jeab.1958.1-123; FREEDMAN PE, 1987, J NEUROL NEUROSUR PS, V50, P398, DOI 10.1136/jnnp.50.4.398; Hackenberg T. D., 1998, HDB RES METHODS HUMA, P541; Heaton PDRK., 1993, WISCONSIN CARD SORTI; HINELINE PN, 1987, QUANTITATIVE ANAL BE, V5, P141; HODOS W, 1967, J EXP ANAL BEHAV, V10, P503, DOI 10.1901/jeab.1967.10-503; Jacobs EA, 1996, J EXP ANAL BEHAV, V65, P5, DOI 10.1901/jeab.1996.65-5; KOSMIDIS MH, 1995, J CLIN EXP NEUROPSYC, V17, P622, DOI 10.1080/01688639508405150; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; *NO CA NEUR GROUP, 1995, MAN COGN; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Schlund MW, 2001, BRAIN INJURY, V15, P1061, DOI 10.1080/02699050110086887; Schlund MW, 2000, BRAIN INJURY, V14, P573, DOI 10.1080/026990500120475; Schlund MW, 2000, BEHAV INTERVENT, V15, P155, DOI 10.1002/1099-078X(200007/09)15:3<155::AID-BIN53>3.0.CO;2-F; SCHLUND MW, IN PRESS BRAIN INJUR; SHALLICE T, 1993, ATTENTION SELECTION, P00171; WANCHISEN BA, 1988, J EXP ANAL BEHAV, V50, P375, DOI 10.1901/jeab.1988.50-375	23	14	14	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2002	16	4					347	357		10.1080/02699050110103977			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	541CM	WOS:000174967700006	11953005				2022-02-06	
J	Stoffel, M; Plesnila, N; Eriskat, J; Furst, M; Baethmann, A				Stoffel, M; Plesnila, N; Eriskat, J; Furst, M; Baethmann, A			Release of excitatory amino acids in the penumbra of a focal cortical necrosis	JOURNAL OF NEUROTRAUMA			English	Article						aspartate; glutamate; microdialysis; penumbra; rats; secondary necrosis growth; traumatic brain injury	TRAUMATIC BRAIN INJURY; RAT HIPPOCAMPUS; INTRACEREBRAL MICRODIALYSIS; GLUTAMATE RELEASE; IMPACT INJURY; L-ARGININE; EDEMA; ISCHEMIA; DAMAGE; INVIVO	A cortical tissue necrosis from focal trauma expands between 30% and 300% from its initial size within 24 h, depending on the species studied. To shed light on the pathophysiological processes in the penumbra 1 zone after a focal cortical lesion, the release of excitatory amino acids into the traumatic penumbra zone 1 was measured throughout the entire period of necrosis expansion. A microdialysis probe was inserted at an oblique angle into the cortex of Sprague-Dawley rats 2 mm below the brain surface. One day later, a highly standardized cortical freezing lesion was induced at the brain cortex above the microdialysis probe. Dialysate was continuously collected prior to, during, and up to 24 h after trauma and analyzed for primary amino acids. In each animal, it was confirmed histologically that the tip of the microdialysis probe was localized in the gray matter in close proximity to the primary lesion. Following induction of the trauma, a statistically significant sharp increase of the dialysate level of aspartate, glutamate, glycine, and serine was observed. Thereafter, the dialysate levels of these amino acids returned to baseline levels without any further increase throughout the remaining observation period. This process ranged in time from a few minutes to a few hours. The level of alanine in the dialysate was essentially not altered throughout the experiment. Although the early post-traumatic increase of the excitatory neurotransmitters aspartate and glutamate may well contribute to the secondary lesion growth of a cortical necrosis after trauma, glutamate receptor targeted therapeutic intervention may be in view of these findings of limited use when initiated post trauma.	Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany; Univ Munich, Klinikum Grosshadern, Inst Surg Res, D-8000 Munich, Germany		Stoffel, M (corresponding author), Univ Bonn, Dept Neurosurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.	michael.stoffel@ukb.uni-bonn.de	Plesnila, Nikolaus/T-7522-2019				Attwell D, 2000, J NUTR, V130, p1023S, DOI 10.1093/jn/130.4.1023S; BAETHMANN A, 1988, CRIT CARE MED, V16, P972, DOI 10.1097/00003246-198810000-00008; BAETHMANN A, 1989, J NEUROSURG, V70, P578, DOI 10.3171/jns.1989.70.4.0578; BAETHMANN A, 1990, ACT NEUR S, V50, P14; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; BENVENISTE H, 1989, J NEUROCHEM, V52, P1741, DOI 10.1111/j.1471-4159.1989.tb07252.x; BENVENISTE H, 1989, J NEUROCHEM, V52, P1667, DOI 10.1111/j.1471-4159.1989.tb07243.x; BENVENISTE H, 1987, ACTA NEUROPATHOL, V74, P234, DOI 10.1007/BF00688186; BONDOLI A, 1981, RESUSCITATION, V9, P119, DOI 10.1016/0300-9572(81)90021-6; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; CHOI DW, 1990, CEREBROVAS BRAIN MET, V2, P105; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; DALKARA T, 1992, BRAIN RES, V576, P197, DOI 10.1016/0006-8993(92)90680-8; DANBOLT NC, 1993, GLUTAMATE TRANSMITTE, P12; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DREJER J, 1985, J NEUROCHEM, V45, P145, DOI 10.1111/j.1471-4159.1985.tb05486.x; EGGERT HR, 1985, NEUROSURGERY, V16, P443, DOI 10.1227/00006123-198504000-00001; ERISKAT J, 1994, ACTA NEUROCHIR, P425; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gagliardi RJ, 2000, ARQ NEURO-PSIQUIAT, V58, P583, DOI 10.1590/S0004-282X2000000300030; GAUCHY C, 1980, BRAIN RES, V193, P129, DOI 10.1016/0006-8993(80)90950-6; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; HALL ED, 1993, RES P ARNMD, V71, P81; HAMBERGER AC, 1979, BRAIN RES, V168, P513, DOI 10.1016/0006-8993(79)90306-8; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; JACOBSON I, 1985, J NEUROSCI METH, V15, P263, DOI 10.1016/0165-0270(85)90107-4; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KEHR J, 1993, J NEUROSCI METH, V48, P251, DOI 10.1016/0165-0270(93)90096-A; KEMPSKI OS, 1994, ANAESTHESIST, V43, pS25; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; Koura SS, 1998, ACT NEUR S, V71, P244; LANGE KW, 1993, GLUTAMATE TRANSMITTE, P30; LINDROTH P, 1979, ANAL CHEM, V51, P1667, DOI 10.1021/ac50047a019; LINDSBERG PJ, 1991, J CEREBR BLOOD F MET, V11, P88, DOI 10.1038/jcbfm.1991.10; MAIERHAUFF K, 1984, RECENT PROGR STUDY T, P183; MARCOUX FW, 1993, GLUTAMATE TRANSMITTE, P76; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; MCBRIDE WJ, 1973, J NEUROBIOL, V4, P557, DOI 10.1002/neu.480040608; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; MURDOCH J, 1990, CAN J ANAESTH, V37, P663, DOI 10.1007/BF03006487; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OLNEY JW, 1993, GLUTAMATE TRANSMITTE, P3; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PLESNILA N, 1997, J CEREB BLOOD FLOW M, V17, pS73; POLITI LE, 1985, NEUROCHEM PATHOL, V3, P249; PUMAIN R, 1985, J NEUROPHYSIOL, V53, P1; ROTHMAN SM, 1985, J NEUROSCI, V5, P1483; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SMITH SE, 1995, STROKE, V26, P117, DOI 10.1161/01.STR.26.1.117; Stoffel M, 2001, J NEUROTRAUM, V18, P425, DOI 10.1089/089771501750171010; Stover JF, 2000, BRAIN RES, V875, P51, DOI 10.1016/S0006-8993(00)02597-X; Unterberg AW, 1997, ACT NEUR S, V70, P106; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; VONHOF S, 1997, THESIS L MAXIMILIANS; WIELOCH T, 1985, PROG BRAIN RES, V63, P69; WYRWICH W, 1997, THESIS L MAXIMILIANS; XUE D, 1994, J CEREBR BLOOD F MET, V14, P251, DOI 10.1038/jcbfm.1994.32; YOUNG AMJ, 1986, J NEUROCHEM, V47, P1399, DOI 10.1111/j.1471-4159.1986.tb00771.x	61	14	17	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2002	19	4					467	477		10.1089/08977150252932415			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	542XP	WOS:000175071200007	11990352				2022-02-06	
J	Rosati, DL				Rosati, DL			Early polyneuropharmacologic rehabilitation, a division of UB intervention in brain injury agitation	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						brain injury; agitation; treatment	PATIENT	Objective: To evaluate clinical outcomes observed in the treatment of posttraumatic brain injury agitation with multiple medications. Design: Longitudinal evaluation of effect of treatment intervention on patients admitted to a level 1 trauma center with traumatic brain injury. Eleven adult patients referred for physiatry consultation to manage posttraumatic brain injury agitation were treated with a combination of medications and other agents (antipsychotics and sedatives) were discontinued. The Rancho Los Amigos scale was rated on initial consultation and follow-up, ranging from 1 to 3 wk. Results: All 11 patients demonstrated an average improvement of three Rancho Los Amigos levels within an average treatment duration of 10 days. Simultaneously, 9 of 11 patients were discontinued from treatment and prescribed antipsychotic and sedative agents. Conclusions: The findings suggest that administration of multiple neuropharmacologic agents used early in the treatment of posttraumatic brain injury agitation may be an effective therapeutic intervention in which behavioral and, possibly, cognitive benefits occur. These results were noted as patients were discontinued from other agents more commonly employed in the acute care setting for the treatment of posttraumatic brain injury agitation. Further research is needed to determine the most effective medication combinations and the best time to initiate treatment.	Hosp Special Care, Dept Phys Med & Rehabil, New Britain, CT 06053 USA; Hartford Hosp, Dept Emergency Med Traumatol & Rehabil, Hartford, CT 06115 USA		Rosati, DL (corresponding author), Hosp Special Care, Dept Phys Med & Rehabil, 2150 Corbin Ave, New Britain, CT 06053 USA.						CARDENAS DD, 1992, PHYS MED REH CLIN N, V3, P273; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; WIERCISIEWSKI DR, 1997, PHYS MED REHABIL CLI, V8, P763	6	14	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	FEB	2002	81	2					90	93		10.1097/00002060-200202000-00003			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	515GJ	WOS:000173486800003	11807342				2022-02-06	
J	Banks, ME; Ackerman, RJ				Banks, ME; Ackerman, RJ			Head and brain injuries experienced by African American women victims of intimate partner violence	WOMEN & THERAPY			English	Article						blacks; head injury; traumatic brain injury; battered women; rehabilitation; neuropsychology	DOMESTIC VIOLENCE; BATTERED WOMEN; REHABILITATION; MRI	Regardless of ethnicity, traumatic brain injury (TBI) is one of the most serious, prevalent, and often undiagnosed results of intimate partner violence. Greater severity of violence, coupled with inadequate health care, places battered African American women at increased risk for head injuries. Accordingly, we review the symptoms associated with head injuries in battered women, with a focus on the experiences of Black women. A case study is used to illustrate rehabilitation and treatment options. Assessment was conducted using the Ackerman-Banks Neuropsychological Rehabilitation Battery. Neuropsychological assessment is recommended, as well as culturally relevant and multidisciplinary treatment strategies that can empower clients. (C) 2002 by The Haworth Press, Inc. All. rights reserved.	ABackans DCP Inc, Res Div, Akron, OH 44313 USA; ABackans DCP Inc, Res & Dev Div, Akron, OH 44313 USA		Banks, ME (corresponding author), ABackans DCP Inc, Res Div, 1700 W Market St,Dept RD 301, Akron, OH 44313 USA.		Banks, Martha/AAB-2391-2021	Banks, Martha/0000-0002-5367-2076			ACKERMAN RJ, IN PRESS WOMEN THERA; ACKERMAN RJ, 2000, ACKERMAN BANKS NEURO; ASBURY CA, 1994, REHABIL PSYCHOL, V39, P113, DOI 10.1037/h0080314; BANKS ME, 1997, POST ASSAULT TRAUMAT; BANKS ME, 1995, VARIATIONS THEME DIV, P29; Deering C, 2001, PERCEPT MOTOR SKILL, V92, P682; Diaz-Olavarrieta C, 1999, ARCH NEUROL-CHICAGO, V56, P681, DOI 10.1001/archneur.56.6.681; Donnelly D.A., 1999, VIOLENCE AGAINST WOM, V5, P710; Grisso JA, 1999, NEW ENGL J MED, V341, P1899, DOI 10.1056/NEJM199912163412506; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Jenkins EJ, 2002, WOMEN THER, V25, P29, DOI 10.1300/J015v25n03_03; JOHNSON LD, 1998, LAW PSYCHOL REV, V22, P271; Kyriacou DN, 1999, NEW ENGL J MED, V341, P1892, DOI 10.1056/NEJM199912163412505; Mahon D, 1989, J Neurosci Nurs, V21, P382; Mahoney P., 2001, SOURCEBOOK VIOLENCE, P143; MALEC JF, 1996, ARCH PHYSICAL MED RE, V77, P149; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McNutt LA, 2000, AM J PREV MED, V19, P264, DOI 10.1016/S0749-3797(00)00233-6; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Muelleman RL, 1996, ANN EMERG MED, V28, P486, DOI 10.1016/S0196-0644(96)70110-5; NABORS NA, IN PRESS WOMEN THERA; ODEN TM, 2001, DISS ABSTR INT, V61; ONEAL J, 1992, HEADLINES, V3, P5; Perciaccante VJ, 1999, J ORAL MAXIL SURG, V57, P760, DOI 10.1016/S0278-2391(99)90808-X; Uswatte G, 1997, REHABIL PSYCHOL, V42, P61, DOI 10.1037/0090-5550.42.1.61; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Voller B, 2001, BRAIN INJURY, V15, P107, DOI 10.1080/026990501458344; Wadman MC, 1999, AM J EMERG MED, V17, P689, DOI 10.1016/S0735-6757(99)90161-4; WHITE E, 1994, CHAIN CHAIN CHANGE B	29	14	14	0	8	HAWORTH PRESS INC	BINGHAMTON	10 ALICE ST, BINGHAMTON, NY 13904-1580 USA	0270-3149			WOMEN THER	Women Ther.		2002	25	3-4					133	143		10.1300/J015v25n03_10			11	Psychology, Multidisciplinary; Women's Studies	Social Science Citation Index (SSCI)	Psychology; Women's Studies	620YY	WOS:000179562800010					2022-02-06	
J	Johnson, PD; Hertel, J; Olmsted, LC; Denegar, CR; Putukian, M				Johnson, PD; Hertel, J; Olmsted, LC; Denegar, CR; Putukian, M			Effect of mild brain injury on an instrumented agility task	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						cerebral concussion; Postconcussion syndrome; functional assessment	MINOR HEAD-INJURIES; CEREBRAL CONCUSSION; CONTACT-SPORTS; PREVENTION; SEQUELAE; GUIDELINES; MANAGEMENT; RETURN	Objective: To identify an objective evaluation technique to guide return-to-play decisions following mild brain injury (MBI) using an agility task that incorporates cognitive and motor performance. Design: Prospective, controlled, repeated measures study. Setting: Collegiate athletic training facility. Participants: 84 athletes (25 male rugby players, 34 female rugby players, 25 male ice hockey players) from 3 intercollegiate club teams participated. 9 athletes who suffered MBI during their competitive seasons and 9 matched controls completed the entire study protocol. Main Outcome Measures: Time to complete an agility task on the Cybex Reactor and a postconcussive symptoms scale score were assessed in all subjects during the preseason. Injured subjects and matched controls were also assessed 1, 3. 5. and 10 days postinjury. Results: Repeated measures analyses of variance revealed significant differences between injured Subjects and controls in postconcussion symptoms, but not agility performance. Post hoc testing revealed that injured Subjects reported significantly more postconcussion symptoms on Day I after injury. Conclusion: The methods of agility assessment used in this study appear to not be sensitive enough to detect functional impairment following MBI.	Penn State Univ, Dept Kinesiol, Athlet Training Res Lab, University Pk, PA 16802 USA; Penn State Univ, Ctr Orthoped & Sports Med, University Pk, PA 16802 USA		Hertel, J (corresponding author), Penn State Univ, Dept Kinesiol, Athlet Training Res Lab, 269 Recreat Bldg, University Pk, PA 16802 USA.		denegar, craig/AAX-7373-2020				[Anonymous], 1991, COL MED SOC REP SPOR; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; CANTU RC, 1988, SPORTS MED DIGEST, V10, P1; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; GUSKIEWICZ KM, 1997, MED SCI SPORTS EXERC, V29, P213; Hertel J, 1999, J SPORT REHABIL, V8, P24, DOI 10.1123/jsr.8.1.24; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LOVELL MR, 1998, SPORTS RELATED CONCU; Macciocchi SN, 1998, CLIN SPORT MED, V17, P27, DOI 10.1016/S0278-5919(05)70058-2; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; MCQUILLEN JB, 1988, AM J FOREN MED PATH, V9, P12, DOI 10.1097/00000433-198803000-00004; NELSON W, 1984, ATHL TRAIN JNATA, V19, P95; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; Putukian M, 1996, PHYSICIAN SPORTSMED, V24, P25, DOI 10.3810/psm.1996.11.1283; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; TORG JS, 1987, CLIN SPORTS MED, V6, P17; TORG JS, 1985, JAMA-J AM MED ASSOC, V254, P3429; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1; WILBERGER JE, 1993, SPORTS MED, V15, P338, DOI 10.2165/00007256-199315050-00005	27	14	15	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2002	12	1					12	17		10.1097/00042752-200201000-00006			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	521CA	WOS:000173820100005	11854583				2022-02-06	
J	Ravens-Sieberer, U; Patrick, PD				Ravens-Sieberer, U; Patrick, PD		CHI Consensus Grp	Quality of life in children with traumatic brain injury - basic issues, assessment, and recommendations - Results of a consensus meeting	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article; Proceedings Paper	Consensus Conference on Quality of Life after Multiple Trauma	SEP 29-OCT 02, 1999	WERMELSKIRCHEN, GERMANY	German Minist Educ & Res		children; quality of life; traumatic brain injury; consensus conference	OF-LIFE; CHILDHOOD; ADOLESCENTS; ASTHMA	An international Task Force was convened under the guidance of BMBF Conference so as to review the "State of the art" for measuring quality of life (QoL) in children who have suffered traumatic brain injury (TBI). After expert review of instruments and evaluation of two independent literature reviews this work group established "inclusion criteria" for the review of current tools that could contribute to the measurement of QoL in children with TBI. Six instruments were determined to meet all or most of the criteria required to be used in current clinical practice and research for children with TBI.	Robert Koch Inst, D-13353 Berlin, Germany; Univ Virginia, Kluge Childrens Rehabil Ctr, Childrens Med Ctr, Charlottesville, VA 22903 USA		Ravens-Sieberer, U (corresponding author), Robert Koch Inst, Seestr 10, D-13353 Berlin, Germany.						BARR RD, 1994, INT J ONCOL, V4, P639; BIRD JE, 1990, PSYCHOL HEALTH, V4, P175; Bruil J, 1996, QUALITY LIFE NEWSLET, V13, P9; BULLINGER M, 1991, THEOR SURG, V6, P143; Bullinger M, 1995, PRAX KINDERPSYCHOL K, V44, P391; Bullinger M, 1994, Z GESUNDHEITSPSYCHOL, V2, P64; BULLINGER M, 1991, CONTROLLED CLIN TRIA, V12, P915; CARNEY N, 1999, EVIDENCE REPORT RE S; Christie MJ, 1991, CHILDHOOD ASTHMA QUE; EDELBROCK C, 1986, J CHILD PSYCHOL PSYC, V27, P181, DOI 10.1111/j.1469-7610.1986.tb02329.x; Eiser C, 1996, BRIT J CANCER, V73, P1313, DOI 10.1038/bjc.1996.251; Eiser C, 1997, ARCH DIS CHILD, V77, P350, DOI 10.1136/adc.77.4.350; Guyatt GH, 1997, PEDIATRICS, V99, P165, DOI 10.1542/peds.99.2.165; GUYER B, 1990, AM J DIS CHILD, V144, P649, DOI 10.1001/archpedi.1990.02150300047016; HALEY SM, 1991, PHYS MED REH CLIN N, V2, P689; HARTER S, 1989, CHILDRENS UNDERSTAND, P81; HERJANIC B, 1975, J ABNORM CHILD PSYCH, V3, P41, DOI 10.1007/BF00916029; Juniper EF, 1996, QUAL LIFE RES, V5, P27, DOI 10.1007/BF00435966; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kraus JF, 1987, HEAD INJURY, V2, P1; Landgraf I, 1997, CHILD HLTH QUESTIONN; Landgraf J. M., 1997, DIALOGUES PEDIAT URO, V20, P5; LANDGRAF JM, 1993, 10 AN M HLTH SERV RE; LEWIS CC, 1989, MED CARE S3, V27, P54; Marra CA, 1996, PHARMACOTHERAPY, V16, P879; Mulhern RK, 1990, PSYCHOL ASSESSMENT, V2, P149; MURGIO A, 1999, 3 WORLD C BRAIN INJ; Ravens-Sieberer U, 1998, QUAL LIFE RES, V7, P399, DOI 10.1023/A:1008853819715; RAVENSSIEBERER U, 1998, MED PSYCHOL EINEM SI; RAVENSSIEBERER U, 1998, QUALITY LIFE CHILDRE; Rosenbaum LP, 1996, QUALITY LIFE PHARMAE, P793; Sartorius N, 1987, QUALITY LIFE CANC PA, P1075; Seiffge-Krenke I., 1990, KRANKHEITSVERARBEITU; SIMEONI MC, 1998, 5 ANN C INT SOC QUAL; Simmons R. G., 1987, MOVING ADOLESCENCE I; Spieth LE, 1996, J PEDIATR PSYCHOL, V21, P175, DOI 10.1093/jpepsy/21.2.175; Spilker B, 1990, QUALITY LIFE ASSESSM; STARFIELD B, 1998, MEASURING HLTH RELAT; STEWART AL, 1981, MED CARE, V19, P473, DOI 10.1097/00005650-198105000-00001; VERRIPS GH, 1997, J APPL THER, V1, P357; Ware JE, 1992, MEASURING FUNCTION W	41	14	14	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2002	20	3-4					151	159					9	Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	633MR	WOS:000180287500009	12454363				2022-02-06	
J	van Dijk, KRA; Scherder, EJA; Scheltens, P; Sergeant, JA				van Dijk, KRA; Scherder, EJA; Scheltens, P; Sergeant, JA			Effects of Transcutaneous Electrical Nerve Stimulation (TENS) on non-pain related cognitive and behavioural functioning	REVIEWS IN THE NEUROSCIENCES			English	Article						transcutaneous electrical nerve stimulation; neglect; stroke; Alzheimer's disease; coma	PROBABLE ALZHEIMERS-DISEASE; RANDOMIZED CONTROLLED TRIALS; ANTERIOR CINGULATE CORTEX; LOCUS-COERULEUS; NEGLECT PATIENTS; CEREBRAL ATROPHY; SPINAL PATHWAYS; SENILE DEMENTIA; RAPHE NUCLEUS; NECK MUSCLES	An extensive search through nine electronic bibliographic databases (PubMed, Cochrane Library, Web of Science, ERIC, PsychINFO, Psyndex, Cinahl, Biological Abstracts, Rehab-data) was performed in order to review the effects of Transcutaneous Electrical Nerve Stimulation (TENS) on non-pain related cognitive and behavioural functioning. Eight studies were identified on neglect due to stroke, six studies on Alzheimer's disease (AD), one study on aging, and two studies on coma due to traumatic brain injury. The results of the various studies revealed that TENS has a variety of effects. These consist of enhancement of. somatosensory functioning, visuo-spatial abilities and postural control in neglect, improved memory, affective behaviour and rest-activity rhythm in AD and acceleration of awakening in coma. Effectiveness of TENS is discussed in relation to various stimulation parameters: duration, frequency, pulse width and intensity. It is argued that arousal may underlie the beneficial influence of TENS in various conditions. Finally, suggestions are offered for future research.	Vrije Univ Amsterdam, Dept Clin Neurophysiol, NL-1081 BT Amsterdam, Netherlands; Vrije Univ Amsterdam, Ctr Med, Dept Neurol, Amsterdam, Netherlands			kra.van.dijk@psy.vu.nl	Van Dijk, Koene/G-3317-2012; Scheltens, Philip/AAL-9631-2020	Van Dijk, Koene/0000-0001-6137-4282; Scheltens, Philip/0000-0002-1046-6408			Arendt T, 1997, J NEUROSCI, V17, P516; ASHBY P, 1976, NEUROLOGY, V26, P1145, DOI 10.1212/WNL.26.12.1145; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Blin J, 1997, NEUROIMAGE, V6, P335, DOI 10.1006/nimg.1997.0296; BOBILLIER P, 1976, BRAIN RES, V113, P449, DOI 10.1016/0006-8993(76)90050-0; Braak H, 1996, ACTA NEUROPATHOL, V92, P197, DOI 10.1007/s004010050508; Braak H, 1991, BRAIN PATHOL, V1, P213, DOI 10.1111/j.1750-3639.1991.tb00661.x; BRODY H, 1992, ACTA NEUROL SCAND, V85, P40, DOI 10.1111/j.1600-0404.1992.tb05037.x; BURSTEIN R, 1989, BRAIN RES, V497, P149, DOI 10.1016/0006-8993(89)90981-5; CARPENTER GA, 1993, TRENDS NEUROSCI, V16, P131, DOI 10.1016/0166-2236(93)90118-6; Carrol EN, 2001, ARCH PHYS MED REHAB, V82, P262, DOI 10.1053/apmr.2001.9176; CHENG RSS, 1981, BRAIN RES, V215, P77; COFFEY CE, 1992, NEUROLOGY, V42, P527, DOI 10.1212/WNL.42.3.527; Cohen J., 2013, STAT POWER ANAL BEHA; COLEMAN PD, 1987, NEUROBIOL AGING, V8, P512; Collette F, 1997, HUM BRAIN MAPP, V5, P110, DOI 10.1002/(SICI)1097-0193(1997)5:2<110::AID-HBM4>3.0.CO;2-6; Cooper JB, 1999, BRAIN INJURY, V13, P261, DOI 10.1080/026990599121638; Cummings JL, 1998, AM J GERIAT PSYCHIAT, V6, pS64, DOI 10.1097/00019442-199821001-00009; CUSUMANO S, 1992, ELECTROEN CLIN NEURO, V84, P499, DOI 10.1016/0168-5597(92)90039-E; Davis KD, 1997, J NEUROPHYSIOL, V77, P3370, DOI 10.1152/jn.1997.77.6.3370; DECARLI C, 1994, AM J NEURORADIOL, V15, P689; DELAMONTE SM, 1989, ANN NEUROL, V25, P450, DOI 10.1002/ana.410250506; DURANTI R, 1988, BRAIN RES, V452, P66, DOI 10.1016/0006-8993(88)90009-1; Facco E., 1993, Neurophysiologie Clinique, V23, P237, DOI 10.1016/S0987-7053(05)80233-3; GIESLER GJ, 1994, TRENDS NEUROSCI, V17, P244, DOI 10.1016/0166-2236(94)90007-8; Glanz M, 1996, ARCH PHYS MED REHAB, V77, P549, DOI 10.1016/S0003-9993(96)90293-2; GOUDSMIT E, 1990, NEUROBIOL AGING, V11, P529, DOI 10.1016/0197-4580(90)90114-F; Guariglia C, 1998, CORTEX, V34, P233, DOI 10.1016/S0010-9452(08)70750-0; Guariglia C, 2000, NEUROREPORT, V11, P1945, DOI 10.1097/00001756-200006260-00027; Haroutunian V, 1998, ARCH NEUROL-CHICAGO, V55, P1185, DOI 10.1001/archneur.55.9.1185; Hitoto T, 1998, NEUROCHEM RES, V23, P1461, DOI 10.1007/BF03177488; HOWSON DC, 1978, PHYS THER, V58, P1467, DOI 10.1093/ptj/58.12.1467; Hozumi S, 1996, INT J NEUROSCI, V88, P1; HUBBARD BM, 1981, J NEUROL SCI, V50, P135, DOI 10.1016/0022-510X(81)90048-4; INGVAR DH, 1975, CIBA F S, V34, P97; Johansson BB, 2001, STROKE, V32, P707, DOI 10.1161/01.STR.32.3.707; KARNATH HO, 1995, EXP BRAIN RES, V105, P321; Kayama Y, 1998, EUR UROL, V33, P12, DOI 10.1159/000052235; KLAWANSKY S, 1995, J NERV MENT DIS, V183, P478, DOI 10.1097/00005053-199507000-00010; Kwan CL, 2000, PAIN, V85, P359, DOI 10.1016/S0304-3959(99)00287-0; LEGORATTISANCHEZ MO, 1989, BRAIN RES BULL, V23, P283, DOI 10.1016/0361-9230(89)90210-4; Levy CE, 2001, AM J PHYS MED REHAB, V80, P4, DOI 10.1097/00002060-200101000-00003; LEWINN EB, 1980, ROY SOC HEALTH J, V100, P19, DOI 10.1177/146642408010000107; Limoge A, 1999, NEUROSCI BIOBEHAV R, V23, P529, DOI 10.1016/S0149-7634(98)00048-7; MANN DMA, 1983, MECH AGEING DEV, V23, P73, DOI 10.1016/0047-6374(83)90100-8; MILNE S, 2001, COCHRANE DATABASE SY, V2; MITCHELL S, 1990, Brain Injury, V4, P273, DOI 10.3109/02699059009026177; MOKHA SS, 1985, EXP BRAIN RES, V58, P213; MOORE RY, 1992, PROG BRAIN RES, V93, P101; Mouton PR, 1998, NEUROBIOL AGING, V19, P371, DOI 10.1016/S0197-4580(98)00080-3; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; OMAHONY D, 1994, NEUROLOGY, V44, P2089, DOI 10.1212/WNL.44.11.2089; OMURA Y, 1983, ACUPUNCTURE ELECTRO, V8, P177; Pan CX, 2000, J PAIN SYMPTOM MANAG, V20, P374, DOI 10.1016/S0885-3924(00)00190-1; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Perennou DA, 2001, ARCH PHYS MED REHAB, V82, P440, DOI 10.1053/apmr.2001.21986; PETROV T, 1992, J COMP NEUROL, V318, P18, DOI 10.1002/cne.903180103; PIERCE J P, 1990, Brain Injury, V4, P191, DOI 10.3109/02699059009026165; Pizzamiglio L, 1996, RESTOR NEUROL NEUROS, V10, P197, DOI 10.3233/RNN-1996-10402; Pollak C P, 1991, J Geriatr Psychiatry Neurol, V4, P204, DOI 10.1177/089198879100400405; REGEUR L, 1994, NEUROBIOL AGING, V15, P347, DOI 10.1016/0197-4580(94)90030-2; Richard C, 2001, NEUROSCI LETT, V301, P64, DOI 10.1016/S0304-3940(01)01598-1; Robbins Trevor W., 1995, P703; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; ROCHE P A, 1990, Physiotherapy Theory and Practice, V6, P25, DOI 10.3109/09593989009087753; ROSSOR M, 1988, HDB PSYCHOPHARMACOLO, P107; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; SALZMANN E, 1992, FORTSCHR NEUROL PSYC, V60, P163, DOI 10.1055/s-2007-999137; Samuelsson H, 1998, J CLIN EXP NEUROPSYC, V20, P73, DOI 10.1076/jcen.20.1.73.1481; SAPER CB, 1988, HDB PSYCHOPHARMACOLO, P131; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Scherder E, 1999, J PAIN SYMPTOM MANAG, V17, P152; SCHERDER EJA, 1995, BEHAV BRAIN RES, V67, P211, DOI 10.1016/0166-4328(94)00115-V; Scherder EJA, 1999, BEHAV BRAIN RES, V101, P105, DOI 10.1016/S0166-4328(98)00150-8; SCHERDER EJA, 1992, J CLIN EXP NEUROPSYC, V14, P951, DOI 10.1080/01688639208402546; Scherder EJA, 1998, BIOL PSYCHIAT, V43, P417, DOI 10.1016/S0006-3223(97)00208-4; Scherder EJA, 1999, BIOL PSYCHIAT, V45, P743, DOI 10.1016/S0006-3223(98)00072-9; Scherder EJA, 2000, BEHAV BRAIN RES, V111, P223, DOI 10.1016/S0166-4328(00)00170-4; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; Sonde L, 2000, CLIN REHABIL, V14, P14, DOI 10.1191/026921500673534278; SWAAB DF, 1991, NEUROBIOL AGING, V12, P317, DOI 10.1016/0197-4580(91)90008-8; SWAAB DF, 1994, NEUROBIOL AGING, V15, P369, DOI 10.1016/0197-4580(94)90037-X; SWAAB DF, 1997, HDB CHEM NEUROANATOM; TAYLOR DN, 1989, ACUPUNCTURE ELECTRO, V14, P29, DOI 10.3727/036012989816358551; VALLAR G, 1995, NEUROPSYCHOLOGIA, V33, P73, DOI 10.1016/0028-3932(94)00088-7; Vallar G, 1996, J Int Neuropsychol Soc, V2, P452; Van Someren EJW, 1998, ALZ DIS ASSOC DIS, V12, P114, DOI 10.1097/00002093-199806000-00010; VANSOMEREN EJW, 1993, BEHAV BRAIN RES, V57, P235, DOI 10.1016/0166-4328(93)90140-L; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; WEBER PL, 1984, ARCH PHYS MED REHAB, V65, P457; White PF, 2001, ANESTH ANALG, V92, P505, DOI 10.1213/00000539-200102000-00042; Wright A, 2001, CLIN J PAIN, V17, P33, DOI 10.1097/00002508-200103000-00006	93	14	15	0	7	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.		2002	13	3					257	270					14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	606LG	WOS:000178735000005	12405228				2022-02-06	
J	Elovic, EP; Zafonte, RD				Elovic, EP; Zafonte, RD			Ginkgo biloba: Applications in traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							EXTRACT EGB-761; CONSTITUENTS; MECHANISMS; VOLUNTEERS; TINNITUS; DEMENTIA; MEMORY; CELLS		Univ Med & Dent New Jersey, New Jersey Med Sch, W Orange, NJ 07052 USA		Elovic, EP (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.						Bastianetto S, 2000, J NEUROCHEM, V74, P2268, DOI 10.1046/j.1471-4159.2000.0742268.x; Blumenthal M., 2000, HERBAL MED EXPANDED; Diamond BJ, 2000, ARCH PHYS MED REHAB, V81, P668, DOI 10.1053/mr.2000.3840; Ernst E, 1999, CLIN OTOLARYNGOL, V24, P164, DOI 10.1046/j.1365-2273.1999.00243.x; FOURTILLAN JB, 1995, THERAPIE, V50, P137; Galluzzi S, 2000, J NEUROL NEUROSUR PS, V68, P679; *GOLD STAND MED, 2001, CLIN PHARM 2000 PHYS; HOLGERS KM, 1994, AUDIOLOGY, V33, P85; Kanowski S, 1996, PHARMACOPSYCHIATRY, V29, P47, DOI 10.1055/s-2007-979544; Kaye AD, 2000, J CLIN ANESTH, V12, P468, DOI 10.1016/S0952-8180(00)00195-1; LeBars PL, 1997, JAMA-J AM MED ASSOC, V278, P1327, DOI 10.1001/jama.278.16.1327; Lyon MR, 2001, J PSYCHIATR NEUROSCI, V26, P221; Ondrizek RR, 1999, FERTIL STERIL, V71, P517, DOI 10.1016/S0015-0282(98)00476-2; Rigney U, 1999, PHYTOTHER RES, V13, P408, DOI 10.1002/(SICI)1099-1573(199908/09)13:5&lt;408::AID-PTR530&gt;3.0.CO;2-C; Shih JC, 2000, ANTIOXID REDOX SIGN, V2, P467, DOI 10.1089/15230860050192242; Soholm B, 1998, ADV THER, V15, P54; Weiss SJ, 2001, ACAD EMERG MED, V8, P41, DOI 10.1111/j.1553-2712.2001.tb00548.x; Xin WJ, 2000, TOXICOLOGY, V148, P103, DOI 10.1016/S0300-483X(00)00200-6; Zhang XY, 2001, J CLIN PSYCHOPHARM, V21, P85, DOI 10.1097/00004714-200102000-00015	19	14	14	0	0	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	2001	16	6					603	607		10.1097/00001199-200112000-00008			5	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	501AL	WOS:000172660800008	11732975				2022-02-06	
J	Groger, A				Groger, A			Ten years of ice hockey-related-injuries in the German Ice Hockey Federation - A ten year prospective study/523 international games	SPORTVERLETZUNG-SPORTSCHADEN			English	Article						hockey; national team; juniors; seniors; injuries; statistics; prospektiv 10-year follow up		Since January 1986 all injuries in players of the German national hockey teams (juniors A/B and seniors A/B), which have occurred during international competitions, have been registrated and evaluated by using a strict definition of injury, standardized reporting strategies and diagnosis by the team physician. Patterns of injury have been identified and correlations between position, zone and cause of injury could be analysed and, as a consequence, measures were taken to prevent them. A total of 147 injuries forcing a consecutive absence from the game during 523 international games of the German national teams were reported. During the 10 year period there was a marked decrease of the total number and incidence of injuries. In addition, injury rate and average absence from game time improved. There were more frequent concussions of the brain but the total number of facial injuries dropped after the introduction of a visor and the full face mask especially in junior hockey. The forward was the position most at risk to be injured and most injuries were caused by players contact.	Tech Univ Munich, Klinikum Rechts Isar, Klin Orthopadie & Sportorthopadie, D-8000 Munich, Germany		Groger, A (corresponding author), Tech Univ Munich, Klin Orthopadie & Sportorthopadie, Ismaninger Str 22, D-81675 Munich, Germany.	sportmedag@web.de					BIASCA N, 1993, UNFALLCHIRURG, V96, P259; BJORKENHEIM JM, 1993, ACTA ORTHOP SCAND, V64, P459; GROGER A, 1995, SPORTORTH SPORTTRAUM, V114, P285; HASTINGS DE, 1974, CAN ACAD SPORTS MED, V4, P1; PASHBY TJ, 1975, CAN MED ASSOC J, V113, P663; PASHBY TJ, 1986, CAN FAM PHYSICIAN, P32; PASHBY TJ, 1977, CMA J, V117, P462; PATTERSSON M, 1993, BRIT J SPORT MED, V27, P251, DOI 10.1136/bjsm.27.4.251; PAULOS LE, 1991, AM J SPORT MED, V19, P337, DOI 10.1177/036354659101900403; RECHL H, 1995, SPORTORTHO SPORTTRAU, V11, P32; RECHL H, 1995, SPORTORTHO SPORTTRAU, V11, P42; REYNEN PD, 1994, AM J SPORT MED, V22, P167, DOI 10.1177/036354659402200203; Tegner Y, 1991, Br J Sports Med, V25, P159; Tegner Y, 1991, Br J Sports Med, V25, P87	14	14	14	0	4	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0932-0555	1439-1236		SPORTVERLETZ SPORTSC	Sportverletz. Sportschaden	DEC	2001	15	4					82	86		10.1055/s-2001-19047			5	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	509HB	WOS:000173140000003	11753779				2022-02-06	
J	Sanz, O; Acarin, L; Gonzalez, B; Castellano, B				Sanz, O; Acarin, L; Gonzalez, B; Castellano, B			Expression of 27 kDa heat shock protein (Hsp27) in immature rat brain after a cortical aspiration lesion	GLIA			English	Article						astrocytes; brain injury; Hsp27; microglia; postnatal development; stress response; vimentin	ALPHA-B-CRYSTALLIN; STRESS GENES; TNF-ALPHA; GLUTATHIONE; INDUCTION; STABILIZATION; ASTROCYTES; VIMENTIN; SYSTEM; HSP70	The 27 kDa heat shock protein (Hsp27) is a well-known member of the astroglial response to injury, playing a protective role against oxidative stress, apoptosis, and cytoskeletal destruction. Although several studies have been focused on the damaged adult brain, little is known about Hsp27 expression in the immature brain. In this work, we have examined the spatiotemporal pattern of Hsp27 expression in the normal postnatal rat brain following a cortical aspiration lesion at postnatal day 9. In the immature brain, Hsp27 is mainly observed in the internal capsule, although some scattered cells are also found in the ependyma, the corpus callosum, the septum, and hypothalamic glia limitans. In the internal capsule, Hsp27 expression is developmentally regulated, being significantly decreased from postnatal day 14. After a cortical aspiration lesion, de novo expression of Hsp27 is observed in cortical injured areas as well as in the secondary affected thalamus. In the cortex, expression of Hsp27 is first seen at day 1 postlesion (PL) surrounding the neurodegenerative area, becoming restricted to the glial scar at longer survival times. Although a pulse-like expression of Hsp27 is observed in some microglial cells at day 1 PL, most Hsp27-labeled cells are reactive astrocytes, which show GFAP overexpression and coexpress vimentin from day 3 PL. In the thalamus, astroglial Hsp27 expression is delayed, being first observed at day 5 PL. Thalamic Hsp27-labeled astrocytes do not show vimentin expression. Our observations demonstrate astroglial expression of Hsp27 in areas of tissue damage following postnatal traumatic injury, suggesting an involvement of this cytoskeleton-stabilizing protein in the remodeling processes following postnatal brain damage. (C) 2001 Wiley-Liss, Inc.	Autonomous Univ Barcelona, Fac Med, Dept Cell Biol Physiol & Immunol, Unit Histol, E-08193 Bellaterra, Spain		Acarin, L (corresponding author), Autonomous Univ Barcelona, Fac Med, Dept Cell Biol Physiol & Immunol, Unit Histol, E-08193 Bellaterra, Spain.	laia.acarin@uab.es	Acarin, Laia/G-2620-2010; Castellano, Bernardo/G-1428-2010; Gonzalez, Berta/G-1428-2010	Castellano, Bernardo/0000-0003-1976-971X; Gonzalez, Berta/0000-0002-1860-3980			ACARIN L, 1994, J HISTOCHEM CYTOCHEM, V42, P1033, DOI 10.1177/42.8.8027523; Arrigo AP, 1995, NEUROPATH APPL NEURO, V21, P488, DOI 10.1111/j.1365-2990.1995.tb01094.x; Bancroft J., 1996, THEORY PRACTICE HIST, P735; Bergeron M, 1998, DEV BRAIN RES, V105, P181, DOI 10.1016/S0165-3806(97)00169-7; Brown IR, 1999, HANDB EXP PHARM, V136, P243; Brown IR, 1998, ANN NY ACAD SCI, V851, P123, DOI 10.1111/j.1749-6632.1998.tb08985.x; Costigan M, 1998, J NEUROSCI, V18, P5891; Earle KL, 1998, J NEUROCYTOL, V27, P127, DOI 10.1023/A:1006951423251; Ehrnsperger M, 1998, ANAL BIOCHEM, V259, P218, DOI 10.1006/abio.1998.2630; FERRER I, 1992, PROG NEUROBIOL, V39, P1, DOI 10.1016/0301-0082(92)90029-E; GERNOLD M, 1993, DEV GENET, V14, P103, DOI 10.1002/dvg.1020140204; Hopkins DA, 1998, EXP NEUROL, V153, P173, DOI 10.1006/exnr.1998.6870; HUTCHINS JB, 1989, GLIA, V2, P55, DOI 10.1002/glia.440020107; KATO H, 1995, BRAIN RES, V679, P1, DOI 10.1016/0006-8993(95)00198-Y; Kato K, 1999, J NEUROCHEM, V73, P229, DOI 10.1046/j.1471-4159.1999.0730229.x; Kolb B, 1996, BEHAV BRAIN RES, V79, P1, DOI 10.1016/0166-4328(95)00254-5; KOLB B, 1994, BRAIN RES, V645, P85, DOI 10.1016/0006-8993(94)91641-1; LAVOIE JN, 1993, J BIOL CHEM, V268, P3420; Lewis SE, 1999, J NEUROSCI, V19, P8945, DOI 10.1523/JNEUROSCI.19-20-08945.1999; MAKAR TK, 1994, J NEUROCHEM, V62, P45; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Mehlen P, 1997, BIOCHEM BIOPH RES CO, V241, P187, DOI 10.1006/bbrc.1997.7635; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Morange M, 1999, HANDB EXP PHARM, V136, P305; Perng MD, 1999, J CELL SCI, V112, P2099; Peuchen S, 1997, PROG NEUROBIOL, V52, P261, DOI 10.1016/S0301-0082(97)00010-5; Piotrowicz RS, 1997, J BIOL CHEM, V272, P7042, DOI 10.1074/jbc.272.11.7042; Piotrowicz RS, 1998, FASEB J, V12, P1481, DOI 10.1096/fasebj.12.14.1481; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; Plumier JCL, 1997, J CEREBR BLOOD F MET, V17, P781; Plumier JCL, 1997, MOL BRAIN RES, V45, P239, DOI 10.1016/S0169-328X(96)00255-0; Plumier JCL, 1996, NEUROSCIENCE, V75, P849, DOI 10.1016/0306-4522(96)00317-X; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P511; SCHIFFER D, 1986, BRAIN RES, V374, P110, DOI 10.1016/0006-8993(86)90399-9; Smith GM, 1997, J NEUROSCI, V17, P9624; Snyder SE, 1998, J COMP NEUROL, V394, P64; Walsh D, 1997, CELL MOL LIFE SCI, V53, P198, DOI 10.1007/PL00000592; Warr W.B., 1981, NEUROANATOMICAL TRAC, P207; Werther GA, 1998, HORM RES, V49, P37, DOI 10.1159/000053066	39	14	15	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	DEC	2001	36	3					259	270		10.1002/glia.1114			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	497TW	WOS:000172472400002	11746764				2022-02-06	
J	Sekharan, J; Dennis, JW; Miranda, FE; Hertz, JA; Veldenz, HC; Dovgan, PS; Frykberg, ER				Sekharan, J; Dennis, JW; Miranda, FE; Hertz, JA; Veldenz, HC; Dovgan, PS; Frykberg, ER			Long-term follow-up of prophylactic Greenfield filters in multisystem trauma patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	60th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	OCT 11-15, 2000	SAN ANTONIO, TEXAS	Amer Assoc Surg Trauma			VENA-CAVAL FILTERS; HIGH-RISK; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; MAJOR TRAUMA; THROMBOSIS; PLACEMENT	Purpose. The efficacy of prophylactic Greenfield filter (PGF) placement in multisystem trauma patients at high risk for venous thromboembolism has been established. The objective of this study is to demonstrate the long-term safety and durability of PGFs placed in young, active trauma patients. Methods. Starting January 1992, all trauma patients at high risk for development of venous thromboembolism were identified for placement of PGFs. These included patients with ISS > 9 and severe closed head injury, spinal injury, pelvic fracture, multiple long bone fracture, or direct iliofemoral venous injury. Four patients with PGFs placed before the study protocol in 1992 were also included. Follow-up was attempted in all patients with at least 5 years' duration since placement of PGF using physical examination, duplex ultrasound (US), and plain abdominal radiograph. Results: There were 108 patients who had a PGF placement during the period of January 1992 to June 1994 that were eligible for the study. Eighteen of these 108 (17%) patients died. Twelve of them (67%) had autopsies and medical records available to determine the cause of death, none from a pulmonary embolism. The average time of death was 2.7 months after injury. The remaining 90 patients and the 4 patients with PGFs placed before 1992 were sought for follow-up, but only 36 patients could be contacted, 33 of which returned for evaluation (35%). The mean time of follow-up from the time of injury to the time of examination was 67.7 months, and the mean age at follow-up was 38.1 years. Although six patients had mild to moderate lower extremity edema on physical examination, none of them had a deep venous thrombosis by US. Radiographs obtained in 19 of the 33 patients showed no migration or breakdown of the Greenfield filters in place. Conclusion: Prophylactic Greenfield filters in high-risk trauma patients are safe and durable. There appears to be no significant consequence in over 5 years of follow-up.	Univ Florida, Hlth Sci Ctr, Dept Surg, Jacksonville, FL 32209 USA		Dennis, JW (corresponding author), Univ Florida, Hlth Sci Ctr, Dept Surg, 653-2 W 8th St, Jacksonville, FL 32209 USA.						BERNSTEIN MJ, 1986, JAMA-J AM MED ASSOC, V256, P744; DENNIS JW, 1993, J TRAUMA, V35, P132, DOI 10.1097/00005373-199307000-00021; ENDERSON BL, 1991, J TRAUMA, V31, P1240, DOI 10.1097/00005373-199109000-00007; FREEARK RJ, 1967, ARCH SURG-CHICAGO, V95, P567; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Greenfield L J, 1995, Cardiovasc Surg, V3, P199, DOI 10.1016/0967-2109(95)90895-C; GREENFIELD LJ, 1973, SURGERY, V73, P599; Greenfield LJ, 2000, J VASC SURG, V32, P490, DOI 10.1067/mva.2000.108636; JOFFE SN, 1975, J NEUROSURG, V42, P201, DOI 10.3171/jns.1975.42.2.0201; KAKKAR V V, 1975, Lancet, V2, P45; KHANSARINIA S, 1995, J VASC SURG, V22, P231, DOI 10.1016/S0741-5214(95)70135-4; KNUDSON MM, 1994, J TRAUMA, V37, P480, DOI 10.1097/00005373-199409000-00025; KNUDSON MM, 1992, J TRAUMA, V32, P2, DOI 10.1097/00005373-199201000-00002; Langan EM, 1999, J VASC SURG, V30, P484, DOI 10.1016/S0741-5214(99)70075-3; LEACH TA, 1994, AM SURGEON, V60, P292; MATOUS SK, 1994, 24 ANN SCI M W TRAUM; McCartney JS, 1934, AM J PATHOL, V10, P709; Patton JH, 1996, J TRAUMA, V41, P231, DOI 10.1097/00005373-199608000-00006; RICHARDSON JD, 1987, ARCH SURG-CHICAGO, V122, P678; Rodriguez JL, 1996, J TRAUMA, V40, P797, DOI 10.1097/00005373-199605000-00020; ROGERS FB, 1993, J TRAUMA, V35, P637, DOI 10.1097/00005373-199310000-00021; Rogers FB, 1998, ARCH SURG-CHICAGO, V133, P406, DOI 10.1001/archsurg.133.4.406; SEVITT S, 1961, BRIT J SURG, V48, P475, DOI 10.1002/bjs.18004821103; SHACKFORD SR, 1990, AM J SURG, V159, P365, DOI 10.1016/S0002-9610(05)81272-3; Todd J W, 1976, Paraplegia, V14, P50; Walsh JJ, 1965, PARAPLEGIA, V3, P209; Watson N, 1968, Paraplegia, V6, P113; Webb L X, 1992, J Orthop Trauma, V6, P139, DOI 10.1097/00005131-199206000-00002	28	14	14	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2001	51	6					1087	1090		10.1097/00005373-200112000-00012			4	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	504CV	WOS:000172840500012	11740258				2022-02-06	
J	Flesher, MR; Delahanty, DL; Raimonde, AJ; Spoonster, E				Flesher, MR; Delahanty, DL; Raimonde, AJ; Spoonster, E			Amnesia, neuroendocrine levels and PTSD in motor vehicle accident victims	BRAIN INJURY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; GLUCOCORTICOID-RECEPTOR NUMBER; URINARY CORTISOL; CATECHOLAMINE EXCRETION; COMBAT VETERANS; CONSCIOUSNESS; ACTIVATION; SEVERITY; SYMPTOMS	Primary objective: To examine the initial neuroendocrine responses and subsequent PTSD symptomatology among amnesic and non-amnesic victims of motor vehicle accidents. It was hypothesized that amnesic patients would be less likely to meet PTSD criteria at 1 month follow-up and would display lower catechalomine levels and higher basal cortisol than non-amnesics. Methods and procedure: Fifteen-hour urinary hormone samples were collected from 70 MVA victims upon hospital admission. Participants were assessed for PTSD symptomatology 1 month later. Main outcomes and results: Amnesic patients displayed lower NE/cortisol ratios than non-amnesics, were less likely than non-amnesics to develop PTSD, and displayed fewer PTSD symptoms than non-amnesics. Conclusions : Amnesics may physiologically experience a motor vehicle accident differently from non-amnesics and have lower subsequent PTSD incidence. These results provide partial support for the hypothesis that amnesia for a traumatic event can serve as a buffering function in the development of subsequent PTSD among MVA victims.	Kent State Univ, Dept Psychol, Kent, OH 44242 USA; Summa Hlth Syst, Akron, OH USA		Delahanty, DL (corresponding author), Kent State Univ, Dept Psychol, 118 Kent Hall, Kent, OH 44242 USA.	ddelahan@kent.edu					Adler A, 1943, J AMER MED ASSOC, V123, P1098, DOI 10.1001/jama.1943.02840520014004; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Delahanty DL, 2000, BIOL PSYCHIAT, V48, P940, DOI 10.1016/S0006-3223(00)00896-9; Dziedzic L, 1998, AM J EMERG MED, V16, P686, DOI 10.1016/S0735-6757(98)90177-2; First M.B., 1996, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedman MJ, 1991, J TRAUMA STRESS, V4, P67; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; HOVENS JE, 1992, J ANXIETY DISORD, V6, P147, DOI 10.1016/0887-6185(92)90013-W; Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372; KOSTEN TR, 1987, PSYCHONEUROENDOCRINO, V12, P13, DOI 10.1016/0306-4530(87)90017-5; LEMIEUX AM, 1995, PSYCHOSOM MED, V57, P105, DOI 10.1097/00006842-199503000-00002; MASON JR, 1988, AM J PSYCHIAT, V102, P670; MASON JW, 1986, J NERV MENT DIS, V174, P149; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; McFarlane AC, 1997, ANN NY ACAD SCI, V821, P437, DOI 10.1111/j.1749-6632.1997.tb48299.x; MCGAUGH JL, 1990, PSYCHOL SCI, V1, P15, DOI 10.1111/j.1467-9280.1990.tb00060.x; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; NAUGLE RI, 1998, INTRO CLIN NEUROPSYC; NELSON A, 1986, J NERV MENT DIS, V174, P73, DOI 10.1097/00005053-198602000-00002; O'Brien M, 1998, BRIT J PSYCHIAT, V173, P102, DOI 10.1192/bjp.173.2.102; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; PITMAN RK, 1990, BIOL PSYCHIAT, V27, P245, DOI 10.1016/0006-3223(90)90654-K; Price K. P., 1994, DEF LAW J, V43, P113; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SBORDONE RJ, 1991, NEUROPSYCHOLOGY ATTO; Sherman JJ, 1998, J TRAUMA STRESS, V11, P413, DOI 10.1023/A:1024444410595; SOLOMON Z, 1993, ISRAEL J PSYCHIAT, V30, P110; TEASDALE G, 1974, LANCET, V2, P81; YEHUDA R, 1990, J NERV MENT DIS, V178, P366, DOI 10.1097/00005053-199006000-00004; YEHUDA R, 1992, J NERV MENT DIS, V180, P321, DOI 10.1097/00005053-199205000-00006; YEHUDA R, 1991, AM J PSYCHIAT, V148, P499; YEHUDA R, 1993, BIOL PSYCHIAT, V34, P18, DOI 10.1016/0006-3223(93)90252-9; YEHUDA R, 1995, ARCH GEN PSYCHIAT, V52, P583; Yehuda R, 1997, NATO ADV SCI I A-LIF, V291, P221; [No title captured]	42	14	14	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2001	15	10					879	889		10.1080/02699050110065682			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	483HF	WOS:000171627000004	11595084				2022-02-06	
J	Vavilala, MS; Roberts, JS; Moore, AE; Newell, DW; Lam, AM				Vavilala, MS; Roberts, JS; Moore, AE; Newell, DW; Lam, AM			The influence of inhaled nitric oxide on cerebral blood flow and metabolism in a child with traumatic brain injury	ANESTHESIA AND ANALGESIA			English	Article							SYNTHASE INHIBITION; HEMODYNAMICS; CIRCULATION; INHALATION		Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA		Vavilala, MS (corresponding author), Harborview Med Ctr, Dept Anesthesiol, 325 9th Ave,Box 359724, Seattle, WA 98104 USA.						Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Berger C, 1998, ACTA NEUROL SCAND, V97, P118; Cardozo RHL, 1996, BIOL NEONATE, V69, P284; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; FARACI FM, 1993, NEUROSURGERY, V33, P648, DOI 10.1227/00006123-199310000-00014; GREENBERG RS, 1994, CRIT CARE MED, V22, P384, DOI 10.1097/00003246-199403000-00006; Hudetz AG, 1998, AM J PHYSIOL-HEART C, V274, pH982; IADECOLA C, 1994, AM J PHYSIOL, V267, pR228, DOI 10.1152/ajpregu.1994.267.1.R228; Jones SC, 1999, AM J PHYSIOL-HEART C, V276, pH1253, DOI 10.1152/ajpheart.1999.276.4.H1253; Kusuda S, 1999, ARCH DIS CHILD-FETAL, V80, pF30, DOI 10.1136/fn.80.1.F30; LADECOLA C, 1992, P NATL ACAD SCI USA, V89, P3913; Richards HK, 1997, ACTA NEUROCHIR, V139, P63, DOI 10.1007/BF01850870; ROSENBERG AA, 1995, CRIT CARE MED, V23, P1391, DOI 10.1097/00003246-199508000-00013; Todd MM, 1997, J CEREBR BLOOD F MET, V17, P1319, DOI 10.1097/00004647-199712000-00007; WEI HM, 1993, ANESTH ANALG, V77, P880; White RP, 1998, STROKE, V29, P467, DOI 10.1161/01.STR.29.2.467	16	14	14	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	AUG	2001	93	2					351	353		10.1097/00000539-200108000-00023			3	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	456YU	WOS:000170111000023	11473859				2022-02-06	
J	Gaudet, L; Crethar, HC; Burger, S; Pulos, S				Gaudet, L; Crethar, HC; Burger, S; Pulos, S			Self-reported consequences of traumatic brain injury: A study of contrasting TBI and non-TBI participants	SEXUALITY AND DISABILITY			English	Article						traumatic brain injury; cognition; ego adaptability; sexuality	DAMAGE	This study examined the affective and behavioral concerns of male and female adults in the areas of cognition, ego adaptability, and sexuality Participants were given two Likert-type questionnaires: affective and behavioral. Three two-way analyses of covariance (ANCOVA) compared the independent variables of gender and injury status to the dependent variables of cognition, ego adaptability, and sexuality. Results suggest that non-Traumatic Brain Injured (TBI) participants have more positive feelings about their cognition, ego adaptability, and sexuality than TBI participants. It was found that although female participants without TBI have more positive feelings about their sexuality than male participants without TBI, the opposite is true for TBI participants. Male participants with TBI had the most concerns about their sexuality of all four groups.	Chadron State Coll, Dept Psychol, Chadron, NE 69337 USA; PREL, Honolulu, HI USA; Univ No Colorado, Dept Educ Psychol, Greeley, CO 80639 USA		Gaudet, L (corresponding author), Chadron State Coll, Dept Psychol, 1000 Main St, Chadron, NE 69337 USA.						Bigler ED, 1996, J LEARN DISABIL-US, V29, P515, DOI 10.1177/002221949602900507; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; GAUDET L, 1995, THESIS U NO COLORADO; KREUTZER SJ, 1989, BRAIN INJURY, V3, P177; Levin H.S., 1989, MILD HEAD INJURY; LEVIN HS, 1989, MILD HEAD INJURY, P189; LEZAK M, 1983, NEUROPSYCHOLOGICAL A, P164; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Marsh NV, 1990, NEUROPSYCHOLOGY, V4, P13, DOI 10.1037/0894-4105.4.1.13; PARKER R, 1990, TRAUMATIC BRAIN INJU; Reitan R, 1985, HALSTEAD REITAN NEUR; Savage R. C., 1994, ED DIMENSIONS ACQUIR; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sosin DM, 1996, BRAIN INJURY, V10, P47; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007; WRIGHTSON P, 1989, MILD HEAD INJURY, P245	18	14	14	0	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0146-1044	1573-6717		SEX DISABIL	Sex. Disabil.	SUM	2001	19	2					111	119		10.1023/A:1010673722429			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	479VM	WOS:000171424300003					2022-02-06	
J	Iwase, H; Kobayashi, M; Kurata, A; Inoue, S				Iwase, H; Kobayashi, M; Kurata, A; Inoue, S			Clinically unidentified dissection of vertebral artery as a cause of cerebellar infarction	STROKE			English	Article						cerebellar infarction; dissection; trauma; vertebral artery	INJURY	Background and Purpose-Dissection of vertebral arteries has been reported in association with minor neck movements without signs of trauma on the surface of the neck. In addition, injury of a vertebral artery can cause brain infarctions. However, few cases have been reported in which fatal brain infarction was due to nonocclusive, clinically undetected, traumatic thrombus formation in a vertebral artery. Case Description-A 62-year-old man was hit by a car, and a right cerebellar infarction was found the day after the accident. The cause of the infarction could not be detected by angiography. Although the patient recovered favorably after surgical removal of the right lateral hemisphere of the cerebellum, he died suddenly 2 weeks after the accident. An autopsy and a microscopic study revealed pulmonary thromboembolism and organizing traumatic lesions of the right vertebral artery without occlusion or noteworthy stenosis of the artery. Conclusions-We concluded that the patient sustained traumatic lesions of the right vertebral artery during the traffic accident 2 weeks before death and that his cerebellar infarction was due to a thrombus resulting from these traumatic lesions.	Univ Tokyo, Dept Forens Med, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Dept Human Pathol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Dept Vasc Surg, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan		Iwase, H (corresponding author), Univ Tokyo, Dept Forens Med, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						ALEXANDER JJ, 1986, J NEUROSURG, V64, P662, DOI 10.3171/jns.1986.64.4.0662; BROMILOW A, 1985, J CLIN PATHOL, V38, P1400, DOI 10.1136/jcp.38.12.1400; CHARLES N, 1992, J NEUROL NEUROSUR PS, V55, P188, DOI 10.1136/jnnp.55.3.188; HEROS RC, 1979, J NEUROSURG, V51, P111, DOI 10.3171/jns.1979.51.1.0111; Hutchinson PJ, 2000, J NEUROL NEUROSUR PS, V68, P98, DOI 10.1136/jnnp.68.1.98; Johnson CP, 2000, FORENSIC SCI INT, V109, P169, DOI 10.1016/S0379-0738(99)00198-X; POTSCH L, 1994, INT J LEGAL MED, V107, P99, DOI 10.1007/BF01225496; SHERMAN DG, 1981, STROKE, V12, P2, DOI 10.1161/01.STR.12.1.2; SPETZLER RF, 1987, J NEUROSURG, V66, P648, DOI 10.3171/jns.1987.66.5.0648; TETTENBORN B, 1993, NEUROLOGY, V43, P471, DOI 10.1212/WNL.43.3_Part_1.471; TRAMO MJ, 1985, STROKE, V16, P1039, DOI 10.1161/01.STR.16.6.1039; VANEZIS P, 1986, J FORENSIC SCI SOC, V26, P281, DOI 10.1016/S0015-7368(86)72496-1; VIKTRUP L, 1995, STROKE, V26, P2194, DOI 10.1161/01.STR.26.11.2194; YOUNG CA, 1991, J NEUROL NEUROSUR PS, V54, P365, DOI 10.1136/jnnp.54.4.365	14	14	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499			STROKE	Stroke	JUN	2001	32	6					1422	1424		10.1161/01.STR.32.6.1422			3	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	440PZ	WOS:000169184600036	11387508	Bronze			2022-02-06	
J	Vath, A; Meixensberger, J; Dings, J; Roosen, K				Vath, A; Meixensberger, J; Dings, J; Roosen, K			Advanced neuromonitoring including cerebral tissue oxygenation and outcome after traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						head injury; prognosis; intracranial pressure; brain tissue oxygenation; cerebral perfusion pressure	SEVERE HEAD-INJURY; EVOKED-POTENTIALS; PRESSURE; EXPERIENCE; COMA; MANAGEMENT; PREDICTION; PROGNOSIS; SCALE	For 51 patients suffering from traumatic brain injury (GCS < 9), we compared the prognostic value of critical parameters derived from neuromonitoring of intracranial pressure (ICP) cerebral perfusion pressure (CPP) and brain tissue oxygenation (PtiO2) during different time periods after trauma (less than or equal to 12, less than or equal to 24, less than or equal to 48, less than or equal to 72 and less than or equal to 96 h). For patients with good outcome (GOS = 4-5, n = 30) the proportion of critical ICP values (> 40 mmHg) was about 0.2% during all time periods. The corresponding proportions for patients with bad outcome (GOS = 1-3, n = 21) rose from 0.2% to 4.7% during increasing time periods. The frequency of critical ICP values was significantly related to outcome (p < 0.001) for time periods > 48 h after trauma. Differences of critical CPP (less than or equal to 50 mmHg) and hypoxic PtiO2 (less than or equal to 5 mmHg) between both outcome groups were less pronounced and for both parameters significant relations to outcome were only obtained for the longest time period (less than or equal to 96 h, p less than or equal to 0.05). Higher thresholds for CPP (less than or equal to 60 mmHg, less than or equal to 70 mmHg) did not reveal any relation to outcome. For all neuromonitoring parameters significant relations between the frequency of critical values and outcome could be determined. Critical ICP values provide the earliest and highest prognostic power, while critical CPP and hypoxic PtiO2 only showed prognostic power in later time periods.	Univ Leipzig, Dept Neurosurg, D-04103 Leipzig, Germany		Meixensberger, J (corresponding author), Univ Leipzig, Dept Neurosurg, Johannisallee 34, D-04103 Leipzig, Germany.	meix@nch.uni-leipzig.de					Bardt TF, 1998, ACT NEUR S, V71, P153; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; CHOI SC, 1996, NEUROTRAUMA, P779; Dings J, 1998, NEUROL RES, V20, pS71; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Facco E, 1998, NEUROL RES, V20, pS40; HOULDEN DA, 1990, NEUROSURGERY, V27, P701, DOI 10.1227/00006123-199011000-00006; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Lang EW, 1997, NEUROL RES, V19, P274, DOI 10.1080/01616412.1997.11740813; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Meixensberger J, 1998, ACT NEUR S, V71, P260; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 1998, ACT NEUR S, V71, P190	20	14	14	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUN	2001	23	4					315	320		10.1179/016164101101198677			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	443RX	WOS:000169355100004	11428507				2022-02-06	
J	Chesser, TJS; Langdon, IJ; Ogilvie, C; Sarangi, PP; Clarke, AM				Chesser, TJS; Langdon, IJ; Ogilvie, C; Sarangi, PP; Clarke, AM			Fractures involving splitting of the humeral head	JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME			English	Article							SHOULDER; DISLOCATIONS	Splitting fractures of the humeral head are rare; part of the humeral head dislocates and the unfractured part remains attached to the shaft. We report eight cases in young patients. In five the diagnosis was made at presentation: three had minimal internal fixation using a superior subacromial approach, one had a closed reduction and one a primary prosthetic replacement. All five patients regained excellent function with no avascular necrosis at two years, In three the injury was initially unrecognised; two developed a painless bony ankylosis and one is awaiting hemiarthroplasty. It is important to obtain the three trauma radiographic views to diagnose these unusual fractures reliably. CT delineates the configuration of the fracture. In young patients open reduction and internal fixation seems preferable to replacement of the humeral head, since we have shown that the head is potentially viable.	Southmead Gen Hosp, Avon Orthopaed Ctr, Bristol BS10 5NB, Avon, England; Bristol Royal Infirm, Bristol BS2 8HW, Avon, England; Musgrave Pk Hosp, Taunton, Somerset, England		Langdon, IJ (corresponding author), Southmead Gen Hosp, Avon Orthopaed Ctr, Bristol BS10 5NB, Avon, England.						Bigliani LU, 1990, SHOULDER, P278; CISTERNINO SJ, 1978, AM J ROENTGENOL, V130, P951, DOI 10.2214/ajr.130.5.951; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, V214, P161; HAWKINS RJ, 1987, J BONE JOINT SURG AM, V69A, P9, DOI 10.2106/00004623-198769010-00003; Jakob RP, 1984, SURG SHOULDER, P330; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; RANDELLI M, 1988, 2 C SOC EUR CHIR EP; RICHARDS RH, 1989, INJURY, V20, P297, DOI 10.1016/0020-1383(89)90174-5; ROCKWOOD CA, 1996, ROCKWOOD GREENS FRAC, P1221; ROWE CR, 1982, J BONE JOINT SURG AM, V64, P494, DOI 10.2106/00004623-198264040-00004; Sperling JW, 1998, J BONE JOINT SURG AM, V80A, P464, DOI 10.2106/00004623-199804000-00002; STABLEFORTH PG, 1992, J BONE JOINT SURG BR, V74, P579, DOI 10.1302/0301-620X.74B4.1624520; WADLINGTON VR, 1992, J TRAUMA, V32, P113, DOI 10.1097/00005373-199201000-00024; WALCH G, 1990, REV CHIR ORTHOP, V76, P546	14	14	20	0	1	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	0301-620X			J BONE JOINT SURG BR	J. Bone Joint Surg.-Br. Vol.	APR	2001	83B	3					423	426		10.1302/0301-620X.83B3.11218			4	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	426KK	WOS:000168348200023	11341432				2022-02-06	
J	Barami, K; Zhao, J; Diaz, FG; Lyman, WD				Barami, K; Zhao, J; Diaz, FG; Lyman, WD			Comparison of neural precursor cell fate in second trimester human brain and spinal cord	NEUROLOGICAL RESEARCH			English	Article						brain; fetal human; glia; neurons; spinal cord; stem cells	FIBROBLAST GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; LEUKEMIA INHIBITORY FACTOR; FIBRILLARY ACIDIC PROTEIN; PROGENITOR CELLS; STEM-CELLS; FACTOR PROMOTES; FETAL BRAIN; RAT; TRANSPLANTATION	Neural transplantation holds promise for the treatment of traumatic brain and spinal cord injury by replacing lost cellular elements as well as repairing neural damage. Fetal human stem cells derived from central nervous system (CNS) tissue are potential transplantable sources for all cell types found in the mature human nervous system including neurons, astrocytes and oligodendroglia. Although nearly all areas of the fetal human neuraxis contain undifferentiated neural precursor cells, the phenotypic fate of the daughter cells might vary from one region to another during a specific developmental period. The purpose of this study was to compare the various cell types derived from neural precursors cultured from second trimester fetal human brain and spinal cord. To this end, brains (n = 8) and spinal cords (n = 8) of 15-24 week fetuses were dissociated and grown in culture medium supplemented with epidermal growth factor (EGF) basic fibroblast growth factor (FGF) and leukemia inhibitory factor (LIF). The proliferating precursor cells from both brain and spinal cord grew as spherical masses that were plated on laminin-coated dishes after seven days in culture. During the next 5-7 days, the cells that emerged from these spheres were fixed and processed for immunocytochemistry. Brain derived spheres gave rise to cells expressing antigens specific for neurons (MAP-2ab and neuron specific-intermediate filaments), astrocytes (GFAP) and oligodendrocytes (A007). in contrast, cells that emerged from spinal cord derived spheres were only immunoreactive for GFAP. These data suggest that neuroepithelial precursor cells from different CNS regions, although similar in their responsiveness to proliferative growth factors, might differ in their ability to generate different cell types in the adult CNS.	Wayne State Univ, Dept Neurosurg, Detroit, MI 48201 USA; Childrens Hosp Michigan, Childrens Res Ctr Michigan, Detroit, MI USA; Wayne State Univ, Detroit Med Ctr, Dept Pediat, Detroit, MI USA		Barami, K (corresponding author), Wayne State Univ, Dept Neurosurg, 4201 St Antoine Blvd,UHC-6E, Detroit, MI 48201 USA.	Barami@neurosurgery.wayne.edu	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763			AHMED S, 1995, J NEUROSCI, V15, P5765; ALOISI F, 1992, GLIA, V5, P171, DOI 10.1002/glia.440050303; Aquino DA, 1996, DEV BRAIN RES, V91, P1, DOI 10.1016/0165-3806(95)00146-8; BANSAL R, 1992, J NEUROCHEM, V58, P2221, DOI 10.1111/j.1471-4159.1992.tb10967.x; Barami K, 2000, NEUROSURGERY, V47, P691; BAYER SA, 1993, NEUROTOXICOLOGY, V14, P83; BOYER KL, 1995, NEUROSURG CLIN N AM, V6, P113; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; CHOI BH, 1981, DEV BRAIN RES, V1, P249, DOI 10.1016/0165-3806(81)90112-7; CHOI BH, 1984, SCIENCE, V223, P407, DOI 10.1126/science.6197755; CULICAN SM, 1990, J NEUROSCI, V10, P684; DELOULME JC, 1991, J NEUROSCI RES, V29, P499, DOI 10.1002/jnr.490290410; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GONZALEZ MF, 1988, EXP NEUROL, V99, P154, DOI 10.1016/0014-4886(88)90135-5; Gritti A, 1996, J NEUROSCI, V16, P1091; Hajihosseini M, 1996, J NEUROSCI, V16, P7981; Horner PJ, 2000, J NEUROSCI, V20, P2218; Kalyani AJ, 1998, BIOCHEM CELL BIOL, V76, P1051, DOI 10.1139/bcb-76-6-1051; Kanelos SK, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199812000-00003; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; Kuhn HG, 1997, J NEUROSCI, V17, P5820; LABBE R, 1983, SCIENCE, V221, P470, DOI 10.1126/science.6683427; Lee JC, 2000, GLIA, V30, P105, DOI 10.1002/(SICI)1098-1136(200004)30:2<105::AID-GLIA1>3.0.CO;2-H; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; Murray K, 1997, J NEUROSCI RES, V50, P146; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Quinn SM, 1999, J NEUROSCI RES, V57, P590, DOI 10.1002/(SICI)1097-4547(19990901)57:5<590::AID-JNR2>3.0.CO;2-X; RAY J, 1994, J NEUROSCI, V14, P3548; REIER PJ, 1992, J NEUROTRAUM, V9, pS223; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, J NEUROSCI RES, V33, P476, DOI 10.1002/jnr.490330314; Richards LJ, 1996, EUR J NEUROSCI, V8, P291, DOI 10.1111/j.1460-9568.1996.tb01213.x; RIVKIN MJ, 1995, ANN NEUROL, V38, P92, DOI 10.1002/ana.410380116; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Roy NS, 2000, NAT MED, V6, P271; Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Soares HD, 1995, J NEUROTRAUM, V12, P1059, DOI 10.1089/neu.1995.12.1059; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; TOHYAMA T, 1991, J COMP NEUROL, V310, P285, DOI 10.1002/cne.903100302; Weidenheim KM, 1996, J NEUROPATH EXP NEUR, V55, P734, DOI 10.1097/00005072-199606000-00008; Weiss S, 1996, J NEUROSCI, V16, P7599; White MG, 1999, CELL TRANSPLANT, V8, P59, DOI 10.1177/096368979900800115	43	14	20	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					260	266		10.1179/016164101101198406			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	422DX	WOS:000168104200019	11320606				2022-02-06	
J	Viguier, D; Dellatolas, G; Gasquet, I; Martin, C; Choquet, M				Viguier, D; Dellatolas, G; Gasquet, I; Martin, C; Choquet, M			A psychological assessment of adolescent and young adult inpatients after traumatic brain injury	BRAIN INJURY			English	Article							PSYCHIATRIC-DISORDERS; HEAD-INJURY; DEPRESSION; ANXIETY; MOOD	The purpose of this study was to evaluate the cognitive, behavioural, depressive and self- awareness disorders, and their relationships, after severe traumatic brain injury (TBI) in adolescent and young adult inpatients. Two groups of patients with (n = 83) and without (n = 103) TBI, aged 14-25 years, hospitalized after severe traumatic pathology, were compared using the clinician' s report and self-report. A higher frequency of depressive tendencies in TBI patients than in controls was shown in the clinician' s therapeutic attitude (i. e. prescription of antidepressant drugs), the clinician's report and the self- report. The same difference between the two groups was observed for behavioural and schooling problems in the clinician' s report, but not in the self- report. Discrepancies between self- and clinician's evaluation were in favour of a lack of self- awareness of behavioural and cognitive disorders among TBI patients. Correlations of depressive mood with anxiety and cognitive complaints were stronger in TBI than in non- TBI patients. Depression in TBI patients seems compatible with some degree of lack of self- awareness of cognitive and behavioural difficulties.	INSERM, U472, F-94807 Villejuif, France; Hop Paul Brousse, Villejuif, France		Viguier, D (corresponding author), INSERM, U472, 16 Av Paul Vaillant Couturier, F-94807 Villejuif, France.	dellatolas@vjf.inserm.fr					Benton AL, 1991, FRONTAL LOBE FUNCTIO; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Choquet M, 1994, ADOLESCENTS ENQUETE; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; Gasquet I., 1995, NEUROPSYCHIAT ENFAN, V43, P366; Gualtari CT, 1991, BRAIN INJURY, V5, P219; GURNS S, 1994, BRAIN INJURY, V8, P413, DOI 10.3109/02699059409150993; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; KANDEL DB, 1982, ARCH GEN PSYCHIAT, V39, P1205; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Lisspers J, 1997, ACTA PSYCHIAT SCAND, V96, P281, DOI 10.1111/j.1600-0447.1997.tb10164.x; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olsson GI, 1999, ACTA PSYCHIAT SCAND, V99, P324, DOI 10.1111/j.1600-0447.1999.tb07237.x; PONSFORD J, 1995, TRAUMATIC BRAIN INJU, P231; Prigatano G. P., 1991, AWARENESS DEFICIT BR; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Silver J. M., 1991, NEUROPSY NEUROPSY BE, V4, P12; Silver JM., 1994, NEUROPSYCHIATRY TRAU; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Winston FK, 1998, BIOM HLTH R, V21, P101	28	14	14	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2001	15	3					263	271					9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	407ZM	WOS:000167302100006	11260774				2022-02-06	
J	Finnie, JW; Van den Heuvel, C; Gebski, V; Manavis, J; Summersides, GE; Blumbergs, PC				Finnie, JW; Van den Heuvel, C; Gebski, V; Manavis, J; Summersides, GE; Blumbergs, PC			Effect of impact on different regions of the head of lambs	JOURNAL OF COMPARATIVE PATHOLOGY			English	Article							AMYLOID PRECURSOR PROTEIN; AXONAL INJURY; BRAIN INJURY; MODEL	The heads of anaesthetized lambs aged 4 5 weeks were subject to impact (temporal, frontal or occipital) of constant strength with a humane stunner. Two hours later, the brains were perfusion-fixed with 4 degrees paraformaldehyde and serial whole coronal slices processed by routine methods. Sections were stained with haematoxylin and eosin or labelled with a monoclonal antibody to amyloid precursor protein, a sensitive marker of axonal injury and neuronal reaction. Microscopical evaluation of axonal, neuronal and vascular damage was performed with a quantitative grid system. Frontal impact produced the greatest damage, followed by occipital then temporal impact. An unusual lesion found in the majority of lambs subjected to impact was multifocal necrosis of the cerebellar granular layer. The findings should assist clinicians in evaluating the probable outcome of traumatic head injury in domestic animals. (C) 2001 Harcourt Publishers Ltd.	Inst Med & Vet Sci, Vet Serv Div, Adelaide, SA 5000, Australia; Inst Med & Vet Sci, Neuropathol Lab, Adelaide, SA 5000, Australia; Univ Adelaide, Dept Pathol, Adelaide, SA 5000, Australia; Univ Sydney, NHMRC, Clin Trials Ctr, Sydney, NSW 2006, Australia		Finnie, JW (corresponding author), Inst Med & Vet Sci, Vet Serv Div, Adelaide, SA 5000, Australia.			, Corinna/0000-0003-0664-8935			Blumbergs PC, 1997, HEAD INJURY PATHOPHY, P39; DALY CC, 1986, RES VET SCI, V41, P353, DOI 10.1016/S0034-5288(18)30629-5; Faden AI., 1994, NEUROBIOLOGY CENTRAL, P3; Finnie J, 1999, J CLIN NEUROSCI, V6, P38, DOI 10.1016/S0967-5868(99)90601-X; Finnie JW, 1997, AUST VET J, V75, P204, DOI 10.1111/j.1751-0813.1997.tb10067.x; Finnie JW, 1999, VET PATHOL, V36, P256, DOI 10.1354/vp.36-3-256; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; SUMMERS BA, 1995, VET NEUROPATHOLOGY, P189; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Ward JD, 1996, NEUROTRAUMA, P859; ZEGAR S, 1986, BIOMETRICS, V42, P121	17	14	17	0	2	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0021-9975			J COMP PATHOL	J. Comp. Pathol.	FEB-APR	2001	124	2-3					159	164		10.1053/jcpa.2000.0446			6	Pathology; Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Pathology; Veterinary Sciences	404ZL	WOS:000167132700010	11222013				2022-02-06	
J	Lehnung, M; Leplow, B; Herzog, A; Benz, B; Ritz, A; Stolze, H; Mehdorn, M; Ferstl, R				Lehnung, M; Leplow, B; Herzog, A; Benz, B; Ritz, A; Stolze, H; Mehdorn, M; Ferstl, R			Children's spatial behavior is differentially affected after traumatic brain injury	CHILD NEUROPSYCHOLOGY			English	Article							PEDIATRIC HEAD-INJURY; PRESCHOOL-CHILDREN; MEMORY; CHILDHOOD; MAZE; IMPAIRMENT; DEFICITS; RATS; CONSEQUENCES; LOCALIZATION	Spatial behavior in 20 children with severe traumatic brain injury (TBI) and 20 healthy controls was investigated using the Kiel Locomotor Maze. Children had to remember defined locations in an experimental chamber with completely controlled intra- and extra-maze cues until learning criterion was reached. In a second experiment, spatial orientation strategies were assessed. Children with TBI were shown to be impaired in spatial learning and spatial memory. Spatial orientation was found to be deficient even in cases where spatial learning and memory proved to be unimpaired, especially in tasks that demanded the use of relational place strategies. Children who suffered a TBI at an early age proved to be more severely impaired in spatial learning and orientation than older children.	Univ Kiel, Dept Psychol, D-24098 Kiel, Germany; Univ Halle Wittenberg, Dept Psychol, D-4010 Halle An Der Saale, Germany; Childrens Rehabil Ctr, Bremen, Germany; Univ Kiel, Dept Physiol, D-24098 Kiel, Germany; Univ Kiel, Clin Neurosurg, D-24098 Kiel, Germany		Lehnung, M (corresponding author), Univ Kiel, Dept Psychol, Olshausenstr 62, D-24098 Kiel, Germany.	lehnung@psychologie.uni-kiel.de	Mehdorn, Maximilian/D-2495-2010				AADLAND J, 1985, DEV PSYCHOBIOL, V18, P163, DOI 10.1002/dev.420180208; ACREDOLO LP, 1980, DEV PSYCHOL, V16, P312, DOI 10.1037/0012-1649.16.4.312; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; BENZ B, 1996, KINDH ENTWICK, V5, P201; Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Cornell EH, 1996, APPL COGNITIVE PSYCH, V10, P301, DOI 10.1002/(SICI)1099-0720(199608)10:4<301::AID-ACP383>3.3.CO;2-1; CORNELL EH, 1983, J EXP CHILD PSYCHOL, V35, P93, DOI 10.1016/0022-0965(83)90072-3; Dennis M, 1994, HDB PERCEPTION COGNI, P219; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; EWINGCOBBS L, 1997, J INT NEUROPSYCH SOC, V3, P568; FOREMAN N, 1984, DEV PSYCHOBIOL, V17, P129, DOI 10.1002/dev.420170204; FOREMAN N, 1994, BRIT J PSYCHOL, V85, P17, DOI 10.1111/j.2044-8295.1994.tb02505.x; FOREMAN N, 1990, J GEN PSYCHOL, V117, P267; FOREMAN N, 1990, J GEN PSYCHOL, V117, P215, DOI 10.1080/00221309.1990.9921139; Hallett T L, 1997, Pediatr Rehabil, V1, P219; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HUTTENLOCHER J, 1994, COGNITIVE PSYCHOL, V27, P115, DOI 10.1006/cogp.1994.1014; JORDAN FM, 1993, APHASIOLOGY, V7, P503, DOI 10.1080/02687039308248626; Lehnung M, 1998, BRIT J PSYCHOL, V89, P463, DOI 10.1111/j.2044-8295.1998.tb02697.x; LEHNUNG MM, 2000, ENTWICKLUNG RAUMLICH; LEPLOW B, 1994, NEUROPSYCHOLOGIE RAU; LEPLOW B, 1998, LECT NOTES ARTIFICAL; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin HS, 1996, CORTEX, V32, P461, DOI 10.1016/S0010-9452(96)80004-9; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; LordMaes J, 1996, J LEARN DISABIL, V29, P609, DOI 10.1177/002221949602900605; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Overman WH, 1996, BEHAV NEUROSCI, V110, P1205, DOI 10.1037/0735-7044.110.6.1205; OVERMAN WH, 1990, ANN NY ACAD SCI, V608, P365, DOI 10.1111/j.1749-6632.1990.tb48903.x; PIAGET J, 1975, NATURLICHE GEOMETRIE; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Sandberg EH, 1996, CHILD DEV, V67, P721, DOI 10.1111/j.1467-8624.1996.tb01761.x; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; SIEGEL AW, 1977, CHILD DEV, V48, P388; Soblosky JS, 1996, BEHAV BRAIN RES, V80, P185, DOI 10.1016/0166-4328(96)00034-4; Stolze H, 1997, ELECTROMYOGR MOTOR C, V105, P490, DOI 10.1016/S0924-980X(97)00055-6; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Yeates K., 2000, PEDIAT NEUROPSYCHOLO; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; [No title captured]	52	14	14	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2001	7	2					59	71		10.1076/chin.7.2.59.3129			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	535QU	WOS:000174656400001	11935414				2022-02-06	
J	Kerr, ME; Marion, D; Sereika, SM; Weber, BB; Orndoff, PA; Henker, R; Wilberger, J				Kerr, ME; Marion, D; Sereika, SM; Weber, BB; Orndoff, PA; Henker, R; Wilberger, J			The effect of cerebrospinal fluid drainage on cerebral perfusion in traumatic brain injured adults	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						cerebral spinal fluid; cerebral perfusion; traumatic brain injury	SEVERE HEAD-INJURY; INTRACRANIAL HYPERTENSION; CARE MANAGEMENT; PRESSURE; BLOOD; EDEMA; SYSTEM; WATER; ICP	Cerebrospinal fluid drainage is a first line treatment used to manage severely elevated intracranial pressure (greater than or equal to 20 mm Pig) and improve outcomes in patients with acute head injury. There is no consensus regarding the optimal method of cerebrospinal fluid removal. The purpose of this investigation was to determine whether cerebrospinal fluid drainage decreases intracranial pressure and improves cerebral perfusion and to identify factors that impact treatment effectiveness. This study involved 31 severely head injured patients. Intracranial pressure and other indices of cerebral perfusion (cerebral perfusion pressure, cerebral blood now velocity, and regional cerebral oximetry) were measured before, during, and after cerebrospinal fluid drainage. Arterial and jugular venous oxygen content was measured before and after cerebrospinal fluid drainage. Patients underwent three randomly ordered cerebrospinal fluid drainage protocols that varied in the volume of cerebrospinal fluid removed (1 mL, 2 mL, and 3 mL) for a total of 6 mL of cerebrospinal fluid removed. There was a significant change in the intracranial pressure from a mean at baseline of 26.1 mm Pig (SD = 4.4) to 22.1 mm Pig immediately after drainage. One third of patients experienced a decrease in the intracranial pressure below 20 mm Pig; in two patients the intracranial pressure dropped less than 1 mm Pig. The following factors predicted 61.5% of the variance in the responsiveness of intracranial pressure to drainage: vecuronium hypothermia, baseline cerebral perfusion pressure and acuity of illness. Cerebrospinal fluid drainage provides a transient decrease in intracranial pressure without a measurable improvement in other indices of cerebral perfusion.	Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA; Allegheny Gen Hosp, Pittsburgh, PA 15212 USA		Kerr, ME (corresponding author), Univ Pittsburgh, Sch Nursing, 4200 5th Ave, Pittsburgh, PA 15213 USA.				NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [NR03451] Funding Source: Medline; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR003451] Funding Source: NIH RePORTER		ARTRU AA, 1988, J CEREBR BLOOD F MET, V8, P750, DOI 10.1038/jcbfm.1988.123; ARTRU AA, 1987, J CEREBR BLOOD F MET, V7, P471, DOI 10.1038/jcbfm.1987.90; BORN JD, 1984, NEUROCHIRURGIE, V30, P329; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Chesnut R M, 1991, Neurosurg Clin N Am, V2, P267; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; CRUZ J, 1993, ACTA NEUROCHIR, P86; Czosnyka M, 1996, CEREBROVAS BRAIN MET, V8, P273; DURWARD QJ, 1983, J NEUROSURG, V59, P803, DOI 10.3171/jns.1983.59.5.0803; EARLY CB, 1974, J NEUROSURG, V41, P590, DOI 10.3171/jns.1974.41.5.0590; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; GHAJAR JB, 1993, ADV NEUROSURG, P173; Go K G, 1997, Adv Tech Stand Neurosurg, V23, P47; GREGORY IC, 1974, J PHYSIOL-LONDON, V236, P625, DOI 10.1113/jphysiol.1974.sp010456; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JAMES HE, 1976, J TRAUMA, V16, P437, DOI 10.1097/00005373-197606000-00002; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LANGFITT TW, 1971, CLIN DEV MED, P118; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; Miller J D, 1993, Acta Neurochir Suppl (Wien), V57, P152; Miller J D, 1979, Acta Neurochir Suppl (Wien), V28, P86; MILLER JD, 1987, ACTA NEUROCHIR, V85, P80, DOI 10.1007/BF01456102; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; PAPO I, 1981, ACTA NEUROCHIR, V56, P191, DOI 10.1007/BF01407230; REULEN HJ, 1976, BRIT J ANAESTH, V48, P741, DOI 10.1093/bja/48.8.741; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729	29	14	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2000	12	4					324	333		10.1097/00008506-200010000-00005			10	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	360PL	WOS:000089676400005	11147381				2022-02-06	
J	Satoh, H; Kumano, K; Ogami, R; Nishi, T; Onda, J; Nishimura, S; Kurisu, K				Satoh, H; Kumano, K; Ogami, R; Nishi, T; Onda, J; Nishimura, S; Kurisu, K			Sigmoid sinus thrombosis after mild closed head injury in an infant: Diagnosis by magnetic resonance imaging in the acute phase - Case Report	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						sinus thrombosis; sigmoid sinus; closed head injury; magnetic resonance imaging	CEREBRAL VENOUS THROMBOSIS; DURAL SINUS; HIGH-FIELD; BLOOD	Intracranial sinus thrombosis following a mild closed head injury without a skull fracture or intracranial hematoma is extremely rare. A 23-month-old girl presented with vomiting and gait ataxia 1 day after occipital trauma. Computed tomography revealed a slightly increased density area in the region of the left sigmoid sinus. T-1-weighted magnetic resonance (MR) imaging demonstrated an isointense area in the left sigmoid sinus and T-2-weighted imaging showed a hyperintense area reflecting the characteristics of oxyhemoglobin. MR angiography and cerebral angiography indicated occlusion of the left sigmoid sinus. After 4 days of conservative treatment, her symptoms subsided completely. Follow-up MR angiography and cerebral angiography showed recanalization of the sigmoid sinus. The MR images and MR angiograms were useful for both early diagnosis and follow-up. Treatment should reflect the severity of individual cases, and early diagnosis will help achieve a good outcome.	Kitakyushu Gen Hosp, Dept Neurosurg, Fukuoka, Japan; Hiroshima Univ, Sch Med, Dept Neurosurg, Hiroshima, Japan		Satoh, H (corresponding author), Hiroshima Prefectural Hosp, Dept Neurosurg, Minami Ku, 1-5-54 Ujina Kanda, Hiroshima 7348530, Japan.						AMERI A, 1992, NEUROL CLIN, V10, P87, DOI 10.1016/S0733-8619(18)30235-4; BJORNEBRINK J, 1976, ANGIOLOGY, V27, P688, DOI 10.1177/000331977602701203; BOUSSER MG, 1985, STROKE, V16, P199, DOI 10.1161/01.STR.16.2.199; BUOANNO F, 1978, J COMPUT ASSIST TOMO, V2, P281; CARRIE AW, 1954, J NEUROSURG, V11, P173, DOI 10.3171/jns.1954.11.2.0173; CRIMMINS TJ, 1984, J NEUROSURG, V60, P179, DOI 10.3171/jns.1984.60.1.0179; D'Alise MD, 1998, SURG NEUROL, V49, P430, DOI 10.1016/S0090-3019(97)00182-1; EINHAUPL KM, 1991, LANCET, V338, P597, DOI 10.1016/0140-6736(91)90607-Q; Ferrera PC, 1998, AM J EMERG MED, V16, P382, DOI 10.1016/S0735-6757(98)90134-6; GOLDBERG AL, 1986, J COMPUT ASSIST TOMO, V10, P16, DOI 10.1097/00004728-198601000-00003; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; HESSELBROCK R, 1985, NEUROSURGERY, V16, P825, DOI 10.1227/00006123-198506000-00017; ISENSEE C, 1994, STROKE, V25, P29, DOI 10.1161/01.STR.25.1.29; Kannuki S, 1990, No To Shinkei, V42, P781; KINAL ME, 1967, J NEUROSURG, V27, P142, DOI 10.3171/jns.1967.27.2.0142; Kuether TA, 1998, NEUROSURGERY, V42, P1163, DOI 10.1097/00006123-199805000-00129; MACCHI PJ, 1986, J COMPUT ASSIST TOMO, V10, P10, DOI 10.1097/00004728-198601000-00002; MCLEAN BN, 1991, BRIT J HOSP MED, V45, P226; MCMURDO SK, 1986, RADIOLOGY, V161, P83, DOI 10.1148/radiology.161.1.3763888; PROVENZALE JM, 1994, J COMPUT ASSIST TOMO, V18, P719, DOI 10.1097/00004728-199409000-00007; RIPPE DJ, 1990, AM J NEURORADIOL, V11, P199; Satoh Hideki, 1993, Neurological Surgery, V21, P953; STRINGER WL, 1983, NEUROSURGERY, V12, P95; SUEISHI K, 1989, THROMBOSIS, P85; SUZUKI M, 1994, THROMB HAEMOSTASIS, V71, P155; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; THULBORN KR, 1982, BIOCHIM BIOPHYS ACTA, V714, P265, DOI 10.1016/0304-4165(82)90333-6; TSAI FY, 1992, AM J NEURORADIOL, V13, P1137; VIRAPONGSE C, 1987, RADIOLOGY, V162, P779, DOI 10.1148/radiology.162.3.3809494	29	14	15	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0387-2572			NEUROL MED-CHIR	Neurol. Med.-Chir.	JUL	2000	40	7					361	365		10.2176/nmc.40.361			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	337JN	WOS:000088354200011	10927903	Bronze			2022-02-06	
J	Mamelak, M				Mamelak, M			The motor vehicle collision injury syndrome	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article							TRAUMATIC BRAIN INJURY; EMISSION COMPUTED-TOMOGRAPHY; CEREBRAL BLOOD-FLOW; MILD HEAD-INJURY; CHRONIC FATIGUE SYNDROME; TECHNETIUM-99M-HMPAO SPECT; WHIPLASH INJURY; FOLLOW-UP; MAJOR DEPRESSION; MITOCHONDRIAL DYSFUNCTION	Objective: The objective of this study was to examine the central nervous system changes that may occur after acceleration/deceleration injuries in motor vehicle accidents. Background: Occupants of motor vehicles involved in a collision often develop a disabling syndrome consisting of head, neck, and back pain, impaired short-term memory and concentration; fatigue and a loss of stamina, poor balance; and a change in personality. Injury victims experience a loss of motivation, emotional lability, and a decrease in libido. The major features of this injury syndrome are subjective, and there usually are few objective findings on physical examination. The pathogenesis of this syndrome is poorly understood. but it is hypothesized that the collision impact produces an inertial strain injury to the anterior regions of the brain which depresses the functions of the frontotemporal lobes, at the same time, sensitizing somatosensory neural afferent systems. Damage to the orbital surfaces of the frontotemporal lobes, in particular, impairs the gating mechanisms that normally limit sensory input to the brain and further promotes central sensitization. The psychiatric disorders that emerge in the wake of these injuries are likely grounded in these pathologic events. Method: The current literature on the biomechanics of head injury and the associated brain imaging findings in minor head injury are reviewed. A summary of some of the biochemical sequelae of strain injury to the brain is also provided, with an emphasis on the changes in energy metabolism and excitatory amino acid release. Results and Conclusions: Early intervention to arrest the injury-induced metabolic cascade, and treatment with agents that activate cerebral metabolism may mitigate the symptoms of this injury syndrome.	Baycrest Ctr Geriatr Care, Toronto, ON M6A 2E1, Canada; Univ Toronto, Dept Psychiat, Toronto, ON, Canada		Mamelak, M (corresponding author), Baycrest Ctr Geriatr Care, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.						Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Alexander MP, 1998, NEUROLOGY, V51, P336, DOI 10.1212/WNL.51.2.336; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Andreasen NC, 1997, LANCET, V349, P1730, DOI 10.1016/S0140-6736(96)08258-X; Armstead WM, 1997, P SOC EXP BIOL MED, V214, P210; Bendtsen L, 1997, ARTHRITIS RHEUM, V40, P98, DOI 10.1002/art.1780400114; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bicik I, 1998, NEUROLOGY, V51, P345, DOI 10.1212/WNL.51.2.345; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Blanchard EB, 1998, J TRAUMA STRESS, V11, P337, DOI 10.1023/A:1024407321677; Bryant B, 1997, MED SCI LAW, V37, P326, DOI 10.1177/002580249703700408; Buskila D, 1997, ARTHRITIS RHEUM, V40, P446, DOI 10.1002/art.1780400310; Castejon OJ, 1998, J SUBMICR CYTOL PATH, V30, P145; CODERRE TJ, 1993, PAIN, V52, P259, DOI 10.1016/0304-3959(93)90161-H; DEROO M, 1989, EUR J NUCL MED, V15, P9, DOI 10.1007/BF00253592; Drevets WC, 1998, ANNU REV MED, V49, P341, DOI 10.1146/annurev.med.49.1.341; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Elsasser A, 1997, CIRCULATION, V96, P2920, DOI 10.1161/01.CIR.96.9.2920; FEE CRA, 1988, ARCH EMERG MED, V5, P12; Ferrari MD, 1998, LANCET, V351, P1043, DOI 10.1016/S0140-6736(97)11370-8; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Fischer AJEM, 1997, CLIN OTOLARYNGOL, V22, P192, DOI 10.1046/j.1365-2273.1997.00031.x; Fischler B, 1996, NEUROPSYCHOBIOLOGY, V34, P175, DOI 10.1159/000119307; FRERICHS KU, 1995, AM J PHYSIOL-REG I, V268, pR445, DOI 10.1152/ajpregu.1995.268.2.R445; Fuster, 2015, PREFRONTAL CORTEX; Galynker II, 1998, J NUCL MED, V39, P608; Gennarelli T, 1996, NEUROSURGERY, V2, P2611; Goodwin GM, 1997, BRIT J PSYCHIAT, V170, P426, DOI 10.1192/bjp.170.5.426; Goodwin GM, 1997, J PSYCHOPHARMACOL, V11, P115, DOI 10.1177/026988119701100204; GRAY BG, 1992, J NUCL MED, V33, P52; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Ho AP, 1996, ARCH GEN PSYCHIAT, V53, P645; HOFFMAN WE, 1986, ANESTH ANALG, V65, P639; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; ICHISE M, 1994, J NUCL MED, V35, P217; ICHISE M, 1992, NUCL MED COMMUN, V13, P767, DOI 10.1097/00006231-199213100-00011; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; JENKINS A, 1986, LANCET, V2, P445; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Klemm E, 1996, PSYCHIAT RES-NEUROIM, V68, P1, DOI 10.1016/S0925-4927(96)02837-5; LANCE JW, 1973, MECH MANAGEMENT HEAD; Lenz FA, 1998, J NEUROPHYSIOL, V79, P2231, DOI 10.1152/jn.1998.79.4.2231; Liddle PF, 1996, BRIT MED BULL, V52, P486; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Mamelak M, 1997, J GERIATR PSYCH NEUR, V10, P29, DOI 10.1177/089198879701000106; MCCANDLESS DW, 1981, BRAIN RES, V215, P225, DOI 10.1016/0006-8993(81)90504-7; MENDELSON G, 1984, INT J LAW PSYCHIAT, V7, P179, DOI 10.1016/0160-2527(84)90031-1; MICHAEL GM, 1992, AM J EMERG MED, V10, P24; MIGLIORELLI R, 1993, J NEUROPSYCH CLIN N, V5, P379; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; MOGHADDAM B, 1993, J NEUROCHEM, V60, P1650, DOI 10.1111/j.1471-4159.1993.tb13387.x; Moller AR, 1997, AM J OTOL, V18, P577; MORRIS JH, 1989, ROBBINS PATHOLOGIC B, P1385; MOUNTZ JM, 1995, ARTHRITIS RHEUM, V38, P926, DOI 10.1002/art.1780380708; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; NORDHOFF LS, 1996, MOTOR VEHICLE COLLIS; OCONNELL RA, 1995, J NEUROIMAGING, V5, P101, DOI 10.1111/jon199552101; OLESEN J, 1991, CEREBROVAS BRAIN MET, V3, P1; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; PAKHOTIN PI, 1993, PROG NEUROBIOL, V40, P123, DOI 10.1016/0301-0082(93)90021-J; PAZDERNIK T, 1994, NEUROCHEM RES, V19, P1393, DOI 10.1007/BF00972468; PEARCE JMS, 1994, NEUROLOGY, V44, P1993, DOI 10.1212/WNL.44.11.1993; RADANOV BP, 1995, MEDICINE, V74, P281, DOI 10.1097/00005792-199509000-00005; Rao VLR, 1998, J NEUROCHEM, V70, P2020; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Russo CM, 1998, ANNU REV MED, V49, P123; Sabri O, 1997, LANCET, V349, P1735, DOI 10.1016/S0140-6736(96)08380-8; Sataloff RT, 1996, AM J OTOL, V17, P909; Schlaepfer TE, 1998, AM J PSYCHIAT, V155, P470, DOI 10.1176/ajp.155.4.470; SCHWARTZ RB, 1994, AM J ROENTGENOL, V162, P943, DOI 10.2214/ajr.162.4.8141022; SETO H, 1994, CLIN NUCL MED, V19, P215, DOI 10.1097/00003072-199403000-00010; SKINNER J E, 1973, P185; Sorensen J, 1998, J RHEUMATOL, V25, P152; STANDAERT DG, 1996, PHARMACOL BASIS THER, P503; STARKSTEIN SE, 1990, ANN NEUROL, V27, P652, DOI 10.1002/ana.410270612; STARKSTEIN SE, 1988, J NERV MENT DIS, V176, P87, DOI 10.1097/00005053-198802000-00004; Stoffel M, 1997, ACT NEUR S, V70, P91; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TENJIN H, 1994, NEUROSURGERY, V35, P971; TIIHONEN J, 1995, BIOL PSYCHIAT, V37, P134, DOI 10.1016/0006-3223(94)00230-Z; Vanoverschelde JLJ, 1997, CIRCULATION, V95, P1961; VARNEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; Venneri A, 1998, NEUROLOGY, V50, P186, DOI 10.1212/WNL.50.1.186; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; VIANO DC, 1998, P 32 STRAPP CAR CRAS, P1; Vink R, 1996, J NEUROCHEM, V66, P2477; Wallis BJ, 1996, PAIN, V66, P223, DOI 10.1016/0304-3959(96)03044-8; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; 1962, LORD BRAIN DIS NERVO	100	14	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	APR	2000	13	2					125	135					11	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	408AL	WOS:000167304300007	10780631				2022-02-06	
J	Orliaguet, C; Rakotoniaina, S; Meyer, P; Blanot, S; Carli, P				Orliaguet, C; Rakotoniaina, S; Meyer, P; Blanot, S; Carli, P			Effect of a pulmonary contusion on the outcome of severely head injured children.	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						head trauma; pulmonary contusion	TRAUMATIC BRAIN INJURY; COMPUTED-TOMOGRAPHY; CHEST INJURIES; SEVERITY; SCALE; PATHOPHYSIOLOGY; MANAGEMENT; PREDICTORS; CHILDHOOD; ADULT	Objectives: To assess the effects of a pulmonary contusion (PC) on the outcome of a severe head trauma (SHT) in children less than -15-year-old. Study design: Retrospective study. Patients: The study included 30 severely head injured children with a Glasgow Coma Scale score (GCS) less than or equal to 8, associated with a PC (PC+) diagnosed on a thoracic CT-scan and 30 severely head injured children without PC (PC-). Methods: Outcome was assessed using the Glasgow Outcome Scale (GOS), on discharge and six months later. Age, body weight, gender, GCS, PTS, ISS, hypoxaemia, arterial hypotension, the results of the cerebral CT-scan, the main treatment administered, complications, the duration of tracheal intubation as well as the duration of stay in the intensive care unit (ICU) and in the hospital were compared between groups. Results: GCS median was lower (6 vs 8, P = 0.001) and ISS median higher (25 vs 23, P = 0.0004) in the PC+ group. Hypoxaemia was more frequent in the PC+ group (n = 12 vs n = 0, P= 0.0001). There was no difference between groups regarding the results of cerebral CT scan. Blood transfusion was more frequently used in the PC+ group (n = 14 vs n = 5, P= 0.03). Median duration of tracheal intubation, and of stay in the ICU and in the hospital were shorter in the PC- group (respectively 8 vs 6 days, P= 0.03; 10 vs 7.5 days, P= 0.008; 13.5 vs 10.5 days, P= 0.01). No difference was observed regarding complications between groups. GOS on discharge was higher in the PC+ group (3 vs 2, P = 0.01). There was an increase in GOS at six months in the two groups, however GOS remained significantly higher in the PC+ group (median values 2 vs 1, P = 0.002). A favourable outcome occurred less frequently in the PC+ group on discharge and at six months (respectively n = 14 vs 25, P= 0.006; n = 20 vs 28, P= 0.02). Conclusion: The association of a PC to a severe head trauma is responsible for a poorer outcome in children, probably because, at least in part, a higher incidence of hypoxaemia. (C) 2000 Editions scientifiques et medicales Elsevier SAS.	Hop Necker Enfants Malad, Detp Anesthesie Reanimat Chirurg & Samu Paris, F-75743 Paris 15, France		Orliaguet, C (corresponding author), Hop Necker Enfants Malad, Detp Anesthesie Reanimat Chirurg & Samu Paris, 149 Rue Sevres, F-75743 Paris 15, France.		Meyer, Philippe/ABE-4242-2020	Meyer, Philippe/0000-0002-3829-6631; Orliaguet, Gilles/0000-0003-0930-2251			Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Allen GS, 1998, SOUTHERN MED J, V91, P1099, DOI 10.1097/00007611-199812000-00002; Allen GS, 1997, J AM COLL SURGEONS, V185, P229, DOI 10.1016/S1072-7515(01)00920-6; Black TL, 1996, SOUTHERN MED J, V89, P494, DOI 10.1097/00007611-199605000-00009; BONADIO WA, 1989, ANN EMERG MED, V18, P1050, DOI 10.1016/S0196-0644(89)80929-1; BRUCE DA, 1979, CHILD BRAIN, V5, P174; DEBEUGNY P, 1991, ANN CHIR, V45, P549; EICHELBERGER MR, 1988, J TRAUMA, V28, P1109, DOI 10.1097/00005373-198808000-00002; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; JENNETT B, 1975, LANCET, V1, P480; KRAUS JF, 1987, PEDIATRICS, V79, P501; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Magu S, 1998, J Indian Med Assoc, V96, P13; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; Meyer P, 1999, CHILD NERV SYST, V15, P732, DOI 10.1007/s003810050462; MEYER P, 1993, REANIM SOINS INTENS, V9, P134; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NAKAYAMA DK, 1989, ANN SURG, V210, P770, DOI 10.1097/00000658-198912000-00013; OPPENHEIMER L, 1979, J APPL PHYSIOL, V47, P718, DOI 10.1152/jappl.1979.47.4.718; ORLIAGUET G, 1996, MED URGENCE, P87; Orliaguet GA, 1998, ANESTH ANALG, V87, P537, DOI 10.1097/00000539-199809000-00006; PEPE PE, 1982, AM J SURG, V144, P124, DOI 10.1016/0002-9610(82)90612-2; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Pinella J, 1982, J TRAUMA, V22, P221; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; Task Force on Blood Pressure Control in Children, 1987, PEDIATRICS, V79, P1; TEPAS JJ, 1988, J TRAUMA, V28, P425, DOI 10.1097/00005373-198804000-00001; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Tocino I, 1987, J Thorac Imaging, V2, P45, DOI 10.1097/00005382-198707000-00008; VENUS B, 1988, CRIT CARE MED, V16, P686, DOI 10.1097/00003246-198807000-00008; WAGNER RB, 1989, SURG CLIN N AM, V69, P31; ZIMMERMAN RA, 1978, RADIOLOGY, V126, P403, DOI 10.1148/126.2.403	37	14	14	0	0	EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS CEDEX 15	23 RUE LINOIS, 75724 PARIS CEDEX 15, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.	MAR	2000	19	3					164	170					7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	301ZL	WOS:000086340400004	10782239				2022-02-06	
J	Hu, WH; Qiang, WA; Li, F; Liu, N; Wang, GQ; Wang, HY; Wan, XCST; Liao, WH; Liu, JS; Jen, MF				Hu, WH; Qiang, WA; Li, F; Liu, N; Wang, GQ; Wang, HY; Wan, XCST; Liao, WH; Liu, JS; Jen, MF			Constitutive and inducible nitric oxide synthases after dynorphin-induced spinal cord injury	JOURNAL OF CHEMICAL NEUROANATOMY			English	Article						nitric oxide; nitric oxide synthase; dynorphin; spinal cord injury; neurotoxicity	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; DORSAL HORN NEURONS; NADPH-DIAPHORASE; MESSENGER-RNA; OPIOID RECEPTORS; NEONATAL RAT; GLIAL-CELLS; EXPRESSION	It has recently been demonstrated that selective inhibition of both neuronal constitutive and inducible nitric oxide synthases (ncNOS and iNOS) is neuroprotective in a model of dynorphin (Dyn) A(1-17)-induced spinal cord injury. In the present study, various methods including the conversion of H-3-L-arginine to H-3-citrulline, immunohistochemistry and in situ hybridization are employed to determine the temporal profiles of the enzymatic activities, immunoreactivities, and mRNA expression for both ncNOS and iNOS after intrathecal injection of a neurotoxic dose (20 nmol) of Dyn A(1-17). The expression of ncNOS immunoreactivity and mRNA increased as early as 30 min after injection and persisted for 1-4 h. At 24-48 h, the number of ncNOS positive cells remained elevated while most neurons died. The cNOS enzymatic activity in the ventral spinal cord also significantly increased at 30 min-48 h, but no significant changes in the dorsal spinal cord were observed. However, iNOS mRNA expression increased later at 2 h, iNOS immunoreactivity and enzymatic activity increased later at 4 h and persisted for 24-48 h after injection of 20 nmol Dyn A(1-17). These results indicate that both ncNOS and iNOS are associated with Dyn-induced spinal cord injury, with ncNOS predominantly involved at an early stags and iNOS at a later stage: (C) 2000 Elsevier Science B.V. All rights reserved.	Third Mil Med Univ, Inst Surg Res, Dept Spinal Cord Injury, Chongqing 400042, Peoples R China; Third Mil Med Univ, Daping Hosp, Chongqing 400042, Peoples R China; Peking Union Med Coll, Inst Basic Med Sci, Dept Pharmacol, Beijing 100005, Peoples R China; Peking Union Med Coll, Inst Basic Med Sci, Dept Neurobiol, Beijing 100005, Peoples R China; Chinese Acad Med Sci, Beijing 100005, Peoples R China		Hu, WH (corresponding author), Third Mil Med Univ, Inst Surg Res, Dept Spinal Cord Injury, Chongqing 400042, Peoples R China.	huwenhui98@hotmail.com	Qiang, Wenan/AAA-7633-2021	Qiang, Wenan/0000-0001-5068-7128			Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; Behrens MI, 1996, NEUROBIOL DIS, V3, P72, DOI 10.1006/nbdi.1996.0007; BEHRMANN DL, 1993, EXP NEUROL, V119, P258, DOI 10.1006/exnr.1993.1028; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bishop A, 1999, FREE RADICAL BIO MED, V26, P978, DOI 10.1016/S0891-5849(98)00284-6; Bolanos JP, 1999, BBA-BIOENERGETICS, V1411, P415, DOI 10.1016/S0005-2728(99)00030-4; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Callsen-Cencic P, 1999, CELL TISSUE RES, V295, P183, DOI 10.1007/s004410051224; Catalan RE, 1996, NEUROSCI RES, V25, P195; CHEN B, 1995, CHIN J PHARM TOXICOL, V9, P36; Coeroli L, 1998, J NEUROCHEM, V70, P2516; DALKARA T, 1994, BRAIN PATHOL, V4, P49; DUBNER R, 1992, TRENDS NEUROSCI, V15, P96, DOI 10.1016/0166-2236(92)90019-5; DUMONT M, 1994, EUR J PHARMACOL, V271, P241, DOI 10.1016/0014-2999(94)90288-7; DUN NJ, 1993, NEUROSCIENCE, V54, P845, DOI 10.1016/0306-4522(93)90579-5; ENDOH M, 1993, NEUROSCI LETT, V154, P125, DOI 10.1016/0304-3940(93)90187-P; Faden A I, 1987, Cent Nerv Syst Trauma, V4, P227; FADEN AI, 1990, ANN NEUROL, V27, P67, DOI 10.1002/ana.410270111; Grossman SD, 1999, J NEUROSCI, V19, P5711, DOI 10.1523/JNEUROSCI.19-14-05711.1999; Guizar-Sahagun G, 1998, NEUROREPORT, V9, P2899, DOI 10.1097/00001756-199808240-00040; Haas J, 1999, NEUROSCI LETT, V264, P129, DOI 10.1016/S0304-3940(99)00191-3; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; Hammarberg H, 1998, J COMP NEUROL, V400, P57; HANEMANN CO, 1993, J HISTOCHEM CYTOCHEM, V41, P1383, DOI 10.1177/41.9.8354878; HASSAN AHS, 1992, NEUROSCI LETT, V140, P85, DOI 10.1016/0304-3940(92)90688-4; Herz A, 1996, PROG BRAIN RES, V110, P95; Higuchi Y, 1996, BRAIN DEV-JPN, V18, P369, DOI 10.1016/0387-7604(96)00019-8; Hu WH, 1996, NEUROSCI LETT, V203, P13, DOI 10.1016/0304-3940(95)12246-X; Hu WH, 1998, EUR J PHARMACOL, V342, P325, DOI 10.1016/S0014-2999(97)01492-1; Hu WH, 1999, J NEUROTRAUM, V16, P85, DOI 10.1089/neu.1999.16.85; HYLDEN JLK, 1991, PAIN, V44, P187, DOI 10.1016/0304-3959(91)90136-L; HYMAN BT, 1992, ANN NEUROL, V32, P818, DOI 10.1002/ana.410320618; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P52, DOI 10.1038/jcbfm.1995.6; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; IKESHIMA H, 1993, J NEUROSCI RES, V36, P111, DOI 10.1002/jnr.490360112; Jacobsson G, 1998, EUR J NEUROSCI, V10, P301, DOI 10.1046/j.1460-9568.1998.00050.x; Kaur C, 1999, HISTOL HISTOPATHOL, V14, P417, DOI 10.14670/HH-14.417; Knerlich F, 1999, MOL BRAIN RES, V68, P73, DOI 10.1016/S0169-328X(99)00064-9; Laughlin TM, 1997, PAIN, V72, P253, DOI 10.1016/S0304-3959(97)00046-8; Lecanu L, 1998, BRIT J PHARMACOL, V125, P584, DOI 10.1038/sj.bjp.0702119; LI FC, 1997, CHIN J REHABIL THEOR, V3, P6; Li QS, 1999, J HUMAN VIROL, V2, P139; Licinio J, 1999, MOL MED TODAY, V5, P225, DOI 10.1016/S1357-4310(99)01453-7; LIU SF, 1993, BIOCHEM BIOPH RES CO, V196, P1208, DOI 10.1006/bbrc.1993.2380; LONG JB, 1994, J PHARMACOL EXP THER, V269, P358; MacLennan AJ, 1999, NEUROSCIENCE, V91, P1401, DOI 10.1016/S0306-4522(98)00717-9; Marsala J, 1997, EXP NEUROL, V145, P165, DOI 10.1006/exnr.1997.6455; MAYER B, 1990, FEBS LETT, V277, P215, DOI 10.1016/0014-5793(90)80848-D; McCann SM, 1998, EXP GERONTOL, V33, P813, DOI 10.1016/S0531-5565(98)00050-3; Meyding-Lamade U, 1998, NEUROSCI LETT, V244, P9, DOI 10.1016/S0304-3940(98)00115-3; MOLANDER C, 1984, J COMP NEUROL, V230, P133, DOI 10.1002/cne.902300112; MUFSON EJ, 1994, NEUROREPORT, V5, P705, DOI 10.1097/00001756-199402000-00011; MURPHY S, 1993, TRENDS NEUROSCI, V16, P323, DOI 10.1016/0166-2236(93)90109-Y; Nakagomi S, 1999, EUR J NEUROSCI, V11, P2160, DOI 10.1046/j.1460-9568.1999.00634.x; Parkinson JF, 1997, J MOL MED, V75, P174, DOI 10.1007/s001090050102; Perez-Severiano F, 1998, NEUROCHEM RES, V23, P1297, DOI 10.1023/A:1020700401678; QIANG WA, 1996, CHIN J MED, V76, P567; Rao AM, 1998, BRAIN RES, V793, P265, DOI 10.1016/S0006-8993(98)00183-8; SALTER M, 1991, FEBS LETT, V291, P145, DOI 10.1016/0014-5793(91)81123-P; SCHMIDT W, 1995, NEUROSCIENCE, V67, P345, DOI 10.1016/0306-4522(95)00027-G; Seidel B, 1997, NEUROSCI LETT, V239, P109, DOI 10.1016/S0304-3940(97)00912-9; Sheng Wen S., 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P359; Shibata T, 1999, J COMP NEUROL, V404, P172, DOI 10.1002/(SICI)1096-9861(19990208)404:2<172::AID-CNE3>3.0.CO;2-U; SHUKLA VK, 1994, TRENDS PHARMACOL SCI, V15, P420, DOI 10.1016/0165-6147(94)90091-4; SKILLING SR, 1992, BRAIN RES, V575, P272, DOI 10.1016/0006-8993(92)90090-V; Stojkovic T, 1998, GLIA, V22, P329, DOI 10.1002/(SICI)1098-1136(199804)22:4<329::AID-GLIA2>3.0.CO;2-Z; Strijbos PJLM, 1998, CRIT REV NEUROBIOL, V12, P223, DOI 10.1615/CritRevNeurobiol.v12.i3.40; Tachibana T, 1998, J NEUROTRAUM, V15, P485, DOI 10.1089/neu.1998.15.485; Takeuchi A, 1998, EUR J NEUROSCI, V10, P1613, DOI 10.1046/j.1460-9568.1998.00168.x; TIAN XF, 1994, CHIN J PHYSL SCI, V10, P289; VANDAM AM, 1995, J NEUROSCI RES, V40, P251, DOI 10.1002/jnr.490400214; VIZZARD MA, 1994, J COMP NEUROL, V339, P62, DOI 10.1002/cne.903390107; Vizzard MA, 1997, DEV NEUROSCI-BASEL, V19, P232, DOI 10.1159/000111212; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; WALLACE MN, 1992, NEUROREPORT, V3, P953, DOI 10.1097/00001756-199211000-00001; Winkler T, 1998, AMINO ACIDS, V14, P131, DOI 10.1007/BF01345253; WU W, 1994, NEUROSCIENCE, V61, P719, DOI 10.1016/0306-4522(94)90394-8; Xu M, 1998, BRAIN RES, V808, P23, DOI 10.1016/S0006-8993(98)00787-2; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yamanaka K, 1998, NEUROSCI RES, V31, P347, DOI 10.1016/S0168-0102(98)00052-2; Zhang FY, 1996, STROKE, V27, P317, DOI 10.1161/01.STR.27.2.317; ZHANG ZG, 1994, BRAIN RES, V654, P85	84	14	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0891-0618	1873-6300		J CHEM NEUROANAT	J. Chem. Neuroanat.	JAN	2000	17	4					183	197		10.1016/S0891-0618(99)00039-3			15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	285FX	WOS:000085380000001	10697245				2022-02-06	
J	Pentland, LM; Anderson, VA; Wrennall, JA				Pentland, LM; Anderson, VA; Wrennall, JA			The implications of childhood bacterial meningitis for language development	CHILD NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; INFLUENZAE MENINGITIS; NARRATIVE DISCOURSE; ADVERSE OUTCOMES; CHILDREN; SEQUELAE; AGE; SURVIVORS; IRRADIATION; ADOLESCENTS	Bacterial meningitis is a life threatening infection of the central nervous system. This illness is most prevalent early in life when the healthy child is rapidly acquiring language. This study investigated whether children with a history of bacterial meningitis were at risk for language difficulties post illness. Thirty post-meningitic children, aged between 9 years 0 months and 11 years 0 months, participated in this study. Each subject was administered a measure of non-verbal cognitive ability and a range of language tasks. These children performed poorly on applied language tasks, which tap skills used in effective discourse. These deficits occurred despite age appropriate performances on measures of linguistic/grammatical knowledge. These findings clearly illustrate that bacterial meningitis has implications for ongoing language development, which emphasises the importance of long term follow up. In developmental terms, this discrepancy between verbal knowledge and problem solving represents a dissociation between language skills which develop early in life and those which emerge later. This pattern of results suggests that bacterial meningitis may result in a delay in language development. A young age at illness was identified as an additional risk factor for adverse outcome. This study highlights the need to inform parents/guardians that post-meningitic children are at risk for experiencing language difficulties throughout childhood.	Royal Childrens Hosp, Dept Psychol, Parkville, Vic 3052, Australia; Univ Melbourne, Parkville, Vic 3052, Australia		Pentland, LM (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	l.pentland@pgrad.unimelb.edu.au					ALAJOUANINE T, 1965, BRAIN, V88, P653, DOI 10.1093/brain/88.4.653; Anderson RC, 1997, ADV OCCUP MED REHAB, V3, P47; ANDERSON V, 1994, ARCH DIS CHILD, V70, P476, DOI 10.1136/adc.70.6.476; Anderson V, 1997, J Int Neuropsychol Soc, V3, P147; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 1997, Pediatr Rehabil, V1, P63; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; Barnes MA, 1996, READING COMPREHENSION DIFFICULTIES, P251; BASSER LS, 1962, BRAIN, V85, P427, DOI 10.1093/brain/85.3.427; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Cohen J., 2013, STAT POWER ANAL BEHA; Daniel A., 1983, POWER PRIVILEGE PRES; DAVIES PA, 1994, CLIN DEV MED, V132; Dennis M, 1996, J NEURO-ONCOL, V29, P91, DOI 10.1007/BF00165522; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; DENNIS M, 1996, TRAUMATIC HEAD INJUR, P165; DENNIS M, 1990, DISCOURSE ABILITY BR, P199; DORVAL B, 1984, MONOGR SOC RES CHILD, V49, P1, DOI 10.2307/1165872; EISER C, 1978, ARCH DIS CHILD, V53, P391, DOI 10.1136/adc.53.5.391; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; FEIGN RD, 1992, TXB PEDIAT INFECT DI, P439; FRANCO SM, 1992, AM J DIS CHILD, V146, P567, DOI 10.1001/archpedi.1992.02160170047014; FRASER DW, 1982, EPIDEMIOLOGY HAEMOPH; GRIMWOOD K, 1995, PEDIATRICS, V95, P646; Grimwood K, 1996, J PAEDIATR CHILD H, V32, P457, DOI 10.1111/j.1440-1754.1996.tb00949.x; HEMPHILL L, 1994, J COMMUN DISORD, V27, P107, DOI 10.1016/0021-9924(94)90037-X; HERSON VC, 1977, PEDIATRICS, V59, P35; HORN JL, 1967, ACTA PSYCHOL, V26, P107, DOI 10.1016/0001-6918(67)90011-X; JADAVJI T, 1986, PEDIATRICS, V78, P21; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; KLEIN JO, 1986, PEDIATRICS, V75, P959; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; *LANG LEARN DIS SP, 1995, LANG LEARN CHECKL LA; Lennenberg E. H., 1967, BIOL FDN LANGUAGE; McGhee P. E., 1979, HUMOR ITS ORIGINS DE; Pan B. A., 1999, DEV LANGUAGE, P229; RUBENSTEIN CL, 1990, J DEV BEHAV PEDIATR, V11, P301; Schank R, 1977, SCRIPTS PLANS GOALS; SELL S, 1983, PEDIATR INFECT DIS J, V6, P775; Semel E., 1995, CLIN EVALUATION LANG, VThird; SNOW CE, 1977, J CHILD LANG, V4, P1, DOI 10.1017/S0305000900000453; TAKAHASHI K, 1992, J MATER SCI LETT, V11, P15, DOI 10.1007/BF00720768; TAYLOR HG, 1990, NEW ENGL J MED, V323, P1657, DOI 10.1056/NEJM199012133232403; TEUBER H, 1962, DEV MED CHILD NEUROL, V4, P20; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wiig E. H., 1989, TEST LANGUAGE COMPET; WRIGHT M, 1994, ARCH DIS CHILD, V71, P64, DOI 10.1136/adc.71.1.64; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375	52	14	14	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2000	6	2					87	100		10.1076/chin.6.2.87.7055			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	378GZ	WOS:000165577800002	16210206				2022-02-06	
J	Rashid, MA; Wikstrom, T; Ortenwall, P				Rashid, MA; Wikstrom, T; Ortenwall, P			Cardiac injuries: a ten-year experience	EUROPEAN JOURNAL OF SURGERY			English	Article; Proceedings Paper	European Symposium on Trauma	SEP, 1998	LINKOPING, SWEDEN			heart injuries; pericardial tamponade; myocardial contusion; commotio cordis	PERICARDIAL TAMPONADE; MYOCARDIAL CONTUSION; TRAUMA; DIAGNOSIS; WOUNDS; HEART	Objective: To present our experience of cardiac injuries treated at one Swedish emergency department in the 10 years 1988-97. Design: Retrospective study. Setting: Teaching hospital. Subjects: 11 patients (9 men and 2 women, mean age 33 years, range 19-54); in 7 they were penetrating injuries and in 4 blunt. Main outcome measures: Morbidity and mortality. Results: The mechanisms of injury were stab wound (n = 7), and car crash, fall, boat crash, and abuse (n = 1 each); drug or alcohol misuse played a part in all those with penetrating injuries. The penetrating wounds involved the left ventricle (n = 3), the right ventricle (n = 2, and the pericardium (n = 2). All 5 patients with ventricular wounds presented with cardiac tamponade, in 1 of whom it was fatal Ore bled to death during emergency thoracotomy). The main complications were anoxic brain damage and postpericardiotomy syndrome (1 each). There was no case of myocardial concussion. Conclusion: Our data reflect the Swedish experience of heart trauma: there are few cases, alcohol and drug misuse is the principal risk factor, and there were no gunshot wounds.	Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Surg, Div Vasc & Trauma Surg, Gothenburg, Sweden		Rashid, MA (corresponding author), Trebackegatan 11, SE-41674 Gothenburg, Sweden.						AALAND MO, 1994, AM SURGEON, V60, P412; AROM KV, 1977, ANN THORAC SURG, V23, P545, DOI 10.1016/S0003-4975(10)63699-5; Asensio JA, 1998, J AM COLL SURGEONS, V186, P24, DOI 10.1016/S1072-7515(97)00144-0; Baker JM, 1998, ARCH SURG-CHICAGO, V133, P855, DOI 10.1001/archsurg.133.8.855; Beck CS, 1935, J AMER MED ASSOC, V104, P714, DOI 10.1001/jama.1935.02760090018005; Campbell NC, 1997, BRIT J SURG, V84, P1737, DOI 10.1046/j.1365-2168.1997.02819.x; DEMETRIADES D, 1986, ANN SURG, V203, P315, DOI 10.1097/00000658-198603000-00018; FRAZEE RC, 1986, J TRAUMA, V26, P510, DOI 10.1097/00005373-198606000-00004; FULDA G, 1991, J TRAUMA, V31, P167, DOI 10.1097/00005373-199131020-00003; Godwin J D, 1987, J Thorac Imaging, V2, P32, DOI 10.1097/00005382-198707000-00007; GUEST TM, 1995, JAMA-J AM MED ASSOC, V273, P1945, DOI 10.1001/jama.273.24.1945; JONES JW, 1975, ANN SURG, V181, P567, DOI 10.1097/00000658-197505000-00009; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; MASON LB, 1958, J THORAC SURG, V29, P524; MATTOX KL, 1992, J TRAUMA, V33, P649; MAYORDAVIES JA, 1992, S AFR J SURG, V30, P18; MORENO C, 1986, J TRAUMA, V26, P821, DOI 10.1097/00005373-198609000-00007; ORALIAGUET G, 1993, J TRAUMA, V34, P455; PARMLEY LF, 1958, CIRCULATION, V18, P371, DOI 10.1161/01.CIR.18.3.371; Rhee PM, 1998, J TRAUMA, V45, P366, DOI 10.1097/00005373-199808000-00028; RuDusky BM, 1996, CHEST, V109, P1413, DOI 10.1378/chest.109.5.1413-a; SUGG WL, 1968, J THORAC CARDIOV SUR, V56, P531, DOI 10.1016/S0022-5223(19)42812-2; TENZER ML, 1985, J TRAUMA, V25, P620, DOI 10.1097/00005373-198507000-00008; WILSON RF, 1966, J AMER MED ASSOC, V195, P513, DOI 10.1001/jama.195.7.513	24	14	15	0	0	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	1102-4151			EUR J SURG	Eur. J. Surg.	JAN	2000	166	1					18	21					4	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	278XY	WOS:000085015300003	10688211				2022-02-06	
J	Wallace, JJ; Caroselli, JS; Scheibel, RS; High, WM				Wallace, JJ; Caroselli, JS; Scheibel, RS; High, WM			Predictive validity of the Neurobehavioural Cognitive Status Examination (NCSE) in a post-acute rehabilitation setting	BRAIN INJURY			English	Article							STROKE PATIENTS; POPULATION; RELIABILITY; IMPAIRMENT	Within the context of a post-acute rehabilitation setting, association and agreement between results from the Neurobehavioural Cognitive Status Examination (NCSE) and from the neuropsychological (NP) evaluation are examined. AU participants (n = 48) had sustained a severe traumatic brain injury and NCSE testing preceded NP testing by an average of 1 month. A significant relationship and fair classification agreement (i.e. presence or absence of cognitive impairment) was found between dir overall results from NCSE and NP evaluation. Significant relationships were also observed between most NCSE subtests and paired NP tests thought to be assessing the same cognitive domains. However, the classification agreement (i.e. the presence or absence of deficient performance) between most NCSE subtests and paired NP tests was poor. The findings are discussed from the standpoint of individual treatment planning.	Transit Learning Ctr Galveston, Galveston, TX 77553 USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Caroselli, JS (corresponding author), Transit Learning Ctr Galveston, POB 1228,1528 PO, Galveston, TX 77553 USA.						BENTON AL, 1978, MANUAL MULTILINGUAL; BENTON AL, 1983, MANUAL JUDGEMENT LIN; Blostein PA, 1997, J NEUROTRAUM, V14, P171, DOI 10.1089/neu.1997.14.171; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Drane DL, 1997, ARCH CLIN NEUROPSYCH, V12, P139, DOI 10.1016/S0887-6177(96)00057-1; ENGLEHART C, 1994, CLIN NEUROPSYCHOL, V8, P405; Fleiss J.L., 1981, STAT METHODS RATES P; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GRUNSEIT AC, 1994, J CLIN EXP NEUROPSYC, V16, P898, DOI 10.1080/01688639408402701; JENNET B, 1981, MANAGEMENT HEAD INJU; Kaplan E., 1987, MANUAL CALIFORNIA VE; Karzmark P, 1997, ASSESSMENT, V4, P1; KAUFMAN DM, 1979, GEN HOSP PSYCHIAT, V1, P247, DOI 10.1016/0163-8343(79)90026-4; KEWMAN DG, 1991, INT J PSYCHIAT MED, V21, P253, DOI 10.2190/FRYK-TMGA-AULW-BM5G; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; LAMARRE CJ, 1994, J PSYCHIATR NEUROSCI, V19, P103; LOGUE PE, 1993, J CLIN PSYCHOL, V49, P80, DOI 10.1002/1097-4679(199301)49:1<80::AID-JCLP2270490111>3.0.CO;2-Z; Marcotte TD, 1997, J CLIN EXP NEUROPSYC, V19, P386, DOI 10.1080/01688639708403867; MEEK PS, 1989, J PSYCHOACTIVE DRUGS, V21, P153, DOI 10.1080/02791072.1989.10472155; Mitrushina M, 1996, J CLIN PSYCHOL, V52, P177, DOI 10.1002/(SICI)1097-4679(199603)52:2<177::AID-JCLP9>3.0.CO;2-R; MITRUSHINA M, 1994, J PSYCHIATR RES, V28, P85, DOI 10.1016/0022-3956(94)90037-X; MYSIW WJ, 1989, AM J PHYS MED REHAB, V68, P168, DOI 10.1097/00002060-198908000-00003; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; NELSON A, 1986, J NERV MENT DIS, V174, P73, DOI 10.1097/00005053-198602000-00002; OSATO SS, 1993, NEUROPSY NEUROPSY BE, V6, P98; OSMON DC, 1992, ARCH PHYS MED REHAB, V73, P414; Roper BL, 1996, NEUROPSY NEUROPSY BE, V9, P54; SCHWAMM LH, 1987, ANN INTERN MED, V107, P486, DOI 10.7326/0003-4819-107-4-486; Spreen O, 1991, COMPENDIUM NEUROPSYC; Veltman R H, 1993, J Neurosci Nurs, V25, P367; WEBSTER JS, 1984, J CLIN PSYCHOL, V40, P237, DOI 10.1002/1097-4679(198401)40:1<237::AID-JCLP2270400146>3.0.CO;2-T; Wechsler D, 1987, MANUAL WECHSLER MEMO; Wechsler D, 1981, WECHSLER ADULT INTEL; Whiteside DM, 1996, CLIN NEUROPSYCHOL, V10, P459, DOI 10.1080/13854049608406707; Wiederman Michael W., 1995, Clinical Gerontologist, V15, P35, DOI 10.1300/J018v15n04_04; 1988, MANUAL NEUROBEHAVIOR	36	14	15	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2000	14	1					63	69		10.1080/026990500120934			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	274CY	WOS:000084747200007	10670662				2022-02-06	
J	Mignani, S; Aloup, JC; Barreau, M; Blanchard, JC; Bohme, GA; Boireau, A; Damour, D; Debono, MW; Dubroeucq, MC; Genevois-Borella, A; Imperato, A; Jimonet, P; Pratt, J; Randle, JCR; Reibaud, M; Ribeill, Y; Stutzmann, JM				Mignani, S; Aloup, JC; Barreau, M; Blanchard, JC; Bohme, GA; Boireau, A; Damour, D; Debono, MW; Dubroeucq, MC; Genevois-Borella, A; Imperato, A; Jimonet, P; Pratt, J; Randle, JCR; Reibaud, M; Ribeill, Y; Stutzmann, JM			Synthesis and pharmacological properties of 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, a new competitive AMPA/KA receptor antagonist	DRUG DEVELOPMENT RESEARCH			English	Article						AMPA/KA antagonists; anticonvulsant agent; neuroprotective agent	AMINO-ACID PHARMACOLOGY; FOCAL CEREBRAL-ISCHEMIA; RAT CORTICAL MEMBRANES; SPINAL-CORD INJURY; NON-NMDA RECEPTOR; ANTICONVULSANT ACTION; NERVOUS-SYSTEM; RILUZOLE; SITE	The excessive release of glutamate, a potent excitatory neurotransmitter, is thought to play an important role in a variety of acute and chronic neurological disorders. Consequently, excitatory amino acid antagonists may have an important therapeutic potential in the treatment of these diseases. Glutamate interacts with at least three types of receptor: 1) NMDA (N-methyl-D-aspartic acid) receptors; 2) AMPA [2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid]/kainic acid (KA) receptors; and 3) metabotropic receptors. Blockade of ionotropic AMPA/KA receptors has been shown to prevent cerebral ischemia insult in experimental models. This article describes the synthesis, pharmacological activity, and neuroprotective properties of 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one (1), a novel AMPA/KA antagonist which showed micromolar affinity at AMPA/KA receptors and competitively inhibited functional responses mediated by these receptors. In mice, 1 had significant anticonvulsive properties and conferred protection against hypobaric hypoxia and KCN intoxication. In rats and gerbils, 1 possesses significant activity in models of global or focal cerebral ischemia, as well as in a model of neurotrauma. Compound 1 was prepared from 2-bromo-indanone using two synthetic pathways in two or three steps with moderate (30%) or good (70%) yields, respectively. (C) 1999 Wiley-Liss, Inc.	Rhone Poulenc Rorer SA, Ctr Rech Vitry Alfortville, F-94403 Vitry, France		Stutzmann, JM (corresponding author), Rhone Poulenc Rorer SA, Ctr Rech Vitry Alfortville, 13 Quai Jules Guesde,BP 14, F-94403 Vitry, France.			Mignani, Serge/0000-0002-1383-5256			ALOUP JC, 1993, Patent No. 9407893; Auberson YP, 1998, BIOORG MED CHEM LETT, V8, P65, DOI 10.1016/S0960-894X(97)10186-X; BENZEL EC, 1990, J SPINAL DISORD, V3, P334; Bigge CF, 1997, EXPERT OPIN THER PAT, V7, P1099, DOI 10.1517/13543776.7.10.1099; BUCHAN AM, 1991, NEUROSCI LETT, V132, P255, DOI 10.1016/0304-3940(91)90314-J; CANTON T, 1992, J PHARM PHARMACOL, V44, P812, DOI 10.1111/j.2042-7158.1992.tb03211.x; CHAPMAN AG, 1987, EUR J PHARMACOL, V139, P91, DOI 10.1016/0014-2999(87)90501-2; CHAPMAN AG, 1991, EXCITATORY AMINO ACI, P265; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; CROUCHER MJ, 1982, SCIENCE, V216, P899, DOI 10.1126/science.7079744; Damour D, 1999, HETEROCYCLES, V50, P259; DAVEY DD, 1987, J ORG CHEM, V52, P4379, DOI 10.1021/jo00228a042; DEBONO MW, 1993, EUR J PHARMACOL, V235, P283, DOI 10.1016/0014-2999(93)90147-A; EPPERSON JR, 1993, BIOORG MED CHEM LETT, V3, P2801, DOI 10.1016/S0960-894X(01)80768-X; GALEAZZI E, 1995, J ORG CHEM, V60, P1090, DOI 10.1021/jo00109a052; HONORE T, 1988, J NEUROCHEM, V51, P457, DOI 10.1111/j.1471-4159.1988.tb01060.x; JACKSON PF, 1991, BIOORG MED CHEM LETT, V1, P751, DOI 10.1016/S0960-894X(01)81062-3; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; MALGOURIS C, 1989, J NEUROSCI, V9, P3720; MCQUAID LA, 1992, J MED CHEM, V35, P3319, DOI 10.1021/jm00096a002; MELDRUM BS, 1991, EXCITATORY AMINO ACI, P1; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; OHMORI J, 1994, J MED CHEM, V37, P467, DOI 10.1021/jm00030a006; Ohmori J, 1997, J MED CHEM, V40, P2053, DOI 10.1021/jm960664c; OLNEY JW, 1989, BIOL PSYCHIAT, V26, P505, DOI 10.1016/0006-3223(89)90072-3; PRATT J, 1992, NEUROSCI LETT, V140, P225, DOI 10.1016/0304-3940(92)90108-J; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SNELL LD, 1988, EUR J PHARMACOL, V156, P105, DOI 10.1016/0014-2999(88)90152-5; SWINYARD EA, 1952, J PHARMACOL EXP THER, V106, P319; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; YOUNG AB, 1988, SCIENCE, V241, P981, DOI 10.1126/science.2841762	33	14	14	0	2	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0272-4391			DRUG DEVELOP RES	Drug Dev. Res.	NOV	1999	48	3					121	129		10.1002/(SICI)1098-2299(199911)48:3<121::AID-DDR4>3.0.CO;2-E			9	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	269TW	WOS:000084494500004					2022-02-06	
J	Levy, O; Pritsch, M; Rath, E				Levy, O; Pritsch, M; Rath, E			An operative technique for recurrent shoulder dislocations in older patients	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article								Recurrent anterior shoulder dislocation in the elderly is not as exceptional as if was once thought to be. That anterior shoulder dislocation in older patients is caused by a rotator cuff fear through the posterior mechanism is well accepted. However, in the subset of patients who have multiple recurrent or intractable dislocations develop, there may be combined pathologic conditions at work: large or massive rotator cuff fears together with anterior capsulolabral injuries such as a Bankart lesion or fracture of the glenoid rim. These patients have multiple recurrences because of disruption of both the anterior and the posterior stability mechanisms. We suggest a procedure that provides anterior stabilization with the capsular shift technique and that is supplemented by Bankart repair as necessary. The capsule transfer is performed superiorly and posteriorly to close the defect in the cuff. In this way a capsulodesis effect can be achieved that displaces the humeral head downward and produces active centering of the head in the course of abduction. Use of only the anterior capsule for the shift, and not the subscapularis tendon, does not compromise subscapularis function. Between 1990 and 1996, we used this technique to treat 16 patients older than 55 years of age with multiple recurrent anterior shoulder dislocation and massive rotator cuff fear. We report the results for the first 10 patients with a minimum follow-up of 2 years (range 2 to 7 years) and an average follow-up of 52 months. There were 7 excellent results, 2 good results, and 1 fair result according to the Rowe criteria. None of the patients had a recurrence of the dislocation. All the patients regained full or functional range of motion with stable shoulders, and most of them could perform activities of daily living without limitation. The average Constant score was 83%. This procedure appears to be successful in treating older patients with recurrent shoulder dislocation.	Ben Gurion Univ Negev, Soroka Med Ctr, Dept Orthopaed, Shoulder Surg Serv, Beer Sheva, Israel; Chaim Sheba Med Ctr, Dept Orthopaed, Shoulder Surg Serv, IL-52621 Tel Hashomer, Israel		Levy, O (corresponding author), Royal Berkshire Hosp, Dept Shoulder Surg, London Rd, Reading RG1 5AN, Berks, England.						CADMAN EA, 1934, SHOULDER, P262; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; COPELAND SA, 1995, OPERATIVE SHOULDER S, P102; CRAIG EV, 1984, CLIN ORTHOP RELAT R, P212; GERBER C, 1991, J BONE JOINT SURG BR, V73, P389, DOI 10.1302/0301-620X.73B3.1670434; GONZALEZ D, 1991, J BONE JOINT SURG AM, V73A, P620, DOI 10.2106/00004623-199173040-00024; HAWKINS RJ, 1986, CLIN ORTHOP RELAT R, P192; HOVELIUS L, 1983, J BONE JOINT SURG AM, V65, P343, DOI 10.2106/00004623-198365030-00008; LEVY O, 1996, J SHOULDER ELBOW S S, V5, pS22; LEVY O, 1993, J SHOULDER ELBOW S S, V2, pS17; MCLAUGHL.HL, 1967, J TRAUM, V7, P191, DOI 10.1097/00005373-196703000-00002; NEER CS, 1972, J BONE JOINT SURG AM, VA 54, P41, DOI 10.2106/00004623-197254010-00003; NEVIASER J S, 1956, Instr Course Lect, V13, P187; Neviaser R J, 1995, J Shoulder Elbow Surg, V4, P416, DOI 10.1016/S1058-2746(05)80032-1; NEVIASER RJ, 1993, CLIN ORTHOP RELAT R, P103; NEVIASER RJ, 1988, J BONE JOINT SURG AM, V70A, P1308, DOI 10.2106/00004623-198870090-00005; NEVIASER RJ, 1980, ORTHOP CLIN N AM, V11, P295; PATTE D, 1986, ENCY MED CHIR TECHNI, P1; PRITSCH M, 1995, P 6 INT C SURG SHOUL; ROWE C R, 1961, Clin Orthop, V20, P40; ROWE CR, 1978, J BONE JOINT SURG AM, V60, P1; SONNABEND DH, 1994, CLIN ORTHOP RELAT R, P74; Stevens JH, 1926, ANN SURG, V83, P84; WALCH G, 1988, FRENCH J ORTHOP SURG, V2, P19	24	14	14	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	SEP-OCT	1999	8	5					452	457		10.1016/S1058-2746(99)90075-7			6	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	250HK	WOS:000083382800010	10543598				2022-02-06	
J	Alexander, BH; Franklin, GM; Fulton-Kehoe, D				Alexander, BH; Franklin, GM; Fulton-Kehoe, D			Comparison of fatal and severe nonfatal traumatic work-related injuries in Washington State	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article						occupational accidents; fatalities; injury severity score; workers' compensation; surveillance	OCCUPATIONAL INJURIES; UNITED-STATES; CONSTRUCTION-INDUSTRY; HIGH-RISK; EMERGENCY; HOMICIDE	Objective To compare fatal and hospitalized nonfatal work-related traumatic injuries by occupation and cause. Methods Fatal and hospitalized nonfatal injuries occurring from 1991-1995 were identified from Washington State workers' compensation claims data. Nonfatal injuries were classified as severe if they harl at least one of the following criteria: a brain or spinal cord injury, an Injury Severity Score of greater than or equal to 16 or were hospitalized for more than 7 days. The frequency and rate of fatal and severe nonfatal injuries were then described by industrial risk class and cause. Results The study identified 335 fatal injuries and 4,405 hospitalized nonfatal injuries, of which 1,105 were classified as severe. Tree topping and pruning, carnival work, roofing, and metal siding and gutters risk classes had several severe nonfatal injuries, but few, if any, fatalities. Causes of fatal and severe nonfatal injuries were notably different for the roofing, restaurant, and orchard workers risk classes. Conclusions: The inclusion of severe hospitalized injuries in occupational injury surveillance systems will provide a broader view of high-risk occupations and profile of injury causation with which to direct occupational injury prevention efforts. Am. J. Ind. Med. 36:317-325, 1999. (C) 1999 Wiley-Liss, Inc.	Univ Washington, Sch Publ Hlth & Community Med, Dept Environm Hlth, Occupat Epidemiol & Hlth Outcomes Program, Seattle, WA 98195 USA; Washington State Dept Labor & Ind, Olympia, WA 98504 USA		Alexander, BH (corresponding author), Univ Minnesota, Div Environm & Occupat Hlth, Box 807,Mayo Bldg,420 Delaware St, Minneapolis, MN 55455 USA.						BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BELL CA, 1991, AM J PUBLIC HEALTH, V81, P729, DOI 10.2105/AJPH.81.6.729; BELL CA, 1990, JAMA-J AM MED ASSOC, V263, P3047, DOI 10.1001/jama.263.22.3047; CASTILLO DN, 1994, J OCCUP ENVIRON MED, V36, P125, DOI 10.1097/00043764-199402000-00006; CHEADLE A, 1994, AM J PUBLIC HEALTH, V84, P190, DOI 10.2105/AJPH.84.2.190; *COMM INJ SCAL, 1985, ABBR INJ SCAL 1985 R; DAVIS H, 1987, AM J PUBLIC HEALTH, V77, P1524, DOI 10.2105/AJPH.77.12.1524; Fosbroke DE, 1997, AM J IND MED, V31, P459, DOI 10.1002/(SICI)1097-0274(199704)31:4<459::AID-AJIM13>3.0.CO;2-Z; FRANKLIN GM, 1991, AM J PUBLIC HEALTH, V81, P741, DOI 10.2105/AJPH.81.6.741; HEINRICH HW, 1980, IND ACC PREV; HEYER NJ, 1994, AM J PUBLIC HEALTH, V84, P1106, DOI 10.2105/AJPH.84.7.1106; INANCSI W, 1987, J OCCUP ENVIRON MED, V29, P730; Jenkins E. Lynn, 1994, Annals of Epidemiology, V4, P146, DOI 10.1016/1047-2797(94)90061-2; KISNER SM, 1994, J OCCUP ENVIRON MED, V36, P137, DOI 10.1097/00043764-199402000-00008; KRAUS JF, 1987, AM J PUBLIC HEALTH, V77, P1285, DOI 10.2105/AJPH.77.10.1285; LOZADALARSEN S, 1987, P HUM FACT SOC 31 AN, V1, P200; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Pollack ES, 1996, AM J IND MED, V30, P325; ROSSIGNOL AM, 1986, J TRAUMA, V26, P1097, DOI 10.1097/00005373-198612000-00007; Ruser JW, 1998, AM J IND MED, V33, P151, DOI 10.1002/(SICI)1097-0274(199802)33:2<151::AID-AJIM6>3.3.CO;2-3; SALMINEN S, 1992, SAFETY SCI, V15, P109, DOI 10.1016/0925-7535(92)90011-N; STOUT N, 1991, AM J PUBLIC HEALTH, V81, P725, DOI 10.2105/AJPH.81.6.725; Toscano G, 1996, Stat Bull Metrop Insur Co, V77, P12; *US DEP LAB BLS, 1995, CENS FAT OCC INJ; VEAZIE MA, 1994, ANNU REV PUBL HEALTH, V15, P203, DOI 10.1146/annurev.pu.15.050194.001223; *WA STAT DEP LAB I, 1993, OCC INJ ILLN SURV RE; Zwerling C, 1996, J OCCUP ENVIRON MED, V38, P698, DOI 10.1097/00043764-199607000-00013	27	14	15	0	1	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0271-3586			AM J IND MED	Am. J. Ind. Med.	AUG	1999	36	2					317	325		10.1002/(SICI)1097-0274(199908)36:2<317::AID-AJIM11>3.3.CO;2-I			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	214GD	WOS:000081319500011	10398940				2022-02-06	
J	Connolly, JF; Major, A; Allen, S; D'Arcy, RC				Connolly, JF; Major, A; Allen, S; D'Arcy, RC			Performance on WISC-III and WAIS-R NI vocabulary subtests assessed with event-related brain potentials: An innovative method of assessment	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							RECEPTIVE VOCABULARY; APHASIA; DETERMINANTS; SENTENCES; LANGUAGE; STROKE; WORDS; P300	Assessment of intellectual functions is essential for rehabilitative interventions with traumatic brain injury and stroke patients. However, many of these patients are difficult or impossible to assess because of aphasia and physical disabilities that prevent their performance on traditionally administered tests of mental functioning. We present normative evidence obtained from healthy individuals for the efficacy of a new method of assessing such patients using standardized and validated tests formatted for computer presentation and using direct measures of brain activity (event-related brain potentials, ERP) as the measurable response instead of verbal or motor behavior.	Dalhousie Univ, Dept Psychol, Life Sci Ctr, Cognit Clin Neurosci Unit, Halifax, NS B3H 4J1, Canada; Dalhousie Univ, Dept Med, Div Psychiat, Halifax, NS, Canada		Connolly, JF (corresponding author), Dalhousie Univ, Dept Psychol, Life Sci Ctr, Cognit Clin Neurosci Unit, Halifax, NS B3H 4J1, Canada.			Connolly, John/0000-0001-8869-5369			Byrne JM, 1995, CHILD NEUROPSYCHOL, V1, P211, DOI 10.1080/09297049508400226; BYRNE JM, 1995, J CLIN EXP NEUROPSYC, V17, P9, DOI 10.1080/13803399508406576; CHIAPPA K, 1997, EVOKED POTENTIALS CL; CONNOLLY J, 1999, UNPUB SPATIOTEMPORAL; CONNOLLY JF, 1992, BRAIN LANG, V43, P1, DOI 10.1016/0093-934X(92)90018-A; CONNOLLY JF, 1995, J CLIN EXP NEUROPSYC, V17, P548, DOI 10.1080/01688639508405145; CONNOLLY JF, 1990, BRAIN LANG, V39, P302, DOI 10.1016/0093-934X(90)90016-A; CONNOLLY JF, 1995, ELECTROEN CLIN NEURO, V94, P276, DOI 10.1016/0013-4694(95)98479-R; CONNOLLY JF, IN PRESS ARCH PHYSIC; CONNOLLY JF, IN PRESS INT J PSYCH; DARCY RCN, 1998, THESIS DALHOUSIE U H; DARCY RCN, IN PRESS NEUROPSYCHO; DARCY RCN, IN PRESS J INT NEURO; Dunn LM., 1981, PEABODY PICTURE VOCA; Enderby P, 1987, Int Rehabil Med, V8, P162; ENDERBY P, 1986, BRIT J DISORD COMMUN, V21, P151; Goodglass H., 1972, ASSESSMENT APHASIA R; Helenius P, 1998, BRAIN, V121, P1133, DOI 10.1093/brain/121.6.1133; Hulley S., 1988, DESIGNING CLIN RES; Ingles JL, 1996, CORTEX, V32, P199, DOI 10.1016/S0010-9452(96)80047-5; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; Kaplan E., 1991, WAIS R NEUROPSYCHOLO; Kay J, 1996, APHASIOLOGY, V10, P159, DOI 10.1080/02687039608248403; Kay J, 1992, PALPA PSYCHOLINGUIST; KERTESZ A, 1982, NEUROPSYCHOLOGIA, V20, P275, DOI 10.1016/0028-3932(82)90102-6; Kutas M., 1994, HDB PSYCHOLINGUISTIC, P83, DOI [10.1016/B978-012369374-7/50018, DOI 10.1016/B978-012369374-7/50018]; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEVIN HS, 1981, ACQUIRED APHASIA, P427; LEZAK M, 1995, AM PSYCHOL, V47, P1007; Marquardsen J, 1969, ACTA NEUROL SCAND  S, V38, P67; NAATANEN R, 1995, EAR HEARING, V16, P6; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P210; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PEDERSEN PM, 1995, ANN NEUROL, V38, P659, DOI 10.1002/ana.410380416; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Rugg Michael D., 1995, P789; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; WADE DT, 1986, J NEUROL NEUROSUR PS, V49, P11, DOI 10.1136/jnnp.49.1.11; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD	41	14	15	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG	1999	21	4					444	464		10.1076/jcen.21.4.444.879			21	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	258LX	WOS:000083841600003	10550805				2022-02-06	
J	Prasad, MR; Ewing-Cobbs, L; Baumgartner, J				Prasad, MR; Ewing-Cobbs, L; Baumgartner, J			Crush head injuries in infants and young children: Neurologic and neuropsychologic sequelae	JOURNAL OF CHILD NEUROLOGY			English	Article; Proceedings Paper	26th Annual Meeting of the International-Neuropsychological-Society	FEB 04-05, 1998	HONOLULU, HI	Int Neuropsychol Soc			SKULL FRACTURES; AGE; SCALE; COMA	Neurologic and neuropsychologic sequelae of crush head injury, which is produced by static forces occurring when the head is stationary and pinned against a rigid structure, were studied prospectively in a series of eight children ranging in age from 13 to 32 months. Hospital course, computed tomographic findings, and neurologic and developmental outcomes were examined. All children sustained pronounced cerebral trauma characterized by multiple fractures throughout the calvaria, extra-axial hemorrhages, and parenchymal contusions. Cranial nerve injuries were noted in three and hemiparesis in two of the cases. Two months after the injury, 63% of the children displayed deficits in either IQ or motor functioning. One year after the injury, five of the six children reevaluated had a good recovery. Motor scores were significantly lower than cognitive scores at baseline and showed the greatest degree of improvement over time. Neuropsychologic outcome after brain injury produced by static loading of the head is more favorable than from traumatic brain injury associated with dynamic loading.	Univ Texas, Hlth Sci Ctr, Dept Pediat, Div Dev Pediat, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Surg, Houston, TX 77030 USA		Ewing-Cobbs, L (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Pediat, Div Dev Pediat, 7000 Fannin,Ste 2431, Houston, TX 77030 USA.	lewing@ped1.med.uth.tmc.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [29462, 21889, 27597] Funding Source: Medline		Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; BAYLEY N, 1984, MANUAL BAYLEY SCALES; Bayley N., 1993, MANUAL BAYLEY SCALES; BERNARD PA, 1998, PEDIATRICS, P102; BERNEY J, 1994, CHILD NERV SYST, V10, P517, DOI 10.1007/BF00335074; Choux M., 1986, HEAD INJURIES NEWBOR, P163; Ciccetti D., 1984, VINELAND ADAPTIVE BE; CORRADINO G, 1990, NEUROSURGERY, V27, P592, DOI 10.1227/00006123-199010000-00015; DUHAIME AC, 1995, NEUROSURGERY, V37, P401, DOI 10.1227/00006123-199509000-00005; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Gennarelli T, 1996, NEUROSURGERY, V2, P2611; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; HARWOODNASH DC, 1971, RADIOLOGY, V101, P151, DOI 10.1148/101.1.151; HISS J, 1995, J TRAUMA, V38, P32, DOI 10.1097/00005373-199501000-00010; JENNETT B, 1975, LANCET, V1, P480; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; MANN KS, 1986, CHILD NERV SYST, V2, P258; McCarthy, 1972, MCCARTHY SCALES CHIL; MINER ME, 1986, NEUROTRAUMA, V1, P233; POSNICK JC, 1994, ANN PLAS SURG, V33, P442, DOI 10.1097/00000637-199410000-00017; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; RUSSELL WR, 1949, J NEUROL NEUROSUR PS, V12, P52, DOI 10.1136/jnnp.12.1.52; Sattler, 1986, STANFORDBINET INTELL; TEASDALE G, 1974, LANCET, V2, P81	25	14	14	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	AUG	1999	14	8					496	501		10.1177/088307389901400803			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Pediatrics	223KX	WOS:000081841200003	10456758				2022-02-06	
J	Dias, MS; Carnevale, F; Li, V				Dias, MS; Carnevale, F; Li, V			Immediate posttraumatic seizures: Is routine hospitalization necessary?	PEDIATRIC NEUROSURGERY			English	Article						posttraumatic seizure; posttraumatic epilepsy; closed head injury; minor brain injury	MILD HEAD-INJURY; CHILDREN; TRAUMA	Objective: A recent Internet survey of pediatric neurosurgeons showed that 86% routinely admitted children with immediate posttraumatic seizures (PTS) for a brief period of observation. We wished to determine whether certain children meeting predefined criteria could instead be safely discharged from the emergency room. Methods: We reviewed the records of children admitted during the past 5 years with a diagnosis of seizure and head injury. Children with a minor head injury, a PTS occurring within 24 h of injury and no intracranial abnormalities on admission CT scan were included. Children with previous neurological conditions, a history of prior seizures (other than PTS or febrile seizures), a prior history of anticonvulsant use, or intracranial abnormalities on the admission CT scan were excluded. Records were abstracted for child's age, gender, length of admission, previous history of PTS or febrile seizures, mechanism of injury, location of impact, time between impact and PTS, the number, length and type of PTS, Glasgow Coma Score (GCS) on admission, subsequent complications and hospital costs. Results: Seventy-one children met the inclusion criteria. Eleven children presented to the emergency room with prolonged seizures, transient apnea or persistently low GCS and required admission to the intensive care unit (ICU). Among the 60 remaining children with simple PTS, none had further seizures during the follow-up period, and none had significant complications. The average cost of hospitalization was known for 58 children; after excluding the costs for 5 patients who were admitted to the ICU, the average hospital cost amounted to USD 1,615 per patient. Conclusions: Our data suggest that children with isolated minor head injuries and simple PTS who recover fully in the emergency room, whose CT scans show no intracranial abnormalities and who have no prior history of neurological disease, epilepsy or anticonvulsant use are at low risk for recurrent seizures or neurological complications, and could potentially be sent home to a reliable caretaker and a stable home situation. However, because of the limited sample size in this study, the statistical risk of a bad outcome may be as high as 9%; we therefore suggest that much larger studies are potentially needed before this becomes a standard policy.	SUNY Buffalo, Childrens Hosp, Dept Neurosurg, Buffalo, NY 14260 USA; SUNY Buffalo, Childrens Hosp, Dept Pediat, Buffalo, NY 14260 USA		Dias, MS (corresponding author), Childrens Hosp, Dept Pediat Neurosurg, 219 Bryant St, Buffalo, NY 14222 USA.						Aldrich EF, 1996, NEUROLOGICAL SURG, P1719; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Bergman DA, 1996, PEDIATRICS, V97, P769; Black P, 1972, T AM NEUROL ASSOC, V97, P247; DASILVA AM, 1990, ACT NEUR S, V50, P48; DAVIES RL, 1995, PEDIATRICS, V95, P345; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; ELDRIDGE AR, 1939, T AM NEURAL ASS, V65, P125; FOULON M, 1977, ACTA NEUROL BELG, V77, P276; GLANTZ GA, 1987, PRIMER BIOSTATISTICS; GRAND W, 1974, J NEUROL NEUROSUR PS, V37, P178, DOI 10.1136/jnnp.37.2.178; HAHN YS, 1993, PEDIATR NEUROSURG, V19, P135, DOI 10.1159/000120718; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; HENDRICK EB, 1968, J TRAUM, V8, P547; Huang MC, 1998, PEDIATR NEUROL, V18, P150, DOI 10.1016/S0887-8994(97)00171-9; JAMISON DL, 1974, ARCH DIS CHILD, V49, P376, DOI 10.1136/adc.49.5.376; Jennet B, 1976, HDB CLIN NEUROLOGY, V24, P445; JENNETT B, 1973, DEV MED CHILD NEUROL, V15, P56; KADISH HA, 1995, ANN EMERG MED, V26, P37, DOI 10.1016/S0196-0644(95)70235-0; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; Kollevold T, 1976, J Oslo City Hosp, V26, P99; MISES J, 1970, EPILEPSIA, V11, P37, DOI 10.1111/j.1528-1157.1970.tb03864.x; MITCHELL KA, 1994, J PEDIATR SURG, V29, P851, DOI 10.1016/0022-3468(94)90001-9; Roddy SP, 1998, PEDIATRICS, V101, P575, DOI 10.1542/peds.101.4.575; ROS S P, 1989, Pediatric Emergency Care, V5, P216, DOI 10.1097/00006565-198912000-00003; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; SHAKELFORD SR, 1992, J TRAUMA, V33, P385; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003	29	14	14	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.	MAY	1999	30	5					232	238		10.1159/000028803			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	227RF	WOS:000082092900002	10461069				2022-02-06	
J	Cantagallo, A; Grassi, L; Della Sala, S				Cantagallo, A; Grassi, L; Della Sala, S			Dissociative disorder after traumatic brain injury	BRAIN INJURY			English	Article							MULTIPLE PERSONALITY-DISORDER; HEAD-INJURY; CAPGRAS SYNDROME; REDUPLICATIVE PARAMNESIA; AUTOBIOGRAPHICAL MEMORY; PSYCHIATRIC-DISORDERS; RETROGRADE-AMNESIA; PSYCHOSIS; EPILEPSY; MMPI	Several episodes of dissociative disorder, including depersonalization and multiple personality, have been observed in a 32-year old man during a period of a few months following a mild traumatic brain injury. The psychogenic or organic aetiology of these psychiatric disorders remains undetermined. This case highlights the need to consider dissociative disorder among the possible (temporary) outcomes of a brain injury.	Univ Aberdeen, Dept Psychol, Kings Coll, Neuropsychol Res Grp, Aberdeen AB24 2UB, Scotland; Ferrara Hosp, Unita Operat Med Riabilitat, Ferrara, Italy; Univ Ferrara, Dept Psychiat, I-44100 Ferrara, Italy		Della Sala, S (corresponding author), Univ Aberdeen, Dept Psychol, Kings Coll, Neuropsychol Res Grp, Aberdeen AB24 2UB, Scotland.			GRASSI, Luigi/0000-0002-1050-4494			ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; ALEXANDER MP, 1979, NEUROLOGY, V29, P334, DOI 10.1212/WNL.29.3.334; ALLAMANNO N, 1987, ITAL J NEUROL SCI, V8, P111, DOI 10.1007/BF02337583; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BARNHILL LJ, 1989, NEUROPSY NEUROPSY BE, V2, P211; BENSON DF, 1976, NEUROLOGY, V26, P147, DOI 10.1212/WNL.26.2.147; BENTON A L, 1978, Archives of Neurology, V35, P364; BIENENFELD D, 1989, J CLIN PSYCHIAT, V50, P68; BLISS EL, 1984, J NERV MENT DIS, V172, P197, DOI 10.1097/00005053-198404000-00002; BORRINI G, 1989, PSYCHOL MED, V19, P215, DOI 10.1017/S0033291700011181; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BRUTON CJ, 1994, NEUROLOGY, V44, P34, DOI 10.1212/WNL.44.1.34; COONS PM, 1988, J NERV MENT DIS, V176, P519, DOI 10.1097/00005053-198809000-00001; COONS PM, 1990, PSYCHOL REP, V66, P831, DOI 10.2466/PR0.66.3.831-834; Della Sala S., 1996, METHOD MADNESS CASE, P209; DELLASALA S, 1992, PSYCHOL MED, V22, P885, DOI 10.1017/S0033291700038460; DERENZI E, 1995, CORTEX, V31, P531, DOI 10.1016/S0010-9452(13)80064-0; EAMES P, 1992, J NEUROL NEUROSUR PS, V55, P1046, DOI 10.1136/jnnp.55.11.1046; EAMES P, 1990, NEUROBEHAVIORAL SEQU, P133; Fann JR, 1997, J PSYCHOSOM RES, V43, P335, DOI 10.1016/S0022-3999(97)00130-X; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FILLEY CM, 1987, NEUROLOGY, V37, P701, DOI 10.1212/WNL.37.4.701; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Gray C, 1998, BRAIN INJURY, V12, P429, DOI 10.1080/026990598122548; GRISBY J, 1986, INT J CLIN NEUROPSYC, V8, P65; GRISBY J, 1993, BRAIN INJURY, V7, P507; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Gualtari CT, 1991, BRAIN INJURY, V5, P219; HATHAWAY SR, 1951, MANUAL MINNESOTA MUL; HODGES JR, 1991, TRANSIENT AMNESIA CL; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; KIHLSTROM JF, 1995, HDB MEMORY DISORDERS, P337; LEVINE DN, 1982, NEUROLOGY, V32, P267, DOI 10.1212/WNL.32.3.267; LISHMAN WA, 1998, ORGANIC PSYCHOL PSYC; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; LUCCHELLI F, 1995, BRAIN, V118, P167, DOI 10.1093/brain/118.1.167; LUKIANOWICZ N, 1960, J MENT SCI, V106, P979; Markowitsch HJ, 1998, NEUROPSYCHOLOGIA, V36, P77, DOI 10.1016/S0028-3932(97)00093-6; MARKOWITSCH HJ, 1990, TRANSIENT GLOBAL AMN; MASDEU JC, 1994, NEUROLOGY, V44, P1970, DOI 10.1212/WNL.44.10.1970; Mayer-Gross W, 1935, BRIT J MED PSYCHOL, V15, P103, DOI 10.1111/j.2044-8341.1935.tb01140.x; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MERSKEY H, 1992, NEUROL CLIN, V10, P895, DOI 10.1016/S0733-8619(18)30186-5; Meyer A, 1904, AM J INSANITY, V60, P373, DOI 10.1176/ajp.60.3.373; Minsky M, 1987, SOC MIND; OHANICK GJ, 1994, NEUROPSYCHIATRY TRAU, P163; PARKER R, 1990, TRAUMATIC BRAIN INJU; SANDEL ME, 1990, ARCH PHYS MED REHAB, V71, P523; SEDMAN G, 1970, BRIT J PSYCHIAT, V117, P1; Silver JM., 1994, NEUROPSYCHIATRY TRAU; SIMS A, 1995, SYMPTOMS MIND; Smeltzer Donald J., 1994, P251; Spanos NP, 1996, MULTIPLE IDENTITIES; SPINNLER H, 1987, ITALIAN J NEUROLOG S, V6; STRACCIARI A, 1994, CORTEX, V30, P459, DOI 10.1016/S0010-9452(13)80341-3; Syz H, 1937, J GEN PSYCHOL, V17, P355, DOI 10.1080/00221309.1937.9918005; TOMSEN I, 1984, J NEUROL NEUROSUR PS, V47, P260; Van Zomeren A. H., 1981, REACTION TIME ATTENT; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Venneri A, 1998, BRAIN INJURY, V12, P605, DOI 10.1080/026990598122368; WATSON CG, 1979, J NERV MENT DIS, V167, P243, DOI 10.1097/00005053-197904000-00008; WESTON MJ, 1971, BRIT J PSYCHIAT, V119, P25, DOI 10.1192/bjp.119.548.25; WILL RG, 1988, BRIT J PSYCHIAT, V152, P410, DOI 10.1192/bjp.152.3.410; Wood RLL, 1990, NEUROBEHAVIORAL SEQU; Zimmerman P., 1992, TESTBATTERIE AUFMERK; [No title captured]	66	14	14	0	5	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	1999	13	4					219	228		10.1080/026990599121593			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	186RH	WOS:000079742400001	10230523				2022-02-06	
J	Katz, S; Aloni, R				Katz, S; Aloni, R			Sexual dysfunction of persons after traumatic brain injury: perceptions of professionals	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						professionals; sexuality; traumatic brain injury		The purpose of this paper was to study the perceptions of professionals in the field of rehabilitation in Israel concerning sexual dysfunction of persons after traumatic brain injury. Thirty professionals filled out an open-ended questionnaire that focused on problems of sexual functioning, dyadic and social relationships, and suggestions for the most appropriate interventions for these problems. The results indicated that for persons with TBI, the physical changes were not identified as the primary obstacle preventing persons after TBI from achieving sexual satisfaction, but rather the cognitive and emotional sequelae of TBI. A number of possible intenvention techniques were also suggested.	Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; Beit Loewenstein Hosp, Raanana, Israel		Katz, S (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.						ALONI R, 1996, THESIS UNION COLL CI; ANDERSON DW, 1980, J NEUROSURGERY S, V53; Berrol S, 1981, SEXUALITY PHYSICAL D, P203; Blackerby WF., 1990, J HEAD TRAUMA REHAB, V5, P73, DOI [10.1097/00001199-199005020-00012, DOI 10.1097/00001199-199005020-00012]; BLACKERBY WF, 1993, HDI PROFESSIONAL SER, V10; DAVIS DL, 1990, J HEAD TRAUMA REHAB, V5, P31, DOI DOI 10.1097/00001199-199005020-00006; Griffith ER, 1993, SEXUALITY PERSON TRA; KATZ S, 1987, INT J PSYCHIAT MED, V16, P325; *NHIF, 1984, SIL EP; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; PONSFORD J, 1995, TRAUMATIC BRAIN INJU, P254; PRIGATANO GP, 1988, 13 ANN C SOC STUD BR; ZASLER ND, 1990, J HEAD TRAUMA REHAB, V5, P14, DOI DOI 10.1097/00001199-199005020-00004; Zasler ND, 1991, SEX DISABIL, V9, P11	14	14	14	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	MAR	1999	22	1					45	53		10.1097/00004356-199903000-00006			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	188VJ	WOS:000079869200006	10207751				2022-02-06	
J	Mayr, JM; Seebacher, U; Schimpl, G; Fiala, F				Mayr, JM; Seebacher, U; Schimpl, G; Fiala, F			Highchair accidents	ACTA PAEDIATRICA			English	Article						accident prevention; child; head injury; highchair; restraint	CHILDREN	In order to establish guidelines for highchair accident prevention we investigated causes, mode and complications of highchair accidents by the following methods: The charts of 103 children attending our Accident & Emergency department for highchair related injuries were studied retrospectively. Questionnaires were sent to the parents to obtain detailed information about the mode of accident. They were also asked to suggest preventive measures. In addition, a random sample survey was performed with 163 families inquiring about the rate of highchair use and the incidence of highchair related accidents. Of the 103 infants, 15.5% had sustained a skull fracture, 13.6% a brain concussion, 2.0% limb fractures and 68.9% a simple contusion of the head or lacerations to the scalp or face. The questionnaires were fully completed by 61.2% of parents. Every second family reported that their infant had tried to stand up in the highchair before falling off (only one child had been wearing a restraint). In a further 14.3% of accidents the highchair tipped over. Eighty-seven percent of parents would appreciate a pre-installation of restraints, 54.0% requested more informative instructions for users, and 33.3% asked for products with better stability. The random sample survey revealed a highchair use rate of 92%; 18% of families used highchairs equipped with restraints, and 6% reported highchair accidents sustained by their children. We conclude that most highchair accidents occur when unrestrained infants try to stand up. Pre-installed child restraints, better manuals for users and increased highchair stability should be recommended as promising accident prevention strategies.	Graz Univ, Dept Paediat Surg, A-8036 Graz, Austria; Austrian Stand Inst, Vienna, Austria; Consumer Council, Vienna, Austria		Mayr, JM (corresponding author), Graz Univ, Dept Paediat Surg, Auenbruggerplatz 34, A-8036 Graz, Austria.						FINISON K, 1983, SCIPP REPORTS, V4, P1; GARRETTSON LK, 1985, PEDIATR CLIN N AM, V32, P153; JAFFE D, 1991, NEW ENGL J MED, V324, P1477; JONES S, 1991, CONSUMER REPORTS BOO, P194; WATSON WL, 1993, J PAEDIATR CHILD H, V29, P228, DOI 10.1111/j.1440-1754.1993.tb00493.x	5	14	15	0	4	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0803-5253			ACTA PAEDIATR	Acta Paediatr.	MAR	1999	88	3					319	322		10.1080/08035259950170105			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	179PR	WOS:000079338200016	10229045				2022-02-06	
J	Watts, R; Perlesz, A				Watts, R; Perlesz, A			Psychosocial outcome risk indicator: predicting psychosocial outcome following traumatic brain injury	BRAIN INJURY			English	Article							FAMILY ASSESSMENT DEVICE; CLOSED-HEAD INJURY; SOCIAL SUPPORT; CAREGIVERS; RELIABILITY; VALIDITY; DISTRESS; HEALTH; IMPACT; LIFE	This study examines the outcome of 29 individuals with traumatic brain injury (TBI) and 23 of their respective significant others, 12 months after discharge from inpatient rehabilitation services, as a means of determining the validity of a measure developed to predict psychosocial outcome. This measure consists of 18 questions that examine 12 factors and requires the rater re make a judgement about the likely impact each factor would have on the individual with TBI and significant other. Results indicate that the serial work raters accurately predicted outcome according to the factors contained in the measure. Scores on the measure at discharge were also found to be associated with general psychological distress, anxiety and insomnia, depression, family functioning, and the problems related to emotion and behaviour. Although the sample size was small, there is an indication that the devised measure is useful in predicting outcome and so has clinical value in identifying adults at greatest risk of pool psychosocial outcome after a traumatic brain injury.	Rehab Plus, Auckland 1002, New Zealand		Watts, R (corresponding author), Rehab Plus, 54 Carrington Rd,POB 44037, Auckland 1002, New Zealand.						ADAMS N, 1996, AUSTR NZ J FAMILY TH, V17, P75; Bishop DS, 1988, J HEAD TRAUMA REHAB, V3, P16; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; CAMPLAIR PS, 1990, COMMUNITY INTEGRATIO, P207; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; GLASS TA, 1993, STROKE, V24, P64, DOI 10.1161/01.STR.24.1.64; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; Goldberg D., 1978, MANUAL GEN HLTH QUES; Gray J.M, 1994, CLIN REHABIL, V8, P188, DOI [10.1177/026921559400800302, DOI 10.1177/026921559400800302, DOI 10.1080/09602010902949207]; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Johnson L H, 1996, J Neurosci Nurs, V28, P259; Kabacoff R.I., 1990, J FAM PSYCHOL, V3, P431, DOI [10.1037/h0080547, DOI 10.1037/H0080547]; KAPLAN SP, 1990, REHABIL COUNS BULL, V34, P16; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; KAY T, 1992, HEAD INJURY FAMILY I; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Kinsella G, 1989, Int Disabil Stud, V11, P9; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; KOSCIULEK JF, 1994, REHABIL COUNS BULL, V37, P244; KOSCIULEK JF, 1993, J REHABILITATION JUL, P40; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LAMONT M, 1993, THESIS TROBE U MELBO; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1995, J NEUROL NEUROSUR PS, V48, P876; Maitz E.A., 1991, HEAD INJURY FAMILY M, P65; MAITZ EA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199504000-00003; MAYER NH, 1993, J HEAD TRAUMA REHAB, V8, pR6; McCubin M. A., 1991, FAMILY ASSESSMENT IN, P3; MCGORRY PD, 1992, AUST NZ J PSYCHIAT, V26, P3, DOI 10.3109/00048679209068305; McMordie W R, 1988, Brain Inj, V2, P357, DOI 10.3109/02699058809150908; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; MOORE A, 1993, BRAIN INJURY, V7, P247, DOI 10.3109/02699059309029677; PARRY A, 1985, THESIS TROBE U MELBO; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; PERLESZ A, 1992, AUSTR NZ J FAMILY TH, V13, P145, DOI DOI 10.1002/J.1467-8438.1992.TB00910.X; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; SACHS PR, 1991, TREATING FAMILIES BR; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548; Tarter S B, 1990, Arch Clin Neuropsychol, V5, P15; THOMPSON K, 1988, WHY CANT S KOWALSKI; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; VANZOMEREN AH, J NEUROLOGY NEUROSUR, V48, P21	52	14	14	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	1999	13	2					113	124		10.1080/026990599121773			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	167HQ	WOS:000078626800004	10079956				2022-02-06	
S	Carbonell, WS; Grady, MS		Trembly, B; Slikker, W		Carbonell, WS; Grady, MS			Evidence disputing the importance of excitotoxicity in hippocampal neuron death after experimental traumatic brain injury	NEUROPROTECTIVE AGENTS: FOURTH INTERNATIONAL CONFERENCE	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	4th International Conference on Neuroprotective Agents - Clinical and Experimental Aspects	NOV 15-19, 1998	ANNAPOLIS, MD	US FDA, Natl Ctr Toxicol Res, Dept Vet Affairs Med Ctr			CONTROLLED CORTICAL IMPACT; CELL-DEATH; GLUTAMATE; NMDA; RECEPTORS; NEUROTOXICITY; VULNERABILITY; CONSEQUENCES; DYSFUNCTION; DISORDERS	The hippocampus is selectively vulnerable to experimental traumatic brain injury (TBI). Beneficial effects of glutamate receptor antagonists and increased extracellular levels of glutamate have suggested that glutamate-mediated excitotoxicity may be responsible for this selective damage. In order to clarify this important issue, we applied a severe parasagittal fluid percussion injury (FPI) to strains of mice shown to be susceptible and resistant to kainic acid (KA)-induced excitotoxic hippocampal damage. Dystrophic neurons were present by 10 min after FPI in the hippocampi of both strains, Damaged hippocampal neurons were absent at 4 days and 7 days. Additionally, there was no significant difference (p = 1.00) in CA3 neuron survival between KA-susceptible and -resistant mice at 4 days. In conclusion, excitotoxicity does not significantly contribute to hippocampal neuron loss after FPI and, in contrast to classic studies of excitotoxicity in vivo, the pattern of hippocampal cell death after TBI is extremely acute.	Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA		Grady, MS (corresponding author), Univ Penn, Hosp Univ Penn, Dept Neurosurg, 3400 Spruce St, Philadelphia, PA 19104 USA.	grady@mail.med.upenn.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30305, NS33107] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS033107, P50NS030305] Funding Source: NIH RePORTER		BAREYRE FM, 1998, J NEUROTRAUM, V15, P857; BEAUCHAMP GK, 1993, PHYSIOL BEHAV, V54, P179, DOI 10.1016/0031-9384(93)90063-L; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273, DOI 10.1016/0166-2236(87)90172-X; DAMBROSIO R, 1998, J NEUROTRAUM, V15, P864; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; GRADY MS, 1996, J NEUROTRAUM, V13, P508; GREENAMYRE JT, 1985, J PHARMACOL EXP THER, V233, P254; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Iijima T, 1998, J NEUROTRAUM, V15, P277, DOI 10.1089/neu.1998.15.277; Ikonomidou C, 1996, METAB BRAIN DIS, V11, P125, DOI 10.1007/BF02069500; KOH JY, 1990, J NEUROSCI, V10, P693; KUBOTA M, 1989, Brain and Nerve (Tokyo), V41, P799; Kurschner VC, 1998, BRAIN RES, V780, P1, DOI 10.1016/S0006-8993(97)01081-0; Lassmann H, 1986, Adv Exp Med Biol, V203, P223; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; McDermott KL, 1997, J NEUROTRAUM, V14, P191, DOI 10.1089/neu.1997.14.191; McIntosh TK, 1996, J NEUROTRAUM, V13, P767, DOI 10.1089/neu.1996.13.767; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4; OBRENOVITCH TP, 1998, IN PRESS PHARM CEREB; PERRY EK, 1993, HIPPOCAMPUS, V3, P307, DOI 10.1002/hipo.450030306; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Sheldon RA, 1998, BRAIN RES, V810, P114, DOI 10.1016/S0006-8993(98)00892-0; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Toth Z, 1997, J NEUROSCI, V17, P8106; VORNOV JJ, 1991, EXP NEUROL, V114, P11, DOI 10.1016/0014-4886(91)90079-R; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; Yang GM, 1997, BRAIN RES, V752, P209, DOI 10.1016/S0006-8993(96)01453-9; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8	41	14	17	0	2	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-223-1; 1-57331-222-3	ANN NY ACAD SCI	Ann.NY Acad.Sci.		1999	890						287	298		10.1111/j.1749-6632.1999.tb08005.x			12	Biochemistry & Molecular Biology; Multidisciplinary Sciences; Clinical Neurology; Pharmacology & Pharmacy	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Science & Technology - Other Topics; Neurosciences & Neurology; Pharmacology & Pharmacy	BP50F	WOS:000085330700026	10668434				2022-02-06	
J	Regan, RF; Guo, YP				Regan, RF; Guo, YP			Potentiation of excitotoxic injury by high concentrations of extracellular reduced glutathione	NEUROSCIENCE			English	Article						brain injury; calcium; cell culture; excitotoxicity; glutamate; ischemia	CORTICAL CELL-CULTURE; CEREBELLAR GRANULE CELLS; SPINAL-CORD NEURONS; NMDA RECEPTOR; AMINO-ACIDS; OXIDIZED GLUTATHIONE; GLUTAMATE TOXICITY; FOREBRAIN NEURONS; BINDING-SITES; RAT	Glutathione is present in the central nervous system in millimolar concentrations, and is a predominant intracellular antioxidant and detoxicant. In addition, glutathione is released into the extracellular space via a depolarization-enhanced process. Although the role of extracellular glutathione has not been precisely defined, a growing body of experimental evidence suggests that it has multifaceted electrophysiological effects. At low micromolar concentrations, glutathione depolarizes neurons by binding to its own receptors and modulates glutamatergic excitatory neurotransmission by displacing glutamate from its ionotropic receptors, At higher concentrations, reduced glutathione may increase N-methyl-D-aspartate receptor responses by interacting with its redox sites. In this study, the effect of extracellular glutathione on excitotoxic neuronal injury was quantitatively assessed in murine cortical cell cultures. Neuronal death due to 20-25 h exposure to 6-9 mu M N-methyl-D-aspartate was not altered by 10-100 mu M reduced glutathione bur was markedly enhanced by 300-1000 mu M reduced glutathione; kainate neurotoxicity was unaffected. Two related compounds that lack a sulfhydryl group, oxidized glutathione and S-hexylglutathione, had no significant effect on N-methyl-D-aspartate neurotoxicity alone but completely blocked the effect of reduced glutathione. Mercaptoethanol, a sulfhydryl reducing agent that increases N-methyl-D-aspartare receptor responses by interacting with redox sites, increased N-methyl-D-aspartate neurotoxicity to a degree comparable to that of reduced glutathione; this effect was also blocked by equimolar S-hexylglutathione or oxidized glutathione. Addition of reduced glutathione to mercaptoethanol did not further increase N-methyl-D-aspartate-induced neuronal death. These results suggest that release of reduced glutathione from central nervous system cells that are subjected to traumatic or ischemic insults may enhance excitotoxic neuronal loss. Although multiple mechanisms may account for this phenomenon, the high concentrations required suggest that it is at least partly mediated by reduction of N-methyl-D-aspartare receptor redox sires. (C) 1999 IBRO. Published by Elsevier Science Ltd.	Thomas Jefferson Univ, Div Emergency Med, Philadelphia, PA 19107 USA		Regan, RF (corresponding author), Thomas Jefferson Univ, Div Emergency Med, 1020 Sanson St,239 Thompson Bldg, Philadelphia, PA 19107 USA.						AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; CHOI DW, 1987, J NEUROSCI, V7, P357; COYLE JT, 1991, EPILEPSY RES, V10, P41, DOI 10.1016/0920-1211(91)90093-U; Dringen R, 1997, J NEUROCHEM, V69, P868; GILBERT KR, 1991, NEUROSCI LETT, V133, P11, DOI 10.1016/0304-3940(91)90045-U; GUO N, 1992, MOL BRAIN RES, V15, P207, DOI 10.1016/0169-328X(92)90110-W; GUO N, 1992, NEUROSCIENCE, V51, P835, DOI 10.1016/0306-4522(92)90524-6; HALLIWELL B, 1989, FREE RADICAL BIO MED, P80; HELD KD, 1994, RADIAT RES, V139, P15, DOI 10.2307/3578727; JANAKY R, 1993, NEUROSCI LETT, V156, P153, DOI 10.1016/0304-3940(93)90461-S; KOHR G, 1994, NEURON, V12, P1031, DOI 10.1016/0896-6273(94)90311-5; LANDOLT H, 1992, J CEREBR BLOOD F MET, V12, P96, DOI 10.1038/jcbfm.1992.12; LANIUS RA, 1994, J NEUROCHEM, V63, P155; LEVY DI, 1991, NEUROREPORT, V2, P345, DOI 10.1097/00001756-199106000-00011; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; MAJEWSKA MD, 1990, BRAIN RES, V537, P328, DOI 10.1016/0006-8993(90)90379-P; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MIYAMOTO M, 1989, J PHARMACOL EXP THER, V250, P1132; MONYER H, 1990, NEURON, V5, P121, DOI 10.1016/0896-6273(90)90302-V; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; OGITA K, 1988, BRAIN RES, V463, P37, DOI 10.1016/0006-8993(88)90524-0; Orlowski M, 1976, Int Rev Neurobiol, V19, P75, DOI 10.1016/S0074-7742(08)60702-3; Pasqualotto BA, 1998, GLUTATHIONE NERVOUS, P197; PUTTFARCKEN PS, 1993, BRAIN RES, V624, P223, DOI 10.1016/0006-8993(93)90081-W; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; Regan RF, 1998, J NEUROTRAUM, V15, P645, DOI 10.1089/neu.1998.15.645; REGAN RF, 1993, NEUROSCI LETT, V153, P219, DOI 10.1016/0304-3940(93)90326-G; REGAN RF, 1995, BRAIN RES, V682, P144, DOI 10.1016/0006-8993(95)00330-S; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; Rose Kamala, 1993, P46; Shaw CA, 1996, NEUROREPORT, V7, P1149, DOI 10.1097/00001756-199604260-00010; SUCHER NJ, 1991, J NEUROSCI RES, V30, P582, DOI 10.1002/jnr.490300316; TATE SS, 1974, J BIOL CHEM, V249, P7593; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; VARGA V, 1989, NEUROCHEM RES, V14, P1223, DOI 10.1007/BF00965513; Varga V, 1997, NEUROCHEM RES, V22, P1165, DOI 10.1023/A:1027377605054; YUDKOFF M, 1990, J NEUROCHEM, V55, P137, DOI 10.1111/j.1471-4159.1990.tb08831.x; ZANGERLE L, 1992, J NEUROCHEM, V59, P181, DOI 10.1111/j.1471-4159.1992.tb08889.x	40	14	16	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		1999	91	2					463	470		10.1016/S0306-4522(98)00597-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190RA	WOS:000079977200006	10366003				2022-02-06	
J	Stamatakis, EA; Wilson, JTL; Wyper, DJ				Stamatakis, EA; Wilson, JTL; Wyper, DJ			Analysis of HMPAO SPECT scans in head injury using statistical parametric mapping	BEHAVIOURAL NEUROLOGY			English	Article							CEREBRAL BLOOD-FLOW; TRAUMATIC BRAIN INJURY; HM-PAO-SPECT; ALZHEIMERS-DISEASE; TECHNETIUM-99M-HMPAO SPECT; COMPUTED-TOMOGRAPHY; TC-99M-HMPAO SPECT; CT; MRI; MILD	The paper examines the ability of Statistical Parametric Mapping (SPM) to contribute towards the quantitative analysis of HMPAO SPECT images containing lesions. A validation study is described in which SPECT images were created that contained synthetic lesions and were analysed with SPM. The study established a set of guidelines concerning the alignment, smoothing, and statistical analysis of images. These were then applied to analysis of SPECT scans from head injured patients. A demonstration is given of the use of SPM to identify localised blood flow abnormalities associated with cognitive deficits after head injury. Correlations between blood flow abnormalities and a test of visual memory are illustrated.	Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; Univ Glasgow, Dept Clin Phys, Glasgow G12 8QQ, Lanark, Scotland			easl@stir.ac.uk	Wilson, Lindsay/O-8883-2019; Wilson, Lindsay/A-3659-2009	Wilson, Lindsay/0000-0003-4113-2328; Wilson, Lindsay/0000-0003-4113-2328; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601			ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; Acton PD, 1998, EUR J NUCL MED, V25, P663; Bartenstein P, 1997, J NUCL MED, V38, P1095; BAVETTA S, 1994, NUCL MED COMMUN, V15, P961, DOI 10.1097/00006231-199412000-00007; BULLOCK R, 1990, ACT NEUR S, V51, P286; CHOKSEY MS, 1991, J NEUROL NEUROSUR PS, V54, P6, DOI 10.1136/jnnp.54.1.6; COSTA DC, 1988, J CEREBR BLOOD F MET, V8, pS109, DOI 10.1038/jcbfm.1988.40; Friston K.J., 1994, FUNCTIONAL NEUROIMAG, P79; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; GRAY BG, 1992, J NUCL MED, V33, P52; HOUSTON AS, 1994, J NUCL MED, V35, P239; Houston AS, 1998, J NUCL MED, V39, P425; ICHISE M, 1994, J NUCL MED, V35, P217; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; JOHNSON KA, 1993, J NUCL MED, V34, P2044; Johnson LS, 1999, J NUCL MED, V40, p270P; KARBE H, 1994, NEURORADIOLOGY, V36, P1, DOI 10.1007/BF00599183; Lee JS, 1999, J NUCL MED, V40, p276P; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; MONTALDI D, 1990, J NEUROL NEUROSUR PS, V53, P33, DOI 10.1136/jnnp.53.1.33; NEDD K, 1993, BRAIN INJURY, V7, P469, DOI 10.3109/02699059309008174; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; PEARLSON GD, 1992, ARCH GEN PSYCHIAT, V49, P402; PIPER I, 1998, INT J INTENSIVE CARE, V5, P140; ROPER SN, 1991, J NUCL MED, V32, P1684; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; Stamatakis EA, 1999, NEUROIMAGE, V10, P397, DOI 10.1006/nimg.1999.0477; STAMATAKIS EA, 1999, P MED IMAGE UNDERSTA, V99, P21; SYED GMS, 1992, NUCL MED COMMUN, V13, P811, DOI 10.1097/00006231-199211000-00007; Tikofsky RS, 1999, J NUCL MED, V40, p272P; Wiedmann KD, 1989, NEUROPSYCHOLOGY, V3, P267, DOI 10.1037//0894-4105.3.4.267; WILSON JTL, 1992, J HEAD TRAUMA REHAB, V7, P29; WILSON JTL, 1996, RECOVERY TRAUMATIC B	38	14	14	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		1999	12	1-2					29	37		10.1155/2000/681916			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	367RM	WOS:000090075300004	11455040	gold, Green Submitted			2022-02-06	
J	Bedell, EA; DeWitt, DS; Prough, DS				Bedell, EA; DeWitt, DS; Prough, DS			Fentanyl infusion preserves cerebral blood flow during decreased arterial blood pressure after traumatic brain injury in cats	JOURNAL OF NEUROTRAUMA			English	Article						brain blood flow; cerebral blood flow; fentanyl; fluid-percussion injury; traumatic brain injury	HEAD-INJURY; ENDOGENOUS OPIOIDS; PERFUSION-PRESSURE; OXYGEN DELIVERY; MILD HEMORRHAGE; SHOCK; HYPOTENSION; RESPONSES; NALOXONE	Hypotension after traumatic brain injury (TBI) has been associated with significant reductions in cerebral blood flow (CBF) in experimental animals. In humans, posttraumatic hypotension is associated with significantly worsened outcome, possibly because of cerebral hypoperfusion. The existence of opioid receptor-mediated cerebrovascular dilatory effects in humans has been theorized. We studied the systemic and cerebral vascular effects of fentanyl after fluid-percussion injury (FPI) TBI in isoflurane-anesthetized cats. In an approved protocol, 17 fasted cats were anesthetized, mechanically ventilated with 1-1.5% isoflurane in 70% N2O/30% O-2, and prepared for FPI. Electroencephalogram (EEG) and intracranial pressure (ICP) were monitored. Cerebral blood flow and cardiac output were measured with radiolabelled microspheres. Animals received moderate FPI (2.2 atm) followed by 15 min of stabilization. Cats were then randomized to control (isoflurane anesthesia plus saline placebo) or fentanyl (isoflurane anesthesia plus fentanyl 50 mu g.kg(-1) h(-1)) groups. CBF, EEG, and ICP were recorded at baseline (Baseline), 15 min post-FPI (post-FPI), and at 15, 75, and 135 min after beginning fentanyl or saline placebo infusions (INF 15, INF 75, INF 135). EEG, ICP, PaCO2, PaO2, pH, and temperature were similar between groups. Mean arterial pressure was signifciantly lower than in the control group after fentanyl administration, while total CBF was not significantly different from control values. In a previous study, decreasing MAP to 80 mm Hg after TBI in isoflurane-anesthetzied cats resulted in a 30% decrease in CBF. In this study, fentanyl after TBI significantly decreased MAP but not CBF. Fentanyl administration was associated with preservation of CBF despite hypotension. Further research is necessary to evaluate the effects of fentanyl on cerebral autoregulation after TBI.	Univ Texas, Med Branch, Dept Anesthesiol 0591, Galveston, TX 77555 USA		Bedell, EA (corresponding author), Univ Texas, Med Branch, Dept Anesthesiol 0591, Galveston, TX 77555 USA.		Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X			BERNTON EW, 1985, FED PROC, V44, P290; Bouma G J, 1995, New Horiz, V3, P384; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DeWitt DS, 1997, J NEUROTRAUM, V14, P931, DOI 10.1089/neu.1997.14.931; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; DeWitt DS, 1996, CRIT CARE MED, V24, P109, DOI 10.1097/00003246-199601000-00019; FADEN AI, 1979, SCIENCE, V205, P317, DOI 10.1126/science.451606; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; HOFFBRAND BI, 1969, CARDIOVASC RES, V3, P426, DOI 10.1093/cvr/3.4.426; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kofke WA, 1997, J NEUROSURG ANESTH, V9, P349, DOI 10.1097/00008506-199710000-00011; KOMJATI K, 1997, SHOCK, V4, P288; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; LANG RE, 1982, REGUL PEPTIDES, P363; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609000-00010; MARMAROU A, 1991, J NEUROSURG S, V75, P59; MASTRIANNI JA, 1989, NEUROSCIENCE, V33, P559, DOI 10.1016/0306-4522(89)90408-9; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P373, DOI 10.1089/neu.1993.10.373; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MILDE LN, 1990, ANESTH ANALG, V70, P138; MUIZELAAR JP, 1985, CENTRAL NERVOUS SYST, P123; PERRY DC, 1995, MOL CHEM NEUROPATHOL, V16, P49; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; PRIOR PF, 1978, BRIT J ANAESTH, V50, P993, DOI 10.1093/bja/50.10.993; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; RUDOLPH AM, 1967, CIRC RES, V21, P163, DOI 10.1161/01.RES.21.2.163; Smith D H, 1995, New Horiz, V3, P562; SPERRY RJ, 1992, ANESTHESIOLOGY, V77, P416, DOI 10.1097/00000542-199209000-00002; Stene Johan K., 1994, ANESTHESIA, P2157; VINK R, 1990, J NEUROSCI, V10, P3524; Wang BG, 1997, J NEUROSURG ANESTH, V9, P335, DOI 10.1097/00008506-199710000-00008; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; [No title captured]	39	14	14	0	3	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	1998	15	11					985	992		10.1089/neu.1998.15.985			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	139RN	WOS:000077043400007	9840771				2022-02-06	
J	Ralph, MAL				Ralph, MAL			Distributed versus localist representations: Evidence from a study of item consistency in a case of classical anemia	BRAIN AND LANGUAGE			English	Article							LEXICAL ACCESS; RETRIEVAL; ACTIVATION	Models of word production and comprehension can be split into two broad classes: localist and distributed. In localist architectures each word within the lexicon is represented by a single unit. The distributed approach, on the other hand, encodes each lexical item as a pattern of activation across a set of shared units. If we assume that the localist representations are more than a convenient shorthand for distributed representations at the neuroanatomical level, it should be possible to find patients who, after brain injury, have lost specific words from their premorbid vocabulary. Following a closed head injury, JS had severe word-finding difficulties with no measurable semantic impairment nor did he make phonological errors in naming. Cueing with an initial phoneme proved relatively ineffective. JS showed a high degree of item consistency across three administrations of two tests of naming to confrontation. This consistency could not be predicted from a linear combination of psycholinguistic variables but the distribution fitted a stochastic model in which it is assumed that a proportion of items have become consistently unavailable. Further evidence is presented which suggests that these items are not, in fact, lost but rather have a very low probability of retrieval. Given phonemic cueing of sufficient length, or delayed repetition priming from a written word, the consistently unnamed items were produced by JS. Additional data is reported which seems to support a distributed model of speech production. JS's naming accuracy for one set of pictures was found to predict his performance on a second set of items only when the names of the pictures were both semantically and phonologically related (e.g., eat-rat). There was no association for pairs of pictures if they were only semantically (e.g., cat-dog) or phonologically related (e.g., cat-cap). It is argued that JS's data are best described in terms of a graded, non-linear, distributed model of speech production. (C) 1998 Academic Press.	MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England		Ralph, MAL (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 2EF, England.		Lambon Ralph, Matthew/A-1695-2009	Lambon Ralph, Matthew/0000-0001-5907-2488			Allport D. A., 1985, CURRENT PERSPECTIVES; Butterworth B., 1989, LEXICAL REPRESENTATI, pI08; CARAMAZZA A, 1990, CORTEX, V26, P95, DOI 10.1016/S0010-9452(13)80077-9; *CTR LEX INF, 1993, CEL LEX DAT; DELL GS, 1992, COGNITION, V42, P287, DOI 10.1016/0010-0277(92)90046-K; Dell GS, 1997, PSYCHOL REV, V104, P801, DOI 10.1037/0033-295X.104.4.801; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; DUNN A, 1965, PEABODY PICTURE VOCA; FAGLIONI P, 1993, CORTEX, V29, P501, DOI 10.1016/S0010-9452(13)80256-0; Franklin S., 1992, ADA COMPREHENSION BA; Graham K, 1995, NEUROCASE, V1, P25; HOWARD D, 1995, Q J EXP PSYCHOL-A, V48, P999, DOI 10.1080/14640749508401426; Howard D., 1988, MISSING MEANING; Howard D, 1992, PYRAMIDS PALM TREES; HOWARD D, 1987, LANGUAGE PERCEPTION; KAPLAN E, 1976, BOSTON NAMING TEST; KAY J, 1987, BRAIN, V110, P613, DOI 10.1093/brain/110.3.613; Kuera H., 1967, COMPUTATIONAL ANAL P; LAMBON RMA, UNPUB COGNITIVE NEUR; LEVELT WJM, 1992, COGNITION, V42, P1, DOI 10.1016/0010-0277(92)90038-J; LEVELT WJM, 1989, SPEAKING INTENTION A; McClelland J.L., 1986, PARALLEL DISTRIBUTED; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P170; MORTON J, 1985, CURRENT PERSPECTVES; PAGE MPA, UNPUB BEHAV BRAIN SC; PLAUT DC, 1993, COGNITIVE NEUROPSYCH, V10, P377, DOI 10.1080/02643299308253469; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; QUINLAN PT, 1992, MRC PSYCHOLINGUISTIC; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Tyler L. K., 1992, SPOKEN LANGUAGE COMP; WARRINGTON EK, GRADED NAMING TEST; WINGFIELD A, 1990, BRAIN LANG, V39, P373, DOI 10.1016/0093-934X(90)90146-8	33	14	14	0	1	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X			BRAIN LANG	Brain Lang.	OCT 1	1998	64	3					339	360					22	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	122EE	WOS:000076058300006	9743547				2022-02-06	
J	Lazorthes, Y; Sallerin, B; Verdie, JC; Casaux, J; Caraoue, F; Sol, JC				Lazorthes, Y; Sallerin, B; Verdie, JC; Casaux, J; Caraoue, F; Sol, JC			Treatment of the spasticity by intrathecal administration of baclofen.	NEUROCHIRURGIE			French	Article							ACQUIRED BRAIN INJURY; CEREBRAL-PALSY; SPINAL ORIGIN; INFUSION	Direct intrathecal administration of baclofen in the treatment of severe spasticity was proposed in 1984 by Richard Penn with the objective to carry out a selective spinal distribution of the active principle thus avoiding supraspinal side effects. We presented our first results at the French Language Association of Neurosurgery in 1985 within the framework of a report on << Functional neurosurgery of cerebral palsy >> (Neurochirurgie, 1985, 31 (suppl 1) : 1-118). This study aims to specify the selection criteria and current indications of this method for the treatment of severe chronic diffused spasticity of spinal and cerebral origin in adults and in children. This report relates to our experience concerning 60 patients (10 children) that benefit from the use of a totally implantable system for chronic administration, The total follow-up of all patients was 48 months (from 3 to 140 months). The initial effective daily amount of baclofen was 156 mu g/24 hours and progressed in time to reach in the long run 280 mu g/24 hours, with a very broad interindividual variability from 36 to 1050 mu g/24 hours. All the patients benefited from a reduction in muscular hypertonicity as well as painful muscular spasms. On the other hand, the functional improvement was very variable from one patient to another and depended primarily on the initial clinical stale and the etiology of the spasticity. The results observed were more significant in post-traumatic paraplegia than those secondary to demyelination disease even if they were stabilized with regard to spasticity of spinal origin. This mode of administration currently plays a significant role in the treatment of spasticity of cerebral origin, in particular in children presenting a motor disorder of cerebral origin with spastic prevalence. The current limitations of this type of treatment are technical because of the frequent catheter malfunctions, but are due essentially to the importance and constraint of the multi-disciplinary organization needed for the out-patient follow-up.	CHU Rangueil, Hop Rangueil, Serv Neurochirurg, F-31054 Toulouse, France		Lazorthes, Y (corresponding author), CHU Rangueil, Hop Rangueil, Serv Neurochirurg, F-31054 Toulouse, France.						ALBRIGHT AL, 1991, JAMA-J AM MED ASSOC, V265, P1418, DOI 10.1001/jama.265.11.1418; ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; Armstrong RW, 1997, J NEUROSURG, V87, P409, DOI 10.3171/jns.1997.87.3.0409; BOWERY NG, 1980, NATURE, V283, P92, DOI 10.1038/283092a0; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; LAZORTHES Y, 1990, J NEUROSURG, V72, P393, DOI 10.3171/jns.1990.72.3.0393; LAZORTHES Y, 1988, LOCAL SPINAL THERAPY, P215; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P461, DOI 10.1016/S0003-9993(96)90034-9; MULLER H, 1987, J NEUROL, V234, P348, DOI 10.1007/BF00314294; MULLER H, 1988, LOCAL SPINAL THERAPY, P155; OCHS G, 1989, J NEUROL NEUROSUR PS, V52, P933, DOI 10.1136/jnnp.52.8.933; PENN RD, 1985, LANCET, V2, P125; PENN RD, 1987, J NEUROSURG, V66, P181, DOI 10.3171/jns.1987.66.2.0181; PENN RD, 1992, J NEUROSURG, V77, P236, DOI 10.3171/jns.1992.77.2.0236; PENN RD, 1984, LANCET, V1, P1078; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; SIEGFRIED J, 1985, NEUROCHIRURGIE, V31, P1; STEINBOK P, 1995, PEDIATR NEUROSURG, V22, P155	19	14	15	0	1	MASSON EDITEUR	PARIS 06	120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE	0028-3770			NEUROCHIRURGIE	Neurochirurgie	SEP	1998	44	3					201	208					8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	129MT	WOS:000076468100008	9827437				2022-02-06	
J	Wogar, MA; van den Broek, MD; Bradshaw, CM; Szabadi, E				Wogar, MA; van den Broek, MD; Bradshaw, CM; Szabadi, E			A new performance-curve method for the detection of simulated cognitive impairment	BRITISH JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							MEMORY; INTELLIGENCE; MATRICES; FAKING; INJURY; AGE	Objectives. To evaluate a new performance-curve method for detecting simulated cognitive impairment. Design. The method was based on quantitative analysis of choice reaction times in a series of eight matching-to-sample tasks of graded complexity, in which participants were required to identify which of two comparison stimuli was identical to a simultaneously presented sample stimulus. The stimuli consisted of arrays of letters, the number of letters ranging from 1 to 10 in the eight tasks. Methods. Mean reaction times of a standardization group of 20 healthy young adults were used to construct regression equations to describe the behaviour of three test groups: 20 healthy individuals instructed to perform to the best of their ability (non-simulators), 20 healthy individuals instructed to simulate cognitive impairment incurred as a result of a head injury (simulators), and 25 patients with a history of closed head injury (patients). Results. There was a linear relationship between individual participants' latencies and the mean latencies of the standardization sample; the patient group showed steeper slopes, and the simulators higher intercepts, than the non-simulator group. A univariate measure of performance, based on the proportionate increase in latency corresponding to a standard increase in the standardization group's latency was able to identify 14/20 simulators while misclassifying 2/20 non-simulators and 2/25 patients. Other measures, including the number of errors made in the choice reaction time task and in recognition memory tasks, and a performance-curve measure based on Raven's Standard Progressive Matrices, were less successful in identifying simulators. Conclusions. This new performance-curve method may prove to be a useful addition to tests currently used to diagnose simulated cognitive impairment in clinical and medicolegal settings.	Univ Nottingham, Queens Med Ctr, Dept Psychiat, Nottingham NG7 2UH, England; Camden & Islington Community Hlth Serv Trust, London, England; Rathbone Hosp, Liverpool, Merseyside, England		Bradshaw, CM (corresponding author), Univ Nottingham, Queens Med Ctr, Dept Psychiat, Nottingham NG7 2UH, England.						BAKER GA, 1993, J CLIN EXP NEUROPSYC, V15, P668, DOI 10.1080/01688639308402588; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; CERELLA J, 1985, PSYCHOL BULL, V98, P67, DOI 10.1037/0033-2909.98.1.67; GUDJONSSON GH, 1986, BRIT J CLIN PSYCHOL, V25, P35, DOI 10.1111/j.2044-8260.1986.tb00668.x; HALE S, 1987, J GERONTOL, V42, P131, DOI 10.1093/geronj/42.2.131; IVERSON GL, 1994, ARCH CLIN NEUROPSYCH, V9, P437, DOI 10.1016/0887-6177(94)90006-X; LORRABEE GJ, 1990, NEUROPSYCHOLOGIA, V4, P239; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MARTIN RC, 1993, J CLIN EXP NEUROPSYC, V15, P867, DOI 10.1080/01688639308402604; MYERSON J, 1989, J EXP ANAL BEHAV, V52, P353, DOI 10.1901/jeab.1989.52-353; NELSON HE, 1975, BRIT J SOC CLIN PSYC, V14, P259, DOI 10.1111/j.2044-8260.1975.tb00178.x; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; Poon, 1980, AGING 1980S PSYCHOL, P332, DOI [10.1037/10050-024, DOI 10.1037/10050-024]; RABBITT P, 1994, Q J EXP PSYCHOL-A, V47, P741, DOI 10.1080/14640749408401135; Raven J. C., 1960, GUIDE STANDARD PROGR; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; RUDDLE HV, 1982, BRIT J CLIN PSYCHOL, V21, P159, DOI 10.1111/j.2044-8260.1982.tb00548.x; Salthouse TA, 1985, THEORY COGNITIVE AGI, V28th; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; Siegel S., 1956, NONPARAMETRIC STAT B, pXVII, 312; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; TRUEBLOOD W, 1993, J CLIN EXPT NEUROPSY, V15, P278; VANDENBROEK MD, 1994, BRIT J CLIN PSYCHOL, V33, P509; Warrington E, 1984, RECOGNITION MEMORY T, V1	27	14	15	0	1	BRITISH PSYCHOLOGICAL SOC	LEICESTER	ST ANDREWS HOUSE, 48 PRINCESS RD EAST, LEICESTER, LEICS, ENGLAND LE1 7DR	0144-6657			BRIT J CLIN PSYCHOL	Br. J. Clin. Psychol.	SEP	1998	37		3				327	339		10.1111/j.2044-8260.1998.tb01389.x			13	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	121FU	WOS:000076003300007	9784887				2022-02-06	
J	Alagarsamy, S; DeWitt, DS; Johnson, KM				Alagarsamy, S; DeWitt, DS; Johnson, KM			Effects of moderate, central fluid percussion traumatic brain injury on nitric oxide synthase activity in rats	JOURNAL OF NEUROTRAUMA			English	Article						arginine; calcium; cerebral blood flow; cortex; fluid percussion; glutamate	CEREBRAL BLOOD-FLOW; SUPEROXIDE; INHIBITION; ISCHEMIA; SLICES	Experimental traumatic brain injury (TBI) damages cerebral vascular endothelium and reduces cerebral blood flow (CBF), The nitric oxide synthase (NOS) substrate, L-arginine, prevents CBF reductions after TBI, but the mechanism is not known. This study examined the possibility that posttraumatic hypoperfusion is due to reductions in the substrate sensitivity of NOS which are overcome by L-arginine, Isoflurane-anesthetized rats were prepared for TBI (midline fluid-percussion, 2.2 atm), sham-TBI, or no surgery (control), and were decapitated 30 min after injury or sham injury. The brains were removed and homogenized or minced for measurements of crude soluble or cell-dependent stimulated NOS activity, respectively, Baseline arterial oxygen, carbon dioxide, pH, or hemoglobin levels did not differ among control, sham, or TBI groups. Total cortical soluble NOS activity in TBI-treated rats was not significantly different from either untreated or sham groups when 0.45 mu M or 1.5 mu M L-arginine was added. Also, there were no differences in cell-dependent NOS activity among the three groups stimulated by 300 mu M N-methyl-D-aspartate, 50 mM K+, or 10 mu M ionomycin, These data suggest that TBI reduces CBF by a mechanism other than altering the substrate specificity or activation of nNOS.	Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Anesthesiol, Charles R Allen Res Labs, Galveston, TX 77550 USA		Alagarsamy, S (corresponding author), Emory Univ, Dept Pharmacol, 5068 Rollins Res Bldg,1510 Clifton Rd, Atlanta, GA 30322 USA.		Johnson, Kenneth/E-7944-2014		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS19355] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019355] Funding Source: NIH RePORTER		ALAGARSAMY S, 1994, J NEUROSCI RES, V38, P648, DOI 10.1002/jnr.490380607; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; BECKMAN JS, 1994, PROG BRAIN RES, V103, P371; BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53; BECKMAN JS, 1991, J CEREB BLOOD FLO S2, V11, pS629; BERGJOHNSEN J, 1987, ACTA PHYSIOL SCAND, V130, P679, DOI 10.1111/j.1748-1716.1987.tb08192.x; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Crow J P, 1995, Adv Pharmacol, V34, P17; DEWITT D S, 1992, Anesthesiology (Hagerstown), V77, pA689, DOI 10.1097/00000542-199209001-00689; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; DEWITT DS, 1997, J NEUROTRAUM, V14, P219; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FABIAN RH, 1995, J CEREBR BLOOD F MET, V15, P242, DOI 10.1038/jcbfm.1995.30; FABRICIUS M, 1995, AM J PHYSIOL-HEART C, V269, pH23, DOI 10.1152/ajpheart.1995.269.1.H23; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; KOBAYASHI H, 1991, J NEUROSURG, V75, P906, DOI 10.3171/jns.1991.75.6.0906; KOVACH AGB, 1994, ANN NY ACAD SCI, V738, P348; KUMURA E, 1994, J CEREBR BLOOD F MET, V14, P487, DOI 10.1038/jcbfm.1994.60; MORIKAWA E, 1994, STROKE, V25, P429, DOI 10.1161/01.STR.25.2.429; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; PELLIGRINO DA, 1993, J CEREBR BLOOD F MET, V13, P80, DOI 10.1038/jcbfm.1993.10; RUBANYI GM, 1986, AM J PHYSIOL, V250, P822; TANAKA K, 1991, NEUROSCI LETT, V127, P129, DOI 10.1016/0304-3940(91)90911-C; TERASAKO K, 1994, ANESTH ANALG, V79, P921; TOBIN JR, 1994, ANESTHESIOLOGY, V81, P1264, DOI 10.1097/00000542-199411000-00021; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	35	14	14	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	1998	15	8					627	633		10.1089/neu.1998.15.627			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	111KP	WOS:000075436500006	9726261				2022-02-06	
J	Gfeller, JD; Cradock, MM				Gfeller, JD; Cradock, MM			Detecting feigned neuropsychological impairment with the Seashore Rhythm Test	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article; Proceedings Paper	1994 Annual Meeting of the National-Academy-of-Neuropsychology	NOV, 1994	ORLANDO, FLORIDA	Natl Acad Neuropsychol			RECOGNITION MEMORY TEST; FORCED-CHOICE METHOD; MILD HEAD-INJURY; VALIDITY; DEFICITS	Sixty undergraduate subjects were randomly assigned to one of three groups and completed the Seashore Rhythm Test (SRT) as part of an investigation regarding simulated neuropsychological impairment. A sophisticated simulator group was instructed to feign impairment and was provided information regarding traumatic brain injury (TBI) sequelae. A naive simulator group was instructed to feign impairment, but was given no such information. A control group was instructed to perform optimally. Additionally, SRT scores for 20 TBI subjects who completed neuropsychological evaluations were analyzed. Mean SRT scores for the sophisticated and naive simulators did not differ but were significantly lower when compared to control subjects and TB subjects. A discriminate function analysis cutting score correctly classified 79% of subjects, while classification rates obtained with two previously investigated cutting scores were 64% and 72%. Implications of using these curling scores are discussed. The findings indicate the SRT is a useful indicator of feigned neurological impairment. (C) 1998 John Wiley & Sons, Inc.	St Louis Univ, Dept Psychol, St Louis, MO 63103 USA; Univ Arkansas Med Sci, Little Rock, AR 72205 USA		Gfeller, JD (corresponding author), St Louis Univ, Dept Psychol, 221 N Grand Blvd, St Louis, MO 63103 USA.						AUBREY JB, 1989, J NEUROL NEUROSUR PS, V52, P842, DOI 10.1136/jnnp.52.7.842; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; BERNARD LC, 1990, J CLIN PSYCHOL, V46, P432, DOI 10.1002/1097-4679(199007)46:4<432::AID-JCLP2270460410>3.0.CO;2-0; BINDER LM, 1990, CLIN NEUROPSYCHOLOGI, V4, P36; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; CRADOCK MM, 1995, THESIS LOUIS U ST LO; Dunn E J, 1990, Arch Clin Neuropsychol, V5, P103, DOI 10.1016/0887-6177(90)90032-K; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; FINN SE, 1995, OXF TEXT CLIN PSY, V2, P224; Frederick R. I., 1991, PSYCHOL ASSESSMENT J, V3, P596, DOI DOI 10.1037/1040-3590.3.4.596; Golden C.J., 1981, INTERPRETATION HALST; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; HAYWARD L, 1987, AUST NZ J PSYCHIAT, V21, P87, DOI 10.3109/00048678709160904; HEATON RK, 1986, NEUROPSYCHOLOGICAL A, P100; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; IVERSON GL, 1993, ARCH CLIN NEUROPSYCH, V8, P234; JARVIS P, 1994, HALSTEADREITAN NEURO; LEESHALEY PR, 1994, J CLIN PSYCHOL, V50, P252, DOI 10.1002/1097-4679(199403)50:2<252::AID-JCLP2270500217>3.0.CO;2-T; MARTIN RC, 1992, ARCH CLIN NEUROPSYCH, V7, P347; MATARAZZO JD, 1990, AM PSYCHOL, V45, P999, DOI 10.1037/0003-066X.45.9.999; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; Miller W., 1992, PHYSICAL MED REHABIL, V6, P547; MILLIS S, 1994, ARCH CLIN NEUROPSYCH, V9, P163; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; Reitan R.M., 1993, HALSTEADREITAN NEURO; SHERER M, 1991, J CLIN EXP NEUROPSYC, V13, P741, DOI 10.1080/01688639108401087; SPECTOR J, 1994, 14 ANN C NAT AC NEUR; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wolfson D, 1989, CLIN NEUROPSYCHOL, V3, P70, DOI [10.1080/13854048908404078, DOI 10.1080/13854048908404078]	32	14	14	0	2	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.	JUN	1998	54	4					431	438		10.1002/(SICI)1097-4679(199806)54:4<431::AID-JCLP5>3.0.CO;2-Q			8	Psychology, Clinical	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Psychology	ZN929	WOS:000073697700005	9623748				2022-02-06	
J	Hinchliffe, FJ; Murdoch, BE; Chenery, HJ; Baglioni, AJ; Harding-Clark, J				Hinchliffe, FJ; Murdoch, BE; Chenery, HJ; Baglioni, AJ; Harding-Clark, J			Cognitive-linguistic subgroups in closed-head injury	BRAIN INJURY			English	Article							PRAGMATIC LANGUAGE-SKILLS; TOMOGRAPHY; DISORDERS; ABILITY; MEMORY	This study examined variability in the interrelationship between language skill and neuropsychological function within a group of 25 severe closed head injury (CHI) subjects and 23 matched controls. All subjects underwent a battery of standardized language and neuropsychological tests. Cluster analyses were conducted to determine whether the CHI sample was universally or differentially impaired. Further subgroup analysis using a Q-type factor analysis outlined the differences in performance profiles within the group of CHI subjects. Results support the hypothesis that while some deficits were common to all CHI subjects, impairments delinated by whole group analysis do not necessarily represent universal impairments. In particular, ability to perform tasks involving auditory comprehension, naming, verbal memory, visual memory and visuospatial skills appeared to be important components in group differentiation. The cognitive-linguistic impairments which were common to all CHI subjects and considered to be the 'cardinal' cognitive-linguistic deficits following severe CHI were deficits in lexical-semantic and sentential semantic skills, Verbal fluency, complex auditory comprehension, and attentional operations. Profile analysis revealed the existence of a double dissociation between performances on naming and verbal memory tasks and performances on visually related cognitive tasks. Results are discussed with reference to findings on previous studies of subgroups in the CHI population.	Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia; Princess Alexandra Hosp, Dept Psychol, Brisbane, Qld 4102, Australia		Hinchliffe, FJ (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia.		Chenery, Helen J/F-5194-2010; Murdoch, Bruce E/C-1397-2012				ADAMOVICH BB, 1990, FOLIA PHONIATR, V42, P11, DOI 10.1159/000266015; AU R, 1988, APHASIOLOGY, V2, P161, DOI 10.1080/02687038808248901; BASSO A, 1985, BRAIN LANG, V26, P201, DOI 10.1016/0093-934X(85)90039-2; BAYLES KA, 1989, J SPEECH HEAR DISORD, V54, P74, DOI 10.1044/jshd.5401.74; BRYAN KL, 1989, RIGHT HEMISPHERE LAN; CHAPMAN S, 1992, BRAIN LANG, V43, P4; CHAPMAN SB, 1995, HDB NEUROLOGICAL SPE, P387; COPPENS P, 1995, BRAIN INJURY, V9, P195, DOI 10.3109/02699059509008192; DAVIS GA, 1989, APHASIOLOGY, V3, P723, DOI 10.1080/02687038908249040; DAVIS GA, 1989, APHASIOLOGY, V3, P759, DOI 10.1080/02687038908249046; DELDOTTO JE, 1985, NEUROPSYCHOLOGY LEAR, P89; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Ehrlich J, 1989, Brain Inj, V3, P193, DOI 10.3109/02699058909004552; Fisher NJ, 1996, J CLIN EXP NEUROPSYC, V18, P349, DOI 10.1080/01688639608408993; Gardner H., 1983, FRAMES MIND THEORY M; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; Hagen C, 1984, LANGUAGE DISORDERS A, P245; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; HARTLEY LL, 1990, APHASIOLOGY, V4, P353, DOI 10.1080/02687039008249088; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; HINCHLIFFE F, 1997, IN PRESS CONCEPTUALI; HOLLAND AL, 1982, CLIN APHASIOLOGY, V12, P345; HOLM S, 1979, SCAND J STAT, V6, P65; HUISINGH R, 1990, WORLD TEST REVISED; Irvine L, 1986, S Afr J Commun Disord, V33, P49; JOANETTE Y, 1992, RES PER ALZ, P33; Kaplan E, 1983, BOSTON NAMING TEST; Kertesz A., 1982, W APHASIA BATTERY; LEVIN H, 1992, J NEUROL NEUROSUR PS, V55, P225; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEZAK M, 1996, NEUROPSYCHOLOGICAL A; MARTIN A, 1990, MODULAR DEFICITS ALZ, P143; MCDONALD S, 1992, Brain Injury, V6, P283, DOI 10.3109/02699059209029670; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; McNeil MR, 1978, REVISED TOKEN TEST; Morse P, 1992, CLIN SYNDROMES ADULT, P85; NORUSIS MJ, 1990, SPSS PC PLUS 4 0; PAYNEJOHNSON JC, 1986, J COMMUN DISORD, V19, P237, DOI 10.1016/0021-9924(86)90030-4; PEACH RK, 1992, J SPEECH HEAR RES, V35, P810, DOI 10.1044/jshr.3504.810; RICE ML, 1983, J SPEECH HEAR DISORD, V48, P347, DOI 10.1044/jshd.4804.347; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Spreen O., 1969, NEUROSENSORY CTR COM; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; ULATOWSKA HK, 1988, NEUROPSYCHOLOGICAL S, P108; VILKKI J, 1992, J CLIN EXP NEUROPSYC, V14, P518, DOI 10.1080/01688639208402841; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1981, WAIS R MANUAL; Wiig E. H., 1989, TEST LANGUAGE COMPET; WIIG EH, 1974, PERCEPT MOTOR SKILL, V38, P171, DOI 10.2466/pms.1974.38.1.171; Wiig EH., 1992, TEST WORD KNOWLEDGE; WILG E, 1988, NEUROPSYCHOLOGICAL S, P188; WILSON JTL, 1992, J HEAD TRAUMA REHAB, V7, P29; [No title captured]	59	14	14	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	1998	12	5					369	398		10.1080/026990598122502			30	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	ZL444	WOS:000073433500002	9591142				2022-02-06	
J	Zhao, YJ; Yang, GY; Ben-Joseph, O; Ross, BD; Chenevert, TL; Domino, EF				Zhao, YJ; Yang, GY; Ben-Joseph, O; Ross, BD; Chenevert, TL; Domino, EF			Acute ethanol effects on focal cerebral ischemia in fasted rats	ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						ethanol; ethyl alcohol; hyperglycemia; insulin; ischemia	TRAUMATIC BRAIN INJURY; ZINC PROTOPORPHYRIN; RISK FACTOR; ALCOHOL; STROKE; EDEMA; INTOXICATION	The effects of acute ethanol intoxication were investigated in a rat model of unilateral middle cerebral artery occlusion. Groups of 5 to 8 male Sprague-Dawley rats were subjected to 4 hr of left middle cerebral artery occlusion. All groups were deprived of food overnight and were pretreated intraperitoneally with 5% dextrose solution (10 ml/kg), 20% ethyl alcohol in 5% dextrose solution (2 g/kg), or 30% ethyl alcohol in a 5% dextrose solution (3 g/kg) 1 hr before middle cerebral artery occlusion. Regional cerebral blood flow during ipsilateral occlusion was similar to 9.1 to 10% of baseline in all groups. The mean % brain water content in control, 2 g/kg ethanol-treated groups, and 3 g/kg ethanol-treated groups were: in the ischemic core-81.6, 81.2, and 82.4; intermediate zone-80.5, 80.6, and 81.7; and outer zone-79.7, 79.7, and 80.8, respectively. Brain Na+ and K+ content in the three groups was related to water content, but much greater with ethanol pretreatment. The water content of the intermediate zones in the 3 g/kg ethanol-treated animals was significantly greater than in the control (p < 0.01 and 0.001) and the 2 g/kg ethanol-treated groups. One-way analysis of variance indicated a significant dose-effect relationship in which the lower dose of ethanol tended to reduce ischemic core water content, and the larger dose increased ischemic core water, compared with the control. None of the overnight fasted groups had any significant hyperglycemia. The group given 3 g/kg ip ethanol 1 hr before had exacerbated edema formation with a mean whole blood level of ethanol of similar to 230 mg/dl. The neurotoxic effects of high concentrations of ethanol were unrelated to any change in plasma glucose concentrations.	Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Surg Neurosurg, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA		Domino, EF (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.						ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; ALTURA BM, 1983, SCIENCE, V220, P331, DOI 10.1126/science.6836278; Barlow OW, 1936, J PHARMACOL EXP THER, V56, P117; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; BUNEGIN L, 1986, CRIT CARE MED, V14, P387, DOI 10.1097/00003246-198604000-00151; CAMARGO CA, 1989, STROKE, V20, P1611, DOI 10.1161/01.STR.20.12.1611; ELLENHORN MJ, 1988, MED TOXICOLOGY DIAGN, P792; Ema M, 1991, Magnes Trace Elem, V10, P269; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; FRANCO CD, 1988, J NATL MED ASSOC, V80, P63; GORELICK P B, 1987, Stroke, V18, P268; GORELICK PB, 1987, STROKE, V18, P359, DOI 10.1161/01.STR.18.2.359; GORELICK PB, 1989, STROKE, V20, P1607, DOI 10.1161/01.STR.20.12.1607; JEHLE D, 1988, ANN EMERG MED, V17, P953, DOI 10.1016/S0196-0644(88)80678-4; KADOYA C, 1995, STROKE, V26, P1035, DOI 10.1161/01.STR.26.6.1035; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; KIRN TF, 1988, JAMA-J AM MED ASSOC, V260, P2480, DOI 10.1001/jama.1988.03410170018005; Koroshetz WJ, 1996, TRENDS PHARMACOL SCI, V17, P227, DOI 10.1016/0165-6147(96)10020-1; MARTZ D, 1990, J CEREBR BLOOD F MET, V10, P352, DOI 10.1038/jcbfm.1990.64; MAYHAN WG, 1995, STROKE, V26, P2097, DOI 10.1161/01.STR.26.11.2097; MOSELEY ME, 1990, AM J NEURORADIOL, V11, P423; POLLACK CV, 1990, J TRAUMA, V30, P888, DOI 10.1097/00005373-199007000-00021; Sorensen AG, 1996, RADIOLOGY, V199, P391, DOI 10.1148/radiology.199.2.8668784; WAGNER JG, 1972, RES COMMUN CHEM PATH, V4, P61; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; ZHANG A, 1993, EUR J PHARM-ENVIRON, V248, P229, DOI 10.1016/0926-6917(93)90049-V; Zhao YJ, 1997, ALCOHOL CLIN EXP RES, V21, P745, DOI 10.1111/j.1530-0277.1997.tb03832.x; Zhao YJ, 1996, STROKE, V27, P2299, DOI 10.1161/01.STR.27.12.2299; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275	31	14	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0145-6008			ALCOHOL CLIN EXP RES	Alcoholism (NY)	MAY	1998	22	3					717	722		10.1097/00000374-199805000-00025			6	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED)	Substance Abuse	ZP311	WOS:000073739600025	9622455	Green Submitted			2022-02-06	
J	Baker, KA; Schmidt, MF; Heinemann, AW; Langley, M; Miranti, SV				Baker, KA; Schmidt, MF; Heinemann, AW; Langley, M; Miranti, SV			The validity of the Katz Adjustment Scale among people with traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article							REHABILITATION SAMPLE; HEAD-INJURY	Deficits in self-and social awareness can impair adjustment following traumatic brain injury (TBT) and draw into question the accuracy of self-report measures of adjustment. This study evaluates the validity of Katz Adjustment Scale (KAS) factor components identified by R. J. Fabiano and D. A. Goran (1992). The KAS is an observer rating scale often used to assess the social adjustment of people with traumatic brain injury. The responses of 105 individuals with TBI to the Symptom Checklist 90-Revised (SCL-90-R; L. R. Derogatis, 1983), a self-report measure of distress, were correlated with observer ratings on the KAS. Results support the use of observer ratings and self-report to assess adjustment and social behavior following TBI. Each contributes valuable information that can guide treatment and enhance adaptive functioning.	Northwestern Univ, Sch Med, Evanston, IL 60208 USA; Rehabil Inst Chicago, Chicago, IL 60611 USA; Clin Psychol Associates, Burlington, WI USA; Schwab Rehabil Hosp & Care Network, Chicago, IL USA		Schmidt, MF (corresponding author), Lutheran Gen Hosp, 1775 W Dempster,Pk Ridge, Pk Ridge, IL 60068 USA.		Heinemann, Allen W/K-6283-2012; Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W/0000-0003-2782-7326; Heinemann, Allen W./0000-0003-2782-7326			CRIPE LI, 1989, REHABIL PSYCHOL, V34, P93; DEROGATIS LR, 1983, SYMPTOM CHECKLIST 90; FABIANO RJ, 1992, REHABIL PSYCHOL, V37, P75, DOI 10.1037/h0079096; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; GORAN DA, 1993, BRAIN INJURY, V7, P219, DOI 10.3109/02699059309029674; JACKSON H F, 1992, Brain Injury, V6, P109, DOI 10.3109/02699059209029650; Kaplan S. P., 1988, J APPLIED REHABILITA, V19, P3; Kaplan SP, 1991, CLIN NEUROPSYCHOL, V5, P360; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; ODDY M, 1984, CLOSED HEAD INJURY P, P108; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano G.P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199112000-00004, DOI 10.1097/00001199-199112000-00004]; STAMBROOK M, 1990, COGNITIVE REHABILITA, V1, P26; WOESSNER R, 1995, J HEAD TRAUMA REHAB, V10, P78, DOI 10.1097/00001199-199504000-00009	19	14	14	0	2	SPRINGER PUBL CO	NEW YORK	536 BROADWAY, NEW YORK, NY 10010-3955 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	SPR	1998	43	1					30	40		10.1037/0090-5550.43.1.30			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	ZL354	WOS:000073424500003					2022-02-06	
J	Max, JE; Lindgren, SD; Knutson, C; Pearson, CS; Ihrig, D; Welborn, A				Max, JE; Lindgren, SD; Knutson, C; Pearson, CS; Ihrig, D; Welborn, A			Child and adolescent traumatic brain injury: correlates of injury severity	BRAIN INJURY			English	Article							COMA	A record review focused on children and adolescents, with a history of traumatic brain injury, who were consecutively admitted to a brain injury clinic in which all new patients are psychiatrically evaluated. Significant correlates of severity of injury in the cognitive, education and communication domains of functioning included Performance IQ but not Verbal IQ nor standardized ratings of language or learning disability. Current organic personality syndrome (OPS) but not attention deficit hyperactivity disorder or oppositional defiant disorder/conduct disorder diagnostic status was significantly related to severity. In conclusion, the findings in this referred sample are similar to prospective studies indicating that Performance IQ appears sensitive in reflecting brain damage. The finding linking OPS to severity of injury is not surprising. This is because OPS is a diagnosis which is dependent on the clinician's judgment of the likelihood that the organic factor is etiologically related to a defined behavioural syndrome. The diagnosis therefore requires a clinical judgment that the threshold of severity of a presumed organic etiological factor has been reached.	Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA		Max, JE (corresponding author), Univ Iowa Hosp & Clin, Dept Psychiat, 200 Hawkins Dr,1876 JPP, Iowa City, IA 52242 USA.			Ihrig, Damien/0000-0002-5083-5853	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH 40856, MHCRC 43271, MH 31593] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH031593, R37MH031593, P30MH043271, R01MH040856, P50MH043271] Funding Source: NIH RePORTER		American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; JEFFREY R, 1986, IOWAS SEVERITY RATIN; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; LEMKUHL G, 1991, BRAIN BEHAV CHILD PS, P267; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; MAX JE, IN PRESS BRAIN INJUR; MAX JE, 1992, THESIS U IOWA IOWA C; MAX JE, IN PRESS J AM ACAD C; ORVASCHEL H, 1982, J AM ACAD CHILD PSY, V21, P392, DOI 10.1016/S0002-7138(09)60944-4; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; TEASDALE G, 1974, LANCET, V2, P81; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Wechsler D., 1949, WECHSLER INTELLIGENC; Wechsler D., 1974, WECHSLER INTELLIGENC; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wilkinson, 1984, WIDE RANGE ACHIEVEME	25	14	14	0	5	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1998	12	1					31	40					10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YT347	WOS:000071592500003	9483335				2022-02-06	
J	Semlyen, JK; Summers, SJ; Barnes, MP				Semlyen, JK; Summers, SJ; Barnes, MP			Aspects of caregiver distress after severe head injury	JOURNAL OF NEUROLOGIC REHABILITATION			English	Article						caregivers; head injury; psychological distress; functional outcome; Newcastle Independence Assessment Form (NIAF); GHQ-28	TRAUMATIC BRAIN INJURY; RELATIVES VIEW; FAMILY NEEDS	The caregivers of 22 severely head-injured individuals were interviewed at 6 and 12 months post injury to obtain information about the extent of their distress and to investigate the relationship between their distress and two aspects of burden: caregivers perceptions of the head-injured person's problems and an objective assessment of functional independence. Caregivers reported high levels of distress. The Factors associated with caregiver distress included the number of perceived problems at 6 months post injury, the overall level of disability, and certain aspects of functional independence at both 6 and 12 months, particularly ii the person required assistance with self-care and home-based tasks. Implications for rehabilitation of both the head-injured individual and his or her caregivers are examined, especially with reference to issues surrounding return to the community.	Hunters Moor Reg Neurol Rehabil Ctr, Acad Unit Neurol Rehabil, Newcastle Upon Tyne NE2 4NR, Tyne & Wear, England			j.k.semlyen@ncl.ac.uk		SEMLYEN, JOANNA/0000-0001-5372-1344			BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROOKS N, 1984, CLOSED HEAD INJURY P; Gervasio AH, 1988, NEUROPSYCHOLOGY, V2, P161; Goldberg D., 1978, MANUAL GEN HLTH QUES; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Gray J.M, 1994, CLIN REHABIL, V8, P188, DOI [10.1177/026921559400800302, DOI 10.1177/026921559400800302, DOI 10.1080/09602010902949207]; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HART T, 1986, CLIN NEUROPSYCHOLOGY; KAUSAR R, 1996, CLIN REHABIL, V10, P159; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; KOETER MWJ, 1992, J AFFECT DISORDERS, V24, P271, DOI 10.1016/0165-0327(92)90112-J; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Livingston M G, 1987, Brain Inj, V1, P33, DOI 10.3109/02699058709034442; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; LIVINGSTON MG, 1985, BMJ-BRIT MED J, V291, P919, DOI 10.1136/bmj.291.6500.919; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; NOVACK TA, 1991, J HEAD TRAUMA REHAB, V6, P69, DOI DOI 10.1097/00001199-199112000-00014; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Panting A, 1972, REHABILITATION, V38, P33; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P681; Semlyen JK, 1997, J NEUROL REHABIL, V11, P213; Semlyen JK, 1998, BRAIN INJURY, V12, P155, DOI 10.1080/026990598122782; Semlyen JK, 1996, J NEUROL REHABIL, V10, P251; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Walker A E, 1972, Scand J Rehabil Med, V4, P5; [No title captured], DOI DOI 10.1097/00001199-198812000-00004	33	14	14	0	3	DEMOS PUBLICATIONS	NEW YORK	386 PARK AVE S STE 201, NEW YORK, NY 10016-8804 USA	0888-4390			J NEUROL REHABIL	J. Neurol. Rehabil.		1998	12	2					53	59					7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	123RB	WOS:000076137200002					2022-02-06	
J	Andary, MT; Crewe, N; Ganzel, SK; HainesPepi, C; Kulkarni, MR; Stanton, DF; Thompson, A; Yosef, M				Andary, MT; Crewe, N; Ganzel, SK; HainesPepi, C; Kulkarni, MR; Stanton, DF; Thompson, A; Yosef, M			Traumatic brain injury chronic pain syndrome: A case comparison study	CLINICAL JOURNAL OF PAIN			English	Article						chronic pain; traumatic brain injury; vocational rehabilitation	MINOR HEAD-INJURY	Objective: To identify the pretreatment characteristics and progress in treatment and outcomes of chronic pain patients, with and without concomitant traumatic brain injury (TBI). Design and Patients: Retrospective cohort study of 12 consecutive patients in a chronic pain treatment program who were discovered to have previously untreated brain injury and a cohort of 12 chronic pain patients from the same program matched for age and sex who did not have brain injury. Setting: Interdisciplinary university-based outpatient rehabilitation medicine clinic. Main Outcome Measures: Length of time in treatment and vocational outcomes. Results: A surprising number of patients referred for treatment of chronic pain were found to have history and symptoms indicative of previously untreated or undiagnosed mild traumatic brain injury (n = 21 of 65). Of these, 12 received therapy for both their brain injury and chronic pain. The 12 treated, dual diagnosed patients did not differ in terms of education, employment status, or marital status from the chronic pain patients. Those with TBI were more likely to have sustained an automobile injury and less likely to have a work-related injury. On admission, 25% of each group were working, and at discharge, that proportion reached 75% for each group. Those with TBI required significantly longer treatment (459 consecutive days) from intake to discharge compared with the control group (295 days). Conclusion: Patients who exhibit memory or concentration problems, who express confusion about their diagnosis, who were injured in an automobile accident, or who complain of pain in the head, neck, or arms should be questioned about the possibility of concurrent TBI. Most of these patients can achieve successful employment outcomes, however, the TBI group may require a longer treatment time.			Andary, MT (corresponding author), MICHIGAN STATE UNIV,COLL OSTEOPATH MED,B-401 W FEE HALL,E LANSING,MI 48823, USA.		Andary, Michael/O-9975-2019	Andary, Michael/0000-0003-3897-6327			ANDARY MT, 1993, PHYS MED REHABIL CLI, V4, P141; ANDERSON JM, 1990, ARCH PHYS MED REHAB, V71, P703; BRAAF MM, 1955, NY STATE J MED, V5, P237; COPE DN, 1990, HDB PHYSICAL MED REH, P1217; ELKIND AH, 1989, OTOLARYNG CLIN N AM, V22, P1251; HOHL M, 1983, CERVICAL SPINE, P282; HORN LJ, 1972, PHYS MED REHABIL STA, V6, P69; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; KEWMAN DG, 1989, ARCH PHYS MED REHAB, V70, pA19; KULKARNI MR, 1987, MICH OSTEOPATH J, P13; Luria A.R., 1973, WORKING BRAIN; MILLER L, 1990, COGNITIVE REHABILITA, V8, P12; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950; [No title captured]	18	14	14	2	3	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0749-8047			CLIN J PAIN	Clin. J. Pain	SEP	1997	13	3					244	250		10.1097/00002508-199709000-00010			7	Anesthesiology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	YF456	WOS:A1997YF45600010	9303257				2022-02-06	
J	Jacobson, S; Henriksen, SJ; ProsperoGarcia, O; Phillips, TR; Elder, JH; Young, WG; Bloom, FE; Fox, HS				Jacobson, S; Henriksen, SJ; ProsperoGarcia, O; Phillips, TR; Elder, JH; Young, WG; Bloom, FE; Fox, HS			Cortical neuronal cytoskeletal changes associated with FIV infection	JOURNAL OF NEUROVIROLOGY			English	Article						FIV; brain; neuron; neurofilament; AIDS	FELINE IMMUNODEFICIENCY VIRUS; CENTRAL-NERVOUS-SYSTEM; SENSORY-MOTOR CORTEX; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; CEREBRAL-CORTEX; COLUMNAR DISTRIBUTION; NEOCORTICAL DAMAGE; RHESUS-MONKEY; AIDS BRAINS	HIV-1 infection is often complicated by central nervous system (CNS) dysfunction. Degenerative neuronal changes as well as neuronal lass have been documented in individuals with AIDS. Feline immunodeficiency virus (FIV) infection of cats provides a model for both the immune and the central nervous system manifestations of HIV infection of humans. In this study we have examined neurons in the frontal cortex of feline immunodeficiency virus-infected cats and controls for immunoreactivity with SMI 32, an antibody recognizing a non-phosphorylated epitope on neurofilaments. We noted a significant increase in the number of immunoreactive pyramidal cells in infected animals compared to controls. The changes seen in the neuronal cytoskeleton as a consequence of the inoculation with FIV were similar to those seen in humans undergoing the normal aging process as well as those suffering from neurological diseases, including Alzheimer's and dementia pugilistica. The changes we noted in the feline brain were also similar to that reported in animals with traumatic injuries or with spontaneously occurring or induced motor neuron diseases, suggesting that the increase in reactivity represents a deleterious effect of FIV on the central nervous system.	Scripps Res Inst, DEPT NEUROPHARMACOL, LA JOLLA, CA 92037 USA; SCRIPPS RES INST, DEPT BIOL MOL, LA JOLLA, CA 92037 USA; TUFTS UNIV, SCH MED, DEPT ANAT & CELLULAR BIOL, BOSTON, MA 02111 USA					Fox, Howard/0000-0003-2032-374X	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH 47680, MH/DA 52154] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P20MH052154, P50MH047680, P01MH052154] Funding Source: NIH RePORTER		Bershadsky A., 1988, CYTOSKELETON; Boche D, 1996, J NEUROVIROL, V2, P377, DOI 10.3109/13550289609146903; BOURAS C, 1994, CEREB CORTEX, V4, P138, DOI 10.1093/cercor/4.2.138; CORK LC, 1982, LAB INVEST, V46, P89; CORK LC, 1988, J NEUROPATH EXP NEUR, V47, P420, DOI 10.1097/00005072-198807000-00003; GOLDMAN PS, 1977, BRAIN RES, V122, P393, DOI 10.1016/0006-8993(77)90453-X; HARLOW HJF, 1965, BIOL BIOCH BASIS BEH, P63; Henriksen SJ, 1995, CURR TOP MICROBIOL, V202, P167; HIGGINS RJ, 1983, ACTA NEUROPATHOL, V59, P288, DOI 10.1007/BF00691495; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; HURTREL M, 1992, AIDS, V6, P399, DOI 10.1097/00002030-199204000-00007; JONES EG, 1977, J COMP NEUROL, V175, P391, DOI 10.1002/cne.901750403; JONES EG, 1979, J COMP NEUROL, V188, P113, DOI 10.1002/cne.901880110; KETZLER S, 1990, ACTA NEUROPATHOL, V80, P92, DOI 10.1007/BF00294228; LAFRADO LJ, 1993, AIDS RES REV, V3, P115; LEWIS DA, 1987, J NEUROSCI, V7, P1799; MASLIAH E, 1993, AM J PATHOL, V142, P871; MASLIAH E, 1992, ANN NEUROL, V32, P321, DOI 10.1002/ana.410320304; MASLIAH E, 1992, LAB INVEST, V66, P285; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; MONTALI RJ, 1974, VET PATHOL, V11, P68, DOI 10.1177/030098587401100108; OSTER S, 1995, APMIS, V103, P525, DOI 10.1111/j.1699-0463.1995.tb01401.x; Phillips TR, 1996, J NEUROVIROL, V2, P388, DOI 10.3109/13550289609146904; PHILLIPS TR, 1994, J GEN VIROL, V75, P979, DOI 10.1099/0022-1317-75-5-979; PRICE RW, 1994, RES P ARNMD, V72, P1; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; ROUSSEAUX CG, 1985, VET PATHOL, V22, P104, DOI 10.1177/030098588502200202; SCHLAEPFER WW, 1987, J NEUROPATH EXP NEUR, V46, P117, DOI 10.1097/00005072-198703000-00001; SEILHEAN D, 1993, NEUROLOGY, V43, P1492, DOI 10.1212/WNL.43.8.1492; SHIELDS RP, 1983, ACTA NEUROPATH BERL, V59, P288; SIEGEL SJ, 1993, BRAIN RES, V619, P299, DOI 10.1016/0006-8993(93)91624-2; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; TROJANOWSKI JQ, 1993, BRAIN PATHOL, V3, P45, DOI 10.1111/j.1750-3639.1993.tb00725.x; TROJANOWSKI JQ, 1976, J COMP NEUROL, V169, P371, DOI 10.1002/cne.901690307; TROJANOWSKI JQ, 1991, ANNU REV GERONTOL, V10, P167; TRONCOSO JC, 1986, BRAIN RES, V364, P295, DOI 10.1016/0006-8993(86)90842-5; TRONCOSO JC, 1985, BRAIN RES, V342, P172, DOI 10.1016/0006-8993(85)91369-1; VICKERS JC, 1992, BRAIN RES, V594, P273, DOI 10.1016/0006-8993(92)91134-Z; WEIS S, 1993, ACTA NEUROPATHOL, V85, P185; WILEY CA, 1991, ANN NEUROL, V29, P651, DOI 10.1002/ana.410290613; Winkler C, 1914, ANATOMICAL GUIDE EXP	41	14	14	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1355-0284			J NEUROVIROL	J. Neurovirol.	AUG	1997	3	4					283	289		10.3109/13550289709029469			7	Neurosciences; Virology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Virology	XT808	WOS:A1997XT80800005	9291236				2022-02-06	
J	Scott, JS; Ockey, RR; Holmes, GE; Varghese, G				Scott, JS; Ockey, RR; Holmes, GE; Varghese, G			Autonomic dysfunction associated with locked-in syndrome in a child	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						autonomic dysfunction; hypothalamic storming; locked-in syndrome; dopamine agonist	TRAUMATIC BRAIN INJURY; SUBARACHNOID HEMORRHAGE; HEAD-INJURY; PROPRANOLOL; HYPERTENSION; HYPERTHERMIA; EPILEPSY; BLOCKADE; ATENOLOL; PLACEBO	This is a report of a young boy with the unusual combination of autonomic dysfunction with locked-in syndrome following multiple shunt revisions for hydrocephalus. A review of the literature on autonomic dysfunction syndrome and the complex clinical picture of the combined syndromes in a pediatric patient are discussed. The marked effectiveness of treatment with carbidopa/levodopa over bromocriptine for both syndromes is noted.	UNIV KANSAS,MED CTR,DEPT PEDIAT,KANSAS CITY,KS 66160; TULSA DEV PEDIAT,TULSA,OK; CTR FAMILY PSYCHOL,TULSA,OK; WILFORD HALL USAF MED CTR,SAN ANTONIO,TX 78236; UNIV KANSAS,MED CTR,DEPT REHABIL MED,KANSAS CITY,KS 66160								ARING CD, 1945, ARCH NEURO PSYCHIATR, V54, P44, DOI 10.1001/archneurpsyc.1945.02300070054005; BALDESSARINI RJ, 1996, PHARM BASIS THERAPEU; BAUER G, 1979, J NEUROL, V221, P77, DOI 10.1007/BF00313105; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; CARMEL PW, 1985, ACTA NEUROCHIR, V75, P113, DOI 10.1007/BF01406331; CHERINGTON M, 1976, NEUROLOGY, V26, P180, DOI 10.1212/WNL.26.2.180; CLIFTON GL, 1981, NEUROSURGERY, V8, P309, DOI 10.1227/00006123-198103000-00002; CORBETT SW, 1983, AM J PHYSIOL, V245, pE535, DOI 10.1152/ajpendo.1983.245.6.E535; ENGEL GL, 1945, ARCH NEURO PSYCHIATR, V54, P37, DOI 10.1001/archneurpsyc.1945.02300070047004; FOX RH, 1973, BRIT MED J, V2, P693, DOI 10.1136/bmj.2.5868.693; GREENBLATT DJ, 1993, CLIN PHARMACOL THER, V53, P577, DOI 10.1038/clpt.1993.73; HACKENBERRY LE, 1982, CRIT CARE MED, V10, P641; JACOME DE, 1990, CLIN ELECTROENCEPHAL, V21, P31, DOI 10.1177/155005949002100112; KATZ RT, 1981, NEUROSURGERY, V73, P403; KHURANA RK, 1980, ANN NEUROL, V8, P439, DOI 10.1002/ana.410080418; LASSER NL, 1989, AM J MED, V86, P98, DOI 10.1016/0002-9343(89)90142-3; LOW PA, 1993, CLIN AUTONOMIC DISOR, P466; MELVILLE KI, 1963, AM J CARDIOL, V12, P781, DOI 10.1016/0002-9149(63)90281-9; MEYTHALER JM, 1994, ARCH PHYS MED REHAB, V75, P816; NEILDWYER G, 1978, BRIT MED J, V2, P990, DOI 10.1136/bmj.2.6143.990; OCKEY RR, 1995, ARCH PHYS MED REHAB, V76, P868, DOI 10.1016/S0003-9993(95)80554-0; OHRY A, 1981, PARAPLEGIA, V28, P73; PALAC DM, 1990, J GEN INTERN MED, V5, P310, DOI 10.1007/BF02600398; PATTERSON JR, 1986, STROKE, V17, P758, DOI 10.1161/01.STR.17.4.758; Penfield W, 1929, ARCH NEURO PSYCHIATR, V22, P358, DOI 10.1001/archneurpsyc.1929.02220020174010; Penfield W, 1954, EPILEPSY FUNCTIONAL; PLUM F, 1996, DIAGNOSIS STUPOR COM; PRANZATELLI MR, 1991, J CHILD NEUROL, V6, P115, DOI 10.1177/088307389100600204; Rao N, 1989, Brain Inj, V3, P207, DOI 10.3109/02699058909004554; RATEY JJ, 1983, AM J PSYCHIAT, V140, P1356; ROBERTSON CS, 1983, J NEUROSURG, V59, P455, DOI 10.3171/jns.1983.59.3.0455; ROGERS TK, 1990, POSTGRAD MED J, V66, P1050, DOI 10.1136/pgmj.66.782.1050; Rossitch E Jr, 1988, Br J Neurosurg, V2, P471, DOI 10.3109/02688698809029601; SIMPSON RK, 1989, SOUTHERN MED J, V82, P1577, DOI 10.1097/00007611-198912000-00031; SOLOMON GE, 1973, J PEDIATR-US, V83, P277, DOI 10.1016/S0022-3476(73)80492-5; TALMAN WT, 1988, ARCH NEUROL-CHICAGO, V45, P1037, DOI 10.1001/archneur.1988.00520330129022; Wurzelmann J, 1987, Cardiol Clin, V5, P689; YUDOFSKY S, 1981, AM J PSYCHIAT, V138, P218; [No title captured]	40	14	15	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAY-JUN	1997	76	3					200	203		10.1097/00002060-199705000-00007			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	XG430	WOS:A1997XG43000007	9207704				2022-02-06	
J	Noel, F; Ijichi, A; Chen, JJ; Gumin, GJ; Tofilon, PJ				Noel, F; Ijichi, A; Chen, JJ; Gumin, GJ; Tofilon, PJ			X-ray-mediated reduction in basic fibroblast growth factor expression in primary rat astrocyte cultures	RADIATION RESEARCH			English	Article							CILIARY NEUROTROPHIC FACTOR; CENTRAL-NERVOUS-SYSTEM; FACTOR MESSENGER-RNA; GENE-EXPRESSION; CEREBRAL-ISCHEMIA; ENDOTHELIAL-CELLS; PROGENITOR CELLS; BRAIN; RADIATION; INJURY	Injury of the normal central nervous system is a major concern in the radiotherapy of brain tumors, but the pathogenesis of injury remains poorly understood, Modulation of the production of growth factors is associated with ischemia and traumatic injury in the central nervous system. Ionizing radiation has been shown to induce basic fibroblast growth factor in endothelial cells and in cells of a human breast carcinoma cell line, The inducibility of basic fibroblast growth factor after irradiation and its potential role in the recovery response of the central nervous system led us to investigate the effects of radiation on the expression of this growth factor in primary cultures of normal rat type 1 astrocytes. Astrocyte monolayers were exposed to ionizing radiation (1 to 10 Gy), Northern blot analysis revealed that doses of 2 to 10 Gy markedly reduced the expression of basic fibroblast growth factor as early as 1 h after irradiation, and that it remained below levels in unirradiated cells for at least 24 h. The effect was not associated with astrocyte cytotoxicity, and it appears to have some specificity for basic fibroblast growth factor since the levels of mRNA coding for ciliary neurotrophic factor and glial fibrillary acidic protein were not affected. (C) 1997 by Radiation Research Society.	UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT EXPT RADIAT ONCOL,HOUSTON,TX 77030						NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA072156] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA1672, CA72156] Funding Source: Medline		BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; ECCLESTON PA, 1985, DEV BRAIN RES, V21, P315, DOI 10.1016/0165-3806(85)90221-4; ECKENSTEIN FP, 1994, J NEUROBIOL, V25, P1467; Fan Lei, 1995, Molecular Brain Research, V30, P125, DOI 10.1016/0169-328X(94)00287-O; FINKLESTEIN SP, 1988, BRAIN RES, V460, P253, DOI 10.1016/0006-8993(88)90370-8; FORNACE AJ, 1992, ANNU REV GENET, V26, P507; FUKS Z, 1994, CANCER RES, V54, P2582; HONG JH, 1995, INT J RADIAT ONCOL, V33, P619, DOI 10.1016/0360-3016(95)00279-8; IJICHI A, 1995, GLIA, V14, P87, DOI 10.1002/glia.440140203; IP NY, 1993, EUR J NEUROSCI, V5, P25, DOI 10.1111/j.1460-9568.1993.tb00201.x; KIMELMAN D, 1989, CELL, V59, P687, DOI 10.1016/0092-8674(89)90015-9; KOKETSU N, 1994, ANN NEUROL, V35, P451, DOI 10.1002/ana.410350413; LEE YJ, 1995, J BIOL CHEM, V270, P28790, DOI 10.1074/jbc.270.48.28790; LEHRMANN E, 1995, EXP NEUROL, V131, P114, DOI 10.1016/0014-4886(95)90013-6; LOGAN A, 1993, TRENDS PHARMACOL SCI, V14, P337, DOI 10.1016/0165-6147(93)90007-7; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCMILLIAN MK, 1994, TRENDS NEUROSCI, V17, P138, DOI 10.1016/0166-2236(94)90086-8; MEYERS R, 1986, BR J CANC S7, V53, P221; MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MULLER HW, 1995, PHARMACOL THERAPEUT, V65, P1, DOI 10.1016/0163-7258(94)00047-7; MURPHY PR, 1994, MOL ENDOCRINOL, V8, P852, DOI 10.1210/me.8.7.852; POWELL PP, 1993, EXP CELL RES, V209, P224, DOI 10.1006/excr.1993.1305; SCHULTHEISS TE, 1992, BRIT J RADIOL, V65, P737, DOI 10.1259/0007-1285-65-777-737; Shibata F, 1991, GROWTH FACTORS, V4, P277, DOI 10.3109/08977199109043913; SHIMASAKI S, 1988, BIOCHEM BIOPH RES CO, V157, P256, DOI 10.1016/S0006-291X(88)80041-X; Speliotes EK, 1996, MOL BRAIN RES, V39, P31, DOI 10.1016/0169-328X(95)00351-R; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; TAKAMI K, 1992, EXP BRAIN RES, V90, P1; UEBA T, 1994, P NATL ACAD SCI USA, V91, P9009, DOI 10.1073/pnas.91.19.9009; VANDERKOGEL AJ, 1986, BRIT J CANCER, V53, P207; VRDOLJAK E, 1994, INT J RADIAT BIOL, V66, P739; WITTE L, 1989, CANCER RES, V49, P5066; WOLSWIJK G, 1992, J CELL BIOL, V118, P889, DOI 10.1083/jcb.118.4.889; WOODWARD WR, 1992, J NEUROSCI, V12, P142; YAKOVLEV AG, 1995, J NEUROTRAUM, V12, P767, DOI 10.1089/neu.1995.12.767	37	14	15	0	0	RADIATION RESEARCH SOC	OAK BROOK	2021 SPRING RD, STE 600, OAK BROOK, IL 60521	0033-7587			RADIAT RES	Radiat. Res.	APR	1997	147	4					484	489		10.2307/3579506			6	Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	WQ559	WOS:A1997WQ55900012	9092929				2022-02-06	
J	Savage, RC				Savage, RC			Integrating rehabilitation and education services for school-age children with brain injuries	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						education; managed care; rehabilitation; special education; traumatic brain injury	REENTRY; PREDICTION; MILD	This article explores the development of service delivery systems in rehabilitation and education for school-age children with TBI. Historical relationships between rehabilitation services and special education services are examined in terms of what the future map hold for these systems within a changing health care world. Examples of critical changes in these delivery systems and the development of program models that merge rehabilitation and special education services for children are profiled.			Savage, RC (corresponding author), MAY INST INC,220 NORWOOD PK S,SUITE 204,NORWOOD,MA 02062, USA.						Begali V., 1987, HEAD INJURY CHILDREN; BLOSSER JL, 1989, TOP LANG DISORD, V9, P67, DOI 10.1097/00011363-198903000-00007; BLOSSER JL, 1994, PED TRAUM BRAIN INJ; BRYAN MR, 1995, ED MANUAL WHAT ED NE; CARNEY J, 1990, Pediatrician, V17, P222; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Cook J., 1987, ABI HDB SERVING STUD; COSTER WJ, 1996, SCH FUNCTION ASSESSM; CURRAN C, 1995, MANAGED CARE Q, V3, P14; DEJONG G, 1995, BRAIN INJ ASS ANN S; DEPOMPEI R, 1991, NEUROREHABILITATION, V1, P29; DEPOMPEI R, 1986, LANGUAGE SPEECH HEAR, V18, P292; *EM MED SERV CHILD, 1996, HOSP HOM TRANS CHILD; Grant P H, 1995, J Healthc Qual, V17, P10; HANSON SL, 1992, PHYSICAL MED REHABIL, V6, P483; Kaufman J., 1996, J CARE MANAGEMENT, V2, P46; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Lash M, 1993, NeuroRehabilitation, V3, P13, DOI 10.3233/NRE-1993-3304; LASH M, 1996, MANUAL FAMILIES CHIL; LAZAR MF, 1995, J HEAD TRAUMA REHAB, V10, P55, DOI 10.1097/00001199-199510000-00007; LEHR E, 1991, PSYCHOL MANAGEMENT H; Lehr E, 1990, PSYCHOL MANAGEMENT T; MACLAREN E, 1994, NURSE WEEK, V7, P10; MIRA M, 1988, TRAUMATIC HEAD INJUR; *RES TRAIN CTR REH, 1995, NAT PED TRAUM REG; ROSEN CD, 1992, HEAD TRAUMA ED REINT; SAVAGE RC, 1996, CHILDREN ACQUIRED BR; SAVAGE RC, 1991, HEAD INJURY FAMILY M; SAVAGE RC, 1995, ED DIMENSIONS ACQUIR; SEIDEL JS, 1991, EM MED SERV CHILDR R; SHURTLEFF HA, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199510000-00008; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Turnbull A. P., 1995, EXCEPTIONAL LIVES SP; TYLER J, 1990, TRAUMATIC HEAD INJUR; WOLCOTT G, 1995, SIGNS STRATEGIES ED; Wolcott G. F, 1995, ED MANUAL WHAT ED NE; YLVISAKER M, 1995, J HEAD TRAUMA REHAB, V10, P42, DOI 10.1097/00001199-199512000-00007; YLVISAKER M, 1995, J HEAD TRAUMA REHAB, V10, P25, DOI 10.1097/00001199-199512000-00006; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006	39	14	14	0	6	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1997	12	2					11	20		10.1097/00001199-199704000-00003			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WT782	WOS:A1997WT78200004					2022-02-06	
J	Gerberich, SG; Gibson, RW; Fife, D; Mandel, JS; Aeppli, D; Le, CT; Maxwell, R; Rolnick, SJ; Renier, C; Burlew, M; Matross, R				Gerberich, SG; Gibson, RW; Fife, D; Mandel, JS; Aeppli, D; Le, CT; Maxwell, R; Rolnick, SJ; Renier, C; Burlew, M; Matross, R			Effects of brain injury on college academic performance	NEUROEPIDEMIOLOGY			English	Article						brain injury, effects; effects on academic performance; mild brain injury	SEVERE HEAD-INJURY; RECOGNITION MEMORY; ALZHEIMERS-DISEASE; RECOVERY; TRAUMA; CONCUSSION; DISABILITY; SEQUELAE; DEFICITS	Brain injury, a leading cause of mortality, morbidity and disability in the United States, has serious consequences and substantial costs. Although previous studies have assessed a variety of outcomes subsequent to brain injury, documentation of performance prior to brain injury using a case-control approach has not been included; preinjury performance differences may confound the estimate of the effects of brain injury on performance. The primary objective of this study was to compare academic performance before and after brain injury in a population of university undergraduate students to determine the extent to which the academic career of the brain-injured person was altered from what would have been expected in the absence of such an injury. Cases included all undergraduate students in a major university, between the ages of 17 and 27, who incurred a brain injury requiring hospitalization between 1980 and 1984 (n = 99). Two comparison groups were used to determine whether changes in academic performance were specifically related to brain injuries or injuries in general: (1) injured controls, i.e. 121 students between the ages of 17 and 27 years, hospitalized for injuries other than to the central nervous system, and (2) uninjured academic controls, i.e. 198 students without injuries requiring hospitalization during the study period, matched 2:1 to the brain-injured students by age, gender, and completed course credits categorized as <90, greater than or equal to 90. Although there were no differences when the total groups, including both males and females, were compared, there was a significant pre- to postinjury decrease in the grade point average for female cases when compared to their uninjured academic controls (p < 0.02). This difference was related to the effects of brain injury, and not to the effects of injury in general. No such difference was observed for the males. There were also no differences when the total groups, including males and females, were compared relevant to return to school. However, a significantly higher proportion of the female cases, compared with their uninjured academic controls, did not return to school after their injury; similar findings were identified for the injured controls as well. Thus, these differences were not specific to brain injury but rather to injury in general. In spite of this observation, the difference be tween female cases who returned and those who did not return was associated with neurological deficits, especially upper left limb motor deficits, at the time of hospital discharge. The findings from this effort are suggestive of gender differences in the consequences of brain injury and serve as a basis for further studies to evaluate the magnitude of this problem.	UNIV MINNESOTA,SCH PUBL HLTH,DIV EPIDEMIOL & ENVIRONM HLTH,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH PUBL HLTH,DIV BIOSTAT,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH MED,DEPT NEUROSURG,MINNEAPOLIS,MN 55455; GRP HLTH FDN,MINNEAPOLIS,MN; UNIV MINNESOTA,DEPT BEHAV SCI,DULUTH,MN 55812; RW JOHNSON PHARMACEUT RES INST,SPRING HOUSE,PA 19477		Gerberich, SG (corresponding author), UNIV MINNESOTA,REG INJURY PREVENT RES CTR,DIV EOH,SPH,POB 807 UMHC,420 DELAWARE ST SE,MINNEAPOLIS,MN 55455, USA.		Gerberich, Susan G/K-9956-2019	Gerberich, Susan G/0000-0001-6424-7131; Renier, Colleen/0000-0001-5083-5282			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BENNETT DR, 1980, AM J SPORT MED, V8, P202, DOI 10.1177/036354658000800312; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BRESLOW NE, 1980, STATISTICAL METHODS; BROOKS D N, 1975, Cortex, V11, P329; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BROWNELL HH, 1986, BRAIN LANG, V27, P310, DOI 10.1016/0093-934X(86)90022-2; *COMM INJ SCAL, 1980, ABBR INJ SCAL 1980; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CRAWFORD C, 1983, NEW ZEAL MED J, V96, P972; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIXON WJ, 1985, PLR STEPWISE LOG REG; ESON ME, 1978, J NEUROL NEUROSUR PS, V41, P1036, DOI 10.1136/jnnp.41.11.1036; Fleiss J, 1981, STAT METHODS RATES P, V2nd; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; FRENCH LR, 1985, AM J EPIDEMIOL, V121, P414, DOI 10.1093/oxfordjournals.aje.a114013; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; GERBERICH SG, 1980, THESIS U MINNESOTA M; GILCHRIST E, 1979, ARCH NEUROL-CHICAGO, V36, P355, DOI 10.1001/archneur.1979.00500420065008; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; GRAYBOW JD, 1984, AM J PUBLIC HEALTH, V74, P710; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1974, PSYCHOL EFFECTS CONC; GUSTAFSON T, 1987, EPISTAT 3 3; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; *INT CLASS DIS, 1980, CLIN MOD, V3; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; JENNETT B, 1976, LANCET, V1, P1031; Jennett B, 1981, MANAGEMENT HEAD INJU; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KIMURA D, 1992, SCI AM, V267, P119; KIMURA D, 1984, PROG BRAIN RES, V61, P423; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1991, NEUROEPIDEMIOLOGY TR; KWENTUS JA, 1985, PSYCHOSOMATICS, V26, P8, DOI 10.1016/S0033-3182(85)72900-3; LANSDELL H, 1962, NATURE, V194, P852, DOI 10.1038/194852a0; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1976, CORTEX, V12, P175, DOI 10.1016/S0010-9452(76)80021-4; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; LUNDHOLM J, 1975, J REHABIL MED, V7, P97; MacKenzie E J, 1989, Md Med J, V38, P725; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; MANTEL N, 1959, J NATL CANCER I, V22, P719; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; NETER J, 1974, APPL LINEAR STAT MOD, P615; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; NEWCOMBE F, 1982, INJURY, V14, P111, DOI 10.1016/0020-1383(82)90046-8; NIE NH, 1975, ANOVA STAT PACKAGE S; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PRIGATANO GP, 1982, J PERCEPTUAL MOTOR S, V54, P859; Rice DP, 1989, COST INJURY US REPOR; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SNOEK JJ, 1981, J NEUROL NEUROSUR PS, V44, P285; SPRINGER SP, 1981, LEFT BRAIN RIGHT BRA, P121; STATON RD, 1982, CORTEX, V18, P23, DOI 10.1016/S0010-9452(82)80016-6; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; SYMONDS C, 1962, LANCET, V1, P1; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019	70	14	14	1	14	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350			NEUROEPIDEMIOLOGY	Neuroepidemiology	JAN-FEB	1997	16	1					1	14		10.1159/000109665			14	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Neurosciences & Neurology	WB536	WOS:A1997WB53600001	8994935				2022-02-06	
J	Lawler, KA; Terregino, CA				Lawler, KA; Terregino, CA			Guidelines for evaluation and education of adult patients with mild traumatic brain injuries in an acute care hospital setting	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive assessment; patient education; postconcussion syndrome; traumatic brain injury	MINOR HEAD-INJURY; NEUROPSYCHOLOGICAL DEFICITS; POST-CONCUSSION; SYMPTOMS; SEQUELAE; RECOVERY; AMNESIA; MEMORY	The purpose of this article is to provide practice guidelines that outline a systematic approach to be followed in an acute care setting with patients who have sustained a mild traumatic brain injury (TBI). Most patients are seen briefly in an emergency department and then released, with little or no information concerning the sequelae of mild TBI. This article reviews the literature supporting the importance of early education of patients concerning the possible effects of mild TBI and proposes a specific protocol to be followed in providing patients with medical assessment, a brief cognitive screening evaluation, educational information, and follow-up treatment.	UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,NEWARK,NJ 07103; COOPER HOSP UNIV MED CTR,DEPT EMERGENCY MED,CAMDEN,NJ 08103		Lawler, KA (corresponding author), COOPER HOSP UNIV MED CTR,DEPT MED,DIV NEUROL,NEUROPSYCHOL LAB,3 COOPER PLAZA,SUITE 320,CAMDEN,NJ 08103, USA.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ALVES W, 1986, J HEAD TRAUMA REHABI, V2, P1; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; CICERONE KD, 1995, BRAIN INJURY, V9, P865; Committee on Mild Traumatic Brain Injury American Congress of Rehabilitation Medicine (ACRM), 1993, J HEAD TRAUMA REHAB, V8, P86; DENCKER SJ, 1958, ACTA PSYCHIAT N S122, V33, P1; DICKER BG, 1992, J HEAD TRAUMA REHAB, V7, P83; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN S, 1989, MILD HEAD INJURY; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; ELKIND AH, 1989, CLIN J PAIN, V5, P77, DOI 10.1097/00002508-198903000-00014; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; GUILMETTE TJ, 1995, NEUROPSYCHOLOGY, V9, P338, DOI 10.1037/0894-4105.9.3.338; HALL S, 1991, J NEUROSURG, V75, P378, DOI 10.3171/jns.1991.75.3.0378; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; KAY T, 1986, MINOR HEAD INJURY IN; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN H, 1989, MODERATE HEAD INJURY; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MILLER H, 1969, BRIT MED J, V1, P9; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; OMMAYA A, 1974, BRAIN, V95, P633; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Stewart DP, 1996, ACAD EMERG MED, V3, P21, DOI 10.1111/j.1553-2712.1996.tb03297.x; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Wechsler D, 1987, MEMORY SCALE REVISED; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILSON G, 1985, RIVERMEAD BEHAV MEMO; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950	44	14	14	0	5	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1996	11	6					18	28		10.1097/00001199-199612000-00005			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VW427	WOS:A1996VW42700004					2022-02-06	
J	Leybaert, L; deHemptinne, A				Leybaert, L; deHemptinne, A			Changes of intracellular free calcium following mechanical injury in a spinal cord slice preparation	EXPERIMENTAL BRAIN RESEARCH			English	Article						intracellular free calcium; traumatic injury; spinal cord; intercellular communication; rat	RAT SENSORY NEURONS; SPREADING DEPRESSION; GAP-JUNCTIONS; INTERCELLULAR COMMUNICATION; MAMMALIAN BRAIN; GLIAL-CELLS; STORES; GLUTAMATE; CHANNELS; WAVES	Intracellular calcium ions are, in addition to free radicals, an important mediator of tissue destruction following traumatic injury to the spinal cord. In vivo measurements of calcium in the interstitial space and in the tissue suggest the occurrence of a posttraumatic shift of calcium from the extracellular to the intracellular compartment at the injury site. No information is, however, available on the posttraumatic changes of calcium in the intracellular compartment, where the ion exerts its crucial messenger function. We developed an in vitro model of local traumatic spinal injury, using a spinal cord slice preparation, allowing us to investigate injury-related changes of intracellular free calcium. The injury consisted of the impact of a small needle, and intracellular free calcium was measured with fura-2. Application of the injury at different places within the gray matter caused a transient and reproducible increase in the fura-2 fluorescence ratio. This injury-induced ratio increase was largely, but not completely, suppressed under zero extracellular calcium conditions. It was also largely depressed in the presence of high extracellular potassium and in the absence of extracellular sodium. It was modestly depressed by the calcium channel blocker nifedipin, by the calcium release channel blocker dantrolene, and by the gap junction blockers halothane and octanol. The calcium channel blocker flunarizine, the N-methyl D-aspartate (NMDA)-receptor-channel blocker MK-801 and the endoplasmic reticulum calcium-ATPase blocker thapsigargin had no effect. The experiments suggest that injury is associated with an increase in intracellular free calcium that is mediated by calcium influx, in part via L-type calcium channels. They furthermore give evidence that sodium influx and gap junctions are involved in these injury-associated changes of intracellular free calcium.			Leybaert, L (corresponding author), STATE UNIV GHENT,LAB NORMALE & PATHOL FYSIOL,DE PINTELAAN 185,B-9000 GHENT,BELGIUM.		Leybaert, Luc/F-4079-2015	Leybaert, Luc/0000-0001-6452-6982			AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; AKAIKE N, 1989, J PHYSIOL-LONDON, V412, P181, DOI 10.1113/jphysiol.1989.sp017610; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; BURT JM, 1993, PROG CELL R, V3, P113; BURT JM, 1989, CIRC RES, V65, P829, DOI 10.1161/01.RES.65.3.829; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P547, DOI 10.1113/jphysiol.1987.sp016551; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; CHARLES AC, 1993, GLIA, V7, P134, DOI 10.1002/glia.440070203; CHARLES AC, 1992, J CELL BIOL, V118, P195, DOI 10.1083/jcb.118.1.195; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DELEY G, 1993, J NEUROTRAUM, V10, P25, DOI 10.1089/neu.1993.10.25; DUCHEN MR, 1990, J PHYSIOL-LONDON, V424, P411, DOI 10.1113/jphysiol.1990.sp018074; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FURUYAMA T, 1993, MOL BRAIN RES, V18, P141, DOI 10.1016/0169-328X(93)90183-P; GIBBONS SJ, 1993, ANN NY ACAD SCI, V679, P22, DOI 10.1111/j.1749-6632.1993.tb18286.x; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; HENZI V, 1992, NEUROSCIENCE, V46, P251, DOI 10.1016/0306-4522(92)90049-8; KWO S, 1989, Journal of Neurotrauma, V6, P13, DOI 10.1089/neu.1989.6.13; LEIBOWITZ DH, 1992, P ROY SOC B-BIOL SCI, V250, P287, DOI 10.1098/rspb.1992.0161; LEYBAERT L, 1993, N-S ARCH PHARMACOL, V348, P269, DOI 10.1007/BF00169155; LEYBAERT L, 1994, EXP BRAIN RES, V100, P369, DOI 10.1007/BF02738397; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MARCOTTE GV, 1990, J CELL PHYSIOL, V142, P78, DOI 10.1002/jcp.1041420111; NEDERGAARD M, 1995, J NEUROBIOL, V28, P433, DOI 10.1002/neu.480280404; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; PEREZARMENDARIZ M, 1991, BIOPHYS J, V59, P76, DOI 10.1016/S0006-3495(91)82200-7; Press W. H., 1989, NUMERICAL RECIPES PA; PURO DG, 1991, GLIA, V4, P456, DOI 10.1002/glia.440040505; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; SANDERSON MJ, 1990, CELL REGUL, V1, P585, DOI 10.1091/mbc.1.8.585; SANDERSON MJ, 1994, MOL CELL ENDOCRINOL, V98, P173, DOI 10.1016/0303-7207(94)90136-8; SCHURR A, 1992, HIPPOCAMPUS, V2, P221, DOI 10.1002/hipo.450020303; Shi RY, 1989, J NEUROTRAUM, V6, P261, DOI 10.1089/neu.1989.6.261; SIESJO BK, 1994, ANN NY ACAD SCI, V747, P140; SILVER IA, 1990, J GEN PHYSIOL, V95, P837, DOI 10.1085/jgp.95.5.837; SOMJEN GG, 1992, CAN J PHYSIOL PHARM, V70, pS248, DOI 10.1139/y92-268; SOMJEN GG, 1989, J NEUROSCI METH, V28, P35, DOI 10.1016/0165-0270(89)90007-1; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TYRGER J, 1991, BRAIN RES, V549, P112; USACHEV Y, 1993, NEUROSCIENCE, V57, P845, DOI 10.1016/0306-4522(93)90029-F; VANHEEL B, 1989, AM J PHYSIOL, V257, pC365, DOI 10.1152/ajpcell.1989.257.2.C365; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1; YOUNG W, 1992, J NEUROTRAUM, V9, pS9	47	14	15	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0014-4819			EXP BRAIN RES	Exp. Brain Res.	DEC	1996	112	3					392	402		10.1007/BF00227945			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WF376	WOS:A1996WF37600006	9007541				2022-02-06	
J	Piper, IR; Thomson, D; Miller, JD				Piper, IR; Thomson, D; Miller, JD			Monitoring weight drop velocity and foam stiffness as an aid to quality control of a rodent model of impact acceleration neurotrauma	JOURNAL OF NEUROSCIENCE METHODS			English	Article						neurotrauma; rodent; methodology; weight drop		Since the publication by Marmarou of a new rodent model of head injury, an increasing number of centres are adopting the model for use in a variety of paradigms. We report on two simple methods we have applied which allows us to monitor weight drop velocity and foam stiffness, both of which are critical factors for producing repeatable closed head injury with this model. We hope the application of these methods will assist in the standardisation of this model between centres.			Piper, IR (corresponding author), WESTERN GEN HOSP,DEPT CLIN NEUROSCI,CREWE RD S,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.						FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291	2	14	14	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	NOV	1996	69	2					171	174		10.1016/S0165-0270(96)00046-5			4	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	VV820	WOS:A1996VV82000006	8946320				2022-02-06	
J	Counihan, T; Napolitano, LM; Heard, SO				Counihan, T; Napolitano, LM; Heard, SO			Transnasal insertion of percutaneous endoscopic gastrostomy in a patient with intermaxillary fixation: Case report	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							MAJOR ABDOMINAL-TRAUMA; BUMPER SYNDROME; COMPLICATIONS; PREVENTION; BENEFITS; REMOVAL	We describe successful placement of a percutaneous endoscopic gastrostomy via the transnasal approach in a patient mho required intermaxillary fixation for an open mandible fracture, and required enteral nutrition for chronic respiratory failure and traumatic brain injury. This method may be useful in other cases where the transoral route is not available for endoscopic insertion of enterostomy tubes.	UNIV MARYLAND, MED CTR, DEPT SURG, BALTIMORE, MD 21201 USA; UNIV MASSACHUSETTS, DEPT SURG, WORCESTER, MA 01605 USA								BOYD JW, 1995, GASTROINTEST ENDOSC, V41, P508, DOI 10.1016/S0016-5107(05)80013-6; CALTON WC, 1992, MIL MED, V157, P358; DUCKWORTH PF, 1991, GASTROINTEST ENDOSC, V37, P241; GRAHM TW, 1989, NEUROSURGERY, V25, P729, DOI 10.1227/00006123-198911000-00007; MA MM, 1995, GASTROINTEST ENDOSC, V41, P505, DOI 10.1016/S0016-5107(05)80012-4; MILLER RE, 1986, ANN SURG, V204, P543, DOI 10.1097/00000658-198611000-00006; MOCHIZUKI H, 1984, ANN SURG, V200, P297, DOI 10.1097/00000658-198409000-00007; MOORE EE, 1986, J TRAUMA, V26, P874, DOI 10.1097/00005373-198610000-00003; MOORE FA, 1989, J TRAUMA, V29, P916, DOI 10.1097/00005373-198907000-00003; MOORE FA, 1992, ANN SURG, V216, P172, DOI 10.1097/00000658-199208000-00008; NAPOLITANO LM, 1994, PROCEDURES TECHNIQUE, P219; PONSKY JL, 1985, AM J SURG, V149, P102, DOI 10.1016/S0002-9610(85)80017-9; RUSSELL TR, 1984, AM J SURG, V148, P132, DOI 10.1016/0002-9610(84)90300-3	13	14	14	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	1996	41	3					530	532		10.1097/00005373-199609000-00025			3	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	VH571	WOS:A1996VH57100029	8810976				2022-02-06	
J	Donders, J; Ballard, E				Donders, J; Ballard, E			Psychological adjustment characteristics of children before and after moderate to severe traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							CLOSED HEAD-INJURY; ADOLESCENTS; BEHAVIOR	Objective: To examine the pre- and postinjury patterns of behavioral and psychosocial adjustment in children with moderate to severe traumatic brain injury, and to identify variables that predict adjustment outcome. Design: Premorbid and follow-up parental ratings of children's adjustment were compared. Outcome predictor variables were identified through stepwise regression analysis. Setting: Pediatric program at a regional comprehensive rehabilitation center. Patients: 50 children with moderate to severe traumatic brain injury, selected from a SG-month series of consecutive clinical inpatient referrals. Measure: Achenbach Child Behavior Checklist. Results: Premorbid behavioral or psychosocial deficits were no more common than in the general population. Level of psychosocial adjustment deteriorated significantly after traumatic brain injury (P < .0001). Significant predictors of psychosocial adjustment at follow-up included premorbid psychosocial adjustment (P < .01), diffuse lesion on computed tomography/magnetic resonance imaging scan (P < .001), and length of coma (P < .10). Conclusions: Postinjury psychosocial impairments are common in children with moderate to severe traumatic brain injury and are related to injury severity. In the majority of the cases, such problems cannot be attributed exclusively to premorbid dysfunction.			Donders, J (corresponding author), MARY FREE BED HOSP,235 WEALTHY SE,GRAND RAPIDS,MI 49503, USA.						Achenbach, 1991, MANUAL TEACHERS REPO; ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; ACHENBACH TM, 1991, MANUAL CHILD BEHAVIO; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; DEATON AV, 1994, ED DIMENSIONS ACQUIR; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FLETCHER JM, 1988, HDB PEDIAT PSYCHOL; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Lehr E, 1990, PSYCHOL MANAGEMENT T; ODDY M, 1993, NEUROPSYCHOL REHABIL, V3, P301, DOI 10.1080/09602019308401444; Parmelee D X, 1989, Psychiatr Med, V7, P11; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; TEASDALE G, 1974, LANCET, V2, P81	18	14	14	1	4	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1996	11	3					67	73		10.1097/00001199-199606000-00010			7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UP774	WOS:A1996UP77400010					2022-02-06	
J	Araujo, M; Wandosell, F				Araujo, M; Wandosell, F			Differential cellular response after glutamate analog hippocampal damage	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						reactive astrocyte; activated microglia; neuronal APP overexpression	AMYLOID PRECURSOR PROTEIN; CENTRAL NERVOUS-SYSTEM; FIBRILLARY ACIDIC PROTEIN; GENE-RELATED PEPTIDE; REACTIVE ASTROCYTES; ALZHEIMERS-DISEASE; RAT-BRAIN; WALLERIAN DEGENERATION; MOLECULAR PATHOLOGY; EXCITOTOXIC LESION	The tissue response after brain damage implicates the cellular ''activation'' of astrocytes and microglia, This glial response is referred as reactive gliosis. Using immunohistochemical markers, we have analyzed the neuronal and glial response to some neurotoxic-induced lesions. We have compared the effects of two glutamate analogs, AMPA and kainic acid, with those of traumatic injury. Our data showed that the time-course of appearance, the relative contribution of and the behavior of reactive astrocytes and microglial cells were clearly different after AMPA or kainic acid administration. The immunoreactivity associated with microglia response, with respect to the immunoreactivity associated with reactive astrocytes, was higher after AMPA damage than after kainic acid treatment. In both cases, however, glial cells were more abundant than after traumatic lesions. Interestingly, the CA1 pyramidal neurons affected by AMPA and some cortical neurons affected by traumatic injury responded with an overexpression of amyloid precursor protein, whereas no neuronal response was detected after the kainic acid treatment. Our data suggest that the gliotic response is highly specific to the type of insult and heterogeneous depending on the brain area affected. (C) 1996 Wiley-Liss, Inc.	UNIV AUTONOMA MADRID, CSIC, CTR BIOL MOLEC SEVERO OCHOA, E-28049 MADRID, SPAIN				Wandosell, Francisco/AAV-6391-2020; Wandosell, Francisco/G-6105-2015	Wandosell, Francisco/0000-0001-6537-2321			BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; BOVOLENTA P, 1984, DEV BIOL, V102, P248, DOI 10.1016/0012-1606(84)90189-1; BOVOLENTA P, 1991, NERVE GROWTH CONE, P477; BOYA J, 1986, ACTA ANAT, V127, P142; CALVO JL, 1991, BRAIN RES, V566, P333, DOI 10.1016/0006-8993(91)91720-L; CARD JP, 1988, NEURON, V1, P835, DOI 10.1016/0896-6273(88)90131-6; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P263, DOI 10.1016/0166-2236(87)90170-6; DAHL D, 1982, DIFFERENTIATION, V22, P185, DOI 10.1111/j.1432-0436.1982.tb01248.x; DRAGUNOW M, 1990, BRAIN RES, V527, P41, DOI 10.1016/0006-8993(90)91058-O; DUMOULIN FL, 1992, ANN NY ACAD SCI, V657, P351, DOI 10.1111/j.1749-6632.1992.tb22782.x; DUSART I, 1991, NEUROSCIENCE, V45, P541, DOI 10.1016/0306-4522(91)90269-T; ENG LF, 1992, PROG BRAIN RES, V94, P353; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; FERNAUDESPINOSA I, 1993, GLIA, V8, P277, DOI 10.1002/glia.440080408; FERRARA N, 1988, BRAIN RES, V462, P223, DOI 10.1016/0006-8993(88)90550-1; GARTHWAITE G, 1989, NEUROSCI LETT, V99, P113, DOI 10.1016/0304-3940(89)90274-7; GEISERT EE, 1990, P NATL ACAD SCI USA, V87, P3967, DOI 10.1073/pnas.87.10.3967; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GIULIAN D, 1993, GLIA, V7, P102, DOI 10.1002/glia.440070116; GIULIAN D, 1987, J NEUROSCI RES, V18, P155, DOI 10.1002/jnr.490180123; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GRAEBER MB, 1989, NEUROSCI LETT, V103, P241, DOI 10.1016/0304-3940(89)90106-7; GRAEBER MB, 1988, J NEUROSCI RES, V21, P18, DOI 10.1002/jnr.490210104; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; GUNN AJ, 1990, BRAIN RES, V531, P105, DOI 10.1016/0006-8993(90)90763-2; HAAS CA, 1990, J NEUROSCI RES, V27, P270, DOI 10.1002/jnr.490270305; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; HEURTEAUX C, 1993, P NATL ACAD SCI USA, V90, P9431, DOI 10.1073/pnas.90.20.9431; KAWARABAYASHI T, 1991, BRAIN RES, V563, P334, DOI 10.1016/0006-8993(91)91558-I; LIESI P, 1985, EMBO J, V4, P2505, DOI 10.1002/j.1460-2075.1985.tb03963.x; MANSOUR H, 1990, J NEUROSCI RES, V25, P300, DOI 10.1002/jnr.490250306; MANTHORPE M, 1986, ASTROCYTES CELL BIOL, V2, P315; MARTY S, 1991, NEUROSCIENCE, V45, P529, DOI 10.1016/0306-4522(91)90268-S; MCGEER PL, 1991, ALZHEIMERS DISEASE : BASIC MECHANISMS, DIAGNOSIS AND THERAPEUTIC STRATEGIES, P587; MORENOFLORES MT, 1993, GLIA, V7, P146, DOI 10.1002/glia.440070204; MURABE Y, 1981, CELL TISSUE RES, V218, P75; NADLER JV, 1981, NEUROSCIENCE, V6, P2505, DOI 10.1016/0306-4522(81)90096-8; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; OLNEY JW, 1978, KAINIC ACID TOOL NEU, P201; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; POTTER H, 1992, PROG BRAIN RES, V94, P447; Reier P J, 1988, Adv Neurol, V47, P87; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; SAMBAMURTI K, 1992, J NEUROSCI RES, V33, P319, DOI 10.1002/jnr.490330216; SCHOEPP D, 1990, TRENDS PHARMACOL SCI, V11, P508, DOI 10.1016/0165-6147(90)90052-A; SELKOE DJ, 1989, NEUROBIOL AGING, V10, P387, DOI 10.1016/0197-4580(89)90072-9; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SHAW G, 1981, EUR J CELL BIOL, V26, P68; SIMAN R, 1989, J NEUROSCI, V9, P1579; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; SINHA S, 1992, NEURODEGENERATION, V1, P169; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SOLA C, 1993, NEUROSCIENCE, V53, P267, DOI 10.1016/0306-4522(93)90304-X; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; STREIT WJ, 1993, J CHEM NEUROANAT, V6, P261, DOI 10.1016/0891-0618(93)90047-8; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; STREIT WJ, 1988, J COMP NEUROL, V268, P248, DOI 10.1002/cne.902680209; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; THOMAS WE, 1992, BRAIN RES REV, V17, P61; WANDOSELL F, 1993, J NEUROPATH EXP NEUR, V52, P205, DOI 10.1097/00005072-199305000-00004; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A	64	14	14	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	MAY 15	1996	44	4					397	409					13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UL385	WOS:A1996UL38500011	8739159				2022-02-06	
J	Markowsky, SJ; Skaar, DJ; Christie, JM; Eyer, SD; Ehresman, DJ				Markowsky, SJ; Skaar, DJ; Christie, JM; Eyer, SD; Ehresman, DJ			Phenytoin protein binding and dosage requirements during acute and convalescent phases following brain injury	ANNALS OF PHARMACOTHERAPY			English	Article							HEPATIC DRUG CLEARANCE; MODEL TRAUMATIC INJURY; POSTTRAUMATIC SEIZURES; DISEASE; DIPHENYLHYDANTOIN; SERUM	OBJECTIVE: To longitudinally evaluate unbound and total serum phenytoin concentrations during intravenous phenytoin maintenance dosage and to determine the relationship among phenytoin protein binding, serum albumin, and unbound fatty acid concentrations in patients with head injuries during intensive care unit (ICU) and convalescent care. DESIGN: Serum albumin and phenytoin unbound fraction were determined twice weekly during ICU and convalescent care in 10 patients receiving phenytoin following acute brain injury. Phenytoin protein binding was also determined in 10 healthy control subjects. MAIN OUTCOME MEASURES: Longitudinal serum phenytoin concentrations associated with dosage adjustments targeted to achieve unbound phenytoin serum concentrations between 1.0 and 2.0 mg/L were documented during ICU and convalescent care. Longitudinal phenytoin protein binding was correlated with serum albumin and unbound fatty acid concentrations in neurotrauma patients. RESULTS: ICU patients received intravenous therapy for a mean of 15.0 days. The mean +/- SD initial phenytoin intravenous dosage regimen of 6.0 +/- 0.7 mg/kg/d resulted in mean +/- SD total and unbound phenytoin concentrations of 3.2 +/- 2.3 and 0.3 +/- 0.2 mg/L. Two patients had seizures associated with low phenytoin concentrations. Four patients continued to receive oral phenytoin therapy during convalescent care; phenytoin dosage requirements decreased over time in these patients. During acute and convalescent care, the phenytoin unbound fraction ranged from 6.0% to 18.3% and correlated with albumin (r(2) = 0.61, p < 0.0001) but did not correlate with unbound fatty acid concentrations. The mean phenytoin unbound fraction was 10.1% and 8.9% for the ICU and convalescent patients with brain injuries, respectively, and was 7.0% for the healthy volunteers. CONCLUSIONS: Phenytoin protein binding was significantly correlated with albumin and was more variable in ICU and convalescent patients with brain injuries than in healthy volunteers. The high dosage requirements and subtherapeutic unbound phenytoin concentrations observed during acute care are best explained by increased metabolism. Phenytoin dosage requirements decreased during convalescence.	UNIV S FLORIDA,DEPT ANESTHESIA,TAMPA,FL; MERCK & CO INC,TAMPA,FL; UNIV FLORIDA,COLL PHARM,GAINESVILLE,FL; PHILADELPHIA COLL PHARM & SCI,PHILADELPHIA,PA 19104; ST PAUL RAMSEY MED CTR,DEPT SURG,SURG INTENS CARE UNIT,ST PAUL,MN 55101; ST PAUL RAMSEY MED CTR,DEPT PATHOL,ST PAUL,MN 55101								BAUER LA, 1982, NEUROLOGY, V32, P570, DOI 10.1212/WNL.32.5.570; BAUER LA, 1983, J TRAUMA, V23, P1058, DOI 10.1097/00005373-198312000-00007; BOUCHER BA, 1988, CLIN PHARMACOL THER, V44, P675, DOI 10.1038/clpt.1988.211; BOUCHER BA, 1991, CLIN PHARMACOL THER, V50, P487, DOI 10.1038/clpt.1991.173; GLASKO AJ, 1969, CLIN PHARMACOL THER, V10, P498; GODOLPHIN W, 1978, CLIN CHEM, V24, P483; GRIFFETH LK, 1983, DRUG METAB DISPOS, V11, P517; HOOPER WD, 1974, CLIN PHARMACOL THER, V15, P276; KABRA PM, 1983, CLIN CHEM, V29, P473; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KUHL DA, 1990, DICP ANN PHARMAC, V24, P277, DOI 10.1177/106002809002400314; KUTT H, 1989, ANTIEPILEPTIC DRUGS, P215; LEPPIK IE, 1986, NEUROLOGY, V36, P1367, DOI 10.1212/WNL.36.10.1367; LEVY RH, 1984, CLIN PHARMACOKINET, V9, P1, DOI 10.2165/00003088-198400091-00001; LUND L, 1974, ARCH NEUROL-CHICAGO, V31, P289, DOI 10.1001/archneur.1974.00490410037002; MARKOWSKY SJ, 1996, INTENS CARE MED, P2338; PERUCCA E, 1981, DRUGS, V21, P120, DOI 10.2165/00003495-198121020-00003; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; RAUCKMAN EJ, 1980, J TRAUMA, V20, P884, DOI 10.1097/00005373-198010000-00012; RICHENS A, 1979, CLIN PHARMACOKINET, V4, P153, DOI 10.2165/00003088-197904030-00001; SHERWIN AL, 1976, NEUROLOGY, V26, P874, DOI 10.1212/WNL.26.9.874; SLAUGHTER RL, 1985, DRUG INTEL CLIN PHAR, V19, P799, DOI 10.1177/106002808501901101; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; WILDER BJ, 1973, CLIN PHARMACOL THER, V14, P798; WILKINSON GR, 1975, CLIN PHARMACOL THER, V18, P377	25	14	15	0	1	HARVEY WHITNEY BOOKS CO	CINCINNATI	PO BOX 42696, CINCINNATI, OH 45242	1060-0280			ANN PHARMACOTHER	Ann. Pharmacother.	MAY	1996	30	5					443	448		10.1177/106002809603000501			6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	UJ215	WOS:A1996UJ21500001	8740320				2022-02-06	
J	Richardson, JTE				Richardson, JTE			Memory impairment in multiple sclerosis: Reports of patients and relatives	BRITISH JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							SEVERE HEAD-INJURY; EVERYDAY MEMORY; COGNITIVE DYSFUNCTION	This paper reports the results of a questionnaire survey on problems in everyday memory that involved 115 community-based patients with multiple sclerosis (MS) and their carers or close relatives. Cluster analyses of their responses enabled the patients to be classified as either 'impaired' or 'unimpaired', though the salient items differed between the reports of the patients and the relatives. Both the self-reports and the relatives' reports indicated that roughly 10 per cent of the patients were impaired, a much lower estimate than that which was previously suggested based upon psychometric testing. It is concluded that neuropsychological assessment may underestimate the capacity of MS patients in their daily activities.			Richardson, JTE (corresponding author), BRUNEL UNIV, DEPT HUMAN SCI, UXBRIDGE UB8 3PH, MIDDX, ENGLAND.			Richardson, John/0000-0002-6267-0603			Babbie E., 1973, SURVEY RES METHODS; BADDELEY A, 1982, ALZHEIMERS DISEASE R, P141; Baltes P. B., 1990, SUCCESSFUL AGING PER, DOI 10.1017/CBO9780511665684; BRADLEY DR, 1979, PSYCHOL BULL, V86, P1290, DOI 10.1037/0033-2909.86.6.1290; Calinski TT., 1974, COMMUN STAT, V3, P1, DOI 10.1080/03610927408827101; CAVANAUGH JC, 1987, INT J AGING HUM DEV, V24, P271, DOI 10.2190/8WTA-P1WP-EJYJ-Q33D; COLVILLE PL, 1983, MULTIPLE SCLEROSIS P, P631; COMPSTON A, 1993, BRAINS DIS NERVOUS S, P351; Corcoran R, 1992, Seizure, V1, P37, DOI 10.1016/1059-1311(92)90053-4; COTTRELL SS, 1929, J NEUROL PSYCHOPATH, V7, P1; CRAWFORD M, 1989, BRIT J PSYCHOL, V80, P391, DOI 10.1111/j.2044-8295.1989.tb02329.x; Everitt B. S., 1993, CLUSTER ANAL; FEINSTEIN A, 1992, J NEUROL NEUROSUR PS, V55, P869, DOI 10.1136/jnnp.55.10.869; FISCHER JS, 1989, CURR PROB N, V10, P39; GERVASIO AH, 1988, B PSYCHONOMIC SOC, V26, P339, DOI 10.3758/BF03337675; GILBERT JJ, 1983, ARCH NEUROL-CHICAGO, V40, P533, DOI 10.1001/archneur.1983.04050080033003; Gilewski M.J., 1986, CLIN MEMORY ASSESSME, P93, DOI [10.1037/10057-008, DOI 10.1037/10057-008]; GRANT I, 1984, J NEUROL NEUROSUR PS, V47, P250, DOI 10.1136/jnnp.47.3.250; HEATON RK, 1985, J CONSULT CLIN PSYCH, V53, P103, DOI 10.1037/0022-006X.53.1.103; HERRMANN DJ, 1990, SELF DIRECTEDNESS CA, P199; HICKOX A, 1992, HDB NEUROPSYCHOLOGIC, P103; KIDEER LH, 1981, RES METHODS SOCIAL R; KURTZKE JF, 1972, ACTA NEUROL SCAND, V48, P19, DOI 10.1111/j.1600-0404.1972.tb07525.x; LINCOLN NB, 1989, BRIT J CLIN PSYCHOL, V28, P61, DOI 10.1111/j.2044-8260.1989.tb00812.x; MACKAY RP, 1967, ARCH NEUROL-CHICAGO, V17, P588, DOI 10.1001/archneur.1967.00470300030007; MCALPINE D, 1972, MULTIPLE SCLEROSIS; MCINTOSHMICHAELIS SA, 1991, BRIT J CLIN PSYCHOL, V30, P333, DOI 10.1111/j.2044-8260.1991.tb00954.x; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Morris P. E, 1984, EVERYDAY MEMORY ACTI, P153; NELSON LM, 1988, J CLIN EPIDEMIOL, V41, P187, DOI 10.1016/0895-4356(88)90093-5; Newcombe F, 1979, Int Rehabil Med, V1, P182; OVERALL JE, 1993, J CLIN PSYCHOL, V49, P459, DOI 10.1002/1097-4679(199307)49:4<459::AID-JCLP2270490402>3.0.CO;2-P; PEYSER JM, 1990, ARCH NEUROL-CHICAGO, V47, P94, DOI 10.1001/archneur.1990.00530010120030; PEYSER JM, 1980, ARCH NEUROL-CHICAGO, V37, P577, DOI 10.1001/archneur.1980.00500580073013; PEYSER JM, 1980, ARCH NEUROL-CHICAGO, V37, P437, DOI 10.1001/archneur.1980.00500560067009; POLLARD P, 1987, PSYCHOL BULL, V102, P159, DOI 10.1037/0033-2909.102.1.159; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1986, J CLIN EXP NEUROPSYC, V8, P503, DOI 10.1080/01688638608405173; RAO SM, 1984, ARCH NEUROL-CHICAGO, V41, P625, DOI 10.1001/archneur.1984.04210080033010; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; RAO SM, 1989, NEUROLOGY, V39, P161, DOI 10.1212/WNL.39.2.161; SCHWARTZ AF, 1989, CORTEX, V25, P665, DOI 10.1016/S0010-9452(89)80026-7; SHEPHERD DI, 1979, ACTA NEUROL SCAND, V60, P218; STENAGER E, 1990, SEMIN NEUROL, V10, P254, DOI 10.1055/s-2008-1041276; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Tabachnick B. G., 1989, USING MULTIVARIATE S; TRUELLE JL, 1987, REV NEUROL, V143, P595; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; WILSON BA, 1991, NEUROPSYCHOL REHABIL, V1, P117, DOI DOI 10.1080/09602019108401386; Zelinski EM, 1980, NEW DIRECTIONS MEMOR, P519; [No title captured]	53	14	14	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0144-6657			BRIT J CLIN PSYCHOL	Br. J. Clin. Psychol.	MAY	1996	35		2				205	219		10.1111/j.2044-8260.1996.tb01177.x			15	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	UM867	WOS:A1996UM86700004	8773798				2022-02-06	
J	Vitale, AE; Sullivan, SJ; Jankowski, LW; Fleury, J; Lefrancois, C; Lebouthillier, E				Vitale, AE; Sullivan, SJ; Jankowski, LW; Fleury, J; Lefrancois, C; Lebouthillier, E			Screening of health risk factors prior to exercise or a fitness evaluation of adults with traumatic brain injury: A consensus by rehabilitation professionals	BRAIN INJURY			English	Article							DELPHI	A modified Delphi technique was used to obtain group consensus among 31 rehabilitation professionals (RPs) from nine rehabilitation centres throughout the province of Quebec (Canada) to ascertain their expert opinion on the health risk factors (HRF) to be verified prior to beginning an exercise programme or evaluation for patients with traumatic brain injury (TBI). From the initial survey 87 items were generated, which were later regrouped into 27 HRFs. The relative importance of each HRF in regard to being screened before exercise in a population with TBI was then assessed by each RP using a five-point ordinal scale (1 = not important to 5 = extremely important). HRFs that were considered extremely important by at least 50% of HPs include: angina pectoris, aortic stenosis, exertional syncope, musculoskeletal sequelae which are exacerbated by exercise, outward aggressivity, pulmonary embolism, uncontrolled epilepsy (seizures), and ventricular arrhythmias. Professionals involved in exercising patients with TBI may and these factors useful to the efficient conduct of their rehabilitation programme.	INST READAPTAT MONTREAL,CTR RECH,MONTREAL,PQ H3S 2J4,CANADA; UNIV MONTREAL,FAC MED,ECOLE READAPTAT,MONTREAL,PQ H3C 3J7,CANADA; CONCORDIA UNIV,DEPT EXERCISE SCI,MONTREAL,PQ,CANADA; INST READAPTAT MONTREAL,DEPT PSYCHIAT,MONTREAL,PQ,CANADA; CTR READAPTAT LUCIE BRUNEA,MONTREAL,PQ,CANADA								*AM COLL SPORTS ME, 1991, GUID EX TEST PRESCR, P6; Couper M R, 1984, ANS Adv Nurs Sci, V7, P72; FROST EAM, 1989, NEUROTRAUMA TREATMEN, V1, P29; GOODMAN CM, 1987, J ADV NURS, V12, P729, DOI 10.1111/j.1365-2648.1987.tb01376.x; GREEN CG, 1993, J AM DIET ASSOC, V93, P1307, DOI 10.1016/0002-8223(93)91962-P; Green L.W., 1980, HLTH ED PLANNING DIA, V1st ed.; HARRINGTON JM, 1994, OCCUP ENVIRON MED, V51, P289, DOI 10.1136/oem.51.5.289; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; LINESTONE HA, 1975, DELPHI METHOD TECHNI, P3; McMurray A R, 1994, J Nurs Staff Dev, V10, P62; MILESTAPPING C, 1990, PHYS THER, V70, P448, DOI 10.1093/ptj/70.7.448; PILON M, 1995, BRAIN INJURY, V9, P365, DOI 10.3109/02699059509005776; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; RAINHORN JD, 1994, B WORLD HEALTH ORGAN, V72, P257; ROBERG AL, 1992, CANADIAN J PROGRAM E, V7, P27; ROSENTHAL M, 1990, REHABILITATION ADULT; SHEPHARD RJ, 1988, SPORTS MED, V5, P185, DOI 10.2165/00007256-198805030-00005; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194; SWAINE BR, 1994, BRAIN INJURY, V8, P323, DOI 10.3109/02699059409150983; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; VITALE AE, 1995, PERCEPT MOTOR SKILL, V80, P57, DOI 10.2466/pms.1995.80.1.57; Whiting S A, 1994, Issues Ment Health Nurs, V15, P37, DOI 10.3109/01612849409074932; WILLIAMS PL, 1994, J ADV NURS, V19, P180, DOI 10.1111/j.1365-2648.1994.tb01066.x; Wolman RL, 1994, CLIN REHABIL, V8, P253	25	14	14	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAY	1996	10	5					367	375		10.1080/026990596124377			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UL742	WOS:A1996UL74200004	8735666				2022-02-06	
J	SchmitterEdgecombe, M				SchmitterEdgecombe, M			Effects of traumatic brain injury on cognitive performance: An attentional resource hypothesis in search of data	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						attention; attention deficit; attentional resources; automaticity; automatic processes; divided attention; effortful processes; traumatic brain injury; treatment	CLOSED-HEAD-INJURY; DIVIDING ATTENTION; MULTIPLE RESOURCES; REACTION-TIME; MEMORY; TASK; FREQUENCY; AUTOMATICITY; DIFFICULTY; DISORDERS	Individuals who sustain severe traumatic brain injuries (TBI) typically exhibit residual performance deficits across a wide range of cognitive tasks. It is therefore possible that the performance deficits of persons with TBI may be at least partially the result of deficiencies in some fundamental cognitive abilities that are involved in the performance of many different activities. This article explores the possibility that attentional processes may be such a fundamental cognitive ability. According to the attentional resource hypothesis, some of the cognitive deficits that follow a TBI may occur because these people have less attentional resources available to allocate to task performances. To evaluate the merits of an attentional resource hypothesis, the TBI literature is reviewed in terms of three explicit predictions of this hypothesis. Several important questions raised by the reviewed research are then addressed. Implications of the attentional resource hypothesis for treatment and intervention strategies are also discussed.			SchmitterEdgecombe, M (corresponding author), WASHINGTON STATE UNIV,DEPT PSYCHOL,PULLMAN,WA 99164, USA.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; BORCHERDING B, 1988, J ABNORM CHILD PSYCH, V16, P333, DOI 10.1007/BF00913804; BRAUN CMJ, 1989, INT J CLIN NEUROPSYC, V11, P167; BROOKS D N, 1975, Cortex, V11, P329; CHA KH, 1990, INT REV RES MENT RET, V16, P51; DRUDGE OW, 1984, J CLIN PSYCHOL, V40, P259, DOI 10.1002/1097-4679(198401)40:1<259::AID-JCLP2270400149>3.0.CO;2-C; DYE OA, 1981, J CLIN PSYCHOL, V37, P472, DOI 10.1002/1097-4679(198107)37:3<472::AID-JCLP2270370304>3.0.CO;2-Q; DYWAN J, 1993, BRAIN COGNITION, V21, P20, DOI 10.1006/brcg.1993.1002; Fahy JF., 1993, NEUROPSYCHOLOGY, V7, P136, DOI [10.1037/0894-4105.7.2.136, DOI 10.1037/0894-4105.7.2.136]; FAHY JF, UNPUB DISSOCIATIONS; FRIEDMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P625, DOI 10.1037/0096-1523.8.5.625; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Gentilini M., 1989, MILD HEAD INJURY; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GLISKY EL, 1988, J LEARN DISABIL-US, V21, P333, DOI 10.1177/002221948802100604; GLISKY EL, 1986, J HEAD TRAUMA REHAB, V1, P54, DOI DOI 10.1097/00001199-198609000-00009; GREENE RL, 1984, MEM COGNITION, V12, P90, DOI 10.3758/BF03197001; Gronwall D, 1974, PSYCHOL EFFECTS CONC; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Haut M W, 1990, Arch Clin Neuropsychol, V5, P299, DOI 10.1016/0887-6177(90)90028-N; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; JACOBY LL, 1989, J EXP PSYCHOL GEN, V118, P115, DOI 10.1037/0096-3445.118.2.115; Kahneman D., 1984, VARIETIES ATTENTION; KAHNEMAN D, 1973, ATTENTION MEMORY; KINCHLA RA, 1980, ATTENTION PERFORMANC, V8; KLENSCH H, 1981, EVACTION TIME ATTENT; LEVIN HS, 1988, BRAIN COGNITION, V7, P283, DOI 10.1016/0278-2626(88)90003-6; LIGHT LL, 1991, ANNU REV PSYCHOL, V42, P333, DOI 10.1146/annurev.ps.42.020191.002001; MATEER CA, 1988, NEUROPSYCHOLOGICAL S; MCDOWD JM, 1988, J EXP PSYCHOL HUMAN, V14, P267, DOI 10.1037/0096-1523.14.2.267; Miller E, 1970, Cortex, V6, P121; MUTTER SA, 1990, COGNITIVE NEUROPSYCH, V7, P329, DOI 10.1080/02643299008253447; NAVEHBENJAMIN M, 1986, J EXP PSYCHOL LEARN, V12, P378, DOI 10.1037/0278-7393.12.3.378; NAVON D, 1979, PSYCHOL REV, V86, P214, DOI 10.1037/0033-295X.86.3.214; NIEMANN H, 1990, J CONSULT CLIN PSYCH, V58, P811, DOI 10.1037/0022-006X.58.6.811; NORRMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236, DOI 10.1111/j.1600-0447.1961.tb07359.x; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; Parasuraman R, 1984, VARIETIES ATTENTION; Parkin A. J., 1990, EUROPEAN J COGNITIVE, V2, P71, DOI [DOI 10.1080/09541449008406198, 10.1080/09541449008406198]; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; POSNER MI, 1987, TRENDS NEUROSCI, V10, P13, DOI 10.1016/0166-2236(87)90116-0; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; ROGERS WA, 1994, PSYCHOL AGING, V9, P398, DOI 10.1037/0882-7974.9.3.398; SALTHOUSE TA, 1984, MEM COGNITION, V12, P613, DOI 10.3758/BF03213350; SALTHOUSE TA, 1990, DEV REV, V10, P101, DOI 10.1016/0273-2297(90)90006-P; SCHMITTEREDGECO.M, UNPUB AUTOMATIC PROC; SCHMITTEREDGECO.M, IN PRESS NEUROPSYCHO; SCHMITTEREDGECO.M, IN PRESS J INT NEURO; SCHMITTEREDGECO.M, UNPUB VISUAL SELECTI; SCHMITTEREDGECO.ME, 1992, J CLIN EXP NEUROPSYC, V14, P728; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SCHNEIDER W, 1982, PERCEPT PSYCHOPHYS, V31, P160, DOI 10.3758/BF03206216; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SHIFFRIN RM, 1981, ATTENTION PERFORMANC, V9; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; SOMBERG BL, 1982, J EXP PSYCHOL HUMAN, V8, P651, DOI 10.1037/0096-1523.8.5.651; SPERLING G, 1978, SCIENCE, V202, P315, DOI 10.1126/science.694536; SPIKMAN JM, 1995, J CLIN EXP NEUROPSYC, V17, P29, DOI 10.1080/13803399508406578; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TOTH JP, 1992, NEUROPSYCHOLOGY MEMO; TREXLER LE, 1988, BRAIN COGNITION, V8, P291, DOI 10.1016/0278-2626(88)90056-5; TWEEDY JR, 1988, J CLIN EXP NEUROPSYC, V10, P664, DOI 10.1080/01688638808402803; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Van Zomeren A. H., 1981, REACTION TIME ATTENT; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; WICKENS CD, 1984, VARIEITES ATTENTION; [No title captured]	72	14	15	0	3	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1996	11	2					17	30		10.1097/00001199-199604000-00003			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UD674	WOS:A1996UD67400003					2022-02-06	
J	Pileggi, R; Dumsha, TC; Myslinksi, NR				Pileggi, R; Dumsha, TC; Myslinksi, NR			The reliability of electrical pulp test after concussion injury	ENDODONTICS & DENTAL TRAUMATOLOGY			English	Article						dental trauma; dental concussion; electric pulp test; pulpal vasculature		Traumatic injuries to teeth present a difficult diagnostic problem with respect to determining the vitality of the affected teeth. Conventionally, a latency period of 4 to 6 weeks is proposed as the amount of time required for the return of a positive electric pulp test (EPT) response; however, this has been based on empirical data. The purpose of this study was to 1) determine a time frame during which a return of a reliable response to EPT may be measured, and 2) correlate this time frame with pulpal vascular changes that occur after traumatic injuries. Four canines from each of nine ferrets were used for this experiment (18 traumatized and 18 control teeth). A reproducible concussion injury was devised by releasing a known weight at a constant height above the facial surface of the experimental teeth. The EPT response was confirmed by the use of an ER IG muscle recorder. Animals were killed at 24, 18 and 72 h and 6, 12 and 28 days after the injury and the teeth analyzed histologically. The histological sections showed an absence of inflammatory cells in both groups; however, according to the NIH image system; an increase in the number of vessels Tvas detected in the experimental group when compared to the controls. In a majority of the cases, a positive response to the EPT returned within 12 days post concussion injury and as early as 10 days. In addition, a significant vascular change was accompanied with the loss of the EPT response. This study provided a reliable method by which concussion injuries may be studied using an animal model.	UNIV MARYLAND,SCH DENT,DEPT ENDODONT,BALTIMORE,MD; UNIV MARYLAND,SCH DENT,DEPT CRANIOFACIAL BIOL SCI,BALTIMORE,MD		Pileggi, R (corresponding author), UNIV MICHIGAN,SCH DENT,DEPT CARIOL RESTORAT SCI & ENDODONT,1011 N UNIV,ANN ARBOR,MI 48109, USA.						ANDREASEN F M, 1986, Endodontics and Dental Traumatology, V2, P9; ANDREASEN F M, 1985, Endodontics and Dental Traumatology, V1, P207; ANDREASEN F M, 1986, Endodontics and Dental Traumatology, V2, P90; ANDREASEN F M, 1987, Endodontics and Dental Traumatology, V3, P103; ANDREASEN JO, 1981, TAUMATIC INJURIES TE; Andreasen JO, 1994, TXB COLOR ATLAS TRAU; CRONALARSSON G, 1991, ENDOD DENT TRAUMATOL, V7, P199; DUMSHA T, 1995, INT ENDOD J, V28, P7, DOI 10.1111/j.1365-2591.1995.tb00149.x; DUMSHA T, 1992, J ENDODONT, V8, P410; Dumsha T C, 1995, Dent Clin North Am, V39, P79; DUMSHA T C, 1992, Dental Clinics of North America, V36, P425; GAMSON EG, 1992, J ENDOD, V18; MYSLINSKI N, 1987, J NEUROSCI METH, V22, P73, DOI 10.1016/0165-0270(87)90092-6; OHMAN A, 1965, ONDONTOL TIDSKR, V4, P165; PATIL S, 1994, INT ENDOD J, V27, P1, DOI 10.1111/j.1365-2591.1994.tb00220.x; POGREL MA, 1989, ORAL SURG ORAL MED O, V67, P583, DOI 10.1016/0030-4220(89)90277-6; ROWE AHR, 1990, INT ENDOD J, V23, P77, DOI 10.1111/j.1365-2591.1990.tb00843.x; Skieller V., 1960, ACTA ODONTOL SCAND, V18, P171; WILDERSMITH PEEB, 1988, INT ENDOD J, V21, P307, DOI 10.1111/j.1365-2591.1988.tb01140.x	19	14	15	0	2	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0109-2502			ENDOD DENT TRAUMATOL	Endod. Dent. Traumatol.	FEB	1996	12	1					16	19					4	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	UB572	WOS:A1996UB57200003	8631284				2022-02-06	
J	Dauch, WA; Schutze, M; Guttinger, M; Bauer, BL				Dauch, WA; Schutze, M; Guttinger, M; Bauer, BL			Posttraumatic prophylaxis for seizures - The results of a survey among 127 neurosurgical departments	ZENTRALBLATT FUR NEUROCHIRURGIE			English	Article						epilepsy; intracranial haemorrhage; risk factors; skull fracture; brain injury	POST-TRAUMATIC SEIZURES; PROPHYLACTICALLY ADMINISTERED PHENYTOIN; HEAD-INJURY; EPILEPSY; RISK; FAILURE	Starting in November, 1993, until January, 1994, we performed a survey among 127 Neurosurgical Departments in Austria, Germany, and Switzerland concerning the practice of antiepileptic prophylaxis in head injured patients. Seventy seven percent of the 12-item multiple choice questionnaires were completed and returned. They indicate a variety of attitudes towards prophylaxis for seizures: in 12% of the responding institutions, antiepileptic prophylaxis is given to every brain trauma patient, in 36%, no prophylaxis is carried out, and in 52% some patients receive prophylaxis while others do not. Penetrating injuries, intracranial haemorrhages and electroencephalographic abnormalities were the most frequent reasons why prophylaxis was initiated. Phenytoin is by far the most popular drug, given usually for at least three months, and in most cases monitored by routine serum level observations. Nevertheless, about three out of four neurosurgeons conceded that a general renunciation of antiepileptic prophylaxis after brain trauma might be justified. There is no uniform way in which patients are informed about a possible risk of seizures, as it may be relevant, for instance, in respect of driving abilities.	ZENTRUM SCHWERST SCHADEL HIROVERLETZTE FREIN & HA,D-22081 HAMBURG,GERMANY; UNIV MARBURG,NEUROCHIRURG KLIN,MARBURG,GERMANY								BAUER J, 1992, NERVENHEILKUNDE, V11, P74; BIRKMAYER W, 1951, Wien Klin Wochenschr, V63, P606; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; De Santis A, 1992, Acta Neurochir Suppl (Wien), V55, P64; GLOTZNER FL, 1979, AKTUEL NEUROL, V6, P241; HAINES SJ, 1983, J NEUROSURG, V59, P730; HEIKKINEN ER, 1990, STEREOT FUNCT NEUROS, V54-5, P25, DOI 10.1159/000100186; Janz D, 1994, Zentralbl Neurochir, V55, P1; JANZ D, 1982, NERVENARZT, V53, P238; KELLY DF, 1989, NEUROSURGERY, V25, P976, DOI 10.1227/00006123-198912000-00022; KUHL DA, 1990, DICP ANN PHARMAC, V24, P277, DOI 10.1177/106002809002400314; MANAKA S, 1992, JPN J PSYCHIAT NEUR, V46, P311; MASSAGLI TL, 1991, ARCH PHYS MED REHAB, V72, P219; MCQUEEN JK, 1983, J NEUROL NEUROSUR PS, V46, P899, DOI 10.1136/jnnp.46.10.899; MURRI L, 1992, ITAL J NEUROL SCI, V13, P755, DOI 10.1007/BF02229161; RAPPORT RL, 1972, EPILEPSIA, V13, P295; RAPPORT RL, 1973, J NEUROSURG, V38, P159, DOI 10.3171/jns.1973.38.2.0159; RISH BL, 1973, J NEUROSURG, V38, P155, DOI 10.3171/jns.1973.38.2.0155; SERVIT Z, 1981, EPILEPSIA, V22, P315, DOI 10.1111/j.1528-1157.1981.tb04115.x; Temkin N R, 1991, Neurosurg Clin N Am, V2, P425; WEISS GH, 1986, ARCH NEUROL-CHICAGO, V43, P771, DOI 10.1001/archneur.1986.00520080019013; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231	23	14	14	0	0	JOHANN AMBROSIUS BARTH VERLAG	HEIDELBERG	IM WEIHER 10, D-69121 HEIDELBERG, GERMANY	0044-4251			ZBL NEUROCHIR	Zent.bl. Neurochir.		1996	57	4					190	195					6	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WG715	WOS:A1996WG71500003	9133148				2022-02-06	
J	Schupp, W				Schupp, W			A concept for treatment, rehabilitation and care of neurological and neurosurgical patients in Germany	NERVENARZT			German	Article						neurological rehabilitation; concept of phases; neurorehabilitational; needs; delivery and chain of services		The German medical service and social support network for patients with neurological diseases and disabilities are publicly criticized as inadequate. However, the German social laws give everybody the legal right to be admitted not only for acute medical treatment but also for rehabilitation measures if they are going to be disabled and at risk of becoming dependent on care or of losing the ability to work. Rehabilitation beginning in the early stage of illness is required. Institutions are now being built up to close the gap between acute medical treatment and the beginning of comprehensive rehabilitation, especially in those neurologically severely disabled patients who need ''rehabilitation before care''. As a basis for planning to improve the situation, a study group set up by the German Pension Insurance Association (Verband Deutscher Rentenversicherer) has developed the following concept of phases in neurological and neurosurgical treatment, rehabilitation and care. The aims and tasks of each phase are defined by the patient's functional status and requirements for recovery: 1. Acute medical treatment and care in intensive care units or normal clinical wards; 2. Early rehabilitation of patients who are not really conscious or cooperative and need intermediate care services should complications arise (''early rehabilitation''); 3. Rehabilitation of patients who are conscious and able to cooperate but depend upon care for functions in activities of daily living (ADL) (''comprehensive'' or ''post-primary rehabilitation''); 4. Rehabilitation of patients who are independent in ADL functions but need comprehensive treatment for further recovery (''medical rehabilitation'' in a traditional sense); 5. Institutional or outpatient rehabilitational aftercare for vocational and/or social reintegration (''aftercare''); 6. Private or institutional care aimed at maintaining the patients' functional status (''permanent care''). Patients with severe traumatic brain injury or cerebral hypoxia often require phase B care, while those who have had a stroke and those with some other neurological diseases (e.g. multiple sclerosis) often require institutions offering phase C rehabilitation. Acute treatment, rehabilitation, care and aftercare must be connected as a chain of services. Problems of sharing the costs among the different parts of the German social insurance system has hitherto led to gaps in that chain.			Schupp, W (corresponding author), FACHKLIN ENZENSBERG,NEUROL & NEUROPSYCHOL ABT,HOHENSTR 56,D-87629 HOPFEN AM SEE,GERMANY.						BAHR E, 1994, HIRNVERLETZTER 2, P20; BAHR E, 1994, HIRNVERLETZER 1, P26; BULAU P, 1994, NERVENARZT, V65, P836; FRIES W, 1993, GESUNDHEITSWESEN, V55, pR27; GARNER C, 1994, NERVENARZT, V65, P361; GARNER C, 1995, NERVENARZT, V66, P462; GARNER C, 1994, PHYS MED REHAB KUROR, V4, P220; GRASSEL E, 1994, DEUT MED WOCHENSCHR, V119, P501, DOI 10.1055/s-2008-1058722; HAUSSLER B, 1995, IN PRESS SCHLAGANFAL; JANZIK HH, 1993, SPEKTRUM NEUROREHABI, P121; JANZIK HH, 1992, STANDARDS NEUROLOGIS; JORK K, 1993, AKTUELLE TRENDS REHA, V2, P50; KAPPOS L, 1992, NERVENARZT, V63, P581; KIRCHBERGER S, 1993, SPEKTRUM NEUROREHABI, P91; KUGELGEN B, 1993, NOT, V3, P22; LEGNER R, 1993, GESUNDHEITSWESEN, V55, pR27; MAASSEN HJ, 1990, GESETZLICHE KRANKENV; MAYER K, 1993, SPEKTRUM NEUROREHABI, P87; MUFFELMANN B, 1995, NERVENARZT, V66, P111; OSTERMANN K, 1993, DTSCH RENTENVERS, V4, P284; SCHLENCK KJ, 1993, DRV SCHRIFTEN, V2, P57; SCHONLE PW, 1995, IN PRESS REHABILITAT; SCHONLE PW, 1993, SPEKTRUM NEUROREHABI, P133; Schupp W, 1991, Rehabilitation (Stuttg), V30, P23; SCHUPP W, 1995, IN PRESS NERVENHEILK; SCHUPP W, 1992, VERHANDLUNGEN DTSCH, V7, P867; SCHUPP W, 1994, DTSCH RENTENVERS, V11, P797; SCHUPP W, 1994, BAYER ARZTEBL, V9, P322; SCHUPP W, 1995, IN PRESS REHABILITAT; SCHUPP W, 1994, KRANKENGYMNASTIK, V46, P1310; Voss A, 1993, SPECTRUM NEUROREHABI, P112; 1993, EMPFEHLUNGEN ARBEITS; 1992, VDR STATISTIK REHABI, V101; 1995, INFORMATIONSSCHRIFT; 1994, DTSCH RENTENVERS, V2, P111; [No title captured]; 1994, REHABILITATION BE 3B, P264	37	14	14	0	3	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0028-2804			NERVENARZT	Nervenarzt	DEC	1995	66	12					907	914					10	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	TM475	WOS:A1995TM47500007	8584075				2022-02-06	
J	THEODOROS, DG; MURDOCH, BE; STOKES, PD				THEODOROS, DG; MURDOCH, BE; STOKES, PD			VARIABILITY IN THE PERCEPTUAL AND PHYSIOLOGICAL FEATURES OF DYSARTHRIA FOLLOWING SEVERE CLOSED-HEAD INJURY - AN EXAMINATION OF 5 CASES	BRAIN INJURY			English	Article							VERBAL IMPAIRMENT; PARKINSONIAN DYSARTHRIA; TRAUMATIC MUTISM; SPEECH DISORDERS; SPEAKERS; RECOVERY	The perceptual and physiological features of the dysarthric speech of five severely closed-head-injured (CHI) subjects were examined in a case-by-case analysis. The five male CHI subjects included in the study were selected to reflect the range of severity and types of dysarthria evident in the CHI population. The perceptual profiles of each subject consisted of the findings of a perceptual speech analysis, the Frenchay Dysarthria Assessment (FDA) and the Assessment of the Intelligibility of Dysarthric Speakers (ASSIDS). The subjects' physiological profiles included the results of instrumental assessments of the respiratory, laryngeal, velopharyngeal and articulatory subsystems of the speech-production mechanism. The case studies highlighted the variability among the individual subjects with respect to the location, physiological nature, and severity of the impairment in their speech-production mechanisms. In addition, the interdependence of the various speech subsystems in determining speech outcome, the presence of differential subsystem impairment in dysarthria following CHI, and the varied therapeutic requirements ofthe individual subjects were identified. Clinically, the case studies highlighted the importance of developing individual treatment programmes based on comprehensive perceptual and physiological evaluations of the speech mechanism in each CHI subject with dysarthric speech.	UNIV QUEENSLAND,DEPT SPEECH & HEARING,MOTOR SPEECH RES UNIT,BRISBANE,QLD 4072,AUSTRALIA				Theodoros, Deborah/F-1362-2010; Murdoch, Bruce E/C-1397-2012				ARONSON AE, 1968, J SPEECH HEAR DISORD, V33, P203, DOI 10.1044/jshd.3303.203; ARONSON AE, 1986, J SPEECH HEAR DISORD, V33, P219; BASSICH CJ, 1986, J SPEECH HEAR DISORD, V51, P125, DOI 10.1044/jshd.5102.125; BELLAIRE K, 1986, J COMMUN DISORD, V19, P271, DOI 10.1016/0021-9924(86)90033-X; BLAUSTEIN S, 1983, J COMMUN DISORD, V16, P157, DOI 10.1016/0021-9924(83)90046-1; BRANCEWICZ TM, 1989, J SPEECH HEAR RES, V32, P837, DOI 10.1044/jshr.3204.837; Brown J.R., 1975, MOTOR SPEECH DISORDE; Bzoch K. R., 1989, COMMUNICATIVE DISORD, V3rd, P137; FEX S, 1992, J VOICE, V6, P155, DOI 10.1016/S0892-1997(05)80130-4; FROKJAERJENSEN B, C INT ASS LOGOPEDICS; HANSON DG, 1983, ANN OTO RHINOL LARYN, V92, P413, DOI 10.1177/000348948309200501; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HARTMAN DE, 1984, ANN OTO RHINOL LARYN, V93, P57, DOI 10.1177/000348948409300114; HIROSE H, 1986, FOLIA PHONIATR, V38, P61, DOI 10.1159/000265824; HIROSE H, 1982, FOLIA PHONIATR, V34, P210, DOI 10.1159/000265651; HOODIN RB, 1989, FOLIA PHONIATR, V41, P249, DOI 10.1159/000265976; KENT R, 1978, J SPEECH HEAR DISORD, V42, P353; KENT RD, 1982, BRAIN LANG, V15, P259, DOI 10.1016/0093-934X(82)90060-8; LABLANCE G R, 1991, Ear Nose and Throat Journal, V70, P691; LEVIN HS, 1981, ACQUIRED APHASIA, P427; Ludlow C., 1983, CLIN DYSARTHRIA, P121; MCCLEAN MD, 1987, J SPEECH HEAR RES, V30, P276, DOI 10.1044/jshr.3002.276; Moncur JP, 1974, MODIFYING VOCAL BEHA; Murdoch B. E., 1990, ACQUIRED SPEECH LANG; MURDOCH BE, 1993, BRAIN INJURY, V7, P295, DOI 10.3109/02699059309034956; NAJENSON T, 1978, SCAND J REHABIL MED, V10, P15; NETSELL R, 1975, J SPEECH HEAR DISORD, V40, P170, DOI 10.1044/jshd.4002.170; NETSELL R, 1969, J SPEECH HEAR DISORD, V34, P113, DOI 10.1044/jshd.3402.113; NETSELL R, 1979, ARCH PHYS MED REHAB, V60, P502; NETSELL R, 1989, RECENT ADV CLIN DYSA, P4; NETSELL R, 1984, SEMINARS SPEECH LANG, V5, P279; RUSK H, 1969, LATE EFFECTS HEAD IN, P327; Sarno M, 1985, SPEECH LANGUAGE EVAL, P323; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; Sherman D, 1954, J SPEECH HEAR DISORD, V19, P312, DOI 10.1044/jshd.1903.312; THEODOROS D, 1993, BRAIN INJURY, V7, P59, DOI 10.3109/02699059309008157; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1994, BRAIN INJURY, V8, P667, DOI 10.3109/02699059409151021; THEODOROS DG, IN PRESS BRAIN INJUR, V9; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VOGEL M, 1983, FOLIA PHONIATR, V35, P294, DOI 10.1159/000265705; VONCRAMON D, 1981, NEUROPSYCHOLOGIA, V19, P801, DOI 10.1016/0028-3932(81)90092-0; Weismer Gary., 1984, SEMIN SPEECH LANG, V5, P293, DOI [10.1055/s-2008-1064291, DOI 10.1055/S-2008-1064291]; ZIEGLER W, 1988, BRIT J DISORD COMMUN, V23, P215; [No title captured]	48	14	14	0	4	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	OCT	1995	9	7					671	696		10.3109/02699059509008225			26	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	RZ814	WOS:A1995RZ81400002	8680396				2022-02-06	
J	LYETH, BG; JIANG, JY; GONG, QZ; HAMM, RJ; YOUNG, HF				LYETH, BG; JIANG, JY; GONG, QZ; HAMM, RJ; YOUNG, HF			EFFECTS OF MU-OPIOID AGONIST AND ANTAGONIST ON NEUROLOGICAL OUTCOME FOLLOWING TRAUMATIC BRAIN INJURY IN THE RAT	NEUROPEPTIDES			English	Article							FLUID-PERCUSSION MODEL; CEREBRAL BLOOD-FLOW; BETA-FUNALTREXAMINE; ENDOGENOUS OPIOIDS; EXTRACELLULAR LEVELS; AMINO-ACIDS; RESPONSES; OPIATE; SCOPOLAMINE; GLUTAMATE	We examined the effects of an exogenous mu opioid agonist and antagonist on systemic physiology and neurological outcome following TBI in the rat. Experiment I: [D-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin (DAMGO) (0.1 nMol or 0.3 nMol in 5 mu l) (n = 10) or artificial CSF (n = 10) was administered 5 min prior to fluid-percussion brain injury (2.1 atmospheres). Motor performance was assessed on days 1-5 after TBI. The mu receptor agonist, DAMGO significantly reduced both beam-walking latency and body weight loss after injury (p < 0.05). DAMGO-treated rats (n = 5) did not differ from CSF-treated rats (n = 5) on either systemic arterial blood pressure or heart rate responses to injury. Experiment II: Beta-funaltrexamine (beta-FNA) (20.0 nMol in 5.0 mu l) (n = 10) or artificial CSF (n = 10) was administered (icv) to rats 5 min prior to fluid percussion brain injury (1.8 atmospheres). Motor performance was assessed on days 1-5 after TBI. The mu receptor antagonist, beta-FNA, significantly increased beam-walking latency after injury (p < 0.05). beta-FNA-treated rats (n = 5) did not differ from CSF-treated rats (n = 5) on either systemic arterial blood pressure or heart rate responses to injury. Experiment III: Neither beta-FNA nor DAMGO affected motor performance in uninjured rats. These results suggest that activation of mu opioid receptors by exogenous agonists may provide protection against deficits in motor performance produced by fluid percussion brain injury.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHOL,RICHMOND,VA 23298		LYETH, BG (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,RICHMOND,VA 23298, USA.			Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 29995] Funding Source: Medline		ADAMS JU, 1990, J PHARMACOL EXP THER, V255, P1027; BRADLEY PB, 1984, BRIT J PHARMACOL, V83, P763, DOI 10.1111/j.1476-5381.1984.tb16231.x; CHOU C-L, 1991, Society for Neuroscience Abstracts, V17, P722; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GLOBUS MYT, 1991, J NEUROCHEM, V57, P470, DOI 10.1111/j.1471-4159.1991.tb03775.x; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; HAYES RL, 1988, J NEUROTRAUM, V5, P287; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; LAPCHAK P A, 1987, Society for Neuroscience Abstracts, V13, P1192; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; LYETH BG, 1992, J NEUROTRAUM, V9, pS463; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MARTIN TJ, 1993, J PHARMACOL EXP THER, V267, P506; MCINTOSH T K, 1988, Society for Neuroscience Abstracts, V14, P1152; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; NICOLL RA, 1977, P NATL ACAD SCI USA, V74, P2584, DOI 10.1073/pnas.74.6.2584; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; SIMONDS WF, 1988, ENDOCR REV, V9, P200, DOI 10.1210/edrv-9-2-200; VINK R, 1991, AM J PHYSIOL, V261, pR1527, DOI 10.1152/ajpregu.1991.261.6.R1527; VINK R, 1990, J NEUROSCI, V10, P3524; WARD SJ, 1982, EUR J PHARMACOL, V80, P377, DOI 10.1016/0014-2999(82)90083-8; WARD SJ, 1982, J PHARMACOL EXP THER, V220, P494; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAO JJ, 1988, NEUROPEPTIDES, V12, P177, DOI 10.1016/0143-4179(88)90051-0; ZIMMERMAN RS, 1990, NEUROSURGERY, V26, P764, DOI 10.1227/00006123-199005000-00005	40	14	15	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH, MIDLOTHIAN, SCOTLAND EH1 3AF	0143-4179			NEUROPEPTIDES	Neuropeptides	JUL	1995	29	1					11	19		10.1016/0143-4179(95)90051-9			9	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	RH553	WOS:A1995RH55300002	7566508				2022-02-06	
J	HAMM, RJ; PIKE, BR; PHILLIPS, LL; ODELL, DM; TEMPLE, MD; LYETH, BG				HAMM, RJ; PIKE, BR; PHILLIPS, LL; ODELL, DM; TEMPLE, MD; LYETH, BG			IMPAIRED GUSTATORY NEOPHOBIA FOLLOWING TRAUMATIC BRAIN INJURY IN RATS	JOURNAL OF NEUROTRAUMA			English	Article						AMYGDALA; GUSTATORY NEOPHOBIA; HIPPOCAMPUS; RATS; TRAUMATIC BRAIN INJURY	HEAD-INJURY; AMYGDALA; MEMORY; HIPPOCAMPUS; DEFICITS; LESIONS; SITES	To investigate the function of the amygdala following traumatic brain injury (TBI), rats were tested on a gustatory neophobia task that is sensitive to amygdala and hippocampaI damage. Rats were either injured at a moderate level of fluid percussion injury (2.1 atm) or surgically prepared but not injured (sham-injury). Seven days after injury (n = 8) or sham injury (n = 9), rats were habituated to the testing chamber without food items present for 30 min. All rats were then food deprived. Twenty-four hours later, rats were placed in the testing chamber for 30 min and allowed to eat freely from four dishes of different foods: rat chow, raisins, potatoes, and cookies. Results showed that injured and sham-injured rats did not differ in their ability to find hidden food, suggesting that TBI does not produce an enduring impairment of olfaction. There was also no difference in the total amount of food eaten between injured and sham groups (p > 0.05). The percentage of each type of food consumed did differ between the two groups with sham controls consuming more familiar food (rat chow) compared to the unfamiliar foods (p < 0.01). The injured animals distributed their eating evenly among the four foods with no particular preference for any one food (p > 0.05). This pattern of eating behavior in injured animals is similar to animals that have lesions to both the hippocampus and amygdala (Sutherland and McDonald, 1990). Therefore, the results of this experiment suggest that, in addition to the hippocampus, the amygdala may also contribute to the behavioral changes observed following TBI.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV NEUROSURG,RICHMOND,VA 23284		HAMM, RJ (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHOL,POB 842018,RICHMOND,VA 23284, USA.			Lyeth, Bruce/0000-0003-4811-1474	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-12857] Funding Source: Medline		Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; Delahunty T. M., 1993, Society for Neuroscience Abstracts, V19, P1879; DELAHUNTY TM, 1992, BRAIN RES, V594, P307, DOI 10.1016/0006-8993(92)91140-A; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; GREENAMYRE JT, 1985, J PHARMACOL EXP THER, V233, P254; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, BEHAV BRAIN RES, V59, P169; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KESNER RP, 1988, NEUROBIOL AGING, V9, P609, DOI 10.1016/S0197-4580(88)80122-2; KESNER RP, 1991, ACTIVATION ACQUISITI, P263; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NACHMAN M, 1974, J COMP PHYSIOL PSYCH, V80, P622; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; OLTON DS, 1978, BRAIN RES, V233, P241; RAY M H, 1991, Society for Neuroscience Abstracts, V17, P167; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROLLS ET, 1973, J COMP PHYSIOL PSYCH, V83, P248, DOI 10.1037/h0034414; ROSEN JB, 1988, PHYSIOL BEHAV, V44, P117, DOI 10.1016/0031-9384(88)90354-X; SARTER M, 1985, BEHAV NEUROSCI, V99, P342, DOI 10.1037/0735-7044.99.2.342; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SUTHERLAND RJ, 1990, BEHAV BRAIN RES, V37, P57, DOI 10.1016/0166-4328(90)90072-M; Wenk G. L., 1987, ANIMAL MODELS DEMENT, P81, DOI [10.1016/j.expneurol.2005.06.020, DOI 10.1016/J.EXPNEUROL.2005.06.020]	31	14	15	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	1995	12	3					307	314		10.1089/neu.1995.12.307			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RM331	WOS:A1995RM33100008	7473805				2022-02-06	
J	RICHARDSON, JTE; CHAN, RCB				RICHARDSON, JTE; CHAN, RCB			THE CONSTITUENT STRUCTURE OF SUBJECTIVE MEMORY QUESTIONNAIRES - EVIDENCE FROM MULTIPLE-SCLEROSIS	MEMORY			English	Article; Proceedings Paper	5th Conference of the European-Society-for-Cognitive-Psychology	SEP 12-16, 1992	PARIS, FRANCE	European Soc Cognit Psychol			EVERYDAY MEMORY; HEAD-INJURY; SELF-REPORT; NEUROPSYCHOLOGY; PERFORMANCE; FAILURES; SKILLS; SMQ	A number of different instruments have been devised for investigating individual differences in memory on the basis of subjective reports. One such questionnaire was mailed to individuals on a register of patients with multiple sclerosis, a condition that is known to be associated with objective impairments in cognition and memory. A similar questionnaire was enclosed to be completed about each patient by a close relative. The patients' and relatives' responses were found to share a factor structure identifying memory problems in five areas: receptive communication, route finding, absent-mindedness, face recognition, and expressive communication. These were dominated by a single second-order factor representing st global subjective memory impairment. There were some minor differences between the patients and relatives in their factor scores, but there was generally a high degree of concordance in their responses.			RICHARDSON, JTE (corresponding author), BRUNEL UNIV,DEPT HUMAN SCI,UXBRIDGE UB8 3PH,MIDDX,ENGLAND.			Richardson, John/0000-0002-6267-0603			Babbie E., 1973, SURVEY RES METHODS; BADDELEY A, 1982, ALZHEIMERS DISEASE R, P141; BENNETTLEVY J, 1980, BRIT J SOC CLIN PSYC, V19, P177, DOI 10.1111/j.2044-8260.1980.tb00946.x; BENNETTLEVY J, 1980, CORTEX, V16, P543, DOI 10.1016/S0010-9452(80)80002-5; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Cattell R. B., 1965, STUD PSYCHOL-MADRID, P223; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; CHAFFIN R, 1985, HUM LEARN, V4, P233; CLIFF N, 1988, PSYCHOL BULL, V103, P276, DOI 10.1037/0033-2909.103.2.276; COMREY AL, 1973, FIRST COURSE FACTOR; Corcoran R, 1992, Seizure, V1, P37, DOI 10.1016/1059-1311(92)90053-4; FISCHER JS, 1989, MENTAL DISORDERS COG, P39; Gilewski M.J., 1986, CLIN MEMORY ASSESSME, P93, DOI [10.1037/10057-008, DOI 10.1037/10057-008]; GRANT I, 1989, MENTAL DISORDERS COG, P17; Herrmann D.J., 1978, PRACTICAL ASPECTS ME, V2, P35; Herrmann D. J., 1984, EVERYDAY MEMORY ACTI, P133; HERRMANN DJ, 1982, PSYCHOL BULL, V92, P434, DOI 10.1037/0033-2909.92.2.434; HERRMANN DJ, IN PRESS EFFECTS MED; HERRMANN DJ, 1990, SELF DIRECTEDNESS CA, P199; HERTZOG C, 1989, DEV PSYCHOL, V25, P687, DOI 10.1037/0012-1649.25.5.687; HICKOX A, 1992, HDB NEUROPSYCHOLOGIC, P103; KAPUR N, 1983, BRIT J PSYCHOL, V74, P409, DOI 10.1111/j.2044-8295.1983.tb01872.x; Kidder L. H, 1981, RES METHODS SOCIAL R; Martin M., 1984, EVERYDAY MEMORY ACTI, P173; Maylor E. A., 1993, ADULT INFORMATION PR, P529; MCMILLAN TM, 1984, CORTEX, V20, P333, DOI 10.1016/S0010-9452(84)80002-7; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; MONTANELLI RG, 1976, PSYCHOMETRIKA, V41, P341, DOI 10.1007/BF02293559; Morris P. E, 1984, EVERYDAY MEMORY ACTI, P153; NORUSIS M, 1986, SPSSIPC ADV STATISTI; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1986, J CLIN EXP NEUROPSYC, V8, P503, DOI 10.1080/01688638608405173; RAO SM, 1989, NEUROLOGY, V39, P161, DOI 10.1212/WNL.39.2.161; ROSS M, 1989, PSYCHOL REV, V96, P341, DOI 10.1037/0033-295X.96.2.341; SEHULSTER JR, 1981, MEM COGNITION, V9, P263, DOI 10.3758/BF03196960; SUNDERLAND A, 1986, J GERONTOL, V41, P376, DOI 10.1093/geronj/41.3.376; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; Sunderland A, 1984, EVERYDAY MEMORY ACTI, P191; [No title captured]; [No title captured]; [No title captured]	42	14	14	0	0	LAWRENCE ERLBAUM ASSOC LTD	HOVE	27 PALMEIRA MANSIONS CHURCH RD, HOVE, E SUSSEX, ENGLAND BN3 2FA	0965-8211			MEMORY	Memory	JUN	1995	3	2					187	200		10.1080/09658219508258965			14	Psychology, Experimental	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Psychology	RG094	WOS:A1995RG09400004	7796304				2022-02-06	
J	SPIKMAN, JM; BERG, IJ; DEELMAN, BG				SPIKMAN, JM; BERG, IJ; DEELMAN, BG			SPARED RECOGNITION CAPACITY IN ELDERLY AND CLOSED-HEAD-INJURY SUBJECTS WITH CLINICAL MEMORY DEFICITS	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article								This study describes the performance of three groups of subjects on a pictorial forced-recognition task, the Hundred Pictures Test. The aim was to determine whether subjects with memory deficits (elderly and closed-head-injured subjects) would perform as well as healthy young subjects, both on immediate and very long-term recognition. The results indicate that memory for complex meaningful pictures is spared in subjects with an otherwise impaired memory, and that despite increasing forgetting rates with increasing retention intervals (up to 27 weeks), still no differences are found between performance of these subjects and healthy young controls. It will be discussed how this result might be interpreted.	UNIV GRONINGEN,DEPT NEUROPSYCHOL,GRONINGEN,NETHERLANDS					Spikman, Jacoba/0000-0002-6477-0763			BERG IJ, 1993, THESIS STATE U GRONI; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; BROWN J, 1977, Q J EXP PSYCHOL, V29, P461, DOI 10.1080/14640747708400622; Craik FI., 1986, HUMAN MEMORY COGNITI, V5, P409; CRAIK FIM, 1987, J EXPT PSYCHOL LEARN, V13, P1; Deelman B. G., 1980, NEUROPSYCHOLOGIE NED, P253; GOLDSTEIN AG, 1970, PERCEPT PSYCHOPHYS, V9, P237; HUPPERT FA, 1989, NEUROPSYCHOLOGIA, V27, P849, DOI 10.1016/0028-3932(89)90008-0; HUPPERT FA, 1978, NATURE, V275, P317, DOI 10.1038/275317a0; Lawton M. P, 1991, ANN REV GERONTOLOGY, V11, P1; NICKERSON RS, 1968, PSYCHON SCI, V11, P58, DOI 10.3758/BF03330991; *RIJKS BUR, 1952, CLASS BER NAAR HUN O; SALTHOUSE TA, 1982, ADULT COGNITION; SCHACTER DL, 1986, J CLIN EXP NEUROPSYC, V8, P727, DOI 10.1080/01688638608405192; SHEPARD RN, 1967, J VERB LEARN VERB BE, V6, P156, DOI 10.1016/S0022-5371(67)80067-7; STANDING L, 1970, PSYCHON SCI, V19, P73, DOI 10.3758/BF03337426; Verhage F, 1964, INTELLIGENTIE LEEFTI; Warrington E, 1984, RECOGNITION MEMORY T, V1; WISEMAN S, 1974, AM J PSYCHOL, V87, P675, DOI 10.2307/1421974; ZOMEREN AH, 1990, HDB CLIN NEUROLOGY, V13, P397	20	14	14	0	1	SWETS ZEITLINGER BV	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB	1995	17	1					29	34		10.1080/13803399508406578			6	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	QJ150	WOS:A1995QJ15000004	7608299				2022-02-06	
J	ASGEIRSSON, B; GRANDE, PO; NORDSTROM, CH				ASGEIRSSON, B; GRANDE, PO; NORDSTROM, CH			THE LUND CONCEPT OF POSTTRAUMATIC BRAIN EDEMA THERAPY	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article; Proceedings Paper	23rd Congress of the Scandinavian-Society-of-Anaesthesiologists	JUN 12-16, 1995	REYKJAVIK, ICELAND	Scandinavian Soc Anaesthesiologists			INTRACRANIAL-PRESSURE; HEAD-INJURY	A new therapy of post-traumatic brain oedema has recently been introduced into clinical practice at the University Hospital of Lund, Sweden (1). This therapy is based on basal physiological principles, presuming that an important part of post-traumatic brain swelling is due to extracellular oedema, in turn caused by disturbance of the normal volume regulation of the brain. Thus, the aim of therapy is to prevent brain herniation by keeping intracranial pressure (ICP) at a safe level until the normal volume regulating mechanisms of the brain, namely the semi-permeable blood-brain barrier (BBB) and cerebrovascular autoregulation, have been restored. Tn clinical practice, this concept has dramatically improved outcome in severely head injured patients, when compared to historical control groups.	LUND UNIV,DEPT NEUROSURG,LUND,SWEDEN; LUND UNIV,DEPT ANAESTHESIA & INTENS CARE,LUND,SWEDEN		ASGEIRSSON, B (corresponding author), UNIV LUND HOSP,DEPT ANAESTHESIA & INTENS CARE,S-22185 LUND,SWEDEN.						ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P567, DOI 10.1007/BF01705723; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P347, DOI 10.1111/j.1399-6576.1995.tb04075.x; ASGEIRSSON B, 1995, IN PRESS ACTA ANAEST; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; CANCIO LC, 1994, RESUSCITATION, V28, P9, DOI 10.1016/0300-9572(94)90049-3; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; GRANDE PO, 1989, INTENS CARE MED, V15, P523, DOI 10.1007/BF00273564; Guyton AC, 1991, TXB MED PHYSL, V8th; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; HAYASHI Y, 1993, BRIT J ANAESTH, V71, P108, DOI 10.1093/bja/71.1.108; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; PAPPIUS HM, 1989, IMPLICATIONS BLOOD B, P293; ROTH B, 1993, INTENS CARE MED, V19, P111, DOI 10.1007/BF01708372; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; SCHALEN W, 1991, ACTA ANAESTH SCAND, P113; SIMARD JM, 1989, AM J CARDIOL, V63, pC32, DOI 10.1016/0002-9149(89)90403-7; TODD NV, 1990, ACT NEUR S, V51, P296; TRANMER BI, 1989, NEUROSURGERY, V25, P173, DOI 10.1227/00006123-198908000-00004	20	14	15	1	2	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.		1995	39			105			103	106		10.1111/j.1399-6576.1995.tb04285.x			4	Anesthesiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	RN486	WOS:A1995RN48600028					2022-02-06	
J	CRONQVIST, AKA; KALLMAN, P; TURESSON, I; BRAHME, A				CRONQVIST, AKA; KALLMAN, P; TURESSON, I; BRAHME, A			VOLUME AND HETEROGENEITY DEPENDENCE OF THE DOSE-RESPONSE RELATIONSHIP FOR HEAD AND NECK TUMORS	ACTA ONCOLOGICA			English	Article							RADIATION-THERAPY; NASOPHARYNGEAL CARCINOMA; EPIDERMOID CARCINOMA; TIME; OPTIMIZATION; RADIOTHERAPY; MANAGEMENT; INJURY; TUMORS; CORD	Based on the Poisson statistics of cell kill a model for the response of heterogeneous tumours to non-uniform dose delivery have been developed. The five parameters required to characterize the response are the 50% response dose, D-50, the normalized dose-response gradient, gamma, the tumour heterogeneity factor, h, the relative volume, upsilon and the extra daily dose required to counteract the tumour cell proliferation, delta. The model has been fitted to data from a number of clinical investigations to allow the derivation of clinically relevant radiation response parameters for head and neck tumours. The D-50 value for T2 larynx cancers is 59.9 Gy in 41 days with a relative standard deviation of 2.1 Gy and the gamma value is 2.9 with a relative standard deviation of 0.3. The value of delta, which is most consistent with the clinical data for laryngeal tumours, is 0.35 Gy/day and this value should be used if the treatment time is changed from the 41 days normalization. The heterogeneity factor, h, is close to zero for laryngeal tumours which indicates that their response is basically governed by Poisson statistics. Nasopharyngeal tumours, on the other hand, exhibit h values around 0.2 which indicates that these tumours are more heterogeneous in their internal organization and so are their responses to radiation.	KAROLINSKA INST,DEPT MED RADIAT PHYS,STOCKHOLM,SWEDEN; UNIV STOCKHOLM,STOCKHOLM,SWEDEN; GOTHENBURG UNIV,SAHLGRENS HOSP,DEPT ONCOL,S-41345 GOTHENBURG,SWEDEN								AGREN A, 1990, INT J RADIAT ONCOL, V19, P1077, DOI 10.1016/0360-3016(90)90037-K; AGREN AK, 1994, IN PRESS MODELLING C; ARISTIZABAL SA, 1972, RADIOLOGY, V130, P419; BEDWINEK JM, 1980, CANCER, V45, P2725, DOI 10.1002/1097-0142(19800601)45:11<2725::AID-CNCR2820451105>3.0.CO;2-1; BRAHME A, 1987, ACTA ONCOL, V26, P377, DOI 10.3109/02841868709104364; BRAHME A, 1984, ACTA RADIOL ONCOL, V23, P379, DOI 10.3109/02841868409136037; BRAHME A, 1995, RAD THERAPY PHYSICS; BRAHME A, 1994, ION BEAM THERAPY; Brahme A, 1988, ACTA ONCOL S, V1, P5; COHEN L, 1960, AMER J ROENTGENOL RA, V84, P741; COHEN L, 1982, INT J RADIAT ONCOL, V8, P2173, DOI 10.1016/0360-3016(82)90565-X; DUTREIX J, 1988, RADIOTHER ONCOL, V11, P239, DOI 10.1016/0167-8140(88)90006-0; HARWOOD AR, 1983, INT J RADIAT ONCOL, V9, P311, DOI 10.1016/0360-3016(83)90289-4; HENDRY JH, 1992, RADIOTHER ONCOL, V25, P308, DOI 10.1016/0167-8140(92)90252-P; HENDRY JH, 1994, RADIOTHER ONCOL, V31, P14, DOI 10.1016/0167-8140(94)90409-X; HJELMHANSEN M, 1979, ACTA RADIOL ONCOL, V18, P385, DOI 10.3109/02841867909128225; JENKIN RDT, 1981, CANCER, V47, P360, DOI 10.1002/1097-0142(19810115)47:2<360::AID-CNCR2820470225>3.0.CO;2-3; KALLMAN P, 1992, INT J RADIAT BIOL, V62, P249, DOI 10.1080/09553009214552071; KIM JC, 1978, CANCER, V42, P1114, DOI 10.1002/1097-0142(197809)42:3<1114::AID-CNCR2820420312>3.0.CO;2-3; LINDBORG L, 1990, RADIAT RES, V124, P23; METZ CE, 1982, INT J RADIAT ONCOL, V8, P1185, DOI 10.1016/0360-3016(82)90066-9; ROBERTSON AG, 1993, EUR J CANCER, V29A, P501, DOI 10.1016/S0959-8049(05)80139-X; SHUKOVSKY LJ, 1970, AMER J ROENTGENOL RA, V108, P27, DOI 10.2214/ajr.108.1.27; SLEVIN NJ, 1992, RADIOTHER ONCOL, V24, P215, DOI 10.1016/0167-8140(92)90226-K; SODERSTROM S, 1995, INT J RADIAT ONCOL B; STEWART JG, 1975, LARYNGOSCOPE, V85, P1107, DOI 10.1288/00005537-197507000-00001; THAMES HD, 1980, BRIT J CANCER, V41, P35; THAMES HD, 1992, INT J RADIAT ONCOL, V22, P241, DOI 10.1016/0360-3016(92)90039-K; TILIKIDIS A, 1994, ACTA ONCOL, V33, P457, DOI 10.3109/02841869409098443; TOKARS RP, 1979, INT J RADIAT ONCOL, V5, P1741, DOI 10.1016/0360-3016(79)90555-8; TRAVIS EL, 1987, INT J RADIAT ONCOL, V13, P283, DOI 10.1016/0360-3016(87)90141-6; TURESSON I, 1992, CLIN RATIONALE HIGH; WITHERS HR, 1988, ACTA ONCOL, V27, P131, DOI 10.3109/02841868809090333; WITHERS HR, 1992, PRINCIPLES PRACTICE, P67; WOLBARST AB, 1984, INT J RADIAT ONCOL, V10, P741, DOI 10.1016/0360-3016(84)90305-5; YAN JH, 1989, INT J RADIAT ONCOL, V16, P1465, DOI 10.1016/0360-3016(89)90950-4	36	14	14	0	0	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0284-186X			ACTA ONCOL	Acta Oncol.		1995	34	6					851	860		10.3109/02841869509127196			10	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	RZ612	WOS:A1995RZ61200022		Bronze			2022-02-06	
J	YAKUBU, A; MABOGUNJE, OA				YAKUBU, A; MABOGUNJE, OA			SKIN-CANCER IN ZARIA, NIGERIA	TROPICAL DOCTOR			English	Article								Skin cancer from 775 patients in the savannah showed a preponderance of squamous cell carcinoma (SCC) of the leg related to neglected, poorly managed and chronic ulcers or scars from burns or injuries. SCC of the head and neck had no predisposing factor. Malignant melanoma overwhelmingly affected the feet, dermatofibrosarcoma affected the trunk and Kaposi sarcoma affected the limbs. Basal cell carcinoma (BCC) comprised only 2% of all skin cancers. The 18 albino patients had a higher frequency of both SCC and BCC mostly on the head and neck. Excisional surgery was generally effective, the wounds being closed primarily or by means of flaps and skin grafts. However, 98 patients required amputation below the knee for tibial involvement by SCC. The prognosis and health care costs of skin cancer will only be improved if burns and injuries are adequately treated.	AHMADU BELLO UNIV HOSP,DEPT SURG,ZARIA,NIGERIA									0	14	14	0	3	ROYAL SOC MEDICINE SERVICES LTD	LONDON	1 WIMPOLE STREET, LONDON, ENGLAND W1M 8AE	0049-4755			TROP DOCT	Trop. Dr.		1995	25			1			63	67		10.1177/00494755950250S120			5	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Tropical Medicine	QH900	WOS:A1995QH90000020	7879275				2022-02-06	
J	DONALD, PJ				DONALD, PJ			FRONTOBASAL APPROACH FOR TRAUMA AND TUMOR	MINIMALLY INVASIVE NEUROSURGERY			English	Article						FRONTOBASAL SURGERY; FRONTAL SINUS TRAUMA; SINUS MALIGNANCY		The potential for remediation of a host of varied disease processes afflicting the skull base has been increasingly realized over the past two decades, Advances in medical technology, the development of new approaches, and most importantly the close cooperation of the head and neck surgeon and the neurological surgeon have made this possible, Surgeons are attempting to diminish the injury to normal uninvolved structures while at the same time maximizing exposure and enabling rectification of the disease or disorder, This is especially pertinent in a number of frontobasal approaches used in anterior craniofacial surgery, The osteoplastic flap approach to the posterior wall of the frontal sinus to repair small cerebrospinal fluid leaks and manage posterior wall fractures saves the patient a larger anterior craniotomy and brain retraction. Cranialization of the frontal sinus in comminuted through-and-through fractures allows for removal of devitalized brain, dural repair, and safe management of the frontal sinus, The lateral rhinotomy medial maxillectomy-ethmosphenoidectomy approach coupled with either an osteoplastic flap of the frontal sinus or a low limited craniotomy is an excellent approach for resection of tumors encroaching on the anterior skull base. Even malignancies of this region can be completely excised with adequate margins, yet produce minimal to no facial aesthetic distortion, Moreover, larger tumors requiring a more extensive lip-splitting incision and total maxillectomy with orbital exenteration can often anticipate minimal deformity, especially with good prosthetic rehabilitation. In the resection of aggressive malignancies, techniques of ocular preservation and facial bone sparing have been developed with encouraging cosmetic results.	UNIV CALIF DAVIS,DEPT OTOLARYNGOL HEAD & NECK SURG,DAVIS,CA 95616; UNIV CALIF DAVIS,CTR SKULL BASE SURG,DAVIS,CA 95616								ALLIS A, 1979, LARYNGOSCOPE, V98, P557; DONALD PJ, 1979, OTOLARYNG HEAD NECK, V87, P557, DOI 10.1177/019459987908700502; DONALD PJ, 1978, LARYNGOSCOPE, V88, P225, DOI 10.1288/00005537-197802000-00002; GANDOUREDWARDS RF, 1993, HEAD NECK-J SCI SPEC, V15, P373, DOI 10.1002/hed.2880150502	4	14	16	0	0	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0942-6027			MINIM INVAS NEUROSUR	Minim. Invasive Neurosurg.	DEC	1994	37	2					37	41		10.1055/s-2008-1053446			5	Clinical Neurology; Neuroimaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RU576	WOS:A1994RU57600001	7882073				2022-02-06	
J	RICHARDSON, ED; SPRINGER, JA; VARNEY, NR; STRUCHEN, MA; ROBERTS, RJ				RICHARDSON, ED; SPRINGER, JA; VARNEY, NR; STRUCHEN, MA; ROBERTS, RJ			DICHOTIC-LISTENING IN THE CLINIC - NEW NEUROPSYCHOLOGICAL APPLICATIONS	CLINICAL NEUROPSYCHOLOGIST			English	Article							EAR EXTINCTION; MULTIPLE-SCLEROSIS; CEREBRAL MALARIA; CORPUS-CALLOSUM; PERFORMANCE	In the first part of this study, a simple dichotic word listening task was administered to 275 normal control subjects. Normative data demonstrated that age and gender both had significant effects on dichotic listening performance (i.e., females outperformed males, and younger adults did better than older adults). In the second part of this study, clinical observations on three patient populations (status--post closed-head injury, cerebral malaria survivors, and Parkinson Disease) demonstrated significantly poorer dichotic listening performance relative to controls. Overall, the results suggest that, when normative observations are systematically collected, dichotic listening tasks may become useful adjuncts to traditional neuropsychological assessments. Dichotic listening may be particularly useful in demonstrating cerebral dysfunction in a wider variety of neurologically impaired patients than has commonly been assumed.	UNIV CINCINNATI,CINCINNATI,OH 45221; YALE UNIV,SCH MED,NEW HAVEN,CT 06510; UNIV HOUSTON,HOUSTON,TX 77004; VET ADM MED CTR,IOWA CITY,IA 52240								ARBOIX A, 1990, ACTA NEUROL SCAND, V81, P507; BARTLETT EJ, 1987, BRAIN LANG, V32, P1, DOI 10.1016/0093-934X(87)90115-5; BLONDER LX, 1987, J CLIN EXP NEUROPSYC, V9, P20; BOUMA A, 1988, J CLIN EXP NEUROPSYC, V10, P709, DOI 10.1080/01688638808402809; DAMASIO H, 1979, NEUROLOGY, V29, P644, DOI 10.1212/WNL.29.5.644; Forrester ATW, 1920, LANCET, V1, P16; Hugdahl KE, 1988, HDB DICHOTIC LISTENI; JACOBSON JT, 1983, EAR HEARING, V4, P311, DOI 10.1097/00003446-198311000-00009; Jerger J, 1975, SCAND AUDIOL, V4, P147, DOI DOI 10.3109/01050397509043077; KIMURA D, 1961, CAN J PSYCHOLOGY, V15, P156, DOI 10.1037/h0083218; KREMEN WS, 1992, J NERV MENT DIS, V180, P89, DOI 10.1097/00005053-199202000-00004; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MOHR E, 1990, J CLIN EXP NEUROPSYC, V12, P235, DOI 10.1080/01688639008400970; MUSIEK F, 1983, MONOGRAPHS CONT AUDI, V4, P1; PUJOL J, 1991, NEUROPSYCHOLOGIA, V29, P177, DOI 10.1016/0028-3932(91)90019-5; RAO SM, 1989, ARCH NEUROL-CHICAGO, V46, P918, DOI 10.1001/archneur.1989.00520440114028; RISSE GL, 1989, ARCH NEUROL-CHICAGO, V46, P437, DOI 10.1001/archneur.1989.00520400097026; Roberts RJ, 1990, NEUROPSYCHOLOGY, V4, P65; ROBERTS RJ, 1990, J CLIN EXP NEUROPSYC, V12, P448, DOI 10.1080/01688639008400992; Sparks R, 1970, Cortex, V6, P249; Sparks R., 1968, CORTEX, V4, P3, DOI DOI 10.1016/S0010-9452(68)80009-7; SPICER KB, 1988, ARCH NEUROL-CHICAGO, V45, P429, DOI 10.1001/archneur.1988.00520280079019; SPRINGER JA, 1991, J NERV MENT DIS, V179, P459, DOI 10.1097/00005053-199108000-00002; SPRINGER SP, 1975, NEUROPSYCHOLOGIA, V13, P341, DOI 10.1016/0028-3932(75)90011-1; TORO G, 1978, ARCH NEUROL-CHICAGO, V35, P271, DOI 10.1001/archneur.1978.00500290017004; VERDUYN W H, 1992, Brain Injury, V6, P245, DOI 10.3109/02699059209029666; WILLIAMS SM, 1989, CORTEX, V25, P523, DOI 10.1016/S0010-9452(89)80067-X	28	14	14	0	2	SWETS ZEITLINGER BV	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	DEC	1994	8	4					416	428		10.1080/13854049408402044			13	Psychology, Clinical; Clinical Neurology; Psychology	Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	PX792	WOS:A1994PX79200005					2022-02-06	
J	ZIELINSKI, JJ				ZIELINSKI, JJ			MALINGERING AND DEFENSIVENESS IN THE NEUROPSYCHOLOGICAL ASSESSMENT OF MILD TRAUMATIC BRAIN INJURY	CLINICAL PSYCHOLOGY-SCIENCE AND PRACTICE			English	Article						MALINGERING; DEFENSIVENESS; NEUROPSYCHOLOGICAL ASSESSMENT; TRAUMATIC BRAIN INJURY	MINOR HEAD-INJURY; FAKING; MMPI; DEFICITS; SYMPTOMS; PROSPECTS; DISORDERS; SEQUELAE	A balanced approach to the detection of malingering and defensiveness in the neuropsychological assessment of mild traumatic brain injury (MTBI) is suggested, while genuine neurobehavioral and psychopathological sequelae are documented. The absence of neuroradiological evidence and heavy reliance on patient report and neuropsychological test data make malingering and defensiveness issues that are critical in forensic contexts and for the credibility of neuropsychology. Deficiencies in interview data collection and the relative strengths and weaknesses of the MMPI (Minnesota Multiphasic Personality Inventory) are reviewed. The potential independence of malingering and defensiveness and of MMPI and neuropsychological data are noted. The equivocal research on malingering is reviewed, with particular emphasis on assessment of memory deficits as one of the most common complaints in MTBI. Arguably, malingering is more similar to than different from other diagnoses, but it has not been so treated in clinical practice. The need for developing sophisticated malingering probes is acknowledged, but the quest for a single malingering test is criticized and preference given to approaches that rely on evaluating data patterns indicating malingering.									ADAMS KB, 1992, 27TH WORKSH COND ANN; Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; Alfano Dennis P, 1992, Clin Neuropsychol, V6, P134, DOI 10.1080/13854049208401850; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; ARKES HR, 1990, PROFESSIONAL PSYCHOL, V21, P3; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BERRY DTR, 1991, CLIN PSYCHOL REV, V11, P585, DOI 10.1016/0272-7358(91)90005-F; BIGLER ED, 1990, J CONSULT CLIN PSYCH, V58, P244, DOI 10.1037/0022-006X.58.2.244; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1987, J CLIN EXP NEUROPSYC, V9, P167, DOI 10.1080/01688638708405357; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BORNSTEIN RA, 1988, NEUROSURGERY, V23, P622, DOI 10.1227/00006123-198811000-00013; CICERONE KD, 1992, PHYSICAL MED REHABIL, V6, P129; Cullum C, 1991, FORENSIC NEUROPSYCHO, P141; Dahlstrom W. G., 1972, MMPI HDB, V1; DELIS D, 1987, CALIFORNIA VERBAL LE; DIAMOND R, 1988, INT J CLIN NEUROPSYC, V10, P35; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DIKMEN S, 1974, PERCEPT MOTOR SKILL, V39, P831, DOI 10.2466/pms.1974.39.2.831; DIKMEN S, 1977, J NERV MENT DIS, V165, P247, DOI 10.1097/00005053-197710000-00004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN S, 1974, J ABNORM PSYCHOL, V83, P675, DOI 10.1037/h0037473; DOERR HO, 1991, FORENSIC NEUROPSYCHO; EKMAN P, 1989, KIDS LIE PARENTS CAN; Evans RW., 1992, PROGNOSIS NEUROLOGIC, P97; FAUST D, 1990, J CONSULT CLIN PSYCH, V58, P248, DOI 10.1037/0022-006X.58.2.248; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; FAUST D, 1991, BRAIN DAMAGE CLAIMS; FINLAYSON MAJ, 1991, FORENSIC NEUROPSYCHO, P123; FRANZEN M D, 1990, Neuropsychology Review, V1, P247, DOI 10.1007/BF01112573; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; GASS CS, 1990, PSYCHOL ASSESSMENT J, V2, P175, DOI DOI 10.1037//1040-3590.2.2.175; GOEBEL RA, 1983, J CLIN PSYCHOL, V39, P731, DOI 10.1002/1097-4679(198309)39:5<731::AID-JCLP2270390515>3.0.CO;2-T; GRAHAM JR, 1991, J PERS ASSESS, V57, P264, DOI 10.1207/s15327752jpa5702_6; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOLOGI, V1, P59; GUILMETTE TJ, 1991, CLIN NEUROPSYCHOL, V5, P197; Hathaway S.R., 1943, MINNESOTA MULTIPHASI; HAYWARD L, 1987, AUST NZ J PSYCHIAT, V21, P87, DOI 10.3109/00048678709160904; Heaton R.K., 1981, WISCONSIN CARD SORTI; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; JONES JC, 1990, CLIN PSYCHOL REV, V10, P299, DOI 10.1016/0272-7358(90)90064-H; KAY T, 1992, NEUROPSYCHOLOGY, V4, P371; KOLB LC, 1987, AM J PSYCHIAT, V144, P989; KROPP PR, 1991, UNPUB CAPACITY PSYCH; Langs R., 1982, PSYCHOTHERAPY BASIC; Lee G. P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI DOI 10.1037/1040-3590.4.1.43; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Levin H.S., 1989, MILD HEAD INJURY; LEWIS M, 1993, LYING DECEPTION EVER; Loftus E. F., 1982, GS HALL LECTURES, P119; MACCIOCCHI SN, 1990, J CLIN PSYCHOL, V46, P628, DOI 10.1002/1097-4679(199009)46:5<628::AID-JCLP2270460514>3.0.CO;2-V; MACNIVEN E, 1993, BRAIN INJURY, V1, P241; MATARAZZO JD, 1986, AM PSYCHOL, V41, P14, DOI 10.1037/0003-066X.41.1.14; MATARAZZO JD, 1990, AM PSYCHOL, V45, P999, DOI 10.1037/0003-066X.45.9.999; MATARAZZO JD, 1986, AM PSYCHOL, V41, P94; McKinley, 1943, MANUAL ADM SCORING M; MENSCH AJ, 1986, INT J CLIN NEUROPSYC, V8, P59; MILLER L, 1993, PSYCHOTHERAPY BRAIN; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; PANKRATZ L, 1990, CLIN NEUROPSYCHOL, V4, DOI DOI 10.1080/13854049008401832; PARKER N, 1979, MED J AUSTRALIA, V1, P568, DOI 10.5694/j.1326-5377.1979.tb127072.x; PILOWSKY I, 1992, STRESS MEDICINE, V8, P77, DOI 10.1002/smi.2460080204; PILOWSKY I, 1985, BRIT J PSYCHIAT, V147, P310, DOI 10.1192/bjp.147.3.310; POPE HS, 1993, MMPI MMPI 2 MMPI A C; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Reitan R. M., 1986, TRAUMATIC BRAIN INJU, VI; Resnick P. J., 1988, CLIN ASSESSMENT MALI, P84; Rey A., 1964, EXAMEN CLIN PSYCHOL; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rogers R., 1984, BEHAVIORAL SCI LAW, V2, P93; ROGERS R, 1988, CLIN ASSESSMENT MALI, P250; ROGERS R, 1988, CLIN ASSESSMENT MALI; ROGERS R, 1992, SIRS STRUCTURED INTE; SCHMIDT JP, 1989, PROF PSYCHOL-RES PR, V20, P140, DOI 10.1037/h0092792; SCHRETLEN D, 1990, J CLIN PSYCHOL, V46, P782, DOI 10.1002/1097-4679(199011)46:6<782::AID-JCLP2270460614>3.0.CO;2-2; Schretlen D., 1992, PSYCHOL ASSESSMENT, V4, P77, DOI [10.1037/1040-3590.4.1.77, DOI 10.1037/1040-3590.4.1.77]; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; Spence D.P., 1982, NARRATIVE TRUTH HIST; Spitzer R.L., 1978, SCHEDULE AFFECTIVE D; TAYLOR S, 1991, J ANXIETY DISORD, V5, P293, DOI 10.1016/0887-6185(91)90030-W; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; WALTERS GD, 1988, J CONSULT CLIN PSYCH, V56, P111, DOI 10.1037/0022-006X.56.1.111; Weed N, 1990, PSYCHOL ASSESSMENT J, V2, P281, DOI DOI 10.1037/1040-3590.2.3.281; WETTER MW, 1992, PSYCHOL ASSESSMENT, V4, P369, DOI DOI 10.1037/1040-3590.4.3.369; WIGGINS EC, 1988, LAW HUMAN BEHAV, V12, P57, DOI 10.1007/BF01064274; WILLIAMS JM, 1991, MEMORY ASSESSMENT SC; WILSON RS, 1991, FORENSIC NEUROPSYCHO, P89; Zasler N., 1993, J HEAD TRAUMA REHAB, V8, P13, DOI 10.1097/00001199-199309000-00004; [No title captured]; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253	96	14	14	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513	0969-5893			CLIN PSYCHOL-SCI PR	Clin. Psychol.-Sci. Pract.	WIN	1994	1	2					169	184		10.1111/j.1468-2850.1994.tb00018.x			16	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	PY450	WOS:A1994PY45000005					2022-02-06	
J	DEPOMPEI, R; WILLIAMS, J				DEPOMPEI, R; WILLIAMS, J			WORKING WITH FAMILIES AFTER TBI - A FAMILY-CENTERED APPROACH	TOPICS IN LANGUAGE DISORDERS			English	Article						COLLABORATION; FAMILY-CENTERED COUNSELING; FAMILY SYSTEMS; TRAUMATIC BRAIN INJURY	HEAD-INJURY	This article focuses on family involvement as critical to successful rehabilitation of individuals with cognitive-communicative impairments following traumatic brain injury (TBI). A family-centered perspective is embraced within which capacity rather than dysfunction in families is sought. Family members are actively included as collaborators in rehabilitation and reintegration to home, school, work, and community life. This family-centered perspective can help develop capability within the family system throughout its life cycle. Suggestions for understanding family responses to TBI and for involving families more fully are presented.	UNIV KANSAS,RES & TRAINING CTR INDEPENDENT LIVING,LAWRENCE,KS 66045		DEPOMPEI, R (corresponding author), UNIV AKRON,SCH COMMUN DISORDERS,AKRON,OH 44325, USA.						ANDREWS J R, 1986, Seminars in Speech and Language, V7, P359, DOI 10.1055/s-0028-1085234; ANDREWS JR, 1993, FAMILY BASED TREATME; BANJA JD, 1992, J HEAD TRAUMA REHAB, V7, P112; Blosser J L, 1992, Clin Commun Disord, V2, P52; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROOKS N, 1984, CLOSED HEAD INJURY P; Carter B, 1988, CHANGING FAMILY LIFE; CAVALLO M, 1992, DEC NAT HEAD INJ F A; Crais ER., 1991, AM J SPEECH LANG PAT, V1, P5; DEPOMPEI R, 1989, TOP LANG DISORD, V9, P78, DOI 10.1097/00011363-198903000-00008; DEPOMPEI R, 1991, NEUROREHABILITATION, V1, P29; DEPOMPEI R, 1988, J HEAD TRAUMA REHAB, V3, P13; DEPOMPEI R, 1993, STAFF DEV CLIN INTER; DEPOMPEI R, 1991, COGNITIVE REHABILITA; DUNST CJ, 1989, NATIONAL STUDENT SPE, V17, P39; GILLETTE Y, 1992, CATCH GUIDE PLANNING; GILLETTE Y, CHILDHOOD LANGUAGE D; Goldenberg H., 1985, FAMILY THERAPY OVERV; HOCK RA, 1984, REHABILITATION CHILD; HOSACK K, 1992, J VOCATIONAL REHABIL, V2, P1; Kbler-Ross E., 1969, DEATH DYING; KLONFF P, 1987, COMMUNITY REENTRY HE; Kreutzer J, 1988, J HEAD TRAUMA REHAB, V3, P51, DOI DOI 10.1097/00001199-198812000-00008; KREUTZER J, 1993, MAR OH SPEECH LANG H; Lehr E, 1990, PSYCHOL MANAGEMENT T; MACDONALD J, 1988, PARENT CHILD INTERAC; MACDONALD JD, 1986, J ASSOC PERS SEVERE, V11, P255; MAITZ E, 1991, HEAD INJURY FAMILY M; McGoldrick M., 1982, ETHNICITY FAMILY THE; MCKINALY WW, 1987, J NEUROL NEUROSUR PS, V44, P527; Minuchin S, 1967, FAMILIES SLUMS; PENN P, 1988, CHANGING FAMILY LIFE; ROLLAND JS, 1988, CHRONIC ILLNESS DISA; ROLLAND JS, 1988, CHANGING FAMILY LIFE; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; Satir V., 1975, HELPING FAMILIES CHA; SAVAGE R, 1991, NEURODEVELOPMENTS NE, V1, P3; SCHROEDER H, 1993, HEADLINES; SENELICK R, 1991, LIVING HEAD INJURY G; Waaland PK, 1990, COMMUNITY REINTEGRAT; WILLER B, 1989, RRTC892 U BUFF TECH; WILLER B, 1989, RRTC895 U BUFF TECH; WILLIAMS J, 1991, HEAD INJURY FAMILY M; Williams Janet M., 1993, Seminars in Speech and Language, V14, P44, DOI 10.1055/s-2008-1064158; YLVISAKER M, 1993, STAFF DEV CLIN INTER; YLVISAKER M, 1987, COMMUNITY REENTRY HE; ZARSKI JJ, 1989, J HEAD TRAUMA REHABI, V3, P31	47	14	14	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0271-8294			TOP LANG DISORD	Top. Lang. Disord.	NOV	1994	15	1					68	81		10.1097/00011363-199411000-00007			14	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	PL838	WOS:A1994PL83800007					2022-02-06	
J	OSTERMANN, PAW; HENRY, SL				OSTERMANN, PAW; HENRY, SL			RUSSEL-TAYLOR RECONSTRUCTION NAIL IN THE TREATMENT OF IPSILATERAL NECK AND SHAFT FRACTURES	CHIRURG			German	Article						IPSILATERAL FEMORAL NECK AND SHAFT FRACTURES; RECONSTRUCTION NAIL; FEMORAL HEAD NECROSIS	FEMORAL-SHAFT; HIP-FRACTURES; FEMUR	Eleven ipsilateral neck and shaft fractures of the femur in 11 patients (4 females, 7 males) were treated between May 1987 and December 1990 at the Department of Orthopedic Surgery, University of Louisville, Trauma center level one. The mean age was 34.5 (16-60) years. All patients sustained their injuries from high energy trauma (8 traffic accidents, 3 falls). All neck fractures were closed and there were 8 closed and 3 open (grade I, grade II, grade IIIA = one each) shaft fractures. All fractures were operated on the fracture table and all were stabilized with the Russell-Taylor reconstruction nail. Thus, antegrade reamed nailing of the shaft fracture was followed by internal fixation of the neck fracture with 8.0 mm and 6.4 mm lag screws. Those were placed with a targeting device through the proximal locking holes of the nail. Then, the distal locking bolts were implanted by free hand technique. The mean follow-up was 36.2 (18-71) months. All fractures of the neck and shaft healed. There was no necrosis of the femoral head. No infection was observed. The mean healing time for the neck fractures was 13.4 weeks and 16.8 weeks for the shaft fractures. In one case autogenous cancellous bone grafting was performed in delayed healing of a shaft fracture. There were no varus or valgus malangulations. Five patients had a minor limited ROM of the hip joint, another 6 patients an average shortening of 1.3 cm of he involved leg. In one case a locking bolt had to be removed due to loosening. The Russell-Taylor reconstruction nail is a favourable device for the stabilization of ipsilateral fractures of the femoral neck and shaft and provides excellent results for these complex injuries.	UNIV LOUISVILLE,HLTH SCI CTR,SCH MED,DEPT ORTHOPED SURG,FRACTURE SERV,LOUISVILLE,KY 40202		OSTERMANN, PAW (corresponding author), UNIV BOCHUM,CHIRURG KLIN & POLIKLIN,BERUFSGENOSSENSCHAFTLICHE KLINIKEN BERGMANNSHEIL,D-44789 BOCHUM,GERMANY.						ASHBY ME, 1977, CLIN ORTHOPAEDICS, V127, P156; BENNETT FS, 1993, CLIN ORTHOP RELAT R, V296, P168; BOSE WJ, 1992, J TRAUMA, V32, P1; BUCHOLZ RW, 1985, ORTHOPEDICS, V8, P1402; CASEY MJ, 1979, J BONE JOINT SURG AM, V61, P503, DOI 10.2106/00004623-197961040-00003; EISKJAER S, 1989, ORTHOPEDICS, V12, P397; FRIEDMAN RJ, 1986, CLIN ORTHOP RELAT R, V208, P188; Geissler W B, 1988, J Orthop Trauma, V2, P297, DOI 10.1097/00005131-198802040-00005; HARRYMAN DT, 1986, CLIN ORTHOPAEDICS, V213, P183; LEUNG KS, 1993, INJURY, V24, P41, DOI 10.1016/0020-1383(93)90082-H; SCHATZKER J, 1968, CAN J SURG, V11, P297; SWIONTKOWSKI MF, 1987, ORTHOP CLIN N AM, V18, P73; SWIONTKOWSKI MF, 1984, J BONE JOINT SURG AM, V66A, P260, DOI 10.2106/00004623-198466020-00013; Wiss D A, 1992, J Orthop Trauma, V6, P159, DOI 10.1097/00005131-199206000-00005; WU CC, 1993, J TRAUMA, V34, P70, DOI 10.1097/00005373-199301000-00013; ZETTAS JP, 1981, CLIN ORTHOP RELAT R, V160, P63	16	14	14	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0009-4722			CHIRURG	Chirurg	NOV	1994	65	11					1042	1045					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	PV069	WOS:A1994PV06900021	7821064				2022-02-06	
J	LEBLANC, KE				LEBLANC, KE			CONCUSSIONS IN SPORTS - GUIDELINES FOR RETURN TO COMPETITION	AMERICAN FAMILY PHYSICIAN			English	Article								Concussion is the most common head injury in sports. The injury ranges from a simple ''ding'' to prolonged loss of consciousness with amnesia. Proper grading of the severity of the injury is necessary to establish a protocol for deciding when to allow an athlete to return to his or her sport. This approach to concussions will minimize the risk of further, even fatal, complications.			LEBLANC, KE (corresponding author), UNIV SW LOUISIANA,MED CTR,LAFAYETTE,LA 70504, USA.							0	14	14	0	1	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797	0002-838X			AM FAM PHYSICIAN	Am. Fam. Physician	SEP 15	1994	50	4					801	806					6	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PH353	WOS:A1994PH35300013	8079910				2022-02-06	
J	KEREN, O; SAZBON, L; GROSWASSER, Z; SHMUEL, M				KEREN, O; SAZBON, L; GROSWASSER, Z; SHMUEL, M			FOLLOW-UP-STUDIES OF SOMATOSENSORY-EVOKED POTENTIALS AND AUDITORY BRAIN-STEM EVOKED-POTENTIALS IN PATIENTS WITH POST-COMA UNAWARENESS (PCU) OF TRAUMATIC BRAIN INJURY	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY; PROGNOSIS	Some patients who suffer severe traumatic brain injury (TBI) fail to recover higher brain functions in spite of giving the appearance of sleep-wake cycles. Such a state is called post-coma unawareness (PCU) and varies in type and degree. Patients may remain in this state for months or even years. This study focused on the follow-up of upper-limb somatosensory evoked potential (USEP) measurements and auditory brainstem responses (ABR), with an emphasis on dynamic changes, in 10 patients with PCU resulting from TBI. The prognostic value of USEP and ABR was evaluated. Results showed that the presence of ABR in PCU patients had no prognostic value, because ABRs were found both in patients who recovered and those who did not, even a year after the trauma. The presence of normal ABR in PCU patients may suggest that the brainstem has been spared in the pathoanatomy of the PCU condition, with the significant damage occurring above this level, in cortical and subcortical (that is, hemispheral) areas. USEP was graded using the new system of Houlden [1] for 'acute' comatose patients. It was found that USEP measurements had some prognostic value in PCU patients. Most of the patients who remained in the PCU state had grade 2 or less initially, whereas most of the patients who later recovered or achieved at least a 'reduced life' state were grade 4 or more. On initial testing (when all patients were still in the PCU state), defined cortical potential (mainly in the slope of the building NI potential) was seen in only some of the patients who later recovered. No dynamic changes or signs of improvement were seen in any of the patients who did not recover (that is, who remained in the PCU state). On the other hand, dynamic changes in evoked potential (amplitude, latency and shortened latency) were found in all patients who got well and, although not homogeneous, the changes involved all the elements of normal patterns and showed a trend towards improvement. Patients who remained comatose showed no change or reduction in Houlden's grade, whereas all patients who recovered showed no change or elevation. (In one of the latter patients, the grade increased from 2 to 5.) In some patients who recovered, morphological changes in cortical potentials were seen, mainly in NI slopes.	LOEWENSTEIN HOSP REHABIL,CTR REHABIL,EVOKED POTENTIALS LAB,RAANANA,ISRAEL; TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL								AMINOFF MJ, 1990, ANN NEUROL, V28, P706, DOI 10.1002/ana.410280517; BUCHNER H, 1988, ELECTROEN CLIN NEURO, V69, P14, DOI 10.1016/0013-4694(88)90031-4; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; CHATRIAN GE, 1990, CURRENT PRACTICE CLI, P425; DELATORRE JC, 1978, EXP NEUROL, V60, P304, DOI 10.1016/0014-4886(78)90085-7; GANES T, 1988, ELECTROEN CLIN NEURO, V69, P6, DOI 10.1016/0013-4694(88)90030-2; Goldberg G, 1987, Electromyogr Clin Neurophysiol, V27, P455; HOULDEN DA, 1990, NEUROSURGERY, V27, P701, DOI 10.1227/00006123-199011000-00006; HUME AL, 1979, ANN NEUROL, V5, P379, DOI 10.1002/ana.410050412; KAJIMA Y, 1991, ELECTROENCEPHALOGRAP, V80, P26; KEREN O, 1991, Brain Injury, V5, P233, DOI 10.3109/02699059109008094; KRESCH EN, 1992, ARCH PHYS MED REHAB, V73, P829; LARSON SJ, 1973, SURGERY, V74, P34; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; LUTSCHG J, 1983, AM J DIS CHILD, V137, P421; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P167, DOI 10.1177/155005948101200403; SAZBON L, 1991, J NEUROL NEUROSUR PS, V54, P149, DOI 10.1136/jnnp.54.2.149; Sazbon L, 1991, Brain Inj, V5, P1, DOI 10.3109/02699059108998504; UZIEL A, 1982, CLIN APPLICATIONS EV, P195; VIGOUROUX PR, 1972, NEUROCHIRURGIE S2, V18, P25	20	14	14	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	APR	1994	8	3					239	247		10.3109/02699059409150976			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	ND714	WOS:A1994ND71400005	8004082				2022-02-06	
J	SEN, S; GOLDMAN, H; MOREHEAD, M; MURPHY, S; PHILLIS, JW				SEN, S; GOLDMAN, H; MOREHEAD, M; MURPHY, S; PHILLIS, JW			OXYPURINOL INHIBITS FREE-RADICAL RELEASE FROM THE CEREBRAL-CORTEX OF CLOSED-HEAD INJURED RATS	NEUROSCIENCE LETTERS			English	Article						CLOSE HEAD INJURY; HEAD TRAUMA; ESR; POBN; HYDROXYL RADICAL; OXYPURINOL	BRAIN INJURY; BLOOD-FLOW; ISCHEMIA	Traumatic brain injury (TBI) is a significant cause of mortality and morbidity. Although the sequence of events underlying the resultant neuronal loss is still poorly understood, there are indications that oxygen-free radical generation is critically involved. Free radical generation in the cerebral cortex of closed head injury rats was monitored by measuring free radical release into cortical superfusates containing the spin trap agent 4-pyridyl-1-oxide-N-tert-butylnitrone (POBN, 100 mM). ESR analysis of the superfusates revealed six line spectra (alpha(N) = 15.4 G and alpha(H)beta = 2.5 G) characteristic of POBN-OH adducts. Administration of oxypurinol (40 mg/kg) 15 min prior to TBI prevented the formation of these radical adducts.	WAYNE STATE UNIV,SCH MED,DEPT PHYSIOL,540 E CANFIELD,DETROIT,MI 48201; WAYNE STATE UNIV,SCH MED,DEPT PHARMACOL,DETROIT,MI 48201						NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026912] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS26912-05] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [G0087C002, H133A20016] Funding Source: Medline		Goldman H, 1991, J NEUROTRAUM, V8, P129, DOI 10.1089/neu.1991.8.129; GRAMMAS P, 1993, FREE RADICAL BIO MED, V14, P553, DOI 10.1016/0891-5849(93)90113-9; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; LANGE D G, 1990, Free Radical Biology and Medicine, V9, P97; LIN Y, 1992, BRAIN RES, V571, P272, DOI 10.1016/0006-8993(92)90665-V; OZAWA T, 1990, BIOCH INT, V26, P477; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; PHILLIS JW, 1989, BRAIN RES BULL, V23, P467, DOI 10.1016/0361-9230(89)90191-3; PHILLIS JW, 1987, J CEREBR BLOOD F MET, V7, P679, DOI 10.1038/jcbfm.1987.122; PHILLIS JW, 1993, DRUG DEVELOP RES, V28, P390, DOI 10.1002/ddr.430280337; PHILLIS JW, 1990, INT J PURINE PYRIMID, V1, P31; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; ZINI I, 1992, NEUROSCI LETT, V138, P279, DOI 10.1016/0304-3940(92)90933-X	14	14	14	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	NOV 12	1993	162	1-2					117	120		10.1016/0304-3940(93)90574-5			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MH359	WOS:A1993MH35900030	8121612				2022-02-06	
J	DEWEY, CW; DOWNS, MO; ARON, DN; MAHAFFEY, EA				DEWEY, CW; DOWNS, MO; ARON, DN; MAHAFFEY, EA			ACUTE TRAUMATIC INTRACRANIAL HEMORRHAGE IN DOGS AND CATS - A RETROSPECTIVE EVALUATION OF 23 CASES	VETERINARY AND COMPARATIVE ORTHOPAEDICS AND TRAUMATOLOGY			English	Article						ACUTE TRAUMATIC INTRACRANIAL HEMORRHAGE; BRAIN INJURY; DOGS; CATS		Twenty-three records of dogs and cats having experienced severe craniocerebral trauma were reviewed. Case selection was restricted to those patients whose brains were examined at necropsy and/or surgery. Records of 14 dogs and nine cats were evaluated for the presence or absence of intracranial haemorrhage. The majority of patients were victims of automobile trauma (n = 16), the remainder being victims of household accidents (n = 4), malicious human behavior (n = 2), and injury inflicted by another animal (n = 1). Six of the 23 (27%) were conscious upon admission. One patient was unconscious upon admission, but regained consciousness following medical therapy. Evidence of intracranial haemorrhage was found in 100% (14/14) of the canine and 89% (8/9) of the feline cases. Four dogs and four cats exhibited two forms of intracranial haemorrhage. One cat exhibited three forms of intracranial haemorrhage. The distribution of intracranial haemorrhage was as follows: two epidural, 10 subdural, 10 subarachnoid and 10 intraparenchymal. Histopathology was available for 10 of the 23 cases. Surgical confirmation of the subdural haematomas, as typical subdural haematomas (focal intradural mass lesions), was available for four cases. Gross pathology of one other of the 10 subdural hematomas described a focal, 2 x 3 cm mass lesion. The remaining five subdural haematomas were of a more diffuse nature (more typical of subarachnoid haemorrhage), but three of these five were described as massive accumulations of blood. Four patients underwent emergency craniotomy/craniectomy; two of these patients made rapid and full recoveries, one died on the operating table, and one was euthanatized at the operation because of uncontrollable brain swelling. Ninety-three percent of the canine and 75% of the feline cases had haemorrhagic lesions that would have been potentially accessible via a lateral craniotomy/craniectomy. The results of this investigation suggest that acute intracranial haemorrhage may be a relatively frequent occurrence, following severe brain injury in dogs and cats. Prospective studies are needed to better define the incidence, anatomical distribution, and potential clinical significance of acute traumatic intracranial haemorrhage in dogs and cats. Comparative aspects of acute traumatic intracranial haemorrhage in people and small animals (dogs and cats) are discussed.			DEWEY, CW (corresponding author), UNIV CALIF DAVIS,SCH VET MED,DEPT VET SURG,DAVIS,CA 95616, USA.							0	14	14	0	8	F K SCHATTAUER VERLAG GMBH	STUTTGART	P O BOX 10 45 45, LENZHALDE 3, D-70040 STUTTGART, GERMANY	0932-0814			VET COMP ORTHOPAED	Vet. Comp. Orthop. Traumatol.	AUG	1993	6	3					153	159					7	Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences; Zoology	LT023	WOS:A1993LT02300005					2022-02-06	
J	CHOUINARD, MJ; BRAUN, CMJ				CHOUINARD, MJ; BRAUN, CMJ			A METAANALYSIS OF THE RELATIVE SENSITIVITY OF NEUROPSYCHOLOGICAL SCREENING-TESTS	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC HEAD-INJURY; MULTIPLE-SCLEROSIS; PARKINSONS-DISEASE; COGNITIVE DISTURBANCES; ALZHEIMERS-DISEASE; FEMALE ALCOHOLICS; HALSTEAD-REITAN; DEFICITS; PERFORMANCE; IMPAIRMENT	The National Institute of Mental Health recently formed a committee of experts which published a proposal for a lengthy neuropsychological test battery judged most apt to detect diffuse brain damage while covering a wide range of cognitive abilities. The purposes of the present study were (1) to assemble empirical evidence of the existence of statistically significantly sensitive screening tests across an equivalently wide range of functional domains, and (2) to present this evidence systematically, in such a manner as to help clinicians select subsets of screening tests manifesting greatest sensitivity to diffuse brain damage. It was found that in certain functional domains (speed of processing, problem solving, executive functions), marked differences in sensitivity occured. Brief tests just as sensitive as time-consuming tests were also identified. The reader is cautioned about possible extraneous sources of the differences obtained (test and group selection bias, test reliability, test difficulty, procedural effects, Type I error). Nevertheless, it was concluded that a brief highly sensitive and functionally wide-ranging neuropsychological test battery for screening cases of putative diffuse brain dysfunction can be assembled.	UNIV QUEBEC, DEPT PSYCHOL, CP 8888, SUCC A, MONTREAL H3C 3P8, QUEBEC, CANADA; UNIV QUEBEC, NEUROSCI COGNIT LAB, MONTREAL H3C 3P8, QUEBEC, CANADA								ACKER C, 1985, ALCOHOL ALCOHOLISM, V20, P379; ADAMS KM, 1990, J CLIN EXP NEUROPSYC, V12, P960, DOI 10.1080/01688639008401034; ARDILA A, 1989, DEV NEUROPSYCHOL, V5, P307, DOI 10.1080/87565648909540441; BAK JS, 1980, J CONSULT CLIN PSYCH, V48, P395, DOI 10.1037/0022-006X.48.3.395; BEATTY PA, 1977, J NERV MENT DIS, V164, P42, DOI 10.1097/00005053-197701000-00008; BEATTY WW, 1989, ARCH NEUROL-CHICAGO, V46, P1113, DOI 10.1001/archneur.1989.00520460103020; BENTON AL, 1957, J ABNORM SOC PSYCH, V54, P109, DOI 10.1037/h0047176; BIGLER E D, 1981, Clinical Neuropsychology, V3, P5; BIGLER E D, 1981, Clinical Neuropsychology, V3, P13; BIRD M, 1991, J CLIN EXP NEUROPSYC, V13, P508, DOI 10.1080/01688639108401067; BIRREN JE, 1980, AGING 1980S; BLACKBURN H L, 1955, Confin Neurol, V15, P327; BLUSEWICZ MJ, 1977, J NERV MENT DIS, V165, P348, DOI 10.1097/00005053-197711000-00006; BOLL TJ, 1974, J NERV MENT DIS, V158, P61, DOI 10.1097/00005053-197401000-00008; BORNSTEIN RA, 1990, PSYCHIAT RES, V31, P15, DOI 10.1016/0165-1781(90)90104-D; BRAUN CMJ, 1989, INT J CLIN NEUROPSYC, V11, P167; Bruhn P, 1971, Cortex, V7, P278; BUTTERS N, 1990, J CLIN EXPT NEUROPSY, V12, P953; CHAPMAN JP, 1983, J NERV MENT DIS, V171, P658, DOI 10.1097/00005053-198311000-00003; DAIGNEAULT S, 1992, DEV NEUROPSYCHOL, V8, P99, DOI 10.1080/87565649209540518; DEE HL, 1971, ACTA PSYCHIAT SCAND, V47, P315, DOI 10.1111/j.1600-0447.1971.tb02217.x; DENBURG SD, 1987, J CLIN EXP NEUROPSYC, V9, P323, DOI 10.1080/01688638708405054; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; DRUDGE OW, 1984, J CLIN PSYCHOL, V40, P259, DOI 10.1002/1097-4679(198401)40:1<259::AID-JCLP2270400149>3.0.CO;2-C; DUBOIS B, 1990, NEUROLOGY, V40, P38, DOI 10.1212/WNL.40.1.38; DYE OA, 1979, ACTA NEUROL SCAND, V59, P10; DYE OA, 1981, J CLIN PSYCHOL, V37, P472, DOI 10.1002/1097-4679(198107)37:3<472::AID-JCLP2270370304>3.0.CO;2-Q; ESTRIN WJ, 1990, J TOXICOL-CLIN TOXIC, V28, P1; FITZHUGH KB, 1961, J CONSULT PSYCHOL, V25, P61, DOI 10.1037/h0043344; GOULETFISHER D, 1986, INT J CLIN NEUROPSYC, V8, P14; GRANT I, 1984, J NEUROL NEUROSUR PS, V47, P250, DOI 10.1136/jnnp.47.3.250; HAXBY JV, 1990, ARCH NEUROL-CHICAGO, V47, P753, DOI 10.1001/archneur.1990.00530070043010; HEAD D, 1989, BIOL PSYCHIAT, V25, P929, DOI 10.1016/0006-3223(89)90272-2; HEATON RK, 1985, J CONSULT CLIN PSYCH, V53, P103, DOI 10.1037/0022-006X.53.1.103; HEATON RK, 1986, NEUROPSYCHOLOGICAL A, P100; HILLBOM M, 1986, J NEUROL NEUROSUR PS, V49, P1348, DOI 10.1136/jnnp.49.12.1348; HOM J, 1990, J CLIN EXP NEUROPSYC, V12, P644, DOI 10.1080/01688639008401008; HUA MS, 1991, J CLIN EXP NEUROPSYC, V13, P495, DOI 10.1080/01688639108401066; JANSSEN RS, 1989, ANN NEUROL, V26, P592, DOI 10.1002/ana.410260503; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; KANE RL, 1985, J CLIN EXP NEUROPSYC, V7, P211, DOI 10.1080/01688638508401254; LEE GP, 1988, J CLIN EXP NEUROPSYC, V10, P769, DOI 10.1080/01688638808402813; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN BE, 1989, NEUROLOGY, V39, P557, DOI 10.1212/WNL.39.4.557; LEVINE J, 1972, J CONSULT CLIN PSYCH, V39, P508, DOI 10.1037/h0034017; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; LIBON DJ, 1990, 18TH ANN M INT NEURO; MATTHEWS CG, 1979, NEUROLOGY, V29, P951, DOI 10.1212/WNL.29.7.951; Matthews CG, 1966, CORTEX, V2, P244; Miller E, 1970, Cortex, V6, P121; MILLER EN, 1990, NEUROLOGY, V40, P197, DOI 10.1212/WNL.40.2.197; MINDEN SL, 1990, J CLIN EXP NEUROPSYC, V12, P566, DOI 10.1080/01688639008401002; MITTENBERG W, 1989, J CLIN EXP NEUROPSYC, V11, P918, DOI 10.1080/01688638908400945; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; MORROW LA, 1990, J OCCUP ENVIRON MED, V32, P444, DOI 10.1097/00043764-199005000-00010; OLEARY MR, 1979, J CLIN PSYCHOL, V35, P204, DOI 10.1002/1097-4679(197901)35:1<204::AID-JCLP2270350133>3.0.CO;2-L; PATTERSON BW, 1989, INT J NEUROSCI, V49, P319, DOI 10.3109/00207458909084830; PETERSON JB, 1990, J STUD ALCOHOL, V51, P114, DOI 10.15288/jsa.1990.51.114; REID WGJ, 1989, INT J NEUROSCI, V48, P205, DOI 10.3109/00207458909002162; RUMSEY JM, 1988, J CLIN EXP NEUROPSYC, V10, P201, DOI 10.1080/01688638808408236; SILBERSTEIN JA, 1981, J ABNORM PSYCHOL, V90, P179, DOI 10.1037/0021-843X.90.2.179; SKENAZY JA, 1984, J CLIN PSYCHOL, V40, P246, DOI 10.1002/1097-4679(198401)40:1<246::AID-JCLP2270400148>3.0.CO;2-P; SKORASZEWSKI MJ, 1991, J CLIN EXP NEUROPSYC, V13, P278, DOI 10.1080/01688639108401043; TARTER RE, 1988, ALCOHOL CLIN EXP RES, V12, P619, DOI 10.1111/j.1530-0277.1988.tb00252.x; Van Zomeren A. H., 1981, REACTION TIME ATTENT; VILLARDITA C, 1985, ARCH GERONTOL GERIAT, V4, P311, DOI 10.1016/0167-4943(85)90038-X; WHEELER L, 1963, PERCEPT MOTOR SKILL, V16, P417, DOI 10.2466/pms.1963.16.2.417; WILKIE FL, 1990, ARCH NEUROL-CHICAGO, V47, P433, DOI 10.1001/archneur.1990.00530040085022; WILSON B, 1987, PSYCHOBIOLOGY, V15, P300; WOLFE N, 1990, ARCH NEUROL-CHICAGO, V47, P129, DOI 10.1001/archneur.1990.00530020025010; YOHMAN JR, 1985, ALCOHOL CLIN EXP RES, V9, P114, DOI 10.1111/j.1530-0277.1985.tb05530.x; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1093/ARCLIN/5.1.23	74	14	14	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL	1993	15	4					591	607		10.1080/01688639308402581			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	LJ168	WOS:A1993LJ16800012	8354711				2022-02-06	
J	KLONOFF, PS; LAGE, GA; CHIAPELLO, DA				KLONOFF, PS; LAGE, GA; CHIAPELLO, DA			VARIETIES OF THE CATASTROPHIC REACTION TO BRAIN INJURY - A SELF PSYCHOLOGY PERSPECTIVE	BULLETIN OF THE MENNINGER CLINIC			English	Article							HEAD-INJURY	Patients with traumatic brain injury sometimes manifest varieties of what Goldstein (1952) called the ''catastrophic reaction.'' Recognizing the particular form of catastrophic reaction is important both to determine proper behavioral management and to help patients accept the effects of the brain injury. Applying Kohutian theory and self psychology constructs, the authors present several case studies to show bow the patients shared the same underlying experience of shame and anxiety over their injury-related impairments. These patients participated in an outpatient, milieu-oriented rehabilitation program intended to increase their independence at borne and to facilitate their return to productive work. The rehabilitation therapist's role was to help patients move from a state of being unable to accept their deficits to one of setting and pursuing attainable goals. The authors discuss ways of managing these catastrophic reactions.			KLONOFF, PS (corresponding author), ST JOSEPHS HOSP, BARROW NEUROL INST, 350 W THOMAS RD, PHOENIX, AZ 85013 USA.						*AM PSYCH ASS, 1989, TREATM PSYCH DIS TA, V3; BAKER HS, 1987, AM J PSYCHIAT, V144, P1; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; Klonoff P. S., 1991, J HEAD TRAUMA REHAB, V6, P11, DOI [10.1097/00001199-199112000-00005, DOI 10.1097/00001199-199112000-00005]; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; KOHUT H, 1978, INT J PSYCHOANAL, V59, P413; Kohut H., 1972, PSYCHOANAL STUD C, V27, P360, DOI [DOI 10.1080/00797308.1972.11822721, 10.1080/00797308.1972.11822721]; Kohut H., 1977, RESTORATION SELF; LAGE GA, 1991, PSYCHOTHERAPY ADOLES; Levin HS., 1982, NEUROBEHAVIORAL CONS; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; Ornstein P.H., 1991, SEARCH SELF SELECTED, V4; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; SANDLER J, 1962, PSYCHOANAL STUD CHIL, V17, P107; SANDLER J, 1973, PATIENT ANAL BASIS P; SCHWABER EA, 1979, STAFF PSYCHIATRY C C; TERMAN DM, 1975, ANNU PSYCHOANAL, V3, P239; Wolf E.S., 1988, TREATING SELF ELEMEN	19	14	14	0	0	GUILFORD PUBLICATIONS INC	NEW YORK	370 SEVENTH AVE, SUITE 1200, NEW YORK, NY 10001-1020 USA	0025-9284	1943-2828		B MENNINGER CLIN	Bull. Menninger Clin.	SPR	1993	57	2					227	241					15	Psychiatry; Psychology, Psychoanalysis	Social Science Citation Index (SSCI)	Psychiatry; Psychology	LC530	WOS:A1993LC53000008	8508158				2022-02-06	
J	STAMBROOK, M; MOORE, AD; LUBUSKO, AA; PETERS, LC; BLUMENSCHEIN, S				STAMBROOK, M; MOORE, AD; LUBUSKO, AA; PETERS, LC; BLUMENSCHEIN, S			ALTERNATIVES TO THE GLASGOW COMA SCALE AS A QUALITY-OF-LIFE PREDICTOR FOLLOWING TRAUMATIC BRAIN INJURY	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; SEVERITY; UNCONSCIOUSNESS; ADULT; AGE	Conventional ''staging'' of traumatic brain injury (TBI) typically uses depth of coma assessed by the Glasgow Coma Scale (GCS) score near admission as a severity marker Frequently, early GCS scores are contaminated by alcohol or drug ingestion and other, nonneurological organ system trauma. As well, this measure's usefulness is limited due to its restricted range in survivors. Here we explore the utility of using length of posttraumatic amnesia, coma duration, and age as indirect markers of severity. Cluster analytic techniques were used to examine the relationship of severity so defined to long-term outcome in 106 mild, moderate, and severe TBI patients. Results indicate complex relationships between cluster groups with the influence of age of patient being highlighted as an important moderator in determining severity of injury and later psychosocial outcome.	UNIV MANITOBA,DEPT PSYCHIAT,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,DEPT PSYCHOL,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,DEPT MED,WINNIPEG R3T 2N2,MANITOBA,CANADA; HLTH SCI CLIN RES CTR,SOC MANITOBANS DISABIL,WINNIPEG R3A 1R9,MB,CANADA		STAMBROOK, M (corresponding author), HLTH SCI CLIN RES CTR,NEUROPSYCHOL RES UNIT,MS-779A THORLAKSON BLDG,820 SHERBROOK ST,WINNIPEG R3A 1R9,MB,CANADA.						ABEL EL, 1985, J STUD ALCOHOL, V46, P228, DOI 10.15288/jsa.1985.46.228; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; BERGNER M, 1976, COPING ADAPTATION, P127; BERROL S, 1989, MILD MODERATE HEAD I, P135; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; COREY MR, 1987, COGNITIVE REHABILITA, V5, P28; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; EWING CL, 1983, IMPACT INJURY HEAD S; GENSEMER IB, 1989, ANN EMERG MED, V18, P9, DOI 10.1016/S0196-0644(89)80303-8; GILL D, 1988, AUG ANN CONV AM PSYC; Gurdjian ES, 1975, IMPACT HEAD INJURY M; HAIR JF, 1987, MULTIVARIATE DATA AN; HANS P, 1987, BRIT J HOSP MED, V23, P535; HOGARTY GE, 1971, ARCH GEN PSYCHIAT, V25, P470; Jennett B, 1981, MANAGEMENT HEAD INJU; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; LYLE DM, 1986, J NEUROSURG, V65, P15, DOI 10.3171/jns.1986.65.1.0015; MARSHALL LF, 1989, MILD MODERATE HEAD I, P29; McNair DM, 1971, EITS MANUAL PROFILE; Moore A. D., 1991, J HEAD TRAUMA REHAB, V6, P83; NOCKLEBY DM, 1987, INT J CLIN NEUROPSYC, V9, P145; OHNO K, 1987, NO SHINKEI GEKA, V16, P607; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; PRUNETI CA, 1988, RES COMMUN PSYCH PSY, V13, P193; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SELECKI BR, 1982, AUST NZ J SURG, V52, P93, DOI 10.1111/j.1445-2197.1982.tb05297.x; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; *SPSS INC, 1986, SPSSX US GUID; STAMBROOK M, 1990, CAN J SURG, V33, P115; STARMARK JE, 1988, J NEUROSURG, V69, P692, DOI 10.3171/jns.1988.69.5.0692; TEASDALE G, 1974, LANCET, V2, P81; UZZELL BP, 1987, SURG NEUROL, V27, P419, DOI 10.1016/0090-3019(87)90247-3; VAPALAHTI M, 1986, ANN CLIN RES, V18, P37	39	14	14	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR-APR	1993	8	2					95	103					9	Psychology, Clinical; Psychology	Social Science Citation Index (SSCI)	Psychology	KK429	WOS:A1993KK42900001	14589667				2022-02-06	
J	EMERSON, CS; VINK, R				EMERSON, CS; VINK, R			INCREASED MORTALITY IN FEMALE RATS AFTER BRAIN TRAUMA IS ASSOCIATED WITH LOWER FREE MG-2+	NEUROREPORT			English	Article						MAGNESIUM; NUCLEAR MAGNETIC RESONANCE; BIOENERGETICS; BRAIN INJURY	MAGNETIC-RESONANCE SPECTROSCOPY; FREE MAGNESIUM; INJURY; PH; METABOLISM	MALE and female Sprague-Dawley rat siblings (200-350 g) were monitored by phosphorus magnetic resonance spectroscopy for 4 h after moderate (2.8 atmospheres) fluid-percussion-induced traumatic brain injury. Following injury, two of nine male animals died whereas 1 00 % of all female rats (n = 16) died (p < 0.01). Prior to injury, brain free magnesium concentration in males was 0.58 +/- 0.05 mM and in females 0.41 +/- 0.09. After injury, mean brain free magnesium concentration in males declined to 0.32 +/- 0.06 whereas mean brain free magnesium concentration in ventilated females (n = 6) after injury declined to 0.17 +/- 0.03 (p < 0.05). There were no significant differences between groups with respect to any other measured variables. We conclude that female rats are more susceptible to irreversible injury afterbrain trauma, and that this increased susceptibility to injury may be related to brain free magnesium levels.	JAMES COOK UNIV N QUEENSLAND,DEPT CHEM & BIOCHEM,TOWNSVILLE,QLD 4811,AUSTRALIA				Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667			Aikawa J.K., 1981, MAGNESIUM ITS BIOL S, V1st ed.; BOCK JL, 1987, BIOCHIM BIOPHYS ACTA, V928, P8, DOI 10.1016/0167-4889(87)90079-6; DEGANI H, 1984, BIOCHEMISTRY-US, V23, P2572, DOI 10.1021/bi00307a006; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GARFINKEL L, 1984, BIOCHEMISTRY-US, V23, P3547, DOI 10.1021/bi00310a025; GUPTA RK, 1983, PHYSIOL CHEM PHYS, V15, P265; JANE JA, 1991, 1991 CENTR NERV SYST; LAWSON JWR, 1979, J BIOL CHEM, V254, P6528; MAGUIRE ME, 1984, TRENDS PHARMACOL SCI, V5, P73, DOI 10.1016/0165-6147(84)90372-9; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781; RUBIN H, 1976, J CELL PHYSL, V89, P61; SIESJO BK, 1985, 1985 CENTR NERV SYST, P5132; SMITH SS, 1989, BRAIN RES, V503, P354, DOI 10.1016/0006-8993(89)91691-0; SMITH SS, 1991, NEUROSCIENCE, V42, P309, DOI 10.1016/0306-4522(91)90377-Z; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; Vink R, 1990, Magnes Res, V3, P163; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; VINK R, 1988, J NEUROTRAUMA, V5, P365; VINK R, 1991, MAGNESIUM EXCITABLE, P695	23	14	14	0	0	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	0959-4965			NEUROREPORT	Neuroreport	NOV	1992	3	11					957	960		10.1097/00001756-199211000-00002			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KA083	WOS:A1992KA08300002	1482764				2022-02-06	
J	HEARY, RF; HUNT, CD; KRIEGER, AJ; ANTONIO, C; LIVINGSTON, DH				HEARY, RF; HUNT, CD; KRIEGER, AJ; ANTONIO, C; LIVINGSTON, DH			ACUTE STABILIZATION OF THE CERVICAL-SPINE BY HALO VEST APPLICATION FACILITATES EVALUATION AND TREATMENT OF MULTIPLE TRAUMA PATIENTS	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	22ND ANNUAL MEETING OF THE WESTERN TRAUMA ASSOC	FEB 29-MAR 07, 1992	STEAMBOAT SPRINGS, CO	W TRAUMA ASSOC			CORD INJURY; FRACTURES; IMMOBILIZATION; FUSION	The management of acute cervical spine injuries has traditionally used bed-based skeletal traction until all non-neurologic injuries have been evaluated. This treatment method substantially hinders the ability to transport patients and to perform imaging studies and surgical procedures. In contrast, early application of a halo/vest apparatus provides immediate cervical stabilization and facilitates the diagnostic work-up and treatment of the patients with multiple injuries. The records of all 78 patients admitted from February 1988 through June 1991 who had acute cervical spine fractures, subluxations, or both with a risk of instability were reviewed. All patients were treated with halo/vests and no patient deteriorated neurologically following halo/vest application. Twenty-nine patients (37%) had a total of 55 associated injuries including long bone/pelvic fractures in 17, thoracic injuries in 13, closed head injuries in 11, facial fractures in 6, noncontiguous spinal fractures in 5, and abdominal injuries in 3. The mean Injury Severity Score (ISS) was 18 (range, 9-54). While in the halo/vest, 43 patients (55%) had a total of 99 diagnostic studies completed and 46 patients (59%) had a total of 76 surgical procedures performed. There were 35 neurosurgical procedures on 32 patients and 41 non-neurosurgical surgical procedures on 24 patients. Over the past year, 20 of 21 patients (95%) had their halo/vests placed in the emergency department. The data demonstrate that many diagnostic and surgical procedures need to be performed on patients with unstable cervical spine injuries. While we recognize that application of the halo/vest is not the definitive treatment in a number of patients with multiple injuries (41% in this series), acute placement of the halo/vest both stabilized the patients' neurologic status and facilitated the expeditious diagnosis and treatment of potentially life-threatening associated injuries.	UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT NURSING,NEWARK,NJ 07103; UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,TRAUMA SECT,NEWARK,NJ 07103		HEARY, RF (corresponding author), UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,CTR NEUROL SURGEONS,DEPT SURG,NEUROL SURG SECT,NEWARK,NJ 07103, USA.						BEHRMAN SW, 1990, J TRAUMA, V30, P792, DOI 10.1097/00005373-199007000-00005; BONE LB, 1989, J BONE JOINT SURG AM, V71A, P336, DOI 10.2106/00004623-198971030-00004; BORDER JR, 1987, ANN SURG, V206, P427, DOI 10.1097/00000658-198710000-00004; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BUCCI MN, 1988, J TRAUMA, V28, P1001, DOI 10.1097/00005373-198807000-00015; BUCHOLZ RD, 1989, J NEUROSURG, V70, P884, DOI 10.3171/jns.1989.70.6.0884; BURNEY RE, 1989, J TRAUMA, V29, P1497, DOI 10.1097/00005373-198911000-00008; CHAN RC, 1983, J NEUROSURG, V58, P508, DOI 10.3171/jns.1983.58.4.0508; COOPER PR, 1979, J NEUROSURG, V50, P603, DOI 10.3171/jns.1979.50.5.0603; COTLER HB, 1990, SPINE, V15, P448, DOI 10.1097/00007632-199006000-00003; Crutchfield WG, 1933, S SURG, V2, P156; GARFIN SR, 1986, J BONE JOINT SURG AM, V68A, P320, DOI 10.2106/00004623-198668030-00002; GARFIN SR, 1989, CLIN ORTHOP RELAT R, V239, P19; GLASER JA, 1986, J NEUROSURG, V65, P762, DOI 10.3171/jns.1986.65.6.0762; JAMES J I, 1960, J R Coll Surg Edinb, V5, P232; JOHNSON KD, 1985, J TRAUMA, V25, P375, DOI 10.1097/00005373-198505000-00001; KEENEN TL, 1990, J TRAUMA, V30, P489, DOI 10.1097/00005373-199030040-00022; KESTERSON L, 1991, J NEUROSURG, V75, P213, DOI 10.3171/jns.1991.75.2.0213; KOSTUIK JP, 1981, CLIN ORTHOP RELAT R, V154, P46; LETTS M, 1988, J BONE JOINT SURG BR, V70, P277, DOI 10.1302/0301-620X.70B2.3346303; LIND B, 1988, SPINE, V13, P425, DOI 10.1097/00007632-198804000-00010; LIND B, 1987, SPINE, V12, P173, DOI 10.1097/00007632-198703000-00014; MARSHALL LF, 1987, J NEUROSURG, V66, P400, DOI 10.3171/jns.1987.66.3.0400; PERRY J, 1959, J BONE JOINT SURG AM, V41, P37, DOI 10.2106/00004623-195941010-00006; POWELL JN, 1989, J TRAUMA, V29, P1146, DOI 10.1097/00005373-198908000-00013; REISS SJ, 1986, NEUROSURGERY, V18, P327, DOI 10.1227/00006123-198603000-00012; ROCKSWOLD GL, 1990, J TRAUMA, V30, P893, DOI 10.1097/00005373-199007000-00022; SABOE LA, 1991, J TRAUMA, V31, P43, DOI 10.1097/00005373-199101000-00010; SCHWEIGEL JF, 1987, SPINE, V12, P838, DOI 10.1097/00007632-198711000-00002; SEARS W, 1990, J NEUROSURG, V72, P426, DOI 10.3171/jns.1990.72.3.0426; SEIBEL R, 1985, ANN SURG, V202, P283, DOI 10.1097/00000658-198509000-00003; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; WATERS JM, 1973, J TRAUMA, V13, P645, DOI 10.1097/00005373-197307000-00009; WOLF A, 1991, J NEUROSURG, V75, P883, DOI 10.3171/jns.1991.75.6.0883	34	14	15	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	1992	33	3					445	451		10.1097/00005373-199209000-00019			7	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	JR171	WOS:A1992JR17100019	1404517				2022-02-06	
J	VONBIERBRAUER, A; WEISSENBORN, K; HINRICHS, H; SCHOLZ, M; KUNKEL, H				VONBIERBRAUER, A; WEISSENBORN, K; HINRICHS, H; SCHOLZ, M; KUNKEL, H			COMPUTER-ASSISTED VERSUS VISUAL EEG-ANALYSIS IN PATIENTS WITH MINOR HEAD-INJURY (A FOLLOW-UP EXAMINATION)	EEG-EMG-ZEITSCHRIFT FUR ELEKTROENZEPHALOGRAPHIE ELEKTROMYOGRAPHIE UND VERWANDTE GEBIETE			German	Article						HEAD INJURIES; BRAIN CONCUSSION; FOLLOW-UP STUDIES; ELECTROENCEPHALOGRAPHY		The study was designed to examine the clinical applicability and use of computer-assisted EEG-analysis in comparsion to visual EEG-analysis in patients with minor head injuries. For this in 31 patients the following examinations were performed within the first 24 hours, one, three and eight weeks after traumatization: EEG, neurological examination and standardized evaluation of subjective complaints. The EEG was analysed visually as well as computer-assisted. The results were compared to the neurological findings and subjective complaints. Reversible posttraumatic EEG-changes were observed in 50% of all patients. The results of computer-analysis and visual analysis were equivalent in respect to baseline-activity (as one of the main characteristic EEG-features). Furthermore, based on computer-assisted analysis a discriminant function is provided, which is of diagnostic and prognostic value in the single patient. We conclude that the computer-assisted EEG-analysis can be a useful alternative in EEG-routine diagnosis after minor head injuries.	HANNOVER MED SCH,ZENTRUMS NEUROL MED,NEUROPHYSIOL KLIN,NEUROL KLIN,W-3000 HANNOVER 61,GERMANY								BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BUCY PC, 1970, JOM-J OCCUP MED, V12, P318; CHRISTIAN W, 1982, KLINISCHE ELEKTROENZ; COONLEYHOGANSON R, 1984, NEUROSURGERY, V14, P315, DOI 10.1227/00006123-198403000-00009; DOLCE G, 1975, CEAN COMPUTERIZED EE; FERBER G, 1983, THESIS HANNOVER; FUNFGELD E W, 1957, Zentralbl Neurochir, V17, P326; GRONWALL D, 1974, LANCET, V2, P605; GULBRANDSEN GB, 1984, J CLIN EXP NEUROPSYC, V3, P257; HJORTH B, 1970, ELECTROEN CLIN NEURO, V29, P306, DOI 10.1016/0013-4694(70)90143-4; JACOME DE, 1984, CLIN ENCEPHALOGR, V4, P214; JENNETT B, 1976, NEW ZEAL MED J, V84, P144; JONKMAN EJ, 1986, HDB ELECTROENCEPHALO, V2, P205; KOUFEN H, 1978, FORTSCHR NEUROL PSYC, V46, P165; KOUFEN H, 1975, THESIS U FREIBURG; KUTZNER M, 1982, UNFALLHEILKUNDE, V85, P179; RIMEL RW, 1982, NEUROSURGERY, V11, P334; RUSSEL WR, 1971, TRAUMATIC AMNESIAS; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SYMONDS C, 1961, LANCET, V1, P1; VANHUFFELEN AC, 1980, ELECTROEN CLIN NEURO, P125; VONBIERBRAUER A, 1989, THESIS HANNOVER	22	14	14	0	0	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0941-3790			EEG-EMG-Z ELEK ELEKT	EEG-EMG-Z. Elektroenz. Elektron. Geb.	SEP	1992	23	3					151	157					7	Engineering, Biomedical; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	JU618	WOS:A1992JU61800008	1425393				2022-02-06	
J	PERRY, DC; LYETH, BG; MILLER, LP; GETZ, RL; JENKINS, LW; HAYES, RL				PERRY, DC; LYETH, BG; MILLER, LP; GETZ, RL; JENKINS, LW; HAYES, RL			EFFECTS OF TRAUMATIC BRAIN INJURY IN RATS ON BINDING TO FOREBRAIN OPIATE RECEPTOR SUBTYPES	MOLECULAR AND CHEMICAL NEUROPATHOLOGY			English	Article						TRAUMATIC BRAIN INJURY; MU OPIATE RECEPTORS; KAPPA OPIATE RECEPTORS; HIPPOCAMPUS; DENTATE GYRUS; ENDOGENOUS OPIOIDS; EXCITOTOXICITY	FLUID-PERCUSSION MODEL; KAPPA-OPIOID RECEPTORS; SPINAL-CORD INJURY; ENDOGENOUS OPIOIDS; GERBIL HIPPOCAMPUS; ISCHEMIA; VULNERABILITY; RESPONSES; DEATH; CAT	Sprague-Dawley rats were subjected to a moderate level (2.2 atm) of traumatic brain injury (TBI) using fluid percussion. Injured animals were allowed to survive posttrauma for periods of 5 min, 3 h, and 24 h. The effect of TBI on binding to forebrain opiate receptors was assessed using quantitative receptor autoradiography, and compared to a sham control group. Binding of [H-3]DAGO to mu receptors in neocortex and the CA1 pyramidal layer of the hippocampus was significantly decreased in the 24-h group (p < 0.05). [H-3]Bremazocine binding to kappa receptors was unchanged at 5 min and 24 h, but showed large decreases 3 h after TBI in the CA1 pyramidal layer (65%, p < 0.05) and dentate gyrus (43%, p < 0.05). Levels of delta binding (measured with [H-3]DSLET) and lambda binding (measured with [H-3]naloxone) were unaffected by TBI. These data support previous suggestions of a role for endogenous opioids in TBI, and provide further evidence that mu and kappa opioid receptor subtypes in neocortex and hippocampus may have different functions in TBI.	VET ADM MED CTR,NEUROSCI LAB 151S,WASHINGTON,DC 20422; GEORGETOWN UNIV,SCH MED,DEPT PHARMACOL,WASHINGTON,DC 20007; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV NEUROSURG,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT ANAT,RICHMOND,VA 23298		PERRY, DC (corresponding author), GEORGE WASHINGTON UNIV,MED CTR,DEPT PHARMACOL,WASHINGTON,DC 20037, USA.			Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, R01NS021458, P50NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 21458, NS 12587] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [D 04191] Funding Source: Medline		DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1987, CLIN NEUROPHARMACOL, V10, P193, DOI 10.1097/00002826-198706000-00001; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FADEN AI, 1988, J PHARMACOL EXP THER, V245, P742; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; HOLADAY JW, 1985, ENDOGENOUS OPIOIDS T; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENKINS LW, 1988, J NEUROTRAUM, V5, P303; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MANSOUR A, 1987, J NEUROSCI, V7, P2445; MCGINTY JF, 1983, P NATL ACAD SCI-BIOL, V80, P589, DOI 10.1073/pnas.80.2.589; MCINTOSH T K, 1988, Society for Neuroscience Abstracts, V14, P1152; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCLEAN S, 1987, J COMP NEUROL, V255, P497, DOI 10.1002/cne.902550403; MIAZAKI S, 1989, INTRACRANIAL PRESSUR, V7, P651; MILLER LP, 1989, BRAIN RES, V495, P367, DOI 10.1016/0006-8993(89)90230-8; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; NORTH RA, 1979, LIFE SCI, V24, P1527, DOI 10.1016/0024-3205(79)90014-6; ORI C, 1989, ANESTHESIOLOGY, V70, P541, DOI 10.1097/00000542-198903000-00027; PATERSON SJ, 1983, BRIT MED BULL, V39, P31, DOI 10.1093/oxfordjournals.bmb.a071787; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PERRY DC, 1986, EUR J PHARMACOL, V129, P147, DOI 10.1016/0014-2999(86)90346-8; PULSINELLI WA, 1985, PROG BRAIN RES, V63, P29; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TEJWANI GA, 1991, NEUROPHARMACOLOGY, V30, P643, DOI 10.1016/0028-3908(91)90085-P; VINK R, 1990, J NEUROSCI, V10, P3524; ZIMMERMAN RS, 1990, NEUROSURGERY, V26, P764, DOI 10.1227/00006123-199005000-00005	32	14	14	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512	1044-7393			MOL CHEM NEUROPATHOL	Mol. Chem. Neuropathol.	FEB-APR	1992	16	1-2					95	107		10.1007/BF03159963			13	Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	HQ515	WOS:A1992HQ51500008	1325802				2022-02-06	
J	MARK, AS; PHISTER, SH; JACKSON, DE; KOLSKY, MP				MARK, AS; PHISTER, SH; JACKSON, DE; KOLSKY, MP			TRAUMATIC LESIONS OF THE SUPRASELLAR REGION - MR IMAGING	RADIOLOGY			English	Article						BRAIN, HEMORRHAGE; BRAIN, INJURIES; BRAIN, MR; NERVES, OPTIC	PITUITARY-STALK RUPTURE; DIABETES-INSIPIDUS; CHIASMAL SYNDROME; HEAD-INJURY	The authors studied nine patients with injuries to the suprasellar region with 1.5-T magnetic resonance (MR) imaging. Five patients had chiasmal injuries diagnosed by means of clinical examination. MR imaging demonstrated complete transection in two of these five patients, contusion of the chiasm by inferior herniation of the gyrus rectus in one, and a normal chiasm in two. Two patients had large tears of the floor of the third ventricle resulting in wide communication between the third ventricle and the prepontine cistern. One of these patients also had an avulsed third nerve. Transection of the pituitary stalk was seen in two patients. MR imaging can demonstrate injuries to the suprasellar structures. The MR imaging appearance of optic chiasm correlates with different types of injury to the chiasm described in the clinical literature and may alleviate the need for additional diagnostic studies to help explain the patient's symptoms.	UNIV CALIF SAN FRANCISCO,DEPT RADIOL,SAN FRANCISCO,CA 94143; GEORGE WASHINGTON UNIV,DEPT RADIOL,WASHINGTON,DC 20052; WASHINGTON HOSP CTR,DEPT OPHTHALMOL,WASHINGTON,DC 20010		MARK, AS (corresponding author), WASHINGTON HOSP CTR,DEPT RADIOL,110 IRVING ST NW,WASHINGTON,DC 20010, USA.						CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; FISHER NF, 1968, AM J OPHTHALMOL, V65, P237, DOI 10.1016/0002-9394(68)93594-0; FUJISAWA I, 1987, RADIOLOGY, V165, P487, DOI 10.1148/radiology.165.2.3659371; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GUY J, 1990, OPHTHALMOLOGY, V97, P592; HALIMI P, 1988, J COMPUT ASSIST TOMO, V12, P135, DOI 10.1097/00004728-198801000-00026; KELLY WM, 1988, AM J NEURORADIOL, V9, P453; MASSOL J, 1987, NEURORADIOLOGY, V29, P299, DOI 10.1007/BF00451773; OSTERBERG G, 1928, ACTA OPHTHALMOL, V16, P466; RESNECK JD, 1981, AM J OPHTHALMOL, V92, P233, DOI 10.1016/0002-9394(81)90778-9; SAVINO PJ, 1980, NEUROLOGY, V30, P963, DOI 10.1212/WNL.30.9.963; Traquair HM, 1935, BRAIN, V58, P398, DOI 10.1093/brain/58.3.398; WALSH FB, 1960, AM J OPHTHALMOL, V50, P1031, DOI 10.1016/0002-9394(60)90990-9; ZIMMERMAN RA, 1986, AM J ROENTGENOL, V147, P1215, DOI 10.2214/ajr.147.6.1215; [No title captured]	16	14	16	0	0	RADIOLOGICAL SOC NORTH AMER	EASTON	20TH AND NORTHAMPTON STS, EASTON, PA 18042	0033-8419			RADIOLOGY	Radiology	JAN	1992	182	1					49	52		10.1148/radiology.182.1.1727308			4	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	GW054	WOS:A1992GW05400012	1727308				2022-02-06	
J	PARKINSON, D				PARKINSON, D			CONCUSSION IS COMPLETELY REVERSIBLE - AN HYPOTHESIS	MEDICAL HYPOTHESES			English	Article								It is hypothesized that there is an entity properly called 'concussion', a transient loss of neuronal function without permanent neuronal damage, as defined years ago by Derek-Denny Brown (1). This implies that multiple concussions leave no deficit. n + 1 times zero is still zero. Arguments are presented indicating that there is a margin of safety between the acceleration inducing 1-10 s loss of function (concussion) and that inducing permanent damage (contusions, lacerations).			PARKINSON, D (corresponding author), UNIV MANITOBA,128 BASIC SCI BLDG,730 WILLIAM AVE,WINNIPEG R3E 0W3,MANITOBA,CANADA.						De Haven H, 1942, WAR MED, V2, P586; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; ESCHUN G, UNPUB MR SPECTROSCOP; FROWEIN RA, 1976, ACTA NEUROCHIR, V34, P5, DOI 10.1007/BF01405858; LINDSAY KW, 1980, BRIT MED J, V281, P789, DOI 10.1136/bmj.281.6243.789; LOMBARD CHARLES F., 1951, JOUR AVIATION MED, V22, P109; PARKINSON D, 1988, SURG NEUROL, V30, P102, DOI 10.1016/0090-3019(88)90094-8; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; PARKINSON D, 1989, UNPUB LIGHT EM STUDI; PARKINSON D, 1988, CHANGES NEUROTRANSMI, pA73; SUTHERLAND GR, 1991, IN PRESS NMR SPECTRO; WEST M, 1980, CAN FED BIOL SCI, V23, P141; WEST M, 1980, CAN J NEUROL SCI	13	14	14	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH, MIDLOTHIAN, SCOTLAND EH1 3AF	0306-9877			MED HYPOTHESES	Med. Hypotheses	JAN	1992	37	1					37	39		10.1016/0306-9877(92)90010-A			3	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	HE576	WOS:A1992HE57600009	1569905				2022-02-06	
J	SJOGREN, A; THELESTAM, M; BLOMQVIST, L; LINDA, H; REMAHL, S; RISLING, M				SJOGREN, A; THELESTAM, M; BLOMQVIST, L; LINDA, H; REMAHL, S; RISLING, M			EXTRAVASATION OF STAPHYLOCOCCAL ALPHA-TOXIN IN NORMAL AND INJURED CNS REGIONS LACKING BLOOD-BRAIN-BARRIER FUNCTION - OBSERVATIONS AFTER VENTRAL ROOT REPLANTATION	BRAIN RESEARCH			English	Article						BLOOD BRAIN BARRIER; INFECTION; BACTERIAL TOXIN; SPINAL CORD LESION; CENTRAL NERVOUS SYSTEM REGENERATION	NERVE GROWTH-FACTOR; SPINAL-CORD; ULTRASTRUCTURAL-LOCALIZATION; AXONAL REGENERATION; OPTIC-NERVE; ADULT CATS; RAT; NEURONS; SYSTEM; REINNERVATION	Staphylococcus aureus plays an important role as a bacterial pathogen after traumatic injury. The majority of isolated strains produces alpha-toxin, a 33-kDa protein, with membrane-damaging and lethal effects. The central nervous system (CNS) has been considered as the possible target for the lethal action of this toxin. A transfer of alpha-toxin across an intact blood-brain barrier (BBB) is however unlikely. The aim of the present study was to determine if alpha-toxin is accumulated in CNS regions which lack the BBB function. The distribution of alpha-toxin after intravascular injections, in normal mice and rats as well as in rats subjected to ventral root replantation, was assessed using immunogold technique. The results show that, although alpha-toxin does not cross the BBB, alpha-toxin-like immunoreactivity could be detected in the area postrema and at the optic nerve-retinal junction. Extravasation of alpha-toxin was also shown to occur in the spinal cord even 22 months after ventral root replantation. This finding suggests that axon regeneration after ventral root replantation takes place in a macromolecular environment which is totally different from the normal CNS. The implications of vascular spread of alpha-toxin to regions devoid of BBB function are discussed in relation to the bacterial infections which might complicate severe spinal injuries.	KAROLINSKA INST,DEPT ANAT,POB 60400,S-10401 STOCKHOLM 60,SWEDEN; KAROLINSKA INST,DEPT BACTERIOL,S-10401 STOCKHOLM 60,SWEDEN								ADAMO P, 1989, CAN J CARDIOL, V5, P395; BASBAUM AI, 1989, J HISTOCHEM CYTOCHEM, V37, P1811, DOI 10.1177/37.12.2479673; BHAKDI S, 1988, PROG ALLERGY, V40, P1; BHAKDI S, 1988, J EXP MED, V168, P527, DOI 10.1084/jem.168.2.527; BLOMQVIST L, 1987, INFECT IMMUN, V55, P1906, DOI 10.1128/IAI.55.8.1906-1913.1987; BLOMQVIST L, 1988, TOXICON, V26, P265, DOI 10.1016/0041-0101(88)90217-6; BORISON HL, 1989, TOXICOL APPL PHARM, V101, P399, DOI 10.1016/0041-008X(89)90190-7; BROMAN T, 1964, ACTA NEUROL SCAND, V40, P21, DOI 10.1111/j.1600-0404.1964.tb04718.x; CARLSTEDT T, 1986, ACTA PHYSIOL SCAND, V128, P645, DOI 10.1111/j.1748-1716.1986.tb08024.x; Carlstedt T, 1977, Acta Physiol Scand Suppl, V446, P5; CARPENTER DO, 1990, CAN J PHYSIOL PHARM, V68, P230, DOI 10.1139/y90-036; CHEN KF, 1987, TOXICON, V25, P631; CULLHEIM S, 1989, NEUROSCIENCE, V29, P725, DOI 10.1016/0306-4522(89)90144-9; DEWAELE M, 1988, J HISTOCHEM CYTOCHEM, V36, P679, DOI 10.1177/36.6.3259250; DUMOULIN GC, 1985, BRAIN RES, V340, P261, DOI 10.1016/0006-8993(85)90922-9; EDELWEJN Z, 1973, TOXICOL APPL PHARM, V25, P1, DOI 10.1016/0041-008X(73)90156-7; GATTI PJ, 1988, BRAIN RES, V448, P313, DOI 10.1016/0006-8993(88)91269-3; HARSHMAN S, 1985, TOXICON, V23, P801, DOI 10.1016/0041-0101(85)90011-X; HILDEBRAND C, 1985, J NEUROCYTOL, V14, P597, DOI 10.1007/BF01200800; HILDEBRAND C, 1976, J COMP NEUROL, V170, P191, DOI 10.1002/cne.901700205; KIERNAN JA, 1979, BIOL REV, V54, P155, DOI 10.1111/j.1469-185X.1979.tb00871.x; KIERNAN JA, 1980, ACTA NEUROPATHOL, V51, P39, DOI 10.1007/BF00688848; KIERNAN JA, 1985, J ANAT, V141, P139; LIPMAN JJ, 1985, TOXICON, V23, P325, DOI 10.1016/0041-0101(85)90155-2; LOHLER J, 1988, J NEUROIMMUNOL, V20, P181, DOI 10.1016/0165-5728(88)90159-2; MELLICK RS, 1968, BRAIN, V91, P141, DOI 10.1093/brain/91.1.141; PERSSON L, 1976, ACTA NEUROPATHOL, V34, P125, DOI 10.1007/BF00684663; PERSSON MAA, 1989, J NEUROIMMUNOL, V22, P135, DOI 10.1016/0165-5728(89)90044-1; PRIESTLEY JV, 1984, IMMUNOLABELLING ELEC, P37; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; RISLING M, 1983, BRAIN RES, V280, P15, DOI 10.1016/0006-8993(83)91169-1; RISLING M, 1989, BRAIN RES, V494, P13, DOI 10.1016/0006-8993(89)90138-8; RISLING M, 1990, PATHOPHYSIOLOGY BLOO, P555; ROSENSTEIN JM, 1987, SCIENCE, V235, P772, DOI 10.1126/science.2433767; ROTH J, 1978, J HISTOCHEM CYTOCHEM, V26, P1074, DOI 10.1177/26.12.366014; SASAKI T, 1986, NEUROSURGERY, V19, P177, DOI 10.1227/00006123-198608000-00002; SCHULTZBERG M, 1988, J NEUROSCI RES, V21, P56, DOI 10.1002/jnr.490210109; STEINWALL O, 1965, ACTA NEUROL SCAND, V4113, P591; STEPHANI U, 1987, J NEUROSCI RES, V17, P25, DOI 10.1002/jnr.490170105; STEWART PA, 1987, J NEUROSURG, V67, P697, DOI 10.3171/jns.1987.67.5.0697; STOECKEL K, 1977, BRAIN RES, V132, P273, DOI 10.1016/0006-8993(77)90421-8; THELESTAM M, 1988, TOXICON, V26, P51, DOI 10.1016/0041-0101(88)90137-7; VARNDELL IM, 1986, MODERN METHODS APPLI, P147; WADSTROM T, 1968, BIOCHIM BIOPHYS ACTA, V168, P228, DOI 10.1016/0005-2795(68)90146-3; ZAMBONI L, 1967, J CELL BIOL, V35, pA148	45	14	14	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	SEP 20	1991	559	2					276	282		10.1016/0006-8993(91)90012-K			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GK827	WOS:A1991GK82700012	1794101				2022-02-06	
J	DEACON, D; CAMPBELL, KB				DEACON, D; CAMPBELL, KB			DECISION-MAKING FOLLOWING CLOSED-HEAD INJURY - CAN RESPONSE SPEED BE RETRAINED	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							REACTION-TIME; P300	The present study was designed to assess the extent to which the effects of feedback (FB) and time windows, on the RTs of closed-head-injured outpatients, might carry-over when these external cues were removed. RT and evoked potentials were recorded while 12 closed-head-injured outpatients and 12 matched controls performed an auditory discrimination task. The FB and time windows were provided on three trials, then gradually removed. Following the removal of the FB and windows, patient RTs remained significantly faster and were approximately equal to the RTs of controls prior to the presentation of the cues. As in controls, the RTs of patients following removal of the cues occurred at approximately the same time as their P300s (the latency of this event-related potential component is thought to index stimulus evaluation time). To this extent, patient RTs did not appear to be exaggerated beyond the time needed for stimulus evaluation. The results obtained, therefore, provided tentative evidence that the experimental manipulation might have a lasting effect on CHI patient RTs.	UNIV OTTAWA,OTTAWA K1N 6N5,ONTARIO,CANADA								ANNETT J, 1966, Q J EXP PSYCHOL, V18, P179, DOI 10.1080/14640746608400027; BROOKHUIS KA, 1983, BIOL PSYCHOL, V17, P277, DOI 10.1016/0301-0511(83)90004-2; CAMPBELL K, 1986, STUDIES EVENT RELATE, V38, P486; Damasio A., 1979, CLIN NEUROPSYCHOLOGY, P360; DEACON D, 1991, ELECTROEN CLIN NEURO, V78, P133, DOI 10.1016/0013-4694(91)90113-I; DEACON D, 1990, UNPUB SPEED DECISION; DENCKER SJ, 1958, ACTA PSYCHIAT NEUROL, V33, P122; DUNCANJOHNSON CC, 1981, SCIENCE, V214, P938, DOI 10.1126/science.7302571; GREEN DM, 1966, SIGNAL DETECTION THE; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gronwall D, 1974, PSYCHOL EFFECTS CONC; JENNETT B, 1975, LANCET, V1, P480; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MAGLIERO A, 1984, PSYCHOPHYSIOLOGY, V21, P169; MAZZIOTTA J C, 1986, P493; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; Miller E, 1970, Cortex, V6, P121; MULDER G, 1984, PSYCHOL RES-PSYCH FO, V46, P15, DOI 10.1007/BF00308590; NORRMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236, DOI 10.1111/j.1600-0447.1961.tb07359.x; Pachella R., 1974, HUMAN INFORMATION PR, P41; Rabbit P.M.A., 1981, HUMAN SKILLS, P153; RABBITT P, 1979, BRIT J PSYCHOL, V70, P305, DOI 10.1111/j.2044-8295.1979.tb01687.x; RAGOT R, 1981, BIOL PSYCHOL, V13, P289, DOI 10.1016/0301-0511(81)90044-2; RAGOT R, 1984, PSYCHOPHYSIOLOGY, V21, P159, DOI 10.1111/j.1469-8986.1984.tb00199.x; RIMEL RW, 1983, REHABILITATION HEAD, P9; Ruesch J, 1944, AM J PSYCHIAT, V100, P480, DOI 10.1176/ajp.100.4.480; Van Zomeren A. H., 1981, REACTION TIME ATTENT; [No title captured]; [No title captured]	31	14	14	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	SEP	1991	13	5					639	651		10.1080/01688639108401079			13	Psychology, Clinical; Clinical Neurology; Psychology	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Neurosciences & Neurology	GK476	WOS:A1991GK47600001	1955521				2022-02-06	
J	THOMPSON, NM; EWINGCOBBS, L; FLETCHER, JM; MINER, ME; LEVIN, HS				THOMPSON, NM; EWINGCOBBS, L; FLETCHER, JM; MINER, ME; LEVIN, HS			LEFT UNILATERAL NEGLECT IN A PRESCHOOL-CHILD	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article								The authors present a case of transient left hemispatial inattention following traumatic brain injury in a three-year-old child. Computed tomographic scan revealed a small right frontal and a right temporo-parietal contusion. Stimuli were developed to quantify the response difference between hemifields in this pre-literate child. Hemispatial inattention showed resolution at 19 days post-trauma and had completely resolved six months later. These findings suggest that right hemisphere systems subserve visually guided attention before six years of age.	UNIV TEXAS,SCH MED,DEPT PSYCHIAT,SAN ANTONIO,TX 78285; UNIV TEXAS,SCH MED,DEPT PEDIAT,SAN ANTONIO,TX 78285; OHIO STATE UNIV,SCH MED,DEPT NEUROSURG,COLUMBUS,OH 43210; UNIV TEXAS,MED BRANCH,DIV NEUROSURG,GALVESTON,TX 77550		THOMPSON, NM (corresponding author), UNIV TEXAS,SCH MED,SW NEUROPSYCHIAT INST,8535 TOM SLICK DR,SAN ANTONIO,TX 78229, USA.		fletcher, jack/Q-5975-2019; Fletcher, Jack/AAX-2931-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline		Brain WR, 1941, BRAIN, V64, P244, DOI 10.1093/brain/64.4.244; CARROLL JB, 1973, J VERB LEARN VERB BE, V12, P556; FERRO JM, 1984, ANN NEUROL, V15, P281, DOI 10.1002/ana.410150314; FERRO JM, 1982, DEV MED CHILD NEUROL, V24, P173; HELLER W, 1989, J CLIN EXP NEUROPSYC, V11, P79; JOHNSTON CW, 1986, CORTEX, V22, P279, DOI 10.1016/S0010-9452(86)80052-1; McCarthy, 1972, MCCARTHY SCALES CHIL; TEASDALE G, 1974, LANCET, V2, P81; TERMAN LM, 1973, STANFORDBINET INTELL; [No title captured]	10	14	14	0	1	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211	0012-1622			DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	JUL	1991	33	7					640	644					5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	FR944	WOS:A1991FR94400011	1879627				2022-02-06	
J	ENDO, M; ICHIKAWA, F; MIYASAKA, Y; YADA, K; OHWADA, T				ENDO, M; ICHIKAWA, F; MIYASAKA, Y; YADA, K; OHWADA, T			CAPSULAR AND THALAMIC INFARCTION CAUSED BY TENTORIAL HERNIATION SUBSEQUENT TO HEAD TRAUMA	NEURORADIOLOGY			English	Article						DESCENDING TRANSTENTORIAL HERNIATION; CAPSULAR INFARCTION; THALAMIC INFARCTION; CT SCAN	COMPUTED TOMOGRAPHY	Five patients (4 male and 1 female) were observed to have capsular and thalamic infarction ascribed to descending transtentorial herniation (DTH) caused by head injury. A lucid interval immediately after the trauma and the presence of an epidural hematoma (EDH) characterized all five cases. At the time of hospitalization consciousness was seriously impaired and signs of cerebral herniation were apparent. Two to four days after the trauma, low attenuation in the computed tomography (CT) images pinpointed intracerebral damage in the anterolateral part of the thalamus and in the internal capsule on the same side as that of the EDH in three patients, and in the other two patients bilateral thalamic and capsular damage was noted. The low attenuation implicated the perforating arteries, that is the anterior thalamoperforating and anterior choroidal arteries, suggesting infarcted regions caused by occlusion of these arteries. Findings in the present study suggest that arterial occlusion in closed head injury may result from DTH. Moreover, infarction may be attributed to the delayed effects of injury.	KITASATO UNIV,SCH MED,DEPT CRIT CARE & EMERGENCY MED,SAGAMIHARA,KANAGAWA 228,JAPAN; KITASATO UNIV,SCH MED,DEPT NEUROSURG,SAGAMIHARA,KANAGAWA 228,JAPAN		ENDO, M (corresponding author), INT GOODWILL GEN HOSP,DEPT NEUROSURG,1-28-1 NISHIGAOKA,IZUMI KU,YOKOHAMA 245,JAPAN.						Evans JP, 1943, ARCH NEURO PSYCHIATR, V50, P258, DOI 10.1001/archneurpsyc.1943.02290210036002; GENTRY LR, 1988, AM J NEURORADIOL, V9, P91; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; LAZORTHES G, 1971, J NEUROSURG, V34, P23, DOI 10.3171/jns.1971.34.1.0023; LINDENBERG R, 1955, J NEUROPATH EXP NEUR, V14, P223, DOI 10.1097/00005072-195507000-00001; NAGASHIMA C, 1985, PROGR COMPUT TOMOGR, V7, P65; NIIKAWA S, 1988, Brain and Nerve (Tokyo), V40, P1151; OSBORN AG, 1977, RADIOLOGY, V123, P93, DOI 10.1148/123.1.93; Plets C, 1970, Acta Neurol Belg, V70, P687; STOVRING J, 1977, NEURORADIOLOGY, V14, P101, DOI 10.1007/BF00333050	10	14	14	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0028-3940			NEURORADIOLOGY	Neuroradiology		1991	33	4					296	299		10.1007/BF00587809			4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GA826	WOS:A1991GA82600002	1922742				2022-02-06	
J	Marsh, NV; Knight, RG; Godfrey, HPD				Marsh, Nigel V.; Knight, Robert G.; Godfrey, Hamish P. D.			Long-Term Psychosocial Adjustment Following Very Severe Closed Head Injury	NEUROPSYCHOLOGY			English	Article						Psychosocial adjustment; very severe closed head injury; chronic, community-dwelling, poor-outcome patients		This study examined the cognitive, psychological, and social functioning of 18 community-dwelling patients who had experienced a very severe closed head injury at least 18 months previously and still required contact with rehabilitation services. Results from the patients were compared to those obtained by a group of normal control subjects matched on age, sex, years of education, and an estimate of premorbid IQ. Information on the subjects' behavior was also obtained from their significant others. Results showed that the closed head injury patients exhibited deficits in their cognitive and social functioning but showed no signs of emotional or psychiatric disturbance. Attempts to find a relationship between the patients' cognitive impairment and their social functioning were only partially successful.	[Marsh, Nigel V.] Univ Waikato, Dept Psychol, Private Bag 3105, Hamilton, New Zealand; [Knight, Robert G.; Godfrey, Hamish P. D.] Univ Otago, Dept Psychol, Dunedin, New Zealand		Marsh, NV (corresponding author), Univ Waikato, Dept Psychol, Private Bag 3105, Hamilton, New Zealand.		Marsh, Nigel V./F-5433-2019; Marsh, Nigel/ABA-3609-2021	Marsh, Nigel V./0000-0002-4060-6432; Marsh, Nigel/0000-0002-4060-6432	Accident Compensation Corporation of New Zealand	This study was funded in part by the Accident Compensation Corporation of New Zealand.	BECK AT, 1972, POSTGRAD MED, V52, P81, DOI 10.1080/00325481.1972.11713319; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS DN, 1984, CLOSED HEAD INJURY P; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Buschke H., 1973, J VERB LEARN VERB BE, V12, P72; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Falloon I.R.H., 1984, FAMILY CARE SCHIZOPH; GODFREY HPD, 1987, NEW ZEAL J PSYCHOL, V16, P49; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; Grove W. M., 1982, J NERV MENT DIS, V170, P2; HOLM S, 1979, SCAND J STAT, V6, P65; KNIGHT RG, 1984, J CONSULT CLIN PSYCH, V52, P769; KNIGHT RG, 1984, J CLIN PSYCHOL, V40, P751, DOI 10.1002/1097-4679(198405)40:3<751::AID-JCLP2270400320>3.0.CO;2-Y; KORIAT A, 1985, J EXP PSYCHOL HUMAN, V11, P490, DOI 10.1037/0096-1523.11.4.490; KRAEMER HC, 1983, PSYCHOL BULL, V94, P367, DOI 10.1037/0033-2909.94.2.367; LARZELERE RE, 1977, PSYCHOL BULL, V84, P557, DOI 10.1037/0033-2909.84.3.557; LEVIN HS, 1982, NEUROBEHAVIOURAL CON; MCCORMICK IA, 1985, BEHAV ASSESS, V7, P95; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; Nelson H.E., 1982, NATL ADULT READING T; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PASHLER H, 1985, J EXP PSYCHOL HUMAN, V11, P105, DOI 10.1037/0096-1523.11.2.105; PECK DF, 1970, J CLIN PSYCHOL, V26, P67, DOI 10.1002/1097-4679(197001)26:1<67::AID-JCLP2270260117>3.0.CO;2-T; POWELL GE, 1980, BRIT J SOC CLIN PSYC, V19, P189, DOI 10.1111/j.2044-8260.1980.tb00947.x; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RATHUS SA, 1973, BEHAV THER, V4, P398, DOI 10.1016/S0005-7894(73)80120-0; RAVEN JC, 1977, MANUAL RAVENS PROGR; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Rosenberg M., 1965, SOC ADOLESCENT SELF; ROSENTHAL M, 1983, REHABILITATION HEAD; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Snedecor G.W., 1980, STAT METHODS, V7th; Spielberger CD, 1979, PRELIMINARY MA UNPUB; Spielberger CD, 1985, ANGER HOSTILITY CARD; Wechsler D., 1955, MANUAL WECHSLER ADUL; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111	41	14	14	0	7	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JAN	1990	4	1					13	27		10.1037/0894-4105.4.1.13			15	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	V44JX	WOS:000209746400002					2022-02-06	
J	LANSER, JBK; JENNEKENSSCHINKEL, A; PETERS, ACB				LANSER, JBK; JENNEKENSSCHINKEL, A; PETERS, ACB			HEADACHE AFTER CLOSED HEAD-INJURY IN CHILDREN	HEADACHE			English	Article									STATE UNIV HOSP LEIDEN,DEPT CHILD NEUROL,2300 RC LEIDEN,NETHERLANDS		LANSER, JBK (corresponding author), STATE UNIV HOSP LEIDEN,DEPT NEUROPSYCHOL,POB 9600,2300 RC LEIDEN,NETHERLANDS.						BARLOW CF, 1984, CLIN DEV MED, V91; BEEKMAN F, 1928, ANN SURG, V3, P355; BILLE B, 1962, ACTA PAEDIATR, V51, P33; BILLE B, 1968, HDB CLINICAL NEUROLO, V5, P239; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BLACK P, 1971, HEAD INJURIES, P131; Black P, 1972, T AM NEUROL ASSOC, V97, P247; BLACK P, 1969, LATE EFFECTS HEAD IN, P142; Black P, 1975, CIBA F S, V34, P215; BLACK P, 1970, PHYSICAL TRAUMA ETIO, P287; BLACK P, 1981, BRAIN DYSFUNCTION CH, P171; BURKINSHAW J, 1960, ARCH DIS CHILD, V35, P205, DOI 10.1136/adc.35.181.205; HJERN B, 1964, ACTA PAEDIAT SCAND S, V152; JAY GW, 1981, HEADACHE, V21, P5, DOI 10.1111/j.1526-4610.1981.hed2101005.x; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KOCH C, 1969, DAN MED BULL, V16, P109; Paris R., 1974, CLIN NEUROPSYCHOLOGY, P179; ROTHNER AD, 1978, HEADACHE, V18, P169, DOI 10.1111/j.1526-4610.1978.hed1803169.x; ROWBOTHAM GF, 1954, BRIT MED J, V1, P726, DOI 10.1136/bmj.1.4864.726; SILANPAA M, 1976, HEADACHE, V16, P288; SSOUHAREVA G, 1935, Z KINDERPSYCHIAT, V1, P165; [No title captured]; [No title captured]; [No title captured]	24	14	15	0	1	AMER ASSOC STUDY HEADACHE	WOODBURY	875 KINGS HIGHWAY, STE 200, WOODBURY, NJ 08096	0017-8748			HEADACHE	Headache	APR	1988	28	3					176	179		10.1111/j.1526-4610.1988.hed2803176.x			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	M8942	WOS:A1988M894200001	3384643				2022-02-06	
J	DAVIS, CS; ACTON, P				DAVIS, CS; ACTON, P			TREATMENT OF THE ELDERLY BRAIN-INJURED PATIENT - EXPERIENCE IN A TRAUMATIC BRAIN INJURY UNIT	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article									GAYLORD HOSP,WALLINGFORD,CT								CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; CARTLIDGE NEF, 1981, MAJOR PROBLEMS NEURO, V10, P13; CAVENESS WF, 1979, ADV NEUROL, V22, P1; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P67, DOI 10.1007/BF01809175; JENNETT B, 1976, LANCET, V1, P1031; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; MALKMUS D, 1980, REHABILITATION HEAD; ROSENTHAL M, 1983, REHABILITATION HEAD; TEASDALE G, 1982, HEAD INJURY BASIC CL, P213	9	14	14	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0002-8614			J AM GERIATR SOC	J. Am. Geriatr. Soc.	MAR	1988	36	3					225	229		10.1111/j.1532-5415.1988.tb01805.x			5	Geriatrics & Gerontology; Gerontology	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	M4419	WOS:A1988M441900007	3339231				2022-02-06	
J	KMIECIAKKOLADA, K; FELINSKA, W; STACHURA, Z; MAJCHRZAK, H; HERMAN, ZS				KMIECIAKKOLADA, K; FELINSKA, W; STACHURA, Z; MAJCHRZAK, H; HERMAN, ZS			CONCENTRATION OF BIOGENIC-AMINES AND THEIR METABOLITES IN DIFFERENT PARTS OF BRAIN AFTER EXPERIMENTAL CEREBRAL CONCUSSION	POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY			English	Article									SILESIAN MED ACAD,DEPT PHARMACOL,PL-41808 ZABRZE,POLAND; SILESIAN MED ACAD,CENT CLIN HOSP,DIV NEUROSURG,PL-40752 KATOWICE,POLAND		KMIECIAKKOLADA, K (corresponding author), SILESIAN MED ACAD,DEPT CLIN PHARMACOL,MEDYKOW 18,PL-40752 KATOWICE,POLAND.						BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BOISMARE E, 1976, CR SOC BIOL, V5, P170; COSTA JL, 1974, NATURE, V248, P135, DOI 10.1038/248135a0; COX RH, 1973, J NEUROCHEM, V20, P1777, DOI 10.1111/j.1471-4159.1973.tb00294.x; DEGROOT J, 1963, RAT FOREBRAIN STEREO; DENNYBROWN D, 1961, ARCH NEUROL-CHICAGO, V5, P1; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; KOBAYASHI R, 1975, CATECHOLAMINES STRES, P29; KORF J, 1975, CATECHOLAMINES STRES, P105; KVETNANSKY R, 1975, CATECHOLAMINES STRES, P39; LJUNGGREN B, 1975, INTRACRANIAL PRESSUR, V2, P189; MILLER F P, 1970, Biochemical Pharmacology, V19, P435, DOI 10.1016/0006-2952(70)90199-1; MRSULJA BB, 1978, J NEURAL TRANSM    S, V14, P23; OSTERHOLM JL, 1972, J NEUROSURG, V36, P386, DOI 10.3171/jns.1972.36.4.0386; OSTERHOLM JL, 1969, J NEUROSURG, V31, P408, DOI 10.3171/jns.1969.31.4.0408; PLECH A, 1981, POL J PHARMACOL PHAR, V33, P393; PORTA M, 1975, EUR NEUROL, V13, P545, DOI 10.1159/000114710; WELCH KMA, 1973, J NEUROL NEUROSUR PS, V36, P724, DOI 10.1136/jnnp.36.5.724; WESTERGAARD E, 1975, ACTA NEUROPATHOL, V32, P27, DOI 10.1007/BF00686065; WESTERINK BHC, 1976, EUR J PHARM, V38, P282; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617	21	14	14	0	0	POLISH ACAD SCIENCES INST PHARMACOLOGY	KRAKOW	SMETNA 12, 31-343 KRAKOW, POLAND	0301-0244			POL J PHARMACOL PHAR			1987	39	1					47	53					7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	H9856	WOS:A1987H985600008	2444951				2022-02-06	
J	FISHER, JM				FISHER, JM			COGNITIVE AND BEHAVIORAL CONSEQUENCES OF CLOSED HEAD-INJURY	SEMINARS IN NEUROLOGY			English	Article											FISHER, JM (corresponding author), NEW MEDICO ASSOC INC, CTR NEUROL, 28 KELLOGG RD, CORTLAND, NY 13045 USA.						ADAMOVICH BB, 1985, COGNITIVE REHABILITA; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BECKER B, 1977, J CLIN PSYCHOL, V47, P307; BENNA P, 1982, ITAL J NEUROL SCI, V3, P281, DOI 10.1007/BF02043575; BENTON A, 1979, CENTRAL NERVOUS SYST, P220; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; BOND MR, 1975, OUTCOME SEVERE DAMAG, P141; BOND MR, 1984, CLOSED HEAD INJURY P, P148; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; BROOKS N, 1985, COMMUNICATION   0429; BROOKS N, 1983, REHABILITATION HEAD, P185; COPE D, 1982, INCIDENCE PREVALENCE, P1; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DRUDGE OW, 1984, J CLIN PSYCHOL, V40, P259, DOI 10.1002/1097-4679(198401)40:1<259::AID-JCLP2270400149>3.0.CO;2-C; DYE OA, 1981, J CLIN PSYCHOL, V37, P472, DOI 10.1002/1097-4679(198107)37:3<472::AID-JCLP2270370304>3.0.CO;2-Q; FISHER J, 1981, THESIS U ROCHESTER; GAROUTTE B, 1984, PSYCHIAT ANN, V14, P507, DOI 10.3928/0048-5713-19840701-08; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1974, LANCET, V2, P605; Hagen C, 1981, TOP LANG DIS, V1, P73; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; JARVIE H, 1963, Curr Med Drugs, V3, P15; Jennett B, 1981, MANAGEMENT HEAD INJU; KALSBEEK WD, 1980, J NEUROSURG, V53, P519; Kolb B, 1980, FUNDAMENTALS HUMAN N; KURTZKE JF, 1982, NEUROLOGY, V32, P1207, DOI 10.1212/WNL.32.11.1207; KWENTUS JA, 1985, PSYCHOSOMATICS, V26, P8, DOI 10.1016/S0033-3182(85)72900-3; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LIPOWSKI ZJ, 1978, COMPR PSYCHIAT, V19, P309, DOI 10.1016/0010-440X(78)90013-5; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; LISHMAN WA, 1978, J IRISH MED ASSOC, V71, P306; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MACKWORTH N, 1982, COGNITIVE VISUAL ASS, P1; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; MILLER E, 1979, BRIT J SOC CLIN PSYC, V18, P87, DOI 10.1111/j.2044-8260.1979.tb00310.x; Miller E, 1970, Cortex, V6, P121; MILLER E, 1984, RECOVERY MANAGEMENT; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MUIR CA, 1983, REHABILITATION HEAD, P381; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Rosenthal M., 1983, REHABILITATION HEAD, P197; ROSENTHAL M, 1983, REHABILITATION HEAD, P407; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; RUTHERFORD WH, 1977, LANCET, V1, P1; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; SMITH E, 1974, J NEUROL NEUROSUR PS, V37, P719, DOI 10.1136/jnnp.37.6.719; Strub R. L., 1981, ORGANIC BRAIN SYNDRO; STUSS D, NEUROSURGERY; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; SYMONDS C, 1962, LANCET, V1, P1; TAYLOR AR, 1966, LANCET, V2, P178; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TRIMBLE M, 1983, POST TRAUMATIC NEURO; TSUANG MT, 1985, AM J PSYCHIAT, V142, P538; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Wood R., 1984, CLOSED HEAD INJURY P, P195	81	14	14	0	3	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.		1985	5	3					197	204		10.1055/s-2008-1041516			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	APU75	WOS:A1985APU7500002					2022-02-06	
J	LEVIN, HS; KALISKY, Z; HANDEL, SF; GOLDMAN, AM; EISENBERG, HM; MORRISON, D; VONLAUFEN, A				LEVIN, HS; KALISKY, Z; HANDEL, SF; GOLDMAN, AM; EISENBERG, HM; MORRISON, D; VONLAUFEN, A			MAGNETIC-RESONANCE IMAGING IN RELATION TO THE SEQUELAE AND REHABILITATION OF DIFFUSE CLOSED HEAD-INJURY - PRELIMINARY FINDINGS	SEMINARS IN NEUROLOGY			English	Article											LEVIN, HS (corresponding author), UNIV TEXAS, MED BRANCH, DIV NEUROSURG, GALVESTON, TX 77550 USA.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDRE A, 1983, J NEUROSURG, V59, P751, DOI 10.3171/jns.1983.59.5.0751; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; BYDDER GM, 1982, AM J ROENTGENOL, V139, P215, DOI 10.2214/ajr.139.2.215; CROOKS LE, 1982, RADIOLOGY, V144, P843, DOI 10.1148/radiology.144.4.7111736; GANDY SE, 1984, ANN NEUROL, V16, P254, DOI 10.1002/ana.410160217; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1974, LANCET, V2, P605; HAN JS, 1984, RADIOLOGY, V150, P71, DOI 10.1148/radiology.150.1.6689790; HANNAY H J, 1982, Journal of Clinical Neuropsychology, V4, P117; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; Holbourn AHS, 1943, LANCET, V2, P438; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; KIMURA D, 1963, ARCH NEUROL-CHICAGO, V8, P264, DOI 10.1001/archneur.1963.00460030048004; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1977, CORTEX, V13, P119, DOI 10.1016/S0010-9452(77)80003-8; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEVIN HS, BRAIN; LEVIN HS, ARCH NEUROL; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; MEYERS CA, 1983, J NEUROL NEUROSUR PS, V46, P1092, DOI 10.1136/jnnp.46.12.1092; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; RUBENS AB, 1977, ARCH NEUROL-CHICAGO, V34, P750, DOI 10.1001/archneur.1977.00500240038006; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; TEASDALE G, 1974, LANCET, V2, P81; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452	38	14	14	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.		1985	5	3					221	232		10.1055/s-2008-1041519			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	APU75	WOS:A1985APU7500005					2022-02-06	
J	BECKER, B				BECKER, B			INTELLECTUAL CHANGES AFTER CLOSED HEAD-INJURY	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article									USN,MED CTR,PSYCHOL DEPT,BETHESDA,MD 20014								HOTELLING H, 1951, 2 P BERK S MATH STAT, V23; Matarazzo JD, 1972, WECHSLERS MEASUREMEN	2	14	14	1	1	CLINICAL PSYCHOLOGY PUBL CO	BRANDON	4 CONANT SQUARE, BRANDON, VT 05733	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.		1975	31	2					307	309		10.1002/1097-4679(197504)31:2<307::AID-JCLP2270310231>3.0.CO;2-Y			3	Psychology, Clinical	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology	AA380	WOS:A1975AA38000030	1133197				2022-02-06	
J	Colvonen, PJ; Almklov, E; Tripp, JC; Ulmer, CS; Pittman, JOE; Afari, N				Colvonen, Peter J.; Almklov, Erin; Tripp, Jessica C.; Ulmer, Christi S.; Pittman, James O. E.; Afari, Niloofar			Prevalence rates and correlates of insomnia disorder in post-9/11 veterans enrolling in VA healthcare	SLEEP			English	Article						insomnia; prevalence rates; co-occurring disorders	POSTTRAUMATIC-STRESS-DISORDER; CLINICAL-PRACTICE GUIDELINE; TRAUMATIC BRAIN-INJURY; SHORT-SLEEP DURATION; CARDIOVASCULAR-DISEASE; IDENTIFICATION TEST; SEVERITY INDEX; ADULTS; RISK; DEPRESSION	Study Objectives: Post-9/11 veterans are particularly vulnerable to insomnia disorder. Having accurate prevalence rates of insomnia disorder in this relatively young, diverse population, is vital to determine the resources needed to identify and treat insomnia disorder. However, there are no accurate prevalence rates for insomnia disorder in post-9/11 veterans enrolling in the VA Healthcare System (VHA). We present accurate prevalence of insomnia disorder, and correlates, in a large sample of post-9/11 veterans enrolling in a VHA. Methods: This was an observational study of 5,552 post-9/11 veterans newly enrolling for health care in a VHA. Data were collected using VA eScreening. Insomnia diagnosis was determined using a clinical cutoff score of >= 11 on the Insomnia Severity Index. Measures also included sociodemographic, service history, posttraumatic stress disorder (PTSD), depression, suicidal ideation, alcohol misuse, military sexual trauma, traumatic brain injury (TBI), and pain intensity. Results: About 57.2% of the sample population had insomnia disorder. Our sample was nationally representative for age, sex, ethnicity, branch of the military, and race. The sample also was at high-risk for a host of clinical disorders, including PTSD, TBI, and pain; all of which showed higher rates of insomnia disorder (93.3%, 77.7%, and 69.6%, respectively). Conclusions: The findings suggest alarmingly high rates of insomnia disorder in this population. Examining and treating insomnia disorder, especially in the context of co-occurring disorders (e.g. PTSD), will be a necessity in the future.	[Colvonen, Peter J.; Almklov, Erin; Tripp, Jessica C.; Pittman, James O. E.; Afari, Niloofar] VA San Diego Healthcare Syst, 3350 La Jolla Village Dr,116B, San Diego, CA 92161 USA; [Colvonen, Peter J.; Tripp, Jessica C.; Pittman, James O. E.; Afari, Niloofar] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Colvonen, Peter J.; Pittman, James O. E.; Afari, Niloofar] VA Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Colvonen, Peter J.] Natl Ctr PTSD, White River Jct, VT USA; [Ulmer, Christi S.] VA Ctr Innovat Accelerate Discovery & Practice Tr, Durham, NC USA; [Ulmer, Christi S.] Duke Univ, Dept Psychiat & Behav Sci, Sch Med, Durham, NC USA		Colvonen, PJ (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr,116B, San Diego, CA 92161 USA.	peter.colvonen@va.gov			Department of Veterans Affairs (VA) Center of Excellence for Stress and Mental Health (CESAMH)US Department of Veterans Affairs; VA Center for Innovation; VA RRD CDA Grant [1lK2Rx002120-01]; VA Interprofessional Advanced Fellowship in Addiction Treatment	This material is the result of work supported by Department of Veterans Affairs (VA) Center of Excellence for Stress and Mental Health (CESAMH) and the VA Center for Innovation. This material also is the result of work supported with resources of the VA San Diego Healthcare System and the Durham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), (CIN 13-410) at the Durham VA Health Care System. Dr. Peter Colvonen is partly funded by VA RR&D CDA Grant #1lK2Rx002120-01. Dr Jessica Tripp is funded by a fellowship in VA Interprofessional Advanced Fellowship in Addiction Treatment supported by the office of academic affiliations.	Alexander M, 2016, SLEEP, V39, P1399, DOI 10.5665/sleep.5972; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Araujo T, 2017, SLEEP MED REV, V31, P58, DOI 10.1016/j.smrv.2016.01.003; Armitage R, 2007, ACTA PSYCHIAT SCAND, V115, P104, DOI 10.1111/j.1600-0447.2007.00968.x; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Buxton OM, 2010, SOC SCI MED, V71, P1027, DOI 10.1016/j.socscimed.2010.05.041; Calhoun DA, 2010, CHEST, V138, P434, DOI 10.1378/chest.09-2954; Cepeda MS, 2016, J CLIN SLEEP MED, V12, P813, DOI 10.5664/jcsm.5876; Cohen J., 2013, STAT POWER ANAL BEHA; Colvonen PJ, 2019, PSYCHOL TRAUMA-US, V11, P107, DOI 10.1037/tra0000402; Colvonen PJ, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0916-9; Colvonen PJ, 2015, J CLIN SLEEP MED, V11, P513, DOI 10.5664/jcsm.4692; Dew MA, 2003, PSYCHOSOM MED, V65, P63, DOI 10.1097/01.PSY.0000039756.23250.7C; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Faestel PM, 2013, J CLIN SLEEP MED, V9, P577, DOI 10.5664/jcsm.2754; Fernandez-Mendoza J, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0418-8; Ford ES, 2015, SLEEP MED, V16, P372, DOI 10.1016/j.sleep.2014.12.008; Fung CH, 2013, J CLIN SLEEP MED, V9, P1173, DOI 10.5664/jcsm.3162; Grandner MA, 2017, J CLIN SLEEP MED, V13, P937, DOI 10.5664/jcsm.6688; Haskell SG, 2010, J WOMENS HEALTH, V19, P267, DOI 10.1089/jwh.2008.1262; Hermes E, 2014, SLEEP MED, V15, P508, DOI 10.1016/j.sleep.2013.12.010; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hughes J, 2013, BEHAV SLEEP MED, V11, P258, DOI 10.1080/15402002.2012.683903; Hughes JM, 2018, CLIN PSYCHOL REV, V59, P118, DOI 10.1016/j.cpr.2017.11.005; Jenkins MM, 2015, SLEEP, V38, P1547, DOI 10.5665/sleep.5044; Katz DA, 2002, J FAM PRACTICE, V51, P229; Killgore WDS, 2006, J SLEEP RES, V15, P7, DOI 10.1111/j.1365-2869.2006.00487.x; Killgore WDS, 2008, SLEEP MED, V9, P517, DOI 10.1016/j.sleep.2007.07.003; Kimerling R, 2007, AM J PUBLIC HEALTH, V97, P2160, DOI 10.2105/AJPH.2006.092999; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Koffel E, 2018, J GEN INTERN MED, V33, P955, DOI 10.1007/s11606-018-4390-1; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leger D, 2010, SLEEP MED REV, V14, P379, DOI 10.1016/j.smrv.2010.01.003; Li M, 2014, INT J CARDIOL, V176, P1044, DOI 10.1016/j.ijcard.2014.07.284; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Manber R, 2012, J CLIN SLEEP MED, V8, P209, DOI 10.5664/jcsm.1786; Manber R, 2009, CURR PSYCHIAT REP, V11, P437, DOI 10.1007/s11920-009-0066-1; Martin JL, 2017, WOMEN HEALTH ISS, V27, P366, DOI 10.1016/j.whi.2016.12.003; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; Meneses-Gaya C, 2010, SUBST USE MISUSE, V45, P1542, DOI 10.3109/10826081003682206; Morin CM, 2013, SLEEP MED CLIN, V8, P281, DOI 10.1016/j.jsmc.2013.05.002; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 1999, SLEEP, V22, P1134, DOI 10.1093/sleep/22.8.1134; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Neylan TC, 1998, AM J PSYCHIAT, V155, P929, DOI 10.1176/ajp.155.7.929; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Pittman JOE, 2017, PSYCHOL SERV, V14, P23, DOI 10.1037/ser0000125; Plumb TR, 2014, PSYCHOL SERV, V11, P209, DOI 10.1037/a0034958; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Reynolds G, 2019, DEMOGRAPHICS US MILI; Roth T, 2007, SLEEP MED, V8, pS1, DOI 10.1016/S1389-9457(08)70001-7; Sateia MJ, 2017, J CLIN SLEEP MED, V13, P307, DOI 10.5664/jcsm.6470; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Seelig AD, 2016, SLEEP, V39, P1111, DOI 10.5665/sleep.5766; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Sjostrom N, 2007, SLEEP, V30, P91; Szentkiralyi Andras, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P49, DOI 10.1586/14737167.9.1.49; Taylor Daniel J, 2003, Behav Sleep Med, V1, P227, DOI 10.1207/S15402010BSM0104_5; Trockel M, 2015, SLEEP, V38, P259, DOI 10.5665/sleep.4410; Ulmer CS, 2017, J CLIN SLEEP MED, V13, P991, DOI 10.5664/jcsm.6702; Ulmer CS, 2015, J CLIN SLEEP MED, V11, P995, DOI 10.5664/jcsm.5012; VA/DOD, 2019, CLIN PRACT GUID MAN; Vgontzas AN, 2013, SLEEP MED REV, V17, P241, DOI 10.1016/j.smrv.2012.09.005; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Weathers F.W., 1993, 9 ANN C ISTSS; Xi B, 2014, SLEEP MED REV, V18, P293, DOI 10.1016/j.smrv.2013.06.001	71	13	13	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	DEC	2020	43	12							zsaa119	10.1093/sleep/zsaa119			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	PR9EQ	WOS:000607534300012	32529231	Green Accepted, hybrid			2022-02-06	
J	van Vliet, EA; Ndode-Ekane, XE; Lehto, LJ; Gorter, JA; Andrade, P; Aronica, E; Grohn, O; Pitkanen, A				van Vliet, Erwin A.; Ndode-Ekane, Xavier Ekolle; Lehto, Lauri J.; Gorter, Jan A.; Andrade, Pedro; Aronica, Eleonora; Grohn, Olli; Pitkanen, Asla			Long-lasting blood-brain barrier dysfunction and neuroinflammation after traumatic brain injury	NEUROBIOLOGY OF DISEASE			English	Article						Epilepsy; Epileptogenesis; Gadolinium; Contrast-enhance magnetic resonance imaging; Perilesional cortex; Thalamus	LATERAL FLUID-PERCUSSION; SPIKE-WAVE DISCHARGES; ANIMAL-MODELS; RAT; EPILEPSY; SEIZURE; LEAKAGE; DISRUPTION; BREAKDOWN; IMPACT	Background: Traumatic brain injury (TBI) causes 10-20% of acquired epilepsy, which typically develops within 2 years post-injury with poorly understood mechanisms. We investigated the location, severity, evolution and persistence of blood-brain barrier (BBB) dysfunction and associated neuroinflammation after TBI, and their contribution to post-traumatic seizure susceptibility. Methods: TBI was induced with lateral fluid-percussion in adult male Sprague-Dawley rats (6 sham, 12 TBI). Permeability of the BBB was assessed using T1-weighted magnetic resonance imaging (MRI) with gadobutrol (Gd) contrast enhancement at 4 days, 2 weeks, 2 months, and 10 months post-injury and with intravenously administered fluorescein at 11 months post-TBI. Continuous (24/7) video-EEG monitoring was performed for 3 weeks at 11 months post-injury followed by the pentylenetetrazol (PTZ) seizure-susceptibility test. In the end, rats were perfused for histology to assess albumin extravasation, iron deposits, calcifications, reactive astrocytes, microglia and monocytes. To investigate the translational value of the data obtained, BBB dysfunction and neuroinflammation were investigated immunohistochemically in autopsy brain tissue from patients with TBI and PTE. Results: MRI indicated persistent Gd leakage in the impacted cortex and thalamus of variable severity in all rats with TBI which correlated with fluorescein extravasation. In the impacted cortex BBB dysfunction was evident from 4 days post-injury onwards to the end of the 10-months follow-up. In the ipsilateral thalamus, leakage was evident at 2 and 10 months post-injury. The greater the BBB leakage in the perilesional cortex at 10 months after the injury, the greater the expression of the endothelial cell antigen RECA-1 (r = 0.734, p < 0.01) and the activated macrophages/monocytes/microglia marker CD68 (r = 0.699, p < 0.05) at 11 months post-injury. Seven of the 12 rats with TBI showed increased seizure susceptibility in the PTZ-test. Unlike expected, we did not find any association between increased Gd-leakage or neuroinflammation with seizure susceptibility at 11 months post-TBI. Analysis of human autopsy tissue indicated that similar to the animal model, chronic BBB dysfunction was also evident in the perilesional cortex and thalamus of patients with PTE, characterized by presence of albumin, iron deposits and calcifications as well as markers of neuroinflammation, including reactive astrocytes, microglia and monocytes. Conclusions: Rats and humans with TBI have long-lasting cortical BBB dysfunction and neuroinflammation. Focal Gd-enhancement matched with loci of neuroinflammation, particularly in the thalamus. Although BBB leakage did not associate with increased seizure susceptibility after TBI, our data suggest that for treatments aimed to mitigate BBB damage and its secondary pathologies like chronic neuroinflammation, there is a regionspecific, long-lasting therapeutic time window.	[van Vliet, Erwin A.; Gorter, Jan A.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, POB 94246, NL-1090 GE Amsterdam, Netherlands; [van Vliet, Erwin A.; Aronica, Eleonora] Univ Amsterdam, Dept Neuro Pathol, Amsterdam Neurosci, Amsterdam UMC, Amsterdam, Netherlands; [Ndode-Ekane, Xavier Ekolle; Lehto, Lauri J.; Andrade, Pedro; Grohn, Olli; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Aronica, Eleonora] Stichting Epilepsie Instellingen Nederland SEIN, Heemstede, Netherlands		van Vliet, EA (corresponding author), Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, POB 94246, NL-1090 GE Amsterdam, Netherlands.	e.a.vanvliet@uva.nl	Andrade, Pedro/N-8410-2018	Andrade, Pedro/0000-0001-9118-8341; van Vliet, Erwin/0000-0001-5747-3202; Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632	European Union's Seventh Framework Programme (FP7/2007-2013) [602102]; Medical Research Council of the Academy of FinlandAcademy of Finland [272249, 273909, 2285733-9]; Sigrid Juselius FoundationSigrid Juselius Foundation; Dutch Epilepsy Foundation [16-05]; COST Action "Brain Extracellular Matrix in Health and Disease" (ECMnet) [BM1001]	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no602102 (EPITARGET; EAvV, EA, JAG, AP), the Medical Research Council of the Academy of Finland (Grants 272249, 273909, and 2285733-9)(AP), the Sigrid Juselius Foundation (AP), the Dutch Epilepsy Foundation, project number 16-05 (EAvV), and COST Action BM1001 "Brain Extracellular Matrix in Health and Disease" (ECMnet; EAvV, JAG, EA, AP)..	Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Andrade P, 2019, J NEUROTRAUM, V36, P1890, DOI 10.1089/neu.2018.6107; Andrade P, 2018, J NEUROSCI METH, V307, P37, DOI 10.1016/j.jneumeth.2018.06.015; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bar-Klein G, 2014, ANN NEUROL, V75, P864, DOI 10.1002/ana.24147; Bar-Klein G, 2017, BRAIN, V140, P1692, DOI 10.1093/brain/awx073; Bar-Klein G, 2016, ANN NEUROL, V80, P896, DOI 10.1002/ana.24804; Frey L, 2014, NEUROL RES, V36, P26, DOI 10.1179/1743132813Y.0000000269; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Hall ED, 2016, TRANSLATIONAL RES TR, P239; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Kadam SD, 2017, EPILEPSIA, V58, P10, DOI 10.1111/epi.13903; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kim H, 2017, J NEUROSURG, V127, P23, DOI 10.3171/2016.7.JNS161263; Kim S, 2019, BRAIN INJURY, V33, P442, DOI 10.1080/02699052.2019.1565896; Lehto LJ, 2012, NEUROIMAGE, V61, P761, DOI 10.1016/j.neuroimage.2012.03.002; LEWIS DA, 1986, J COMP NEUROL, V248, P1, DOI 10.1002/cne.902480102; Liao CC, 2008, ANAT REC, V291, P960, DOI 10.1002/ar.20696; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Michalak Z, 2012, J NEUROPATH EXP NEUR, V71, P826, DOI 10.1097/NEN.0b013e31826809a6; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; Obermeier B., 2016, BLOOD BRAIN BARRIER, P39, DOI [10.1016/B978-0-444-63432-0.00003-7, DOI 10.1016/B978-0-444-63432-0.00003-7]; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Perry D.C., 2017, PSYCHIAT DIS METAANA, V124, P511, DOI [10.3171/2015.2.JNS14503, DOI 10.3171/2015.2.JNS14503.TRAUMATIC]; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Schweser F, 2019, NEUROIMAGE, V200, P250, DOI 10.1016/j.neuroimage.2019.06.024; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Taylor JA, 2019, J NEUROSCI, V39, P4829, DOI 10.1523/JNEUROSCI.1167-18.2019; Taylor JA, 2017, J NEUROSCI, V37, P5861, DOI 10.1523/JNEUROSCI.3235-16.2017; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; van Vliet EA, 2015, SEMIN CELL DEV BIOL, V38, P26, DOI 10.1016/j.semcdb.2014.10.003; van Vliet EA, 2014, NEUROSCIENCE, V277, P455, DOI 10.1016/j.neuroscience.2014.07.030; van Vliet EA, 2014, NEUROBIOL DIS, V63, P74, DOI 10.1016/j.nbd.2013.11.019; Vezzani A, 2002, EPILEPSIA, V43, P30, DOI 10.1046/j.1528-1157.43.s.5.14.x; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yasmin A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00863; Young GB, 2010, NEUROLOGY, V75, P760, DOI 10.1212/WNL.0b013e3181f32141	58	13	13	5	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	NOV	2020	145								105080	10.1016/j.nbd.2020.105080			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OC5HY	WOS:000579188500023	32919030	hybrid, Green Published			2022-02-06	
J	Rajan, KB; Aggarwal, NT; McAninch, EA; Weuve, J; Barnes, LL; Wilson, RS; DeCarli, C; Evans, DA				Rajan, Kumar B.; Aggarwal, Neelum T.; McAninch, Elizabeth A.; Weuve, Jennifer; Barnes, Lisa L.; Wilson, Robert S.; DeCarli, Charles; Evans, Denis A.			Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study	ANNALS OF NEUROLOGY			English	Article							PLASMA NEUROFILAMENT LIGHT; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; CLINICAL-DIAGNOSIS; WHITE DECEDENTS; IMPAIRMENT; ASSOCIATION; MILD; CHAIN; SEGMENTATION	Objective The longitudinal association of the blood biomarkers total tau (t-tau), neurofilament light (Nf-L), and glial fibrillary acidic protein (GFAP) with common sporadic Alzheimer disease (AD) and cognitive decline is not established. Methods Using a single molecule array technology, ultrasensitive immunoassays for serum concentrations of t-tau, Nf-L, and GFAP were measured in a population sample of 1,327 participants (60% African Americans and women) who had a clinical evaluation for AD, had completed in-home cognitive assessments, and had undergone 1.5T structural magnetic resonance imaging. Results Higher concentrations of serum biomarkers were associated with the development of clinical AD; especially, the time-specific associations were notable: t-tau 8 to 16 years, and Nf-L and GFAP 4 to 8 years prior to clinical AD. Serum biomarkers were associated with faster cognitive decline over 16 years; baseline t-tau > 0.40pg/ml had 30% faster decline, Nf-L > 25.5pg/ml had 110% faster decline, and GFAP > 232pg/ml had 130% faster decline compared to those in the lowest quartile. Participants with baseline GFAP > 232pg/ml showed 160% faster decline in hippocampal volume compared to those with values < 160pg/ml. Additionally, higher baseline t-tau was associated with faster increase in 3rd ventricular volume, and baseline Nf-L and GFAP were associated with faster decline in cortical thickness. Interpretation Serum t-tau, Nf-L, and GFAP predict the development of sporadic AD and cognitive decline, and changes in structural brain characteristics, suggesting their usefulness not only as screening and predictive biomarkers, but also in capturing the pathogenesis of Alzheimer dementia. ANN NEUROL 2020	[Rajan, Kumar B.] Univ Calif Davis, Dept Publ Hlth Sci, One Shields Ave,Med Sci 1C,Room 117, Davis, CA 95616 USA; [Rajan, Kumar B.] Univ Calif Davis, Alzheimers Dis Ctr, Sacramento, CA 95817 USA; [Aggarwal, Neelum T.; Barnes, Lisa L.; Wilson, Robert S.] Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [McAninch, Elizabeth A.; Evans, Denis A.] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Weuve, Jennifer] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; [DeCarli, Charles] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA		Rajan, KB (corresponding author), Univ Calif Davis, Dept Publ Hlth Sci, One Shields Ave,Med Sci 1C,Room 117, Davis, CA 95616 USA.	kbrajan@ucdavis.edu	DeCarli, Charles/B-5541-2009	McAninch, Elizabeth/0000-0003-3993-4663	NIH R01 grantsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AG051635, RF1AG057532, R01AG058679]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG010129]	This study was supported by NIH R01 grants R01AG051635, RF1AG057532, and R01AG058679 and National Institute on Aging grants P30AG010129.	Aggarwal NT, 2010, ARCH NEUROL-CHICAGO, V67, P475, DOI 10.1001/archneurol.2010.42; Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; Barnes LL, 2015, NEUROLOGY, V85, P528, DOI 10.1212/WNL.0000000000001834; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Bennett DA, 2006, NEUROEPIDEMIOLOGY, V27, P169, DOI 10.1159/000096129; Cairns NJ, 2004, J PATHOL, V204, P438, DOI 10.1002/path.1650; Das SR, 2009, NEUROIMAGE, V45, P867, DOI 10.1016/j.neuroimage.2008.12.016; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Diggle P., 2002, ANAL LONGITUDINAL DA; Elahi FM, 2020, ALZHEIMERS DEMENT, V16, P681, DOI 10.1016/j.jalz.2019.09.004; Fakhoury M, 2018, CURR NEUROPHARMACOL, V16, P508, DOI 10.2174/1570159X15666170720095240; Filshtein TJ, 2019, J ALZHEIMERS DIS, V68, P145, DOI 10.3233/JAD-180992; Fletcher E, 2012, IEEE ENG MED BIO, P106, DOI 10.1109/EMBC.2012.6345882; Fletcher E, 2012, IEEE ENG MED BIO, P5319, DOI 10.1109/EMBC.2012.6347195; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Gattringer T, 2017, NEUROLOGY, V89, P2108, DOI 10.1212/WNL.0000000000004645; Hansson O, 2017, NEUROLOGY, V88, P930, DOI 10.1212/WNL.0000000000003680; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Lee DY, 2010, STROKE, V41, P1791, DOI 10.1161/STROKEAHA.110.582163; Lin CH, 2019, NEUROLOGY, V93, pE1104, DOI 10.1212/WNL.0000000000008088; Liu ZW, 2016, PROG NEUROBIOL, V144, P103, DOI 10.1016/j.pneurobio.2015.09.008; Lu CH, 2015, NEUROLOGY, V84, P2247, DOI 10.1212/WNL.0000000000001642; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mielke MM, 2017, JAMA NEUROL, V74, P1073, DOI 10.1001/jamaneurol.2017.1359; Moore EE, 2018, NEUROBIOL AGING, V70, P233, DOI 10.1016/j.neurobiolaging.2018.06.023; Oeckl P, 2019, J ALZHEIMERS DIS, V67, P481, DOI 10.3233/JAD-180325; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/s1474-4422(16)00070-3, 10.1016/S1474-4422(16)00070-3]; Pase MP, 2019, JAMA NEUROL, V76, P598, DOI 10.1001/jamaneurol.2018.4666; Pase MP, 2018, NEUROLOGY, V91, P1479, DOI 10.1212/WNL.0000000000006360; Peltz CB, 2020, NEUROLOGY, V95, pE1126, DOI 10.1212/WNL.0000000000010087; Preische O, 2019, NAT MED, V25, P277, DOI 10.1038/s41591-018-0304-3; R Core Team, 2012, R LANG ENV STAT COMP; Rajan KB, 2015, NEUROLOGY, V85, P898, DOI 10.1212/WNL.0000000000001774; Rajapakse JC, 1996, MAGN RESON IMAGING, V14, P1053, DOI 10.1016/S0730-725X(96)00113-0; Rojas JC, 2016, ANN CLIN TRANSL NEUR, V3, P216, DOI 10.1002/acn3.290; Sandelius A, 2018, NEUROLOGY, V90, pE518, DOI 10.1212/WNL.0000000000004932; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Swan GE, 1998, NEUROLOGY, V51, P986, DOI 10.1212/WNL.51.4.986; Thambisetty M, 2010, BIOMARK MED, V4, P65, DOI 10.2217/BMM.09.84; Vannini P, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.102097; Weston PSJ, 2017, NEUROLOGY, V89, P2167, DOI 10.1212/WNL.0000000000004667; Wilson RS, 1999, J GERONTOL B-PSYCHOL, V54, pP155, DOI 10.1093/geronb/54B.3.P155; Zetterberg H, 2008, EUR J NEUROL, V15, P1143, DOI 10.1111/j.1468-1331.2008.02275.x; Zetterberg H, 2019, J NEUROSCI METH, V319, P2, DOI 10.1016/j.jneumeth.2018.10.025	47	13	13	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	DEC	2020	88	6					1065	1076		10.1002/ana.25874		SEP 2020	12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OR5IQ	WOS:000573345300001	32799383				2022-02-06	
J	Luostarinen, T; Virta, J; Satopaa, J; Backlund, M; Kivisaari, R; Korja, M; Raj, R				Luostarinen, Teemu; Virta, Jyri; Satopaa, Jarno; Backlund, Minna; Kivisaari, Riku; Korja, Miikka; Raj, Rahul			Intensive care of traumatic brain injury and aneurysmal subarachnoid hemorrhage in Helsinki during the Covid-19 pandemic	ACTA NEUROCHIRURGICA			English	Article						COVID-19; Traumatic brain injury; Subarachnoid hemorrhage; Intensive care		Background To ensure adequate intensive care unit (ICU) capacity for SARS-CoV-2 patients, elective neurosurgery and neurosurgical ICU capacity were reduced. Further, the Finnish government enforced strict restrictions to reduce the spread. Our objective was to assess changes in ICU admissions and prognosis of traumatic brain injury (TBI) and aneurysmal subarachnoid hemorrhage (SAH) during the Covid-19 pandemic. Methods Retrospective review of all consecutive patients with TBI and aneurysmal SAH admitted to the neurosurgical ICU in Helsinki from January to May of 2019 and the same months of 2020. The pre-pandemic time was defined as weeks 1-11, and the pandemic time was defined as weeks 12-22. The number of admissions and standardized mortality rates (SMRs) were compared to assess the effect of the Covid-19 pandemic on these. Standardized mortality rates were adjusted for case mix. Results Two hundred twenty-four patients were included (TBIn= 123, SAHn= 101). There were no notable differences in case mix between TBI and SAH patients admitted during the Covid-19 pandemic compared with before the pandemic. No notable difference in TBI or SAH ICU admissions during the pandemic was noted in comparison with early 2020 or 2019. SMRs were no higher during the pandemic than before. Conclusion In the area of Helsinki, Finland, there were no changes in the number of ICU admissions or in prognosis of patients with TBI or SAH during the Covid-19 pandemic.	[Luostarinen, Teemu] Helsinki Univ Hosp, Dept Anaesthesiol Intens Care & Pain Med, Div Anaesthesiol, Topeliuksenkatu 5,POB 266, Helsinki 00029, Finland; [Virta, Jyri; Satopaa, Jarno; Kivisaari, Riku; Korja, Miikka; Raj, Rahul] Univ Helsinki, Dept Neurosurg, Helsinki, Finland; [Virta, Jyri; Satopaa, Jarno; Kivisaari, Riku; Korja, Miikka; Raj, Rahul] Helsinki Univ Hosp, Helsinki, Finland; [Backlund, Minna] Helsinki Univ Hosp, Dept Anaesthesiol Intens Care & Pain Med, Div Intens Care, Helsinki, Finland		Luostarinen, T (corresponding author), Helsinki Univ Hosp, Dept Anaesthesiol Intens Care & Pain Med, Div Anaesthesiol, Topeliuksenkatu 5,POB 266, Helsinki 00029, Finland.	teemu.luostarinen@hus.fi	Satopaa, Jarno/E-9102-2015; Korja, Miikka/E-4292-2016	Satopaa, Jarno/0000-0002-2674-0301; Korja, Miikka/0000-0002-4463-6954; Virta, Jyri/0000-0002-5150-938X	University of Helsinki including Helsinki University Central Hospital	Open access funding provided by Open access funding provided by University of Helsinki including Helsinki University Central Hospital.	Alko, 2020, ALK MYYNT TUOT LAAJ; Backes D, 2016, J NEUROSURG, V125, P737, DOI 10.3171/2015.8.JNS151473; De Filippo O, 2020, NEW ENGL J MED, V383, P88, DOI 10.1056/NEJMc2009166; Diegoli H, 2020, STROKE, V51, P2315, DOI 10.1161/STROKEAHA.120.030481; Hecht N, 2020, ACTA NEUROCHIR, V162, P1795, DOI 10.1007/s00701-020-04437-z; Hoyer C, 2020, STROKE, V51, P2224, DOI 10.1161/STROKEAHA.120.030395; Huhtakangas J, 2015, STROKE, V46, P1813, DOI 10.1161/STROKEAHA.115.009288; Hulsbergen AFC, 2020, ACTA NEUROCHIR, V162, P1485, DOI 10.1007/s00701-020-04375-w; Jean WC, 2020, ACTA NEUROCHIR, V162, P1229, DOI 10.1007/s00701-020-04342-5; Lindfors M, 2018, ACTA NEUROCHIR, V160, P2107, DOI 10.1007/s00701-018-3670-1; Mathiesen T, 2020, ACTA NEUROCHIR, V162, P2221, DOI 10.1007/s00701-020-04482-8; Puljula J, 2013, ACTA NEUROL SCAND, V127, P192, DOI 10.1111/j.1600-0404.2012.01697.x; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Sebastian S, 2019, STROKE, V50, P2216, DOI 10.1161/STROKEAHA.119.025872; Suomen virallinen tilasto (SVT), 2020, TIEL VERKK; Tartara F, 2020, ACTA NEUROCHIR, V162, P1501, DOI 10.1007/s00701-020-04385-8; Teo KC, 2020, STROKE, V51, P2228, DOI 10.1161/STROKEAHA.120.030105; THL, 2020, INFL JA B SUOM; Zoia C, 2020, ACTA NEUROCHIR, V162, P1221, DOI 10.1007/s00701-020-04305-w	19	13	13	1	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2020	162	11					2715	2724		10.1007/s00701-020-04583-4		SEP 2020	10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OC5DX	WOS:000572616500001	32974834	Green Published, hybrid			2022-02-06	
J	Alosco, ML; Tripodis, Y; Baucom, ZH; Mez, J; Stein, TD; Martin, B; Haller, O; Conneely, S; McClean, M; Nosheny, R; Mackin, S; Mckee, AC; Weiner, MW; Stern, RA				Alosco, Michael L.; Tripodis, Yorghos; Baucom, Zachary H.; Mez, Jesse; Stein, Thor D.; Martin, Brett; Haller, Olivia; Conneely, Shannon; McClean, Michael; Nosheny, Rachel; Mackin, Scott; Mckee, Ann C.; Weiner, Michael W.; Stern, Robert A.			Late contributions of repetitive head impacts and TBI to depression symptoms and cognition	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; RISK; DEMENTIA; ENCEPHALOPATHY; CONSCIOUSNESS; ASSOCIATION; CONCUSSION; TUTORIAL; VALIDITY	Objective To test the hypothesis that repetitive head impacts (RHIs), like those from contact sport play and traumatic brain injury (TBI) have long-term neuropsychiatric and cognitive consequences, we compared middle-age and older adult participants who reported a history of RHI and/or TBI with those without this history on measures of depression and cognition. Methods This cross-sectional study included 13,323 individuals (mean age, 61.95; 72.5% female) from the Brain Health Registry who completed online assessments, including the Ohio State University TBI Identification Method, the Geriatric Depression Scale (GDS-15), and the CogState Brief Battery and Lumos Labs NeuroCognitive Performance Tests. Inverse propensityweighted linear regressions accounting for age, sex, race/ethnicity, and education tested the effects of RHI and TBI compared to a non-RHI/TBI group. Results A total of 725 participants reported RHI exposure (mostly contact sport play and abuse) and 7,277 reported TBI (n = 2,604 with loss of consciousness [LOC]). RHI (beta, 1.24; 95% CI, 0.36-2.12), TBI without LOC (beta, 0.43; 95% CI, 0.31- 0.54), and TBI with LOC (beta, 0.75; 95% CI, 0.59-0.91) corresponded to higher GDS-15 scores. While TBI with LOC had the most neuropsychological associations, TBI without LOC had a negative effect on CogState Identification (beta, 0.004; 95% CI, 0.001-0.01) and CogState One Back Test (beta, 0.004; 95% CI, 0.0002-0.01). RHI predicted worse CogState One Back Test scores (beta, 0.02; 95% CI, -0.01 to 0.05). There were RHI x TBI interaction effects on several neuropsychological subtests, and participants who had a history of both RHI and TBI with LOC had the greatest depression symptoms and worse cognition. Conclusions RHI and TBI independently contributed to worse mid- to later-life neuropsychiatric and cognitive functioning.	[Alosco, Michael L.; Mez, Jesse; Haller, Olivia; Conneely, Shannon; Mckee, Ann C.; Stern, Robert A.] Boston Univ, Alzheimers Dis Ctr, Dept Neurol, Boston, MA 02215 USA; [Stein, Thor D.; Mckee, Ann C.] Boston Univ, Dept Pathol & Lab Med, Dept Neurol, Boston, MA 02215 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Tripodis, Yorghos; Baucom, Zachary H.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Martin, Brett] Boston Univ, Sch Publ Hlth, Biostat & Epidemiol Data Analyt Ctr, Boston, MA USA; [McClean, Michael] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Stein, Thor D.; Mckee, Ann C.] VA Boston Healthcare Syst, Bedford, MA USA; [Stein, Thor D.; Mckee, Ann C.] Dept Vet Affairs Med Ctr, Bedford, MA USA; [Nosheny, Rachel; Mackin, Scott; Weiner, Michael W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Biomed Imaging, San Francisco, CA 94143 USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Nosheny, Rachel; Mackin, Scott; Weiner, Michael W.] Ctr Imaging & Neurodegenerat Dis, Dept Vet AffairsMed Ctr, San Francisco, CA USA		Alosco, ML (corresponding author), Boston Univ, Alzheimers Dis Ctr, Dept Neurol, Boston, MA 02215 USA.	malosco@bu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01NS093334, K23AG046377, K23NS102399, P30AG013846]	This work was supported by grant funding from the NIH (U01NS093334, K23AG046377, K23NS102399, P30AG013846).	Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Alosco ML, 2019, JAMA NEUROL, V76, P1298, DOI 10.1001/jamaneurol.2019.2244; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Baldwin GT, 2018, HAND CLINIC, V158, P63, DOI 10.1016/B978-0-444-63954-7.00007-0; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Elze MC, 2017, J AM COLL CARDIOL, V69, P345, DOI 10.1016/j.jacc.2016.10.060; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Grauwmeijer E, 2018, J NEUROTRAUM, V35, P1543, DOI 10.1089/neu.2017.5404; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kaup AR, 2017, J INT NEUROPSYCH SOC, V23, P56, DOI 10.1017/S1355617716000849; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Mackin R Scott, 2018, Alzheimers Dement (Amst), V10, P573, DOI 10.1016/j.dadm.2018.05.005; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; McCaffrey DF, 2013, STAT MED, V32, P3388, DOI 10.1002/sim.5753; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Morley WA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00166; Morrison GE, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01652; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Nosheny Rachel L, 2018, Alzheimers Dement (N Y), V4, P565, DOI 10.1016/j.trci.2018.09.008; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Sugarman MA, 2019, ALZHEIMERS DEMENT, V15, P686, DOI 10.1016/j.jalz.2018.12.015; Tripodis Y, 2017, J ALZHEIMERS DIS, V59, P251, DOI 10.3233/JAD-160585; Weiner MW, 2018, ALZHEIMERS DEMENT, V14, P1063, DOI 10.1016/j.jalz.2018.02.021; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; Weiner Michael W, 2017, Alzheimers Dement (N Y), V3, P177, DOI 10.1016/j.trci.2017.02.005; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	47	13	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	AUG 18	2020	95	7					E793	E804		10.1212/WNL.0000000000010040			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	QI8ZW	WOS:000619277100002	32591472	Green Published			2022-02-06	
J	Devoto, C; Lai, C; Qu, BX; Guedes, VA; Leete, J; Wilde, E; Walker, WC; Diaz-Arrastia, R; Kenney, K; Gill, J				Devoto, Christina; Lai, Chen; Qu, Bao-Xi; Guedes, Vivian A.; Leete, Jacqueline; Wilde, Elisabeth; Walker, William C.; Diaz-Arrastia, Ramon; Kenney, Kimbra; Gill, Jessica			Exosomal MicroRNAs in Military Personnel with Mild Traumatic Brain Injury: Preliminary Results from the Chronic Effects of Neurotrauma Consortium Biomarker Discovery Project	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; concussion; exosomes; military; mTBI	GROWTH-FACTOR-I; RETINOIC ACID; MESSENGER-RNAS; INSULIN; EXPRESSION; PATHWAYS; SIRT1; DIFFERENTIATION; INHIBITION; PLASTICITY	Chronic symptoms after mild traumatic brain injury (mTBI) are common among veterans and service members, and represent a significant source of morbidity, with those who sustain multiple mTBIs at greatest risk. Exosomal micro-RNAs (miRNAs), mediators of intercellular communication, may be involved in chronic TBI symptom persistence. Exosomal miRNA (exomiR) was extracted from 153 participants enrolled in the Chronic Effect of Neurotrauma Consortium (CENC) longitudinal study (no TBI,n = 35; >= 3 mTBIs (rTBI),n = 45; 1-2 mTBIs,n = 73). Analyses were performed with nCounter(R)Human miRNA Expression Panels and Ingenuity Pathway Analysis (IPA) for identification of gene networks associated with TBI. Generalized linear models were used to analyze the predictive value of exomiR dysregulation and remote neurobehavioral symptoms. Compared with controls, there were 17 dysregulated exomiRs in the entire mTBI group and 32 dysregulated exomiRs in the rTBI group. Two miRNAs, hsa-miR-139-5p and hsa-miR-18a-5p, were significantly differentially expressed in the rTBI and 1-2 mTBI groups. IPA analyses showed that these dysregulated exomiRs correlated with pathways of inflammatory regulation, neurological disease, and cell development. Within the rTBI group, exomiRs correlated with gene activity for hub-genes of tumor protein TP53, insulin-like growth factor 1 receptor, and transforming growth factor beta. TBI history and neurobehavioral symptom survey scores negatively and significantly correlated with hsa-miR-103a-3p expression. Participants with remote mTBI have distinct exomiR profiles, which are significantly linked to inflammatory and neuronal repair pathways. These profiles suggest that analysis of exosomal miRNA expression may provide novel insights into the underlying pathobiology of chronic TBI symptom persistence.	[Devoto, Christina; Lai, Chen; Guedes, Vivian A.; Leete, Jacqueline; Gill, Jessica] NINR, Tissue Injury Branch, NIH, Bethesda, MD 20892 USA; [Devoto, Christina; Gill, Jessica] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Rehabil Med, NIH, Bethesda, MD 20814 USA; [Qu, Bao-Xi; Kenney, Kimbra] Uniformed Serv Univ Hlth Sci, Dept Neurol, NIH, Bethesda, MD 20814 USA; [Qu, Bao-Xi; Kenney, Kimbra] Uniformed Serv Univ Hlth Sci, CENC Biorepository, Rockville, MD USA; [Wilde, Elisabeth] Univ Utah, CENC Imaging Core, Salt Lake City, UT USA; [Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Diaz-Arrastia, Ramon] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA		Kenney, K (corresponding author), Bldg 51,Room 1502B 4860 South Palmer Rd, Bethesda, MD 20889 USA.; Gill, J (corresponding author), NINR, NIH, 1 Cloisters Court Bldg 60,Room 259, Bethesda, MD 20892 USA.	kimbra.kenney@usuhs.edu; gillj@nih.gov		de Alvarenga Guedes, Vivian/0000-0001-8478-2465	VHA Central Office VA TBI Model Systems Program of Research/DHA Contracting Office (CO-NCR) [W91YTZ-13-C-0015/HT0014-19-C-0004, HT0014]; United States Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); United States Department of Veterans Affairs Chronic Effects of Neurotrauma ConsortiumUS Department of Veterans Affairs [W81XWH-13-2-0095]	This work was prepared under Contract W91YTZ-13-C-0015/HT0014-19-C-0004 with VHA Central Office VA TBI Model Systems Program of Research/DHA Contracting Office (CO-NCR) HT0014 and, therefore, is defined as United States government work under Title 17 U.S.C.x101. Per Title 17 U.S.C.x105, copyright protection is not available for any work of the U.S. Government. For more information, please contactdha.DVBICinfo@mail.mil.This material is also based upon work supported by the United States Army Medical Research and Material Com-mand and from the United States Department of Veterans Affairs Chronic Effects of Neurotrauma Consortium under Award No. W81XWH-13-2-0095. The United States Army Medical Research Acquisition Activity, 820 Chandler Street, Fort DetrickMD217025014 is the awarding and administering acquisition office.	Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Alemzadeh E, 2020, J BIOMED MATER RES B, V108, P555, DOI 10.1002/jbm.b.34411; Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Chandran R, 2017, BRAIN INJURY, V31, P106, DOI 10.1080/02699052.2016.1213420; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Connolly RM, 2013, CLIN CANCER RES, V19, P1651, DOI 10.1158/1078-0432.CCR-12-3175; Das BC, 2014, BIOORGAN MED CHEM, V22, P673, DOI 10.1016/j.bmc.2013.11.025; DeKosky, 1998, Semin Clin Neuropsychiatry, V3, P176; Diez del Corral R, 2003, NEURON, V40, P65; Ding I, 1997, CYTOKINE, V9, P59, DOI 10.1006/cyto.1996.0136; Edgar JR, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0268-z; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Fujita Y, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00778; Glover JC, 2006, J NEUROBIOL, V66, P705, DOI 10.1002/neu.20272; Gui YX, 2015, ONCOTARGET, V6, P37043, DOI 10.18632/oncotarget.6158; Haenzi B, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/2740768; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Huang B, 2012, NEUROBIOL DIS, V46, P204, DOI 10.1016/j.nbd.2012.01.008; Jeong WY, 2017, BIOSCI BIOTECH BIOCH, V81, P1356, DOI 10.1080/09168451.2017.1308243; Labandeira-Garcia JL, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00365; Lee DC, 2009, MOL CELL NEUROSCI, V41, P348, DOI 10.1016/j.mcn.2009.04.010; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Leidinger P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r78; Levy AD, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00116; Liou CJ, 2019, ASN NEURO, V11, DOI 10.1177/1759091419839515; Liu PT, 2005, J IMMUNOL, V174, P2467, DOI 10.4049/jimmunol.174.5.2467; Lugli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139233; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Maden M, 2006, J NEUROBIOL, V66, P726, DOI 10.1002/neu.20248; Magni M, 2018, MUTAT RES-REV MUTAT, V776, P1, DOI 10.1016/j.mrrev.2018.03.004; Management of Concussion-Mild Traumatic Brain Injury Working Group, 2016, J REHABILITATION RES, V46; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; McCaffery PJ, 2003, EUR J NEUROSCI, V18, P457, DOI 10.1046/j.1460-9568.2003.02765.x; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Murray B, 1998, P NATL ACAD SCI USA, V95, P11975, DOI 10.1073/pnas.95.20.11975; Noel A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00140; Patel JP, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/708306; Patz S, 2013, J NEUROTRAUM, V30, P1232, DOI 10.1089/neu.2012.2596; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Pons-Espinal M, 2017, STEM CELL REP, V8, P1046, DOI 10.1016/j.stemcr.2017.02.012; Pulliam L, 2015, DNA CELL BIOL, V34, P459, DOI 10.1089/dna.2015.2884; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Reza-Zaldivar EE, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00317; Sergi C, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00093; Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith-Vikos T, 2013, GENOME BIOL, V14, DOI 10.1186/gb4116; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Stanley M, 2016, J EXP MED, V213, P1375, DOI 10.1084/jem.20160493; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Taylor SM, 2019, DEV NEUROBIOL, V79, P202, DOI 10.1002/dneu.22666; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Wang XY, 2002, J NEUROTRAUM, V19, P615, DOI 10.1089/089771502753754082; Wang YJ, 2019, EUR J MED CHEM, V161, P48, DOI 10.1016/j.ejmech.2018.10.028; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhou S, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00748	67	13	13	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2020	37	23					2482	2492		10.1089/neu.2019.6933		JUL 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PC0XQ	WOS:000547823900001	32458732	Green Published			2022-02-06	
J	Olesen, MA; Torres, AK; Jara, C; Murphy, MP; Tapia-Rojas, C				Olesen, Margrethe A.; Torres, Angie K.; Jara, Claudia; Murphy, Michael P.; Tapia-Rojas, Cheril			Premature synaptic mitochondrial dysfunction in the hippocampus during aging contributes to memory loss	REDOX BIOLOGY			English	Article						Synaptic; Non-synaptic; Mitochondria; Aging; Hippocampus; Memory	TARGETED ANTIOXIDANT MITOQ; TRAUMATIC BRAIN-INJURY; SPATIAL MEMORY; NONSYNAPTIC MITOCHONDRIA; OXIDATIVE STRESS; CEREBRAL-CORTEX; CURCUMIN; SYNAPTOSOMES; EXPRESSION; PLASTICITY	Aging is a process characterized by cognitive impairment and mitochondrial dysfunction. In neurons, these organelles are classified as synaptic and non-synaptic mitochondria depending on their localization. Interestingly, synaptic mitochondria from the cerebral cortex accumulate more damage and are more sensitive to swelling than non-synaptic mitochondria. The hippocampus is fundamental for learning and memory, synaptic processes with high energy demand. However, it is unknown if functional differences are found in synaptic and non-synaptic hippocampal mitochondria; and whether this could contribute to memory loss during aging. In this study, we used 3, 6, 12 and 18 month-old (mo) mice to evaluate hippocampal memory and the function of both synaptic and non-synaptic mitochondria. Our results indicate that recognition memory is impaired from 12mo, whereas spatial memory is impaired at 18mo. This was accompanied by a differential function of synaptic and non-synaptic mitochondria. Interestingly, we observed premature dysfunction of synaptic mitochondria at 12mo, indicated by increased ROS generation, reduced ATP production and higher sensitivity to calcium overload, an effect that is not observed in non-synaptic mitochondria. In addition, at 18mo both mitochondrial populations showed bioenergetic defects, but synaptic mitochondria were prone to swelling than non-synaptic mitochondria. Finally, we treated 2, 11, and 17mo mice with MitoQ or Curcumin (Cc) for 5 weeks, to determine if the prevention of synaptic mitochondrial dysfunction could attenuate memory loss. Our results indicate that reducing synaptic mitochondrial dysfunction is sufficient to decrease age-associated cognitive impairment. In conclusion, our results indicate that age-related alterations in ATP produced by synaptic mitochondria are correlated with decreases in spatial and object recognition memory and propose that the maintenance of functional synaptic mitochondria is critical to prevent memory loss during aging.	[Olesen, Margrethe A.; Torres, Angie K.; Jara, Claudia; Tapia-Rojas, Cheril] Univ San Sebastian, Ctr Biol Celular & Biomed CEBICEM, Lab Neurobiol Aging, Santiago, Chile; [Murphy, Michael P.] Univ Cambridge, MRC, Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge, England		Tapia-Rojas, C (corresponding author), Univ San Sebastian, Lab Neurobiol Aging, CEBICEM, Carmen Sylva 2444, Santiago, Chile.	cheril.tapia@uss.cl		Jara, Claudia/0000-0001-7478-1143; Tapia Rojas, Cheril/0000-0002-7084-0318	FONDECYTComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT [11170546]; Medical Research Council UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U105663142]; Wellcome Trust Investigator awardWellcome Trust [110159/Z/15/Z]; PIA CONICYTComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [ECM-07]; CONICYT PAI [77170091]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U105663142, MC_UU_00015/3] Funding Source: UKRI	This work was supported by FONDECYT No 11170546 and CONICYT PAI N degrees 77170091 to CTR. Work in the MPM lab was supported by the Medical Research Council UK (MC_U105663142) and by a Wellcome Trust Investigator award (110159/Z/15/Z). The authors acknowledge the services provided by UC CINBIOT Animal Facility funded by PIA CONICYT* ECM-07. *Program for Associative Research, of the Chilean National Countil for Science and Technology.	Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Baumgartner HK, 2009, J BIOL CHEM, V284, P20796, DOI 10.1074/jbc.M109.025353; Behzadfar L, 2017, METALLOMICS, V9, P969, DOI 10.1039/c7mt00075h; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Burke SN, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00015; Canas PM, 2009, NEUROBIOL AGING, V30, P1877, DOI 10.1016/j.neurobiolaging.2008.01.003; Chakraborty M, 2017, INDIAN J PHARMACOL, V49, P65, DOI 10.4103/0253-7613.201015; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen WX, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8285065; de Castro AL, 2015, MOL CELL BIOCHEM, V408, P235, DOI 10.1007/s11010-015-2501-4; Devine MJ, 2018, NAT REV NEUROSCI, V19, P63, DOI 10.1038/nrn.2017.170; Dillon SE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13853-8; Ding WX, 2012, J BIOL CHEM, V287, P42373, DOI 10.1074/jbc.M112.413674; Divakaruni SS, 2018, NEURON, V100, P860, DOI 10.1016/j.neuron.2018.09.025; Du H, 2012, ANTIOXID REDOX SIGN, V16, P1467, DOI 10.1089/ars.2011.4277; Du SP, 2019, J MOL NEUROSCI, V67, P540, DOI 10.1007/s12031-019-01267-2; Emelyanova L, 2018, J GERONTOL A-BIOL, V73, P608, DOI 10.1093/gerona/glx160; Erickson CA, 2003, EXP GERONTOL, V38, P61, DOI 10.1016/S0531-5565(02)00160-2; Ferrarini L, 2014, INT PSYCHOGERIATR, V26, P1067, DOI 10.1017/S1041610213002627; Fjell AM, 2014, PROG NEUROBIOL, V117, P20, DOI 10.1016/j.pneurobio.2014.02.004; Foster DJ, 2012, CURR OPIN NEUROBIOL, V22, P294, DOI 10.1016/j.conb.2011.12.005; Freeman David W., 2017, MATTERS, P387; Fukui K, 2002, ANN NY ACAD SCI, V959, P275, DOI 10.1111/j.1749-6632.2002.tb02099.x; Gilmer LK, 2010, MECH AGEING DEV, V131, P133, DOI 10.1016/j.mad.2009.12.011; Gioscia-Ryan RA, 2018, J APPL PHYSIOL, V124, P1194, DOI 10.1152/japplphysiol.00670.2017; GOLOMB J, 1993, ARCH NEUROL-CHICAGO, V50, P967, DOI 10.1001/archneur.1993.00540090066012; Gonzalez-Freire M, 2015, J GERONTOL A-BIOL, V70, P1334, DOI 10.1093/gerona/glv070; Graham LC, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0221-9; Grimm A, 2017, J NEUROCHEM, V143, P418, DOI 10.1111/jnc.14037; Gutierrez-Aguilar M, 2015, BBA-GEN SUBJECTS, V1850, P2041, DOI 10.1016/j.bbagen.2014.11.009; Haider S, 2014, AGE, V36, P1291, DOI 10.1007/s11357-014-9653-0; Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123; Hara Y, 2014, P NATL ACAD SCI USA, V111, P486, DOI 10.1073/pnas.1311310110; Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002; Ishii T, 2017, AGING CELL, V16, P39, DOI 10.1111/acel.12523; Ivannikov MV, 2013, J MOL NEUROSCI, V49, P223, DOI 10.1007/s12031-012-9848-8; Jara C., 2019, BOOK MITOCHONDRIAL B; Jara C, 2018, REDOX BIOL, V18, P279, DOI 10.1016/j.redox.2018.07.010; Jiang J, 2015, TOXICOL LETT, V234, P139, DOI 10.1016/j.toxlet.2015.02.012; Kaja S, 2015, MOL NEUROBIOL, V52, P545, DOI 10.1007/s12035-014-8877-4; Karadayian AG, 2015, NEUROSCIENCE, V304, P47, DOI 10.1016/j.neuroscience.2015.07.012; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kiebish MA, 2009, ASN NEURO, V1, DOI 10.1042/AN20090011; Kim Y., 2018, INT J ENV RES PUBL H, V15; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Levy M, 2003, J BIOL CHEM, V278, P17727, DOI 10.1074/jbc.M212878200; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lindenberger U, 2008, FRONT NEUROSCI-SWITZ, V2, P234, DOI 10.3389/neuro.01.039.2008; Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100; Lores-Arnaiz S, 2019, EXP GERONTOL, V118, P88, DOI 10.1016/j.exger.2019.01.012; Lores-Arnaiz S, 2011, NEUROSCIENCE, V188, P117, DOI 10.1016/j.neuroscience.2011.04.060; Lores-Arnaiz S, 2016, NEUROCHEM RES, V41, P353, DOI 10.1007/s11064-015-1817-5; Mattson MP, 2018, CELL METAB, V27, P1176, DOI 10.1016/j.cmet.2018.05.011; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; McKenzie M., 2017, JOVE, V119; McManus MJ, 2011, J NEUROSCI, V31, P15703, DOI 10.1523/JNEUROSCI.0552-11.2011; Meghana K, 2007, EUR J PHARMACOL, V577, P183, DOI 10.1016/j.ejphar.2007.09.002; Mercer JR, 2012, FREE RADICAL BIO MED, V52, P841, DOI 10.1016/j.freeradbiomed.2011.11.026; Miquel E, 2014, FREE RADICAL BIO MED, V70, P204, DOI 10.1016/j.freeradbiomed.2014.02.019; Muller M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00470; Na LX, 2013, MOL NUTR FOOD RES, V57, P1569, DOI 10.1002/mnfr.201200131; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Nyberg L, 2017, J INTERN MED, V281, P65, DOI 10.1111/joim.12533; O'Shea A, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00298; Parajuli B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.503; Pardo J., 2018, J GERONTOL A, V73; Perez MJ, 2017, DEV BIOL, V426, P1, DOI 10.1016/j.ydbio.2017.04.018; Picard B.S.M. Martin, 2014, MITOCHONDRIA IMPACT; Picard M, 2014, P NATL ACAD SCI USA, V111, P7, DOI 10.1073/pnas.1321881111; Pistell PJ, 2012, NEUROBIOL AGING, V33, P2431, DOI 10.1016/j.neurobiolaging.2011.12.004; Porto ML, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0201-8; Priyadarsini KI, 2003, FREE RADICAL BIO MED, V35, P475, DOI 10.1016/S0891-5849(03)00325-3; Reddy PH, 2011, CURR ALZHEIMER RES, V8, P393; Rodriguez-Cuenca S, 2010, FREE RADICAL BIO MED, V48, P161, DOI 10.1016/j.freeradbiomed.2009.10.039; Rossi MJ, 2019, CURR OPIN NEUROBIOL, V57, P149, DOI 10.1016/j.conb.2019.02.001; Santos-Parker JR, 2017, AGING-US, V9, P187, DOI 10.18632/aging.101149; Satrustegui J, 1996, LIFE SCI, V59, P429, DOI 10.1016/0024-3205(96)00322-0; Seo KI, 2008, MOL NUTR FOOD RES, V52, P995, DOI 10.1002/mnfr.200700184; Smith RAJ, 2011, DISCOV MED, V11, P106; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445; Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5; Stauch KL, 2014, J PROTEOME RES, V13, P2620, DOI 10.1021/pr500295n; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Tapia-Rojas C, 2019, NEUROSCIENCE, V406, P356, DOI 10.1016/j.neuroscience.2019.03.018; Tapia-Rojas C, 2018, J NEUROCHEM, V144, P443, DOI 10.1111/jnc.14278; VILLALBA M, 1995, NEUROBIOL AGING, V16, P809, DOI 10.1016/0197-4580(95)00087-U; Villanueva-Castillo C, 2017, NEUROBIOL AGING, V49, P119, DOI 10.1016/j.neurobiolaging.2016.09.010; Volgyi K, 2015, J PROTEOMICS, V120, P142, DOI 10.1016/j.jprot.2015.03.005; Vogel-Ciernia Annie, 2014, Curr Protoc Neurosci, V69, DOI 10.1002/0471142301.ns0831s69; Vos Melissa, 2010, Front Synaptic Neurosci, V2, P139, DOI 10.3389/fnsyn.2010.00139; Wang YL, 2017, CELL PHYSIOL BIOCHEM, V43, P2226, DOI 10.1159/000484302; Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003; Weinrich TW, 2017, NEUROBIOL AGING, V60, P34, DOI 10.1016/j.neurobiolaging.2017.08.016; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Xi Y, 2018, BBA-MOL BASIS DIS, V1864, P2859, DOI 10.1016/j.bbadis.2018.05.018; Yilmaz S, 2019, IRAN J BASIC MED SCI, V22, P418, DOI 10.22038/ijbms.2019.33623.8019; Yu P., 2018, J CEREBR BLOOD FLOW; Villar MFZ, 2018, J NEURAL TRANSM, V125, P1787, DOI 10.1007/s00702-018-1928-7; Zhou J, 2018, AM J TRANSL RES, V10, P1887; Zhuravliova E, 2012, CELL MOL NEUROBIOL, V32, P1311, DOI 10.1007/s10571-012-9857-8; Zinski J, 2017, ELIFE, V6, DOI 10.7554/eLife.22199	105	13	13	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2213-2317			REDOX BIOL	Redox Biol.	JUL	2020	34								101558	10.1016/j.redox.2020.101558			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	ME8MS	WOS:000544908000014	32447261	Green Published, gold			2022-02-06	
J	Ashina, H; Iljazi, A; Al-Khazali, HM; Eigenbrodt, AK; Larsen, EL; Andersen, AM; Hansen, KJ; Brauner, KB; Morch-Jessen, T; Chaudhry, B; Antic, S; Christensen, CE; Ashina, M; Amin, FM; Schytz, HW				Ashina, Hakan; Iljazi, Afrim; Al-Khazali, Haidar Muhsen; Eigenbrodt, Anna Kristina; Larsen, Eigil Lindekilde; Andersen, Amalie Middelboe; Hansen, Kevin John; Brauner, Karoline Bendix; Morch-Jessen, Thomas; Chaudhry, Basit; Antic, Sonja; Christensen, Casper Emil; Ashina, Messoud; Amin, Faisal Mohammad; Schytz, Henrik Winther			Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study	JOURNAL OF HEADACHE AND PAIN			English	Article						Concussion; Secondary headache; Head trauma; Head injury; Clinical management	PAIN	Background Calcitonin gene-related peptide (CGRP) has recently been implicated in the pathogenesis of post-traumatic headache (PTH), which raises the prospect for therapeutic use of monoclonal antibodies targeting CGRP or its receptor. Therefore, we decided to assess the efficacy, tolerability, and safety of erenumab for prevention of persistent PTH attributed to mild traumatic brain injury. Methods A single-center, non-randomized, single-arm, open-label study of erenumab for adults aged 18-65 years with persistent PTH. Patients were assigned to receive 140-mg erenumab monthly by two subcutaneous 1-mL injections, given every 4 weeks for 12 weeks. The primary outcome measure was the mean change in number of monthly headache days of moderate to severe intensity from baseline (4-week pretreatment period) to week 9 through 12. Tolerability and safety endpoints were adverse events (i.e. number and type). Results Eighty-nine of 100 patients completed the open-label trial. At baseline, the mean monthly number of headache days of moderate to severe intensity was 15.7. By week 9 through 12, the number was reduced by 2.8 days. The most common adverse events were constipation (n = 30) and injection-site reactions (n = 15). Of 100 patients who received at least one dose of erenumab, two patients discontinued the treatment regimen due to adverse events. Conclusions Among patients with persistent PTH, erenumab resulted in a lower frequency of moderate to severe headache days in this 12-week open-label trial. In addition, erenumab was well-tolerated as discontinuations due to adverse events were low. Placebo-controlled randomized clinical trials are needed to adequately evaluate the efficacy and safety of erenumab in patients with persistent PTH.	[Ashina, Hakan; Iljazi, Afrim; Al-Khazali, Haidar Muhsen; Eigenbrodt, Anna Kristina; Larsen, Eigil Lindekilde; Andersen, Amalie Middelboe; Hansen, Kevin John; Brauner, Karoline Bendix; Morch-Jessen, Thomas; Chaudhry, Basit; Christensen, Casper Emil; Ashina, Messoud; Amin, Faisal Mohammad; Schytz, Henrik Winther] Univ Copenhagen, Fac Hlth & Med Sci, Rigshosp Glostrup, Danish Headache,Ctr Dept Neurol, Valdemar Hansens Vej 5, DK-2600 Glostrup, Denmark; [Antic, Sonja] Aarhus Univ Hosp, Dept Neurol, Aarhus, Denmark		Schytz, HW (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Rigshosp Glostrup, Danish Headache,Ctr Dept Neurol, Valdemar Hansens Vej 5, DK-2600 Glostrup, Denmark.	henrik.winther.schytz.01@regionh.dk		Ashina, Hakan/0000-0002-6268-727X; Christensen, Casper Emil/0000-0003-4906-9204; Schytz, Henrik Winther/0000-0002-6262-2986; Ashina, Messoud/0000-0003-0951-5804; Amin, Faisal Mohammad/0000-0003-3803-3599	Novartis Healthcare A/S	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this Article: The study was supported by an investigator-initiated research grant from Novartis Healthcare A/S who also provided the study drug.	[Anonymous], 2018, Cephalalgia, V38, P1, DOI 10.1177/0333102417738202; Ashina H, 2020, CEPHALALGIA, V40, P554, DOI 10.1177/0333102420909865; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Ashina M, 2020, CEPHALALGIA, V40, P241, DOI 10.1177/0333102420905132; Ashina M, 2018, CEPHALALGIA, V38, P1611, DOI 10.1177/0333102418788347; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Charles A, 2019, LANCET, V394, P1765, DOI 10.1016/S0140-6736(19)32504-8; Cushman DM, 2019, HEADACHE, V59, P371, DOI 10.1111/head.13451; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Goadsby PJ, 2019, CEPHALALGIA, V39, P817, DOI 10.1177/0333102419835459; Goadsby PJ, 2017, NEW ENGL J MED, V377, P2123, DOI 10.1056/NEJMoa1705848; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Larsen EL, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1051-7; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Navratilova E, 2019, CEPHALALGIA, V39, P1762, DOI 10.1177/0333102419877662; RASMUSSEN BK, 1992, NEUROLOGY, V42, P1225, DOI 10.1212/WNL.42.6.1225; Reuter U, 2018, LANCET, V392, P2280, DOI 10.1016/S0140-6736(18)32534-0; Silberstein SD, 2017, NEW ENGL J MED, V377, P2113, DOI 10.1056/NEJMoa1709038; Stauffer VL, 2018, JAMA NEUROL, V75, P1080, DOI 10.1001/jamaneurol.2018.1212; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]	21	13	13	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	JUN 3	2020	21	1							62	10.1186/s10194-020-01136-z			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY1XA	WOS:000540313500001	32493206	gold, Green Published, Green Submitted			2022-02-06	
J	Chaban, V; Clarke, GJB; Skandsen, T; Islam, R; Einarsen, CE; Vik, A; Damas, JK; Mollnes, TE; Haberg, AK; Pischke, SE				Chaban, Viktoriia; Clarke, Gerard J. B.; Skandsen, Toril; Islam, Rakibul; Einarsen, Cathrine E.; Vik, Anne; Damas, Jan K.; Mollnes, Tom E.; Haberg, Asta K.; Pischke, Soeren E.			Systemic Inflammation Persists the First Year after Mild Traumatic Brain Injury: Results from the Prospective Trondheim Mild Traumatic Brain Injury Study	JOURNAL OF NEUROTRAUMA			English	Article						concussion; cytokines; growth factors; immune system; pathophysiology	NECROSIS-FACTOR-ALPHA; TNF-ALPHA; NEUROINFLAMMATION; CYTOKINE; EXPRESSION; EPIDEMIOLOGY; PROFILES	Innate immune activation has been attributed a key role in traumatic brain injury (TBI) and successive morbidity. In mild TBI (mTBI), however, the extent and persistence of innate immune activation are unknown. We determined plasma cytokine level changes over 12 months after an mTBI in hospitalized and non-hospitalized patients compared with community controls; and examined their associations to injury-related and demographic variables at admission. Prospectively, 207 patients presenting to the emergency department (ED) or general practitioner with clinically confirmed mTBI and 82 matched community controls were included. Plasma samples were obtained at admission, after 2 weeks, 3 months, and 12 months. Cytokine levels were analysed with a 27-plex beads-based immunoassay. Brain magnetic resonance imaging (MRI) was performed on all participants. Twelve cytokines were reliably detected. Plasma levels of interferon gamma (IFN-gamma), interleukin 8 (IL-8), eotaxin, macrophage inflammatory protein-1-beta (MIP-1 beta), monocyte chemoattractant protein 1 (MCP-1), IL-17A, IL-9, tumor necrosis factor (TNF), and basic fibroblast growth factor (FGF-basic) were significantly increased at all time-points in patients compared with controls, whereas IFN-gamma-inducing protein 10 (IP-10), platelet-derived growth factor (PDGF), and IL-1ra were not. IL-17A and FGF-basic showed significant increases in patients from admission to follow-up at 3 months, and remained increased at 12 months compared with admission. Interestingly, MRI findings were negatively associated with four cytokines: eotaxin, MIP-1 beta, IL-9, and IP-10, whereas age was positively associated with nine cytokines: IL-8, eotaxin, MIP-1 beta, MCP-1, IL-17A, IL-9, TNF, FGF-basic, and IL-1ra. TNF was also increased in those with presence of other injuries. In conclusion, mTBI activated the innate immune system consistently and this is the first study to show that several inflammatory cytokines remain increased for up to 1 year post-injury.	[Chaban, Viktoriia; Islam, Rakibul; Mollnes, Tom E.; Pischke, Soeren E.] Oslo Univ Hosp, Dept Immunol, Oslo, Norway; [Pischke, Soeren E.] Oslo Univ Hosp, Clin Emergencies & Crit Care, Oslo, Norway; [Pischke, Soeren E.] Univ Oslo, Sognsvannsveien 20, N-0372 Oslo, Norway; [Clarke, Gerard J. B.; Skandsen, Toril; Einarsen, Cathrine E.; Vik, Anne; Haberg, Asta K.] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Damas, Jan K.; Mollnes, Tom E.] Norwegian Univ Sci & Technol NTNU, Ctr Mol Inflammat Res, Dept Clin & Mol Res, Trondheim, Norway; [Clarke, Gerard J. B.; Haberg, Asta K.] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Skandsen, Toril; Einarsen, Cathrine E.] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Vik, Anne] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Neurosurg, Trondheim, Norway; [Damas, Jan K.] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Infect Dis, Trondheim, Norway; [Mollnes, Tom E.] Nordland Hosp Bodo, Res Lab, Tromso, Norway; [Mollnes, Tom E.] Univ Tromso, KG Jebsen TREC, Tromso, Norway		Pischke, SE (corresponding author), Univ Oslo, Sognsvannsveien 20, N-0372 Oslo, Norway.; Pischke, SE (corresponding author), Oslo Univ Hosp, Sognsvannsveien 20, N-0372 Oslo, Norway.	s.e.pischke@medisin.uio.no	Mollnes, Tom/ABI-5183-2020; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Pischke, Soeren Erik/AAX-9676-2021	Pischke, Soeren Erik/0000-0003-2543-3251; CLARKE, GERARD/0000-0003-0202-1318; Islam, Rakibul/0000-0002-7174-9225	Central Norway Regional Health Authority; Norwegian University of Science and Technology (NTNU); Department of Radiology and Nuclear Medicine, St. Olavs Hospital, Trondheim University Hospital; Odd Fellow Foundation; Simon Fougner Hartmann Family Fund; Norwegian Council on Cardiovascular Disease [13117]; Norwegian Research CouncilResearch Council of NorwayEuropean Commission [274352]; National Norwegian Advisory Unit for Functional MRI	The Trondheim Mild TBI study was funded by the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (NTNU). In addition, the MRI study was partly funded by the National Norwegian Advisory Unit for Functional MRI and Department of Radiology and Nuclear Medicine, St. Olavs Hospital, Trondheim University Hospital. Additional, general financial support was obtained from The Odd Fellow Foundation and The Simon Fougner Hartmann Family Fund. Individual funding was received as follows: VC (The Norwegian Council on Cardiovascular Disease, 13117), SEP (Norwegian Research Council, 274352).	Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bupp MRG, 2015, CELL IMMUNOL, V294, P102, DOI 10.1016/j.cellimm.2015.02.002; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Casault C, 2019, NEUROCRIT CARE, V30, P22, DOI 10.1007/s12028-018-0522-z; Chandrasekar A, 2017, INT IMMUNOPHARMACOL, V51, P66, DOI 10.1016/j.intimp.2017.08.002; Chen J, 2018, J NEUROTRAUM, V35, P2091, DOI 10.1089/neu.2017.5271; Cherry JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185541; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Di Battista AP, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1402-y; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Duran WN, 2008, AM J PHYSIOL-HEART C, V295, pH2221, DOI 10.1152/ajpheart.01050.2008; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; Fan HY, 2017, IMMUNOL LETT, V181, P71, DOI 10.1016/j.imlet.2016.12.002; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Flachenecker P, 2004, MULT SCLER J, V10, P165, DOI 10.1191/1352458504ms991oa; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Gallentine WB, 2017, EPILEPSIA, V58, P1102, DOI 10.1111/epi.13750; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Harawa V, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2590-0; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Henno LT, 2017, CYTOKINE, V97, P86, DOI 10.1016/j.cyto.2017.05.014; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Karnes JM, 2015, BONE, V78, P87, DOI 10.1016/j.bone.2015.05.001; Kunis G, 2013, BRAIN, V136, P3427, DOI 10.1093/brain/awt259; Kushi H, 2003, ACTA NEUROCHIR SUPPL, V86, P347; Lagerstedt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193278; Licastro F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00189; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marcet Paul, 2017, Neuroimmunol Neuroinflamm, V4, P82, DOI 10.20517/2347-8659.2017.07; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Merchant-Borna K, 2016, J NEUROTRAUM, V33, P1576, DOI 10.1089/neu.2015.4191; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Parkin GM, 2019, J NEUROTRAUM, V36, P1768, DOI 10.1089/neu.2018.6042; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; R Core Team, 2019, R LANG ENV STAT COMP; Roselli F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00458; Ross J, 2013, CURR ALZHEIMER RES, V10, P742, DOI 10.2174/13892037113149990144; Sankar SB, 2019, NEUROBIOL DIS, V124, P544, DOI 10.1016/j.nbd.2018.12.018; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Stapleton PP, 2004, J SURG RES, V122, P1, DOI 10.1016/j.jss.2004.04.020; Sun YX, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01120; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Wojkowska DW, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051000; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	49	13	14	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2020	37	19					2120	2130		10.1089/neu.2019.6963		JUN 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NV1ON	WOS:000538187400001	32326805	Green Published, Green Submitted, hybrid			2022-02-06	
J	Angoa-Perez, M; Zagorac, B; Anneken, JH; Briggs, DI; Winters, AD; Greenberg, JM; Ahmad, M; Theis, KR; Kuhn, DM				Angoa-Perez, Mariana; Zagorac, Branislava; Anneken, John H.; Briggs, Denise, I; Winters, Andrew D.; Greenberg, Jonathan M.; Ahmad, Madison; Theis, Kevin R.; Kuhn, Donald M.			Repetitive, mild traumatic brain injury results in a progressive white matter pathology, cognitive deterioration, and a transient gut microbiota dysbiosis	SCIENTIFIC REPORTS			English	Article							MILITARY; ENCEPHALOPATHY; EPIDEMIOLOGY; MICE; TBI	Traumatic brain injury (TBI) is often accompanied by gastrointestinal and metabolic disruptions. These systemic manifestations suggest possible involvement of the gut microbiota in head injury outcomes. Although gut dysbiosis after single, severe TBI has been documented, the majority of head injuries are mild, such as those that occur in athletes and military personnel exposed to repetitive head impacts. Therefore, it is important to determine if repetitive, mild TBI (rmTBI) will also disrupt the gut microbiota. Male mice were exposed to mild head impacts daily for 20 days and assessed for cognitive behavior, neuropathology and disruptions in the gut microbiota at 0, 45 or 90 days after injury. Deficits in recognition memory were evident at the late post-injury points. Brains show an early increase in microglial activation at the 0-day time point that persisted until 90 days post-injury. This was compounded by substantial increases in astrocyte reactivity and phosphorylated tau at the 90-day time point. In contrast, changes in the microbial community were minor and transient, and very few differences were observed in mice exposed to rmTBI compared to controls. While the progressive emergence of white matter damage and cognitive alterations after rmTBI resembles the alterations observed in athletes and military personnel exposed to rmTBI, these changes could not be linked to systematic modifications in the gut microbiota.	[Angoa-Perez, Mariana; Zagorac, Branislava; Anneken, John H.; Briggs, Denise, I; Kuhn, Donald M.] John D Dingell VA Med Ctr, Res & Dev Serv, Detroit, MI 48201 USA; [Angoa-Perez, Mariana; Zagorac, Branislava; Anneken, John H.; Briggs, Denise, I; Kuhn, Donald M.] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA; [Winters, Andrew D.; Greenberg, Jonathan M.; Ahmad, Madison; Theis, Kevin R.] Wayne State Univ, Sch Med, Dept Biochem Microbiol & Immunol, Detroit, MI USA; [Theis, Kevin R.] Wayne State Univ, Sch Med, Perinatal Res Initiat Maternal Perinatal & Child, Detroit, MI USA; [Briggs, Denise, I] Stanford Univ, Med Sch, Stanford Behav & Funct Neurosci Lab, Dept Neurosurg, Stanford, CA 94305 USA		Angoa-Perez, M (corresponding author), John D Dingell VA Med Ctr, Res & Dev Serv, Detroit, MI 48201 USA.; Angoa-Perez, M (corresponding author), Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA.	maperez@med.wayne.edu			Department of Veterans AffairsUS Department of Veterans Affairs [I 01 BX004340-01A2]	This research was supported by a grant from the Department of Veterans Affairs (I 01 BX004340-01A2).	Aleman FDD, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007727; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Angoa-Perez M, 2014, J NEUROCHEM, V129, P916, DOI 10.1111/jnc.12690; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Briggs DI, 2016, AM J PATHOL, V186, P2869, DOI 10.1016/j.ajpath.2016.07.013; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Charrueau C, 2009, J NEUROTRAUM, V26, P1911, DOI 10.1089/neu.2008.0737; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cryan JF, 2020, LANCET NEUROL, V19, P179, DOI 10.1016/S1474-4422(19)30356-4; Cryan JF, 2019, PHYSIOL REV, V99, P1877, DOI 10.1152/physrev.00018.2018; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Erdman J., 2011, NUTR TRAUMATIC BRAIN, V431; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greer N., 2019, RELATIONSHIP DEPLOYM, P1; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Haring RS, 2015, BRAIN INJURY, V29, P989, DOI 10.3109/02699052.2015.1033014; Hennessy E, 2015, J NEUROSCI, V35, P8411, DOI 10.1523/JNEUROSCI.2745-14.2015; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kim S, 2018, GERONTOLOGY, V64, P513, DOI 10.1159/000490615; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; Ma YY, 2019, J NUTR, V149, P1543, DOI 10.1093/jn/nxz105; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Matharu D, 2019, J BIOSCIENCES, V44, DOI 10.1007/s12038-019-9940-0; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; MYCHASIUK R, 2014, JOVE-J VIS EXP, V94, DOI [10.3791/51820, DOI 10.3791/51820]; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Nicholson SE, 2019, SHOCK, V52, P240, DOI 10.1097/SHK.0000000000001211; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Pu HY, 2013, INT GEOSCI REMOTE SE, P2547, DOI 10.1109/IGARSS.2013.6723341; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schloss PD, 2012, GUT MICROBES, V3, P383, DOI 10.4161/gmic.21008; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Scrimgeour AG, 2014, J NEUROTRAUM, V31, P989, DOI 10.1089/neu.2013.3234; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shen L, 2017, J ALZHEIMERS DIS, V56, P385, DOI 10.3233/JAD-160884; Stevens SL, 2014, STROKE, V45, P2527, DOI 10.1161/STROKEAHA.114.002879; Theadom A., 2020, NEUROEPIDEMIOLOGY, P1; Theadom A, 2014, J SCI MED SPORT, V17, P591, DOI 10.1016/j.jsams.2014.02.001; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Urban R.J., 2020, J NEUROTRAUMA; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wen L, 2019, JOVE-J VIS EXP, DOI 10.3791/59410; [No title captured]	62	13	14	1	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUN 2	2020	10	1							8949	10.1038/s41598-020-65972-4			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NB8XA	WOS:000560797800011	32488168	gold, Green Published			2022-02-06	
J	Edwards, KA; Pattinson, CL; Guedes, VA; Peyer, J; Moore, C; Davis, T; Devoto, C; Turtzo, LC; Latour, L; Gill, JM				Edwards, Katie A.; Pattinson, Cassandra L.; Guedes, Vivian A.; Peyer, Jordan; Moore, Candace; Davis, Tara; Devoto, Christina; Turtzo, L. Christine; Latour, Lawrence; Gill, Jessica M.			Inflammatory Cytokines Associate With Neuroimaging After Acute Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						cytokines; neuroimaging; mild traumatic brain injury; inflammation; cardiovascular disease risk	ENDOTHELIAL GROWTH-FACTOR; HEAD-INJURY; TNF-ALPHA; INTERLEUKIN-10; CONCUSSION; EXPRESSION; BIOMARKERS; RISK; VEGF; IL-6	Introduction: Elevated levels of blood-based proinflammatory cytokines are linked to acute moderate to severe traumatic brain injuries (TBIs), yet less is known in acute mild (m)TBI cohorts. The current study examined whether blood-based cytokines can differentiate patients with mTBI, with and without neuroimaging findings (CT and MRI). Material and Methods: Within 24 h of a mTBI, determined by a Glasgow Coma Scale (GCS) between 13 and 15, participants (n = 250) underwent a computed tomography (CT) and magnetic resonance imaging (MRI) scan and provided a blood sample. Participants were classified into three groups according to imaging findings; (1) CT+, (2) MRI+ (CT-), (3) Controls (CT- MRI-). Plasma levels of circulating cytokines (IL-6, IL-10, TNF alpha), and vascular endothelial growth factor (VEGF) were measured using an ultra-sensitive immunoassay. Results: Concentrations of inflammatory cytokines (IL-6, TNF alpha) and VEGF were elevated in CT+, as well as MRI+ groups (p < 0.001), compared to controls, even after controlling for age, sex and cardiovascular disease (CVD)-related risk factors; hypertension, and hyperlipidemia. Post-concussive symptoms were associated with imaging groupings, but not inflammatory cytokines in this cohort. Levels of VEGF, IL-6, and TNF alpha differentiated patients with CT+ findings from controls, with the combined biomarker model (VEGF, IL-6, TNF alpha, and IL-10) showing good discriminatory power (AUC 0.92, 95% CI 0.87-0.97). IL-6 was a fair predictor of MRI+ findings compared to controls (AUC 0.70, 95% CI 0.60-0.78). Finally, the combined biomarker model discriminated patients with MRI+ from CT+ with an AUC of 0.71 (95% CI 0.62-0.80). Conclusions: When combined, IL-6, TNF alpha, and VEGF may provide a promising biomarker cytokine panel to differentiate mTBI patients with CT+ imaging vs. controls. Singularly, IL-6 was a fair discriminator between each of the imaging groups. Future research directions may help elucidate mechanisms related to injury severity and potentially, recovery following an mTBI.	[Edwards, Katie A.; Pattinson, Cassandra L.; Guedes, Vivian A.; Peyer, Jordan; Moore, Candace; Devoto, Christina; Gill, Jessica M.] NINR, NIH, Bethesda, MD 20892 USA; [Edwards, Katie A.; Devoto, Christina] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Davis, Tara] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Davis, Tara] Johns Hopkins Suburban Hosp, Bethesda, MD USA; [Turtzo, L. Christine; Latour, Lawrence] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Gill, Jessica M.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Biomarker Core, Bethesda, MD 20814 USA		Edwards, KA (corresponding author), NINR, NIH, Bethesda, MD 20892 USA.; Edwards, KA (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.	katie.edwards@nih.gov	Latour, Larry/AAH-5663-2021; Pattinson, Cassandra/AAY-5974-2020	Latour, Larry/0000-0001-6160-5263; Peyer, Jordan/0000-0002-4136-0315; Edwards, Katie/0000-0002-7682-8598; de Alvarenga Guedes, Vivian/0000-0001-8478-2465; Davis, Tara/0000-0002-6293-3602	National Institute of Nursing Research (NINR) Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); National Institute of Neurological Disease and Stroke (NINDS) Team; Center for Neuroscience and Regenerative Medicine, Acute Studies and Biomarker Core	This work was supported by National Institute of Nursing Research (NINR) Intramural Research Program, National Institute of Neurological Disease and Stroke (NINDS) Team, Center for Neuroscience and Regenerative Medicine, Acute Studies and Biomarker Core.	Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Argandona EG, 2012, CURR NEUROVASC RES, V9, P72; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CDC, 2003, REP C MILD TRAUM BRA; Devoto C, 2017, CELL TRANSPLANT, V26, P1169, DOI 10.1177/0963689717714098; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Karr JE, 2020, BRAIN INJURY, V34, P26, DOI 10.1080/02699052.2019.1669825; Kawata K, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00239; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li M, 2016, CLIN NEUROL NEUROSUR, V144, P7, DOI 10.1016/j.clineuro.2016.02.032; Lynch CE, 2016, BRAIN INJURY, V30, P1414, DOI 10.1080/02699052.2016.1219060; Maloney JP, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/387842; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; McCarthy MT, 2015, ANN NY ACAD SCI, V1345, P89, DOI 10.1111/nyas.12736; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mellergard P, 2010, BRIT J NEUROSURG, V24, P261, DOI 10.3109/02688690903521605; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Nitta ME, 2019, NEUROLOGY, V93, pE497, DOI 10.1212/WNL.0000000000007864; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Sun YX, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01120; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vempati P, 2014, CYTOKINE GROWTH F R, V25, P1, DOI 10.1016/j.cytogfr.2013.11.002; Voormolen DC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111921; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Werhane Madeleine L, 2017, Concussion, V2, pCNC30, DOI 10.2217/cnc-2016-0022; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	51	13	13	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 19	2020	11								348	10.3389/fneur.2020.00348			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LV4KD	WOS:000538405300001	32508732	gold, Green Published			2022-02-06	
J	Lange, RT; French, LM; Lippa, SM; Bailie, JM; Brickell, TA				Lange, Rael T.; French, Louis M.; Lippa, Sara M.; Bailie, Jason M.; Brickell, Tracey A.			Posttraumatic Stress Disorder is a Stronger Predictor of Long-Term Neurobehavioral Outcomes Than Traumatic Brain Injury Severity	JOURNAL OF TRAUMATIC STRESS			English	Article							QUALITY-OF-LIFE; DETECT SYMPTOM EXAGGERATION; CLINICAL UTILITY; PSYCHOMETRIC PROPERTIES; VALIDITY-10 SCALE; TBI-QOL; MILD; HEALTH; AFGHANISTAN; MODERATE	Concurrent posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) is common in military populations. The purpose of this study was to examine long-term neurobehavioral outcomes in service members and veterans (SMVs) with versus without PTSD symptoms following TBI of all severities. Participants were 536 SMVs prospectively enrolled from three military medical treatment facilities who were recruited into three experimental groups: TBI, injured controls (IC), and noninjured controls (NIC). Participants completed the PTSD Checklist, Neurobehavioral Symptom Inventory, and the TBI-Quality of Life (TBI-QOL) and were divided into six subgroups based on the three experimental categories, two PTSD categories (i.e., present vs. absent), and two broad TBI severity categories (unMTBI, which included uncomplicated mild TBI; and smcTBI, which included severe TBI, moderate TBI, and complicated mild TBI): (a) NIC/PTSD-absent, (b) IC/PTSD-absent, (c) unMTBI/PTSD-absent, (d) unMTBI/PTSD-present, (e) smcTBI/PTSD-absent, and (f) smcTBI/PTSD-present. There were significant main effects across the six groups for all TBI-QOL measures, ps < .001. Select pairwise comparisons revealed significantly lower scores, p < .001, on all TBI-QOL measures in the PTSD-present groups when compared to the PTSD-absent groups within the same TBI severity classification, ds = 0.90-2.11. In contrast, when controlling for PTSD, there were no significant differences among the TBI severity groups for any TBI-QOL measures. These results provide support for the strong influence of PTSD but not TBI severity on neurobehavioral outcomes following TBI. Concurrent PTSD and TBI of all severities should be considered a risk factor for poor long-term neurobehavioral outcomes that require ongoing monitoring.	[Lange, Rael T.; French, Louis M.; Lippa, Sara M.; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Room 5003,Bldg 19,8901 Wisconsin Ave, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Lange, Rael T.; French, Louis M.; Lippa, Sara M.; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [French, Louis M.; Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Bailie, Jason M.] Naval Hosp Camp Pendleton, Def & Vet Brain Injury Ctr, Oceanside, CA USA; [Lange, Rael T.; Lippa, Sara M.; Bailie, Jason M.; Brickell, Tracey A.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA		Lange, RT (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Room 5003,Bldg 19,8901 Wisconsin Ave, Bethesda, MD 20814 USA.	rlange@dvbic.org		french, louis/0000-0002-9451-0604			Alway Y, 2016, DEPRESS ANXIETY, V33, P19, DOI 10.1002/da.22396; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brickell TA, 2019, REHABIL PSYCHOL, V64, P307, DOI 10.1037/rep0000272; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Cohen GH, 2015, EPIDEMIOL REV, V37, P7, DOI 10.1093/epirev/mxu007; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Department of Defense, 2018, DEP DEF RES REV MILD; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Dretsch MN, 2017, APPL NEUROPSYCH-ADUL, V24, P376, DOI 10.1080/23279095.2016.1220947; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Haarbauer-Krupa J, 2017, J NEUROTRAUM, V34, P50, DOI 10.1089/neu.2015.4158; Hines LA, 2014, CAN J PSYCHIAT, V59, P468, DOI 10.1177/070674371405900903; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; Jackson CE, 2016, J TRAUMA STRESS, V29, P309, DOI 10.1002/jts.22110; Lange RT, 2016, J HEAD TRAUMA REHAB, V31, P62, DOI 10.1097/HTR.0000000000000149; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Lippa SM, 2016, J REHABIL RES DEV, V53, P379, DOI 10.1682/JRRD.2015.01.0009; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; McCrae M., 2008, MILD TRAUMATIC BRAIN; Olatunji BO, 2007, CLIN PSYCHOL REV, V27, P572, DOI 10.1016/j.cpr.2007.01.015; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P353, DOI 10.1080/23279095.2015.1079714; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	42	13	13	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	JUN	2020	33	3					318	329		10.1002/jts.22480		MAY 2020	12	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	LX9HH	WOS:000531255400001	32379932				2022-02-06	
J	Arena, JD; Smith, DH; Lee, EB; Gibbons, GS; Irwin, DJ; Robinson, JL; Lee, VMY; Trojanowski, JQ; Stewart, W; Johnson, VE				Arena, John D.; Smith, Douglas H.; Lee, Edward B.; Gibbons, Garrett S.; Irwin, David J.; Robinson, John L.; Lee, Virginia M-Y; Trojanowski, John Q.; Stewart, William; Johnson, Victoria E.			Tau immunophenotypes in chronic traumatic encephalopathy recapitulate those of ageing and Alzheimer's disease	BRAIN			English	Article						chronic traumatic encephalopathy; tau; ageing-related tau astrogliopathy; traumatic brain injury; TBI	THORN-SHAPED ASTROCYTES; BRAIN-BARRIER DYSFUNCTION; CASPASE-CLEAVAGE; PICKS-DISEASE; NEURODEGENERATIVE DISEASES; CORTICOBASAL DEGENERATION; NEUROFIBRILLARY TANGLES; EARLY EVENT; PATHOLOGY; PROTEIN	Traumatic brain injury (TBI) is a risk factor for neurodegenerative disease, including chronic traumatic encephalopathy (CTE). Preliminary consensus criteria define the pathognomonic lesion of CTE as patchy tau pathology within neurons and astrocytes at the depths of cortical sulci. However, the specific tau isoform composition and post-translational modifications in CTE remain largely unexplored. Using immunohistochemistry, we performed tau phenotyping of CTE neuropathologies and compared this to a range of tau pathologies, including Alzheimer's disease, primary age-related tauopathy, ageing-related tau astrogliopathy and multiple subtypes of frontotemporal lobar degeneration with tau inclusions. Cases satisfying preliminary consensus diagnostic criteria for CTE neuropathological change (CTE-NC) were identified (athletes, n = 10; long-term survivors of moderate or severe TBI, n = 4) from the Glasgow TBI Archive and Penn Neurodegenerative Disease Brain Bank. In addition, material from a range of autopsy-proven ageing-associated and primary tauopathies in which there was no known history of exposure to TBI was selected as non-injured controls (n = 32). Each case was then stained with a panel of tau antibodies specific for phospho-epitopes (PHF1, CP13, AT100, pS262), microtubule-binding repeat domains (3R, 4R), truncation (Tau-C3) or conformation (GT-7, GT-38) and the extent and distribution of staining assessed. Cell types were confirmed with double immunofluorescent labelling. Results demonstrate that astroglial tau pathology in CTE is composed of 4R-immunoreactive thorn-shaped astrocytes, echoing the morphology and immunophenotype of astrocytes encountered in ageing-related tau astrogliopathy. In contrast, neurofibrillary tangles of CTE contain both 3R and 4R tau, with post-translational modifications and conformations consistent with Alzheimer's disease and primary age-related tauopathy. Our observations establish that the astroglial and neurofibrillary tau pathologies of CTE are phenotypically distinct from each other and recapitulate the tau immunophenotypes encountered in ageing and Alzheimer's disease. As such, the immunohistochemical distinction of CTE neuropathology from other mixed 3R/4R tauopathies of Alzheimer's disease and ageing may rest solely on the pattern and distribution of pathology.	[Arena, John D.; Smith, Douglas H.; Johnson, Victoria E.] Univ Penn, Penn Ctr Brain Injury & Repair, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Lee, Edward B.; Gibbons, Garrett S.; Robinson, John L.; Lee, Virginia M-Y; Trojanowski, John Q.] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Lee, Edward B.] Univ Penn, Translat Neuropathol Res Lab, Philadelphia, PA 19104 USA; [Irwin, David J.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Stewart, William] Queen Elizabeth Univ Hosp, Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland; [Stewart, William] Univ Glasgow, Inst Neurosci & Psychol, Glasgow G12 8QQ, Lanark, Scotland		Johnson, VE (corresponding author), Univ Penn, Dept Neurosurg, Penn Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA.	vje@pennmedicine.upenn.edu	Lee, Edward/AAU-8436-2021; Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Arena, John/0000-0002-4322-4472; Stewart, William/0000-0003-2199-2582	National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS115322, R01NS092398, R01NS094003, R01NS038104]; NIH National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG010124, AG017586, AG054991, AG09215, AG17586]; NHS Research Scotland; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F32AG053036]; Clinical and Translational Science Awards training grant [TL1TR001880]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1100578, MR/N004272/1, G0701018] Funding Source: UKRI	Research reported in this publication was supported by: the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) under award number, U54NS115322, R01NS092398, R01NS094003 and R01NS038104; NIH National Institute on Aging grants AG010124, AG017586, AG054991, AG09215 and AG17586; NHS Research Scotland; Clinical and Translational Science Awards training grant TL1TR001880 (J.D.A.); and NIH F32AG053036 (G.S.G.).	Abraha A, 2000, J CELL SCI, V113, P3737; Arai T, 2001, ACTA NEUROPATHOL, V101, P167; Berry RW, 2003, BIOCHEMISTRY-US, V42, P8325, DOI 10.1021/bi027348m; Buee L, 1999, BRAIN PATHOL, V9, P681; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Chung CW, 2001, NEUROBIOL DIS, V8, P162, DOI 10.1006/nbdi.2000.0335; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Cotman CW, 2005, J NEUROPATH EXP NEUR, V64, P104, DOI 10.1093/jnen/64.2.104; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; de Silva R, 2003, NEUROPATH APPL NEURO, V29, P288, DOI 10.1046/j.1365-2990.2003.00463.x; Delacourte A, 1998, ANN NEUROL, V43, P193, DOI 10.1002/ana.410430209; Delobel P, 2008, AM J PATHOL, V172, P123, DOI 10.2353/ajpath.2008.070627; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Fasulo L, 2005, J ALZHEIMERS DIS, V7, P3; Fasulo L, 2000, J NEUROCHEM, V75, P624, DOI 10.1046/j.1471-4159.2000.0750624.x; Ferrer I, 2002, ACTA NEUROPATHOL, V104, P658, DOI 10.1007/s00401-002-0600-2; Ferrer I, 2014, J NEUROPATH EXP NEUR, V73, P81, DOI 10.1097/NEN.0000000000000030; Ferrer I, 2018, BRAIN PATHOL, V28, P965, DOI 10.1111/bpa.12593; Forrest SL, 2019, J NEUROPATH EXP NEUR, V78, P398, DOI 10.1093/jnen/nlz017; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; Gibbons GS, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0687-5; Gibbons GS, 2018, J NEUROPATH EXP NEUR, V77, P216, DOI 10.1093/jnen/nly010; Goldfinger MH, 2018, ACTA NEUROPATHOL, V136, P973, DOI 10.1007/s00401-018-1926-8; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; Guillozet-Bongaarts AL, 2007, ACTA NEUROPATHOL, V113, P513, DOI 10.1007/s00401-007-0209-6; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hoffmann R, 1997, BIOCHEMISTRY-US, V36, P8114, DOI 10.1021/bi970380+; Ikeda K, 1998, NEUROBIOL AGING, V19, pS85, DOI 10.1016/S0197-4580(98)00034-7; Ikeda K, 1996, NEUROPATHOLOGY, V16, P71, DOI 10.1111/j.1440-1789.1996.tb00158.x; IKEDA K, 1995, ACTA NEUROPATHOL, V90, P620; Irwin DJ, 2016, ANN NEUROL, V79, P272, DOI 10.1002/ana.24559; Iverson GL, 2019, J NEUROPATH EXP NEUR, V78, P615, DOI 10.1093/jnen/nlz045; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kanaan NM, 2016, J NEUROPATH EXP NEUR, V75, P19, DOI 10.1093/jnen/nlv001; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; Kovacs GG, 2018, NEUROPATH APPL NEURO, V44, P491, DOI 10.1111/nan.12427; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Kovacs GG, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0552-y; Kovacs GG, 2017, BRAIN PATHOL, V27, P675, DOI 10.1111/bpa.12536; Kovacs GG, 2017, J NEUROPATH EXP NEUR, V76, P270, DOI 10.1093/jnen/nlx007; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Kovacs GG, 2013, ACTA NEUROPATHOL, V126, P365, DOI 10.1007/s00401-013-1157-y; Lace G, 2012, DEMENT GERIATR COGN, V34, P15, DOI 10.1159/000341581; Lee EB, 2019, ACTA NEUROPATHOL, V138, P389, DOI 10.1007/s00401-019-02030-y; Lee EB, 2018, ACTA NEUROPATHOL, V135, P643, DOI 10.1007/s00401-018-1827-x; Liu AKL, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0330-7; Lopez-Gonzalez I, 2013, BRAIN PATHOL, V23, P144, DOI 10.1111/j.1750-3639.2012.00627.x; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Probst A, 1996, ACTA NEUROPATHOL, V92, P588, DOI 10.1007/s004010050565; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Santa-Maria I, 2012, ACTA NEUROPATHOL, V124, P693, DOI 10.1007/s00401-012-1017-1; Schultz C, 2004, NEUROBIOL AGING, V25, P397, DOI 10.1016/S0197-4580(03)00113-1; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stewart W, 2016, QJM-INT J MED, V109, P11, DOI 10.1093/qjmed/hcv070; Toledo JB, 2014, ALZHEIMERS DEMENT, V10, P477, DOI 10.1016/j.jalz.2013.06.003; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x; Zhukareva V, 2002, ANN NEUROL, V51, P730, DOI 10.1002/ana.10222; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	84	13	13	3	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	MAY	2020	143		5				1572	1587		10.1093/brain/awaa071			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MA2VV	WOS:000541777000034	32390044	Green Published, Green Accepted, Bronze			2022-02-06	
J	Doran, SJ; Henry, RJ; Shirey, KA; Barrett, JP; Ritzel, RM; Lai, W; Blanco, JC; Faden, AI; Vogel, SN; Loane, DJ				Doran, Sarah J.; Henry, Rebecca J.; Shirey, Kari Ann; Barrett, James P.; Ritzel, Rodney M.; Lai, Wendy; Blanco, Jorge C.; Faden, Alan, I; Vogel, Stefanie N.; Loane, David J.			Early or Late Bacterial Lung Infection Increases Mortality After Traumatic Brain Injury in Male Mice and Chronically Impairs Monocyte Innate Immune Function	CRITICAL CARE MEDICINE			English	Article						immunosuppression; lung infection; monocyte function; neuroinflammation; Streptococcus pneumoniae; traumatic brain injury	STREPTOCOCCUS-PNEUMONIAE; INDUCED IMMUNODEFICIENCY; ACTIVATION; STROKE; NEURODEGENERATION; PREVENTION	Objectives: Respiratory infections in the postacute phase of traumatic brain injury impede optimal recovery and contribute substantially to overall morbidity and mortality. This study investigated bidirectional innate immune responses between the injured brain and lung, using a controlled cortical impact model followed by secondary Streptococcus pneumoniae infection in mice. Design: Experimental study. Setting: Research laboratory. Subjects: Adult male C57BL/6J mice. Interventions: C57BL/6J mice were subjected to sham surgery or moderate-level controlled cortical impact and infected intranasally with S. pneumoniae (1,500 colony-forming units) or vehicle (phosphate-buffered saline) at 3 or 60 days post-injury. Main Results: At 3 days post-injury, S. pneumoniae-infected traumatic brain injury mice (TBI + Sp) had a 25% mortality rate, in contrast to no mortality in S. pneumoniae-infected sham (Sham + Sp) animals. TBI + Sp mice infected 60 days post-injury had a 60% mortality compared with 5% mortality in Sham + Sp mice. In both studies, TBI + Sp mice had poorer motor function recovery compared with TBI + PBS mice. There was increased expression of pro-inflammatory markers in cortex of TBI + Sp compared with TBI + PBS mice after both early and late infection, indicating enhanced post-traumatic neuroinflammation. In addition, monocytes from lungs of TBI + Sp mice were immunosuppressed acutely after traumatic brain injury and could not produce interleukin-1 beta, tumor necrosis factor-alpha, or reactive oxygen species. In contrast, after delayed infection monocytes from TBI + Sp mice had higher levels of interleukin-1 beta, tumor necrosis factor-alpha, and reactive oxygen species when compared with Sham + Sp mice. Increased bacterial burden and pathology was also found in lungs of TBI + Sp mice. Conclusions: Traumatic brain injury causes monocyte functional impairments that may affect the host's susceptibility to respiratory infections. Chronically injured mice had greater mortality following S. pneumoniae infection, which suggests that respiratory infections even late after traumatic brain injury may pose a more serious threat than is currently appreciated.	[Doran, Sarah J.; Henry, Rebecca J.; Barrett, James P.; Ritzel, Rodney M.; Faden, Alan, I; Loane, David J.] Univ Maryland, Sch Med, Dept Anesthesiol & Shock, Trauma & Anesthesiol Res Star Ctr, Baltimore, MD 21201 USA; [Shirey, Kari Ann; Lai, Wendy; Vogel, Stefanie N.] Univ Maryland, Dept Microbiol & Immunol, Sch Med, Baltimore, MD 21201 USA; [Blanco, Jorge C.] Sigmovir Biosyst Inc, Rockville, MD USA; [Loane, David J.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland		Loane, DJ (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol & Shock, Trauma & Anesthesiol Res Star Ctr, Baltimore, MD 21201 USA.; Loane, DJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland.	loanedj@tcd.ie	Blanco, Jorge/AAW-3752-2020; Loane, David/ABD-5177-2021	Loane, David/0000-0003-0393-3503; Henry, Rebecca/0000-0001-8548-1170; Barrett, James/0000-0002-0924-9449; Ritzel, Rodney/0000-0002-0160-2930	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS082308, R01NS037313, F32NS105355, R01125215]; Science Foundation IrelandScience Foundation IrelandEuropean Commission [17/FRL/4860];  [T32AI095190]	Supported, in part, by grant from the National Institutes of Health grants R01NS082308 (to Dr. Loane), R01NS037313 (to Dr. Faden), F32NS105355 (to Dr. Ritzel), and R01125215 (to Dr. Vogel), and Science Foundation Ireland grant 17/FRL/4860 (to Dr. Loane). Support for Dr. Doran was provided by T32AI095190 (to Dr. Vogel).	Barbier F, 2014, LANCET RESP MED, V2, P674, DOI 10.1016/S2213-2600(14)70123-7; Blanco Jorge C G, 2014, Trials Vaccinol, V3, P52; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Cazzadori A, 1997, RESP MED, V91, P193, DOI 10.1016/S0954-6111(97)90038-X; Chen WH, 2012, IMMUNOL LETT, V141, P227, DOI 10.1016/j.imlet.2011.10.009; Courties G, 2015, CIRC RES, V116, P407, DOI 10.1161/CIRCRESAHA.116.305207; Denes A, 2014, ANN NEUROL, V75, P670, DOI 10.1002/ana.24146; Denes A, 2011, J CEREBR BLOOD F MET, V31, P1036, DOI 10.1038/jcbfm.2010.198; Dong TT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0663-y; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Esnault P, 2017, NEUROCRIT CARE, V27, P187, DOI 10.1007/s12028-017-0397-4; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Gouel-Cheron A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033095; Griffin GD, 2015, MED HYPOTHESES, V85, P224, DOI 10.1016/j.mehy.2015.05.005; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Kafka D, 2008, INT IMMUNOL, V20, P1139, DOI 10.1093/intimm/dxn071; Kerr NA, 2018, J NEUROTRAUM, V35, P2067, DOI 10.1089/neu.2017.5430; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Lafargue M, 2012, FASEB J, V26, P2919, DOI 10.1096/fj.11-197384; Li Y, 2019, NEUROCRIT CARE; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lopez-Aguilar J, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.02.24; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Nicolls MR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010259; Norden DM, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1191-8; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Paradisi F, 2001, CLIN MICROBIOL INFEC, V7, P34, DOI 10.1046/j.1469-0691.2001.00056.x; Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Principi N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010030; Pruss H, 2017, NAT NEUROSCI, V20, P1549, DOI 10.1038/nn.4643; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; QUATTROCCHI KB, 1992, J NEUROSURG, V77, P694, DOI 10.3171/jns.1992.77.5.0694; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Ritzel RM, 2019, NEUROBIOL AGING, V77, P194, DOI 10.1016/j.neurobiolaging.2019.02.010; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Scott BNV, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-68; Sharma R, 2019, BRAIN BEHAV IMMUN, V79, P63, DOI 10.1016/j.bbi.2019.04.034; Shirey KA, 2019, MBIO, V10, DOI 10.1128/mBio.00810-19; Tang Y, 2006, J CEREBR BLOOD F MET, V26, P1089, DOI 10.1038/sj.jcbfm.9600264; Vermeij JD, 2013, J NEUROTRAUM, V30, P2073, DOI 10.1089/neu.2013.3060; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Wang LP, 2015, INT J CLIN EXP PATHO, V8, P4815; Webster KM, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112979; Weiser JN, 2018, NAT REV MICROBIOL, V16, P354, DOI 10.1038/s41579-018-0001-8; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	54	13	13	4	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	MAY	2020	48	5					E418	E428		10.1097/CCM.0000000000004273			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LG3UY	WOS:000528031100009	32149839	Green Accepted			2022-02-06	
J	Moore, HB; Tessmer, MT; Moore, EE; Sperry, JL; Cohen, MJ; Chapman, MP; Pusateri, AE; Guyette, FX; Brown, JB; Neal, MD; Zuckerbraun, B; Sauaia, A				Moore, Hunter B.; Tessmer, Matthew T.; Moore, Ernest E.; Sperry, Jason L.; Cohen, Mitchell J.; Chapman, Michael P.; Pusateri, Anthony E.; Guyette, Francis X.; Brown, Joshua B.; Neal, Matthew D.; Zuckerbraun, Brian; Sauaia, Angela			Forgot calcium? Admission ionized-calcium in two civilian randomized controlled trials of prehospital plasma for traumatic hemorrhagic shock	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	78th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery	SEP 18-21, 2019	Dallas, TX	Amer Assoc Surg Trauma		Trauma-induced coagulopathy; coagulation; calcium; hemorrhage; transfusion	PARATHYROID RESPONSE; MASSIVE TRANSFUSIONS; RECEIVED BLOOD; HYPOCALCEMIA; MORTALITY; CITRATE; MANAGEMENT; RATIO	BACKGROUND Randomized clinical trials (RCTs) support the use of prehospital plasma in traumatic hemorrhagic shock, especially in long transports. The citrate added to plasma binds with calcium, yet most prehospital trauma protocols have no guidelines for calcium replacement. We reviewed the experience of two recent prehospital plasma RCTs regarding admission ionized-calcium (i-Ca) blood levels and its impact on survival. We hypothesized that prehospital plasma is associated with hypocalcemia, which in turn is associated with lower survival. METHODS We studied patients enrolled in two institutions participating in prehospital plasma RCTs (control, standard of care; experimental, plasma), with i-Ca collected before calcium supplementation. Adults with traumatic hemorrhagic shock (systolic blood pressure <= 70 mm Hg or 71-90 mm Hg + heart rate >= 108 bpm) were eligible. We use generalized linear mixed models with random intercepts and Cox proportional hazards models with robust standard errors to account for clustered data by institution. Hypocalcemia was defined as i-Ca of 1.0 mmol/L or less. RESULTS Of 160 subjects (76% men), 48% received prehospital plasma (median age, 40 years [interquartile range, 28-53 years]) and 71% suffered blunt trauma (median Injury Severity Score [ISS], 22 [interquartile range, 17-34]). Prehospital plasma and control patients were similar regarding age, sex, ISS, blunt mechanism, and brain injury. Prehospital plasma recipients had significantly higher rates of hypocalcemia compared with controls (53% vs. 36%; adjusted relative risk, 1.48; 95% confidence interval [CI], 1.03-2.12;p= 0.03). Severe hypocalcemia was significantly associated with decreased survival (adjusted hazard ratio, 1.07; 95% CI, 1.02-1.13;p= 0.01) and massive transfusion (adjusted relative risk, 2.70; 95% CI, 1.13-6.46;p= 0.03), after adjustment for confounders (randomization group, age, ISS, and shock index). CONCLUSION Prehospital plasma in civilian trauma is associated with hypocalcemia, which in turn predicts lower survival and massive transfusion. These data underscore the need for explicit calcium supplementation guidelines in prehospital hemotherapy.	[Moore, Hunter B.; Moore, Ernest E.; Cohen, Mitchell J.; Chapman, Michael P.; Sauaia, Angela] Univ Colorado, Dept Surg, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Sauaia, Angela] Univ Colorado, Sch Publ Hlth, Dept Hlth Syst Management & Policy, Anschutz Med Campus,13011 E 17th Pl,Room E-3309, Aurora, CO 80045 USA; [Tessmer, Matthew T.; Sperry, Jason L.; Guyette, Francis X.; Brown, Joshua B.; Neal, Matthew D.; Zuckerbraun, Brian] Univ Pittsburgh, Pittsburgh, PA USA; [Moore, Ernest E.; Cohen, Mitchell J.] Denver Hlth, Ernest E Moore Shock Trauma Ctr, Denver, CO USA; [Pusateri, Anthony E.] US Army, Combat Casualty Care Res Program, Med Res Mat Command, Ft Detrick, MD USA		Sauaia, A (corresponding author), Univ Colorado, Sch Publ Hlth, Dept Hlth Syst Management & Policy, Anschutz Med Campus,13011 E 17th Pl,Room E-3309, Aurora, CO 80045 USA.	angela.sauaia@cuanschutz.edu			Department of Defense, US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC)United States Department of Defense; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50 GM049222]; NIH/NCRR Colorado CTSI Grant [UL1 RR025780]	This work was funded by the Department of Defense, US Army Medical Research and Materiel Command. E.E.M. and A.S. were partially funded through the National Institute of General Medical Sciences, grant P50 GM049222. Supplies for viscoelastic tests were obtained at a discounted rate from Haemonetics and Instrumentation Laboratory, none of which had any role in the current research or article elaboration. Data storagewas supported in part by NIH/NCRR Colorado CTSI Grant Number UL1 RR025780.	Aberegg SK, 2016, CHEST, V149, P846, DOI 10.1016/j.chest.2015.12.001; Adams WE, 1944, ANN SURG, V120, P656, DOI 10.1097/00000658-194412040-00019; [Anonymous], 2018, STUD COURS MAN 2018; Bicakci Z, 2014, TRANSFUS APHER SCI, V50, P418, DOI 10.1016/j.transci.2014.03.002; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; BURTON GW, 1964, ANAESTHESIA, V19, P408, DOI 10.1111/j.1365-2044.1964.tb00396.x; CHURCHIL.HC, 1968, P ROY SOC MED, V61, P681, DOI 10.1177/003591576806100731; DiFrancesco NR, 2019, J TRAUMA NURS, V26, P186, DOI 10.1097/JTN.0000000000000447; Giancarelli A, 2016, J SURG RES, V202, P182, DOI 10.1016/j.jss.2015.12.036; Hanigan WC, 1996, MIL MED, V161, P392, DOI 10.1093/milmed/161.7.392; Hastbacka J, 2003, ACTA ANAESTH SCAND, V47, P1264, DOI 10.1046/j.1399-6576.2003.00236.x; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Kagen MH, 2000, CUTIS, V65, P193; KASHUK JL, 1982, J TRAUMA, V22, P672, DOI 10.1097/00005373-198208000-00004; Kyle T, 2018, EMERG MED J, V35, P176, DOI 10.1136/emermed-2017-206717; Lewisohn R, 1916, ANN SURG, V64, P618, DOI 10.1097/00000658-191611000-00017; Lier H, 2008, J TRAUMA, V65, P951, DOI 10.1097/TA.0b013e318187e15b; LUCAS CE, 1984, SURGERY, V96, P711; Lucas CE, 1996, AM J SURG, V171, P399, DOI 10.1016/S0002-9610(97)89618-3; Lucas CE, 2009, J TRAUMA, V66, P92, DOI 10.1097/TA.0b013e3181929ce3; MacKay EJ, 2017, ANESTH ANALG, V125, P895, DOI 10.1213/ANE.0000000000002312; Magnotti LJ, 2011, J TRAUMA, V70, P391, DOI 10.1097/TA.0b013e31820b5d98; MCGONIGAL MD, 1987, AM SURGEON, V53, P429; Mollison PL, 2000, BRIT J HAEMATOL, V108, P13; Moore EE, 2014, SHOCK, V41, P35, DOI 10.1097/SHK.0000000000000110; Moore HB, 2018, LANCET, V392, P283, DOI 10.1016/S0140-6736(18)31553-8; Pusateri AE, 2019, JAMA SURG, pe195085; Reitz KM, 2020, J TRAUMA ACUTE CARE, V88, P33, DOI 10.1097/TA.0000000000002485; Robertson O H, 1918, Br Med J, V1, P691; Spahn DR, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2347-3; Sperry JL, 2018, NEW ENGL J MED, V379, P315, DOI 10.1056/NEJMoa1802345; Steele T, 2013, CRIT CARE, V17, DOI 10.1186/cc12756; Vivien B, 2005, CRIT CARE MED, V33, P1946, DOI 10.1097/01.CCM.0000171840.01892.36; Webster S, 2016, EMERG MED J, V33, P569, DOI 10.1136/emermed-2015-205096; Zhang Z., 2014, PLOS ONE, V9, P95204	36	13	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2020	88	5					588	596		10.1097/TA.0000000000002614			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	NE5OT	WOS:000562650900004	32317575	Green Accepted			2022-02-06	
J	Jolly, AE; Scott, GT; Sharp, DJ; Hampshire, AH				Jolly, Amy E.; Scott, Gregory T.; Sharp, David J.; Hampshire, Adam H.			Distinct patterns of structural damage underlie working memory and reasoning deficits after traumatic brain injury	BRAIN			English	Article						traumatic brain injury; structural connectome; working memory; reasoning; graph theory	DEFAULT MODE NETWORK; COGNITIVE IMPAIRMENT; FRONTAL LOBES; DISCONNECTION; ARCHITECTURE; ACTIVATION; MECHANISMS; SYSTEM	It is well established that chronic cognitive problems after traumatic brain injury relate to diffuse axonal injury and the consequent widespread disruption of brain connectivity. However, the pattern of diffuse axonal injury varies between patients and they have a correspondingly heterogeneous profile of cognitive deficits. This heterogeneity is poorly understood, presenting a non-trivial challenge for prognostication and treatment. Prominent amongst cognitive problems are deficits in working memory and reasoning. Previous functional MRI in controls has associated these aspects of cognition with distinct, but partially overlapping, networks of brain regions. Based on this, a logical prediction is that differences in the integrity of the white matter tracts that connect these networks should predict variability in the type and severity of cognitive deficits after traumatic brain injury. We use diffusion-weighted imaging, cognitive testing and network analyses to test this prediction. We define functionally distinct subnetworks of the structural connectome by intersecting previously published functional MRI maps of the brain regions that are activated during our working memory and reasoning tasks, with a library of the white matter tracts that connect them. We examine how graph theoretic measures within these subnetworks relate to the performance of the same tasks in a cohort of 92 moderate-severe traumatic brain injury patients. Finally, we use machine learning to determine whether cognitive performance in patients can be predicted using graph theoretic measures from each subnetwork. Principal component analysis of behavioural scores confirm that reasoning and working memory form distinct components of cognitive ability, both of which are vulnerable to traumatic brain injury. Critically, impairments in these abilities after traumatic brain injury correlate in a dissociable manner with the information-processing architecture of the subnetworks that they are associated with. This dissociation is confirmed when examining degree centrality measures of the subnetworks using a canonical correlation analysis. Notably, the dissociation is prevalent across a number of node-centric measures and is asymmetrical: disruption to the working memory subnetwork relates to both working memory and reasoning performance whereas disruption to the reasoning subnetwork relates to reasoning performance selectively. Machine learning analysis further supports this finding by demonstrating that network measures predict cognitive performance in patients in the same asymmetrical manner. These results accord with hierarchical models of working memory, where reasoning is dependent on the ability to first hold task-relevant information in working memory. We propose that this finer grained information may be useful for future applications that attempt to predict long-term outcomes or develop tailored therapies.	[Jolly, Amy E.; Scott, Gregory T.; Sharp, David J.; Hampshire, Adam H.] Imperial Coll London, Dept Brain Sci, Computat Cognit & Clin Neuroimaging Lab, Burlington Danes Bldg,Hammersmith Campus, London W12 ONN, England		Jolly, AE (corresponding author), Imperial Coll London, Hammersmith Hosp, Computat Cognit & Clin Neuroimaging Lab, 3rd Floor,Burlington Danes Bldg,Du Cane Rd, London W12 ONN, England.	amy.jolly@imperial.ac.uk		Scott, Gregory/0000-0001-8063-5871; Jolly, Amy/0000-0002-7413-9772	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; National Institute of Health Research Professorship [NIHR-RP-011-048]; NIHR CRF; Biomedical Research Centre at Imperial College Healthcare NHS Trust; Dementia Research Institute; NIHR Imperial Biomedical Research Centre; MRC grantUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/R005370/1]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006, 1769568] Funding Source: UKRI	This work was supported by the Medical Research Council. D.J.S. was funded by a National Institute of Health Research Professorship (NIHR-RP-011-048) and the work was supported by the NIHR CRF and Biomedical Research Centre at Imperial College Healthcare NHS Trust. A.H.H. is supported by the Dementia Research Institute, the NIHR Imperial Biomedical Research Centre and MRC grant MR/R005370/1.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Braun U., 2015, ELS, P1, DOI DOI 10.1002/9780470015902.A0025783; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Cattell RB, 1949, CULTURE FREE INTELLI; Christophel TB, 2017, TRENDS COGN SCI, V21, P111, DOI 10.1016/j.tics.2016.12.007; Cohen JR, 2016, J NEUROSCI, V36, P12083, DOI 10.1523/JNEUROSCI.2965-15.2016; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; Daws RE, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02191; De Simoni S, 2018, BRAIN, V141, P148, DOI 10.1093/brain/awx309; De Simoni S, 2016, BRAIN, V139, P3137, DOI 10.1093/brain/aww241; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Gaffan D, 2005, SCIENCE, V309, P2172, DOI 10.1126/science.1119445; Gould Stephen Jay, 1981, MISMEASURE MAN; Haier RJ, 2014, INTELLIGENCE, V46, P323, DOI 10.1016/j.intell.2014.02.007; Hampshire A, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00221; Hampshire A, 2016, NEUROIMAGE, V127, P123, DOI 10.1016/j.neuroimage.2015.11.060; Hampshire A, 2012, NEURON, V76, P1225, DOI 10.1016/j.neuron.2012.06.022; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kuceyeski AF, 2019, HUM BRAIN MAPP, V40, P4441, DOI 10.1002/hbm.24713; Li LM, 2019, HUM BRAIN MAPP, V40, P904, DOI 10.1002/hbm.24420; Li YC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058272, 10.1371/journal.pone.0073186]; Lorenz R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03657-3; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Petrides Michael, 1994, Current Opinion in Neurobiology, V4, P207, DOI 10.1016/0959-4388(94)90074-4; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schrouff J, 2013, NEUROINFORMATICS, V11, P319, DOI 10.1007/s12021-013-9178-1; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Soreq E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08840-8; Squarcina L, 2012, NEUROIMAGE, V63, P779, DOI 10.1016/j.neuroimage.2012.07.016; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Violante IR, 2017, ELIFE, V6, DOI [10.7554/elife.22001.001, 10.7554/eLife.22001]; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zhang SW, 2018, NEUROIMAGE, V172, P40, DOI 10.1016/j.neuroimage.2018.01.046	51	13	13	1	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	APR	2020	143		4				1158	1176		10.1093/brain/awaa067			19	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	MA2TO	WOS:000541770600024	32243506	hybrid, Green Published			2022-02-06	
J	Saunders, TD; Le, RK; Breedlove, KM; Bradney, DA; Bowman, TG				Saunders, Tabitha D.; Le, Rachel K.; Breedlove, Katherine M.; Bradney, Debbie A.; Bowman, Thomas G.			Sex differences in mechanisms of head impacts in collegiate soccer athletes	CLINICAL BIOMECHANICS			English	Article						xPatch; Futbol; Head impact biomechanics	PLAYERS; INJURY; ACCELERATION; CONCUSSIONS; SPORTS	Background: There has been growing interest in head impacts related to sports participation due to potential long- and short-term consequences of head injuries. Our purpose was to compare head impact magnitude and frequency between men's and women's intercollegiate soccer players based on head impact mechanism. Methods: 28 collegiate soccer players (16 women: age = 19.94 (1.06) years, height = 163.75 (5.15) cm, mass = 61.21 (5.09) kg; 12 men: age = 20.25 (1.14) years, height = 180.34 (6.03) cm, mass = 74.09 (9.32) kg) wore xPatch (X2 Biosystems, Seattle, WA) head impact sensors. Each practice and game was video recorded in order to confirm head impacts. The independent variable was impact mechanism (head to head, head to body (other than head), head to ground, ball to head, goal to head, and combination). Sensors collected linear and rotational accelerations and frequency of head impacts per 1000 athlete exposures. Findings: Men were more likely to sustain head impacts than women (IRR = 1.74, CI95 = 1.59-1.92). The highest head impact incidence rate for men was head to body (IR = 611.68, CI95 = 553.11-670.25) while the highest impact incidence rate for women was ball to head (IR = 302.29, CI95 = 270.93-333.64). The interaction between sex and mechanism was significant for rotational accelerations (F-4,F- (1720) = 3.757, P = .005, omega(2) = 0.013) but not for linear accelerations (F-4,F- (1720) = 0.680, P = .606, omega(2) < 0.001, 1 - beta = 0.223). Interpretation: To reduce the frequency of head impacts in men, perhaps rules governing player to player contact should be more strictly enforced as these data confirm frequent player-to-head contact during soccer practices and games. Prevention efforts for women should be focused on limiting the amount of purposeful heading (planned contact between the head and ball) occurring during play especially since these impacts had higher magnitudes compared to men.	[Saunders, Tabitha D.; Le, Rachel K.; Bradney, Debbie A.; Bowman, Thomas G.] Univ Lynchburg, Dept Athlet Training, Lynchburg, VA USA; [Breedlove, Katherine M.] Brigham & Womens Hosp, Dept Radiol, Ctr Clin Spect, 75 Francis St, Boston, MA 02115 USA; [Breedlove, Katherine M.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA		Bowman, TG (corresponding author), 1501 Lakeside Dr, Lynchburg, VA 24501 USA.	Bowman.t@lynchburg.edu	Bowman, Tom/AAU-6473-2020		University of Lynchburg through the Percy Wootton Student-Faculty Research Award; University of Lynchburg through Schewel Student-Faculty Research Fund	Financial support was provided from the University of Lynchburg through the Percy Wootton Student-Faculty Research Award and the Schewel Student-Faculty Research Fund. The results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation.	Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Caccese J., 2016, INT RES SCI SOCCER; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Erev I, 2010, BEHAV PROCESS, V84, P366, DOI 10.1016/j.beproc.2010.01.008; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kaminski TW, 2008, RES Q EXERCISE SPORT, V79, P235; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lomax R.G., 2013, INTRO STAT CONCEPTS; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; National Collegiate Athletic Association, 2016, SOCC 2016 2017 RUL; National Collegiate Athletic Association, 2016, SPORT SPONS PART DEM; National Collegiate Athletic Association, 2016, IC HOCK 2016 17 2017; Nevins D., 2019, ATHLETIC TRAINING SP, V11, P174, DOI [10.3928/19425864-20180802-02, DOI 10.3928/19425864-20180802-02]; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	38	13	13	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	APR	2020	74						14	20		10.1016/j.clinbiomech.2020.02.003			7	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Orthopedics; Sport Sciences	LN1AV	WOS:000532678100003	32097766				2022-02-06	
J	Sawchuk, T; Buchhalter, J; Senft, B				Sawchuk, Tyson; Buchhalter, Jeffrey; Senft, Birgit			Psychogenic nonepileptic seizures in children-Prospective validation of a clinical care pathway & risk factors for treatment outcome	EPILEPSY & BEHAVIOR			English	Article						PNES; Nonepileptic event; Care pathway; Treatment; Epilepsy; Outcomes	ADOLESCENTS; THERAPY; MANAGEMENT; PNES	Purpose: The purpose of this study was to prospectively validate a care pathway for psychogenic nonepileptic seizures (PNES) in a pediatric setting. The pathway was developed based on a previous study of patients at our center, which demonstrated positive treatment outcomes of 80% full or partial remission. Sequentially referred patients with PNES in the validation cohort received care prospectively according to the pathway algorithm. It was hypothesized that the validation cohort would achieve outcomes similar to that of the development cohort as a result of standardized care. Method: We performed a retrospective chart review of 43 children sequentially referred, assessed, and treated within a specialized neurology psychology service for suspected PNES over a 5-year period. The majority of patients (n = 41, 95%) met diagnostic criteria for probable, dinically established, or documented PNES, according to the International League Against Epilepsy (ILAE) criteria. Results: Ages ranged from 6 to 18 years of age at time of diagnosis, with the majority of patients being female (n = 29, 67%) and adolescent (n = 31, 72%). There was a high level of adherence to the care algorithm (n = 34, 84%). The development and validation cohorts were similar across demographic, clinical, and psychological characteristics. Standardized care resulted in high rates of full ( n = 27, 63%) and partial (n = 12, 28%) remission, as self-reported at discharge. A 96% decrease in mean monthly frequency of total PNES events was also observed at discharge, as was a significant reduction in healthcare utilization related to PNES (74% fewer ambulance calls and 85% fewer emergency department (ED) visits). Post hoc analyses demonstrated that duration of PNES illness longer than 12 months (at diagnosis) increased odds of not achieving full remission by discharge (odds ratio = 5.94, p = 0.02). Developmental period of onset (child versus adolescent), having abnormal electroencephalogram (EEG) result, previous concussion, chronic versus acute stressor, more than one PNES event type, or additional functional neurological symptoms did not significantly impact treatment response. Conclusions: This study demonstrates, for the first time prospectively in a pediatric setting, that standardized care for PNES leads to improved clinical outcomes and reduced healthcare utilization. Delayed diagnosis and treatment of PNES longer than 12 months also appears to be associated with less favorable outcomes in children. (C) 2020 Elsevier Inc. All rights reserved.	[Sawchuk, Tyson] Alberta Childrens Prov Gen Hosp, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada; [Sawchuk, Tyson] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Sawchuk, Tyson; Buchhalter, Jeffrey; Senft, Birgit] Univ Nicosia, Sch Social Sci, Dept Psychol, Nicosia, Cyprus; [Buchhalter, Jeffrey] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB, Canada; [Buchhalter, Jeffrey] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada		Sawchuk, T (corresponding author), Alberta Childrens Prov Gen Hosp, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	tyson.sawchuk@ahs.ca	Sawchuk, Tyson/AAP-2093-2020	Sawchuk, Tyson/0000-0001-7197-0221			Asadi-Pooya AA, 2019, EPILEPSY BEHAV, V98, P36, DOI 10.1016/j.yebeh.2019.06.013; Barry JJ, 2008, EPILEPSY BEHAV, V13, P624, DOI 10.1016/j.yebeh.2008.06.013; Beck JS, 2001, BLOOMINGTON; Beghi M, 2019, EPILEPSY BEHAV, V98, P288, DOI 10.1016/j.yebeh.2019.06.025; Bursch B, 2021, J CLIN PSYCHOL MED S, V28, P67, DOI 10.1007/s10880-019-09668-6; Caplan R, 2017, PEDIATRIC PSYCHOGENI; Carter A, 2018, SEIZURE-EUR J EPILEP, V61, P227, DOI 10.1016/j.seizure.2018.08.025; Chinta SS, 2008, ANN INDIAN ACAD NEUR, V11, P159, DOI 10.4103/0972-2327.42935; Doss JL, 2018, CHILD ADOL PSYCH CL, V27, P53, DOI 10.1016/j.chc.2017.08.007; Gasparini S, 2019, EUR J NEUROL, V26, P205, DOI 10.1111/ene.13818; Goldstein LH, 2010, NEUROLOGY, V74, P1986, DOI 10.1212/WNL.0b013e3181e39658; Goldstein LH, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0350-0; Hingray C, 2018, EPILEPSIA, V59, P203, DOI 10.1111/epi.13952; Hunter EC, 2017, BMJ-BRIT MED J, V356, pj745; Irwin K, 2000, ARCH DIS CHILD, V82, P474, DOI 10.1136/adc.82.6.474; Kinsman L, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-31; Kozlowska K, 2018, CLIN CHILD PSYCHOL P, V23, P140, DOI 10.1177/1359104517732118; Kozlowska K, 2018, CLIN CHILD PSYCHOL P, V23, P160, DOI 10.1177/1359104517730116; Kozlowska K, 2017, EUR CHILD ADOLES PSY, V26, P1207, DOI 10.1007/s00787-017-0976-0; Kozlowska K, 2016, CLIN CHILD PSYCHOL P, V21, P669, DOI 10.1177/1359104515621960; Kozlowska K, 2015, PSYCHOSOM MED, V77, P356, DOI 10.1097/PSY.0000000000000184; LaFrance WC, 2014, JAMA PSYCHIAT, V71, P997, DOI 10.1001/jamapsychiatry.2014.817; LaFrance WC, 2013, EPILEPSIA, V54, P53, DOI 10.1111/epi.12106; LaFrance WC, 2009, EPILEPSY BEHAV, V14, P591, DOI 10.1016/j.yebeh.2009.02.016; Luthy SK, 2018, HOSP PEDIAT, V8, P1; Milan-Tomas A, 2018, CAN J NEUROL SCI, V45, P130, DOI 10.1017/cjn.2017.283; Millon T., 1993, MILLON ADOLESCENT CL; Myers L, 2019, SEIZURE-EUR J EPILEP, V70, P49, DOI 10.1016/j.seizure.2019.06.028; Myers L, 2017, EPILEPSY BEHAV, V66, P86, DOI 10.1016/j.yebeh.2016.10.019; Pick S, 2018, J NEUROPSYCHOL, V12, P341, DOI 10.1111/jnp.12144; Pinto M, 2004, BEHAV RES THER, V42, P1505, DOI 10.1016/j.brat.2003.10.006; Reilly C, 2013, EPILEPSIA, V54, P1715, DOI 10.1111/epi.12336; Reuber M, 2017, SEIZURE-EUR J EPILEP, V44, P199, DOI 10.1016/j.seizure.2016.10.029; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Roberts NA, 2014, EPILEPSY BEHAV, V30, P43, DOI 10.1016/j.yebeh.2013.09.035; Rooney E, 2014, GERODONTOLOGY, V31, P52, DOI 10.1111/ger.12084; Sawchuk T, 2017, PSYCHOGENIC NONEPILE; Sawchuk T, 2015, EPILEPSY BEHAV, V52, P49, DOI 10.1016/j.yebeh.2015.08.032; Taskforce A., 2017, APSAC PRACTICE GUIDE, P8; Tolchin B, 2018, EPILEPSIA, V59, pE18, DOI 10.1111/epi.13969; Wyllie E, 1999, ARCH PEDIAT ADOL MED, V153, P244; Yadav A, 2015, EPILEPSY BEHAV, V53, P168, DOI 10.1016/j.yebeh.2015.10.017	42	13	13	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	APR	2020	105								106971	10.1016/j.yebeh.2020.106971			8	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	KY2GA	WOS:000522387700020	32126506				2022-02-06	
J	Roumes, H; Dumont, U; Sanchez, S; Mazuel, L; Blanc, J; Raffard, G; Chateil, JF; Pellerin, L; Bouzier-Sore, AK				Roumes, Helene; Dumont, Ursule; Sanchez, Stephane; Mazuel, Leslie; Blanc, Jordy; Raffard, Gerard; Chateil, Jean-Francois; Pellerin, Luc; Bouzier-Sore, Anne-Karine			Neuroprotective role of lactate in rat neonatal hypoxia-ischemia	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Neonatal hypoxia-ischemia; lactate; neuroprotection; astrocyte to neuron lactate shuttle; MRI	TRAUMATIC BRAIN-INJURY; NEURONAL MONOCARBOXYLATE TRANSPORTER; PENTOSE-PHOSPHATE PATHWAY; CENTRAL-NERVOUS-SYSTEM; PYRUVATE CARBOXYLATION; GLUCOSE-UTILIZATION; CEREBRAL-ISCHEMIA; ENERGY-METABOLISM; GLUTAMATE UPTAKE; EXPRESSION	Hypoxic-ischemic (HI) encephalopathy remains a major cause of perinatal mortality and chronic disability in newborns worldwide (1-6 for 1000 births). The only current clinical treatment is hypothermia, which is efficient for less than 60% of babies. Mainly considered as a waste product in the past, lactate, in addition to glucose, is increasingly admitted as a supplementary fuel for neurons and, more recently, as a signaling molecule in the brain. Our aim was to investigate the neuroprotective effect of lactate in a neonatal (seven day old) rat model of hypoxia-ischemia. Pups received intra-peritoneal injection(s) of lactate (40 mu mol). Size and apparent diffusion coefficients of brain lesions were assessed by magnetic resonance diffusion-weighted imaging. Oxiblot analyses and long-term behavioral studies were also conducted. A single lactate injection induced a 30% reduction in brain lesion volume, indicating a rapid and efficient neuroprotective effect. When oxamate, a lactate dehydrogenase inhibitor, was co-injected with lactate, the neuroprotection was completely abolished, highlighting the role of lactate metabolism in this protection. After three lactate injections (one per day), pups presented the smallest brain lesion volume and a complete recovery of neurological reflexes, sensorimotor capacities and long-term memory, demonstrating that lactate administration is a promising therapy for neonatal HI insult.	[Roumes, Helene; Dumont, Ursule; Sanchez, Stephane; Mazuel, Leslie; Blanc, Jordy; Raffard, Gerard; Chateil, Jean-Francois; Pellerin, Luc; Bouzier-Sore, Anne-Karine] Univ Bordeaux, Ctr Resonance Magnet Syst Biol, CNRS, UMR5536, 146 Rue Leo Saignat, F-33076 Bordeaux, France; [Pellerin, Luc] Univ Lausanne, Dept Physiol, Lausanne, Switzerland		Bouzier-Sore, AK (corresponding author), Univ Bordeaux, Ctr Resonance Magnet Syst Biol, CNRS, UMR5536, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	akb@rmsb.u-bordeaux.fr	; Pellerin, Luc/A-8912-2017	Roumes, Helene/0000-0002-0387-7823; Bouzier-Sore, Anne-Karine/0000-0002-3470-0940; CHATEIL, Jean-Francois/0000-0002-6143-7607; Pellerin, Luc/0000-0002-1016-1970; Mazuel, Leslie/0000-0002-0180-871X	TRAIL (Translational Research and Advanced Imaging Laboratory) cluster of excellence of Bordeaux University; program IdEx; LabEx TRAIL [ANR-10-IDEX, ANR-10-LABX-57]; international French (ANR)/Swiss (FNS)French National Research Agency (ANR) [ANR-15-CE37-0012]; FNSSwiss National Science Foundation (SNSF) [310030E164271]; program IdEx Bordeaux [ANR-10-IDEX-03-02]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by the TRAIL (Translational Research and Advanced Imaging Laboratory) cluster of excellence of Bordeaux University. AKBS has received financial support from the program IdEx and the LabEx TRAIL, reference ANR-10-IDEX and ANR-10-LABX-57. AKBS and LP have received financial support from an international French (ANR)/Swiss (FNS) grant, references ANR-15-CE37-0012 and FNS no 310030E164271. LP received financial support from the program IdEx Bordeaux ANR-10-IDEX-03-02.	Alessandri B, 2012, J NEUROTRAUM, V29, P2181, DOI 10.1089/neu.2011.2067; Allen KA, 2011, NEWBORN INFANT NURS, V11, P125, DOI 10.1053/j.nainr.2011.07.004; Arteaga O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142424; Bak LK, 2018, J PHYSIOL-LONDON, V596, P351, DOI 10.1113/JP274945; Balduini W, 2000, BRAIN RES, V859, P318, DOI 10.1016/S0006-8993(00)01997-1; Barros LF, 2018, J PHYSIOL-LONDON, V596, P347, DOI 10.1113/JP274944; BENYOSEPH O, 1994, DEV NEUROSCI-BASEL, V16, P328, DOI 10.1159/000112127; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Bergersen Linda H, 2012, Front Neuroenergetics, V4, P5, DOI 10.3389/fnene.2012.00005; Berthet C, 2012, CEREBROVASC DIS, V34, P329, DOI 10.1159/000343657; Berthet C, 2009, J CEREBR BLOOD F MET, V29, P1780, DOI 10.1038/jcbfm.2009.97; Bolanos JP, 2016, J NEUROCHEM, V139, P115, DOI 10.1111/jnc.13486; Bouet V, 2010, BEHAV BRAIN RES, V212, P56, DOI 10.1016/j.bbr.2010.03.043; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Bouzier AK, 2000, J NEUROCHEM, V75, P480, DOI 10.1046/j.1471-4159.2000.0750480.x; Bouzier-Sore AK, 2003, BIOCHIMIE, V85, P841, DOI 10.1016/j.biochi.2003.08.003; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; Bouzier-Sore AK, 2002, J PHYSIOL-PARIS, V96, P273, DOI 10.1016/S0928-4257(02)00016-5; Bouzier-Sore AK, 2006, EUR J NEUROSCI, V24, P1687, DOI 10.1111/j.1460-9568.2006.05056.x; Bouzier-Sore AK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00179; Brekke E, 2015, NEUROCHEM INT, V82, P33, DOI 10.1016/j.neuint.2015.02.002; Brekke EMF, 2014, J CEREBR BLOOD F MET, V34, P724, DOI 10.1038/jcbfm.2014.8; Brissaud O, 2010, PEDIATR RES, V68, P123, DOI 10.1203/00006450-201011001-00237; Camandola S, 2017, EMBO J, V36, P1474, DOI 10.15252/embj.201695810; Castillo X, 2015, J CEREBR BLOOD F MET, V35, P1561, DOI 10.1038/jcbfm.2015.115; Cater HL, 2003, J NEUROCHEM, V87, P1381, DOI 10.1046/j.1471-4159.2003.02100.x; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; CHEW W, 1991, AM J NEURORADIOL, V12, P603; Chouthai Nitin S, 2015, J Neonatal Perinatal Med, V8, P125, DOI 10.3233/NPM-15814075; Cotten C Michael, 2010, Expert Rev Obstet Gynecol, V5, P227, DOI 10.1586/eog.10.7; Cremillieux Y, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3861; Davidson JO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00198; FREEMAN R, 1981, J MAGN RESON, V42, P341, DOI 10.1016/0022-2364(81)90227-4; Fridman EA, 2014, P NATL ACAD SCI USA, V111, P6473, DOI 10.1073/pnas.1320969111; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Guggisberg N., 2016, MEMOIRE MAITRISE MED, V3394, P1; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Ikeda T, 2001, BEHAV BRAIN RES, V118, P17, DOI 10.1016/S0166-4328(00)00287-4; Iwata O, 2007, BRAIN RES, V1154, P173, DOI 10.1016/j.brainres.2007.03.083; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Juul SE, 2014, CLIN PERINATOL, V41, P119, DOI 10.1016/j.clp.2013.09.004; Karalis F, 2011, BRAIN RES, V1425, P98, DOI 10.1016/j.brainres.2011.09.044; Kraut JA, 2014, NEW ENGL J MED, V371, P2309, DOI 10.1056/NEJMra1309483; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; LEBLANC MH, 1994, STROKE, V25, P1443, DOI 10.1161/01.STR.25.7.1443; LEBLANC MH, 1993, STROKE, V24, P1055, DOI 10.1161/01.STR.24.7.1055; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; Magistretti PJ, 1996, CEREB CORTEX, V6, P50, DOI 10.1093/cercor/6.1.50; Mazuel L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174990; Morken TS, 2014, NEUROCHEM RES, V39, P556, DOI 10.1007/s11064-013-1014-3; MYERS RE, 1977, ARCH NEUROL-CHICAGO, V34, P65, DOI 10.1001/archneur.1977.00500140019003; NEHLIG A, 1993, PROG NEUROBIOL, V40, P163, DOI 10.1016/0301-0082(93)90022-K; Ohki S, 1999, PEDIATR NEUROL, V21, P543, DOI 10.1016/S0887-8994(99)00039-9; Pan YS, 2017, STROKE, V48, P3006, DOI 10.1161/STROKEAHA.117.019081; Patet C, 2015, J NEUROTRAUM, V32, P1560, DOI 10.1089/neu.2014.3781; Pellerin L, 1998, P NATL ACAD SCI USA, V95, P3990, DOI 10.1073/pnas.95.7.3990; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Pierre K, 2002, J CEREBR BLOOD F MET, V22, P586, DOI 10.1097/00004647-200205000-00010; Pierre K, 2009, EUR J NEUROSCI, V29, P1951, DOI 10.1111/j.1460-9568.2009.06756.x; Quintard H, 2016, J NEUROTRAUM, V33, P681, DOI 10.1089/neu.2015.4057; Rafiki A, 2003, NEUROSCIENCE, V122, P677, DOI 10.1016/j.neuroscience.2003.08.040; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Ros J, 2001, J NEUROSCI RES, V66, P790, DOI 10.1002/jnr.10043; Rosafio K, 2014, GLIA, V62, P477, DOI 10.1002/glia.22618; ROTHMAN DL, 1985, P NATL ACAD SCI USA, V82, P1633, DOI 10.1073/pnas.82.6.1633; Sada N, 2015, SCIENCE, V347, P1362, DOI 10.1126/science.aaa1299; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Sampol Denys, 2013, Front Neuroenergetics, V5, P5, DOI 10.3389/fnene.2013.00005; Sanches EF, 2013, NEUROSCIENCE, V237, P208, DOI 10.1016/j.neuroscience.2013.01.066; Schurr A, 2001, BRAIN RES, V895, P268, DOI 10.1016/S0006-8993(01)02082-0; Schurr A, 1997, BRAIN RES, V744, P105, DOI 10.1016/S0006-8993(96)01106-7; Shah PS, 2010, SEMIN FETAL NEONAT M, V15, P238, DOI 10.1016/j.siny.2010.02.003; Shalak L, 2004, EARLY HUM DEV, V80, P125, DOI 10.1016/j.earlhumdev.2004.06.003; SUTHERLA.EW, 1969, DIABETES, V18, P797, DOI 10.2337/diab.18.12.797; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Taher M, 2016, EUR J PAEDIATR NEURO, V20, P3, DOI 10.1016/j.ejpn.2015.09.008; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Wagner BP, 2002, PEDIATR RES, V51, P354, DOI 10.1203/00006450-200203000-00015	82	13	13	1	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	FEB	2021	41	2					342	358	0271678X20908355	10.1177/0271678X20908355		MAR 2020	17	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	PS9BL	WOS:000523907800001	32208801	Green Published, hybrid			2022-02-06	
J	Alshareef, A; Giudice, JS; Forman, J; Shedd, DF; Reynier, KA; Wu, TT; Sochor, S; Sochor, MR; Salzar, RS; Panzer, MB				Alshareef, Ahmed; Giudice, J. Sebastian; Forman, Jason; Shedd, Daniel F.; Reynier, Kristen A.; Wu, Taotao; Sochor, Sara; Sochor, Mark R.; Salzar, Robert S.; Panzer, Matthew B.			Biomechanics of the Human Brain during Dynamic Rotation of the Head	JOURNAL OF NEUROTRAUMA			English	Article						brain biomechanics; FE model validation; sonomicrometry; traumatic brain injury	STRAIN RESPONSES; INJURY; DEFORMATION; MECHANICS	Traumatic brain injuries (TBI) are a substantial societal burden. The development of better technologies and systems to prevent and/or mitigate the severity of brain injury requires an improved understanding of the mechanisms of brain injury, and more specifically, how head impact exposure relates to brain deformation. Biomechanical investigations have used computational models to identify these relations, but more experimental brain deformation data are needed to validate these models and support their conclusions. The objective of this study was to generate a dataset describing in situ human brain motion under rotational loading at impact conditions considered injurious. Six head-neck human post-mortem specimens, unembalmed and never frozen, were instrumented with 24 sonomicrometry crystals embedded throughout the parenchyma that can directly measure dynamic brain motion. Dynamic brain displacement, relative to the skull, was measured for each specimen with four loading severities in the three directions of controlled rotation, for a total of 12 tests per specimen. All testing was completed 42-72 h post-mortem for each specimen. The final dataset contains approximately 5,000 individual point displacement time-histories that can be used to validate computational brain models. Brain motion was direction-dependent, with axial rotation resulting in the largest magnitude of displacement. Displacements were largest in the mid-cerebrum, and the inferior regions of the brain-the cerebellum and brainstem-experienced relatively lower peak displacements. Brain motion was also found to be positively correlated to peak angular velocity, and negatively correlated with angular velocity duration, a finding that has implications related to brain injury risk-assessment methods. This dataset of dynamic human brain motion will form the foundation for the continued development and refinement of computational models of the human brain for predicting TBI.	[Alshareef, Ahmed; Giudice, J. Sebastian; Forman, Jason; Shedd, Daniel F.; Reynier, Kristen A.; Wu, Taotao; Sochor, Sara; Sochor, Mark R.; Salzar, Robert S.; Panzer, Matthew B.] Univ Virginia, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA		Panzer, MB (corresponding author), Univ Virginia, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA.	panzer@virginia.edu		Shedd, Daniel/0000-0002-0101-8910; Forman, Jason/0000-0001-8705-3997; Giudice, Sebastian/0000-0003-1074-4890	National Highway Traffic Safety Administration [DTNH221500022/0002]	This study was sponsored by the National Highway Traffic Safety Administration under contract number DTNH221500022/0002.	Alshareef A, 2020, BIOMED SIGNAL PROCES, V56, DOI 10.1016/j.bspc.2019.101691; Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Benson, 1977, SAE TECHNICAL PAPER, DOI [10.4271/770921, DOI 10.4271/770921]; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dione D, 1997, P ANN INT IEEE EMBS, V19, P848, DOI 10.1109/IEMBS.1997.757790; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Gabler L.F., 2018, ANN BIOMED ENG, V47, P1971; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Gennarelli T.A., 1987, SAE T, V96, P1355; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Giudice JS, 2019, ANN BIOMED ENG, V47, P1855, DOI 10.1007/s10439-018-02161-5; Giudice JS, 2019, ANN BIOMED ENG, V47, P464, DOI 10.1007/s10439-018-02155-3; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Holbourn AHS, 1943, LANCET, V2, P438; Horstemeyer MF, 2019, ANN BIOMED ENG, V47, P1829, DOI 10.1007/s10439-019-02351-9; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; Mallory A.E., 2014, THESIS, pUniversity; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Meoli D, 1998, PROCEEDINGS OF THE IEEE 24TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P64, DOI 10.1109/NEBC.1998.664878; Newman J A, 2000, Stapp Car Crash J, V44, P215; Nusholtz G. S., 1984, SAE T, V93, P800; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; Panzer MB, 2018, J NEUROTRAUM, V35, pA148; Robbins D.H., 1983, SAE TECHNICAL PAPER, DOI [10.4271/831617, DOI 10.4271/831617]; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; SAE International, 1995, J2111 SAE; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Sanchez EJ, 2017, J NEUROTRAUM, V34, P2410, DOI 10.1089/neu.2016.4681; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Sugawara O, 1996, SPINE, V21, P2089, DOI 10.1097/00007632-199609150-00006; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thibault L.E., 1972, SAE TECHNICAL PAPER, P720970, DOI [10.4271/720970, DOI 10.4271/720970]; VANTRIGT P, 1981, AM J PHYSIOL, V240, pH664, DOI 10.1152/ajpheart.1981.240.4.H664; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; Yanaoka T, 2017, 25 INT TECHN C ENH S; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	47	13	13	4	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2020	37	13					1546	1555		10.1089/neu.2019.6847		MAR 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ME4JC	WOS:000525040500001	31952465	Green Published			2022-02-06	
J	Erdodi, LA; Abeare, CA				Erdodi, Laszlo A.; Abeare, Christopher A.			Stronger Together: The Wechsler Adult Intelligence Scale-Fourth Edition as a Multivariate Performance Validity Test in Patients with Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Performance validity assessment; Embedded validity indicators; WAIS-IV; Multivariate measurement models; Wechsler Validity Index	VERBAL-LEARNING TEST; MALINGERED NEUROCOGNITIVE DYSFUNCTION; FORCED-CHOICE RECOGNITION; FINGER TAPPING TEST; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; COMPLEX IDEATIONAL MATERIAL; FALSE-POSITIVE RATES; RELIABLE DIGIT SPAN; RAW SCORE CUTOFFS; CARD SORTING TEST	Objective: This study was designed to evaluate the classification accuracy of a multivariate model of performance validity assessment using embedded validity indicators (EVIs) within the Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV). Method: Archival data were collected from 100 adults with traumatic brain injury (TBI) consecutively referred for neuropsychological assessment in a clinical setting. The classification accuracy of previously published individual EVIs nested within the WAIS-IV and a composite measure based on six independent EVIs were evaluated against psychometrically defined noncredible performance. Results: Univariate validity cutoffs based on age-corrected scaled scores on Coding, Symbol Search, Digit Span, Letter-Number-Sequencing, Vocabulary minus Digit Span, and Coding minus Symbol Search were strong predictors of psychometrically defined non-credible responding. Failing >= 3 of these six EVIs at the liberal cutoff improved specificity (.91-.95) over univariate cutoffs (.78-.93). Conversely, failing >= 2 EVIs at the more conservative cutoff increased and stabilized sensitivity (.43-.67) compared to univariate cutoffs (.11-.63) while maintaining consistently high specificity (.93-.95). Conclusions: In addition to being a widely used test of cognitive functioning, the WAIS-IV can also function as a measure of performance validity. Consistent with previous research, combining information from multiple EVIs enhanced the classification accuracy of individual cutoffs and provided more stable parameter estimates. If the current findings are replicated in larger, diagnostically and demographically heterogeneous samples, the WAIS-IV has the potential to become a powerful multivariate model of performance validity assessment. Brief Summary: Using a combination of multiple performance validity indicators embedded within the subtests of the Wechsler Adult Intelligence Scale, the credibility of the response set can be established with a high level of confidence. Multivariate models improve classification accuracy over individual tests. Relying on existing test data is a cost-effective approach to performance validity assessment.	[Erdodi, Laszlo A.; Abeare, Christopher A.] Univ Windsor, Dept Psychol, Neuropsychol Track, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada		Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, Neuropsychol Track, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com		Abeare, Christopher/0000-0002-7163-7434	Faculty of Arts, Humanities, and Social Sciences at the University of Windsor	This research was supported by a Collaborative Research Grant from the Faculty of Arts, Humanities, and Social Sciences at the University of Windsor.	Abeare C, 2019, PSYCHOL INJ LAW, V12, P170, DOI 10.1007/s12207-019-09353-x; Abeare C, 2019, J HEAD TRAUMA REHAB, V34, pE20, DOI 10.1097/HTR.0000000000000451; An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Bilder RM, 2014, CLIN NEUROPSYCHOL, V28, P1212, DOI 10.1080/13854046.2014.969774; Bolinger E, 2014, ARCH CLIN NEUROPSYCH, V29, P7, DOI 10.1093/arclin/act082; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P675, DOI 10.1016/j.acn.2007.07.005; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Cottingham ME, 2014, CLIN NEUROPSYCHOL, V28, P1030, DOI 10.1080/13854046.2014.951397; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Donders J, 2013, J CLIN EXP NEUROPSYC, V35, P827, DOI 10.1080/13803395.2013.824557; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Erdodi L. A., 2019, ASSESSMENT FEIGNED C; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P113, DOI 10.1007/s12207-019-09352-y; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P155, DOI 10.1007/s12207-019-09356-8; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P307, DOI 10.1007/s12207-018-9337-7; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Fazio RL, 2017, CLIN NEUROPSYCHOL, V31, P251, DOI 10.1080/13854046.2016.1213316; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Greher MR, 2017, J PSYCHIATR PRACT, V23, P134, DOI 10.1097/PRA.0000000000000218; Greve KW, 2009, ASSESSMENT, V16, P237, DOI 10.1177/1073191108326227; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P534, DOI 10.1080/13854040802232690; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Heaton R. K., 2004, REVISED COMPREHENSIV; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Henry GK, 2018, J INT NEUROPSYCH SOC, V24, P735, DOI 10.1017/S1355617718000218; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Kolb B., 2009, FUNDAMENTALS HUMAN N; Lange RT, 2017, CLIN NEUROPSYCHOL, V31, P1015, DOI 10.1080/13854046.2017.1335438; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee G. J., 2012, FORENSIC NEUROPSYCHO, P117; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2019, CLIN NEUROPSYCHOL, V33, P1354, DOI 10.1080/13854046.2019.1614227; Larrabee GJ, 2014, CLIN NEUROPSYCHOL, V28, P1230, DOI 10.1080/13854046.2014.988754; Leighton A, 2014, J INT NEUROPSYCH SOC, V20, P873, DOI 10.1017/S135561771400085X; Lichtenstein JD, 2019, PSYCHOL INJ LAW, V12, P127, DOI 10.1007/s12207-019-09354-w; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McDaniel MA, 2006, INTELLIGENCE, V34, P607, DOI 10.1016/j.intell.2006.08.007; Meyers JE, 2014, ARCH CLIN NEUROPSYCH, V29, P224, DOI 10.1093/arclin/acu001; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Pearson, 2009, ADV CLIN SOLUTIONS W; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Persinger VC, 2018, CLIN NEUROPSYCHOL, V32, P1039, DOI 10.1080/13854046.2017.1419507; Piffer D, 2014, INTELLIGENCE, V46, P246, DOI 10.1016/j.intell.2014.07.006; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rai J., 2019, PSYCHOL NEUROSCIENCE, V12, P451, DOI [10.1037/pne0000175, DOI 10.1037/PNE0000175]; Rai JK, 2021, APPL NEUROPSYCH-ADUL, V28, P185, DOI 10.1080/23279095.2019.1613994; Ready RE, 2014, PROF PSYCHOL-RES PR, V45, P278, DOI 10.1037/a0037439; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Roye S, 2019, CLIN NEUROPSYCHOL, V33, P1138, DOI 10.1080/13854046.2018.1520303; Ryan JJ, 2010, APPL NEUROPSYCHOL, V17, P246, DOI 10.1080/09084282.2010.499802; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P466, DOI 10.1080/13854046.2018.1484517; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Shura RD, 2017, PSYCHOL ASSESSMENT, V29, P1458, DOI 10.1037/pas0000436; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; Silverberg ND, 2008, CLIN NEUROPSYCHOL, V22, P140, DOI 10.1080/13854040601160597; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Soble JR, 2018, J CLIN EXP NEUROPSYC, V40, P317, DOI 10.1080/13803395.2017.1342773; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Suhr J, 2012, CLIN NEUROPSYCHOL, V26, P1128, DOI 10.1080/13854046.2012.713121; Sussman Z. W., 2017, APPL NEUROPSYCHOLOGY; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; Vallabhajosula B, 2001, J AM ACAD PSYCHIATRY, V29, P207; Warrington E, 1984, RECOGNITION MEMORY T, V1; Williamson D. J., 2014, CLIN NEUROPSYCHOL, V26, P588; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	138	13	13	3	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2020	35	2					188	204		10.1093/arclin/acz032			17	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NY8KM	WOS:000576631900008	31696203	Bronze			2022-02-06	
J	Tabibkhooei, A; Izadpanahi, M; Arab, A; Zare-Mirzaei, A; Minaeian, S; Rostami, A; Mohsenian, A				Tabibkhooei, Alireza; Izadpanahi, Maryam; Arab, Abolfazl; Zare-Mirzaei, Ali; Minaeian, Sara; Rostami, Ali; Mohsenian, Alireza			Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Circulating MicroRNAs; GBM; Biomarkers; Plasma exosomal-microRNAs; Prognosis; EGFR and MET signaling pathways	MESENCHYMAL STEM-CELLS; GLIOBLASTOMA-MULTIFORME; EXPRESSION; PROGNOSIS; GROWTH; TUMORS; CLASSIFICATION; TEMOZOLOMIDE; MECHANISMS; SIGNATURE	Objective: Glioblastoma (GBM) is the most common primary malignant neoplasm of the central nervous system (CNS). Despite the progress in therapeutic strategies such as surgical techniques, radiotherapy, chemotherapy, and targeted therapy, prognosis and therapeutically convenient monitoring tools in patients with GBM has not improved significantly up to now.Therefore, exosomal miRNAs as novel non-invasive biomarkers having high sensitivity and specificity are required to improve diagnosis and to develop new targeted therapy strategies for GBM patients. The aim of the present study was to investigate a novel miRNA signature as a predictive biomarker for diagnosis and measurement of response to therapeutic interventions in plasma of GBM patients versus traumatic brain injury and diffuse low-grade astrocytoma (LGA) patients. Patients and methods: Plasma exosomal-microRNAs were isolated from GBM (n = 25), LGA (n = 25), and head trauma patients (n = 15) as non-glioma control from March 2017 to June 2018 in Department of Neurosurgery at Rasoul-e-Akram Hospital. Through a bioinformatics analysis, we used Miranda, TargetScan, mirBase, DIANA-microT-CDS, and KEGG database as well as microarray data analysis from GEO for microRNA candidates. Finally, miR-210, miR-185, miR-5194, and miR-449 were selected among those miRNAs because they were recorded to target the maximum number of genes in EGFR and c-MET signaling pathways. Then, exosomal microRNAs were extracted from plasma of patients and quantitated by locked nucleic acid real-time PCR in GBM, LGA, and trauma patients. Results: This result is the first report on the role of circulating miR-185, miR-449, and miR-5194 in GBM compared to LGA and trauma. The plasma expression of miR-210 as an oncogenic miR was upregulated in GBM and LGA groups (P < 0.0001). Otherwise, miR-185, miR-5194, and miR-449 were significantly downregulated (P <= 0.05) in GBM and LGA compared to trauma patients. There was no significant downregulation in the expression of miR-185 between GBM and LGA, while the expression of miR-5194 (P <= 0.05) and miR-449 (P <= 0.05) was significantly decreased in GBM patients compared with LGA. Conclusions: These results indicate that the levels of miR-210, miR-449, and miR-5194 are a promising diagnostic and prognostic biomarker positively correlated with histopathological grade and invasiveness of GBM. These findings imply that circulating microRNA can be potentially used as novel biomarkers for glioma that might be beneficial in clinical management of glioma patients.	[Tabibkhooei, Alireza; Izadpanahi, Maryam; Rostami, Ali; Mohsenian, Alireza] Iran Univ Med Sci, Dept Neurosurg, Tehran, Iran; [Arab, Abolfazl] Univ Tehran, Fac New Sci & Technol, Tehran, Iran; [Zare-Mirzaei, Ali] Iran Univ Med Sci, Dept Pathol, Tehran, Iran; [Minaeian, Sara] Iran Univ Med Sci, Antimicrobial Resistance Res Ctr, Inst Immunol & Infect Dis, Tehran, Iran		Tabibkhooei, A; Izadpanahi, M (corresponding author), Hazrat Rasool Hosp, Neurosurg Ward, Niyayesh St,Sattarkhan Ave, Tehran, Iran.	Tabibkhooei.a@iums.ac.ir; science_izadpanahi@yahoo.com	Rostami, Ali/R-3347-2017	Rostami, Ali/0000-0002-1358-1321; arab, abolfazl/0000-0002-0024-2937	Department of Neurosurgery, Hazrat Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran	This work was supported by Department of Neurosurgery, Hazrat Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran. The authors confirm that there are no conflicts of interest, and take this opportunity to appreciate Exiqon, Dr. Daniel Kiani,Dr.Ehsan Arefian for their help during this project.	Abounader R., 2009, CNS CANC CANC DRUG D, P933; Agnihotri S, 2013, ARCH IMMUNOL THER EX, V61, P25, DOI 10.1007/s00005-012-0203-0; Agrahari V, 2019, TRENDS BIOTECHNOL; Akers JC, 2017, ONCOTARGET, V8, P68769, DOI 10.18632/oncotarget.18332; Alexander BM, 2017, J CLIN ONCOL, V35, P2402, DOI 10.1200/JCO.2017.73.0119; Alexiou GA, 2019, EPILEPSY SURG INTRIN, P261; Alexiou GA, 2012, CURR RADIOPHARM, V5, P308, DOI 10.2174/1874471011205040308; Areeb Z, 2015, J NEURO-ONCOL, V125, P237, DOI 10.1007/s11060-015-1912-0; Awad AJ, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.9.FOCUS14520; Baglio SR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00359; Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8; Bradshaw A.A., 2009, HDB CELL SIGNALING; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chakraborty S, 2019, INT CONF ADV COMMUN, P260, DOI 10.23919/ICACT.2019.8701983; Chakravarty D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08940-9; Chhabda S, 2016, QUANT IMAGING MED SU, V6, P486, DOI 10.21037/qims.2016.10.01; D'Urso PI, 2015, CURR GENOMICS, V16, P304, DOI 10.2174/1389202916666150707155610; Dai XJ, 2019, INT J ONCOL, V54, P261, DOI 10.3892/ijo.2018.4621; Damiani E, 2019, BIOCHEM J, V476, P245, DOI 10.1042/BCJ20180384; Davis ME, 2016, CLIN J ONCOL NURS, V20, P2, DOI 10.1188/16.CJON.S1.2-8; Di Somma A, 2019, WORLD NEUROSURG, V122, P441, DOI 10.1016/j.wneu.2018.11.057; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Ebrahimkhani S, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0071-0; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Garajova Ingrid, 2015, Transl Oncogenomics, V7, P13, DOI 10.4137/TOG.S30534; Graner MW, 2013, PROC SPIE, V8723, DOI 10.1117/12.2027435; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hanif Farina, 2017, Asian Pac J Cancer Prev, V18, P3; Hardee ME, 2012, AM J PATHOL, V181, P1126, DOI 10.1016/j.ajpath.2012.06.030; Hintenlang LL, 2018, J CLIN NEUROSCI, V48, P118, DOI 10.1016/j.jocn.2017.11.003; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Hossain A, 2015, STEM CELLS, V33, P2400, DOI 10.1002/stem.2053; Hua Z, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0628-5; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; Itakura H, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7582; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Koochekpour S, 1997, CANCER RES, V57, P5391; Kudo-Saito C, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00023; Lai NS, 2015, BRIT J CANCER, V112, P1241, DOI 10.1038/bjc.2015.91; Lai NS, 2014, J CLIN NEUROSCI, V21, P755, DOI 10.1016/j.jocn.2013.06.024; Lai NS, 2014, FOLIA NEUROPATHOL, V52, P79, DOI 10.5114/fn.2014.41746; Li HY, 2016, EUR REV MED PHARMACO, V20, P3599; Li S, 2015, INT J CLIN EXP PATHO, V8, P11854; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Malara N., 2018, BLOOD BRAIN BARRIER; Massey S.C., 2019, BIORXIV; Mikaelian I, 2013, TOXICOL PATHOL, V41, P18, DOI 10.1177/0192623312448939; Minniti G, 2019, NEUROREHABILITATION, P53; Modrek AS, 2017, CELL REP, V21, P1267, DOI 10.1016/j.celrep.2017.10.009; Murray LMA, 2019, STEM CELLS, V37, P14, DOI 10.1002/stem.2922; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Osti D, 2019, CLIN CANCER RES, V25, P266, DOI 10.1158/1078-0432.CCR-18-1941; Otani R, 2018, CANCER SCI, V109, P2327, DOI 10.1111/cas.13635; Pelloski C.E., 2007, CURRENT TREATMENT OP; Pessina F, 2017, J NEURO-ONCOL, V131, P377, DOI 10.1007/s11060-016-2310-y; Qiu J, 2013, MOL MED REP, V7, P1955, DOI 10.3892/mmr.2013.1431; Qiu SW, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-10; Romano A, 2018, J NEURO-ONCOL, V139, P455, DOI 10.1007/s11060-018-2887-4; Saadatpour L, 2016, CANCER GENE THER, V23, P415, DOI 10.1038/cgt.2016.48; Sana J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20929-6; Santangelo A, 2018, J NEURO-ONCOL, V136, P51, DOI 10.1007/s11060-017-2639-x; Santangelo A, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.15; Schotte D, 2011, LEUKEMIA, V25, P1389, DOI 10.1038/leu.2011.105; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shahar T, 2017, NEURO-ONCOLOGY, V19, P660, DOI 10.1093/neuonc/now239; Shi YF, 2017, NAT REV DRUG DISCOV, V16, P35, DOI 10.1038/nrd.2016.193; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Spinelli C, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5010001; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Szopa W, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8013575; Tang HL, 2015, J CANCER RES THER, V11, P630, DOI 10.4103/0973-1482.146121; Tang HL, 2012, CURR CANCER DRUG TAR, V12, P1032, DOI 10.2174/156800912803251180; Tiberio P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/731479; Tumilson CA, 2014, MOL NEUROBIOL, V50, P545, DOI 10.1007/s12035-014-8679-8; Unkelbach J., 2014, PHYS MED BIOL, V59; Vallabhaneni KC, 2015, ONCOTARGET, V6, P4953, DOI 10.18632/oncotarget.3211; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Visani M, 2014, MOL ONCOL, V8, P417, DOI 10.1016/j.molonc.2013.12.010; Wang Q, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-97; Westphal M, 2015, NAT REV NEUROL, V11, P556, DOI 10.1038/nrneurol.2015.171; Wu J, 2015, MOL NEUROBIOL, V52, P783, DOI 10.1007/s12035-014-8918-z; Wu ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047270; Xie Q, 2012, P NATL ACAD SCI USA, V109, P570, DOI 10.1073/pnas.1119059109; Xing W, 2017, TUMOR BIOL, V39, P5; Yano S, 2014, JPN J CLIN ONCOL, V44, P9, DOI 10.1093/jjco/hyt188; Yung WKA, 2000, BRIT J CANCER, V83, P588, DOI 10.1054/bjoc.2000.1316; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001; Zhang R, 2016, MOL NEUROBIOL, V53, P1452, DOI 10.1007/s12035-014-9079-9; Zhi F, 2015, NEURO-ONCOLOGY, V17, P383, DOI 10.1093/neuonc/nou169	92	13	13	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAR	2020	190								105652	10.1016/j.clineuro.2019.105652			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KW9PE	WOS:000521514800027	31896490				2022-02-06	
J	Tomfohr-Madsen, L; Madsen, JW; Bonneville, D; Virani, S; Plourde, V; Barlow, KM; Yeates, KO; Brooks, BL				Tomfohr-Madsen, Lianne; Madsen, Joshua W.; Bonneville, Dominique; Virani, Shane; Plourde, Vickie; Barlow, Karen M.; Yeates, Keith Owen; Brooks, Brian L.			A Pilot Randomized Controlled Trial of Cognitive-Behavioral Therapy for Insomnia in Adolescents With Persistent Postconcussion Symptoms	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; concussion; insomnia; sleep; therapy; treatment; youth	TRAUMATIC BRAIN-INJURY; SEVERITY INDEX; SLEEP QUALITY; INTERNET; CHILDREN; EFFICACY; RECOMMENDATIONS; METAANALYSIS; VALIDATION	Objective: Cognitive-behavioral therapy for insomnia (CBT-I) is an effective insomnia treatment but has yet to be applied to adolescents with sleep disruption following concussion. This pilot study evaluated CBT-I to improve insomnia in adolescents with protracted concussion recovery. Setting: Tertiary pediatric hospital. Participants: Participants (N = 24) were 12 to 18 years old (M = 15.0, SD = 1.4), 15.1 weeks (SD = 9.2) postinjury, and presenting with sleep disruption and persistent postconcussion symptoms. Design: A single-blind, parallel-group randomized controlled trial (RCT) design comparing 6 weeks of CBT-I and a treatment-as-usual control group. Outcomes were measured before treatment, at treatment completion, and 4 weeks after completion. Main Measures: Primary outcome was Insomnia Severity Index. Secondary outcomes included Pittsburgh Sleep Quality Index, Dysfunctional Beliefs and Attitudes about Sleep Scale, 7-night sleep diary, PROMIS Depression, PROMIS Anxiety, and Health and Behavior Inventory. Results: Adolescents who received CBT-I demonstrated large and clinically significant improvements in insomnia ratings at posttreatment that were maintained at follow-up. They also reported improved sleep quality, fewer dysfunctional beliefs about sleep, better sleep efficiency, shorter sleep-onset latency, and longer sleep time compared with those with treatment as usual. There was also a modest reduction in postconcussion symptoms. Conclusion: In this pilot RCT, 6 weeks of CBT-I produced significant improvement in sleep in adolescents with persistent postconcussion symptoms. A larger trial is warranted.	[Tomfohr-Madsen, Lianne; Madsen, Joshua W.; Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Bonneville, Dominique] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [Virani, Shane] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Plourde, Vickie] Univ Alberta, Fac St Jean, Edmonton, AB, Canada; [Virani, Shane; Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neuropsychol Serv, Calgary, AB, Canada; [Barlow, Karen M.] Fac Med, Univ Queensland, Brisbane, Qld, Australia; [Tomfohr-Madsen, Lianne; Barlow, Karen M.; Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Pediat, Cumming Sch Med, Calgary, AB, Canada; [Tomfohr-Madsen, Lianne; Virani, Shane; Yeates, Keith Owen; Brooks, Brian L.] Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Cumming Sch Med, Calgary, AB, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, 28 Oki Dr NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@ahs.ca	Barlow, Karen/I-6492-2019; Yeates, Keith/AAJ-4223-2020; Barlow, Karen/C-1323-2014	Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507; Plourde, Vickie/0000-0002-0098-5431	University of Calgary's Cumming School of Medicine Clinical Research Fund [CRF15-010]; Ronald and Irene WardChair in Pediatric Brain Injury at the University of Calgary	This project was funded by the University of Calgary's Cumming School of Medicine Clinical Research Fund (CRF15-010) awarded to Brian Brooks (principal investigator; coinvestigators: Lianne Tomfohr-Madsen, KeithOwen Yeates, and Karen Barlow). Salary support for Brian Brooks was provided by the CIHR Embedded Clinical Research Award. Salary support for Lianne Tomfohr-Madsen was provided by the Canadian Child Health Clinician Scientist Program. Keith Owen Yeates is supported by the Ronald and Irene WardChair in Pediatric Brain Injury at the University of Calgary. The authors thank the families at Alberta Children's Hospital for agreeing to participate in this clinical trial, the clinical trial nurse, nurses, and nurse practitioners in the Alberta Children's Hospital Brain Injury Clinic who facilitated recruitment (Heather Godfrey, Lisa Bodell, Lisette Lockyer, and Sarah Schantz), and the PhD student clinicians who provided the treatment (Ivan Sedov, Emily Cameron, Briana Cassetta, Jessica Switzer, and Jenna Thomas).	American Academy of Pediatrics, 2016, AM AC PED SUPP CHILD; Arora T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072406; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Barlow DH, 2010, AM PSYCHOL, V65, P13, DOI 10.1037/a0015643; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beaulieu-Bonneau S, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx002; Blake M, 2016, J CONSULT CLIN PSYCH, V84, P1039, DOI 10.1037/ccp0000142; Blake MJ, 2017, CLIN CHILD FAM PSYCH, V20, P227, DOI 10.1007/s10567-017-0234-5; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Buysse D J, 1989, Psychiatry Res, V28, P193; Buysse DJ, 2006, SLEEP, V29, P1155, DOI 10.1093/sleep/29.9.1155; Carney CE, 2010, J PSYCHOSOM RES, V68, P57, DOI 10.1016/j.jpsychores.2009.08.007; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Czajkowski SM, 2015, HEALTH PSYCHOL, V34, P971, DOI 10.1037/hea0000161; de Bruin EJ, 2018, J CHILD PSYCHOL PSYC, V59, P509, DOI 10.1111/jcpp.12834; De Bruin EJ, 2016, SLEEP, V39, P1571, DOI 10.5665/sleep.6024; de Bruin EJ, 2015, SLEEP, V38, P1913, DOI 10.5665/sleep.5240; de Bruin EJ, 2014, BEHAV SLEEP MED, V12, P235, DOI 10.1080/15402002.2013.784703; Dimidjian S, 2010, AM PSYCHOL, V65, P21, DOI 10.1037/a0017299; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Edinger JD, 2005, CLIN PSYCHOL REV, V25, P539, DOI 10.1016/J.CPR.2005.04.003; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Hedges LV, 2007, J EDUC BEHAV STAT, V32, P341, DOI 10.3102/1076998606298043; IBM Corp, 2017, SPSS STAT WIND; Irwin DE, 2010, QUAL LIFE RES, V19, P595, DOI 10.1007/s11136-010-9619-3; Irwin DE, 2010, QUAL LIFE RES, V19, P585, DOI 10.1007/s11136-010-9618-4; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meltzer Lisa J, 2007, Behav Sleep Med, V5, P297; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Morin CM, 2007, SLEEP, V30, P1547, DOI 10.1093/sleep/30.11.1547; Morin CM, 2012, LANCET, V379, P1129, DOI 10.1016/S0140-6736(11)60750-2; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; Morin CM, 2003, SLEEP MED REV, V7, P263, DOI 10.1053/smrv.2002.0274; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Owen J, 2015, J CLIN PSYCHOL, V71, P817, DOI 10.1002/jclp.22191; Palermo TM, 2017, J CLIN SLEEP MED, V13, P401, DOI 10.5664/jcsm.6490; Psychology Statistics, 2018, PSYSTAT SPSS GEN; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Schmidt AT, 2015, COGN BEHAV NEUROL, V28, P53, DOI 10.1097/WNN.0000000000000056; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Sullivan KA, 2018, J NEUROTRAUM, V35, P195, DOI 10.1089/neu.2016.4958; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Theadom A, 2018, CLIN REHABIL, V32, P619, DOI 10.1177/0269215517736671; Wu JQ, 2015, JAMA INTERN MED, V175, P1461, DOI 10.1001/jamainternmed.2015.3006; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	52	13	13	2	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2020	35	2			SI		E103	E112		10.1097/HTR.0000000000000504			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LC0HT	WOS:000525012500006	31246882				2022-02-06	
J	Hurst, FG; Ownsworth, T; Beadle, E; Shum, DHK; Fleming, J				Hurst, Felicity G.; Ownsworth, Tamara; Beadle, Elizabeth; Shum, David H. K.; Fleming, Jennifer			Domain-specific deficits in self-awareness and relationship to psychosocial outcomes after severe traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; self-awareness; functional domains; psychosocial functioning	ANXIETY STRESS SCALES; COMPETENCE RATING-SCALE; ALZHEIMERS-DISEASE; EMOTIONAL STATUS; DEPRESSION; PERFORMANCE; ASSOCIATION; ADJUSTMENT; VALIDITY; FEEDBACK	Purpose: To investigate the evidence for domain-specific deficits in self-awareness on the Patient Competency Rating Scale (PCRS) and the relationship to psychosocial outcomes after severe traumatic brain injury (TBI). Methods: Fifty-six adults with severe TBI (75% males, M age =36.96, SD = 12.96), and 50 age- and gender-matched controls (72% male, M age =34.12, SD = 11.43) were administered the PCRS self-report form, and the Depression, Anxiety, Stress Scales. Relatives of TBI and control participants completed the PCRS informant version. Relatives of the TBI group also completed the Sydney Psychosocial Rating Scale. Results: A within-group analysis indicated that self-awareness varied according to PCRS domain (p <.01). Relative to their own profile, TBI participants displayed significantly poorer self-awareness on the activities of daily living (ADLs) domain than on the interpersonal and emotional domains (p < 0.01). Further, TBI participants displayed significantly poorer self-awareness of ADLs than controls (p < 0.001), but there were no significant between-group differences in other domains. Hierarchical regression analyses revealed that poorer self-awareness of cognitive difficulties was related to lower occupational functioning (p = 0.01), whereas poorer self-awareness of difficulties with ADLs was related to lower independent living skills (p < 0.001). Conclusions: The results provide only limited support for domain-specific deficits in self-awareness after severe TBI, with impairment most evident for ADLs. Poorer self-awareness in the ADLs and cognitive domains were associated with lower independence and occupational functioning, respectively. The findings highlight the potential benefits of targeting self-awareness related to difficulties with ADLs in the rehabilitation of people with severe TBI.	[Hurst, Felicity G.; Ownsworth, Tamara; Beadle, Elizabeth; Shum, David H. K.] Griffith Univ, Sch Appl Psychol, Mt Gravatt Campus, Brisbane, Qld 4111, Australia; [Hurst, Felicity G.; Ownsworth, Tamara; Beadle, Elizabeth; Shum, David H. K.] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia; [Shum, David H. K.] Griffith Univ, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, CAS Key Lab Mental Hlth,Chinese Acad Sci, Beijing, Peoples R China; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia		Ownsworth, T (corresponding author), Griffith Univ, Sch Appl Psychol, Mt Gravatt Campus, Brisbane, Qld 4111, Australia.	t.ownsworth@griffith.edu.au	Ownsworth, Tamara/ABB-6961-2021; Shum, David H. K./A-3914-2008	Ownsworth, Tamara/0000-0003-1835-7094; Fleming, Jennifer/0000-0002-5603-2410; Shum, David H. K./0000-0002-4810-9262	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP1043677]	This research was partially funded by a National Health and Medical Research Council Project Grant [APP1043677].	Aboulafia-Brakha T, 2016, J HEAD TRAUMA REHAB, V31, pE21, DOI 10.1097/HTR.0000000000000171; Agnew SK, 1998, AGING MENT HEALTH, V2, P7, DOI 10.1080/13607869856876; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Clare L, 2010, AGING NEUROPSYCHOL C, V17, P462, DOI 10.1080/13825580903581558; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 1996, BRAIN INJURY, V10, P1; Geytenbeek M, 2017, BRAIN INJURY, V31, P1791, DOI 10.1080/02699052.2017.1346297; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Imhoff S, 2017, INT MED CASE REP J, V10, P41, DOI 10.2147/IMCRJ.S120918; Kolakowsky-Hayner S., 2010, PATIENT COMPETENCY R; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; Murdoch BE, 2001, TRAUMATIC BRAIN INJU; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T., 2017, NEUROPSYCHOLOGICAL R; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Ownsworth T, 2017, NEUROREHAB NEURAL RE, V31, P1072, DOI 10.1177/1545968317740635; Pachana NA, 2006, CLIN GERONTOL, V30, P23, DOI DOI 10.1300/J018V30N01_03; Powell JM, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020909; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Randall D, 2017, J HEAD TRAUMA REHAB, V32, P134, DOI 10.1097/HTR.0000000000000250; Richardson C, 2015, J HEAD TRAUMA REHAB, V30, pE43, DOI 10.1097/HTR.0000000000000048; Sandhaug M, 2012, DISABIL REHABIL, V34, P904, DOI 10.3109/09638288.2011.626484; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Schmitter-Edgecombe M, 2004, BRAIN INJURY, V18, P997, DOI 10.1080/02699050410001719934; Schoo LA, 2013, APPL NEUROPSYCH-ADUL, V20, P95, DOI 10.1080/09084282.2012.670144; Sherer M, 2010, AWARENESS QUESTIONNA; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; Stansfeld SA, 2008, OCCUP ENVIRON MED, V65, P634, DOI 10.1136/oem.2007.036640; Sveen U, 2015, DISABIL REHABIL, V37, P239, DOI 10.3109/09638288.2014.913706; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate R, 2012, AUST PSYCHOL, V47, P20, DOI 10.1111/j.1742-9544.2011.00060.x; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Winter L, 2016, DISABIL REHABIL, V38, P1280, DOI 10.3109/09638288.2015.1077531; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977; Zimmermann Nicolle, 2014, Trends Psychiatry Psychother., V36, P40, DOI 10.1590/2237-6089-2013-0021	53	13	13	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	FEB 27	2020	42	5					651	659		10.1080/09638288.2018.1504993			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	KR1EM	WOS:000517362100006	30449205				2022-02-06	
J	Sun, MK; Passaro, AP; Latchoumane, CF; Spellicy, SE; Bowler, M; Geoden, M; Martin, WJ; Holmes, PV; Stice, SL; Karumbaiah, L				Sun, Min Kyoung; Passaro, Austin P.; Latchoumane, Charles-Francois; Spellicy, Samantha E.; Bowler, Michael; Geoden, Morgan; Martin, William J.; Holmes, Philip, V; Stice, Steven L.; Karumbaiah, Lohitash			Extracellular Vesicles Mediate Neuroprotection and Functional Recovery after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						extracellular vesicles; neural stem cell; neuroprotection; TBI	ENDOTHELIAL GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; SEX-DIFFERENCES; PART II; GENDER; VEGF; PROGESTERONE; CHALLENGES; MIGRATION; INFUSION	The lack of effective therapies for moderate-to-severe traumatic brain injuries (TBIs) leaves patients with lifelong disabilities. Neural stem cells (NSCs) have demonstrated great promise for neural repair and regeneration. However, direct evidence to support their use as a cell replacement therapy for neural injuries is currently lacking. We hypothesized that NSC-derived extracellular vesicles (NSC EVs) mediate repair indirectly after TBI by enhancing neuroprotection and therapeutic efficacy of endogenous NSCs. We evaluated the short-term effects of acute intravenous injections of NSC EVs immediately following a rat TBI. Male NSC EV-treated rats demonstrated significantly reduced lesion sizes, enhanced presence of endogenous NSCs, and attenuated motor function impairments 4 weeks post-TBI, when compared with vehicle- and TBI-only male controls. Although statistically not significant, we observed a therapeutic effect of NSC EVs on brain lesion volume, nestin expression, and behavioral recovery in female subjects. Our study demonstrates the neuroprotective and functional benefits of NSC EVs for treating TBI and points to gender-dependent effects on treatment outcomes, which requires further investigation.	[Sun, Min Kyoung; Passaro, Austin P.; Latchoumane, Charles-Francois; Spellicy, Samantha E.; Stice, Steven L.; Karumbaiah, Lohitash] Univ Georgia, Regenerat Biosci Ctr, ADS Complex,425 River Rd, Athens, GA 30602 USA; [Sun, Min Kyoung; Passaro, Austin P.; Spellicy, Samantha E.; Holmes, Philip, V; Stice, Steven L.; Karumbaiah, Lohitash] Univ Georgia, Interdisciplinary Neurosci Program, Athens, GA 30602 USA; [Latchoumane, Charles-Francois; Stice, Steven L.; Karumbaiah, Lohitash] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA; [Bowler, Michael; Geoden, Morgan] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Martin, William J.] Univ Georgia, Coll Vet Med, Anim Hlth Res Ctr, Athens, GA 30602 USA; [Holmes, Philip, V] Univ Georgia, Dept Psychol, Athens, GA 30602 USA		Karumbaiah, L (corresponding author), Univ Georgia, Regenerat Biosci Ctr, ADS Complex,425 River Rd, Athens, GA 30602 USA.	lohitash@uga.edu	Spellicy, Samantha/AAL-8021-2021	Spellicy, Samantha/0000-0001-5648-8816; Sun, Min Kyoung/0000-0003-4389-9880; Latchoumane, Charles-Francois Vincent/0000-0001-7018-0439; Karumbaiah, Lohitash/0000-0001-7969-417X; Passaro, Austin/0000-0001-5449-3021	NIH R01 awardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS099596]; regenerative engineering in medicine (REM) partnership	This work was funded in part by a seed grant from the regenerative engineering in medicine (REM) partnership, and an NIH R01 award (R01NS099596) to LK.	Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Addington CP, 2015, BIOMARK INSIGHTS, V10, P43, DOI [10.4137/BMI.S20062, 10.4137/BMIMI.S20062]; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Betancur MI, 2017, ACS BIOMATER SCI ENG, V3, P420, DOI 10.1021/acsbiomaterials.6b00805; Bhatoe HS, 2005, INDIAN J NEUROTRAUM, V2, P1; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Chang EH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00332; Coritsidis G, 2015, J CLIN NEUROSCI, V22, P1332, DOI 10.1016/j.jocn.2015.02.025; Dixon KJ, 2015, J NEUROTRAUM, V32, P753, DOI 10.1089/neu.2014.3390; Driscoll D, 2017, STEM CELL TRANSL MED, V6, DOI 10.1002/sctm.16-0487; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Fonoff ET, 2009, BEHAV BRAIN RES, V202, P138, DOI 10.1016/j.bbr.2009.03.018; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hammell CL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1683; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Karumbaiah L, 2013, BIOMATERIALS, V34, P8061, DOI 10.1016/j.biomaterials.2013.07.016; Kejriwal R, 2009, NEW ZEAL MED J, V122, P40; Lai CPK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00228; Lee C, 2010, J NEUROTRAUM, V27, P541, DOI 10.1089/neu.2009.0905; Lever J, 2017, NAT METHODS, V14, P641, DOI 10.1038/nmeth.4346; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu L, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3252-8; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Ma YH, 2012, J NEUROSCI RES, V90, P1873, DOI 10.1002/jnr.23088; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Nowacka MM, 2012, NEUROPEPTIDES, V46, P1, DOI 10.1016/j.npep.2011.05.005; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Rabinowicz T, 2002, J NEUROPATH EXP NEUR, V61, P46, DOI 10.1093/jnen/61.1.46; Raghava Narayan, 2017, Neurosci Neuroecon, V6, P15, DOI 10.2147/NAN.S105134; Reekmans K, 2012, STEM CELL REV REP, V8, P262, DOI 10.1007/s12015-011-9266-2; Reis C, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/6392592; Shabbir A, 2015, STEM CELLS DEV, V24, P1635, DOI 10.1089/scd.2014.0316; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sung BH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8164; Sutterlin Chester E 3rd, 2016, J Spine Surg, V2, P266, DOI 10.21037/jss.2016.11.01; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb RL, 2018, TRANSL STROKE RES, V9, P530, DOI 10.1007/s12975-017-0599-2; Webb RL, 2018, STROKE, V49, P1248, DOI 10.1161/STROKEAHA.117.020353; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Wittko-Schneider IM, 2013, CELL MOL LIFE SCI, V70, P1705, DOI 10.1007/s00018-013-1279-3; Wright DW, 2014, ACAD EMERG MED, V21, P1414, DOI 10.1111/acem.12532; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Xin H., 2012, EXOSOME MEDIATED TRA; Xiong LL, 2018, MOL NEUROBIOL, V55, P2696, DOI 10.1007/s12035-017-0551-1; Yamashita T, 2018, BIOL PHARM BULL, V41, P835, DOI 10.1248/bpb.b18-00133; Zoerle T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00354; Zornow M H, 1995, New Horiz, V3, P488	62	13	13	3	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2020	37	11					1358	1369		10.1089/neu.2019.6443		FEB 2020	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LT0OT	WOS:000512586200001	31774030	Green Published, Bronze			2022-02-06	
J	Stubbs, JL; Green, KE; Silverberg, ND; Howard, A; Dhariwal, AK; Brubacher, JR; Garraway, N; Heran, MKS; Sekhon, MS; Aquino, A; Purcell, V; Hutchison, JS; Torres, IJ; Panenka, WJ				Stubbs, Jacob L.; Green, Katherine E.; Silverberg, Noah D.; Howard, Andrew; Dhariwal, Amrit K.; Brubacher, Jeffrey R.; Garraway, Naisan; Heran, Manraj K. S.; Sekhon, Mypinder S.; Aquino, Angela; Purcell, Victoria; Hutchison, James S.; Torres, Ivan J.; Panenka, William J.		Natl Biobank Database Patients Tra; Canadian Traumatic Brain Injury Re	Atypical Somatic Symptoms in Adults With Prolonged Recovery From Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						somatization; concussion; post-concussion syndrome; somatic symptoms; mild traumatic brain injury (mTBI)	HEAD-INJURY; SOMATIZATION; CONCUSSION; SOLDIERS; IDENTIFICATION; ASSOCIATION; PREDICTORS; DEPRESSION; VALIDITY; SCALE	Somatization may contribute to persistent symptoms after mild traumatic brain injury (mTBI). In two independently-recruited study samples, we characterized the extent to which symptoms atypical of mTBI but typical for patients suffering from somatization (e.g., gastrointestinal upset, musculoskeletal, and cardiorespiratory complaints) were present in adult patients with prolonged recovery following mTBI. The first sample was cross-sectional and consisted of mTBI patients recruited from the community who reported ongoing symptoms attributable to a previous mTBI (n = 16) along with a healthy control group (n = 15). The second sample consisted of patients with mTBI prospectively recruited from a Level 1 trauma center who had either good recovery (GOSE = 8; n = 32) or poor recovery (GOSE < 8; n = 29). In all participants, we evaluated atypical somatic symptoms using the Patient Health Questionnaire-15 and typical post-concussion symptoms with the Rivermead Post-Concussion Symptom Questionnaire. Participants with poor recovery from mTBI had significantly higher "atypical" somatic symptoms as compared to the healthy control group in Sample 1 (b = 4.308, p < 0.001) and to mTBI patients with good recovery in Sample 2 (b = 3.169, p < 0.001). As would be expected, participants with poor outcome in Sample 2 had a higher burden of typical rather than atypical symptoms [t((28)) = 4.750, p < 0.001, d = 0.88]. However, participants with poor recovery still reported atypical somatic symptoms that were significantly higher (1.4 standard deviations, on average) than those with good recovery. Our results suggest that although "typical" post-concussion symptoms predominate after mTBI, a broad range of somatic symptoms also frequently accompanies mTBI, and that somatization may represent an important, modifiable factor in mTBI recovery.	[Stubbs, Jacob L.; Green, Katherine E.; Howard, Andrew; Dhariwal, Amrit K.; Aquino, Angela; Purcell, Victoria; Torres, Ivan J.; Panenka, William J.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Stubbs, Jacob L.; Howard, Andrew; Panenka, William J.] Univ British Columbia, British Columbia Neuropsychiat Program, Vancouver, BC, Canada; [Stubbs, Jacob L.; Dhariwal, Amrit K.; Torres, Ivan J.; Panenka, William J.] British Columbia Mental Hlth & Subst Use Serv Res, Vancouver, BC, Canada; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Brubacher, Jeffrey R.] Univ British Columbia, Vancouver Gen Hosp, Dept Emergency Med, Vancouver, BC, Canada; [Garraway, Naisan] Univ British Columbia, Vancouver Gen Hosp, Dept Surg, Vancouver, BC, Canada; [Heran, Manraj K. S.] Univ British Columbia, Vancouver Gen Hosp, Div Neuroradiol, Vancouver, BC, Canada; [Sekhon, Mypinder S.] Univ British Columbia, Vancouver Gen Hosp, Div Crit Care, Vancouver, BC, Canada; [Hutchison, James S.] Hosp Sick Children, Dept Crit Care, Toronto, ON, Canada; [Hutchison, James S.] Hosp Sick Children, Neurosci & Mental Hlth Res Program, Res Inst, Toronto, ON, Canada; [Hutchison, James S.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Hutchison, James S.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada		Panenka, WJ (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.; Panenka, WJ (corresponding author), Univ British Columbia, British Columbia Neuropsychiat Program, Vancouver, BC, Canada.; Panenka, WJ (corresponding author), British Columbia Mental Hlth & Subst Use Serv Res, Vancouver, BC, Canada.	wpanenka@mail.ubc.ca		Panenka, William/0000-0001-7143-6512; Brubacher, Jeffrey/0000-0002-4866-4231; Dhariwal, Amrit/0000-0001-5724-5584	UBC Neuropsychiatry program research fund; Brain Canada; Genome BC	Funding for this study was provided by the UBC Neuropsychiatry program research fund, Brain Canada, and Genome BC. NS received research salary support from the Michael Smith Foundation for Health Research.	Barsky AJ, 2005, ARCH GEN PSYCHIAT, V62, P903, DOI 10.1001/archpsyc.62.8.903; Canty A, 2019, BOOT BOOTSTRA FUNCTI; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; FINK P, 1992, J PSYCHOSOM RES, V36, P439, DOI 10.1016/0022-3999(92)90004-L; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Goldsworthy R, 2019, PSYCHOL ASSESSMENT, V31, P1145, DOI 10.1037/pas0000742; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kessler RC, 2014, JAMA PSYCHIAT, V71, P504, DOI 10.1001/jamapsychiatry.2014.28; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Laferton JAC, 2017, PSYCHOSOM MED, V79, P974, DOI 10.1097/PSY.0000000000000530; Lee JEC, 2015, PSYCHOSOM MED, V77, P1006, DOI 10.1097/PSY.0000000000000250; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; LIPOWSKI ZJ, 1988, AM J PSYCHIAT, V145, P1358; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; R Core Team, 2019, R LANG ENV STAT COMP; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; Scamvougeras A., 2018, UNDERSTANDING MANAGI; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Sitnikova K, 2017, J PSYCHOSOM RES, V103, P42, DOI 10.1016/j.jpsychores.2017.10.005; Stone J, 2011, NEUROL CLIN, V29, P1, DOI 10.1016/j.ncl.2010.10.011; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wittenbrook JM, 1941, J NERV MENT DIS, V94, P170, DOI 10.1097/00005053-194194020-00004; Wood RLL, 2009, BRAIN INJURY, V23, P649, DOI 10.1080/02699050902970786; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172; Zijlema WL, 2013, J PSYCHOSOM RES, V74, P459, DOI 10.1016/j.jpsychores.2013.03.093	40	13	13	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 4	2020	11								43	10.3389/fneur.2020.00043			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KO5FB	WOS:000515574100001	32117012	Green Published, Green Submitted, gold			2022-02-06	
J	Corbett, JM; Ho, KM; Honeybul, S				Corbett, Jade-Marie; Ho, Kwok M.; Honeybul, Stephen			Prognostic significance of abnormal hematological parameters in severe traumatic brain injury requiring decompressive craniectomy	JOURNAL OF NEUROSURGERY			English	Article						head injury; hemorrhage; prognosis; surgery; trauma; traumatic brain injury	PLASMA TRANSFUSION; LYMPHOCYTE RATIO; COAGULOPATHY; PLATELET; CRASH; VALIDATION; NEUTROPHIL; MODELS	OBJECTIVE Hematological abnormalities after severe traumatic brain injury (TBI) are common, and are associated with a poor outcome. Whether these abnormalities offer additional prognostic significance over and beyond validated TBI prognostic models is uncertain. METHODS This retrospective cohort study compared the ability of admission hematological abnormalities to that of the IMPACT (International Mission for Prognosis and Analysis of Clinical Trials) prognostic model to predict 18-month neurological outcome of 388 patients who required a decompressive craniectomy after severe TBI, between 2004 and 2016, in Western Australia. Area under the receiver operating characteristic (AUROC) curve was used to assess predictors' ability to discriminate between patients with and without an unfavorable outcome of death, vegetative state, or severe disability. RESULTS Of the 388 patients included in the study, 151 (38.9%) had an unfavorable outcome at 18 months after decompressive craniectomy for severe TBI. Abnormalities in admission hemoglobin (AUROC 0.594, p = 0.002), plasma glucose (AUROC 0.592, p = 0.002), fibrinogen (AUROC 0.563, p = 0.036), international normalized ratio (INR; AUROC 0.645, p = 0.001), activated partial thromboplastin time (AUROC 0.564, p = 0.033), and disseminated intravascular coagulation score (AUROC 0.623, p = 0.001) were all associated with a higher risk of unfavorable outcome at 18 months after severe TBI. As a marker of inflammation, neutrophil to lymphocyte ratio was not significantly associated with the risk of unfavorable outcome (AUROC 0.500, p = 0.998). However, none of these parameters, in addition to the platelet count, were significantly associated with an unfavorable outcome after adjusting for the IMPACT predicted risk (odds ratio [OR] per 10% increment in risk 2.473, 95% confidence interval [CI] 2.061-2.967; p = 0.001). After excluding 8 patients (2.1%) who were treated with warfarin prior to the injury, there was a suggestion that INR was associated with some additional prognostic significance (OR 3.183, 95% CI 0.856-11.833; p = 0.084) after adjusting for the IMPACT predicted risk. CONCLUSIONS In isolation, INR was the best hematological prognostic parameter in severe TBI requiring decompressive craniectomy, especially when patients treated with warfarin were excluded. However, the prognostic significance of admission hematological abnormalities was mostly captured by the IMPACT prognostic model, such that they did not offer any additional prognostic information beyond the IMPACT predicted risk. These results suggest that new prognostic factors for TBI should be evaluated in conjunction with predicted risks of a comprehensive prognostic model that has been validated, such as the IMPACT prognostic model.	[Corbett, Jade-Marie; Ho, Kwok M.] Royal Perth Hosp, Dept Intens Care Med, Perth, WA, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia; [Ho, Kwok M.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Honeybul, Stephen] Royal Perth & Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia		Ho, KM (corresponding author), Royal Perth Hosp, Perth, WA, Australia.	kwok.ho@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004	Department of Intensive Care Medicine, Royal Perth Hospital	This study was solely supported by the Department of Intensive Care Medicine, Royal Perth Hospital. No external support was received for this study.	Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Bauer DF, 2011, J TRAUMA, V70, P1112, DOI 10.1097/TA.0b013e3181e7c2ae; Chang R, 2017, SURGERY, V161, P538, DOI 10.1016/j.surg.2016.08.023; Chen WQ, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000320; Dekker SE, 2016, J SURG RES, V205, P147, DOI 10.1016/j.jss.2016.06.023; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Herbert JP, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070092; Honeybul S, 2016, INJURY, V47, P1886, DOI 10.1016/j.injury.2016.04.017; Honeybul S, 2014, J NEUROSURG, V120, P1131, DOI 10.3171/2014.1.JNS131559; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rowell SE, 2014, J TRAUMA ACUTE CARE, V77, P846, DOI 10.1097/TA.0000000000000459; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tao CY, 2017, NEUROCRIT CARE, V26, P393, DOI 10.1007/s12028-016-0332-0; Toh CH, 2007, J THROMB HAEMOST, V5, P604, DOI 10.1111/j.1538-7836.2007.02313.x; Wang F, 2018, CNS NEUROSCI THER; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205	21	13	13	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2020	132	2					545	551		10.3171/2018.10.JNS182293			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KS5YL	WOS:000518384200024	30738401				2022-02-06	
J	Betts, DCTN; Wehrle, E; Paul, GR; Kuhn, GA; Christen, P; Hofmann, S; Muller, R				Betts, Duncan C. Tourolle ne; Wehrle, Esther; Paul, Graeme R.; Kuhn, Gisela A.; Christen, Patrik; Hofmann, Sandra; Muller, Ralph			The association between mineralised tissue formation and the mechanical local in vivo environment: Time-lapsed quantification of a mouse defect healing model	SCIENTIFIC REPORTS			English	Article							COMPUTED TOMOGRAPHY ASSESSMENT; TRAUMATIC BRAIN-INJURY; BONE-FORMATION; STIFFNESS; STRAIN; DIFFERENTIATION; ADAPTATION; RESORPTION; PATTERNS; SIZE	An improved understanding of how local mechanical stimuli guide the fracture healing process has the potential to enhance clinical treatment of bone injury. Recent preclinical studies of bone defect in animal models have used cross-sectional data to examine this phenomenon indirectly. In this study, a direct time-lapsed imaging approach was used to investigate the local mechanical strains that precede the formation of mineralised tissue at the tissue scale. The goal was to test two hypotheses: 1) the local mechanical signal that precedes the onset of tissue mineralisation is higher in areas which mineralise, and 2) this local mechanical signal is independent of the magnitude of global mechanical loading of the tissue in the defect. Two groups of mice with femoral defects of length 0.85 mm (n = 10) and 1.45 mm (n = 9) were studied, allowing for distinct distributions of tissue scale strains in the defects. The regeneration and (re)modelling of mineralised tissue was observed weekly using in vivo micro-computed tomography (micro-CT), which served as a ground truth for resolving areas of mineralised tissue formation. The mechanical environment was determined using micro-finite element analysis (micro-FE) on baseline images. The formation of mineralised tissue showed strong association with areas of higher mechanical strain (area-under-the-curve: 0.91 +/- 0.04, true positive rate: 0.85 +/- 0.05) while surface based strains could correctly classify 43% of remodelling events. These findings support our hypotheses by showing a direct association between the local mechanical strains and the formation of mineralised tissue.	[Betts, Duncan C. Tourolle ne; Wehrle, Esther; Paul, Graeme R.; Kuhn, Gisela A.; Christen, Patrik; Hofmann, Sandra; Muller, Ralph] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Hofmann, Sandra] Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands; [Hofmann, Sandra] Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands		Muller, R (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	ram@ethz.ch	Wehrle, Esther/AAH-6656-2021; Muller, Ralph/A-1198-2008; Hofmann, Sandra/F-2832-2010	Wehrle, Esther/0000-0003-2723-7342; Muller, Ralph/0000-0002-5811-7725; Hofmann, Sandra/0000-0002-2568-8388; Christen, Patrik/0000-0001-8854-0682	European UnionEuropean Commission [BIODESIGN FP7-NMP-2012-262948]; ETH Postdoctoral Fellowship Program (MSCA-COFUND) [FEL-25_15-1]	The authors gratefully acknowledge funding from the European Union (BIODESIGN FP7-NMP-2012-262948) and computational time from the Swiss National Supercomputing Centre (CSCS). E. Wehrle received funding from the ETH Postdoctoral Fellowship Program (MSCA-COFUND, FEL-25_15-1).	Betts DC, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00211; Bottlang M, 2008, J BIOMECH, V41, P701, DOI 10.1016/j.jbiomech.2007.10.024; Burke DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040737; Charles JP, 2020, J ANAT, V237, P941, DOI 10.1111/joa.13261; Christen P, 2017, CURR OSTEOPOROS REP, V15, P311, DOI 10.1007/s11914-017-0372-1; Christen P, 2015, BIOMECH MODEL MECHAN, V14, P427, DOI 10.1007/s10237-014-0602-8; Christen P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5855; Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5; Epari DR, 2006, CLIN BIOMECH, V21, P646, DOI 10.1016/j.clinbiomech.2006.01.003; Flaig, 2012, HIGHLY SCALABLE MEMO; Freeman TA, 2009, J ORTHOP RES, V27, P673, DOI 10.1002/jor.20771; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Gardner MJ, 2011, J ORTHOP SCI, V16, P298, DOI 10.1007/s00776-011-0051-5; Geris L, 2009, PHILOS T R SOC A, V367, P2031, DOI 10.1098/rsta.2008.0293; GOODSHIP AE, 1993, J BIOMECH, V26, P1027, DOI 10.1016/S0021-9290(05)80002-8; Haffner-Luntzer M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174283; Harris J. S, 2013, BONE; Kohler T, 2007, BONE, V41, P659, DOI 10.1016/j.bone.2007.05.018; Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Mehta M, 2012, EUR CELLS MATER, V24, P71; Miller GJ, 2015, BIOMECH MODEL MECHAN, V14, P1239, DOI 10.1007/s10237-015-0670-4; Morgan EF, 2010, J BIOMECH, V43, P2418, DOI 10.1016/j.jbiomech.2010.04.019; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; Mulder L, 2007, BONE, V41, P256, DOI 10.1016/j.bone.2007.04.188; O'Neill KR, 2012, BONE, V50, P1357, DOI 10.1016/j.bone.2012.03.008; Pistoia W, 2002, BONE, V30, P842, DOI 10.1016/S8756-3282(02)00736-6; Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6; Repp F, 2015, MED BIOL ENG COMPUT, V53, P829, DOI 10.1007/s11517-015-1285-8; Schell H, 2006, BONE, V38, P547, DOI 10.1016/j.bone.2005.09.018; Schell H, 2005, J ORTHOP RES, V23, P1022, DOI 10.1016/j.orthres.2005.03.005; Schulte FA, 2014, COMPUT METHOD BIOMEC, V17, P539, DOI 10.1080/10255842.2012.699526; Schulte FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062172; Schulte FA, 2013, BONE, V52, P485, DOI 10.1016/j.bone.2012.09.008; Schulte FA, 2011, BONE, V48, P433, DOI 10.1016/j.bone.2010.10.007; Shefelbine SJ, 2005, BONE, V36, P480, DOI 10.1016/j.bone.2004.11.007; Simon U, 2011, COMPUT METHOD BIOMEC, V14, P79, DOI 10.1080/10255842.2010.499865; Steiner M, 2012, MED ENG PHYS, V34, P1521, DOI 10.1016/j.medengphy.2012.09.013; Trussel A, 2015, J BONE MINER RES, V30, pS100; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Vetter A, 2012, BIOMECH MODEL MECHAN, V11, P147, DOI 10.1007/s10237-011-0299-x; Webster D, 2015, J BIOMECH, V48, P866, DOI 10.1016/j.jbiomech.2014.12.009; Webster DJ, 2008, COMPUT METHOD BIOMEC, V11, P435, DOI 10.1080/10255840802078014; Wehrle E., 2016, EUR CELL MAT, V31; Wehrle E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53822-x; Weis J. A., 2012, J BIOMECH; Zwingenberger S, 2013, J SURG RES, V181, pE7, DOI 10.1016/j.jss.2012.06.039	47	13	12	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JAN 24	2020	10	1							1100	10.1038/s41598-020-57461-5			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE8HW	WOS:000562846200003	31980656	Green Published, Green Submitted, gold			2022-02-06	
J	Bader, M; Li, YZ; Tweedie, D; Shlobin, NA; Bernstein, A; Rubovitch, V; Tovar-y-Romo, LB; DiMarchi, RD; Hoffer, BJ; Greig, NH; Pick, CG				Bader, Miaad; Li, Yazhou; Tweedie, David; Shlobin, Nathan A.; Bernstein, Adi; Rubovitch, Vardit; Tovar-y-Romo, Luis B.; DiMarchi, Richard D.; Hoffer, Barry J.; Greig, Nigel H.; Pick, Chaim G.			Neuroprotective Effects and Treatment Potential of Incretin Mimetics in a Murine Model of Mild Traumatic Brain Injury	FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY			English	Article						glucagon-like peptide-1; glucose-dependent insulinotropic polypeptide; incretin; traumatic brain injury; concussive head injury; twincretin; liraglutide	GLUCAGON-LIKE PEPTIDE-1; DEPENDENT INSULINOTROPIC POLYPEPTIDE; RECEPTOR AGONIST; COGNITIVE DEFICITS; ANIMAL-MODEL; MOUSE MODEL; DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; SIGNALING PATHWAY	Traumatic brain injury (TBI) is a commonly occurring injury in sports, victims of motor vehicle accidents, and falls. TBI has become a pressing public health concern with no specific therapeutic treatment. Mild TBI (mTBI), which accounts for approximately 90% of all TBI cases, may frequently lead to long-lasting cognitive, behavioral, and emotional impairments. The incretins glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are gastrointestinal hormones that induce glucose-dependent insulin secretion, promote beta-cell proliferation, and enhance resistance to apoptosis. GLP-1 mimetics are marketed as treatments for type 2 diabetes mellitus (T2DM) and are well tolerated. Both GLP-1 and GIP mimetics have shown neuroprotective properties in animal models of Parkinson's and Alzheimer's disease. The aim of this study is to evaluate the potential neuroprotective effects of liraglutide, a GLP-1 analog, and twincretin, a dual GLP-1R/GIPR agonist, in a murine mTBI model. First, we subjected mice to mTBI using a weight-drop device and, thereafter, administered liraglutide or twincretin as a 7-day regimen of subcutaneous (s.c.) injections. We then investigated the effects of these drugs on mTBI-induced cognitive impairments, neurodegeneration, and neuroinflammation. Finally, we assessed their effects on neuroprotective proteins expression that are downstream to GLP-1R/GIPR activation; specifically, PI3K and PKA phosphorylation. Both drugs ameliorated mTBI-induced cognitive impairments evaluated by the novel object recognition (NOR) and the Y-maze paradigms in which neither anxiety nor locomotor activity were confounds, as the latter were unaffected by either mTBI or drugs. Additionally, both drugs significantly mitigated mTBI-induced neurodegeneration and neuroinflammation, as quantified by immunohistochemical staining with Fluoro-Jade/anti-NeuN and anti-Iba-1 antibodies, respectively. mTBI challenge significantly decreased PKA phosphorylation levels in ipsilateral cortex, which was mitigated by both drugs. However, PI3K phosphorylation was not affected by mTBI. These findings offer a new potential therapeutic approach to treat mTBI, and support further investigation of the neuroprotective effects and mechanism of action of incretin-based therapies for neurological disorders.	[Bader, Miaad; Bernstein, Adi; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Li, Yazhou; Tweedie, David; Tovar-y-Romo, Luis B.; Greig, Nigel H.] NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Shlobin, Nathan A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Tovar-y-Romo, Luis B.] Univ Nacl Autonoma Mexico, Div Neurosci, Inst Cellular Physiol, Mexico City, DF, Mexico; [DiMarchi, Richard D.] Indiana Univ, Dept Chem, Bloomington, IN USA; [Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH USA; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Ctr Biol Addict Dis, Tel Aviv, Israel		Bader, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel.	miaad.bader@gmail.com	Tovar-y-Romo, Luis B/I-7615-2019	Tovar-y-Romo, Luis B/0000-0003-2605-1378	Ari and Regine Aprijaskis Fund, at Tel Aviv University; Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Disease at Tel Aviv University; Intramural Research Program of the National Institute on Aging, National Institutes of Health, United States; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R56AG057028]	This research was supported in part by (i) the Ari and Regine Aprijaskis Fund, at Tel Aviv University, (ii) the Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Disease at Tel Aviv University, and (iii) the Intramural Research Program of the National Institute on Aging, National Institutes of Health, United States, and NIH grant R56AG057028.	Anderberg RH, 2016, PSYCHONEUROENDOCRINO, V65, P54, DOI 10.1016/j.psyneuen.2015.11.021; Athauda D, 2019, JAMA NEUROL, V76, P420, DOI 10.1001/jamaneurol.2018.4304; Athauda D, 2018, NEUROPHARMACOLOGY, V136, P260, DOI 10.1016/j.neuropharm.2017.09.023; Athauda D, 2017, LANCET, V390, P1664, DOI 10.1016/S0140-6736(17)31585-4; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295; Bader M, 2019, NEUROBIOL DIS, V124, P439, DOI 10.1016/j.nbd.2018.11.023; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Barreto-Vianna ARC, 2017, METAB BRAIN DIS, V32, P1735, DOI 10.1007/s11011-017-0059-4; Batista AF, 2018, J PATHOL, V245, P85, DOI 10.1002/path.5056; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763, 10.1371/journal.pone.0050456]; Choe MC, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0573-9; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Cui Qi, 2004, Anatomical Science International, V79, P209, DOI 10.1111/j.1447-073x.2004.00089.x; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Egefjord L, 2012, DAN MED J, V59; Faivre E, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt174; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Figueiredo CP, 2011, PEPTIDES, V32, P781, DOI 10.1016/j.peptides.2010.12.010; Finan B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007218; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Frias JP, 2017, CELL METAB, V26, P343, DOI 10.1016/j.cmet.2017.07.011; Gao YY, 2016, J SURG RES, V206, P67, DOI 10.1016/j.jss.2016.07.014; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gejl M, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00108; Glotfelty EJ, 2019, ACS PHARMACOL TRANSL, V2, P66, DOI 10.1021/acsptsci.9b00003; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Gullo F, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00500; Hamilton A, 2009, NEUROREPORT, V20, P1161, DOI 10.1097/WNR.0b013e32832fbf14; Han L, 2016, NEUROREPORT, V27, P23, DOI 10.1097/WNR.0000000000000490; Holscher C, 2014, J ENDOCRINOL, V221, pT31, DOI 10.1530/JOE-13-0221; Holscher C, 2010, NEUROBIOL AGING, V31, P1495, DOI 10.1016/j.neurobiolaging.2008.08.023; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Isacson R, 2011, EUR J PHARMACOL, V650, P249, DOI 10.1016/j.ejphar.2010.10.008; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Iwai T, 2006, NEUROSCI RES, V55, P352, DOI 10.1016/j.neures.2006.04.008; Kappe C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-276; Kim DS, 2017, CELL TRANSPLANT, V26, P1560, DOI 10.1177/0963689717721234; Kim S, 2009, J ENDOCRINOL, V202, P431, DOI 10.1677/JOE-09-0132; Lee CH, 2011, J NEUROSCI RES, V89, P1103, DOI 10.1002/jnr.22596; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li YW, 2016, NEUROPHARMACOLOGY, V101, P255, DOI 10.1016/j.neuropharm.2015.10.002; Li YZ, 2015, J NEUROCHEM, V135, P1203, DOI 10.1111/jnc.13169; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; McGrath R, 2015, J STEROIDS HORM SCI, V6, P152, DOI [10.4172/2157-7536.1000.152, DOI 10.4172/2157-7536.1000.152]; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Nyberg J, 2005, J NEUROSCI, V25, P1816, DOI 10.1523/jneurosci.4920-04.2005; Paratore Sabrina, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P210; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Perry T, 2003, TRENDS PHARMACOL SCI, V24, P377, DOI 10.1016/S0165-6147(03)00160-3; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Perry T, 2007, EXP NEUROL, V203, P293, DOI 10.1016/j.expneurol.2006.09.028; Portron A, 2017, DIABETES OBES METAB, V19, P1446, DOI 10.1111/dom.13025; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Schmitt C, 2017, DIABETES OBES METAB, V19, P1436, DOI 10.1111/dom.13024; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Seino Y, 2010, J DIABETES INVEST, V1, P8, DOI 10.1111/j.2040-1124.2010.00022.x; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Shi LJ, 2017, BEHAV BRAIN RES, V327, P65, DOI 10.1016/j.bbr.2017.03.032; Spielman LJ, 2017, EUR J CELL BIOL, V96, P240, DOI 10.1016/j.ejcb.2017.03.004; Tabuchi A, 2002, J BIOL CHEM, V277, P35920, DOI 10.1074/jbc.M204784200; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tamargo IA, 2017, EXP NEUROL, V288, P176, DOI 10.1016/j.expneurol.2016.11.005; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Trumper A, 2001, MOL ENDOCRINOL, V15, P1559, DOI 10.1210/me.15.9.1559; Tweedie D, 2016, J NEUROSCI METH, V272, P4, DOI 10.1016/j.jneumeth.2016.02.003; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; U.S. Department of Health and Human Services Centers for Disease Control and Prevention and National Center for Health Statistics, 2016, DHHS PUBLICATION, V2016-1604; U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research, 2005, EST SAF START DOS CL; Verma MK, 2018, EXPERT OPIN THER TAR, V22, P615, DOI 10.1080/14728222.2018.1487952; Verma MK, 2017, EUR J PHARMACOL, V804, P38, DOI 10.1016/j.ejphar.2017.03.059; Wang WJ, 2018, BRAIN INJURY, V32, P1858, DOI 10.1080/02699052.2018.1537513; Wang ZF, 2017, BIOCHEM BIOPH RES CO, V482, P948, DOI 10.1016/j.bbrc.2016.11.138; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu HY, 2018, J NEUROIMMUNOL, V316, P17, DOI 10.1016/j.jneuroim.2017.12.005; Yu YW, 2016, J NEUROTRAUM, V33, P2044, DOI 10.1089/neu.2015.4229; Yuan ZY, 2017, EUR J PHARMACOL, V812, P82, DOI 10.1016/j.ejphar.2017.06.029; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	104	13	14	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-634X			FRONT CELL DEV BIOL	Front. Cell. Dev. Biol.	JAN 10	2020	7								356	10.3389/fcell.2019.00356			18	Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Developmental Biology	MW0QY	WOS:000556753400001	31998717	Green Published, gold			2022-02-06	
J	Alkhaibary, A; Alharbi, A; Abbas, M; Algarni, A; Abdullah, JM; Almadani, WH; Khairy, I; Alkhani, A; Aloraidi, A; Khairy, S				Alkhaibary, Ali; Alharbi, Ahoud; Abbas, Munzir; Algarni, Abdulaziz; Abdullah, Jamal M.; Almadani, Wedad H.; Khairy, Ibtesam; Alkhani, Ahmed; Aloraidi, Ahmed; Khairy, Sami			Predictors of Surgical Site Infection in Autologous Cranioplasty: A Retrospective Analysis of Subcutaneously Preserved Bone Flaps in Abdominal Pockets	WORLD NEUROSURGERY			English	Article						Complication; Craniectomy; Cranioplasty; Decompressive; Infection; Trauma	DECOMPRESSIVE CRANIECTOMY	BACKGROUND: Decompressive craniectomy (DC) is a surgical procedure performed to manage intracranial hypertension. Once performed, patients are obligated to undergo another surgical procedure known as cranioplasty to reconstruct the cranial defect. Cranioplasty still has one of the highest rates of infection. The factors contributing to the high rate of surgical site infection (SSI) after cranioplasty are not well established. This study aims to estimate the incidence of SSI and determine its possible risk factors for patients who underwent cranioplasty using bone flaps subcutaneously preserved in abdominal pockets. METHODS: A retrospective cohort study was conducted to investigate the predictors of infection among patients who underwent cranioplasty from subcutaneously preserved bone flaps in abdominal pockets between January 2005 and December 2018 at a level I trauma center. RESULTS: A total of 103 cases of cranioplasty from subcutaneously preserved bone flaps were included in the study. The mean age of the patients was 31.2 +/- 14.8 years (range, 5-67 years). The median interval between DC and cranioplasty was 115 days. The most frequent indication for DC was traumatic brain injury (76.4%). The incidence of SSI was noted in 15.7% of patients. The most significant predictors of infection in patients requiring cranioplasty were blood glucose levels and skull defect size (P = 0.03 and P = 0.02, respectively). CONCLUSIONS: Blood glucose levels and skull defect size were the only identifiable risk factors associated with SSI. Storing bone flaps in subcutaneous abdominal pockets is cost-efficient but carries considerable risk of infection.	[Alkhaibary, Ali; Alharbi, Ahoud; Abbas, Munzir; Algarni, Abdulaziz; Abdullah, Jamal M.; Alkhani, Ahmed; Aloraidi, Ahmed; Khairy, Sami] King Saud bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia; [Alkhaibary, Ali; Alharbi, Ahoud; Abbas, Munzir; Algarni, Abdulaziz; Alkhani, Ahmed; Aloraidi, Ahmed; Khairy, Sami] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Abbas, Munzir; Algarni, Abdulaziz; Alkhani, Ahmed; Aloraidi, Ahmed; Khairy, Sami] Minist Natl Guard Hlth Affairs, Dept Neurosurg, Riyadh, Saudi Arabia; [Abdullah, Jamal M.] Prince Sultan Mil Med City, Dept Neurosurg, Riyadh, Saudi Arabia; [Almadani, Wedad H.] Saudi Hlth Council, Natl Ctr Evidence Based Healthcare, Riyadh, Saudi Arabia; [Khairy, Ibtesam] Jazan Univ, Fac Appl Med Sci, Jazan, Saudi Arabia		Alkhaibary, A (corresponding author), King Saud bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia.; Alkhaibary, A (corresponding author), King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.	AlkhaibaryA@hotmail.com	Alkhaibary, Ali/ABB-4332-2021	Alharbi, Ahoud/0000-0002-8827-4588			Acciarri N, J NEUROSURG SCI, V6; Aydin S, 2011, J NEUROSCI RURAL PRA, V2, P162, DOI 10.4103/0976-3147.83584; Cheah PP, 2017, MALAYS J MED SCI, V24, P68, DOI 10.21315/mjms2017.24.6.8; Cho Yong Jun, 2017, Korean J Neurotrauma, V13, P9, DOI 10.13004/kjnt.2017.13.1.9; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Hng D, 2015, CRANIOMAX TRAUM REC, V8, P190, DOI 10.1055/s-0034-1395383; Inamasu J, 2010, J TRAUMA, V68, P183, DOI 10.1097/TA.0b013e3181c45384; Kim H, 2013, ACTA NEUROCHIR, V155, P2171, DOI 10.1007/s00701-013-1877-8; Kreider GN, 1920, J AMER MED ASSOC, V74, P1024, DOI 10.1001/jama.1920.26210150001013; Lee BS, 2012, KOREAN J NEUROTRAUMA, V8, P21; Movassaghi K, 2006, PLAST RECONSTR SURG, V117, P202, DOI 10.1097/01.prs.0000187152.48402.17; Riordan MA, 2016, WORLD NEUROSURG, V87, P207, DOI 10.1016/j.wneu.2015.11.070; Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033; Shoakazemi A, 2009, NEUROSURGERY, V65, P505, DOI 10.1227/01.NEU.0000350870.69891.86; Tybor Krzysztof, 2005, Neurol Neurochir Pol, V39, P220	16	13	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2020	133						E627	E632		10.1016/j.wneu.2019.09.120			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JX8QN	WOS:000503993700125	31568916				2022-02-06	
J	Decker, W; Baker, A; Ye, X; Brown, P; Stitzel, J; Gayzik, FS				Decker, William; Baker, Alex; Ye, Xin; Brown, Philip; Stitzel, Joel; Gayzik, F. Scott			Development and Multi-Scale Validation of a Finite Element Football Helmet Model	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Finite element model; Football helmet model; Computational modeling; Finite element analysis; Validation; Injury biomechanics	HIGH-SCHOOL; PROFESSIONAL FOOTBALL; IMPACT PERFORMANCE; UNITED-STATES; BRAIN-INJURY; CONCUSSION; EPIDEMIOLOGY; BIOMECHANICS; RESPONSES; SPORTS	Head injury is a growing concern within contact sports, including American football. Computational tools such as finite element (FE) models provide an avenue for researchers to study, and potentially optimize safety tools, such as helmets. The goal of this study was to develop an accurate representative helmet model that could be used in further study of head injury to mitigate the toll of concussions in contact sports. An FE model of a Schutt Air XP Pro football helmet was developed through three major steps: geometry development, material characterization, and model validation. The fully assembled helmet model was fit onto a Hybrid III dummy head-neck model and National Operating Committee on Standards for Athletic Equipment (NOCSAE) head model and validated through a series of 67 representative impacts similar to those experienced by a football player. The kinematic and kinetic response of the model was compared to the response of the physical experiments, which included force, head linear acceleration, head angular velocity, and carriage acceleration. The outputs between the model and the physical tests were quantitatively evaluated using CORelation and Analysis (CORA), amounting to an overall averaged score of 0.76. The model described in this study has been extensively validated and can function as a building block for innovation in player safety.	[Decker, William; Baker, Alex; Ye, Xin; Brown, Philip; Stitzel, Joel; Gayzik, F. Scott] Wake Forest Univ, Bowman Gray Sch Med, Biomed Engn, 575 Patterson Ave, Winston Salem, NC 27101 USA		Gayzik, FS (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Biomed Engn, 575 Patterson Ave, Winston Salem, NC 27101 USA.	wdecker@wakehealth.edu; sgayzik@wakehealth.edu		Baker, Alexander/0000-0003-4150-6924	Football Research, Inc. (FRI); National Football League (NFL); Biomechanical Consulting and Research, LLC (Biocore)	The research presented in this paper was made possible by a Grant from Football Research, Inc. (FRI), the National Football League (NFL), and Biomechanical Consulting and Research, LLC (Biocore). The authors acknowledge the contributions of the NFLPA. The views expressed are solely those of the authors and do not represent those of FRI, the NFL, Biocore, or any of their affiliates or funding sources. The Schutt AirXPPro COE at Wake Forest University's Center for Injury Biomechanics gratefully acknowledges Virginia Tech University and Biocore for providing the test data necessary for this study. Biocore and FRI, with support from the NFL, have collaborated with Centers of Expertise (COEs) at their university partners to develop open-source FE models of four modern football helmets and associated test equipment and methods. These FE models are licensed and distributed by Biocore subject to the terms of the Licensing Agreement and Citation Policy. Material testing was performed at Veryst Engineering (Needham Heights, MA, USA). This model is freely available for download https://www.playsmartpl aysafe.com/resource/finite-element-models/.	Aare M, 2007, INT J IMPACT ENG, V34, P596, DOI 10.1016/j.ijimpeng.2005.08.001; Bandak FA, 1994, SAE T, P1708; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Bustamante MC, 2019, J DYNAM BEHAV MAT, V5, P117, DOI 10.1007/s40870-019-00189-9; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis Matthew L, 2016, Stapp Car Crash J, V60, P509; Decker W, 2017, TRAFFIC INJ PREV, V18, pS155, DOI 10.1080/15389588.2017.1315637; Dixit P, 2017, ARCH COMPUT METHOD E, V24, P979, DOI 10.1007/s11831-016-9196-x; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Dwarampudi R., 2003, P 2003 IRCOBI C; Funk J. R., 2006, ANN P ASS ADV AUTOMO, V51, P343; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gayzik FS., 2012, 12 INT LS DYNA US C; Gehre C., 2009, 21 ESV C STUTTG GERM; Giudice JS, 2019, ANN BIOMED ENG, V47, P1855, DOI 10.1007/s10439-018-02161-5; Giudice JS, 2019, ANN BIOMED ENG, V47, P464, DOI 10.1007/s10439-018-02155-3; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Kang H.-S., 1997, SAE TECHNICAL PAPER; Kisanuki Y., 2002, INT RES COUNC BIOM I; Klossner D., 2017, 201801 NAT CTR CAT I; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; LSTC, 2014, LS DYNA KEYW US MAN; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Miller LE, 2019, J NEUROTRAUM, V36, P1561, DOI 10.1089/neu.2018.6037; Miller LE, 2017, COMPUT METHOD BIOMEC, V20, P1273, DOI 10.1080/10255842.2017.1340462; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; NHTSA F.E.A, 1995, 201 NHTSA FEA FMVSS; NOCSAE, 2009, STAND TEST METH EQ U; Noureddine A, 2002, MATH COMPUT MODEL, V35, P885, DOI 10.1016/S0895-7177(02)00057-2; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pietsch Hollie A, 2016, Stapp Car Crash J, V60, P199; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Scott D-SL, 1997, CRASHWORTHINESS OCCU, V225, P199; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; TAN LB, 2012, INT J IMPACT ENG, V50, P99, DOI DOI 10.1016/j.ijimpeng.2012.06.003; Thunert C., 2012, CORARELEASE 3 6 1 US; Thunnissen J. G. M., 1996, IMPACT HEAD INJURY R; Vavalle NA, 2015, ANN BIOMED ENG, V43, P2163, DOI 10.1007/s10439-015-1286-7; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Withnall, 2017, NFL LINEAR IMPACTOR; Yu H, 2004, INT J CRASHWORTHINES, V9, P175, DOI 10.1533/ijcr.2004.0276; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088	57	13	13	3	12	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2020	48	1					258	270		10.1007/s10439-019-02345-7			13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	KI7BE	WOS:000511504100001	31520331	hybrid, Green Published			2022-02-06	
J	Elblehi, SS; El Euony, OI; El-Sayed, YS				Elblehi, Samar S.; El Euony, Omnia, I; El-Sayed, Yasser S.			Apoptosis and astrogliosis perturbations and expression of regulatory inflammatory factors and neurotransmitters in acrylamide-induced neurotoxicity under omega 3 fatty acids protection in rats	NEUROTOXICOLOGY			English	Article						Omega-3; Acrylamide; Neurotoxicity; Neurotransmitters; Apoptosis; GFAP	FIBRILLARY ACIDIC PROTEIN; TRAUMATIC BRAIN-INJURY; ESSENTIAL FATTY-ACIDS; OXIDATIVE STRESS; NEURONAL APOPTOSIS; PROINFLAMMATORY CYTOKINES; ENDOPLASMIC-RETICULUM; INDUCED NEUROPATHY; AXONAL-TRANSPORT; GLIAL-CELLS	This study was aimed to investigate the potential ameliorative effects of omega-3 (omega 3) fatty acids against acrylamide (ACR)-induced neurotoxicity. Thirty-two adult male Sprague Dawley rats were randomly assigned into four groups (n = 8) as follows: control, omega 3 fatty acids (1000 mg/kg bwt/day orally), ACR-treated (50 mg/kg bwt/day IP) and ACR plus omega 3 fatty acids group. Treatments were performed every other day for 21 consecutive days. ACR induced abnormal gait and elevated serum levels of proinflarrunatory cytokines (IL-6 and TNF-alpha), brain and spinal cord MDA levels and decreased brain and spinal cord GSH levels. Moreover, it reduced neurotransmitters (acetylcholine, GABA, serotonin and noradrenaline levels) and increased AChE activity in brain tissues. Histopathologically, ACR caused various degenerative changes, necrosis and glial cell activation in the cerebrum, cerebellum, hippocampus, spinal cord and sciatic nerve. Likewise, the histomorphometric analysis was constant with ACR-induced neurotoxicity. The ACR induced axonal atrophy and myelin disruption and decreased g-ratio of the sciatic nerve. Immunohistochemically, strong positive expressions of apoptotic marker caspase-3 and astroglial GFAP in the examined tissues were detected. Contrariwise, concurrent administration of omega 3 fatty acids partially attenuated ACR impacts, as it improved the gait performance, reduced oxidative stress and pro-inflammatory cytokines, and modulate the levels of the neurotransmitters. It also ameliorated the intensity of ACR-induced histopathological and histomorphometric alterations within the examined nervous tissues. It could be concluded that omega 3 fatty acids have antioxidant, anti-inflammatory and anti-apoptotic potentials against ACR neurotoxicity via suppression of oxidative stress, lipid peroxidation and pro-inflammatory cytokines, and inhibition of AChE activity and downregulation of caspase-3 and GFAP expressions in the nervous tissues.	[Elblehi, Samar S.] Fac Vet Med, Dept Pathol, Alexandria 22758, Egypt; [El Euony, Omnia, I] Fac Vet Med, Dept Forens Med & Toxicol, Alexandria 22758, Egypt; [El-Sayed, Yasser S.] Damanhour Univ, Fac Vet Med, Dept Forens Med & Toxicol, Damanhour 22511, Egypt		El-Sayed, YS (corresponding author), Damanhour Univ, Fac Vet Med, Dept Forens Med & Toxicol, Damanhour 22511, Egypt.	elsayed-ys@vetmed.dmu.edu.eg	Elblehi, Samar Saad/AAN-4903-2020; El-Sayed, Yasser/E-6400-2010	Elblehi, Samar Saad/0000-0003-4939-1754; El-Sayed, Yasser/0000-0003-3915-4640			Allam A, 2011, TOXICOL IND HEALTH, V27, P291, DOI 10.1177/0748233710386412; Alquraan L, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9030100; Bargagna-Mohan P, 2010, J BIOL CHEM, V285, P7657, DOI 10.1074/jbc.M109.093765; Bates KA, 2002, NEUROSCIENCE, V113, P785, DOI 10.1016/S0306-4522(02)00230-0; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; CAVALETTI G, 1992, ACTA NEUROPATHOL, V84, P364; Ceballos D, 1999, J ANAT, V195, P563, DOI 10.1046/j.1469-7580.1999.19540563.x; Celik I, 2009, PESTIC BIOCHEM PHYS, V94, P1, DOI 10.1016/j.pestbp.2009.02.003; Chaabane M, 2017, HUM EXP TOXICOL, V36, P854, DOI 10.1177/0960327116672911; Cherick M. C., 2013, Iranian Journal of Veterinary Medicine, V7, P129; CHRETIEN M, 1981, BRAIN RES, V205, P15, DOI 10.1016/0006-8993(81)90716-2; Delattre AM, 2017, MOL NEUROBIOL, V54, P2090, DOI 10.1007/s12035-016-9803-8; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; El-Derieny E., 2014, EGYPT J HISTOL, V37, P350, DOI [10.1097/01.EHX.0000446580.88948.42, DOI 10.1097/01.EHX.0000446580.88948.42]; Elblehi SS, 2019, ENVIRON SCI POLLUT R, V26, P23306, DOI 10.1007/s11356-019-05607-y; Elblehi SS, 2019, ENVIRON SCI POLLUT R, V26, P9333, DOI 10.1007/s11356-019-04395-9; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fennell TR, 2005, ADV EXP MED BIOL, V561, P109; Firlag M, 2013, FOLIA NEUROPATHOL, V51, P235, DOI 10.5114/fn.2013.37708; Friedman M, 2003, J AGR FOOD CHEM, V51, P4504, DOI 10.1021/jf030204+; Gladman SJ, 2012, J NEUROSCI, V32, P563, DOI 10.1523/JNEUROSCI.3371-11.2012; GOLD BG, 1985, J NEUROSCI, V5, P1755; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; He Y, 2017, TOXICOL MECH METHOD, V27, P298, DOI 10.1080/15376516.2017.1279251; HSU SM, 1981, AM J CLIN PATHOL, V75, P816, DOI 10.1093/ajcp/75.6.816; Ignarro RS, 2013, J CHEM NEUROANAT, V48-49, P14, DOI 10.1016/j.jchemneu.2013.02.005; Imam R.A, 2018, FOLIA MORPHOL WARSZ; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Johnson M, 2009, J ATTEN DISORD, V12, P394, DOI 10.1177/1087054708316261; Khafaga AF, 2018, LIFE SCI, V196, P9, DOI 10.1016/j.lfs.2018.01.010; Khafaga AF, 2018, N-S ARCH PHARMACOL, V391, P59, DOI 10.1007/s00210-017-1437-5; Komoike Y, 2016, TOXICOL APPL PHARM, V310, P68, DOI 10.1016/j.taap.2016.09.005; Kudryashov IE, 2002, NEUROSCI LETT, V332, P95, DOI 10.1016/S0304-3940(02)00937-0; Kutting B, 2009, INT J HYG ENVIR HEAL, V212, P470, DOI 10.1016/j.ijheh.2009.01.002; Kunnel Shinomol George, 2019, Central Nervous System Agents in Medicinal Chemistry, V19, P100, DOI 10.2174/1871524919666190207160236; Lakshmi D, 2012, NEUROCHEM RES, V37, P1859, DOI 10.1007/s11064-012-0794-1; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Lebda MA, 2018, LIFE SCI, V192, P136, DOI 10.1016/j.lfs.2017.11.036; Lebda MA, 2012, NEUROTOXICOLOGY, V33, P98, DOI 10.1016/j.neuro.2011.12.008; Lehning EJ, 1998, TOXICOL APPL PHARM, V151, P211, DOI 10.1006/taap.1998.8464; LOPACHIN RM, 1994, NEUROTOXICOLOGY, V15, P247; LoPachin RM, 2005, ADV EXP MED BIOL, V561, P21; LoPachin RM, 2004, NEUROTOXICOLOGY, V25, P617, DOI 10.1016/j.neuro.2004.01.004; LoPachin RM, 2002, NEUROTOXICOLOGY, V23, P95, DOI 10.1016/S0161-813X(02)00003-7; Cabezas IL, 2014, NEUROLOGIA, V29, P305, DOI 10.1016/j.nrl.2012.10.006; Mabile L, 2001, AM J CLIN NUTR, V74, P449; Maiese K, 2010, EXP GERONTOL, V45, P217, DOI 10.1016/j.exger.2010.01.004; Mantzioris E, 2000, AM J CLIN NUTR, V72, P42; Matsuoka Y, 2011, PSYCHOTHER PSYCHOSOM, V80, P310, DOI 10.1159/000322980; Mehri S, 2015, IRAN J BASIC MED SCI, V18, P902; Mirnikjoo B, 2001, J BIOL CHEM, V276, P10888, DOI 10.1074/jbc.M008150200; MOKUNO K, 1989, J NEUROSCI RES, V23, P396, DOI 10.1002/jnr.490230405; Mottram DS, 2002, NATURE, V419, P448, DOI 10.1038/419448a; Nakagawa-Yagi Y, 2001, BRAIN RES, V909, P8, DOI 10.1016/S0006-8993(01)02608-7; Oda SS, 2017, DRUG DEVELOP RES, V78, P349, DOI 10.1002/ddr.21400; Ohsawa K, 2000, J CELL SCI, V113, P3073; Okasha Ebtsam F, 2016, J Microsc Ultrastruct, V4, P175, DOI 10.1016/j.jmau.2016.02.001; Onaolapo Olakunle James, 2016, Pathophysiology, V23, P147, DOI 10.1016/j.pathophys.2016.05.001; Osborn LM, 2016, PROG NEUROBIOL, V144, P121, DOI 10.1016/j.pneurobio.2016.01.001; Pan XQ, 2017, MOL NEUROBIOL, V54, P4781, DOI 10.1007/s12035-016-0021-1; Park HR, 2010, TOXICOL LETT, V193, P86, DOI 10.1016/j.toxlet.2009.12.015; PLACER ZA, 1966, ANAL BIOCHEM, V16, P359, DOI 10.1016/0003-2697(66)90167-9; Prasad SN, 2013, NEUROCHEM RES, V38, P330, DOI 10.1007/s11064-012-0924-9; Rampello L, 2012, ACTA MEDICA MEDITERR, V28, P139; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Ren HX, 2017, MOL NEUROBIOL, V54, P3317, DOI 10.1007/s12035-016-9931-1; Robson LG, 2010, NEUROBIOL AGING, V31, P678, DOI 10.1016/j.neurobiolaging.2008.05.027; Ross BM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-21; Santhanasabapathy R, 2015, NEUROSCIENCE, V308, P212, DOI 10.1016/j.neuroscience.2015.08.067; Simopoulos AP, 2000, POULTRY SCI, V79, P961, DOI 10.1093/ps/79.7.961; Singh PK, 2017, ANN NEUROSCI, V24, P221, DOI 10.1159/000481808; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Sun XQ, 2009, BEHAV BRAIN RES, V199, P197, DOI 10.1016/j.bbr.2008.11.035; Tohamy HG, 2019, ENVIRON SCI POLLUT R, V26, P21524, DOI 10.1007/s11356-019-05521-3; Uchida A, 2012, TOXICOLOGY, V302, P292, DOI 10.1016/j.tox.2012.08.011; Vornov JJ, 1998, EXP NEUROL, V149, P109, DOI 10.1006/exnr.1997.6673; Vuceljic Marina, 2006, Vojnosanit Pregl, V63, P545, DOI 10.2298/VSP0606545V; WAINWRIGHT PE, 1992, NEUROSCI BIOBEHAV R, V16, P193, DOI 10.1016/S0149-7634(05)80180-0; Wang XK, 2005, MOL BRAIN RES, V140, P120, DOI 10.1016/j.molbrainres.2005.07.018; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Yu SF, 2006, NEUROCHEM RES, V31, P1197, DOI 10.1007/s11064-006-9176-x; Zararsiz I, 2006, CELL BIOCHEM FUNCT, V24, P237, DOI 10.1002/cbf.1204; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhu YJ, 2008, NEUROCHEM RES, V33, P2310, DOI 10.1007/s11064-008-9730-9	85	13	13	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	JAN	2020	76						44	57		10.1016/j.neuro.2019.10.004			14	Neurosciences; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	KF7KS	WOS:000509418700005	31647937				2022-02-06	
J	Gupta, S; Khajanchi, M; Kumar, V; Raykar, NP; Alkire, BC; Roy, N; Park, KB				Gupta, Saksham; Khajanchi, Monty; Kumar, Vineet; Raykar, Nakul P.; Alkire, Blake C.; Roy, Nobhojit; Park, Kee B.			Third delay in traumatic brain injury: time to management as a predictor of mortality	JOURNAL OF NEUROSURGERY			English	Article						third delay; traumatic brain injury; trauma process metrics; surgical access; LMICs; low- and middle-income countries; developing countries	CARE; REHABILITATION; AVAILABILITY; PERFORMANCE; LENGTH; IMPACT	OBJECTIVE Traumatic brain injury (TBI) is a global epidemic with an increasing incidence in low- and middle-income countries (LMICs). The time from arrival at the hospital to receiving appropriate treatment ("third delay") can vary widely in LMICs, although its association with mortality in TBI remains unknown. METHODS A retrospective cohort analysis with multivariable logistic regression was conducted using the Toward Improved Trauma Care Outcomes in India database, which contains data from 4 urban trauma centers in India from 2013-2015. RESULTS There were 6278 TBIs included in the cohort. The patients' median age was 39 years (interquartile range 27-52 years) and 80% of patients were male. The most frequent mechanisms of injury were road traffic accidents (52%) and falls (34%). A majority of cases were transfers from other facilities (79%). In-hospital 30-day mortality was 27%; of patients who died, 21% died within 24 hours of arrival. The median third delay was 10 minutes (interquartile range 0-60 minutes); 34% of cases had moderate third delay (10-60 minutes) and 22% had extended third delay (>= 61 minutes). Overall 30-day mortality was associated with moderate third delay (OR 1.3, p = 0.001) and extended third delay (OR 1.3, p = 0.001) after adjustment by pertinent covariates. This effect was pronounced for 24-hour mortality: moderate and extended third delays were independently associated with ORs of 3.4 and 3.8, respectively, for 24-hour mortality (both p < 0.001). CONCLUSIONS Third delay is associated with early mortality in patients with TBI, and represents a target for process improvement in urban trauma centers.	[Gupta, Saksham] Harvard Med Sch, Boston, MA 02115 USA; [Khajanchi, Monty] Seth GS Med Coll & King Edward Mem Hosp, Dept Surg, Mumbai, Maharashtra, India; [Kumar, Vineet] Lokmanya Tilak Municipal Med Coll & Gen Hosp, Dept Surg, Mumbai, Maharashtra, India; [Raykar, Nakul P.] Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA; [Raykar, Nakul P.; Park, Kee B.] Harvard Med Sch, Program Global Surg & Social Change, Boston, MA 02115 USA; [Alkire, Blake C.] Massachusetts Eye & Ear Inst, Dept Otolaryngol, Boston, MA USA; [Roy, Nobhojit] Govt India, Minist Hlth & Family Welf, NHSRC, New Delhi, India; [Roy, Nobhojit] BARC Hosp, WHO Collaborating Ctr Res Surg Care Delivery LMIC, Mumbai, Maharashtra, India		Gupta, S (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	saksham_gupta@hms.harvard.edu	Alkire, Blake/AAY-6463-2020	Roy, Nobhojit/0000-0003-2022-7416			Alkire BC, 2015, LANCET GLOB HEALTH, V3, pE316, DOI 10.1016/S2214-109X(15)70115-4; Annadurai K, 2015, INDIAN J CRIT CARE M, V19, P434, DOI 10.4103/0972-5229.160303; Assarag B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116675; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; David E, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0401-3; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Forshaw J, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1098-2; Gale SC, 2016, BRAIN INJURY, V30, P437, DOI 10.3109/02699052.2016.1140808; Gerdin M, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0079-0; Ginde AA, 2008, ACAD EMERG MED, V15, P780, DOI 10.1111/j.1553-2712.2008.00192.x; Goodman DM, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1407-4; Gopalakrishnan S, 2012, J Family Med Prim Care, V1, P144, DOI 10.4103/2249-4863.104987; Horwitz LI, 2010, ANN EMERG MED, V55, P133, DOI 10.1016/j.annemergmed.2009.07.023; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kidwai AS, 2015, J AM COLL RADIOL, V12, P1151, DOI 10.1016/j.jacr.2015.03.041; Knight HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063846; Kovacs-Litman A, 2016, J HOSP MED, V11, P862, DOI 10.1002/jhm.2632; Leonard KL, 2017, SOC SCI MED, V181, P54, DOI 10.1016/j.socscimed.2017.03.041; Mahmoodian F, 2014, ARCH TRAUMA RES, V3, DOI 10.5812/atr.19507; Mansourati M, 2018, BRIT J SURG, V105, P1274, DOI 10.1002/bjs.10862; Marcoux J, 2016, J NEUROSURG, V125, P642, DOI 10.3171/2015.6.JNS15175; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; McLane HC, 2015, NEUROLOGY, V85, P1614, DOI 10.1212/WNL.0000000000002090; Newgard CD, 2015, ANN EMERG MED, V66, P30, DOI 10.1016/j.annemergmed.2014.12.004; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roy N, 2010, PREHOSP DISASTER MED, V25, P145, DOI 10.1017/S1049023X00007883; Storm-Versloot MN, 2014, EMERG MED J, V31, P13, DOI 10.1136/emermed-2012-201099; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Theunissen BHJJ, 2014, EUR J TRAUMA EMERG S, V40, P87, DOI 10.1007/s00068-013-0324-0; Usichenko TI, 2013, BRIT J ANAESTH, V110, P659, DOI 10.1093/bja/aet040; Uthkarsh Pallavi Sarji, 2016, Bull Emerg Trauma, V4, P93; Vaca SD, 2018, NEUROSURGERY	33	13	13	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2020	132	1					289	295		10.3171/2018.8.JNS182182			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JZ4EG	WOS:000505053700037	30660121	Green Submitted			2022-02-06	
J	Lu, GY; Zhu, L; Wang, XD; Zhang, HZ; Li, YP				Lu, Guangyu; Zhu, Lei; Wang, Xingdong; Zhang, Hengzhu; Li, Yuping			Decompressive Craniectomy for Patients with Traumatic Brain Injury: A Pooled Analysis of Randomized Controlled Trials	WORLD NEUROSURGERY			English	Article						Decompressive craniectomy; Functional outcome; Meta-analysis; Traumatic brain injury	INTRACRANIAL-PRESSURE; CEREBRAL OXYGENATION; MANAGEMENT; HEMICRANIECTOMY; GUIDELINES; PERFUSION; CHILDREN	BACKGROUND: Decompressive hemicraniectomy (DHC) is widely applied for patients with traumatic brain injury (TBI). Although previous studies have indicated that DHC can lead to similar or worse outcomes compared with medical treatment (MT) in patients with TBI, recent trials have suggested the benefit of DHC for neurologic function recovery. Therefore, we performed this meta-analysis to assess the efficacy and functional outcomes of DHC in patients with TBI. METHODS: In accordance with PRISMA guidelines, we searched English and Chinese databases to identify relevant randomized controlled trials (RCTs) reporting DHC for TBI. The outcomes measures included mortality, favorable outcome, unfavorable outcome, postoperative intracranial pressure (ICP), adverse events with hematoma, and hospital stay. RESULTS: Seven RCTs with a total of 779 patients with TBI were included in this meta-analysis. Compared with the MT group, the DHC group demonstrated significantly lower rates of mortality (P < 0.00001), postoperative ICP (P < 0.00001), and postoperative hematoma (P = 0.01), and significantly shorter hospital length of stay (P = 0.02). However, the rate of unfavorable outcomes was higher in the DHC group compared with the MT group (P = 0.0001). CONCLUSIONS: Our results indicate that DHC could be effective in reducing the mortality rate, incidence of ICP, and hospital length of stay in patients with TBI. However, the proportion of patients surviving with unfavorable outcomes was significantly higher in the DHC group compared with the MT group. Despite the limitations of the metaanalysis, our findings target extremely important topic and provide important evidence to facilitate clinical decision making.	[Lu, Guangyu] Yangzhou Univ, Dept Prevent Med, Med Coll, Yangzhou, Jiangsu, Peoples R China; [Zhu, Lei; Wang, Xingdong; Zhang, Hengzhu; Li, Yuping] Yangzhou Univ, Dept Neurosurg, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China; [Li, Yuping] Xuzhou Med Univ, Dept Neurosurg, Yangzhou Clin Med Coll, Xuzhou, Jiangsu, Peoples R China		Li, YP (corresponding author), Yangzhou Univ, Dept Neurosurg, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China.; Li, YP (corresponding author), Xuzhou Med Univ, Dept Neurosurg, Yangzhou Clin Med Coll, Xuzhou, Jiangsu, Peoples R China.	dr.yuping.li@gmail.com	; Li, Yuping/C-4122-2014	zhu, lei/0000-0001-5133-7840; Lu, Guangyu/0000-0003-2568-7091; Li, Yuping/0000-0002-4527-2582	Jiangsu Young Medical Talents Key Projects [QNRC2016326]; Jiangsu Commission of Health Projects [H2018064]	This study was funded by Jiangsu Young Medical Talents Key Projects (QNRC2016326) and the Jiangsu Commission of Health Projects (H2018064).	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; [Anonymous], 2018, LANCET, V391, P813, DOI 10.1016/S0140-6736(18)30547-6; [Anonymous], 2011, COCHRANE HDB SYSTEMA; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; FAIRBURN B, 1956, BMJ-BRIT MED J, V1, P1335, DOI 10.1136/bmj.1.4979.1335; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; Higgins JPT, COCHRANE HDB SYSTEMA; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Lazaridis C, 2012, NEUROCRIT CARE, V16, P478, DOI 10.1007/s12028-012-9685-1; LI PGL, 2011, JIANGXI MED J, V46, P609; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Moein H, 2012, NEUROSURG QUART, V22, P149, DOI 10.1097/WNQ.0b013e318240f1e0; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Shutter LA, 2016, NEW ENGL J MED, V375, P1183, DOI 10.1056/NEJMe1609722; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D; Wang R, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001733; Zhao G, 2015, ADV SOC SCI EDUC HUM, V17, P20	37	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2020	133						E135	E148		10.1016/j.wneu.2019.08.184			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JX8QN	WOS:000503993700018	31491576				2022-02-06	
J	Zhao, ZL; Zhou, Y; Hilton, T; Li, FJ; Han, C; Liu, L; Yuan, HJ; Li, Y; Xu, X; Wu, XP; Zhang, FY; Thiagarajan, P; Cap, A; Shi, FD; Zhang, JN; Dong, JF				Zhao, Zilong; Zhou, Yuan; Hilton, Tristan; Li, Fanjian; Han, Cha; Liu, Li; Yuan, Hengjie; Li, Ying; Xu, Xin; Wu, Xiaoping; Zhang, Fangyi; Thiagarajan, Perumal; Cap, Andrew; Shi, Fu-Dong; Zhang, Jianning; Dong, Jing-fei			Extracellular mitochondria released from traumatized brains induced platelet procoagulant activity	HAEMATOLOGICA			English	Article							STROMAL CELLS; INJURY; CD36; COAGULOPATHY; ACTIVATION; STRESS; DNA; PHOSPHATIDYLSERINE; MICROPARTICLES; CONTRIBUTES	Coagulopathy often develops soon after acute traumatic brain injury and its cause remains poorly understood. We have shown that injured brains release cellular microvesicles that disrupt the endothelial barrier and induce consumptive coagulopathy. Morphologically intact extracellular mitochondria accounted for 55.2% of these microvesicles, leading to the hypothesis that these extracellular mitochondria are metabolically active and serve as a source of oxidative stress that activates platelets and renders them procoagulant. In testing this hypothesis experimentally, we found that the extracellular mitochondria purified from brain trauma mice and those released from brains subjected to freeze-thaw injury remained metabolically active and produced reactive oxygen species. These extracellular mitochondria bound platelets through the phospholipid-CD36 interaction and induced alpha-granule secretion, microvesiculation, and procoagulant activity in an oxidant-dependent manner, but failed to induce aggregation. These results define an extracellular mitochondria-induced and redox-dependent intermediate phenotype of platelets that contribute to the pathogenesis of traumatic brain injury-induced coagulopathy and inflammation.	[Zhao, Zilong; Zhou, Yuan; Hilton, Tristan; Han, Cha; Xu, Xin; Wu, Xiaoping; Dong, Jing-fei] BloodWorks Res Inst, Seattle, WA 98102 USA; [Zhao, Zilong; Zhou, Yuan; Li, Fanjian; Liu, Li; Yuan, Hengjie; Li, Ying; Shi, Fu-Dong; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Tianjin Inst Neurol, Dept Neurosurg, Tianjin, Peoples R China; [Zhao, Zilong; Zhou, Yuan; Li, Fanjian; Liu, Li; Yuan, Hengjie; Li, Ying; Shi, Fu-Dong; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Tianjin Inst Neurol, Dept Neurol, Tianjin, Peoples R China; [Zhang, Fangyi] Univ Washington, Sch Med, Dept Neurosurg, Seattle, WA USA; [Thiagarajan, Perumal] Michael E DeBakey VA Med Ctr, Dept Med, Houston, TX USA; [Thiagarajan, Perumal] Michael E DeBakey VA Med Ctr, Dept Pathol, Houston, TX USA; [Thiagarajan, Perumal] Baylor Coll Med, Houston, TX 77030 USA; [Cap, Andrew] US Army Inst Surg Res, San Antonio, TX USA; [Shi, Fu-Dong] St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ USA; [Dong, Jing-fei] Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA		Dong, JF (corresponding author), BloodWorks Res Inst, Seattle, WA 98102 USA.; Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Inst Neurol, Dept Neurosurg, Tianjin, Peoples R China.; Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Inst Neurol, Dept Neurol, Tianjin, Peoples R China.; Dong, JF (corresponding author), Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA.	jianningzhang@hotmail.com; jfdong@bloodworksnw.org	Zhao, Zilong/AAZ-2196-2020		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS087296, HL71895]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81330029, 81720108015, 81271361, 81271359, 81601068]; Natural Science Foundation of TianjinNatural Science Foundation of Tianjin [17JCQNJC12100];  [16PTSTJC00180]	This study was supported by NIH grants NS087296 and HL71895 (JFD), National Natural Science Foundation of China State Key Program grant 81330029 (JNZ), National Natural Science Foundation of China Major International Joint Research Project 81720108015 (JNZ), National Natural Science Foundation of China Research grants 81271361, 81271359 (JNZ) and 81601068 (ZLZ), Natural Science Foundation of Tianjin 17JCQNJC12100 (ZLZ) and a regional scientific grant 16PTSTJC00180 (JNZ).	Alberio L, 2000, BLOOD, V95, P1694, DOI 10.1182/blood.V95.5.1694.005k24_1694_1702; Arthur JF, 2012, J THROMB HAEMOST, V10, P1133, DOI 10.1111/j.1538-7836.2012.04734.x; Begonja AJ, 2005, BLOOD, V106, P2757, DOI 10.1182/blood-2005-03-1047; BOSIN TR, 1991, BIOCHEM PHARMACOL, V41, P967, DOI 10.1016/0006-2952(91)90203-H; Bulstrode H, 2014, ANN NEUROL, V75, P186, DOI 10.1002/ana.24116; Cap AP, 2011, J TRAUMA, V71, pS78, DOI 10.1097/TA.0b013e3182218cd8; CARR ME, 1995, THROMB HAEMOSTASIS, V73, P499; CARR ME, 1995, BLOOD COAGUL FIBRIN, V6, P79, DOI 10.1097/00001721-199502000-00013; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Ghosh A, 2008, J CLIN INVEST, V118, P1934, DOI 10.1172/JCI34904; Hamilton SF, 2004, J LAB CLIN MED, V143, P320, DOI 10.1016/j.lab.2004.02.001; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Hierso R, 2014, BRIT J HAEMATOL, V166, P601, DOI 10.1111/bjh.12912; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; Lorente L, 2014, THROMB RES, V134, P832, DOI 10.1016/j.thromres.2014.07.034; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Moschoi R, 2016, BLOOD, V128, P253, DOI 10.1182/blood-2015-07-655860; NEWMAN PJ, 1987, BLOOD, V69, P668; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Prodan CI, 2016, J NEUROTRAUM, V33, P818, DOI 10.1089/neu.2014.3846; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; Saliba AE, 2015, NAT REV MOL CELL BIO, V16, P753, DOI 10.1038/nrm4080; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Tait JF, 1999, J BIOL CHEM, V274, P3048, DOI 10.1074/jbc.274.5.3048; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; TRACY PB, 1983, P NATL ACAD SCI-BIOL, V80, P2380, DOI 10.1073/pnas.80.8.2380; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Walko TD, 2014, SHOCK, V41, P499, DOI 10.1097/SHK.0000000000000160; Yuan HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143964; Zhang JN, 2003, THROMB HAEMOSTASIS, V90, P672, DOI 10.1160/TH03-03-0145; Zhao ZL, 2016, BLOOD, V127, P2763, DOI [10.1182/blood-2015-12688838, 10.1182/blood-2015-12-688838]; Zhou Y, 2018, BLOOD, V131, P563, DOI 10.1182/blood-2017-08-801738	44	13	13	4	6	FERRATA STORTI FOUNDATION	PAVIA	VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY	0390-6078			HAEMATOLOGICA	Haematologica	JAN 1	2020	105	1					209	217		10.3324/haematol.2018.214932			9	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	JZ3ZR	WOS:000505041200036	30975909	Green Published, gold			2022-02-06	
J	Grashow, R; Weisskopf, MG; Miller, KK; Nathan, DM; Zafonte, R; Speizer, FE; Courtney, TK; Baggish, A; Taylor, HA; Pascual-Leone, A; Nadler, LM; Roberts, AL				Grashow, Rachel; Weisskopf, Marc G.; Miller, Karen K.; Nathan, David M.; Zafonte, Ross; Speizer, Frank E.; Courtney, Theodore K.; Baggish, Aaron; Taylor, Herman A.; Pascual-Leone, Alvaro; Nadler, Lee M.; Roberts, Andrea L.			Association of Concussion Symptoms With Testosterone Levels and Erectile Dysfunction in Former Professional US-Style Football Players	JAMA NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; DISEASE RISK-FACTORS; PITUITARY DYSFUNCTION; ANTIPITUITARY ANTIBODIES; PREMATURE EJACULATION; SEXUAL DYSFUNCTION; METABOLIC SYNDROME; SELF-ASSESSMENT; DRUG-USE; DEPRESSION	This cross-sectional study examines the association between self-reported concussion symptoms at the time of US-style football injury and self-reported low testosterone levels and erectile dysfunction indicators in US former professional football players. Question Are professional US-style football players with a history of multiple concussion symptoms more likely to report indicators of low testosterone levels or erectile dysfunction (ED)? Findings In this cross-sectional study of 3409 former players, a monotonically increasing association was found between the number of concussion symptoms and the odds of reporting an indicator of low testosterone level and ED. Meaning Concussion symptoms among former football players were associated with low testosterone levels and ED indicators, suggesting that men with a history of head injury may benefit from discussions with their health care clinicians regarding these treatable outcomes. Importance Small studies suggest that head trauma in men may be associated with low testosterone levels and sexual dysfunction through mechanisms that likely include hypopituitarism secondary to ischemic injury and pituitary axonal tract damage. Athletes in contact sports may be at risk for pituitary insufficiencies or erectile dysfunction (ED) because of the high number of head traumas experienced during their careers. Whether multiple symptomatic concussive events are associated with later indicators of low testosterone levels and ED is unknown. Objective To explore the associations between concussion symptom history and participant-reported indicators of low testosterone levels and ED. Design, Setting, and Participants This cross-sectional study of former professional US-style football players was conducted in Boston, Massachusetts, from January 2015 to March 2017. Surveys on past football exposures, demographic factors, and current health conditions were sent via electronic and postal mail to participants within and outside of the United States. Analyses were conducted in Boston, Massachusetts; the data analysis began in March 2018 and additional analyses were performed through June 2019. Of the 13720 male former players eligible to enroll who were contacted, 3506 (25.6%) responded. Exposures Concussion symptom score was calculated by summing the frequency with which participants reported 10 symptoms, such as loss of consciousness, disorientation, nausea, memory problems, and dizziness, at the time of football-related head injury. Main Outcomes and Measures Self-reported recommendations or prescriptions for low testosterone or ED medication served as indicators for testosterone insufficiency and ED. Results In 3409 former players (mean [SD] age, 52.5 [14.1] years), the prevalence of indicators of low testosterone levels and ED was 18.3% and 22.7%, respectively. The odds of reporting low testosterone levels or ED indicators were elevated for previously established risk factors (eg, diabetes, sleep apnea, and mood disorders). Models adjusted for demographic characteristics, football exposures, and current health factors showed a significant monotonically increasing association of concussion symptom score with the odds of reporting the low testosterone indicator (highest vs lowest quartile, odds ratio, 2.39; 95% CI, 1.79-3.19; P < .001). The ED indicator showed a similar association (highest quartile vs lowest, odds ratio, 1.72; 95% CI, 1.30-2.27; P < .001). Conclusions and Relevance Concussion symptoms at the time of injury among former football players were associated with current participant-reported low testosterone levels and ED indicators. These findings suggest that men with a history of head injury may benefit from discussions with their health care clinicians regarding testosterone deficiency and sexual dysfunction.	[Grashow, Rachel; Weisskopf, Marc G.; Speizer, Frank E.; Courtney, Theodore K.; Roberts, Andrea L.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, 655 Huntington Ave,Bldg 1,Ste 1402, Boston, MA 02215 USA; [Grashow, Rachel; Weisskopf, Marc G.; Miller, Karen K.; Nathan, David M.; Zafonte, Ross; Speizer, Frank E.; Courtney, Theodore K.; Baggish, Aaron; Taylor, Herman A.; Pascual-Leone, Alvaro; Nadler, Lee M.] Harvard Med Sch, Football Players Hlth Study, Boston, MA 02115 USA; [Weisskopf, Marc G.; Courtney, Theodore K.] Harvard TH Chan Sch Publ Hlth, Environm & Occupat Med & Epidemiol Program, Boston, MA USA; [Miller, Karen K.] Massachusetts Gen Hosp, Dept Med, Neuroendocrine Unit, Boston, MA 02114 USA; [Miller, Karen K.] Harvard Med Sch, Boston, MA 02115 USA; [Nathan, David M.] Massachusetts Gen Hosp, Ctr Diabet, Boston, MA 02114 USA; [Nathan, David M.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Zafonte, Ross] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Zafonte, Ross] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Speizer, Frank E.] Harvard Med Sch, Channing Div Network Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Baggish, Aaron] Massachusetts Gen Hosp, Cardiovasc Performance Program, Boston, MA 02114 USA; [Taylor, Herman A.] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Pascual-Leone, Alvaro] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Div Cognit Neurol,Dept Neurol, Boston, MA 02115 USA; [Nadler, Lee M.] Dana Farber Canc Inst, Boston, MA 02115 USA		Grashow, R (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, 655 Huntington Ave,Bldg 1,Ste 1402, Boston, MA 02215 USA.	rgrashow@hsph.harvard.edu	Courtney, Theodore K./P-4829-2019; Miller, Karen/AAI-6901-2021	Courtney, Theodore K./0000-0001-8139-1565; 	Sidney R. Baer Jr Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01MH100186, R21AG051846, R01MH111875, R01MH115949, R01 MH117063, R24AG06142, P01 AG031720]; National Science FoundationNational Science Foundation (NSF); DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA); Football Players Health Study at Harvard University; Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Studies National Institutes of Health [UL1 RR025758]; NFLPA	This study was partly supported by the Sidney R. Baer Jr Foundation, the National Institutes of Health (grants R01MH100186, R21AG051846, R01MH111875, R01MH115949, R01 MH117063, R24AG06142, and P01 AG031720), the National Science Foundation, DARPA, the Football Players Health Study at Harvard University, and Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Studies National Institutes of Health grant UL1 RR025758; Dr Pascual Leone) as well as the NFLPA.	Albuquerque FN, 2010, J AM COLL CARDIOL, V56, P1432, DOI 10.1016/j.jacc.2010.03.099; Allen TW, 2010, PHYSICIAN SPORTSMED, V38, P21, DOI 10.3810/psm.2010.04.1758; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Bassil Nazem, 2009, Ther Clin Risk Manag, V5, P427; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Brown TT, 2006, AM J INFECT DIS, V2, P130, DOI 10.3844/ajidsp.2006.130.135; Camilo J, 2011, CAN J DIABETES, V35, P486, DOI 10.1016/S1499-2671(11)80002-X; Cappelleri JC, 2001, CLIN THER, V23, P1707, DOI 10.1016/S0149-2918(01)80138-7; CARROLL JL, 1990, J SEX MARITAL THER, V16, P70; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Chambers CC, 2017, AM J SPORT MED, V45, P167, DOI 10.1177/0363546516673350; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Churchill TW, 2018, AM J MED, V131, P1491, DOI 10.1016/j.amjmed.2018.07.042; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; CONTE HR, 1983, ARCH SEX BEHAV, V12, P555, DOI 10.1007/BF01542217; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; Derby CA, 2000, INT J IMPOT RES, V12, P197, DOI 10.1038/sj.ijir.3900542; Didehbani N., 2017, ANN SPORT MED RES, V4, P1115; Dodson CC, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116631949; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fronczak CM, 2012, J ANDROL, V33, P515, DOI 10.2164/jandrol.110.011874; Grashow RG, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119829212; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hatzimouratidis K, 2005, DRUGS, V65, P1621, DOI 10.2165/00003495-200565120-00003; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Hobbs JG, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15617; Hohl A, 2009, ARQ BRAS ENDOCRINOL, V53, P908, DOI 10.1590/S0004-27302009000800003; Horn S, 2009, AM J PHYS MED REHAB, V88, P192, DOI 10.1097/PHM.0b013e318198b622; Johnson SD, 2004, ARCH SEX BEHAV, V33, P55, DOI 10.1023/B:ASEB.0000007462.97961.5a; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Klose M, 2009, EUR J ENDOCRINOL, V161, pS75, DOI 10.1530/EJE-09-0328; KOSTELJANETZ M, 1981, ACTA NEUROL SCAND, V63, P169; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Kubin M, 2003, INT J IMPOT RES, V15, P63, DOI 10.1038/sj.ijir.3900949; LaBotz M, 2005, CLIN J SPORT MED, V15, P73, DOI 10.1097/01.jsm.0000157649.99867.fc; Lehman EJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt188; Lehmann K, 2000, J UROLOGY, V163, P91, DOI 10.1016/S0022-5347(05)67980-3; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Luyster FS, 2017, NAT SCI SLEEP, V9, P31, DOI 10.2147/NSS.S125228; McCabe MP, 2008, J SEX MED, V5, P1795, DOI 10.1111/j.1743-6109.2008.00878.x; McCabe MP, 2014, J SEX MED, V11, P347, DOI 10.1111/jsm.12374; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Montorsi F, 2010, J SEX MED, V7, P3572, DOI 10.1111/j.1743-6109.2010.02062.x; O'Donnell AB, 2005, J GEN INTERN MED, V20, P515, DOI 10.1111/j.1525-1497.2005.0076.x; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Plummer F, 2016, GEN HOSP PSYCHIAT, V39, P24, DOI 10.1016/j.genhosppsych.2015.11.005; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Pro-Football-Reference, SPORTS REF; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Rowland DL, 2011, CURR MED RES OPIN, V27, P1509, DOI 10.1185/03007995.2011.590968; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Scranton RA, 2015, J CLIN MED, V4, P1463, DOI 10.3390/jcm4071463; Seidman S N, 2000, Curr Psychiatry Rep, V2, P201, DOI 10.1007/s11920-996-0008-0; Shabsigh R, 2004, BJU INT, V94, P1055, DOI 10.1111/j.1464-410X.2004.05104.x; Shiri R, 2007, J UROLOGY, V177, P669, DOI 10.1016/j.juro.2006.09.030; Silva PPB, 2015, J NEUROTRAUM, V32, P1789, DOI 10.1089/neu.2015.3998; Simpson GK, 2016, NEUROREHABILITATION, V38, P281, DOI 10.3233/NRE-161319; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Sotomayor M, 2005, J SEX MED, V2, P110, DOI 10.1111/j.1743-6109.2005.20371.x; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Sundaram NK, 2013, ENDOCRIN METAB CLIN, V42, P565, DOI 10.1016/j.ecl.2013.05.003; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Trexler ET, 2018, MED SCI SPORT EXER, V50, P684, DOI [10.1249/mss.0000000000001492, 10.1249/MSS.0000000000001492]; Tucker AM, 2009, JAMA-J AM MED ASSOC, V301, P2111, DOI 10.1001/jama.2009.716; Undurti A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00072; War Firdous A, 2014, Asian J Neurosurg, V9, P29, DOI 10.4103/1793-5482.131061; Webner D, 2016, BRAIN INJURY, V30, P1718, DOI 10.1080/02699052.2016.1202451; Westley CJ, 2015, J SEX MED, V12, P1753, DOI 10.1111/jsm.12937; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Yang YJ, 2018, AM J MENS HEALTH, V12, P913, DOI 10.1177/1557988317750970; Yuan JQ, 2013, EUR UROL, V63, P902, DOI 10.1016/j.eururo.2013.01.012; Zafonte R, 2019, AM J IND MED, V62, P643, DOI 10.1002/ajim.22991	89	13	13	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	DEC	2019	76	12					1428	1438		10.1001/jamaneurol.2019.2664			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JZ6BI	WOS:000505186000006	31449296	Green Published, hybrid			2022-02-06	
J	Smith, LGF; Milliron, E; Ho, ML; Hu, HH; Rusin, J; Leonard, J; Sribnick, EA				Smith, Luke G. F.; Milliron, Eric; Ho, Mai-Lan; Hu, Houchun H.; Rusin, Jerome; Leonard, Jeffrey; Sribnick, Eric A.			Advanced neuroimaging in traumatic brain injury: an overview	NEUROSURGICAL FOCUS			English	Article						traumatic brain injury; neuroimaging; MRI; CT	MAGNETIC-RESONANCE ELASTOGRAPHY; PERFUSION COMPUTED-TOMOGRAPHY; CEREBRAL-BLOOD-FLOW; HEAD-INJURY; AXONAL INJURY; DEFAULT MODE; FIBER TRACTOGRAPHY; PROGNOSTIC VALUE; UNITED-STATES; CT PERFUSION	Traumatic brain injury (TBI) is a common condition with many potential acute and chronic neurological consequences. Standard initial radiographic evaluation includes noncontrast head CT scanning to rapidly evaluate for pathology that might require intervention. The availability of fast, relatively inexpensive CT imaging has fundamentally changed the clinician's ability to noninvasively visualize neuroanatomy. However, in the context of TBI, limitations of head CT without contrast include poor prognostic ability, inability to analyze cerebral perfusion status, and poor visualization of underlying posttraumatic changes to brain parenchyma. Here, the authors review emerging advanced imaging for evaluation of both acute and chronic TBI and include QuickBrain MRI as an initial imaging modality. Dynamic susceptibility-weighted contrast-enhanced perfusion MRI, MR arterial spin labeling, and perfusion CT are reviewed as methods for examining cerebral blood flow following TBI. The authors evaluate MR-based diffusion tensor imaging and functional MRI for prognostication of recovery post-TBI. Finally, MR elastography, MR spectroscopy, and convolutional neural networks are examined as future tools in TBI management. Many imaging technologies are being developed and studied in TBI, and some of these may hold promise in improving the understanding and management of TBI.	[Smith, Luke G. F.; Leonard, Jeffrey; Sribnick, Eric A.] Ohio State Univ, Wexner Med Ctr, Dept Neurol Surg, Columbus, OH 43210 USA; [Milliron, Eric] Ohio State Univ, Coll Med, Wexner Med Ctr, Columbus, OH 43210 USA; [Ho, Mai-Lan; Hu, Houchun H.; Rusin, Jerome] Nationwide Childrens Hosp, Dept Radiol, Columbus, OH USA; [Leonard, Jeffrey; Sribnick, Eric A.] Nationwide Childrens Hosp, Div Neurol Surg, Columbus, OH USA		Smith, LGF (corresponding author), Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA.	luke.smith@osumc.edu	Ho, Mai-Lan/ABB-4057-2021; Sribnick, Eric/AAH-6693-2020	Ho, Mai-Lan/0000-0002-9455-1350			Aaen GS, 2010, PEDIATRICS, V125, P295, DOI 10.1542/peds.2008-3312; Alfasi AM, 2013, J NEUROSURG, V119, P1255, DOI 10.3171/2013.7.JNS121973; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Astrakas LG, 2016, PEDIATR RADIOL, V46, P941, DOI 10.1007/s00247-014-3204-9; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bendinelli C, 2017, WORLD J SURG, V41, P2512, DOI 10.1007/s00268-017-4030-7; Boulet T, 2013, J NEUROTRAUM, V30, P1512, DOI 10.1089/neu.2012.2788; Celli P, 1997, Minerva Chir, V52, P1467; Chartrand G, 2017, RADIOGRAPHICS, V37, P2113, DOI 10.1148/rg.2017170077; de Figueiredo EHMSG, 2011, MAGN RESON IMAGING C, V19, P1, DOI 10.1016/j.mric.2010.10.005; Deibler AR, 2008, AM J NEURORADIOL, V29, P1228, DOI 10.3174/ajnr.A1030; Di Perri C, 2016, LANCET NEUROL, V15, P830, DOI 10.1016/S1474-4422(16)00111-3; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Douglas David B, 2018, Med Sci (Basel), V7, DOI 10.3390/medsci7010002; Douglas DB, 2018, NEUROIMAG CLIN N AM, V28, P55, DOI 10.1016/j.nic.2017.09.002; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1710, DOI 10.1016/j.apmr.2018.07.002; GRAHAM DI, 1971, LANCET, V1, P265; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hemphill JC, 2005, AM J NEURORADIOL, V26, P1095; Hiscox LV, 2018, NEUROBIOL AGING, V65, P158, DOI 10.1016/j.neurobiolaging.2018.01.010; Hiscox LV, 2016, PHYS MED BIOL, V61, pR401, DOI 10.1088/0031-9155/61/24/R401; Holshouser B, 2019, J NEUROTRAUM, V36, P1352, DOI 10.1089/neu.2018.5919; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; JENNETT B, 1976, LANCET, V1, P1031; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Klatt D, 2015, J MAGN RESON IMAGING, V42, P297, DOI 10.1002/jmri.24806; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lev MH, 2001, STROKE, V32, P2021, DOI 10.1161/hs0901.095680; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Liu SF, 2019, NEUROIMAGE, V198, P271, DOI 10.1016/j.neuroimage.2019.05.046; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Muthupillai R, 1996, NAT MED, V2, P601, DOI 10.1038/nm0596-601; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Peterson AB, 2019, SURVEILLANCE REPORT; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rubin GD, 2014, RADIOLOGY, V273, pS45, DOI 10.1148/radiol.14141356; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Sheridan DC, 2017, J NEUROSURG-PEDIATR, V19, P259, DOI 10.3171/2016.7.PEDS16204; Shetty VS, 2016, J AM COLL RADIOL, V13, P668, DOI 10.1016/j.jacr.2016.02.023; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Skibsted AP, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01012; Soustiel JF, 2008, NEURORADIOLOGY, V50, P189, DOI 10.1007/s00234-007-0337-7; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Stiell IG, 2001, ANN EMERG MED, V38, P317, DOI 10.1067/mem.2001.116795; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Threlkeld ZD, 2018, CORTEX, V106, P299, DOI 10.1016/j.cortex.2018.05.004; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Wintermark M, 2001, AM J NEURORADIOL, V22, P905; Wintermark M, 2001, EUR RADIOL, V11, P1220, DOI 10.1007/s003300000707; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	82	13	14	3	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	DEC	2019	47	6							E17	10.3171/2019.9.FOCUS19652			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JS4IR	WOS:000500270900002	32364704	gold			2022-02-06	
J	Zhang, JX; Shi, CQ; Wang, HC; Gao, C; Chang, P; Chen, XP; Shan, HY; Zhang, MY; Tao, LY				Zhang, Jiaxin; Shi, Chaoqun; Wang, Haochen; Gao, Cheng; Chang, Pan; Chen, Xiping; Shan, Haiyan; Zhang, Mingyang; Tao, Luyang			Hydrogen sulfide protects against cell damage through modulation of PI3K/Akt/Nrf2 signaling	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Article						Hydrogen sulfide; Traumatic brain injury; Autophagic cell death; Apoptosis; Oxidative stress; PC12 cell	TRAUMATIC BRAIN-INJURY; CYSTATHIONINE BETA-SYNTHASE; IN-VITRO; PROVIDES NEUROPROTECTION; DEFENSE-MECHANISMS; OXIDATIVE STRESS; SCRATCH INJURY; UP-REGULATION; MODEL; CONTRIBUTES	Hydrogen sulfide as the third endogenous gaseous mediator had protective effects against traumatic brain injury-induced neuronal damage in mice. However, the exact pathophysiological mechanism underlying traumatic brain injury is complicated and the protective role of H2S is not yet fully known. Therefore, we combined the mechanical injury (scratch) with secondary injury including metabolic impairment (no glucose) together to investigate the underlying cellular mechanism of hydrogen sulfide in vitro models of traumatic brain injury. In the present study, we found that H2S could prevent the scratch-induced decrease in the expression of cystathionine-beta-synthetase, a key enzyme involved in the source of hydrogen sulfide, and endogenous hydrogen sulfide generation in PC12 cells. We also found that hydrogen sulfide could prevent scratch-induced cellular injury, alteration of mitochondrial membrane potential, intracellular accumulation of reactive oxygen species and cell death (autophagic cell death and apoptosis) in PC12 cells. It was also found that blocking PI3K/AKT pathway by LY294002, abolished the protection of H2S against scratch-induced cellular reactive oxygen species level and NRF2 accumulation and function in the nucleus. These results suggest that hydrogen sulfide protects against cell damage induced by scratch injury through modulation of the PI3K/Akt/Nrf2 pathway. This study raises the possibility that hydrogen sulfide may have therapeutic efficacy in traumatic brain injury.	[Zhang, Jiaxin; Shi, Chaoqun; Wang, Haochen; Gao, Cheng; Chen, Xiping; Zhang, Mingyang; Tao, Luyang] Soochow Univ, Inst Forens Sci, Suzhou 215123, Peoples R China; [Shan, Haiyan] Nanjing Med Univ, Dept Obstet & Gynecol, Affiliated Suzhou Hosp, Suzhou 215000, Peoples R China; [Zhang, Mingyang] Soochow Univ, Sch Pharm, Suzhou 215000, Peoples R China; [Chang, Pan] Xian Med Coll, Cent Lab, Affiliated Hosp 2, Xian 710038, Shaanxi, Peoples R China		Zhang, MY (corresponding author), Soochow Univ, Inst Forens Sci, Suzhou 215123, Peoples R China.; Shan, HY (corresponding author), Nanjing Med Univ, Dept Obstet & Gynecol, Affiliated Suzhou Hosp, Suzhou 215000, Peoples R China.	ghostqth@163.com; mingyangzhang@suda.edu.cn	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Zhang, Mingyang/0000-0003-1612-0763	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601306, 81301039, 81530062]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015M570476]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Talent Youth Medical Program [QNRC2016245]; Shanghai Key Lab of Forensic Medicine [KF1801]; Suzhou Science and Technology Development Project [SYS2018082]; Fifth Batch of Gusu District Health Talent Training Project [GSWS2019060]	This work was supported by the National Natural Science Foundation of China (No.81601306, No.81301039, No.81530062); China Postdoctoral Science Foundation Funded Project (No.2015M570476); The Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Talent Youth Medical Program (QNRC2016245); Shanghai Key Lab of Forensic Medicine (KF1801); Suzhou Science and Technology Development Project (SYS2018082), and the Fifth Batch of Gusu District Health Talent Training Project (GSWS2019060).	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Baez-Jurado E., 2017, MOL NEUROBIOL, V9; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Cao X., 2017, BIOCH PHARM, V12; Chang RY, 2016, BRAIN RES BULL, V121, P75, DOI 10.1016/j.brainresbull.2016.01.001; DiNicolantonio JJ, 2017, OPEN HEART, V4, DOI 10.1136/openhrt-2017-000600; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Faden AI, 2005, NEUROPHARMACOLOGY, V49, P410, DOI 10.1016/j.neuropharm.2005.04.001; Ferlito M, 2014, J IMMUNOL, V192, P1806, DOI 10.4049/jimmunol.1300835; Gao C, 2018, INT J MOL MED, V41, P242, DOI 10.3892/ijmm.2017.3227; Gao K, 2013, GLIA, V61, P2063, DOI 10.1002/glia.22577; George AK, 2017, BRAIN RES BULL, V130, P251, DOI 10.1016/j.brainresbull.2017.02.002; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Han M, 2008, ARCH PHARM RES, V31, P749, DOI 10.1007/s12272-001-1222-5; Huang CW, 2015, HANDB EXP PHARMACOL, V230, P3, DOI 10.1007/978-3-319-18144-8_1; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI 10.1089/ARS.2008.2132; Islam KN, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001986; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Jia J, 2013, NEUROCHEM INT, V62, P1072, DOI 10.1016/j.neuint.2013.04.001; Jiang WW, 2017, FEBS OPEN BIO, V7, P1686, DOI 10.1002/2211-5463.12301; Jin SF, 2015, EXP CELL RES, V339, P289, DOI 10.1016/j.yexcr.2015.11.013; Jin W, 2009, J SURG RES, V157, P251, DOI 10.1016/j.jss.2008.08.003; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Lee M, 2009, NEUROBIOL AGING, V30, P1523, DOI 10.1016/j.neurobiolaging.2009.06.001; Lee SW, 2006, GLIA, V54, P116, DOI 10.1002/glia.20362; Lim JL, 2014, ARCH TOXICOL, V88, P1773, DOI 10.1007/s00204-014-1338-z; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Loov C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055983; Ma J, 2016, AM J TRANSL RES, V8, P1895; Ma YH, 2012, NEUROSCI LETT, V510, P14, DOI 10.1016/j.neulet.2011.12.061; Miyamoto R, 2014, J NEUROCHEM, V130, P29, DOI 10.1111/jnc.12698; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; Rao W, 2015, BBA-MOL BASIS DIS, V1852, P2402, DOI 10.1016/j.bbadis.2015.08.014; Robert K, 2003, J HISTOCHEM CYTOCHEM, V51, P363, DOI 10.1177/002215540305100311; Shan HY, 2017, MOL MED REP, V16, P5938, DOI 10.3892/mmr.2017.7363; Shefa U, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1689341; Shen QH, 2016, WORLDV EVID-BASED NU, V13, P380, DOI 10.1111/wvn.12167; Tang XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054829; Tang XQ, 2011, NEUROTOX RES, V19, P403, DOI 10.1007/s12640-010-9180-4; Tardiolo G, 2018, MOLECULES, V23, DOI 10.3390/molecules23123305; Tay AS, 2010, NEUROSCIENCE, V167, P277, DOI 10.1016/j.neuroscience.2010.02.006; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Wang SSS, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.18; Wang XY, 2016, EXP CELL RES, V346, P111, DOI 10.1016/j.yexcr.2016.06.010; Xie L, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8640284; Xie ZZ, 2014, ANTIOXID REDOX SIGN, V21, P2531, DOI 10.1089/ars.2013.5604; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yan JW, 2013, CHIN J TRAUMATOL, V16, P3, DOI 10.3760/cma.j.issn.1008-1275.2013.01.001; Yang CT, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00664; Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763; Zhang M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109589, 10.1371/journal.pone.0105994]; Zhang MY, 2017, CELL MOL NEUROBIOL, V37, P291, DOI 10.1007/s10571-016-0369-9; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4; Zhang MJ, 2017, BRAIN BEHAV IMMUN, V66, P332, DOI 10.1016/j.bbi.2017.07.156; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zheng JF, 2015, CHEM-BIOL INTERACT, V242, P353, DOI 10.1016/j.cbi.2015.10.021; Zhou D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165224; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	68	13	14	2	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725	1878-5875		INT J BIOCHEM CELL B	Int. J. Biochem. Cell Biol.	DEC	2019	117								105636	10.1016/j.biocel.2019.105636			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JU4PY	WOS:000501660700010	31654751				2022-02-06	
J	Juengst, SB; Nabasny, A; Terhorst, L				Juengst, Shannon B.; Nabasny, Andrew; Terhorst, Lauren			Neurobehavioral Symptoms in Community-Dwelling Adults With and Without Chronic Traumatic Brain Injury: Differences by Age, Gender, Education, and Health Condition	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; behavior; emotion; gender; age; education	ETHNIC DISPARITIES; MENTAL-HEALTH; CHALLENGING BEHAVIOR; SEX-DIFFERENCES; DEPRESSION; OUTCOMES; WOMEN; PTSD; TBI; IMPULSIVITY	Neurobehavioral symptoms after Traumatic Brain Injury (TBI) are prevalent, persist for many years, and negatively affect long-term health, function, and quality of life. Symptoms may differ based on age, gender, education, race, ethnicity, and injury severity. To better understand neurobehavioral functioning after TBI, we need a comprehensive picture of emotional, cognitive, and behavioral symptoms in the context of personal factors that may affect these symptoms. We also need to understand the extent to which these symptoms are specific to TBI, shared across other neurological conditions, or attributable to factors outside of the injury itself. We collected neurobehavioral symptoms via the self-reported Behavioral Assessment Screening Tool (BAST) in a National Cohort of English (n = 2,511) and Spanish speaking (n = 350) community-dwelling adults with and without chronic TBI and other neurological and mental health conditions. The primary focus of the present study was to comprehensively describe neurobehavioral symptoms in adults with and without TBI, broken down by gender and health conditions and then further by age group or educational attainment. As expected, participants with TBI reported more symptoms than Healthy Controls. Regardless of condition, women reported more fatigue, while men reported more substance abuse and impulsivity. Hispanic participants reported more neurobehavioral symptoms than non-Hispanic participants did across health conditions, though primarily Spanish-speakers reported fewer symptoms than English-speakers, suggesting that level of acculturation may contribute to symptom reporting. These data provide a comprehensive characterization of neurobehavioral symptoms in adults with TBI and adults without TBI (healthy controls, adults with other neurological conditions, and adults with mental health conditions).	[Juengst, Shannon B.; Nabasny, Andrew] Univ Texas Southwestern Med Ctr, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Terhorst, Lauren] Univ Pittsburgh, Dept Occupat Therapy, Pittsburgh, PA USA		Juengst, SB (corresponding author), Univ Texas Southwestern Med Ctr, Dept Phys Med & Rehabil, Dallas, TX 75390 USA.	shannon.juengst@utsouthwestern.edu			National Institutes for Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD) [R03HD09445]	This work was funded by the National Institutes for Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD). Grant no:R03HD09445 (PI: Juengst).	Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P814, DOI 10.3109/02699052.2012.655360; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P801, DOI 10.3109/02699052.2012.655368; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Arcia E, 2001, SOC SCI MED, V53, P41, DOI 10.1016/S0277-9536(00)00310-5; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Bauldry S, 2015, SOC MENT HEALTH, V5, P145, DOI 10.1177/2156869314564399; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brannlund A, 2017, J MENT HEALTH, V26, P318, DOI 10.1080/09638237.2017.1294739; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Cianelli R, 2008, CULT HEALTH SEX, V10, P297, DOI 10.1080/13691050701861439; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Cooper K. D, 1983, NEUROEPIDEMIOLOGY, V2, P79, DOI [10.1159/000110513, DOI 10.1159/000110513]; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cross CP, 2011, PSYCHOL BULL, V137, P97, DOI 10.1037/a0021591; Cruz-Flores S, 2011, STROKE, V42, P2091, DOI 10.1161/STR.0b013e3182213e24; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Diamantopoulou S, 2007, DEV NEUROPSYCHOL, V32, P521, DOI 10.1080/87565640701360981; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fuentes A, 2019, REHABIL PSYCHOL, V64, P229, DOI 10.1037/rep0000260; Gao SY, 2018, J HEAD TRAUMA REHAB, V33, pE40, DOI 10.1097/HTR.0000000000000338; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Guerra-Carrillo B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182276; Gum Amber M, 2009, Am J Geriatr Psychiatry, V17, P769, DOI 10.1097/JGP.0b013e3181ad4f5a; Halbreich U, 2007, J AFFECT DISORDERS, V102, P245, DOI 10.1016/j.jad.2006.09.023; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Higashi Robin T, 2019, Health Lit Res Pract, V3, pe243, DOI 10.3928/24748307-20190925-01; Hiott Ann, 2006, Fam Syst Health, V24, P137, DOI 10.1037/1091-7527.24.2.137; Holzer KJ, 2019, J PSYCHIATR RES, V114, P149, DOI 10.1016/j.jpsychires.2019.05.002; Iverson GL, 2019, J NEUROPSYCHIATRY CL, DOI [10.1176/appi.neuropsych.1901002131587629, DOI 10.1176/APPI.NEUROPSYCH.1901002131587629]; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Juengst S, 2014, ARCH PHYS MED REHAB, V95, pE71, DOI [10.1016/j.apmr.2014.07.227, DOI 10.1016/J.APMR.2014.07.227]; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Juengst SB, 2018, DISABIL REHABIL, DOI [10.1080/09638288.2018.149648730451025, DOI 10.1080/09638288.2018.149648730451025]; Juengst SB, 2019, DISABIL REHABIL, V41, P1200, DOI 10.1080/09638288.2017.1423403; Juengst SB, 2017, J CLIN EXP NEUROPSYC, V39, P513, DOI 10.1080/13803395.2016.1240758; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Lequerica AH, 2018, ARCH PHYS MED REHAB, V99, P1811, DOI 10.1016/j.apmr.2018.03.023; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; McGuive TG, 2008, HEALTH AFFAIR, V27, P393, DOI 10.1377/hlthaff.27.2.393; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Myers CE, 2012, PSYCHIAT RES, V196, P271, DOI 10.1016/j.psychres.2011.11.015; Myrga JM, 2016, NEUROREHAB NEURAL RE, V30, P920, DOI 10.1177/1545968316648409; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Nunnari D, 2014, NEUROL SCI, V35, P1513, DOI 10.1007/s10072-014-1897-z; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Perrin PB, 2014, ARCH PHYS MED REHAB, V95, P2288, DOI 10.1016/j.apmr.2014.07.409; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Reynolds K, 2015, WORLD PSYCHIATRY, V14, P74, DOI 10.1002/wps.20193; Riggio S, 2010, PSYCHIAT CLIN N AM, V33, P807, DOI 10.1016/j.psc.2010.08.004; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; ten Kate J, 2017, SOCIOL SPECTRUM, V37, P63, DOI 10.1080/02732173.2016.1274248; Todd M, 2018, AM J ORTHOPSYCHIAT, DOI [10.1037/ort000037030382727, DOI 10.1037/ORT000037030382727]; Vazquez C. I., 2014, MARIA PARADOX LATINA; Weafer J, 2014, ADDICT BEHAV, V39, P1573, DOI 10.1016/j.addbeh.2013.10.033; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900	62	13	13	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 20	2019	10								1210	10.3389/fneur.2019.01210			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JV0YS	WOS:000502094600001	31849805	Green Published, gold			2022-02-06	
J	Arun, P; Wilder, DM; Eken, O; Urioste, R; Batuure, A; Sajja, S; Van Albert, S; Wang, Y; Gist, ID; Long, JB				Arun, Peethambaran; Wilder, Donna M.; Eken, Ondine; Urioste, Rodrigo; Batuure, Andrew; Sajja, Sujith; Van Albert, Stephen; Wang, Ying; Gist, Irene D.; Long, Joseph B.			Long-Term Effects of Blast Exposure: A Functional Study in Rats Using an Advanced Blast Simulator	JOURNAL OF NEUROTRAUMA			English	Article						advanced blast simulator; blast exposure; brain injury; chronic effects; neurobehavioral functions	TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENTS; OXIDATIVE STRESS; HEAD-INJURY; MODEL; CONSEQUENCES; DEPLOYMENT; SYMPTOMS; MEMORY; IRAQ	Anecdotal observations of blast victims indicate that significant neuropathological and neurobehavioral defects may develop at later stages of life. To pre-clinically model this phenomenon, we have examined neurobehavioral changes in rats up to 1 year after exposure to single and tightly coupled repeated blasts using an advanced blast simulator. Neurobehavioral changes were monitored at acute, sub-acute, and chronic time-points using Morris water maze test of spatial learning and memory, novel object recognition test of short-term memory, open field exploratory activity as a test of anxiety/depression, a rotating pole test for vestibulomotor function, and a rotarod balance test for motor coordination. Single and repeated blasts resulted in significant functional deficits at both acute and chronic time-points. In most functional tests, rats exposed to repeated blasts performed more poorly than rats exposed to single blast. Interestingly, several functional deficits post-blast were most pronounced at 6 months and beyond. Significant neuromotor impairments occurred at early stages after blast exposure and the severity increased with repeated exposures. The novel object recognition testing revealed short-term memory deficits at 6 and 12 months post-blast. The water maze test revealed impairments at acute and chronic stages after blast exposure. The most substantial changes in the blast-exposed rats were observed with the center time and margin time legacies in the open field exploration test at 6, 9, and 12 months post-blast. Notably, these two outcome measures were minimally altered acutely, recovered during sub-acute stages, and were markedly affected during the chronic stages after blast exposures and may implicate development of chronic anxiety and depressive-like behaviors.	[Arun, Peethambaran; Wilder, Donna M.; Eken, Ondine; Urioste, Rodrigo; Batuure, Andrew; Sajja, Sujith; Van Albert, Stephen; Wang, Ying; Gist, Irene D.; Long, Joseph B.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA		Arun, P (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	peethambaran.arun.ctr@mail.mil	Sajja, Sujith/I-5289-2019	Sajja, Sujith/0000-0002-1992-9501	Military Operational Medicine Research Program at United States Army Medical Research and Materiel Command	This study was funded by the Military Operational Medicine Research Program at United States Army Medical Research and Materiel Command.	Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Arun P, 2018, NEUROCHEM INT, V112, P234, DOI 10.1016/j.neuint.2017.07.014; Arun P, 2010, J NEUROTRAUM, V27, P293, DOI 10.1089/neu.2009.0994; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; de Lanerolle NC, 2014, ANN CLIN TRANSL NEUR, V1, P692, DOI 10.1002/acn3.98; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Gardner RC, 2017, J GERONTOL A-BIOL, V72, P1233, DOI 10.1093/gerona/glw341; Graner J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00016; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kontos Anthony P, 2015, J Trauma Acute Care Surg, V79, pS146, DOI 10.1097/TA.0000000000000667; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Mattiasson GJ, 2000, J NEUROSCI METH, V95, P75, DOI 10.1016/S0165-0270(99)00162-4; Miller DR, 2017, BRAIN IMAGING BEHAV, V11, P1129, DOI 10.1007/s11682-016-9593-7; Muelbl MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28062-0; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Pagulayan K.F., 2018, BRAIN IMAGING BEHAV; Perez-Garcia G, 2019, NEUROPHARMACOLOGY, V145, P220, DOI 10.1016/j.neuropharm.2018.09.023; Perez-Garcia G, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0357-17.2018; Perez-Garcia G, 2018, BEHAV BRAIN RES, V340, P117, DOI 10.1016/j.bbr.2016.09.061; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Rich NJ, 2010, J NEUROSCI RES, V88, P2933, DOI 10.1002/jnr.22443; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Rubovitch V, 2019, J MOL NEUROSCI, V67, P613, DOI 10.1007/s12031-019-01271-6; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sajja VSSS, 2015, SHOCK, V44, P71, DOI 10.1097/SHK.0000000000000311; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Tschiffely AE, 2015, J NEUROSCI RES, V93, P1769, DOI 10.1002/jnr.23641; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vu PA, 2018, BRAIN RES, V1700, P138, DOI 10.1016/j.brainres.2018.08.034; Walker WC, 2015, BRAIN INJURY, V29, P1581, DOI 10.3109/02699052.2015.1075151; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Xie K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064907	54	13	13	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2020	37	4					647	655		10.1089/neu.2019.6591		NOV 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	KI3UL	WOS:000496152400001	31595810	Bronze			2022-02-06	
J	Shen, J; Xin, WQ; Li, QF; Gao, YL; Yuan, LL; Zhang, JN				Shen, Jun; Xin, Wenqiang; Li, Qifeng; Gao, Yalong; Yuan, Lili; Zhang, Jianning			Methylene Blue Reduces Neuronal Apoptosis and Improves Blood-Brain Barrier Integrity After Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						adenosine triphosphate; apoptosis; blood-brain barrier; methylene blue; reactive oxygen species; traumatic brain injury	ALZHEIMERS-DISEASE; MITOCHONDRIA; DAMAGE	Objective: To investigate whether methylene blue (MB) treatment can reverse neuronal mitochondrial dysfunction caused by oxygen glucose deprivation/reoxygenation (OGD) injury and then investigate whether MB treatment can reduce neuronal apoptosis and improve blood-brain barrier (BBB) integrity in traumatic brain injury (TBI) animals. Methods: Reactive oxygen species (ROS), mitochondrial membrane potential (MMP), and adenosine triphosphate (ATP) were used to evaluate mitochondrial function. The terminal deoxynucleotidyl transferase-dUTP nick end labeling (TUNEL) assay was used to assess neuronal apoptosis in vitro. TUNEL and immunofluorescence staining for neuronal nuclei (NeuN) were combined to assess neuronal apoptosis in vivo. An Evans blue (EB) permeability assay and brain water content (BWC) were used to measure BBB permeability in vivo. The Morris water maze (MWM), rotarod test, and modified Neurological Severity Score (mNSS) test were employed to assess the prognosis of TBI mice. Results: MB treatment significantly reversed neuronal mitochondrial dysfunction caused by OGD injury. Both in vitro and in vivo, MB treatment reduced neuronal apoptosis and improved BBB integrity. In TBI animals, treatment with MB not only improved cognitive and motor function caused by TBI but also significantly improved overall neurological function. Conclusions: Our findings suggest that MB is a potential candidate for the treatment of TBI. Future research should focus on other therapeutic effects and mechanisms of MB in secondary brain injury.	[Shen, Jun] Wannan Med Coll, Dept Neurosurg, Yijishan Hosp, Wuhu, Peoples R China; [Shen, Jun; Xin, Wenqiang; Li, Qifeng; Gao, Yalong; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Shen, Jun; Xin, Wenqiang; Li, Qifeng; Gao, Yalong; Zhang, Jianning] Tianjin Neurol Inst, Tianjin, Peoples R China; [Shen, Jun; Xin, Wenqiang; Li, Qifeng; Gao, Yalong; Zhang, Jianning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent, Tianjin, Peoples R China; [Yuan, Lili] Wannan Med Coll, Yijishan Hosp, Dept Neurol, Wuhu, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China.; Zhang, JN (corresponding author), Tianjin Neurol Inst, Tianjin, Peoples R China.; Zhang, JN (corresponding author), Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent, Tianjin, Peoples R China.; Yuan, LL (corresponding author), Wannan Med Coll, Yijishan Hosp, Dept Neurol, Wuhu, Peoples R China.	molly8338@126.com; jianningzhang@hotmail.com		Xin, Wenqiang/0000-0003-0231-6474	Collegiate Major Natural Science Research Projects [KJ2017A267]; (Anhui Provincial Department of Education, China)	This study was supported by grants from Collegiate Major Natural Science Research Projects (Grant No. KJ2017A267, Anhui Provincial Department of Education, China).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Arimoto-Matsuzaki K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10252; Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Atamna H, 2010, J ALZHEIMERS DIS, V20, pS439, DOI 10.3233/JAD-2010-100414; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Giannoccaro MP, 2017, MOVEMENT DISORD, V32, P346, DOI 10.1002/mds.26966; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Myers RB, 2016, CRIT CARE MED, V44, P1754, DOI 10.1097/CCM.0000000000001838; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Paban V, 2014, NEUROPHARMACOLOGY, V76, P68, DOI 10.1016/j.neuropharm.2013.06.033; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Rodriguez P, 2014, BRAIN RES, V1588, P144, DOI 10.1016/j.brainres.2014.09.007; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Scheindlin S, 2008, MOL INTERV, V8, P268, DOI 10.1124/mi.8.6.1; Serlin Y, 2015, SEMIN CELL DEV BIOL, V38, P2, DOI 10.1016/j.semcdb.2015.01.002; Shen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079833; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Tucker D, 2018, MOL NEUROBIOL, V55, P5137, DOI 10.1007/s12035-017-0712-2; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wang WX, 2017, PROG NEURO-PSYCHOPH, V73, P104, DOI 10.1016/j.pnpbp.2016.02.011; Watts LT, 2016, J NEUROTRAUM, V33, P194, DOI 10.1089/neu.2015.3904; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; Wong VS, 2016, NEUROSCI LETT, V625, P26, DOI 10.1016/j.neulet.2016.04.009; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Zhao MF, 2016, MOL MED REP, V13, P13, DOI 10.3892/mmr.2015.4551; Zhu YH, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4783602	33	13	13	3	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 8	2019	10								1133	10.3389/fneur.2019.01133			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JQ5DD	WOS:000498965200001	31787917	gold, Green Published			2022-02-06	
J	Alsalaheen, B; Johns, K; Bean, R; Almeida, A; Eckner, J; Lorincz, M				Alsalaheen, Bara; Johns, Kelly; Bean, Ryan; Almeida, Andrea; Eckner, James; Lorincz, Matthew			Women and Men Use Different Strategies to Stabilize the Head in Response to Impulsive Loads: Implications for Concussion Injury Risk	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						head injury; loading; neck; perturbation; response; stability	NECK DISABILITY INDEX; PROFESSIONAL FOOTBALL; MUSCLE-ACTIVITY; SEX-DIFFERENCES; NORMAL VALUES; IMPACTS; ONSET; BIOMECHANICS; STRENGTH; EPIDEMIOLOGY	BACKGROUND: Cervical musculoskeletal and neuromuscular attributes, which may vary between men and women, influence an individual's capacity to stabilize the head. OBJECTIVES: To examine sex differences in cervical musculoskeletal and neuromuscular attributes and their impact on head stability. The secondary objective was to examine the effects of anticipation and preload on head kinematics. METHODS: Thirty-four (20 men, 14 women) recreationally active adult athletes completed a perturbation protocol with anticipation and preloading conditions in this descriptive cross-sectional study. We assessed the neuromuscular response of the sternocleidomastoid to perturbation and head kinematics. We measured neck girth, sternocleidomastoid physiological cross-sectional area, and isometric strength. RESULTS: Women had smaller neck girth, smaller sternocleidomastoid physiological crosssectional area, and lower isometric strength than men. Women had greater baseline electromyography (EMG) amplitude and greater peak EMG response than men. There were no sex differences in sternocleidomastoid onset latency or head kinematics. Women had a greater increase in baseline EMG amplitude after preloading and anticipated conditions. Preloading attenuated sex differences in muscle onset latency. Across the sexes, there was a significant main effect of anticipation on head kinematics. CONCLUSION: Men and women used different strategies to stabilize the head, and responded differently to the preloading and anticipation conditions.	[Alsalaheen, Bara; Johns, Kelly; Bean, Ryan] Univ Michigan, Dept Phys Therapy, 2157 William S White Bldg,303 East Kearsley St, Flint, MI 48502 USA; [Alsalaheen, Bara; Almeida, Andrea; Lorincz, Matthew] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Alsalaheen, Bara; Almeida, Andrea; Eckner, James; Lorincz, Matthew] Univ Michigan, Michigan Med, Michigan NeuroSport, Ann Arbor, MI 48109 USA; [Eckner, James] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA		Alsalaheen, B (corresponding author), Univ Michigan, Dept Phys Therapy, 2157 William S White Bldg,303 East Kearsley St, Flint, MI 48502 USA.	Alsalahe@umich.edu			Dr Ben F. Bryer Foundation Medical Research Fund; University of Michigan-Flint's Research and Creative Activity Award	This project was supported by the Dr Ben F. Bryer Foundation Medical Research Fund and by the University of Michigan-Flint's Research and Creative Activity Award.	Abbink JH, 1998, J ORAL REHABIL, V25, P365; Alkjaer T, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.99; Almosnino S., 2009, THESIS; Almosnino S, 2009, BMC SPORTS SCI MED R, V1, DOI 10.1186/1758-2555-1-22; Alsalaheen B, 2018, J ELECTROMYOGR KINES, V39, P70, DOI 10.1016/j.jelekin.2018.01.011; [Anonymous], 2017, PLUG IN GAIT REF GUI; Arts IMP, 2010, MUSCLE NERVE, V41, P32, DOI 10.1002/mus.21458; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Coolbaugh CL, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00195; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Debison-Larabie C., 2016, THESIS; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Falla D, 2002, EUR J APPL PHYSIOL, V87, P542, DOI 10.1007/s00421-002-0661-x; Gallagher V, 2018, J NEUROTRAUM, V35, P1242, DOI 10.1089/neu.2017.5453; Hamill J., 2014, RES METHODS BIOMECHA, P35; Hernandez IA, 2006, EUR SPINE J, V15, P876, DOI 10.1007/s00586-005-0956-9; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0921-884X(96)95190-5; Hrysomallis C, 2016, SPORTS MED, V46, P1111, DOI 10.1007/s40279-016-0490-4; Javanshir K, 2011, J BODYW MOV THER, V15, P50, DOI 10.1016/j.jbmt.2009.07.005; Keshwani N, 2015, J ORTHOP SPORT PHYS, V45, P808, DOI 10.2519/jospt.2015.6143; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lauer RT, 2009, ANN BIOMED ENG, V37, P1584, DOI 10.1007/s10439-009-9727-9; Le Flao E, 2018, SPORTS MED, V48, P2641, DOI 10.1007/s40279-018-0984-3; Li XY, 2007, ANN BIOMED ENG, V35, P1532, DOI 10.1007/s10439-007-9320-z; MacDermid JC, 2009, J ORTHOP SPORT PHYS, V39, P400, DOI 10.2519/jospt.2009.2930; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Netto Kevin J, 2006, Work, V26, P123; Noraxon USA Inc, 2014, TELEMYO DESKT DTS SY; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rankin G, 2005, MANUAL THER, V10, P108, DOI 10.1016/j.math.2004.08.004; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Simoneau M, 2008, J BIOMECH, V41, P2097, DOI 10.1016/j.jbiomech.2008.05.002; Solnik S, 2008, ACTA BIOENG BIOMECH, V10, P65; Stemper BD, 2006, SPINE, V31, pE733, DOI 10.1097/01.brs.0000240210.23617.e7; Stevens Sean T, 2008, Res Sports Med, V16, P68, DOI 10.1080/15438620701879020; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Zheng LY, 2013, J BIOMECH, V46, P899, DOI 10.1016/j.jbiomech.2012.12.018	49	13	13	3	7	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	NOV	2019	49	11					779	786		10.2519/jospt.2019.8760			8	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Sport Sciences	JJ1VP	WOS:000493950100003	31092121				2022-02-06	
J	Dellazizzo, L; Demers, SP; Charbonney, E; Williams, V; Serri, K; Albert, M; Giguere, JF; Laroche, M; Williamson, D; Bernard, F				Dellazizzo, Laura; Demers, Simon-Pierre; Charbonney, Emmanuel; Williams, Virginie; Serri, Karim; Albert, Martin; Giguere, Jean-Francois; Laroche, Mathieu; Williamson, David; Bernard, Francis			Minimal PaO2 threshold after traumatic brain injury and clinical utility of a novel brain oxygenation ratio	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; oxygen; disease management; intracranial pressure; multimodal treatment	CEREBRAL PERFUSION-PRESSURE; CARDIAC-ARREST; HYPEROXIA; METABOLISM; THERAPY; TENSION; DIFFUSION; OUTCOMES; VASOREACTIVITY; AUTOREGULATION	OBJECTIVE Avoiding decreases in brain tissue oxygenation (PbtO(2)) after traumatic brain injury (TBI) is important. How best to adjust PbtO(2) remains unclear. The authors investigated the association between partial pressure of oxygen (PaO2) and PbtO(2) to determine the minimal PaO2 required to maintain PbtO(2) above the hypoxic threshold (> 20 mm Hg), accounting for other determinants of PbtO(2) and repeated measurements in the same patient. They also explored the clinical utility of a novel concept, the brain oxygenation ratio (BOx ratio = PbtO(2)/PaO2) to detect overtreatment with the fraction of inspired oxygen (FiO(2)). METHODS A retrospective cohort study at an academic level 1 trauma center included 38 TBI patients who required the insertion of a monitor to measure PbtO(2). Various determinants of PbtO(2) were collected simultaneously whenever a routine arterial blood gas was drawn. A PbtO(2)/PaO2 ratio was calculated for each blood gas and plotted over time for each patient. All patients were managed according to a standardized clinical protocol. A mixed effects model was used to account for repeated measurements in the same patient. RESULTS A total of 1006 data points were collected. The lowest mean PaO2 observed to maintain PbtO(2) above the ischemic threshold was 94 mm Hg. Only PaO2 and cerebral perfusion pressure were predictive of PbtO(2) in multivariate analysis. The PbtO(2)/PaO2 ratio was below 0.15 in 41.7% of all measures and normal PbtO(2) values present despite an abnormal ratio in 27.1% of measurements. CONCLUSIONS The authors' results suggest that the minimal PaO2 target to ensure adequate cerebral oxygenation during the first few days after TBI should be higher than that suggested in the Brain Trauma Foundation guidelines. The use of a PbtO(2)/PaO2 ratio (BOx ratio) may be clinically useful and identifies abnormal O-2 delivery mechanisms (cerebral blood flow, diffusion, and cerebral metabolic rate of oxygen) despite normal PbtO(2).	[Dellazizzo, Laura] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Demers, Simon-Pierre; Charbonney, Emmanuel; Serri, Karim; Albert, Martin; Bernard, Francis] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Albert, Martin; Giguere, Jean-Francois; Laroche, Mathieu; Williamson, David] Univ Montreal, Dept Neurosurg, Montreal, PQ, Canada; [Albert, Martin] Univ Montreal, Dept Pharm, Montreal, PQ, Canada; [Dellazizzo, Laura; Demers, Simon-Pierre; Charbonney, Emmanuel; Williams, Virginie; Serri, Karim; Albert, Martin; Giguere, Jean-Francois; Laroche, Mathieu; Williamson, David; Bernard, Francis] Hop Sacre Coeur Montreal, Dept Crit Care, Ctr Integre Univ Sante & Serv Sociaux CIUSSS Nord, Montreal, PQ, Canada		Bernard, F (corresponding author), Hop Sacre Coeur Montreal, Montreal, PQ, Canada.	f.bernard@umontreal.ca					Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Bardt TF, 1998, ACT NEUR S, V71, P153; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Elmer J, 2015, INTENS CARE MED, V41, P49, DOI 10.1007/s00134-014-3555-6; Floyd TF, 2003, J APPL PHYSIOL, V95, P2453, DOI 10.1152/japplphysiol.00303.2003; Gracias VH, 2004, J TRAUMA, V56, P469, DOI 10.1097/01.TA.0000114274.95423.C0; Habler OP, 1997, TRANSFUS SCI, V18, P425, DOI 10.1016/S0955-3886(97)00041-6; Hazelton JL, 2010, J NEUROTRAUM, V27, P753, DOI 10.1089/neu.2009.1186; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Johnston AJ, 2003, BRIT J ANAESTH, V90, P774, DOI 10.1093/bja/aeg104; Kilgannon JH, 2011, CIRCULATION, V123, P2717, DOI 10.1161/CIRCULATIONAHA.110.001016; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; McCarthy MC, 2009, SURGERY, V146, P585, DOI 10.1016/j.surg.2009.06.059; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reinert M, 2004, J NEUROSURG, V101, P323, DOI 10.3171/jns.2004.101.2.0323; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Wang CH, 2014, RESUSCITATION, V85, P1142, DOI 10.1016/j.resuscitation.2014.05.021; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Youn CS, 2018, CRIT CARE MED, V46, pE279, DOI 10.1097/CCM.0000000000002935; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	45	13	13	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2019	131	5					1639	1647		10.3171/2018.5.JNS18651			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JJ2EE	WOS:000493973300037	30485198	Bronze			2022-02-06	
J	Hameed, MQ; Hsieh, TH; Morales-Quezada, L; Lee, HHC; Damar, U; MacMullin, PC; Hensch, TK; Rotenberg, A				Hameed, Mustafa Q.; Hsieh, Tsung-Hsun; Morales-Quezada, Leon; Lee, Henry H. C.; Damar, Ugur; MacMullin, Paul C.; Hensch, Takao K.; Rotenberg, Alexander			Ceftriaxone Treatment Preserves Cortical Inhibitory Interneuron Function via Transient Salvage of GLT-1 in a Rat Traumatic Brain Injury Model	CEREBRAL CORTEX			English	Article						ceftriaxone; GLT-1; intracortical inhibition; parvalbumin; traumatic brain injury	GLIAL GLUTAMATE TRANSPORTER; FLUID-PERCUSSION INJURY; TRANSCRANIAL MAGNETIC STIMULATION; POSTTRAUMATIC EPILEPSY; OXIDATIVE STRESS; NEUROTROPHIC FACTOR; NETWORK ACTIVITY; ANIMAL-MODELS; PLASTICITY; EXCITOTOXICITY	Traumatic brain injury (TBI) results in a decrease in glutamate transporter-1 (GLT-1) expression, the major mechanism for glutamate removal from synapses. Coupled with an increase in glutamate release from dead and dying neurons, this causes an increase in extracellular glutamate. The ensuing glutamate excitotoxicity disproportionately damages vulnerable GABAergic parvalbumin-positive inhibitory interneurons, resulting in a progressively worsening cortical excitatory:inhibitory imbalance due to a loss of GABAergic inhibitory tone, as evidenced by chronic post-traumatic symptoms such as epilepsy, and supported by neuropathologic findings. This loss of intracortical inhibition can be measured and followed noninvasively using long-interval paired-pulse transcranial magnetic stimulation with mechanomyography (LI-ppTMS-MMG). Ceftriaxone, a beta-lactam antibiotic, is a potent stimulator of the expression of rodent GLT-1 and would presumably decrease excitotoxic damage to GABAergic interneurons. It may thus be a viable antiepileptogenic intervention. Using a rat fluid percussion injury TBI model, we utilized LI-ppTMS-MMG, quantitative PCR, and immunohistochemistry to test whether ceftriaxone treatment preserves intracortical inhibition and cortical parvalbumin-positive inhibitory interneuron function after TBI in rat motor cortex. We show that neocortical GLT-1 gene and protein expression are significantly reduced 1 week after TBI, and this transient loss is mitigated by ceftriaxone. Importantly, whereas intracortical inhibition declines progressively after TBI, 1 week of post-TBI ceftriaxone treatment attenuates the loss of inhibition compared to saline-treated controls. This finding is accompanied by significantly higher parvalbumin gene and protein expression in ceftriaxone-treated injured rats. Our results highlight prospects for ceftriaxone as an intervention after TBI to prevent cortical inhibitory interneuron dysfunction, partly by preserving GLT-1 expression.	[Hameed, Mustafa Q.; Hsieh, Tsung-Hsun; Damar, Ugur; MacMullin, Paul C.; Rotenberg, Alexander] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Div Epilepsy & Clin Neurophysiol,Neuromodulat Pro, Boston, MA 02115 USA; [Hameed, Mustafa Q.; Lee, Henry H. C.; Damar, Ugur; MacMullin, Paul C.; Hensch, Takao K.; Rotenberg, Alexander] Harvard Med Sch, FM Kirby Neurobiol Ctr, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Hameed, Mustafa Q.] Harvard Med Sch, Boston Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Dept Phys Therapy, Taoyuan 33302, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Grad Inst Rehabil Sci, Taoyuan 33302, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Mem Hosp, Neurosci Res Ctr, Linkou Med Ctr, Taoyuan 33302, Taiwan; [Morales-Quezada, Leon] Harvard Med Sch, Spaulding Neuromodulat Ctr, Spaulding Rehabil Hosp, Charlestown, MA 02129 USA; [Hensch, Takao K.] Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA		Rotenberg, A (corresponding author), Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA.	alexander.rotenberg@childrens.harvard.edu	Hsieh, Tung-Hsun/AAZ-5010-2020	Hsieh, Tung-Hsun/0000-0002-1794-7941	National Institute of Neurological Disorders and Stroke at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS088583]; Boston Children's Hospital Translational Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088583] Funding Source: NIH RePORTER	The National Institute of Neurological Disorders and Stroke at the National Institutes of Health (grant number: 1R01NS088583 to A.R.) and the Boston Children's Hospital Translational Research Program to A.R. No competing financial interests exist for any of the authors.	Al-Otaibi F., 2012, EPILEPSY RES TREAT, V2012; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Anthonymuthu TS, 2018, FREE RADICAL BIO MED, V124, P493, DOI 10.1016/j.freeradbiomed.2018.06.031; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Baldelli P, 2005, J NEUROSCI, V25, P3358, DOI 10.1523/JNEUROSCI.4227-04.2005; Bar-Klein G, 2016, ANN NEUROL, V80, P896, DOI 10.1002/ana.24804; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; BONDY SC, 1993, FREE RADICAL BIO MED, V14, P633, DOI 10.1016/0891-5849(93)90144-J; Boston-Howes W, 2006, J BIOL CHEM, V281, P14076, DOI 10.1074/jbc.M600653200; Botchway EN, 2019, J NEUROTRAUM, V36, P669, DOI 10.1089/neu.2018.5743; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Cammarota M, 2013, J PHYSIOL-LONDON, V591, P807, DOI 10.1113/jphysiol.2012.238154; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Choo AM, 2012, NEUROCHEM INT, V60, P506, DOI 10.1016/j.neuint.2012.02.007; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Conti AC, 1998, J NEUROSCI, V18, P5663; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; CROLL SD, 1994, EUR J NEUROSCI, V6, P1343, DOI 10.1111/j.1460-9568.1994.tb00325.x; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Curia G, 2011, CEREB CORTEX, V21, P1574, DOI 10.1093/cercor/bhq218; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; David Y, 2009, J NEUROSCI, V29, P10588, DOI 10.1523/JNEUROSCI.2323-09.2009; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; DeGrauw X, 2018, EPILEPSY RES, V146, P41, DOI 10.1016/j.eplepsyres.2018.07.012; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Dorsett CR, 2017, J NEUROTRAUM, V34, P220, DOI 10.1089/neu.2015.4372; Elliott JE, 2018, J CLIN SLEEP MED, V14, P1177, DOI 10.5664/jcsm.7220; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Gu F, 2017, NEUROBIOL DIS, V108, P100, DOI 10.1016/j.nbd.2017.08.008; Hall ED, 2018, NEUROPHARMACOLOGY; Hameed MQ, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0719-0; Hameed MQ, 2014, NEUROREPORT, V25, P532, DOI 10.1097/WNR.0000000000000132; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hsieh TH, 2017, CEREB CORTEX, V27, P5509, DOI 10.1093/cercor/bhw318; Hsieh TH, 2012, J NEUROPHYSIOL, V107, P966, DOI 10.1152/jn.00690.2011; Ishikawa M, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/528940; Jagadapillai R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100230; Kalmbach DA, 2018, SLEEP, V1, P41; Kann O, 2016, NEUROBIOL DIS, V90, P75, DOI 10.1016/j.nbd.2015.08.005; Kelsom C, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-19; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Kohara K, 2007, J NEUROSCI, V27, P7234, DOI 10.1523/JNEUROSCI.1943-07.2007; Krzyzanowska W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186243; Kumar RG, 2018, J NEUROTRAUMA; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; LaRiviere MJ, 2016, FRONT SURG, V3, DOI 10.3389/fsurg.2016.00064; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Lewerenz J, 2006, J NEUROCHEM, V98, P916, DOI 10.1111/j.1471-4159.2006.03921.x; Lewerenz J, 2009, J NEUROCHEM, V111, P332, DOI 10.1111/j.1471-4159.2009.06347.x; Li B, 2002, NAT NEUROSCI, V5, P833, DOI 10.1038/nn912; Luo Chun, 2002, Chin J Traumatol, V5, P24; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; Marty S, 1997, TRENDS NEUROSCI, V20, P198, DOI 10.1016/S0166-2236(96)01026-0; McIntosh TK, 1996, LAB INVEST, V74, P315; Miyazaki S, 1989, INTRACRANIAL PRESSUR, P651; Moga D, 2002, J CHEM NEUROANAT, V23, P249, DOI 10.1016/S0891-0618(02)00012-1; Nakagawa T, 2008, EUR J NEUROSCI, V28, P1719, DOI 10.1111/j.1460-9568.2008.06494.x; Nguyen TP, 2018, J ALZHEIMERS DIS, V66, P717, DOI 10.3233/JAD-180586; Patel TP, 2014, J NEUROSCI, V34, P4200, DOI 10.1523/JNEUROSCI.4172-13.2014; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Petr GT, 2015, J NEUROSCI, V35, P5187, DOI 10.1523/JNEUROSCI.4255-14.2015; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rao VLR, 2001, EUR J NEUROSCI, V13, P119, DOI 10.1046/j.1460-9568.2001.01367.x; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Sahara S, 2012, J NEUROSCI, V32, P4755, DOI 10.1523/JNEUROSCI.6412-11.2012; Schousboe A, 2005, NEUROTOX RES, V8, P221, DOI 10.1007/BF03033975; Schwaller B, 2004, MOL CELL NEUROSCI, V25, P650, DOI 10.1016/j.mcn.2003.12.006; Smith D, 2018, EPILEPSY RES, V147, P87, DOI 10.1016/j.eplepsyres.2018.09.005; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Takahashi M, 1997, J EXP BIOL, V200, P401; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tikhonova MA, 2017, BEHAV BRAIN RES, V330, P8, DOI 10.1016/j.bbr.2017.05.002; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Vascak M, 2018, CEREB CORTEX, V28, P1625, DOI 10.1093/cercor/bhx058; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wood RL, 2017, BRAIN INJURY, V31, P1270, DOI 10.1080/02699052.2017.1332387; Wright MJ, 2014, J CLIN EXP NEUROPSYC, V36, P268, DOI 10.1080/13803395.2014.884543; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yamamoto T, 1999, ACT NEUR S, V75, P17; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yi JH, 2005, GLIA, V49, P121, DOI 10.1002/glia.20099; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190; Zhuang Z, 2018, ACS CHEM NEUROSCI; Zumkehr J, 2015, NEUROBIOL AGING, V36, P2260, DOI 10.1016/j.neurobiolaging.2015.04.005	103	13	14	0	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	NOV	2019	29	11					4506	4518		10.1093/cercor/bhy328			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KB9NI	WOS:000506813700003	30590449	Green Published			2022-02-06	
J	Wright, DK; Brady, RD; Kamnaksh, A; Trezise, J; Sun, M; McDonald, SJ; Mychasiuk, R; Kolbe, SC; Law, M; Johnston, LA; O'Brien, TJ; Agoston, DV; Shultz, SR				Wright, David K.; Brady, Rhys D.; Kamnaksh, Alaa; Trezise, Jack; Sun, Mujun; McDonald, Stuart J.; Mychasiuk, Richelle; Kolbe, Scott C.; Law, Meng; Johnston, Leigh A.; O'Brien, Terence J.; Agoston, Denes V.; Shultz, Sandy R.			Repeated mild traumatic brain injuries induce persistent changes in plasma protein and magnetic resonance imaging biomarkers in the rat	SCIENTIFIC REPORTS			English	Article							ENDOTHELIAL GROWTH-FACTOR; FLUID PERCUSSION INJURY; HYPERPHOSPHORYLATED TAU; SODIUM SELENATE; ANIMAL-MODEL; CERULOPLASMIN; CONCUSSION; IRON; NEUROGENESIS; ANGIOGENESIS	A single mild traumatic brain injury (mTBI) typically causes only transient symptoms, but repeated mTBI (RmTBI) is associated with cumulative and chronic neurological abnormalities. Clinical management of mTBI is challenging due to the heterogeneous, subjective and transient nature of symptoms, and thus would be aided by objective biomarkers. Promising biomarkers including advanced magnetic resonance imaging (MRI) and plasma levels of select proteins were examined here in a rat model of RmTBI. Rats received either two mild fluid percussion or sham injuries administered five days apart. Rats underwent MRI and behavioral testing 1, 3, 5, 7, and 30 days after the second injury and blood samples were collected on days 1, 7, and 30. Structural and diffusion-weighted MRI revealed that RmTBI rats had abnormalities in the cortex and corpus callosum. Proteomic analysis of plasma found that RmTBI rats had abnormalities in markers indicating axonal and vascular injury, metabolic and mitochondrial dysfunction, and glial reactivity. These changes occurred in the presence of ongoing cognitive and sensorimotor deficits in the RmTBI rats. Our findings demonstrate that RmTBI can result in chronic neurological abnormalities, provide insight into potential contributing pathophysiological mechanisms, and supports the use of MRI and plasma protein measures as RmTBI biomarkers.	[Wright, David K.; Brady, Rhys D.; Sun, Mujun; McDonald, Stuart J.; Mychasiuk, Richelle; Kolbe, Scott C.; Law, Meng; O'Brien, Terence J.; Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic 3004, Australia; [Wright, David K.; Johnston, Leigh A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3052, Australia; [Brady, Rhys D.; Trezise, Jack; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3052, Australia; [Kamnaksh, Alaa; Agoston, Denes V.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Johnston, Leigh A.] Univ Melbourne, Dept Biomed Engn, Melbourne, Vic 3052, Australia		Shultz, SR (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic 3004, Australia.; Shultz, SR (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3052, Australia.	sandy.shultz@monash.edu	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	O'Brien, Terence/0000-0002-7198-8621; Wright, David/0000-0002-7535-8651; Sun, Mujun/0000-0002-9923-9913; McDonald, Stuart/0000-0001-5190-3179			Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Aungst S. L., 2014, J CEREB BLOOD FLOW M, V34; Ayton S, 2014, FREE RADICAL BIO MED, V69, P331, DOI 10.1016/j.freeradbiomed.2014.01.041; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bitsch A, 2002, EUR NEUROL, V47, P45, DOI 10.1159/000047946; Brady RD, 2016, J NEUROTRAUM, V33, P2154, DOI 10.1089/neu.2014.3836; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Costello DM, 2018, J CLIN NEUROSCI, V56, P1, DOI 10.1016/j.jocn.2018.07.002; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Dash PK, 2010, J NEUROSCI RES, V88, P1719, DOI 10.1002/jnr.22336; DeGiorgio CM, 1996, EPILEPSIA, V37, P606, DOI 10.1111/j.1528-1157.1996.tb00623.x; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Lee C, 2009, EXP NEUROL, V220, P400, DOI 10.1016/j.expneurol.2009.08.019; Lee WC, 2012, BIOCHEM BIOPH RES CO, V425, P842, DOI 10.1016/j.bbrc.2012.08.002; Lehman EJ, 2012, NEUROLOGY; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Mustafi S. M., 2017, J NEUROTRAUMA; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Pannek K, 2011, NEUROIMAGE, V55, P133, DOI 10.1016/j.neuroimage.2010.12.010; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Pham L, 2019, J NEUROTRAUM, V36, P2260, DOI 10.1089/neu.2018.6169; Pianta S., 2019, NEUROMOLECULAR MED, V1; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Potts Mathew B, 2006, NeuroRx, V3, P143; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; ROESER HP, 1970, J CLIN INVEST, V49, P2408, DOI 10.1172/JCI106460; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schulte S, 2014, J ATHL TRAINING, V49, P830, DOI 10.4085/1062-6050-49.3.33; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Sheoran A, 2017, PROCEEDINGS OF THE 2017 WORKSHOP ON HOT TOPICS IN CONTAINER NETWORKING AND NETWORKED SYSTEMS (HOTCONNET 17), P12, DOI 10.1145/3094405.3094408; Shetty T, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00836; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Thau-Zuchman O, 2012, NEUROSCIENCE, V202, P334, DOI 10.1016/j.neuroscience.2011.11.071; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; Ward R, 2014, LANCET NEUROL, V13, P1045, DOI 10.1016/S1474-4422(14)70117-6; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wortman RC, 2018, ANN CLIN TRANSL NEUR, V5, P1588, DOI 10.1002/acn3.667; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298	73	13	13	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 10	2019	9								14626	10.1038/s41598-019-51267-w			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JC8WG	WOS:000489556200004	31602002	Green Published, gold			2022-02-06	
J	Campolettano, ET; Rowson, S; Duma, SM; Stemper, B; Shah, A; Harezlak, J; Riggen, LD; Mihalik, J; Brooks, A; Cameron, K; Giza, CC; McAllister, T; Broglio, SP; McCrea, M				Campolettano, Eamon T.; Rowson, Steven; Duma, Stefan M.; Stemper, Brian; Shah, Alok; Harezlak, Jaroslaw; Riggen, Larry D.; Mihalik, Jason; Brooks, Alison; Cameron, Kenneth; Giza, Christoper C.; McAllister, Thomas; Broglio, Steven P.; McCrea, Michael			Factors Affecting Head Impact Exposure in College Football Practices: A Multi-Institutional Study	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Brain injury; Biomechanics	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; UNITED-STATES; PLAYERS; CONCUSSION; EPIDEMIOLOGY; ACCELERATIONS; BIOMECHANICS; MAGNITUDE; SEASON	Biomechanical data collected from head impacts in football have been used to characterize exposure and predict injury risk. This study sought to specifically quantify the factors that contribute towards player head impact exposure in college football practices. All players included in this study were outfitted with football helmets instrumented with accelerometer arrays (Head Impact Telemetry System). Head impact exposure was defined by the number of head impacts each player experienced in practice, the number of practice head impacts normalized by the number of practice sessions (practice head impact rate), and the 95th percentile linear and rotational resultant head impact accelerations. Practice head impact rate was observed to vary significantly with player position (p < 0.0001; eta(2) = 0.46), team (p = 0.0016; eta(2) = 0.03), and the number of game impacts (p < 0.0001; eta(2) = 0.03), which served as a correlate for player ability. Even after controlling for practice participation, player position, team, and ability, differences between individuals accounted for 48% of the variance in head impact exposure in practice. This work demonstrates the importance of considering head impact exposure on a subject-specific basis rather than estimating head impact exposure from aggregate data.	[Campolettano, Eamon T.; Rowson, Steven; Duma, Stefan M.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [Stemper, Brian; Shah, Alok; McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Harezlak, Jaroslaw; Riggen, Larry D.] Indiana Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Bloomington, IN USA; [Mihalik, Jason] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Brooks, Alison] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped, Madison, WI USA; [Cameron, Kenneth] US Mil Acad, John A Feagin Jr Sports Med Fellowship, Keller Army Hosp, West Point, NY USA; [Giza, Christoper C.] Univ Calif Los Angeles, David Geffen Sch Med, Steve Tisch BrainSPORT Program, Dept Neurosurg, Los Angeles, CA 90095 USA; [Giza, Christoper C.] Univ Calif Los Angeles, David Geffen Sch Med, Steve Tisch BrainSPORT Program, Dept Pediat, Los Angeles, CA 90095 USA; [McAllister, Thomas] Indiana Sch Med, Dept Psychiat, Indianapolis, IN USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA		Campolettano, ET (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.	eamonc@vt.edu	Stemper, Brian/AAX-7611-2020; Rowson, Steven/B-1270-2012; Harezlak, Jaroslaw/P-8557-2014	Rowson, Steven/0000-0002-3227-0596; Harezlak, Jaroslaw/0000-0002-3070-7686	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - Department of Defense (DoD); U.S. Army Medical Research Acquisition Activity; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This investigation was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DoD). The U.S. Army Medical Research Acquisition Activity is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (DHP funds). The authors thank the following investigators: Christopher Giza and John DiFiori (University of California Los Angeles), Kevin Guskiewicz (University of North Carolina at Chapel Hill), Darren Campbell and Gerald McGinty (United States Air Force Academy), and Steven Svoboda (United States Military Academy). The authors thank the on-field HITS operators at each site: Julia Ford and Corey Rodrigo (University of North Carolina at Chapel Hill), Gus Hendricks and Max Zeiger (University of California Los Angeles [UCLA]), Quinn Lukens (University of Wisconsin), Brett Griesemer (Virginia Tech), Dom Calhoun (Air Force), and Sean Roach (West Point).	Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Cobb B. R, 2015, THESIS; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dick R, 2007, J ATHL TRAINING, V42, P221; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P789, DOI 10.2307/2287160; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoffman J. R, 2008, SPORTS SCI EXCHANGE, V28, P1; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Moon D W, 1971, Med Sci Sports, V3, P44; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Reid S E, 1974, J Sports Med, V2, P86; REID SE, 1971, SURG GYNECOL OBSTETR, V133, P929; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003	39	13	13	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2019	47	10			SI		2086	2093		10.1007/s10439-019-02309-x			8	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	JQ0HT	WOS:000498636800005	31240507				2022-02-06	
J	Harper, MM; Woll, AW; Evans, LP; Delcau, M; Akurathi, A; Hedberg-Buenz, A; Soukup, DA; Boehme, N; Hefti, MM; Dutca, LM; Anderson, MG; Bassuk, AG				Harper, Matthew M.; Woll, Addison W.; Evans, Lucy P.; Delcau, Michael; Akurathi, Abhigna; Hedberg-Buenz, Adam; Soukup, Dana A.; Boehme, Nickolas; Hefti, Marco M.; Dutca, Laura M.; Anderson, Michael G.; Bassuk, Alexander G.			Blast Preconditioning Protects Retinal Ganglion Cells and Reveals Targets for Prevention of Neurodegeneration Following Blast-Mediated Traumatic Brian Injury	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						blast TBI; brain injury; neuroprotection; retinal ganglion cell; kyneurinine-3-monooxygenase	LOW-LEVEL BLAST; BRAIN-INJURY; MOUSE MODEL; RODENT MODEL; KYNURENINE PATHWAY; AXONAL INJURY; EXPOSURE; VULNERABILITY; VETERANS; IRAQ	PURPOSE. The purpose of this study was to examine the effect of multiple blast exposures and blast preconditioning on the structure and function of retinal ganglion cells (RGCs), to identify molecular pathways that contribute to RGC loss, and to evaluate the role of kynurenine-3-monooxygenase (KMO) inhibition on RGC structure and function. METHODS. Mice were subjected to sham blast injury, one single blast injury, or three blast injuries separated by either 1 hour or 1 week, using a blast intensity of 20 PSI. To examine the effect of blast preconditioning, mice were subjected to sham blast injury, one single 20-PSI injury, or three blast injuries separated by 1 week (5 PSI, 5 PSI, 20 PSI and 5 PSI, 5 PSI, 5 PSI). RGC structure was analyzed by optical coherence tomography (OCT) and function was analyzed by the pattern electroretinogram (PERG). BRN3A-positive cells were quantified to determine RGC density. RNA-seq analysis was used to identify transcriptional changes between groups. RESULTS. Analysis of mice with multiple blast exposures of 20 PSI revealed no significant differences compared to one 20-pounds per square inch (PSI) exposure using OCT, PERG, or BRN3A cell counts. Analysis of mice exposed to two preconditioning 5-PSI blasts prior to one 20-PSI blast showed preservation of RGC structure and function. RNA-seq analysis of the retina identified multiple transcriptomic changes between conditions. Pharmacologic inhibition of KMO preserved RGC responses compared to vehicle-treated mice. CONCLUSIONS. Preconditioning protects RGC from blast injury. Protective effects appear to involve changes in KMO activity, whose inhibition is also protective.	[Harper, Matthew M.; Woll, Addison W.; Delcau, Michael; Akurathi, Abhigna; Hedberg-Buenz, Adam; Boehme, Nickolas; Dutca, Laura M.; Anderson, Michael G.] Iowa City Dept Vet Affairs, Med Ctr, Ctr Prevent & Treatment Visual Loss, Iowa City, IA USA; [Harper, Matthew M.; Woll, Addison W.; Delcau, Michael; Boehme, Nickolas; Dutca, Laura M.; Anderson, Michael G.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52772 USA; [Evans, Lucy P.] Univ Iowa, Med Scientist Training Program, Iowa City, IA 52772 USA; [Evans, Lucy P.; Bassuk, Alexander G.] Univ Iowa, Dept Pediat, Iowa City, IA 52772 USA; [Hedberg-Buenz, Adam; Soukup, Dana A.; Anderson, Michael G.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52772 USA; [Hefti, Marco M.] Univ Iowa, Dept Pathol, Iowa City, IA 52772 USA; [Bassuk, Alexander G.] Univ Iowa, Dept Neurol, Iowa City, IA 52772 USA		Harper, MM (corresponding author), Univ Iowa, Ctr Prevent & Treatment Visual Loss, Dept Vet Affairs, Dept Ophthalmol & Visual Sci, 601 Highway 6 West, Iowa City, IA 52772 USA.	matthew-harper@uiowa.edu	; Anderson, Michael/B-4580-2009	Hefti, Marco/0000-0002-3127-4528; Harper, Matthew/0000-0003-3395-2406; Bassuk, Alexander/0000-0002-4067-2157; Anderson, Michael/0000-0001-5730-6105	Department of Veterans AffairsUS Department of Veterans Affairs [RX000952]; Department of DefenseUnited States Department of Defense [W81XWH-14-1-0583]; Iowa City VA Center for the Prevention and Treatment of Visual Loss; U.S. Department of Veterans Affairs Rehabilitation Research and Development (Rehab. RD) ServiceUS Department of Veterans Affairs [IK2-RX002003]; University of Iowa Carver College of Medicine;  [T32 DK112751-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T32DK112751] Funding Source: NIH RePORTER	Supported by the Department of Veterans Affairs (RX000952); the Department of Defense (W81XWH-14-1-0583); the Iowa City VA Center for the Prevention and Treatment of Visual Loss; Career Development/Capacity Building Award IK2-RX002003 from the U.S. Department of Veterans Affairs Rehabilitation Research and Development (Rehab. R&D) Service (LMD); Training Grant T32 DK112751-01 (AH-B). The RNA-seq were obtained at the Genomics Division of the Iowa Institute of Human Genetics, which is supported, in part, by the University of Iowa Carver College of Medicine. The authors alone are responsible for the content and writing of the paper.	Abdel-Magid AF, 2015, ACS MED CHEM LETT, V6, P954, DOI 10.1021/acsmedchemlett.5b00274; Allen RS, 2018, J NEUROTRAUM, V35, P2104, DOI 10.1089/neu.2017.5394; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arun P, 2018, NEUROCHEM INT, V112, P234, DOI 10.1016/j.neuint.2017.07.014; Arun P, 2013, J NEUROTRAUM, V30, P1645, DOI 10.1089/neu.2012.2834; Badea A, 2018, NEUROIMAGE-CLIN, V18, P60, DOI 10.1016/j.nicl.2018.01.007; Bailoor S, 2015, BIOMECH MODEL MECHAN, V14, P1227, DOI 10.1007/s10237-015-0667-z; Bandak F A, 2015, Handb Clin Neurol, V127, P89, DOI 10.1016/B978-0-444-52892-6.00006-4; Baruzzo G, 2017, NAT METHODS, V14, P135, DOI [10.1038/NMETH.4106, 10.1038/nmeth.4106]; Basalay MV, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0684-z; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bjork JM, 2016, PSYCHIAT RES, V246, P321, DOI 10.1016/j.psychres.2016.10.008; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Bugay V, 2020, J NEUROTRAUM, V37, P248, DOI 10.1089/neu.2018.6333; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Capo-Aponte JE, 2017, OPTOMETRY VISION SCI, V94, P7, DOI 10.1097/OPX.0000000000000825; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chen G, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00040; Cho RI, 2009, J TRAUMA, V67, P516, DOI 10.1097/TA.0b013e3181a5f08d; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; Chou TH, 2014, INVEST OPHTH VIS SCI, V55, P2469, DOI 10.1167/iovs.14-13943; Couch JR, 2016, HEADACHE, V56, P1004, DOI 10.1111/head.12837; Davis I, 2015, EXPERT REV NEUROTHER, V15, P719, DOI 10.1586/14737175.2015.1049999; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Effgen GB, 2016, J NEUROTRAUM, V33, P1901, DOI 10.1089/neu.2015.4327; Eftaxiopoulou T, 2016, INJURY, V47, P625, DOI 10.1016/j.injury.2016.01.017; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Garrison AM, 2018, PSYCHONEUROENDOCRINO, V94, P1, DOI 10.1016/j.psyneuen.2018.04.019; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hedberg-Buenz A, 2016, EXP EYE RES, V146, P386, DOI 10.1016/j.exer.2015.07.020; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Hoffman GE, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1323-z; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Ikonomovic MD, 2017, AGEING RES REV, V34, P51, DOI 10.1016/j.arr.2016.11.003; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kawoos U, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00650; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Laksari K, 2014, J MECH BEHAV BIOMED, V32, P132, DOI 10.1016/j.jmbbm.2013.12.021; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lemke S, 2016, OPHTHALMOLOGY, V123, P415, DOI 10.1016/j.ophtha.2015.10.003; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Mohan K, 2012, VET OPHTHALMOL, V15, P94, DOI 10.1111/j.1463-5224.2012.01034.x; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Notghi B, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037072; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Rhea CK, 2017, MIL MED, V182, P147, DOI 10.7205/MILMED-D-16-00140; Ryan-Gonzalez C, 2019, J NEUROTRAUM, V36, P1584, DOI 10.1089/neu.2017.5590; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; Shedd DE, 2018, INVEST OPHTH VIS SCI, V59, P349, DOI 10.1167/iovs.17-21530; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Song HL, 2018, BEHAV BRAIN RES, V347, P148, DOI 10.1016/j.bbr.2018.03.007; Sullivan DR, 2018, J INT NEUROPSYCH SOC, V24, P662, DOI 10.1017/S1355617718000279; Swan AA, 2018, BRAIN INJURY, V32, P1197, DOI 10.1080/02699052.2018.1495340; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Townsend MT, 2019, ANN BIOMED ENG, V47, P2019, DOI 10.1007/s10439-018-02178-w; Tzekov R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153608; Vest V, 2019, J NEUROTRAUM, V36, P1646, DOI 10.1089/neu.2018.6046; Walker WC, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000251; Watson R, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.4.8; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wonodi I, 2011, ARCH GEN PSYCHIAT, V68, P665, DOI 10.1001/archgenpsychiatry.2011.71; Yan EB, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0328-2; Zander NE, 2017, CELL MOL NEUROBIOL, V37, P1331, DOI 10.1007/s10571-017-0463-7; Zander NE, 2016, ANAL BIOCHEM, V504, P4, DOI 10.1016/j.ab.2016.03.009; Zander NE, 2015, J NEUROSCI RES, V93, P1353, DOI 10.1002/jnr.23594; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	91	13	13	0	5	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	OCT	2019	60	13					4159	4170		10.1167/iovs.19-27565			12	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Ophthalmology	JF4FF	WOS:000491342400002	31598627	Green Published, gold			2022-02-06	
J	Mattson, EK; Nelson, NW; Sponheim, SR; Disner, SG				Mattson, Elsa K.; Nelson, Nathaniel W.; Sponheim, Scott R.; Disner, Seth G.			The Impact of PTSD and mTBI on the Relationship Between Subjective and Objective Cognitive Deficits in Combat-Exposed Veterans	NEUROPSYCHOLOGY			English	Article						PTSD; mTBI; neuropsychology; cognition	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; BLAST-RELATED CONCUSSION; OEF/OIF VETERANS; ASSOCIATION; SYMPTOMS; MEMORY; DYSFUNCTION; COMPLAINTS	Objective: Cognitive complaints, such as attentional or memory concerns, are commonly reported by veterans diagnosed with posttraumatic stress disorder (PTSD) or a history of mild traumatic brain injury (mTBI). The degree to which those complaints actually map onto measurable cognitive deficits is unclear and is likely complicated by the severity of trauma-related sequelae. In the present study we sought to characterize the degree to which PTSD symptoms and mTBI accounted for the relationship of subjective cognitive complaints to objective cognitive performance, with the goal of facilitating the accurate assessment of trauma-exposed veterans complaining of cognitive decline. Method: A sample of 203 U.S. military veterans previously deployed to Iraq and/or Afghanistan were assessed for PTSD severity, history of blast and impact mTBI, objective cognitive function, and subjective cognitive complaints. Separate mediation analyses were conducted to explore the degree that PTSD severity, blast mTBI severity, and impact mTBI severity influenced the association between subjective cognitive complaints and objective cognitive performance. Models reflecting significant mediation were followed by post hoc moderated mediation analyses. Results: Subjective cognitive complaints and objective cognitive performance were significantly associated (beta = -6.49, SE = 2.85, p=.03), but this relationship was mediated by PTSD severity (beta = -2.95, SE = 2.86, p=.30). PTSD mediation was not moderated by either blast or impact mTBI. Conclusion: The present results delineate the prominent impact of PTSD symptoms, relative to blast and impact mTBI, on cognition following combat. These findings highlight the importance of assessing for trauma-related psychopathology in those seeking neuropsychological assessment or rehabilitative care for cognitive complaints.	[Mattson, Elsa K.; Sponheim, Scott R.; Disner, Seth G.] Minneapolis VA Hlth Care Syst, 1 Vet Dr,B68-2, Minneapolis, MN 55417 USA; [Nelson, Nathaniel W.] Univ St Thomas, Grad Sch Profess Psychol, St Paul, MN USA; [Sponheim, Scott R.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA		Disner, SG (corresponding author), Minneapolis VA Hlth Care Syst, 1 Vet Dr,B68-2, Minneapolis, MN 55417 USA.	seth.disner@va.gov		Mattson, Elsa/0000-0001-6924-4634	Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0038]; Department of Veterans Affairs, Rehabilitation RD ProgramUS Department of Veterans Affairs [101RX000622, 1IK1RX002325]; Veterans AffairsUS Department of Veterans Affairs [IK1RX002325] Funding Source: NIH RePORTER	This work was supported by Congressionally Directed Medical Research Program Grant W81XWH-08-2-0038 (principal investigator [PI]: Scott R. Sponheim) and Department of Veterans Affairs, Rehabilitation R&D Program Grants 101RX000622 (PI: Scott R. Sponheim) and 1IK1RX002325 (PI: Seth G. Disner).	American Psychiatric Association, 2000, DIAGN CRIT DSM 4 TR; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Basford JR, 2015, ARCH PHYS MED REHAB, V96, P977, DOI 10.1016/j.apmr.2015.02.025; Ben-Porath Y., 2012, INTERPRETING MMPI 2; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; DeJong J, 2009, ASSESSMENT, V16, P328, DOI 10.1177/1073191109336989; Delis D.C., 2000, MANUAL CALIFORNIA VE; Donnelly K, 2018, CLIN NEUROPSYCHOL, V32, P436, DOI 10.1080/13854046.2017.1390163; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; First M.B., 2004, COMPREHENSIVE HDB PS, V2, P134, DOI DOI 10.1002/9780471726753; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Gervais RO, 2009, CLIN NEUROPSYCHOL, V23, P996, DOI 10.1080/13854040902748249; Hayes AF, 2018, COMMUN MONOGR, V85, P4, DOI 10.1080/03637751.2017.1352100; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1373, DOI 10.1080/13854046.2013.851740; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Middleton LS, 2006, ARCH CLIN NEUROPSYCH, V21, P487, DOI 10.1016/j.acn.2006.06.008; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Nelson N. W., 2015, BRAIN NEUROTRAUMA MO, P449, DOI [10.1201/b18126-38, DOI 10.1201/B18126-38]; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Ragsdale KA, 2013, J ANXIETY DISORD, V27, P420, DOI 10.1016/j.janxdis.2013.04.003; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Samuelson KW, 2017, J TRAUMA STRESS, V30, P521, DOI 10.1002/jts.22223; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Srisurapanont M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04353-w; Svendsen AM, 2012, NORD J PSYCHIAT, V66, P248, DOI 10.3109/08039488.2011.626870; Tellegen, 2008, MINNESOTA MULTIPHASI; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Yehuda R, 2002, PSYCHONEUROENDOCRINO, V27, P171, DOI 10.1016/S0306-4530(01)00043-9; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083	46	13	13	1	15	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	2019	33	7					913	921		10.1037/neu0000560			9	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	JA7EA	WOS:000488003100001	31192654	Green Accepted			2022-02-06	
J	Raghuram, A; Cotter, SA; Gowrisankaran, S; Kanji, J; Howell, DR; Meehan, WP; Shah, AS				Raghuram, Aparna; Cotter, Susan A.; Gowrisankaran, Sowjanya; Kanji, Jameel; Howell, David R.; Meehan, William P., III; Shah, Ankoor S.			Postconcussion: Receded Near Point of Convergence is not Diagnostic of Convergence Insufficiency	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							RANDOMIZED CLINICAL-TRIAL; MOTOR SCREENING VOMS; CONCUSSION; NEARPOINT; CHILDREN; ACCOMMODATION; RELIABILITY; DYSFUNCTION; ADAPTATION; RECOVERY	PURPOSE: To determine the frequency of occurrence of receded near point of convergence (NPC) in patients with chronic concussion-related symptoms and in those with receded NPC to enumerate the frequency of convergence insufficiency and other oculomotor disorders. DESIGN: Retrospective cross-sectional study. METHODS: Clinic charts were retrospectively reviewed for the prior 3.5 years to identify all patients < 21 years old who were > 28 days postconcussion, had chronic concussion-related symptoms, had normal visual acuity, and had received a comprehensive sensorimotor examination. The frequency of receded NPC and oculomotor diagnoses were determined. RESULTS: Of the 83 eligible patients, 74 (89%) had receded NPC. Of these, 70 (95%) had oculomotor disorders; 30 (41%) had disorders of accommodation only; 21 (28%) had convergence insufficiency and accommodation deficits; and 6 (8%) had convergence insufficiency only. Six (8%) had a convergence deficit other than convergence insufficiency (all with concurrent accommodative disorders); 4.(5%) had both a nonspecific vergence dysfunction and accommodation deficits; 2 (3%) had convergence excess only; and 1 (1%) had both convergence excess and accommodative deficits. CONCLUSION: A receded NPC was present in the majority of young patients with chronic postconcussion symptoms. Associated with numerous underlying oculomotor dysfunctions, the clinical finding of a receded NPC is not synonymous with the diagnosis of convergence insufficiency. Because treatment options for the various oculomotor dysfunctions differ, it is prudent that these patients undergo a thorough examination of their vergence and accommodative systems so that an accurate diagnosis can be made and appropriate treatment prescribed. (C) 2019 Elsevier Inc. All rights reserved.	[Raghuram, Aparna; Gowrisankaran, Sowjanya; Shah, Ankoor S.] Boston Childrens Hosp, Dept Ophthalmol, 300 Longwood Ave, Boston, MA 02115 USA; [Raghuram, Aparna; Shah, Ankoor S.] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA; [Cotter, Susan A.] Marshall B Ketchum Univ, Southern Calif Coll Optometry, Fullerton, CA USA; [Kanji, Jameel] New England Coll Optometry, Boston, MA USA; [Howell, David R.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Howell, David R.; Meehan, William P., III] Boston Childrens Hosp, Dept Orthoped, Div Sports Med, Boston, MA USA; [Howell, David R.; Meehan, William P., III] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Orthoped Surg, Boston, MA 02115 USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Shah, Ankoor S.] Massachusetts Eye & Ear, Dept Ophthalmol, Boston, MA USA		Raghuram, A (corresponding author), Boston Childrens Hosp, Dept Ophthalmol, 300 Longwood Ave, Boston, MA 02115 USA.	aparna.raghuram@childrens.harvard.edu		Raghuram, Aparna/0000-0002-2913-6046	Boston Children's Ophthalmology Foundation Discovery Award	Boston Children's Ophthalmology Foundation Discovery Award.	Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Barrett TB, 2013, CLIN PROCEDURES PRIM, P147; BUGOLA J, 1977, American Orthoptic Journal, V27, P85; Martinez PC, 2009, OPTOMETRY, V80, P702, DOI 10.1016/j.optm.2009.06.011; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Convergence Insufficiency Treatment Study Group, PROC MAN; Convergence Insufficiency Treatment Trial Group, MAN PROC; Cooper Jeffrey, 2012, Optometry, V83, P137; DAUM KM, 1983, DOC OPHTHALMOL, V55, P177, DOI 10.1007/BF00140808; Davis AL, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6963976; Duane A, 1922, Trans Am Ophthalmol Soc, V20, P132; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; DWYER P, 1995, OPTOMETRY VISION SCI, V72, P224, DOI 10.1097/00006324-199504000-00002; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Eskridge JB, 1991, CLIN PROCEDURES OPTO, pxv; FINCHAM EF, 1957, J PHYSIOL-LONDON, V137, P488, DOI 10.1113/jphysiol.1957.sp005829; GARZIA RP, 1982, J AM OPTOM ASSOC, V53, P821; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hayes GJ, 1998, OPTOMETRY VISION SCI, V75, P506, DOI 10.1097/00006324-199807000-00019; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Jampolsky A, 1970, Trans Am Ophthalmol Soc, V68, P730; Jimenez R, 2004, OPHTHAL PHYSL OPT, V24, P528, DOI 10.1111/j.1475-1313.2004.00234.x; Johansson J, 2017, CLIN EXP OPTOM, V100, P234, DOI 10.1111/cxo.12458; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Khurana AK, 2017, THEORY PRACTICE OPTI; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marran LF, 2006, OPTOMETRY VISION SCI, V83, P281, DOI 10.1097/01.opx.0000216097.78951.7b; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Matuseviciene G, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018734; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; PASSMORE JW, 1957, AM J OPHTHALMOL, V43, P448, DOI 10.1016/0002-9394(57)92346-2; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Rabbetts RB, 2007, BENNETT RABBETTS CLI; Rosenfield M., 2009, OPTOMETRY SCI TECHNI, P230; Rouse MW, 2002, OPTOMETRY VISION SCI, V79, P254, DOI 10.1097/00006324-200204000-00012; Rouse MW, 1999, OPTOMETRY VISION SCI, V76, P643, DOI 10.1097/00006324-199909000-00022; Rutstein R P, 1987, J Am Optom Assoc, V58, P548; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; Scheiman M., 2014, CLIN MANAGEMENT BINO; Scheiman M, 2015, VIS DEV REHABIL, V1, P214; Scheiman M, 2008, ARCH OPHTHALMOL-CHIC, V126, P1336, DOI 10.1001/archopht.126.10.1336; Scheiman M, 2011, OPTOMETRY VISION SCI, V88, P1343, DOI 10.1097/OPX.0b013e31822f4d7c; Scheiman MM, 2016, OPTOMETRY VISION SCI, V93, P1457; SCHOR C, 1988, AM J OPTOM PHYS OPT, V65, P464; Siderov J, 2001, OPHTHAL PHYSL OPT, V21, P356, DOI 10.1046/j.1475-1313.2001.00609.x; Sreenivasan V, 2008, VISION RES, V48, P1262, DOI 10.1016/j.visres.2008.02.015; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; VonNoorden GK, 2002, BINOCULAR VISION OCU, pxvi	55	13	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	OCT	2019	206						235	244		10.1016/j.ajo.2019.04.008			10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	JL8VM	WOS:000495805400025	31004592				2022-02-06	
J	Servadei, F; Tropeano, MP; Spaggiari, R; Cannizzaro, D; Al Fauzi, A; Bajamal, AH; Khan, T; Kolias, AG; Hutchinson, PJ				Servadei, Franco; Tropeano, Maria Pia; Spaggiari, Riccardo; Cannizzaro, Delia; Al Fauzi, Asra; Bajamal, Abdul Hafid; Khan, Tarik; Kolias, Angelos G.; Hutchinson, Peter J.			Footprint of Reports From Low- and Low- to Middle-Income Countries in the Neurosurgical Data: A Study From 2015 to 2017	WORLD NEUROSURGERY			English	Article						Developing countries; Education; Global neurosurgery; Literature; World health	TRAUMATIC BRAIN-INJURY; HEALTH; EPIDEMIOLOGY; JOURNALS	OBJECTIVE: In 2015, the Lancet Commission on Global Surgery highlighted the disparities in surgical care worldwide. The aim of the present study was to investigate the research productivity of low-income countries (LICs) and low- to middle-income countries (LMICs) in selected journals representing the worldwide neurosurgical data and their ability to report and communicate globally the existing differences between high-income countries (HICs) and LMICs. METHODS: We performed a retrospective bibliometric analysis using PubMed and Scopus databases to record all the reports from 2015 to 2017 by investigators affiliated with neurosurgical departments in LICs and LMICs. RESULTS: A total of 8459 reports by investigators self-identified as members of neurosurgery departments worldwide were identified. Of these, 6708 reports were included in accordance with our method in the final analysis. The systematic search resulted in 459 studies reported by LICs and LMICs. Of these, 334 reports were included for the full text evaluation. Of the 6708 reports, 303 (4.52%) had been reported with an LMIC affiliation and only 31 (0.46%) with an LIC. The leading countries were India with 182 (54.5% among LMICs and LICs; 2.71% overall), followed by Egypt at 66 (19.76% among the LMICs and LICs; 0.98% overall), with a large difference compared with other countries such as Uganda at 9 (2.69% among the LMICs and LICs) and Tunisia and Pakistan at 8 each (2.4% among the LMICs and LICs). A few reports studies had been generated by collaboration with HIC neurosurgeons. CONCLUSIONS: Our results have shown that research studies from LMICs are underrepresented. Understanding and discussing the reasons for this underrepresentation are necessary to start addressing the disparities in neurosurgical research and care capacity. Future engagements from international journals, more partnership collaboration from HICs, and tailored funding to support investigators, collaborations, and networks could be of help.	[Servadei, Franco; Tropeano, Maria Pia; Spaggiari, Riccardo; Cannizzaro, Delia] Humanitas Clin & Res Hosp, Dept Neurosurg, Milan, Italy; [Servadei, Franco; Tropeano, Maria Pia; Spaggiari, Riccardo; Cannizzaro, Delia] Humanitas Univ, Milan, Italy; [Tropeano, Maria Pia; Kolias, Angelos G.; Hutchinson, Peter J.] Univ Cambridge, Natl Inst Hlth Res Global Hlth Res Grp Neurotraum, Cambridge, England; [Al Fauzi, Asra; Bajamal, Abdul Hafid] Univ Airlangga, Dr Soetomo Acad Med Ctr Hosp, Dept Neurosurg, Surabaya, Indonesia; [Khan, Tarik] North Western Gen & Res Hosp, Dept Neurosurg, Peshawar, Pakistan; [Kolias, Angelos G.; Hutchinson, Peter J.] Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Kolias, Angelos G.; Hutchinson, Peter J.] Univ Cambridge, Cambridge, England		Tropeano, MP (corresponding author), Humanitas Clin & Res Hosp, Dept Neurosurg, Milan, Italy.; Tropeano, MP (corresponding author), Humanitas Univ, Milan, Italy.; Tropeano, MP (corresponding author), Univ Cambridge, Natl Inst Hlth Res Global Hlth Res Grp Neurotraum, Cambridge, England.	mariapia.tropeano@libero.it	Cannizzaro, Delia/K-7197-2016	Cannizzaro, Delia/0000-0002-1611-0840; Kolias, Angelos/0000-0003-3992-0587; Al Fauzi, Asra/0000-0002-5155-2476; Spaggiari, Riccardo/0000-0001-6069-7514	National Institute for Health Research (NIHR) Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); NIHR Global Health Research Group on Neurotrauma; NIHR Research Professorship; United Kingdom NIHR [16/137/105]	Angelos Kolias and Peter Hutchinson are supported by the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre and the NIHR Global Health Research Group on Neurotrauma. Peter Hutchinson is also supported by a NIHR Research Professorship. The NIHR Global Health Research Group on Neurotrauma was commissioned by the United Kingdom NIHR using Official Development Assistance funding (project no. 16/137/105). The views expressed in this manuscript are those of the authors and are not necessarily those of the United Kingdom National Health Service, NIHR, or the Department of Health. The remaining authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Adeleye AO, 2012, WORLD NEUROSURG, V78, DOI [10.1016/j.wneu.2011.07.015, 10.1016/J.WNEU.2011.07.015]; Adeleye AO, 2016, J CRANIOFAC SURG, V27, P1302, DOI 10.1097/SCS.0000000000002791; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chow DS, 2010, RADIOLOGY, V257, P410, DOI 10.1148/radiol.10100070; Chua MH, 2018, WORLD NEUROSURG, V114, P375, DOI 10.1016/j.wneu.2018.03.057; Cruccu G, 2018, EUR J NEUROL, V25, P1128, DOI 10.1111/ene.13666; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Goel A, 2013, WORLD NEUROSURG, V79, P632, DOI 10.1016/j.wneu.2013.03.009; Haglund MM, 2017, NEUROSURGERY, V80, P656, DOI 10.1093/neuros/nyw159; Hauptman JS, 2011, J NEUROSURG, V115, P1262, DOI 10.3171/2011.8.JNS11857; Helal AE, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18258; Horton R, 2003, LANCET, V361, P712, DOI 10.1016/S0140-6736(03)12665-7; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; Kulkarni AV, 2017, NEW ENGL J MED, V377, P2456, DOI 10.1056/NEJMoa1707568; Langer A, 2004, B WORLD HEALTH ORGAN, V82, P802; Lund-Johansen M, 2017, WORLD NEUROSURG, V99, P403, DOI 10.1016/j.wneu.2016.12.051; Meara JG, 2014, LANCET, V383, P12, DOI 10.1016/S0140-6736(13)62345-4; Morimoto T, 2003, INT J HEMATOL, V77, P192, DOI 10.1007/BF02983221; Park KB, 2016, WORLD NEUROSURG, V88, P32, DOI 10.1016/j.wneu.2015.12.048; Patel V, 2001, BRIT J PSYCHIAT, V178, P406, DOI 10.1192/bjp.178.5.406; Patel V, 2007, BRIT J PSYCHIAT, V190, P77, DOI 10.1192/bjp.bp.106.025692; Peeters S, 2017, WORLD NEUROSURG, V97, P580, DOI 10.1016/j.wneu.2016.09.127; Saxena S, 2006, BRIT J PSYCHIAT, V188, P81, DOI 10.1192/bjp.bp.105.011221; Servadei F, 2018, WORLD NEUROSURG, V112, P315, DOI 10.1016/j.wneu.2018.01.047; Smart LR, 2017, WORLD NEUROSURG, V105, P238, DOI 10.1016/j.wneu.2017.05.101; Spanu F, 2018, WORLD NEUROSURG, V111, P326, DOI 10.1016/j.wneu.2017.12.146; Sumathipala Athula, 2004, BMC Med Ethics, V5, pE5; Twitchell S, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2018.1.FOCUS17775; Uthman OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078517; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; Walcott BP, 2016, JAMA NEUROL, V73, P1002, DOI 10.1001/jamaneurol.2016.0609; Yang Xiang, 2018, J Spine Surg, V4, P490, DOI 10.21037/jss.2018.06.11	33	13	13	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2019	130						E822	E830		10.1016/j.wneu.2019.06.230			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JB0MH	WOS:000488248200104	31295603	Green Accepted			2022-02-06	
J	Meier, TB; Giraldo-Chica, M; Espana, LY; Mayer, AR; Harezlak, J; Nencka, AS; Wang, Y; Koch, KM; Wu, YC; Saykin, AJ; Giza, CC; Goldman, J; DiFiori, JP; Guskiewicz, KM; Mihalik, JP; Brooks, A; Broglio, SP; McAllister, T; McCrea, MA				Meier, Timothy B.; Giraldo-Chica, Monica; Espana, Lezlie Y.; Mayer, Andrew R.; Harezlak, Jaroslaw; Nencka, Andrew S.; Wang, Yang; Koch, Kevin M.; Wu, Yu-Chien; Saykin, Andrew J.; Giza, Christopher C.; Goldman, Joshua; DiFiori, John P.; Guskiewicz, Kevin M.; Mihalik, Jason P.; Brooks, Alison; Broglio, Steven P.; McAllister, Thomas; McCrea, Michael A.			Resting-State fMRI Metrics in Acute Sport-Related Concussion and Their Association with Clinical Recovery: A Study from the NCAA-DOD CARE Consortium	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						functional connectivity; magnetic resonance imaging; mild traumatic brain injury; resting state; sport-related concussion	TRAUMATIC BRAIN-INJURY; DEFAULT-MODE NETWORK; SUBJECT-SPECIFIC ABNORMALITIES; COLLEGIATE FOOTBALL PLAYERS; FUNCTIONAL CONNECTIVITY; LONGITUDINAL ASSESSMENT; REGIONAL HOMOGENEITY; PARCELLATION; ACCURATE; ROBUST	There has been a recent call for longitudinal cohort studies to track the physiological recovery of sport-related concussion (SRC) and its relationship with clinical recovery. Resting-state functional magnetic resonance imaging (rs-fMRI) has shown potential for detecting subtle changes in brain function after SRC. We investigated the effects of SRC on rs-fMRI metrics assessing local connectivity (regional homogeneity; REHO), global connectivity (average nodal strength), and the relative amplitude of slow oscillations of rs-fMRI (fractional amplitude of low-frequency fluctuations; fALFF). Athletes diagnosed with SRC (n = 92) completed visits with neuroimaging at 24-48 h post-injury (24 h), after clearance to begin the return-to-play (RTP) progression (asymptomatic), and 7 days following unrestricted RTP (post-RTP). Non-injured athletes (n = 82) completed visits yoked to the schedule of matched injured athletes and served as controls. Concussed athletes had elevated symptoms, worse neurocognitive performance, greater balance deficits, and elevated psychological symptoms at the 24-h visit relative to controls.These deficits were largely recovered by the asymptomatic visit. Concussed athletes still reported elevated psychological symptoms at the asymptomatic visit relative to controls. Concussed athletes also had elevated REHO in the right middle and superior frontal gyri at the 24-h visit that returned to normal levels by the asymptomatic visit. Additionally, REHO in these regions at 24 h predicted psychological symptoms at the asymptomatic visit in concussed athletes. Current results suggest that SRC is associated with an acute alteration in local connectivity that follows a similar time course as clinical recovery. Our results do not indicate strong evidence that concussion-related alterations in rs-fMRI persist beyond clinical recovery.	[Meier, Timothy B.; Giraldo-Chica, Monica; Espana, Lezlie Y.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI USA; [Nencka, Andrew S.; Wang, Yang; Koch, Kevin M.] Med Coll Wisconsin, Dept Radiol, Milwaukee, WI USA; [Mayer, Andrew R.] Univ New Mexico, Dept Neurol & Psychiat, Mind Res Network, Lovelace Biomed & Environm Res Inst, Albuquerque, NM USA; [Harezlak, Jaroslaw] Univ New Mexico, Univ New Mexico Sch Med, Dept Psychol, Albuquerque, NM USA; [Wu, Yu-Chien] Indiana Univ, Dept Epidemiol & Biostat, Bloomington, IN USA; [Saykin, Andrew J.; Giza, Christopher C.] Indiana Univ, Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN USA; [McAllister, Thomas] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN USA; [Giza, Christopher C.] Univ Calif Los Angeles, Dept Pediat & Neurosurg, Los Angeles, CA USA; [Goldman, Joshua] Univ Calif Los Angeles, Dept Family Med & Orthopaed Surg, Los Angeles, CA USA; [Goldman, Joshua] Orthopaed Inst Children, Ctr Sports Med, Los Angeles, CA USA; [DiFiori, John P.] Primary Sports Med Serv, Hosp Special Surg, New York, NY USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Brooks, Alison] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped & Rehabil, Madison, WI USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI USA		Meier, TB (corresponding author), Med Coll Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	tmeier@mcw.edu	Koch, Kevin/AAD-6403-2021; Harezlak, Jaroslaw/P-8557-2014	Harezlak, Jaroslaw/0000-0002-3070-7686	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium; Department of Defense (DoD)United States Department of Defense; U.S. Army Medical Research Acquisition Activity (Fort Detrick, MD); Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436]; National Collegiate Athletic Association (NCAA)	This project was funded with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DoD). The U.S. Army Medical Research Acquisition Activity (820 Chandler Street, Fort Detrick, MD 21702-5014) is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award Number W81XWH-14-2-0151. The REDCap electronic database used for this project was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, Award Number UL1TR001436. This research was completed in part with computational resources and technical support provided by the Research Computing Center at the Medical College of Wisconsin.	Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Chen G, 2013, NEUROIMAGE, V73, P176, DOI 10.1016/j.neuroimage.2013.01.047; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Dodd AB, 2018, BRAIN IMAGING BEHAV, V12, P1828, DOI 10.1007/s11682-018-9836-x; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Friedman L, 2006, NEUROIMAGE, V32, P1656, DOI 10.1016/j.neuroimage.2006.03.062; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Glover GH, 2012, J MAGN RESON IMAGING, V36, P39, DOI 10.1002/jmri.23572; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Guo CC, 2012, NEUROIMAGE, V61, P1471, DOI 10.1016/j.neuroimage.2012.03.027; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hamilton JP, 2015, BIOL PSYCHIAT, V78, P224, DOI 10.1016/j.biopsych.2015.02.020; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kaushal M, 2019, HUM BRAIN MAPP, V40, P1211, DOI 10.1002/hbm.24440; Klein AP, 2019, J NEUROTRAUM, V36, P1776, DOI 10.1089/neu.2018.6055; Lancaster MA, 2018, HUM BRAIN MAPP, V39, P4276, DOI 10.1002/hbm.24245; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Madhavan R, 2019, J NEUROTRAUM, V36, P650, DOI 10.1089/neu.2018.5739; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Mayer AR, 2018, BRAIN IMAGING BEHAV, V12, P437, DOI 10.1007/s11682-017-9702-2; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCuddy WT, 2018, NEUROIMAGE-CLIN, V19, P434, DOI 10.1016/j.nicl.2018.05.011; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mijalkov M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178798; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Nencka AS, 2018, BRAIN IMAGING BEHAV, V12, P1121, DOI 10.1007/s11682-017-9775-y; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Reynolds BB, 2018, BRAIN IMAGING BEHAV, V12, P1332, DOI 10.1007/s11682-017-9790-z; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rolls ET, 2015, NEUROIMAGE, V122, P1, DOI 10.1016/j.neuroimage.2015.07.075; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; Sepulcre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000808; Taylor PA, 2013, BRAIN CONNECT, V3, P523, DOI 10.1089/brain.2013.0154; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; Wang YH, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9010019; WechslerD, 2001, WECHSLER TEST ADULT; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhan J, 2015, J NERV MENT DIS, V203, P786, DOI 10.1097/NMD.0000000000000368; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	72	13	13	3	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2019.6471		SEP 2019	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IZ0PT	WOS:000486793600001	31407610	Green Published			2022-02-06	
J	Mallah, K; Quanico, J; Raffo-Romero, A; Cardon, T; Aboulouard, S; Devos, D; Kobeissy, F; Zibara, K; Salzet, M; Fournier, I				Mallah, Khalil; Quanico, Jusal; Raffo-Romero, Antonella; Cardon, Tristan; Aboulouard, Soulaimane; Devos, David; Kobeissy, Firas; Zibara, Kazem; Salzet, Michel; Fournier, Isabelle			Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging of Lipids in Experimental Model of Traumatic Brain Injury Detecting Acylcarnitines as Injury Related Markers	ANALYTICAL CHEMISTRY			English	Article							APOPTOTIC CELLS; ATTRACTION; METABOLISM; PHAGOCYTES; EXPOSURE	Identifying new lipid markers linked to traumatic brain injury (TBI) is of major importance in characterizing their central role in the regeneration process and inflammatory response in such an injury model. In the present study, an advanced lipidomics analysis using high spectral resolution matrix-assisted laser desorption/ionization-mass spectrometry imaging was performed on different brain regions in an experimental rat model of moderate controlled cortical impact (CCI) while considering different time points (1 day, 3 days, 7 days, and 10 days) assessing the acute and subacute phase after injury. Our results revealed a new family of lipids, the acylcarnitines, as TBI-lipid related markers, with maximum expression at 3 days after impact and main colocalization within resident microglia of the brain. Furthermore, our experiments highlighted the upregulation of these acylcarnitine lipids, secreted by microglia, in the ipsilateral substantia nigra, the main region in the brain affected in Parkinsons disease (PD).	[Mallah, Khalil; Quanico, Jusal; Raffo-Romero, Antonella; Cardon, Tristan; Aboulouard, Soulaimane; Salzet, Michel; Fournier, Isabelle] Univ Lille, INSERM, U1192, Lab Prote Reponse Inflammatoire & Spectrometrie M, F-59000 Lille, France; [Mallah, Khalil; Zibara, Kazem] Lebanese Univ, Fac Sci 1, Dept Biol, PRASE,Lab Stem Cells,ER045, POB 6573-14 Badaro, Beirut, Lebanon; [Devos, David] Univ Lille, CHU Lille, INSERM,Dept Neurol,UMR S 1171, Expert Ctr Parkinsons Dis,Dept Pharmacol,LICEND, F-59000 Lille, France; [Kobeissy, Firas] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut 11072020, Lebanon		Salzet, M; Fournier, I (corresponding author), Univ Lille, INSERM, U1192, Lab Prote Reponse Inflammatoire & Spectrometrie M, F-59000 Lille, France.	michel.salzet@univ-lille.fr; isabelle.fournier@univ-lille.fr	FOURNIER, Isabelle/H-9195-2015; Kobeissy, Firas/E-7042-2017; Salzet, Michel/A-7675-2011; Cardon, Tristan/AAD-2991-2022; Quanico, Jusal/AAE-3366-2020; Devos, David/E-4059-2013	FOURNIER, Isabelle/0000-0003-1096-5044; Kobeissy, Firas/0000-0002-5008-6944; Salzet, Michel/0000-0003-4318-0817; Cardon, Tristan/0000-0003-1751-0528; Devos, David/0000-0002-2417-799X; Zibara, Kazem/0000-0002-9887-072X; Raffo Romero, Antonella Milagros/0000-0002-3905-9101; Mallah, Khalil/0000-0001-7622-8106	Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation (MESRI); Institut National de la Sante et de la Recherche Medicale (INSEAM)Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille; Association of Scientific Orientation and Specialization (ASOS Scholarship)	This research was supported by funding from Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation (MESRI), Institut National de la Sante et de la Recherche Medicale (INSEAM), and Universite de Lille. K.M. acknowledges funding from the Association of Scientific Orientation and Specialization (ASOS Scholarship).	Adibhatla RM, 2008, FRONT BIOSCI-LANDMRK, V13, P1250, DOI 10.2741/2759; Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Alexandrov T, 2011, BIOINFORMATICS, V27, pI230, DOI 10.1093/bioinformatics/btr246; Berry KAZ, 2011, CHEM REV, V111, P6491, DOI 10.1021/cr200280p; Chughtai K, 2013, J LIPID RES, V54, P333, DOI 10.1194/jlr.M027961; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Franck J, 2013, ANAL CHEM, V85, P8127, DOI 10.1021/ac4009397; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Hankin JA, 2011, J AM SOC MASS SPECTR, V22, P1014, DOI 10.1007/s13361-011-0122-z; Hines DJ, 2009, GLIA, V57, P1610, DOI 10.1002/glia.20874; Hulme HE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03100-5; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Mallah K, 2018, ANAL CHEM, V90, P10568, DOI 10.1021/acs.analchem.8b02682; Mueller RB, 2007, AUTOIMMUNITY, V40, P342, DOI 10.1080/08916930701356911; NAKADATE T, 1987, CANCER RES, V47, P6537; Naoi M, 1999, MECH AGEING DEV, V111, P175, DOI 10.1016/S0047-6374(99)00064-0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Quanico J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34518-0; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Schooneman MG, 2013, DIABETES, V62, P1, DOI 10.2337/db12-0466; Sparvero LJ, 2016, J NEUROCHEM, V139, P659, DOI 10.1111/jnc.13840; Vilskersts R, 2015, VASC PHARMACOL, V72, P101, DOI 10.1016/j.vph.2015.05.005; Wang X, 2015, GLIA, V63, P635, DOI 10.1002/glia.22774; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h	30	13	13	2	26	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	SEP 17	2019	91	18					11879	11887		10.1021/acs.analchem.9b02633			9	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	IZ5XR	WOS:000487156900052	31412203				2022-02-06	
J	LaValle, CR; Carr, WS; Egnoto, MJ; Misistia, AC; Salib, JE; Ramos, AN; Kamimori, GH				LaValle, Christina R.; Carr, Walter S.; Egnoto, Michael J.; Misistia, Anthony C.; Salib, Jonathan E.; Ramos, Alejandro N.; Kamimori, Gary H.			Neurocognitive Performance Deficits Related to Immediate and Acute Blast Overpressure Exposure	FRONTIERS IN NEUROLOGY			English	Article						military; blast; cognition; breacher; practice effect	LOW-LEVEL BLAST; TRAUMATIC BRAIN-INJURY	Addressing the concerns surrounding blast injury for the military community is a pressing matter. Specifically, sub-concussive blast effects, or those blast effects which do not yield a medical diagnosis but can result in symptom reporting and negative self-reported outcomes, are becoming increasingly important. This work evaluates explosive blast overpressure and impulse effects at the sub-concussive level on neurocognitive performance assessed with the Defense Automated Neurobehavioral Assessment (DANA) across seven breacher training courses conducted by the US Military. The results reported here come from 202 healthy, male military volunteer participants. Findings indicate that the neurocognitive task appearing most sensitive to identifying performance change is the DANA Procedural Reaction Time (PRT) subtask which may involve a sufficient level of challenge to reliably detect a small, transient cognitive impairment among a healthy undiagnosed population. The blast characteristic that was consistently associated with performance change was peak overpressure. Overall, this study provides evidence that increasing blast overpressure, defined as peak overpressure experienced in a training day, can lead to transient degradations in neurocognitive performance as seen on the DANA PRT subtask, which may generalize to other capabilities.	[LaValle, Christina R.; Carr, Walter S.; Egnoto, Michael J.; Misistia, Anthony C.; Salib, Jonathan E.; Ramos, Alejandro N.; Kamimori, Gary H.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci Res Walter, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA		LaValle, CR (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci Res Walter, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA.	christina.r.lavalle.ctr@mail.mil			U.S. Army Medical Research and Development Command (USAMRDC) Military Operational Medicine Research Program; Office of the Assistant Secretary of Defense for Health Affairs, BAA Award [W81XWH-16-2-0001]	This work was supported by the U.S. Army Medical Research and Development Command (USAMRDC) Military Operational Medicine Research Program and Office of the Assistant Secretary of Defense for Health Affairs, BAA Award No. W81XWH-16-2-0001. This research was supported in part by an appointment to the Research Participation Program at the Walter Reed Army Institute of Research administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and USAMRDC.	Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Carr W, 2017, SHOCK WAVES, V27, P829, DOI 10.1007/s00193-017-0766-0; Carr W, 2012, SLEEP, V35, pA77; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, J NEUROTRAUM, V32, pA109; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Dewey JM, 2016, SHOCK WAVE SCI TECHN, V9, P53, DOI 10.1007/978-3-319-23745-9_2; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; European Medicines Agency, 2015, COMM MED PROD HUM US; FEMA 428 (Federal Emergency Management Agency), 2003, 428 FEMA; Hirsch FG, 1966, 1858 DEF AT SUPP AG, DOI [10.21236/AD0653129, DOI 10.21236/AD0653129]; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Kamimori G, 2019, J NEUROTRAUM, V36, pA46; Kamimori Gary H, 2018, Mil Med, V183, P28, DOI 10.1093/milmed/usx186; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Magnuson J., 2018, TRAUMATIC BRAIN INJU, P39; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Picchioni Dante, 2014, Sleep, V37, P387, DOI 10.5665/sleep.3422; Polejaeva E, 2019, J INT NEUROPSYCH SOC, V25, P331, DOI [10.1017/S1355617719000663, DOI 10.1017/S1355617719000663]; Roebuck-Spencer T, 2007, ARCH CLIN NEUROPSYCH, V22, pS79, DOI 10.1016/j.acn.2006.10.011; Rogers NL, 2003, FRONT BIOSCI-LANDMRK, V8, pS1056, DOI 10.2741/1174; Sajja VSSS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00891; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Wallace A, 2015, ALZHEIMERS DEMENTI S, V11, pP703, DOI [10.1016/j.jalz.2015.06.1558, DOI 10.1016/J.JALZ.2015.06.1558]	29	13	13	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 13	2019	10								949	10.3389/fneur.2019.00949			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IX4LS	WOS:000485658300001	31572285	gold, Green Published			2022-02-06	
J	Nakae, R; Yokobori, S; Takayama, Y; Kanaya, T; Fujiki, Y; Igarashi, Y; Suzuki, G; Naoe, Y; Fuse, A; Yokota, H				Nakae, Ryuta; Yokobori, Shoji; Takayama, Yasuhiro; Kanaya, Takahiro; Fujiki, Yu; Igarashi, Yutaka; Suzuki, Go; Naoe, Yasutaka; Fuse, Akira; Yokota, Hiroyuki			A retrospective study of the effect of fibrinogen levels during fresh frozen plasma transfusion in patients with traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Blood coagulation disorders; Brain injuries; traumatic; Fibrinogen; Fibrinolysis; Prognosis	RESPIRATORY-DISTRESS-SYNDROME; SEVERE HEAD-INJURY; BLOOD-TRANSFUSION; ORGAN FAILURE; TIME-COURSE; COAGULOPATHY; COAGULATION; RESUSCITATION; PROGRESSION; GUIDELINES	Background The association between traumatic brain injury (TBI) and coagulopathy is well established. While coagulopathy prophylaxis in TBI involves replenishing coagulation factors with fresh frozen plasma (FFP), its effectiveness is controversial. We investigated the relationship between plasma fibrinogen concentration 3 h after initiating FFP transfusion and outcomes and evaluated the correlation with D-dimer levels at admission. Methods We retrospectively examined data from 380 patients with severe isolated TBI with blood samples collected a maximum of 1 h following injury. Plasma fibrinogen and D-dimer concentrations were obtained at admission, and plasma fibrinogen concentration was again assessed 3-4 h following injury. The patients were divided into two groups based on whether or not they received FFP transfusion. Patients were also divided into subgroups according their fibrinogen level: >= 150 mg/dL (high-fibrinogen subgroup) or < 150 mg/dL (low-fibrinogen subgroup) 3 h after injury. Demographic, clinical, radiological and laboratory data were compared between these subgroups. Results Glasgow Outcome Scale (GOS) scores at discharge and 3 months after injury were significantly lower in the FFP transfusion group than in the FFP non-transfusion group. Among patients who received FFP, GOS scores at discharge and 3 months after injury were significantly higher in the high-fibrinogen subgroup than in the low-fibrinogen subgroup. Elevated admission D-dimer predicted subsequent fibrinogen decrease. Conclusions In FFP transfusion, fibrinogen level >= 150 mg/dL 3 h after injury was associated with better outcomes in TBI patients. Assessing the admission D-dimer and tracking the fibrinogen are crucial for optimal coagulopathy prophylaxis in TBI patients.	[Nakae, Ryuta; Yokobori, Shoji; Takayama, Yasuhiro; Kanaya, Takahiro; Igarashi, Yutaka; Fuse, Akira; Yokota, Hiroyuki] Nippon Med Sch, Dept Emergency & Crit Care Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan; [Fujiki, Yu; Suzuki, Go; Naoe, Yasutaka] Kawaguchi Municipal Med Ctr, Emergency & Crit Care Ctr, Saitama, Japan		Nakae, R (corresponding author), Nippon Med Sch, Dept Emergency & Crit Care Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	nakae@nms.ac.jp		Nakae, Ryuta/0000-0003-1820-2463	General Insurance Association of Japan [18-1-49]	This study was supported in part by a medical research grant on traffic accidents from the General Insurance Association of Japan (#18-1-49). The funders had no role in the execution of this study or interpretation of the results.	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; [Anonymous], 2013, GUID MAN SEV HEAD IN; [Anonymous], 1998, ABBR INJ SCAL AIS 19; Chang R, 2017, SURGERY, V161, P538, DOI 10.1016/j.surg.2016.08.023; Cotton BA, 2009, J TRAUMA, V66, P41, DOI 10.1097/TA.0b013e31819313bb; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; Fries D, 2010, ANASTH INTENSIV NOTF, V45, P552, DOI 10.1055/s-0030-1265746; Gando S, 2015, SEMIN THROMB HEMOST, V41, P26, DOI 10.1055/s-0034-1398378; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; HIIPPALA ST, 1995, ANESTH ANALG, V81, P360, DOI 10.1097/00000539-199508000-00026; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Levy JH, 2014, TRANSFUSION, V54, P1389, DOI 10.1111/trf.12431; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; May AK, 1997, AM SURGEON, V63, P233; Moore FA, 1997, ARCH SURG-CHICAGO, V132, P620; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; O'Shaughnessy DF, 2004, BRIT J HAEMATOL, V126, P11, DOI 10.1111/j.1365-2141.2004.04972.x; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; Silverboard H, 2005, J TRAUMA, V59, P717, DOI 10.1097/01.ta.0000174919.35240.21; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Watson GA, 2009, J TRAUMA, V67, P221, DOI 10.1097/TA.0b013e3181ad5957; WINTER JP, 1989, ANN EMERG MED, V18, P553, DOI 10.1016/S0196-0644(89)80842-X; Zhang LM, 2017, WORLD NEUROSURG, V104, P381, DOI 10.1016/j.wneu.2017.04.140	43	13	13	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	SEP	2019	161	9					1943	1953		10.1007/s00701-019-04010-3			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IS9FL	WOS:000482453900026	31309303				2022-02-06	
J	Shi, WZ; Tian, Y; Li, J				Shi, Wen-Zhen; Tian, Ye; Li, Juan			GCN2 suppression attenuates cerebral ischemia in mice by reducing apoptosis and endoplasmic reticulum (ER) stress through the blockage of FoxO3a-regulated ROS production	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Ischemic stroke; GCN2; Apoptosis and ERS; Oxidative stress; FoxO3a	TRAUMATIC BRAIN-INJURY; TRANSLATIONAL CONTROL; OXIDATIVE STRESS; STROKE; ACTIVATION; PATHWAY; FOXO3A; MODEL	Ischemic stroke is one of the leading causes of morbidity and mortality among human worldwide. Unfortunately, cerebral I/R still lacks effective therapeutic targets and strategies. In the study, we found that general control nonderepressible 2 (GCN2) expression was increased following ischemia in the ischemic penumbra in vivo and in vitro. GCN2 suppression using its significant inhibitor, GCN2iB, exhibited a protective role in cerebral I/R injury in mice, as evidenced by the improved neurological deficits and function. GCN2 inhibition with either GCN2iB or genetic knockdown led to significant reduction of proapoptotic protein expression, endoplasmic reticulum stress (ERS)-related protein and oxidative stress both in I/R-induced cerebral injury and oxygen-glucose deprivation and reoxygenation (OGD/R) stimulation in N2a cells. OGD/R-triggered apoptosis and ERS were significantly depended on oxidative stress in vitro. In addition, Forkhead box O 3a (FoxO3a), involved in the reactive oxygen species (ROS) production, was increased during OGD/R stimulation-regulated apoptosis and ERS, which could be abrogated by GCN2 suppression. Consistently, FoxO3a-regulated generation of ROS was markedly ameliorated upon GCN2 suppression with GCN2iB. Thereby, our findings indicated that GCN2 suppression alleviated apoptosis and ERS in cerebral ischemia through reducing FoxO3a-dependent ROS production, illustrating that GCN2 could be a promising target for the therapeutic interventions in cerebral ischemic stroke. (C) 2019 Published by Elsevier Inc.	[Shi, Wen-Zhen; Tian, Ye] Xian 3 Hosp, Dept Neurol, Xian 710018, Shaanxi, Peoples R China; [Li, Juan] Shangluo Cent Hosp, Dept Neurol, Shangluo City 726000, Shaanxi, Peoples R China		Li, J (corresponding author), Shangluo Cent Hosp, 148,Beixin St, Shangluo 710018, Shaanxi, Peoples R China.	shiwenzhen19@foxmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81660210]; Key Research and Development Foundation of Shaanxi Province, China [2016SF-173, 20185F-107]; Science and Technology Project of Xi'an, Shaanxi Province, China [2017114SF/YX008(3)]	National Natural Science Foundation of China (81660210); The Key Research and Development Foundation of Shaanxi Province, China (2016SF-173, 20185F-107); Science and Technology Project of Xi'an, Shaanxi Province, China (2017114SF/YX008(3)).	Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Baker BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002760; Bang OY, 2015, STROKE, V46, P3302, DOI 10.1161/STROKEAHA.115.010508; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Chien CT, 2001, J AM SOC NEPHROL, V12, P973, DOI 10.1681/ASN.V125973; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Guo M, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00086; He ZH, 2012, STROKE, V43, P484, DOI 10.1161/STROKEAHA.111.626432; Ishihara Y, 2016, NEUROSCIENCE, V337, P242, DOI 10.1016/j.neuroscience.2016.09.027; Jeon JH, 2015, J VET SCI, V16, P75, DOI [10.4142/jvs.2015.16.1.67, 10.4142/jvs.2015.16.1.75]; Li DY, 2017, BRAIN RES BULL, V132, P1, DOI 10.1016/j.brainresbull.2017.05.001; Liu HQ, 2015, INT J BIOL SCI, V11, P525, DOI 10.7150/ijbs.10927; Liu SS, 2018, BBA-MOL BASIS DIS, V1864, P3257, DOI 10.1016/j.bbadis.2018.07.012; Lu ZB, 2014, HYPERTENSION, V63, P128, DOI 10.1161/HYPERTENSIONAHA.113.02313; Menon V, 2018, CURR OPIN HEMATOL, V25, P290, DOI 10.1097/MOH.0000000000000441; Qiu J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0739-8; Sood R, 2000, GENETICS, V154, P787; Sun LQ, 2018, BEHAV BRAIN RES, V337, P271, DOI 10.1016/j.bbr.2017.08.042; Sun LQ, 2017, BIOCHEM BIOPH RES CO, V482, P1141, DOI 10.1016/j.bbrc.2016.12.001; Wang T, 2009, FREE RADICAL BIO MED, V47, P229, DOI 10.1016/j.freeradbiomed.2009.02.027; Wang Y, 2018, REDOX BIOL, V17, P25, DOI 10.1016/j.redox.2018.04.009; Wei N, 2017, NEUROCHEM RES, V42, P1345, DOI 10.1007/s11064-017-2179-y; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Wen Q, 2012, NEUROGENETICS, V13, P105, DOI 10.1007/s10048-012-0320-2; Wu GY, 2018, NEUROBIOL DIS, V110, P59, DOI 10.1016/j.nbd.2017.11.009; Wu TT, 2011, EUR J PHARM SCI, V42, P496, DOI 10.1016/j.ejps.2011.02.005; Yao HK, 2017, MOL MED REP, V16, P9197, DOI 10.3892/mmr.2017.7712; Yu ZH, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00319; Yuan YJ, 2011, BRAIN RES, V1367, P85, DOI 10.1016/j.brainres.2010.10.017; Zhao HP, 2016, AGING DIS, V7, P295, DOI 10.14336/AD.2015.1009; Zhou JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27096	31	13	15	1	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	AUG 13	2019	516	1					285	292		10.1016/j.bbrc.2019.05.181			8	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	IK4UB	WOS:000476580800043	31255283				2022-02-06	
J	Buunk, AM; Spikman, JM; Metzemaekers, JDM; van Dijk, JMC; Groen, RJM				Buunk, Anne M.; Spikman, Jacoba M.; Metzemaekers, Jan D. M.; van Dijk, J. Marc C.; Groen, Rob J. M.			Return to work after subarachnoid hemorrhage: The influence of cognitive deficits	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; TRAUMATIC BRAIN-INJURY; LONG-TERM OUTCOMES; QUALITY-OF-LIFE; REINTEGRATION; SATISFACTION; IMPAIRMENTS; DEPRESSION	Introduction Cognitive deficits are frequently found after subarachnoid hemorrhage (SAH), but their influence on return to work is largely unknown. To improve identification of those patients at-risk for long-term return to work problems, we aimed to examine the value of cognitive deficits in the prediction of long-term return to work after subarachnoid hemorrhage. Methods SAH patients (N = 71) who were employed before SAH and were able to undergo neuropsychological assessment, were included. Demographic characteristics and acute SAH-related variables (SAH-type and external cerebrospinal fluid drainage) were taken into account. Neuropsychological tests for memory, speed, attention, executive function, and emotion recognition and a questionnaire for executive functions were used. Return to work was assessed using the Role Resumption List. Results Results showed that patients with incomplete return to work had significantly lower scores on neuropsychological measures for complex attention and executive functions (p < 0.05) compared to patients with complete return to work. Return to work could not be significantly predicted using only demographic characteristics and acute SAH-related variables, but adding measures of complex attention and executive functions resulted in a prognostic model that could reliably distinguish between complete and incomplete return to work. Statistically significant predictors in the final model were cerebrospinal fluid drainage and scores on a questionnaire for executive functions: patients with cerebrospinal fluid drainage and higher scores on the a questionnaire for executive functions were less likely to return to work. Discussion Together, these findings show that neuropsychological measures, especially for complex attention and executive functions, have added value to acute SAH-related and demographic variables in the prediction of long-term return to work after SAH.	[Buunk, Anne M.; Spikman, Jacoba M.] Univ Groningen, Subdept Neuropsychol, Dept Neurol, Univ Med Ctr Groningen, Groningen, Netherlands; [Metzemaekers, Jan D. M.; van Dijk, J. Marc C.; Groen, Rob J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, Groningen, Netherlands		Buunk, AM (corresponding author), Univ Groningen, Subdept Neuropsychol, Dept Neurol, Univ Med Ctr Groningen, Groningen, Netherlands.	a.m.buunk@umcg.nl	van Dijk, J. Marc C./C-1078-2013	van Dijk, J. Marc C./0000-0002-0814-5680; Spikman, Jacoba/0000-0002-6477-0763; Groen, Rob J.M./0000-0003-3067-763X	charitable foundation Catharina Heerdt	This study was funded by the charitable foundation Catharina Heerdt to JMS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Alfieri A, 2011, J CLIN NEUROSCI, V18, P1478, DOI 10.1016/j.jocn.2011.02.036; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Blonder LX, 2012, J CLIN EXP NEUROPSYC, V34, P634, DOI 10.1080/13803395.2012.667069; Boerboom W, 2014, J REHABIL MED, V46, P28, DOI 10.2340/16501977-1236; Burgess P, 1996, BEHAV ASSESSMENT DYS; Buunk AM, 2016, NEUROPSYCHOLOGY; Buunk AM, 2017, NEUROPSYCHOLOGIA, V103, P131, DOI 10.1016/j.neuropsychologia.2017.07.015; CANHAO P, 1995, ACTA NEUROCHIR, V132, P14, DOI 10.1007/BF01404842; Carter BS, 2000, NEUROSURGERY, V46, P1326, DOI 10.1097/00006123-200006000-00008; Deelman B, 1980, NEUROPSYCHOLOGIE NED; Degos V, 2012, ANESTHESIOLOGY, V117, P1289, DOI 10.1097/ALN.0b013e318267395b; Doerfler S, 2018, WORLD NEUROSURG, V114, pE483, DOI 10.1016/j.wneu.2018.02.195; Dupont S, 2013, NEUROL RES, V35, P107, DOI 10.1179/1743132812Y.0000000122; Edwards JD, 2018, INT J STROKE, V13, P243, DOI 10.1177/1747493017743059; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; Golden CJ, 1978, STROOP COLOR WORD TE; Hedlund M, 2011, BRIT J NEUROSURG, V25, P693, DOI 10.3109/02688697.2011.578769; HUTTER BO, 1993, NEUROSURGERY, V33, P999; HUTTER BO, 1994, ACTA NEUROCHIR, V127, P129, DOI 10.1007/BF01808755; HUTTER BO, 1995, J CLIN EXP NEUROPSYC, V17, P499, DOI 10.1080/01688639508405141; Kauranen T, 2013, J NEUROL NEUROSUR PS, V84, P316, DOI 10.1136/jnnp-2012-302629; Kollegger H, 1989, Int Disabil Stud, V11, P57; Konczalla J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-140; Lago A, 2016, NEUROL RES, V38, P692, DOI 10.1080/01616412.2016.1200306; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Morris PG, 2004, NEUROSURGERY, V54, P47, DOI 10.1227/01.NEU.0000097198.94828.E1; Passier PECA, 2011, J STROKE CEREBROVASC, V20, P324, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.001; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Schweizer TA, 2012, J NEUROL SCI, V316, P137, DOI 10.1016/j.jns.2012.01.003; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; Sonesson B, 2018, J NEUROSURG, V128, P785, DOI 10.3171/2016.11.JNS16805; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stienen MN, 2014, WORLD NEUROSURG; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Taufique Z, 2016, NEUROSURGERY, V78, P256, DOI 10.1227/NEU.0000000000001042; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; van der Kemp J, 2019, NEUROPSYCHOL REHABIL, V29, P638, DOI 10.1080/09602011.2017.1313746; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Verhage F, 1964, INTELLIGENTIE LEEFTI; Vilkki JS, 2004, NEUROSURGERY, V55, P790, DOI 10.1227/01.NEU.0000137629.17424.6D; Vilkki J, 2012, ACTA NEUROCHIR, V154, P1437, DOI 10.1007/s00701-012-1417-y; Wallmark S, 2016, ACTA NEUROCHIR, V158, P233, DOI 10.1007/s00701-015-2665-4; Young A., 2002, FACIAL EXPRESSIONS E	49	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220972	10.1371/journal.pone.0220972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	WOS:000485004000033	31398223	Green Published, Green Submitted, gold			2022-02-06	
J	Draxler, DF; Awad, MM; Hanafi, G; Daglas, M; Ho, HD; Keragala, C; Galle, A; Roquilly, A; Lyras, D; Sashindranath, M; Medcalf, RL				Draxler, Dominik F.; Awad, Milena M.; Hanafi, Gryselda; Daglas, Maria; Ho, Heidi; Keragala, Charithani; Galle, Adam; Roquilly, Antoine; Lyras, Dena; Sashindranath, Maithili; Medcalf, Robert L.			Tranexamic Acid Influences the Immune Response, but not Bacterial Clearance in a Model of Post-Traumatic Brain Injury Pneumonia	JOURNAL OF NEUROTRAUMA			English	Article						immune response; pneumonia; plasmin; tranexamic acid; traumatic brain injury	FIBRINOLYSIS-SHUTDOWN; PLASMINOGEN ACTIVATION; TRAUMA PATIENTS; HEMORRHAGE; CRASH-2; INFLAMMATION; COAGULATION; MORTALITY; SYSTEM	The antifibrinolytic agent, tranexamic acid (TXA), an inhibitor of plasmin formation, currently is evaluated to reduce bleeding in various conditions, including traumatic brain injury (TBI). Because plasmin is implicated in inflammation and immunity, we investigated the effects of plasmin inhibition on the immune response after TBI in the presence or absence of induced pneumonia. Wild-type mice treated with vehicle or TXA or mice deficient in plasminogen (plg(-/-)) underwent TBI using the controlled cortical impact model. Mice were then subjected to Staphylococcus aureus induced pneumonia and the degree of immune competence determined. Significant baseline changes in the innate immune cell profile were seen in plg(-/-) mice with increases in spleen weight and white blood cell counts, and elevation in plasma interleukin-6 levels. The plg(-/-) mice subjected to TBI displayed no additional changes in these parameters at the 72 h or one week time point post-TBI. The plg(-/-) mice subjected to TBI did not exhibit any further increase in susceptibility to endogenous infection. Pneumonia was induced by intratracheal instillation of S. aureus. The TBI did not worsen pneumonia symptoms or delay recovery in plg(-/-) mice. Similarly, in wild type mice, treatment with TXA did not impact on the ability of mice to counteract pneumonia after TBI. Administration of TXA after TBI and subsequent pneumonia, however, altered the number and surface marker expression of several myeloid and lymphoid cell populations, consistent with enhanced immune activation at the 72 h time point. This investigation confirms the immune-modulatory properties of TXA, thereby highlighting its effects unrelated to inhibition of fibrinolysis.	[Draxler, Dominik F.; Hanafi, Gryselda; Daglas, Maria; Ho, Heidi; Keragala, Charithani; Galle, Adam; Sashindranath, Maithili; Medcalf, Robert L.] Monash Univ, Australian Ctr Blood Dis, Mol Neurotrauma & Haemostasis, Melbourne, Vic, Australia; [Awad, Milena M.; Lyras, Dena] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Melbourne, Vic, Australia; [Awad, Milena M.; Lyras, Dena] Monash Univ, Dept Microbiol, Melbourne, Vic, Australia; [Roquilly, Antoine] CHU Nantes, Anaesthesia Intens Care Unit, Nantes, France		Medcalf, RL (corresponding author), Monash Univ, Australian Ctr Blood Dis, Mol Neurotrauma & Haemostasis, Melbourne, Vic, Australia.	robert.medcalf@monash.edu	Sashindranath, Maithili/AAI-7408-2021	Sashindranath, Maithili/0000-0002-9712-4784; Roquilly, Antoine/0000-0002-1029-6242; Daglas, Maria/0000-0002-9356-4061; Awad, Milena/0000-0002-9275-3979	NHMRCNational Health and Medical Research Council of Australia; Alzheimers Australia Dementia Research Foundation grant	We want to acknowledge AMREP Flow Cytometry Core Facility for technical assistance with the flow cytometry experiments. We would also like to thank Debbie Ramsey and David Spiteri from Baker IDI for their assistance in the infection experiments. Moreover, we want to acknowledge Tom Chung, PhD, from Jomar Life Research and Crux Biolab for performing the multiplex cytokine assays and Roger Lijnen, PhD (KU Leuven, Centre for Molecular and Vascular Biology), for providing reagents and protocol for the PAP ELISA. This investigation was funded by NHMRC. RLM is a NHMRC Principal Research Fellow. MS is the recipient of an Alzheimers Australia Dementia Research Foundation grant.	[Anonymous], PROGR REP 2003 2013; Borg RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131216; Boudreau RM, 2017, J SURG RES, V215, P47, DOI 10.1016/j.jss.2017.03.031; Cardenas JC, 2019, SHOCK, V51, P273, DOI 10.1097/SHK.0000000000001160; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; da Silva HB, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00480; Das R, 2014, BLOOD, V124, P679, DOI 10.1182/blood-2014-01-549659; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Draxler DF, 2017, SEMIN THROMB HEMOST, V43, P143, DOI 10.1055/s-0036-1586227; Gall LS, 2019, ANN SURG, V269, P1184, DOI 10.1097/SLA.0000000000002733; Gomez-Builes JC, 2018, ANESTH ANALG, V127, P840, DOI 10.1213/ANE.0000000000003341; Griffin GD, 2011, MIL MED, V176, P364, DOI 10.7205/MILMED-D-10-00021; Guo YZ, 2008, ARTHRITIS RHEUM, V58, P764, DOI 10.1002/art.23263; Guo YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024774; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Huet O, 2013, SHOCK, V39, P488, DOI 10.1097/SHK.0b013e3182939831; Jansohn E, 2017, SCAND J CLIN LAB INV, V77, P289, DOI 10.1080/00365513.2017.1306877; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Klak M, 2010, SCAND J INFECT DIS, V42, P351, DOI 10.3109/00365540903510690; Kwiecinski J, 2016, J INFECT DIS, V213, P139, DOI 10.1093/infdis/jiv360; Later AFL, 2013, J THORAC CARDIOV SUR, V145, P1611, DOI 10.1016/j.jtcvs.2012.11.042; Leeper CM, 2017, ANN SURG, V266, P508, DOI 10.1097/SLA.0000000000002355; Lijnen HR, 1996, INT J CLIN LAB RES, V26, P1, DOI 10.1007/BF02644767; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Margraf A, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1846-3; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McCormack PL, 2012, DRUGS, V72, P585, DOI 10.2165/11209070-000000000-00000; Medcalf RL, 2015, BLOOD, V125, P2457, DOI 10.1182/blood-2015-02-629808; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meizoso JP, 2017, J AM COLL SURGEONS, V224, P575, DOI 10.1016/j.jamcollsurg.2016.12.018; Mitra B, 2014, EMERG MED AUSTRALAS, V26, P194, DOI 10.1111/1742-6723.12172; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Myles PS, 2017, NEW ENGL J MED, V376, P136, DOI 10.1056/NEJMoa1606424; Nishida T, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0201-0; Okada K, 2000, BLOOD COAGUL FIBRIN, V11, P645, DOI 10.1097/00001721-200010000-00009; Peetermans M, 2016, CRIT REV MICROBIOL, V42, P866, DOI 10.3109/1040841X.2015.1080214; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Ploplis VA, 1998, BLOOD, V91, P2005, DOI 10.1182/blood.V91.6.2005.2005_2005_2009; Plow EF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/141806; Popescu C, 2015, J Med Life, V8, P272; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Roy M, 2017, J SURG RES, V208, P104, DOI 10.1016/j.jss.2016.09.023; Samson AL, 2012, CELL REP, V2, P889, DOI 10.1016/j.celrep.2012.08.026; Samson AL, 2009, BLOOD, V114, P1937, DOI 10.1182/blood-2009-02-203448; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Stanley D, 2016, NAT MED, V22, P1277, DOI 10.1038/nm.4194; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; TOTH LA, 1988, INFECT IMMUN, V56, P1785, DOI 10.1128/IAI.56.7.1785-1791.1988; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; Wang JH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00606; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	60	13	13	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2019	36	23					3297	3308		10.1089/neu.2018.6030		AUG 2019	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JO9FY	WOS:000479861600001	31140372				2022-02-06	
J	Luo, WS; Liu, T; Li, SS; Wen, HM; Zhou, FH; Zafonte, R; Luo, X; Xu, MZ; Black-Schaffer, R; Wood, LJ; Wang, YL; Wang, QM				Luo, Wenshu; Liu, Tao; Li, Shanshan; Wen, Hongmei; Zhou, Fenghua; Zafonte, Ross; Luo, Xun; Xu, Minghzu; Black-Schaffer, Randie; Wood, Lisa J.; Wang, Yulong; Wang, Qing Mei			The Serum BDNF Level Offers Minimum Predictive Value for Motor Function Recovery After Stroke	TRANSLATIONAL STROKE RESEARCH			English	Article						Stroke rehabilitation; BDNF (brain-derived neurotrophic factor); FIM (functional independence measure); FA (fractional anisotropy)	NEUROTROPHIC FACTOR LEVELS; TRAUMATIC BRAIN-INJURY; CORTICOSPINAL TRACT; FRACTIONAL ANISOTROPY; SYNAPTIC PLASTICITY; ACTIVATION; NEUROPLASTICITY; REHABILITATION; EXERCISE	Brain-derived neurotrophic factor (BDNF) plays an important role in neuroplasticity and neurogenesis following ischemic and non-ischemic brain injury. The predictive value of BDNF for short-term outcome after stroke is controversial. The objective of this study was to investigate the relationship among serum BDNF level, fractional anisotropy (FA), and functional outcome during post-acute stroke rehabilitation. Serum BDNF levels were measured on admission to an acute inpatient rehabilitation hospital. The primary functional outcome was functional independence measure (FIM) motor subscore at discharge. The secondary outcome measures were FIM total score at discharge, FIM motor subscore on admission, length of stay in the hospital, and discharge destination. We investigated the relationship among the level of serum BDNF and FA as well as functional outcome measures. Three hundred forty-eight consecutive stroke subjects were included in the analysis. Serum BDNF levels on admission were statistically but not clinically correlated with FIM motor subscore at discharge (r=0.173, P=0.001) and FIM total score at discharge (r=0.155, P=0.004). Receiver operating characteristic (ROC) analysis of BDNF as a predictor for FIM motor subscore improvement showed low accuracy of prediction with an area under the curve (AUC) of 0.581 (P=0.026). Serum BDNF significantly correlated with FA in the high FIM motor group (n=10, r=0.609, P=0.031) but not in the low FIM motor group (n=11, r=-0.132, P=0.349). The serum BDNF level alone offers minimum predictive value for recovery of motor function during post-acute rehabilitation. Our findings suggest that serum BDNF level may be correlated with FA.	[Luo, Wenshu; Liu, Tao; Li, Shanshan; Wen, Hongmei; Zhou, Fenghua; Xu, Minghzu; Wang, Qing Mei] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Stroke Biol Recovery Lab, Charlestown, MA 02129 USA; [Luo, Wenshu] Shenzhen Tradit Chinese Med Hosp, Dept Acupuncture & Moxibust, Shenzhen 518033, Guangdong, Peoples R China; [Liu, Tao] Huaiyin Inst Technol, Jiangsu Prov Key Lab Intervent Med Devices, Huaian 223003, Jiangsu, Peoples R China; [Li, Shanshan] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Wen, Hongmei] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rehabil Med, 600 Tianhe Rd, Guangzhou 510630, Guangdong, Peoples R China; [Zhou, Fenghua] China Med Univ, Shengjing Hosp, Dept Phys Med & Rehabil, Shenyang 110003, Liaoning, Peoples R China; [Zafonte, Ross; Black-Schaffer, Randie; Wang, Qing Mei] Harvard Med Sch, Brigham & Womens Hosp, Spaulding Rehabil Hosp Network, Dept Phys Med, Boston, MA 02115 USA; [Zafonte, Ross; Black-Schaffer, Randie; Wang, Qing Mei] Harvard Med Sch, Brigham & Womens Hosp, Spaulding Rehabil Hosp Network, Dept Rehabil, Boston, MA 02115 USA; [Zafonte, Ross; Black-Schaffer, Randie; Wang, Qing Mei] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Luo, Xun] Kerry Rehabil Med Res Inst, Shenzhen 518048, Guangdong, Peoples R China; [Luo, Xun] Harvard Med Sch, Spaulding Rehabil Hosp, Shenzhen Sanming Project Grp, Charlestown, MA 02129 USA; [Wood, Lisa J.] MGH Inst Hlth Profess, Sch Nursing, Charlestown, MA 02129 USA; [Wang, Yulong] Shenzhen Univ, Shenzhen Second Peoples Hosp, Affiliated Hosp 1, Shenzhen 518035, Guangdong, Peoples R China		Wang, QM (corresponding author), Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Stroke Biol Recovery Lab, Charlestown, MA 02129 USA.; Wang, QM (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Spaulding Rehabil Hosp Network, Dept Phys Med, Boston, MA 02115 USA.; Wang, QM (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Spaulding Rehabil Hosp Network, Dept Rehabil, Boston, MA 02115 USA.; Wang, QM (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.; Wang, YL (corresponding author), Shenzhen Univ, Shenzhen Second Peoples Hosp, Affiliated Hosp 1, Shenzhen 518035, Guangdong, Peoples R China.	ylwang66@126.com; wang.qingmei@mgh.harvard.edu	Black-Schaffer, Randie/AAY-4671-2021; Li, Shanshan/S-4184-2019; LI, SHANSHAN/G-5246-2015	Li, Shanshan/0000-0002-3420-0567; LI, SHANSHAN/0000-0002-3420-0567; Wood, Lisa/0000-0003-1145-3649	Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University and its affiliated academic health care centers; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [12ykpy39]; Shenzhen "Sanming project" [SZSM201610039]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001102] Funding Source: NIH RePORTER	This study was supported by the Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health award no. UL1 TR001102); Harvard University and its affiliated academic health care centers; and Fundamental Research Funds for the Central Universities (grant no. 12ykpy39). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health.r This study was also supported by Shenzhen "Sanming project" (SZSM201610039).	Ahn YH, 2006, NEUROREPORT, V17, P987, DOI 10.1097/01.wnr.0000220128.01597.e0; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bejot Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029405; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Dalby RB, 2013, ACTA PSYCHIAT SCAND, V128, P387, DOI 10.1111/acps.12085; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; Dwivedi Y, 2013, AM J GERIAT PSYCHIAT, V21, P433, DOI 10.1016/j.jagp.2012.10.026; Elkabes S, 1996, J NEUROSCI, V16, P2508; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Jang SH, 2004, NEUROREPORT, V15, P395, DOI 10.1097/00001756-200403010-00002; Jiang YJ, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/372423; Jickling GC, 2015, STROKE, V46, P915, DOI 10.1161/STROKEAHA.114.005604; Jin JF, 2017, WORLD J EMERG MED, V8, P99, DOI 10.5847/wjem.j.1920-8642.2017.02.003; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kaess BM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001544; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Kim B, 2017, NEUROREHAB NEURAL RE, V31, P3, DOI 10.1177/1545968316662708; Kim EJ, 2016, EUR J NEUROL, V23, P76, DOI 10.1111/ene.12791; Klein AB, 2011, INT J NEUROPSYCHOPH, V14, P347, DOI 10.1017/S1461145710000738; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Mang CS, 2013, PHYS THER, V93, P1707, DOI 10.2522/ptj.20130053; Munkholm K, 2014, PSYCHONEUROENDOCRINO, V47, P199, DOI 10.1016/j.psyneuen.2014.05.011; Naegelin Y, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0419-17.2018; Nalichowski Ruth, 2006, AMIA Annu Symp Proc, P1044; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Pearson-Fuhrhop KM, 2010, PM&R, V2, pS227, DOI 10.1016/j.pmrj.2010.09.011; Polyakova M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061189; Puig J, 2013, STROKE, V44, P2016, DOI 10.1161/STROKEAHA.111.000382; Simon NG, 2014, NEUROLOGY, V83, P1382, DOI 10.1212/WNL.0000000000000861; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Spampinato MV, 2017, AM J NEURORADIOL, V38, P1328, DOI 10.3174/ajnr.A5180; Stanne TM, 2016, STROKE, V47, P1943, DOI 10.1161/STROKEAHA.115.012383; Tsuchimine S, 2014, NEUROPSYCHOBIOLOGY, V69, P83, DOI 10.1159/000358061; Wang J, 2017, MOL NEUROBIOL, V54, P7335, DOI 10.1007/s12035-016-0236-1; Ward NS, 2006, BRAIN, V129, P809, DOI 10.1093/brain/awl002; Weinstein G, 2014, JAMA NEUROL, V71, P55, DOI 10.1001/jamaneurol.2013.4781; Wen HM, 2016, ARCH PHYS MED REHAB, V97, P1487, DOI 10.1016/j.apmr.2016.04.010; Yang LL, 2011, INT J GERIATR PSYCH, V26, P495, DOI 10.1002/gps.2552	47	13	15	1	15	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	AUG	2019	10	4					342	351		10.1007/s12975-018-0648-5			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IJ0YS	WOS:000475626500002	30074228	Green Accepted			2022-02-06	
J	Skarupa, DJ; Khan, M; Hsu, A; Madbak, FG; Ebler, DJ; Yorkgitis, B; Rahmathulla, G; Alcindor, D; Joseph, B				Skarupa, David J.; Khan, Muhammad; Hsu, Albert; Madbak, Firas G.; Ebler, David J.; Yorkgitis, Brian; Rahmathulla, Gazanfar; Alcindor, Dunbar; Joseph, Bellal			Trends in civilian penetrating brain injury: A review of 26,871 patients	AMERICAN JOURNAL OF SURGERY			English	Article; Proceedings Paper	30th Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma (EAST)	JAN 09-15, 2018	Lake Buena Vista, FL	Eastern Assoc Surg Trauma		Penetrating injury; Traumatic brain injury; Gunshot; Trends	GUNSHOT WOUNDS; PREDICTORS; MORTALITY; IMPACT; EPIDEMIOLOGY; GUIDELINES; MANAGEMENT; PROGNOSIS	Introduction: The aim of our study is to analyze the 5 years' trends, mortality rate, and factors that influence mortality after civilian penetrating traumatic brain injury (pTBI). Methods: We performed a 5-year-analysis of all trauma patients diagnosed with pTBI in the TQIP. Our outcome measures were trends of pTBI. Results: A total of 26,871 had penetrating brain injury over the 5-year period. Mean age was 36.2 +/- 18 years. Overall 55% of the patients had severe TBI and mortality rate was 43.8%. There was an increase in the rate of pTBI from 3042/100,000 (2010) to 7578/100,000 trauma admissions (2014) (p < 0.001). The mortality rate has increased from 35% (2010) to 48% (2011) (p < 0.001) followed by a linear decrease in mortality to 40% (2014). Independent predictors of mortality were age, pre-hospital intubation, suicide attempt, and craniotomy/craniectomy. Conclusions: Incidence and mortality for patients who are brought to hospitals following pTBI have gradually increased over the five-year period. Self-inflicted injury and prehospital intubation were the two most significant predictors of mortality. (C) 2018 Elsevier Inc. All rights reserved.	[Skarupa, David J.; Hsu, Albert; Madbak, Firas G.; Ebler, David J.; Yorkgitis, Brian] Univ Florida, Coll Med, Dept Surg, Div Acute Care Surg, Jacksonville, FL 32209 USA; [Khan, Muhammad; Joseph, Bellal] Univ Arizona, Coll Med, Dept Surg, Div Trauma Crit Care Burn & Emergency Surg, Tucson, AZ USA; [Rahmathulla, Gazanfar; Alcindor, Dunbar] Univ Florida, Coll Med, Dept Neurosurg, Jacksonville, FL 32209 USA		Skarupa, DJ (corresponding author), Univ Florida, Dept Surg, Div Acute Care Surg, 655 West 8th St, Jacksonville, FL 32209 USA.	David.Skarupa@jax.ufl.edu; mkhan17@surgery.arizona.edu; albert.hsu@jax.ufl.edu; firas.madbak@jax.ufl.edu; david.ebler@jax.ufl.edu; brian.yorkgitis2@jax.ufl.edu; gazanfar.rahmathulla@jax.ufl.edu; dunbar.alcindor@jax.ufl.edu; bjoseph@surgery.arizona.edu	Skarupa, David/AAI-1894-2019; Rahmathulla, Gazanfar/D-1890-2014	Rahmathulla, Gazanfar/0000-0002-0904-1840			Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; Ahmad F., 2016, Q PROVISIONAL ESTIMA; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; [Anonymous], 2001, J Trauma, V51, pS3; [Anonymous], 2017, SUICIDE STAT AFSP; [Anonymous], 2017, RAT TBI REL EM DEP V; Badjatia N, 2008, PREHOSP EMERG CAR S1, V12; Bertisch H, 2017, ARCH PHYS MED REHAB, V98, P2288, DOI 10.1016/j.apmr.2017.04.006; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carey ME, 2003, SURG NEUROL, V60, P112, DOI 10.1016/S0090-3019(03)00352-5; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control, 2017, WISQARS WEB BAS INJ; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Davidsson J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00051; Denninghoff KR, 2008, WEST J EMERG MED, V9, P184; Jehan F, 2017, J INJURY VIOLENCE RE, V10; Jehan F, 2017, J TRAUMA ACUTE CARE, V83, P1148, DOI 10.1097/TA.0000000000001658; KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P701, DOI 10.1016/s1042-3680(18)30426-1; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Khan M, 2017, J SURG RES, V216, P109, DOI 10.1016/j.jss.2017.04.026; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovasik BP, 2016, WORLD NEUROSURG, V94, P309, DOI 10.1016/j.wneu.2016.07.022; Muehlschlegel S, 2016, NEUROLOGY, V87, P2244, DOI 10.1212/WNL.0000000000003355; Nathens AB, 2012, SURG CLIN N AM, V92, P441, DOI 10.1016/j.suc.2012.01.003; Peek-Asa C, 2001, BRAIN INJURY, V15, P801, DOI 10.1080/02699050010025768; Pruitt BA, 2001, J TRAUMA, V51, pS1, DOI 10.1097/00005373-200108001-00001; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; Srinivasan VM, 2014, J NEUROSURG, V120, P228, DOI 10.3171/2013.6.JNS121577; Taylor CA, 2017, MMWR SURVEILL SUMM, P66; Turco L, 2017, WORLD NEUROSURG, V104, P653, DOI 10.1016/j.wneu.2017.05.068; Vakil MT, 2017, EMERG RADIOL, V24, P301, DOI 10.1007/s10140-016-1477-z; Zyck S, 2016, WORLD NEUROSURG, V91, P297, DOI 10.1016/j.wneu.2016.04.012	33	13	13	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	AUG	2019	218	2					255	260		10.1016/j.amjsurg.2018.11.034			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	II6IZ	WOS:000475298900004	30558803				2022-02-06	
J	Wilkins, TE; Beers, SR; Borrasso, AJ; Brooks, J; Mesley, M; Puffer, R; Chang, YF; Okonkwo, DO; Puccio, AM				Wilkins, Tiffany E.; Beers, Sue R.; Borrasso, Allison J.; Brooks, Jordan; Mesley, Matthew; Puffer, Ross; Chang, Yue-Fang; Okonkwo, David O.; Puccio, Ava M.			Favorable Functional Recovery in Severe Traumatic Brain Injury Survivors beyond Six Months	JOURNAL OF NEUROTRAUMA			English	Article						Glasgow Outcome Scale-Extended; long-term functional status; traumatic brain injury	MIDDLE-CEREBRAL-ARTERY; NATIONAL INSTITUTE; DISABILITY; CONSCIOUSNESS; TRAJECTORIES; OUTCOMES; TBI	Favorable long-term functional outcomes after severe traumatic brain injury (TBI) may be underestimated. We analyzed 24-month functional outcomes from a consecutive series of severe TBI survivors. A prospective, observational database of severe TBI survivors from a single institution was analyzed. Glasgow Outcome Scale-Extended (GOS-E) scores were obtained at 3, 6, 12, and 24 months post-injury. GOS-E scores were dichotomized into unfavorable and favorable outcomes, and the proportion of survivors changing from unfavorable to favorable outcomes was calculated using Wilcoxon signed-rank tests. Surviving adults (N = 304; mean age +/- standard deviation = 35.06 +/- 15.11; 80.92% male; mode of initial GCS = 7) were analyzed. A statistically significant mean increase in GOS-E was noted from 3 to 6, 6 to 12, 12 to 24, and 6 to 24 months after injury (0.65 [p < 0.0001], 0.42 [p < 0.0001], 0.23 [p = 0.020], and 0.61 [p < 0.0001], respectively). Moreover, 43% of survivors from 3 to 6 months, 36% from 6 to 12 months, 38% from 12 to 24 months, and 54% from 6 to 24 months progressed from an unfavorable to a favorable outcome. Two thirds of survivors in the unfavorable category at 3 months had favorable outcomes at 2 years. Overall, 74% of surviving adults with a documented GOS-E at 2 years after injury had a favorable outcome. Severe TBI survivors demonstrated significant improvement in functional outcomes from 3 to 24 months after injury. At 2 years, three fourths of survivors had a favorable outcome. Long-term prognosis in severe TBI is better than broadly appreciated.	[Wilkins, Tiffany E.; Borrasso, Allison J.; Brooks, Jordan; Mesley, Matthew; Chang, Yue-Fang; Okonkwo, David O.; Puccio, Ava M.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Beers, Sue R.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Puffer, Ross] Mayo Clin, Dept Neurol Surg, Rochester, MN USA		Puccio, AM (corresponding author), Univ Pittsburgh, Dept Neurol Surg, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA.	Puccam@upmc.edu			National Institutes of Health (Brain Trauma Research Center: Department of Neurosurgery, University of Pittsburgh) [NS30318, NIH/NINRR00 NR013176]	This work was supported, in part, by the National Institutes of Health (NS30318; Brain Trauma Research Center: Department of Neurosurgery, University of Pittsburgh): NIH/NINRR00 NR013176 (AMP).	Bonds B, 2021, J NEUROTRAUM, V38, P1168, DOI 10.1089/neu.2014.3742; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Edlow BL, 2013, NEUROCRIT CARE, V19, P364, DOI 10.1007/s12028-013-9870-x; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Forslund MV, 2017, BRAIN INJURY, V31, P329, DOI 10.1080/02699052.2016.1255778; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JENNETT B, 1975, LANCET, V1, P480; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; KAUFMANN MA, 1992, RESUSCITATION, V23, P199, DOI 10.1016/0300-9572(92)90003-U; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Sandsmark DK, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0654-5; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wright J, 2011, ENCY CLIN NEUROPSYCH	21	13	13	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2019	36	22					3158	3163		10.1089/neu.2018.6153		JUL 2019	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JI6MG	WOS:000479781400001	31210093	Green Published			2022-02-06	
J	Abderezaei, J; Zhao, W; Grijalva, CL; Fabris, G; Ji, SB; Laksari, K; Kurt, M				Abderezaei, Javid; Zhao, Wei; Grijalva, Carissa L.; Fabris, Gloria; Ji, Songbai; Laksari, Kaveh; Kurt, Mehmet			Nonlinear Dynamical Behavior of the Deep White Matter during Head Impact	PHYSICAL REVIEW APPLIED			English	Article							DIFFUSE AXONAL INJURY; PROPER ORTHOGONAL DECOMPOSITION; HIGH-SCHOOL; MECHANICAL SYSTEMS; UNITED-STATES; BRAIN; STRAIN; CONCUSSION; SPORTS; MODEL	Traumatic brain injury (TBI) is a major public health concern, affecting as many as 3 million people each year in the U.S. Despite substantial research efforts in recent years, our physical understanding of the cause of injury remains rather limited. In this paper, we characterize the nonlinear dynamical behavior of the brain-skull system through modal analysis and advanced finite-element (FE) simulations. We observe nonlinear behavior in the deep-white-matter (WM) structures near the dural folds, with an energy redistribution of around 30% between the dominant modes. We find evidence of shear-wave redirection near the falx and the tentorium (approximately 15 degrees in the axial and 8 degrees in the coronal plane) as a result of geometric nonlinearities. The shift in the falx mode shape, which is perpendicular to the deformation of the brain, causes geometrical nonlinear effects at the falx-brain tissue boundary. This is accompanied by a lateral sliding of the tentorium below the brain tissue, which induces higher local strains at its interface with deep regions of the brain. We observe that deep regions of the brain with high principal strains coincide with the identified nonlinear regions. The onset of nonlinear behavior in brain tissue is closely associated with the previously reported concussion thresholds, suggesting a possible link between the damage mechanism and the underlying nonlinear brain biomechanics.	[Abderezaei, Javid; Fabris, Gloria; Kurt, Mehmet] Stevens Inst Technol, Dept Mech Engn, Hoboken, NJ 07030 USA; [Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Grijalva, Carissa L.; Laksari, Kaveh] Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA; [Kurt, Mehmet] Icahn Sch Med Mt Sinai, Translat & Mol Imaging Inst, New York, NY 10029 USA		Kurt, M (corresponding author), Stevens Inst Technol, Dept Mech Engn, Hoboken, NJ 07030 USA.; Kurt, M (corresponding author), Icahn Sch Med Mt Sinai, Translat & Mol Imaging Inst, New York, NY 10029 USA.	mkurt@stevens.edu	Kurt, Mehmet/AAX-3303-2021; Abderezaei, Javid/AAT-5749-2020	Kurt, Mehmet/0000-0002-5618-0296	NSFNational Science Foundation (NSF) [CMMI-1826270, CMMI-1728186]	This research was supported by NSF Grants No. CMMI-1826270 and No. CMMI-1728186. We also thank Professor Alexander Vakakis for his helpful suggestions and feedback.	Aletras AH, 1999, J MAGN RESON, V137, P247, DOI 10.1006/jmre.1998.1676; Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Bellet R, 2010, J SOUND VIB, V329, P2768, DOI 10.1016/j.jsv.2010.01.029; Bradshaw DRS, 2001, J BIOMECH, V34, P85, DOI 10.1016/S0021-9290(00)00135-4; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Chartrain AG, 2019, NEUROSURG REV, V42, P1, DOI 10.1007/s10143-017-0862-8; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; Feeny BF, 1998, J SOUND VIB, V211, P607, DOI 10.1006/jsvi.1997.1386; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Georgiou IT, 1999, SIAM J APPL MATH, V59, P1178, DOI 10.1137/S0036139997299802; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giammarinaro B, 2018, PHYS REV APPL, V9, DOI 10.1103/PhysRevApplied.9.014011; Giannini O, 2013, COMPUT STRUCT, V129, P166, DOI 10.1016/j.compstruc.2013.05.002; Giordano C., 2014, EVALUATION AXONAL ST; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; GURDJIAN ES, 1968, J NEUROSURG, V29, P70, DOI 10.3171/jns.1968.29.1.0070; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hardy Warren N., 2001, INVESTIGATION HEAD I; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ho J, 2017, J BIOMECH, V60, P243, DOI 10.1016/j.jbiomech.2017.06.023; Holbourn AHS, 1944, J NEUROSURG, V1, P190, DOI 10.3171/jns.1944.1.3.0190; Holbourn AHS, 1943, LANCET, V2, P438; Holmes P, 2012, CAMB MG MEC, P1, DOI 10.1017/CBO9780511919701; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Kappagantu RV, 2000, NONLINEAR DYNAM, V23, P1, DOI 10.1023/A:1008303406091; Kerschen G, 2005, NONLINEAR DYNAM, V41, P147, DOI 10.1007/s11071-005-2803-2; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S., 2007, PREDICTORS TRAUMATIC; KORNHAUSER M, 1954, J APPL MECH-T ASME, V21, P371; Kurt M, 2019, J NEUROIMAGING, V29, P440, DOI 10.1111/jon.12619; Kurt M, 2014, COMMUN NONLINEAR SCI, V19, P2905, DOI 10.1016/j.cnsns.2013.12.018; Kurt M, 2014, J SOUND VIB, V333, P2054, DOI 10.1016/j.jsv.2013.11.021; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Laksari K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.138101; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Laksari K, 2015, BIOMECH MODEL MECHAN, V14, P459, DOI 10.1007/s10237-014-0616-2; Laksari K, 2012, J BIOMECH, V45, P642, DOI 10.1016/j.jbiomech.2011.12.023; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Lee YS, 2008, P I MECH ENG K-J MUL, V222, P77, DOI 10.1243/14644193JMBD118; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lu Y. - C., 2019, ANN BIOMED ENG, V1; Ma XH, 2001, J VIB ACOUST, V123, P36, DOI 10.1115/1.1320813; Malone D., 2008, INVESTIGATION TRAUMA; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Massouros PG, 2014, INT J SOLIDS STRUCT, V51, P305, DOI 10.1016/j.ijsolstr.2013.09.022; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Noel JP, 2014, MECH SYST SIGNAL PR, V43, P217, DOI 10.1016/j.ymssp.2013.10.016; Okamoto RJ, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519840444; Ommaya AK, 1985, BIOMECHANICS TRAUMA, P249; Patton DA, 2012, P I MECH ENG P-J SPO, V226, P177, DOI 10.1177/1754337112438305; Rega G, 2001, INT J SOLIDS STRUCT, V38, P2049, DOI 10.1016/S0020-7683(00)00152-9; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Starosvetsky Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026603; Steindl A, 2001, INT J SOLIDS STRUCT, V38, P2131, DOI 10.1016/S0020-7683(00)00157-8; Takhounts Erik G., 2013, DEV BRAIN INJURY CRI; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Terem I, 2018, MAGN RESON MED, V80, P2549, DOI 10.1002/mrm.27236; Tumer IY, 2000, MECH SYST SIGNAL PR, V14, P1011, DOI 10.1006/mssp.1999.1278; Vakakis A. F., 2008, NONLINEAR TARGETED E, V156; Versace J, 1971, REV SEVERITY INDEX; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhao W, 2015, IRCOBI C LYON FRANC, P208; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634	70	13	13	0	9	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	2331-7019			PHYS REV APPL	Phys. Rev. Appl.	JUL 30	2019	12	1							014058	10.1103/PhysRevApplied.12.014058			8	Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Physics	IM3UJ	WOS:000477920000001		Green Published, hybrid			2022-02-06	
J	Li, JY; Gu, Y; An, HW; Zhou, ZY; Zheng, D; Wang, ZH; Wen, ZH; Shen, HY; Wang, Q; Wang, HH				Li, Jiayu; Gu, Yong; An, Hongwei; Zhou, Zheyi; Zheng, Dong; Wang, Zhanhang; Wen, Zehuai; Shen, Hai-Ying; Wang, Qi; Wang, Honghao			Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis	BRAIN AND BEHAVIOR			English	Article						anti-NMDAR encephalitis; cerebrospinal fluid; cytokine; modified Rankin scale; neurofilament heavy subunit; neurofilament light subunit	TRAUMATIC BRAIN-INJURY; CSF; PROTEINS; DAMAGE; CELLS; MICE	Background Neurofilaments (Nf) are a series of highly specific scaffolding proteins of neurons. Neurofilament light chains (Nf-L) and the heavy one (Nf-H) are subunits of Nf, and they are recognized as potent productions of neural damage. The concentrations of Nf aggrandized significantly in neurological disease including neuromyelitis optica, multiple sclerosis, and Alzheimer's disease. However, whether Nf in cerebrospinal fluid (CSF) elevated in anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is unclear. Here, we aimed to detect whether CSF Nf is altered in NMDAR and whether changes in CSF Nf can serve as an objective and effective biomarker to evaluate disease severity and prognosis. Methods We collected 24 anti-NMDAR encephalitis patients, 11 viral meningoencephalitis/encephalitis (VM) patients, and 21 controls in this study. CSF Nf-L, Nf-H, and cytokine levels (IL-1 beta, IL-6, and IL-17A) were determined by enzyme-linked immunosorbent assay (ELISA) and compared between groups. We evaluated patients' clinical outcomes or prognosis according to modified Rankin scale (mRS) score. Results Compared with controls, both CSF Nf-L and Nf-H levels were significantly increased in anti-NMDAR encephalitis patients. While compared with VM patients, only Nf-L were increased in anti-NMDAR encephalitis patients. Moreover, CSF Nf-L were positively correlated with concentration of cytokines (IL-1 beta, IL-17A) and mRS scores in anti-NMDAR encephalitis patients. After treatment, both CSF Nf-L and Nf-H levels decreased. Furthermore, the Nf-L during follow-up positively correlated with 3-month mRS scores, and Delta Nf-L positively correlated with Delta mRS. Conclusions Briefly, CSF Nf-L levels notably increased in anti-NMDAR encephalitis patients in acute phase and positively correlated with disease severity. It could be considered as a useful indicator for clinical outcomes and prognosis.	[Li, Jiayu; Wang, Honghao] Southern Med Univ, Nanfang Hosp, Dept Neurol, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China; [Li, Jiayu; Wen, Zehuai; Wang, Qi] Guangzhou Univ Chinese Med, Inst Clin Pharmacol, Guangzhou 510405, Guangdong, Peoples R China; [Gu, Yong] Hainan Prov Hosp Tradit Chinese Med, Dept Encephalopathy, Haikou, Hainan, Peoples R China; [An, Hongwei; Zhou, Zheyi] Liuzhou Tradit Chinese Med Hosp, Dept Neurol, Liuzhou, Peoples R China; [Zheng, Dong] Guangzhou Med Univ, Dept Neurol, Affiliated Brain Hosp, Guangzhou, Guangdong, Peoples R China; [Wang, Zhanhang] 999 Brain Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Shen, Hai-Ying] Legacy Res Inst, RS Dow Neurobiol Labs, Portland, OR 97232 USA		Wang, HH (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Neurol, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China.; Wang, Q (corresponding author), Guangzhou Univ Chinese Med, Inst Clin Pharmacol, Guangzhou 510405, Guangdong, Peoples R China.; Shen, HY (corresponding author), Legacy Res Inst, Dept Neurobiol, 1225 NE 2nd Ave, Portland, OR 97232 USA.	hshen@downeurobiology.org; wangqi@gzucm.edu.cn; wang_whh@163.com	wang, honghao/AAF-5764-2020	wang, honghao/0000-0002-1215-6219; Shen, Hai-Ying/0000-0001-8430-2978	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81673950]; Natural Science Foundation of Guangdong Province of ChinaNational Natural Science Foundation of Guangdong Province [2016A030313828]; Guangdong Provincial Science and Technology plan Projects [2016A020215101, 2017A020215182]; Liuzhou "A 1000 Talent Project in the New Century" Special Funds [2209.06-00210]; Science and Technology Innovation Ability and the Condition of Construction Project of Liuzhou [2014J030407]	This work is funded by National Natural Science Foundation of China (grant number 81673950); Natural Science Foundation of Guangdong Province of China (grant number 2016A030313828); Guangdong Provincial Science and Technology plan Projects (grant numbers 2016A020215101 and 2017A020215182).; Liuzhou "A 1000 Talent Project in the New Century" Special Funds (grant number 2209.06-00210); and the Science and Technology Innovation Ability and the Condition of Construction Project of Liuzhou (grant number 2014J030407).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Ai P, 2018, ACTA NEUROL SCAND, V137, P277, DOI 10.1111/ane.12850; Axelsson M, 2014, MULT SCLER J, V20, P43, DOI 10.1177/1352458513490544; Bossu P, 2007, J NEUROL NEUROSUR PS, V78, P807, DOI 10.1136/jnnp.2006.103242; Camdessanche JP, 2011, EUR J NEUROL, V18, P929, DOI 10.1111/j.1468-1331.2010.03180.x; Chen JY, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00727; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050; Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; GEISLER N, 1981, J MOL BIOL, V151, P565, DOI 10.1016/0022-2836(81)90011-5; GOLDSTEIN ME, 1987, J NEUROIMMUNOL, V14, P149, DOI 10.1016/0165-5728(87)90049-X; Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9; Hachiya Y, 2013, J NEUROIMMUNOL, V265, P128, DOI 10.1016/j.jneuroim.2013.09.017; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Julien JP, 1998, PROG NUCLEIC ACID RE, V61, P1, DOI 10.1016/S0079-6603(08)60823-5; Kayser MS, 2013, JAMA NEUROL, V70, P1133, DOI 10.1001/jamaneurol.2013.3216; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Kuhle J, 2015, NEUROLOGY, V84, P1639, DOI 10.1212/WNL.0000000000001491; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; Li ZH, 2006, BRAIN RES, V1113, P200, DOI 10.1016/j.brainres.2006.07.041; Liu BZ, 2018, CLIN CHIM ACTA, V480, P79, DOI 10.1016/j.cca.2018.01.016; Madeddu R, 2013, NEUROL SCI, V34, P181, DOI 10.1007/s10072-012-0974-4; Patakas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049715; PENG Y, 2019, FRONT IMMUNOL, V10, DOI DOI 10.3389/FIMMU.2019.00103; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Pradillo JM, 2012, J CEREBR BLOOD F MET, V32, P1810, DOI 10.1038/jcbfm.2012.101; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Singh P, 2011, J NEUROL SCI, V304, P117, DOI 10.1016/j.jns.2011.01.025; Sjogren M, 2000, NEUROLOGY, V54, P1960, DOI 10.1212/WNL.54.10.1960; Tuzun E, 2009, ACTA NEUROPATHOL, V118, P737, DOI 10.1007/s00401-009-0582-4; Uzawa A, 2010, MULT SCLER J, V16, P1443, DOI 10.1177/1352458510379247; Wang HH, 2013, NEUROCHEM INT, V63, P805, DOI 10.1016/j.neuint.2013.10.008; Zandi MS, 2015, J NEUROL NEUROSUR PS, V86, P708, DOI 10.1136/jnnp-2014-308736; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	40	13	15	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	AUG	2019	9	8							e01354	10.1002/brb3.1354		JUL 2019	8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	IU4PR	WOS:000476290200001	31313506	Green Published, gold			2022-02-06	
J	Christy, JB; Cochrane, GD; Almutairi, A; Busettini, C; Swanson, MW; Weise, KK				Christy, Jennifer B.; Cochrane, Graham D.; Almutairi, Anwar; Busettini, Claudio; Swanson, Mark W.; Weise, Katherine K.			Peripheral Vestibular and Balance Function in Athletes With and Without Concussion	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						dizziness; human movement system; mild traumatic brain injury; physical therapy; postconcussion syndrome	MOTOR SCREENING VOMS; RELIABILITY; RECOVERY; CHILDREN; YOUTH	Background and Purpose: According to the most recent consensus statement on management of sport-related concussion (SRC), athletes with suspected SRC should receive a comprehensive neurological examination. However, which measures to include in such an examination are not defined. Our objectives were to (1) evaluate test-retest reliability and normative data on vestibular and balance tests in athletes without SRC; (2) compare athletes with and without SRC on the subtests; and (3) identify subtests for concussion testing protocols. Methods: Healthy athletes (n = 87, mean age 20.6 years; standard deviation = 1.8 years; 39 female and 48 male) and athletes with SRC (n = 28, mean age 20.7 years; standard deviation = 1.9 years; 11 female and 17 male) were tested using rotary chair, cervical vestibular-evoked myogenic potential (c-VEMP), and the Sensory Organization Test (SOT). A subset (n = 43) were tested twice. We analyzed reliability of the tests, and compared results between athletes with and without SRC. Results: Reliability ranged from poor to strong. There was no significant difference between athletes with and without SRC for tests of peripheral vestibular function (ie, rotary chair and c-VEMP). Athletes with SRC had significantly worse scores (P < 0.05) on vestibular-ocular reflex (VOR) cancellation gain, subjective visual vertical and horizontal variance, and all conditions of the SOT. Discussion and Conclusion: SRC did not affect medium frequency VOR or saccular function. SRC did affect the ability to use vestibular inputs for perception of vertical and postural control, as well as ability to cancel the VOR. Video Abstract available for more insights from the authors ( see Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A274).	[Christy, Jennifer B.; Cochrane, Graham D.; Almutairi, Anwar] Univ Alabama Birmingham, Dept Phys Therapy, SHPB 346,1720 2nd Ave South, Birmingham, AL 35294 USA; [Busettini, Claudio; Swanson, Mark W.; Weise, Katherine K.] Univ Alabama Birmingham, Dept Optometry & Vis Sci, Birmingham, AL USA; [Busettini, Claudio] Univ Alabama Birmingham, Vis Sci Res Ctr, Birmingham, AL USA		Christy, JB (corresponding author), Univ Alabama Birmingham, Dept Phys Therapy, SHPB 346,1720 2nd Ave South, Birmingham, AL 35294 USA.	jbraswel@uab.edu		Cochrane, Graham/0000-0003-1548-9382	Health Service Foundation General Endowment Fund; NIH-NEIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30 EY-03039]; Alabama Department of Commerce grant; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY003039] Funding Source: NIH RePORTER	This research was funded by a grant from the Health Service Foundation General Endowment Fund to James Johnston, MD, and Claudio Busettini, PhD, the NIH-NEI P30 EY-03039 Vision Science Research Center Core Grant, and an Alabama Department of Commerce grant.	Akin F. W., 2008, BALANCE FUNCTION ASS, P405; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Alshehri MM, 2016, J VESTIBUL RES-EQUIL, V26, P439, DOI 10.3233/VES-160598; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Chen HM, 2009, NEUROREHAB NEURAL RE, V23, P435, DOI 10.1177/1545968308331146; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Kumar L, 2017, OTOL NEUROTOL, V38, pE378, DOI 10.1097/MAO.0000000000001525; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leigh RJ., 2015, NEUROLOGY EYE MOVEME, P289; Massingale S, 2018, J NEUROL PHYS THER, V42, P149, DOI 10.1097/NPT.0000000000000225; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meyer N, 2015, INT J AUDIOL, V54, P143, DOI 10.3109/14992027.2014.971468; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Zaki R, 2013, IRAN J BASIC MED SCI, V16, P803	26	13	13	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JUL	2019	43	3					153	159		10.1097/NPT.0000000000000280			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	IH1IQ	WOS:000474244900004	31205229	Green Accepted			2022-02-06	
J	Esterman, M; Fortenbaugh, FC; Pierce, ME; Fonda, JR; DeGutis, J; Milberg, W; McGlinchey, R				Esterman, Michael; Fortenbaugh, Francesca C.; Pierce, Meghan E.; Fonda, Jennifer R.; DeGutis, Joseph; Milberg, William; McGlinchey, Regina			Trauma-Related Psychiatric and Behavioral Conditions Are Uniquely Associated With Sustained Attention Dysfunction	NEUROPSYCHOLOGY			English	Article						PTSD; mTBI; sustained attention; gradCPT; veterans	POSTTRAUMATIC-STRESS-DISORDER; STRUCTURED CLINICAL INTERVIEW; CHRONIC PAIN; RESPONSE-INHIBITION; SUBSTANCE-ABUSE; BRAIN-INJURY; PSYCHOLOGICAL SYMPTOMS; SLEEP-DEPRIVATION; DEFAULT NETWORK; WORKING-MEMORY	Objective: It is increasingly recognized that trauma victims, particularly Veterans, have co-occurring psychological and physical conditions that impact cognition, especially the domains of sustained attention and executive functioning. Although previous work has generally attempted to isolate the unique cognitive effects of common combat-related comorbidities, less work has been done to examine how these conditions co-occur, and whether unique cognitive signatures accompany certain clinical combinations. Method: to address this gap, we examined how several deployment-related conditions were associated with performance on a well-validated measure of sustained attention (i.e., gradual onset continuous performance task IgradCPTI) and a battery of standard neuropsychological measures in 123 Veterans from the Translational Research Center for TBI and Stress Disorders. Initially, a Principal component analysis was conducted to investigate how comorbid conditions grouped together. Results: Several sustained attention measures from the gradCPT were differentially associated with four unique combinations of trauma-related pathology. Specifically. a somatic component representing the combination of current pain, sleep disturbance, and mild traumatic brain injury was associated with a higher rate of failures of attentional engagement. On the other hand. a comorbid posttraumatic stress disorder (PTSD) and mood disorder component (moodPTSD), as well as a substance use disorder component, were associated with higher rates of inhibitory control failures. Increased attentional instability was associated with moodPTSD as well as an anxiety disorder component. In contrast, the cognitive effects of deployment-related trauma were not observed on standard neuropsychological measures. Cone/mime These findings suggest that unique combinations of trauma-related pathology have dissociable effects on sustained attentional control.	[Esterman, Michael; Fortenbaugh, Francesca C.; Pierce, Meghan E.; Fonda, Jennifer R.; DeGutis, Joseph; Milberg, William; McGlinchey, Regina] Vet Affairs Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders, 150 South Huntington Ave, Boston, MA 02130 USA; [Esterman, Michael; Fortenbaugh, Francesca C.; Pierce, Meghan E.; Fonda, Jennifer R.; DeGutis, Joseph; Milberg, William; McGlinchey, Regina] Vet Affairs Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, 150 South Huntington Ave, Boston, MA 02130 USA; [Esterman, Michael; Fonda, Jennifer R.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Fortenbaugh, Francesca C.; Pierce, Meghan E.; DeGutis, Joseph; Milberg, William; McGlinchey, Regina] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA		Esterman, M (corresponding author), Vet Affairs Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders, 150 South Huntington Ave, Boston, MA 02130 USA.; Esterman, M (corresponding author), Vet Affairs Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, 150 South Huntington Ave, Boston, MA 02130 USA.	michael.esterman@va.gov	Fonda, Jennifer R./ABG-2890-2021	Fonda, Jennifer R./0000-0001-9482-2918	Department of Veterans Affairs (VA) Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development National Network Center for TBI Research [B9254-C]; Department of Veterans Affairs Clinical Sciences Research and DevelopmentUS Department of Veterans Affairs [1IK2CX000706-01A2, I01CX001653, CX001327]; Department of Veterans Affairs Rehabilitation Research and DevelopmentUS Department of Veterans Affairs [1IK2RX002268-01A2]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NCCIH R21 AT009430-01]; Stuart T. Hauser Clinical Research Training Program T32, National Institute of Mental Health [4T32MH016259-37]; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21AT009430] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001653, IK2RX002268, IK2CX000706] Funding Source: NIH RePORTER	This research was supported in part by the Department of Veterans Affairs (VA) Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development National Network Center for TBI Research (B9254-C) to Regina McGlinchey. Michael Esterman has Career Development Award 1IK2CX000706-01A2 and Merit Review Award I01CX001653 from the Department of Veterans Affairs Clinical Sciences Research and Development. Francesca C. Fortenbaugh has a Career Development Award 1IK2RX002268-01A2 from the Department of Veterans Affairs Rehabilitation Research and Development. Regina McGlinchey has Merit Review Award CX001327 from Department of Veterans Affairs Clinical Sciences Research and Development. William Milberg is supported by National Institutes of Health (NCCIH R21 AT009430-01). Meghan E. Pierce is supported by the Stuart T. Hauser Clinical Research Training Program T32, National Institute of Mental Health (4T32MH016259-37). The contents of this article are the views of the authors and do not represent the views of the Department of Veterans Affairs or the U.S. government.	Akiskal HS, 1998, ACTA PSYCHIAT SCAND, V98, P66, DOI 10.1111/j.1600-0447.1998.tb05969.x; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; Amick MM, 2013, J INT NEUROPSYCH SOC, V19, P792, DOI 10.1017/S1355617713000544; Arnsten AFT, 1998, TRENDS COGN SCI, V2, P436, DOI 10.1016/S1364-6613(98)01240-6; Auerbach RP, 2014, PSYCHIAT RES, V220, P579, DOI 10.1016/j.psychres.2014.07.027; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Ayalon L, 2009, SLEEP, V32, P373, DOI 10.1093/sleep/32.3.373; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Beckham JC, 1997, J PSYCHOSOM RES, V43, P379, DOI 10.1016/S0022-3999(97)00129-3; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; Bleich A, 1997, BRIT J PSYCHIAT, V170, P479, DOI 10.1192/bjp.170.5.479; BROWN PJ, 1994, DRUG ALCOHOL DEPEN, V35, P51, DOI 10.1016/0376-8716(94)90110-4; BROWN PJ, 1995, ADDICT BEHAV, V20, P251, DOI 10.1016/0306-4603(94)00060-3; Buhle J, 2010, PAIN, V149, P19, DOI 10.1016/j.pain.2009.10.027; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Chun MM, 2011, NEUROPSYCHOLOGIA, V49, P1407, DOI 10.1016/j.neuropsychologia.2011.01.029; Clark L, 2002, BRIT J PSYCHIAT, V180, P313, DOI 10.1192/bjp.180.4.313; Creswell JD, 2017, ANNU REV PSYCHOL, V68, P491, DOI 10.1146/annurev-psych-042716-051139; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; DeGutis J, 2018, BEHAV SLEEP MED, V16, P38, DOI 10.1080/15402002.2016.1173550; DeGutis J, 2015, J INT NEUROPSYCH SOC, V21, P342, DOI 10.1017/S1355617715000235; DeGutis JM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00060; Delis D., 2001, D KEFS EXAMINERS TEC; Dick BD, 2007, ANESTH ANALG, V104, P1223, DOI 10.1213/01.ane.0000263280.49786.f5; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Dutilh G, 2012, ATTEN PERCEPT PSYCHO, V74, P454, DOI 10.3758/s13414-011-0243-2; Dutra Sunny J, 2018, Chronic Stress (Thousand Oaks), V2, DOI 10.1177/2470547018812400; Ehring T, 2008, COGNITIVE THER RES, V32, P488, DOI 10.1007/s10608-006-9089-7; Ellenbogen MA, 2009, BEHAV RES THER, V47, P128, DOI 10.1016/j.brat.2008.10.021; Esterman M, 2017, CEREB CORTEX, V27, P4022, DOI 10.1093/cercor/bhw214; Esterman M, 2017, NEUROIMAGE, V156, P190, DOI 10.1016/j.neuroimage.2017.05.011; Esterman M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159741; Esterman M, 2014, J EXP PSYCHOL GEN, V143, P2287, DOI 10.1037/xge0000019; Esterman M, 2013, J INT NEUROPSYCH SOC, V19, P835, DOI 10.1017/S135561771300057X; Esterman M, 2013, CEREB CORTEX, V23, P2712, DOI 10.1093/cercor/bhs261; EYSENCK MW, 1979, J RES PERS, V13, P363, DOI 10.1016/0092-6566(79)90001-1; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; First M.B., 1996, STRUCTURED CLIN INTE; Forster S, 2015, CEREB CORTEX, V25, P609, DOI 10.1093/cercor/bht248; Fortenbaugh FC, 2018, NEUROIMAGE, V171, P148, DOI 10.1016/j.neuroimage.2018.01.002; Fortenbaugh FC, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.684; Fortenbaugh FC, 2017, ANN NY ACAD SCI, V1396, P70, DOI 10.1111/nyas.13318; Fortenbaugh FC, 2017, VISION RES, V131, P26, DOI 10.1016/j.visres.2016.12.002; Fortenbaugh FC, 2015, PSYCHOL SCI, V26, P1497, DOI 10.1177/0956797615594896; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Golier J, 1997, INTEGR PHYS BEH SCI, V32, P52, DOI 10.1007/BF02688613; Grafton KV, 2005, CLIN J PAIN, V21, P73, DOI 10.1097/00002508-200501000-00009; GREEN BL, 1992, J NERV MENT DIS, V180, P760, DOI 10.1097/00005053-199212000-00004; Green P, 2004, GREENS MED SYMPTOM V; HELZER JE, 1987, NEW ENGL J MED, V317, P1630, DOI 10.1056/NEJM198712243172604; Jenkins MA, 2000, CLIN NEUROPSYCHOL, V14, P7, DOI 10.1076/1385-4046(200002)14:1;1-8;FT007; Joormann J, 2011, PSYCHOL SCI, V22, P979, DOI 10.1177/0956797611415539; Kar Nilamadhab, 2006, Clin Pract Epidemiol Ment Health, V2, P17, DOI 10.1186/1745-0179-2-17; Keane T. M., 1987, RECENT DEV ALCOHOLIS, V6, P27; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kucyi A, 2016, P NATL ACAD SCI USA, V113, P13899, DOI 10.1073/pnas.1611743113; Kucyi A, 2013, P NATL ACAD SCI USA, V110, P18692, DOI 10.1073/pnas.1312902110; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Lavie P, 2001, NEW ENGL J MED, V345, P1825, DOI 10.1056/NEJMra012893; Leark RA, 2007, TEST VARIABLES ATTEN; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Ling S, 2006, NAT NEUROSCI, V9, P1243, DOI 10.1038/nn1761; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; McAuley E, 2000, Exerc Sport Sci Rev, V28, P85; MCFALL ME, 1992, J STUD ALCOHOL, V53, P357, DOI 10.15288/jsa.1992.53.357; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Michael T, 2007, DEPRESS ANXIETY, V24, P307, DOI 10.1002/da.20228; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Monterosso JR, 2005, DRUG ALCOHOL DEPEN, V79, P273, DOI 10.1016/j.drugalcdep.2005.02.002; Moore DJ, 2017, PAIN, V158, P2035, DOI 10.1097/j.pain.0000000000001011; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Moser JS, 2012, EMOTION, V12, P213, DOI 10.1037/a0026156; Nawijn L, 2015, NEUROSCI BIOBEHAV R, V51, P189, DOI 10.1016/j.neubiorev.2015.01.019; Norman SB, 2008, PSYCHOL MED, V38, P533, DOI 10.1017/S0033291707001389; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; Oosterman JM, 2012, PAIN RES MANAG, V17, P159, DOI 10.1155/2012/962786; Ouimette P, 2003, TRAUMA AND SUBSTANCE ABUSE: CAUSES, CONSEQUENCES, AND TREATMENT OF COMORBID DISORDERS, P91, DOI 10.1037/10460-005; Paelecke-Habermann Y, 2005, J AFFECT DISORDERS, V89, P125, DOI 10.1016/j.jad.2005.09.006; Pineles SL, 2007, BEHAV RES THER, V45, P1903, DOI 10.1016/j.brat.2006.08.021; Pineles SL, 2009, BEHAV RES THER, V47, P1050, DOI 10.1016/j.brat.2009.08.001; Pope HG, 2001, ARCH GEN PSYCHIAT, V58, P909, DOI 10.1001/archpsyc.58.10.909; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rosenberg MD, 2016, NAT NEUROSCI, V19, P165, DOI 10.1038/nn.4179; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sanchez A, 2013, J ABNORM PSYCHOL, V122, P303, DOI 10.1037/a0031529; Sang CN, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-016-0601-9; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Seli P, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00265; Seli P, 2013, J EXP PSYCHOL HUMAN, V39, P1, DOI 10.1037/a0030954; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Shucard JL, 2008, BIOL PSYCHOL, V79, P223, DOI 10.1016/j.biopsycho.2008.05.005; Silver H, 2005, J NEUROPSYCH CLIN N, V17, P391, DOI 10.1176/appi.neuropsych.17.3.391; Speckens AEM, 2007, MEMORY, V15, P249, DOI 10.1080/09658210701256449; Steinmayr R, 2010, LEARN INDIVID DIFFER, V20, P14, DOI 10.1016/j.lindif.2009.10.009; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Swick D, 2013, NEUROPSYCHOLOGIA, V51, P3033, DOI 10.1016/j.neuropsychologia.2013.10.008; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Takano K, 2009, BEHAV RES THER, V47, P260, DOI 10.1016/j.brat.2008.12.008; U. S. Department of Veterans Affairs & U. S. Department of Defense, 2009, VA DOD CLIN PRACT GU; van Rooij SJH, 2014, J PSYCHIATR NEUROSCI, V39, P330, DOI 10.1503/jpn.130223; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Wechsler D., 2008, WECHSLER ADULT INTEL; Weiss KE, 2018, PAIN MED, V19, P60, DOI 10.1093/pm/pnx020; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Wu E, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000152; Wu JH, 2010, NEUROSCI LETT, V486, P117, DOI 10.1016/j.neulet.2010.07.040; Xiao JX, 2010, PROC CVPR IEEE, P3485, DOI 10.1109/CVPR.2010.5539970; Yanko MR, 2014, HUM FACTORS, V56, P260, DOI 10.1177/0018720813495280; Zakzanis KK, 1998, NEUROPSY NEUROPSY BE, V11, P111; Zlotnick C, 1999, J TRAUMA STRESS, V12, P89, DOI 10.1023/A:1024746316245	129	13	13	1	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2019	33	5					711	724		10.1037/neu0000525			14	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	IF4AD	WOS:000473023300010	31144830	Bronze, Green Accepted			2022-02-06	
J	Haar, CV; Martens, KM; Bashir, A; McInnes, KA; Cheng, WH; Cheung, H; Stukas, S; Barron, C; Ladner, T; Welch, KA; Cripton, PA; Winstanley, CA; Wellington, CL				Haar, Cole Vonder; Martens, Kris M.; Bashir, Asma; McInnes, Kurt A.; Cheng, Wai Hang; Cheung, Honor; Stukas, Sophie; Barron, Carlos; Ladner, Tessa; Welch, Kassandra A.; Cripton, Peter A.; Winstanley, Catharine A.; Wellington, Cheryl L.			Repetitive closed-head impact model of engineered rotational acceleration (CHIMERA) injury in rats increases impulsivity, decreases dopaminergic innervation in the olfactory tubercle and generates white matter inflammation, tau phosphorylation and degeneration	EXPERIMENTAL NEUROLOGY			English	Article						CHIMERA; Repetitive TBI; Impulsivity; Reward circuitry; White matter inflammation; Corpus callosum degeneration; Tau phosphorylation	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; DECISION-MAKING; SUBSTANCE USE; CONCUSSION; DEPRESSION; RISK; ENCEPHALOPATHY; DISINHIBITION; DYSFUNCTION	Traumatic brain injury (TBI) affects at least 3 M people annually. In humans, repetitive mild TBI (rmTBI) can lead to increased impulsivity and may be associated with chronic traumatic encephalopathy. To better understand the relationship between repetitive TBI (rTBI), impulsivity and neuropathology, we used CHIMERA (Closed-Head Injury Model of Engineered Rotational Acceleration) to deliver five TBIs to rats, which were continuously assessed for trait impulsivity using the delay discounting task and for neuropathology at endpoint. Compared to sham controls, rats with rTBI displayed progressive impairment in impulsive choice. Histological analyses revealed reduced dopaminergic innervation from the ventral tegmental area to the olfactory tubercle, consistent with altered impulsivity neurocircuitry. Consistent with diffuse axonal injury generated by CHIMERA, white matter inflammation, tau immunoreactivity and degeneration were observed in the optic tract and corpus callosum. Finally, pronounced grey matter microgliosis was observed in the olfactory tubercle. Our results provide insight into the mechanisms by which rTBI leads to post-traumatic psychiatric-like symptoms in a novel rat TBI platform.	[Haar, Cole Vonder; Martens, Kris M.] West Virginia Univ, Dept Psychol, Injury & Recovery Lab, Morgantown, WV 26508 USA; [Haar, Cole Vonder; Martens, Kris M.; Bashir, Asma; Cheng, Wai Hang; Cheung, Honor; Stukas, Sophie; Barron, Carlos; Ladner, Tessa; Welch, Kassandra A.; Winstanley, Catharine A.; Wellington, Cheryl L.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V6T 1Z3, Canada; [McInnes, Kurt A.; Cripton, Peter A.] Univ British Columbia, Dept Mech Engn, Int Ctr Repair Discoveries, Vancouver, BC V5Z 1M9, Canada		Wellington, CL (corresponding author), Univ British Columbia, Dept Pathol, Lab Med, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	cole.vonderhaar@mail.wvu.edu; kris.martens@mail.wvu.edu; asma.bashir@ubc.ca; sophie.stukas@ubc.ca; cbe37@mail.ubc.ca; cripton@mech.ubc.ca; cwinstanley@psych.ubc.ca; wcheryl@mail.ubc.ca	Cripton, Peter Alec/AAC-8268-2020	Cripton, Peter Alec/0000-0002-5067-0833; Bashir, Asma/0000-0002-3616-9436; Vonder Haar, Cole/0000-0001-7949-2068; Cheng, Wai Hang/0000-0002-3408-9184; Cheung, Honor/0000-0002-9780-2522	Weston Brain Institute [TRA140070]; Djavad Mowafaghian Centre for Brain Health; Canadian Institutes of Health Research Graduate AwardCanadian Institutes of Health Research (CIHR); University of British Columbia Doctoral Fellowship; Canadian Institutes of Health Research post-doctoral fellowshipCanadian Institutes of Health Research (CIHR)	Operating funding for this work was provided by a Transformational grant from the Weston Brain Institute to CLW (TRA140070), and an internal grant from the Djavad Mowafaghian Centre for Brain Health to CV, KMM, CAW, and CLW. AB was supported by a Canadian Institutes of Health Research Graduate Award and is supported by a University of British Columbia Doctoral Fellowship. CV was supported by a Canadian Institutes of Health Research post-doctoral fellowship. We would like to thank Dr. Haakon Nygaard for use of his confocal microscope and the Canadian Traumatic Brain Injury Research Consortium for constructive feedback.	Arnould A, 2016, ANN PHYS REHABIL MED, V59, P18, DOI 10.1016/j.rehab.2015.09.002; Baik JH, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00152; Bailey MR, 2016, NEUROBIOL LEARN MEM, V133, P233, DOI 10.1016/j.nlm.2016.07.015; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Banks SJ, 2014, J NEUROPSYCH CLIN N, V26, P44, DOI 10.1176/appi.neuropsych.12070185; Bjork JM, 2017, ARCH PHYS MED REHAB, V98, P1646, DOI 10.1016/j.apmr.2017.03.022; Bjork JM, 2016, PSYCHIAT RES, V246, P321, DOI 10.1016/j.psychres.2016.10.008; Brewer JA, 2008, BIOCHEM PHARMACOL, V75, P63, DOI 10.1016/j.bcp.2007.06.043; Brooks DM, 2017, EXP NEUROL, V297, P62, DOI 10.1016/j.expneurol.2017.07.015; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen YH, 2017, CELL TRANSPLANT, V26, P1156, DOI 10.1177/0963689717714105; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Dixon MR, 2005, BEHAV INTERVENT, V20, P101, DOI 10.1002/bin.173; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Frieden T.R., 2015, CDC NIH REP C, P1, DOI [10.3171/2009.10.JNS091500, DOI 10.3171/2009.10.JNS091500]; Gao HB, 2017, BRAIN RES, V1657, P1, DOI 10.1016/j.brainres.2016.11.028; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; Hodel AS, 2016, DEVELOPMENTAL SCI, V19, P221, DOI 10.1111/desc.12307; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kocka A, 2014, BEHAV SCI, V4, P352, DOI 10.3390/bs4040352; Liu M, 2017, J NEUROTRAUM, V34, P414, DOI 10.1089/neu.2015.4361; Mahar I, 2017, NEUROSCI BIOBEHAV R, V83, P622, DOI 10.1016/j.neubiorev.2017.08.023; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Merkel SF, 2017, NEUROSCI BIOBEHAV R, V77, P209, DOI 10.1016/j.neubiorev.2017.03.015; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mountney A., 2017, J NEUROTRAUM, DOI [10.1089/neu.2016.4679.2789,p.neu.2016.4679, DOI 10.1089/NEU.2016.4679.2789,P.NEU.2016.4679]; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Namjoshi DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053529; Ozga JE, 2018, BEHAV PHARMACOL, V29, P617, DOI 10.1097/FBP.0000000000000430; Rizzi G, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00110; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Thomsen GM, 2017, J TRAUMA ACUTE CARE, V82, P1039, DOI 10.1097/TA.0000000000001443; Thomsen GM, 2016, J TRAUMA ACUTE CARE, V81, P1070, DOI 10.1097/TA.0000000000001248; Vonder Haar C, 2017, J NEUROTRAUM, V34, P2790, DOI 10.1089/neu.2016.4813; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Weafer J, 2013, EXP CLIN PSYCHOPHARM, V21, P475, DOI 10.1037/a0033659; Weil ZM, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00135; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Winstanley C. A., 2010, IMPULSIVITY BEHAV NE, P95, DOI [10.1037/12069-004, DOI 10.1037/12069-004]; Winstanley CA, 2007, ANN NY ACAD SCI, V1121, P639, DOI 10.1196/annals.1401.024; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	60	13	13	2	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2019	317						87	99		10.1016/j.expneurol.2019.02.012			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IC2PY	WOS:000470803400008	30822421				2022-02-06	
J	Kotagama, P; Phadnis, A; Manning, KC; Rykaczewski, K				Kotagama, Praveen; Phadnis, Akshay; Manning, Kenneth C.; Rykaczewski, Konrad			Rational Design of Soft, Thermally Conductive Composite Liquid-Cooled Tubes for Enhanced Personal, Robotics, and Wearable Electronics Cooling	ADVANCED MATERIALS TECHNOLOGIES			English	Article						contact resistance; soft composites; soft heat exchangers; thermal conductivity; thermoregulation; wearable cooling; wearable electronics	TRAUMATIC BRAIN-INJURY; HEAT-STRESS; HUMAN SKIN; GARMENTS; DEVICES; SYSTEM; PERFORMANCE; MANAGEMENT	Thermoregulatory garments composed of liquid-cooled plastic tubes have users ranging from astronauts to multiple sclerosis patients and are emerging as a flexible cooling solution for wearable electronics and high-power robotics. Despite the plethora of applications, the current cooling systems are cumbersome to use due to their excessive size. In this work this issue is resolved by developing soft, thermally conductive silicone-aluminum composite tubes. To achieve optimal device performance, the material must be designed to balance the decrease in bulk thermal resistance and the increase in interfacial tube-substrate resistance due to composite stiffening. Thus, to enable the rational design of such tubes, a closed form thermomechanical model that predicts cooling performance as a function of tube geometry and filler fraction is developed and experimentally validated. Predictions via this model and experiments are used to reveal how the tube's geometrical and material design can be adjusted to minimize the required length of tubing and maximize the heat extracted from a metallic surface and skin. Lastly, through a holistic analysis, this work demonstrates that besides significantly increasing overall cooling capability, the use of low-resistance tubing can provide a multifold reduction in the cooling system size and enable novel operating modes.	[Kotagama, Praveen; Phadnis, Akshay; Manning, Kenneth C.; Rykaczewski, Konrad] Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ 85287 USA		Rykaczewski, K (corresponding author), Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ 85287 USA.	konradr@asu.edu		Rykaczewski, Konrad/0000-0002-5801-7177	National Science FoundationNational Science Foundation (NSF) [1724452]	The authors gratefully acknowledge funding from the National Science Foundation through award number CBET #1724452. The authors would like to thank Hooman Daghooghi Mobarakeh and Ahmad Bamasag from ASU, who helped in the initial stages of this work in their Advanced Heat Transfer graduate class project. The authors would also like to thank Matt Ralphs from ASU for his assistance with SEM imaging. The authors gratefully acknowledge the use of facilities within the Center for Solid State Science at Arizona State University.	Bartlett MD, 2017, P NATL ACAD SCI USA, V114, P2143, DOI 10.1073/pnas.1616377114; Bejan A., 2003, HEAT TRANSFER HDB, V1, P261; Bejan A., 2008, DESIGN CONSTRUCTAL T; Bergman T., 2011, FUNDAMENTALS HEAT MA; BUDIANSK.B, 1965, J MECH PHYS SOLIDS, V13, P223, DOI 10.1016/0022-5096(65)90011-6; Cadarette BS, 2006, ERGONOMICS, V49, P209, DOI 10.1080/00140130500436106; Cadogan DP, 2015, AM SCI, V103, P36, DOI 10.1511/2015.116.338; Cao H., 2005, J ASTM INT, V2, P12100; Cao HT, 2006, TEXT RES J, V76, P587, DOI 10.1177/0040517506067375; Cevallos JG, 2012, HEAT TRANSFER ENG, V33, P1075, DOI 10.1080/01457632.2012.663654; Chambers A., 1972, 2ND C PORT LIF SUPP, P283; Chen HY, 2016, PROG POLYM SCI, V59, P41, DOI 10.1016/j.progpolymsci.2016.03.001; Chen XJ, 2016, RENEW SUST ENERG REV, V60, P1367, DOI 10.1016/j.rser.2016.03.024; Christensen R., 2012, MECH COMPOSITE MAT; Conger B., 2019, 46 INT C ENV SYST HO, P1; COOPER MG, 1969, INT J HEAT MASS TRAN, V12, P279, DOI 10.1016/0017-9310(69)90011-8; Davis SL, 2010, J APPL PHYSIOL, V109, P1531, DOI 10.1152/japplphysiol.00460.2010; Denton M., 1972, TEXTILES, V3, P12; Dignicap, CLIN PROV RED HAIR L; Dionne J. P., 2003, THERMAL MANIKIN EVAL; Ernst TC, 2013, APPL THERM ENG, V60, P316, DOI 10.1016/j.applthermaleng.2013.06.019; Flouris AD, 2006, ANN BIOMED ENG, V34, P359, DOI 10.1007/s10439-005-9061-9; Fornasiero F, 2017, CURR OPIN CHEM ENG, V16, P1, DOI 10.1016/j.coche.2017.02.001; Fu SY, 2008, COMPOS PART B-ENG, V39, P933, DOI 10.1016/j.compositesb.2008.01.002; Gao TT, 2017, ACS NANO, V11, P11513, DOI 10.1021/acsnano.7b06295; Greenemeier L, 2008, SCI AM, V298, P34, DOI 10.1038/scientificamerican0408-34c; GUTHRIE TC, 1995, J NEUROL SCI, V129, P1, DOI 10.1016/0022-510X(94)00248-M; Hill D, 2017, INT J TECHNOL ASSESS, V33, P160, DOI 10.1017/S0266462317000460; Holt B, 2008, J BIOMECH, V41, P2689, DOI 10.1016/j.jbiomech.2008.06.008; Hwang DG, 2018, ACS APPL MATER INTER, V10, P6747, DOI 10.1021/acsami.7b18594; Jeong SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep18257; Johnston NJ, 2006, RESUSCITATION, V70, P254, DOI 10.1016/j.resuscitation.2006.02.010; Katrycz C. W., 2018, BIOINSPIRED ENG THER, P129; Kendrick J. T., 2018, THESIS; KERNER EH, 1956, P PHYS SOC LOND B, V69, P808, DOI 10.1088/0370-1301/69/8/305; Kim D, 2017, 2017 IEEE-RAS 17TH INTERNATIONAL CONFERENCE ON HUMANOID ROBOTICS (HUMANOIDS), P710, DOI 10.1109/HUMANOIDS.2017.8246950; Kim JH, 2011, J OCCUP ENVIRON HYG, V8, P409, DOI 10.1080/15459624.2011.584840; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; KUZNETZ LH, 1980, J BIOMECH ENG-T ASME, V102, P155, DOI 10.1115/1.3138213; Li YH, 2016, THEOR APPL MECH LETT, V6, P32, DOI 10.1016/j.taml.2015.12.001; Li YH, 2013, P ROY SOC A-MATH PHY, V469, DOI 10.1098/rspa.2013.0142; Midwest Research Institute, 1975, LIQ COOL GARM; Norton BA, 2015, LANDSCAPE URBAN PLAN, V134, P127, DOI 10.1016/j.landurbplan.2014.10.018; NUNNELEY SA, 1970, SPACE LIFE SCI, V2, P335, DOI 10.1007/BF00929293; Paxman, PION SCALP COOL; Polar Products, LEAD US MAN BOD COOL; Prasher RS, 2004, IEEE T COMPON PACK T, V27, P702, DOI 10.1109/TCAPT.2004.838883; Qiu WS, 2006, J CLIN NEUROSCI, V13, P995, DOI 10.1016/j.jocn.2006.02.027; Ralphs MI, 2018, ACS APPL MATER INTER, V10, P2083, DOI 10.1021/acsami.7b15814; Ridderheim M, 2003, SUPPORT CARE CANCER, V11, P371, DOI 10.1007/s00520-003-0451-y; Rini D. P., 2006, USA, Patent No. [US12495279, 12495279]; Rothmaier M, 2008, MED BIOL ENG COMPUT, V46, P825, DOI 10.1007/s11517-008-0363-6; Rykaczewski Konrad, 2019, Temperature (Austin), V6, P97, DOI 10.1080/23328940.2019.1574201; Rykaczewski Konrad, 2019, Temperature (Austin), V6, P85, DOI 10.1080/23328940.2018.1551706; Sentis L., 2017, USA, Patent No. [US20170341227A1, 20170341227]; Style RW, 2015, NAT PHYS, V11, P82, DOI 10.1038/nphys3181; Sun Y, 2015, BUILD ENVIRON, V93, P50, DOI 10.1016/j.buildenv.2015.06.008; T'Joen C, 2009, INT J REFRIG, V32, P763, DOI 10.1016/j.ijrefrig.2008.11.008; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Tong JK, 2015, ACS PHOTONICS, V2, P769, DOI 10.1021/acsphotonics.5b00140; Tutika R, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201804336; Wang FM, 2017, J THERM BIOL, V70, P37, DOI 10.1016/j.jtherbio.2017.05.007; Wang H, 2015, TRANSL NEUROSCI, V6, P20, DOI 10.1515/tnsci-2015-0004; Webb P., 1967, BIOTHERMAL RESPONSE; Webb RC, 2013, NAT MATER, V12, P938, DOI [10.1038/NMAT3755, 10.1038/nmat3755]; Welkins LLC, WELK PROV INN PROD E; Wong CP, 2017, MAT ADV PACKAGING, P511; Yang YF, 2012, APPL THERM ENG, V47, P18, DOI 10.1016/j.applthermaleng.2012.04.012; Yang Y, 2016, APL MATER, V4, DOI 10.1063/1.4944749; Yazdi MM, 2014, J TEXT I, V105, P1231, DOI 10.1080/00405000.2014.895088; Yin YF, 2018, APPL THERM ENG, V144, P504, DOI 10.1016/j.applthermaleng.2018.08.088; Zhang GZ, 2016, ADV MATER, V28, P4811, DOI 10.1002/adma.201506118; Zhao MM, 2013, INT J IND ERGONOM, V43, P232, DOI 10.1016/j.ergon.2013.01.001; Zhao RK, 2018, SOFT MATTER, V14, P2515, DOI 10.1039/c7sm02338c	74	13	13	6	39	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2365-709X			ADV MATER TECHNOL-US	Adv. Mater. Technol.	JUL	2019	4	7							1800690	10.1002/admt.201800690			12	Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Materials Science	IH7FJ	WOS:000474669100013		Bronze			2022-02-06	
J	Maynard, ME; Underwood, EL; Redell, JB; Zhao, J; Kobori, N; Hood, KN; Moore, AN; Dash, PK				Maynard, Mark E.; Underwood, Erica L.; Redell, John B.; Zhao, Jing; Kobori, Nobuhide; Hood, Kimberly N.; Moore, Anthony N.; Dash, Pramod K.			Carnosic Acid Improves Outcome after Repetitive Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain tissue respiration; NF-kappa B; Nrf2 activator; repeat concussive injury; tissue respiration; white matter inflammation	MITOCHONDRIAL DYSFUNCTION; TEMPORAL WINDOW; NRF2; VULNERABILITY; SULFORAPHANE; ANTIOXIDANT; CONCUSSIONS; ACTIVATION; THERAPIES; PROTECTS	In the majority of cases, the cognitive and behavioral impairments resulting from a mild traumatic brain injury (TBI) (also referred to as concussion) wane within days to weeks. In contrast, these impairments can persist for months to years after repetitive mild TBI (rmTBI). The cellular and molecular mechanisms underlying these impairments are not well understood. In the present study, we examined the consequences of rmTBI (three weight drops each separated by 72 h) on brain tissue respiration, pathology, and cognitive performance in mice. The transcription factor nuclear factor-erythroid 2-realted factor 2 (Nrf2) has been demonstrated to enhance the expression of numerous cytoprotective genes. Carnosic acid (CA) has been shown to activate Nrf2 and suppress the proinflammatory transcription factor nuclear factor kappa B (NF-kappa B). Because contemporaneous activation of cytoprotective genes and inhibition of proinflammatory genes can be beneficial, we questioned whether CA can be used to mitigate the pathobiology of rmTBI. The rmTBI increased hippocampal adenosine triphosphate-linked tissue respiration and proton leak that were unaffected by CA treatment. The rmTBI also caused significant motor and cognitive dysfunction, as tested using the foot fault, Barnes maze, and novel object recognition tasks. These impairments occurred in the absence of visible neuronal or dendritic loss. Post-rmTBI administration of CA significantly improved motor and cognitive function, and decreased Gfap and Iba1 immunoreactivities within white matter tracks. Taken together, these results show that rmTBI can cause cognitive impairments in the absence of overt neuronal pathologies, and post-injury treatment with CA can lessen some of these impairments.	[Maynard, Mark E.; Underwood, Erica L.; Redell, John B.; Zhao, Jing; Kobori, Nobuhide; Hood, Kimberly N.; Moore, Anthony N.; Dash, Pramod K.] Univ Texas Houston, McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX USA		Dash, PK (corresponding author), Univ Texas Houston, Med Sch, Dept Neurobiol & Anat, POB 20708, Houston, TX 77225 USA.	p.dash@uth.tmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS087149, NS086301]; Gillson Longenbaugh Foundation/Mission Connect; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS086301, R01NS087149] Funding Source: NIH RePORTER	This research was supported in part by grants from the National Institutes of Health (NS087149, NS086301), and funds made available by the Gillson Longenbaugh Foundation/Mission Connect.	Aruoma OI, 1996, FOOD CHEM TOXICOL, V34, P449, DOI 10.1016/0278-6915(96)00004-X; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Dash PK, 2015, J NEUROTRAUM, V32, P1608, DOI 10.1089/neu.2014.3772; Davis AR, 2010, J NEUROSCI METH, V189, P84, DOI 10.1016/j.jneumeth.2010.03.012; de Oliveira MR, 2017, MOL NEUROBIOL, V54, P5961, DOI 10.1007/s12035-016-0100-3; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hubbard WB, 2018, J NEUROSCI RES, V96, P1677, DOI 10.1002/jnr.24271; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Lipton SA, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.389; Lyons DN, 2018, J NEUROTRAUM, V35, P2435, DOI 10.1089/neu.2018.5663; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Miller DM, 2013, FREE RADICAL BIO MED, V57, P1, DOI 10.1016/j.freeradbiomed.2012.12.011; Mimura J, 2011, J BIOCHEM, V150, P209, DOI 10.1093/jb/mvr065; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Schwager J, 2016, MOLECULES, V21, DOI 10.3390/molecules21040465; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yanagitai M, 2012, BIOCHEM BIOPH RES CO, V418, P22, DOI 10.1016/j.bbrc.2011.12.087; Zhao J, 2006, NEUROSCI LETT, V393, P108, DOI 10.1016/j.neulet.2005.09.065; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007	32	13	13	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2019	36	13					2147	2152		10.1089/neu.2018.6155			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IF4KG	WOS:000473049600436	30672378	Green Published			2022-02-06	
J	Oerter, S; Forster, C; Bohnert, M				Oerter, Sabrina; Foerster, Carola; Bohnert, Michael			Validation of sodium/glucose cotransporter proteins in human brain as a potential marker for temporal narrowing of the trauma formation	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Traumatic brain injury; Sodium-glucose transporters; SGLT; Biomarker; Human; Post-mortem	ACUTE-PHASE RESPONSE; GLUCOSE-TRANSPORTER; IN-VITRO; EXPRESSION; INJURY; TISSUE; SGLT1; GENE; RNA	In many forensic cases, the existence of a traumatic brain injury (TBI) is an essential factor, and the determination of the survival time is nearly as important as the determination of whether or not a trauma exists. Since it is known that glucose uptake increases in injured brain cells in order to perpetuate the neuronal integrity, this study focuses on the pathomechanism of brain glucose supply via sodium/glucose cotransporters 1 and 2 (SGLT1, SGLT2) following traumatization. Human cerebrum tissue of male and female individuals who died following TBI was taken from the contusional and contralateral regions, as well as from individuals deceased due to cardiac arrest (control group). Total SGLT1 and SGLT2 protein expression was analyzed by immunoblotting comparing injured and non-injured tissue. The immunoreactivity in contusional cerebral cortex region began to increase 3 to 7h following traumatization. We found that both SGLT1 and SGLT2 protein expression increased significantly 37h post-injury compared to the control group. SGLT1 rose significantly at 52h post-injury and peaked significantly at 72h, while SGLT2 rose significantly at 52 and 72h after injury. By compiling these data, we predict a standard operator via SGLT expression as a comparative expression assertion to determine post-injury survival time for unknown cases. Our result suggests that SGLT1 and SGLT2 protein expression may be useful in forensic practice as an effective target to analyze the existence of a TBI and to determine the time of the traumatization.	[Oerter, Sabrina; Bohnert, Michael] Julius Maximilian Univ Wuerzburg, Inst Legal Med, Versbacher Str 3, D-97078 Wurzburg, Germany; [Foerster, Carola] Univ Hosp Wuerzburg, Ctr Operat Med, Dept Anesthesia & Crit Care, D-97080 Wurzburg, Germany		Oerter, S (corresponding author), Julius Maximilian Univ Wuerzburg, Inst Legal Med, Versbacher Str 3, D-97078 Wurzburg, Germany.	sabrina.oerter@uuni-wuerzburg.de		Oerter, Sabrina/0000-0002-2493-4866			BARTON AJL, 1993, J NEUROCHEM, V61, P1, DOI 10.1111/j.1471-4159.1993.tb03532.x; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Blair JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151615; Davidsson P, 2001, PROTEOMICS, V1, P444; De Paepe ME, 2002, DIAGN MOL PATHOL, V11, P170, DOI 10.1097/00019606-200209000-00008; Destatis, 2017, GES TOD DEUTSCHL; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Elfeber K, 2004, HISTOCHEM CELL BIOL, V121, P201, DOI 10.1007/s00418-004-0633-9; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Harada S, 2013, BRAIN RES, V1541, P61, DOI 10.1016/j.brainres.2013.09.041; Hausmann R, 2000, INT J LEGAL MED, V113, P288, DOI 10.1007/s004149900126; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; Huang ZG, 1999, CAN J NEUROL SCI, V26, P298, DOI 10.1017/S0317167100000421; Huth A, 2013, INT J LEGAL MED, V127, P335, DOI 10.1007/s00414-012-0787-2; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; KUMAGAI AK, 1994, BBA-BIOMEMBRANES, V1193, P24, DOI 10.1016/0005-2736(94)90328-X; Li DR, 2012, LEGAL MED-TOKYO, V14, P84, DOI 10.1016/j.legalmed.2011.12.007; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nagatsu T, 2005, CURR PHARM DESIGN, V11, P999, DOI 10.2174/1381612053381620; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Orihara Y, 2002, INT J LEGAL MED, V116, P92, DOI 10.1007/s00414-001-0265-8; PanayotovaHeiermann M, 1997, J BIOL CHEM, V272, P20324, DOI 10.1074/jbc.272.33.20324; Pandey GN, 2018, SCHIZOPHR RES, V192, P247, DOI 10.1016/j.schres.2017.04.043; PERRETT CW, 1988, J NEUROL NEUROSUR PS, V51, P325, DOI 10.1136/jnnp.51.3.325; Poppe R, 1997, J NEUROCHEM, V69, P84, DOI 10.1046/j.1471-4159.1997.69010084.x; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Sajja RK, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-8; Salvador E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00323; Salvador E, 2013, JOVE-J VIS EXP, DOI 10.3791/50928; Sasseville LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154589; Schrag B, 2012, INT J LEGAL MED, V126, P505, DOI 10.1007/s00414-011-0596-z; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Tyagi NK, 2005, BIOCHEMISTRY-US, V44, P15514, DOI 10.1021/bi051377q; Vemula S, 2009, J PHARMACOL EXP THER, V328, P487, DOI 10.1124/jpet.108.146589; Wais Sebastian, 2012, THESIS; Wang XY, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00025; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009	39	13	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JUL	2019	133	4					1107	1114		10.1007/s00414-018-1893-6			8	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	IG3EQ	WOS:000473685700018	30073510				2022-02-06	
J	Szarka, N; Toth, L; Czigler, A; Kellermayer, Z; Ungvari, Z; Amrein, K; Czeiter, E; Bali, ZK; Tadepalli, SA; Wahr, M; Hernadi, I; Koller, A; Buki, A; Toth, P				Szarka, Nikolett; Toth, Luca; Czigler, Andras; Kellermayer, Zoltan; Ungvari, Zoltan; Amrein, Krisztina; Czeiter, Endre; Bali, Zsolt Kristof; Tadepalli, Sai Ambika; Wahr, Matyas; Hernadi, Istvan; Koller, Akos; Buki, Andras; Toth, Peter			Single Mild Traumatic Brain Injury Induces Persistent Disruption of the Blood-Brain Barrier, Neuroinflammation and Cognitive Decline in Hypertensive Rats	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						hypertension; vascular injury; mild brain trauma; BBB; cognitive dysfunction	OXIDATIVE STRESS; DYSFUNCTION; PROTEIN; PATHOPHYSIOLOGY; EPIDEMIOLOGY; DEGENERATION; EXPRESSION; KINASE; MODEL; OLDER	Traumatic brain injury (TBI) induces blood-brain barrier (BBB) disruption, which contributes to secondary injury of brain tissue and development of chronic cognitive decline. However, single mild (m)TBI, the most frequent form of brain trauma disrupts the BBB only transiently. We hypothesized, that co-morbid conditions exacerbate persistent BBB disruption after mTBI leading to long term cognitive dysfunction. Since hypertension is the most important cerebrovascular risk factor in populations prone to mild brain trauma, we induced mTBI in normotensive Wistar and spontaneously hypertensive rats (SHR) and we assessed BBB permeability, extravasation of blood-borne substances, neuroinflammation and cognitive function two weeks after trauma. We found that mTBI induced a significant BBB disruption two weeks after trauma in SHRs but not in normotensive Wistar rats, which was associated with a significant accumulation of fibrin and increased neuronal expression of inflammatory cytokines TNF alpha, IL-1 beta and IL-6 in the cortex and hippocampus. SHRs showed impaired learning and memory two weeks after mild TBI, whereas cognitive function of normotensive Wistar rats remained intact. Future studies should establish the mechanisms through which hypertension and mild TBI interact to promote persistent BBB disruption, neuroinflammation and cognitive decline to provide neuroprotection and improve cognitive function in patients with mTBI.	[Szarka, Nikolett; Toth, Luca; Czigler, Andras; Amrein, Krisztina; Czeiter, Endre; Koller, Akos; Buki, Andras; Toth, Peter] Univ Pecs, Med Sch, Dept Neurosurg, Ret U 2, H-7623 Pecs, Hungary; [Szarka, Nikolett; Toth, Luca; Czigler, Andras; Amrein, Krisztina; Czeiter, Endre; Koller, Akos; Buki, Andras; Toth, Peter] Univ Pecs, Med Sch, Szentagothai Res Ctr, Ret U 2, H-7623 Pecs, Hungary; [Szarka, Nikolett; Toth, Luca; Czigler, Andras; Toth, Peter] Univ Pecs, Med Sch, Inst Translat Med, Szigeti Ut 12, H-7624 Pecs, Hungary; [Szarka, Nikolett; Toth, Peter] Univ Szeged, Clin Med Doctoral Sch, Tisza Lajos Krt 109, H-6725 Szeged, Hungary; [Kellermayer, Zoltan] Univ Pecs, Med Sch, Dept Immunol & Biotechnol, Szigeti Ut 12, H-7624 Pecs, Hungary; [Ungvari, Zoltan] Univ Oklahoma, Hlth Sci Ctr, Donald W Reynolds Dept Geriatr Med, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK 73104 USA; [Czeiter, Endre; Toth, Peter] MTA PTE Clin Neurosci MR Res Grp, Ret U 2, H-7623 Pecs, Hungary; [Bali, Zsolt Kristof; Tadepalli, Sai Ambika; Hernadi, Istvan] Univ Pecs, Szentagothai Res Ctr, Translat Neurosci Res Grp, Ifjusag Utja 20, H-7624 Pecs, Hungary; [Bali, Zsolt Kristof; Hernadi, Istvan] Univ Pecs, Grastyan Translat Res Ctr, Ifjusag Utja 6, H-7624 Pecs, Hungary; [Wahr, Matyas] Univ Pecs, Med Sch, Inst Physiol, Cellular Neurobiol, Szigeti Ut 12, H-7624 Pecs, Hungary; [Hernadi, Istvan] Univ Pecs, Fac Sci, Dept Expt Neurobiol, Ifjusag Utja 6, H-7624 Pecs, Hungary; [Koller, Akos] Semmelweis Univ, Fac Hlth Sci, Dept Morphol & Physiol, Ulloi Ut 26, H-1085 Budapest, Hungary; [Koller, Akos] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA		Toth, P (corresponding author), Univ Pecs, Med Sch, Dept Neurosurg, Ret U 2, H-7623 Pecs, Hungary.; Toth, P (corresponding author), Univ Pecs, Med Sch, Szentagothai Res Ctr, Ret U 2, H-7623 Pecs, Hungary.; Toth, P (corresponding author), Univ Pecs, Med Sch, Inst Translat Med, Szigeti Ut 12, H-7624 Pecs, Hungary.; Toth, P (corresponding author), Univ Szeged, Clin Med Doctoral Sch, Tisza Lajos Krt 109, H-6725 Szeged, Hungary.; Toth, P (corresponding author), MTA PTE Clin Neurosci MR Res Grp, Ret U 2, H-7623 Pecs, Hungary.	toth.peter@pte.hu	Czigler, Andras/AAO-2969-2020; Czigler, Andras/AAK-8425-2021; Bali, Zsolt Kristof/L-1653-2014	Czigler, Andras/0000-0001-6751-3298; Bali, Zsolt Kristof/0000-0003-0712-0788; Czeiter, Endre/0000-0002-9578-6944; Toth, Luca/0000-0002-5425-1863	National Research, Development and Innovation OfficeNational Research, Development & Innovation Office (NRDIO) - Hungary [NKFI-FK123798, K108444, K129247]; Higher Education Institutional Excellence Program at Semmelweis University; National Bionika Program [ED_17-1-2017-0009]; Hungarian Academy of Sciences Bolyai Research Scholarship [BO/00634/15]; PTE AOK-KA [3/2016 04.01/F]; New National Excellence Program of the Ministry of Human Capacities [UNKP-18-4-PTE-6]; Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary-Grant [20765-3/2018/FEKUTSTRAT, FIKP II/5, EFOP-3.6.2.-16-2017-00008, GINOP-2.3.2-15-2016-00048, GINOP-2.3.3-15-2016-00032]; Hungarian National Brain Research Program Grant [2017-1.2.1-NKP-2017-00002]; Marie Curie Actions SMARTER 7th Framework Program of the European Union [606998]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-AG055395, R01-NS100782, R01-AT006526];  [UNKP-18-3-I-PTE-223 to L];  [UNKP-17-4-I-PTE-83]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG055395] Funding Source: NIH RePORTER	This work was supported by grants from the National Research, Development and Innovation Office to P.T. (NKFI-FK123798) and A.K. (K108444) and I.H. (K129247), Higher Education Institutional Excellence Program at Semmelweis University to AK and the National Bionika Program ED_17-1-2017-0009 to AK, the Hungarian Academy of Sciences Bolyai Research Scholarship BO/00634/15 to P.T., the PTE AOK-KA 3/2016 04.01/F to P.T., the UNKP-18-4-PTE-6 New National Excellence Program of the Ministry of Human Capacities to PT, UNKP-18-3-I-PTE-223 to LT and UNKP-17-4-I-PTE-83 to Z.K., Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary-Grant No. 20765-3/2018/FEKUTSTRAT, FIKP II/5., EFOP-3.6.2.-16-2017-00008, GINOP-2.3.2-15-2016-00048 and GINOP-2.3.3-15-2016-00032 to P.T., I.H. and A.B., the Hungarian National Brain Research Program Grant No. 2017-1.2.1-NKP-2017-00002 to I.H. and A.B.; the Marie Curie Actions SMARTER 7th Framework Program of the European Union 606998 to N.S. and A.K., National Institute of Health R01-AG055395, R01-NS100782, R01-AT006526 to Z.U.	Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; [Anonymous], 2015, C TRAUM BRAIN INJ US; Carrano A, 2012, NEURODEGENER DIS, V10, P329, DOI 10.1159/000334916; Cortese GP, 2017, BEHAV BRAIN RES, V322, P269, DOI 10.1016/j.bbr.2016.08.027; Fiala M, 2002, EUR J CLIN INVEST, V32, P360, DOI 10.1046/j.1365-2362.2002.00994.x; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Haorah J, 2007, J NEUROCHEM, V101, P566, DOI 10.1111/j.1471-4159.2006.04393.x; Jaworski T, 2011, AM J PATHOL, V179, P2001, DOI 10.1016/j.ajpath.2011.06.025; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Li W, 2016, BRAIN RES, V1646, P53, DOI 10.1016/j.brainres.2016.05.036; Marcano DC, 2013, J NEUROTRAUM, V30, P789, DOI 10.1089/neu.2011.2301; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Montagne A, 2018, NAT MED, V24, P326, DOI 10.1038/nm.4482; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; Pinto CC, 2007, FREE RADICAL RES, V41, P1151, DOI 10.1080/10715760701632816; Rochfort KD, 2015, BIOCHEM SOC T, V43, P702, DOI 10.1042/BST20140319; Rodriguez-Grande B, 2017, AAPS J, V19, P1615, DOI 10.1208/s12248-017-0123-3; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com; Schwarzmaier SM, 2015, J NEUROTRAUM, V32, P731, DOI 10.1089/neu.2014.3650; Singh K, 2016, NMR BIOMED, V29, P1748, DOI 10.1002/nbm.3627; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Sun HJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.470; Szarka N, 2018, J NEUROTRAUM, V35, P930, DOI 10.1089/neu.2017.5056; Szarka N, 2017, J NEUROTRAUM, V34, P2315, DOI 10.1089/neu.2016.4962; Tarjanyi O, 2013, NEUROCHEM INT, V63, P413, DOI 10.1016/j.neuint.2013.07.008; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Toth P, 2013, J CEREBR BLOOD F MET, V33, P1732, DOI 10.1038/jcbfm.2013.143; Tucsek Z, 2014, J GERONTOL A-BIOL, V69, P1212, DOI 10.1093/gerona/glt177; Wang QL, 2019, EXP THER MED, V17, P2741, DOI 10.3892/etm.2019.7249	32	13	13	0	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUL 1	2019	20	13							3223	10.3390/ijms20133223			10	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	IL1EG	WOS:000477041100110	31262044	Green Published, Green Submitted, gold			2022-02-06	
J	Tzeng, NS; Chung, CH; Lin, FH; Yeh, CB; Huang, SY; Lu, RB; Chang, HA; Kao, YC; Yeh, HW; Chiang, WS; Chou, YC; Tsao, CH; Wu, YF; Chien, WC				Tzeng, Nian-Sheng; Chung, Chi-Hsiang; Lin, Fu-Huang; Yeh, Chin-Bin; Huang, San-Yuan; Lu, Ru-Band; Chang, Hsin-An; Kao, Yu-Chen; Yeh, Hui-Wen; Chiang, Wei-Shan; Chou, Yu-Ching; Tsao, Chang-Huei; Wu, Yung-Fu; Chien, Wu-Chien			Risk of Dementia in Adults With ADHD: A Nationwide, Population-Based Cohort Study in Taiwan	JOURNAL OF ATTENTION DISORDERS			English	Article						adults; ADHD adults; cohort study; dementia; National Health Insurance Research Database; Longitudinal Health Insurance Database	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; DSM-IV; PREDICTIVE-VALIDITY; BIPOLAR DISORDER; HEALTH INSURANCE; MEDICATION; CHILDREN; ADOLESCENTS	Objective:This study aimed to investigate the association between adults with ADHD and the risk of developing dementia. Method: Utilizing National Health Insurance Research Database of Taiwan, ADHD patients were identified and compared with age- and gender-matched controls (1:3). Results: Of the study participants, 37 (5.48%) developed dementia compared with 81 (4.0%) in the control group. Cox proportional hazards regression analysis revealed that the study participants were more likely to develop dementia. The crude hazard ratio (HR) is 3.418 (95% confidence interval [CI] = [2.289, 5.106], p < .001), and adjusted HR is 4.008 (95% CI = [2.526, 6.361], p < .001) in risk of developing dementia after adjusted for age, gender, comorbidities, geographical area of residence, urbanization level of residence, and monthly income. Conclusion: Adults with ADHD have a 3.4-fold risk of developing dementia, and other large or national data sets should be explored to support the current findings.	[Tzeng, Nian-Sheng; Yeh, Chin-Bin; Huang, San-Yuan; Lu, Ru-Band; Chang, Hsin-An; Kao, Yu-Chen; Yeh, Hui-Wen; Chiang, Wei-Shan] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Psychiat, Taipei, Taiwan; [Tzeng, Nian-Sheng; Chang, Hsin-An] Natl Def Med Ctr, Student Counseling Ctr, Taipei, Taiwan; [Chung, Chi-Hsiang; Lin, Fu-Huang; Chou, Yu-Ching; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang; Tsao, Chang-Huei; Wu, Yung-Fu; Chien, Wu-Chien] Triserv Gen Hosp, Sch Med, Dept Med Res, Natl Def Med Ctr, Taipei, Taiwan; [Chung, Chi-Hsiang] Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ, Dept Psychiat, Coll Med & Hosp, Tainan, Taiwan; [Kao, Yu-Chen] Triserv Gen Hosp, Natl Def Med Ctr, Song Shan Branch, Dept Psychiat, Taipei, Taiwan; [Yeh, Hui-Wen] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Yeh, Hui-Wen] Kang Ning Univ, Dept Nursing, Taipei Campus, Taipei, Taiwan; [Chiang, Wei-Shan] Tamkang Univ, Dept & Inst Math, New Taipei, Taiwan; [Tsao, Chang-Huei] Natl Def Med Ctr, Dept & Inst Microbiol & Immunol, Sch Med, Taipei, Taiwan		Chien, WC (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Med Res, 7115R,325,Sect 2,Cheng Kung Rd, Taipei 11490, Taiwan.	chienwu@ndmctsgh.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021; Tzeng, Nian-Sheng/AAU-4945-2021	Chang, Hsin-An/0000-0001-5572-7109	Tri-Service General Hospital Research Foundation [TSGH-C105-003, TSGH-C105-130, TSGH-C106-002]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by Tri-Service General Hospital Research Foundation (TSGH-C105-003, TSGH-C105-130, and TSGH-C106-002).	Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Balint Sara, 2015, Psychiatr Hung, V30, P363; Ben-Itzhak R, 2008, J AM GERIATR SOC, V56, P695, DOI 10.1111/j.1532-5415.2007.01623.x; Biederman J, 1999, BIOL PSYCHIAT, V46, P1234, DOI 10.1016/S0006-3223(99)00192-4; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Chang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089867; Chang Z, 2014, JAMA PSYCHIAT, V71, P319, DOI 10.1001/jamapsychiatry.2013.4174; Chen MH, 2015, BIPOLAR DISORD, V17, P315, DOI 10.1111/bdi.12266; Chen MH, 2014, J AFFECT DISORDERS, V156, P232, DOI 10.1016/j.jad.2013.10.053; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chien WC, 2017, RES DEV DISABIL, V65, P57, DOI 10.1016/j.ridd.2017.04.011; Chinese Hospital Association, 2000, ICD 9 900 ENGL CHIN; Chou IC, 2013, J DEV BEHAV PEDIATR, V34, P181, DOI 10.1097/DBP.0b013e3182829f2b; Chuang CS, 2013, NEUROEPIDEMIOLOGY, V41, P139, DOI 10.1159/000353559; Cortese S, 2015, J AM ACAD CHILD PSY, V54, P164, DOI 10.1016/j.jaac.2014.12.010; Coulthard E, 2006, CURR OPIN NEUROL, V19, P613, DOI 10.1097/01.wco.0000247605.57567.9a; Craig F, 2016, NEUROPSYCH DIS TREAT, V12, P1191, DOI 10.2147/NDT.S104620; Dalsgaard S, 2015, LANCET PSYCHIAT, V2, P702, DOI 10.1016/S2215-0366(15)00271-0; Dalsgaard S, 2014, J CHILD ADOL PSYCHOP, V24, P253, DOI 10.1089/cap.2013.0101; Deberdt W, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0624-5; Dopfner M, 2008, EUR CHILD ADOLES PSY, V17, P59, DOI 10.1007/s00787-008-1007-y; Fuh Jong-Ling, 2008, Acta Neurol Taiwan, V17, P153; Gau SSF, 2005, AM J PSYCHIAT, V162, P1344, DOI 10.1176/appi.ajp.162.7.1344; Golimstok A, 2011, EUR J NEUROL, V18, P78, DOI 10.1111/j.1468-1331.2010.03064.x; Goulardins JB, 2015, BEHAV BRAIN RES, V292, P484, DOI 10.1016/j.bbr.2015.07.009; Huang SW, 2015, SCI REP-UK, V5, DOI 10.1038/srep10145; Ilie G, 2015, J PSYCHIATR RES, V69, P174, DOI 10.1016/j.jpsychires.2015.08.004; Lahey BB, 2006, J CHILD PSYCHOL PSYC, V47, P472, DOI 10.1111/j.1469-7610.2005.01590.x; Lee MJ, 2016, J AFFECT DISORDERS, V189, P110, DOI 10.1016/j.jad.2015.09.015; Lee SI, 2008, J CHILD PSYCHOL PSYC, V49, P70, DOI 10.1111/j.1469-7610.2007.01784.x; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Liang JA, 2011, CANCER EPIDEM BIOMAR, V20, P473, DOI 10.1158/1055-9965.EPI-10-1280; Lin CC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002331; Lin SJ, 2006, ANN PHARMACOTHER, V40, P506, DOI 10.1345/aph.1G437; Lin YJ, 2016, AUST NZ J PSYCHIAT, V50, P548, DOI 10.1177/0004867415609423; Ljung T, 2014, JAMA PSYCHIAT, V71, P958, DOI 10.1001/jamapsychiatry.2014.363; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; Newhouse P A, 2000, Pharm Acta Helv, V74, P91, DOI 10.1016/S0031-6865(99)00047-3; Potter AS, 2014, CNS DRUGS, V28, P1103, DOI 10.1007/s40263-014-0208-9; Seifan A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129919; Semeijn EJ, 2013, J AM GERIATR SOC, V61, P882, DOI 10.1111/jgs.12261; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Shyu YC, 2015, SCHIZOPHR RES, V168, P161, DOI 10.1016/j.schres.2015.08.033; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100303; Surman CBH, 2017, ADHD-ATTEND DEFICIT, V9, P161, DOI 10.1007/s12402-017-0217-x; Surman CBH, 2009, J CLIN PSYCHIAT, V70, P1523, DOI 10.4088/JCP.08m04514; Tai YM, 2013, J ATTEN DISORD, V17, P660, DOI 10.1177/1087054712437581; Tai YM, 2013, RES DEV DISABIL, V34, P1100, DOI 10.1016/j.ridd.2012.11.027; Taiwan Alzheimer's Disease Association, 2013, 2015 2056 EXP DEM PO; Thapar A, 2016, LANCET, V387, P1240, DOI 10.1016/S0140-6736(15)00238-X; Thomas R, 2015, PEDIATRICS, V135, pE994, DOI 10.1542/peds.2014-3482; Tzeng N. S., 2017, TAIWANESE J PSYCHIAT; Tzeng N-S., 2015, J MED SCI, V35, P239, DOI [10.4103/1011-4564.172999, DOI 10.4103/1011-4564.172999]; van Stralen J, 2016, ADHD-ATTEND DEFICIT, V8, P175, DOI 10.1007/s12402-016-0199-0; Wang H. Y., J AM ACAD PSYCHIAT L; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wang LJ, 2017, EPIDEMIOL PSYCH SCI, V26, P624, DOI 10.1017/S2045796016000500; Wang LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161061; Wang LJ, 2016, J PSYCHIATR RES, V72, P6, DOI 10.1016/j.jpsychires.2015.10.014; Wang Ya-Ching, 1993, Journal of the Formosan Medical Association, V92, P133; WHO, 2012, DEM CAS SET TRIPL 20; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Williamson D, 2015, CLIN PSYCHOL REV, V40, P15, DOI 10.1016/j.cpr.2015.05.005	65	13	13	1	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1087-0547	1557-1246		J ATTEN DISORD	J. Atten. Disord.	JUL	2019	23	9			SI		995	1006		10.1177/1087054717714057			12	Psychology, Developmental; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	IW9EC	WOS:000485295200010	28629260				2022-02-06	
J	Janatpour, ZC; Korotcov, A; Bosomtwi, A; Dardzinski, BJ; Symes, AJ				Janatpour, Zachary C.; Korotcov, Alexandru; Bosomtwi, Asamoah; Dardzinski, Bernard J.; Symes, Aviva J.			Subcutaneous Administration of Angiotensin-(1-7) Improves Recovery after Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						angiotensin-(1-7); controlled cortical impact; Mas receptor; renin-angiotensin system; traumatic brain injury	MORRIS WATER MAZE; ACE2/ANG-(1-7)/MAS PATHWAY; ANTERIOR THALAMUS; LESION VOLUME; RECEPTOR; MAS; BARRIER; AT(1); HIPPOCAMPUS; DEFICITS	Angiotensin II (Ang II)-mediated activation of its type I receptor (AT1R) in the central nervous system promotes glial proliferation, local inflammation, and a decrease of cerebral blood flow. Angiotensin-(1-7) (Ang-(1-7))-an Ang II derivative peptide-signals through the Mas receptor (MasR) in opposition to Ang II/AT1R, promoting anti-inflammatory, vasodilatory, and neuroprotective effects. As our laboratory has previously demonstrated beneficial effects of AT1R inhibition following controlled cortical impact (CCI) in mice, we asked whether activation of Ang-(1-7)/MasR signaling would also be beneficial in this model. Adult male C57BL/6 mice were injured by CCI. Ang-(1-7) or vehicle was administered subcutaneously (S.Q.) at 1 mg/kg/day at 1 or 6 h post-injury, until animals were sacrificed at 3 or 29 days post-injury (dpi). Ang-(1-7) attenuated motor deficits at 3 dpi and improved performance in the Morris Water Maze at 28 dpi. Brain histology or magnetic resonance imaging (MRI) indicated that Ang-(1-7)-treated mice had smaller lesion volumes at 3, 10, 24, and 29 dpi. Pre-treatment with A779, a MasR antagonist, prevented Ang-(1-7) from reducing lesion volume at 3 dpi, suggesting that the benefits of Ang-(1-7) were MasR-dependent. Immunohistochemistry revealed that Ang-(1-7) reduced microgliosis at 3 and 29 dpi, and astrogliosis at 29 dpi. Ang-(1-7) decreased neuronal and capillary loss at 29 dpi. In summary, S.Q. administration of Ang-(1-7) after injury had anti-inflammatory, neuroprotective, and cerebrovascular-protective actions leading to improved functional and pathological recovery in a mouse model of traumatic brain injury (TBI). These data show for the first time that Ang-(1-7) has potential therapeutic use for TBI.	[Janatpour, Zachary C.; Symes, Aviva J.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol & Mol Therapeut, Program Mol & Cell Biol, Bethesda, MD USA; [Korotcov, Alexandru; Bosomtwi, Asamoah; Dardzinski, Bernard J.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Translat Imaging Core, Bethesda, MD USA; [Dardzinski, Bernard J.] Uniformed Serv Univ Hlth Sci, Dept Radiol & Radiol Sci, Bethesda, MD USA		Symes, AJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol & Mol Therapeut, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	aviva.symes@usuhs.edu			Department of Defense Centre for Neuroscience and Regenerative MedicineUnited States Department of Defense	This work was supported by a grant from the Department of Defense Centre for Neuroscience and Regenerative Medicine (AJS). We thank Dr. Rick Franklin (Constant Pharmaceuticals) for the gift of the Ang-(1-7) and Dr. Rick Franklin and Professor Thomas Walter for many informative discussions. We are grateful to Dr. Cara Olson for biostatistical consultations and members of the Symes laboratory and Zachary Janatpour's thesis committee for their helpful comments and suggestions.	Alluri H, 2018, METHODS MOL BIOL, V1717, P37, DOI 10.1007/978-1-4939-7526-6_4; Bader M, 2013, PFLUG ARCH EUR J PHY, V465, P79, DOI 10.1007/s00424-012-1120-0; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bennion DM, 2015, HYPERTENSION, V66, P141, DOI 10.1161/HYPERTENSIONAHA.115.05185; Bennion DM, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0512-2; Bosnyak S, 2011, CLIN SCI, V121, P297, DOI 10.1042/CS20110036; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chappel MC, 2006, KIDNEY INT, V70, P7, DOI 10.1038/sj.ki.5000321; Chen J, 2014, NEUROPHARMACOLOGY, V79, P550, DOI 10.1016/j.neuropharm.2014.01.004; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Ditor DS, 2008, J NEUROSURG-SPINE, V9, P301, DOI 10.3171/SPI/2008/9/9/301; Freund M, 2012, CELL TISSUE RES, V348, P29, DOI 10.1007/s00441-012-1354-3; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hay M, 2017, BEHAV NEUROSCI, V131, P99, DOI 10.1037/bne0000182; Jackson ALR, 2018, ROUT RES INT ENV LAW, P19; Jiang T, 2018, AGING-US, V10, P645, DOI 10.18632/aging.101419; Jiang T, 2014, BRIT J PHARMACOL, V171, P4222, DOI 10.1111/bph.12770; Knecht KR, 2010, EXP BIOL MED, V235, P1479, DOI 10.1258/ebm.2010.010149; Le Nobin J, 2014, BJU INT, V114, pE105, DOI 10.1111/bju.12750; Lee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142087; Leonhardt J, 2017, HYPERTENSION, V69, P1128, DOI 10.1161/HYPERTENSIONAHA.116.08814; Liu M, 2016, J NEUROCHEM, V136, P163, DOI 10.1111/jnc.13386; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; MARTIN KA, 1992, DEV BRAIN RES, V68, P75, DOI 10.1016/0165-3806(92)90249-V; Moore ED, 2013, FREE RADICAL BIO MED, V65, P1060, DOI 10.1016/j.freeradbiomed.2013.08.183; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Nishimura Y, 2000, BRAIN RES, V871, P29, DOI 10.1016/S0006-8993(00)02377-5; Popescu C, 2015, J Med Life, V8, P272; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Redish AD, 1998, NEURAL COMPUT, V10, P73, DOI 10.1162/089976698300017908; Regenhardt RW, 2014, EXP PHYSIOL, V99, P442, DOI 10.1113/expphysiol.2013.075242; Regenhardt RW, 2013, NEUROPHARMACOLOGY, V71, P154, DOI 10.1016/j.neuropharm.2013.03.025; Saavedra JM, 2005, CELL MOL NEUROBIOL, V25, P485, DOI 10.1007/s10571-005-4011-5; Saavedra JM, 2006, J HYPERTENS, V24, pS131, DOI 10.1097/01.hjh.0000220418.09021.ee; Saavedra JM, 2012, CLIN SCI, V123, P567, DOI 10.1042/CS20120078; Saavedra JM, 2012, CELL MOL NEUROBIOL, V32, P667, DOI 10.1007/s10571-011-9754-6; Saavedra JM, 2006, CELL MOL NEUROBIOL, V26, P1099, DOI 10.1007/s10571-006-9009-0; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RA, 2014, HYPERTENSION, V63, P1138, DOI 10.1161/HYPERTENSIONAHA.113.01274; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Shi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092937; Solinski HJ, 2014, PHARMACOL REV, V66, P570, DOI 10.1124/pr.113.008425; Souza APS, 2013, CLIN SCI, V125, P449, DOI 10.1042/CS20120519; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Stackman RW, 2012, J NEUROSCI, V32, P10211, DOI 10.1523/JNEUROSCI.4868-11.2012; Sullivan JC, 2015, AM J PHYSIOL-HEART C, V308, pH1171, DOI 10.1152/ajpheart.00897.2014; Tetzner A, 2016, HYPERTENSION, V68, P185, DOI 10.1161/HYPERTENSIONAHA.116.07572; Vasam G, 2017, DIABETES, V66, P505, DOI 10.2337/db16-1039; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Villapol S, 2015, AM J HYPERTENS, V28, P289, DOI 10.1093/ajh/hpu197; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Walther T, 2002, FASEB J, V16, P169, DOI 10.1096/fj.01-0601com; Wang Y, 2010, CIRC-HEART FAIL, V3, P286, DOI 10.1161/CIRCHEARTFAILURE.109.905968; Warburton EC, 1999, BEHAV BRAIN RES, V98, P27; Warburton EC, 2000, EUR J NEUROSCI, V12, P1714, DOI 10.1046/j.1460-9568.2000.00039.x; Williams IM, 2016, HYPERTENSION, V67, P983, DOI 10.1161/HYPERTENSIONAHA.115.06935; Xiao X, 2015, EXP CELL RES, V336, P58, DOI 10.1016/j.yexcr.2015.06.010; Xu P, 2011, AM J PHYSIOL-REG I, V300, pR804, DOI 10.1152/ajpregu.00222.2010; YOUNG D, 1988, P NATL ACAD SCI USA, V85, P5339, DOI 10.1073/pnas.85.14.5339; Zheng J, 2014, NEUROSCIENCE, V273, P39, DOI 10.1016/j.neuroscience.2014.04.060	66	13	14	3	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2019	36	22					3115	3131		10.1089/neu.2019.6376		JUN 2019	17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JI6MG	WOS:000472108700001	31037999	Bronze			2022-02-06	
J	Kostic, D; Carlson, R; Henke, D; Rohn, K; Tipold, A				Kostic, Draginja; Carlson, Regina; Henke, Diana; Rohn, Karl; Tipold, Andrea			Evaluation of IL-1 levels in epilepsy and traumatic brain injury in dogs	BMC NEUROSCIENCE			English	Article						Interleukin-1 beta; Epilepsy; Traumatic brain injury; Cerebrospinal fluid; Serum; Canine	INTERNATIONAL VETERINARY EPILEPSY; INFLAMMATORY CYTOKINES; RISK-FACTORS; SPINAL-CORD; INTERLEUKIN-1; IL-1-BETA; SEIZURES; CANINE; EXPRESSION; BIOMARKERS	BackgroundEpilepsy is a common neurological disease in dogs affecting approximately 0.6-0.75% of the canine population. There is much evidence of neuroinflammation presence in epilepsy, creating new possibilities for the treatment of the disease. An increased expression of interleukin-1 beta (IL-1) was reported in epileptogenic foci. We hypothesized that there is an elevation of IL-1 in serum and CSF of dogs with epilepsy, as well as in serum of dogs with TBI, reflecting involvement of this cytokine in pathophysiology of naturally occurring canine epilepsy in a clinical setting.ResultsIL-1 levels were evaluated in CSF and serum of six healthy and 51 dogs with epilepsy (structural and idiopathic). In 16 dogs with TBI, only serum was tested. IL-1 concentrations in CSF were not detectable. Serum values were not elevated in dogs with TBI in comparison to healthy controls (p>0.05). However, dogs with epilepsy had increased levels of IL-1 in serum (p=0.003) regardless of the underlying cause of the disease (p=0.0045). There was no significant relationship between the variables and IL-1 levels. Statistically noticeable (p=0.0630) was that approximately 10% of dog with epilepsy (R-2=0.105) had increased seizure frequency and IL-1 elevation.ConclusionIncreased IL-1 levels were detected in the peripheral blood in dogs with idiopathic and structural epilepsy leading to the assumption that there is an involvement of inflammation in pathophysiology of epilepsy which should be considered in the search for new therapeutic strategies for this disease. However, to better understand the pathogenic role of this cytokine in epilepsy, further evaluation of IL-1 in brain tissue is desired.	[Kostic, Draginja; Carlson, Regina; Tipold, Andrea] Univ Vet Med Hannover, Dept Small Anim Med & Surg, Buenteweg 9, D-30559 Hannover, Germany; [Henke, Diana] Anim Clin Hasenberg, Stuttgart, Germany; [Rohn, Karl] Univ Vet Med, Inst Biometry Epidemiol & Informat Proc, Hannover, Germany; [Kostic, Draginja; Tipold, Andrea] Ctr Syst Neurosci, Hannover, Germany		Kostic, D (corresponding author), Univ Vet Med Hannover, Dept Small Anim Med & Surg, Buenteweg 9, D-30559 Hannover, Germany.; Kostic, D (corresponding author), Ctr Syst Neurosci, Hannover, Germany.	draginja1kostic@gmail.com		Kostic, Draginja/0000-0001-5771-992X	Bruns Stiftung; Die Gesellschaft zur Forderung Kynologischer Forschung	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The first author was financially supported by "Bruns Stiftung" and, Die Gesellschaft zur Forderung Kynologischer Forschung". Author's funding source had no influence on the conduct of the research and/or preparation of the article.	Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Aronica E, 2011, EPILEPSIA, V52, P26, DOI 10.1111/j.1528-1167.2011.03033.x; Auvin S, 2010, EPILEPSIA, V51, P34, DOI 10.1111/j.1528-1167.2010.02606.x; Berendt M, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0461-2; Bhatti SFM, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0464-z; Blasi F, 1999, BIOL CHEM, V380, P259, DOI 10.1515/BC.1999.034; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Coates JR, 2014, VET CLIN N AM-SMALL, V44, P1157, DOI 10.1016/j.cvsm.2014.07.009; De Risio L, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0462-1; De Risio L, 2014, CANINE AND FELINE EPILEPSY: DIAGNOSIS AND MANAGEMENT, P101, DOI 10.1079/9781780641096.0101; Dey A, 2016, TRENDS PHARMACOL SCI, V37, P463, DOI 10.1016/j.tips.2016.03.001; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; DiFazio J, 2013, VET CLIN N AM-SMALL, V43, P915, DOI 10.1016/j.cvsm.2013.03.002; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Farooq RK, 2017, BIOMED REP, V6, P15, DOI 10.3892/br.2016.807; Freundt-Revilla J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0784-3; Gao F, 2017, ACTA NEUROL SCAND, V135, P663, DOI 10.1111/ane.12665; Grone A, 2000, J NEUROIMMUNOL, V110, P20, DOI 10.1016/S0165-5728(00)00332-5; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hesse R, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0707-z; Hewett Sandra J, 2012, Eur J Neurodegener Dis, V1, P195; Hofer MJ, 2016, BRIT J PHARMACOL, V173, P716, DOI 10.1111/bph.13175; Jewett KA, 2012, VITAM HORM, V89, P241, DOI 10.1016/B978-0-12-394623-2.00013-5; Kauffman MA, 2008, GENET MED, V10, P83, DOI 10.1097/GIM.0b013e318161317c; Kempuraj D., 2016, J NEUROL NEUROSURG S, V1, P1003; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; KRUEGER JM, 1984, AM J PHYSIOL, V246, pR994, DOI 10.1152/ajpregu.1984.246.6.R994; Lancaster E, 2010, LANCET NEUROL, V9, P67, DOI 10.1016/S1474-4422(09)70324-2; Loddick SA, 1996, J CEREBR BLOOD F MET, V16, P932, DOI 10.1097/00004647-199609000-00017; Lovett MC, 2014, VET J, V200, P312, DOI 10.1016/j.tvjl.2014.03.003; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Luheshi NM, 2009, BRIT J PHARMACOL, V157, P1318, DOI 10.1111/j.1476-5381.2009.00331.x; Marin I, 2013, LEARN MEMORY, V20, P601, DOI 10.1101/lm.028357.112; Moore SA, 2012, VET IMMUNOL IMMUNOP, V148, P348, DOI 10.1016/j.vetimm.2012.07.001; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; Potschka H, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0465-y; Potts Mathew B, 2006, NeuroRx, V3, P143; Prachar Christian, 2013, OPEN J VET MED, V3, P302, DOI DOI 10.4236/ojvm.2013.37049; Rijkers K, 2009, EXP NEUROL, V216, P258, DOI 10.1016/j.expneurol.2008.12.014; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Rodriguez-Smith J, 2017, ARTHRITIS RHEUMATOL, V69, P1325, DOI 10.1002/art.40055; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Schwartz M, 2011, J SMALL ANIM PRACT, V52, P632, DOI 10.1111/j.1748-5827.2011.01131.x; Shores A., 1983, CURRENT VET THERAPY, P847; Srinivasan D, 2004, J NEUROSCI, V24, P6482, DOI 10.1523/JNEUROSCI.5712-03.2004; Steinmetz S, 2013, EPILEPSIA, V54, P580, DOI 10.1111/epi.12071; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Uludag IF, 2015, SEIZURE-EUR J EPILEP, V26, P22, DOI 10.1016/j.seizure.2015.01.009; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; van Vliet EA, 2018, NEUROPATH APPL NEURO, V44, P91, DOI 10.1111/nan.12444; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; Watt JA, 2000, J NEUROSCI RES, V60, P478, DOI 10.1002/(SICI)1097-4547(20000515)60:4<478::AID-JNR6>3.0.CO;2-R; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Xanthos DN, 2014, NAT REV NEUROSCI, V15, P43, DOI 10.1038/nrn3617; YAO JB, 1992, BRAIN RES, V591, P88, DOI 10.1016/0006-8993(92)90981-E; Yu CH, 2011, J VET SCI, V12, P299, DOI 10.4142/jvs.2011.12.3.299; Zhang WD, 2000, J CEREBR BLOOD F MET, V20, P967, DOI 10.1097/00004647-200006000-00009	62	13	13	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	JUN 17	2019	20								29	10.1186/s12868-019-0509-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ID7VX	WOS:000471892000001	31208341	gold, Green Published			2022-02-06	
J	Rosendale, N; Guterman, EL; Betjemann, JP; Josephson, A; Douglas, VC				Rosendale, Nicole; Guterman, Elan L.; Betjemann, John P.; Josephson, Andrew; Douglas, Vanja C.			Hospital admission and readmission among homeless patients with neurologic disease	NEUROLOGY			English	Article							RISK-FACTORS; SUBSTANCE USE; CARE; HEALTH; QUALITY; PREDICTORS; DISCHARGE; STROKE; PREVALENCE; EPILEPSY	Objective To characterize the most common neurologic diagnoses leading to hospitalization for homeless compared to housed individuals and to assess whether homelessness is an independent risk factor for 30-day readmission after an admission for a neurologic illness. Methods We performed a retrospective serial cross-sectional study using data from the Healthcare Cost and Utilization Project California State Inpatient Database from 2006 to 2011. Adult patients with a primary neurologic discharge diagnosis were included. The primary outcome was 30-day readmission. We used multilevel logistic regression to examine the association between homelessness and readmission after adjustment for patient factors. Results We identified 1,082,347 patients with a neurologic primary diagnosis. The rate of homelessness was 0.37%. The most common indications for hospitalization among homeless patients were seizure and traumatic brain injury, both of which were more common in the homeless compared to housed population (19.3% vs 8.1% and 31.9% vs 9.2%, respectively, p < 0.001). A multilevel mixed-effects model controlling for patient age, sex, race, insurance type, comorbid conditions, and clustering on the hospital level found that homelessness was associated with increased 30-day readmission (odds ratio 1.5, 95% confidence interval 1.4-1.6, p < 0.001). This association persisted after this analysis was repeated within specific diagnoses (patients with epilepsy, trauma, encephalopathy, and neuromuscular disease). Conclusion The most common neurologic reasons for admission among homeless patients are seizure and traumatic brain injury; these patients are at high risk for readmission. Future interventions should target the drivers of readmissions in this vulnerable population.	[Rosendale, Nicole; Guterman, Elan L.; Betjemann, John P.; Josephson, Andrew; Douglas, Vanja C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Rosendale, Nicole; Guterman, Elan L.; Betjemann, John P.; Josephson, Andrew; Douglas, Vanja C.] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA		Rosendale, N (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	nicole.rosendale@ucsf.edu		Guterman, Elan/0000-0003-0817-3144	Sara and Evan Williams Endowed Neurohospitalist Chair at the University of California, San Francisco; National Center for Advancing Translational Sciences, NIH, through University of California, San Francisco Clinical AMP; Translational Science Institute [UL1 TR001872]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001872] Funding Source: NIH RePORTER	This study was funded by the Sara and Evan Williams Endowed Neurohospitalist Chair at the University of California, San Francisco. This project was supported by the National Center for Advancing Translational Sciences, NIH, through University of California, San Francisco Clinical & Translational Science Institute grant UL1 TR001872. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Aidala AA, 2016, AM J PUBLIC HEALTH, V106, pE1, DOI 10.2105/AJPH.2015.302905; Barshes NR, 2016, INT J LOW EXTR WOUND, V15, P303, DOI 10.1177/1534734616661058; Bjerkreim AT, 2015, J STROKE CEREBROVASC, V24, P2095, DOI 10.1016/j.jstrokecerebrovasdis.2015.05.019; Boehme AK, 2017, STROKE, V48, P574, DOI 10.1161/STROKEAHA.116.016162; Burke JF, 2014, NEUROLOGY, V82, P2196, DOI 10.1212/WNL.0000000000000514; Camfield C, 2016, EPILEPSIA, V57, P1826, DOI 10.1111/epi.13576; Doran KM, 2013, MED CARE, V51, P767, DOI 10.1097/MLR.0b013e31829fafbb; Douglas VC, 2011, NEUROHOSPITALIST, V1, P8, DOI 10.1177/1941875210380676; FISCHER PJ, 1991, AM PSYCHOL, V46, P1115, DOI 10.1037/0003-066X.46.11.1115; GELBERG L, 1990, ARCH INTERN MED, V150, P2325, DOI 10.1001/archinte.150.11.2325; George MG, 2017, JAMA NEUROL, V74, P695, DOI 10.1001/jamaneurol.2017.0020; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Greysen SR, 2013, J HEALTH CARE POOR U, V24, P444, DOI 10.1353/hpu.2013.0070; Greysen SR, 2012, J GEN INTERN MED, V27, P1484, DOI 10.1007/s11606-012-2117-2; Guterman EL, 2016, NEUROLOGY, V86, P669, DOI 10.1212/WNL.0000000000002379; Hamilton JE, 2016, AUST NZ J PSYCHIAT, V50, P584, DOI 10.1177/0004867415605171; Healthcare Cost and Utilization Project, 2017, CLIN CLASS SOFTW CCS; Healthcare Cost and Utilization Project, 2018, HCUP SUPPL VAR REV A; Henry M, 2017, 2017 ANN HOMELESS AS, P100; Hesselink G, 2013, INT J QUAL HEALTH C, V25, P66, DOI 10.1093/intqhc/mzs066; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hwang SW, 2001, CAN MED ASSOC J, V164, P229; Keyhani S, 2014, ANN INTERN MED, V161, P775, DOI 10.7326/M14-0361; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; Kushel M, 2018, MED CARE, V56, P457, DOI 10.1097/MLR.0000000000000920; Kushel MB, 2003, ARCH INTERN MED, V163, P2492, DOI 10.1001/archinte.163.20.2492; Laporte A, 2006, EUR J PUBLIC HEALTH, V16, P484, DOI 10.1093/eurpub/ckl011; McCormick N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135834; McIntyre LK, 2016, JAMA SURG, V151, P855, DOI 10.1001/jamasurg.2016.1258; National Coalition for the Homeless, 2009, SUBST AB HOM; National Health Care for the Homeless Council, 2018, CAL STAT NAT HLTH CA; Newey CR, 2013, J NEUROIMAGING, V23, P58, DOI 10.1111/j.1552-6569.2012.00763.x; Quan H, 2004, MED CARE, V42, P801, DOI 10.1097/01.mlr.0000132391.59713.0d; Reid KW, 2008, J HEALTH CARE POOR U, V19, P1212, DOI 10.1353/hpu.0.0068; Santa Maria DM, 2018, J ADDICT NURS, V29, P23, DOI 10.1097/JAN.0000000000000206; Spinelli MA, 2017, SUBST ABUS, V38, P88, DOI 10.1080/08897077.2016.1264534; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; Substance Abuse and Mental Health Service Administration, 2017, POV HOUS; Svoboda T, 2014, EMERG MED J, V31, P571, DOI 10.1136/emermed-2012-201761; Tian N, 2018, MMWR-MORBID MORTAL W, V67, P437, DOI 10.15585/mmwr.mm6715a1; Tiesman H, 2007, J NEUROTRAUM, V24, P1189, DOI 10.1089/neu.2006.0196; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; US Interagency Council on Homelessness, 2017, HOM STAT STAT; Walkey Allan J, 2013, Ann Am Thorac Soc, V10, P10, DOI 10.1513/AnnalsATS.201206-034OC; Wasfy JH, 2015, CIRC-CARDIOVASC QUAL, V8, P477, DOI 10.1161/CIRCOUTCOMES.115.001855; Williams MV, 2013, JAMA-J AM MED ASSOC, V309, P394, DOI 10.1001/jama.2012.233964; Wittman F, 2017, DRUGS ALCOHOL TODAY, V17, P157, DOI 10.1108/DAT-12-2016-0032	47	13	13	3	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUN 11	2019	92	24					E2822	E2831		10.1212/WNL.0000000000007645			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IQ5FP	WOS:000480777800010	31127074	Green Published			2022-02-06	
J	Akbik, OS; Starling, RV; Gahramanov, S; Zhu, YL; Lewis, J				Akbik, Omar S.; Starling, Robert, V; Gahramanov, Seymur; Zhu, Yiliang; Lewis, Jeremy			Mortality and Functional Outcome in Surgically Evacuated Acute Subdural Hematoma in Elderly Patients	WORLD NEUROSURGERY			English	Article						Acute subdural hematoma; Elderly traumatic brain injury	PREINJURY WARFARIN; INJURY; AGE	BACKGROUND: Significant morbidity and mortality is associated with surgical evacuation of acute subdural hematomas (ASDHs) in the elderly population. The literature remains mixed on risk factors associated with poor outcomes, specifically preoperative antithrombotic usage and postoperative seizures. METHODS: Between January 1, 2013, and December 31, 2017, we retrospectively identified 62 patients >= 65 years of age who underwent a craniotomy for evacuation of an ASDH, with the primary outcome being Glasgow Outcome Scale (GOS) score at discharge and 3- and 6-month follow-up. RESULTS: Of the patients, 52% were women, with a median age of 78 years (range, 65-93 years). The mechanism of injury was because of a fall in 40 patients. Twenty-eight patients (44%) had a poor outcome (GOS score 1-2) at discharge, increasing to 31 patients (50%) at 3-month follow-up. Eight patients (13%) had a good outcome (GOS score 4-5) at discharge, increasing to 17 patients (27%) at 3-month follow-up. Perioperative mortality rate was 39%, increasing to 44% at 3-month follow-up. The strongest associations with mortality in descending order were 24-hour postoperative Glasgow Come Scale (GCS) score, midline shift, preoperative GCS score, and pupillary abnormalities. Although age was not a statistically significant factor for mortality, patients with a favorable outcome (GOS score 4-5) had a median age of 71 years versus 78 years for GOS score 1-3. Preoperative antithrombotic usage and postoperative seizures were not significant predictors of outcome or mortality. CONCLUSIONS: A high percentage of morbidity and mortality remains in the management of ASDHs in the elderly population; however, a significant percentage (27%) can still go on to have a favorable outcome.	[Akbik, Omar S.; Starling, Robert, V; Gahramanov, Seymur; Zhu, Yiliang; Lewis, Jeremy] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA		Akbik, OS (corresponding author), Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA.	osakbik@salud.unm.edu					Benedetto N, 2017, BRIT J NEUROSURG, V31, P244, DOI 10.1080/02688697.2016.1244249; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; He W., 2016, AGING WORLD 2015; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Inamasu J, 2010, NEUROL MED-CHIR, V50, P1051, DOI 10.2176/nmc.50.1051; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; McGinity MJ, 2017, BRIT J NEUROSURG, V31, P714, DOI 10.1080/02688697.2017.1341041; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Pollandt S, 2017, J CLIN NEUROPHYSIOL, V34, P55, DOI 10.1097/WNP.0000000000000311; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; Ushewokunze S, 2004, BRIT J NEUROSURG, V18, P604, DOI 10.1080/02688690400022763; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17417	15	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2019	126						E1235	E1241		10.1016/j.wneu.2019.02.234			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IA0BU	WOS:000469222400155	30885866				2022-02-06	
J	Andrade, P; Banuelos-Cabrera, I; Lapinlampi, N; Paananen, T; Ciszek, R; Ndode-Ekane, XE; Pitkanen, A				Andrade, Pedro; Banuelos-Cabrera, Ivette; Lapinlampi, Niina; Paananen, Tomi; Ciszek, Robert; Ndode-Ekane, Xavier Ekolle; Pitkanen, Asia			Acute Non-Convulsive Status Epilepticus after Experimental Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						antiepileptic drugs; epileptogenesis; lateral fluid-percussion injury; seizure; video-EEG monitoring	INTRACRANIAL-PRESSURE CHANGES; FLUID-PERCUSSION; ELECTRICAL-STIMULATION; MODEL; COMPLICATIONS; SEIZURES; SURGERY; ELECTROENCEPHALOGRAPHY; MANAGEMENT; MORTALITY	Severe traumatic brain injury (TBI) induces seizures or status epilepticus (SE) in 20-30% of patients during the acute phase. We hypothesized that severe TBI induced with lateral fluid-percussion injury (FPI) triggers post-impact SE. Adult Sprague-Dawley male rats were anesthetized with isoflurane and randomized into the sham-operated experimental control or lateral FPI-induced severe TBI groups. Electrodes were implanted right after impact or sham-operation, then video-electroencephalogram (EEG) monitoring was started. In addition, video-EEG was recorded from naive rats. During the first 72 h post-TBI, injured rats had seizures that were intermingled with other epileptiform EEG patterns typical to non-convulsive SE, including occipital intermittent rhythmic delta activity, lateralized or generalized periodic discharges, spike-and-wave complexes, poly-spikes, poly-spike-and-wave complexes, generalized continuous spiking, burst suppression, or suppression. Almost all (98%) of the electrographic seizures were recorded during 0-72 h post-TBI (23.2 +/- 17.4 seizures/rat). Mean latency from the impact to the first electrographic seizure was 18.4 +/- 15.1 h. Mean seizure duration was 86 +/- 57 sec. Analysis of high-resolution videos indicated that only 41% of electrographic seizures associated with behavioral abnormalities, which were typically subtle (Racine scale 1-2). Fifty-nine percent of electrographic seizures did not show any behavioral manifestations. In most of the rats, epileptiform EEG patterns began to decay spontaneously on Days 5-6 after TBI. Interestingly, also a few sham-operated and naive rats had post-operation seizures, which were not associated with EEG background patterns typical to non-convulsive SE seen in TBI rats. To summarize, our data show that lateral FPI-induced TBI results in non-convulsive SE with subtle behavioral manifestations; this explains why it has remained undiagnosed until now. The lateral FPI model provides a novel platform for assessing the mechanisms of acute symptomatic non-convulsive SE and for testing treatments to prevent post-injury SE in a clinically relevant context.	[Andrade, Pedro; Banuelos-Cabrera, Ivette; Lapinlampi, Niina; Paananen, Tomi; Ciszek, Robert; Ndode-Ekane, Xavier Ekolle; Pitkanen, Asia] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi	Andrade, Pedro/N-8410-2018	Andrade, Pedro/0000-0001-9118-8341; Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632; Lapinlampi, Niina/0000-0003-3210-6312	Medical Research Council of the Academy of FinlandAcademy of Finland [272249, 273909]; NINDS Center without Walls [U54 NS100064]; CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [CVU 333114]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS100064] Funding Source: NIH RePORTER	We thank Jarmo Hartikainen for his excellent technical help. This study was supported by the Medical Research Council of the Academy of Finland (Grants 272249 and 273909), NINDS Center without Walls, U54 NS100064 (EpiBioS4Rx) and the CONACYT (CVU 333114).	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; [Anonymous], 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P1; Avdic U, 2018, EPILEPSIA, V59, P945, DOI 10.1111/epi.14070; Beniczky S, 2013, EPILEPSIA, V54, P28, DOI 10.1111/epi.12270; Beric A, 2001, STEREOT FUNCT NEUROS, V77, P73, DOI 10.1159/000064600; Boviatsis EJ, 2010, ACTA NEUROCHIR, V152, P2053, DOI 10.1007/s00701-010-0749-8; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Drislane FW, 2011, EPILEPSY BEHAV, V22, P342, DOI 10.1016/j.yebeh.2011.07.013; Fenoy AJ, 2014, J NEUROSURG, V120, P132, DOI 10.3171/2013.10.JNS131225; Gabrielian L, 2011, J NEUROTRAUM, V28, P2103, DOI 10.1089/neu.2011.1785; Hickman DL, 2010, J AM ASSOC LAB ANIM, V49, P155; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Kane N, 2017, CLIN NEUROPHYS PRACT, V2, P170, DOI 10.1016/j.cnp.2017.07.002; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kim H, 2017, J NEUROSURG, V127, P23, DOI 10.3171/2016.7.JNS161263; Kim H, 2015, J NEUROTRAUM, V32, P1210, DOI 10.1089/neu.2014.3771; Kim JA, 2018, ANN NEUROL, V83, P858, DOI 10.1002/ana.25211; Lewczuk E, 2018, EPILEPSIA, V59, P369, DOI 10.1111/epi.13972; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Lyons KE, 2001, J NEUROL NEUROSUR PS, V71, P682, DOI 10.1136/jnnp.71.5.682; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Ndode-Ekane XE, 2017, J NEUROTRAUM, V34, P459, DOI 10.1089/neu.2016.4404; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; Pahwa R, 2003, J NEUROSURG, V99, P71, DOI 10.3171/jns.2003.99.1.0071; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A., 2018, NEUROBIOL DIS; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; R. C. T, 2017, LANG ENV STAT COMP; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Rowe RK, 2018, J NEUROSURG-PEDIATR, V22, P22, DOI 10.3171/2018.1.PEDS17449; RStudio Team, 2016, RSTUDIO INT DEV R; Sandsmark DK, 2016, J HEAD TRAUMA REHAB, V31, P101, DOI 10.1097/HTR.0000000000000217; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Smith DH, 1997, NEUROSCI LETT, V231, P135, DOI 10.1016/S0304-3940(97)00551-X; Starr PA, 2008, CURR CLIN NEUROL, P135, DOI 10.1007/978-1-59745-360-8_7; Sutter R, 2016, NAT REV NEUROL, V12, P281, DOI 10.1038/nrneurol.2016.45; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Thal SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050752; TREIMAN DM, 1990, EPILEPSY RES, V5, P49, DOI 10.1016/0920-1211(90)90065-4; Trinka E, 2015, EPILEPSIA, V56, P1515, DOI 10.1111/epi.13121; Trinka E, 2015, EPILEPSY BEHAV, V49, P203, DOI 10.1016/j.yebeh.2015.05.005; Umemura A, 2003, J NEUROSURG, V98, P779, DOI 10.3171/jns.2003.98.4.0779; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Voges J, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.081232; Wang X, 2016, BRAIN RES, V1646, P174, DOI 10.1016/j.brainres.2016.05.055; Wellmer J, 2012, EPILEPSIA, V53, P1322, DOI 10.1111/j.1528-1167.2012.03545.x; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	59	13	13	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1890	1907		10.1089/neu.2018.6107			18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600019	30543155	Green Published			2022-02-06	
J	Dai, XP; Yi, M; Wang, DS; Chen, YY; Xu, X				Dai, Xingping; Yi, Min; Wang, Dongsheng; Chen, Yanyi; Xu, Xia			Changqin NO. 1 inhibits neuronal apoptosis via suppressing GAS5 expression in a traumatic brain injury mice model	BIOLOGICAL CHEMISTRY			English	Article						GAS5; long non-coding RNA; neuronal apoptosis; Rasa1; traditional Chinese medicine; traumatic brain injury	TRADITIONAL CHINESE MEDICINE; LONG NONCODING RNAS; SURVIVIN EXPRESSION; MIR-335; PATHWAY	The present study was designed to investigate the mechanism of the traditional Chinese medicine Changqin NO. 1 on the amelioration of traumatic brain injury (TBI). Adult male C57BL/6J mice and newborn mice were used to generate a mouse TBI model and harvest primary neurons, respectively. The localizations of specific neural markers neuropilin-1 (Nrp-1), growth-associated protein-43 (GAP-43) and microtubule-associated protein Tau (Tau) were examined in brain tissues by immunohistochemistry. Terminal deoxynucleotidyl transferase dUTP nick end labeling apoptotic cell detection in tissue sections and the CCK-8 cell viability assay were performed to examine neuronal apoptosis. Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot were also carried out in this study. The association between long non-coding RNA (lncRNA) growth-arrest specific 5 (GAS5), miR-335 and RAS p21 GTPase activating protein 1 (Rasa1) was disclosed using the dual-luciferase reporter assay. Changqin NO. 1 inhibited TBI-induced neuronal apoptosis in vivo and in vitro. GAS5 functioned as a competing endogenous RNA (ceRNA) by sponging miR-335 to upregulate Rasa1 expression in mouse neuronal cells. Further investigations demonstrated that GAS5 promoted neuronal apoptosis following TBI via the miR-335/Rasa1 axis. In vivo experiments indicated that Changqin NO. 1 exerted neuroprotection during TBI via the GAS5/miR-335/Rasa1 axis. Changqin NO. 1 promoted neuroprotective effects by inhibiting neuronal apoptosis via the GAS5/miR-335/Rasa1 axis in TBI.	[Dai, Xingping; Yi, Min; Wang, Dongsheng; Chen, Yanyi; Xu, Xia] Cent S Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, 87 Xiangya Rd, Changsha 410078, Hunan, Peoples R China		Dai, XP (corresponding author), Cent S Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, 87 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.	xingpingd@yeah.net		Yi, Min/0000-0002-8752-0054			Chen LL, 2014, ADV EXP MED BIOL, V825, P129, DOI 10.1007/978-1-4939-1221-6_4; [陈彦伊 Chen Yanyi], 2017, [中国中医药信息杂志, Chinese Journal of Information on Traditional Chinese Medicine], V24, P17; Coupland KG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157924; Dong HY, 2014, MOLECULES, V19, P5634, DOI 10.3390/molecules19055634; Hancock ML, 2014, J NEUROSCI, V34, P66, DOI 10.1523/JNEUROSCI.3371-13.2014; Hao NB, 2017, ONCOTARGET, V8, P81572, DOI 10.18632/oncotarget.19197; Hsieh TT, 2017, CONT CLIN TRIAL COMM, V6, P127, DOI 10.1016/j.conctc.2017.04.005; Huang LP, 2016, BEHAV BRAIN RES, V313, P370, DOI 10.1016/j.bbr.2016.07.028; Lapinski PE, 2012, J CLIN INVEST, V122, P733, DOI 10.1172/JCI46116; Liu HJ, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00661; Liu ZF, 2016, EUR REV MED PHARMACO, V20, P1251; Ning BL, 2016, NEUROCHEM RES, V41, P2097, DOI 10.1007/s11064-016-1922-0; Santoro M, 2016, J MOL NEUROSCI, V59, P18, DOI 10.1007/s12031-016-0741-8; Surgucheva I, 2014, MOL CELL NEUROSCI, V63, P114, DOI 10.1016/j.mcn.2014.10.005; Tsai MC, 2015, J NEUROIMMUNE PHARM, V10, P45, DOI 10.1007/s11481-014-9570-0; Tsai P.C., 2014, LANG COGNIT PROCESSE, V15, P87; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Wang CF, 2017, J NEUROTRAUM, V34, P2100, DOI 10.1089/neu.2016.4642; Wang F, 2018, HEPATOLOGY, V67, P940, DOI 10.1002/hep.29586; Wu XM, 2013, INT J CLIN EXP PATHO, V6, P1282; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Yang BR, 2016, TUMOR BIOL, V37, P1771, DOI 10.1007/s13277-015-3951-8	22	13	14	0	12	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1431-6730	1437-4315		BIOL CHEM	Biol. Chem.	JUN	2019	400	6					753	763		10.1515/hsz-2018-0340			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX6RT	WOS:000467531700006	30653462				2022-02-06	
J	Faheem, H; Mansour, A; Elkordy, A; Rashad, S; Shebl, M; Madi, M; Elwy, S; Niizuma, K; Tominaga, T				Faheem, Heba; Mansour, Ahmed; Elkordy, Alaa; Rashad, Sherif; Shebl, Mohamed; Madi, Mohamed; Elwy, Salma; Niizuma, Kuniyasu; Tominaga, Teiji			Neuroprotective effects of minocycline and progesterone on white matter injury after focal cerebral ischemia	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Cerebral ischemia; Minocycline; Progesterone; Stroke; White matter	TRAUMATIC BRAIN-INJURY; MICROGLIAL ACTIVATION; CELL-DEATH; STROKE; EXPRESSION; ALLOPREGNANOLONE; DAMAGE; REPERFUSION; PROMOTES; DEFICITS	Stroke induced white matter injury can induce marked neurological deficits even after relatively small infarcts, due to the tightly packed nature of white matter tracts especially in certain areas in the brain. Many drugs which were successful in the pre-clinical trials failed in clinical trials, which was attributed in part to the focus on grey matter injury completely and ignoring their effect on white matter. In this work we selected two known neuroprotective drugs (minocycline and progesterone) and examined their effect on white matter injury after focal cerebral ischemia/reperfusion injury in rats. Focal cerebral ischemia was induced in male Wistar rats (one-hour ischemia followed by reperfusion). Progesterone and minocycline were administered immediately after reperfusion onset. Infarct size, microglial activation and white matter injury were assessed and compared between the treatment and no-treatment groups and Sham operated animals. Our data showed that both progesterone and minocycline reduced infarct size, microglial activation and white matter injury. This work shows a new neuroprotective mechanism of both drugs, via white matter injury reduction, that can be exploited for stroke management. While the utility of either drugs as a sole agent in the management of stroke is questionable, there is a value of using either drugs as an adjuvant therapy to traditional stroke therapy, making use of the white matter protective effect that would improve outcome and facilitate healing after stroke. (C) 2019 Elsevier Ltd. All rights reserved.	[Faheem, Heba; Mansour, Ahmed; Elkordy, Alaa; Rashad, Sherif; Niizuma, Kuniyasu; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi, Japan; [Faheem, Heba; Shebl, Mohamed; Madi, Mohamed; Elwy, Salma] Tanta Univ, Dept Physiol, Tanta, Egypt; [Mansour, Ahmed] Menoufia Univ, Grad Sch Med, Dept Neurosurg, Menoufia, Egypt; [Elkordy, Alaa] Tanta Univ, Fac Med, Dept Neuropsychiat, Tanta, Egypt; [Rashad, Sherif; Niizuma, Kuniyasu] Tohoku Univ, Grad Sch Med, Dept Neurosurg Engn & Translat Neurosci, Sendai, Miyagi, Japan; [Niizuma, Kuniyasu] Tohoku Univ, Grad Sch Biomed Engn, Dept Neurosurg Engn & Translat Neurosci, Sendai, Miyagi, Japan		Rashad, S (corresponding author), Tohoku Univ, Dept Neurosurg, Grad Sch Med, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	sherif@nsg.med.tohoku.ac.jp	Rashad, Sherif/B-4237-2014	Rashad, Sherif/0000-0002-4511-6360			Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Andrabi SS, 2017, DIS MODEL MECH, V10, P787, DOI 10.1242/dmm.025692; Arevalo MA, 2013, HORM BEHAV, V63, P216, DOI 10.1016/j.yhbeh.2012.02.021; Atif F, 2013, NEUROPHARMACOLOGY, V67, P78, DOI 10.1016/j.neuropharm.2012.10.004; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Chen YZ, 2013, BRAIN RES, V1495, P11, DOI 10.1016/j.brainres.2012.12.006; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Doyle S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03427-1; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; Feuerstein GZ, 2008, J CEREBR BLOOD F MET, V28, P217, DOI 10.1038/sj.jcbfm.9600516; Fields RD, 2008, SCI AM, V298, P54; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Ginsberg MD, 2016, PROG NEUROBIOL, V145, P46, DOI 10.1016/j.pneurobio.2016.09.002; Hill JW, 2012, NEUROSCIENCE, V220, P277, DOI 10.1016/j.neuroscience.2012.06.019; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jin ZQ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0264-1; Perez-Alvarez MJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-157; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Kraus RL, 2005, J NEUROCHEM, V94, P819, DOI 10.1111/j.1471-4159.2005.03219.x; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Patel Anita R, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P73; Rashad S, 2016, NEUROSURG REV, V39, P615, DOI 10.1007/s10143-016-0734-7; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Sonmez E, 2013, SPINE, V38, P1253, DOI 10.1097/BRS.0b013e3182895587; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Tachibana M, 2017, STROKE, V48, P2222, DOI 10.1161/STROKEAHA.117.016689; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; WAKITA H, 1994, ACTA NEUROPATHOL, V87, P484; Wali B, 2014, BRAIN, V137, P486, DOI 10.1093/brain/awt319; Wang JP, 2010, BEHAV BRAIN RES, V209, P119, DOI 10.1016/j.bbr.2010.01.026; Wang Y, 2016, PROG NEUROBIOL, V141, P45, DOI [10.1016/j.pneurobio.2016.04.00, 10.1016/j.pneurobio.2016.04.005]; Won S, 2015, BRAIN BEHAV IMMUN, V49, P267, DOI 10.1016/j.bbi.2015.06.007; Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018; Yang Y, 2013, J CEREBR BLOOD F MET, V33, P1104, DOI 10.1038/jcbfm.2013.56; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Yousuf S, 2013, NEUROSCIENCE, V239, P92, DOI 10.1016/j.neuroscience.2012.10.017; Zhao Y, 2015, NEUROPSYCH DIS TREAT, V11, P507, DOI 10.2147/NDT.S73836	42	13	13	2	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUN	2019	64						206	213		10.1016/j.jocn.2019.04.012			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IC6LJ	WOS:000471083300049	31023573				2022-02-06	
J	Tucker, LB; Velosky, AG; Fu, AH; McCabe, JT				Tucker, Laura B.; Velosky, Alexander G.; Fu, Amanda H.; McCabe, Joseph T.			Chronic Neurobehavioral Sex Differences in a Murine Model of Repetitive Concussive Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; mouse; concussion; repetitive brain injury; behavior; active place avoidance; microbleeds; sex differences	CONTROLLED CORTICAL IMPACT; CHRONIC TRAUMATIC ENCEPHALOPATHY; MOUSE MODEL; WHITE-MATTER; BEHAVIORAL PERFORMANCE; COGNITIVE DYSFUNCTION; UNITED-STATES; AXONAL INJURY; MILD; GENDER	Traumatic brain injury (TBI) resulting from repeated head trauma is frequently characterized by diffuse axonal injury and long-term motor, cognitive and neuropsychiatric symptoms. Given the delay, often decades, between repeated head traumas and the presentation of symptoms in TBI patients, animal models of repeated injuries should be studied longitudinally to properly assess the longer-term effects of multiple concussive injuries on functional outcomes. In this study, male and cycling female C57BL/6J mice underwent repeated (three) concussive brain injuries (rCBI) delivered via a Leica ImpactOne cortical impact device and were assessed chronically on motor (open field and rotarod), cognitive (y-maze and active place avoidance), and neuropsychiatric (marble-burying, elevated zero maze and tail suspension) tests. Motor deficits were significant on the rotarod on the day following the injuries, and slight impairment remained for up to 6 months. All mice that sustained rCBI had significant cognitive deficits on the active place avoidance test and showed greater agitation (less immobility) in the tail suspension test. Only injured male mice were significantly hyperactive in the open field, and had increased time spent in the open quadrants of the elevated zero maze. One year after the injuries, mice of both sexes exhibited persistent pathological changes by the presence of Prussian blue staining (indication of prior microbleeds), primarily in the cortex at the site of the injury, and increased GFAP staining in the perilesional cortex and axonal tracts (corpus callosum and optic tracts). These data demonstrate that a pathological phenotype with motor, cognitive, and neuropsychiatric symptoms can be observed in an animal model of rCBI for at least one year post-injury, providing a pre-clinical setting for the study of the link between multiple brain injuries and neurodegenerative disorders. Furthermore, this is the first study to include both sexes in a pre-clinical long-term rCBI model, and female mice are less impaired functionally than males.	[Tucker, Laura B.; Fu, Amanda H.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Preclin Studies Core, Bethesda, MD 20814 USA; [Tucker, Laura B.; Velosky, Alexander G.; Fu, Amanda H.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA		McCabe, JT (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Preclin Studies Core, Bethesda, MD 20814 USA.; McCabe, JT (corresponding author), Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.	joseph.mccabe@usuhs.edu	McCabe, Joseph T/J-6293-2014	McCabe, Joseph T/0000-0002-1159-7442; Tucker, Laura/0000-0002-5984-6399	Center for Neuroscience and Regenerative Medicine (Department of Defense)United States Department of Defense [65310-309318-6.01]	This work was supported by The Center for Neuroscience and Regenerative Medicine (Department of Defense), 65310-309318-6.01. The opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army, Department of Defense, the U.S. Government or the Uniformed Services University of the Health Sciences. The use of trade names does not constitute an official endorsement or approval of the use of reagents or commercial hardware or software. This document may not be cited for purposes of advertisement.	Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Briggs DI, 2016, AM J PATHOL, V186, P2869, DOI 10.1016/j.ajpath.2016.07.013; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Casson IR, 2011, SPORTS HEALTH, V3, P11, DOI 10.1177/1941738110391413; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Clevenger AC, 2018, J MOL NEUROSCI, V64, P410, DOI 10.1007/s12031-018-1038-x; Covassin T, 2003, J ATHL TRAINING, V38, P238; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis-Hayes C, 2017, J AM ACAD ORTHOP SUR, V25, P818, DOI 10.5435/JAAOS-D-17-00276; Dellu F, 2000, NEUROBIOL LEARN MEM, V73, P31, DOI 10.1006/nlme.1999.3919; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Free KE, 2017, EXP NEUROL, V296, P62, DOI 10.1016/j.expneurol.2017.07.004; Gangolli M, 2019, J NEUROTRAUM, V36, P735, DOI 10.1089/neu.2018.5700; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Logue OC, 2016, EXP NEUROL, V277, P227, DOI 10.1016/j.expneurol.2015.12.019; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Mahar I, 2017, NEUROSCI BIOBEHAV R, V83, P622, DOI 10.1016/j.neubiorev.2017.08.023; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; McEwen BS, 2017, J NEUROSCI RES, V95, P24, DOI 10.1002/jnr.23809; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Resch JE, 2017, CLIN SPORT MED, V36, P717, DOI 10.1016/j.csm.2017.05.002; Ricciardi MC, 2017, J NEUROTRAUM, V34, P23, DOI 10.1089/neu.2015.4338; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rubenstein R, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00124; Sangobowale MA, 2018, J NEUROTRAUM, V35, P907, DOI 10.1089/neu.2017.5348; Sauerbeck AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25737-6; Save E, 2009, NEUROBIOL LEARN MEM, V91, P172, DOI 10.1016/j.nlm.2008.08.005; Semple BD, 2019, NEUROBIOL DIS, V123, P27, DOI 10.1016/j.nbd.2018.07.018; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yang ZH, 2016, JOVE-J VIS EXP, DOI 10.3791/54530; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942	82	13	13	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 22	2019	10								509	10.3389/fneur.2019.00509			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HZ0VD	WOS:000468562700001	31178814	Green Published, gold			2022-02-06	
J	Silverberg, ND; Martin, P; Panenka, WJ				Silverberg, Noah D.; Martin, Paul; Panenka, William J.			Headache Trigger Sensitivity and Avoidance after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain concussion; craniocerebral trauma; headache; post-concussion syndrome; post-traumatic headache	CONCUSSION SYMPTOMS QUESTIONNAIRE; POSTTRAUMATIC HEADACHE; RECURRENT HEADACHE; COGNIPHOBIA; PREVALENCE; ISSUES	Most patients with primary headache disorders identify environmental stimuli (e.g., visual glare), situational factors (e.g., stress), physiological states (e.g., hormones), or activities (e.g., exercise) as triggers that elicit or worsen headache episodes. Headache triggers have not been previously studied in post-traumatic headache (PTH). The present study explored the frequency of headache triggers and their avoidance in PTH. Participants with mild traumatic brain injury (TBI) were recruited from outpatient specialty clinics and completed questionnaires at or soon after their initial clinic visit. The research assessment included a list of 12 possible headache triggers where participants were asked to rate sensitivity (how often they get a headache when exposed to the trigger) and avoidance (how often they try to avoid the trigger). Enrolled participants were 40.6 years old (standard deviation [SD] = 11.8 years) on average, predominantly female (69.8%) and Caucasian (69.8%), and injured in a motor vehicle crash (47.2%) or fall (20.8%). They were assessed at 9.4 weeks (SD = 6.8) post-injury. Most patients with mild TBI in this consecutive series (82.7%) reported ongoing headaches. Mental exertion, stress, and lack of sleep were rated as the most potent headache triggers and among the most frequently avoided. Odors or foods, hunger, and weather conditions were rated as the least potent triggers. Headache trigger sensitivity and avoidance were moderately correlated (r = 0.736, p < 0.001). Headache severity was more associated with trigger sensitivity [F(2,49) = 13.45, p < 0.001] than trigger avoidance [F(2,47) = 2.97, p = 0.062]. In summary, the pattern of headache triggers in persistent PTH after mild TBI appears somewhat different from that in primary headache disorders, with mental exertion emerging as uniquely important. Pervasive avoidance of mental exertion to prevent headaches (cogniphobia) might be a worthwhile behavioral intervention target after mild TBI.	[Silverberg, Noah D.] Univ British Columbia, GF Strong Rehab Ctr, Div Phys Med & Rehabil, Rehabil Res Program, Vancouver, BC, Canada; [Martin, Paul] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia; [Panenka, William J.] Univ British Columbia, Dept Psychiat, British Columbia Neuropsychiat Program, Vancouver, BC, Canada		Silverberg, ND (corresponding author), GF Strong Rehab Ctr, Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca		Panenka, William/0000-0001-7143-6512			Brown AW, 2015, PM&R, V7, P3, DOI 10.1016/j.pmrj.2014.06.016; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Department of Veterans Affairs; Department of Defense, 2018, VA DOD CLIN PRACT GU; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kamins J, 2018, HEADACHE, V58, P811, DOI 10.1111/head.13312; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Kubik SU, 2017, HEADACHE, V57, P236, DOI 10.1111/head.12940; Lazarus R., 1966, PSYCHOL STRESS COPIN; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lucas S, 2018, HEADACHE, V58, P873, DOI 10.1111/head.13311; Lucas S, 2016, HEADACHE, V56, P323, DOI 10.1111/head.12762; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Martelli MF, 1999, ARCH CLIN NEUROPSYCH, V14, P804, DOI 10.1016/S0887-6177(99)80356-4; Martin PR, 2007, ANXIETY STRESS COPIN, V20, P393, DOI 10.1080/10615800701628843; Martin PR, 2014, BEHAV RES THER, V61, P1, DOI 10.1016/j.brat.2014.07.002; Martin PR, 2010, CURR PAIN HEADACHE R, V14, P221, DOI 10.1007/s11916-010-0112-z; Martin PR, 2009, CLIN PSYCHOL REV, V29, P483, DOI 10.1016/j.cpr.2009.05.002; Martin PR, 2000, PSYCHOL HEALTH, V15, P801, DOI 10.1080/08870440008405582; Martin PR, 2001, BEHAV RES THER, V39, P545, DOI 10.1016/S0005-7967(00)00032-2; McLeod T.C.V., 2010, HUM KINET ATHL THER, V15, P3; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Pellegrino ABW, 2018, CEPHALALGIA, V38, P1188, DOI 10.1177/0333102417727535; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Seng EK, 2017, PSYCHOL ASSESSMENT, V29, P1296, DOI 10.1037/pas0000432; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Suhr J, 2012, CLIN NEUROPSYCHOL, V26, P1128, DOI 10.1080/13854046.2012.713121; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Turner DP, 2018, CEPHALALGIA, V38, P1545, DOI 10.1177/0333102417739310	41	13	13	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2019	36	10					1544	1550		10.1089/neu.2018.6025			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HX7CZ	WOS:000467562900006	30489228				2022-02-06	
J	Shannon, MM; Elf, M; Churilov, L; Olver, J; Pert, A; Bernhardt, J				Shannon, Michelle M.; Elf, Marie; Churilov, Leonid; Olver, John; Pert, Alan; Bernhardt, Julie			Can the physical environment itself influence neurological patient activity?	DISABILITY AND REHABILITATION			English	Article						Physical environment; healthcare design; Behavioral Mapping; brain injury; neurological; physical activity; social activity; neuroplasticity	TRAUMATIC BRAIN-INJURY; HOSPITAL ENVIRONMENT; REHABILITATION UNIT; QUALITY INDICATORS; CARE ENVIRONMENTS; STROKE PATIENTS; SINGLE ROOMS; HEALTH; DESIGN; BEHAVIOR	Purpose: To evaluate if a changed physical environment following redesign of a hospital ward influenced neurological patient physical and social activity. Methods: A "before and after" observational design was used that included 17 acute neurological patients pre-move (median age 77 (IQR 69-85) years Ward A and 20 post-move (median age 70 (IQR 57-81) years Ward B. Observations occurred for 1 day from 08.00-17.00 using Behavioral Mapping of patient physical and social activity, and location of that activity. Staff and ward policies remained unchanged throughout. An Environmental Description Checklist of each ward was also completed. Results: Behavioral Mapping was conducted pre-/post-move with a total of 801 Ward A and 918 Ward B observations. Environmental Description Checklists showed similarities in design features in both neurological wards with similar numbers of de-centralized nursing stations, however there were more single rooms and varied locations to congregate in Ward B (30% more single-patient rooms and separate allied health therapy room). Patients were alone >60% of time in both wards, although there was more in bed social activity in Ward A and more out of bed social activity in Ward B. There were low amounts of physical activity outside of patient rooms in both wards. Significantly more physical activity occurred in Ward B patient rooms (median = 47%, IQR 14-74%) compared to Ward A (median = 2% IQR 0-14%), Wilcoxon Rank Sum test z = -3.28, p = 0.001. Conclusions: Overall, patient social and physical activity was low, with little to no use of communal spaces. However we found more physical activity in patient rooms in the Ward B environment. Given the potential for patient activity to drive brain reorganization and repair, the physical environment should be considered an active factor in neurological rehabilitation and recovery.	[Shannon, Michelle M.; Churilov, Leonid; Bernhardt, Julie] NHMRC Ctr Res Excellence Stroke Rehabil & Recover, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Elf, Marie] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden; [Elf, Marie] Chalmers Univ Technol, Dept Architecture, Gothenburg, Sweden; [Olver, John] Monash Univ, Rehabil Div, Epworth Hosp, Clin Sci Sch, Melbourne, Vic, Australia; [Pert, Alan] Univ Melbourne, Melbourne Sch Design, Melbourne, Vic, Australia		Shannon, MM (corresponding author), Florey Inst Neurosci & Mental Hlth, Level 1,245 Burgundy St, Heidelberg, Vic 3084, Australia.	mshannon1@student.unimelb.edu.au	Shannon, Michelle M./J-4133-2019	Shannon, Michelle M./0000-0002-6805-078X			Alvaro C, 2016, HERD-HEALTH ENV RES, V9, P82, DOI 10.1177/1937586715605779; Andrade C, 2012, J ENVIRON PSYCHOL, V32, P97, DOI 10.1016/j.jenvp.2011.12.001; Andrade CC, 2013, HEALTH PLACE, V21, P122, DOI 10.1016/j.healthplace.2013.01.013; [Anonymous], 2008, HEALTHC CROSSS ROADS; Astrand A, 2016, J STROKE CEREBROVASC, V25, P938, DOI 10.1016/j.jstrokecerebrovasdis.2015.12.046; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; Bernhardt J, 2008, STROKE, V39, P2059, DOI 10.1161/STROKEAHA.107.507160; Bevan V, 2016, HEALTHY AGING RES, V5; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Chaudhury H, 2006, APPL NURS RES, V19, P118, DOI 10.1016/j.apnr.2005.06.002; Choi YS, 2013, HERD-HEALTH ENV RES, V6, P53, DOI 10.1177/193758671300600404; Connellan K, 2013, HERD-HEALTH ENV RES, V6, P127, DOI 10.1177/193758671300600408; Daemen EML, 2014, METHOD INFORM MED, V53, P406, DOI 10.3414/ME13-02-0032; Dijkstra K, 2008, J ENVIRON PSYCHOL, V28, P268, DOI 10.1016/j.jenvp.2008.02.007; Douglas CH, 2005, HEALTH EXPECT, V8, P264, DOI 10.1111/j.1369-7625.2005.00336.x; Drahota A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005315.pub2; Elf M, 2017, J ADV NURS, V73, P2796, DOI 10.1111/jan.13281; Ellison J, 2014, CAN J INFECT DIS MED, V25, P265, DOI 10.1155/2014/685402; Ferdous F, 2015, AM J ALZHEIMERS DIS, V30, P209, DOI 10.1177/1533317514545378; Fini NA, 2015, DISABIL REHABIL, V37, P1717, DOI 10.3109/09638288.2014.978508; Fornara F, 2006, J ENVIRON PSYCHOL, V26, P321, DOI 10.1016/j.jenvp.2006.07.003; Foti F, 2011, CEREBELLUM, V10, P104, DOI 10.1007/s12311-010-0236-z; Gimenez MC, 2017, J SLEEP RES, V26, P236, DOI 10.1111/jsr.12470; Gray WA, 2012, HERD-HEALTH ENV RES, V5, P46, DOI 10.1177/193758671200500306; Harris DD, 2006, J PERINATOL, V26, pS38, DOI 10.1038/sj.jp.7211583; Healy S, 2015, HERD-HEALTH ENV RES, V8, P43, DOI 10.1177/1937586714565612; Hokstad A, 2015, J STROKE CEREBROVASC, V24, P1333, DOI 10.1016/j.jstrokecerebrovasdis.2015.02.009; Huisman ERCM, 2012, BUILD ENVIRON, V58, P70, DOI 10.1016/j.buildenv.2012.06.016; Janssen H, 2014, DISABIL REHABIL, V36, P255, DOI 10.3109/09638288.2013.788218; Janssen H, 2010, NEUROREHAB NEURAL RE, V24, P802, DOI 10.1177/1545968310372092; Johansson BB, 2002, J CEREBR BLOOD F MET, V22, P89, DOI 10.1097/00004647-200201000-00011; Kandel E. R., 2000, PRINCIPLES NEURAL SC, V4; Khan F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006036.pub2; Khan F, 2016, J REHABIL MED, V48, P417, DOI 10.2340/16501977-2081; Kodama T, 2010, J NEUROTRAUM, V27, P1577, DOI 10.1089/neu.2009.1119; Koskinen S, 2011, DISABIL REHABIL, V33, P2464, DOI 10.3109/09638288.2011.574776; Lambert K, 2016, NEUROSCIENCE, V330, P386, DOI 10.1016/j.neuroscience.2016.05.037; Larsen LS, 2014, J ADV NURS, V70, P395, DOI 10.1111/jan.12204; Laursen J, 2014, HERD-HEALTH ENV RES, V7, P108, DOI 10.1177/193758671400700410; Lorenz SG, 2011, HERD-HEALTH ENV RES, V4, P23, DOI 10.1177/193758671100400204; Lowson K., 2011, PS041 PSRP U YORK; Mackey F, 1996, ARCH PHYS MED REHAB, V77, P1066, DOI 10.1016/S0003-9993(96)90070-2; Mackrill JB, 2013, ERGONOMICS, V56, P1687, DOI 10.1080/00140139.2013.835873; McCarthey J., 2008, HERD, V2, P17; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Newall JT, 1997, CLIN REHABIL, V11, P146, DOI 10.1177/026921559701100208; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Okcu S, 2011, J ACOUST SOC AM, V130, P1348, DOI 10.1121/1.3607418; Parker C, 2004, AGEING SOC, V24, P941, DOI 10.1017/S0144686X04002387; Pennington H, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5695; Plano Clark, 2018, DESIGNING CONDUCTING; Raanaas RK, 2012, CLIN REHABIL, V26, P21, DOI 10.1177/0269215511412800; Rashid M, 2009, ENVIRON PLANN B, V36, P432, DOI 10.1068/b33034; Salonen H, 2013, INTELL BUILD INT, V5, P3, DOI 10.1080/17508975.2013.764838; Schloesser RJ, 2010, MOL PSYCHIATR, V15, P1152, DOI 10.1038/mp.2010.34; Schreiber S, 2014, BEHAV BRAIN RES, V271, P59, DOI 10.1016/j.bbr.2014.05.060; Sheehan B, 2013, PSYCHIAT SERV, V64, P789, DOI 10.1176/appi.ps.201200208; Shepley MM, 2002, CHILD HEALTH CARE, V31, P237, DOI 10.1207/S15326888CHC3103_5; Shraiky J, 2012, ENQUIRY, V9, P44; Stans SEA, 2017, DISABIL REHABIL, V39, P2594, DOI 10.1080/09638288.2016.1239769; Steinberg JP, 2013, HERD-HEALTH ENV RES, V7, P46, DOI 10.1177/193758671300701S06; Steiner B, 2006, EXP NEUROL, V199, P291, DOI 10.1016/j.expneurol.2005.11.004; Tanja-Dijkstra K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006210.pub3; Threatt AL, 2014, C P SESS INT CAR SUP; Ulrich RS, 2010, HERD-HEALTH ENV RES, V4, P95, DOI 10.1177/193758671000400107; Ulrich RS, 2008, HERD-HEALTH ENV RES, V1, P61, DOI 10.1177/193758670800100306; van de Glind I, 2007, HEALTH POLICY, V84, P153, DOI 10.1016/j.healthpol.2007.06.002; van Hoof J, 2009, BUILD ENVIRON, V44, P146, DOI 10.1016/j.buildenv.2008.02.005; Watts G, 2016, APPL ACOUST, V104, P135, DOI 10.1016/j.apacoust.2015.11.007; Yelden K, 2015, DISABIL REHABIL, V37, P91, DOI 10.3109/09638288.2014.906662	70	13	13	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	MAY 8	2019	41	10					1177	1189		10.1080/09638288.2017.1423520			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	HU3XK	WOS:000465208200006	29343110				2022-02-06	
J	De Blasio, D; Fumagalli, S; Orsini, F; Neglia, L; Perego, C; Ortolano, F; Zanier, ER; Picetti, E; Locatelli, M; Stocchetti, N; Longhi, L; Garred, P; De Simoni, MG				De Blasio, Daiana; Fumagalli, Stefano; Orsini, Franca; Neglia, Laura; Perego, Carlo; Ortolano, Fabrizio; Zanier, Elisa R.; Picetti, Edoardo; Locatelli, Marco; Stocchetti, Nino; Longhi, Luca; Garred, Peter; De Simoni, Maria-Grazia			Human brain trauma severity is associated with lectin complement pathway activation	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Traumatic brain injury; complement system; lectin complement pathway; neuroinflammation; MBL-associated serine proteases	MANNOSE-BINDING LECTIN; MONOCLONAL-ANTIBODIES; SERINE PROTEASE-3; INJURY; EXPRESSION; DYSFUNCTION; INHIBITION; COMPONENTS; NEOANTIGEN; FICOLIN-3	We explored the involvement of the lectin pathway of complement in post-traumatic brain injury (TBI) pathophysiology in humans. Brain samples were obtained from 28 patients who had undergone therapeutic contusion removal, within 12 h (early) or from >12 h until five days (late) from injury, and from five non-TBI patients. Imaging analysis indicated that lectin pathway initiator molecules (MBL, ficolin-1, ficolin-2 and ficolin-3), the key enzymes MASP-2 and MASP-3, and the downstream complement components (C3 fragments and TCC) were present inside and outside brain vessels in all contusions. Only ficolin-1 was found in the parenchyma of non-TBI tissues. Immunoassays in brain homogenates showed that MBL, ficolin-2 and ficolin-3 increased in TBI compared to non-TBI (2.0, 2.2 and 6.0-times) samples. MASP-2 increased with subarachnoid hemorrhage and abnormal pupil reactivity, two indicators of structural and functional damage. C3 fragments and TCC increased, respectively, by 3.5 - and 4.0-fold in TBI compared to non-TBI tissue and significantly correlated with MBL, ficolin-2, ficolin-3, MASP-2 and MASP-3 levels in the homogenates. In conclusion, we show for the first time the direct presence of lectin pathway components in human cerebral contusions and their association with injury severity, suggesting a central role for the lectin pathway in the post-traumatic pathophysiology of human TBI.	[De Blasio, Daiana; Fumagalli, Stefano; Orsini, Franca; Neglia, Laura; Perego, Carlo; Zanier, Elisa R.; De Simoni, Maria-Grazia] Ist Ric Farmacol Mario Negri, IRCCS, Via Giuseppe La Masa 19, I-20156 Milan, Italy; [Ortolano, Fabrizio; Stocchetti, Nino] Osped Maggiore Policlin, Dept Anesthesia & Crit Care Med, Fdn IRCCS Ca Granda, Milan, Italy; [Picetti, Edoardo] Azienda Osped Univ Parma, Div Anesthesia & Intens Care, Parma, Italy; [Locatelli, Marco] Osped Maggiore Policlin, Dept Neurosurg, Fdn IRCCS Ca Granda, Milan, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Longhi, Luca] Azienda Socio Sanit Terr Papa Giovanni XXIII, Dept Anesthesia & Crit Care Med, Neurosurg Intens Care Unit, Bergamo, Italy; [Garred, Peter] Univ Copenhagen, Fac Med & Hlth Sci, Rigshosp, Lab Mol Med,Dept Clin Immunol, Copenhagen, Denmark		De Simoni, MG (corresponding author), Ist Ric Farmacol Mario Negri, IRCCS, Via Giuseppe La Masa 19, I-20156 Milan, Italy.	desimoni@marionegri.it	Zanier, Elisa/AAA-8095-2020; Perego, Carlo/AAA-6513-2020; De Simoni, Maria Grazia/I-6021-2012; Longhi, Luca/AAF-9903-2021; Locatelli, Marco/AAC-5745-2022	Zanier, Elisa/0000-0002-3011-8718; Perego, Carlo/0000-0002-0259-0003; De Simoni, Maria Grazia/0000-0001-6695-5297; Longhi, Luca/0000-0001-9894-8788; Locatelli, Marco/0000-0003-0778-3653; Garred, Peter/0000-0002-2876-8586; Orsini, Franca/0000-0001-7415-9936; Fumagalli, Stefano/0000-0003-3598-6263	Fondazione CariploFondazione Cariplo [2012-0590]; Italian Ministry of Health (Ministero della Salute)Ministry of Health, Italy; ERANET-NEURON, JTC 2016: New therapeutic strategies in the treatment of traumatic brain injury by targeting the LEctin Activation Pathway of complement (LEAP) [NEURON9-FP-044]; Novo Nordisk Research FoundationNovo Nordisk Foundation; Danish Research Council for Independent ResearchDet Frie Forskningsrad (DFF)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Financial support including Drs De Blasio and Fumagalli fellowships was provided by Fondazione Cariplo (grant number 2012-0590). This study was partially supported by Italian Ministry of Health (Ministero della Salute) and ERANET-NEURON, JTC 2016: New therapeutic strategies in the treatment of traumatic brain injury by targeting the LEctin Activation Pathway of complement (LEAP, NEURON9-FP-044). The study was supported by grants from the Novo Nordisk Research Foundation and the Danish Research Council for Independent Research (PG).	[Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; BECKER P, 1987, ANAESTHESIST, V36, P301; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Burk AM, 2012, SHOCK, V37, P348, DOI 10.1097/SHK.0b013e3182471795; Cervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008433; De Blasio D, 2017, J CEREBR BLOOD F MET, V37, P938, DOI 10.1177/0271678X16647397; DEAN RB, 1951, ANAL CHEM, V23, P636, DOI 10.1021/ac60052a025; Dobo J, 2016, IMMUNOL REV, V274, P98, DOI 10.1111/imr.12460; Dobo J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31877; Endo Y, 2011, INT J BIOCHEM CELL B, V43, P705, DOI 10.1016/j.biocel.2011.02.003; Finnie JW, 2016, J COMP PATHOL, V154, P323, DOI 10.1016/j.jcpa.2016.03.005; Fumagalli S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00288; Fumagalli S, 2016, STROKE, V47, P3067, DOI 10.1161/STROKEAHA.116.012407; Garred P, 2016, IMMUNOL REV, V274, P74, DOI 10.1111/imr.12468; GASQUE P, 1992, J IMMUNOL, V149, P1381; Gesuete R, 2009, ANN NEUROL, V66, P332, DOI 10.1002/ana.21740; Iwaki D, 2011, J IMMUNOL, V187, P3751, DOI 10.4049/jimmunol.1100280; Kennedy AD, 2003, BLOOD, V101, P1071, DOI 10.1182/blood-2002-03-0876; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Kuraya M, 2003, INT IMMUNOL, V15, P109, DOI 10.1093/intimm/dxg008; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P197, DOI 10.1111/j.1365-3083.1985.tb01871.x; MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P183, DOI 10.1111/j.1365-3083.1985.tb01870.x; Orsini F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0684-6; Orsini F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00380; Orsini F, 2012, CIRCULATION, V126, P1484, DOI 10.1161/CIRCULATIONAHA.112.103051; Ortolano F, 2009, J NEUROPATH EXP NEUR, V68, P964, DOI 10.1097/NEN.0b013e3181b20670; Osthoff M, 2017, J NEUROTRAUM, V34, P2560, DOI 10.1089/neu.2016.4941; Pan JW, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0444-z; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; RORABACHER DB, 1991, ANAL CHEM, V63, P139, DOI 10.1021/ac00002a010; Rosbjerg A, 2014, J IMMUNOL, V192, P4352, DOI 10.4049/jimmunol.1303263; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Skjoedt MO, 2010, IMMUNOBIOLOGY, V215, P921, DOI 10.1016/j.imbio.2009.10.006; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stahel PF, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Yu W, 2015, CLIN CHIM ACTA, V451, P111, DOI 10.1016/j.cca.2015.10.017; Zangari R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0481-2; Zanier ER, 2014, NEUROLOGY, V82, P126, DOI 10.1212/WNL.0000000000000020; Zanier ER, 2011, INTENS CARE MED, V37, P302, DOI 10.1007/s00134-010-2075-2	57	13	13	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2019	39	5								10.1177/0271678X18758881			14	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	HY5YS	WOS:000468206000004	29425056	Green Published			2022-02-06	
J	Hajiaghamemar, M; Lan, IS; Christian, CW; Coats, B; Margulies, SS				Hajiaghamemar, Marzieh; Lan, Ingrid S.; Christian, Cindy W.; Coats, Brittany; Margulies, Susan S.			Infant skull fracture risk for low height falls	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Pediatric traumatic brain injury; Head impact; Anthropomorphic surrogate; Accidental falls; Finite element modeling; Injury risk curve	HEAD-INJURIES; MECHANICAL-PROPERTIES; CHILDREN FALL; IMPACT; BIOMECHANICS; PARIETAL; SUTURE; MODEL; BODY; MASS	Skull fractures are common injuries in young children, typically caused by accidental falls and child abuse. The paucity of detailed biomechanical data from real-world trauma in children has hampered development of biomechanical thresholds for skull fracture in infants. The objectives of this study were to identify biomechanical metrics to predict skull fracture, determine threshold values associated with fracture, and develop skull fracture risk curves for low-height falls in infants. To achieve these objectives, we utilized an integrated approach consisting of case evaluation, anthropomorphic reconstruction, and finite element simulation. Four biomechanical candidates for predicting skull fracture were identified (first principal stress, first principal strain, shear stress, and von Mises stress) and evaluated against well-witnessed falls in infants (0-6 months). Among the predictor candidates, first principal stress and strain correlated best with the occurrence of parietal skull fracture. The principal stress and strain thresholds associated with 50 and 95% probability of parietal skull fracture were 25.229 and 36.015 MPa and 0.0464 and 0.0699, respectively. Risk curves using these predictors determined that infant falls from 0.3 m had a low probability (0-54%) to result in parietal skull fracture, particularly with carpet impact (0-1%). Head-first falls from 0.9 m had a high probability of fracture (86-100%) for concrete impact and a moderate probability (34-81%) for carpet impact. Probabilities of fracture in 0.6 m falls were dependent on impact surface. Occipital impacts from 0.9 m onto the concrete also had the potential (27-90% probability) to generate parietal skull fracture. These data represent a multi-faceted biomechanical assessment of infant skull fracture risk and can assist in the differential diagnosis for head trauma in children.	[Hajiaghamemar, Marzieh; Margulies, Susan S.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, UA Whitaker Bldg,313 Ferst Dr,Suite 2116, Atlanta, GA 30332 USA; [Hajiaghamemar, Marzieh; Margulies, Susan S.] Emory Univ, UA Whitaker Bldg,313 Ferst Dr,Suite 2116, Atlanta, GA 30332 USA; [Lan, Ingrid S.] Stanford Univ, Shriram Ctr, Dept Bioengn, 443 Via Ortega,Rm 119, Stanford, CA 94305 USA; [Christian, Cindy W.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Coats, Brittany] Univ Utah, Dept Mech Engn, 1495 E 100 St,1550 MEK, Salt Lake City, UT 84112 USA		Hajiaghamemar, M (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, UA Whitaker Bldg,313 Ferst Dr,Suite 2116, Atlanta, GA 30332 USA.; Hajiaghamemar, M (corresponding author), Emory Univ, UA Whitaker Bldg,313 Ferst Dr,Suite 2116, Atlanta, GA 30332 USA.	memar@gatech.edu; ingridl@stanford.edu; christian@email.chop.edu; brittany.coats@utah.edu; susan.margulies@gatech.edu	Coats, Brittany/A-4523-2009	Lan, Ingrid/0000-0002-1390-0636; Margulies, Susan/0000-0002-3615-7902	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [NCIPC R49CE000411]; National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS097549] Funding Source: NIH RePORTER	This study if supported by the Centers for Disease Control and Prevention grant NCIPC R49CE000411 and the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) grant R01NS039679.	Arnholz D, 1998, J TRAUMA, V45, P172, DOI 10.1097/00005373-199807000-00039; Cao Li-Bo, 2014, Chinese Journal of Biomedical Engineering, V33, P63, DOI 10.3969/j.issn.0258-8021.2014.01.010; CDC, 2016, CDC WISQARS DAT; Coats B, 2007, THESIS; Coats B, 2007, STAPP CAR CRASH JO, V51, P1; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Davis MT, 2012, J BIOMECH, V45, P2493, DOI 10.1016/j.jbiomech.2012.07.001; Desantis Klinich Kathleen, 2002, Stapp Car Crash J, V46, P165; DUHAIME AC, 1992, PEDIATRICS, V90, P179; EVANS FG, 1957, J APPL PHYSIOL, V10, P493, DOI 10.1152/jappl.1957.10.3.493; Ghajari M, 2009, P IRCOBI C YORK UK; Ghajari M, 2011, INT J CRASHWORTHINES, V16, P285, DOI 10.1080/13588265.2011.559798; Gurdijan ES, 1947, SURG GYNECOL OBSTET, V83, P219; GURDJIAN ES, 1950, RADIOLOGY, V54, P313, DOI 10.1148/54.3.313; Hajiaghamemar M, 2015, ANN BIOMED ENG, V43, P2143, DOI 10.1007/s10439-015-1255-1; HELFER RE, 1977, PEDIATRICS, V60, P533; Hughes J, 2016, ARCH DIS CHILD, V101, P310, DOI 10.1136/archdischild-2014-306803; Ibrahim NG, 2012, INT J DEV NEUROSCI, V30, P201, DOI 10.1016/j.ijdevneu.2011.10.007; Ibrahim NG, 2010, J NEUROSURG-PEDIATR, V6, P57, DOI 10.3171/2010.3.PEDS09357; JENSEN RK, 1986, J BIOMECH, V19, P359, DOI 10.1016/0021-9290(86)90012-6; KUCZMARSKI RJ, 2000, ADV DATA, V0314, P00001; Kunz SN, 2018, INT J LEGAL MED, V132, P205, DOI 10.1007/s00414-017-1663-x; Li ZG, 2015, INT J LEGAL MED, V129, P1055, DOI 10.1007/s00414-015-1190-6; Loyd A.M., 2011, THESIS; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Miyazaki Y., 2009, IMPACT TECHNOLOGY SP, P417; Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030; NIMITYONGSKUL P, 1987, J PEDIATR ORTHOPED, V7, P184, DOI 10.1097/01241398-198703000-00014; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Post A, 2017, J NEUROSURG-PEDIATR, V19, P502, DOI 10.3171/2016.10.PEDS16449; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Powell BJ, 2013, J FORENSIC SCI, V58, P678, DOI 10.1111/1556-4029.12094; Prange Michael T, 2004, Stapp Car Crash J, V48, P279; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Roth S, 2008, COMPUT METH PROG BIO, V90, P262, DOI 10.1016/j.cmpb.2008.01.007; Roth S, 2010, COMPUT METH PROG BIO, V99, P25, DOI 10.1016/j.cmpb.2009.10.004; Runyan CW, 2005, AM J PREV MED, V28, P80, DOI 10.1016/j.amepre.2004.09.017; Seidi M, 2015, INT J CRASHWORTHINES, V20, P134, DOI 10.1080/13588265.2014.983261; Sullivan S, 2015, ACCIDENT ANAL PREV, V82, P143, DOI 10.1016/j.aap.2015.05.020; Thomas AG, 2013, ARCH DIS CHILD, V98, P787, DOI 10.1136/archdischild-2013-304267; Untaroiu C, 2007, 20 INT TECH C ENH SA; Wang JW, 2014, MED SCI MONITOR, V20, P1808, DOI 10.12659/MSM.892278; WEBER W, 1984, J LEGAL MED, V92, P87; Weber W, 1985, J LEGAL MED, V94, P23; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8; Zhou Z, 2016, COMPUT METH PROG BIO, V131, P13, DOI 10.1016/j.cmpb.2016.04.013	48	13	13	1	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	MAY	2019	133	3					847	862		10.1007/s00414-018-1918-1			16	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	HT8XL	WOS:000464848100025	30194647	Green Published, hybrid			2022-02-06	
J	Ma, JL; Ni, HB; Rui, Q; Liu, HX; Jiang, F; Gao, R; Gao, YP; Li, D; Chen, G				Ma, Jialing; Ni, Haibo; Rui, Qin; Liu, Huixiang; Jiang, Feng; Gao, Rong; Gao, Yanping; Li, Di; Chen, Gang			Potential Roles of NIX/BNIP3L Pathway in Rat Traumatic Brain Injury	CELL TRANSPLANTATION			English	Article						NIX; BNIP3L; autophagy; apoptosis; traumatic brain injury	INDUCED NEURONAL APOPTOSIS; INTRACEREBRAL HEMORRHAGE; FUNCTIONAL RECOVERY; SIGNALING PATHWAY; PROTEIN BNIP3L; AUTOPHAGY; MITOPHAGY; EXPRESSION; MOUSE; PATHOPHYSIOLOGY	NIX/BNIP3L is known as a proapoptotic protein that is also related to mitophagy. Previous reports have shown that NIX could be involved in neuronal apoptosis after intracerebral hemorrhage, but it also plays a protective role in mitophagy in ischemic brain injury. How NIX works in traumatic brain injury (TBI) is unclear. Thus, this study was designed to observe the expression of NIX and perform a preliminary exploration of the possible effects of NIX in a rat TBI model. The results showed that NIX expression decreased after damage, and colocalized with neuronal cells in cortical areas. Moreover, when we induced upregulation of NIX, autophagy was increased, while neuronal apoptosis and brain water content decreased along with neurological deficits. These findings remind us that NIX probably plays a neuroprotective role in TBI through autophagy and apoptosis pathways.	[Ma, Jialing; Gao, Yanping] Soochow Univ, Peoples Hosp Zhangjiagang 1, Dept Anesthesia, Suzhou, Peoples R China; [Ni, Haibo; Liu, Huixiang; Jiang, Feng; Gao, Rong; Li, Di] Soochow Univ, Peoples Hosp Zhangjiagang 1, Dept Neurosurg, Suzhou, Peoples R China; [Rui, Qin] Soochow Univ, Peoples Hosp Zhangjiagang 1, Dept Lab, Suzhou, Peoples R China; [Li, Di] Soochow Univ, Peoples Hosp Zhangjiagang 1, Translat Med Ctr, Suzhou, Peoples R China; [Chen, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Peoples R China; [Chen, Gang] Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Suzhou, Peoples R China		Li, D (corresponding author), Soochow Univ, Dept Neurosurg, 68 Jiyang Western Rd, Suzhou 215006, Peoples R China.; Li, D (corresponding author), Soochow Univ, Translat Med Ctr, 68 Jiyang Western Rd, Suzhou 215006, Peoples R China.; Gao, YP (corresponding author), Soochow Univ, Dept Anesthesia, 68 Jiyang Western Rd, Suzhou 215006, Peoples R China.	zjg_gyp@163.com; lidilab@sina.com		Li, Di/0000-0003-3423-9047			Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Diwan A, 2008, CIRCULATION, V117, P396, DOI 10.1161/CIRCULATIONAHA.107.727073; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gao F, 2015, HUM MOL GENET, V24, P2528, DOI 10.1093/hmg/ddv017; Gao YY, 2017, AM J TRANSL RES, V9, P887; Gao Y, 2017, MOL NEUROBIOL, V54, P3879, DOI 10.1007/s12035-016-9947-6; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; He HF, 2018, DRUG DES DEV THER, V12, P629, DOI 10.2147/DDDT.S158313; Hu L, 2016, OXID MED CELL LONGEV; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; Imazu T, 1999, ONCOGENE, V18, P4523, DOI 10.1038/sj.onc.1202722; Jiang HS, 2018, CELL MOL NEUROBIOL, V38, P1009, DOI 10.1007/s10571-017-0570-5; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu YF, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317708779; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; O'Sullivan TE, 2015, IMMUNITY, V43, P331, DOI 10.1016/j.immuni.2015.07.012; Paschen W, 2003, J CEREBR BLOOD F MET, V23, P449, DOI 10.1097/01.WCB.0000054216.21675.AC; Pedanou VE, 2016, ELIFE, V5, DOI 10.7554/eLife.16844; Rui Q, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00051; Rui Y, 2013, J MOL HISTOL, V44, P497, DOI 10.1007/s10735-013-9506-7; Saita S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2400; Shen JB, 2017, CELL TISSUE RES, V368, P13, DOI 10.1007/s00441-016-2510-y; Tang CH, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2923182; Vavilis T, 2016, CELL MOL NEUROBIOL, V36, P701, DOI 10.1007/s10571-015-0250-2; Vesela B, 2015, CONNECT TISSUE RES, V56, P326, DOI 10.3109/03008207.2015.1040546; Wang CX, 2017, CELL BIOL INT, V41, P1039, DOI 10.1002/cbin.10820; Wen ZJ, 2017, NEUROCHEM RES, V42, P2372, DOI 10.1007/s11064-017-2257-1; Wilfinger N, 2016, ONCOTARGET, V7, P1242, DOI 10.18632/oncotarget.6233; Wu H, 2015, ANTIOXID REDOX SIGN, V22, P1032, DOI 10.1089/ars.2014.6204; Wu J, 2016, STROKE, V47, P1319, DOI 10.1161/STROKEAHA.115.011552; Wu J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0790-0; Xu KB, 2018, CHEM-BIOL INTERACT, V286, P96, DOI 10.1016/j.cbi.2018.02.028; Xu WL, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00176; Yang L Y, 2017, Zhonghua Yi Xue Za Zhi, V97, P1071, DOI 10.3760/cma.j.issn.0376-2491.2017.14.009; Yuan C, 2018, EXP THER MED, V15, P235, DOI 10.3892/etm.2017.5372; Yuan Y, 2017, AUTOPHAGY, V13, P1754, DOI 10.1080/15548627.2017.1357792; Zeng XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0316-4; Zhang Bao, 2017, Journal of China Medical University, V46, P97, DOI 10.12007/j.issn.0258-4646.2017.02.001; Zhang FC, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1315-1; Zhang JY, 2018, J NEUROTRAUM, V35, P802, DOI 10.1089/neu.2016.4871; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang YH, 2016, ONCOTARGET, V7, P40939, DOI 10.18632/oncotarget.10172	51	13	13	2	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.	MAY	2019	28	5					585	595		10.1177/0963689719840353			11	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	IM4NH	WOS:000477971000008	30961359	Green Published, gold			2022-02-06	
J	Wang, WZ; Su, YL; Tang, S; Li, HF; Xie, W; Chen, JA; Shen, L; Pan, XD; Ning, B				Wang, Wenzhao; Su, Yanlin; Tang, Shi; Li, Hongfei; Xie, Wei; Chen, Jianan; Shen, Lin; Pan, Xinda; Ning, Bin			Identification of noncoding RNA expression profiles and regulatory interaction networks following traumatic spinal cord injury by sequence analysis	AGING-US			English	Article						traumatic spinal cord injury; noncoding RNA; competing endogenous RNA; axonal regeneration	SCAR FORMATION; FIBROBLASTS; BRAIN	Aim: To systematically profile and characterize the noncoding RNA (ncRNA) expression pattern in the lesion epicenter of spinal tissues after traumatic spinal cord injury (TSCI) and predicted the structure and potential functions of the regulatory networks associated with these differentially expressed ncRNAs and mRNAs. Results: A total of 498 circRNAs, 458 lncRNAs, 155 miRNAs and 1203 mRNAs were identified in TSCI mice models to be differentially expressed. The regulatory networks associated with these differentially expressed ncRNAs and mRNAs were constructed. Materials and methods: We used RNA-Seq, Gene ontology (GO), KEGG pathway analysis and co-expression network analyses to profle the expression and regulation patterns of noncoding RNAs and mRNAs of mice models after TSCI. The findings were validated by quantitative real-time PCR (qRT-PCR) and Luciferase assay. Conclusion: noncoding RNAs might play important roles via the competing endogenous RNA regulation pattern after TSCI, further findings arising from this study will not only expand the understanding of potential ncRNA biomarkers but also help guide therapeutic strategies for TSCI.	[Wang, Wenzhao; Su, Yanlin; Li, Hongfei; Chen, Jianan; Shen, Lin; Pan, Xinda; Ning, Bin] Shandong Univ, Jinan Cent Hosp, Jinan, Shandong, Peoples R China; [Wang, Wenzhao] Sichuan Univ, West China Hosp, Dept Orthopaed, Chengdu, Sichuan, Peoples R China; [Tang, Shi] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu, Sichuan, Peoples R China; [Xie, Wei] Taishan Med Univ, Dept Emergency Med, Affiliated Hosp, Tai An, Shandong, Peoples R China		Ning, B (corresponding author), Shandong Univ, Jinan Cent Hosp, Jinan, Shandong, Peoples R China.	ningbin@sdu.edu.cn		Wang, Wenzhao/0000-0001-5106-4862	National Natural Science Fund of ChinaNational Natural Science Foundation of China (NSFC) [81401014, 81771346]; Chinese Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015T80725]; Technology Research and Development Program of Jinan City [201704133]	Grant support was provided by the National Natural Science Fund of China (Nos. 81401014, 81771346), the Chinese Postdoctoral Science Foundation (No. 2014M561935), the Chinese Postdoctoral Science Foundation (No. 2015T80725), and Technology Research and Development Program of Jinan City (No. 201704133).	Alexandru Daniela, 2012, Perm J, V16, P46; Tran AP, 2018, PHYSIOL REV, V98, P881, DOI 10.1152/physrev.00017.2017; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Berindan-Neagoe I, 2014, CA-CANCER J CLIN, V64, P311, DOI 10.3322/caac.21244; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Catenaccio A, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.489; Chen W, 2016, TRENDS NEUROSCI, V39, P597, DOI 10.1016/j.tins.2016.06.006; Cristante AF, 2012, CLINICS, V67, P1219, DOI 10.6061/clinics/2012(10)16; Dias DO, 2018, CELL, V173, P153, DOI 10.1016/j.cell.2018.02.004; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Fouad K, 2011, BRAIN RES BULL, V84, P337, DOI 10.1016/j.brainresbull.2010.04.017; Garfin SR, 2001, SPINE, V26, P1511, DOI 10.1097/00007632-200107150-00002; Geng YT, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0643-z; Ghibaudi M, 2017, PROG NEUROBIOL, V158, P69, DOI 10.1016/j.pneurobio.2017.07.005; Hara M, 2017, NAT MED, V23, P818, DOI 10.1038/nm.4354; Holmes D, 2017, NATURE, V552, pS49, DOI 10.1038/d41586-017-07550-9; Jensen ME, 1997, AM J NEURORADIOL, V18, P1897; Jiang ZS, 2018, INT J BIOL MACROMOL, V120, P66, DOI 10.1016/j.ijbiomac.2018.08.002; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kleaveland B, 2018, CELL, V174, P350, DOI 10.1016/j.cell.2018.05.022; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Liu RH, 2018, AGING-US, V10, P1474, DOI 10.18632/aging.101484; Qi XL, 2015, J MED GENET, V52, P710, DOI 10.1136/jmedgenet-2015-103334; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; Schwab JM, 2018, LANCET NEUROL, V17, P581, DOI 10.1016/S1474-4422(18)30206-0; Sofroniew MV, 2018, NATURE, V557, P343, DOI 10.1038/s41586-018-0068-4; Stoicea N, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00011; Stroman PW, 2016, J NEUROTRAUM, V33, P1450, DOI 10.1089/neu.2015.4257; van Middendorp JJ, 2012, SPINAL CORD, V50, P686, DOI 10.1038/sc.2012.34; Wang WZ, 2018, EXP CELL RES, V370, P24, DOI 10.1016/j.yexcr.2018.06.002; Wang WZ, 2018, INT J BIOL SCI, V14, P178, DOI 10.7150/ijbs.24074; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang ZR, 2018, EBIOMEDICINE, V34, P267, DOI 10.1016/j.ebiom.2018.07.036; Zhou ZB, 2018, MOL THER-NUCL ACIDS, V12, P718, DOI 10.1016/j.omtn.2018.07.011; 2018, THERANOSTICS, V8, P3408, DOI DOI 10.7150/THNO.25156	37	13	13	0	9	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1945-4589			AGING-US	Aging-US	APR 30	2019	11	8					2352	2368		10.18632/aging.101919			17	Cell Biology; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Geriatrics & Gerontology	HW5ZW	WOS:000466768900015	30998503	Green Published, Green Submitted, gold			2022-02-06	
J	McNerney, MW; Hobday, T; Cole, B; Ganong, R; Winans, N; Matthews, D; Hood, J; Lane, S				McNerney, M. Windy; Hobday, Thomas; Cole, Betsy; Ganong, Rick; Winans, Nina; Matthews, Dennis; Hood, Jim; Lane, Stephen			Objective Classification of mTBI Using Machine Learning on a Combination of Frontopolar Electroencephalography Measurements and Self-reported Symptoms	SPORTS MEDICINE-OPEN			English	Article						EEG; mTBI; Machine learning	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; EPIDEMIOLOGY; CONCUSSION; ENCEPHALOPATHY	Background: The reliable diagnosis of a mild traumatic brain injury (mTBI) is a pervasive problem in sports and in the military. The frequency and severity of each occurrence, while difficult to quantify, may impact long term cognitive function and quality of life. Despite the new revelations concerning brain disfunction from head injuries, individuals still feel pressure to remain on the field despite a debilitating injury. In this study, we evaluated the accuracy of a system that could be employed on the sidelines or in the locker room to provide an immediate objective mTBI assessment. Methods: Participants consisted of 38 individuals with a recent mTBI and 47 controls with no history of mTBI within the last 5 years. Participants were administered a simple symptom questionnaire, behavioral tests, and resting state EEG was measured using three frontopolar electrodes. An advanced machine learning algorithm called boosting was utilized to classify subjects into either injured or controls using power spectral densities on 1-min of resting EEG and the symptom questionnaire. Results: Results based on leave-one-out cross-validation revealed that the addition of EEG measurements boosted the accuracy to approximately 91 +/- 2% compared to 82 +/- 4% from the symptom questionnaire alone. Conclusion: This study demonstrated the potential benefit of including EEG measurements to diagnose suspected brain injury patients. This is a step toward accurate and objective classification measurements that can be implemented on the field as a future injury assessment tool.	[McNerney, M. Windy; Hobday, Thomas; Cole, Betsy; Matthews, Dennis; Hood, Jim; Lane, Stephen] Tahoe Inst Rural Hlth Res, 10121 Pine Ave,POB 759, Truckee, CA 96160 USA; [Ganong, Rick; Winans, Nina] Tahoe Forest Hosp, Truckee, CA USA; [Matthews, Dennis; Lane, Stephen] Univ Calif Davis, Dept Neurol Surg, Sacramento, CA 95817 USA		McNerney, MW (corresponding author), Tahoe Inst Rural Hlth Res, 10121 Pine Ave,POB 759, Truckee, CA 96160 USA.	windymc@tirhr.com			Tahoe Institute for Rural Health Research	This study was funded in full by the Tahoe Institute for Rural Health Research.	Anderson BL, 2013, PED AC SOC ANN M; [Anonymous], 2013, LANCET NEUROL, V12, P1127, DOI 10.1016/S1474-4422(13)70266-7; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Chang WD, 2016, COMPUT METH PROG BIO, V124, P19, DOI 10.1016/j.cmpb.2015.10.011; Conley AC, 2019, J NEUROTRAUM, V36, P1, DOI 10.1089/neu.2018.5761; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dougherty ER, 2010, CURR BIOINFORM, V5, P53, DOI 10.2174/157489310790596385; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gay M, 2015, DEV NEUROPSYCHOL, V40, P248, DOI 10.1080/87565641.2015.1014486; Giza CC, 2001, J ATHL TRAINING, V36, P228; Graham R, 2014, CONCUSSION RECOGNITI; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Haneef Z, 2013, J NEUROTRAUM, V30, P653, DOI 10.1089/neu.2012.2585; Hanley D, 2017, ACAD EMERG MED, V24, P617, DOI 10.1111/acem.13175; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Hastie T, 2011, ELEMENTS STAT LEARNI; Hawkins DM, 2003, J CHEM INF COMP SCI, V43, P579, DOI 10.1021/ci025626i; Huff JS, 2017, AM J EMERG MED, V35, P1777, DOI 10.1016/j.ajem.2017.05.027; Krzanowski WJ, 2009, MONOGRAPHS STAT APPL; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Munia TTK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17414-x; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Provost F., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P445; Provost F, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P706; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Ratsch G., 2006, P 23 INT C MACH LEAR, P1001; Reches A, 2017, BRAIN INJURY, V31, P237, DOI 10.1080/02699052.2016.1231343; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schapire RE, 2014, BOOSTING; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thurmdan D, 1999, TRAUMATIC BRAIN INJU	43	13	13	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2199-1170	2198-9761		SPORTS MED-OPEN	Sports Med.-Open	APR 18	2019	5	1							14	10.1186/s40798-019-0187-y			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KO1MR	WOS:000515313100001	31001724	gold, Green Published			2022-02-06	
J	Civiletti, F; Assenzio, B; Mazzeo, AT; Medica, D; Giaretta, F; Deambrosis, I; Fanelli, V; Ranieri, VM; Cantaluppi, V; Mascia, L				Civiletti, Federica; Assenzio, Barbara; Mazzeo, Anna Teresa; Medica, Davide; Giaretta, Fulvia; Deambrosis, Ilaria; Fanelli, Vito; Ranieri, Vito Marco; Cantaluppi, Vincenzo; Mascia, Luciana			Acute Tubular Injury is Associated With Severe Traumatic Brain Injury: in Vitro Study on Human Tubular Epithelial Cells	SCIENTIFIC REPORTS			English	Article							ACUTE KIDNEY INJURY; INTERCELLULAR-ADHESION MOLECULE-1; NEUROLOGICAL ORGAN DYSFUNCTION; EXTRACRANIAL COMPLICATIONS; ICAM-1 EXPRESSION; INTENSIVE-CARE; INFLAMMATION; CYTOKINES; INVOLVEMENT; ACTIVATION	Acute kidney injury following traumatic brain injury is associated with poor outcome. We investigated in vitro the effects of plasma of brain injured patients with acute tubular kidney injury on kidney tubular epithelial cell function. we performed a prospective observational clinical study in ICU in a trauma centre of the University hospital in Italy including twenty-three ICU patients with traumatic brain injury consecutively enrolled. Demographic data were recorded on admission: age 39 +/- 19, Glasgow Coma Score 5 (3-8). Neutrophil Gelatinase-Associated Lipocalin and inflammatory mediators were measured in plasma on admission and after 24, 48 and 72 hours; urine were collected for immunoelectrophoresis having healthy volunteers as controls. Human renal proximal tubular epithelial cells were stimulated with patients or controls plasma. Adhesion of freshly isolated human neutrophils and trans-epithelial electrical resistance were assessed; cell viability (XTT assay), apoptosis (TUNEL staining), Neutrophil Gelatinase-Associated Lipocalin and Megalin expression (quantitative real-time PCR) were measured. All patients with normal serum creatinine showed increased plasmatic Neutrophil Gelatinase-Associated Lipocalin and increased urinary Retinol Binding Protein and alpha 1-microglobulin. Neutrophil Gelatinase-Associated Lipocalin was significantly correlated with both inflammatory mediators and markers of tubular damage. Patient' plasma incubated with tubular cells significantly increased adhesion of neutrophils, reduced trans-epithelial electrical resistance, exerted a cytotoxic effect and triggered apoptosis and down-regulated the endocytic receptor Megalin compared to control. Plasma of brain injured patients with increased markers of subclinical acute kidney induced a pro-inflammatory phenotype, cellular dysfunction and apoptotic death in tubular epithelial cells.	[Civiletti, Federica; Assenzio, Barbara; Mazzeo, Anna Teresa; Fanelli, Vito; Mascia, Luciana] Univ Turin, Citta Salute & Sci Molinette Univ Hosp, Dept Anesthesia & Intens Care, Turin, Italy; [Medica, Davide; Giaretta, Fulvia; Deambrosis, Ilaria; Cantaluppi, Vincenzo] Univ Turin, Citta Salute & Sci Molinette Univ Hosp, Ctr Expt Med Res CeRMS, Turin, Italy; [Cantaluppi, Vincenzo] Maggiore Carita Univ Hosp, Univ Eastern Piedmont A Avogadro, Dept Translat Med, Nephrol Dialysis & Kidney Transplantat Unit, Novara, Italy; [Mascia, Luciana] Univ Roma La Sapienza, Dept Med & Surg Sci & Biotechnol, Anesthesia & Intens Care, Rome, Italy; [Ranieri, Vito Marco] Univ Roma La Sapienza, Anesthesia & Intens Care, Dept Anesthesiol, Rome, Italy; [Ranieri, Vito Marco] Univ Roma La Sapienza, Anesthesia & Intens Care, Dept Crit Care, Rome, Italy; [Ranieri, Vito Marco] Univ Roma La Sapienza, Anesthesia & Intens Care, Dept Pain Med, Rome, Italy		Mascia, L (corresponding author), Univ Turin, Citta Salute & Sci Molinette Univ Hosp, Dept Anesthesia & Intens Care, Turin, Italy.; Mascia, L (corresponding author), Univ Roma La Sapienza, Dept Med & Surg Sci & Biotechnol, Anesthesia & Intens Care, Rome, Italy.	luciana.mascia@uniroma1.it	Cantaluppi, Vincenzo/K-8531-2016; Fanelli, Vito/K-4028-2018; Medica, Davide/AAM-7691-2021	Cantaluppi, Vincenzo/0000-0002-4120-3555; Medica, Davide/0000-0002-6171-8919; Mazzeo, Anna Teresa/0000-0002-8454-7243	Fondazione CRTFondazione CRT	Study was supported by Fondazione CRT co-founded PhD program 2011-14. The clinical study was performed at the Department of Anesthesia and Intensive Care, University of Torino and the in vitro study at the Center for Experimental Medical Research (CeRMS), University of Torino.	Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1569, DOI 10.1093/ndt/gfn009; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BURNS AR, 1994, J IMMUNOL, V153, P3189; Cantaluppi V, 2014, NEPHROL DIAL TRANSPL, V29, P2004, DOI 10.1093/ndt/gfu046; Cantaluppi V, 2010, CRIT CARE, V14, DOI 10.1186/cc8835; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chambers I, 2008, ACTA NEUROCHIR SUPPL, V102, P223, DOI 10.1007/978-3-211-85578-2_43; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Christensen EI, 2012, PHYSIOLOGY, V27, P223, DOI 10.1152/physiol.00022.2012; Conaldi PG, 1998, J CLIN INVEST, V102, P2041, DOI 10.1172/JCI3480; Conaldi PG, 2002, AM J PATHOL, V161, P53, DOI 10.1016/S0002-9440(10)64156-9; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Cruz DN, 2010, CONTRIB NEPHROL, V164, P24, DOI 10.1159/000313717; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Haase M, 2012, NAT REV NEPHROL, V8, P735, DOI 10.1038/nrneph.2012.197; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Huang GTJ, 1996, J CLIN INVEST, V98, P572, DOI 10.1172/JCI118825; Humphreys BD, 2016, J AM SOC NEPHROL, V27, P990, DOI 10.1681/ASN.2015030286; Kellum John A, 2002, Curr Opin Crit Care, V8, P509, DOI 10.1097/00075198-200212000-00005; Kompanje EJO, 2006, INTENS CARE MED, V32, P217, DOI 10.1007/s00134-005-0001-9; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levi Talita Machado, 2013, Rev. bras. ter. intensiva, V25, P290, DOI 10.5935/0103-507X.20130050; LHOTTA K, 1991, CLIN SCI, V81, P477, DOI 10.1042/cs0810477; LOOK DC, 1992, AM J PHYSIOL, V263, pL79, DOI 10.1152/ajplung.1992.263.1.L79; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; LUCISANO YM, 1984, J IMMUNOL, V132, P2015; MACKERSIE RC, 1991, ANN SURG, V213, P143, DOI 10.1097/00000658-199102000-00009; Mariano F, 2008, CRIT CARE, V12, DOI 10.1186/cc6848; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mazzeo AT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0624-5; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; MORGANTIKOSSMANN MC, 1992, TRENDS PHARMACOL SCI, V13, P286, DOI 10.1016/0165-6147(92)90087-M; Nechemia-Arbely Y, 2008, J AM SOC NEPHROL, V19, P1106, DOI 10.1681/ASN.2007070744; Ostermann M, 2007, CRIT CARE MED, V35, P1837, DOI 10.1097/01.CCM.0000277041.13090.0A; Parkos CA, 1996, MOL MED, V2, P489, DOI 10.1007/BF03401908; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Subauste MC, 2001, INFLAMMATION, V25, P373, DOI 10.1023/A:1012850630351; Viedt C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015609.31253.7F; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zemans RL, 2009, AM J RESP CELL MOL, V40, P519, DOI 10.1165/rcmb.2008-0348TR; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0; Zygun DA, 2003, J CRIT CARE, V18, P238, DOI 10.1016/j.jcrc.2003.10.007	49	13	13	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 15	2019	9								6090	10.1038/s41598-019-42147-4			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT3XF	WOS:000464495800014	30988316	gold, Green Published			2022-02-06	
J	Carlozzi, NE; Kallen, MA; Sander, AM; Brickell, TA; Lange, RT; French, LM; Ianni, PA; Miner, JA; Hanks, R				Carlozzi, Noelle E.; Kallen, Michael A.; Sander, Angelle M.; Brickell, Tracey A.; Lange, Rael T.; French, Louis M.; Ianni, Phillip A.; Miner, Jennifer A.; Hanks, Robin			The Development of a New Computer Adaptive Test to Evaluate Anxiety in Caregivers of Individuals With Traumatic Brain Injury: TBI-CareQOL Caregiver-Specific Anxiety	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Anxiety; Caregiver; Families of Veterans; Health-related quality of life; Patient reported outcome; Rehabilitation; Traumatic brain injury; Veterans	QUALITY-OF-LIFE; SOCIAL SUPPORT; FAMILY CAREGIVERS; TIME-COURSE; RECOVERY; OUTCOMES; PREDICTORS; REHABILITATION; BURDEN; SCALE	Objective: To design a new measure of caregiver-specific anxiety for use in caregivers of individuals with traumatic brain injury (TBI), the Traumatic Brain Injury Caregiver Quality of Life (TBI-CareQOL) Caregiver-Specific Anxiety item bank. Design: Cross-sectional survey study. Setting: Three TBI Model Systems rehabilitation hospitals, an academic medical center, and a military medical treatment facility. Participants: Three hundred forty-four caregivers of civilians with TBI and 216 caregivers of service members/veterans with TBI (N=560). Interventions: Not applicable. Main Outcome Measures: TBI-CareQOL Caregiver-Specific Anxiety item bank. Results: The retention of 40 Caregiver-Specific Anxiety items was supported by exploratory and confirmatory factor analyses. Graded response model (GRM) and differential item functioning analyses supported the retention of 33 items in the final measure. Expert review and GRM calibration data was used to select a 6-item static short form, and GRM calibration data was used to program the TBI-CareQOL Caregiver-Specific Anxiety computer adaptive test (CAT). Conclusions: Established, rigorous measurement development standards were used to develop the new TBI-CareQOL Caregiver-Specific Anxiety CAT and corresponding 6-item short form. This measure is the first patient-reported outcome measure designed to assess caregiver-specific anxiety in caregivers of individuals with TBI. The measure exhibits strong psychometric properties. (C) 2018 by the American Congress of Rehabilitation Medicine	[Carlozzi, Noelle E.; Ianni, Phillip A.; Miner, Jennifer A.] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Kallen, Michael A.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [Hanks, Robin] Rehabil Inst Michigan, Dept Psychol & Neuropsychol, Detroit, MI USA; [Hanks, Robin] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	french, louis/AAB-2083-2020	Hanks, Robin/0000-0002-3432-4789; french, louis/0000-0002-9451-0604	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NR013658]; National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002240, UL1TR000433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658] Funding Source: NIH RePORTER	Supported by grant number R01NR013658 from the National Institutes of Health, National Institute of Nursing Research, the National Center for Advancing Translational Sciences (UL1TR000433), and the Defense and Veterans Brain Injury Center. We thank the investigators, coordinators, and research associates/assistants who worked on this study and organizations who supported recruitment efforts. The University of Michigan Research Team would also like to thank the Hearts of Valor and the Brain Injury Association of Michigan for assistance with community outreach for recruitment efforts at this site.	Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Burns Anthony S, 2012, Handb Clin Neurol, V109, P47, DOI 10.1016/B978-0-444-52137-8.00003-6; Cappelleri JC, 2014, CLIN THER, V36, P648, DOI 10.1016/j.clinthera.2014.04.006; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Cook KF, 2009, QUAL LIFE RES, V18, P447, DOI 10.1007/s11136-009-9464-4; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Crane PK, 2006, MED CARE, V44, pS115, DOI 10.1097/01.mlr.0000245183.28384.ed; Degeneffe CE, 2011, REHABIL PSYCHOL, V56, P243, DOI 10.1037/a0024465; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; DITUNNO JF, 1992, ARCH PHYS MED REHAB, V73, P431; DVBIC, 2015, DOD WORLDW NUMB TBI; Elliott TR, 2001, J COUNS PSYCHOL, V48, P223, DOI 10.1037//0022-0167.48.2.223; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hatcher L, 1994, STEP BY STEP APPROAC, P325; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P399, DOI 10.1016/S0003-9993(95)80567-2; Kitter B, 2015, BRAIN INJURY, V29, P1082, DOI 10.3109/02699052.2015.1018323; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Kreutzer JS, 2010, J HEAD TRAUMA REHAB, V25, P113, DOI 10.1097/HTR.0b013e3181cf0712; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mazlan M, 2016, DISABIL REHABIL, V38, P2198, DOI 10.3109/09638288.2015.1123307; McDonald R, 1999, TEST THEORY UNIFIED; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Ramkumar NA, 2010, NEUROREHABILITATION, V27, P105, DOI 10.3233/NRE-2010-0585; Reise SP, 2007, QUAL LIFE RES, V16, P19, DOI 10.1007/s11136-007-9183-7; Samejima F, 1996, HDB MODERN ITEM RESP, P85; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 2013, BRAIN IMPAIR, V14, P113, DOI 10.1017/BrImp.2013.12; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Smith A M, 1998, Rehabil Nurs, V23, P252; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Temple JL, 2016, BRAIN INJURY, V30, P1672, DOI 10.3109/02699052.2015.1113561; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Waters R L, 1998, J Spinal Cord Med, V21, P195; WATERS RL, 1993, ARCH PHYS MED REHAB, V74, P242; WATERS RL, 1992, ARCH PHYS MED REHAB, V73, P784; WATERS RL, 1994, ARCH PHYS MED REHAB, V75, P67; Zaider TI, 2003, PSYCHOL MED, V33, P611, DOI 10.1017/S0033291703007414	62	13	13	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2019	100	4		1			S22	S30		10.1016/j.apmr.2018.05.027			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HR2FV	WOS:000462951900003	29958902	Green Accepted			2022-02-06	
J	Hogg, FRA; Gallagher, MJ; Chen, SL; Zoumprouli, A; Papadopoulos, MC; Saadoun, S				Hogg, Florence R. A.; Gallagher, Mathew J.; Chen, Suliang; Zoumprouli, Argyro; Papadopoulos, Marios C.; Saadoun, Samira			Predictors of Intraspinal Pressure and Optimal Cord Perfusion Pressure After Traumatic Spinal Cord Injury	NEUROCRITICAL CARE			English	Article						Blood pressure; Perfusion pressure; Spinal cord injury; Trauma	OPTIMAL RADIOLOGIC METHOD; INTRACRANIAL-PRESSURE; REACTIVITY INDEX; CANAL COMPROMISE; PART II; BRAIN; COMPRESSION; AGE; DUROPLASTY	Background/ObjectivesWe recently developed techniques to monitor intraspinal pressure (ISP) and spinal cord perfusion pressure (SCPP) from the injury site to compute the optimum SCPP (SCPPopt) in patients with acute traumatic spinal cord injury (TSCI). We hypothesized that ISP and SCPPopt can be predicted using clinical factors instead of ISP monitoring.MethodsSixty-four TSCI patients, grades A-C (American spinal injuries association Impairment Scale, AIS), were analyzed. For 24h after surgery, we monitored ISP and SCPP and computed SCPPopt (SCPP that optimizes pressure reactivity). We studied how well 28 factors correlate with mean ISP or SCPPopt including 7 patient-related, 3 injury-related, 6 management-related, and 12 preoperative MRI-related factors.ResultsAll patients underwent surgery to restore normal spinal alignment within 72h of injury. Fifty-one percentage had U-shaped sPRx versus SCPP curves, thus allowing SCPPopt to be computed. Thirteen percentage, all AIS grade A or B, had no U-shaped sPRx versus SCPP curves. Thirty-six percentage (22/64) had U-shaped sPRx versus SCPP curves, but the SCPP did not reach the minimum of the curve, and thus, an exact SCPPopt could not be calculated. In total 5/28 factors were associated with lower ISP: older age, excess alcohol consumption, nonconus medullaris injury, expansion duroplasty, and less intraoperative bleeding. In a multivariate logistic regression model, these 5 factors predicted ISP as normal or high with 73% accuracy. Only 2/28 factors correlated with lower SCPPopt: higher mean ISP and conus medullaris injury. In an ordinal multivariate logistic regression model, these 2 factors predicted SCPPopt as low, medium-low, medium-high, or high with only 42% accuracy. No MRI factors correlated with ISP or SCPPopt.ConclusionsElevated ISP can be predicted by clinical factors. Modifiable factors that may lower ISP are: reducing surgical bleeding and performing expansion duroplasty. No factors accurately predict SCPPopt; thus, invasive monitoring remains the only way to estimate SCPPopt.	[Hogg, Florence R. A.; Gallagher, Mathew J.; Chen, Suliang; Papadopoulos, Marios C.; Saadoun, Samira] St Georges Univ London, Acad Neurosurgery Unit, Mol & Clin Sci Inst, London SW17 0RE, England; [Zoumprouli, Argyro] St George Hosp, Neurointens Care Units, London, England		Saadoun, S (corresponding author), St Georges Univ London, Acad Neurosurgery Unit, Mol & Clin Sci Inst, London SW17 0RE, England.	ssaadoun@sgul.ac.uk		Saadoun, Samira/0000-0002-5480-5678; Papadopoulos, Marios/0000-0001-9174-4176; Zoumprouli, Argyro/0000-0003-0890-690X	Wings for Life Spinal Cord Research Foundation; Neurosciences Research Foundation (Fletcher Fund); London Deanery; Fletcher Fund; Neurosciences Research Foundation	This work was supported by grants awarded to MCP and SS from the Wings for Life Spinal Cord Research Foundation and to MCP from the Neurosciences Research Foundation (Fletcher Fund). FRAH is a UK Stem Cell Foundation and Royal College of Surgeons of England research fellow. MJG is supported by the Neurosciences Research Foundation (Fletcher Fund) and the London Deanery. Supported by the Wings for Life Spinal Cord Research Foundation, the Fletcher Fund, the Neurosciences Research Foundation and the London Deanery.	[Anonymous], 2014, J Spinal Cord Med, V37, P659, DOI 10.1179/1079026814Z.000000000341; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Biering-Sorensen F, 2015, SPINAL CORD, V53, P265, DOI 10.1038/sc.2014.246; BONDURANT FJ, 1990, SPINE, V15, P161, DOI 10.1097/00007632-199003000-00002; Chen SL, 2017, J NEUROTRAUM, V34, P2941, DOI 10.1089/neu.2017.4982; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Fehlings MG, 1999, SPINE, V24, P605, DOI 10.1097/00007632-199903150-00023; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Gallagher MJ, J NEUROTRAUMA; Garcia-Valdecasas-Campelo E, 2007, ALCOHOL ALCOHOLISM, V42, P533, DOI 10.1093/alcalc/agm065; HARPER C, 1985, J NEUROL NEUROSUR PS, V48, P211, DOI 10.1136/jnnp.48.3.211; Huber E, 2017, ANN NEUROL, V81, P740, DOI 10.1002/ana.24932; Kato F, 2012, EUR SPINE J, V21, P1499, DOI 10.1007/s00586-012-2176-4; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Papadopoulos MC, 2015, NEUROSURGERY, V77, pE500, DOI 10.1227/NEU.0000000000000862; Park JW, 2016, J INT MED RES, V44, P950, DOI 10.1177/0300060516652751; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Phang I, 2016, J NEUROSURG-SPINE, V25, P398, DOI 10.3171/2016.1.SPINE151317; Phang I, 2015, NEUROCRIT CARE, V23, P414, DOI 10.1007/s12028-015-0153-6; Phang I, 2015, J NEUROTRAUM, V32, P865, DOI 10.1089/neu.2014.3668; Rao SC, 1999, SPINE, V24, P598, DOI 10.1097/00007632-199903150-00022; Ruegg TB, 2015, J NEUROSURG-SPINE, V22, P230, DOI 10.3171/2014.10.SPINE14346; Saadoun S, 2016, BRIT J NEUROSURG, V30, P582, DOI 10.3109/02688697.2016.1173191; Skeers P, 2018, J BONE JOINT SURG AM, V100, P305, DOI 10.2106/JBJS.16.00995; Squair JW, 2017, NEUROLOGY, V89, P1660, DOI 10.1212/WNL.0000000000004519; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Talbott JF, 2015, J NEUROSURG-SPINE, V23, P495, DOI 10.3171/2015.1.SPINE141033; Tykocki T, 2017, WORLD NEUROSURG, V105, P145, DOI 10.1016/j.wneu.2017.05.138; van Middendorp JJ, 2011, GLOB SPINE J, V1, P1, DOI 10.1055/s-0031-1296049; van Middendorp JJ, 2013, J NEUROTRAUM, V30, P1781, DOI 10.1089/neu.2013.2932; Varsos GV, 2015, J NEUROSURG-SPINE, V23, P763, DOI 10.3171/2015.3.SPINE14870; Walters BC, 2013, NEUROSURGERY, V60, P82, DOI 10.1227/01.neu.0000430319.32247.7f; Werndle MC, 2016, ACTA NEUROCHIR SUPPL, V122, P323, DOI 10.1007/978-3-319-22533-3_64; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Werndle MC, 2012, J NEUROTRAUM, V29, P880, DOI 10.1089/neu.2011.2038	39	13	14	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2019	30	2					421	428		10.1007/s12028-018-0616-7			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HP0UB	WOS:000461380900026	30328047	Green Published, hybrid, Green Accepted			2022-02-06	
J	Irimia, A; Maher, AS; Rostowsky, KA; Chowdhury, NF; Hwang, DH; Law, EM				Irimia, Andrei; Maher, Alexander S.; Rostowsky, Kenneth A.; Chowdhury, Nahian F.; Hwang, Darryl H.; Law, E. Meng			Brain Segmentation From Computed Tomography of Healthy Aging and Geriatric Concussion at Variable Spatial Resolutions	FRONTIERS IN NEUROINFORMATICS			English	Article						segmentation; tissue classification; computed tomography; multimodal imaging; concussion; geriatrics	SURFACE-BASED ANALYSIS; WHITE-MATTER; IMAGE QUALITY; GRAY-MATTER; CT; RELIABILITY; FREESURFER	When properly implemented and processed, anatomic T-1-weighted magnetic resonance imaging (MRI) can be ideal for the noninvasive quantification of white matter (WM) and gray matter (GM) in the living human brain. Although MRI is more suitable for distinguishing GM from WM than computed tomography (CT), the growing clinical use of the latter technique has renewed interest in head CT segmentation. Such interest is particularly strong in settings where MRI is unavailable, logistically unfeasible or prohibitively expensive. Nevertheless, whereas MRI segmentation is a sophisticated and technically-mature research field, the task of automatically classifying soft brain tissues from CT remains largely unexplored. Furthermore, brain segmentation methods for MRI hold considerable potential for adaptation and application to CT image processing. Here we demonstrate this by combining probabilistic, atlas-based classification with topologically-constrained tissue boundary refinement to delineate WM, GM and cerebrospinal fluid (CSF) from head CT images. The feasibility and utility of this approach are revealed by comparison of MRI-only vs. CT-only segmentations in geriatric concussion victims with both MRI and CT scans. Comparison of the two segmentations yields mean Sorensen-Dice coefficients of 85.5 +/- 4.6% (WM), 86.7 +/- 5.6% (GM) and 91.3 +/- 2.8% (CSF), as well as average Hausdorff distances of 3.76 +/- 1.85 mm (WM), 3.43 +/- 1.53 mm (GM) and 2.46 +/- 1.27 mm (CSF). Bootstrapping results suggest that the segmentation approach is sensitive enough to yield WM, GM and CSF volume estimates within similar to 5%, similar to 4%, and similar to 3% of their MRI-based estimates, respectively. To our knowledge, this is the first 3D segmentation approach for CT to undergo rigorous within-subject comparison with high-resolution MRI. Results suggest that (1) standardquality CT allows WM/GM/CSF segmentation with reasonable accuracy, and that (2) the task of soft brain tissue classification from CT merits further attention from neuroimaging researchers.	[Irimia, Andrei; Maher, Alexander S.; Rostowsky, Kenneth A.; Chowdhury, Nahian F.] Univ Southern Calif, USC Leonard Davis Sch Gerontol, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90007 USA; [Hwang, Darryl H.; Law, E. Meng] Univ Southern Calif, Keck Sch Med, Dept Radiol, Los Angeles, CA USA; [Law, E. Meng] Univ Southern Calif, Viterbi Sch Engn, Dept Biomed Engn, Los Angeles, CA USA; [Law, E. Meng] Monash Univ, Cent Clin Sch, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia		Irimia, A (corresponding author), Univ Southern Calif, USC Leonard Davis Sch Gerontol, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90007 USA.	irimia@usc.edu	Irimia, Andrei/B-8275-2008	Irimia, Andrei/0000-0002-9254-9388; Maher, Alexander/0000-0003-4140-6085	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 100973, RF1 AG 054442]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG054442] Funding Source: NIH RePORTER	This study was funded by the National Institutes of Health, grants R01 NS 100973 (to AI) and RF1 AG 054442 (subaward to AI). AI wishes to thank Caleb E. Finch, Hillard S. Kaplan, Gregory S. Thomas, M. Linda, and James D. Sutherland, and the other members of the Tsimane Health & Life History Project for useful discussions, suggestions, support and encouragement. The authors also thank study volunteers for their participation.	Ashburner J, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P81, DOI 10.1016/B978-012372560-8/50006-1; Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Bier G, 2016, NEURORADIOLOGY, V58, P649, DOI 10.1007/s00234-016-1674-1; Bishop C. M., 1995, NEURAL NETWORKS PATT; CDC, 2010, NUMB MAGN RES IM MRI; CHRISTENSEN GE, 1994, PHYS MED BIOL, V39, P609, DOI 10.1088/0031-9155/39/3/022; COLLINS DL, 1995, COMP IMAG VIS, V3, P139; Craddock C, 2006, J COMPUT ASSIST TOMO, V30, P734, DOI 10.1097/01.rct.0000216111.16774.d2; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Diwakar M, 2014, 2014 INTERNATIONAL CONFERENCE ON PARALLEL, DISTRIBUTED AND GRID COMPUTING (PDGC), P94, DOI 10.1109/PDGC.2014.7030722; DUBUISSON MP, 1994, INT C PATT RECOG, P566, DOI 10.1109/ICPR.1994.576361; Eggert LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045081; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; Ewert S, 2019, NEUROIMAGE, V184, P586, DOI 10.1016/j.neuroimage.2018.09.061; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P3, DOI 10.1016/B978-012372560-8/50001-2; Fushimi Y, 2007, EUR RADIOL, V17, P2921, DOI 10.1007/s00330-007-0688-9; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Gupta V, 2010, ACAD RADIOL, V17, P1350, DOI 10.1016/j.acra.2010.06.005; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Iscan Z, 2015, HUM BRAIN MAPP, V36, P3472, DOI 10.1002/hbm.22856; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kaplan H, 2017, LANCET, V389, P1730, DOI 10.1016/S0140-6736(17)30752-3; Kemmling A, 2012, CLIN NEURORADIOL, V22, P79, DOI 10.1007/s00062-011-0123-0; Li ZL, 2014, EUR RADIOL, V24, P1906, DOI 10.1007/s00330-014-3247-1; Manniesing R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00239-z; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Pelc NJ, 2014, ANN BIOMED ENG, V42, P260, DOI 10.1007/s10439-014-0974-z; Rapalino O, 2012, AM J NEURORADIOL, V33, P609, DOI 10.3174/ajnr.A2826; Seo Y, 2008, SEMIN NUCL MED, V38, P177, DOI 10.1053/j.semnuclmed.2008.01.001; Shou H, 2013, COGN AFFECT BEHAV NE, V13, P714, DOI 10.3758/s13415-013-0196-0; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Velasco-Annis C, 2018, J NEUROIMAGING, V28, P162, DOI 10.1111/jon.12483; WEDDERBURN RWM, 1974, BIOMETRIKA, V61, P439, DOI 10.1093/biomet/61.3.439; Williamson C, 2017, SEMIN RESP CRIT CARE, V38, P840, DOI 10.1055/s-0037-1608770; Yu Lifeng, 2009, Imaging Med, V1, P65, DOI 10.2217/iim.09.5	39	13	13	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5196			FRONT NEUROINFORM	Front. Neuroinformatics	MAR 18	2019	13								9	10.3389/fninf.2019.00009			12	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Neurosciences & Neurology	HP6DV	WOS:000461774200001	30936828	Green Published, gold			2022-02-06	
J	Carey, L; Stanwell, P; Terry, DP; McIntosh, AS; Caswell, SV; Iverson, GL; Gardner, AJ				Carey, Lauchlan; Stanwell, Peter; Terry, Douglas P.; McIntosh, Andrew S.; Caswell, Shane, V; Iverson, Grant L.; Gardner, Andrew J.			Verifying Head Impacts Recorded by a Wearable Sensor using Video Footage in Rugby League: a Preliminary Study	SPORTS MEDICINE-OPEN			English	Article						Head impacts; Rugby league; Wearable sensors; Accelerometer; Video review	COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; INSTRUMENTED MOUTHGUARD; CONCUSSION DIAGNOSIS; PLAYING POSITION; BIOMECHANICS; VALIDATION; EXPOSURE; SYSTEM; KINEMATICS	Background: Rugby league is a full-contact collision sport with an inherent risk of concussion. Wearable instrumented technology was used to observe and characterize the level of exposure to head impacts during game play. Purpose: To verify the impacts recorded by the x-patch (TM) with video analysis. Study design: Observational case series. Methods: The x-patch (TM) was used on eight men's semi-professional rugby league players during the 2016 Newcastle Rugby League competition (five forwards and three backs). Game day footage was recorded by a trained videographer using a single camera located at the highest midfield location to verify the impact recorded by the x-patch (TM). Videographic and accelerometer data were time synchronized. Results: The x-patch (TM) sensors recorded a total of 779 impacts >= 20 g during the games, of which 732 (94.0%) were verified on video. In addition, 817 impacts were identified on video that did not record an impact on the sensors. The number of video-verified impacts >= 20 g, per playing hour, was 7.8 for forwards and 4.8 for backs (range = 3.9-19.0). Impacts resulting in a diagnosed concussion had much greater peak linear acceleration (M = 76.1 g, SD = 17.0) than impacts that did not result in a concussion (M = 34.2g, SD = 18.0; Cohen's d = 2.4). Conclusions: The vast majority (94%) of impacts >= 20 g captured by the x-patch (TM) sensor were video verified in semiprofessional rugby league games. The use of a secondary source of information to verify impact events recorded by wearable sensors is beneficial in clarifying game events and exposure levels.	[Carey, Lauchlan; Stanwell, Peter] Univ Newcastle, Ctr Stroke & Brain Injury, Sch Hlth Sci, Fac Hlth, Callaghan, NSW, Australia; [Terry, Douglas P.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Terry, Douglas P.; Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Terry, Douglas P.; Iverson, Grant L.] MassGen Hosp Children, Sport Concuss Program, Boston, MA USA; [Terry, Douglas P.; Iverson, Grant L.] Home Base, Boston, MA USA; [Terry, Douglas P.; Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [McIntosh, Andrew S.] Edith Cowan Univ, Sch Engn, Perth, WA, Australia; [McIntosh, Andrew S.] Edith Cowan Univ, Australian Collaborat Res Injury Sport & Its Prev, Perth, WA, Australia; [McIntosh, Andrew S.] Monash Univ, Accid Res Ctr, Clayton, Vic, Australia; [Caswell, Shane, V] George Mason Univ, Sports Med Assessment Res & Testing Smart Lab, Manassas, VA USA; [Gardner, Andrew J.] Hunter New England Local Hlth Dist Sports Concuss, New Lambton Hts, NSW, Australia; [Gardner, Andrew J.] Univ Newcastle, Ctr Stroke & Brain Injury, Sch Med & Publ Hlth, Callaghan, NSW, Australia		Gardner, AJ (corresponding author), Hunter New England Local Hlth Dist Sports Concuss, New Lambton Hts, NSW, Australia.; Gardner, AJ (corresponding author), Univ Newcastle, Ctr Stroke & Brain Injury, Sch Med & Publ Hlth, Callaghan, NSW, Australia.	Andrew.Gardner@newcastle.edu.au	Stanwell, Peter/F-9136-2012	Stanwell, Peter/0000-0002-4780-0393; Gardner, Andrew/0000-0001-5031-5586	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [Early Career Research Fellowship] Funding Source: Medline; Hunter New England Local Health District [Clinical Research Fellowship] Funding Source: Medline		Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Caswell SV, 2017, AM J SPORT MED, V45, P3374, DOI 10.1177/0363546517724754; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Cortes N, 2016, MED SCI SPORT EXER, V25, P2772; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Davis G, 2016, J SCI MED SPORT, V19, P898, DOI 10.1016/j.jsams.2016.02.005; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gabbett TJ, 2005, J STRENGTH COND RES, V19, P749; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner AJ, 2017, BRAIN INJURY, V31, P1918, DOI 10.1080/02699052.2017.1358399; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Gardner AJ, 2017, INT J SPORTS MED, V38, P71, DOI 10.1055/s-0042-116072; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gissane C, 1997, Aust J Sci Med Sport, V29, P91; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hanlon EM, 2012, REAL TIME HEAD ACCEL, P1102; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hoskins W, 2006, J SCI MED SPORT, V9, P46, DOI 10.1016/j.jsams.2006.03.013; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King DA, 2016, J NEUROSURG-PEDIATR, V18, P65, DOI 10.3171/2015.12.PEDS15605; Kohler R, 2017, BR J SPORTS MED, V51, pA78; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Makdissi M, 2016, J SCI MED SPORT, V19, P958, DOI 10.1016/j.jsams.2016.02.014; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; McCrory P, 2017, BR J SPORTS MED; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Nevins D, 2015, PROCEDIA ENG; O'Day KM, 2017, CLIN BIOMECH, V43, P23, DOI 10.1016/j.clinbiomech.2017.01.013; Press JN, 2016, CLIN J SPORT MED OFF, P1; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Temper BD, 2018, ANN BIOMED ENG; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Willmott C, 2018, J SCI MED SPORT, V21, P442, DOI 10.1016/j.jsams.2017.09.591; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	61	13	13	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2199-1170	2198-9761		SPORTS MED-OPEN	Sports Med.-Open	MAR 14	2019	5	1							9	10.1186/s40798-019-0182-3			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KO1JX	WOS:000515305800001	30874938	gold, Green Published			2022-02-06	
J	Alexander, KA; Tseng, HW; Fleming, W; Jose, B; Salga, M; Kulina, I; Millard, SM; Pettit, AR; Genet, F; Levesque, JP				Alexander, Kylie A.; Tseng, Hsu-Wen; Fleming, Whitney; Jose, Beulah; Salga, Marjorie; Kulina, Irina; Millard, Susan M.; Pettit, Allison R.; Genet, Francois; Levesque, Jean-Pierre			Inhibition of JAK1/2 Tyrosine Kinases Reduces Neurogenic Heterotopic Ossification After Spinal Cord Injury	FRONTIERS IN IMMUNOLOGY			English	Article						spinal cord injury complications; heterotopic ossification; JAK- STAT signaling pathway; ruxolitinib; oncostatin M receptor	ONCOSTATIN-M; REACTIVE ASTROCYTES; SIGNAL-TRANSDUCTION; RISK-FACTORS; STAT3; RECEPTOR; DIFFERENTIATION; OSTEOGENESIS; INFLAMMATION; MACROPHAGES	Neurogenic heterotopic ossifications (NHO) are very incapacitating complications of traumatic brain and spinal cord injuries (SCI) which manifest as abnormal formation of bone tissue in periarticular muscles. NHO are debilitating as they cause pain, partial or total joint ankylosis and vascular and nerve compression. NHO pathogenesis is unknown and the only effective treatment remains surgical resection, however once resected, NHO can re-occur. To further understand NHO pathogenesis, we developed the first animal model of NHO following SCI in genetically unmodified mice, which mimics most clinical features of NHO in patients. We have previously shown that the combination of (1) a central nervous system lesion (SCI) and (2) muscular damage (via an intramuscular injection of cardiotoxin) is required for NHO development. Furthermore, macrophages within the injured muscle play a critical role in driving NHO pathogenesis. More recently we demonstrated that macrophage-derived oncostatin M (OSM) is a key mediator of both human and mouse NHO. We now report that inflammatory monocytes infiltrate the injured muscles of SCI mice developing NHO at significantly higher levels compared to mice without SCI. Muscle infiltrating monocytes and neutrophils expressed OSM whereas mouse muscle satellite and interstitial cell expressed the OSM receptor (OSMR). In vitro recombinant mouse OSM induced tyrosine phosphorylation of the transcription factor STAT3, a downstream target of OSMR:gp130 signaling in muscle progenitor cells. As STAT3 is tyrosine phosphorylated by JAK1/2 tyrosine kinases downstream of OSMR:gp130, we demonstrated that the JAK1/2 tyrosine kinase inhibitor ruxolitinib blocked OSM driven STAT3 tyrosine phosphorylation in mouse muscle progenitor cells. We further demonstrated in vivo that STAT3 tyrosine phosphorylation was not only significantly higher but persisted for a longer duration in injured muscles of SCI mice developing NHO compared to mice with muscle injury without SCI. Finally, administration of ruxolitinib for 7 days post-surgery significantly reduced STAT3 phosphorylation in injured muscles in vivo as well as NHO volume at all analyzed time-points up to 3 weeks post-surgery. Our results identify the JAK/STAT3 signaling pathway as a potential therapeutic target to reduce NHO development following SCI.	[Alexander, Kylie A.; Tseng, Hsu-Wen; Fleming, Whitney; Jose, Beulah; Salga, Marjorie; Kulina, Irina; Millard, Susan M.; Pettit, Allison R.; Levesque, Jean-Pierre] Univ Queensland, Translat Res Inst, Mater Res Inst, Woolloongabba, Qld, Australia; [Salga, Marjorie; Genet, Francois] Raymond Poincare Univ Hosp, AP HP, CIC IT 1429, Serv Med Phys & Readaptat, Garches, France; [Genet, Francois] Univ Versailles St Quentin Yvelines, INSERM, U1179, END ICAP, Montigny Le Bretonneux, France		Levesque, JP (corresponding author), Univ Queensland, Translat Res Inst, Mater Res Inst, Woolloongabba, Qld, Australia.	jp.levesque@mater.uq.edu.au	Levesque, Jean-Pierre/C-5426-2011; Alexander, Kylie/P-2666-2016; Pettit, Allison/O-4462-2019; Millard, Susan/C-8115-2011	Levesque, Jean-Pierre/0000-0002-7299-6025; Alexander, Kylie/0000-0001-5772-0277; Pettit, Allison/0000-0003-4707-7892; Millard, Susan/0000-0003-1738-3362	National Health and Medical Research Council of Australia (NHMRC)National Health and Medical Research Council of Australia [1101620]; Congressionally Approved Spinal Cord Injury Research Program of the US Department of Defense [W81XWH-15-1-0606]; Mater Foundation; NHMRCNational Health and Medical Research Council of Australia [1136130]; Australian Research CouncilAustralian Research Council [ARP FT150500335]; Federal Government of Australia	This research was supported by Project Grant 1101620 from the National Health and Medical Research Council of Australia (NHMRC) to J-PL, ARP and FG, and award W81XWH-15-1-0606 from the Congressionally Approved Spinal Cord Injury Research Program of the US Department of Defense to J-PL, ARP, and FG, and by funds from the Mater Foundation. J-PL is supported by Research Fellowship 1136130 from the NHMRC. ARP is supported by an Australian Research Council Future Fellowship ARP FT150500335. The Translational Research Institute is partly funded by the Federal Government of Australia.	Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; Allan EH, 2008, J BONE MINER RES, V23, P1170, DOI [10.1359/jbmr.080324, 10.1359/JBMR.080324]; Banovac K, 2004, SPINAL CORD, V42, P707, DOI 10.1038/sj.sc.3101628; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; Brady RD, 2018, BONE, V109, P35, DOI 10.1016/j.bone.2017.05.015; Cui M, 2016, BIOSCI TRENDS, V10, P460, DOI 10.5582/bst.2016.01160; Dizdar D, 2013, BRAIN INJURY, V27, P807, DOI 10.3109/02699052.2013.775490; Ehlting C, 2015, CELL SIGNAL, V27, P555, DOI 10.1016/j.cellsig.2014.12.016; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; Genet F, 2019, ANN PHYS REHABIL MED, V62, P225, DOI 10.1016/j.rehab.2018.09.004; Genet F, 2009, J BONE JOINT SURG BR, V91B, P1493, DOI 10.1302/0301-620X.91B11.22305; Genet F, 2015, J PATHOL, V236, P229, DOI 10.1002/path.4519; Genet F, 2012, J HEAD TRAUMA REHAB, V27, P443, DOI 10.1097/HTR.0b013e31822b54ba; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023129; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; Gerhartz C, 1996, J BIOL CHEM, V271, P12991, DOI 10.1074/jbc.271.22.12991; Guihard P, 2015, AM J PATHOL, V185, P765, DOI 10.1016/j.ajpath.2014.11.008; Guihard P, 2012, STEM CELLS, V30, P762, DOI 10.1002/stem.1040; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hermanns HM, 1999, J IMMUNOL, V163, P6651; Ichihara M, 1997, BLOOD, V90, P165; Jenkins BJ, 2005, BLOOD, V105, P3512, DOI 10.1182/blood-2004-09-3751; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kaur S, 2018, BLOOD, V132, P735, DOI 10.1182/blood-2018-01-829663; Lacroix S, 2002, J COMP NEUROL, V454, P213, DOI 10.1002/cne.10407; Levesque JP, 2018, J BONE MINER RES, V33, P365, DOI 10.1002/jbmr.3346; Levy JB, 1996, ENDOCRINOLOGY, V137, P1159, DOI 10.1210/en.137.4.1159; Magrangeas F, 2001, EUR CYTOKINE NETW, V12, P309; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; Ohlmeier M, 2017, SPINE J, V17, P1519, DOI 10.1016/j.spinee.2017.04.021; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Pavey GJ, 2016, BONE, V90, P159, DOI 10.1016/j.bone.2016.06.014; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Qureshi AT, 2017, AM J PATHOL, V187, P2536, DOI 10.1016/j.ajpath.2017.07.010; Reznik JE, 2014, J MUSCULOSKEL NEURON, V14, P19; Salga M, 2015, SKELETAL RADIOL, V44, P233, DOI 10.1007/s00256-014-2003-6; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sampath SC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03876-8; Sims Natalie A, 2014, Bonekey Rep, V3, P527, DOI 10.1038/bonekey.2014.22; Song HY, 2007, J CELL BIOCHEM, V101, P1238, DOI 10.1002/jcb.21245; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Torossian F, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96034; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Wright CR, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/7517350	50	13	14	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	MAR 7	2019	10								377	10.3389/fimmu.2019.00377			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HN9ES	WOS:000460503200001	30899259	gold, Green Published			2022-02-06	
J	Dean, NA				Dean, Nikolaus A.			"Just Act Normal": Concussion and the (Re)negotiation of Athletic Identity	SOCIOLOGY OF SPORT JOURNAL			English	Article							SPORT; INJURY; RISK; AUTOETHNOGRAPHY; PAIN; EPIDEMIOLOGY; MASCULINITY; EXPERIENCES; IMPACT; FIELD	In this autoethnography, I describe my own personal experiences and dealings with a sport-related concussion. In particular, I focus on the (re)negotiation of my student- athlete identity due to the repercussive affects of concussion. Weaving together personal narratives with Erving Goffman' s presentation of self theory, I attempt to highlight some of the complexities of the injury in relation to athletic identity, and use the theory as a departure point to further discuss how sport-related concussion can be understood within a socio-cultural context. In doing so, I attempt to move beyond my own personal experiences, as a way to comment on the larger social, cultural, and political forces that affect how athletes come to understand and embody concussion.	[Dean, Nikolaus A.] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada		Dean, NA (corresponding author), Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada.	nik.dean@ubc.ca					Allen-Collinson J., 2007, LEISURE STUD, V26, P381; Allen-Collinson J, 2017, ROUT INT HANDB, P267; Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Barth JT, 2012, J CLIN SPORT PSYCHOL, V6, P409, DOI 10.1123/jcsp.6.4.409; Benson P, 2017, J SPORT SOC ISSUES, V41, P307, DOI 10.1177/0193723517707699; Blinde E. M., 1992, Journal of Sport Behavior, V15, P3; Brayton S, 2019, COMMUN SPORT, V7, P110, DOI 10.1177/2167479517740342; BREWER BW, 1993, INT J SPORT PSYCHOL, V24, P237; Budgeon, 2003, BODY SOC, V9, P35, DOI DOI 10.1177/1357034X030091003; CURRY TJ, 1993, SYMB INTERACT, V16, P273, DOI 10.1525/si.1993.16.3.273; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dashper K, 2015, CURR SOCIOL, V63, P511, DOI 10.1177/0011392115583879; Dashper K, 2013, SOCIOL SPORT J, V30, P323, DOI 10.1123/ssj.30.3.323; Denzin N., 1997, REPRESENTATION TEXT, P179; Donnelly Peter., 2004, SPORTING BODIES DAMA, P29, DOI DOI 10.1016/S1476-2854(04)02001-1; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis C., 2004, ETHNOGRAPHIC; Ellis C., 2014, AUTOETHNOGRAPHY UNDE; Ellis Carolyn., 2009, REVISION AUTOETHNOGR; Gaetz M, 2017, MED HYPOTHESES, V102, P130, DOI 10.1016/j.mehy.2017.03.023; Goffman E., 1963, STIGMA NOTES MANAGEM; Goffman E., 1956, PRESENTATION SELF EV; Green SL, 2001, J APPL SPORT PSYCHOL, V13, P40, DOI 10.1080/10413200109339003; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Howe P. D., 2001, International Review for the Sociology of Sport, V36, P289, DOI 10.1177/101269001036003003; HUGHES R, 1991, SOCIOL SPORT J, V8, P307, DOI 10.1123/ssj.8.4.307; Jago B., 1996, QUALITATIVE INQUIRY, V2, P495, DOI DOI 10.1177/107780049600200406; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurendeau J, 2019, QUAL RES SPORT EXERC, V11, P246, DOI 10.1080/2159676X.2018.1433227; Laurendeau J, 2014, EMOT SPACE SOC, V12, P11, DOI 10.1016/j.emospa.2013.03.010; Laurendeau J, 2011, SOCIOL SPORT J, V28, P404, DOI 10.1123/ssj.28.4.404; Liston K, 2018, INT REV SOCIOL SPORT, V53, P668, DOI 10.1177/1012690216679966; Malcolm D, 2018, SOCIOL SPORT J, V35, P141, DOI 10.1123/ssj.2017-0113; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McMahon J, 2017, SOCIOL SPORT J, V34, P223, DOI 10.1123/ssj.2016-0134; Merriam Webster Dictionary, 2018, MERRIAM WEBSTER DICT; Messner M. A., 1990, International Review for the Sociology of Sport, V25, P203, DOI 10.1177/101269029002500303; Nixon H. L. II, 1994, Journal of Sport and Social Issues, V18, P340, DOI 10.1177/019372394018004004; Nixon HL, 1996, SOCIOL SPORT J, V13, P78, DOI 10.1123/ssj.13.1.78; NIXON HL, 1993, SOCIOL SPORT J, V10, P315, DOI 10.1123/ssj.10.3.315; NIXON HL, 1993, SOCIOL SPORT J, V10, P183, DOI 10.1123/ssj.10.2.183; Pike ECJ, 2003, SOCIOL SPORT J, V20, P232, DOI 10.1123/ssj.20.3.232; RICHARDSON L, 1994, J CONTEMP ETHNOGR, V23, P3, DOI 10.1177/089124194023001001; Roderick M, 2017, SOCIOL SPORT J, V34, P99, DOI 10.1123/ssj.2017-0082; Saffary R, 2012, AM J LIFESTYLE MED, V6, P133, DOI 10.1177/1559827611411649; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Smith B., 1999, QUAL INQ, V5, P264; Snow D. A, 1995, SYMBOLIC INTERACTION; Sparkes AC, 2002, ETHNOGR ALT BOOK SER, V9, P209; Tullis JA, 2013, HANDBOOK OF AUTOETHNOGRAPHY, P244; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002; Young K., 1995, Journal of Sport and Social Issues, V19, P45, DOI 10.1177/019372395019001004; YOUNG K, 1994, SOCIOL SPORT J, V11, P175, DOI 10.1123/ssj.11.2.175; YOUNG K, 1993, SOCIOL SPORT J, V10, P373, DOI 10.1123/ssj.10.4.373; Young K., 2004, SPORTING BODIES DAMA, P1; Young K., 2012, SPORT VIOLENCE SOC; Zavattaro S, 2014, QUAL RES J, V14, P272, DOI 10.1108/QRJ-11-2012-0027	63	13	13	1	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0741-1235	1543-2785		SOCIOL SPORT J	Sociol. Sport J.	MAR	2019	36	1					22	31		10.1123/ssj.2018-0033			10	Hospitality, Leisure, Sport & Tourism; Sociology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sociology; Sport Sciences	HP0FA	WOS:000461340000003					2022-02-06	
J	Frenguelli, BG				Frenguelli, Bruno G.			The Purine Salvage Pathway and the Restoration of Cerebral ATP: Implications for Brain Slice Physiology and Brain Injury	NEUROCHEMICAL RESEARCH			English	Article						ATP; Adenosine; Stroke; TBI; Purines; Traumatic brain injury	ACTIVITY-DEPENDENT RELEASE; SYNAPTIC-TRANSMISSION; ADENINE-NUCLEOTIDES; HIPPOCAMPAL SLICES; ADENOSINE RELEASE; RAT HIPPOCAMPUS; EXTRACELLULAR ADENOSINE; MYOCARDIAL ISCHEMIA; AMPA RECEPTORS; ENERGY USE	Brain slices have been the workhorse for many neuroscience labs since the pioneering work of Henry McIlwain in the 1950s. Their utility is undisputed and their acceptance as appropriate models for the central nervous system is widespread, if not universal. However, the skeleton in the closet is that ATP levels in brain slices are lower than those found in vivo, which may have important implications for cellular physiology and plasticity. Far from this being a disadvantage, the ATP-impoverished slice can serve as a useful and experimentally-tractable surrogate for the injured brain, which experiences similar depletion of cellular ATP. We have shown that the restoration of cellular ATP in brain slices to in vivo values is possible with a simple combination of d-ribose and adenine (RibAde), two substrates for ATP synthesis. Restoration of ATP in slices to physiological levels has implications for synaptic transmission and plasticity, whilst in the injured brain in vivo RibAde shows encouraging positive results. Given that ribose, adenine, and a third compound, allopurinol, are all separately in use in man, their combined application after acute brain injury, in accelerating ATP synthesis and increasing the reservoir of the neuroprotective metabolite, adenosine, may help reduce the morbidity associated with stroke and traumatic brain injury.	[Frenguelli, Bruno G.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England		Frenguelli, BG (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	b.g.frenguelli@warwick.ac.uk	Frenguelli, Bruno/C-5007-2015	Frenguelli, Bruno/0000-0001-7214-3172	Wellcome TrustWellcome TrustEuropean Commission; University of Warwick Alumnus Fund; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC); Rosetrees TrustRosetrees Trust	I am grateful to Dr Martin Lochner for providing a ChemDraw template for some of the structures used in Fig. 1 and which formed the basis for the structures shown. Any errors are solely the author's. I am also grateful to Dr Lilya Andrianova for translating the paper by Belen'kii et al. [50] from the original Russian, and to Dr Mark Wall for reading a draft of this review. This work was supported by funding from The Wellcome Trust, Research into Aging, The University of Warwick Alumnus Fund, BBSRC, The Rosetrees Trust.	AGNEW WF, 1967, ACTA PHYSIOL SCAND, V70, P168, DOI 10.1111/j.1748-1716.1967.tb03612.x; Amato S, 2011, CELL CYCLE, V10, P3452, DOI 10.4161/cc.10.20.17953; ARAI A, 1990, NEUROSCI LETT, V119, P41, DOI 10.1016/0304-3940(90)90750-4; ARAKAWA T, 1991, NEUROSCI LETT, V130, P53, DOI 10.1016/0304-3940(91)90225-I; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Baines AE, 2011, NEUROPHARMACOLOGY, V61, P1, DOI 10.1016/j.neuropharm.2011.02.005; Bakthavachalam P, 2017, J NEUROL SCI, V375, P417, DOI 10.1016/j.jns.2017.02.043; Balestrino M, 2016, AMINO ACIDS, V48, P1955, DOI 10.1007/s00726-016-2173-8; Barsotti C, 2002, J BIOL CHEM, V277, P9865, DOI 10.1074/jbc.M111418200; Bayram Melike, 2015, Ther Adv Cardiovasc Dis, V9, P56, DOI 10.1177/1753944715572752; BELEN'Kn E. E., 1966, FARMAKOL TOKSIKOL, V29, P685; BENSON ES, 1961, AM J PHYSIOL, V201, P687, DOI 10.1152/ajplegacy.1961.201.4.687; BETZ AL, 1985, J NEUROCHEM, V44, P574, DOI 10.1111/j.1471-4159.1985.tb05451.x; BETZ AL, 1975, BIOCHIM BIOPHYS ACTA, V406, P505; BINGMANN D, 1982, EXP BRAIN RES, V48, P89; Blatherwick EQ, 2013, INT J MASS SPECTROM, V345, P19, DOI 10.1016/j.ijms.2013.02.004; Boison D, 2016, NEUROPHARMACOLOGY, V104, P131, DOI 10.1016/j.neuropharm.2015.08.046; Bollee G, 2012, CLIN J AM SOC NEPHRO, V7, P1521, DOI 10.2215/CJN.02320312; Boswell-Casteel RC, 2017, NUCLEOS NUCLEOT NUCL, V36, P7, DOI 10.1080/15257770.2016.1210805; Brager DH, 2003, J NEUROPHYSIOL, V89, P22, DOI 10.1152/jn.00554.2002; Chen ZC, 2016, NEUROCHEM RES, V41, P1085, DOI 10.1007/s11064-015-1799-3; Chinopoulos C, 2011, FEBS LETT, V585, P1255, DOI 10.1016/j.febslet.2011.04.004; Chinopoulos C, 2010, BBA-MOL BASIS DIS, V1802, P221, DOI 10.1016/j.bbadis.2009.08.008; CHUN J, 1991, BRAIN RES, V568, P159, DOI 10.1016/0006-8993(91)91392-E; Cicero AFG, 2017, CURR PHARM DESIGN, V23, P1265, DOI 10.2174/1381612823666170124120518; Clark PM, 2014, P NATL ACAD SCI USA, V111, pE2866, DOI 10.1073/pnas.1410326111; COFFMAN JD, 1960, CIRC RES, V8, P649; COLLINGRIDGE GL, 1995, J NEUROSCI METH, V59, P5, DOI 10.1016/0165-0270(94)00187-L; Constantinescu AO, 2011, CLIN NEUROPHYSIOL, V122, P1117, DOI 10.1016/j.clinph.2010.09.015; CORNFORD EM, 1975, BIOCHIM BIOPHYS ACTA, V394, P211, DOI 10.1016/0005-2736(75)90259-X; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; Dale N, 2009, CURR NEUROPHARMACOL, V7, P160, DOI 10.2174/157015909789152146; Dennis SH, 2011, J NEUROSCI, V31, P11941, DOI 10.1523/JNEUROSCI.1183-11.2011; Dienel GA, 2014, J CEREBR BLOOD F MET, V34, P1736, DOI 10.1038/jcbfm.2014.153; Diogenes MJ, 2014, CEREB CORTEX, V24, P67, DOI 10.1093/cercor/bhs284; Drury AN, 1929, J PHYSIOL-LONDON, V68, P213, DOI 10.1113/jphysiol.1929.sp002608; DUX E, 1990, BRAIN RES, V516, P248, DOI 10.1016/0006-8993(90)90925-2; Engl E, 2015, J PHYSIOL-LONDON, V593, P3417, DOI 10.1113/jphysiol.2014.282517; Etherington LAV, 2009, NEUROPHARMACOLOGY, V56, P429, DOI 10.1016/j.neuropharm.2008.09.016; FALK JS, 1972, TRANSFUSION, V12, P376; Faller KM, 2017, BRAIN NEUROSCI ADV; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; FOWLER JC, 1989, BRAIN RES, V490, P378, DOI 10.1016/0006-8993(89)90258-8; FOWLER JC, 1990, BRAIN RES, V509, P331, DOI 10.1016/0006-8993(90)90560-X; FOX AC, 1979, AM J CARDIOL, V43, P52, DOI 10.1016/0002-9149(79)90044-4; Fu R, 2014, BRAIN, V137, P1282, DOI 10.1093/brain/awt202; FUJII T, 1982, PFLUG ARCH EUR J PHY, V393, P83, DOI 10.1007/BF00582396; GAITONDE MK, 1971, J NEUROCHEM, V18, P1971, DOI 10.1111/j.1471-4159.1971.tb09603.x; GERLACH E, 1971, EXPERIENTIA, V27, P876, DOI 10.1007/BF02135716; GERLACH E, 1958, PFLUG ARCH GES PHYS, V266, P266, DOI 10.1007/BF00416777; Gervitz LM, 2001, AM J PHYSIOL-REG I, V280, pR639, DOI 10.1152/ajpregu.2001.280.3.R639; Gilbert E, 2006, BRAIN RES, V1117, P213, DOI 10.1016/j.brainres.2006.07.107; GOLDTHWAIT DA, 1957, J CLIN INVEST, V36, P1572, DOI 10.1172/JCI103555; GROSS M, 1991, KLIN WOCHENSCHR, V69, P31, DOI 10.1007/BF01649054; Hall J, 2015, SOC NEUR ANN M, V766, pC59; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Hess JR, 2006, VOX SANG, V91, P13, DOI 10.1111/j.1423-0410.2006.00778.x; Hossmann KA, 2008, NEUROPHARMACOLOGY, V55, P257, DOI 10.1016/j.neuropharm.2007.12.004; Ilie A, 2006, EUR J NEUROSCI, V23, P2135, DOI 10.1111/j.1460-9568.2006.04747.x; Ilie A, 2006, J NEUROPHYSIOL, V96, P2809, DOI 10.1152/jn.00466.2006; Ipata PL, 2011, CURR TOP MED CHEM, V11, P909; Jacobson KA, 2016, NEUROPHARMACOLOGY, V104, P31, DOI 10.1016/j.neuropharm.2015.12.001; Jauch-Chara K, 2014, NEUROSCIENCE, V283, P202, DOI 10.1016/j.neuroscience.2014.04.059; JOANNY P, 1969, BIOCHEM J, V112, P367, DOI 10.1042/bj1120367; Juul SE, 2014, CLIN PERINATOL, V41, P119, DOI 10.1016/j.clp.2013.09.004; KANATANI T, 1995, EXPERIENTIA, V51, P213, DOI 10.1007/BF01931098; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; Kerr SE, 1942, J BIOL CHEM, V145, P647; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kirino T, 2002, J CEREBR BLOOD F MET, V22, P1283, DOI 10.1097/01.WCB.0000040942.89393.88; Kukley M, 2005, J NEUROSCI, V25, P2832, DOI 10.1523/JNEUROSCI.4260-04.2005; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lipton P, 1982, SOC NEUR ABST, V8, P283; Liu HH, 2014, ANAL CHEM, V86, P10114, DOI 10.1021/ac5034566; LLOYD HGE, 1988, BRAIN RES, V462, P391, DOI 10.1016/0006-8993(88)90571-9; Lovatt D, 2012, P NATL ACAD SCI USA, V109, P6265, DOI 10.1073/pnas.1120997109; LOWRY OH, 1964, J BIOL CHEM, V239, P18; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Maliekal P, 2007, J BIOL CHEM, V282, P31844, DOI 10.1074/jbc.M706818200; MCILWAIN H, 1956, BIOCHEM J, V63, P250, DOI 10.1042/bj0630250; MCILWAIN H, 1951, BIOCHEM J, V48, P12, DOI 10.1042/bj0480012; MCILWAIN H, 1950, BRIT MED BULL, V6, P301, DOI 10.1093/oxfordjournals.bmb.a073620; MCILWAIN H, 1956, BIOCHEM J, V64, P332, DOI 10.1042/bj0640332; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; Moore KA, 2003, P NATL ACAD SCI USA, V100, P14397, DOI 10.1073/pnas.1835831100; Moriwaki Y, 1999, HISTOL HISTOPATHOL, V14, P1321, DOI 10.14670/HH-14.1321; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Mulder IA, 2016, PROTEOMICS, V16, P1652, DOI 10.1002/pmic.201500402; Newman GC, 1998, J CEREBR BLOOD F MET, V18, P675, DOI 10.1097/00004647-199806000-00010; Panayiotou C, 2014, INT J BIOCHEM CELL B, V49, P75, DOI 10.1016/j.biocel.2014.01.014; Parkinson FE, 2011, CURR TOP MED CHEM, V11, P948; Patching SG, 2017, MOL NEUROBIOL, V54, P1046, DOI 10.1007/s12035-015-9672-6; Pearson T, 2001, J NEUROSCI, V21, P2298, DOI 10.1523/JNEUROSCI.21-07-02298.2001; Pearson T, 2003, J CELL MOL MED, V7, P362, DOI 10.1111/j.1582-4934.2003.tb00239.x; Pearson T, 2006, J NEUROCHEM, V97, P1357, DOI 10.1111/j.1471-4159.2006.03823.x; Pedata F, 2016, NEUROPHARMACOLOGY, V104, P105, DOI 10.1016/j.neuropharm.2015.11.007; Perasso L, 2013, MED RES REV, V33, P336, DOI 10.1002/med.20255; Percie du Sert N, 2017, J CEREB BLOOD FLOW M; PHILLIS JW, 1989, BRAIN RES BULL, V23, P467, DOI 10.1016/0361-9230(89)90191-3; PHILLIS JW, 1995, J NEUROCHEM, V64, P2177; PRATHER JW, 1970, J MEMBRANE BIOL, V2, P150, DOI 10.1007/BF01869857; Prins ML, 2014, J LIPID RES, V55, P2450, DOI 10.1194/jlr.R046706; PULL I, 1972, BIOCHEM J, V126, P965, DOI 10.1042/bj1260965; REID KH, 1988, PROG NEUROBIOL, V31, P1, DOI 10.1016/0301-0082(88)90020-2; Ribeiro FF, 2016, NEUROPHARMACOLOGY, V104, P226, DOI 10.1016/j.neuropharm.2015.11.006; Sacerdote MG, 2005, P NATL ACAD SCI USA, V102, P6004, DOI 10.1073/pnas.0408440102; Shecterle Linda M, 2010, Recent Pat Cardiovasc Drug Discov, V5, P138; SIEGEL DC, 1971, ANN SURG, V174, P932, DOI 10.1097/00000658-197112000-00008; Siklos L, 1997, NEUROSCIENCE, V79, P1013, DOI 10.1016/S0306-4522(97)00031-6; Sims RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087481; Stockwell J, 2016, NEUROPHARMACOLOGY, V102, P254, DOI 10.1016/j.neuropharm.2015.11.018; Stoddart LA, 2015, NEUROPHARMACOLOGY, V98, P68, DOI 10.1016/j.neuropharm.2015.04.013; Sweatt JD, 2016, J NEUROCHEM, V139, P179, DOI 10.1111/jnc.13580; THOMAS J, 1956, BIOCHEM J, V64, P335, DOI 10.1042/bj0640335; THOMAS J, 1956, J NEUROCHEM, V1, P1, DOI 10.1111/j.1471-4159.1956.tb12047.x; THOMAS J, 1957, BIOCHEM J, V66, P655, DOI 10.1042/bj0660655; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Valtysson J, 1998, ACTA NEUROCHIR, V140, P387, DOI 10.1007/s007010050113; Wall MJ, 2008, NEUROPHARMACOLOGY, V55, P1251, DOI 10.1016/j.neuropharm.2008.08.005; WARD HB, 1983, J SURG RES, V34, P292, DOI 10.1016/0022-4804(83)90074-4; WARD HB, 1984, SURGERY, V96, P248; WARNER WL, 1977, TRANSFUSION, V17, P326, DOI 10.1046/j.1537-2995.1977.17477216860.x; Wei CY, 2013, ASTROBIOLOGY, V13, P177, DOI 10.1089/ast.2012.0901; Weigand MA, 1999, ANESTHESIOLOGY, V91, P414, DOI 10.1097/00000542-199908000-00015; WHITTINGHAM TS, 1984, J NEUROSCI, V4, P793; Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zimmer HG, 1998, CARDIOVASC DRUG THER, V12, P179, DOI 10.1023/A:1007704817774; ZIMMER HG, 1991, CIRC RES, V69, P1575, DOI 10.1161/01.RES.69.6.1575; ZIMMER HG, 1978, PFLUG ARCH EUR J PHY, V376, P223, DOI 10.1007/BF00584954; zur Nedden S, 2014, J NEUROCHEM, V128, P111, DOI 10.1111/jnc.12397; zur Nedden S, 2011, J NEUROSCI, V31, P6221, DOI 10.1523/JNEUROSCI.4039-10.2011; zur Nedden S, 2009, ANAL BIOCHEM, V388, P108, DOI 10.1016/j.ab.2009.02.017	134	13	13	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAR	2019	44	3					661	675		10.1007/s11064-017-2386-6			15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	HP0TR	WOS:000461379900015	28836168	hybrid, Green Published			2022-02-06	
J	Haines, KL; Nguyen, BP; Vatsaas, C; Alger, A; Brooks, K; Agarwal, SK				Haines, Krista L.; Nguyen, Benjamin P.; Vatsaas, Cory; Alger, Amy; Brooks, Kelli; Agarwal, Suresh K.			Socioeconomic Status Affects Outcomes After Severity-Stratified Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	13th Annual Meeting of the Academic-Surgical-Congress/Society-of-University-Surgeons/Association-for-Academic-Surgery (AAS)	JAN 30-FEB 01, 2018	Jacksonville, FL	Acad Surg Congress, Soc Univ Surg, Assoc Acad Surg		Trauma outcomes; Socioeconomic disparities; Traumatic brain injury; Racial disparities	RACIAL DISPARITIES; INSURANCE STATUS; ETHNIC-DIFFERENCES; REHABILITATION; DISCHARGE; RACE; CARE; MORTALITY; MODERATE; LIFE	Background: Socioeconomic status (SES) and race have been shown to increase the incidence of being afflicted by a traumatic brain injury (TBI) resulting in worse post-hospitalization outcomes. The goal of this study was to determine the effect disparities have on in-hospital mortality, discharge to inpatient rehabilitation, hospital length of stay (LOS), and TBI procedures performed stratified by severity of TBI. Methods: This was a retrospective cohort study of patients with closed head injuries using the National Trauma Data Bank (2012-2015). Multivariate logistic/linear regression models were created to determine the impact of race and insurance status in groups graded by head Abbreviated Injury Scale (AIS). Results: We analyzed 131,461 TBI patients from NTDB. Uninsured patients experienced greater mortality at an AIS of 5 (odds ratio [OR] = 1.052, P = 0.001). Uninsured patients had a decreased likelihood of being discharged to inpatient rehabilitation with an increasing AIS beginning from an AIS of 2 (OR = 0.987, P = 0.008) to an AIS of 5 (OR = 0.879, P < 0.001). Black patients had an increased LOS as their AIS increased from an AIS of 2 (0.153 d, P < 0.001) to 5 (0.984 d, P < 0.001) with the largest discrepancy in LOS occurring at an AIS of 5. Conclusions: Disparities in race and SES are associated with differences in mortality, LOS, and discharge to inpatient rehabilitation. Patients with more severe TBI have the greatest divergence in treatment and outcome when stratified by race and ethnicity as well as SES. (C) 2018 Elsevier Inc. All rights reserved.	[Haines, Krista L.; Vatsaas, Cory; Alger, Amy; Brooks, Kelli; Agarwal, Suresh K.] Duke Univ, Med Ctr, Dept Surg, Div Trauma Crit Care & Acute Care Surg, DUMC 2837,2301 Erwin Rd, Durham, NC 27710 USA; [Nguyen, Benjamin P.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA		Haines, KL (corresponding author), Duke Univ, Med Ctr, Dept Surg, Div Trauma Crit Care & Acute Care Surg, DUMC 2837,2301 Erwin Rd, Durham, NC 27710 USA.	Krista.Haines@duke.edu		Haines, Krista/0000-0002-2056-1820			Alban RF, 2010, AM SURGEON, V76, P1108; [Anonymous], 1999, JAMA, V282, P974; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P5, DOI 10.3233/NRE-2009-0449; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Berry C, 2010, J SURG RES, V163, P303, DOI 10.1016/j.jss.2010.03.018; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Bradbury R C, 2001, Health Serv Manage Res, V14, P203, DOI 10.1258/0951484011912708; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Cooper Z, 2012, J HEALTH CARE POOR U, V23, P857, DOI 10.1353/hpu.2012.0064; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Hawkins ML, 1996, J TRAUMA, V41, P257, DOI 10.1097/00005373-199608000-00010; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Hwabejire JO, 2013, JAMA SURG, V148, P956, DOI 10.1001/jamasurg.2013.2148; Kane WG, 2014, J HEAD TRAUMA REHAB, V29, pE10, DOI 10.1097/HTR.0000000000000028; Khaliq Amir A, 2003, J Health Hum Serv Adm, V25, P471; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; Masel BE, 2010, TRAUMATIC BRAIN INJU, DOI [10.1089/neu.2010.1358, DOI 10.1089/NEU.2010.1358]; McLafferty FS, 2016, NEUROREHABILITATION, V39, P423, DOI 10.3233/NRE-161373; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Missios S, 2016, INJURY, V47, P154, DOI 10.1016/j.injury.2015.06.037; Nirula R, 2009, J TRAUMA, V66, P255, DOI 10.1097/TA.0b013e31815ede46; Sacks GD, 2011, J TRAUMA, V71, P1011, DOI 10.1097/TA.0b013e3182092c27; Schiraldi M, 2015, J NEUROL SURG PART A, V76, P224, DOI 10.1055/s-0034-1543958; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Weygandt PL, 2012, J SURG RES, V177, P288, DOI 10.1016/j.jss.2012.07.003; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0	31	13	13	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAR	2019	235						131	140		10.1016/j.jss.2018.09.072			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	HI9LL	WOS:000456777000018	30691786				2022-02-06	
J	Hengst, JA; Duff, MC; Jones, TA				Hengst, Julie A.; Duff, Melissa C.; Jones, Theresa A.			Enriching Communicative Environments: Leveraging Advances in Neuroplasticity for Improving Outcomes in Neurogenic Communication Disorders	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article; Proceedings Paper	47th Clinical Aphasiology Conference (CAC)	2017	UT				GLOBAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; REPORTED SPEECH; DENDRITIC GROWTH; CORTICAL INJURY; VISUAL-CORTEX; VERBAL PLAY; ENRICHMENT; RATS; STROKE	Purpose: Research manipulating the complexity of housing environments for healthy and brain-damaged animals has offered strong, well-replicated evidence for the positive impacts in animal models of enriched environments on neuroplasticity and behavioral outcomes across the lifespan. This article reviews foundational work on environmental enrichment from the animal literature and considers how it relates to a line of research examining rich communicative environments among adults with aphasia, amnesia, and related cognitive-communication disorders. Method: Drawing on the authors' own research and the broader literature, this article first presents a critical review of environmental complexity from the animal literature. Building on that animal research, the second section begins by defining rich communicative environments for humans (highlighting the combined effects of complexity, voluntariness, and experiential quality). It then introduces key frameworks for analyzing and designing rich communicative environments: distributed communication and functional systems along with sociocultural theories of learning and development in humans that support them. The final section provides an overview of Hengst's and Duff's basic and translational research, which has been designed to exploit the insights of sociocultural theories and research on environmental complexity. In particular, this research has aimed to enrich communicative interactions in clinical settings, to trace specific communicative resources that characterize such interactions, and to marshal rich communicative environments for therapeutic goals for individuals with aphasia and amnesia. Conclusions: This article concludes by arguing that enriching and optimizing environments and experiences offers a very promising approach to rehabilitation efforts designed to enhance the reorganization of cognitive-communicative abilities after brain injury. Such interventions would require clinicians to use the principles outlined here to enrich communicative environments and to target distributed communication in functional systems (not the isolated language of individuals).	[Hengst, Julie A.] Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA; [Duff, Melissa C.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN USA; [Jones, Theresa A.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA		Hengst, JA (corresponding author), Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA.	hengst@illinois.edu	Jones, Theresa A/F-1182-2010	Jones, Theresa A/0000-0003-0906-6439	Mary Jane Neer Grant, College of Applied Life Science, University of Illinois (Hengst); National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01 DC011755]; Marion Morse Woods Fellowship, Graduate College, University of Illinois; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056839, R37NS056839] Funding Source: NIH RePORTER	We would like to acknowledge the many funding sources that have supported the research reported here, especially the Mary Jane Neer Grant, College of Applied Life Science, University of Illinois (Hengst); the National Institute on Deafness and Other Communication Disorders Grant R01 DC011755 (Duff); and the Marion Morse Woods Fellowship, Graduate College, University of Illinois (Devanga).	Agha A, 2007, STUD SOC CULT FOUND, V24, P1, DOI 10.2277/ 0521576857; Alwis DS, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00156; Bauer PM, 2009, BIOL PSYCHIAT, V66, P1100, DOI 10.1016/j.biopsych.2009.06.014; BEAULIEU C, 1987, J COMP NEUROL, V266, P478, DOI 10.1002/cne.902660404; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Briones TL, 2006, EXP NEUROL, V198, P530, DOI 10.1016/j.expneurol.2005.12.032; Brookshire R. H., 1995, AM J SPEECH-LANG PAT, V4, P74; Buchhold B, 2007, RESTOR NEUROL NEUROS, V25, P467; Burghardt G.M., 2014, ANIM BEHAV COGNITION, V1, P90, DOI [DOI 10.12966/ABC.05.01.2014, 10.12966/abc.05.01.2014]; Burghardt GM, 2011, OXFORD HDB DEV PLAY, P9; Butler EN, 2014, TOP STROKE REHABIL, V21, P246, DOI 10.1310/tsr2103-246; Chapey R., 2000, ASHA LEADER, V5, P4, DOI [10.1044/leader.FTR.05032000.4, DOI 10.1044/LEADER.FTR.05032000.4]; Churchill JD, 2002, NEUROBIOL AGING, V23, P941, DOI 10.1016/S0197-4580(02)00028-3; Clark H. H., 1992, ARENAS LANGUAGE USE, P107; Cole M., 1996, CULTURAL PSYCHOL ONC; Comery TA, 1996, NEUROBIOL LEARN MEM, V66, P93, DOI 10.1006/nlme.1996.0049; Corbett D, 2017, NEUROREHAB NEURAL RE, V31, P699, DOI 10.1177/1545968317724285; Covington N, 2016, J INTERACT RES COM D, V7, P79, DOI 10.1558/jircd.v7i1.29037; Crystal David., 1998, LANGUAGE PLAY; Csikszentmihalyi M., 1990, FLOW PSYCHOL OPTIMAL; Dahlqvist P, 2004, EUR J NEUROSCI, V19, P2288, DOI 10.1111/j.0953-816X.2004.03248.x; Davidson PSR, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00531; de Jong IC, 2000, PHYSIOL BEHAV, V68, P571, DOI 10.1016/S0031-9384(99)00212-7; del Rio P, 2007, CAMBRIDGE COMPANION TO VYGOTSKY, P276; Devanga S., 2017, THESIS; DIAMOND MC, 1964, J COMP NEUROL, V123, P111, DOI 10.1002/cne.901230110; Duff MC, 2006, NAT NEUROSCI, V9, P140, DOI 10.1038/nn1601; Duff MC, 2008, BRAIN LANG, V106, P41, DOI 10.1016/j.bandl.2007.10.004; Duff MC, 2007, APHASIOLOGY, V21, P702, DOI 10.1080/02687030701192265; Duff MC, 2015, J INTERACT RES COM D, V6, P97, DOI 10.1558/jircd.v6i1.97; Duff MC, 2013, J COMP NEUROL, V521, P4356, DOI 10.1002/cne.23433; Duff MC, 2012, SEMIN SPEECH LANG, V33, P44, DOI 10.1055/s-0031-1301162; Duff MC, 2011, PSYCHOL SCI, V22, P666, DOI 10.1177/0956797611404897; Duff MC, 2011, APHASIOLOGY, V25, P675, DOI 10.1080/02687038.2010.536841; Duff MC, 2009, APHASIOLOGY, V23, P926, DOI 10.1080/02687030802533748; Edwards Dorothy F, 2006, J Stroke Cerebrovasc Dis, V15, P151, DOI 10.1016/j.jstrokecerebrovasdis.2006.04.001; Federmeier KD, 2002, NEUROSCI LETT, V332, P180, DOI 10.1016/S0304-3940(02)00759-0; Finger S., 1982, BRAIN DAMAGE RECOVER; FLOETER MK, 1979, SCIENCE, V206, P227, DOI 10.1126/science.113873; Frasca Diana, 2013, Front Hum Neurosci, V7, P31, DOI 10.3389/fnhum.2013.00031; Freret T, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.028; FULLER JL, 1967, SCIENCE, V158, P1645, DOI 10.1126/science.158.3809.1645; Gordon RG, 2016, APHASIOLOGY, V30, P1461, DOI 10.1080/02687038.2015.1136050; GRABOWSKI M, 1995, EXP NEUROL, V133, P96, DOI 10.1006/exnr.1995.1011; GREEN EJ, 1983, BRAIN RES, V264, P233, DOI 10.1016/0006-8993(83)90821-1; Greenough W. T, 1976, NEURAL MECHANISMS LE, P255; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; GREENOUGH WT, 1986, BRAIN RES, V380, P136, DOI 10.1016/0006-8993(86)91437-X; Grippo AJ, 2014, PSYCHOSOM MED, V76, P277, DOI 10.1097/PSY.0000000000000052; Grossman AW, 2002, PROG BRAIN RES, V138, P91, DOI 10.1016/S0079-6123(02)38073-7; Gupta R, 2012, NEUROPSYCHOLOGIA, V50, P145, DOI 10.1016/j.neuropsychologia.2011.11.012; Gupta R, 2011, NEUROPSYCHOLOGY, V25, P137, DOI 10.1037/a0021123; Hanks W., 1996, LANGUAGE COMMUNICATI; Harley T., 2014, PSYCHOL LANGUAGE DAT; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hengst J., 2007, TOP LANG DISORD, V27, P36; Hengst JA, 2005, J SPEECH LANG HEAR R, V48, P137, DOI 10.1044/1092-4388(2005/011); Hengst JA, 2003, J SPEECH LANG HEAR R, V46, P831, DOI 10.1044/1092-4388(2003/065); Hengst JA, 2008, INT J LANG COMM DIS, V43, P58, DOI 10.1080/13682820701698093; Hengst JA, 2006, APHASIOLOGY, V20, P312, DOI 10.1080/02687030500475010; Hengst JA, 2015, J COMMUN DISORD, V57, P16, DOI 10.1016/j.jcomdis.2015.09.001; Hengst JA, 2010, EXPLORING SEMIOTIC REMEDIATION AS DISCOURSE PRACTICE, P107; Hengst JA, 2010, APHASIOLOGY, V24, P887, DOI 10.1080/02687030903478330; Hildebrand M, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/548682; Hollan J., 2000, ACM Transactions on Computer-Human Interaction, V7, P174, DOI 10.1145/353485.353487; Holzman L., 2017, VYGOTSKY WORK PLAY; Huizinga, 1950, HOMOLUDENS STUDY PLA; Hutchins E, 1995, COGNITION WILD; Hutchins E, 2008, PHILOS T R SOC B, V363, P2011, DOI 10.1098/rstb.2008.0003; Irvine JudithT., 1996, NATURAL HIST DISCOUR, P131; Janssen H, 2010, NEUROREHAB NEURAL RE, V24, P802, DOI 10.1177/1545968310372092; JOHANSSON BB, 2010, BRAIN REPAIR STROKE, P47; Jones TA, 1996, NEUROBIOL LEARN MEM, V65, P48, DOI 10.1006/nlme.1996.0005; Jones TA, 1998, MENT RETARD DEV D R, V4, P231, DOI 10.1002/(SICI)1098-2779(1998)4:3<231::AID-MRDD11>3.0.CO;2-W; Jones TA, 2017, NAT REV NEUROSCI, V18, P267, DOI 10.1038/nrn.2017.26; Jones TA, 2015, PHYSIOLOGY, V30, P358, DOI 10.1152/physiol.00014.2015; Kolb B, 1991, CEREB CORTEX, V1, P189, DOI 10.1093/cercor/1.2.189; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; KRAUSS RM, 1969, CHILD DEV, V40, P255, DOI 10.2307/1127172; LaDage LD, 2009, BEHAV NEUROSCI, V123, P284, DOI 10.1037/a0014817; Leahy MM, 2004, LANG SPEECH HEAR SER, V35, P70, DOI 10.1044/0161-1461(2004/008); Levin AR, 2014, J PEDIATR-US, V164, P123, DOI 10.1016/j.jpeds.2013.09.026; Livingston-Thomas J, 2016, NEUROTHERAPEUTICS, V13, P395, DOI 10.1007/s13311-016-0423-9; Luria A. R., 1979, MAKING MIND; Luria AR, 1928, PEDAGOG SEMIN J GEN, V35, P493; Luria AR, 1963, RESTORATION FUNCTION; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; Marshall R., 1993, AM J SPEECH-LANG PAT, V2, P31, DOI DOI 10.1044/1058-0360.0202.31; Mering S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00106; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Pellegrini A. D., 2011, OXFORD HDB DEV PLAY; Purves BA, 2011, APHASIOLOGY, V25, P688, DOI 10.1080/02687038.2010.536842; Radabaugh HL, 2017, EXP NEUROL, V294, P12, DOI 10.1016/j.expneurol.2017.04.013; Rieber R, 1999, COLLECTED WORKS LS V, P1; Risedal A, 2002, BRAIN RES BULL, V58, P315, DOI 10.1016/S0361-9230(02)00796-7; Robey RR, 2004, J COMMUN DISORD, V37, P401, DOI 10.1016/j.jcomdis.2004.04.003; Robey RR, 1998, APHASIOLOGY, V12, P787, DOI 10.1080/02687039808249573; Rogoff B., 2003, CULTURAL NATURE HUMA; ROSE FD, 1993, BEHAV BRAIN RES, V56, P93, DOI 10.1016/0166-4328(93)90025-L; ROSE FD, 1993, NEUROREPORT, V4, P163, DOI 10.1097/00001756-199302000-00012; ROSE FD, 1987, BEHAV BRAIN RES, V24, P195, DOI 10.1016/0166-4328(87)90057-X; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; ROSENZWEIG MR, 1972, J COMP PHYSIOL PSYCH, V80, P304, DOI 10.1037/h0032978; Salvanes AGV, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1331; Shune S, 2012, APHASIOLOGY, V26, P811, DOI 10.1080/02687038.2011.650626; Simmons-Mackie N, 1999, CONSTRUCTING (IN) COMPETENCE, P313; Simmons-Mackie N, 2011, INT J LANG COMM DIS, V46, P312, DOI 10.3109/13682822.2010.507616; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; SOLOMON P, 1961, SENSORY DEPRIVATION; Tannen D., 1989, TALKING VOICES REPET; TATE R, 2002, HDB MEMORY DISORDERS, P785; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Trueswell J.C., 2005, APPROACHES STUDYING; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; Vygotski LS, 1929, PEDAGOG SEMIN J GEN, V36, P415; Vygotsky L.S., 1987, COLLECTED WORKS LS V, V1; Vygotsky L. S., 1997, ED PSYCHOL; Wadowska M, 2015, NEUROPATH APPL NEURO, V41, P544, DOI 10.1111/nan.12146; Wertsch J.V., 1991, VOICES MIND SOCIOCUL; WEST RW, 1972, BEHAV BIOL, V7, P279, DOI 10.1016/S0091-6773(72)80207-4; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Yule George., 1997, REFERENTIAL COMMUNIC; Zhang B, 2017, ZOOL RES, V38, P7, DOI 10.13918/j.issn.2095-8137.2017.002	130	13	13	4	11	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAR	2019	28	1		S	SI		216	229		10.1044/2018_AJSLP-17-0157			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	HQ3UL	WOS:000462335900002	30453323	Green Published			2022-02-06	
J	Srikanth, M; Asmatulu, R; Cluff, K; Yao, L				Srikanth, Madhulika; Asmatulu, Ramazan; Cluff, Kim; Yao, Li			Material Characterization and Bioanalysis of Hybrid Scaffolds of Carbon Nanomaterial and Polymer Nanofibers	ACS OMEGA			English	Article							FIBRILLARY ACIDIC PROTEIN; TRAUMATIC BRAIN-INJURY; ELECTROSPUN NANOFIBERS; PCL MEMBRANE; ASTROCYTES; MIGRATION; NEUROGENESIS; PEPTIDE; GROWTH; GLIA	The interconnected porous structures that mimic the extracellular matrix support cell growth in tissue engineering. Nanofibers generated by electrospinning can act as a vehicle for therapeutic cell delivery to a neural lesion. The incorporation of carbon nanomaterials with excellent electrical conductivity in nanofibers is an attractive aspect for design of a nanodevice for neural tissue regeneration. In this study, nanoscaffolds were created by electrospinning poly(epsilon-caprolactone) (PCL) and three different types of carbon nanomaterials, which are carbon nanotubes, graphene, and fullerene. The component of carbon nanomaterials in nanofibers was confirmed by Fourier transform infrared spectroscopy. The fiber diameter was determined by scanning electron microscopy, and it was found that the diameter varied depending on the type of nanomaterial in the fibers. The incorporation of carbon nanotubes and graphene in the PCL fibers increased the contact angle significantly, while the incorporation of fullerene reduced the contact angle significantly. Incorporation of CNT, fullerene, and graphene in the PCL fibers increased dielectric constant. Astrocytes isolated from neonatal rats were cultured on PCL-nanomaterial nanofibers. The cell viability assay showed that the PCL-nanomaterial nanofibers were not toxic to the cultured astrocytes. The immunolabeling showed the growth and morphology of astrocytes on nanofiber scaffolds. SEM was performed to determine the cell attachment and interaction with the nanoscaffolds. This study indicates that PCL nanofibers containing nanomaterials are biocompatible and could be used for cell and drug delivery into the nervous system.	[Srikanth, Madhulika; Asmatulu, Ramazan] Wichita State Univ, Dept Mech Engn, 1845 Fairmt St, Wichita, KS 67260 USA; [Cluff, Kim] Wichita State Univ, Dept Biomed Engn, 1845 Fairmt St, Wichita, KS 67260 USA; [Yao, Li] Wichita State Univ, Dept Biol Sci, 1845 Fairmt St, Wichita, KS 67260 USA		Asmatulu, R (corresponding author), Wichita State Univ, Dept Mech Engn, 1845 Fairmt St, Wichita, KS 67260 USA.; Yao, L (corresponding author), Wichita State Univ, Dept Biol Sci, 1845 Fairmt St, Wichita, KS 67260 USA.	ramazan.asmatulu@wichita.edu; li.yao@wichita.edu			National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20 GM103418]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103418] Funding Source: NIH RePORTER	We acknowledge the National Institute of General Medical Sciences (P20 GM103418) of the National Institutes of Health for support of this study.	Al-Nasiry S, 2007, HUM REPROD, V22, P1304, DOI 10.1093/humrep/dem011; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Antczak C, 2007, J BIOMOL SCREEN, V12, P521, DOI 10.1177/1087057107300463; Azemi E, 2010, J NEUROSURG, V113, P673, DOI 10.3171/2010.1.JNS09313; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Basser Peter J., 2004, Journal of Integrative Neuroscience, V3, P227, DOI 10.1142/S0219635204000427; Berndt M, 2017, ACS BIOMATER SCI ENG, V3, P1313, DOI 10.1021/acsbiomaterials.6b00229; Cheng K, 2010, BIOTECHNOL PROGR, V26, P838, DOI 10.1002/btpr.391; Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; DeVivo M. J., 2016, J SPINAL CORD MED, V25, P335; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fu W, 2014, INT J NANOMED, V9, P2335, DOI 10.2147/IJN.S61375; Gartlon J, 2006, TOXICOL IN VITRO, V20, P1569, DOI 10.1016/j.tiv.2006.07.009; Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Hartman O, 2010, BIOMATERIALS, V31, P5700, DOI 10.1016/j.biomaterials.2010.03.017; Izquierdo R, 2008, J BIOMED MATER RES A, V85A, P25, DOI 10.1002/jbm.a.31396; Kabiri M, 2015, EXCLI J, V14, P851, DOI 10.17179/excli2015-282; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175; MCLENDON RE, 1994, BRAIN PATHOL, V4, P221, DOI 10.1111/j.1750-3639.1994.tb00837.x; MEAD C, 1990, P IEEE, V78, P1629, DOI 10.1109/5.58356; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Naebe M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04375; Park E. - S, 2013, PREPARATION CHARACTE; Saeedfar K, 2013, SENSORS-BASEL, V13, P16851, DOI 10.3390/s131216851; Saleh T. A., 2013, ROLE CARBON NANOTUBE; Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009; Seyedhassantehrani N, 2016, INTEGR BIOL-UK, V8, P624, DOI 10.1039/c6ib00003g; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Tan PS, 2007, MAT SCI ENG C-BIO S, V27, P304, DOI 10.1016/j.msec.2006.03.010; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Tiaw KS, 2005, BIOMATERIALS, V26, P763, DOI 10.1016/j.biomaterials.2004.03.010; Tsubo T, 2018, BIOPHYS PHYSICOBIOL, V15, P214, DOI 10.2142/biophysico.15.0_214; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Yao L, 2016, STEM CELL REV REP, V12, P365, DOI 10.1007/s12015-016-9654-8; Yao L, 2009, J BIOMED MATER RES B, V90B, P483, DOI 10.1002/jbm.b.31308; Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128; Zhao YH, 2017, J BIOMAT SCI-POLYM E, V28, P2171, DOI 10.1080/09205063.2017.1386835	43	13	13	0	15	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2470-1343			ACS OMEGA	ACS Omega	MAR	2019	4	3					5044	5051		10.1021/acsomega.9b00197			8	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	HR1UT	WOS:000462921900057	30949614	Green Published, gold			2022-02-06	
J	Brayton, S; Helstein, MT; Ramsey, M; Rickards, N				Brayton, Sean; Helstein, Michelle T.; Ramsey, Mike; Rickards, Nicholas			Exploring the Missing Link Between the Concussion "Crisis" and Labor Politics in Professional Sports	COMMUNICATION & SPORT			English	Article						concussions; labor; National Hockey League; National Football League; brain injury	INJURY	This study focuses on connections between labor struggles in professional sports and the epidemic of concussions among athletes, specifically in the National Football League (NFL) and National Hockey League (NHL). Using a critical discourse analysis (CDA), we explain how popular media presents concussions in ways that are informative but often avoid a more politicized discussion of the athlete as a manual worker whose body succumbs to use and abuse of sport. We found two recurring themes in the North American popular press, including a tendency to (1) rely on a trope of "millionaires-versus-billionaires" to explain (and minimize) recent labor lockouts in the NFL and NHL and (2) shift focus on league deniability to athletes' self-responsibility in the concussion "crisis." Despite the urgency in which sports concussions and brain injuries have been reported in recent years, the two narratives work to discourage readers from recognizing how such health issues arise under specific relations of production, and that an athlete is a particular type of worker whose body is subjected to decline and disposability like so many other bodies under late capitalism. As we argue, working conditions are inseparable from concussions in professional sports, a phenomenon that requires further development within the popular press.	[Brayton, Sean; Helstein, Michelle T.; Ramsey, Mike; Rickards, Nicholas] Univ Lethbridge, Dept Kinesiol & Phys Educ, 4401 Univ Dr W, Lethbridge, AB T1K 3M4, Canada		Brayton, S (corresponding author), Univ Lethbridge, Dept Kinesiol & Phys Educ, 4401 Univ Dr W, Lethbridge, AB T1K 3M4, Canada.	sean.brayton@uleth.ca			University of Lethbridge Research Fund	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was made possible by the University of Lethbridge Research Fund.	[Anonymous], 2012, STAR; [Anonymous], 2012, CBC SPORTS      1030; [Anonymous], 2016, GUARDIAN; Bairner A, 2007, SOCIOL SPORT J, V24, P20, DOI 10.1123/ssj.24.1.20; Barzilai Peter, 2014, US TODAY; Battista J., 2012, NY TIMES; BEAMISH R, 2002, THEORY SPORT SOC, P25; Belson K, 2016, NY TIMES; Benson P, 2017, J SPORT SOC ISSUES, V41, P307, DOI 10.1177/0193723517707699; Branch J, 2016, NY TIMES; Brohm J-M., 1978, SPORT PRISON MEASURE; Brooks L., 2015, NEW YORK POST; Chouliaraki Lilie, 1999, DISCOURSE LATE MODER; Clayton J., 2012, ESPN; Collins T., 2013, SPORT CAPITALIST SOC; Davis M., 2015, NATL POST; Demovsky R., 2015, ESPN; Dyer-Witheford N., 2001, RETHINKING MARXISM, V13, P70, DOI DOI 10.1080/089356901101242009; Dyer-Witheford Nick, 1999, CYBER MARX CYCLES CI; Edwards Harry, 1969, REVOLT BLACK ATHLETE; Fainaru S., 2013, LEAGUE DENIAL NFL CO; Fainaru S., 2015, ESPN; Fairclough Norman., 2003, NALYSING DISCOURSE T; Fairclough Norman, 1995, MEDIA DISCOURSE; Ferguson D., 2015, SPORT ILLUSTRAT 1229; Florio M., 2011, NBC SPORTS      0303; Gasper C., 2015, BOSTON GLOBE; George KB, 2017, ROUTL RES SPORT CULT, P254; Gibney A., 2011, LAST GLADIATOR MOTIO; GIULIANOTTI R, 2005, SPORT CRITICAL SOCIO; Goldberg DS, 2013, J LEGAL MED, V34, P157, DOI 10.1080/01947648.2013.800792; Goss N., 2012, NHL LOCKOUT BEST QUO; Gruneau Richard, 1983, CLASS SPORTS SOCIAL; Gustashaw M., 2016, GQ; Hall S., 1997, REPRESENTATION CULTU; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Hoch P., 1972, RIP OFF THE BIG GAME; Jackson N., 2014, I LET GO MY NFL CARE; Keating P., 2012, ESPN; Kelly C., 2016, GLOBE MAIL; King C. R, 2011, COMMODIFIED CRIMINAL; King S, 2014, J SPORT SOC ISSUES, V38, P184, DOI 10.1177/0193723513515890; Larkin M., 2016, THE HOCKEY NEWS 0210; Laws W., 2015, SPORTS ILLUSTRATED; Linker B., 2014, HUFFINGTON POST; Lipsyte R., 2011, NATION; Litke J., 2011, CBS SPORTS      0214; McDonald I., 2009, MARXISM CULTURAL STU, P32; McDonald I., 2009, MARXISM CULTURAL STU, P88; MCNALLY D, 2001, BODIES MEANING STUDI; Moore J., 2016, GQ; Morgan W. J., 1994, LEFTIST THEORIES SPO; Myers G., 2011, NEW YORK DAILY NEWS; Nadkarni R., 2016, GQ; O'Halloran K., 2003, CRITICAL DISCOURSE A; Petchesky B., 2016, DEADSPIN        0329; Pinchevsky T., 2015, ESPN; Porteau A., 2013, THE HOCKEY NEWS 0228; Prisco P., 2013, CBS SPORTS      0829; RHODEN WC, 2006, 40 MILLION DOLLAR SL; RIGAUER B., 1981, SPORT WORK; Robeson R, 2014, J LAW MED ETHICS, V42, P334, DOI 10.1111/jlme.12150; Schiavone Michael, 2015, SPORTS LABOR US; Schwarz A, 2009, NY TIMES, pA1; SCOTT J, 1971, ATHLETIC REVOLUTION; Shulman G., 2013, HUFFINGTON POST; Skretta D., 2011, SAN DIEGO UNION TRIB; Spies-Gans Juliet., 2016, HUFFINGTON POST; Standing G., 2014, PRECARIAT NEW DANGER; Swados H., 1957, ON THE LINE; Turner R., 2012, WINNIPEG FREE PRESS; Willis J., 2012, EDMONTON J; Zirin D., 2015, NATION; Zirin David, 2013, NATION; [No title captured]	75	13	13	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-4795	2167-4809		COMMUN SPORT	Commun. Sport	FEB	2019	7	1					110	131		10.1177/2167479517740342			22	Communication; Hospitality, Leisure, Sport & Tourism	Social Science Citation Index (SSCI)	Communication; Social Sciences - Other Topics	HH6HQ	WOS:000455831100006		Bronze			2022-02-06	
J	Hardin, KY; Kelly, JP				Hardin, Kathryn Y.; Kelly, James P.			The Role of Speech-Language Pathology in an Interdisciplinary Care Model for Persistent Symptomatology of Mild Traumatic Brain Injury	SEMINARS IN SPEECH AND LANGUAGE			English	Article						speech pathology; speech therapy; concussion; mild traumatic brain injury; interdisciplinary	QUALITY-OF-LIFE; COMMUNICATION ABILITIES; POSTCONCUSSION SYNDROME; COLLEGE-STUDENTS; CONCUSSION; VETERANS; REHABILITATION; MANAGEMENT; COMPLAINTS; ADULTS	The Marcus Institute for Brain Health (MIBH) provides interdisciplinary care for adults struggling with persistent effects of mild traumatic brain injury and accompanying changes in behavioral health, with specific emphases on Veterans and retired elite athletes. The cognitive, physical, and behavioral symptoms associated with mild traumatic brain injury are interrelated, with neurobiopsychosocial modeling encompassing the factors related to recovery from a traumatic brain injury. The diffuse impacts of chronic concussive injuries require multiple clinical providers to address the breadth of symptoms, facilitating both interdisciplinary and transdisciplinary care models. By implementing integrated practice units, patients receive advanced medical care, imaging, speech-language pathology, physical therapy, behavioral health, neuropsychology, and clinical pharmacy for a cohesive diagnostic and intervention plan. Nationally, speech-language pathologists report challenges with best-practice options for concussion, particularly in the domain of assessment practices. At the MIBH, speech-language pathologists begin their assessment with a structured clinical interview that focuses on patients' needs and concerns. Evaluation modalities focus on hearing, communication, and functional cognition to guide therapeutic treatment planning. The intensive outpatient care program at MIBH incorporates both individual sessions targeting patient-centered goals and group care, where speech-language pathologists work transdisciplinarily to generalize care from all disciplines out into the community. Care practices for concussive injuries continue to evolve rapidly; speech-language pathology at the MIBH offers one such vision for excellence in clinical care.	[Hardin, Kathryn Y.; Kelly, James P.] Univ Colorado Anschutz Med Campus, Marcus Inst Brain Hlth, Aurora, CO USA; [Hardin, Kathryn Y.] Univ Colorado, Sch Med Aurora, Dept Phys Med & Rehabil, Aurora, CO USA; [Hardin, Kathryn Y.] Univ Colorado, Dept Speech Language & Hearing Sci, Boulder, CO USA; [Hardin, Kathryn Y.; Kelly, James P.] Univ Colorado, Grad Sch, Colorado Clin Translat Sci Inst, Clin Sci Grad Program, Aurora, CO USA; [Kelly, James P.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA		Hardin, KY (corresponding author), 12348 E Montview Blvd,Mail Stop C263, Aurora, CO 80045 USA.	Kathryn.Hardin@ucdenver.edu	Hardin, Kathryn/AAO-1700-2020	Hardin, Kathryn/0000-0001-9799-0220			American Speech-Language-Hearing Association, 2003, TECHNICAL REPORT; Atcherson S R, 2016, BRAIN DISORD THER, V5, P1; Barrow IM, 2003, J TRAUMA, V54, P888, DOI 10.1097/01.TA.0000057150.60668.7C; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Bellerose J, 2017, NEUROPSYCHOLOGY, V31, P229, DOI 10.1037/neu0000341; Benton A., 1976, MULTILINGUAL APHASIA; Biauska A, 2017, BRAIN BEHAV, V7; Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Callahan ML, 2018, APPL NEUROPSYCH-ADUL, V25, P126, DOI 10.1080/23279095.2016.1261867; Cherney LR, 2010, J HEAD TRAUMA REHAB, V25, P219, DOI 10.1097/HTR.0b013e3181dc82c1; Childers C, 2016, J POSTSECOND EDUC DI, V29, P389; Choi BCK, 2006, CLIN INVEST MED, V29, P351; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Conners C. K., 2015, CONNERS CONTINUOUS P; Cornis-Pop M, 2012, J REHABIL RES DEV, V49, pXI, DOI 10.1682/JRRD.2012.03.0048; D'Hondt F, 2017, COGN AFFECT BEHAV NE, V17, P124, DOI 10.3758/s13415-016-0467-7; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dinnes C, 2017, COMMUN DISORD Q, V39, P1; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Duff MC, 2015, BRAIN INJURY, V29, P64, DOI 10.3109/02699052.2014.965747; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Etymotic Research, 2001, QUICKSIN SPEECH NOIS; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Gallun FJ, 2017, BRAIN INJURY, V31, P1183, DOI 10.1080/02699052.2016.1274781; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Haskins A C, 2012, COGNITIVE REHABILITA; Hoover EC, 2017, J AM ACAD AUDIOL, V28, P325, DOI 10.3766/jaaa.16051; Hunt Cindy, 2016, Concussion, V1, pCNC21, DOI 10.2217/cnc-2016-0009; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Isaki E, 2000, BRAIN INJURY, V14, P441; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kennedy MRT, 2011, J HEAD TRAUMA REHAB, V26, P212, DOI 10.1097/HTR.0b013e318218dd0e; Ketcham C J, 2017, CUR RES CONCUSSION, V4, pe8; King KA, 2006, APHASIOLOGY, V20, P233, DOI 10.1080/02687030500473155; Krug H., 2015, SIG 2 PERSPECTIVES N, V25, P17, DOI [10.1044/nnsld25.1.17., DOI 10.1044/NNSLD25.1.17, 10.1044/nnsld25.1.17]; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; MacDonald S., 1998, FUNCTIONAL ASSESSMEN; Mah K, 2018, DISABIL REHABIL, V40, P960, DOI 10.1080/09638288.2016.1277402; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Miller W. R., 2013, MOTIVATIONAL INTERVI, V3; Nelson LD, 2018, J NEUROTRAUM, V35, P249, DOI 10.1089/neu.2017.4988; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Parrish C., 2009, SIG 2 PERSPECTIVES N, V19, P47, DOI [DOI 10.1044/NNS1D19.2.47, 10.1044/nnsld19.2.47, DOI 10.1044/NNSLD19.2.47]; Porter ME, 2013, HARVARD BUS REV, V91, P1; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Riedeman S, 2018, AM J SPEECH-LANG PAT, V27, P181, DOI 10.1044/2017_AJSLP-17-0011; Ryan NP, 2018, PSYCHOL MED, V48, P679, DOI 10.1017/S0033291717002057; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Schneider E., 2018, PERSPECTIVES ASHA SP, V3, P31, DOI [10.1044/persp3.sig2.31, DOI 10.1044/PERSP3.SIG2.31]; Schrank F. A., 2014, WOODCOCK JOHNSON 4 R; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Snell DL, 2017, DISABIL REHABIL, V39, P1968, DOI 10.1080/09638288.2016.1213895; Sohlberg MM, 2014, AM J SPEECH-LANG PAT, V23, P160, DOI 10.1044/2013_AJSLP-12-0005; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stergiou-Kita M, 2016, ARCH PHYS MED REHAB, V97, pS40, DOI 10.1016/j.apmr.2015.04.008; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; Vander Werff Kathy R., 2016, Seminars in Hearing, V37, P216, DOI 10.1055/s-0036-1584409; Vargo MM, 2016, PM&R, V8, P241, DOI 10.1016/j.pmrj.2015.07.006; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba; Working Group to Develop a Clinician's Guide to Cognitive Rehabilitation in mTBI, 2016, APPL MIL SERV MEMB V; Wylie Glenn R, 2017, Concussion, V2, pCNC50, DOI 10.2217/cnc-2017-0003	71	13	14	0	18	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0734-0478	1098-9056		SEMIN SPEECH LANG	Semin. Speech Lang.	FEB	2019	40	1					65	77		10.1055/s-0038-1676452			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	HG5OT	WOS:000455027900008	30616296				2022-02-06	
J	Immonen, R; Smith, G; Brady, RD; Wright, D; Johnston, L; Harris, NG; Manninen, E; Salo, R; Branch, C; Duncan, D; Cabeen, R; Ndode-Ekane, XE; Gomez, CS; Casillas-Espinosa, PM; Ali, I; Shultz, SR; Andrade, P; Puhakka, N; Staba, RJ; O'Brien, TJ; Toga, AW; Pitkanen, A; Grohn, O				Immonen, Riikka; Smith, Gregory; Brady, Rhys D.; Wright, David; Johnston, Leigh; Harris, Neil G.; Manninen, Eppu; Salo, Raimo; Branch, Craig; Duncan, Dominique; Cabeen, Ryan; Ndode-Ekane, Xavier Ekolle; Gomez, Cesar Santana; Casillas-Espinosa, Pablo M.; Ali, Idrish; Shultz, Sandy R.; Andrade, Pedro; Puhakka, Noora; Staba, Richard J.; O'Brien, Terence J.; Toga, Arthur W.; Pitkanen, Asla; Grohn, Olli			Harmonization of pipeline for preclinical multicenter MRI biomarker discovery in a rat model of post-traumatic epileptogenesis	EPILEPSY RESEARCH			English	Article						Common data element; Diffusion tensor imaging; Magnetization transfer imaging; Multi-site harmonization; Post-traumatic epilepsy; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; IMAGING METRICS; EPILEPSY; MATTER; WHITE	Preclinical imaging studies of posttraumatic epileptogenesis (PTE) have largely been proof-of-concept studies with limited animal numbers, and thus lack the statistical power for biomarker discovery. Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) is a pioneering multicenter trial investigating preclinical imaging biomarkers of PTE. EpiBios4Rx faced the issue of harmonizing the magnetic resonance imaging (MRI) procedures and imaging data metrics prior to its execution. We present here the harmonization process between three preclinical MRI facilities at the University of Eastern Finland (UEF), the University of Melbourne (Melbourne), and the University of California, Los Angeles (UCLA), and evaluate the uniformity of the obtained MRI data. Adtilt, male rats underwent a lateral fluid percussion injury (FPI) and were followed by MRI 2 days, 9 days, 1 month, and 5 months post-injury. Ex vivo scans of fixed brains were conducted 7 months post-injury as an end point follow-up. Four MRI modalities were used: T2-weighted imaging, multi-gradient-echo imaging, diffusion weighted imaging, and magnetization transfer imaging, and acquisition parameters for each modality were tailored to account for the different field strengths (4.7 T and 7 T) and different MR hardwares used at the three participating centers. Pilot data collection resulted in comparable image quality across sites. In interim analysis (of data obtained by April 30, 2018), the within-site variation of the quantified signal properties was low, while some differences between sites remained. In T2-weighted images the signal-to-noise ratios were high at each site, being 35 at UEF, 48 at Melbourne, and 32 at UCLA (p < 0.05). The contrast-to-noise ratios were similar between the sites (9, 10, and 8, respectively). Magnetization transfer ratio maps had identical white matter/gray matter contrast between the sites, with white matter showing 15% higher MTR than gray matter despite different absolute MTR values (MTR both in white and gray matter was 3% lower in Melbourne than at UEF, p < 0.05). Diffusion-weighting yielded different degrees of signal attenuation across sites, being 83% at UEF, 76% in Melbourne, and 80% at UCLA (p < 0.05). Fractional anisotropy values differed as well, being 0.81 at UEF, 0.73 in Melbourne, and 0.84 at UCLA (p < 0.05). The obtained values in sham animals showed low variation within each site and no change over time, suggesting high repeatability of the measurements. Quality control scans with phantoms demonstrated stable hardware performance over time. Timing of post-TBI scans was designed to target specific phases of the dynamic pathology, and the execution at different centers was highly accurate. Besides a few outliers, the 2-day scans were done within an hour from the target time point. At day 9, most animals were scanned within an hour from the target time point, and all but 2 outliers within 24 h from the target. The 1-month post-TBI scans were done within 31 3 days. MRI procedures and animal physiology during scans were similar between the sites. Taken together, the 10% inter-site difference in FA and 3% difference in MTR values should be included into analysis as a covariate or balanced out in post-processing in order to detect disease-related effects on brain structure at the same scale. However, for a MRI biomarker for post-traumatic epileptogenesis to have realistic chance of being successfully translated to validation in clinical trials, it would need to be a robust TBI-induced structural change which tolerates the inter-site methodological variability described here.	[Immonen, Riikka; Manninen, Eppu; Salo, Raimo; Ndode-Ekane, Xavier Ekolle; Andrade, Pedro; Puhakka, Noora; Pitkanen, Asla; Grohn, Olli] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FIN-70211 Kuopio, Finland; [Smith, Gregory; Harris, Neil G.; Gomez, Cesar Santana; Staba, Richard J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Brady, Rhys D.; Wright, David; Casillas-Espinosa, Pablo M.; Ali, Idrish; Shultz, Sandy R.; O'Brien, Terence J.] Monash Univ, Alfred Hlth, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Brady, Rhys D.; Wright, David; Casillas-Espinosa, Pablo M.; Ali, Idrish; Shultz, Sandy R.; O'Brien, Terence J.] Monash Univ, Alfred Hlth, Cent Clin Sch, Dept Neurol, Melbourne, Vic, Australia; [Johnston, Leigh] Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Branch, Craig] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Duncan, Dominique; Cabeen, Ryan; Toga, Arthur W.] Univ Southern Calif, Keck Sch Med USC, USC Stevens Neuroimaging & Informat Inst, Los Angeles, CA 90033 USA; [Brady, Rhys D.; Casillas-Espinosa, Pablo M.; Ali, Idrish; Shultz, Sandy R.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Brady, Rhys D.; Casillas-Espinosa, Pablo M.; Ali, Idrish; Shultz, Sandy R.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia		Immonen, R (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FIN-70211 Kuopio, Finland.	riikka.immonen@uef.fi	Staba, Richard/AAN-3149-2021; Ali, Idrish/P-4989-2018; O'Brien, Terence/AAU-5525-2021; Duncan, Dominique/AAP-9734-2020; Santana-Gomez, Cesar/AAY-1014-2021; Andrade, Pedro/N-8410-2018; Johnston, Leigh A/D-7102-2014; O'Brien, Terence/L-8102-2013	Ali, Idrish/0000-0002-0971-4654; Santana-Gomez, Cesar/0000-0001-9163-5615; Andrade, Pedro/0000-0001-9118-8341; Johnston, Leigh A/0000-0002-5032-4674; Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632; Salo, Raimo/0000-0003-3610-236X; Manninen, Eppu/0000-0002-9353-6079; O'Brien, Terence/0000-0002-7198-8621; Duncan, Dominique/0000-0002-6154-9262	National Institute of Neurological Disorders and Stroke (NINDS) Center without Walls of the National Institutes of Health (NIH) [U54NS100064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD087101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS100064] Funding Source: NIH RePORTER	This research was supported by the National Institute of Neurological Disorders and Stroke (NINDS) Center without Walls of the National Institutes of Health (NIH) under Award Number U54NS100064 (EpiBioS4Rx).	Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Bertoglio D, 2017, NEUROSCIENCE, V358, P277, DOI 10.1016/j.neuroscience.2017.06.062; Cabeen R.P., 2018, P INT SOC MAGN RES M; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Dinov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013070; Engel J, 2013, EPILEPSIA, V54, P61, DOI 10.1111/epi.12299; Eroglua O, 2017, INJURY, V48, P2675, DOI 10.1016/j.injury.2017.09.032; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Heidelbaugh Joel J, 2016, FP Essent, V451, P25; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Immonen R, 2013, J NEUROTRAUM, V30, P1305, DOI 10.1089/neu.2012.2815; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Mirzaalian H, 2018, BRAIN IMAGING BEHAV, V12, P284, DOI 10.1007/s11682-016-9670-y; Molaie AM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00176; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Phillips KF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00438; Pitkanen A, 2019, NEUROBIOL DIS, V123, P42, DOI 10.1016/j.nbd.2018.05.007; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Toth P, 2016, AM J PHYSIOL-HEART C, V311, pH1118, DOI 10.1152/ajpheart.00267.2016; van Vliet EA, 2018, NEUROPATH APPL NEURO, V44, P91, DOI 10.1111/nan.12444; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	27	13	13	1	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	FEB	2019	150						46	57		10.1016/j.eplepsyres.2019.01.001			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HP1CY	WOS:000461404200007	30641351	Green Accepted			2022-02-06	
J	Murray, NG; Szekely, B; Moran, R; Ryan, G; Powell, D; Munkasy, B; Buckley, TA; Guskiewicz, K				Murray, N. G.; Szekely, B.; Moran, R.; Ryan, G.; Powell, D.; Munkasy, Ba; Buckley, T. A.; Guskiewicz, K.			Concussion history associated with increased postural control deficits after subsequent injury	PHYSIOLOGICAL MEASUREMENT			English	Article						posture; mTBI; balance; center of pressure	TRAUMATIC BRAIN-INJURY; RECURRENT CONCUSSION; FOOTBALL PLAYERS; BALANCE; STABILITY; RECOVERY; ADULTS; RISK; PERFORMANCE; COMPLEXITY	Objective: Postural control deficits have been extensively reported following sport-related concussions. Concussed athletes demonstrate these deficits as early as 24 h post-concussion and may persist for up to six months. Many of these prior studies have included mixed samples with prior injury history that may affect the postural control data. The purpose of this investigation was to evaluate the effect of concussion history on postural control 24-48 h following sport-related concussion in Division I athletes. Approach: Twenty-eight Division I athletes (seven athlete controls (CON), seven no history (SRC0), seven with a previous concussion (SRC1), and seven with 2-3 concussions (SRC3) participated in this study. All participants were assessed within 24-48 h postsubsequent SRC and performed three trials of quiet stance in the eyes closed (EC) conditions for 30 s each on a force platform (1000 Hz). The data were analyzed with root mean square (RMS) and mean excursion velocity (MEV) in the anteroposterior (AP) and mediolateral (ML) directions. Two 3 x 2 MANOVAs were run by direction for group comparisons. Main results: SRC2 had significantly greater RMS than CON, SRC0, and SRC1 in the AP direction and ML direction. SRC2 exhibited significantly greater AP and ML MEV than CON, SRC0, and SRC1. Significance: These results demonstrate that having 2-3 prior concussions negatively affects the postural system after a subsequent head injury. Sports medicine staff should approach the recovery process with caution with those that have a prior history of concussion, due to the negative effects that history of concussion has on postural control strategies.	[Murray, N. G.] Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA; [Szekely, B.; Ryan, G.; Munkasy, Ba] Georgia Southern Univ, Waters Coll Hlth Profess, Dept Hlth Sci & Kinesiol, Statesboro, GA USA; [Moran, R.] Univ Alabama, Dept Hlth Sci, Coll Human Environm Sci, Tuscaloosa, AL USA; [Powell, D.] Univ Memphis, Sch Hlth Studies, Memphis, TN 38152 USA; [Buckley, T. A.] Univ Delaware, Coll Hlth Sci, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Guskiewicz, K.] Univ N Carolina, Coll Arts & Sci, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA		Murray, NG (corresponding author), Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA.	nicholasmurray@unr.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Szekely, Brian/0000-0001-9502-0984; Murray, Nicholas/0000-0003-3288-2995			Alonso AC, 2012, CLINICS, V67, P1433, DOI 10.6061/clinics/2012(12)14; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; [Anonymous], 1995, GAIT POSTURE; Baloh RW, 1998, ARCH NEUROL-CHICAGO, V55, P649, DOI 10.1001/archneur.55.5.649; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Busa MA, 2016, J SPORT HEALTH SCI, V5, P44, DOI 10.1016/j.jshs.2016.01.018; Creath R, 2005, NEUROSCI LETT, V377, P75, DOI 10.1016/j.neulet.2004.11.071; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; Degani AM, 2017, BRAIN INJURY, V31, P49, DOI 10.1080/02699052.2016.1225982; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Gao JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016749; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; HOLM S, 1979, SCAND J STAT, V6, P65; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Kanekar N, 2014, EXP BRAIN RES, V232, P1127, DOI 10.1007/s00221-014-3822-3; Kim J, 2012, INT J PRECIS ENG MAN, V13, P963, DOI 10.1007/s12541-012-0125-0; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lipsitz LA, 2002, J GERONTOL A-BIOL, V57, pB115, DOI 10.1093/gerona/57.3.B115; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; McCall AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00112; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McPherson A. L., 2018, AM J SPORTS MED; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Murray NG, 2018, INT J PSYCHOPHYSIOL, V132, P81, DOI 10.1016/j.ijpsycho.2017.09.018; Paillard T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/891390; Palmieri RM, 2002, J SPORT REHABIL, V11, P51, DOI 10.1123/jsr.11.1.51; Porter S, 2015, GAIT POSTURE, V41, P666, DOI 10.1016/j.gaitpost.2015.01.021; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Purves D, 2014, NEUROSCIENCE, P371; Reed-Jones RJ, 2014, SEMIN SPEECH LANG, V35, P186, DOI 10.1055/s-0034-1384680; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Schlenstedt C, 2016, PARKINSONISM RELAT D, V24, P107, DOI 10.1016/j.parkreldis.2015.12.011; Schmidt JD, 2018, J ATHL TRAINING, V53, P109, DOI 10.4085/1062-6050-326-16; Schmit JM, 2006, EXP BRAIN RES, V168, P357, DOI 10.1007/s00221-005-0094-y; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Takakusaki K, 2017, J MOV DISORD, V10, P1, DOI 10.14802/jmd.16062; Teel EF, 2017, J ATHL TRAINING, V52, P288, DOI 10.4085/1062-6050-52.1.12; Vieira TMM, 2009, BRAZ J MED BIOL RES, V42, P665, DOI 10.1590/S0100-879X2009000700012; Williams DSB, 2016, J SPORT HEALTH SCI, V5, P70, DOI 10.1016/j.jshs.2016.01.010; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	58	13	13	0	6	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	FEB	2019	40	2							024001	10.1088/1361-6579/aafcd8			9	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biophysics; Engineering; Physiology	HM2VI	WOS:000459328500001	30625441				2022-02-06	
J	Chen, XJ; Taylor-Nguyen, NN; Riley, AM; Herring, BP; White, FA; Obukhov, AG				Chen, Xingjuan; Taylor-Nguyen, Natalie N.; Riley, Ashley M.; Herring, B. Paul; White, Fletcher A.; Obukhov, Alexander G.			The TRPC6 inhibitor, larixyl acetate, is effective in protecting against traumatic brain injury-induced systemic endothelial dysfunction	JOURNAL OF NEUROINFLAMMATION			English	Article						Traumatic brain injury; TRPC channels; Endothelial dysfunction; Aorta; Mice	UNITED-STATES; EPIDEMIOLOGY; ACTIVATION; RISK; PERMEABILITY; EXPRESSION; VASOSPASM; CHANNELS; CA2+	BackgroundThe incidence of traumatic brain injuries (TBIs) is on the rise in the USA. Concussions, or mild TBIs without skull fracture, account for about 75% of all TBIs. Mild TBIs (mTBIs) lead to memory and cognitive deficits, headaches, intraocular pressure rises, axonal degeneration, neuroinflammation, and an array of cerebrovascular dysfunctions, including increased vascular permeability and decreased cerebral blood flow. It has been recently reported that besides vascular dysfunction in the cerebral circulation, mTBI may also cause a significant impairment of endothelial function in the systemic circulation, at least within mesenteric microvessels. In this study, we investigated whether mTBI affects endothelial function in aortas and determined the contribution of transient receptor potential canonical (TRPC) channels to modulating mTBI-associated endothelial dysfunction.MethodsWe used a model of closed-head mTBI in C57BL/6, 129S, 129S-C57BL/6-F2 mice, and 129S-TRPC1 and 129S-C57BL/6-TRPC6 knockout mice to determine the effect of mTBI on endothelial function in mouse aortas employing ex vivo isometric tension measurements. Aortic tissue was also analyzed using immunofluorescence and qRT-PCR for TRPC6 expression following mTBI.ResultsWe show that in various strains of mice, mTBI induces a pronounced and long-lasting endothelial dysfunction in the aorta. Ablation of TRPC6 protects mice from mTBI-associated aortic endothelial dysfunction, while TRPC1 ablation does not impact brain injury-induced endothelial impairment in the aorta. Consistent with a role of TRPC6 activation following mTBI, we observed improved endothelial function in wild type control mice subjected to mTBI following 7-day in vivo treatment with larixyl acetate, an inhibitor of TRPC6 channels. Conversely, in vitro treatment with the pro-inflammatory endotoxin lipopolysaccharide, which activates endothelial TRPC6 in a Toll-like receptor type 4 (TLR4)-dependent manner, worsened aortic endothelial dysfunction in wild type mice. Lipopolysaccharide treatment in vitro failed to elicit endothelial dysfunction in TRPC6 knockout mice. No change in endothelial TRPC6 expression was observed 7days following TBI.ConclusionsThese data suggest that TRPC6 activation may be critical for inducing endothelial dysfunction following closed-head mTBI and that pharmacological inhibition of the channel may be a feasible therapeutic strategy for preventing mTBI-associated systemic endothelial dysfunction.	[Chen, Xingjuan; Riley, Ashley M.; Herring, B. Paul; Obukhov, Alexander G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Taylor-Nguyen, Natalie N.; White, Fletcher A.] Indiana Univ Sch Med, Dept Anesthesia, Indianapolis, IN 46202 USA; [Taylor-Nguyen, Natalie N.; White, Fletcher A.; Obukhov, Alexander G.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA		Obukhov, AG (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA.; White, FA (corresponding author), Indiana Univ Sch Med, Dept Anesthesia, Indianapolis, IN 46202 USA.	chen361@iupui.edu; fawhite@iu.edu; aobukhov@iu.edu	chen, xingjuan/V-4064-2019; Obukhov, Alexander G./C-7246-2008; White, Fletcher/F-3203-2015	chen, xingjuan/0000-0002-7380-8399; Obukhov, Alexander G./0000-0002-3862-6004; White, Fletcher/0000-0002-8408-9262	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HL115140]; Indiana State Department of Health Trauma and Injury Prevention: the Indiana Spinal Cord and Brain Injury Research Fund; St. Vincent Research Foundation; Indiana Clinical and Translational Sciences Institute's "The Concepts to Clinic Project Development Team funding-ICReATE Program" - NIH-National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [UL1TR001108]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL115140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS102415] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002209] Funding Source: NIH RePORTER	This study was supported by the grants from the NIH to A.G.O. (R01 HL115140), the Indiana State Department of Health Trauma and Injury Prevention: the Indiana Spinal Cord and Brain Injury Research Fund (A.G.O. and F.A.W.), the St. Vincent Research Foundation (F.A.W.), and the Indiana Clinical and Translational Sciences Institute's "The Concepts to Clinic Project Development Team funding-ICReATE Program" funded by the NIH-National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award (# UL1TR001108).	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Ahmadi N, 2015, BRAIN INJURY, V29, P1635, DOI 10.3109/02699052.2015.1075149; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Chakraborty S, 2011, J PHARMACOL EXP THER, V339, P329, DOI 10.1124/jpet.111.183673; Chen XJ, 2017, J BIOL CHEM, V292, P898, DOI 10.1074/jbc.M116.755470; Chen XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148569; Chen XJ, 2014, CELLS-BASEL, V3, P247, DOI 10.3390/cells3020247; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dzik JM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00544; Gaddam Samson Sujit Kumar, 2015, Handb Clin Neurol, V127, P205, DOI 10.1016/B978-0-444-52892-6.00014-3; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; Hald ES, 2014, TRANSL STROKE RES, V5, P385, DOI 10.1007/s12975-013-0300-3; Hiett SC, 2014, CARDIOVASC RES, V103, P607, DOI 10.1093/cvr/cvu152; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kong FW, 2015, CELL PHYSIOL BIOCHEM, V36, P1928, DOI 10.1159/000430161; Li WN, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0643-0; Mordi I, 2016, J HYPERTENS, V34, P1464, DOI 10.1097/HJH.0000000000000965; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Mudau M, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2011-068; O'Brien NF, 2015, CRIT CARE MED, V43, P674, DOI 10.1097/CCM.0000000000000745; Obukhov AG, 2002, J BIOL CHEM, V277, P16172, DOI 10.1074/jbc.M111664200; Pervez M, 2018, NEUROIMAG CLIN N AM, V28, P1, DOI 10.1016/j.nic.2017.09.010; Peters M, 2012, J NEUROTRAUM, V29, P2831, DOI 10.1089/neu.2012.2575; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Rout UK, 1997, CELL CALCIUM, V22, P463, DOI 10.1016/S0143-4160(97)90074-9; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Urban N, 2016, MOL PHARMACOL, V89, P197, DOI 10.1124/mol.115.100792; van Ierssel SH, 2015, J NEUROSCI RES, V93, P866, DOI 10.1002/jnr.23566; Vanhoutte PM, 2017, ACTA PHYSIOL, V219, P22, DOI 10.1111/apha.12646; Villalba N, 2017, J NEUROTRAUM, V34, P192, DOI 10.1089/neu.2015.4340; Weber DJ, 2014, SCI TRANSL MED, V6, P252; Yang ZH, 2016, JOVE-J VIS EXP, DOI 10.3791/54530; Zhao Q, 2019, J NEUROTRAUM, V36, P619, DOI 10.1089/neu.2018.5766	45	13	15	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JAN 31	2019	16								21	10.1186/s12974-019-1407-6			13	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	HJ9SR	WOS:000457539800001	30704505	Green Published, gold			2022-02-06	
J	Wilkinson, CM; Fedor, BA; Aziz, JR; Nadeau, CA; Brar, PS; Clark, JJA; Colbourne, F				Wilkinson, Cassandra M.; Fedor, Brittany A.; Aziz, Jasmine R.; Nadeau, Colby A.; Brar, Paul S.; Clark, Julia J. A.; Colbourne, Frederick			Failure of bumetanide to improve outcome after intracerebral hemorrhage in rat	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CHLORIDE HOMEOSTASIS; SEIZURE ACTIVITY; INJURY; COLLAGENASE; FUROSEMIDE; STROKE; HYPERTENSION; FREQUENCY; HEMATOMA	After intracerebral hemorrhage (ICH), brain edema commonly occurs and can cause death. Along with edema, there are significant alterations in the concentrations of key ions such as sodium, potassium, and chloride, which are essential to brain function. NKCC1, a cation-chloride cotransporter, is upregulated after brain damage, such as traumatic injury and ischemic stroke. NKCC1 brings sodium and chloride into the cell, possibly worsening ion dyshomeostasis. Bumetanide, a specific NKCC1 antagonist, blocks the transport of chloride into cells, and thus should attenuate the increases in chloride, which should lessen brain edema and improve neuronal functioning post-ICH, as with other injuries. We used the collagenase model of ICH to test whether bumetanide treatment for three days (vs. vehicle) would improve outcome. We gave bumetanide beginning at two hours or seven days post-ICH and measured behavioural outcome, edema, and brain ion content after treatment. There was some evidence for a minor reduction in edema after early dosing, but this did not improve behaviour or lessen injury. Contrary to our hypothesis, bumetanide did not normalize ion concentrations after late dosing. Bumetanide did not improve behavioural outcome or affect lesion volume. After ICH, bumetanide is safe to use in rats but does not improve functional outcome in the majority of animals.	[Wilkinson, Cassandra M.; Aziz, Jasmine R.; Nadeau, Colby A.; Brar, Paul S.; Clark, Julia J. A.; Colbourne, Frederick] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Fedor, Brittany A.; Colbourne, Frederick] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada		Colbourne, F (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.; Colbourne, F (corresponding author), Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada.	fcolbour@ualberta.ca	Colbourne, Frederick/ABB-7774-2020	Colbourne, Frederick/0000-0002-9567-2082	Canada Research Chair awardNatural Resources CanadaCanadian Forest ServiceCanada Research Chairs; Undergraduate Research Initiative award; Alberta Innovates Health Solutions award; Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada [G-16-00014065]	FC is supported by a Canada Research Chair award (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx). CMW is supported by an Undergraduate Research Initiative award (https://www.ualberta.ca/undergraduate-research-initiative/). JRA was supported by an Alberta Innovates Health Solutions award (http://albertain.com/companies/alberta-innovates-health-solutions/). This research was supported by the Heart and Stroke Foundation of Canada to FC (G-16-00014065, http://www.heartandstroke.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A, 2008, VASC HEALTH RISK MAN, V4, P715; Bachmann O, 2003, J PHYSIOL-LONDON, V549, P525, DOI 10.1113/jphysiol.2002.030205; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; Biffi A, 2016, BRAIN, V139, P2694, DOI 10.1093/brain/aww199; Brandt C, 2010, J NEUROSCI, V30, P8602, DOI 10.1523/JNEUROSCI.0633-10.2010; BRATER DC, 1983, CLIN PHARMACOL THER, V34, P207, DOI 10.1038/clpt.1983.154; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cote MP, 2014, J NEUROSCI, V34, P8976, DOI 10.1523/JNEUROSCI.0678-14.2014; DIXON DW, 1981, J CLIN PHARMACOL, V21, P680, DOI 10.1002/j.1552-4604.1981.tb05683.x; Eftekhari S, 2013, EPILEPSIA, V54, pe9, DOI 10.1111/j.1528-1167.2012.03654.x; Fernandez-Bouzas A, 2002, CLIN ELECTROENCEPHAL, V33, P70, DOI 10.1177/155005940203300205; Hiploylee C, 2014, EXP NEUROL, V255, P49, DOI 10.1016/j.expneurol.2014.02.017; Ikram MA, 2012, CURR ATHEROSCLER REP, V14, P300, DOI 10.1007/s11883-012-0252-1; Jiang B, 2017, TRANSL STROKE RES, V8, P183, DOI 10.1007/s12975-016-0506-2; Kaila K, 2010, EPILEPSIA, V51, P52, DOI 10.1111/j.1528-1167.2010.02838.x; Keep RF, 2008, ACT NEUR S, V105, P73; Keep RF, 2014, FLUIDS BARRIERS CNS, V11, DOI [10.1186/2045-8118-11-11, DOI 10.1186/2045-8118-11-11]; Klahr AC, 2016, THER HYPOTHERMIA TEM, V6, P40, DOI 10.1089/ther.2015.0028; Klahr AC, 2015, TRANSL STROKE RES, V6, P29, DOI 10.1007/s12975-014-0361-y; KONECKE LL, 1981, J CLIN PHARMACOL, V21, P688, DOI 10.1002/j.1552-4604.1981.tb05684.x; LEE SH, 1994, J PHARMACOKINET BIOP, V22, P1, DOI 10.1007/BF02353407; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lu KT, 2007, NEUROL RES, V29, P404, DOI 10.1179/016164107X204738; Lu KT, 2017, J NEUROCHEM, V140, P718, DOI 10.1111/jnc.13920; MacLellan CL, 2008, J CEREBR BLOOD F MET, V28, P516, DOI 10.1038/sj.jcbfm.9600548; MacLellan CL, 2006, J CEREBR BLOOD F MET, V26, P1031, DOI 10.1038/sj.jcbfm.9600255; Merkler AE, 2018, STROKE, V49, P1319, DOI 10.1161/STROKEAHA.117.020178; Mesko MF, 2011, INT J MASS SPECTROM, V307, P137, DOI 10.1016/j.ijms.2011.04.009; Nadeau CA, 2018, TRANSL STROKE RES, DOI [10.1007/s12975-018-0636-910.1007/s12975-018-0636-9, DOI 10.1007/S12975-018-0636-910.1007/S12975-018-0636-9]; Patel TR, 1999, BRAIN RES, V829, P125, DOI 10.1016/S0006-8993(99)01378-5; Portbury SD, 2018, METALLOMICS, V10, P846, DOI 10.1039/c8mt00068a; Reynolds A, 2007, J PHYSIOL-LONDON, V582, P507, DOI 10.1113/jphysiol.2007.129718; Romermann K, 2017, NEUROPHARMACOLOGY, V117, P182, DOI 10.1016/j.neuropharm.2017.02.006; ROSENBERG GA, 1993, NEUROSCI LETT, V160, P117, DOI 10.1016/0304-3940(93)90927-D; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Rubenstein JLR, 2013, CELLULAR MIGRATION F, DOI [10.1016/C2011-0-07731-1, DOI 10.1016/C2011-0-07731-1]; SCHWARTZ MA, 1981, J CLIN PHARMACOL, V21, P555, DOI 10.1002/j.1552-4604.1981.tb05664.x; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Shah QA, 2007, J NEUROL SCI, V261, P74, DOI 10.1016/j.jns.2007.04.036; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Sun D, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P501; Thiex Ruth, 2007, Neurosurg Focus, V22, pE6; Tollner K, 2015, EUR J PHARMACOL, V746, P167, DOI 10.1016/j.ejphar.2014.11.019; Tollner K, 2014, ANN NEUROL, V75, P550, DOI 10.1002/ana.24124; van der Heijden M, 1998, J CLIN PHARMACOL, V38, P630, DOI 10.1002/j.1552-4604.1998.tb04470.x; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Wang F, 2016, BRAIN STRUCT FUNCT, V222, P1, DOI [10.1007/s00429-016-1218-9, DOI 10.1007/S00429-016-1218-9]; Wang GB, 2014, INT J CLIN EXP PATHO, V7, P1487; Williamson MR, 2017, TRANSL STROKE RES, V8, P386, DOI 10.1007/s12975-017-0530-x; Williamson MR, 2017, STROKE, V48, P195, DOI 10.1161/STROKEAHA.116.015404; Xu WS, 2017, MOL NEUROBIOL, V54, P2406, DOI 10.1007/s12035-016-9819-0; Zhang MA, 2016, ENERGY STORAGE MATER, V4, P1, DOI 10.1016/j.ensm.2016.02.001	52	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210660	10.1371/journal.pone.0210660			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	WOS:000455483000121	30629699	Green Published, Green Submitted, gold			2022-02-06	
J	Alamri, A; Rogers, P; Kearns, C; Doke, T; Al-Habib, A; Servadei, F; Hutchinson, PJ; Kolias, AG; Uff, C				Alamri, A.; Rogers, P.; Kearns, C.; Doke, T.; Al-Habib, A.; Servadei, F.; Hutchinson, P. J.; Kolias, A. G.; Uff, Chris			Social media for dissemination and public engagement in neurosurgerythe example of Brainbook	ACTA NEUROCHIRURGICA			English	Article						Brainbook; Neurosurgery; Global surgery; Public engagement; Science dissemination		BackgroundPublic engagement has become one of the most effective tools in gaining feedback and perspectives from members of the public, involving patients with decisions, and inspiring young people to carry the medical profession forwards. Brainbook is a multi-platform, social media-based resource that was created specifically to enhance public engagement in neurosurgery and results from one of its case discussions will be reported in this paper.MethodsA Brainbook case was created in collaboration with the NIHR Global Health Research Group on Neurotrauma and presented over 3days (23-25 February 2018). YouTube videos were created depicting the management of an acute subdural haematoma using patient interviews, medical illustration, consultant-led discussion and operative footage. Content was shared across all Brainbook social media platforms and analytics were gathered through social media applications.ResultsOver a 72-hour time period, and across multiple social media accounts, 101,418 impressions were achieved (defined as penetrance onto individual media feeds and total views of the content), with active discussion on social media.ConclusionsNeurosurgical content published across multiple social media outlets represents an encouraging and exciting potential for global engagement across multiple audiences. Social media can be an effective method of not only disseminating neurosurgical knowledge, but activating and engaging the public, allied healthcare professionals, medical students and neurosurgeons.	[Alamri, A.; Rogers, P.; Doke, T.; Uff, Chris] Royal London Hosp, Dept Neurosurg, London, England; [Kearns, C.] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland; [Kearns, C.] Univ Edinburgh, Artibiot, Edinburgh, Midlothian, Scotland; [Al-Habib, A.] King Saud Univ, Fac Med, Riyadh, Saudi Arabia; [Servadei, F.] Humanitas Univ & Res Hosp, Dept Neurosurg, Milan, Italy; [Servadei, F.] World Federat Neurosurg Soc, Nyon, Switzerland; [Hutchinson, P. J.; Kolias, A. G.] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Hutchinson, P. J.; Kolias, A. G.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Hutchinson, P. J.; Kolias, A. G.] Addenbrookes Hosp, Cambridge, England; [Uff, Chris] Queen Mary Univ London, London, England		Uff, C (corresponding author), Royal London Hosp, Dept Neurosurg, London, England.	Chris.uff@bartshealth.nhs.uk	Kearns, Cilein/AAG-8448-2020	Kearns, Cilein/0000-0003-1254-8287; Kolias, Angelos/0000-0003-3992-0587; Hutchinson, Peter/0000-0002-2796-1835	NIHR Global Health Research Group on Neurotrauma [16/137/105]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G0502030, G1002277, G0601025, G9439390] Funding Source: UKRI	The project was funded by The NIHR Global Health Research Group on Neurotrauma, which was commissioned by the NIHR using Official Development Assistance (ODA) funding (project 16/137/105). The sponsor had no role in the design or conduct of this research.	Bruni RA, 2008, CAN MED ASSOC J, V179, P15, DOI 10.1503/cmaj.071656; Flynn D, 2012, ACAD EMERG MED, V19, P959, DOI 10.1111/j.1553-2712.2012.01414.x; GMC, 2013, GOOD MED PRACTICE; HAM C, 1993, BMJ-BRIT MED J, V307, P435, DOI 10.1136/bmj.307.6901.435; Hibbard JH, 2013, HEALTH AFFAIR, V32, P207, DOI 10.1377/hlthaff.2012.1061; Joseph-Williams N, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1744; National Coordinating Centre for Public Engagement, 2018, WHAT IS PUBL ENG; Riesch H, 2016, B SCI TECHNOL SOC, V36, P179, DOI [10.1177/0270467617690057, DOI 10.1177/0270467617690057]; Srinivas KR, 2017, TRENDS BIOTECHNOL, V35, P281, DOI 10.1016/j.tibtech.2017.02.004; Stewart K., 2016, SOCIAL CHANGE PUBLIC; Stilgoe J, 2014, PUBLIC UNDERST SCI, V23, P4, DOI 10.1177/0963662513518154; The Wellcome Trust, 2013, SHAR OUR PRACT SUCC; Traulsen JM, 2005, PHARM WORLD SCI, V27, P273, DOI 10.1007/s11096-005-8512-6	13	13	13	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JAN	2019	161	1					5	9		10.1007/s00701-018-3757-8			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HH2SH	WOS:000455568300003	30535760	Green Published, hybrid			2022-02-06	
J	Aneja, RK; Alcamo, AM; Cummings, J; Vagni, V; Feldman, K; Wang, Q; Dixon, CE; Billiar, TR; Kochanek, PM				Aneja, Rajesh K.; Alcamo, Alicia M.; Cummings, Jessica; Vagni, Vincent; Feldman, Keri; Wang, Qingde; Dixon, C. Edward; Billiar, Timothy R.; Kochanek, Patrick M.			Lack of Benefit on Brain Edema, Blood-Brain Barrier Permeability, or Cognitive Outcome in Global Inducible High Mobility Group Box 1 Knockout Mice Despite Tissue Sparing after Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						BBB permeability; cognitive impairment; HMGB1; traumatic brain injury	NITRIC-OXIDE SYNTHASE; HMGB1; ACTIVATION; EXPRESSION; PROTEIN; SEPSIS; RATS; INFLAMMATION; INVOLVEMENT; DEFICIENT	High mobility group box 1 (HMGB1) is a prototypical danger-associated molecular pattern molecule that is considered a late mediator of neuro-inflammation after traumatic brain injury (TBI). Prior studies have suggested that targeting HMGB1 may lead to neuroprotective effects, but none of these studies have reported cognitive outcomes. We hypothesized that loss of HMGB1 before and after TBI would markedly attenuate post-traumatic brain edema, blood-brain barrier (BBB) permeability, improve functional deficits and long-term neuropathology versus control mice. Using the controlled cortical impact model and conditional global HMGB1 knockout (HMGB1 KO) mice, we demonstrate that there was a neuroprotective effect seen in the HMGB1 KO versus wild-type control evidenced by a significant reduction in contusion volume. However, two surprising findings were 1) the lack of benefit on either post-traumatic brain edema or BBB permeability, and 2) that spatial memory performance was impaired in HMGB1 KO naive mice such that the behavioral effects of HMGB1 deletion in uninjured naive mice were similar to those observed after TBI. Our data suggest the possibility that the role of HMGB1 in TBI is a double-edged sword; that is, despite the benefits on selected aspects of secondary injury, the sustained absence of HMGB1 may impair cognitive function, even in naive mice. Given the pleiotropic actions of extracellular and intracellular HMGB1, when evaluating the potential use of therapies targeting HMGB1, effects on long-term cognitive outcome should be carefully evaluated. It also may be prudent in future studies to examine cell-specific effects of manipulating the HMGB1 pathway.	[Aneja, Rajesh K.; Alcamo, Alicia M.; Cummings, Jessica; Vagni, Vincent; Feldman, Keri; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Aneja, Rajesh K.; Alcamo, Alicia M.; Cummings, Jessica] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Wang, Qingde; Billiar, Timothy R.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Dixon, C. Edward] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA		Aneja, RK (corresponding author), Childrens Hosp Pittsburgh, Div Crit Care Med, 4401 Penn Ave,Fac Pavil Bldg,Suite 2000, Pittsburgh, PA 15224 USA.	anejar@upmc.edu	Alcamo, Alicia/AAF-2968-2019		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 HD040686, RO1 GM098474]; US Department of DefenseUnited States Department of Defense [WH81XWH-14-2-0018]; Ake N. Grenvik Professorship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM098474] Funding Source: NIH RePORTER	We thank the NIH T32 HD040686 (AMA), RO1 GM098474 (RKA), the US Department of Defense WH81XWH-14-2-0018 (PMK), and the Ake N. Grenvik Professorship (PMK) for support.	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; [Anonymous], 2012, LANCET NEUROL, V11, P651, DOI 10.1016/S1474-4422(12)70166-7; Au AK, 2012, J NEUROTRAUM, V29, P2013, DOI 10.1089/neu.2011.2171; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Castiglioni A, 2011, CELL TISSUE RES, V343, P189, DOI 10.1007/s00441-010-1033-1; Chavan SS, 2012, MOL MED, V18, P930, DOI 10.2119/molmed.2012.00195; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Gu XJ, 2014, CHIN J TRAUMATOL, V17, P1, DOI 10.3760/cma.j.issn.1008-1275.2014.01.001; Guazzi S, 2003, GENE EXPR PATTERNS, V3, P29, DOI 10.1016/S1567-133X(02)00093-5; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Kawamata Tatsuro, 2007, Neurosurg Focus, V22, pE5, DOI 10.3171/foc.2007.22.5.6; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Manson J, 2012, BRIT J SURG, V99, P12, DOI 10.1002/bjs.7717; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Okun E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047522; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Pedrazzi M, 2007, J IMMUNOL, V179, P8525, DOI 10.4049/jimmunol.179.12.8525; Peltz ED, 2009, SHOCK, V32, P17, DOI 10.1097/SHK.0b013e3181997173; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tehranian R, 2006, BRAIN RES, V1101, P126, DOI 10.1016/j.brainres.2006.05.049; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Wallisch J, 2016, CRIT CARE MED, V44; Wang HH, 2001, AM J RESP CRIT CARE, V164, P1768, DOI 10.1164/ajrccm.164.10.2106117; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zhao X, 2011, J BIOL CHEM, V286, P23200, DOI 10.1074/jbc.M111.223834; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907; Zhu DY, 2003, J NEUROSCI, V23, P223	44	13	13	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					360	369		10.1089/neu.2018.5664			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000459444800018	30045665	Green Published			2022-02-06	
S	Cristofori, I; Cohen-Zimerman, S; Grafman, J		DEsposito, M; Grafman, JH		Cristofori, Irene; Cohen-Zimerman, Shira; Grafman, Jordan			Executive functions	FRONTAL LOBES, VOL 163	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; DELAYED-RESPONSE PERFORMANCE; CARD SORTING TEST; WORKING-MEMORY; PREFRONTAL CORTEX; FRONTAL-LOBE; COGNITIVE FLEXIBILITY; ECOLOGICAL VALIDITY; APOLIPOPROTEIN-E; HEAD-INJURY	Executive functions (EFs) include high-order cognitive abilities such as working memory, inhibitory control, cognitive flexibility, planning, reasoning, and problem solving. EFs enable humans to achieve goals, adapt to novel everyday life situations, and manage social interactions. Traditionally EFs have been associated with frontal lobe functioning. More recent evidence shows that posterior and subcortical regions also play a crucial role in EF processing, especially in the integration of sensory information and emotion. This chapter reviews the variety of EFs and their neural underpinning, based on lesion mapping and neuroimaging studies, as well as the evidence for rehabilitation interventions, neuropsychological assessment based on standard and ecologically valid tests, development, and genetic predisposition for recovery of executive functions after brain injury. Taken together, the EFs are critical for unique human abilities and more careful analyses of their subcomponents may help the development of targeted translational interventions to improve them.	[Cristofori, Irene] Inst Cognit Sci Marc Jeannerod, Lyon, France; [Cristofori, Irene] Univ Lyon 1 Claude Bernard, Dept Human Biol, Lyon, France; [Cohen-Zimerman, Shira; Grafman, Jordan] Shirley Ryan AbilityLab, Brain Injury Res, Cognit Neurosci Lab, 355 E Erie St, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Dept Phys Med & Rehabil, Evanston, IL USA		Grafman, J (corresponding author), Shirley Ryan AbilityLab, Brain Injury Res, Cognit Neurosci Lab, 355 E Erie St, Chicago, IL 60611 USA.	jgrafman@northwestern.edu	Cohen-Zimerman, Shira/X-8330-2019	Cohen-Zimerman, Shira/0000-0001-6098-2550; Cristofori, Irene/0000-0003-2339-1457			Adibhatla RM, 2007, FUTURE LIPIDOL, V2, P403, DOI 10.2217/17460875.2.4.403; Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; Ando J, 2001, BEHAV GENET, V31, P615, DOI 10.1023/A:1013353613591; Andres P, 2003, CORTEX, V39, P871, DOI 10.1016/S0010-9452(08)70868-2; Armitage SG, 1946, ANAL CERTAIN PSYCHOL; Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Audoin B, 2005, MAGN RESON MATER PHY, V18, P96, DOI 10.1007/s10334-004-0098-9; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; Badre D, 2006, P NATL ACAD SCI USA, V103, P7186, DOI 10.1073/pnas.0509550103; Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Bailey CE, 2007, ANN NY ACAD SCI, V1118, P122, DOI 10.1196/annals.1412.011; Baldo JV, 2006, NEUROPSYCHOLOGY, V20, P529, DOI 10.1037/0894-4105.20.5.529; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Barbas H, 2007, NEUROSCIENTIST, V13, P532, DOI 10.1177/1073858407301369; Barbey AK, 2014, BRAIN, V137, P2823, DOI 10.1093/brain/awu207; Barbey AK, 2013, NEUROIMAGE, V82, P547, DOI 10.1016/j.neuroimage.2013.05.087; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Barbey AK, 2011, CEREB CORTEX, V21, P789, DOI 10.1093/cercor/bhq153; Barch DM, 2005, ANNU REV CLIN PSYCHO, V1, P321, DOI 10.1146/annurev.clinpsy.1.102803.143959; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Benson D.F., 1986, FRONTAL LOBES; Beste C, 2010, J NEUROSCI, V30, P10727, DOI 10.1523/JNEUROSCI.2493-10.2010; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Bissonette GB, 2008, J NEUROSCI, V28, P11124, DOI 10.1523/JNEUROSCI.2820-08.2008; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Boggio PS, 2007, RESTOR NEUROL NEUROS, V25, P123; Boulougouris V, 2007, BEHAV BRAIN RES, V179, P219, DOI 10.1016/j.bbr.2007.02.005; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Brown TE, 2010, POSTGRAD MED, V122, P42, DOI 10.3810/pgm.2010.09.2200; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Champod AS, 2007, P NATL ACAD SCI USA, V104, P14837, DOI 10.1073/pnas.0607101104; Channon S, 1999, NEUROPSYCHOLOGIA, V37, P757, DOI 10.1016/S0028-3932(98)00138-9; CHEN EYH, 1995, PSYCHIAT RES, V56, P183, DOI 10.1016/0165-1781(95)02535-2; Chen Zhe-Yu, 2008, Novartis Found Symp, V289, P180; Chiaravalloti ND, 2003, COGN BEHAV NEUROL, V16, P54, DOI 10.1097/00146965-200303000-00007; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CICERONE KD, 1987, ARCH PHYS MED REHAB, V68, P111; Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Coolidge FL, 2000, DEV NEUROPSYCHOL, V17, P273, DOI 10.1207/S15326942DN1703_1; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Crawford JR, 2000, AGING NEUROPSYCHOL C, V7, P9, DOI 10.1076/anec.7.1.9.806; Crescioni AW, 2011, J HEALTH PSYCHOL, V16, P750, DOI 10.1177/1359105310390247; Cristofori I, 2015, NEUROLOGY, V84, P1394, DOI 10.1212/WNL.0000000000001446; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; Dajani DR, 2015, TRENDS NEUROSCI, V38, P571, DOI 10.1016/j.tins.2015.07.003; Davis JC, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-16; Denson TF, 2011, PERS SOC PSYCHOL B, V37, P850, DOI 10.1177/0146167211401420; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Durston S, 2002, DEVELOPMENTAL SCI, V5, pF9, DOI 10.1111/1467-7687.00235; Dywan J, 1996, J HEAD TRAUMA REHAB, V11, P79, DOI 10.1097/00001199-199604000-00008; Eakin L, 2004, J Atten Disord, V8, P1, DOI 10.1177/108705470400800101; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Enge S, 2011, NEUROPSYCHOLOGIA, V49, P3776, DOI 10.1016/j.neuropsychologia.2011.09.038; Evans JJ, 2009, J INT NEUROPSYCH SOC, V15, P112, DOI 10.1017/S1355617708090152; Fairchild G, 2009, BIOL PSYCHIAT, V66, P162, DOI 10.1016/j.biopsych.2009.02.024; Fincham JM, 2002, P NATL ACAD SCI USA, V99, P3346, DOI 10.1073/pnas.052703399; FISHER AG, 1993, AM J OCCUP THER, V47, P319, DOI 10.5014/ajot.47.4.319; Fregni F, 2006, MOVEMENT DISORD, V21, P1693, DOI 10.1002/mds.21012; FUNAHASHI S, 1993, J NEUROSCI, V13, P1479; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; Gansler DA, 1996, BRAIN COGNITION, V30, P194, DOI 10.1006/brcg.1996.0012; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gilbert SJ, 2008, CURR BIOL, V18, pR110, DOI 10.1016/j.cub.2007.12.014; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; Goel V, 1997, BRAIN, V120, P1805, DOI 10.1093/brain/120.10.1805; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Goldberg E, 2000, J CLIN EXP NEUROPSYC, V22, P56, DOI 10.1076/1380-3395(200002)22:1;1-8;FT056; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Grafman G., 2002, PRINCIPLES FRONTAL L, P292; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Guevara AB, 2016, J HEAD TRAUMA REHAB, V31, pE48, DOI 10.1097/HTR.0000000000000151; Hackman DA, 2015, DEVELOPMENTAL SCI, V18, P686, DOI 10.1111/desc.12246; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hasher L, 1988, PSYCHOL LEARNING MOT, P193, DOI DOI 10.1016/S0079-7421(08)60041-9; Heaton C, 1993, WISCONSIN CARD SORTI; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Hoffmann Michael, 2013, ISRN Neurol, V2013, P892459, DOI 10.1155/2013/892459; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Humes GE, 1997, ASSESSMENT, V4, P249, DOI 10.1177/107319119700400305; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kuntsi Jonna, 1800, Behav Brain Funct, V2, P27, DOI 10.1186/1744-9081-2-27; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Li JJ, 2015, J INT NEUROPSYCH SOC, V21, P62, DOI 10.1017/S1355617714001039; Libin AV, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0061-2; Lie CH, 2006, NEUROIMAGE, V30, P1038, DOI 10.1016/j.neuroimage.2005.10.031; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; Lu HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep14769; Lui M, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-12; Luria A.R., 1973, WORKING BRAIN INTRO; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Mateer C A, 1999, Semin Clin Neuropsychiatry, V4, P50; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; McGarry LM, 2017, CELL REP, V21, P1426, DOI 10.1016/j.celrep.2017.10.046; Miller MW, 2013, J TRAUMA STRESS, V26, P71, DOI 10.1002/jts.21773; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Munakata Y, 2011, TRENDS COGN SCI, V15, P453, DOI 10.1016/j.tics.2011.07.011; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; OWEN AM, 1991, NEUROPSYCHOLOGIA, V29, P993, DOI 10.1016/0028-3932(91)90063-E; Owen AM, 1997, EUR J NEUROSCI, V9, P1329, DOI 10.1111/j.1460-9568.1997.tb01487.x; Padgett CR, 2016, J CLIN EXP NEUROPSYC, V38, P551, DOI 10.1080/13803395.2015.1137557; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; Petrides KV, 2007, BRIT J PSYCHOL, V98, P273, DOI 10.1348/000712606X120618; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; Prado J, 2011, J COGNITIVE NEUROSCI, V23, P3483, DOI 10.1162/jocn_a_00063; Puig MV, 2011, MOL NEUROBIOL, V44, P449, DOI 10.1007/s12035-011-8214-0; Ratiu P, 2004, J NEUROTRAUM, V21, P637, DOI 10.1089/089771504774129964; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Ready RE, 2001, CLIN NEUROPSYCHOL, V15, P314, DOI 10.1076/clin.15.3.314.10269; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Rhodes MG, 2004, PSYCHOL AGING, V19, P482, DOI 10.1037/0882-7974.19.3.482; Riggs N, 2010, CHILD NEUROPSYCHOL, V16, P279, DOI 10.1080/09297041003601488; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; ROBERTSON IH, 2000, NEW COGNITIVE NEUROS, P563; Rose S.A., 2016, EXECUTIVE FUNCTION P, P139, DOI DOI 10.1037/14797-007; Rudebeck PH, 2013, NAT NEUROSCI, V16, P1140, DOI 10.1038/nn.3440; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Seamans JK, 1998, J NEUROSCI, V18, P1613; Semendeferi K, 2002, NAT NEUROSCI, V5, P272, DOI 10.1038/nn814; Sepulcre J, 2009, NEUROIMAGE, V47, P773, DOI 10.1016/j.neuroimage.2009.04.054; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Simpson A, 2002, BRAIN INJURY, V16, P1075, DOI 10.1080/02699050210155249; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Sohlberg K, 2001, COGNITIVE REHABILITA; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sorel O, 2008, BRAIN COGNITION, V66, P196, DOI 10.1016/j.bandc.2007.07.006; Srimal R, 2008, NEUROIMAGE, V39, P455, DOI 10.1016/j.neuroimage.2007.08.040; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; STUSS DT, 1991, SELF : INTERDISCIPLINARY APPROACHES, P255; Tabibnia G, 2011, J NEUROSCI, V31, P4805, DOI 10.1523/JNEUROSCI.2859-10.2011; Tavares JVT, 2007, BIOL PSYCHIAT, V62, P917, DOI 10.1016/j.biopsych.2007.05.034; Taylor SJ, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015.00252, 10.3389/finbeh.2015.00252]; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Tsuchida A, 2009, J COGNITIVE NEUROSCI, V21, P2263, DOI 10.1162/jocn.2008.21172; Unterrainer JM, 2006, J PHYSIOL-PARIS, V99, P308, DOI 10.1016/j.jphysparis.2006.03.014; Urbanski M, 2016, BRAIN, V139, P1783, DOI 10.1093/brain/aww072; Van der Linden M, 2000, PSYCHOL BELG, V40, P275; Vanderhasselt MA, 2007, BRAIN RES, V1137, P111, DOI 10.1016/j.brainres.2006.12.050; Verhaeghen P, 2011, CURR DIR PSYCHOL SCI, V20, P174, DOI 10.1177/0963721411408772; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Volle E, 2008, CEREB CORTEX, V18, P2460, DOI 10.1093/cercor/bhn010; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Walker SC, 2006, EUR J NEUROSCI, V23, P3119, DOI 10.1111/j.1460-9568.2006.04826.x; Westwood SJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00166; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Wilson A, 1996, BEHAV ASSESSMENT DYS	185	13	15	5	10	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-804326-4; 978-0-12-804281-6	HAND CLINIC			2019	163						197	219		10.1016/B978-0-12-804281-6.00011-2			23	Clinical Neurology; Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BO9RA	WOS:000532148800013	31590731				2022-02-06	
J	Sicard, V; Moore, RD; Ellemberg, D				Sicard, Veronik; Moore, Robert D.; Ellemberg, Dave			Sensitivity of the Cogstate Test Battery for Detecting Prolonged Cognitive Alterations Stemming From Sport-Related Concussions	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						computerized testing; clinical decision-making; executive functions; persistent deficits; long-term	TRAUMATIC BRAIN-INJURY; BASE-LINE; INTERNATIONAL-CONFERENCE; PERSISTENT INFLUENCE; CONSENSUS STATEMENT; WORKING-MEMORY; SOCCER PLAYERS; NORMATIVE DATA; ATTENTION; PERFORMANCE	Objective: To determine if the Cogstate test battery contains the requisite sensitivity to detect prolonged cognitive alterations. Methods: One hundred twenty collegiate athletes (71 with a history of concussion; 49 controls) completed the Cogstate test battery, to which we added a 2-back condition. In addition to the Cogstate clinical (transformed variables), we analyzed the raw data. Results: The clinical variables failed to reveal any group differences. Further, although the raw data failed to reveal group differences for tasks measuring lower-level cognition, group differences were observed for accuracy on the 1- and 2-back tasks, which require multiple aspects of higher cognition. The overall classification accuracy was higher using the raw data than the clinical variables. The combined sensitivity of the 1- and 2-back task was moderate and specificity was high. Conclusions: These results suggest that using the raw scores over clinical variables increases the sensitivity of the test battery. Moreover, these results add another piece of evidence suggesting that concussive injuries are associated with subtle long-term alterations in aspects of higher cognition. Importantly, these deficits would have gone unobserved if we had relied solely on automated clinical variables. The current results further our scientific understanding of concussion and may be used to advance clinical practices.	[Sicard, Veronik; Moore, Robert D.; Ellemberg, Dave] Univ Montreal, Dept Kinesiol, Montreal, PQ, Canada; [Sicard, Veronik; Moore, Robert D.; Ellemberg, Dave] Univ Montreal, Ctr Rech Neuropsychol & Cognit, Montreal, PQ, Canada; [Moore, Robert D.] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA		Ellemberg, D (corresponding author), 2100 Edouard Montpetit, Montreal, PQ H3T 1J4, Canada.	dave.ellemberg@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [CIHR MOP-102608]	Supported by a grant from the Canadian Institutes of Health Research (CIHR MOP-102608) to D. Ellemberg.	Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Cromer JA, 2015, CLIN NEUROPSYCHOL, V29, P542, DOI 10.1080/13854046.2015.1054437; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Forns J, 2014, NEUROPSYCHOLOGY, V28, P519, DOI 10.1037/neu0000085; Furger R. E., 2016, CONCUSSION, V1, pCNC11; Gardner A, 2012, APPL NEUROPSYCH-ADUL, V19, P90, DOI 10.1080/09084282.2011.643945; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Moore RD, 2016, BRAIN IMAGING BEHAV, V10, P1108, DOI 10.1007/s11682-015-9473-6; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V55, P303; Pontifex MB, 2012, RES Q EXERCISE SPORT, V83, P553; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	47	13	13	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2019	29	1					62	68		10.1097/JSM.0000000000000492			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	IQ4PZ	WOS:000480734000013	29023272				2022-02-06	
J	Vavilala, MS; King, MA; Yang, JT; Erickson, SL; Mills, B; Grant, RM; Blayney, C; Qiu, Q; Chesnut, RM; Jaffe, KM; Weiner, BJ; Johnston, BD				Vavilala, Monica S.; King, Mary A.; Yang, Jen-Ting; Erickson, Scott L.; Mills, Brianna; Grant, Rosemary M.; Blayney, Carolyn; Qiu, Qian; Chesnut, Randall M.; Jaffe, Kenneth M.; Weiner, Bryan J.; Johnston, Brian D.			The Pediatric Guideline Adherence and Outcomes (PEGASUS) programme in severe traumatic brain injury: a single-centre hybrid implementation and effectiveness study	LANCET CHILD & ADOLESCENT HEALTH			English	Article							CLINICAL CARE; CHILDREN; MANAGEMENT	Background As far as we know, there are no tested in-hospital care programmes for paediatric traumatic brain injury We aimed to assess implementation and effectiveness of the Pediatric Guideline Adherence and Outcomes (PEGASUS) programme in children with severe traumatic brain injury. Methods We did a prospective hybrid implementation and effectiveness study at the Harborview Medical Center (Seattle, WA, USA). We included children (aged <18 years) with traumatic brain injury (trauma mechanism and image findings). We assessed service provision, adherence to three key performance indicators, and discharge outcomes associated with the PEGASUS programme. The three key performance indicators were early initiation of enteral (oral or tube feeds) or parenteral nutrition; avoidance of any unwanted hypocarbia (PaCO2 <30 mm Hg) without brain herniation; and maintenance of cerebral perfusion pressure (>40 mm Hg) for 72 h after the diagnosis of severe traumatic brain injury. Poisson regression with robust standard errors was used to estimate the association between adhering to key performance indicators and discharge outcomes. Findings Between May 1, 2011, and July 1, 2017, 199 children (median age 11.9 years [IQR 3.4-16.1]) participated in the PEGASUS programme, of whom 193 (97%) had severe traumatic brain injury and six (3%) had moderate traumatic brain injury. 105 patients contributed data for all three key performance indicators. Adherence to at least one key performance indicator was achieved by 101 (96%) of 105 participants, and 44 (42%) achieved adherence to all three key performance indicators. Programme participants achieved adherence to the key performance indicators of hypocarbia (76 of 105 [72%]), nutrition (162 of 199 [81%]), and cerebral perfusion pressure (128 of 199 [64%]). Adherence to the nutrition key performance indicator was associated with higher discharge survival (relative risk [RR] 2.70, 95% CI 1.54-4.73) and a more favourable discharge disposition (3.05, 1.52-6.11). Adherence to the cerebral perfusion pressure key performance indicator was also associated with higher discharge survival (RR 1.33, 95% CI 1.12-1.59) and favourable disposition (1.53, 1.19-1.96). Adherence to each additional key performance indicator was associated with higher survival (RR 1.27,1.12-1.44) and a more favourable discharge disposition (1.46, 1.23-1.72), in a dose-response manner. Interpretation The multilevel, hospital-wide, high-fidelity PEGASUS programme might benefit children and adolescents admitted to the emergency department with severe traumatic brain injury. Cerebral perfusion pressure, nutrition, and hypocarbia targets are essential components of the PEGASUS programme and are associated with favourable discharge outcomes. Copyright (C) 2018 Elsevier Ltd. All rights reserved.	[Vavilala, Monica S.; King, Mary A.; Yang, Jen-Ting; Erickson, Scott L.; Mills, Brianna; Qiu, Qian; Chesnut, Randall M.; Jaffe, Kenneth M.; Johnston, Brian D.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Vavilala, Monica S.; Yang, Jen-Ting] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Vavilala, Monica S.; King, Mary A.; Johnston, Brian D.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Erickson, Scott L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Chesnut, Randall M.] Univ Washington, Dept Neurol Surg & Global Hlth Med, Seattle, WA 98195 USA; [Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Weiner, Bryan J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Grant, Rosemary M.; Blayney, Carolyn] Univ Washington, Harborview Med Ctr, Clin Educ, 325 9Th Ave, Seattle, WA 98104 USA		Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, 325 9Th Ave, Seattle, WA 98104 USA.	vavilala@uw.edu		Weiner, Bryan/0000-0002-6996-9480; Erickson, Scott L/0000-0002-7694-6287; Chesnut, Randall/0000-0001-6377-3666	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	National Institutes of Health.	Ajdari A, 2017, J HEALTHC QUAL, V39, P334, DOI 10.1097/JHQ.0000000000000052; Belenkiy SM, 2015, INT J BURNS TRAUMA, V5, P66; Bennett TD, 2017, JAMA PEDIATR, V171, P965, DOI 10.1001/jamapediatrics.2017.2127; Brolliar SM, 2016, J NEUROTRAUM, V33, P1554, DOI 10.1089/neu.2015.4183; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carroll C, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-40; Chandee T, 2017, PEDIATR CRIT CARE ME, V18, P1166, DOI 10.1097/PCC.0000000000001350; COCHRAN WG, 1965, J R STAT SOC SER A-G, V128, P234, DOI 10.2307/2344179; Graves JM, 2016, PEDIATR CRIT CARE ME, V17, P438, DOI 10.1097/PCC.0000000000000698; Isbell CL, 2012, SHOCK, V37, P103, DOI 10.1097/SHK.0b013e3182391862; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lindsey C, 2010, STATA J, V10, P650, DOI 10.1177/1536867X1101000407; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Markham C, 2017, CURR OPIN PEDIATR, V29, P266, DOI 10.1097/MOP.0000000000000497; Moore M, 2015, PEDIATR CRIT CARE ME, V16, P758, DOI 10.1097/PCC.0000000000000494; O'Lynnger TM, 2016, J NEUROSURG-PEDIATR, V17, P19, DOI 10.3171/2015.5.PEDS1544; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Plaisant Catherine, 2008, AMIA Annu Symp Proc, P601; Pronovost P, 2005, J PATIENT SAF, V1, P33, DOI DOI 10.1097/01209203-200503000-00008; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2008, J CRIT CARE, V23, P207, DOI 10.1016/j.jcrc.2007.09.002; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c309; Rakes L, 2016, BMJ QUAL IMPROV REP; Seddon ME, 2001, QUAL HEALTH CARE, V10, P152, DOI 10.1136/qhc.0100152..; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	28	13	13	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2352-4642			LANCET CHILD ADOLESC	Lancet Child. Adolesc. Health	JAN	2019	3	1					23	34		10.1016/S2352-4642(18)30341-9			12	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	HE1XW	WOS:000453068200015	30473440	Green Accepted			2022-02-06	
J	Mizuma, A; Kim, JY; Kacimi, R; Stauderman, K; Dunn, M; Hebbar, S; Yenari, MA				Mizuma, Atsushi; Kim, Jong Youl; Kacimi, Rachid; Stauderman, Ken; Dunn, Michael; Hebbar, Sudarshan; Yenari, Midori A.			Microglial Calcium Release-Activated Calcium Channel Inhibition Improves Outcome from Experimental Traumatic Brain Injury and Microglia-Induced Neuronal Death	JOURNAL OF NEUROTRAUMA			English	Article						calcium release-activated calcium channel; microglia; store-operated calcium entry; traumatic brain injury	HEAT-SHOCK-PROTEIN; CYCLOSPORINE-A; MILD HYPOTHERMIA; CALCINEURIN INHIBITORS; NEUROPROTECTIVE ACTION; MOLECULAR-MECHANISMS; EXPERIMENTAL STROKE; CEREBRAL-ISCHEMIA; TACROLIMUS FK506; DOWN-REGULATION	Store-operated Ca2+ entry (SOCE) mediated by calcium release-activated calcium (CRAC) channels contributes to calcium signaling. The resulting intracellular calcium increases activate calcineurin, which in turn activates immune transcription factor nuclear factor of activated T cells (NFAT). Microglia contain CRAC channels, but little is known whether these channels play a role in acute brain insults. We studied a novel CRAC channel inhibitor to explore the therapeutic potential of this compound in microglia-mediated injury. Cultured microglial BV2 cells were activated by Toll-like receptor agonists or IFN gamma. Some cultures were treated with a novel CRAC channel inhibitor (CM-EX-137). Western blots revealed the presence of CRAC channel proteins STIM1 and Orai1 in BV2 cells. CM-EX-137 decreased nitric oxide (NO) release and inducible nitric oxide synthase (iNOS) expression in activated microglia and reduced agonist-induced intracellular calcium accumulation in microglia, while suppressing inflammatory transcription factors nuclear factor kappa B (NF-kappa B) and nuclear factor of activated T cells (NFAT). Male C57/BL6 mice exposed to experimental brain trauma and treated with CM-EX-137 had decreased lesion size, brain hemorrhage, and improved neurological deficits with decreased microglial activation, iNOS and Orai1 and STIM1 levels. We suggest a novel anti-inflammatory approach for managing acute brain injury. Our observations also shed light on new calcium signaling pathways not described previously in brain injury models.	[Mizuma, Atsushi; Kim, Jong Youl; Kacimi, Rachid; Yenari, Midori A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Mizuma, Atsushi; Kim, Jong Youl; Kacimi, Rachid; Yenari, Midori A.] San Francisco VA Med Ctr, San Francisco, CA USA; [Mizuma, Atsushi] Tokai Univ, Sch Med, Dept Neurol, Isehara, Kanagawa, Japan; [Kim, Jong Youl] Yonsei Univ, Coll Med, Dept Anat, Seoul, South Korea; [Stauderman, Ken; Dunn, Michael; Hebbar, Sudarshan] CalciMedica Inc, La Jolla, CA USA		Yenari, MA (corresponding author), Univ Calif San Francisco, San Francisco VAMC, Dept Neurol, 4150 Clement St,MS 127, San Francisco, CA 94121 USA.	yenari@alum.mit.edu		Yenari, Midori/0000-0003-3916-8006	Veterans Affairs Merit AwardUS Department of Veterans Affairs [I01 BX000589]; NIH National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03 NS101246]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS101246] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX000589] Funding Source: NIH RePORTER	This work was supported by grants from the Veterans Affairs Merit Award I01 BX000589 and NIH National Institute of Neurological Disorders and Stroke R03 NS101246, and gift funds from CalciMedica, Inc (to MY) and the SENSHIN Medical Research Foundation (to AM). Grants to MY were administered by the Northern California Institute for Research and Education, and supported by resources from the Veterans Affairs Medical Center, San Francisco, CA.	Bechstein WO, 2000, TRANSPL INT, V13, P313, DOI 10.1111/j.1432-2277.2000.tb01004.x; Beck A, 2008, J PHYSIOL-LONDON, V586, P427, DOI 10.1113/jphysiol.2007.145151; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Cho TH, 2013, INT J STROKE, V8, P669, DOI 10.1111/j.1747-4949.2012.00849.x; Christians U, 2004, BRIT J PHARMACOL, V143, P388, DOI 10.1038/sj.bjp.0705939; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Deng H, 2003, STROKE, V34, P2495, DOI 10.1161/01.STR.0000091269.67384.E7; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; Eylenstein A, 2012, J BIOL CHEM, V287, P2719, DOI 10.1074/jbc.M111.275925; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Furman JL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0158-7; Furuichi Y, 2004, BRAIN RES, V1014, P120, DOI 10.1016/j.brainres.2004.04.031; Furuichi Y, 2007, EXP NEUROL, V204, P138, DOI 10.1016/j.expneurol.2006.10.003; Gold BG, 2004, J NEUROSCI RES, V77, P367, DOI 10.1002/jnr.20165; Han HS, 2002, J NEUROSCI, V22, P3921, DOI 10.1523/JNEUROSCI.22-10-03921.2002; Heo DK, 2015, CELL SIGNAL, V27, P177, DOI 10.1016/j.cellsig.2014.11.003; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Hou PF, 2015, CELL MOL NEUROBIOL, V35, P283, DOI 10.1007/s10571-014-0123-0; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Kacimi R, 2015, GLIA, V63, P1200, DOI 10.1002/glia.22811; Kacimi R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-7; Kaminska B, 2004, J CELL MOL MED, V8, P45, DOI 10.1111/j.1582-4934.2004.tb00259.x; Kim JY, 2013, J NEUROTRAUM, V30, P1170, DOI 10.1089/neu.2012.2691; Kim N, 2015, NEUROSCIENCE, V284, P912, DOI 10.1016/j.neuroscience.2014.11.010; Kraft R, 2015, CHANNELS, V9, P244, DOI 10.1080/19336950.2015.1071747; Kuroda S, 1999, BRAIN RES, V835, P148, DOI 10.1016/S0006-8993(99)01535-8; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Ma JA, 2010, EUR J IMMUNOL, V40, P3028, DOI 10.1002/eji.201040614; Macleod MR, 2005, J CEREBR BLOOD F MET, V25, P713, DOI 10.1038/sj.jcbfm.9600064; Malvezzi P, 2015, EXPERT OPIN DRUG SAF, V14, P1531, DOI 10.1517/14740338.2015.1083974; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Nighoghossian N, 2015, NEUROLOGY, V84, P2216, DOI 10.1212/WNL.0000000000001639; Ohana L, 2009, CHANNELS, V3, P129, DOI 10.4161/chan.3.2.8609; Osman MM, 2011, NEUROPEPTIDES, V45, P359, DOI 10.1016/j.npep.2011.04.002; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rao W, 2015, BBA-MOL BASIS DIS, V1852, P2402, DOI 10.1016/j.bbadis.2015.08.014; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Saganova K, 2012, LIFE SCI, V91, P77, DOI 10.1016/j.lfs.2012.06.022; Serkova N, 2004, MOL INTERV, V4, P97, DOI 10.1124/mi.4.2.7; Servais H, 2008, APOPTOSIS, V13, P11, DOI 10.1007/s10495-007-0151-z; Shim AHR, 2015, J MOL BIOL, V427, P77, DOI 10.1016/j.jmb.2014.09.021; SIEKIERKA JJ, 1992, CURR OPIN IMMUNOL, V4, P548, DOI 10.1016/0952-7915(92)90024-9; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Tang XAN, 2010, J NEUROSCI METH, V190, P240, DOI 10.1016/j.jneumeth.2010.05.004; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wang GJ, 2002, NEUROSCIENCE, V114, P1081, DOI 10.1016/S0306-4522(02)00350-0; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng Z, 2008, J CEREBR BLOOD F MET, V28, P53, DOI 10.1038/sj.jcbfm.9600502	53	13	15	1	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					996	1007		10.1089/neu.2018.5856		DEC 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HR6BY	WOS:000451965900003	30351197	Green Published			2022-02-06	
J	Carlson, KF; Gilbert, TA; Morasco, BJ; Wright, D; Van Otterloo, J; Herrndorf, A; Cook, LJ				Carlson, Kathleen F.; Gilbert, Tess A.; Morasco, Benjamin J.; Wright, Dagan; Van Otterloo, Joshua; Herrndorf, Aldona; Cook, Lawrence J.			Linkage of VA and State Prescription Drug Monitoring Program Data to Examine Concurrent Opioid and Sedative-Hypnotic Prescriptions among Veterans	HEALTH SERVICES RESEARCH			English	Article						Veterans; VA health care system; data linkage; opioid safety, medication safety; dual use	TRAUMATIC BRAIN-INJURY; HEALTH-CARE; RECORD LINKAGE; NONCANCER PAIN; UNITED-STATES; AFFAIRS; BENZODIAZEPINE; AFGHANISTAN; REDUCTIONS; MORTALITY	Objective To examine the prevalence of concurrent Veterans Health Administration (VA) and non-VA prescriptions for opioids and sedative-hypnotic medications among post-9/11 veterans in Oregon. Data Sources VA health care and prescription data were probabilistically linked with Oregon Prescription Drug Monitoring Program (PDMP) data. Study Design This retrospective cohort study examined concurrent prescriptions among n = 19,959 post-9/11 veterans, by year (2014-2016) and by patient demographic and clinical characteristics. Veterans were included in the cohort for years in which they received VA outpatient care; those receiving hospice or palliative care were excluded. Concurrent prescriptions were defined as >= 1 days of overlap between outpatient prescriptions for opioids and/or sedative-hypnotics (categorized as benzodiazepines vs. non-benzodiazepines). Principal Findings Among 5,882 veterans who filled opioid or sedative-hypnotic prescriptions at VA pharmacies, 1,036 (17.6 percent) filled concurrent prescriptions from non-VA pharmacies. Within drug class, 15.1, 8.8, and 4.6 percent received concurrent VA and non-VA opioids, benzodiazepines, and non-benzodiazepines, respectively. Veteran demographics and clinical diagnoses were associated with the likelihood of concurrent prescriptions, as was enrollment in the Veterans Choice Program. Conclusions A considerable proportion of post-9/11 veterans receiving VA care in Oregon filled concurrent prescriptions for opioids and sedative-hypnotics. Fragmentation of care may contribute to prescription drug overdose risk among veterans.	[Carlson, Kathleen F.] VA Portland Hlth Care Syst R&D 66, HSR&D Ctr Improve Vet Involvement Care CIVIC, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Carlson, Kathleen F.; Wright, Dagan] Portland State Univ, Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97207 USA; [Gilbert, Tess A.; Morasco, Benjamin J.; Herrndorf, Aldona] VA Portland Hlth Care Syst, HSR&D Ctr Improve Vet Involvement Care CIVIC, Portland, OR USA; [Morasco, Benjamin J.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Wright, Dagan] OCHIN, Portland, OR USA; [Van Otterloo, Joshua] Oregon Hlth Author, Publ Hlth Div, Prescript Drug Monitoring Program, Portland, OR USA; [Cook, Lawrence J.] Univ Utah, Dept Pediat, Div Crit Care, Salt Lake City, UT USA		Carlson, KF (corresponding author), VA Portland Hlth Care Syst R&D 66, HSR&D Ctr Improve Vet Involvement Care CIVIC, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	kathleen.carlson@va.-gov		Carlson, Kathleen/0000-0001-9261-7742	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development ServiceUS Department of Veterans Affairs [IIR15-091]; Veterans AffairsUS Department of Veterans Affairs [I01HX001891] Funding Source: NIH RePORTER	This research was supported by Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development Service, project # IIR15-091, Kathleen F. Carlson, Principal Investigator. The Portland Center to Improve Veteran Involvement in Care (CIVIC), a VA Center of Innovation, provided data programming resources for this work. None of the co-authors have any financial or other disclosures or conflicts of interest related to the material contained in this manuscript.	Abrahamsson T, 2017, DRUG ALCOHOL DEPEN, V174, P58, DOI 10.1016/j.drugalcdep.2017.01.013; Ali MM, 2017, ADDICT BEHAV, V69, P65, DOI 10.1016/j.addbeh.2017.01.011; Bao YH, 2016, HEALTH AFFAIR, V35, P1045, DOI 10.1377/hlthaff.2015.1673; Basham C, 2011, SUICIDE LIFE-THREAT, V41, P287, DOI 10.1111/j.1943-278X.2011.00028.x; Becker WC, 2017, MED CARE, V55, pS33, DOI 10.1097/MLR.0000000000000722; Bohnert ASB, 2011, MED CARE, V49, P393, DOI 10.1097/MLR.0b013e318202aa27; Brandeis University  Heller School for Social Policy and Management Prescription Drug Monitoring Program Training and Technical Assistance Center (PMDP TTAC), 2018, PDMP MAND QUER PROV; Brandeis University  Heller School for Social Policy and Management Prescription Drug Monitoring Program Training and Technical Assistance Center (PMDP TTAC), 2017, STAT PROF; Brandeis University  Heller School for Social Policy and Management Prescription Drug Monitoring Program Training and Technical Assistance Center (PMDP TTAC), 2016, PDMP PRESCR US MAND; Brandeis University  Heller School for Social Policy and Management Prescription Drug Monitoring Program Training and Technical Assistance Center (PMDP TTAC), 2018, PDMP MAND ENR PROV D; Carlson, 2015, INJ EPIDEMIOL, V2, P32, DOI DOI 10.1186/s40621-015-0063-2; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cook LJ, 2001, METHOD INFORM MED, V40, P196; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6501e1; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Finklea KM, 2013, PRESCRIPTION DRUG MO; Garg RK, 2017, MED CARE, V55, P661, DOI 10.1097/MLR.0000000000000738; Gellad WF, 2017, JAMA INTERN MED, V177, P611, DOI 10.1001/jamainternmed.2017.0147; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Griggs CA, 2015, WEST J EMERG MED, V16, P67, DOI 10.5811/westjem.2014.10.24197; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hudson TJ, 2017, PAIN, V158, P1039, DOI 10.1097/j.pain.0000000000000874; Hynes DM, 2007, MED CARE, V45, P214, DOI 10.1097/01.mlr.0000244657.90074.b7; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Jones JD, 2012, DRUG ALCOHOL DEPEN, V125, P8, DOI 10.1016/j.drugalcdep.2012.07.004; Kane WG, 2014, J HEAD TRAUMA REHAB, V29, pE10, DOI 10.1097/HTR.0000000000000028; Kizer KW, 2009, ANNU REV PUBL HEALTH, V30, P313, DOI 10.1146/annurev.publhealth.29.020907.090940; Lin LWA, 2017, PAIN, V158, P833, DOI 10.1097/j.pain.0000000000000837; Macey TA, 2011, PAIN MED, V12, P1502, DOI 10.1111/j.1526-4637.2011.01226.x; National Guard of Oregon, 2003, OR SENT OFF NEWSL OR; Office of the Secretary HHS, 2009, FED REGISTER, V74, P3328; Oregon Health Authority  Division of Public Health, 2017, 2016 ANN REP PDMP AD; Oregon Heatlh Authority, 2018, OR PRESCR DRUG MON P; Patrick SW, 2016, HEALTH AFFAIR, V35, P1324, DOI 10.1377/hlthaff.2015.1496; Quinn PD, 2017, PAIN, V158, P140, DOI 10.1097/j.pain.0000000000000730; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Shen YJ, 2003, MED CARE RES REV, V60, P253, DOI 10.1177/1077558703060002007; Suda KJ, 2017, J AM PHARM ASSOC, V57, P333, DOI 10.1016/j.japh.2017.02.018; Sun EC, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j760; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; US Centers for Disease Control and Prevention National Center for Health Statistics, 2017, MULT CAUS DEATH 1999; US Centers for Disease Control and Prevention; National Center for Health Statistics: International Classification of Diseases (ICD 10 CM/PCS), 2017, INT CLASS DIS; US Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2016, CDC COMP BENZ MUSCL; US Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2017, DAT DRIV PREV IN DDP; US Centers for Medicare & Medicaid Services, 2016, 2017 ICD 10 CM GEMS; US Department of Agriculture Economic Research Service, 2016, DOC 2010 RUR URB COM; US Department of Veterans Affairs, 2017, VET CHOIC PROGR; US Department of Veterans Affairs, 2018, FR; US Department of Veterans Affairs, 2018, BUDG IN BRIEF 2019; US Department of Veterans Affairs, 2009, FED REGISTER, V74, P37093; US Department of Veterans Affairs, 2018, VA MISSION ACT NEW V; US Department of Veterans Affairs, 2017, VET HLTH ADM; US Department of Veterans Affairs. Office of Inspector General, 2017, HEALTHC INSP OP PRES; US Department of Veterans Affairs Pharmacy Benefits Management Services, 2017, VA NAT FORM; US Substance Abuse and Mental Health Services Administration, 2017, NAT SURV DRUG US HLT; Westanmo A, 2015, PAIN MED, V16, P1019, DOI 10.1111/pme.12699; Wolinsky FD, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-131; Yoon J, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2504-9	58	13	13	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-9124	1475-6773		HEALTH SERV RES	Health Serv. Res.	DEC	2018	53			3	SI		5285	5308		10.1111/1475-6773.13025			24	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	HA4TG	WOS:000450256200009	30088271	Green Published			2022-02-06	
J	Degeilh, F; Bernier, A; Gravel, J; Beauchamp, MH				Degeilh, Fanny; Bernier, Annie; Gravel, Jocelyn; Beauchamp, Miriam H.			Developmental trajectories of adaptive functioning following early mild traumatic brain injury	DEVELOPMENTAL PSYCHOBIOLOGY			English	Article						concussion; growth curve modeling; preschool children; social competence; traumatic brain injury	OUTCOME 30 MONTHS; SOCIAL OUTCOMES; HEAD-INJURY; SHORT-TERM; CHILDREN; BEHAVIOR; EPIDEMIOLOGY; ADOLESCENTS; PREDICTORS; RECOVERY	Adaptive behavior impairments have been reported in children with severe traumatic brain injury (TBI) but are not typically found following mild TBI. It is possible that mild TBI induces subtle changes in adaptive functioning that are not captured in conventional group comparisons. This study aimed to explore time course changes in adaptive functioning following early mild TBI. Parents of 63 children with mild TBI and 53 children with orthopedic injuries aged between 1.5 and 5 years at the time of injury completed the Adaptive Behavior Assessment System-II at three time points: retrospectively to assess pre-injury functioning, then at 6 and 18 months post-injury. Developmental trajectories of adaptive functioning domains (practical, conceptual, and social) reported by parents were modeled using linear mixed-model analyses. Findings suggest that mild TBI may disrupt the expected developmental progression of children's social adaptive behavior, but does not appear to alter practical and conceptual domains.	[Degeilh, Fanny; Bernier, Annie; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Degeilh, Fanny; Beauchamp, Miriam H.] St Justine Res Ctr, Montreal, PQ, Canada; [Gravel, Jocelyn] Univ Montreal, St Justine Hosp, Montreal, PQ, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.	miriam.beauchamp@umontreal.ca	Degeilh, Fanny/AAA-7445-2019	Degeilh, Fanny/0000-0002-5802-4975	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP111036]; Fonds de Recherche du Quebec en SanteFonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research (CIHR), Grant/Award Number: MOP111036; Fonds de Recherche du Quebec en Sante	Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2017, J NEUROTRAUM, V34, P2261, DOI 10.1089/neu.2016.4692; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; [Anonymous], 2006, MONOGR SOC RES CHILD, V71, P65; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beauchamp MH, 2017, NEUROPSYCHOLOGY, V31, P981, DOI 10.1037/neu0000395; Beauchamp MH, 2017, J NEUROTRAUM, V34, P2545, DOI 10.1089/neu.2016.4868; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bellerose J, 2017, NEUROPSYCHOLOGY, V31, P229, DOI 10.1037/neu0000341; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Caravella KE, 2017, RES AUTISM SPECT DIS, V40, P1, DOI 10.1016/j.rasd.2017.05.002; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Forsyth R, 2012, CAN MED ASSOC J, V184, P1257, DOI 10.1503/cmaj.111045; Frith C, 2005, CURR BIOL, V15, pR644, DOI 10.1016/j.cub.2005.08.041; Gagner C, 2018, PSYCHOL MED, V48, P1551, DOI 10.1017/S0033291717003221; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Gibbons RD, 2010, ANNU REV CLIN PSYCHO, V6, P79, DOI 10.1146/annurev.clinpsy.032408.153550; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hoffman L, 2015, MULTIVAR APPL SER, P1; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Mirman D, 2014, GROWTH CURVE ANAL VI; Murray A, 2014, J INTELL DISABIL RES, V58, P777, DOI 10.1111/jir.12092; Oakland T, 2008, ADAPTIVE BEHAV ASSES; Reynolds CR., 1992, BEHAV ASSESSMENT SYS; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Schalock R.L., 2010, INTELLECTUAL DISABIL, V11th ed.; Shultz EL, 2016, NEUROPSYCHOLOGY, V30, P830, DOI 10.1037/neu0000288; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; SPARROW SS, 1984, INTERVIEW EDITION EX; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Thurber S., 2012, ARCH ASSESSMENT PSYC, V2, P73; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Verger K, 2000, BRAIN INJURY, V14, P495; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wang M. C., 2009, NEUROTRAUMA CRITICAL, P87; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	61	13	13	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1630	1098-2302		DEV PSYCHOBIOL	Dev. Psychobiol.	DEC	2018	60	8					1037	1047		10.1002/dev.21786			11	Developmental Biology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Developmental Biology; Psychology	HE8DT	WOS:000453674500014	30276812				2022-02-06	
J	Lynall, RC; Mihalik, JP; Pierpoint, LA; Currie, DW; Knowles, SB; Wasserman, EB; Dompier, TP; Comstock, RD; Marshall, SW; Kerr, ZY				Lynall, Robert C.; Mihalik, Jason P.; Pierpoint, Lauren A.; Currie, Dustin W.; Knowles, Sarah B.; Wasserman, Erin B.; Dompier, Thomas P.; Comstock, R. Dawn; Marshall, Stephen W.; Kerr, Zachary Y.			The First Decade of Web-Based Sports Injury Surveillance: Descriptive Epidemiology of Injuries in US High School Boys' Ice Hockey (2008-2009 Through 2013-2014) and National Collegiate Athletic Association Men's and Women's Ice Hockey (2004-2005 Through 2013-2014)	JOURNAL OF ATHLETIC TRAINING			English	Article						musculoskeletal injuries; concussions; ligament sprains; injury rate	UNITED-STATES; BODY CHECKING; RISK-FACTORS; CONCUSSION; SYSTEM; PREVENTION; POLICY	Context: Web-based sports injury surveillance via programs such as the High School Reporting Information Online system and the National Collegiate Athletic Association Injury Surveillance Program has aided efforts to collect data on ice hockey injuries. Objective: To describe the epidemiology of injuries sustained in high school boy's ice hockey in the 2008-2009 through 2013-2014 academic years and collegiate men's and women's ice hockey in the 2004-2005 through 2013-2014 academic years using Web-based surveillance. Design: Descriptive epidemiology study. Setting: Online injury surveillance of ice hockey teams of high school boys (annual average = 34), collegiate men (annual average = 20), and collegiate women (annual average = 11). Patients or Other Participants: Boys', men's, and women's ice hockey players who participated in practices and competitions during the 2008-2009 through 2013-2014 high school academic years or the 2004-2005 through 2013-2014 collegiate academic years. Main Outcome Measure(s): Athletic trainers collected time-loss (>= 24 hours) injury and exposure data. We calculated injury rates per 1000 athlete-exposures (AEs), injury rate ratios (IRRs) with 95% confidence intervals (Cis), and injury proportions by body site and diagnosis. Results: The High School Reporting Information Online system documented 831 boys' ice hockey time-loss injuries during 356 997 AEs; the National Collegiate Athletic Association Injury Surveillance Program documented 2611 men's ice hockey time-loss injuries during 552 642 AEs and 752 women's ice hockey injuries during 232 051 AEs. Injury rates were higher in collegiate men than in high school boys during 2008-2009 through 2013-2014 (4.38 versus 2.33/1000 AEs; IRR = 1.88; 95% CI = 1.73, 2.05) and collegiate women during 2004-2005 through 2013-2014 (IRR = 1.46; 95% CI = 1.34, 1.58). Most injuries occurred during competitions (boys = 80.0%, men = 66.9%, women = 55.3%); injury rates were higher in competitions than in practices for boys (IRR = 8.14; 95% CI = 6.87, 9.65), men (IRR = 6.58; 95% CI = 6.06, 7.13), and women (IRR =3.63; 95% CI =3.14, 4.19). At all levels, most injuries occurred to the head/face and shoulder/clavicle and resulted in concussions, contusions, or ligament sprains. Conclusions: Injury rates varied across sports but were consistently higher in competitions than in practices. In competitions, concussions were common injuries, highlighting the need for continued development of injury-prevention strategies.	[Lynall, Robert C.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Pierpoint, Lauren A.; Currie, Dustin W.; Comstock, R. Dawn] Univ Colorado Anschutz, Dept Epidemiol, Colorado Sch Publ Hlth, Aurora, CO USA; [Knowles, Sarah B.] Palo Alto Med Fdn, Res Inst, Palo Alto, CA 94301 USA; [Wasserman, Erin B.] Sports Injury Res & Prevent Inc, Datalys Ctr, Indianapolis, IN USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Annville, PA USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA		Kerr, ZY (corresponding author), Univ N Carolina, Injury Prevent Res Ctr, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu	; Lynall, Robert/M-2888-2014	Wasserman, Erin/0000-0001-5957-5878; Lynall, Robert/0000-0002-0785-6640	NCAA; Centers for Disease Control and Prevention grants [R49/CE000674-01, R49/CE001172-01]; National Center for Research Resources awardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025754]; National Federation of State High School Assocations (Indianapolis, IN); National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); DonJoy Orthotics (Vista, CA); EyeBlack (Potomac, MD)	The NCAA ISP data were provided by the Datalys Center for Sports Injury Research and Prevention. The ISP was funded by the NCAA. Funding for HS RIO was provided in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01 and the National Center for Research Resources award KL2 RR025754. We also acknowledge the research funding contributions of the National Federation of State High School Assocations (Indianapolis, IN), National Operating Committee on Standards for Athletic Equipment (Overland Park, KS), DonJoy Orthotics (Vista, CA), and EyeBlack (Potomac, MD). The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. We thank the many ATs who have volunteered their time and efforts to submit data to HS RIO and the NCAAISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of high school and collegiate student-athletes.	Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2007, J ATHL TRAINING, V42, P249; [Anonymous], 1981, STUD ATHL PART; [Anonymous], PART STAT; [Anonymous], CENS REG US; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hagel BE, 2003, AM J EPIDEMIOL, V157, P825, DOI 10.1093/aje/kwg050; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; Knowles SB, 2009, EPIDEMIOLOGY, V20, P302, DOI 10.1097/EDE.0b013e318193107c; Krolikowski MP, 2017, AM J SPORT MED, V45, P468, DOI 10.1177/0363546516669701; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Matic GT, 2015, PHYSICIAN SPORTSMED, V43, P119, DOI 10.1080/00913847.2015.1035210; Parsons J, 2014, 2014 15 NCAA SPORTS; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Tuominen M, 2016, BRIT J SPORT MED, V50, P1406, DOI 10.1136/bjsports-2015-094647; Tuominen M, 2015, BRIT J SPORT MED, V49, P30, DOI 10.1136/bjsports-2014-093688; Turbeville SD, 2003, AM J SPORT MED, V31, P974, DOI 10.1177/03635465030310063801; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002	26	13	13	1	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	DEC	2018	53	12					1129	1142		10.4085/1062-6050-176-17			14	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HK4AE	WOS:000457860600002	30721630	Green Published, gold			2022-02-06	
J	Martindale, SL; Epstein, EL; Taber, KH; Rowland, JA				Martindale, Sarah L.; Epstein, Erica L.; Taber, Katherine H.; Rowland, Jared A.		Mid-Atlantic MIRECC Workgrp	Behavioral and Health Outcomes Associated With Deployment and Nondeployment Acquisition of Traumatic Brain Injury in Iraq and Afghanistan Veterans	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Depression; Pain; Rehabilitation; Sleep; Traumatic brain injury; Veterans	POSTTRAUMATIC-STRESS-DISORDER; COMBAT EXPOSURE; RISK; ARMY; DEPRESSION; DIAGNOSES; SYMPTOMS; SCALE; PTSD	Objective: To characterize behavioral and health outcomes in veterans with traumatic brain injury (TBI) acquired in nondeployment and deployment settings. Design: Cross-sectional assessment evaluating TBI acquired during and outside of deployment, mental and behavioral health symptoms, and diagnoses. Setting: Veterans Affairs Medical Centers. Participants: Iraq and Afghanistan veterans who were deployed to a warzone (N=1399). Interventions: Not applicable. Main Outcome Measures: Comprehensive lifetime TBI interview, Structured Clinical Interview for DSM-IV Disorders, Combat Exposure Scale, and behavioral and health measures. Results: There was a main effect of deployment TBI on depressive symptoms, posttraumatic stress symptoms, poor sleep quality, substance use, and pain. Veterans with deployment TBI were also more likely to have a diagnosis of bipolar, major depressive, alcohol use, and posttraumatic stress disorders than those who did not have a deployment TBI. Conclusions: TBIs acquired during deployment are associated with different behavioral and health outcomes than TBI acquired in nondeployment environments. The presence of TBI during deployment is associated with poorer behavioral outcomes, as well as a greater lifetime prevalence of behavioral and health problems in contrast to veterans without deployment TBI. These results indicate that problems may persist chronically after a deployment TBI and should be considered when providing care for veterans. Veterans with deployment TBI may require treatment alterations to improve engagement and outcomes. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine.	[Martindale, Sarah L.; Epstein, Erica L.; Taber, Katherine H.; Rowland, Jared A.] Salisbury VA Hlth Care Syst, Res & Acad Affairs Serv Line, 1601 Brenner Ave, Salisbury, NC 28144 USA; [Martindale, Sarah L.; Epstein, Erica L.; Taber, Katherine H.; Rowland, Jared A.] VA Mid Atlantic Mental Illness Res Educ & Clin Ct, Durham, NC USA; [Martindale, Sarah L.; Rowland, Jared A.] Wake Forest Sch Med, Dept Psychiat & Behav Med, Winston Salem, NC USA; [Taber, Katherine H.] Via Coll Osteopath Med, Div Biomed Sci, Blacksburg, VA USA; [Taber, Katherine H.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA		Martindale, SL (corresponding author), Salisbury VA Hlth Care Syst, Res & Acad Affairs Serv Line, 1601 Brenner Ave, Salisbury, NC 28144 USA.	Martindale-Supak@va.gov	Martindale, Sarah L/O-8553-2018; Epstein, Erica/O-7698-2018; Taber, Katherine H/B-8260-2011; Rowland, Jared A./AAN-3030-2021	Martindale, Sarah L/0000-0002-0059-3454; Epstein, Erica/0000-0002-7316-8141; Taber, Katherine H/0000-0001-7382-6151; Rowland, Jared A./0000-0002-3655-3411	Department of Veterans Affairs Clinical Science Research and Development Career Development Award [IK2CX000718, IK2CX000525, 1IK2RX000703-01, 11K2RX000908, 1K2RX001298]	The VA Mid-Atlantic MIRECC Workgroup contributors for this paper include Mira Brancu, PhD; Jean C. Beckham, PhD; Patrick S. Calhoun, PhD; Eric Dedert, PhD; Eric B. Elbogen, PhD; John A. Fairbank, PhD; Kimberly T. Green, MS; Robin A. Hurley, MD; Jason D. Kilts, PhD; Nathan Kimbrel, PhD; Angela Kirby, MS; Christine E. Marx, MD, MS; Gregory McCarthy, PhD; Scott D. McDonald, PhD; Marinell Miller-Mumford, PhD; Scott D. Moore, MD, PhD; Rajendra A. Morey, MD, MS; Jennifer C. Naylor, PhD; Treven C. Pickett, PsyD; Jennifer J. Runnals, PhD; Cindy Swinkels, PhD; Steven T. Szabo, MD, PhD; Larry A. Tupler, PhD; Elizabeth E. Van Voorhees, PhD; H. Ryan Wagner, PhD; Richard D. Weiner, MD, PhD; Ruth E. Yoash-Gantz, PsyD. Dr. Dedert is funded by a Department of Veterans Affairs Clinical Science Research and Development Career Development Award (IK2CX000718). Dr. Kimbrel is funded by a Department of Veterans Affairs Clinical Science Research and Development Career Development Award (IK2CX000525). Dr. McDonald is funded by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (1IK2RX000703-01). Dr. Naylor is funded by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (11K2RX000908). Dr. Van Voorhees is funded by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (1K2RX001298).	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Babor T.F., 2001, AUDIT THE ALCOHOL US; Bagalman E, 2013, R40941 C RES SERV; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brancu M, 2017, INT J METH PSYCH RES, V26, P1; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cleeland CS., 2009, BRIEF PAIN INVENTORY; Conaton E., 2012, 649011 DODI; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; Defense and Veterans Brain Injury Center, 2015, DOD WORLDW NUMB TBI; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; First M.B., 1996, STRUCTURED CLIN INTE; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hill N, 2011, PHILOS T R SOC B, V366, P231, DOI 10.1098/rstb.2010.0213; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, JAMA-J AM MED ASSOC, V312, P1685, DOI 10.1001/jama.2014.6670; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kaup AR, 2017, J INT NEUROPSYCH SOC, V23, P56, DOI 10.1017/S1355617716000849; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Leo P, 2016, TRANSLATIONAL RES TR; Levy BS, 2013, LANCET, V381, P949, DOI 10.1016/S0140-6736(13)60254-8; LUND M, 1984, J CLIN PSYCHOL, V40, P1323, DOI 10.1002/1097-4679(198411)40:6<1323::AID-JCLP2270400607>3.0.CO;2-I; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Quartana PJ, 2015, J PSYCHOSOM RES, V78, P478, DOI 10.1016/j.jpsychores.2014.11.017; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Wells TS, 2010, AM J PUBLIC HEALTH, V100, P90, DOI 10.2105/AJPH.2008.155432; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	51	13	13	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2018	99	12					2485	2495		10.1016/j.apmr.2018.04.029			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HE2MW	WOS:000453113200010	29859179				2022-02-06	
J	Shackelford, SA; del Junco, DJ; Reade, MC; Bell, R; Becker, T; Gurney, J; McCafferty, R; Marion, DW				Shackelford, Stacy A.; del Junco, Deborah J.; Reade, Michael C.; Bell, Randy; Becker, Tyson; Gurney, Jennifer; McCafferty, Randall; Marion, Donald W.			Association of time to craniectomy with survival in patients with severe combat-related brain injury	NEUROSURGICAL FOCUS			English	Article						craniectomy; military trauma system; timing of craniectomy; severe traumatic brain injury	ACUTE SUBDURAL-HEMATOMA; EXTRADURAL HEMATOMA; DECOMPRESSIVE CRANIECTOMY; MORTALITY; OUTCOMES; SURGERY; HYPOTENSION; MORBIDITY; ADULTS	OBJECTIVE In combat and austere environments, evacuation to a location with neurosurgery capability is challenging. A planning target in terms of time to neurosurgery is paramount to inform prepositioning of neurosurgical and transport resources to support a population at risk. This study sought to examine the association of wait time to craniectomy with mortality in patients with severe combat-related brain injury who received decompressive craniectomy. METHODS Patients with combat-related brain injury sustained between 2005 and 2015 who underwent craniectomy at deployed surgical facilities were identified from the Department of Defense Trauma Registry and Joint Trauma System Role 2 Registry. Eligible patients survived transport to a hospital capable of diagnosing the need for craniectomy and performing surgery. Statistical analyses included unadjusted comparisons of postoperative mortality by elapsed time from injury to start of craniectomy, and Cox proportional hazards modeling adjusting for potential confounders. Time from injury to craniectomy was divided into quintiles, and explored in Cox models as a binary variable comparing early versus delayed craniectomy with cutoffs determined by the maximum value of each quintile (quintile 1 vs 2-5, quintiles 1-2 vs 3-5, etc.). Covariates included location of the facility at which the craniectomy was performed (limited-resource role 2 facility vs neurosurgically capable role 3 facility), use of head CT scan, US military status, age, head Abbreviated Injury Scale score, Injury Severity Score, and injury year. To reduce immortal time bias, time from injury to hospital arrival was included as a covariate, entry into the survival analysis cohort was defined as hospital arrival time, and early versus delayed craniectomy was modeled as a time-dependent covariate. Follow-up for survival ended at death, hospital discharge, or hospital day 16, whichever occurred first. RESULTS Of 486 patients identified as having undergone craniectomy, 213 (44%) had complete date/time values. Unadjusted postoperative mortality was 23% for quintile 1 (n = 43, time from injury to start of craniectomy 30-152 minutes); 7% for quintile 2 (n = 42, 154-210 minutes); 7% for quintile 3 (n = 43, 212-320 minutes); 19% for quintile 4 (n = 42, 325-639 minutes); and 14% for quintile 5 (n = 43, 665-3885 minutes). In Cox models adjusted for potential confounders and immortal time bias, postoperative mortality was significantly lower when time to craniectomy was within 5.33 hours of injury (quintiles 1-3) relative to longer delays (quintiles 4-5), with an adjusted hazard ratio of 0.28, 95% CI 0.10-0.76 (p = 0.012). CONCLUSIONS Postoperative mortality was significantly lower when craniectomy was initiated within 5.33 hours of injury. Further research to optimize craniectomy timing and mitigate delays is needed. Functional outcomes should also be evaluated.	[Shackelford, Stacy A.; del Junco, Deborah J.; Gurney, Jennifer] Def Ctr Excellence, Joint Trauma Syst, San Antonio, TX USA; [del Junco, Deborah J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Reade, Michael C.] Australian Def Force, Joint Hlth Command, Brisbane, Qld, Australia; [Bell, Randy] Walter Reed Natl Mil Med Ctr, Dept Neurosurg, Bethesda, MD USA; [Becker, Tyson] San Antonio Mil Med Ctr, Dept Surg, San Antonio, TX USA; [McCafferty, Randall] San Antonio Mil Med Ctr, Dept Neurosurg, San Antonio, TX USA; [Marion, Donald W.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA		Shackelford, SA (corresponding author), DHA, Combat Support, San Antonio, TX 78234 USA.	stacy.a.shackelford.mil@mail.mil	Marion, Donald/AAR-5749-2021; Reade, Michael/G-7035-2012	Reade, Michael/0000-0003-1570-0707			Arifin MZ, 2013, J NEUROSURG SCI, V57, P277; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Bell R, 2018, JOINT TRAUMA SYSTEM; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; COPES WS, 1995, J TRAUMA, V38, P432, DOI 10.1097/00005373-199503000-00027; De Vloo P, 2018, WORLD NEUROSURG, V114, pE546, DOI 10.1016/j.wneu.2018.03.032; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; Fountain DM, 2017, ANN SURG, V265, P590, DOI 10.1097/SLA.0000000000001682; GUTTERMAN P, 1970, J NEUROSURG, V32, P330, DOI 10.3171/jns.1970.32.3.0330; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JAMIESON KG, 1968, J NEUROSURG, V29, P13, DOI 10.3171/jns.1968.29.1.0013; Kim YJ, 2014, INT EMERG NURS, V22, P214, DOI 10.1016/j.ienj.2014.02.005; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; KVARNES TL, 1978, ACTA NEUROCHIR, V41, P223, DOI 10.1007/BF01809151; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Marshall SA, 2012, TRAUMATIC BRAIN INJU, P69; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; McCafferty R, 2017, JOINT TRAUMA SYSTEM; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; POON WS, 1991, INJURY, V22, P323, DOI 10.1016/0020-1383(91)90016-8; *ROYAL COLL SURG E, 1999, REP WORK PART MAN PA; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sergides IG, 2006, BRIT J NEUROSURG, V20, P301, DOI 10.1080/02688690600999976; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Spaite DW, 2017, ANN EMERG MED, V70, P522; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; STONE JL, 1983, SURG NEUROL, V19, P216, DOI 10.1016/S0090-3019(83)80005-6; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; Walcott BP, 2014, J CLIN NEUROSCI, V21, P2107, DOI 10.1016/j.jocn.2014.05.016; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	45	13	13	2	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	DEC	2018	45	6							E2	10.3171/2018.9.FOCUS18404			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HD6HR	WOS:000452637400002	30544314	gold			2022-02-06	
J	Aubrecht, TG; Faden, AI; Sabirzhanov, B; Glaser, EP; Roelofs, BA; Polster, BM; Makarevich, O; Stoica, BA				Aubrecht, Taryn G.; Faden, Alan I.; Sabirzhanov, Boris; Glaser, Ethan P.; Roelofs, Brian A.; Polster, Brian M.; Makarevich, Oleg; Stoica, Bogdan A.			Comparing effects of CDK inhibition and E2F1/2 ablation on neuronal cell death pathways in vitro and after traumatic brain injury	CELL DEATH & DISEASE			English	Article							CONTROLLED CORTICAL IMPACT; C-JUN PHOSPHORYLATION; DNA-DAMAGE; TERMINAL PHOSPHORYLATION; PROVIDES NEUROPROTECTION; LIMITS NEUROINFLAMMATION; PROMOTE SURVIVAL; APOPTOSIS; ACTIVATION; P53	Traumatic brain injury (TBI) activates multiple neuronal cell death mechanisms, leading to post-traumatic neuronal loss and neurological deficits. TBI-induced cell cycle activation (CCA) in post-mitotic neurons causes regulated cell death involving cyclin-dependent kinase (CDK) activation and initiation of an E2F transcription factor-mediated pro-apoptotic program. Here we examine the mechanisms of CCA-dependent neuronal apoptosis in primary neurons in vitro and in mice exposed to controlled cortical impact (CCI). In contrast to our prior work demonstrating robust neuroprotective effects by CDK inhibitors after TBI, examination of neuronal apoptotic mechanisms in E2F1(-/-)/E2F2(-/-) or E2F2(-/-) transgenic mice following CCI suggests that E2F1 and/or E2F2 likely play only a modest role in neuronal cell loss after brain trauma. To elucidate more critical CCA molecular pathways involved in post-traumatic neuronal cell death, we investigated the neuroprotective effects and mechanisms of the potent CDK inhibitor CR8 in a DNA damage model of cell death in primary cortical neurons. CR8 treatment significantly reduced caspase activation and cleavage of caspase substrates, attenuating neuronal cell death. CR8 neuroprotective effects appeared to reflect inhibition of multiple pathways converging on the mitochondrion, including injury-induced elevation of pro-apoptotic Bcl-2 homology region 3 (BH3)-only proteins Puma and Noxa, thereby attenuating mitochondrial permeabilization and release of cytochrome c and AIF, with reduction of both caspase-dependent and - independent apoptosis. CR8 administration also limited injury-induced deficits in mitochondrial respiration. These neuroprotective effects may be explained by CR8-mediated inhibition of key upstream injury responses, including attenuation of c-Jun phosphorylation/activation as well as inhibition of p53 transactivation of BH3-only targets.	[Aubrecht, Taryn G.; Faden, Alan I.; Sabirzhanov, Boris; Glaser, Ethan P.; Roelofs, Brian A.; Polster, Brian M.; Makarevich, Oleg; Stoica, Bogdan A.] Univ Maryland, Sch Med, Dept Anesthesiol & Shock, Trauma & Anesthesiol Res STAR Ctr, Baltimore, MD 21201 USA		Aubrecht, TG; Stoica, BA (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol & Shock, Trauma & Anesthesiol Res STAR Ctr, Baltimore, MD 21201 USA.	taubrecht@som.umaryland.edu; bstoica@som.umaryland.edu		Polster, Brian/0000-0003-2571-7510; Faden, Alan I./0000-0003-0128-2348	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS091191, R01 NS096002, R01 NS085165];  [F32 NS 096895]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS096895, R01NS096002, R01NS085165, R01NS091191] Funding Source: NIH RePORTER	T.G.A. was supported by F32 NS 096895. This work was supported by National Institutes of Health (NIH) grants R01 NS091191 to A.I.F., R01 NS096002 to B.A.S and B.S., and R01 NS085165 to B.M.P. Dr. Leone generously provided the E2F transgenic breeding pairs. We are grateful for the technical support provided by Xiaoyi Lin and Guanghui Li.	Ade KK, 2016, BIOL PSYCHIAT, V80, P522, DOI 10.1016/j.biopsych.2016.04.023; Akhter R, 2015, J NEUROCHEM, V134, P1091, DOI 10.1111/jnc.13128; Arbour N, 2008, J NEUROSCI, V28, P6068, DOI 10.1523/JNEUROSCI.4940-07.2008; Besirli CG, 2005, J CELL BIOL, V170, P401, DOI 10.1083/jcb.200501138; Besirli CG, 2003, J BIOL CHEM, V278, P22357, DOI 10.1074/jbc.M300742200; Bettayeb K, 2008, ONCOGENE, V27, P5797, DOI 10.1038/onc.2008.191; Bettayeb Karima, 2010, Genes Cancer, V1, P369, DOI 10.1177/1947601910369817; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Chen D, 2013, CELL DEATH DIFFER, V20, P931, DOI 10.1038/cdd.2013.24; Cho YY, 2009, CANCER RES, V69, P272, DOI 10.1158/0008-5472.CAN-08-3125; Clerc P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034465; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; DeGregori J, 2006, CURR MOL MED, V6, P739; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Dyson HJ, 2016, J BIOL CHEM, V291, P6714, DOI 10.1074/jbc.R115.692020; Faul M, 2010, TRAUMATIC BRAIN INJU; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Frade JM, 2015, CELL CYCLE, V14, P712, DOI 10.1080/15384101.2015.1004937; Furukawa Y, 2002, J BIOL CHEM, V277, P39760, DOI 10.1074/jbc.M200805200; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Gardoni F, 2002, EUR J NEUROSCI, V16, P777, DOI 10.1046/j.1460-9568.2002.02141.x; Gendron TF, 2001, J NEUROCHEM, V78, P316, DOI 10.1046/j.1471-4159.2001.00423.x; Guadagno J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.151; Herdegen T, 1998, J NEUROSCI, V18, P5124, DOI 10.1523/JNEUROSCI.18-14-05124.1998; Ho DH, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0145-7; Iyirhiaro GO, 2014, J BIOL CHEM, V289, P18202, DOI 10.1074/jbc.M114.574145; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; Lee JH, 2007, J CELL SCI, V120, P2259, DOI 10.1242/jcs.03468; Liu W, 2013, J MOL HISTOL, V44, P147, DOI 10.1007/s10735-013-9481-z; MacManus JP, 2003, J CEREBR BLOOD F MET, V23, P1020, DOI 10.1097/01.WCB.0000084249.20114.FA; Martinez LA, 2010, MOL CELL BIOL, V30, P524, DOI 10.1128/MCB.00938-09; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Nam C, 2010, HISTOL HISTOPATHOL, V25, P485, DOI 10.14670/HH-25.485; Nikhil K, 2017, J CELL SCI, V130, P3023, DOI 10.1242/jcs.205666; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Park DS, 1997, J NEUROSCI, V17, P8975; Park DS, 1996, J BIOL CHEM, V271, P8161, DOI 10.1074/jbc.271.14.8161; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Putkonen N, 2011, EUR J NEUROSCI, V34, P1212, DOI 10.1111/j.1460-9568.2011.07858.x; Saavedra HI, 2002, CELL GROWTH DIFFER, V13, P215; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sabirzhanov B, 2018, J NEUROTRAUM, V35, P2462, DOI 10.1089/neu.2017.5572; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Semple B. D., 2012, TRAUMATIC BRAIN SPIN, V155; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Stoica BA, 2003, MOL CELL NEUROSCI, V22, P365, DOI 10.1016/S1044-7431(02)00028-3; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Ting JH, 2014, J NEUROCHEM, V129, P850, DOI 10.1111/jnc.12655; Toh WH, 2004, J BIOL CHEM, V279, P44713, DOI 10.1074/jbc.M407672200; Vanden Bush TJ, 2011, PLOS ONE, V6, pe19468, DOI 10.1371/journal.pone.0019468; Wu JF, 2015, CELL CYCLE, V14, P3698, DOI 10.1080/15384101.2015.1104436; Wu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044027, 10.1371/journal.pone.0046393]; Wyttenbach A, 2006, J NEUROCHEM, V96, P1213, DOI 10.1111/j.1471-4159.2005.03676.x; Yoshida K, 2002, INVEST OPHTH VIS SCI, V43, P1631; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739	72	13	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	NOV 6	2018	9								1121	10.1038/s41419-018-1156-y			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	GZ5QS	WOS:000449481900001	30401820	Green Published, gold			2022-02-06	
J	Castle, MJ; Cheng, YH; Asokan, A; Tuszynski, MH				Castle, Michael J.; Cheng, Yuhsiang; Asokan, Aravind; Tuszynski, Mark H.			Physical positioning markedly enhances brain transduction after intrathecal AAV9 infusion	SCIENCE ADVANCES			English	Article							CENTRAL-NERVOUS-SYSTEM; GENE-THERAPY; PRIMATE MODELS; ADULT MICE; DELIVERY; NEURONS; EXPRESSION; VECTORS; DISEASE; CORTEX	Several neurological disorders may benefit from gene therapy. However, even when using the lead vector candidate for intrathecal administration, adeno-associated virus serotype 9 (AAV9), the strength and distribution of gene transfer to the brain are inconsistent. On the basis of preliminary observations that standard intrathecal AAV9 infusions predominantly drive reporter gene expression in brain regions where gravity might cause cerebrospinal fluid to settle, we tested the hypothesis that counteracting vector "settling" through animal positioning would enhance vector delivery to the brain. When rats are either inverted in the Trendelenburg position or continuously rotated after intrathecal AAV9 infusion, we find (i) a significant 15-fold increase in the number of transduced neurons, (ii) a marked increase in gene delivery to cortical regions, and (iii) superior animal-to-animal consistency of gene expression. Entorhinal, prefrontal, frontal, parietal, hippocampal, limbic, and basal forebrain neurons are extensively transduced: 95% of transduced cells are neurons, and greater than 70% are excitatory. These findings provide a novel and simple method for broad gene delivery to the cortex and are of substantial relevance to translational programs for neurological disorders, including Alzheimer's disease and related dementias, stroke, and traumatic brain injury.	[Castle, Michael J.; Cheng, Yuhsiang; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Asokan, Aravind] Univ North Carolina Chapel Hill, Gene Therapy Ctr, Chapel Hill, NC 27599 USA; [Asokan, Aravind] Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA; [Asokan, Aravind] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Tuszynski, Mark H.] Vet Adm Med Ctr, 3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Asokan, Aravind] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Dept Surg, 203 Res Dr,MSRB1, Durham, NC 27710 USA		Castle, MJ; Tuszynski, MH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.; Tuszynski, MH (corresponding author), Vet Adm Med Ctr, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	mcastle@ucsd.edu; mtuszynski@ucsd.edu		Castle, Michael/0000-0001-7566-6454; Asokan, Aravind/0000-0001-5563-4877	Veteran's AdministrationUS Department of Veterans Affairs; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG10435, AG043416, T32AG000216, R01NS099371]; Alzheimer's Association Zenith AwardAlzheimer's Association; Alzheimer's Association Research Fellowship [16-443284]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL089221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS099371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000216, U01AG043416] Funding Source: NIH RePORTER	This project was supported by the Veteran's Administration; NIH awards AG10435 (to M.H.T.), AG043416 (to M.H.T.), T32AG000216 (to M.J.C.), and R01NS099371 (to A.A.); and the Alzheimer's Association Zenith Award (to M.H.T.) and Alzheimer's Association Research Fellowship 16-443284 (to M.J.C.).	Bangaru MLY, 2015, NEUROSCIENCE, V300, P116, DOI 10.1016/j.neuroscience.2015.05.007; Bankiewicz KS, 2006, MOL THER, V14, P564, DOI 10.1016/j.ymthe.2006.05.005; Bey K, 2017, GENE THER, V24, P325, DOI 10.1038/gt.2017.18; Bucher T, 2014, GENE THER, V21, P522, DOI 10.1038/gt.2014.16; Carty N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059626; Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593; ClinicalTrials. gov, STUD INTR ADM AVXS 1; ClinicalTrials. gov, INTR ADM SCAAV9 JET; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Fink DJ, 2011, ANN NEUROL, V70, P207, DOI 10.1002/ana.22446; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Fu HY, 2003, MOL THER, V8, P911, DOI 10.1016/j.ymthe.2003.08.021; Gray SJ, 2013, GENE THER, V20, P450, DOI 10.1038/gt.2012.101; Gray SJ, 2011, MOL THER, V19, P1058, DOI 10.1038/mt.2011.72; Gritti I, 2006, NEUROSCIENCE, V143, P1051, DOI 10.1016/j.neuroscience.2006.09.024; Hinderer C, 2018, HUM GENE THER, V29, P15, DOI 10.1089/hum.2017.026; Hordeaux J, 2015, GENE THER, V22, P316, DOI 10.1038/gt.2014.121; Hordeaux J, 2018, MOL THER, V26, P664, DOI 10.1016/j.ymthe.2018.01.018; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; Kordower JH, 2006, ANN NEUROL, V60, P706, DOI 10.1002/ana.21032; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; Matsuzaki Y, 2018, NEUROSCI LETT, V665, P182, DOI 10.1016/j.neulet.2017.11.049; Matsuzaki Y, 2017, MOL NEUROBIOL, V54, P1745, DOI 10.1007/s12035-016-9777-6; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Meyer K, 2015, MOL THER, V23, P477, DOI 10.1038/mt.2014.210; Murlidharan G, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88034; Nagahara AH, 2013, J NEUROSCI, V33, P15596, DOI 10.1523/JNEUROSCI.5195-12.2013; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Samaranch L, 2013, HUM GENE THER, V24, P526, DOI 10.1089/hum.2013.005; Samaranch L, 2012, HUM GENE THER, V23, P382, DOI 10.1089/hum.2011.200; Schuster DJ, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00042; Sen T, 2011, SINGAP MED J, V52, P410; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Vulchanova L, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-31; Warrell D.A., 2010, OXFORD TXB MED; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Zhao LZ, 2016, NEUROBIOL AGING, V44, P159, DOI 10.1016/j.neurobiolaging.2016.04.020	41	13	13	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	NOV	2018	4	11							eaau9859	10.1126/sciadv.aau9859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QK	WOS:000452212000074	30443600	Green Published, gold			2022-02-06	
J	Clark, AL; Sorg, SF; Holiday, K; Bigler, ED; Bangen, KJ; Evangelista, ND; Bondi, MW; Schiehser, DM; Delano-Wood, L				Clark, Alexandra L.; Sorg, Scott F.; Holiday, Kelsey; Bigler, Erin D.; Bangen, Katherine J.; Evangelista, Nicole D.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa			Fatigue Is Associated With Global and Regional Thalamic Morphometry in Veterans With a History of Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						central fatigue; fatigue; mild traumatic brain injury; mTBI; thalamic morphometry; thalamic shape; thalamic volume; thalamus; Veterans	1ST 2 YEARS; COGNITIVE FATIGUE; VOLUME; INTEGRITY; SYMPTOMS; IMPACT; INFLAMMATION; CONNECTIVITY; ATROPHY; NUCLEI	Objective: Fatigue is a complex, multidimensional phenomenon that commonly occurs following traumatic brain injury (TBI). The thalamusa structure vulnerable to both primary and secondary injuries in TBIis thought to play a pivotal role in the manifestation of fatigue. We explored how neuroimaging markers of local and global thalamic morphometry relate to the subjective experience of fatigue post-TBI. Methods: Sixty-three Veterans with a history of mild TBI underwent structural magnetic resonance imaging and completed questionnaires related to fatigue and psychiatric symptoms. FMRIB's Software (FSL) was utilized to obtain whole brain and thalamic volume estimates, as well as to perform regional thalamic morphometry analyses. Results: Independent of age, sex, intracranial volume, posttraumatic stress disorder, and depressive symptoms, greater levels of self-reported fatigue were significantly associated with decreased right (P = .026) and left (P = .046) thalamic volumes. Regional morphometry analyses revealed that fatigue was significantly associated with reductions in the anterior and dorsomedial aspects of the right thalamic body (P < .05). Similar trends were observed for the left thalamic body (P < .10). Conclusions: Both global and regional thalamic morphometric changes are associated with the subjective experience of fatigue in Veterans with a history of mild TBI. These findings support a theory in which disruption of thalamocorticostriatal circuitry may result in the manifestation of fatigue in individuals with a history of neurotrauma.	[Clark, Alexandra L.; Holiday, Kelsey] San Diego State Univ Univ Calif San Diego SDSU UC, San Diego, CA USA; [Clark, Alexandra L.; Sorg, Scott F.; Holiday, Kelsey; Bangen, Katherine J.; Evangelista, Nicole D.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa] VASDHS, San Diego, CA USA; [Schiehser, Dawn M.; Delano-Wood, Lisa] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Sorg, Scott F.; Bangen, Katherine J.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa] Univ Calif San Diego, Sch Med, Dept Psychiat, 9500 Gillman Dr, La Jolla, CA 92093 USA; [Bigler, Erin D.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA		Delano-Wood, L (corresponding author), VA San Diego Healthcare Syst 151B, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ldelano@ucsd.edu			Veterans AffairsUS Department of Veterans Affairs [829-MR-NB-25860, CDA-2-065-10S, CDA-2-CX001508]; Department of DefenseUnited States Department of Defense [W81XWH-10-2-0169]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS09870]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS098704] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2CX001508, I01CX000842] Funding Source: NIH RePORTER	This work was supported by Veterans Affairs grants awarded to Drs Delano-Wood (829-MR-NB-25860), Schiehser (CDA-2-065-10S), and Sorg (CDA-2-CX001508). This work was further supported by grants awarded by the Department of Defense (W81XWH-10-2-0169) to Dr Delano-Wood and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (F31NS09870) to Ms Clark.	Abe O, 2008, NEUROBIOL AGING, V29, P102, DOI 10.1016/j.neurobiolaging.2006.09.003; Anderson CV, 1996, J NEUROTRAUM, V13, P35, DOI 10.1089/neu.1996.13.35; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Berginstrom N, 2018, J HEAD TRAUMA REHAB, V33, P266, DOI 10.1097/HTR.0000000000000340; Bernitsas E, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080102; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Cherubini A, 2009, NEUROIMAGE, V48, P29, DOI 10.1016/j.neuroimage.2009.06.035; Clark AL, 2017, BRAIN IMAGING BEHAV, V11, P1548, DOI 10.1007/s11682-016-9594-6; Clark AL, 2017, NEUROIMAGE-CLIN, V14, P308, DOI 10.1016/j.nicl.2016.12.017; Clark AL, 2016, J HEAD TRAUMA REHAB, V31, P346, DOI 10.1097/HTR.0000000000000183; Damasceno A, 2016, MULT SCLER J, V22, P822, DOI 10.1177/1352458515599451; Dobryakova E, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00052; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Fernandez-Espejo D, 2010, J NEUROTRAUM, V27, P1187, DOI 10.1089/neu.2010.1297; Finke C, 2015, MULT SCLER J, V21, P925, DOI 10.1177/1352458514555784; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Genova HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078811; Gooijers J, 2016, NEUROREHAB NEURAL RE, V30, P603, DOI 10.1177/1545968315613448; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lutkenhoff ES, 2013, NEUROIMAGE-CLIN, V3, P396, DOI 10.1016/j.nicl.2013.09.010; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Miller AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098156; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Nakajima M, 2017, CURR OPIN NEUROBIOL, V44, P127, DOI 10.1016/j.conb.2017.04.001; Nathan DE, 2017, BRAIN CONNECT, V7, P236, DOI 10.1089/brain.2016.0433; Nourbakhsh B, 2016, MULT SCLER RELAT DIS, V5, P29, DOI 10.1016/j.msard.2015.10.006; Okada T, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-14; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ota M, 2007, NEUROREPORT, V18, P1071, DOI 10.1097/WNR.0b013e3281c10e27; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pauls KAM, 2014, MOVEMENT DISORD, V29, P953, DOI 10.1002/mds.25884; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Roy-Byrne P, 2004, PSYCHOL MED, V34, P363, DOI 10.1017/S0033291703008894; Schiehser DM, 2017, NEUROPSYCHOL REHABIL, V27, P1031, DOI 10.1080/09602011.2016.1215999; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, P116, DOI 10.1097/HTR.0000000000000019; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Siegert RJ, 2009, J INT NEUROPSYCH SOC, V15, P142, DOI 10.1017/S1355617708090048; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P550, DOI 10.1007/s11682-015-9424-2; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; SPSS, 2012, IBM SPSS STAT VERS 2, P126; Sun LH, 2015, NEUROPSYCHOLOGIA, V78, P88, DOI 10.1016/j.neuropsychologia.2015.10.001; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tatel DF, 2016, J NEUROL, V263, P2065, DOI 10.1007/s00415-016-8236-7; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Weathers F.W., 1993, ANN CONV INT SOC TRA; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wylie GR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08846-6; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Yeo SS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00416; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310	73	13	13	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2018	33	6					382	392		10.1097/HTR.0000000000000377			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QK	WOS:000450886600014	29385016	Green Accepted			2022-02-06	
J	Clifton, DR; Onate, JA; Hertel, J; Pierpoint, LA; Currie, DW; Wasserman, EB; Knowles, SB; Dompier, TP; Marshall, SW; Comstock, RD; Kerr, ZY				Clifton, Daniel R.; Onate, James A.; Hertel, Jay; Pierpoint, Lauren A.; Currie, Dustin W.; Wasserman, Erin B.; Knowles, Sarah B.; Dompier, Thomas P.; Marshall, Stephen W.; Comstock, R. Dawn; Kerr, Zachary Y.			The First Decade of Web-Based Sports Injury Surveillance: Descriptive Epidemiology of Injuries in US High School Boys' Basketball (2005-2006 Through 2013-2014) and National Collegiate Athletic Association Men's Basketball (2004-2005 Through 2013-2014)	JOURNAL OF ATHLETIC TRAINING			English	Article						injury surveillance; basketball; males	ANTERIOR CRUCIATE LIGAMENT; TRAINING-PROGRAM; FOOTBALL; RISK; PREVENTION; SYSTEM; PLAYERS; LEVEL; RATES	Context: The advent of Web-based sports injury surveillance via programs such as the High School Reporting Information Online system and the National Collegiate Athletic Association Injury Surveillance Program has aided the acquisition of boys' and men's basketball injury data. Objective: To describe the epidemiology of injuries sustained in high school boys' basketball in the 2005-2006 through 2013-2014 academic years and collegiate men's basketball in the 2004-2005 through 2013-2014 academic years using Web-based sports injury surveillance. Design: Descriptive epidemiology study. Setting: Online injury surveillance from basketball teams of high school boys (annual average = 100) and collegiate men (annual average = 55). Patients or Other Participants: Boys' and men's basketball players who participated in practices and competitions during the 2005-2006 through 2013-2014 academic years in high school or the 2004-2005 through 2013-2014 academic years in college. Main Outcome Measures: Athletic trainers collected time-loss (>= 24 hours) injury and exposure data. Injury rates per 1000 athlete-exposures (AEs) were calculated. Injury rate ratios (IRRs) with 95% confidence intervals (CIs) compared injury rates by school size or division, time in season, event type, and competition level. Results: The High School Reporting Information Online system documented 3056 time-loss injuries during 1 977 480 AEs; the National Collegiate Athletic Association Injury Surveillance Program documented 4607 time-loss injuries during 868 631 AEs. The injury rate was higher for college than for high school (5.30 versus 1.55/1000 AE; IRR = 3.43; 95% CI = 3.28, 3.59). The injury rate was higher for competitions than for practices in both high school (IRR = 2.38; 95% CI = 2.22, 2.56) and college (IRR = 2.02; 95% CI = 1.90, 2.14). The most common injuries at both levels were ligament sprains, muscle/tendon strains, and concussions; most injuries affected the ankle, knee, and head/face. Injuries were most often caused by contact with another player or noncontact mechanisms. Conclusions: Injury rates were greater among collegiate players compared with high school players and were greater during competitions than practices at both levels. Distributions of injuries by body part, diagnoses, and mechanisms of injury were similar, suggesting that athletes at both levels may benefit from similar injury-prevention strategies.	[Clifton, Daniel R.; Onate, James A.] Ohio State Univ, Sch Hlth & Rehabil Sci, Div Athlet Training, Columbus, OH 43210 USA; [Onate, James A.] Ohio State Univ, Wexner Med Ctr, Jameson Crane Sports Med Res Inst, Columbus, OH 43210 USA; [Hertel, Jay] Univ Virginia, Dept Kinesiol & Orthopaed Surg, Charlottesville, VA USA; [Pierpoint, Lauren A.; Currie, Dustin W.; Comstock, R. Dawn] Univ Colorado Anschutz, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Knowles, Sarah B.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Knowles, Sarah B.] Palo Alto Med Fdn Res Inst, Palo Alto, CA USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Annville, PA USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Marshall, Stephen W.; Comstock, R. Dawn; Kerr, Zachary Y.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym CB 8700, Chapel Hill, NC 27599 USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu		Wasserman, Erin/0000-0001-5957-5878; Clifton, Daniel/0000-0003-3857-124X	NCAA; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025754]; National Federation of State High School Associations (Indianapolis, IN); National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); DonJoy Orthotics (Vista, CA); EyeBlack (Potomac, MD)	The NCAA-ISP data were provided by the Datalys Center for Sports Injury Research and Prevention. The ISP was funded by the NCAA. Funding for HS RIO was provided in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01 and the National Center for Research Resources award KL2 RR025754). The authors also acknowledge the research funding contributions of the National Federation of State High School Associations (Indianapolis, IN), the National Operating Committee on Standards for Athletic Equipment (Overland Park, KS), DonJoy Orthotics (Vista, CA), and EyeBlack (Potomac, MD). The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. We thank the many ATs who have volunteered their time and efforts to submit data to HS RIO and the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of high school and collegiate student-athletes.	[Anonymous], 2014, 2014 15 SPORTS MED H; [Anonymous], 2015, 2015 2016 2016 2017; Beynnon BD, 2014, AM J SPORT MED, V42, P1806, DOI 10.1177/0363546514540862; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Chomiak J, 2000, AM J SPORT MED, V28, pS58; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Dick R, 2007, J ATHL TRAINING, V42, P278; Dick R, 2007, J ATHL TRAINING, V42, P194; Dragoo JL, 2012, AM J SPORT MED, V40, P990, DOI 10.1177/0363546512442336; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Feeley BT, 2008, AM J SPORT MED, V36, P1597, DOI 10.1177/0363546508316021; FURBY L, 1992, DEV REV, V12, P1, DOI 10.1016/0273-2297(92)90002-J; Giza E, 2005, BRIT J SPORT MED, V39, P212, DOI 10.1136/bjsm.2004.011973; Harmon KG, 1998, CLIN J SPORT MED, V8, P260, DOI 10.1097/00042752-199810000-00002; Holme E, 1999, SCAND J MED SCI SPOR, V9, P104; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hopper Diana M., 1995, Journal of Sports Sciences, V13, P213, DOI 10.1080/02640419508732230; Hosea TM, 2000, CLIN ORTHOP RELAT R, P45; Joseph AM, 2013, J ATHL TRAINING, V48, P810, DOI 10.4085/1062-6050-48.6.03; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kreck C, 2014, STATES ADDRESS CONCE; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Longo UG, 2012, AM J SPORT MED, V40, P996, DOI 10.1177/0363546512438761; Mandelbaum BR, 2005, AM J SPORT MED, V33, P1003, DOI 10.1177/0363546504272261; McGuine TA, 2006, AM J SPORT MED, V34, P1103, DOI 10.1177/0363546505284191; McGuine TA, 2012, AM J SPORT MED, V40, P49, DOI 10.1177/0363546511422332; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Reeser JC, 2015, SPORTS HEALTH, V7, P504, DOI 10.1177/1941738115600143; Silvers-Granelli H, 2015, AM J SPORT MED, V43, P2628, DOI 10.1177/0363546515602009; Tolbert TA, 2011, STRENGTH COND J, V33, P82, DOI 10.1519/SSC.0b013e31821e2f93; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002	32	13	13	1	6	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV	2018	53	11					1025	1036		10.4085/1062-6050-148-17			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HH3VE	WOS:000455647200002	30715912	gold, Green Published			2022-02-06	
J	Katzenellenbogen, JM; Atkins, E; Thompson, SC; Hersh, D; Coffin, J; Flicker, L; Hayward, C; Ciccone, N; Woods, D; Greenland, ME; McAllister, M; Armstrong, EM				Katzenellenbogen, Judith M.; Atkins, Emily; Thompson, Sandra C.; Hersh, Deborah; Coffin, Juli; Flicker, Leon; Hayward, Colleen; Ciccone, Natalie; Woods, Deborah; Greenland, Melanie E.; McAllister, Meaghan; Armstrong, Elizabeth M.			Missing Voices: Profile, Extent, and 12-Month Outcomes of Nonfatal Traumatic Brain Injury in Aboriginal and Non-Aboriginal Adults in Western Australia Using Linked Administrative Records	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Aboriginal; acquired communication disorder; Australia; epidemiology; indigenous; rehabilitation; traumatic brain injury	ACQUIRED COMMUNICATION DISORDERS; NEW-SOUTH-WALES; INDIGENOUS AUSTRALIANS; REHABILITATION; COMORBIDITIES; EPIDEMIOLOGY; SERVICES; PEOPLE; NEED	Objective: To investigate differences in the profile and outcomes between Aboriginal and non-Aboriginal Western Australians (WAs) hospitalized with traumatic brain injury (TBI). Setting: WA hospitals. Participants: TBI cases aged 15 to 79 years surviving their first admission during 2002-2011. Design: Patients identified from diagnostic codes and followed up for 12 months or more using WA-wide person-based linked hospital and mortality data. Main Measures: Demographic profile, 5-year comorbidity history, injury mechanism, injury severity, 12-month readmission, and mortality risks. Determinants of 12-month readmission. Results: Of 16 601 TBI survivors, 14% were Aboriginal. Aboriginal patients were more likely to be female, live remotely, and have comorbidities. The mechanism of injury was an assault in 57% of Aboriginal patients (vs 20%) and transport in 33% of non-Aboriginal patients (vs 17%), varying by remoteness. One in 10 Aboriginal TBI patients discharged themselves against medical advice. Crude 12-month readmission but not mortality risk was significantly higher in Aboriginal patients (48% vs 36%). The effect of age, sex, and injury mechanism on 12-month readmission was different for Aboriginal and non-Aboriginal patients. Conclusion: These findings suggest an urgent need for multisectoral primary prevention of TBI, as well as culturally secure and logistically appropriate medical and rehabilitation service delivery models to optimize outcomes.	[Katzenellenbogen, Judith M.; Atkins, Emily; Thompson, Sandra C.; Greenland, Melanie E.] Univ Western Australia, Sch Populat & Global Hlth, 35 Stirling Highway,GPO Box U1987, Perth, WA 6009, Australia; [Katzenellenbogen, Judith M.; Coffin, Juli] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA, Australia; [Flicker, Leon] Univ Western Australia, Western Australian Ctr Hlth & Ageing, Med Res Ctr, Perth, WA, Australia; [Atkins, Emily] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia; [Hersh, Deborah; Ciccone, Natalie; McAllister, Meaghan; Armstrong, Elizabeth M.] Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia; [Coffin, Juli; Woods, Deborah] Geraldton Reg Aboriginal Med Serv, Rangeway, Australia; [Coffin, Juli] Univ Notre Dame, Broome Campus, Broome, Australia; [Hayward, Colleen] Edith Cowan Univ, Kurongkurl Katitjin Ctr Indigenous Australian Edu, Mt Lawley, Australia		Katzenellenbogen, JM (corresponding author), Univ Western Australia, Sch Populat & Global Hlth, 35 Stirling Highway,GPO Box U1987, Perth, WA 6009, Australia.	Judith.katzenellenbogen@uwa.edu.au	Atkins, Emily R/J-5504-2013; Thompson, Sandra/H-5955-2014	Atkins, Emily R/0000-0003-2522-3510; Thompson, Sandra/0000-0003-0327-7155; Greenland, Melanie/0000-0001-9363-8844; Flicker, Leon/0000-0002-3650-0475; Ciccone, Natalie/0000-0002-1822-7217; Katzenellenbogen, Judith/0000-0001-5287-5819	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [1046228]; Australian Heart Foundation Future Leader Fellowship [100807]; Australian Government's Department of HealthAustralian GovernmentDepartment of Health & Ageing	This work was supported by the National Health and Medical Research Council of Australia (grant number 1046228). J.M.K. is funded by an Australian Heart Foundation Future Leader Fellowship (grant number 100807). The Western Australians Centre for Rural Health received funding from the Australian Government's Department of Health.	Aboriginal and Torres Strait Islander Social Justice Commissioner, 2010, SOC JUST REP 2010; Alfandre DJ, 2009, MAYO CLIN PROC, V84, P255, DOI 10.1016/S0025-6196(11)61143-9; Armstrong E, 2015, MISSING VOICES ABORI; Armstrong E, 2015, BRAIN IMPAIR, V16, P145, DOI 10.1017/BrImp.2015.15; Armstrong EM, 2017, INT J SPEECH-LANG PA, V19, P297, DOI 10.1080/17549507.2017.1290136; Australian Bureau of Statistics, 2011, SOC IND AR GETT HAND; Australian Health Ministers' Advisory Council, 2017, AB TORR STRAIT ISL H; Australian Institute of Health and Welfare, 2004, RUR REG REM HLTH GUI; Australian Institute of Health and Welfare (AIHW), 2016, AUSTR BURD DIS STUD; Ballestas T, 2011, EPIDEMIOLOGY INJURY; Bohanna I, 2013, ASSESSMENT ACQUIRED; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Choi MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022362; Christensen D, 2014, AUST J SOC ISSUES, V49, P423, DOI 10.1002/j.1839-4655.2014.tb00322.x; Code, 2014, SOCIAL COMMUNICATION, P1; Coffin Juli, 2007, ABORIGINAL ISLANDER, V31, P22; Cunningham J, 2013, HEALTH INF MANAG J, V42, P4, DOI 10.1177/183335831304200303; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gauld S, 2011, DISABIL REHABIL, V33, P1901, DOI 10.3109/09638288.2010.550382; Gilroy J, 2017, DISABIL REHABIL, V39, P1664, DOI 10.1080/09638288.2016.1201151; Helps YLM, 2006, HOSP INJURY AUSTR AB; Henley G., 2009, INJURY SEVERITY SCAL; Hersh D, 2015, DISABIL REHABIL, V37, P33, DOI 10.3109/09638288.2014.890675; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Karmali S, 2005, CAN MED ASSOC J, V172, P1007, DOI 10.1503/cmaj.1040432; Katzenellenbogen JM, 2016, INT J STROKE, V11, P103, DOI 10.1177/1747493015607521; Katzenellenbogen JM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-330; Kendall E, 2004, REHABIL PSYCHOL, V49, P5, DOI 10.1037/0090-5550.49.1.5; Lasry Oliver, 2016, CMAJ Open, V4, pE249, DOI 10.9778/cmajo.20150105; Lowell A, 2012, INT J SPEECH-LANG PA, V14, P200, DOI 10.3109/17549507.2012.663791; Mitsch V, 2014, BRAIN INJURY, V28, P1504, DOI 10.3109/02699052.2014.938120; O'Neill M, 1993, DOUBLE DISADVANTAGE; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Productivity Commission, 2011, DIS CAR SUPP INQ REP, V2; Productivity Commission, 2011, DIS CAR SUPP INQ REP, V1; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Shahid S, 2011, AUST HEALTH REV, V35, P235, DOI 10.1071/AH09835; Simpson GK, 2016, J HEAD TRAUMA REHAB, V31, pE26, DOI 10.1097/HTR.0000000000000160; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; System Performance and Aboriginal Policy Unit, 2002, AB CULT SEC OUTL POL; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Tovell A, 2012, HOSP SEPARATIONS DUE	44	13	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2018	33	6					412	423		10.1097/HTR.0000000000000371			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QK	WOS:000450886600017	29601340				2022-02-06	
J	MacManus, DB; Murphy, JG; Gilchrist, MD				MacManus, David B.; Murphy, Jeremiah G.; Gilchrist, Michael D.			Mechanical characterisation of brain tissue up to 35% strain at 1, 10, and 100/s using a custom-built micro-indentation apparatus	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Traumatic brain injury; Micro-indentation; Custom-built apparatus; Constitutive model	VISCOELASTIC PROPERTIES; MOUSE-BRAIN; HEAD; MODELS; EXAMINE; NEURONS; LEVEL; CELLS; SHEAR	Understanding the behaviour of soft tissues under large strains and high loading rates is crucial in the field of biomechanics in order to investigate tissue behaviour during pathological processes such as traumatic brain injury (TBI). It is, therefore, necessary to characterise the mechanical properties of such tissues under large strain and high strain rates that are similar to those experienced during injury. However, there is a dearth of large strain and high rate mechanical properties for brain tissue. This is likely driven by the lack of commercially available equipment to perform such tests and the difficulties associated with developing appropriate custom-built apparatus. Here, we address this problem by presenting a novel, custom-built micro-indentation apparatus that is capable of characterising the mechanical properties of brain tissue up to 35% at 100/s with a spatial resolution of 250 mu m. Indentations were performed on the cortex and cerebellum of five-week-old mouse brains up to 35% strain at 1, 10, and 100/s. Three hyperelastic models were fitted to the experimental data that demonstrate the strong rate-dependency of the tissue. The neo-Hookean shear modulus for the cortex tissue was calculated to be 2.36 +/- 0.46, 3.64 +/- 0.48, and 8.98 +/- 0.66 kPa (mean +/- SD) for 1, 10, and 100/s, respectively. Similarly, the cerebellum shear modulus was calculated to be 1.12 +/- 0.26, 1.58 +/- 0.32, 3.10 +/- 0.70 kPa for 1, 10, and 100/s, respectively. Student's t-tests were used to show statistically significant differences between the cortex and cerebellum at each strain rate. Furthermore, we discuss the apparent strain-softening effect in the 100/s force-displacement curves for both regions after approximately 30% strain.	[MacManus, David B.; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Murphy, Jeremiah G.] Dublin City Univ, Sch Mech & Mfg Engn, Dublin, Ireland		MacManus, DB (corresponding author), Univ Coll Dublin, Engn & Mat Sci Ctr, Dublin 4, Ireland.	david.macmanus@ucd.ie		MacManus, David/0000-0003-2959-698X	Science Foundation IrelandScience Foundation IrelandEuropean Commission [12/IP/1732]	This work was made possible by Science Foundation Ireland (Grant no. 12/IP/1732).	Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bernick K.B, 2010, P 27 ARM SCI C ORL; Bernick KB, 2011, ACTA BIOMATER, V7, P1210, DOI 10.1016/j.actbio.2010.10.018; Bilston L. E, 2016, INFLUENCE MICROSTRUC, P1; BOX GEP, 1951, J R STAT SOC B, V13, P1, DOI 10.1111/j.2517-6161.1951.tb00067.x; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Colgan NC, 2010, PROG BIOPHYS MOL BIO, V103, P304, DOI 10.1016/j.pbiomolbio.2010.09.008; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; DeFelipe J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00029; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrer I, 2007, J NEUROPATHOL EXP NE, V66; Finan JD, 2017, ACTA BIOMATER, V55, P333, DOI 10.1016/j.actbio.2017.03.037; Finan JD, 2014, BIOMECH MODEL MECHAN, V13, P573, DOI 10.1007/s10237-013-0519-7; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; Fountoulakis M, 2001, EXP NEUROL, V167, P86, DOI 10.1006/exnr.2000.7529; Fox, 2005, INTRO THEORY ELASTIC; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Johnson K.L., 2003, CONTACT MECH; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Li K., 2015, PLOS ONE, V10; Libertiaux V, 2011, J MECH BEHAV BIOMED, V4, P1177, DOI 10.1016/j.jmbbm.2011.03.028; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; MacManus DB, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170894; MacManus D. B, 2016, SCI REP, P6; MacManus DB, 2017, ACTA BIOMATER, V57, P384, DOI 10.1016/j.actbio.2017.05.022; MacManus DB, 2017, ACTA BIOMATER, V48, P309, DOI 10.1016/j.actbio.2016.10.029; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Pervin F, 2011, NEUROIMAGE, V54, pS98, DOI 10.1016/j.neuroimage.2010.03.077; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Pierrat B, 2018, J MECH BEHAV BIOMED, V78, P515, DOI 10.1016/j.jmbbm.2017.03.033; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Prange M T, 2000, Stapp Car Crash J, V44, P205; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Rivlin R. S., 1948, PHILOS T R SOC A, V241; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; Rueda MAF, 2010, INJURY, V41, P533, DOI 10.1016/j.injury.2009.05.009; Sharp AA, 2009, IEEE T BIO-MED ENG, V56, P45, DOI 10.1109/TBME.2008.2003261; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040; Willinger R, 1999, CR ACAD SCI II B, V327, P125, DOI 10.1016/S1287-4620(99)80021-0; Zhang J, 2011, J BIOMECH, V44, P1909, DOI 10.1016/j.jbiomech.2011.04.034; Zhang M, 1997, MED ENG PHYS, V19, P512, DOI 10.1016/S1350-4533(97)00017-9	63	13	13	0	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	NOV	2018	87						256	266		10.1016/j.jmbbm.2018.07.025			11	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	GV7EY	WOS:000446286000028	30096513				2022-02-06	
J	Toshkezi, G; Kyle, M; Longo, SL; Chin, LS; Zhao, LR				Toshkezi, Gentian; Kyle, Michele; Longo, Sharon L.; Chin, Lawrence S.; Zhao, Li-Ru			Brain repair by hematopoietic growth factors in the subacute phase of traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; hematopoietic growth factor; SCF; G-CSF; brain repair; functional recovery; stem cell factor; granulocyte colony-stimulating factor	STEM-CELL FACTOR; COLONY-STIMULATING FACTOR; G-CSF; FUNCTIONAL RECOVERY; BONE-MARROW; STROKE; MOUSE; NEURODEGENERATION; PURIFICATION; ISCHEMIA	OBJECTIVE Traumatic brain injury (TBI) is a major cause of long-term disability and death in young adults. The lack of pharmaceutical therapy for post-acute TBI recovery remains a crucial medical challenge. Stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF), which are 2 key hematopoietic growth factors, have shown neuroprotective and neurorestorative effects in experimental stroke. The objective of this study was to determine the therapeutic efficacy of combined treatment (SCF + G-CSF) in subacute TBI. METHODS Young-adult male C57BL mice were subject to TBI in the cortex of the right hemisphere. After TBI induction, mice were randomly divided into 2 groups: a vehicle control group and an SCF + G-CSF treatment group. Mice without TBI served as sham operative controls. Treatment was initiated 2 weeks after TBI induction. SCF (200 mg/kg) and G-CSF (50 mg/kg) or an equal volume of vehicle solution was subcutaneously injected daily for 7 days. A battery of neurobehavioral tests for evaluation of memory and cognitive function (water maze and novel object recognition tests), anxiety (elevated plus maze test), and motor function (Rota-Rod test) was performed during the period of 2-9 weeks after treatment. Neurodegeneration and dendritic density in both hemispheres were determined through histochemistry and immunohistochemistry at 11 weeks posttreatment. RESULTS Water maze testing showed that TBI-impaired spatial learning and memory was restored by SCF + G-CSF treatment. The findings from the elevated plus maze tests revealed that SCF + G-CSF treatment recovered TBI-caused anxiety and risk-taking behavior. There were no significant differences between the treated and nontreated TBI mice in both the Rota-Rod test and novel object recognition test. In the brain sections, the authors observed that widespread degenerating neurons were significantly increased in both hemispheres in the TBI-vehicle control mice. TBI-induced increases in neurodegeneration were significantly reduced by SCF + G-CSF treatment in the contralateral hemisphere, making it no different from that of the sham controls. Dendritic density in the frontal cortex of the contralateral hemisphere was significantly reduced in the TBI-vehicle control mice, whereas SCF + G-CSF-treated TBI mice showed significant increases of the dendritic density in the same brain region. SCF + G-CSF-treated TBI mice also showed a trend toward increasing dendritic density in the contralateral hippocampus. CONCLUSIONS SCF + G-CSF treatment in the subacute phase of TBI restored TBI-impaired spatial learning and memory, prevented posttraumatic anxiety and risk-taking behavior, inhibited TBI-induced neurodegeneration, and enhanced neural network remodeling. These findings suggest the therapeutic potential of hematopoietic growth factors for brain repair in the subacute phase of TBI.	[Toshkezi, Gentian; Kyle, Michele; Longo, Sharon L.; Chin, Lawrence S.; Zhao, Li-Ru] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA		Zhao, LR (corresponding author), SUNY Upstate Med Univ, Syracuse, NY 13210 USA.	zhaol@upstate.edu			Neurosurgery Research and Education Foundation	This study was supported by the Neurosurgery Research and Education Foundation through a 2015-2016 Research Grant and Young Clinician Investigator Award. We acknowledge Xuecheng Qiu for his assistance in preparing some of the figure images, Dr. Dongliang Wang for his assistance with statistical analysis, and Sandra McGillis for her assistance with proofreading.	Badre D, 2010, NEURON, V66, P315, DOI 10.1016/j.neuron.2010.03.025; CARNAHAN JF, 1994, J NEUROSCI, V14, P1433, DOI 10.1523/JNEUROSCI.14-03-01433.1994; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Corso P, 2015, INJURY PREV, V21, P432, DOI [10.1136/injuryprev-2015-041862, 10.1136/ip.2005.010983rep]; Cui L, 2016, ASN NEURO, V8, P1; Cui LL, 2015, EXP NEUROL, V263, P17, DOI 10.1016/j.expneurol.2014.08.026; Cui LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064684; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Dhandapani KM, 2005, J NEUROCHEM, V95, P9, DOI 10.1111/j.1471-4159.2005.03319.x; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Gibson CL, 2005, J CEREBR BLOOD F MET, V25, P431, DOI 10.1038/sj.jcbfm.9600033; HIRATA T, 1993, DEVELOPMENT, V119, P49; Kawada H, 2006, CIRCULATION, V113, P701, DOI 10.1161/CIRCULATIONAHA.105.563668; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Komine-Kobayashi M, 2006, J CEREBR BLOOD F MET, V26, P402, DOI 10.1038/sj.jcbfm.9600195; Lee ST, 2005, BRAIN RES, V1058, P120, DOI 10.1016/j.brainres.2005.07.076; Liu BY, 2008, NEUROL RES, V30, P594, DOI 10.1179/174313208X310296; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Piao Chun-Shu, 2012, Exp Transl Stroke Med, V4, P25, DOI 10.1186/2040-7378-4-25; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Sehara Y, 2007, J NEUROSCI RES, V85, P2167, DOI 10.1002/jnr.21341; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Six I, 2003, EUR J PHARMACOL, V458, P327, DOI 10.1016/S0014-2999(02)02785-1; Su Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075562; Svetlov SI PV, 2015, NEUROL NEUROBIOL, V1, P103; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tshibanda L, 2009, PROG BRAIN RES, V177, P215, DOI 10.1016/S0079-6123(09)17715-4; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; WELTE K, 1985, P NATL ACAD SCI USA, V82, P1526, DOI 10.1073/pnas.82.5.1526; Zhao Li R, 2013, Recent Pat CNS Drug Discov, V8, P2; Zhao LR, 2007, STROKE, V38, P2804, DOI 10.1161/STROKEAHA.107.486217; Zhao LR, 2007, STROKE, V38, P2584, DOI 10.1161/STROKEAHA.106.476457; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	41	13	13	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2018	129	5					1286	1294		10.3171/2017.7.JNS17878			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HE4XT	WOS:000453373600024	29372883	Bronze			2022-02-06	
J	Zhang, ZW; Yu, JB				Zhang, Zhanwei; Yu, Jianbai			Nurr1 exacerbates cerebral ischemia-reperfusion injury via modulating YAP-INF2-mitochondrial fission pathways	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Article						Nurr1; Cerebral IR injury; YAP-INF2 axis; Mitochondrial fission	REQUIRED MITOCHONDRIAL FISSION; TARGETED ANTIOXIDANT MITOQ; TRAUMATIC BRAIN-INJURY; APOPTOSIS; MITOPHAGY; NR4A1; DRP1	Nurr1, a nuclear transcription factor, has been linked to ischemia-reperfusion injury (IRI) in heart and kidney via modulating mitochondrial homeostasis. However, its role in cerebral ischemia-reperfusion has not been defined. In the present study, we found that cerebral IRI significantly increased the expression of Nurr1 and genetic ablation of Nurr1 attenuated the infarction area and reduced the neuron apoptosis under brain IRI burden. Functional studies have demonstrated that Nurr1 induced neuron death via activating mitochondrial fission. Aberrant mitochondrial fission promoted mitochondrial membrane potential reduction, evoked cellular oxidative stress and activated caspase-9-dependent mitochondrial apoptotic pathway. Interestingly, Nurr1 deletion alleviated fission-mediated mitochondrial damage, sustaining mitochondrial homeostasis and favoring neuron survival. Further, we found that Nurr1 deletion modulated mitochondrial fission via preventing INF2 upregulation in a manner dependent on YAP pathways. Either pharmacological blockade of YAP pathway or over expression of INF2 abrogated the inhibitory effect of Nurr1 deletion on mitochondrial fission, leading to neuron death via mitochondrial apoptosis. Altogether, our results report that the pathogenesis of cerebral ischemia-reperfusion injury is associated with Nurr1 upregulation followed by augmented mitochondrial fission via an abnormal YAP-INF2 pathways.	[Zhang, Zhanwei; Yu, Jianbai] Hunan Univ Chinese Med, Affiliated Hosp 1, Dept Neurosurg, Changsha 410007, Hunan, Peoples R China		Yu, JB (corresponding author), Hunan Univ Chinese Med, Affiliated Hosp 1, Dept Neurosurg, Changsha 410007, Hunan, Peoples R China.	pijia7819@126.com					Banta KL, 2018, J BIOL CHEM, V293, P4724, DOI 10.1074/jbc.RA117.001101; Bavarsad K., 2018, MOL NEUROBIOL, DOI [10.1007/x12035-018-1.169-7, DOI 10.1007/X12035-018-1.169-7]; Cheng ZK, 2011, EUR HEART J, V32, P2179, DOI 10.1093/eurheartj/ehq496; Chun SK, 2018, AGING CELL, V17, DOI 10.1111/acel.12761; Fan JJ, 2017, NEUROSCI LETT, V647, P45, DOI 10.1016/j.neulet.2017.02.065; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gan L, 2018, TOXICOL APPL PHARM, V341, P1, DOI 10.1016/j.taap.2018.01.003; Geng C., 2018, ACTA NEUROL BELG, DOI [10.1007/s13760-018-0944-6, DOI 10.1007/S13760-018-0944-6]; Ho DH, 2018, EXP NEUROBIOL, V27, P171, DOI 10.5607/en.2018.27.3.171; Hu MJ, 2017, MOL CELL, V66, P141, DOI 10.1016/j.molcel.2017.03.008; Ji WK, 2015, ELIFE, V4, DOI [10.7554/eLife.11553.001, 10.7554/eLife.11553]; Jin QH, 2018, REDOX BIOL, V14, P576, DOI 10.1016/j.redox.2017.11.004; Jin XF, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006748; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Lan R, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/4147502; Li RB, 2018, REDOX BIOL, V18, P229, DOI 10.1016/j.redox.2018.07.011; Martin JL, 2019, PEDIATR NEPHROL, V34, P1167, DOI 10.1007/s00467-018-3984-5; Park H, 2018, YONSEI MED J, V59, P736, DOI 10.3349/ymj.2018.59.6.736; Peiris-Pages Maria, 2018, Oncotarget, V9, P13254, DOI 10.18632/oncotarget.24285; Perez MJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00441; Reynolds MS, 2016, AM J PHYSIOL-ENDOC M, V311, pE186, DOI 10.1152/ajpendo.00022.2016; Russell AL, 2018, ENDOCRINOLOGY, V159, P2363, DOI 10.1210/en.2018-00203; Singh Varinder, 2018, Journal of Basic and Clinical Physiology and Pharmacology, V29, P403, DOI 10.1515/jbcpp-2017-0070; Steffen J, 2018, J CELL BIOL, V217, P15, DOI 10.1083/jcb.201711075; Stepanova A, 2017, J CEREBR BLOOD F MET, V37, P3649, DOI 10.1177/0271678X17730242; Tang YY, 2016, BRAIN RES, V1646, P73, DOI 10.1016/j.brainres.2016.05.042; Wei Z, 2015, INT J CLIN EXP PATHO, V8, P15599; Yu W, 2018, NEUROCHEM RES, V43, P420, DOI 10.1007/s11064-017-2437-z; Zhao H, 2018, CELL STRESS CHAPERON, V23, P1079, DOI 10.1007/s12192-018-0917-y; Zhou H., 2018, J PINEAL RES, V64; Zhou H, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00755; Zhou H, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0682-1; Zhou H, 2018, ANGIOGENESIS, V21, P599, DOI 10.1007/s10456-018-9611-z; Zhou J, 2018, AM J TRANSL RES, V10, P1887	34	13	15	4	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725	1878-5875		INT J BIOCHEM CELL B	Int. J. Biochem. Cell Biol.	NOV	2018	104						149	160		10.1016/j.biocel.2018.09.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1KC	WOS:000449126000015	30267803				2022-02-06	
J	Toma, M; Nguyen, PDH				Toma, Milan; Nguyen, Paul D. H.			Fluid-structure interaction analysis of cerebrospinal fluid with a comprehensive head model subject to a rapid acceleration and deceleration	BRAIN INJURY			English	Article						Fluid-structure interaction; cerebral spinal fluid; comprehensive head model; brain injury; deceleration; acceleration	FINITE-ELEMENT; DRUG TRANSPORT; BRAIN; INJURIES; SIMULATION; TRAUMA; RAT	Primary Objective: Closed brain injuries are a common danger in contact sports and motorized vehicular collisions. Mild closed brain injuries, such as concussions, are not easily visualized by computed imaging or scans. Having a comprehensive head/brain model and using fluid-structure interaction (FSI) simulations enable us to see the exact movement of the cerebrospinal fluid (CSF) under such conditions and to identify the areas of brain most affected. Research Design: The presented work is based on the first FSI model capable of simulating the interaction between the CSF flow and brain. Methods and Procedures: FSI analysis combining smoothed-particle hydrodynamics and high-order finite-element method is used. Main Outcomes and Results: The interaction between the CSF and brain under rapid acceleration and deceleration is demonstrated. The cushioning effect of the fluid and its effect on brain are shown. Conclusions: The capability to locate areas (down to the exact gyri and sulci) of the brain the most affected under given loading conditions, and therefore assess the possible damage to the brain and consequently predict the symptoms, is shown.	[Toma, Milan] New York Inst Technol, Sch Engn & Comp Sci, Dept Mech Engn, Computat BioFSI Lab, Old Westbury, NY 11568 USA; [Nguyen, Paul D. H.] Penn State Coll Med, Hershey, PA USA		Toma, M (corresponding author), New York Inst Technol, Sch Engn & Comp Sci, Dept Mech Engn, Old Westbury Campus,HSH116A,Northern Blvd, Old Westbury, NY 11568 USA.	tomamil@tomamil.eu	Toma, Milan/D-4178-2011	Toma, Milan/0000-0003-2154-3728			Bailes JE, 2001, J ATHL TRAINING, V36, P236; BARBER TW, 1970, ACTA NEUROL SCAND, V46, P85, DOI 10.1111/j.1600-0404.1970.tb05606.x; Battal B, 2011, BRIT J RADIOL, V84, P758, DOI 10.1259/bjr/66206791; Bei L, 2016, 8 INT C MEAS TECHN M, P756; Brodmann K ., 1909, VERGLEICHENDE LOKALI; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; FRY FJ, 1978, J ACOUST SOC AM, V63, P1576, DOI 10.1121/1.381852; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Ghaffari M, 2017, COMPUT BIOL MED, V91, P353, DOI 10.1016/j.compbiomed.2017.10.028; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Hsu CY, 2017, MAGN RESON MED, V77, P398, DOI 10.1002/mrm.26087; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Liang ZY, 2015, APPL BIONICS BIOMECH, V2015, P1, DOI 10.1155/2015/837585; Limited TCT Research (ed, 2012, CORT FUNCT; Linninger AA, 2008, J BIOMECH, V41, P2176, DOI 10.1016/j.jbiomech.2008.04.025; Linninger AA, 2016, ANNU REV FLUID MECH, V48, P219, DOI 10.1146/annurev-fluid-122414-034321; Liu GR., 2003, SMOOTHED PARTICLE HY, DOI [10.1142/5340, DOI 10.1142/5340, 10. 1142/5340]; Lui ACP, 1998, CAN J ANAESTH, V45, P297, DOI 10.1007/BF03012018; Luo YH, 2012, P I MECH ENG H, V226, P499, DOI 10.1177/0954411912445729; Madhukar A, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2881; Moore SW, 2011, DEV NEUROBIOL, V71, P1090, DOI 10.1002/dneu.20947; Morrison AL, 1998, AM J FOREN MED PATH, V19, P109, DOI 10.1097/00000433-199806000-00002; Poirier MP, 2003, CLIN PEDIATR EMERG M, V4, P179, DOI DOI 10.1016/S1522-8401(03)00061-2; Schonauer M, 1979, J Neurosurg Sci, V23, P279; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sweetman B, 2011, COMPUT BIOL MED, V41, P67, DOI 10.1016/j.compbiomed.2010.12.001; Tangen KM, 2015, J BIOMECH, V48, P2144, DOI 10.1016/j.jbiomech.2015.02.018; Toma M, 2010, INT J SIMUL MODEL, V9, P143, DOI 10.2507/IJSIMM09(3)3.164; Toma M, 2017, SIGNIFIC BIOENGG BIO, V1, pSBB000502; Toma M, 2016, INT J NUMER METH BIO, V33, P4, DOI 10. 1002/cnm. 2815; Toma M, 2016, COMPUT STRUCT, V173, P84, DOI 10.1016/j.compstruc.2016.06.001; Tyler WJ, 2012, NAT REV NEUROSCI, V13, P867, DOI 10.1038/nrn3383; Vorwerk J, 2012, BIOMED ENG-BIOMED TE, V57, P795, DOI [10.1515/btm-2012-4152, 10.1515/bmt-2012-4152]; Watanabe D, 2007, AUTOTECHNOLOGY, V7, P34	37	13	14	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2018	32	12					1576	1584		10.1080/02699052.2018.1502470			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GX0EO	WOS:000447382800017	30059633				2022-02-06	
J	Wecht, JM; Weir, JP; Katzelnick, CG; Wylie, G; Eraifej, M; Nguyen, N; Dyson-Hudson, T; Bauman, WA; Chiaravalloti, N				Wecht, Jill M.; Weir, Joseph P.; Katzelnick, Caitlyn G.; Wylie, Glenn; Eraifej, Mastanna; Nhuquynh Nguyen; Dyson-Hudson, Trevor; Bauman, William A.; Chiaravalloti, Nancy			Systemic and Cerebral Hemodynamic Contribution to Cognitive Performance in Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						BP; CBFv; cognition; paraplegia; tetraplegia	TRAUMATIC BRAIN-INJURY; BLOOD-PRESSURE ABNORMALITIES; CLOSED HEAD-INJURY; ORTHOSTATIC HYPOTENSION; AUTONOMIC FUNCTION; FLOW; INDIVIDUALS; DYSFUNCTION; VETERANS; DEFICITS	Cognitive deficits are prevalent in the spinal cord injury (SCI) population, and consensus suggests that concomitant traumatic brain injury or comorbid conditions are primarily responsible for these deficits. However, mounting evidence supports the possibility that systemic and cerebral hemodynamic dysfunction may contribute to the cognitive deficits reported in persons with SCI. We sought to determine the contribution of changes in blood pressure (BP) and changes in cerebral blood flow velocity (CBFv) to test performance on the Symbol Digit Modalities Test (SDMT) in persons with SCI compared with matched non-SCI controls. Participants included 36 non-SCI controls and 67 persons with SCI: 33 with paraplegia (T2-T12) and 34 with tetraplegia (C3-T1). Continuous beat-to-beat BP and simultaneous CBFv was monitored for 5min during seated rest and during the SDMT, which assesses information processing speed, sustained attention, and visual working memory. The results indicate significantly lower SDMT scores in the group with tetraplegia (44 +/- 10) compared to the non-SCI controls (53 +/- 14; p<0.01); however, SDMT scores did not differ significantly between the non-SCI controls and the group with paraplegia (49 +/- 13). Whereas group affiliation was the most significant predictor of test performance (F=4.84; p=0.010, (2)=0.088), change in systolic BP (SBP) (r(2)=0.047, p=0.028) and change in diastolic CBFv (DFV) (r(2)=0.047, p=0.028) contributed significantly to SDMT scores. Further, change in SBP accounted for a significant amount of variance in change in DFV in the total study sample (r(2)=0.090; p=0.002). These results support previous findings of cognitive deficits in persons with SCI and indicate that inadequate systemic and cerebral hemodynamic responses to testing contribute to test performance. Therefore, clinical treatment of cognitive dysfunction in the SCI population should consider focusing on increasing systemic BP to improve CBFv, particularly in individuals with lesions above T1.	[Wecht, Jill M.; Katzelnick, Caitlyn G.; Eraifej, Mastanna; Nhuquynh Nguyen; Bauman, William A.] James J Peters VAMC, VA RR&D Natl Ctr Med Consequences SCI, Bronx, NY USA; [Wecht, Jill M.; Bauman, William A.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Wecht, Jill M.; Bauman, William A.] Icahn Sch Med Mt Sinai, Rehabil Med, New York, NY 10029 USA; [Weir, Joseph P.] Univ Kansas, Dept Hlth Sport & Exercise Sci, Lawrence, KS 66045 USA; [Katzelnick, Caitlyn G.; Wylie, Glenn; Dyson-Hudson, Trevor; Chiaravalloti, Nancy] Kessler Fdn, W Orange, NJ USA; [Wylie, Glenn; Dyson-Hudson, Trevor; Chiaravalloti, Nancy] Rutgers Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Wylie, Glenn] VA War Related Illness & Injury Study Ctr, E Orange, NJ USA		Wecht, JM (corresponding author), James J Peters VA Med Ctr, Natl Ctr Med Consequences Spinal Cord Injury, Room 7A-13,130 West Kingsbridge Rd, Bronx, NY 10468 USA.	JM.Wecht@va.gov		Chiaravalloti, Nancy/0000-0003-2943-7567; Dyson-Hudson, Trevor/0000-0002-0252-2764	New Jersey Commission for Spinal Cord Research [CSCR13IRG018]; Veterans Affairs Department of Rehabilitation Research & Development Service [B9212-C, B2020-C]	We acknowledge and thank all study participants for their time and compliance with our study protocol. This work was supported by the New Jersey Commission for Spinal Cord Research (grant: CSCR13IRG018) and the Veterans Affairs Department of Rehabilitation Research & Development Service (grants: B9212-C and B2020-C).	Arntzen KA, 2011, EUR J NEUROL, V18, P737, DOI 10.1111/j.1468-1331.2010.03263.x; Benedict RHB, 2017, MULT SCLER J, V23, P721, DOI 10.1177/1352458517690821; Bleton H, 2015, COGN NEURODYNAMICS, V9, P615, DOI 10.1007/s11571-015-9355-z; Claydon VE, 2006, J NEUROTRAUM, V23, P1713, DOI 10.1089/neu.2006.23.1713; Cohen ML, 2017, REHABIL PSYCHOL, V62, P425, DOI 10.1037/rep0000140; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; Davidoff G, 1990, Arch Clin Neuropsychol, V5, P77, DOI 10.1016/0887-6177(90)90009-E; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; DAVIDOFF GN, 1990, ARCH PHYS MED REHAB, V71, P326; Dowler R N, 1995, Appl Neuropsychol, V2, P124, DOI 10.1207/s15324826an0203&4_4; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Duschek S, 2004, PSYCHOPHYSIOLOGY, V41, P905, DOI 10.1111/j.1469-8986.2004.00249.x; Duschek S, 2007, PSYCHOPHYSIOLOGY, V44, P145, DOI 10.1111/j.1469-8986.2006.00472.x; Duschek S, 2009, BIOL PSYCHOL, V81, P110, DOI 10.1016/j.biopsycho.2009.03.003; Duschek S, 2008, HYPERTENS RES, V31, P1873, DOI 10.1291/hypres.31.1873; Harkema SJ, 2008, J NEUROTRAUM, V25, P1467, DOI 10.1089/neu.2008.0572; Hubli M, 2015, AM J HYPERTENS, V28, P173, DOI 10.1093/ajh/hpu122; Jegede AB, 2010, CLIN AUTON RES, V20, P3, DOI 10.1007/s10286-009-0036-z; Kaffashian S, 2011, EUR HEART J, V32, P2326, DOI 10.1093/eurheartj/ehr133; Karlsson AK, 1998, BRAIN, V121, P1711, DOI 10.1093/brain/121.9.1711; Keary T.A., 2012, CARDIOVASC PSYCHIAT; Krassioukov A, 2012, CLIN J SPORT MED, V22, P39, DOI 10.1097/JSM.0b013e3182420699; Kushner DS, 2014, PHYS MED REH CLIN N, V25, P681, DOI 10.1016/j.pmr.2014.04.005; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Molina B, 2018, SPINAL CORD, V56, P796, DOI 10.1038/s41393-018-0076-0; Munakata M, 1997, J HYPERTENS, V15, P1745, DOI 10.1097/00004872-199715120-00083; Phillips AA, 2016, J PHYSIOL-LONDON, V594, P1677, DOI 10.1113/JP270925; Phillips AA, 2018, J NEUROTRAUM, V35, P573, DOI 10.1089/neu.2017.5188; Phillips AA, 2017, J NEUROTRAUM, V34, P1283, DOI 10.1089/neu.2016.4751; Phillips AA, 2013, BRAIN SCI, V3, P781, DOI 10.3390/brainsci3020781; Phillips AA, 2014, J CEREBR BLOOD F MET, V34, P794, DOI 10.1038/jcbfm.2014.3; Phillips AA, 2014, J APPL PHYSIOL, V116, P645, DOI 10.1152/japplphysiol.01090.2013; Riccitelli GC, 2019, MULT SCLER J, V25, P204, DOI 10.1177/1352458517743091; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; Rosado-Rivera D, 2011, J SPINAL CORD MED, V34, P395, DOI 10.1179/2045772311Y.0000000019; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Sahota IS, 2012, J NEUROTRAUM, V29, P2446, DOI 10.1089/neu.2012.2379; Saleem S, 2018, AM J PHYSIOL-HEART C, V314, pH1108, DOI 10.1152/ajpheart.00152.2017; Schmid A, 1998, J AUTONOM NERV SYST, V68, P96, DOI 10.1016/S0165-1838(97)00127-6; Schmid A, 1985, J APPL PHYSIOL, V85, P635; Wecht JM, 2017, J SPINAL CORD MED, V40, P159, DOI 10.1080/10790268.2015.1135556; Wecht JM, 2016, CLIN AUTON RES, V26, P49, DOI 10.1007/s10286-015-0328-4; Wecht JM, 2015, ARCH PHYS MED REHAB, V96, P1071, DOI 10.1016/j.apmr.2015.01.018; Wecht JM, 2013, J SPINAL CORD MED, V36, P454, DOI 10.1179/2045772313Y.0000000109; Wecht JM, 2013, J SPINAL CORD MED, V36, P74, DOI 10.1179/2045772312Y.0000000056; Wecht JM, 2012, CLIN AUTON RES, V22, P25, DOI 10.1007/s10286-011-0139-1; Wecht JM, 2018, AUTON NEUROSCI-BASIC, V209, P51, DOI 10.1016/j.autneu.2017.04.004; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Zarrinkoob L, 2015, J CEREBR BLOOD F MET, V35, P648, DOI 10.1038/jcbfm.2014.241; Zhu C, 2013, J SPINAL CORD MED, V36, P463, DOI 10.1179/2045772313Y.0000000145	51	13	14	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2018	35	24					2957	2964		10.1089/neu.2018.5760		OCT 2018	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HE8KF	WOS:000446276400001	30113243				2022-02-06	
J	Cheng, LJ; Cortese, D; Monti, MM; Wang, FY; Riganello, F; Arcuri, F; Di, HB; Schnakers, C				Cheng, Lijuan; Cortese, Daniela; Monti, Martin M.; Wang, Fuyan; Riganello, Francesco; Arcuri, Francesco; Di, Haibo; Schnakers, Caroline			Do Sensory Stimulation Programs Have an Impact on Consciousness Recovery?	FRONTIERS IN NEUROLOGY			English	Article						brain injuries; consciousness; persistent vegetative state; minimally conscious state; sensory stimulation	TRAUMATIC BRAIN-INJURY; PLACEBO-CONTROLLED TRIAL; ENVIRONMENTAL ENRICHMENT; GENE-EXPRESSION; CORTEX; SCALE; STATE; COMPLEXITY; DISORDERS; AROUSAL	Objectives: Considering sensory stimulation programs (SSP) as a treatment for disorders of consciousness is still debated today. Previous studies investigating its efficacy were affected by various biases among which small sample size and spontaneous recovery. In this study, treatment-related changes were assessed using time-series design in patients with disorders of consciousness (i.e., vegetative state-VS and minimally conscious state-MCS). Methods: A withdrawal design (ABAB) was used. During B phases, patients underwent a SSP (3 days a week, including auditory, visual, tactile, olfactory, and gustatory stimulation). The program was not applied during A phases. To assess behavioral changes, the Coma Recovery Scale-Revised (CRS-R) was administered by an independent rater on a weekly basis, across all phases. Each phase lasted 4 weeks. In a subset of patients, resting state functional magnetic resonance imaging (fMRI) data were collected at the end of each phase. Results: Twenty nine patients (48 +/- 19 years old; 15 traumatic; 21 > a year post-injury; 11 VS and 18 MCS) were included in our study. Higher CRS-R total scores (medium effect size) as well as higher arousal and oromotor subscores were observed in the B phases (treatment) as compared to A phases (no treatment), in the MCS group but not in the VS group. In the three patients who underwent fMRI analyses, a modulation of metabolic activity related to treatment was observed in middle frontal gyrus, superior temporal gyrus as well as ventro-anterior thalamic nucleus. Conclusion: Our results suggest that SSP may not be sufficient to restore consciousness. SSP might nevertheless lead to improved behavioral responsiveness in MCS patients. Our results show higher CRS-R total scores when treatment is applied, and more exactly, increased arousal and oromotor functions.	[Cheng, Lijuan; Wang, Fuyan; Di, Haibo] Hangzhou Normal Univ, Int Vegetat State & Consciousness Sci Inst, Hangzhou, Zhejiang, Peoples R China; [Cortese, Daniela; Riganello, Francesco; Arcuri, Francesco] S Anna Inst, Res Adv Neurorehabil, Crotone, Italy; [Monti, Martin M.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Monti, Martin M.] UCLA, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Schnakers, Caroline] Casa Colina Hosp & Ctr Healthcare, Res Inst, Pomona, CA 91767 USA		Di, HB (corresponding author), Hangzhou Normal Univ, Int Vegetat State & Consciousness Sci Inst, Hangzhou, Zhejiang, Peoples R China.; Schnakers, C (corresponding author), Casa Colina Hosp & Ctr Healthcare, Res Inst, Pomona, CA 91767 USA.	dihaibo19@aliyun.com; cschnakers@casacolina.org	Wang, Fuyan/AAE-9666-2019; Cortese, Maria Daniela/AAB-9480-2022; Riganello, Francesco/N-2615-2014; Riganello, Francesco/AAC-3976-2020; Arcuri, Francesco/AAB-8718-2019; Laureys, Steven/A-3349-2011	Cortese, Maria Daniela/0000-0002-8524-6581; Riganello, Francesco/0000-0003-0678-9252; Riganello, Francesco/0000-0003-0678-9252; Arcuri, Francesco/0000-0002-7104-6378; wang, fuyan/0000-0001-9629-6712; Monti, Martin M/0000-0001-5511-3780			ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BEAULIEU C, 1987, J COMP NEUROL, V266, P478, DOI 10.1002/cne.902660404; Byiers BJ, 2012, AM J SPEECH-LANG PAT, V21, P397, DOI 10.1044/1058-0360(2012/11-0036); Cohen J, 1969, STAT POWER ANAL BEHA; Cossu G, 2014, BRIT J NEUROSURG, V28, P187, DOI 10.3109/02688697.2013.841845; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di HB, 2017, BRAIN INJURY, V31, P363, DOI 10.1080/02699052.2016.1255780; Di Stefano C, 2012, BRAIN INJURY, V26, P1250, DOI 10.3109/02699052.2012.667588; DIAMOND MC, 1964, J COMP NEUROL, V123, P111, DOI 10.1002/cne.901230110; Dronkers NF, 2004, COGNITION, V92, P145, DOI 10.1016/j.cognition.2003.11.002; Farrell R, 2001, NEUROSCIENCE, V107, P585, DOI 10.1016/S0306-4522(01)00386-4; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GREENOUGH WT, 1973, EXP NEUROL, V41, P371, DOI 10.1016/0014-4886(73)90278-1; HALL M E, 1992, Brain Injury, V6, P435, DOI 10.3109/02699059209008139; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; HOLLOWAY RALPH L., 1966, BRAIN RES, V2, P393, DOI 10.1016/0006-8993(66)90009-6; Johansson BB, 1996, STROKE, V27, P324, DOI 10.1161/01.STR.27.2.324; Kolb B, 1991, CEREB CORTEX, V1, P189, DOI 10.1093/cercor/1.2.189; Koopmans GC, 2006, EUR J NEUROSCI, V23, P1035, DOI 10.1111/j.1460-9568.2006.04627.x; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; Lang PJ., 1997, INT AFFECTIVE PICTUR; Laureys S., 2018, COMA DISORDERS CONSC, P17, DOI 10.1007/978-3-319-55964-3; Lazarus M, 2013, CURR OPIN NEUROBIOL, V23, P780, DOI 10.1016/j.conb.2013.02.001; LEWINN EB, 1978, LANCET, V2, P156; Lotze M, 2011, J REHABIL MED, V43, P230, DOI 10.2340/16501977-0653; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Meyer MJ, 2010, BRAIN INJURY, V24, P722, DOI 10.3109/02699051003692134; MOLLGAARD K, 1971, International Journal of Neuroscience, V2, P113, DOI 10.3109/00207457109148764; Monti MM, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00028; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Oh H, 2003, J CLIN NURS, V12, P394, DOI 10.1046/j.1365-2702.2003.00750.x; Padilla R, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.021022; Pape TLB, 2015, NEUROREHAB NEURAL RE, V29, P537, DOI 10.1177/1545968314554626; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Perrin F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01102; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Ronnback A, 2005, NEUROSCI LETT, V385, P173, DOI 10.1016/j.neulet.2005.05.016; ROSENZWE.MR, 1966, AM PSYCHOL, V21, P321, DOI 10.1037/h0023555; ROSENZWEIG MR, 1964, J COMP PHYSIOL PSYCH, V57, P438, DOI 10.1037/h0046387; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; Sacco S, 2011, BRAIN INJURY, V25, P488, DOI 10.3109/02699052.2011.558043; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; Salmani F, 2017, INT J NURS STUD, V74, P44, DOI 10.1016/j.ijnurstu.2017.05.014; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schnakers C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00297; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; van Huijzen, 2008, HUMAN CENTRAL NERVOU; Vetrivelan R, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00145; Whyte J, 2014, NEUROLOGY, V82, P1106, DOI 10.1212/WNL.0000000000000276; Wood R L, 1992, Brain Inj, V6, P411, DOI 10.3109/02699059209008137	55	13	13	1	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 2	2018	9								826	10.3389/fneur.2018.00826			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GV5AI	WOS:000446112700001	30333789	Green Published, gold			2022-02-06	
J	Bonow, RH; Oron, AP; Hanak, BW; Browd, SR; Chesnut, RM; Ellenbogen, RG; Vavilala, MS; Rivara, FP				Bonow, Robert H.; Oron, Assaf P.; Hanak, Brian W.; Browd, Samuel R.; Chesnut, Randall M.; Ellenbogen, Richard G.; Vavilala, Monica S.; Rivara, Frederick P.			Post-Traumatic Hydrocephalus in Children: A Retrospective Study in 42 Pediatric Hospitals Using the Pediatric Health Information System	NEUROSURGERY			English	Article; Proceedings Paper	CNS-AANS-Joint-Pediatrics-Section Meeting	DEC 07, 2016	Orlando, FL	CNS AANS Joint Pediat Sect		Craniotomy; Decompressive craniectomy; Hydrocephalus; Pediatrics; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; RISK-FACTORS; OUTCOMES; INFANTS	BACKGROUND: Post-traumatic hydrocephalus (PTH) is a potentially treatable cause of poor recovery from traumatic brain injury (TBI) that remains poorly understood, particularly among children. OBJECTIVE: To better understand the risk factors for pediatric PTH using a large, multi institutional database. METHODS: We conducted a retrospective cohort study using administrative data from 42 pediatric hospitals participating in the Pediatric Health Information System. All patients <= 21 yr surviving a hospitalization with an International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code for TBI were identified. The primary outcome was PTH, defined by an ICD-9-CM procedure code for surgical management of hydrocephalus within 6 mo. Data were analyzed using multivariable logistic regression. RESULTS: We identified 91 583 patients <= 21 yr with TBI, 846 of whom developed PTH. Odds of PTH were significantly higher in children <1 yr compared to older age groups. A total of 48.7% of PTH cases were victims of abuse (adjusted odds ratio [aOR] 2.62, 95% confidence interval [CI] 2.16-3.18). PTH was more common after craniotomy (aOR 1.60, 95% C11.30-1.97). Craniectomy without early cranioplasty was associated with markedly increased odds of PTH (aOR3.67, 95% CI 2.66-5.07), an effect not seen in those undergoing cranioplasty within 30 d (aOR 1.19, 95% CI 0.75-1.89). CONCLUSION: PTH was seen in 0.9% of children who sustained a TBI and was more common in those <1 yr. Severe injury, abuse, and craniectomy with delayed cranioplasty were associated with greatly increased likelihood of PTH. Early cranioplasty in children who require craniectomy may reduce the risk for PTH.	[Bonow, Robert H.; Hanak, Brian W.; Browd, Samuel R.; Chesnut, Randall M.; Ellenbogen, Richard G.] Univ Washington, Dept Neurol Surg, 325 9th Ave,Box 359924, Seattle, WA 98104 USA; [Bonow, Robert H.; Chesnut, Randall M.; Vavilala, Monica S.; Rivara, Frederick P.] Harborview Med Ctr, Harborview Injury Prevent Res Ctr, Seattle, WA USA; [Oron, Assaf P.] Seattle Childrens Res Inst, Ctr Clin & Translat Res, Seattle, WA USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA		Bonow, RH (corresponding author), Univ Washington, Dept Neurol Surg, 325 9th Ave,Box 359924, Seattle, WA 98104 USA.	rbonow@uw.edu		Hanak, Brian/0000-0002-3155-7413	Seattle Children's Hospital Pediatric Concussion Research Fund	This study was funded by the Seattle Children's Hospital Pediatric Concussion Research Fund. Dr Bonow received partial, indirect salary support from an educational grant provided to the Department of Neurological Surgery, University of Washington by Codman Neuro. Dr Browd has ownership in Aqueduct Neurosciences Inc, Aqueduct Critical Care Inc, and Navisonics Inc. Dr Chesnut holds an Endowed Neurotrauma Professorship from Integra LifeSciences. These commercial entities had no role in the design, conduct, or reporting of this research. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; Berger RP, 2015, INJURY PREV, V21, pE133, DOI 10.1136/injuryprev-2013-040924; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; Dandy WE, 1914, AM J DIS CHILD, V8, P406; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2011, NEUROSURGERY, V68, pE1777, DOI 10.1227/NEU.0b013e31821787b6; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818; Fodstad H, 1979, Acta Neurochir Suppl (Wien), V28, P514; Guyot LL, 2000, NEUROL RES, V22, P25; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Licata C, 2001, J Neurosurg Sci, V45, P141; Marr A., 2004, CENTRAL NERVOUS SYST; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Oluigbo CO, 2012, J NEUROSURG-PEDIATR, V9, P125, DOI 10.3171/2011.11.PEDS09449; Pachatouridis D, 2014, TURK NEUROSURG, V24, P855, DOI 10.5137/1019-5149.JTN.8871-13.1; Paul AR, 2014, TRANSL PEDIATR, V3, P195, DOI 10.3978/j.issn.2224-4336.2014.06.01; Scollato A, 2015, BRIT J NEUROSURG, V29, P440, DOI 10.3109/02688697.2014.997671; Simon TD, 2008, J NEUROS-PEDIATR, V1, P131, DOI 10.3171/PED/2008/1/2/131; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Williams K, 2012, PEDIATRICS, V129, pS153, DOI 10.1542/peds.2012-0055I	27	13	14	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	OCT	2018	83	4					732	739		10.1093/neuros/nyx470			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Surgery	HF6PB	WOS:000454359400040	29029289				2022-02-06	
J	Ge, XT; Yu, JW; Huang, S; Yin, ZY; Han, ZL; Chen, FL; Wang, ZG; Zhang, JN; Lei, P				Ge, Xintong; Yu, Jinwen; Huang, Shan; Yin, Zhenyu; Han, Zhaoli; Chen, Fanglian; Wang, Zengguang; Zhang, Jianning; Lei, Ping			A novel repetitive mild traumatic brain injury mouse model for chronic traumatic encephalopathy research	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Repetitive mild traumatic brain injury; Chronic traumatic encephalopathy; Closed-head impact; Neurodegeneration; Neuroinflammation; Cognitive dysfunction	TIME-POINTS; CONSEQUENCES; EPIDEMIOLOGY; INFLAMMATION; IMPROVES; MEMORY	Background: Athletes, military personnel and mobility-declined elderly people are prone to repetitive mild traumatic brain injury (rmTBI). The injury does not cause acute pathological changes, but leads to chronic neurodegeneration, long-term cognitive dysfunction and even chronic traumatic encephalopathy (GTE). Many existing rmTBI animal models reported uncontrollable adverse effects and long experiment period. Therefore, an improved model needs to be designed. New method: Our rmTBI mouse model is a modification of the closed head injury method using electronic controlled cortical impact system. Discontinuous 4 impacts with 48-h interval were performed. A key facet of the model is the use of our designed molded acrylic cast and concave metal disc (as a helmet). They could scatter and transmit hitting power to the whole brain, thus produced a mild diffused injury. The procedure does not require scalp incision or craniotomy, which allows the impacting to be completed in 2 min. Results: Our model did not induce acute macroscopic brain damage and brain edema. It could lead to sustained neuroinflammation and chronic neurodegeneration in injured brain, and resulted in cognitive dysfunction within 5 weeks post-injury. Comparison with existing methods: Previously reported adverse effects including skull fractures, hemorrhage and brain tissue loss were not observed in our model. An experiment period of 5 weeks was allowed for observing chronic neurodegeneration and cognitive dysfunction. Conclusions: Our model is beneficial to use for simplicity, reproducibility and time saver. It could serve as a platform for research on the pathogenesis, diagnosis and potential therapeutics for rmTBI and CTE.	[Ge, Xintong; Wang, Zengguang; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Ge, Xintong; Chen, Fanglian; Wang, Zengguang; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin 300052, Peoples R China; [Ge, Xintong; Chen, Fanglian; Wang, Zengguang; Zhang, Jianning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Yu, Jinwen; Huang, Shan; Yin, Zhenyu; Han, Zhaoli; Lei, Ping] Tianjin Med Univ Gen Hosp, Tianjin Geriatr Inst, Lab Neurotrauma & Neurodegenerat Disorders, Tianjin 300052, Peoples R China; [Yu, Jinwen; Huang, Shan; Yin, Zhenyu; Han, Zhaoli; Lei, Ping] Tianjin Med Univ Gen Hosp, Dept Geriatr, 154 Anshan Rd, Tianjin 300052, Peoples R China		Wang, ZG; Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.; Lei, P (corresponding author), Tianjin Med Univ Gen Hosp, Dept Geriatr, 154 Anshan Rd, Tianjin 300052, Peoples R China.	zgwang@tmu.edu; jnzhang@tmu.edu; plei@tmu.edu	Ge, Xintong/X-4889-2019	Ge, Xintong/0000-0001-7153-952X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81501055, 81772060, 81720108015, 81471252]; Tianjin Traditional Medicine Key Research Project [2018001]; Tianjin Municipal Science and Technology Commission natural fund project [16PTSYJC00180]	This work was supported by the National Natural Science Foundation of China (grant number 81501055, 81772060, 81720108015 and 81471252), Tianjin Traditional Medicine Key Research Project (grant number 2018001), and Tianjin Municipal Science and Technology Commission natural fund project (grant number 16PTSYJC00180). The authors appreciate Daniel T. Laskowitz and Haichen Wang from Duke University Medical Center, and Shu Zhang, Li Liu, Weiyun Cui and Lei Zhou from Tianjin Neurological Institute for their technical support.	Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Ferguson S, 2017, J NEUROTRAUM, V34, P1676, DOI 10.1089/neu.2016.4636; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2018, BRAIN RES, V1697, P10, DOI 10.1016/j.brainres.2018.06.008; Ge XT, 2019, J NEUROTRAUM, V36, P1291, DOI 10.1089/neu.2018.5728; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Han ZL, 2015, DNA CELL BIOL, V34, P703, DOI 10.1089/dna.2015.2800; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; IRRERA N, 2017, FRONT PHARM, V8; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Laskowitz DT, 2017, SCI REP-UK, V7, DOI 10.1038/srep46461; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Moulin S, 2017, CURR ALZHEIMER RES, V14, P686, DOI 10.2174/1567205012666151027141730; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Zhang YL, 2017, NATURE, V548, P52, DOI 10.1038/nature23282	43	13	13	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	OCT 1	2018	308						162	172		10.1016/j.jneumeth.2018.07.021			11	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GZ5GP	WOS:000449447500014	30076860				2022-02-06	
J	Lapointe, AP; Nolasco, LA; Sosnowski, A; Andrews, E; Martini, DN; Palmieri-Smith, RM; Gates, DH; Broglio, SP				Lapointe, Andrew P.; Nolasco, Luis A.; Sosnowski, Aniela; Andrews, Eva; Martini, Douglas N.; Palmieri-Smith, Riann M.; Gates, Deanna H.; Broglio, Steven P.			Kinematic differences during a jump cut maneuver between individuals with and without a concussion history	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Concussion; Anterior cruciate ligament; ACL; Jump cut; Kinematics	CRUCIATE LIGAMENT INJURY; STABILITY FOLLOWING CONCUSSION; TRAUMATIC BRAIN-INJURY; POSTURAL-CONTROL; GAIT STABILITY; KNEE-JOINT; MUSCULOSKELETAL INJURY; CEREBRAL CONCUSSION; CUTTING MANEUVERS; RECOVERY	Recent evidence suggests that athletes are at a higher risk of lower-body injuries in the months and years following a concussion. However, little is known about how people modify their movements post-concussion. This study examined kinematics during a jump cut motion in young adults with a concussion history (n = 9; 4 males, 5 females; 3.1 years' post-injury) and 10 controls (6 males, 4 females). Peak center of mass and peak knee angles during the landing phase of a jump-cut maneuver were evaluated. Participants with a concussion history demonstrated decreased knee varus (left: M-conc =-0.5 +/- 1.0 degrees, M-ctrl = 3.6 +/- 1.0 degrees; right: M-conc = 5.1 +/- 1.2, M-ctrl = 7.8 +/- 1.12 degrees) and external rotation (left: M-conc = 2.5 +/- 1.6 degrees, M-ctrl = 13.0 +/- 1.5% right: M-conc = 7.7 +/- 1.6 degrees, M-ctrl = 12.8 +/- 1.5 degrees) regardless of whether the cut was oriented towards to the left or right. The kinematic patterns demonstrated in individuals with a concussion history may be suggestive of increased knee injury risk. This study adds to the growing body of literature linking orthopedic injury in those no longer displaying the acute signs and symptoms of concussion.	[Lapointe, Andrew P.; Sosnowski, Aniela; Andrews, Eva] Univ Michigan, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Nolasco, Luis A.; Gates, Deanna H.] Univ Michigan, Rehabil Biomech Lab, Ann Arbor, MI 48109 USA; [Martini, Douglas N.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Palmieri-Smith, Riann M.] Univ Michigan, Ann Arbor, MI 48109 USA; [Broglio, Steven P.] Univ Michigan, Injury Ctr, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA		Broglio, SP (corresponding author), 401 Washtenaw Ave, Ann Arbor, MI 48109 USA.	broglio@umich.edu		Nolasco, Luis/0000-0001-6038-9669	Carl AMP; Joan Kreager Research Fund	This project was supported by the Carl & Joan Kreager Research Fund.	Barrack RL, 2000, PROPRIOCEPTION NEURO; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bates NA, 2016, KNEE SURG SPORT TR A, V24, P2778, DOI 10.1007/s00167-014-3478-3; Bates NA, 2013, J BIOMECH, V46, P1237, DOI 10.1016/j.jbiomech.2013.02.024; Belanger H. G, 2005, NEUROPSYCHOLOGICAL I, P345; Besier TF, 2001, MED SCI SPORT EXER, V33, P1176; Besier TF, 2001, MED SCI SPORT EXER, V33, P1168; Borotikar BS, 2008, CLIN BIOMECH, V23, P81, DOI 10.1016/j.clinbiomech.2007.08.008; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Burman E, 2016, BMJ OPEN SPORT EXERC, V2, pe000092, DOI DOI 10.1136/BMJSEM-2015-000092; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Chappell JD, 2007, AM J SPORT MED, V35, P235, DOI 10.1177/0363546506294077; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Churchill N, 2016, BRAIN INJURY, P1; Davidson TW, 2016, CLIN NEUROPHYSIOL, V127, P3364, DOI 10.1016/j.clinph.2016.07.012; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dubose D. F, 2016, PUBLISHED AHEAD PRIN; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Gamada K, 2014, PHYS MED REHABILITAT, V2, P1; Gilbert F. C, 2016, SPORTS HLTH; Guskiewicz K. M, 2011, PHYS MED REHABIL, V3; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Littleton A, 2013, J SPORT HEALTH SCI, V2, P227, DOI 10.1016/j.jshs.2013.04.003; Malinzak RA, 2001, CLIN BIOMECH, V16, P438, DOI 10.1016/S0268-0033(01)00019-5; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McLean SG, 2010, CLIN BIOMECH, V25, P563, DOI 10.1016/j.clinbiomech.2010.02.013; McLean SG, 2004, MED SCI SPORT EXER, V36, P1008, DOI 10.1249/01.MSS.0000128180.51443.83; Nordenvall R, 2012, AM J SPORT MED, V40, P1808, DOI 10.1177/0363546512449306; Nyberg G, 2015, CURR RES CONCUSSION, V2, P109; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Pollard CD, 2007, CLIN J SPORT MED, V17, P38, DOI 10.1097/JSM.0b013e3180305de8; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Rochefort C, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117695507; Shimokochi Y, 2008, J ATHL TRAINING, V43, P396, DOI 10.4085/1062-6050-43.4.396; Sigward SM, 2015, CLIN J SPORT MED, V25, P529, DOI 10.1097/JSM.0000000000000155; Silverman AK, 2011, J BIOMECH, V44, P379, DOI 10.1016/j.jbiomech.2010.10.027; Sinsurin Komsak, 2013, Asian J Sports Med, V4, P195; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stearns KM, 2013, AM J SPORT MED, V41, P918, DOI 10.1177/0363546513476853; Wilken JM, 2012, GAIT POSTURE, V35, P301, DOI 10.1016/j.gaitpost.2011.09.105; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	57	13	13	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2018	132		A		SI		93	98		10.1016/j.ijpsycho.2017.08.003			6	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	GV7GC	WOS:000446289000013	28818697				2022-02-06	
J	Trillo-Contreras, JL; Ramirez-Lorca, R; Hiraldo-Gonzalez, L; Sanchez-Gomar, I; Galan-Cobo, A; Suarez-Luna, N; de Rojas-de Pedro, E; Toledo-Aral, JJ; Villadiego, J; Echevarria, M				Luis Trillo-Contreras, Jose; Ramirez-Lorca, Reposo; Hiraldo-Gonzalez, Laura; Sanchez-Gomar, Ismael; Galan-Cobo, Ana; Suarez-Luna, Nela; Sanchez de Rojas-de Pedro, Eva; Jose Toledo-Aral, Juan; Villadiego, Javier; Echevarria, Miriam			Combined effects of aquaporin-4 and hypoxia produce age-related hydrocephalus	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						AQP4; Hypoxia; Aging; Mice; Hydrocephalus; Cerebrospinal fluid	NORMAL-PRESSURE HYDROCEPHALUS; CEREBROSPINAL-FLUID HYDRODYNAMICS; TRAUMATIC BRAIN-INJURY; CHOROID-PLEXUS; WATER CHANNEL; PARKINSONS-DISEASE; HIGH-ALTITUDE; BLOOD-FLOW; MPTP MODEL; EXPRESSION	Aquaporin-4, present in ependymal cells, in glia limiting and abundantly in pericapillary astrocyte foot processes, and aquaporin-1, expressed in choroid plexus epithelial cells, play an important role in cerebrospinal fluid production and may be involved in the pathophysiology of age-dependent hydrocephalus. The finding that brain aquaporins expression is regulated by low oxygen tension led us to investigate how hypoxia and elevated levels of cerebral aquaporins may result in an increase in cerebrospinal fluid production that could be associated with a hydrocephalic condition. Here we have explored, in young and aged mice exposed to hypoxia, whether aquaporin-4 and aquaporin-1 participate in the development of age-related hydrocephalus. Choroid plexus, striatum, cortex and ependymal tissue were analyzed separately both for mRNA and protein levels of aquaporins. Furthermore, parameters such as total ventricular volume, intraventricular pressure, cerebrospinal fluid outflow rate, ventricular compliance and cognitive function were studied in wild type, aquaporin-1 and aquaporin-4 knock-out animals subjected to hypoxia or normoxia. Our data demonstrate that hypoxia is involved in the development of age-related hydrocephalus by a process that depends on aquaporin-4 channels as a main route for cerebrospinal fluid movement. Significant increases in aquaporin-4 expression that occur over the course of animal aging, together with a reduced cerebrospinal fluid outflow rate and ventricular compliance, contribute to produce more severe hydrocephalus related to hypoxic events in aged mice, with a notable impairment in cognitive function. These results indicate that physiological events and/or pathological conditions presenting with cerebral hypoxia/ischemia contribute to the development of chronic adult hydrocephalus.	[Luis Trillo-Contreras, Jose; Ramirez-Lorca, Reposo; Hiraldo-Gonzalez, Laura; Sanchez-Gomar, Ismael; Galan-Cobo, Ana; Suarez-Luna, Nela; Sanchez de Rojas-de Pedro, Eva; Jose Toledo-Aral, Juan; Villadiego, Javier; Echevarria, Miriam] Univ Seville, Spanish Natl Res Council CSIC, Virgen del Rocio Univ Hosp HUVR, Inst Biomed Seville IBiS, Seville 41013, Spain; [Luis Trillo-Contreras, Jose; Ramirez-Lorca, Reposo; Hiraldo-Gonzalez, Laura; Suarez-Luna, Nela; Jose Toledo-Aral, Juan; Villadiego, Javier; Echevarria, Miriam] Univ Seville, Dept Physiol & Biophys, E-41009 Seville, Spain; [Jose Toledo-Aral, Juan; Villadiego, Javier] Network Ctr Biomed Res Neurodegenerat Dis CIBERNE, Madrid, Spain		Villadiego, J; Echevarria, M (corresponding author), Inst Biomed Sevilla IBiS, Avda Manuel Siurot S-N, Seville 41013, Spain.	fvilladiego@us.es; irusta@us.es	Echevarria, Miriam/E-6682-2010; Toledo-Aral, Juan J/F-2613-2015; Hiraldo, Laura/M-7135-2016; Reposo, Ramirez-Lorca/D-7907-2014; Sanchez-Gomar, Ismael/AAN-3436-2020; Villadiego, Javier/F-2594-2015	Echevarria, Miriam/0000-0002-4758-9428; Toledo-Aral, Juan J/0000-0001-7512-7135; Hiraldo, Laura/0000-0002-1382-6798; Sanchez-Gomar, Ismael/0000-0002-6654-4217; Villadiego, Javier/0000-0003-2131-9013; Galan Cobo, Ana/0000-0002-0988-1823; Ramirez Lorca, Reposo/0000-0002-1594-0404; SUAREZ-LUNA, NELA/0000-0002-2779-6913	Spanish Ministry of Economy and CompetitivenessSpanish Government [FIS: PI12/01882, PI16/00493]; Carlos III Health Institute (ISCIII)Instituto de Salud Carlos III; European Regional Development Fund (FEDER)European Commission; Regional Government of AndalusiaJunta de Andalucia; FEDER funds through a program for recruitment of young researchers	This study has been supported by grants FIS: PI12/01882 and PI16/00493 from the Spanish Ministry of Economy and Competitiveness, co-financed by the Carlos III Health Institute (ISCIII) and European Regional Development Fund (FEDER). JLTC was partially supported by the Regional Government of Andalusia and FEDER funds through a program for recruitment of young researchers.	Abreu-Rodriguez I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028385; Aghayev K, 2012, ACTA NEUROCHIR, V154, P753, DOI 10.1007/s00701-011-1241-9; AKAI K, 1987, ACTA PATHOL JAPON, V37, P97; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; Chen SJ, 2014, P NATL ACAD SCI USA, V111, P13199, DOI 10.1073/pnas.1404493111; CURRANEVERETT DC, 1991, AM J PHYSIOL, V261, pH103, DOI 10.1152/ajpheart.1991.261.1.H103; DAVSON H, 1970, Brain Behavior and Evolution, V93, P665, DOI 10.1093/brain/93.4.665; Desai B, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.7.FOCUS16191; DESTIAN S, 1989, AM J NEURORADIOL, V10, P1021; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Dombrowski SM, 2008, NEUROSCIENCE, V152, P346, DOI 10.1016/j.neuroscience.2007.11.049; Dubowitz DJ, 2009, J APPL PHYSIOL, V107, P244, DOI 10.1152/japplphysiol.90349.2008; Dyer EAW, 2008, RESP PHYSIOL NEUROBI, V160, P267, DOI 10.1016/j.resp.2007.10.010; Echevarria M, 2007, J BIOL CHEM, V282, P30207, DOI 10.1074/jbc.M702639200; Espay AJ, 2017, ANN NEUROL, V82, P503, DOI 10.1002/ana.25046; Filippidis AS, 2012, ACTA NEUROCHIR SUPPL, V113, P55, DOI 10.1007/978-3-7091-0923-6_12; Fryclenlund DS, 2006, P NATL ACAD SCI USA, V103, P13532, DOI 10.1073/pnas.0605796103; Galan-Cobo A, 2016, J CELL PHYSIOL, V231, P243, DOI 10.1002/jcp.25078; Gao F, 2016, ACTA NEUROCHIR SUPPL, V121, P373, DOI 10.1007/978-3-319-18497-5_64; Gilbert Gordon J, 2014, Neurology, V83, P1773, DOI 10.1212/WNL.0000000000000994; Hashimoto M., 2010, CEREBROSPINAL FLUID, V7, P18, DOI DOI 10.1186/1743-8454-7-18; Hellstrom P, 2012, ACTA NEUROL SCAND, V126, P229, DOI 10.1111/j.1600-0404.2012.01677.x; Igarashi H, 2014, NEUROREPORT, V25, P39, DOI 10.1097/WNR.0000000000000042; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ivkovic M, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0004-z; Johanson C. E., 1995, SCIENCE; Kalani MYS, 2012, ACTA NEUROCHIR SUPPL, V113, P51, DOI 10.1007/978-3-7091-0923-6_11; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Lawley JS, 2016, J APPL PHYSIOL, V120, P251, DOI 10.1152/japplphysiol.00370.2015; LOSCALZO J, 1994, CIRCULATION, V90, P2556, DOI 10.1161/01.CIR.90.5.2556; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Menyhart A, 2017, AM J PHYSIOL-HEART C, V313, pH328, DOI 10.1152/ajpheart.00222.2017; Munoz-Cabello AM, 2010, PFLUG ARCH EUR J PHY, V459, P775, DOI 10.1007/s00424-009-0774-8; Munoz-Manchado AB, 2016, J NEUROCHEM, V136, P373, DOI 10.1111/jnc.13409; Munoz-Manchado AB, 2013, NEUROBIOL AGING, V34, P902, DOI 10.1016/j.neurobiolaging.2012.06.001; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Oreskovic D, 2011, PROG NEUROBIOL, V94, P238, DOI 10.1016/j.pneurobio.2011.05.005; Oreskovic D, 2017, NEUROSCIENCE, V354, P69, DOI 10.1016/j.neuroscience.2017.04.025; Oshio K, 2005, NEUROSURGERY, V56, P375, DOI 10.1227/01.NEU.0000148904.57841.6B; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; PAGE LK, 1985, CHILD NERV SYST, V1, P12, DOI 10.1007/BF00706724; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Peng WG, 2016, NEUROBIOL DIS, V93, P215, DOI 10.1016/j.nbd.2016.05.015; Ringstad G, 2017, BRAIN, V140, P2691, DOI 10.1093/brain/awx191; Sakas DE, 1999, J CLIN NEUROSCI, V6, P324, DOI 10.1016/S0967-5868(99)90056-5; Schmidt MJ, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0034-1; SEGAL MB, 1977, EXP EYE RES, V25, P127, DOI 10.1016/S0014-4835(77)80012-2; Skjolding AD, 2013, NEUROPATH APPL NEURO, V39, P179, DOI 10.1111/j.1365-2990.2012.01275.x; Speake T, 2001, MICROSC RES TECHNIQ, V52, P49, DOI 10.1002/1097-0029(20010101)52:1<49::AID-JEMT7>3.0.CO;2-C; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; Tourdias T, 2009, NEUROIMAGE, V47, P659, DOI 10.1016/j.neuroimage.2009.04.070; Tumani H, 2018, HAND CLINIC, V146, P21, DOI 10.1016/B978-0-12-804279-3.00002-2; Verkman AS, 2002, ANN MED, V34, P192, DOI 10.1080/713782138; Villadiego J, 2018, GLIA, V66, P191, DOI 10.1002/glia.23237; WALD A, 1978, BRAIN RES, V151, P283, DOI 10.1016/0006-8993(78)90885-5; Wang DW, 2011, MOL CELL NEUROSCI, V46, P318, DOI 10.1016/j.mcn.2010.10.003; WELCH K, 1963, AM J PHYSIOL, V205, P617, DOI 10.1152/ajplegacy.1963.205.3.617; Wessling H, 2007, ACTA NEUROCHIR, V149, P239, DOI 10.1007/s00701-006-1083-z; Williams H, 2016, MED HYPOTHESES, V94, P30, DOI 10.1016/j.mehy.2016.06.013; Wilson MH, 2011, HIGH ALT MED BIOL, V12, P379, DOI 10.1089/ham.2011.1026; Wolf A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147733; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022; Zeppenfeld DM, 2017, JAMA NEUROL, V74, P91, DOI 10.1001/jamaneurol.2016.4370; Zhang CC, 2015, MOL MED REP, V12, P7351, DOI 10.3892/mmr.2015.4372	71	13	14	3	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	OCT	2018	1864	10					3515	3526		10.1016/j.bbadis.2018.08.006			12	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	GU5FS	WOS:000445312000035	30293570	Bronze			2022-02-06	
J	Merritt, VC; Clark, AL; Crocker, LD; Sorg, SF; Werhane, ML; Bondi, MW; Schiehser, DM; Delano-Wood, L				Merritt, Victoria C.; Clark, Alexandra L.; Crocker, Laura D.; Sorg, Scott F.; Werhane, Madeleine L.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa			Repetitive mild traumatic brain injury in military veterans is associated with increased neuropsychological infra-individual variability	NEUROPSYCHOLOGIA			English	Article						antra-individual variability; Dispersion; Head injury; Cognitive functioning; Neuropsychological assessment	SPORTS-RELATED CONCUSSION; INTRAINDIVIDUAL VARIABILITY; REACTION-TIME; OLDER-ADULTS; TEST-PERFORMANCE; COGNITIVE IMPAIRMENT; SYMPTOMS; DISEASE; METAANALYSIS; CONSISTENCY	Although across-test intra-individual variability (IIV), or dispersion; has been shown to be a valuable marker of neurological health in a variety of clinical samples, IIV has not been well examined in the context of mild traumatic brain injury (mTBI). In the present study, we examined measures of IN in military Veterans with and without a history of mTBI. Secondly, we examined how measures of IIV relate to traditional indices of mean cognitive performance, TBI characteristics, and neuropsychiatric symptoms in mTBI. Participants included 120 Veterans (67 mTBI, 53 military controls [MCs]) who completed a comprehensive neuropsychological assessment. Two dispersion indices were calculated using 13 norm-referenced variables: an average standard deviation (ASD) score and a maximum discrepancy (MD) score. Compared to MCs, Veterans with a history of mTBI demonstrated greater IIV as indicated by the MD index after adjusting for relevant demographic variables, PTSD symptoms, and mean-level cognitive performance (p = 0.027; eta(2)(p) = 0.043), and there was a trend finding in the same direction for the ASD index (p = 0.091; eta(2)(p) = 0.025). Among the mTBI participants, the two IIV indices were positively correlated with each other (p < 0.001, r = 0.921) and negatively correlated with mean cognitive performance (p = 0.017-0.022, r = -[0.279-0.291]). In contrast, ASD and MD scores were not associated with a measure of premorbid intellectual functioning or neuropsychiatric symptoms (all p's > 0.05). However, higher ASD scores were positively related to lifetime number of mTBIs, such that greater cognitive variability was observed in Veterans with a history of multiple mTBIs (i.e., >= 3 mTBIs; p = 0.037, r = 0.255). Overall, our results demonstrate that Veterans with mTBI show greater IIV relative to MCs, and that repetitive mTBI is associated with increased cognitive performance variability. Findings indicate that, in the context of mTBI-which is considerably heterogeneous in nature measures of dispersion may be more appropriate indicators of cognitive dysfunction when compared to traditional mean neuropsychological scores, especially in those with remote mTBI histories. Future longitudinal studies are needed to further establish the long-term clinical implications and brain-based correlates of these findings.	[Merritt, Victoria C.; Clark, Alexandra L.; Crocker, Laura D.; Sorg, Scott F.; Werhane, Madeleine L.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa] VASDHS, 3350 La Jolla Village Dr,MC 151B, San Diego, CA 92161 USA; [Clark, Alexandra L.; Werhane, Madeleine L.] Univ Calif San Diego, SDSU, Joint Doctoral Program Clin Psychol, 6363 Alvarado Court,Suite 103, San Diego, CA 92120 USA; [Sorg, Scott F.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa] Univ Calif San Diego, Sch Med, Dept Psychiat, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Schiehser, Dawn M.; Delano-Wood, Lisa] VASDHS, Ctr Excellence Stress & Mental Hlth, 3350 La Jolla Village Dr,MC151B, San Diego, CA 92161 USA		Delano-Wood, L (corresponding author), VASDHS, 3350 La Jolla Village Dr,MC 151B, San Diego, CA 92161 USA.; Delano-Wood, L (corresponding author), Univ Calif San Diego, Sch Med, Dept Psychiat, 9500 Gilman Dr, La Jolla, CA 92093 USA.; Delano-Wood, L (corresponding author), VASDHS, Ctr Excellence Stress & Mental Hlth, 3350 La Jolla Village Dr,MC151B, San Diego, CA 92161 USA.	vcabarnes@gmail.com; alexandra.leigh.cl@gmail.com; laura.crocker@va.gov; ssorg@ucsd.edu; mlwerhane@gmail.com; mbondi@ucsd.edu; dschiehser@ucsd.edu; ldelano@ucsd.edu		Merritt, Victoria/0000-0001-5683-4168	Veterans AffairsUS Department of Veterans Affairs [829-MR-NB-25860, CDA-2-065-10S, CDA-2-CX001508, IK2 RX002459]; Department of DefenseUnited States Department of Defense [W81XWH-10-2-0169]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS09870]; Department of Veterans Affairs Office of Academic Affiliations Postdoctoral Residency Program in Neuropsychology (VA San Diego Healthcare System); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K24 AG026431]; Veterans AffairsUS Department of Veterans Affairs [IK2RX002459] Funding Source: NIH RePORTER	This work was supported by Veterans Affairs grants awarded to Drs. Delano-Wood (829-MR-NB-25860), Schiehser (CDA-2-065-10S), Sorg (CDA-2-CX001508), and Crocker (IK2 RX002459). This work was further supported by grants awarded by the Department of Defense (W81XWH-10-2-0169) to Dr. Delano-Wood and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (F31NS09870) to Ms. Clark. Finally, this research is supported by the Department of Veterans Affairs Office of Academic Affiliations Postdoctoral Residency Program in Neuropsychology (VA San Diego Healthcare System) and a grant awarded to Dr. Bondi by the National Institutes of Health (K24 AG026431).	American Psychatric Association, 2000, DIAGN STAT MAN MENT; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Burton CL, 2006, J CLIN EXP NEUROPSYC, V28, P67, DOI 10.1080/13803390490918318; Clark AL, 2016, BRAIN INJURY, V30, P864, DOI 10.3109/02699052.2016.1144894; Cole VT, 2011, SCHIZOPHR RES, V129, P91, DOI 10.1016/j.schres.2011.03.007; Cole Wesley R, 2017, J Int Neuropsychol Soc, P1, DOI 10.1017/S1355617717000856; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Grogan A, 2009, CEREB CORTEX, V19, P2690, DOI 10.1093/cercor/bhp023; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Haynes BI, 2017, J INT NEUROPSYCH SOC, V23, P431, DOI 10.1017/S1355617717000236; Heaton R.K., 1981, WISCONSIN CARD SORTI; Hilborn JV, 2009, J CLIN EXP NEUROPSYC, V31, P412, DOI 10.1080/13803390802232659; Hill BD, 2013, ARCH CLIN NEUROPSYCH, V28, P640, DOI 10.1093/arclin/act045; Hines LJ, 2016, BRAIN IMAGING BEHAV, V10, P640, DOI 10.1007/s11682-015-9441-1; Holtzer R, 2008, JAMA-J AM MED ASSOC, V300, P823, DOI 10.1001/jama.300.7.823; Hultsch DF, 2000, NEUROPSYCHOLOGY, V14, P588, DOI 10.1037/0894-4105.14.4.588; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kaplan E., 2001, BOSTON NAMING TEST; Karr JE, 2014, J CLIN EXP NEUROPSYC, V36, P15, DOI 10.1080/13803395.2013.863833; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; MacDonald SWS, 2009, PSYCHOL AGING, V24, P792, DOI 10.1037/a0017798; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Meyers JE., 1995, REY COMPLEX FIGURE T; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Morgan EE, 2011, NEUROPSYCHOLOGY, V25, P645, DOI 10.1037/a0023792; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Rabinowitz AR, 2013, NEUROPSYCHOLOGY, V27, P481, DOI 10.1037/a0033023; Roalf DR, 2016, J ALZHEIMERS DIS, V54, P325, DOI 10.3233/JAD-160259; Schmiedek F, 2009, PSYCHOL AGING, V24, P841, DOI 10.1037/a0017799; Schoenberg MR, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P1, DOI 10.1007/978-0-387-76978-3_1; Schretlen DJ, 2003, J INT NEUROPSYCH SOC, V9, P864, DOI 10.1017/S1355617703960061; Sorg SF, 2016, J HEAD TRAUMA REHAB, V31, P297, DOI 10.1097/HTR.0000000000000189; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Tanner-Eggen C, 2015, ARCH CLIN NEUROPSYCH, V30, P217, DOI 10.1093/arclin/acv008; Thaler NS, 2015, J CLIN EXP NEUROPSYC, V37, P622, DOI 10.1080/13803395.2015.1039962; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Troyer AK, 2016, NEUROPSYCHOLOGIA, V90, P110, DOI 10.1016/j.neuropsychologia.2016.06.011; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Weathers F. W., 1991, PCL M FOR DSM 4; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Wechsler D., 2008, WECHSLER ADULT INTEL; West R, 2002, BRAIN COGNITION, V49, P402, DOI 10.1006/brcg.2001.1507; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME	61	13	13	3	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	OCT	2018	119						340	348		10.1016/j.neuropsychologia.2018.08.026			9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	HA8MM	WOS:000450543800036	30176300				2022-02-06	
J	Park, SH; Hwang, SK				Park, Seong-Hyun; Hwang, Sung-Kyoo			Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Biomarker; IL-6; NSE; Pediatric; S100B; Traumatic brain injury	HEAD-INJURY; CHILDREN; MARKERS; DAMAGE; MILD; S-100B; BIOMARKERS; PHASE	OBJECTIVE: To analyze serum levels of S100 calcium-binding protein B (S100B), neuron-specific enolase (NSE), and interleukin (IL)-6 in pediatric patients with traumatic brain injury (TBI) and to assess their relationship with clinical outcome. METHODS: To measure biomarkers, peripheral venous blood was collected within 6 hours and 1 week after TBI. Initial Glasgow Coma Scale (GCS) scores and Glasgow Outcome Scale scores 6 months after the trauma were used to evaluate clinical outcome. RESULTS: Median serum levels of S100B (178.12 pg/mL), NSE (16.54 ng/mL), and IL-6 (15.48 pg/mL) at admission decreased significantly 1 week after TBI to 40.86 pg/mL, 5.85 ng/mL, and 8.63 pg/mL. In the group with poor GCS scores, serum S100B and NSE levels both at admission and 1 week after TBI were significantly higher than levels in the group with good GCS scores. Serum S100B and NSE levels 1 week after injury in patients with unfavorable 6-month outcomes were significantly higher than levels 1 week after injury in patients with favorable outcomes. CONCLUSIONS: Serum levels of S100B, NSE, and IL-6 decreased 1 week after injury. Serum levels of S100B and NSE at admission were related to initial GCS scores, and these levels 1 week after TBI were related to 6-month Glasgow Outcome Scale scores. Thus, serial measurements of serum S100B and NSE, but not IL-6, may help assess brain damage and clinical outcome of pediatric patients with TBI.	[Park, Seong-Hyun; Hwang, Sung-Kyoo] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Neurosurg, Daegu, South Korea		Park, SH (corresponding author), Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Neurosurg, Daegu, South Korea.	nsdoctor@naver.com			Biomedical Research Institute [2016-General-08]; Kyungpook National University Hospital	This work was supported by Biomedical Research Institute (grant no. 2016-General-08), Kyungpook National University Hospital (2016).	Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Berger RP, 2010, DEV NEUROSCI-BASEL, V32, P396, DOI 10.1159/000316803; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Cotena S, 2006, J NEUROSURG, V104, P435, DOI 10.3171/ped.2006.104.6.435; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Raheja A, 2016, J NEUROSURG, V125, P631, DOI 10.3171/2015.6.JNS15674; Ramont L, 2005, CLIN CHEM LAB MED, V43, P1215, DOI 10.1515/CCLM.2005.210; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; THELIN EP, 2016, CRIT CARE, V20; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	24	13	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2018	118						E534	E542		10.1016/j.wneu.2018.06.234			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GU1NY	WOS:000445032000069	30257306				2022-02-06	
J	Komura, A; Kawasaki, T; Yamada, Y; Uzuyama, S; Asano, Y; Shinoda, J				Komura, Akifumi; Kawasaki, Tomohiro; Yamada, Yuichi; Uzuyama, Shiho; Asano, Yoshitaka; Shinoda, Jun			Cerebral Glucose Metabolism in Patients with Chronic Mental and Cognitive Sequelae after a Single Blunt Mild Traumatic Brain Injury without Visible Brain Lesions	JOURNAL OF NEUROTRAUMA			English	Article						cerebral glucose uptake; FDG-PET; mild traumatic brain injury; neuropsychological examination; post-traumatic sequelae	FDG-PET; HEAD-INJURY; SCHIZOPHRENIA; HYPOTHESIS; DYSREGULATION; EPIDEMIOLOGY; DISORDER; ADULTS	The aim of this study is to investigate glucose uptake on 18F-fluorodeoxyglucose positron emission tomography positron emission tomography (FDG-PET) in patients with chronic mental and cognitive symptoms following a single blunt mild traumatic brain injury (TBI) and without visible brain lesions on computed tomography (CT)/magnetic resonance imaging (MRI). Eighty-nine consecutive patients (mean age 43.8 +/- 10.75 years) who had a single blunt mild TBI from a traffic accident and suffering from chronic mental and cognitive symptoms without visible brain lesions on CT/MRI were enrolled in the study. Patients underwent FDG-PET imaging, and the mean interval between the TBI and FDG-PET was 50.0 months. The Wechsler Adult Intelligence Scale version III (WAIS-III) testing was performed within 1 month of the FDG-PET. A control group consisting of 93 healthy adult volunteers (mean age 42.2 +/- 14.3 years) also underwent FDG-PET. The glucose uptake pattern from FDG-PET in the patient group was compared with that from normal controls using statistical parametric mapping. Glucose uptake was significantly decreased in the bilateral prefrontal area and significantly increased around the limbic system in the patient group compared with normal controls. This topographical pattern of glucose uptake is different from that reported previously in patients with diffuse axonal injury (DAI), but may be similar to that seen in patients with major depression disorder. These results suggest that the pathological mechanism causing chronic mental and cognitive symptoms in patients with a single blunt mild TBI and without visible brain lesions might be different from that due to primary axonopathy in patients with DAI.	[Komura, Akifumi; Kawasaki, Tomohiro; Yamada, Yuichi; Asano, Yoshitaka; Shinoda, Jun] Gifu Univ, Grad Sch Med, Dept Clin Brain Sci, Minokamo, Japan; [Komura, Akifumi] Heisei Coll Hlth Sci, Dept Rehabil, Gifu, Japan; [Kawasaki, Tomohiro; Yamada, Yuichi; Uzuyama, Shiho; Asano, Yoshitaka; Shinoda, Jun] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Minokamo, Japan		Komura, A (corresponding author), Gifu Univ, Grad Sch Med, Dept Clin Brain Sci, 630 Shimo KobiKobi Cho, Minokamo City, Gifu 5050034, Japan.	koumura-ot@umin.ac.jp					Abu-Judeh H H, 2000, Nucl Med Rev Cent East Eur, V3, P5; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; [Anonymous], 2012, NEWSWISE ALBERT EINS; Asano Y, 2012, NEUROL MED-CHIR, V52, P31, DOI 10.2176/nmc.52.31; Audenaert Kurt, 2003, Med Sci Monit, V9, pMT112; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Berk M, 2007, ACTA PSYCHIAT SCAND, V116, P41, DOI 10.1111/j.1600-0447.2007.01058.x; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Brooks JO, 2009, J PSYCHIATR RES, V43, P497, DOI 10.1016/j.jpsychires.2008.08.001; Caroll L.J., 2004, J REHABILI MED S, V43; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; COPPEN A, 1967, BRIT J PSYCHIAT, V113, P1237, DOI 10.1192/bjp.113.504.1237; Epstein J, 1999, ANN NY ACAD SCI, V877, P562, DOI 10.1111/j.1749-6632.1999.tb09289.x; Fernandez-Egea E, 2010, EUR ARCH PSY CLIN N, V260, P69, DOI 10.1007/s00406-009-0020-6; Fu C, 2017, EXP THER MED, V14, P1058, DOI 10.3892/etm.2017.4594; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Hashimoto K, 2007, J REHABIL MED, V39, P418, DOI 10.2340/16501977-0065; Haznedar MM, 2004, SCHIZOPHR RES, V71, P249, DOI 10.1016/j.schres.2004.02.025; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Ito K, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6019403; Ito K, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3794029; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Le Roux PD, 2000, HEAD INJURY, P175; Levin H, 2013, LANCET NEUROL, V12, P15, DOI 10.1016/S1474-4422(12)70300-9; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lull N, 2010, NEUROLOGIA, V25, P174; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Papakostas GI, 2006, EUR NEUROPSYCHOPHARM, V16, P391, DOI 10.1016/j.euroneuro.2005.12.002; Park HJ, 2006, NEUROIMAGE, V31, P1434, DOI 10.1016/j.neuroimage.2006.02.001; PRANGE AJ, 1974, ARCH GEN PSYCHIAT, V30, P56; Sacher J, 2012, J AFFECT DISORDERS, V140, P142, DOI 10.1016/j.jad.2011.08.001; SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509; Seethalakshmi R, 2006, Indian J Psychiatry, V48, P149, DOI 10.4103/0019-5545.31577; Shinoda J, 2017, NEUROL MED-CHIR, V57, P199, DOI 10.2176/nmc.ra.2016-0293; Soares JC, 1999, BIOL PSYCHIAT, V46, P600, DOI 10.1016/S0006-3223(99)00015-3; Su L, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0321-9; Sundman M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00334; Tashiro M, 2004, PSYCHO-ONCOLOGY, V13, P486, DOI 10.1002/pon.817; Teasdale G, 1996, NEUROLOGICAL SURG, P1533; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Yasokawa YT, 2007, J NEUROTRAUM, V24, P163, DOI 10.1089/neu.2006.0073; Zhang J, 2010, J NEUROTRAUM, V27, P35, DOI 10.1089/neu.2009.1049	51	13	13	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2019	36	5					641	649		10.1089/neu.2018.5641		SEP 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HR2BG	WOS:000444714500001	29921156				2022-02-06	
J	Prabhakara, KS; Kota, DJ; Jones, GH; Srivastava, AK; Cox, CS; Olson, SD				Prabhakara, Karthik S.; Kota, Daniel J.; Jones, Gregory H.; Srivastava, Amit K.; Cox, Charles S., Jr.; Olson, Scott D.			Teriflunomide Modulates Vascular Permeability and Microglial Activation after Experimental Traumatic Brain Injury	MOLECULAR THERAPY			English	Article							CONTROLLED CORTICAL IMPACT; DE-NOVO SYNTHESIS; AGOUTI RAT MODEL; RHEUMATOID-ARTHRITIS; T-LYMPHOCYTES; IMMUNOMODULATORY DRUG; CLINICAL-TRIAL; DENTATE GYRUS; DOUBLE-BLIND; LEFLUNOMIDE	Despite intensive research and clinical trials with numerous therapeutic treatments, traumatic brain injury (TBI) is a serious public health problem in the United States. There is no effective FDA-approved treatment to reduce morbidity and mortality associated with TBI. Inflammation plays a pivotal role in the pathogenesis of TBI. We looked to re-purpose existing drugs that reduce immune activation without broad immunosuppression. Teriflunomide, an FDA-approved drug, has been shown to modulate immunological responses outside of its ability to inhibit pyrimidine synthesis in rapidly proliferating cells. In this study, we tested the efficacy of teriflunomide to treat two different injury intensities in rat models of TBI. Our results show that teriflunomide restores blood-brain barrier integrity, decreases inflammation, and increases neurogenesis in the subgranular zone of the hippocampus. While we were unable to detect neurocognitive effects of treatment on memory and special learning abilities after treatment, a 2-week treatment following injury was sufficient to reduce neuroinflammation up to 120 days later.	[Prabhakara, Karthik S.; Jones, Gregory H.; Srivastava, Amit K.; Cox, Charles S., Jr.; Olson, Scott D.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, Program Childrens Regenerat Med, Houston, TX 77030 USA; [Kota, Daniel J.] Emory Univ, Sch Med, Emory Personalized Immunotherapy Core Labs, Atlanta, GA 30322 USA		Olson, SD (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, 6431 Fannin St MSE R162, Houston, TX 77030 USA.	scott.d.olson@uth.tmc.edu		Srivastava, Amit/0000-0001-7554-7201; Olson, Scott/0000-0001-8032-3755	Genzyme SanofiSanofi-AventisGenzyme Corporation [GZ-2013-11010]	The authors would like to thank Genzyme Sanofi for providing teriflunomide and supporting this study through the Independent Investigatory Study award GZ-2013-11010.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Albrecht DS, 2016, ACS CHEM NEUROSCI, V7, P470, DOI 10.1021/acschemneuro.6b00056; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Ambrosius B, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0829-2; BARTLETT RR, 1991, AGENTS ACTIONS, V32, P10, DOI 10.1007/BF01983301; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bedi SS, 2013, J TRAUMA ACUTE CARE, V75, P410, DOI 10.1097/TA.0b013e31829617c6; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Burger D, 2003, RHEUMATOLOGY, V42, P89, DOI 10.1093/rheumatology/keg038; Cao WW, 1996, TRANSPL P, V28, P3079; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Clausen F, 2019, J NEUROTRAUM, V36, P201, DOI 10.1089/neu.2018.5636; Claussen MC, 2012, CLIN IMMUNOL, V142, P49, DOI 10.1016/j.clim.2011.02.011; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Cutolo M, 2003, ANN RHEUM DIS, V62, P297, DOI 10.1136/ard.62.4.297; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Deage V, 1998, EUR CYTOKINE NETW, V9, P663; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; Dimitrova P, 2002, J IMMUNOL, V169, P3392, DOI 10.4049/jimmunol.169.6.3392; FAIRBANKS LD, 1995, J BIOL CHEM, V270, P29682; Fox RI, 1999, CLIN IMMUNOL, V93, P198, DOI 10.1006/clim.1999.4777; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Furman NET, 2018, CYTOM PART A, V93A, P182, DOI 10.1002/cyto.a.23267; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Groh J, 2017, MOL THER, V25, P1889, DOI 10.1016/j.ymthe.2017.04.021; Haghikia A, 2014, NAT REV NEUROL, V10, P183, DOI 10.1038/nrneurol.2014.42; He D., 2016, COCHRANE DB SYST REV, V3; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Herrmann ML, 2000, IMMUNOPHARMACOLOGY, V47, P273, DOI 10.1016/S0162-3109(00)00191-0; Iglesias-Bregna D, 2013, J PHARMACOL EXP THER, V347, P203, DOI 10.1124/jpet.113.205146; Jin YC, 2017, WORLD NEUROSURG, V100, P351, DOI 10.1016/j.wneu.2017.01.033; Korn T, 2004, J LEUKOCYTE BIOL, V76, P950, DOI 10.1189/jlb.0504308; Kota DJ, 2017, STEM CELLS, V35, P1416, DOI 10.1002/stem.2603; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Kraan MC, 2000, ARTHRITIS RHEUM, V43, P1488, DOI 10.1002/1529-0131(200007)43:7<1488::AID-ANR11>3.0.CO;2-G; Kraan MC, 2000, ARTHRITIS RHEUM, V43, P1820, DOI 10.1002/1529-0131(200008)43:8<1820::AID-ANR18>3.0.CO;2-D; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Li L, 2013, J NEUROIMMUNOL, V265, P82, DOI 10.1016/j.jneuroim.2013.10.003; Liao GP, 2015, PEDIATR CRIT CARE ME, V16, P245, DOI 10.1097/PCC.0000000000000324; Liao GP, 2014, J SURG RES, V190, P628, DOI 10.1016/j.jss.2014.05.011; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lynch MA, 2012, BRAIN BEHAV IMMUN, V26, P1, DOI 10.1016/j.bbi.2011.05.013; Manna SK, 1999, J IMMUNOL, V162, P2095; Merrill JE, 2009, J NEUROL, V256, P89, DOI 10.1007/s00415-009-0075-3; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; O'Connor P, 2016, NEUROLOGY, V86, P920, DOI 10.1212/WNL.0000000000002441; Oh J, 2014, THER ADV NEUROL DISO, V7, P239, DOI 10.1177/1756285614546855; Peterson TC, 2015, BEHAV BRAIN RES, V294, P254, DOI 10.1016/j.bbr.2015.08.007; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rowe RK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1200-y; Ruckemann K, 1998, J BIOL CHEM, V273, P21682, DOI 10.1074/jbc.273.34.21682; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Streit WJ, 1996, NEUROTOXICOLOGY, V17, P671; Tajiri N, 2014, BRAIN RES, V1559, P65, DOI 10.1016/j.brainres.2014.02.041; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Wostradowski T, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0715-3; Zeyda M, 2005, ARTHRITIS RHEUM-US, V52, P2730, DOI 10.1002/art.21255	68	13	13	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	SEP 5	2018	26	9					2152	2162		10.1016/j.ymthe.2018.06.022			11	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	GX5BY	WOS:000447756800009	30037655	Green Published, hybrid			2022-02-06	
J	Rong, HT; Fan, YS; Yang, MC; Zhang, BL; Sun, DD; Zhao, ZL; Wang, D; Fan, WD; Wang, JH; Gu, G; Li, FJ; Liu, XL; Rao, CX; Chen, HJ; Wang, Y; Tian, Y; Zhang, JN				Rong, Hongtao; Fan, Yueshan; Yang, Mengchen; Zhang, Baoliang; Sun, Dongdong; Zhao, Zilong; Wang, Dong; Fan, Weidong; Wang, Jianhao; Gu, Gang; Li, Fanjian; Liu, Xilei; Rao, Chenxu; Chen, Huijiao; Wang, Yi; Tian, Ye; Zhang, Jianning			Brain-derived microparticles activate microglia/macrophages and induce neuroinflammation	BRAIN RESEARCH			English	Article						Microparticles; Microglia/macrophages; Inflammation; Inflammation factors	NECROSIS-FACTOR-ALPHA; INFLAMMATORY CELLS; TNF-ALPHA; INJURY; POLARIZATION; COAGULOPATHY; EXPRESSION; RAT; CNS	Microparticles are cell fragments derived from damaged cells that are able to present an antigen from the parent cells to other cells to activate intracellular signaling pathways. Microparticles are closely related to the inflammatory response. Brain-derived microparticles (BDMPs) play an important role in brain injury. However, the inflammatory effect of BDMPs on microglia/macrophages remains unclear. The BDMPs were consumed by microglia/macrophages in vivo and in vitro. The BDMPs activated microglia/macrophages and changed their morphology in vitro. The BDMPs dysregulate the production of pro inflammatory factors, suggesting that the effect of the BDMPs on microglia/macrophages is pro inflammatory. In this study, we used flow cytometry, hopping probe ion conductance microscopy, immunofluorescence and other techniques to study the effect of brain-derived microparticle activation on microglia/macrophages that leads to neuroinflammation. BDMPs might be possible targets for the treatment of traumatic brain injury (TBI) changes after secondary nerve inflammation. (C) 2018 Elsevier B.V. All rights reserved.	[Rong, Hongtao; Fan, Yueshan; Yang, Mengchen; Zhang, Baoliang; Sun, Dongdong; Zhao, Zilong; Wang, Dong; Wang, Jianhao; Gu, Gang; Li, Fanjian; Liu, Xilei; Rao, Chenxu; Chen, Huijiao; Wang, Yi; Tian, Ye; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Fan, Yueshan; Yang, Mengchen; Sun, Dongdong; Wang, Jianhao; Gu, Gang; Li, Fanjian; Liu, Xilei; Rao, Chenxu] Tianjin Med Univ, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China; [Fan, Weidong] Hebei Prov Xianxian People Hosp, 4 Xianxian Hlth Rd, Shijiazhuang, Hebei, Peoples R China		Tian, Y; Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, 154 Anshan Rd, Tianjin 300052, Peoples R China.	tianye030710@163.com; JianningZhang_0@163.com	Zhao, Zilong/AAZ-2196-2020		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81501057, 81671380]; Tianjin Natural Science FoundationNatural Science Foundation of Tianjin [16JCQNJC10600, 17JCQNJC12000, 15JCQNJC11300, 17JCZDJC35900]; Tianjin Research Program of Application Foundation and Advanced Technology [15JCQNJC11300]; Tianjin Medical University General Hospital Funding [ZYYFY201614, ZYYFY201616]; Sience & Technology Development Fund of Tianjin Education Commission for Higher Education [2016YD02, 2017KJ193]	This work was supported by the National Natural Science Foundation of China (Grant No.: 81501057 and 81671380), Tianjin Natural Science Foundation (Grant No.: 16JCQNJC10600, 17JCQNJC12000, 15JCQNJC11300 and 17JCZDJC35900), Tianjin Research Program of Application Foundation and Advanced Technology (Grant No.: 15JCQNJC11300) the Tianjin Medical University General Hospital Funding (Grant No.: ZYYFY201614 and ZYYFY201616) and The Sience & Technology Development Fund of Tianjin Education Commission for Higher Education (Grant No.: 2016YD02 and 2017KJ193).	Berman J, 2005, J IMMUNOL, V174, P485, DOI 10.4049/jimmunol.174.1.485; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mantovani A, 2009, BLOOD, V114, P3135, DOI 10.1182/blood-2009-07-231795; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Schuette-Nuetgen K, 2012, EXP NEUROL, V233, P849, DOI 10.1016/j.expneurol.2011.12.011; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sobrino Justin, 2013, Proc (Bayl Univ Med Cent), V26, P120; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Trembovler V, 1999, J INTERF CYTOK RES, V19, P791, DOI 10.1089/107999099313640; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zhou Y., 2017, BLOOD	22	13	15	1	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 1	2018	1694						104	110		10.1016/j.brainres.2018.05.015			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM8LK	WOS:000438479900012	29777675				2022-02-06	
J	Ryu, KM; Chang, SW				Ryu, Kyoung Min; Chang, Sung Wook			Heparin-free extracorporeal membrane oxygenation in a patient with severe pulmonary contusions and bronchial disruption	CLINICAL AND EXPERIMENTAL EMERGENCY MEDICINE			English	Article						Lung injury; Bronchi; Heparin; Extracorporeal membrane oxygenation	RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; ANTICOAGULATION	Pulmonary contusion complicated with endobronchial hemorrhage is potentially life-threatening, particularly in patients with tracheobronchial tree disruption and severe airway bleeding after blunt trauma, and pose a high mortality risk. In such cases, extracorporeal membrane oxygenation (ECMO) can be used as a salvage treatment modality. However, the use of ECMO for moribund trauma patients with respiratory failure may be limited for several reasons, such as intractable bleeding. In this case report, we describe a patient with severe bilateral pulmonary contusions with tracheobronchial tree disruption that was successfully treated using heparin-free venovenous ECMO.	[Ryu, Kyoung Min; Chang, Sung Wook] Dankook Univ Hosp, Dept Thorac & Cardiovasc Surg, 201 Manghyang Ro, Cheonan 31116, South Korea; [Chang, Sung Wook] Dankook Univ Hosp, Trauma Ctr, Cheonan, South Korea		Chang, SW (corresponding author), Dankook Univ Hosp, Dept Thorac & Cardiovasc Surg, 201 Manghyang Ro, Cheonan 31116, South Korea.	changsw3@naver.com		Chang, Sung Wook/0000-0002-2689-3068			Biscotti M, 2015, PERFUSION-UK, V30, P407, DOI 10.1177/0267659114554327; Bosarge PL, 2016, J TRAUMA ACUTE CARE, V81, P236, DOI 10.1097/TA.0000000000001068; Della Rocca G, 2013, CURR OPIN ANESTHESIO, V26, P40, DOI 10.1097/ACO.0b013e32835c4ea2; Hwang Jung Joo, 2013, Korean J Thorac Cardiovasc Surg, V46, P197, DOI 10.5090/kjtcs.2013.46.3.197; Kabon B, 2001, CHEST, V120, P1399, DOI 10.1378/chest.120.4.1399; Lamarche Y, 2010, INNOVATIONS, V5, P424, DOI 10.1097/IMI.0b013e3182029a83; Lee SH, 1996, KOREAN J THORAC CARD, V29, P208; Muellenbach RM, 2012, J TRAUMA ACUTE CARE, V72, P1444, DOI 10.1097/TA.0b013e31824d68e3; Oliver WC, 2009, SEMIN CARDIOTHORAC V, V13, P154, DOI 10.1177/1089253209347384	9	13	14	0	3	SEOUL KOREAN SOC EMERGENCY MEDICINE	SEOUL	101-3305, BROWNSTONE SEOUL, 464 CHEONGPA-RO, JUNG-GU, SEOUL, 06351, SOUTH KOREA	2383-4625			CLIN EXP EMERG MED	Clin. Exp. Emerg. Med.	SEP	2018	5	3					204	207		10.15441/ceem.17.252			4	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	GU1MM	WOS:000445026700010	29706054	Green Submitted, hybrid, Green Published			2022-02-06	
J	Sufrinko, AM; Howie, EK; Elbin, RJ; Collins, MW; Kontos, AP				Sufrinko, Alicia M.; Howie, Erin K.; Elbin, R. J.; Collins, Michael W.; Kontos, Anthony P.			A Preliminary Investigation of Accelerometer-Derived Sleep and Physical Activity Following Sport-Related Concussion	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						physical activity; recovery; sleep; sport-related concussion	POSTCONCUSSIVE ACTIVITY LEVELS; SEX-BASED DIFFERENCES; SYMPTOMS; TIME; ADOLESCENTS; PROGRESSION; STATEMENT; CHILDREN; RECOVERY; DURATION	Objective: Describe changes in postconcussion activity levels and sleep throughout recovery in a sample of pediatric sport-related concussion (SRC) patients, and examine the predictive value of accelerometer-derived activity and sleep on subsequent clinical outcomes at a follow-up clinic visit. Setting: Outpatient concussion clinic. Participants: Twenty athletes aged 12 to 19 years with diagnosed SRC. Methods: Prospective study including visit 1 (<72 hours postinjury) and visit 2 (6-18 days postinjury). Linear regressions used to predict scores (ie, neurocognitive, vestibular/oculomotor) at visit 2 from accelerometer-derived data collected 0 to 6 days postinjury. Linear mixed models evaluated changes in activity and sleep across recovery. Main Measures: Symptom, neurocognitive, and vestibular/oculomotor scores; sleep and activity data (Actigraph GT3x+) Results: The maximum intensity of physical activity increased (P = .009) and time in bed decreased throughout recovery (P = .026). Several physical activity metrics from 0 to 6 days postinjury were predictive of worse vestibular/oculomotor scores at visit 2 (P < .05). Metrics indicative of poor sleep 0 to 6 days postinjury were associated with worse reaction time at visit 2 (P < .05). Conclusions: This exploratory study suggests physical activity and sleep change from the acute to subacute postinjury time period in adolescent SRC patients. In our small sample, excess physical activity and poor sleep the first week postinjury may be associated with worse outcomes at follow-up in the subacute stage of recovery. This study further supported the feasibility of research utilizing wearable technology in concussion patients, and future research in a large, diverse sample of concussion patients examined at concise time intervals postinjury is needed.	[Sufrinko, Alicia M.; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA USA; [Howie, Erin K.; Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA		Sufrinko, AM (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, 3200 S Water St, Pittsburgh, PA 15221 USA.	sufrinkoam@upmc.edu			Manner's Foundation Award	This study was funded through Manner's Foundation Award (2016).	Aadland E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134606; Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; [Anonymous], 2011, IMP APPL TECHN MAN; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; de Vries SI, 2006, J CLIN EPIDEMIOL, V59, P670, DOI 10.1016/j.jclinepi.2005.11.020; Esliger DW, 2007, APPL PHYSIOL NUTR ME, V32, pS195, DOI 10.1139/H07-107; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Lee KY, 2017, JAMA PEDIATR, V171, P493, DOI 10.1001/jamapediatrics.2017.0131; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makela K., 2016, Advances in Physical Education, V6, P378, DOI 10.4236/ape.2016.64038; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Moser RS, 2015, BRAIN INJURY, V29, P58, DOI 10.3109/02699052.2014.964771; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Stone S, 2017, SPORTS HEALTH, V9, P41, DOI 10.1177/1941738116672184; Sufrinko A, 2016, CLIN J SPORTS MED; Sufrinko A, 2016, NEUROPSYCHOLOGY, V30, P484, DOI 10.1037/neu0000250; Sufrinko A, 2015, AM J SPORT MED, V43, P830, DOI 10.1177/0363546514566193; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Wiebe DJ, 2016, JAMA PEDIATR, V170, P1108, DOI 10.1001/jamapediatrics.2016.1979	33	13	13	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2018	33	5					E64	E74		10.1097/HTR.0000000000000387			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QJ	WOS:000450886500009	29601343				2022-02-06	
J	Wang, ML; Yu, MM; Yang, DX; Liu, YL; Wei, XE; Li, WB				Wang, M. -L.; Yu, M. -M.; Yang, D. -X.; Liu, Y. -L.; Wei, X. -E.; Li, W. -B.			Longitudinal Microstructural Changes in Traumatic Brain Injury in Rats: A Diffusional Kurtosis Imaging, Histology, and Behavior Study	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							WHITE-MATTER DAMAGE; MORRIS WATER MAZE; COGNITIVE IMPAIRMENT; TENSOR; PATHOLOGY; DISEASE; ANISOTROPY; MODERATE; IMPACT; MYELIN	BACKGROUND AND PURPOSE: Traumatic brain injury is a major public health problem worldwide. Accurately evaluating the brain microstructural changes in traumatic brain injury is crucial for the treatment and prognosis assessment. This study aimed to assess the longitudinal brain microstructural changes in traumatic brain injury in the rat using diffusional kurtosis imaging. MATERIALS AND METHODS: Diffusional kurtosis imaging was performed in a group of 5 rats at preinjury and 3, 14, and 28 days after traumatic brain injury. The diffusional kurtosis imaging parameters were measured in the bilateral cortex, hippocampus, and corpus callosum. Another 4 groups of 5 rats were used in brain immunohistochemistry analysis of neuron (neuron-specific nuclear protein [NeuN]), astroglia (glial fibrillary acidic protein [GFAP]), microglia (ionized calcium binding adaptor molecule 1 [Iba-1]), and myelin (myelin basic protein [MBP]) in the same area as the diffusional kurtosis imaging parameter measurements. Furthermore, 2 groups of 6 rats underwent a Morris water maze test at 28 days after traumatic brain injury. The diffusional kurtosis imaging parameters, immunohistochemistry results, and Morris water maze test results were compared longitudinally or between traumatic brain injury and control groups. RESULTS: Compared with baseline, traumatic brain injury in the rat showed higher mean kurtosis and mean diffusivity values in the ipsilateral perilesional cortex and hippocampus and lower fractional anisotropy values in the corpus callosum (P < .05). The traumatic brain injury group showed higher staining of GFAP and Iba-1 and lower immunohistochemistry staining of NeuN and MBP in all ipsilateral ROIs (P < .05). There was no significant difference in the contralateral ROIs in diffusional kurtosis imaging parameters or immunohistochemistry results. The Morris water maze test revealed lower platform crossing times in the probe test (P < .05). CONCLUSIONS: Our study indicated that there were longitudinal changes in diffusional kurtosis imaging parameters, accompanied by multiple pathologic changes at different time points following traumatic brain injury, and that mean kurtosis is more sensitive to detect microstructural changes, especially in gray matter, than mean diffusivity and fractional anisotropy.	[Wang, M. -L.; Yu, M. -M.; Wei, X. -E.; Li, W. -B.] Shanghai Jiao Tong Univ, Dept Radiol, Affiliated Peoples Hosp 6, Sch Med, Shanghai, Peoples R China; [Yang, D. -X.; Liu, Y. -L.] Shanghai Jiao Tong Univ, Dept Neurosurg, Affiliated Peoples Hosp 6, Sch Med, Shanghai, Peoples R China; [Li, W. -B.] Kashgar Prefecture Second Peoples Hosp, Imaging Ctr, Kashgar, Peoples R China		Li, WB (corresponding author), 600 Yi Shan Rd, Shanghai 200233, Peoples R China.	liwenbin@sjtu.edu.cn		Wang, Ming-Liang/0000-0003-1752-898X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271540, 81301213]; Natural Science Foundation of Xinjiang Province [2016D01C083]; Medical-Engineering Cross Project of Shanghai Jiao Tong University [YG2015MS19]; Shanghai Health and Family Planning Commission [20164Y0065]; Shanghai Key Discipline of Medical Imaging [2017ZZ02005]	This work was supported by the National Natural Science Foundation of China (No. 81271540, 81301213), Natural Science Foundation of Xinjiang Province (No. 2016D01C083), Medical-Engineering Cross Project of Shanghai Jiao Tong University (No. YG2015MS19), the Shanghai Health and Family Planning Commission research projects (No. 20164Y0065), and the Shanghai Key Discipline of Medical Imaging (No. 2017ZZ02005).	BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Brabazon F, 2017, J CEREBR BLOOD F MET, V37, P3203, DOI 10.1177/0271678X16685106; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chida Y, 2011, BRAIN RES, V1414, P22, DOI 10.1016/j.brainres.2011.07.026; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Gong NJ, 2017, HUM BRAIN MAPP, V38, P2495, DOI 10.1002/hbm.23535; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Guglielmetti C, 2016, NEUROIMAGE, V125, P363, DOI 10.1016/j.neuroimage.2015.10.052; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Radabaugh HL, 2016, EXP NEUROL, V286, P61, DOI 10.1016/j.expneurol.2016.09.015; Rudrapatna SU, 2014, NEUROIMAGE, V97, P363, DOI 10.1016/j.neuroimage.2014.04.013; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang ML, 2016, J NEUROL SCI, V370, P244, DOI 10.1016/j.jns.2016.09.049; Wiley CA, 2016, J NEUROTRAUM, V33, P1866, DOI 10.1089/neu.2015.4272; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhuo JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136151; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	39	13	14	0	1	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	SEP	2018	39	9					1650	1656		10.3174/ajnr.A5737			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GS1PD	WOS:000443301100016	30049720	hybrid, Green Published			2022-02-06	
J	Watanabe, T; Kawai, Y; Iwamura, A; Maegawa, N; Fukushima, H; Okuchi, K				Watanabe, Tomoo; Kawai, Yasuyuki; Iwamura, Asami; Maegawa, Naoki; Fukushima, Hidetada; Okuchi, Kazuo			Outcomes after Traumatic Brain Injury with Concomitant Severe Extracranial Injuries	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						traumatic brain injury; extracranial injury; mortality; prognosis; prognostic model	HEAD-INJURY; MORTALITY; TRENDS; IMPACT; DEATH; CARE	Traumatic brain injury (TBI) is a leading cause of death and disability in trauma patients. Patients with TBI frequently sustain concomitant injuries in extracranial regions. The effect of severe extracranial injury (SEI) on the outcome of TBI is controversial. For 8 years, we retrospectively enrolled 485 patients with the blunt head injury with head abbreviated injury scale (AIS) >= 3. SEI was defined as AIS >= 3 injuries in the face, chest, abdomen, and pelvis/extremities. Vital signs and coagulation parameter values were also extracted from the database. Total patients were dichotomized into isolated TBI (n = 343) and TBI associated with SEI (n = 142). The differences in severity and outcome between these two groups were analyzed. To assess the relation between outcome and any variables showing significant differences in univariate analysis, we included the parameters in univariable and multivariable logistic regression analyses. Mortality was 17.8% in the isolated TBI group and 21.8% in TBI with SEI group (P = 0.38), but the Glasgow Outcome Scale (GOS) in the TBI with SEI group was unfavorable compared to the isolated TBI group (P = 0.002). Patients with SBP <= 90 mmHg were frequent in the TBI with SEI group. Adjusting for age, GCS, and length of hospital stay, SEI was a strong prognostic factor for mortality with adjusted ORs of 2.30. Hypotension and coagulopathy caused by SEI are considerable factors underlying the secondary insults to TBI. It is important to manage not only the brain but the whole body in the treatment of TBI patients with SEI.	[Watanabe, Tomoo; Kawai, Yasuyuki; Iwamura, Asami; Maegawa, Naoki; Fukushima, Hidetada; Okuchi, Kazuo] Nara Med Univ, Dept Emergency & Crit Care, 840 Shijo Cho, Kashihara, Nara 6398522, Japan		Okuchi, K (corresponding author), Nara Med Univ, Dept Emergency & Crit Care, 840 Shijo Cho, Kashihara, Nara 6398522, Japan.	okucci@m4.kcn.ne.jp					Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Braet V, 2002, EMERG MED J, V19, P510; Chen H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685174; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Heinzelmann M, 1996, INJURY, V27, P345, DOI 10.1016/0020-1383(95)00223-5; Ho KM, 2010, CRIT CARE MED, V38, P1562, DOI 10.1097/CCM.0b013e3181e2ccd8; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Yang L, 2016, SCAND J IMMUNOL, V83, P26, DOI 10.1111/sji.12393; Yu WY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176907	21	13	15	0	1	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	SEP	2018	58	9					393	399		10.2176/nmc.oa.2018-0116			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GV1BT	WOS:000445802800004	30101808	Green Published, gold			2022-02-06	
J	Willer, BS; Tiso, MR; Haider, MN; Hinds, AL; Baker, JG; Miecznikowski, JC; Leddy, JJ				Willer, Barry S.; Tiso, Michael R.; Haider, Mohammad N.; Hinds, Andrea L.; Baker, John G.; Miecznikowski, Jeffery C.; Leddy, John J.			Evaluation of Executive Function and Mental Health in Retired Contact Sport Athletes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						athlete; chronic traumatic encephalopathy; concussion; dementia; executive function	CHRONIC TRAUMATIC ENCEPHALOPATHY; DEPRESSIVE SYMPTOMS; VERBAL FLUENCY; BRIEF-A; AGE; INVENTORY; PLAYERS; PERFORMANCE; FOOTBALL	Objective: To compare retired professional contact sport athletes with age-matched noncontact sport athletes on measures of executive function and mental health. Setting: The University Concussion Management Clinic. Participants: Twenty-one retired National Football League (NFL) and National Hockey League (NHL) players (mean age 56 years) and 21 age-matched noncontact sport athlete controls. Designs: Case control. Main Measure: The self- and informant-reported Behavior Rating Inventory of Executive Function-Adult form (BRIEF-A); Wisconsin Card Sorting Test; Delis-Kaplan Executive Function System; Trail Making Part A and B; Wechsler Adult Intelligence Scale; Neuropsychological Assessment Battery; List Learning; Controlled Oral Word Association Test; Beck Depression Inventory; Beck Anxiety Inventory; and Personality Inventory of the DSM-5. Results: Former NFL and NHL players perceived themselves to have some impairment in 2 of the 9 domains of executive function on the BRIEF-A; however, their informants reported no difference when compared with informants of noncontact athletes. No significant differences were found when comparing contact sport athletes with noncontact athletes on objective neuropsychological testing. Contact sport athletes qualified as clinically anxious and had more unusual beliefs and experiences, although they remained within with age-based norms. Conclusion: Participation in contact sports at the professional level may not lead to later-life executive dysfunction, as the popular media and some research currently suggest.	[Willer, Barry S.; Haider, Mohammad N.; Hinds, Andrea L.] SUNY Buffalo, Dept Psychiat, G96 Farber Hall,Main St Campus, Buffalo, NY 14214 USA; [Haider, Mohammad N.; Leddy, John J.] SUNY Buffalo, Dept Orthoped & Sports Med, Buffalo, NY USA; [Baker, John G.] SUNY Buffalo, Dept Nucl Med, Buffalo, NY USA; [Miecznikowski, Jeffery C.] SUNY Buffalo, Dept Biostat, Buffalo, NY USA; [Tiso, Michael R.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Tiso, Michael R.] Ohio State Univ, Dept Sports Med, Columbus, OH USA		Willer, BS (corresponding author), SUNY Buffalo, Dept Psychiat, G96 Farber Hall,Main St Campus, Buffalo, NY 14214 USA.	bswiller@buffalo.edu			National Institutes of Health (National Center for Advancing Translational Sciences) [UL1TR001412]; Robert Rich Family Foundation; Program for Understanding Childhood Concussion and Stroke; Buffalo Bills (Ralph Wilson) Team Physician Fund; Buffalo Sabres Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412] Funding Source: NIH RePORTER	We wish to thank the following organizations for financial support: The National Institutes of Health (National Center for Advancing Translational Sciences) award number UL1TR001412; the Robert Rich Family Foundation; Program for Understanding Childhood Concussion and Stroke; Buffalo Bills (Ralph Wilson) Team Physician Fund; and the Buffalo Sabres Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or any other funding source. We also want to thank the research team at Boston University, in particular Dr Robert Stern, for their willingness to share their protocol for evaluation of neurocognitive performance.	Allen MS, 2013, EUR J SPORT SCI, V13, P697, DOI 10.1080/17461391.2013.771381; Association A.P, 2013, DIAGN STAT MAN MENT; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Davis GA, 2015, NEUROSURGERY, V76, P643, DOI 10.1227/NEU.0000000000000722; Delis DC., 2001, DELIS KAPLAN EXECUTI; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Elwood P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081877; Esopenko C, 2017, J NEUROL NEUROSUR PS, V88, P512, DOI 10.1136/jnnp-2016-315260; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; Karr JE, 2014, J CLIN EXP NEUROPSYC, V36, P15, DOI 10.1080/13803395.2013.863833; Kiernan PT, 2015, SEMIN NEUROL, V35, P20, DOI 10.1055/s-0035-1545080; Krueger RF, 2014, ANNU REV CLIN PSYCHO, V10, P477, DOI 10.1146/annurev-clinpsy-032813-153732; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; R Core Team, 2013, LANGUAGE ENV STAT CO, DOI DOI 11/44679/INDEX.HTM; Rabin LA, 2006, ARCH CLIN NEUROPSYCH, V21, P721, DOI 10.1016/j.acn.2006.08.004; Riley DO, 2015, BRAIN INJURY, V29, P154, DOI 10.3109/02699052.2014.965215; Rodriguez-Aranda C, 2006, DEV NEUROPSYCHOL, V30, P697, DOI 10.1207/s15326942dn3002_3; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern RA, 2003, NAB NEUROPSYCHOLOGIC; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tseng BY, 2013, J MAGN RESON IMAGING, V38, P1169, DOI 10.1002/jmri.24085; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Willer BS, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000421	41	13	13	4	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2018	33	5					E9	E15		10.1097/HTR.0000000000000423			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QJ	WOS:000450886500002	30080797	Green Accepted			2022-02-06	
J	Zivadinov, R; Polak, P; Schweser, F; Bergsland, N; Hagemeier, J; Dwyer, MG; Ramasamy, DP; Baker, JG; Leddy, JJ; Willer, BS				Zivadinov, Robert; Polak, Paul; Schweser, Ferdinand; Bergsland, Niels; Hagemeier, Jesper; Dwyer, Michael G.; Ramasamy, Deepa P.; Baker, John G.; Leddy, John J.; Willer, Barry S.			Multimodal Imaging of Retired Professional Contact Sport Athletes Does Not Provide Evidence of Structural and Functional Brain Damage	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain atrophy; cerebral microbleeds; concussion; diffusion-imaging; perfusion imaging; spectroscopy; sport athletes; susceptibility imaging; white matter signal abnormalities	FOOTBALL LEAGUE PLAYERS; MULTIPLE-SCLEROSIS; NFL PLAYERS; CONCUSSION; HISTORY; ROBUST; NEUROPATHOLOGY; ABNORMALITIES; DYSFUNCTION; SYMPTOMS	Background: Long-term consequences of playing professional football and hockey on brain function and structural neuronal integrity are unknown. Objectives: To investigate multimodal metabolic and structural brain magnetic resonance imaging (MRI) differences in retired professional contact sport athletes compared with noncontact sport athletes. Methods: Twenty-one male contact sport athletes and 21 age-matched noncontact sport athletes were scanned on a 3 tesla (3T) MRI using a multimodal imaging approach. The MRI outcomes included presence, number, and volume of focal white matter signal abnormalities, volumes of global and regional tissue-specific brain structures, diffusion-tensor imaging tract-based spatial statistics measures of mean diffusivity and fractional anisotropy, quantitative susceptibility mapping of deep gray matter, presence, number, and volume of cerebral microbleeds, MR spectroscopy N-acetyl-aspartate, glutamate, and glutamine concentrations relative to creatine and phosphor creatine of the corpus callosum, and perfusion-weighted imaging mean transit time, cerebral blood flow, and cerebral blood volume outcomes. Subjects were also classified as having mild cognitive impairment. Results: No significant differences were found for structural or functional MRI measures between contact sport athletes and noncontact sport athletes. Conclusions: This multimodal imaging study did not show any microstructural, metabolic brain tissue injury differences in retired contact versus non-contact sport athletes.	[Zivadinov, Robert; Polak, Paul; Schweser, Ferdinand; Bergsland, Niels; Hagemeier, Jesper; Dwyer, Michael G.; Ramasamy, Deepa P.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo Neuroimaging Anal Ctr, Dept Neurol, Buffalo, NY USA; [Zivadinov, Robert; Schweser, Ferdinand] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, MR Imaging Clin & Translat Res Ctr, Buffalo, NY USA; [Baker, John G.; Leddy, John J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Orthopaed, Buffalo, NY USA; [Baker, John G.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Nucl Med, Buffalo, NY USA; [Willer, Barry S.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA		Zivadinov, R (corresponding author), Buffalo Neuroimaging Anal Ctr, Jacobs Sch Med & Biomed Sci, Translat Imaging Ctr Clin Translat, Res Ctr,Dept Neurol, 100 High St, Buffalo, NY 14203 USA.	rzivadinov@bnac.net	Bergsland, Niels/H-3077-2019; Ramasamy, Deepa/X-5780-2019; Zivadinov, Robert/Q-2054-2019; Schweser, Ferdinand/Q-6932-2019	Bergsland, Niels/0000-0002-7792-0433; Zivadinov, Robert/0000-0002-7799-1485; Schweser, Ferdinand/0000-0003-0399-9211; Hagemeier, Jesper/0000-0002-3286-5207	National Institutes of Health (National Center for Advancing Translational Sciences) [UL1TR001412]; Robert Rich Family Foundation; Ralph and Mary Wilson Foundation; Biogen IdecBiogen; Teva PharmaceuticalsTeva Pharmaceutical Industries; Sanofi-GenzymeSanofi-AventisGenzyme Corporation; NovartisNovartis; Claret Medical; Coherus-Intekrin; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412] Funding Source: NIH RePORTER	We wish to thank the following organizations for financial support: The National Institutes of Health (National Center for Advancing Translational Sciences) award number UL1TR001412; the Robert Rich Family Foundation; and the Ralph and Mary Wilson Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or any other funding source. We also want to thank the research team at Boston University, in particular Dr Robert Stern, for their willingness to share their protocol for evaluation of neurocognitive performance.; Robert Zivadinov received personal compensation from EMD Serono, Novartis, Celgene, Genentech, Claret Medical, and Sanofi-Genzyme for speaking and consultant fees. R. Zivadinov received financial support for research activities from Biogen Idec, Teva Pharmaceuticals, Sanofi-Genzyme, Novartis, Claret Medical, and Coherus-Intekrin. Michael G. Dwyer received personal compensation from Claret Medical for speaking and consultant fees. He received financial support for research activities from Novartis.	Abdul-Rahman HS, 2007, APPL OPTICS, V46, P6623, DOI 10.1364/AO.46.006623; Adler CM, 2018, CLIN J SPORT MED, V28, P100, DOI 10.1097/JSM.0000000000000391; Amen DG, 2016, J ALZHEIMERS DIS, V53, P237, DOI 10.3233/JAD-160207; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; Dwyer MG, 2008, NEUROL RES, V30, P827, DOI 10.1179/174313208X340987; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Hammond KE, 2008, NEUROIMAGE, V39, P1682, DOI 10.1016/j.neuroimage.2007.10.037; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Kuhn AW, 2017, SPORTS HEALTH, V9, P30, DOI 10.1177/1941738116674006; Lewis GN, 2017, NEW ZEAL MED J, V130, P34; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Schweser F, 2012, NEUROIMAGE, V62, P2083, DOI 10.1016/j.neuroimage.2012.05.067; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Tkac I, 2004, MAGN RESON MED, V52, P478, DOI 10.1002/mrm.20184; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Willer BS, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000421; Williams VB, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0569-5; Zivadinov R, 2016, RADIOLOGY, V281, P884, DOI 10.1148/radiol.2016160060; Zivadinov R, 2012, NEUROIMAGE, V59, P331, DOI 10.1016/j.neuroimage.2011.07.045	45	13	13	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2018	33	5					E24	E32		10.1097/HTR.0000000000000422			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QJ	WOS:000450886500004	30080799	Green Accepted			2022-02-06	
J	Geribaldi-Doldan, N; Carrasco, M; Murillo-Carretero, M; Dominguez-Garcia, S; Garcia-Cozar, FJ; Munoz-Miranda, JP; del Rio-Garcia, V; Verastegui, C; Castro, C				Geribaldi-Doldan, Noelia; Carrasco, Manuel; Murillo-Carretero, Maribel; Dominguez-Garcia, Samuel; Garcia-Cozar, Francisco J.; Pedro Munoz-Miranda, Juan; del Rio-Garcia, Valme; Verastegui, Cristina; Castro, Carmen			Specific inhibition of ADAM17/TACE promotes neurogenesis in the injured motor cortex	CELL DEATH & DISEASE			English	Article							ALPHA-CONVERTING ENZYME; TRAUMATIC BRAIN-INJURY; EPIDERMAL-GROWTH-FACTOR; PROGENITOR-CELL PROLIFERATION; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; ADULT BRAIN	Brain injuries in the adult mammalian brain are accompanied by a fast neurogenic response inside neurogenic niches. However, this response does not contribute to the generation of new neurons within damaged tissues like the cerebral cortex, which are essentially non-neurogenic. This occurs because injuries create a hostile environment that favors gliogenesis. Overexpression and sequential activation of the ADAM17/TGF alpha/EGFR signaling cascade are crucial for the generation of this gliogenic/non-neurogenic environment. Here, we demonstrate that chronic local infusion of a general metalloprotease inhibitor in areas of traumatic cortical injury in adult mice moderately increased the number of neuroblasts around the lesion, by facilitating the survival of neuroblasts and undifferentiated progenitors, which had migrated to the perilesional area from the subventricular zone. Next, we generated a dominant-negative version of ADAM17 metalloprotease, consisting of a truncated protein containing only the pro-domain (ADAM17-Pro). Specific inhibition of ADAM17 activity by ADAM17-Pro overexpression increased the generation of new neurons in vitro. Local overexpression of ADAM17-Pro in injured cortex in vivo, mediated by lentiviral vectors, dramatically increased the number of neuroblasts observed at the lesion 14 days after injury. Those neuroblasts were able to differentiate into cholinergic and GABAergic neurons 28 days after injury. We conclude that ADAM17 is a putative target to develop new therapeutic tools for the treatment of traumatic brain injury.	[Geribaldi-Doldan, Noelia; Carrasco, Manuel; Murillo-Carretero, Maribel; Dominguez-Garcia, Samuel; del Rio-Garcia, Valme; Castro, Carmen] Univ Cadiz, Fac Med, Area Fisiol, Cadiz, Spain; [Geribaldi-Doldan, Noelia; Carrasco, Manuel; Murillo-Carretero, Maribel; Dominguez-Garcia, Samuel; Garcia-Cozar, Francisco J.; Pedro Munoz-Miranda, Juan; del Rio-Garcia, Valme; Verastegui, Cristina; Castro, Carmen] Univ Cadiz, Inst Invest & Innovac Ciencias Biomed Prov Cadiz, Cadiz, Spain; [Garcia-Cozar, Francisco J.; Pedro Munoz-Miranda, Juan] Univ Cadiz, Area Inmunol, Fac Med, Cadiz, Spain; [Verastegui, Cristina] Univ Cadiz, Dept Anat, Fac Med, Cadiz, Spain		Castro, C (corresponding author), Univ Cadiz, Fac Med, Area Fisiol, Cadiz, Spain.; Castro, C (corresponding author), Univ Cadiz, Inst Invest & Innovac Ciencias Biomed Prov Cadiz, Cadiz, Spain.	carmen.castro@uca.es	Garcia, Samuel Dominguez/AAS-8879-2020; Escolano, Cristina Verastegui/L-7264-2014; Doldan, Noelia Geribaldi/O-7286-2019; Doldan, Noelia Geribaldi/L-4478-2014; Carmen, Castro/C-7813-2009; Garcia-Cozar, Francisco/A-6212-2013	Garcia, Samuel Dominguez/0000-0003-4319-3466; Escolano, Cristina Verastegui/0000-0002-9342-2127; Doldan, Noelia Geribaldi/0000-0003-2149-9050; Carmen, Castro/0000-0002-6802-0572; Garcia-Cozar, Francisco/0000-0003-3720-259X	Spanish Consejeria de Innovacion, Ciencia y Empleo, Junta de AndaluciaJunta de Andalucia [P10CTS6639]; Ministerio de Economia y Competitividad, MINECO/FEDER [BFU2015-68652-R]; Fundacion Rodriguez-Pascual 2015	This work was supported by the Spanish Consejeria de Innovacion, Ciencia y Empleo, Junta de Andalucia (Grant Numbers P10CTS6639), Ministerio de Economia y Competitividad (Grant Number BFU2015-68652-R, MINECO/FEDER), and Fundacion Rodriguez-Pascual 2015. We thank the animal facility (SEPA) of the University of Cadiz for their support and the Core Biomedical Research Facility (sc-IBM, University of Cadiz) where some of the experiments were performed. We thank J. Antonio Torres for his technical assistance. SD-G is a Fellow of the University of Cadiz (Plan Propio de Investigacion 2017).	ADRIAN EK, 1962, J NEUROPATH EXP NEUR, V21, P597, DOI 10.1097/00005072-196210000-00007; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Benarroch EE, 2013, NEUROLOGY, V81, P1079, DOI 10.1212/WNL.0b013e3182a4a577; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; CAVANAGH JB, 1970, J ANAT, V106, P471; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Duan CL, 2015, GLIA, V63, P1660, DOI 10.1002/glia.22837; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Gonzales PE, 2008, BIOCHEMISTRY-US, V47, P9911, DOI 10.1021/bi801049v; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; Gonzalez-Perez O, 2009, STEM CELLS, V27, P2032, DOI 10.1002/stem.119; Hosseini-Sharifabad M, 2007, J NEUROSCI METH, V162, P206, DOI 10.1016/j.jneumeth.2007.01.009; Itai T, 2001, EUR J BIOCHEM, V268, P2074, DOI 10.1046/j.1432-1327.2001.02085.x; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014; Leonard JD, 2005, BIOCHEM J, V387, P797, DOI 10.1042/BJ20041727; Liu JL, 1998, J NEUROSCI, V18, P7768; Llorens-Bobadilla E, 2015, CELL STEM CELL, V17, P329, DOI 10.1016/j.stem.2015.07.002; Magavi SS, 2002, DEV BRAIN RES, V134, P57, DOI 10.1016/S0165-3806(01)00316-9; Marin-Teva JL, 2011, NEURON GLIA BIOL, V7, P25, DOI 10.1017/S1740925X12000014; Milla ME, 2006, CELL BIOCHEM BIOPHYS, V44, P342, DOI 10.1385/CBB:44:3:342; Moraga A, 2014, FASEB J, V28, P4710, DOI 10.1096/fj.14-252452; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Paez-Gonzalez P, 2014, NAT NEUROSCI, V17, P934, DOI 10.1038/nn.3734; Parent JM, 1997, J NEUROSCI, V17, P3727; Rabaneda LG, 2008, FASEB J, V22, P3823, DOI 10.1096/fj.08-109306; Rhodes KE, 2003, NEUROSCIENCE, V120, P41, DOI 10.1016/S0306-4522(03)00285-9; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Romero-Grimaldi C, 2011, STEM CELLS, V29, P1628, DOI 10.1002/stem.710; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Seidenfaden R, 2006, MOL CELL NEUROSCI, V32, P187, DOI 10.1016/j.mcn.2006.04.003; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Teramoto T, 2003, J CLIN INVEST, V111, P1125, DOI 10.1172/JCI200317170; Tropepe V, 1997, J NEUROSCI, V17, P7850; Wei ZJ, 2015, MOL MED REP, V12, P63, DOI 10.3892/mmr.2015.3395; West M J, 2001, Folia Morphol (Warsz), V60, P11	44	13	13	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	AUG 28	2018	9								862	10.1038/s41419-018-0913-2			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	GR9MK	WOS:000443087500019	30154402	gold, Green Published			2022-02-06	
J	Arulsamy, A; Teng, J; Colton, H; Corrigan, F; Collins-Praino, L				Arulsamy, Alina; Teng, Jason; Colton, Holly; Corrigan, Frances; Collins-Praino, Lyndsey			Evaluation of early chronic functional outcomes and their relationship to pre-frontal cortex and hippocampal pathology following moderate-severe traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Neurodegeneration; Cognition; Depression; Head injury; Dementia	OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; LONGITUDINAL CHANGES; RATS; PROTEINS; DEFICITS; OVEREXPRESSION; INFLAMMATION; ASSOCIATIONS; ACTIVATION	TBI is a significant risk factor for the development of dementia, with the interaction between structural damage from TBI and neuroinflammation potentially driving this relationship. This study investigated the early chronic post-TBI neuroinflammatory response and its relationship to both neurodegenerative pathology and functional impairment up to 3 months post-injury. Sprague-Dawley rats underwent either sham surgery or the Marmarou model of diffuse moderate-severe TBI. At 1-month and 3-months post-injury, a functional battery encompassing motor function, depressive-like behaviour, anxiety and cognition was performed. Western blot and immunohistochemical analysis assessed a range of inflammatory, neurodegenerative and oxidative stress markers. At both 1 and 3-months post injury, depressive-like behaviour was significantly increased in TBI animals, with TBI animals also exhibiting impaired cognitive flexibility at 3 months, although learning and memory remained intact. This was accompanied by a significant decrease in markers of synaptic integrity and astrocytic and microglia number within the pre-frontal cortex at 1-month post-injury, although this resolved by 3-months post injury. In contrast, minimal pathology was evident within the hippocampus at 1 month, with only a decrease in neurofilament-light seen at 3 months post-injury. Thus, following a moderate-severe diffuse injury, the prefrontal cortex is most vulnerable to early neuro-structural changes. While these changes are resolved at 3 months post-injury, future studies should investigate whether they re-emerge or progress to other areas, such as the hippocampus, at later time points, which could predispose individuals to the development of dementia.	[Arulsamy, Alina; Teng, Jason; Colton, Holly; Corrigan, Frances; Collins-Praino, Lyndsey] Univ Adelaide, Adelaide Ctr Neurosci Res, Translat Neuropathol Lab, Adelaide Med Sch, Adelaide, SA 5005, Australia		Collins-Praino, L (corresponding author), Univ Adelaide, Adelaide Med Sch, Adelaide, SA 5005, Australia.	lyndsey.collins-praino@adelaide.edu.au	Collins-Praino, Lyndsey/AAB-3318-2019; Arulsamy, Alina/AAU-9166-2021	Collins-Praino, Lyndsey/0000-0002-4380-7600; Arulsamy, Alina/0000-0003-0993-5622; Corrigan, Frances/0000-0001-6150-8893	Neurosurgical Research Foundation	This work was supported by funding from the Neurosurgical Research Foundation.	Silva LFA, 2011, J NEUROL SCI, V308, P35, DOI 10.1016/j.jns.2011.06.030; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Belanger Mireille, 2009, Dialogues Clin Neurosci, V11, P281; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bizon JL, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00019; BLANKENFELD GV, 1991, MOL NEUROBIOL, V5, P31, DOI 10.1007/BF02935611; Bogdanova OV, 2013, PHYSIOL BEHAV, V118, P227, DOI 10.1016/j.physbeh.2013.05.012; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Castagne V, 2009, FRONT NEUROSCI, P103; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; Coimbra-Costa D, 2017, REDOX BIOL, V12, P216, DOI 10.1016/j.redox.2017.02.014; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Correia PA, 2017, ELIFE, V6, DOI 10.7554/eLife.20975; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2609; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Endo H, 2007, J CEREBR BLOOD F MET, V27, P975, DOI 10.1038/sj.jcbfm.9600399; Faul M, 2010, TRAUMATIC BRAIN INJU; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frieden T.R., 2014, C TRAUM BRAIN INJ US; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Geppetti P., 1995, CAN J PHYSL PHARM, V73; Gomes C, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-16; Gupta A, 2012, ANN INDIAN ACAD NEUR, V15, P120, DOI 10.4103/0972-2327.94995; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Johnston-Wilson NL, 2000, MOL PSYCHIATR, V5, P142, DOI 10.1038/sj.mp.4000696; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maughan PH, 2000, J NEUROTRAUM, V17, P1141, DOI 10.1089/neu.2000.17.1141; Medina A, 2016, J PSYCHIATR RES, V72, P15, DOI 10.1016/j.jpsychires.2015.10.010; Miguel-Hidalgo JJ, 2005, ALCOHOL CLIN EXP RES, V29, P766, DOI 10.1097/01.ALC.0000164378.92680.FA; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Plummer S.L., 2015, PLOS ONE, V13; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ramanathan L, 2005, J NEUROCHEM, V93, P47, DOI 10.1111/j.1471-4159.2004.02988.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Sugawara T, 2002, J NEUROSCI, V22, P209, DOI 10.1523/JNEUROSCI.22-01-00209.2002; Sunyer B, 2007, BARNES MAZE USEFUL T; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Toyomoto M, 2005, NEUROSCI LETT, V379, P185, DOI 10.1016/j.neulet.2004.12.063; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Turner RJ, 2004, J AM COLL NUTR, V23, p534S, DOI 10.1080/07315724.2004.10719397; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; Wataya T, 2002, J BIOL CHEM, V277, P4644, DOI 10.1074/jbc.M110913200; Wright R.L., STRESS AMST NETH, V8; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729; Zhao J., 2017, J NEUROTRAUMA	77	13	13	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	AUG 1	2018	348						127	138		10.1016/j.bbr.2018.04.009			12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	GR8NM	WOS:000442980600013	29653127				2022-02-06	
J	Chen, SF; Su, WS; Wu, CH; Lan, TH; Yang, FY				Chen, Szu-Fu; Su, Wei-Shen; Wu, Chun-Hu; Lan, Tsuo-Hung; Yang, Feng-Yi			Transcranial Ultrasound Stimulation Improves Long-Term Functional Outcomes and Protects Against Brain Damage in Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article						Ultrasound; Traumatic brain injury; Brain edema; Apoptosis; Inflammation	INTENSITY PULSED ULTRASOUND; CEREBRAL-ISCHEMIA; MATRIX METALLOPROTEINASES; BARRIER DYSFUNCTION; HEAD-INJURY; CELL-DEATH; BCL-2; EDEMA; MODEL; RATS	The purpose of this study was to assess the long-term treatment efficacy of low-intensity pulsed ultrasound (LIPUS) on functional outcomes, brain edema, and the possible involvement of reactions in mice following traumatic brain injury (TBI). Mice subjected to controlled cortical impact injury received LIPUS treatment daily for a period of 4 weeks. The effects of LIPUS on edema were detected by MR imaging in the mouse brain at 148 days following TBI. Long-term functional outcomes of LIPUS stimulation were evaluated by behavioral analyses. One-way or two-way analysis of variance and Student's t test were used for statistical analyses, with a significant level of .05. Up to post-injury day 148, treatment with LIPUS significantly improved functional outcomes (all p < 0.05). LIPUS also significantly attenuated brain edema and neuronal death at day 148 after TBI (all p < 0.05). Furthermore, LIPUS reduced MMP9 activity, neutrophil infiltration, and microglial activation at day 1 or day 4 following TBI (all p < 0.05). Meanwhile, LIPUS increased the Bcl-2/Bax ratio and enhanced the phosphorylation of Bad and FOXO-1 at day 1 or day 4 following TBI (all p < 0.05). Almost 5 months of follow-up showed that the treatment efficacy of post-injury LIPUS stimulation on reduced brain edema and improved functional outcomes persisted over time after TBI. The neuroprotective effects of LIPUS are associated with a reduction of early inflammatory events and inhibition of apoptotic progression.	[Chen, Szu-Fu] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Szu-Fu] Natl Def Med Ctr, Dept Physiol & Biophys, Taipei, Taiwan; [Su, Wei-Shen; Yang, Feng-Yi] Natl Yang Ming Univ, Sch Biomed Sci & Engn, Dept Biomed Imaging & Radiol Sci, 155 Sec 2,Li Nong St, Taipei 11221, Taiwan; [Wu, Chun-Hu] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lan, Tsuo-Hung] Natl Yang Ming Univ, Dept Psychiat, Taipei, Taiwan; [Lan, Tsuo-Hung] Taichung Vet Gen Hosp, Dept Psychiat, Taichung, Taiwan; [Yang, Feng-Yi] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei, Taiwan		Yang, FY (corresponding author), Natl Yang Ming Univ, Sch Biomed Sci & Engn, Dept Biomed Imaging & Radiol Sci, 155 Sec 2,Li Nong St, Taipei 11221, Taiwan.; Yang, FY (corresponding author), Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei, Taiwan.	fyyang@ym.edu.tw	WU, CHUN-HU/P-3958-2018	WU, CHUN-HU/0000-0001-6851-7936; Lan, Tsuo-Hung/0000-0002-2796-1026	Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [MOST 105-2221E-010-003, MOST 104-2314-B-010-003-MY3, 101-2314-B-350-001-MY3]; Veterans General Hospitals University System of Taiwan Joint Research Program [VGHUST107-G7-6-1, VGHUST106-G7-6-1]; Cheng Hsin General Hospital Foundation [CY10721, CY10622, CHGH103-34]; Biophotonics & Molecular Imaging Research Center	This study was supported by grants from the Ministry of Science and Technology of Taiwan (no. MOST 105-2221E-010-003, MOST 104-2314-B-010-003-MY3, and 101-2314-B-350-001-MY3), the Veterans General Hospitals University System of Taiwan Joint Research Program (VGHUST107-G7-6-1 and VGHUST106-G7-6-1), the Cheng Hsin General Hospital Foundation (no. CY10721, CY10622, and CHGH103-34), and the Biophotonics & Molecular Imaging Research Center.	Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen CY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092271, 10.1371/journal.pone.0108021, 10.1371/journal.pone.0106248]; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045763; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Huang SL, 2017, RADIOLOGY, V282, P113, DOI 10.1148/radiol.2016160095; Karmacharya MB, 2015, NEUROPATH APPL NEURO, V41, pe80, DOI 10.1111/nan.12182; Lin WT, 2015, SCI REP-UK, V5, DOI 10.1038/srep09671; Liu SH, 2017, CEREB CORTEX, V27, P3152, DOI 10.1093/cercor/bhw169; Marmarou A, 2003, ACT NEUR S, V86, P7; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; Nakao J, 2014, BONE, V58, P17, DOI 10.1016/j.bone.2013.09.018; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Sato M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0798-8; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Su WS, 2017, BRAIN STIMUL, V10, P1032, DOI 10.1016/j.brs.2017.09.003; Su WS, 2015, ONCOTARGET, V6, P42290, DOI 10.18632/oncotarget.5978; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Yang FY, 2015, BRAIN STIMUL, V8, P465, DOI 10.1016/j.brs.2014.11.017; Yang FY, 2014, NEUROIMAGE, V90, P93, DOI 10.1016/j.neuroimage.2013.12.033; Yoon SH, 2012, PEDIATR NEUROSURG, V48, P102, DOI 10.1159/000343011; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	35	13	16	2	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2018	55	8					7079	7089		10.1007/s12035-018-0897-z			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO1YO	WOS:000439758300060	29383687				2022-02-06	
J	Chen, XB; Wang, ZL; Yang, QY; Zhao, FY; Qin, XL; Tang, XE; Du, JL; Chen, ZH; Zhang, K; Huang, FJ				Chen, Xian-Bing; Wang, Zi-Li; Yang, Qing-Yu; Zhao, Fang-Yu; Qin, Xiao-Li; Tang, Xian-E; Du, Jun-Long; Chen, Zong-Hai; Zhang, Kui; Huang, Fei-Jun			Diosgenin Glucoside Protects against Spinal Cord Injury by Regulating Autophagy and Alleviating Apoptosis	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						spinal cord injury; autophagy; diosgenin glucoside; Rheb/mTOR signal pathway; miR-155-3p; apoptosis	PROMOTES FUNCTIONAL RECOVERY; SIGNALING PATHWAY; TRILLIUM-KAMTSCHATICUM; NEURONAL APOPTOSIS; REPERFUSION INJURY; UNDERGROUND PARTS; UP-REGULATION; RATS; BRAIN; MTOR	Spinal cord injury (SCI) is a severe traumatic lesion of central nervous system (CNS) with only a limited number of restorative therapeutic options. Diosgenin glucoside (DG), a major bioactive ingredient of Trillium tschonoskii Max., possesses neuroprotective effects through its antioxidant and anti-apoptotic functions. In this study, we investigated the therapeutic benefit and underlying mechanisms of DG treatment in SCI. We found that in Sprague-Dawley rats with traumatic SCI, the expressions of autophagy marker Light Chain 3 (LC3) and Beclin1 were decreased with concomitant accumulation of autophagy substrate protein p62 and ubiquitinated proteins, indicating an impaired autophagic activity. DG treatment, however, significantly attenuated p62 expression and upregulated the Rheb/mTOR signaling pathway (evidenced as Ras homolog enriched in brain) due to the downregulation of miR-155-3p. We also observed significantly less tissue injury and edema in the DG-treated group, leading to appreciable functional recovery compared to that of the control group. Overall, the observed neuroprotection afforded by DG treatment warrants further investigation on its therapeutic potential in SCI.	[Chen, Xian-Bing; Zhang, Kui; Huang, Fei-Jun] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Chengdu 610041, Sichuan, Peoples R China; [Chen, Xian-Bing; Wang, Zi-Li; Yang, Qing-Yu; Zhao, Fang-Yu; Qin, Xiao-Li; Tang, Xian-E; Du, Jun-Long; Chen, Zong-Hai] Hubei Univ Nationalities, Coll Med, Enshi 445000, Peoples R China		Huang, FJ (corresponding author), Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Chengdu 610041, Sichuan, Peoples R China.	1998023@hbmy.edu.cn; wangzili2018731@gmail.com; yangqingyuyqy@gmail.com; fangyuzhao584@gmail.com; xiaolitan965@gmail.com; tangx483@gmail.com; dujunlong666@gmail.com; chenzonghai666@gmail.com; zhk@scu.edu.cn; hfj@scu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81660672]	This work was financially supported by the National Natural Science Foundation of China (No. 81660672).	Andorfer CA, 2011, TRENDS MOL MED, V17, P313, DOI 10.1016/j.molmed.2011.01.006; Bai LJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42288; Brown HLD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044888; Campolo M, 2013, FASEB J, V27, P4489, DOI 10.1096/fj.13-234716; Cao MH, 2013, NEUROCHEM INT, V62, P406, DOI 10.1016/j.neuint.2013.01.025; Chen HC, 2013, J SURG RES, V179, pE203, DOI 10.1016/j.jss.2012.02.023; Chen JJ, 2013, J MOL NEUROSCI, V51, P82, DOI 10.1007/s12031-013-0003-y; Chen MH, 2014, CELL TISSUE RES, V358, P277, DOI 10.1007/s00441-014-1946-1; [陈显兵 Chen Xianbing], 2015, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V40, P622; Cheung HH, 2011, ONCOGENE, V30, P3404, DOI 10.1038/onc.2011.60; Cripps RA, 2011, SPINAL CORD, V49, P493, DOI 10.1038/sc.2010.146; Dellago H, 2013, AGING CELL, V12, P446, DOI 10.1111/acel.12069; Don ASA, 2012, DRUG DISCOV TODAY, V17, P861, DOI 10.1016/j.drudis.2012.04.010; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Filip Agata, 2007, Postepy Biochem, V53, P413; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Gracias NG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4506; Greco R, 2018, J NEUROSCI RES, V96, P151, DOI 10.1002/jnr.24101; Gregory EN, 2010, NEUROSCIENCE, V169, P1392, DOI 10.1016/j.neuroscience.2010.05.067; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Gu TT, 2014, BIOL OPEN, V3, P81, DOI 10.1242/bio.20136437; Hao HH, 2013, NEUROSCI BULL, V29, P484, DOI 10.1007/s12264-013-1355-6; Hartman NW, 2013, CELL REP, V5, P433, DOI 10.1016/j.celrep.2013.09.017; Hu JZ, 2013, J NEUROTRAUM, V30, P1349, DOI 10.1089/neu.2012.2748; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jovicic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054222; Jung SY, 2014, EXP THER MED, V7, P587, DOI 10.3892/etm.2013.1451; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Liu YJ, 2015, J CELL BIOCHEM, V116, P2870, DOI 10.1002/jcb.25234; Ono M, 2003, CHEM PHARM BULL, V51, P1328, DOI 10.1248/cpb.51.1328; Ono M, 2007, CHEM PHARM BULL, V55, P1093, DOI 10.1248/cpb.55.1093; Sekiguchi A, 2012, J NEUROTRAUM, V29, P946, DOI 10.1089/neu.2011.1919; Shu QM, 2014, J MOL NEUROSCI, V54, P243, DOI 10.1007/s12031-014-0281-z; Walker CL, 2012, PLOS ONE, V7, P315, DOI 10.1371/journal.pone.0030012; Wan G, 2014, AUTOPHAGY, V10, P70, DOI 10.4161/auto.26534; Wang JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003697; Wang LJ, 2018, BIOMED PHARMACOTHER, V98, P516, DOI 10.1016/j.biopha.2017.12.046; Wu H, 2016, CAN J PHYSIOL PHARM, V94, P1291, DOI 10.1139/cjpp-2016-0228; Wu J, 2012, HUM IMMUNOL, V73, P31, DOI 10.1016/j.humimm.2011.10.003; Xu LJ, 2017, BIOMED PHARMACOTHER, V90, P524, DOI 10.1016/j.biopha.2017.03.105; Yan WJ, 2011, BRAIN RES, V1402, P109, DOI 10.1016/j.brainres.2011.05.049; Yang K, 2014, J INFECT DIS, V210, P89, DOI 10.1093/infdis/jiu002; Yin YM, 2015, SYNAPSE, V69, P139, DOI 10.1002/syn.21802; Yu QJ, 2016, LIFE SCI, V148, P86, DOI 10.1016/j.lfs.2016.02.005; Zhang C, 2017, REPROD FERT DEVELOP, V29, P768, DOI 10.1071/RD15230; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zhao J, 2015, J MOL NEUROSCI, V57, P595, DOI 10.1007/s12031-015-0642-2; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020; 姜国良, 2013, [中国老年学杂志, Chinese Journal of Gerontology], V33, P1101	51	13	13	2	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	AUG	2018	19	8							2274	10.3390/ijms19082274			16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	GR7LE	WOS:000442869800126	30072674	Green Published, gold, Green Submitted			2022-02-06	
J	Santi, A; Bot, M; Aleman, A; Penninx, BWJH; Aleman, IT				Santi, A.; Bot, M.; Aleman, A.; Penninx, B. W. J. H.; Torres Aleman, I.			Circulating insulin-like growth factor I modulates mood and is a biomarker of vulnerability to stress: from mouse to man	TRANSLATIONAL PSYCHIATRY			English	Article							TRAUMATIC BRAIN-INJURY; BRITISH BIRTH COHORT; IGF-I; PERIPHERAL-BLOOD; GENE-EXPRESSION; SERUM IGF1; DISORDER; ASSOCIATION; FKBP5; HORMONE	Individual susceptibility to anxiety disorders after maladaptive responses to stress is not well understood. We now report that while exploring stress responses in mice after traumatic brain injury (TBI), a condition associated to stress susceptibility, we observed that the anxiogenic effects of either TBI or exposure to life-threatening experiences (predator) were blocked when both stressors were combined. Because TBI increases the entrance into the brain of serum insulin-like growth factor I (IGF-I), a known modulator of anxiety with a wide range of concentrations in the human population, we then determined whether circulating IGF-I is related to anxiety measures. In mice, anxiety-like responses to predator were inversely related to circulating IGF-I levels. Other indicators of mood regulation such as sensitivity to dexamethasone suppression and expression levels of blood and brain FK506 binding protein 5 (FKBP5), a co-chaperone of the glucocorticoid receptor that regulates its activity, were also associated to circulating IGF-I. Indeed, brain FKBP5 expression in mice was stimulated by IGF-I. In addition, we observed in a large human cohort (n = 2686) a significant relationship between plasma IGF-I and exposure to recent stressful life events, while FKBP5 expression in blood cells was significantly associated to plasma IGF-I levels. Collectively, these data indicate that circulating IGF-I appears to be involved in mood homeostasis across different species. Furthermore, the data in mice allow us to indicate that IGF-I may be acting at least in part by modulating FKBP5 expression.	[Santi, A.; Torres Aleman, I.] Cajal Inst Neurobiol, Madrid, Spain; [Santi, A.; Torres Aleman, I.] Ciberned, Madrid, Spain; [Bot, M.; Penninx, B. W. J. H.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Bot, M.; Penninx, B. W. J. H.] Amsterdam Publ Hlth Res Inst, GGZ InGeest, Amsterdam Neurosci, Amsterdam, Netherlands; [Aleman, A.] Univ Groningen, Dept Neurosci, Groningen, Netherlands; [Aleman, A.] Univ Med Ctr Groningen, Groningen, Netherlands		Aleman, IT (corresponding author), Cajal Inst Neurobiol, Madrid, Spain.; Aleman, IT (corresponding author), Ciberned, Madrid, Spain.	torres@cajal.csic.es	Torres-Aleman, Ignacio/A-1613-2008; Penninx, Brenda WJH/S-7627-2017	Torres-Aleman, Ignacio/0000-0001-8107-7947; Penninx, Brenda WJH/0000-0001-7779-9672; Santi, Andrea/0000-0001-9282-2340	MINECO, Spain [SAF2010-60051/SAF2013-40710-R]; CIBERNEDInstituto de Salud Carlos III	This work was funded by grants SAF2010-60051/SAF2013-40710-R (MINECO, Spain), and CIBERNED.	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Agha A, 2007, CLIN ENDOCRINOL, V66, P459, DOI 10.1111/j.1365-2265.2007.02763.x; Almli LM, 2014, INT J NEUROPSYCHOPH, V17, P355, DOI 10.1017/S1461145713001090; Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Baldini S, 2013, J NEUROSCI, V33, P11715, DOI 10.1523/JNEUROSCI.3541-12.2013; Bann D, 2015, SOC SCI MED, V147, P190, DOI 10.1016/j.socscimed.2015.11.001; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bot M, 2016, PSYCHONEUROENDOCRINO, V68, P148, DOI 10.1016/j.psyneuen.2016.02.028; Bourron O, 2015, J CLIN ENDOCR METAB, V100, P1879, DOI 10.1210/jc.2014-3968; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Colao A, 2008, EUR J ENDOCRINOL, V159, P389, DOI 10.1530/EJE-08-0201; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cruz EMV, 2007, HORM BEHAV, V51, P611, DOI 10.1016/j.yhbeh.2007.02.010; Daskalakis NP, 2013, ENDOCRIN METAB CLIN, V42, P503, DOI 10.1016/j.ecl.2013.05.004; de Graaf R, 2002, AM J PSYCHIAT, V159, P620, DOI 10.1176/appi.ajp.159.4.620; Deuschle M, 1997, PSYCHONEUROENDOCRINO, V22, P493, DOI 10.1016/S0306-4530(97)00046-2; Friedrich N, 2009, J CLIN ENDOCR METAB, V94, P1732, DOI 10.1210/jc.2008-2138; Frystyk J, 2010, MED SCI SPORT EXER, V42, P58, DOI 10.1249/MSS.0b013e3181b07d2d; Ghosh S, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12397; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Grant G., 2016, TRANSLATIONAL RES TR; Haviland MG, 2016, J NERV MENT DIS, V204, P78, DOI 10.1097/NMD.0000000000000432; Hawkes CP, 2015, PEDIATR ENDOCR REV P, V13, P499; Holz NE, 2015, BRAIN STRUCT FUNCT, V220, P1355, DOI 10.1007/s00429-014-0729-5; Hoshaw BA, 2008, EUR J PHARMACOL, V594, P109, DOI 10.1016/j.ejphar.2008.07.023; Jansen R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-33; Jedlicka P, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00574; Kaouane N, 2012, SCIENCE, V335, P1510, DOI 10.1126/science.1207615; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Kumari M, 2008, ANN EPIDEMIOL, V18, P664, DOI 10.1016/j.annepidem.2008.03.001; Lee RS, 2010, ENDOCRINOLOGY, V151, P4332, DOI 10.1210/en.2010-0225; Lu W, 2016, BIOL PSYCHOL, V120, P46, DOI 10.1016/j.biopsycho.2016.08.005; LUO JM, 1989, ENDOCRINOLOGY, V125, P165, DOI 10.1210/endo-125-1-165; Malberg JE, 2007, NEUROPSYCHOPHARMACOL, V32, P2360, DOI 10.1038/sj.npp.1301358; McKlveen JM, 2013, BIOL PSYCHIAT, V74, P672, DOI 10.1016/j.biopsych.2013.03.024; MIELL JP, 1993, J ENDOCRINOL, V136, P525, DOI 10.1677/joe.0.1360525; Mitschelen M, 2011, NEUROSCIENCE, V185, P50, DOI 10.1016/j.neuroscience.2011.04.032; Motzkin Julian C, 2015, Handb Clin Neurol, V128, P633, DOI 10.1016/B978-0-444-63521-1.00039-X; Nishijima T, 2010, NEURON, V67, P834, DOI 10.1016/j.neuron.2010.08.007; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Santi A, 2018, CEREB CORTEX, V28, P2007, DOI 10.1093/cercor/bhx106; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; THAKORE JH, 1994, LIFE SCI, V55, P1083, DOI 10.1016/0024-3205(94)00237-1; Torres-Aleman I, 2010, DEV NEUROBIOL, V70, P384, DOI 10.1002/dneu.20778; TORRESALEMAN I, 1990, NEUROSCIENCE, V35, P601, DOI 10.1016/0306-4522(90)90332-X; Trejo JI, 2007, MOL PSYCHIATR, V12, P1118, DOI 10.1038/sj.mp.4002076; van Aken MO, 2003, CLIN CHEM, V49, P1408, DOI 10.1373/49.8.1408; Vancampfort D, 2017, AM J EPIDEMIOL, V186, P979, DOI 10.1093/aje/kwx159; Vidal JS, 2016, J ALZHEIMERS DIS, V52, P641, DOI 10.3233/JAD-151162; Volzke H, 2007, J CLIN ENDOCR METAB, V92, P4039, DOI 10.1210/jc.2007-0816; Volzke H, 2009, EUR J ENDOCRINOL, V161, P705, DOI 10.1530/EJE-09-0374; Vreeburg SA, 2009, PSYCHONEUROENDOCRINO, V34, P1109, DOI 10.1016/j.psyneuen.2009.04.024; Willour VL, 2009, MOL PSYCHIATR, V14, P261, DOI 10.1038/sj.mp.4002141; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zannas AS, 2016, NEUROPSYCHOPHARMACOL, V41, P261, DOI 10.1038/npp.2015.235	59	13	13	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	2158-3188			TRANSL PSYCHIAT	Transl. Psychiatr.	AUG 1	2018	8								142	10.1038/s41398-018-0196-5			11	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	GP2BL	WOS:000440624500003	30068974	gold, Green Published			2022-02-06	
J	Sullivan, DR; Hayes, JP; Lafleche, G; Salat, DH; Verfaellie, M				Sullivan, Danielle R.; Hayes, Jasmeet P.; Lafleche, Ginette; Salat, David H.; Verfaellie, Mieke			Functional Brain Alterations Associated With Cognitive Control in Blast-Related Mild Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						mTBI; Task fMRI; Default mode network; Salience network; Central executive network; OEF/OIF	CHRONIC POSTCONCUSSION SYMPTOMS; WHITE-MATTER ABNORMALITIES; DEFAULT-MODE NETWORK; EVENT-RELATED FMRI; RESPONSE COMPETITION; ICA-AROMA; CONNECTIVITY; ROBUST; METAANALYSIS; CONCUSSION	Objectives: Research on the cognitive sequelae of mild traumatic brain injury (mTBI) suggests that, despite generally rapid recovery, difficulties may persist in the domain of cognitive control. The goal of this study was to examine whether individuals with chronic blast-related mTBI show behavioral or neural alterations associated with cognitive control. Methods: We collected event-related functional magnetic resonance imaging (fMRI) data during a flanker task in 17 individuals with blast-related mTBI and 16 individuals with blast-exposure without TBI (control). Results: Groups did not significantly differ in behavioral measures of cognitive control. Relative to the control group, the mTBI group showed greater deactivation of regions associated with the default mode network during the processing of errors. Additionally, error processing in the mTBI group was associated with enhanced negative coupling between the default mode network and the dorsal anterior cingulate cortex as well as the dorsolateral prefrontal cortex, regions of the salience and central executive networks that are associated with cognitive control. Conclusions: These results suggest that deactivation of default mode network regions and associated enhancements of connectivity with cognitive control regions may act as a compensatory mechanism for successful cognitive control task performance in mTBI.	[Sullivan, Danielle R.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Sullivan, Danielle R.; Lafleche, Ginette; Verfaellie, Mieke] VA Boston Healthcare Syst, Memory Disorders Res Ctr, 151A,150 S Huntington Ave, Boston, MA 02130 USA; [Hayes, Jasmeet P.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA 02130 USA; [Hayes, Jasmeet P.; Lafleche, Ginette; Verfaellie, Mieke] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Hayes, Jasmeet P.; Salat, David H.] VA Boston Healthcare Syst, Neuroimaging Res Vet Ctr, Boston, MA 02130 USA; Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Salat, David H.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA		Sullivan, DR (corresponding author), VA Boston Healthcare Syst, Memory Disorders Res Ctr, 151A,150 S Huntington Ave, Boston, MA 02130 USA.	drsulliv@bu.edu	Hayes, Jasmeet/AAN-4150-2020; Lang, Steven/AAE-8102-2021	Hayes, Jasmeet/0000-0002-5157-0666; Lang, Steven/0000-0003-1669-9146; Sullivan, Danielle R./0000-0002-0141-5887; Verfaellie, Mieke/0000-0001-5535-4584	VA Rehabilitation Research & Development Service [I01RX000216, I21RX001594]; VA Clinical Science Research and Development Service; National Center for PTSD; Veterans AffairsUS Department of Veterans Affairs [I01RX000216, I21RX001594] Funding Source: NIH RePORTER	The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. The authors thank Michael Esterman, Ph.D., for valuable input on this work. The authors declare no conflicts of interest. This work was supported by the VA Rehabilitation Research & Development Service (M.V., grant number I01RX000216 and J.P.H., grant number I21RX001594); the VA Clinical Science Research and Development Service; and the National Center for PTSD. This work was further supported with resources and the use of facilities at the Neuroimaging Research for Veterans Center, VA Boston Healthcare System.	Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hazeltine E, 2003, NEUROPSYCHOLOGIA, V41, P1208, DOI 10.1016/S0028-3932(03)00040-X; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Matthews S, 2011, PSYCHIAT RES-NEUROIM, V191, P76, DOI 10.1016/j.pscychresns.2010.09.013; Mayer AR, 2015, HUM BRAIN MAPP, V36, P4394, DOI 10.1002/hbm.22930; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; McCrea M., 2008, MILD TRAUMATIC BRAIN; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; O'Reilly JX, 2012, SOC COGN AFFECT NEUR, V7, P604, DOI 10.1093/scan/nss055; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Pruim RHR, 2015, NEUROIMAGE, V112, P278, DOI 10.1016/j.neuroimage.2015.02.063; Pruim RHR, 2015, NEUROIMAGE, V112, P267, DOI 10.1016/j.neuroimage.2015.02.064; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Weathers F.W., 1991, PTSD CHECKLIST MILIT; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023	56	13	13	0	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2018	24	7					662	672		10.1017/S1355617718000279			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	GR6FA	WOS:000442739900002	29954465	Green Accepted			2022-02-06	
J	Suttipongkaset, P; Chaikittisilpa, N; Vavilala, MS; Lele, AV; Watanitanon, A; Chandee, T; Krishnamoorthy, V				Suttipongkaset, Pratthana; Chaikittisilpa, Nophanan; Vavilala, Monica S.; Lele, Abhijit V.; Watanitanon, Arraya; Chandee, Theerada; Krishnamoorthy, Vijay			Blood Pressure Thresholds and Mortality in Pediatric Traumatic Brain Injury	PEDIATRICS			English	Article							CHILDREN; GUIDELINES; MANAGEMENT; OUTCOMES; RESUSCITATION; HYPOTENSION; LIFE	BACKGROUND: Hypotension after pediatric traumatic brain injury (TBI) is associated with poor outcomes, but definitions of low systolic blood pressure (SBP) vary. Age-and sex-specific, percentile-based definitions of hypotension may help to better identify children at risk for poor outcomes compared with traditional thresholds recommended in pediatric trauma care. METHODS: Using the National Trauma Data Bank between 2007 and 2014, we conducted a retrospective cohort study of children with isolated severe TBI. We classified admission SBP into 5 percentile categories according to population-based values: (1) SBP less than the fifth percentile, (2) SBP in the fifth to 24th percentile, (3) SBP in the 25th to 74th percentile, (4) SBP in the 75th to 94th percentile, and (5) SBP >= 95th percentile. These definitions were compared with the American College of Surgeons (ACS) hypotension definition. The association between SBP percentiles and in-hospital mortality was analyzed by using multivariable Poisson regression models. RESULTS: There were 10 473 children with severe TBI included in this study. There were 2388 (22.8%) patients who died while in the hospital. Compared with SBP in the 75th to 94th percentile, mortality was higher with SBP less than the fifth percentile (relative risk [RR] 3.2; 95% confidence interval [CI] 2.9-3.6), SBP in the fifth to 24th percentile (RR 2.3; 95% CI 2.0-2.7), and SBP in the 25th to 74th percentile (RR 1.4; 95% CI 1.2-1.6). An increased risk of mortality with SBP <75th percentile was present across all age subgroups. SBP targets using the ACS hypotension definition were higher than the fifth percentile hypotension definition, but were lower than the 75th percentile hypotension definition. CONCLUSIONS: Admission SBP <75th percentile was associated with a higher risk of in-hospital mortality after isolated severe TBI in children. SBP targets based on the 75th percentile were higher compared with traditional ACS targets. Percentile-based SBP targets should be considered in defining hypotension in pediatric TBI.	[Suttipongkaset, Pratthana] Sirindhorn Hosp, Dept Anesthesiol, Bangkok, Thailand; [Suttipongkaset, Pratthana; Chaikittisilpa, Nophanan; Vavilala, Monica S.; Watanitanon, Arraya; Chandee, Theerada; Krishnamoorthy, Vijay] Univ Washington, Seattle, WA 98195 USA; [Vavilala, Monica S.; Lele, Abhijit V.; Watanitanon, Arraya; Chandee, Theerada] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Chaikittisilpa, Nophanan] Mahidol Univ, Siriraj Hosp, Dept Anesthesiol, Fac Med, Bangkok, Thailand; [Krishnamoorthy, Vijay] Duke Univ, Sch Med, Dept Anesthesiol, 2301 Erwin Rd, Durham, NC 27710 USA		Krishnamoorthy, V (corresponding author), Duke Univ, Sch Med, Dept Anesthesiol, 2301 Erwin Rd, Durham, NC 27710 USA.	vijay.krishnamoorthy@duke.edu					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; de Caen AR, 2015, CIRCULATION, V132, pS177, DOI 10.1161/CIR.0000000000000275; DESWIET M, 1980, PEDIATRICS, V65, P1028; Flynn JT, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-3035; Flynn JT, 2017, HYPERTENSION, V70, P683, DOI 10.1161/HYPERTENSIONAHA.117.10050; Gross BW, 2017, J TRAUMA ACUTE CARE, V82, P368, DOI 10.1097/TA.0000000000001291; Guilliams K, 2016, J CHILD NEUROL, V31, P35, DOI 10.1177/0883073814562626; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Harris BH, 1998, J PEDIATR SURG, V33, P338; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Krishnamoorthy V, 2017, J NEUROSURG ANESTH, V29, P382, DOI 10.1097/ANA.0000000000000370; Loizou E, 2010, RESUSCITATION, V81, P418, DOI 10.1016/j.resuscitation.2009.12.017; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	27	13	13	1	2	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	AUG	2018	142	2							e20180594	10.1542/peds.2018-0594			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	GO9WX	WOS:000440459900035	30064999	Bronze			2022-02-06	
J	Karlsson, M; Pukenas, B; Chawla, S; Ehinger, JK; Plyler, R; Stolow, M; Gabello, M; Hugerth, M; Elmer, E; Hansson, MJ; Margulies, S; Kilbaugh, T				Karlsson, Michael; Pukenas, Bryan; Chawla, Sanjeev; Ehinger, Johannes K.; Plyler, Ross; Stolow, Madeline; Gabello, Melissa; Hugerth, Matilda; Elmer, Eskil; Hansson, Magnus J.; Margulies, Susan; Kilbaugh, Todd			Neuroprotective Effects of Cyclosporine in a Porcine Pre-Clinical Trial of Focal Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						magnetic resonance imaging; magnetic resonance spectroscopy imaging; mitochondria; traumatic brain injury	MITOCHONDRIAL PERMEABILITY TRANSITION; ANAPHYLACTIC REACTION; MAGNETIC-RESONANCE; AXONAL INJURY; CYCLOPHILIN-D; CELL-DEATH; DAMAGE; DYSFUNCTION; MECHANISMS; DEPRESSION	Mitochondrial dysfunction is thought to be a hallmark of traumatic brain injury (TBI) and plays a pivotal role in the resulting cellular injury. Cyclophilin D-mediated activation of the mitochondrial permeability transition pore has been suggested to contribute to this secondary injury cascade. Cyclosporine possesses neuroprotective properties that have been attributed to the desensitization of mitochondrial permeability transition pore activation. In vivo animal experiments have demonstrated neuroprotective effects of cyclosporine in more than 20 independent experimental studies in a multitude of different experimental models. However, the majority of these studies have been carried out in rodents. The aim of the present study was to evaluate the efficacy of a novel and cremophor/kolliphor EL-free lipid emulsion formulation of cyclosporine in a translational large animal model of TBI. A mild-to-moderate focal contusion injury was induced in piglets using a controlled cortical impact device. After initial step-wise analyses of pharmacokinetics and comparing with exposure of cyclosporine in clinical TBI trials, a 5-day dosing regimen with continuous intravenous cyclosporine infusion (20mg/kg/day) was evaluated in a randomized and blinded placebo-controlled setting. Cyclosporine reduced the volume of parenchymal injury by 35%, as well as improved markers of neuronal injury, as measured with magnetic resonance spectroscopic imaging. Further, a consistent trend toward positive improvements in brain metabolism and mitochondrial function was observed in the pericontusional tissue. In this study, we have demonstrated efficacy using a novel cyclosporine formulation in clinically relevant and translatable outcome metrics in a large animal model of focal TBI.	[Karlsson, Michael; Ehinger, Johannes K.; Gabello, Melissa; Kilbaugh, Todd] Univ Penn, Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Perelman Sch Med, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Karlsson, Michael; Ehinger, Johannes K.; Elmer, Eskil; Hansson, Magnus J.] Lund Univ, Dept Clin Sci, Mitochondrial Med, Lund, Sweden; [Karlsson, Michael] Rigshosp, Dept Neurosurg, Copenhagen, Denmark; [Karlsson, Michael; Ehinger, Johannes K.; Hugerth, Matilda; Elmer, Eskil; Hansson, Magnus J.] NeuroVive Pharmaceut AB, Lund, Sweden; [Pukenas, Bryan; Chawla, Sanjeev] Univ Penn, Hosp Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Plyler, Ross; Stolow, Madeline; Margulies, Susan] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Karlsson, M (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Perelman Sch Med, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	karlssonm@email.chop.edu	Karlsson, Michael/AAL-8743-2020; Elmer, Eskil/F-9341-2014; Hansson, Magnus/G-4486-2014; Ehinger, Johannes/D-7120-2013	Karlsson, Michael/0000-0002-7247-2133; Elmer, Eskil/0000-0001-7901-1826; Kilbaugh, Todd/0000-0002-4959-3092; Hansson, Magnus/0000-0002-0201-0638; Ehinger, Johannes/0000-0002-2417-5767	NeuroVive Pharmaceutical AB; Department of Anesthesiology and Critical Care Medicine at The Children's Hospital of Philadelphia; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 N5 097549]	The authors thank Anna Borkon for technical support with neuroimaging and veterinarian Blythe Philips for her extensive veterinary support. Support was provided by NeuroVive Pharmaceutical AB, The Department of Anesthesiology and Critical Care Medicine at The Children's Hospital of Philadelphia, and NIH RO1 N5 097549.	Abdel Baki SG, 2010, PLOS ONE, V5; Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baker MT, 2005, ANESTHESIOLOGY, V103, P860, DOI 10.1097/00000542-200510000-00026; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; Bernardi P, 1998, BIOFACTORS, V8, P273, DOI 10.1002/biof.5520080315; Brophy GM, 2013, J NEUROTRAUM, V30, P1484, DOI 10.1089/neu.2012.2524; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; CHAPUIS B, 1985, NEW ENGL J MED, V312, P1259; Chawla S, 2010, J NEUROL, V257, P114, DOI 10.1007/s00415-009-5283-3; Colley BS, 2010, EXP NEUROL, V224, P241, DOI 10.1016/j.expneurol.2010.03.026; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Cung TT, 2015, NEW ENGL J MED, V373, P1021, DOI 10.1056/NEJMoa1505489; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; DYE D, 1980, BRIT MED J, V280, P1353, DOI 10.1136/bmj.280.6228.1353; Ederoth P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012299; Ehinger KHJ, 2013, CLIN DRUG INVEST, V33, P25, DOI 10.1007/s40261-012-0029-x; Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0; FRIEDMAN LS, 1985, AM J MED, V78, P343, DOI 10.1016/0002-9343(85)90447-4; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Hajnoczky G, 2000, CELL CALCIUM, V28, P349, DOI 10.1054/ceca.2000.0169; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Hansson MJ, 2008, FREE RADICAL BIO MED, V45, P284, DOI 10.1016/j.freeradbiomed.2008.04.021; Hansson MJ, 2011, J NEUROTRAUM, V28, P143, DOI 10.1089/neu.2010.1613; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; HOWRIE DL, 1985, DRUG INTEL CLIN PHAR, V19, P425, DOI 10.1177/106002808501900603; HUTTEL MS, 1980, BRIT J ANAESTH, V52, P77, DOI 10.1093/bja/52.1.77; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kilbaugh TJ, 2016, MITOCHONDRION, V26, P19, DOI 10.1016/j.mito.2015.11.001; Kilbaugh TJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002232; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lemasters JJ, 1999, J BIOENERG BIOMEMBR, V31, P305, DOI 10.1023/A:1005419617371; Lemasters JJ, 1999, AM J PHYSIOL-GASTR L, V276, pG1, DOI 10.1152/ajpgi.1999.276.1.G1; LEUNISSEN KML, 1985, LANCET, V1, P636; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Maas AIR, 2012, LANCET NEUROL, V11, P12, DOI 10.1016/S1474-4422(11)70267-8; Maciel EN, 2001, J NEUROCHEM, V79, P1237, DOI 10.1046/j.1471-4159.2001.00670.x; Margulies SS, 2015, BRAIN PATHOL, V25, P289, DOI 10.1111/bpa.12247; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Morota S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067747; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Shutter L, 2006, J HEAD TRAUMA REHAB, V21, P334, DOI 10.1097/00001199-200607000-00005; Siesjo BK, 1999, ACTA NEUROCHIR SUPPL, V73, P7; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Snyder SH, 1998, TRENDS PHARMACOL SCI, V19, P21, DOI 10.1016/S0165-6147(97)01146-2; Staal JA, 2007, DEV NEUROBIOL, V67, P1831, DOI 10.1002/dneu.20552; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Trapani G, 2000, CURR MED CHEM, V7, P249, DOI 10.2174/0929867003375335; TSAO PW, 1992, DEV PHARMACOL THERAP, V18, P20, DOI 10.1159/000480594; Turkoglu OF, 2010, BRIT J NEUROSURG, V24, P578, DOI 10.3109/02688697.2010.487126; Uchino H, 1995, ACTA PHYSIOL SCAND, V155, P469, DOI 10.1111/j.1748-1716.1995.tb09999.x; Van den Heuvel C, 2004, J NEUROTRAUM, V21, P1562, DOI 10.1089/0897715042441783; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Votyakova TV, 2005, J NEUROCHEM, V93, P526, DOI 10.1111/j.1471-4159.2005.03042.x; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yamaki T, 1996, J NUCL MED, V37, P1166; Yin Wei-dong, 2004, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V16, P214	83	13	13	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					14	24		10.1089/neu.2018.5706		JUL 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000439666100001	29929438	Green Submitted, Green Published, hybrid			2022-02-06	
J	Wintermark, M; Li, Y; Ding, VY; Xu, YD; Jiang, B; Ball, RL; Zeineh, M; Gean, A; Sanelli, P				Wintermark, Max; Li, Ying; Ding, Victoria Y.; Xu, Yingding; Jiang, Bin; Ball, Robyn L.; Zeineh, Michael; Gean, Alisa; Sanelli, Pina			Neuroimaging Radiological Interpretation System for Acute Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						clinical decision support; common data elements; CT; outcome; TBI	COMMON DATA ELEMENTS; CLASSIFICATION; VARIABILITY; MAMMOGRAPHY; LEXICON	The purpose of the study was to develop an outcome-based NeuroImaging Radiological Interpretation System (NIRIS) for patients with acute traumatic brain injury (TBI) that would standardize the interpretation of noncontrast head computer tomography (CT) scans and consolidate imaging findings into ordinal severity categories that would inform specific patient management actions and that could be used as a clinical decision support tool. We retrospectively identified all patients transported to our emergency department by ambulance or helicopter for whom a trauma alert was triggered per established criteria and who underwent a noncontrast head CT because of suspicion of TBI, between November 2015 and April 2016. Two neuroradiologists reviewed the noncontrast head CTs and assessed the TBI imaging common data elements (CDEs), as defined by the National Institutes of Health (NIH). Using descriptive statistics and receiver operating characteristic curve analyses to identify imaging characteristics and associated thresholds that best distinguished among outcomes, we classified patients into five mutually exclusive categories: 0-discharge from the emergency department; 1-follow-up brain imaging and/or admission; 2-admission to an advanced care unit; 3-neurosurgical procedure; 4-death up to 6 months after TBI. Sensitivity of NIRIS with respect to each patient's true outcome was then evaluated and compared with that of the Marshall and Rotterdam scoring systems for TBI. In our cohort of 542 patients with TBI, NIRIS was developed to predict discharge (182 patients), follow-up brain imaging/admission (187 patients), need for advanced care unit (151 patients), neurosurgical procedures (10 patients), and death (12 patients). NIRIS performed similarly to the Marshall and Rotterdam scoring systems in terms of predicting death. We developed an interpretation system for neuroimaging using the CDEs that informs specific patient management actions and could be used as a clinical decision support tool for patients with TBI. Our NIRIS classification, with evidence-based grouping of the CDEs into actionable categories, will need to be validated in different TBI populations.	[Wintermark, Max; Li, Ying; Xu, Yingding; Jiang, Bin; Zeineh, Michael] Stanford Univ, Dept Radiol, Neuroradiol Div, 300 Pasteur Dr,Room S047, Stanford, CA 94305 USA; [Ding, Victoria Y.; Ball, Robyn L.] Stanford Univ, Dept Med, Quantitat Sci Unit, Stanford, CA 94305 USA; [Gean, Alisa] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Radiol, Neuroradiol Sect, San Francisco, CA 94143 USA; [Gean, Alisa] Univ Calif San Francisco, Trauma Ctr, San Francisco, CA 94143 USA; [Sanelli, Pina] Northwell Hlth, Northwell Hofstra Sch Med, Dept Radiol, Manhasset, NY USA		Wintermark, M (corresponding author), Stanford Univ, Dept Radiol, Neuroradiol Div, 300 Pasteur Dr,Room S047, Stanford, CA 94305 USA.	Max.Wintermark@gmail.com					Baker JA, 1996, AM J ROENTGENOL, V166, P773, DOI 10.2214/ajr.166.4.8610547; Balleyguier C, 2007, EUR J RADIOL, V61, P192, DOI 10.1016/j.ejrad.2006.08.033; Burnside Elizabeth S, 2009, J Am Coll Radiol, V6, P851, DOI 10.1016/j.jacr.2009.07.023; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Edwards SD, 2013, MAGN RESON IMAGING C, V21, P483, DOI 10.1016/j.mric.2013.02.005; FAUL M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.1016/J.NEUROIMAGE.2010.09.025; Grieve FM, 2010, BRIT J RADIOL, V83, P17, DOI 10.1259/bjr/16360063; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Krupinski EA, 2012, J DIGIT IMAGING, V25, P63, DOI 10.1007/s10278-011-9424-8; Langlotz Curtis P, 2009, J Am Coll Radiol, V6, P861, DOI 10.1016/j.jacr.2009.09.015; Lazarus E, 2006, RADIOLOGY, V239, P385, DOI 10.1148/radiol.2392042127; Lee B, 2017, CURR PROBL DIAGN RAD, V46, P186, DOI 10.1067/j.cpradiol.2016.11.005; Levy L, 2007, EUR J RADIOL, V61, P202, DOI 10.1016/j.ejrad.2006.08.035; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mercado CL, 2014, RADIOL CLIN N AM, V52, P481, DOI 10.1016/j.rcl.2014.02.008; Obenauer S, 2005, EUR RADIOL, V15, P1027, DOI 10.1007/s00330-004-2593-9; Plumb AAO, 2009, CLIN RADIOL, V64, P386, DOI 10.1016/j.crad.2008.11.009; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Team, 2000, R LANG DEF	21	13	13	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2018	35	22					2665	2672		10.1089/neu.2017.5311		JUL 2018	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GZ0MO	WOS:000439648900001	29665763				2022-02-06	
J	Zeiler, FA; Smielewski, P				Zeiler, F. A.; Smielewski, P.			Application of robotic transcranial Doppler for extended duration recording in moderate/severe traumatic brain injury: first experiences	CRITICAL ULTRASOUND JOURNAL			English	Article						Robotic transcranial Doppler; TCD; Traumatic brain injury; TBI; Technology review	ULTRASOUND		[Zeiler, F. A.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge, England; [Zeiler, F. A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada; [Zeiler, F. A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Smielewski, P.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Sect Brain Phys,Div Neurosurg, Cambridge, England		Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada.	umzeiler@myumanitoba.ca		Zeiler, Frederick/0000-0003-1737-0510	Cambridge Commonwealth Trust Scholarship; Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery; University of Manitoba Clinician Investigator Program	This work was made possible through salary support through the Cambridge Commonwealth Trust Scholarship, the Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery and the University of Manitoba Clinician Investigator Program.	Kalanuria A, 2013, NEUROSURG CLIN N AM, V24, P441, DOI 10.1016/j.nec.2013.02.005; Purkayastha S, 2012, SEMIN NEUROL, V32, P411, DOI 10.1055/s-0032-1331812; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Zeiler FA, 2018, J NEUROTRAUM, V35, P314, DOI 10.1089/neu.2017.5364; Zeiler FA, 2017, J NEUROTRAUM, V34, P3207, DOI 10.1089/neu.2017.5085	5	13	13	0	1	SPRINGEROPEN	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2036-3176	2036-7902		CRIT ULTRASOUND J	Crit. Ultrasound J.	JUL 23	2018	10								16	10.1186/s13089-018-0097-0			8	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	GO5SO	WOS:000440086900001	30033501	Green Published, gold, Green Submitted			2022-02-06	
J	Bier, B; Ouellet, E; Belleville, S				Bier, Bianca; Ouellet, Emilie; Belleville, Sylvie			Computerized Attentional Training and Transfer With Virtual Reality: Effect of Age and Training Type	NEUROPSYCHOLOGY			English	Article						dual-task; cognitive training; transfer; virtual-reality; aging	MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; OLDER-ADULTS; MEMORY; REHABILITATION; INTERVENTIONS; PLASTICITY; DEFICITS; IMPACT; SKILL	Objective: The aims of this study were to assess whether computerized attentional training improves dual-tasking abilities in older adults and whether its effect and transfer are modulated by age and the type of training provided. This study also used virtual reality (VR) as a proxy to measure transfer in a real life related context. Method: Sixty participants (30 older and 30 younger adults) were randomized to either: (a) single-task training (two tasks practiced in focused attention; visual detection and alphanumeric equation task); or (b) divided attention variable-priority training (varying the amount of attention to put on each task when performed concurrently). Training effects were assessed at pre- and post-training with tasks similar to the one used in training. Transfer was measured with the virtual car ride, an immersive dual-task scenario and a self-reported questionnaire. Results: In older adults, variable-priority improved attentional control abilities and led to better transfer in the VR dual-task scenario compared with single-task. Younger adults benefited equally from the two types of training and transfer was found on the Alpha span task when performed concurrently in VR. Single-task improved the ability of all participants to carry out the tasks in the focused attention condition. No transfer effects were found on the self-reported measure for either training type or age. Conclusion: Attention remains plastic in old age and programs designed to improve attentional control might be beneficial to older adults. Importantly, training can produce transfer to more real life related tasks and transfer remains possible throughout the life span. General Scientific Summary This study shows the importance of selecting the appropriate training program on the basis of (a) what we want to improve and (b) the population to which it is addressed. Indeed, older adults were found to benefit to a larger extent than younger adults from a training targeting attentional control abilities (for which difficulties were found prior to training), and that this training gain may transfer to tasks of everyday life.	[Bier, Bianca; Ouellet, Emilie; Belleville, Sylvie] Inst Univ Geriatrie Montreal, Res Ctr, 4565 Queen Mary, Montreal, PQ H3W 1W5, Canada; [Bier, Bianca; Ouellet, Emilie; Belleville, Sylvie] Univ Montreal, Dept Psychol, Montreal, PQ, Canada		Belleville, S (corresponding author), Inst Univ Geriatrie Montreal, Res Ctr, 4565 Queen Mary, Montreal, PQ H3W 1W5, Canada.	sylvie.belleville@umontreal.ca					Allain P, 2014, J INT NEUROPSYCH SOC, V20, P468, DOI 10.1017/S1355617714000344; Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Barker-Collo SL, 2009, STROKE, V40, P3293, DOI 10.1161/STROKEAHA.109.558239; Barnett SM, 2002, PSYCHOL BULL, V128, P612, DOI 10.1037//0033-2909.128.4.612; Belleville S, 1998, MEM COGNITION, V26, P572, DOI 10.3758/BF03201163; Belleville S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102710; Bherer L, 2005, PSYCHOL AGING, V20, P695, DOI 10.1037/0882-7974.20.4.695; Bherer L, 2008, EXP AGING RES, V34, P188, DOI 10.1080/03610730802070068; Bier B, 2014, AGE, V36, DOI 10.1007/s11357-014-9688-2; Boot WR, 2010, ACTA PSYCHOL, V135, P349, DOI 10.1016/j.actpsy.2010.09.005; Bransford J. D., 2000, LEARNING TRANSFER PE; Braver T. S., 2008, HDB AGING COGNITION, P311; Braver TS, 2001, J EXP PSYCHOL GEN, V130, P746, DOI 10.1037//0096-3445.130.4.746; Brehmer Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00063; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; BUTTERFIELD EC, 1991, COGNITION INSTRUCT, V8, P69, DOI 10.1207/s1532690xci0801_3; Chandler MJ, 2016, NEUROPSYCHOL REV, V26, P225, DOI 10.1007/s11065-016-9330-4; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Corriveau-Lecavalier N., 2017, NEUROPSYCHOLOGICAL R; Cushman LA, 2008, NEUROLOGY, V71, P888, DOI 10.1212/01.wnl.0000326262.67613.fe; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Derwinger A, 2003, AGING NEUROPSYCHOL C, V10, P202, DOI 10.1076/anec.10.3.202.16452; Erickson KI, 2010, CEREB CORTEX, V20, P2522, DOI 10.1093/cercor/bhp293; Fetta J, 2017, J NEUROSCI NURS, V49, P235, DOI 10.1097/JNN.0000000000000298; Gagnon LG, 2012, NEUROPSYCHOL REHABIL, V22, P809, DOI 10.1080/09602011.2012.691044; GOPHER D, 1989, ACTA PSYCHOL, V71, P147, DOI 10.1016/0001-6918(89)90007-3; GOPHER D, 1994, HUM FACTORS, V36, P387, DOI 10.1177/001872089403600301; Gopher D., 2007, ATTENTION THEORY PRA, V101, P209; HART SG, 1992, PROCEEDINGS OF THE HUMAN FACTORS SOCIETY, 36TH ANNUAL MEETING, VOLS 1 AND 2, P1291; HAWKINS HL, 1992, PSYCHOL AGING, V7, P643, DOI 10.1037/0882-7974.7.4.643; Jaeggi SM, 2014, MEM COGNITION, V42, P464, DOI 10.3758/s13421-013-0364-z; Jaeggi SM, 2011, P NATL ACAD SCI USA, V108, P10081, DOI 10.1073/pnas.1103228108; Karbach J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00048; Katz B., 2016, COGNITIVE TRAINING O, P157, DOI DOI 10.1007/978-3-319-42662-4_15; KRAMER AF, 1995, J EXP PSYCHOL-APPL, V1, P50, DOI 10.1037/1076-898X.1.1.50; Kramer AF, 1999, ACTA PSYCHOL, V101, P339, DOI 10.1016/S0001-6918(99)00011-6; Kuhn S., 2016, HDB PSYCHOL AGING, P105, DOI DOI 10.1016/B978-0-12-411469-2.00006-6; Lee H, 2012, BEHAV BRAIN RES, V232, P348, DOI 10.1016/j.bbr.2012.03.043; Leeb R, 2007, IEEE T NEUR SYS REH, V15, P473, DOI 10.1109/TNSRE.2007.906956; Lobato J, 2006, J LEARN SCI, V15, P431, DOI 10.1207/s15327809jls1504_1; Lovden M, 2010, PSYCHOL BULL, V136, P659, DOI 10.1037/a0020080; Lussier M., 2016, RESTORATIVE NEUROLOG, V35, P237; Lussier M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00129; Lustig C, 2009, NEUROPSYCHOL REV, V19, P504, DOI 10.1007/s11065-009-9119-9; MCDOWD JM, 1991, J GERONTOL, V46, pP340, DOI 10.1093/geronj/46.6.P340; MCDOWD JM, 2000, HDB AGING COGNITION, P00221; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Milham MP, 2002, BRAIN COGNITION, V49, P277, DOI 10.1006/brcg.2001.1501; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; NEELY AS, 1993, EDUC GERONTOL, V19, P105, DOI 10.1080/0360127930190202; Noack H, 2009, RESTOR NEUROL NEUROS, V27, P435, DOI 10.3233/RNN-2009-0496; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Palmese CA, 2000, BRAIN INJURY, V14, P535; Park NW, 1999, NEUROPSYCHOL REHABIL, V9, P135, DOI 10.1080/713755595; Perkins D. N., 1992, INT ENCY ED, P6452; PERKINS DN, 1988, EDUC LEADERSHIP, V46, P22; Plancher G, 2010, NEUROPSYCHOLOGY, V24, P379, DOI 10.1037/a0018680; Rebok GW, 2014, J AM GERIATR SOC, V62, P16, DOI 10.1111/jgs.12607; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; SALTHOUSE TA, 1984, MEM COGNITION, V12, P613, DOI 10.3758/BF03213350; Saposnik G, 2016, LANCET NEUROL, V15, P1019, DOI 10.1016/S1474-4422(16)30121-1; Schuchat J, 2012, NON PHARM THERAPIES, V3, P35; Schuemie MJ, 2001, CYBERPSYCHOL BEHAV, V4, P183, DOI 10.1089/109493101300117884; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Stuss DT, 2007, J INT NEUROPSYCH SOC, V13, P120, DOI 10.1017/S1355617707070154; Voss MW, 2012, NEUROIMAGE, V59, P138, DOI 10.1016/j.neuroimage.2011.03.052; Waller D, 1998, PRESENCE-TELEOP VIRT, V7, P129, DOI 10.1162/105474698565631; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Zanardo F, 2006, AGING CLIN EXP RES, V18, P425, DOI 10.1007/BF03324839; Zendel BR, 2016, NEUROBIOL AGING, V47, P10, DOI 10.1016/j.neurobiolaging.2016.06.023; Zinke K, 2014, DEV PSYCHOL, V50, P304, DOI 10.1037/a0032982; Zinke K, 2012, GERONTOLOGY, V58, P79, DOI 10.1159/000324240	76	13	13	1	23	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2018	32	5					597	614		10.1037/neu0000417			18	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GK8VT	WOS:000436509600008	29952612				2022-02-06	
J	Deane, AM; Lamontagne, F; Dukes, GE; Neil, D; Vasist, L; Barton, ME; Hacquoil, K; Ou, XL; Richards, D; Stelfox, HT; Mehta, S; Day, AG; Chapman, MJ; Heyland, DK				Deane, Adam M.; Lamontagne, Francois; Dukes, George E.; Neil, David; Vasist, Lakshmi; Barton, Matthew E.; Hacquoil, Kimberley; Ou, Xiaoling; Richards, Duncan; Stelfox, Henry T.; Mehta, Sangeeta; Day, Andrew G.; Chapman, Marianne J.; Heyland, Daren K.			Nutrition Adequacy Therapeutic Enhancement in the Critically Ill: A Randomized Double-Blind, Placebo-Controlled Trial of the Motilin Receptor Agonist Camicinal (GSK962040): The NUTRIATE Study	JOURNAL OF PARENTERAL AND ENTERAL NUTRITION			English	Article						Critical illness; enteral nutrition; gastrointestinal agent; gastrointestinal diseases; motilin	INTENSIVE-CARE PATIENTS; ENTERAL NUTRITION; FEED INTOLERANCE; CRITICAL ILLNESS; GASTROINTESTINAL DYSMOTILITY; ERYTHROMYCIN; METOCLOPRAMIDE; PROVISION; PROTEIN; ENERGY	BackgroundCamicinal is a novel, nonmacrolide, motilin receptor agonist that accelerates gastric emptying in critically ill patients with established feed intolerance. The primary question was whether the preemptive administration of camicinal increased the provision of enteral nutrition (EN) to critically ill patients with risk factors that predisposed to feed intolerance. MethodsThis was an international, multicenter, parallel-group, blinded, randomized controlled trial. Patients at risk for feed intolerance, defined as receiving moderate to high doses of vasopressors or opiates, or admitted because of multiple traumatic injuries or with brain injury, received either enteral camicinal 50 mg or placebo daily for a maximum of 7 days, along with EN administered according to a standardized feeding protocol. The primary outcome was the daily adequacy of enteral feed delivered, as assessed by percentage of goal volume (delivered/prescribed x 100) before development of intolerance. ResultsEighty-four patients participated. The administration of camicinal did not result in a statistically significant clinical difference in the daily average percentage goal volume delivered (camicinal vs placebo: 77% [95% confidence interval: 71, 83] vs 68% (58, 78); mean difference 9% [-5, 23]; P = 0.21). Similarly, there were no differences in the percentage goal calories (76% [65, 88] vs 68% [60, 77]) and protein (76% [66, 86] vs 70% [61, 80]) administered, or the incidence of feed intolerance (15% vs 14%). ConclusionThe incidence of feed intolerance was low in both groups. In this cohort the preemptive administration of enteral camicinal did not significantly augment the provision of goal EN.	[Deane, Adam M.; Chapman, Marianne J.] Royal Adelaide Hosp, Dept Crit Care Serv, Adelaide, SA, Australia; [Deane, Adam M.; Chapman, Marianne J.] Univ Adelaide, Discipline Acute Care Med, Adelaide, SA, Australia; [Deane, Adam M.] Royal Melbourne Hosp, Intens Care Unit, Melbourne, Vic, Australia; [Lamontagne, Francois] Univ Sherbrooke, Dept Med, Sherbrooke, PQ, Canada; [Lamontagne, Francois] Ctr Hosp Univ Sherbrooke, Sherbrooke, PQ, Canada; [Dukes, George E.; Neil, David; Vasist, Lakshmi; Barton, Matthew E.] GlaxoSmithKline R&D, Res Triangle Pk, NC USA; [Barton, Matthew E.] Mallinckrodt Pharmaceut Inc, Hampton, NJ USA; [Hacquoil, Kimberley] GlaxoSmithKline R&D, Stevenage, Herts, England; [Ou, Xiaoling] Phastar, Chiswick, England; [Richards, Duncan] GlaxoSmithKline R&D, Cambridge, England; [Stelfox, Henry T.] Univ Calgary, OBrien Inst Publ Hlth, Dept Crit Care Med, Calgary, AB, Canada; [Stelfox, Henry T.] Univ Calgary, OBrien Inst Publ Hlth, Dept Med, Calgary, AB, Canada; [Stelfox, Henry T.] Univ Calgary, OBrien Inst Publ Hlth, Dept Community Hlth Sci, Calgary, AB, Canada; [Mehta, Sangeeta] Sinai Hlth Syst, Div Crit Care Med, Dept Med, Toronto, ON, Canada; [Mehta, Sangeeta] Sinai Hlth Syst, Div Crit Care Med, Interdept, Toronto, ON, Canada; [Mehta, Sangeeta] Univ Toronto, Toronto, ON, Canada; [Day, Andrew G.; Heyland, Daren K.] Kingston Gen Hosp, Clin Evaluat Res Unit, Kingston, ON, Canada; [Heyland, Daren K.] Queens Univ, Dept Crit Care Med, Kingston, ON, Canada		Heyland, DK (corresponding author), Kingston Gen Hosp, Clin Evaluat Res Unit, Kingston, ON, Canada.	dkh2@queensu.ca	Deane, Adam/AAF-7370-2020; Mehta, Sangeeta/C-4623-2015	Deane, Adam/0000-0002-7620-5577; Stelfox, Henry/0000-0003-1231-1490; Richards, Duncan/0000-0002-8093-7084			Alberda C, 2009, INTENS CARE MED, V35, P1728, DOI 10.1007/s00134-009-1567-4; Allingstrup MJ, 2012, CLIN NUTR, V31, P462, DOI 10.1016/j.clnu.2011.12.006; Berne JD, 2002, J TRAUMA, V53, P422, DOI 10.1097/00005373-200209000-00004; Blaser AR, 2015, CLIN NUTR, V34, P956, DOI 10.1016/j.clnu.2014.10.006; Cahill NE, 2010, CRIT CARE MED, V38, P395, DOI 10.1097/CCM.0b013e3181c0263d; Chapman MJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1420-4; Chapman MJ, 2013, CURR OPIN CLIN NUTR, V16, P209, DOI 10.1097/MCO.0b013e32835c1fa5; Deane A, 2010, CRIT CARE, V14, DOI 10.1186/cc9039; Deane AM, 2014, CRIT CARE MED, V42, P57, DOI 10.1097/CCM.0b013e318298a8af; Deane AM, 2012, AM J CLIN NUTR, V95, P1396, DOI 10.3945/ajcn.112.035691; Deane AM, 2009, CRIT CARE RESUSC, V11, P180; Deane AM, 2009, CRIT CARE RESUSC, V11, P132; DIVE A, 1995, CRIT CARE MED, V23, P1356, DOI 10.1097/00003246-199508000-00008; Fruhwald S, 2007, INTENS CARE MED, V33, P36, DOI 10.1007/s00134-006-0452-7; Gungabissoon U, 2015, JPEN-PARENTER ENTER, V39, P441, DOI 10.1177/0148607114526450; Herbert MK, 2008, CLIN NUTR, V27, P25, DOI 10.1016/j.clnu.2007.08.001; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Heyland DK, 2013, CRIT CARE MED, V41, P2743, DOI 10.1097/CCM.0b013e31829efef5; Heyland DK, 2011, CRIT CARE MED, V39, P2619, DOI 10.1097/CCM.0b013e318226641d; Heyland DK, 2011, CLIN NUTR, V30, P148, DOI 10.1016/j.clnu.2010.09.011; Heyland DK, 2010, JPEN-PARENTER ENTER, V34, P675, DOI 10.1177/0148607110364843; JANSSENS J, 1990, NEW ENGL J MED, V322, P1028, DOI 10.1056/NEJM199004123221502; Kar P, 2015, CLIN NUTR, V34, P557, DOI 10.1016/j.clnu.2014.11.003; MacLaren R, 2008, JPEN-PARENTER ENTER, V32, P412, DOI 10.1177/0148607108319803; Nguyen NQ, 2007, CRIT CARE MED, V35, P483, DOI 10.1097/01.CCM.0000253410.36492.E9; Reignier J, 2002, CRIT CARE MED, V30, P1237, DOI 10.1097/00003246-200206000-00012; Ritz MA, 2005, INTENS CARE MED, V31, P949, DOI 10.1007/s00134-005-2663-8; Stupak DP, 2012, J CLIN GASTROENTEROL, V46, P449, DOI 10.1097/MCG.0b013e31824e14c1; Taylor BE, 2016, CRIT CARE MED, V44, P390, DOI [10.1097/CCM.0000000000001525, 10.1177/0148607115621863]; van Zanten ARH, 2015, JPEN-PARENTER ENTER, V39, P763, DOI 10.1177/0148607114567711; Wei XJ, 2015, CRIT CARE MED, V43, P1569, DOI 10.1097/CCM.0000000000001000; Weijs PJM, 2012, JPEN-PARENTER ENTER, V36, P60, DOI 10.1177/0148607111415109	32	13	14	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0148-6071	1941-2444		JPEN-PARENTER ENTER	J. Parenter. Enter. Nutr.	JUL	2018	42	5					949	959		10.1002/jpen.1038			11	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	GM7GD	WOS:000438348900016	29957868	Green Published			2022-02-06	
J	Li, CY; Karmarkar, A; Adhikari, D; Ottenbacher, K; Kuo, YF				Li, Chih-Ying; Karmarkar, Amol; Adhikari, Deepak; Ottenbacher, Kenneth; Kuo, Yong-Fang			Effects of Age and Sex on Hospital Readmission in Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Age groups; Brain injuries; Long-term care; Patient readmission; Rehabilitation	OLDER-ADULTS; OUTCOMES; REHOSPITALIZATION; REHABILITATION; HEALTH; US	Objective: To investigate the effects of age and sex on 30-, 60-, and 90-day hospital readmission after acute hospital discharge for individuals with traumatic brain injury (TBI). Design: Retrospective cohort study. Setting: Acute hospitals and postacute discharge settings. Participants: Individuals (N=52,877) with Diagnosis Related Group codes of TBI, who were divided into 4 age groups: 18 to 40, 41 to 65, 66 to 75, and >= 76 years. Interventions: Not applicable. Main Outcome Measures: All-cause hospital readmission. Results: Sex differences in 30-, 60-, and 90-day hospital readmission were found among all age groups (P<.05 for all). The largest sex differences in hospital readmission were in the 2 oldest groups (66-75 and >= 76y). For both sexes, the oldest group (>= 76y) had the highest adjusted 90-day readmission risk (eg, 90-d readmission: odds ratio, 2.32 [95% confidence interval, 2.01-2.69] for men; odds ratio, 1.96 [95% confidence interval, 1.59-2.43] for women). Among those readmitted within 90 days, the youngest group (18-40y) had the highest cumulative readmission percentage (35% for both sexes) within the first week of hospital discharge. Conclusions: Age and sex were significantly associated with hospital readmission during the first 90 days postdischarge in our TBI sample. Specifically, those aged 66 to 75 or >= 76 years had the highest readmission risk over 90 days for both sexes. The findings suggest that clinicians should consider age and sex in discharge planning and for the entire episode of care for the population with TBI. (C) 2018 by the American Congress of Rehabilitation Medicine	[Li, Chih-Ying; Karmarkar, Amol; Ottenbacher, Kenneth] Univ Texas Med Branch, Sch Hlth Profess, Div Rehabil Sci, 301 Univ Blvd, Galveston, TX 77555 USA; [Adhikari, Deepak; Kuo, Yong-Fang] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA		Li, CY (corresponding author), Univ Texas Med Branch, Sch Hlth Profess, Div Rehabil Sci, 301 Univ Blvd, Galveston, TX 77555 USA.	chili@utmb.edu		Li, Chih-Ying/0000-0003-4817-554X	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90AR5009]; National Center for Medical Rehabilitation Research, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P2C HD065702, R01HD069443, K01HD086290]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P2CHD065702, K01HD086290, R01HD069443] Funding Source: NIH RePORTER	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (grant no. 90AR5009) and by the National Center for Medical Rehabilitation Research, National Institutes of Health (grant nos. P2C HD065702, R01HD069443, and K01HD086290).	Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, C TRAUM BRAIN INJ US; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Dhawan P, 2006, BCMJ, V9, P442; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Goodman D, 2013, REVOLVING DOOR REPOR; Hammond FM, 2015, ARCH PHYS MED REHAB, V96; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; HCUP, OV NAT READM DAT NRD; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Intiso D, 2017, EUR J PHYS REHAB MED, V53, P268, DOI 10.23736/S1973-9087.16.04288-X; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jensen PH, 2009, HEALTH ECON, V18, P1440, DOI 10.1002/hec.1435; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Marcoux J, 2016, CAN J NEUROL SCI, V26, P1; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Network for Excellence in Health Innovation, 2012, THINK OUTS PILLB IMP; Olufajo OA, 2016, AM J SURG, V211, P677, DOI 10.1016/j.amjsurg.2015.11.016; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Sethuraman KN, 2014, ACAD EMERG MED, V21, P1386, DOI 10.1111/acem.12536; Simpson GK, 2007, MED J AUSTRALIA, V187, P229, DOI 10.5694/j.1326-5377.2007.tb01206.x; Slocum C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142180; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; TUEL S M, 1992, Brain Injury, V6, P363, DOI 10.3109/02699059209034951; Turner-Stokes L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub3	29	13	13	1	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2018	99	7					1279	1288		10.1016/j.apmr.2017.12.006			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GL9JZ	WOS:000437552100004	29307813	Green Accepted			2022-02-06	
J	Nourallah, B; Zeiler, FA; Calviello, L; Smielewski, P; Czosnyka, M; Menon, DK				Nourallah, Basil; Zeiler, Frederick A.; Calviello, Leanne; Smielewski, Peter; Czosnyka, Marek; Menon, David K.			Critical thresholds for intracranial pressure vary over time in non-craniectomised traumatic brain injury patients	ACTA NEUROCHIRURGICA			English	Article						Neuromonitoring; Neurocritical care; Traumatic brain injury; Threshold; Intracranial pressure; Cerebral perfusion pressure	CEREBRAL PERFUSION-PRESSURE; CEREBROVASCULAR REACTIVITY; MORTALITY; IMPACT	Intracranial pressure (ICP)- and cerebral perfusion pressure (CPP)-guided therapy is central to neurocritical care for traumatic brain injury (TBI) patients. We sought to identify time-dependent critical thresholds for mortality and unfavourable outcome for ICP and CPP in non-craniectomised TBI patients. This is a retrospective cohort study of 355 patients with moderate-to-severe TBI who received ICP monitoring and were managed without decompressive craniectomy in a tertiary hospital neurocritical care unit. Patients were grouped in 2 x 2 tables according to survival/death or favourable/unfavourable outcomes at 6 months and serial thresholds of mean ICP and CPP, using increments of 0.1 and 0.5 mmHg respectively. Sequential chi-square analysis was performed, and the thresholds yielding the highest chi-square test statistic were taken as having the best discriminative value for outcome. This process was repeated over monitoring periods of 1, 3, 5 and 7 days and for each day of recording to establish time-dependent thresholds. The same analysis was performed for age and sex subgroups. Global ICP thresholds were 21.3 and 20.5 mmHg for mortality and unfavourable outcome respectively (p < 0.001). After the first day of ICP monitoring, ICP thresholds fell to between 15 and 20 mmHg and remained significant (p < 0.05). Significant time-dependent CPP thresholds for mortality or unfavourable outcome were often not identified, and no identifiable trends were produced. Critical ICP thresholds in non-craniectomised TBI patients vary with time and fall below established ICP targets after the first day of monitoring.	[Nourallah, Basil; Zeiler, Frederick A.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Calviello, Leanne; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Sect Brain Phys, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Nourallah, B (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England.	basilnourallah@gmail.com; umzeiler@myumanitoba.ca; lac76@cam.ac.uk; ps10011@cam.ac.uk; mc141@medschl.cam.ac.uk; dkm13@cam.ac.uk		Zeiler, Frederick/0000-0003-1737-0510; czosnyka, marek/0000-0003-2446-8006	Cambridge Commonwealth Trust Scholarship; Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery; University of Manitoba Clinician Investigator Program; National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Senior Investigator Award; European Union Framework Program 7 grant (CENTER-TBI) [602150]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea [HI17C1790]	This work was made possible through salary support through the Cambridge Commonwealth Trust Scholarship, the Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery and the University of Manitoba Clinician Investigator Program.; These studies were supported by the National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Senior Investigator Award to DKM. The authors were also supported by a European Union Framework Program 7 grant (CENTER-TBI; Grant Agreement No. 602150).; MC is supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI17C1790).	Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Calviello L, 2017, NEUROCRIT CARE, P1; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Maas AI, 2014, NEUROSURGERY, V76, P67; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; National Research Ethics Service, 2012, CHANG REM RES ETH CO; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Sauvigny T, 2017, J NEUROSURG, P1; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; UK Health Departments, 2011, GOV ARR RES ETH COMM; Vik A, 2008, RELATIONSHIP DOSE IN; Zeiler FA, 2018, J NEUROTRAUM, V35, P314, DOI 10.1089/neu.2017.5364	27	13	13	0	6	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2018	160	7					1315	1324		10.1007/s00701-018-3555-3			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GJ0XT	WOS:000434978600003	29732476	Green Published, hybrid			2022-02-06	
J	Ozinga, SJ; Linder, SM; Miller, M; Dey, T; Figler, R; Russman, AN; So, R; Rosenthal, AH; Cruickshank, J; Alberts, JL				Ozinga, Sarah J.; Linder, Susan M.; Miller, Mandy; Dey, Tanujit; Figler, Richard; Russman, Andrew N.; So, Richard; Rosenthal, Alan H.; Cruickshank, Jason; Alberts, Jay L.			Normative Performance on the Balance Error Scoring System by Youth, High School, and Collegiate Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						postural stability; concussion; reference values; motor control	SPORT-RELATED CONCUSSION; MILD HEAD-INJURY; POSTURAL STABILITY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; FOOTBALL PLAYERS; CHILDREN; ADOLESCENTS; ASSESSMENTS; MATURATION	Context: Annually, more than 1 million youth athletes in the United States receive or are suspected of receiving a concussion. The Balance Error Scoring System (BESS) is the most commonly used clinical balance evaluation designed to provide a better understanding of the motor-control processes of individuals with concussion. Despite the widespread use of the BESS, a fundamental gap exists in applying this tool to young athletes, as normative values are lacking for this population. Objective: To determine age- and sex-specific normative values for the BESS in youth, high school, and collegiate athletes. Design: Cross-sectional study. Setting: Local youth sport organizations, high schools, and colleges. Patients or Other Participants: Student-athletes (N = 6762) completed preseason baseline concussion testing as part of a comprehensive concussion-management program. Groups were youth males aged 5 to 13 years (n = 360), high school males aged 14 to 18 years (n = 3743), collegiate males aged 19 to 23 years (n = 497), youth females aged 5 to 13 years (n = 246), high school females aged 14 to 18 years (n = 1673), and collegiate females aged 19 to 23 years (n = 243). Main Outcome Measure(s): Errors according to the BESS specifications. Results: Performance on the BESS was worse (P < .01) in youth athletes than in high school and collegiate athletes. In the youth and high school cohorts, females exhibited better scores than males (P < .05). Sex was not a factor for collegiate athletes. Data from the youth cohort were further subdivided into 4-year bins to evaluate potential motor-development differences. The error count was highest for 5- to 9-year-old males and decreased with age. Conclusions: Performance on the BESS depended on sex and age, particularly in youth athletes. These sex- and age-specific normative values provide a reference to facilitate and unify clinical decision making across multiple providers caring for youth athletes with concussions.	[Ozinga, Sarah J.; Linder, Susan M.; Miller, Mandy; Alberts, Jay L.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Linder, Susan M.; Figler, Richard; Russman, Andrew N.; Cruickshank, Jason; Alberts, Jay L.] Cleveland Clin, Concuss Ctr, Cleveland, OH 44195 USA; [Dey, Tanujit] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Figler, Richard] Cleveland Clin, Orthoped & Rheumatol Inst, Cleveland, OH 44195 USA; [So, Richard; Rosenthal, Alan H.] Cleveland Clin, Pediat Inst, Cleveland, OH 44195 USA		Alberts, JL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, 9500 Euclid Ave, Cleveland, OH 44195 USA.	albertj@ccf.org			Edward and Barbara Bell endowed chair	This study was supported by The Edward and Barbara Bell endowed chair (Dr Alberts).	Alsalaheen B, 2016, BRAIN INJURY, V30, P914, DOI 10.3109/02699052.2016.1146965; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cohen J., 2013, STAT POWER ANAL BEHA; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gosselin G, 2015, CHIROPR MAN THER, V23, DOI 10.1186/s12998-014-0045-4; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hansen C, 2016, CLIN J SPORT MED, V26, P497, DOI 10.1097/JSM.0000000000000285; HIRABAYASHI S, 1995, BRAIN DEV-JPN, V17, P111, DOI 10.1016/0387-7604(95)00009-Z; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; Khanna NK, 2015, SPORTS HEALTH, V7, P341, DOI 10.1177/1941738115571508; Liu B, 2008, FRONT MED-PRC, V2, P361; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; NASHNER LM, 1990, NEUROL CLIN, V8, P331, DOI 10.1016/S0733-8619(18)30359-1; Olson B., 2012, 46 ANN CAN ATHL THER; Pawlowski B, 2003, AM J HUM BIOL, V15, P144, DOI 10.1002/ajhb.10136; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; PILLAI KCS, 1955, ANN MATH STAT, V26, P117, DOI 10.1214/aoms/1177728599; Rajyaguru, 2015, INT J NEW TECHNOL SC, V2, P22, DOI DOI 10.1109/ISIT.2014.6875215; RIACH CL, 1987, DEV MED CHILD NEUROL, V29, P650; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Zimmer A, 2013, J ATHL TRAINING, V48, P659, DOI 10.4085/1062-6050-48.5.06	41	13	13	1	7	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2018	53	7					636	645		10.4085/1062-6050-129-17			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GS8PB	WOS:000443973200003	30109948	gold, Green Published			2022-02-06	
J	Gumustas, S; Tosun, HB; Isyar, M; Serbest, S; Oznam, K; Bulut, G				Gumustas, Seyitali; Tosun, Haci Bayram; Isyar, Mehmet; Serbest, Sancar; Oznam, Kadir; Bulut, Guven			Femur neck fracture in young adults, is it really an urgent surgery indication: retrospective clinical study	PAN AFRICAN MEDICAL JOURNAL			English	Article						Timing of surgery; femoral neck fractures; internal determination; complication	FEMORAL-NECK; DELAYED FIXATION; INTRACAPSULAR FRACTURES; SUBCAPITAL FRACTURES; INTERNAL-FIXATION; SCREW FIXATION; OPEN REDUCTION; HIP-FRACTURES; FOLLOW-UP; MANAGEMENT	Introduction: Femur neck fracture comprises a significant part of intracapsular femur fracture in the intracapsular area of proximal femur and it is mostly seen in elder people. However, these kinds of fractures may be seen in young adults. The present study aims to search factors that affect femoral neck fractures in young adults after surgery carried out by internal determination method. Methods: Files of patients who were applied internal determination through closed reduction and cannulated screw because of intracapsular femur neck fractures between 2010 and 2015 were analyzed retrospectively. Fractures were evaluated by means of Garden classification, which is based on radiological appearance. The cases were examined in terms of timing of surgery in two groups. Cases operated in the first 24 hours after trauma consisted of group 1 and after 24 hours group 2. Radiological staging in femoral head avascular necrosis was evaluated by ficat-Arlet classification system whereas acetabular fractures and hip functionality was evaluated by Letournel and Judet system, which is based on direct graph of fracture line. Results: Mean age at the time of surgery for 31 cases included in the study was 40.04 9.63 year. The average duration from injury to surgery was 6.6 (1-20) days. Thirty nine percent of fractures was nondisplaced whereas 61% was displaced. The average follow-up period was 4.9 1.35 years. The rate of nonunion was found 16% and femoral head avascular necrosis 6.4%. According to Judet System, 67.7% of cases showed excellent/good and 32.3% moderate/bad functional results. Six cases had a secondary surgery. Cases who had displaced fractures statistically showed worse functional results and underwent more secondary surgery than patients with nondisplaced fractures (P>0.05). As a result of logistic regression analysis, presence of displacement was a factor negatively affecting the judet score but did not affect the rate of complication. There were no significant differences between the two groups according to the surgical timing in terms of functional outcomes and complications. Conclusion: Because of surgical treatment of femoral neck fractures in the first 24 hours does not affect functional outcomes and complication rate, surgery is recommended in optimal conditions. In the case of displacement, care must be taken in terms of poor functional results.	[Gumustas, Seyitali; Bulut, Guven] Dr Lutfi Kirdar Kartal Training & Res Hosp, Dept Orthopaed & Traumatol, Istanbul, Turkey; [Tosun, Haci Bayram] Adiyaman Univ, Fac Med, Dept Orthopaed & Traumatol, Adiyaman, Turkey; [Isyar, Mehmet] Med Pk Bahcelievler, Dept Orthopaed & Traumatol, Istanbul, Turkey; [Serbest, Sancar] Kirikkale Univ, Fac Med, Dept Orthopaed & Traumatol, Kirikkale, Turkey; [Oznam, Kadir] Istanbul Medipol Univ, Sch Med, Dept Orthopaed & Traumatol, TR-34214 Istanbul, Turkey		Tosun, HB (corresponding author), Adiyaman Univ, Fac Med, Dept Orthopaed & Traumatol, Adiyaman, Turkey.						Al-Ani AN, 2013, ACTA ORTHOP, V84, P54, DOI 10.3109/17453674.2013.765639; Bachiller FGC, 2002, CLIN ORTHOP RELAT R, P87; BARNES R, 1976, J BONE JOINT SURG BR, V58, P2, DOI 10.1302/0301-620X.58B1.1270491; BRAUN W, 1991, UNFALLCHIRURG, V94, P325; Butt MF, 2008, INJURY, V39, P238, DOI 10.1016/j.injury.2007.09.002; COBB AG, 1986, INJURY, V17, P259, DOI 10.1016/0020-1383(86)90232-9; Damany DS, 2005, INJURY, V36, P131, DOI 10.1016/j.injury.2004.05.023; Elmi A, 2013, TRAUMA MON, V18, P8, DOI 10.5812/traumamon.11275; FICAT RP, 1985, J BONE JOINT SURG BR, V67, P3, DOI 10.1302/0301-620X.67B1.3155745; Forsh DA, 2012, CURR REV MUSCULOSKE, V5, P214, DOI 10.1007/s12178-012-9127-x; GARDEN RS, 1961, J BONE JOINT SURG BR, V43, P647, DOI 10.1302/0301-620X.43B4.647; Gautam VK, 1998, INJURY, V29, P215, DOI 10.1016/S0020-1383(97)00184-8; Haidukewych GJ, 2004, J BONE JOINT SURG AM, V86A, P1711, DOI 10.2106/00004623-200408000-00015; Heetveld MJ, 2009, J ORTHOP TRAUMA, V23, P395, DOI 10.1097/BOT.0b013e318176147d; Helin M, 2015, ORTHOP TRAUMATOL-SUR, V101, P45, DOI 10.1016/j.otsr.2014.11.009; Higgins G A, 2004, Hip Int, V14, P244, DOI 10.5301/HIP.2008.1656; Jain R, 2002, J BONE JOINT SURG AM, V84A, P1605, DOI 10.2106/00004623-200209000-00013; JUDET R, 1952, J BONE JOINT SURG BR, V34, P173; KELLER CS, 1980, CLIN ORTHOP RELAT R, P131; Kuner E. H., 1995, Unfallchirurg, V98, P251; Liu C, 2015, CHINESE MED J-PEKING, V128, P483, DOI 10.4103/0366-6999.151092; Ly TV, 2008, INDIAN J ORTHOP, V42, P3, DOI 10.4103/0019-5413.38574; Parker MJ, 2007, CLIN ORTHOP RELAT R, P175, DOI 10.1097/BLO.0b013e3180325a42; Parker MJ, 2000, J BONE JOINT SURG BR, V82B, P937, DOI 10.1302/0301-620X.82B7.11595; RAGNARSSON JI, 1993, CLIN ORTHOP RELAT R, P30; Razik F, 2012, INT ORTHOP, V36, P2127, DOI 10.1007/s00264-012-1619-1; Riaz O, 2016, ANN ROY COLL SURG, V98, P376, DOI 10.1308/rcsann.2016.0124; Rickman M, 2014, CLIN ORTHOP RELAT R, V472, P3375, DOI 10.1007/s11999-014-3467-3; Roshan A, 2008, CLIN MED RES, V6, P33, DOI 10.3121/cmr.2008.752; Schweitzer Daniel, 2013, Eur J Orthop Surg Traumatol, V23, P61, DOI 10.1007/s00590-011-0936-1; Scolaro JA, 2010, U PENNSYLVANIA ORTHO, V20, P5; Shah AK, 2002, CLIN ORTHOP RELAT R, P28; Slobogean GP, 2015, INJURY, V46, P435, DOI 10.1016/j.injury.2014.11.028; Slobogean GP, 2015, INJURY, V46, P484, DOI 10.1016/j.injury.2014.10.010; Smektala R, 2014, UNFALLCHIRURG, V117, P1012, DOI 10.1007/s00113-013-2422-1; Sprague S, 2015, INJURY, V46, P507, DOI 10.1016/j.injury.2014.11.020; SWIONTKOWSKI MF, 1994, J BONE JOINT SURG AM, V76A, P129, DOI 10.2106/00004623-199401000-00019; Tarantino U, 2011, AGING CLIN EXP RES, V23, P25; Thein R, 2014, J ORTHOP TRAUMA, V28, P70, DOI 10.1097/BOT.0b013e3182a225fa; Upadhyay A, 2004, J BONE JOINT SURG BR, V86B, P1035, DOI 10.1302/0301-620X.86B7.15047; Varghese VD, 2016, WORLD J ORTHOP, V7, P301, DOI 10.5312/wjo.v7.i5.301; Verma R, 2010, ORTHOPEDICS, V33; Vertelis Arunas, 2002, Medicina (Kaunas), V38, P505; Ye Y, 2015, ORTHOPEDICS, V38, P625, DOI 10.3928/01477447-20151002-05	44	13	14	0	5	AFRICAN FIELD EPIDEMIOLOGY NETWORK-AFENET	KAMPALA	PO BOX 12874, KAMPALA, 00000, UGANDA	1937-8688			PAN AFR MED J	Pan Afr. Med. J.	JUN 12	2018	30								112	10.11604/pamj.2018.30.112.13643			7	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	GM0WW	WOS:000437781600002	30364439	gold, Green Published, Green Submitted			2022-02-06	
J	Gilbert, N; Bernier, RA; Calhoun, VD; Brenner, E; Grossner, E; Rajtmajer, SM; Hillary, FG				Gilbert, Nicholas; Bernier, Rachel A.; Calhoun, Vincent D.; Brenner, Einat; Grossner, Emily; Rajtmajer, Sarah M.; Hillary, Frank G.			Diminished neural network dynamics after moderate and severe traumatic brain injury	PLOS ONE			English	Article							PROCESSING SPEED DEFICITS; WORKING-MEMORY; FUNCTIONAL CONNECTIVITY; ATTENTION DEFICITS; COGNITIVE-CONTROL; FMRI; SEGMENTATION; REGIONS; MRI	Over the past decade there has been increasing enthusiasm in the cognitive neurosciences around using network science to understand the system-level changes associated with brain disorders. A growing literature has used whole-brain fMRI analysis to examine changes in the brain's subnetworks following traumatic brain injury (TBI). Much of network modeling in this literature has focused on static network mapping, which provides a window into gross inter-nodal relationships, but is insensitive to more subtle fluctuations in network dynamics, which may be an important predictor of neural network plasticity. In this study, we examine the dynamic connectivity with focus on state-level connectivity (state) and evaluate the reliability of dynamic network states over the course of two runs of intermittent task and resting data. The goal was to examine the dynamic properties of neural networks engaged periodically with task stimulation in order to determine: 1) the reliability of inter-nodal and network-level characteristics over time and 2) the transitions between distinct network states after traumatic brain injury. To do so, we enrolled 23 individuals with moderate and severe TBI at least 1-year post injury and 19 age-and education-matched healthy adults using functional MRI methods, dynamic connectivity modeling, and graph theory. The results reveal several distinct network "states" that were reliably evident when comparing runs; the overall frequency of dynamic network states are highly reproducible (r-values>0.8) for both samples. Analysis of movement between states resulted in fewer state transitions in the TBI sample and, in a few cases, brain injury resulted in the appearance of states not exhibited by the healthy control (HC) sample. Overall, the findings presented here demonstrate the reliability of observable dynamic mental states during periods of on-task performance and support emerging evidence that brain injury may result in diminished network dynamics.	[Gilbert, Nicholas; Bernier, Rachel A.; Brenner, Einat; Grossner, Emily; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Gilbert, Nicholas; Bernier, Rachel A.; Brenner, Einat; Grossner, Emily; Hillary, Frank G.] Social & Life & Engn Sci Imaging Ctr, University Pk, PA 16802 USA; [Calhoun, Vincent D.] Mind Res Network, Albuquerque, NM USA; [Calhoun, Vincent D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Rajtmajer, Sarah M.] Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA; [Hillary, Frank G.] Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA		Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, University Pk, PA 16802 USA.; Hillary, FG (corresponding author), Social & Life & Engn Sci Imaging Ctr, University Pk, PA 16802 USA.; Hillary, FG (corresponding author), Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021	Bernier, Rachel/0000-0002-2759-9186	National Center for Advancing Translational Sciences, NIHUL [Tr000127]; Social Life and Engineering Sciences imaging Center; Social Sciences Research Institute at the Pennsylvania state; University, University Park, PA, USA; Quantitative Science Solutions (QS2); National Center for Advancing Translational Sciences, NIHUL through the Clinical Translational Science Institute [Tr000127]	This research was supported by the National Center for Advancing Translational Sciences, NIHUL Tr000127, the Social Life and Engineering Sciences imaging Center and the Social Sciences Research Institute at the Pennsylvania state and the University, University Park, PA, 16801, USA to FGH. Quantitative Science Solutions (QS2) provided support in the form of salary for one author (SMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We want to thank Dr. Arnab Roy for his support of this work and for his mentorship of the first author during analysis and manuscript preparation. This research was supported by the National Center for Advancing Translational Sciences, NIHUL Tr000127 through the Clinical Translational Science Institute, the Social Life and Engineering Sciences imaging Center and the Social Sciences Research Institute at the Pennsylvania state and the University, University Park, PA, 16801, USA.	Allen E. A., 2012, CEREB CORTEX; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; [Anonymous], 2009, HUM BRAIN MAPP; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; BERNIER RA, 2017, FRONT NEUROL, V8; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Caeyenberghs K., 2016, NEUROIMAGE; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Genova HM, 2009, J INT NEUROPSYCH SOC, V15, P383, DOI 10.1017/S1355617709090535; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Goni J, 2014, P NATL ACAD SCI USA, V111, P833, DOI 10.1073/pnas.1315529111; Gu S, 2017, NEUROIMAGE; Hallquist MN, 2018, NETW NEUROSCI, V3, P1, DOI 10.1162/netn_a_00054; Hillary FG, 2014, BRAIN IMAGING BEHAV, V8, P435, DOI 10.1007/s11682-012-9205-0; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2017, TRENDS COGN SCI; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Hutchison RM, 2013, HUM BRAIN MAPP, V34, P2154, DOI 10.1002/hbm.22058; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jones DT, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039731, 10.1371/journal.pone.0044294]; Lindquist MA, 2008, HUM BRAIN MAPP, V29, P1276, DOI 10.1002/hbm.20475; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Manktelow AE, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00058; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Medaglia JD, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00407; Medaglia JD, 2011, NETWORK-COMP NEURAL, V22, P148, DOI 10.3109/09638237.2011.639604; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Nenadovic V, 2008, J NEUROTRAUM, V25, P615, DOI 10.1089/neu.2007.0474; Nugent AC, 2015, J CEREBR BLOOD F MET, V35, P583, DOI 10.1038/jcbfm.2014.228; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Poldrack RA, 2016, ANNU REV PSYCHOL, V67, P587, DOI 10.1146/annurev-psych-122414-033729; Rabinowitz AR, 2013, NEUROPSYCHOLOGY, V27, P481, DOI 10.1037/a0033023; Raja Beharelle A, 2012, NEUROIMAGE, V60, P1528, DOI 10.1016/j.neuroimage.2012.01.037; Rajtmajer SM, 2015, FRONT NEUROANAT, V9, DOI [10.3389/fnana.7015.00097, 10.3389/fnana.2015.00097]; Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170541; Roy A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00146; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; SCHMAHMANN JD, 1991, ARCH NEUROL-CHICAGO, V48, P1178, DOI 10.1001/archneur.1991.00530230086029; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2017, EXP BRAIN RES, V235, P799, DOI 10.1007/s00221-016-4841-z; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; TEASDALE G, 1974, LANCET, V2, P81; Telesford QK, 2016, NEUROIMAGE, V142, P188, DOI 10.1016/j.neuroimage.2016.05.078; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Vergara VM, 2017, NEUROIMAGE, V145, P365, DOI 10.1016/j.neuroimage.2016.03.038; Zamora-Lopez G, 2010, FRONT NEUROINFORM, V4	68	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0197419	10.1371/journal.pone.0197419			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI7ZT	WOS:000434728100005	29883447	Green Published, gold, Green Submitted			2022-02-06	
J	de Rooij, R; Kuhl, E				de Rooij, Rijk; Kuhl, Ellen			Physical Biology of Axonal Damage	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						tau protein; microtubules; slip bonds; diffuse axonal injury; neurodegeneration; multiscale modeling; finite element analysis	CHRONIC TRAUMATIC ENCEPHALOPATHY; MICROTUBULE DYNAMICS; TAU PROTEINS; HUMAN HEAD; IN-VIVO; INJURY; BRAIN; MODEL; NEURONS; ADHESION	Excessive physical impacts to the head have direct implications on the structural integrity at the axonal level. Increasing evidence suggests that tau, an intrinsically disordered protein that stabilizes axonal microtubules, plays a critical role in the physical biology of axonal injury. However, the precise mechanisms of axonal damage remain incompletely understood. Here we propose a biophysical model of the axon to correlate the dynamic behavior of individual tau proteins under external physical forces to the evolution of axonal damage. To propagate damage across the scales, we adopt a consistent three-step strategy: First, we characterize the axonal response to external stretches and stretch rates for varying tau crosslink bond strengths using a discrete axonal damage model. Then, for each combination of stretch rates and bond strengths, we average the axonal force-stretch response of n = 10 discrete simulations, from which we derive and calibrate a homogenized constitutive model. Finally, we embed this homogenized model into a continuum axonal damage model of [1-d]-type in which d is a scalar damage parameter that is driven by the axonal stretch and stretch rate. We demonstrate that axonal damage emerges naturally from the interplay of physical forces and biological crosslinking. Our study reveals an emergent feature of the crosslink dynamics: With increasing loading rate, the axonal failure stretch increases, but axonal damage evolves earlier in time. For a wide range of physical stretch rates, from 0.1 to 10/s, and biological bond strengths, from 1 to 100 pN, our model predicts a relatively narrow window of critical damage stretch thresholds, from 1.01 to 1.30, which agrees well with experimental observations. Our biophysical damage model can help explain the development and progression of axonal damage across the scales and will provide useful guidelines to identify critical damage level thresholds in response to excessive physical forces.	[de Rooij, Rijk; Kuhl, Ellen] Stanford Univ, Dept Mech Engn & Bioengn, Stanford, CA 94305 USA		Kuhl, E (corresponding author), Stanford Univ, Dept Mech Engn & Bioengn, Stanford, CA 94305 USA.	ekuhl@stanford.edu	Kuhl, Ellen/G-4444-2011	Kuhl, Ellen/0000-0002-6283-935X	Stanford Graduate FellowshipStanford University; Stanford Bio-X IIP seed grant Molecular Mechanisms of Chronic Traumatic Encephalopathy; NSFNational Science Foundation (NSF) [CMMI 1727268]	This study was supported by the Stanford Graduate Fellowship to RdR and by the Stanford Bio-X IIP seed grant Molecular Mechanisms of Chronic Traumatic Encephalopathy and the NSF grant CMMI 1727268 Understanding Neurodegeneration across the Scales to EK.	Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Beatty MF, 2000, Z ANGEW MATH PHYS, V51, P984; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BRAY D, 1981, J NEUROCYTOL, V10, P589, DOI 10.1007/BF01262592; Budday S, 2017, ACTA BIOMATER, V60, P315, DOI 10.1016/j.actbio.2017.06.024; Caminiti R, 2013, J NEUROSCI, V33, P14501, DOI 10.1523/JNEUROSCI.0761-13.2013; Choi MC, 2017, BBA-GEN SUBJECTS, V1861, P3456, DOI 10.1016/j.bbagen.2016.09.011; Chung PJ, 2015, P NATL ACAD SCI USA, V112, pE6416, DOI 10.1073/pnas.1513172112; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Coles CH, 2015, CURR BIOL, V25, pR677, DOI 10.1016/j.cub.2015.06.020; De Borst R., 1993, Engineering Computations, V10, P99; de Rooij R, 2017, COMPUT MECH, V59, P523, DOI 10.1007/s00466-016-1359-y; de Rooij R, 2018, BIOPHYS J, V114, P201, DOI 10.1016/j.bpj.2017.11.010; de Rooij R, 2016, APPL MECH REV, V68, DOI 10.1115/1.4032436; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Eisenberg DS, 2017, NATURE, V547, P170, DOI 10.1038/nature23094; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Fan A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13830-1; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Garcia-Grajales JA, 2017, COMPUT METHOD APPL M, V314, P147, DOI 10.1016/j.cma.2016.07.032; Geers M.G.D., 1994, DIANA COMPUT MECH, V94, P127; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Goriely A, 2015, ADV APPL MECH, V48, P79, DOI 10.1016/bs.aams.2015.10.002; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; HAAK RA, 1976, J PHYSIOL-LONDON, V263, P115, DOI 10.1113/jphysiol.1976.sp011624; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; Howard J., 2001, MECH MOTOR PROTEINS, Vfirst; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Hyland C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04961; Igaev M, 2014, BIOPHYS J, V107, P2567, DOI 10.1016/j.bpj.2014.09.016; Jakobs M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00441; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kachanov L.M., 1986, INTRO CONTINUUM DAMA; Kadavath H, 2015, ANGEW CHEM INT EDIT, V54, P10347, DOI 10.1002/anie.201501714; Kirkcaldie MTK, 2016, J CHEM NEUROANAT, V76, P9, DOI 10.1016/j.jchemneu.2016.05.006; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Krieg M, 2017, ELIFE, V6, DOI [10.7554/eLife.20172, 10.7554/elife.20172]; Kuhl E, 2000, COMPUT METHOD APPL M, V183, P87, DOI 10.1016/S0045-7825(99)00213-3; Kuo C, 2017, J NEUROTRAUM, V34, P3198, DOI 10.1089/neu.2016.4893; Lazarus C, 2015, BIOPHYS J, V109, P231, DOI 10.1016/j.bpj.2015.06.029; Lemaitre J., 1992, COURSE DAMAGE MECH; Li WG, 2016, J MED BIOL ENG, V36, P285, DOI 10.1007/s40846-016-0132-1; Li XH, 2015, J AM CHEM SOC, V137, P9218, DOI 10.1021/jacs.5b04561; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Marini G, 2012, INT J NUMER METH BIO, V28, P87, DOI 10.1002/cnm.1472; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; O'Toole M, 2008, BIOPHYS J, V94, P2610, DOI 10.1529/biophysj.107.117424; O'Toole M, 2015, BIOPHYS J, V108, P1027, DOI 10.1016/j.bpj.2015.01.021; Ouyang H, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-21; Peerlings RHJ, 2001, INT J SOLIDS STRUCT, V38, P7723, DOI 10.1016/S0020-7683(01)00087-7; Pereira LF, 2017, ENG FRACT MECH, V176, P281, DOI 10.1016/j.engfracmech.2017.03.048; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Rajagopalan J, 2010, BIOPHYS J, V99, P3208, DOI 10.1016/j.bpj.2010.09.029; Recho P, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.032410; Roberts K, 2014, MOL BIOL CELL, V6th; Singh A., 2016, STAPP CAR CRASH J, V50, P601; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tofangchi A, 2016, BIOPHYS J, V111, P1519, DOI 10.1016/j.bpj.2016.08.024; van den Bedem H, 2017, CURR OPIN BIOMED ENG, V1, P23, DOI 10.1016/j.cobme.2017.02.003; van den Bedem H, 2015, BIOPHYS J, V109, P2215, DOI 10.1016/j.bpj.2015.10.020; Vemu A, 2016, J BIOL CHEM, V291, P12907, DOI 10.1074/jbc.C116.731133; Verhulst PF., 1845, NOUV MDM ACAD R SCI, V18, P1; Wegmann S, 2011, J BIOL CHEM, V286, P20512, DOI 10.1074/jbc.M111.237875; Weickenmeier J, 2017, COMPUT METHOD APPL M, V314, P180, DOI 10.1016/j.cma.2016.08.011; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040; Weisbecker H, 2012, J MECH BEHAV BIOMED, V12, P93, DOI 10.1016/j.jmbbm.2012.03.012; Woerman AL, 2016, P NATL ACAD SCI USA, V113, pE8187, DOI 10.1073/pnas.1616344113; YU WQ, 1994, J NEUROSCI, V14, P2818; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	86	13	13	0	13	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	JUN 6	2018	12								144	10.3389/fncel.2018.00144			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GI3XU	WOS:000434306200001	29928193	gold, Green Published			2022-02-06	
J	Dhall, SS; Haefeli, J; Talbott, JF; Ferguson, AR; Readdy, WJ; Bresnahan, JC; Beattie, MS; Pan, JZ; Manley, GT; Whetstone, WD				Dhall, Sanjay S.; Haefeli, Jenny; Talbott, Jason F.; Ferguson, Adam R.; Readdy, William J.; Bresnahan, Jacqueline C.; Beattie, Michael S.; Pan, Jonathan Z.; Manley, Geoffrey T.; Whetstone, William D.			Motor Evoked Potentials Correlate With Magnetic Resonance Imaging and Early Recovery After Acute Spinal Cord Injury	NEUROSURGERY			English	Article						Spinal cord injury; Evoked potentials; Intraoperative monitoring; BASIC score	SCOLIOSIS SURGERY; STIMULATION; IMPAIRMENT; SEVERITY	BACKGROUND: While the utilization of neurophysiologic intraoperative monitoring with motor evoked potentials (MEPs) has become widespread in surgery for traumatic spine fractures and spinal cord injury (SCI), clinical validation of its diagnostic and therapeutic benefit has been limited. OBJECTIVE: To describe the use of intraoperative MEP at a large level I trauma center and assess the prognostic capability of this technology. METHODS: The SCI REDCap database at our institution, a level I traumacenter, was queried for acute cervical SCI patients who underwent surgery with intraoperative monitoring between 2005 and 2011, yielding 32 patients. Of these, 23 patients had severe SCI (association impairment scale [AIS] A, B, C). We assessed preoperative and postoperative SCI severity (AIS grade), surgical data, use of steroids, and early magnetic resonance imaging (MRI) findings (preoperatively in 27 patients), including axial T2 MRI grade (Brain and Spinal Injury Center score). RESULTS: The presence of MEPs significantly predicted AIS at discharge (P<.001). In the group of severe SCI (ie, AIS A, B, C) patients with elicitable MEPs, AIS improved by an average of 1.5 grades (median = 1), as compared to the patients without elicitable MEP who improved on average 0.5 grades (median = 0, P<.05). In addition, axial MRI grade significantly correlated with MEP status. Patients without MEPs had a significantly higher axial MRI grade in comparison to the patients with MEPs (P<.001). CONCLUSION: In patients with severe SCI, MEPs predicted neurological improvement and correlated with axial MRI grade. These significant findings warrant future prospective studies of MEPs as a prognostic tool in SCI.	[Dhall, Sanjay S.; Haefeli, Jenny; Ferguson, Adam R.; Readdy, William J.; Bresnahan, Jacqueline C.; Beattie, Michael S.; Manley, Geoffrey T.; Whetstone, William D.] Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus Ave,Rm M-779, San Francisco, CA 94143 USA; [Dhall, Sanjay S.; Haefeli, Jenny; Talbott, Jason F.; Ferguson, Adam R.; Bresnahan, Jacqueline C.; Beattie, Michael S.; Pan, Jonathan Z.; Manley, Geoffrey T.] San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [Dhall, Sanjay S.; Haefeli, Jenny; Talbott, Jason F.; Ferguson, Adam R.; Readdy, William J.; Bresnahan, Jacqueline C.; Beattie, Michael S.; Pan, Jonathan Z.; Manley, Geoffrey T.; Whetstone, William D.] Transforming Res & Clin Knowledge Spinal Cord Inj, San Francisco, CA USA; [Talbott, Jason F.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Ferguson, Adam R.] SF VA Med Ctr, Dept Neurol Surg, San Francisco, CA USA; [Pan, Jonathan Z.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Whetstone, William D.] ZSFGH Emergency Ctr Neurocrit Emergencies, Dept Emergency Med, San Francisco, CA USA		Dhall, SS (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus Ave,Rm M-779, San Francisco, CA 94143 USA.	sanjaydhall@gmail.com	Beattie, Michael S/A-8953-2009	Ferguson, Adam/0000-0001-7102-1608	Department of Defense CDMRP award [SC120259]; Craig H. Nielsen Foundation	Partial support provided by Department of Defense CDMRP award SC120259 (MSB, GTM, JCB, WDW, ARF) and the Craig H. Nielsen Foundation (JH). The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Bozzo A, 2011, J NEUROTRAUM, V28, P1401, DOI 10.1089/neu.2009.1236; CALANCIE B, 1991, J NEUROSURG, V74, P897, DOI 10.3171/jns.1991.74.6.0897; Castellon AT, 2009, SPINE, V34, P2662, DOI 10.1097/BRS.0b013e3181bf151b; Consortium Spinal Cord Med, 2008, J SPINAL CORD MED, V31, P403; Costa P, 2014, SPINAL CORD, V52, P749, DOI 10.1038/sc.2014.138; Curt A, 1998, ARCH PHYS MED REHAB, V79, P81, DOI 10.1016/S0003-9993(98)90213-1; Davey NJ, 1999, EXP BRAIN RES, V127, P382, DOI 10.1007/s002210050806; Ellaway PH, 2007, J REHABIL RES DEV, V44, P69, DOI 10.1682/JRRD.2005.08.0140; FEHLINGS MG, 1989, ELECTROEN CLIN NEURO, V74, P241, DOI 10.1016/0168-5597(89)90055-5; Flanders AE, 1996, RADIOLOGY, V201, P649, DOI 10.1148/radiology.201.3.8939210; FORBES HJ, 1991, J BONE JOINT SURG BR, V73, P487, DOI 10.1302/0301-620X.73B3.1670455; Hadley MN, 2013, NEUROSURGERY, V72, P40, DOI 10.1227/NEU.0b013e318276edda; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; Kirshblum SC, 2002, AM J PHYS MED REHAB, V81, P502, DOI 10.1097/00002060-200207000-00006; Mabray MC, 2016, J NEUROTRAUM, V33, P954, DOI 10.1089/neu.2015.4093; NUWER MR, 1995, EVOKED POTENTIAL, V96, P6, DOI 10.1016/0013-4694(94)00235-D; Park JH, 2015, WORLD J CLIN CASES, V3, P765, DOI 10.12998/wjcc.v3.i9.765; Ryken TC, 2013, NEUROSURGERY, V72, P84, DOI 10.1227/NEU.0b013e318276ee16; Talbott JF, 2015, J NEUROSURG-SPINE, V23, P495, DOI 10.3171/2015.1.SPINE141033; Thirumala P, 2016, J CLIN NEUROSCI, V25, P122, DOI 10.1016/j.jocn.2015.10.010; Tsirikos AI, 2004, J SPINAL DISORD TECH, V17, P385, DOI 10.1097/01.bsd.0000095825.98982.1a; Wilson JR, 2012, J NEUROTRAUM, V29, P2263, DOI 10.1089/neu.2012.2417	22	13	13	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUN	2018	82	6					870	876		10.1093/neuros/nyx320			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GO1GL	WOS:000439697700026	28973360				2022-02-06	
J	Doerfler, S; Faerber, J; McKhann, GM; Elliott, JP; Winn, HR; Kumar, M; Levine, J; Le Roux, PD				Doerfler, Sean; Faerber, Jennifer; McKhann, Guy M.; Elliott, J. Paul; Winn, H. Richard; Kumar, Monisha; Levine, Joshua; Le Roux, Peter D.			The Incidence and Impact of Secondary Cerebral Insults on Outcome After Aneurysmal Subarachnoid Hemorrhage	WORLD NEUROSURGERY			English	Article						Aneurysm; Hyperglycemia; Hypotension; Hypoxia; Intracranial hypertension; Intracranial pressure; Outcome; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; EXTRACEREBRAL ORGAN DYSFUNCTION; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; MEDICAL COMPLICATIONS; NEUROINTENSIVE CARE; HEMOGLOBIN CONCENTRATION; NEUROCRITICAL CARE; PERFUSION-PRESSURE; BLOOD-TRANSFUSION	INTRODUCTION: Secondary cerebral insults can adversely affect patients with traumatic brain injury. By contrast, the incidence of secondary cerebral insults after aneurysmal subarachnoid hemorrhage (SAH) and their impact on outcome have been less well studied. METHODS: Four hundred and twenty-one patients with SAH who underwent surgical occlusion of their ruptured aneurysm and who received intensive care unit care for >= 48 hours were retrospectively identified from a prospective observational database. Patients were managed according to standard recommendations for SAH. Three secondary cerebral insults were examined: hypotension (<90 mmHg systolic), hypoxia (PaO2 < 60 mm Hg), and hyperglycemia (>200 mg/dL). RESULTS: A secondary cerebral insult was observed in 309 (73.4%) patients including 135 (32.1%) who had multiple insults. There was an association between worse clinical grade and development of secondary insults (P = 0.0002), particularly multiple insults (P < 0.0001). When stratified by clinical grade, single (adjusted odds ratio [OR], 2.23; 95% confidence interval [CI], 1.10-4.51; P = 0.026) and multiple (adjusted OR, 4.37; 95% CI, 2.14-8.93; P < 0.0001) secondary cerebral insults were associated with worse outcome. In multivariate analysis and controlling for age, admission clinical grade, severity of SAH on computed tomography, intracerebral hematoma, increased intracranial pressure (>20 mm Hg), rebleed, intraoperative rupture, and hydrocephalus, secondary cerebral insults were independently associated with poor outcome (adjusted OR, 2.45; 95% CI, 1.20-5.02; P = 0.014). CONCLUSIONS: Secondary cerebral insults (hypoxia, hypotension, and hyperglycemia) are common after SAH, including among patients with a good clinical grade. These insults after SAH are associated with worse outcome. These data suggest that prevention of secondary cerebral insults may provide an opportunity to improve patient outcome after SAH.	[Doerfler, Sean] Univ Penn, Ctr Clin Epidemiol & Biostat, Dept Neurosurg, Philadelphia, PA 19104 USA; [Faerber, Jennifer] Univ Penn, Ctr Clin Epidemiol & Biostat, Dept Biostat, Philadelphia, PA 19104 USA; [McKhann, Guy M.] Columbia Univ, Dept Neurosurg, New York, NY USA; [Elliott, J. Paul] Rocky Mt Neurosurg Alliance, Dept Neurosurg, Englewood, CO USA; [Winn, H. Richard] Mt Sinai Med Ctr, Dept Neurosurg, New York, NY 10029 USA; [Kumar, Monisha; Levine, Joshua] Univ Penn, Div Neurocrit Care, Philadelphia, PA 19104 USA; [Le Roux, Peter D.] Brain & Spine Ctr, Wynnewood, PA 19096 USA; [Le Roux, Peter D.] Lankenau Med Ctr, Lankenua Med Res Inst, Wynnewood, PA 19096 USA		Le Roux, PD (corresponding author), Brain & Spine Ctr, Wynnewood, PA 19096 USA.; Le Roux, PD (corresponding author), Lankenau Med Ctr, Lankenua Med Res Inst, Wynnewood, PA 19096 USA.	lerouxp@mlhs.org			Sharpe Foundation for Neurosurgical Research	Part of this work was supported by a grant from the Sharpe Foundation for Neurosurgical Research to P.L.R.	Ahmadian A, 2013, HEART LUNG VESSEL, V5, P168; Alvarez-Sabin J, 2004, STROKE, V35, P2493, DOI 10.1161/01.STR.0000143728.45516.c6; Anderson C, 2000, STROKE, V31, P1843; Ariza M, 2004, J NEUROTRAUM, V21, P864, DOI 10.1089/0897715041526203; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Barton CW, 2005, ACAD EMERG MED, V12, P1, DOI 10.1197/j.aem.2004.08.043; Beaumont A, 2002, ACT NEUR S, V81, P217; Bonds BW, 2015, J TRAUMA ACUTE CARE, V79, P85, DOI 10.1097/TA.0000000000000698; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Chang HS, 2000, J NEUROSURG, V92, P971, DOI 10.3171/jns.2000.92.6.0971; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Claassen J, 2004, CRIT CARE MED, V32, P832, DOI 10.1097/01.CCM.0000114830.48833.8A; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Coppadoro A, 2011, MINERVA ANESTESIOL, V77, P74; Cossu G, 2016, MINERVA ANESTESIOL, V82, P684; Cossu G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/628597; Dasenbrock HH, 2016, WORLD NEUROSURG, V88, P459, DOI 10.1016/j.wneu.2015.10.054; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Donnelly J, 2015, EXPERT REV NEUROTHER, V15, P169, DOI 10.1586/14737175.2015.996552; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Elf K, 2003, EUR J TRAUMA, V29, P74; Enblad P, 1997, J NEUROL NEUROSUR PS, V62, P512, DOI 10.1136/jnnp.62.5.512; FOGELHOLM R, 1993, STROKE, V24, P1649, DOI 10.1161/01.STR.24.11.1649; Frazer D, 2007, NEUROSURGERY, V60, P434, DOI 10.1227/01.NEU.0000255335.72662.25; Frontera JA, 2006, STROKE, V37, P199, DOI 10.1161/01.STR.0000194960.73883.0f; Frykholm P, 2004, ACTA NEUROL SCAND, V109, P25, DOI 10.1034/j.1600-0404.2003.00174.x; Fujita Y, 2014, CHILD NERV SYST, V30, P1201, DOI 10.1007/s00381-014-2353-3; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; GIANNOTTA SL, 1991, NEUROSURGERY, V28, P531, DOI 10.1227/00006123-199104000-00008; Gruber A, 1999, CRIT CARE MED, V27, P505, DOI 10.1097/00003246-199903000-00026; Guiza F, 2017, J NEUROTRAUM, V34, P2425, DOI 10.1089/neu.2016.4807; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Hall A, 2018, WORLD NEUROSURG, V109, P381, DOI 10.1016/j.wneu.2017.10.016; Hemphill JC, 2005, PHYSIOL MEAS, V26, P373, DOI 10.1088/0967-3334/26/4/004; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Ingall T, 2000, STROKE, V31, P1054, DOI 10.1161/01.STR.31.5.1054; JENNETT B, 1975, LANCET, V1, P480; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; Ke CS, 2002, EXP NEUROL, V178, P194, DOI 10.1006/exnr.2002.8037; Kramer AH, 2008, CRIT CARE MED, V36, P2070, DOI 10.1097/CCM.0b013e31817c1095; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; Lackner P, 2017, CURR DRUG TARGETS, V18, P1417, DOI 10.2174/1389450117666160401124426; LANZINO G, 1993, J NEUROSURG, V79, P885, DOI 10.3171/jns.1993.79.6.0885; Ledwith MB, 2010, J NEUROSCI NURS, V42, P280, DOI 10.1097/JNN.0b013e3181ecafd4; LEROUX PD, 1995, J NEUROSURG, V83, P394, DOI 10.3171/jns.1995.83.3.0394; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manoel ALD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1193-9; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; MAYBERG MR, 1994, CIRCULATION, V90, P2592, DOI 10.1161/01.CIR.90.5.2592; McKhann GM, 2004, MANAGEMENT CEREBRAL, P431; Naidech AM, 2005, ARCH NEUROL-CHICAGO, V62, P410, DOI 10.1001/archneur.62.3.410; Naidech AM, 2007, CRIT CARE MED, V35, P2383, DOI 10.1097/01.CCM.0000284516.17580.2C; Naidech AM, 2006, NEUROSURGERY, V59, P775, DOI 10.1227/01.NEU.0000232662.86771.A9; Nyholm L, 2012, ISRN NEUROL, V2012; Nyholm L, 2014, J NEUROSCI NURS, V46, P285, DOI 10.1097/JNN.0000000000000077; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; Rabinstein Alejandro A, 2015, Acta Neurochir Suppl, V120, P239, DOI 10.1007/978-3-319-04981-6_40; ROPPER AH, 1984, J NEUROSURG, V60, P909, DOI 10.3171/jns.1984.60.5.0909; Ryttlefors M, 2007, NEUROSURGERY, V61, P704, DOI 10.1227/01.NEU.0000298898.38979.E3; Ryttlefors M, 2010, ACTA NEUROCHIR, V152, P241, DOI 10.1007/s00701-009-0496-x; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Scaravilli V, 2011, NEUROCRIT CARE, V15, P287, DOI 10.1007/s12028-011-9588-6; Schuiling WJ, 2005, NEUROCRIT CARE, V3, P1, DOI 10.1385/NCC:3:1:001; Smith MJ, 2004, J NEUROSURG, V101, P1, DOI 10.3171/jns.2004.101.1.0001; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Stein M, 2015, J CLIN NEUROSCI, V22, P530, DOI 10.1016/j.jocn.2014.08.026; Swanson EW, 2010, NEUROSURGERY, V66, P925, DOI 10.1227/01.NEU.0000368543.59446.A4; TIDSWELL P, 1995, NEUROLOGY, V45, P875; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Uyttenboogaart M, 2007, BRAIN, V130, P1626, DOI 10.1093/brain/awm087; van der Bilt IAC, 2009, NEUROLOGY, V72, P635, DOI 10.1212/01.wnl.0000342471.07290.07; Veeravagu A, 2014, WORLD NEUROSURG, V82, pE235, DOI 10.1016/j.wneu.2014.02.030; Verweij B H, 1996, J Craniomaxillofac Trauma, V2, P8; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Wan H, 2014, EXPERT OPIN PHARMACO, V15, P231, DOI 10.1517/14656566.2014.865724; Wartenberg KE, 2006, CURR OPIN CRIT CARE, V12, P78, DOI 10.1097/01.ccx.0000216571.80944.65; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Wartenberg KE, 2007, 5 ANN NEUR CAR SOC M; Winn HR., 2004, MANAGEMENT CEREBRAL, P303; Zoerle T, 2015, CRIT CARE MED, V43, P168, DOI 10.1097/CCM.0000000000000670; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0	88	13	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2018	114						E483	E494		10.1016/j.wneu.2018.02.195			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8PI	WOS:000432959600055	29574224				2022-02-06	
J	Karki, P; Hong, P; Johnson, J; Pajarillo, E; Son, DS; Aschner, M; Lee, EY				Karki, Pratap; Hong, Peter; Johnson, James, Jr.; Pajarillo, Edward; Son, Deok-Soo; Aschner, Michael; Lee, Eunsook Y.			Arundic Acid Increases Expression and Function of Astrocytic Glutamate Transporter EAAT1 Via the ERK, Akt, and NF-kappa B Pathways	MOLECULAR NEUROBIOLOGY			English	Article						Astrocytes; EAAT1; Arundic acid; NF-kappa B; Manganese	DEPENDENT TRANSCRIPTIONAL REGULATION; DELAYED INFARCT EXPANSION; PERMANENT FOCAL ISCHEMIA; CELL-SURFACE EXPRESSION; INDUCED UP-REGULATION; YIN YANG 1; ALZHEIMERS-DISEASE; MODULATING AGENT; DIFFERENTIAL EXPRESSION; DOPAMINERGIC-NEURONS	Glutamate is the major excitatory neurotransmitter in the brain, but excessive synaptic glutamate must be removed to prevent excitotoxic injury and death. Two astrocytic glutamate transporters, excitatory amino acid transporter (EAAT) 1 and 2, play a major role in eliminating excess glutamate from the synapse. Dysregulation of EAAT1 contributes to the pathogenesis of multiple neurological disorders, such as Alzheimer's disease (AD), ataxia, traumatic brain injuries, and glaucoma. In the present study, we investigated the effect of arundic acid on EAAT1 to determine its efficacy in enhancing the expression and function of EAAT1, and its possible mechanisms of action. The studies were carried out in human astrocyte H4 cells as well as in human primary astrocytes. Our findings show that arundic acid upregulated EAAT1 expression at the transcriptional level by activating nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B). Arundic acid increased astrocytic EAAT1 promoter activity, messenger RNA (mRNA)/protein levels, and glutamate uptake, while pharmacological inhibition of NF-kappa B ormutation on NF-kappa B binding sites in the EAAT1 promoter region abrogated these effects. Arundic acid increased NF-kappa B reporter activity and induced NF-kappa B nuclear translocation as well as its bindings to the EAAT1 promoter. Furthermore, arundic acid activated the Akt and ERK signaling pathways to enhance EAAT1 mRNA/protein levels. Finally, arundic acid attenuated manganese-induced decrease in EAAT1 expression by inhibiting expression of the transcription factor Ying Yang 1 (YY1). These results demonstrate that arundic acid increases the expression and function of EAAT1 via the Akt, ERK, and NF-kappa B signaling pathways, and reverses Mn-induced EAAT1 repression by inhibiting the Mn-induced YY1 activation.	[Karki, Pratap; Pajarillo, Edward; Lee, Eunsook Y.] Florida A&M Univ, Coll Pharm, Dept Pharmaceut Sci, Tallahassee, FL 32307 USA; [Hong, Peter; Johnson, James, Jr.; Son, Deok-Soo] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA		Lee, EY (corresponding author), Florida A&M Univ, Coll Pharm, Dept Pharmaceut Sci, Tallahassee, FL 32307 USA.	eunsook.lee@famu.edu	Pajarillo, Edward Alain/ABF-9202-2021	Pajarillo, Edward Alain/0000-0002-5044-7607	 [R01 ES024756];  [SC1 GM089630];  [SC1 CA200519];  [R01 ES10563];  [1R03 ES024849];  [1R21 ES025415]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [SC1CA200519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES010563, R03ES024849, R01ES024756, R21ES025415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [SC1GM089630, R25GM059994] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54MD007586] Funding Source: NIH RePORTER	The present study has been supported in part by R01 ES024756 (EL), SC1 GM089630 (EL), SC1 CA200519 (DS), R01 ES10563 (MA), 1R03 ES024849 (MA), and 1R21 ES025415 (MA).	Aguirre G, 2008, NEUROCHEM INT, V52, P1322, DOI 10.1016/j.neuint.2008.01.015; Allritz C, 2009, NEUROCHEM INT, V55, P22, DOI 10.1016/j.neuint.2008.12.020; Anderson CM, 2000, GLIA, V32, P1; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Asano T, 2005, CNS NEUROL DISORD-DR, V4, P127, DOI 10.2174/1568007053544084; Aschner Judy L., 2005, Molecular Aspects of Medicine, V26, P353, DOI 10.1016/j.mam.2005.07.003; Baltan S, 2011, J NEUROSCI, V31, P3990, DOI 10.1523/JNEUROSCI.5379-10.2011; BarPeled O, 1997, J NEUROCHEM, V69, P2571; Bonde C, 2003, NEUROCHEM INT, V43, P381, DOI 10.1016/S0197-0186(03)00025-1; BROUILLET EP, 1993, EXP NEUROL, V120, P89, DOI 10.1006/exnr.1993.1042; Carbone M, 2012, NEUROCHEM INT, V60, P31, DOI 10.1016/j.neuint.2011.10.017; Castro-Coronel Y, 2011, TOXICOL SCI, V122, P539, DOI 10.1093/toxsci/kfr126; Chen KH, 2011, J ALZHEIMERS DIS, V26, P755, DOI 10.3233/JAD-2011-110002; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; de Vries B, 2009, ARCH NEUROL-CHICAGO, V66, P97, DOI 10.1001/archneurol.2008.535; Dobson AW, 2004, ANN NY ACAD SCI, V1012, P115, DOI 10.1196/annals.1306.009; Duan SM, 1999, J NEUROSCI, V19, P10193; Erikson KM, 2007, TOXICOL SCI, V97, P459, DOI 10.1093/toxsci/kfm044; Fernandes RA, 2013, CURR MED CHEM, V20, P2315, DOI 10.2174/0929867311320180003; Figiel M, 2003, EXP NEUROL, V183, P124, DOI 10.1016/S0014-4886(03)00134-1; Furuta A, 1997, J NEUROSCI, V17, P8363; Gegelashvili G, 1997, J NEUROCHEM, V69, P2612; Ghosh M, 2011, J NEUROSCI, V31, P9159, DOI 10.1523/JNEUROSCI.0302-11.2011; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Harada T, 1998, P NATL ACAD SCI USA, V95, P4663, DOI 10.1073/pnas.95.8.4663; Harada T, 2007, J CLIN INVEST, V117, P1763, DOI 10.1172/JCI30178; Hazell AS, 1997, NEUROCHEM RES, V22, P1443, DOI 10.1023/A:1021994126329; Himeda T, 2006, NEUROPHARMACOLOGY, V50, P329, DOI 10.1016/j.neuropharm.2005.09.014; Jarvis WD, 1997, MOL PHARMACOL, V52, P935, DOI 10.1124/mol.52.6.935; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; Kanai H, 2004, PHARMACOGENOMICS J, V4, P336, DOI 10.1038/sj.tpj.6500269; Karki P, 2015, J BIOL CHEM, V290, P23725, DOI 10.1074/jbc.M115.649327; Karki P, 2014, GLIA, V62, P1270, DOI 10.1002/glia.22679; Karki P, 2014, MOL CELL BIOL, V34, P1280, DOI 10.1128/MCB.01176-13; Karki P, 2013, J BIOL CHEM, V288, P28975, DOI 10.1074/jbc.M113.483826; Kato H, 2004, BRAIN RES, V1030, P66, DOI 10.1016/j.brainres.2004.09.046; Kato H, 2003, J NEUROL SCI, V208, P9, DOI 10.1016/S0022-510X(02)00411-2; Kim SY, 2003, J NEUROCHEM, V87, P1485, DOI 10.1046/j.1471-4159.2003.02128.x; Lee ESY, 2009, J NEUROCHEM, V110, P530, DOI 10.1111/j.1471-4159.2009.06105.x; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Liang Z, 2002, J NEUROCHEM, V80, P807, DOI 10.1046/j.0022-3042.2002.00779.x; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; Masliah E, 1996, ANN NEUROL, V40, P759, DOI 10.1002/ana.410400512; Matsui T, 2002, J CEREBR BLOOD F MET, V22, P711, DOI 10.1097/00004647-200206000-00010; Mori T, 2004, NEUROCHEM INT, V45, P381, DOI 10.1016/j.neuint.2003.06.001; Mutkus L, 2005, BIOL TRACE ELEM RES, V107, P221, DOI 10.1385/BTER:107:3:221; Naskar R, 2000, INVEST OPHTH VIS SCI, V41, P1940; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Oki C, 2008, CELL MOL NEUROBIOL, V28, P417, DOI 10.1007/s10571-007-9241-2; Pawlak J, 2005, MOL BRAIN RES, V138, P1, DOI 10.1016/j.molbrainres.2004.10.043; Platt SR, 2007, VET J, V173, P278, DOI 10.1016/j.tvjl.2005.11.007; Rauen T, 1998, CELL TISSUE RES, V291, P19; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Rosas S, 2007, J NEUROCHEM, V101, P1134, DOI 10.1111/j.1471-4159.2007.04517.x; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Rozyczka J, 2004, BRAIN PATHOL, V14, P406; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shigeri Y, 2004, BRAIN RES REV, V45, P250, DOI 10.1016/j.brainresrev.2004.04.004; Sims KD, 2000, J BIOL CHEM, V275, P5228, DOI 10.1074/jbc.275.7.5228; Stice JP, 2012, SHOCK, V38, P128, DOI 10.1097/SHK.0b013e31825da754; Sun Y, 2012, J CELL SCI, V125, P4507, DOI 10.1242/jcs.105023; Suzuki K, 2001, J CELL SCI, V114, P3717; Swanson RA, 1997, J NEUROSCI, V17, P932; Takahashi K, 2015, CELL MOL LIFE SCI, V72, P3489, DOI 10.1007/s00018-015-1937-8; Tateishi N, 2002, J CEREBR BLOOD F MET, V22, P723, DOI 10.1097/00004647-200206000-00011; Toulany M, 2014, CANCER BIOL THER, V15, P317, DOI 10.4161/cbt.27311; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Winter JN, 2011, AM J PHYSIOL-CELL PH, V300, pC1172, DOI 10.1152/ajpcell.00504.2010; Yanagisawa M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.45	73	13	15	1	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2018	55	6					5031	5046		10.1007/s12035-017-0709-x			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GF5FI	WOS:000431991500041	28812276	Green Accepted			2022-02-06	
J	Qian, L; Zhao, HW; Guo, Y; Li, YS; Zhou, MX; Yang, LG; Wang, ZW; Sun, YF				Qian, Long; Zhao, Hongwei; Guo, Yue; Li, Yuanshang; Zhou, Mingxing; Yang, Liguo; Wang, Zhiwei; Sun, Yifan			Influence of strain rate on indentation response of porcine brain	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Indentation response; Mechanical properties; Strain rate; Porcine brain; Cortex	MECHANICAL-PROPERTIES; LARGE-DEFORMATION; WHITE-MATTER; IN-VIVO; TISSUE; MODELS; BEHAVIOR; IMPACT; INJURY; VITRO	Knowledge of brain tissue mechanical properties may be critical for formulating hypotheses about some specific diseases mechanisms and its accurate simulations such as traumatic brain injury (TBI) and tumor growth. Compared to traditional tests (e.g. tensile and compression), indentation shows superiority by virtue of its pinpoint and nondestructive/quasi-nondestructive. As a viscoelastic material, the properties of brain tissue depend on the strain rate by definition. However most efforts focus on the aspect of velocity in the field of brain indentation, rather than strain rate. The influence of strain rate on indentation response of brain tissue is taken little attention. Further, by comparing different results from literatures, it is also obvious that strain rate rather than velocity is more appropriate to characterize mechanical properties of brain. In this paper, to systematically characterize the influence of strain rate, a series of indentation-relaxation tests n = 210) are performed on the cortex of porcine brain using a custom-designed indentation device. The mechanical response that correlates with indenter diameters, depths of indentation and velocities, is revealed for the indentation portion, and elastic behavior of brain tissue is analyzed as the function of strain rate. Similarly, a linear viscoelastic model with a Prony series is employed for the indentation-relaxation portion, wherein the brain tissue shows more viscous and responds more quickly with increasing strain rate. Understanding the effect of strain rate on mechanical properties of brain indentation may be far-reaching for brain injury biomechanics and accurate simulations, but be important for bridging between indentation results of different literatures.	[Qian, Long; Zhao, Hongwei; Guo, Yue; Li, Yuanshang; Zhou, Mingxing; Yang, Liguo; Wang, Zhiwei; Sun, Yifan] Jilin Univ, Sch Mech Sci & Engn, Changchun 130025, Jilin, Peoples R China		Zhao, HW (corresponding author), Jilin Univ, Sch Mech Sci & Engn, Changchun 130025, Jilin, Peoples R China.	503624347@qq.com; hwzhao@jlu.edu.cn; amybezz@126.com; 13331660409@163.com; zhoumx_jlu@163.com; 724155669@qq.com; 741491973@qq.com; 2861052137@qq.com		Qian, Long/0000-0001-8833-8038	National Natural Science Funds for Excellent Young Scholar [51422503]; Special Projects for Development of National Major Scientific Instruments and Equipments [2012YQ030075]; Fund Guiding on Strategic Adjustment of Jilin Provincial Economic Structure Project [2014Z045]; Major project of Jilin Province Science and Technology development plan [20150203014GX]; special fund project of Jilin provincial industrial innovation [2016C030]; Jilin Provincial Middle and Young Scientific and Technological Innovation Talent and Team Project [20170519001JH]; Program for JLU Science and Technology Innovative Research Team [2017TD-04]	This research was funded by the National Natural Science Funds for Excellent Young Scholar (51422503), Special Projects for Development of National Major Scientific Instruments and Equipments (2012YQ030075), Fund Guiding on Strategic Adjustment of Jilin Provincial Economic Structure Project (2014Z045), Major project of Jilin Province Science and Technology development plan (20150203014GX), the special fund project of Jilin provincial industrial innovation (2016C030), Jilin Provincial Middle and Young Scientific and Technological Innovation Talent and Team Project (20170519001JH), and Program for JLU Science and Technology Innovative Research Team (2017TD-04).	Allen M. P., 1997, UNDERSTANDING REGRES, P113; Ambrosi D, 2002, INT J ENG SCI, V40, P1297, DOI 10.1016/S0020-7225(02)00014-9; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Budday S, 2014, J MECH PHYS SOLIDS, V72, P75, DOI 10.1016/j.jmps.2014.07.010; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chen FQ, 2015, ANN BIOMED ENG, V43, P2903, DOI 10.1007/s10439-015-1350-3; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Elkin BS, 2011, J NEUROTRAUM, V28, P2235, DOI 10.1089/neu.2010.1604; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Falland-Cheung L, 2018, J MECH BEHAV BIOMED, V77, P609, DOI 10.1016/j.jmbbm.2017.10.026; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Garo A, 2007, BIORHEOLOGY, V44, P51; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Huang H, 2013, MATERIALS, V6, P1496, DOI 10.3390/ma6041496; Jiang Y, 2015, BIOMECH MODEL MECHAN, V14, P1119, DOI 10.1007/s10237-015-0658-0; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; Lee E.H., 1960, J APPL MECH, V33, P395; Li Y, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5775-5; Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9; MacManus DB, 2015, J BIOMECH, V48, P3213, DOI 10.1016/j.jbiomech.2015.06.028; MacManus DB, 2017, ACTA BIOMATER, V48, P309, DOI 10.1016/j.actbio.2016.10.029; MacManus DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21569; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Samadi-Dooki A, 2018, J MECH BEHAV BIOMED, V77, P24, DOI 10.1016/j.jmbbm.2017.08.037; Samadi-Dooki A, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036486; Shulyakov AV, 2011, J MECH BEHAV BIOMED, V4, P484, DOI 10.1016/j.jmbbm.2010.12.012; Sneddon IN, 1965, INT J ENG SCI, V3, P47, DOI [DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4]; Subbaroyan J, 2005, J NEURAL ENG, V2, P103, DOI 10.1088/1741-2560/2/4/006; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P79; Tallinen T, 2016, NAT PHYS, V12, P588, DOI [10.1038/NPHYS3632, 10.1038/nphys3632]; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang JY, 2011, J BIOMECH, V44, P391, DOI 10.1016/j.jbiomech.2010.10.024; Zhang M.G., 2014, J APPL MECH T ASME, V81	53	13	14	5	42	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JUN	2018	82						210	217		10.1016/j.jmbbm.2018.03.031			8	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	GG2GS	WOS:000432508800025	29621688				2022-02-06	
J	Tollefsen, MH; Vik, A; Skandsen, T; Sandrod, O; Deane, SF; Rao, V; Moen, KG				Tollefsen, Marie Hexeberg; Vik, Anne; Skandsen, Toril; Sandrod, Oddrun; Deane, Susan Frances; Rao, Vidar; Moen, Kent Goran			Patients with Moderate and Severe Traumatic Brain Injury: Impact of Preinjury Platelet Inhibitor or Warfarin Treatment	WORLD NEUROSURGERY			English	Article						Craniocerebral trauma; Hematologic agents; Glasgow Coma Scale; Glasgow Outcome Scale; Platelet aggregation inhibitors; Tomography; X-ray computed	BLUNT HEAD TRAUMA; ANTIPLATELET AGENTS; HEMORRHAGIC PROGRESSION; MORTALITY; OUTCOMES; THERAPY; ANTICOAGULATION; CLASSIFICATION; METAANALYSIS; MANAGEMENT	OBJECTIVE: We aimed to examine the effect of preinjury antithrombotic medication on clinical and radiologic neuroworsening in traumatic brain injury (TBI) and study the effect on outcome. METHODS: A total of 184 consecutive patients >= 50 years old with moderate and severe TBI admitted to a level 1 trauma center were included. Neuroworsening was assessed clinically by using the Glasgow Coma Scale (GCS) score and radiologically by using the Rotterdam CT score on repeated time points. Functional outcome was assessed with the Glasgow Outcome Scale Extended 6 months after injury. RESULTS: The platelet inhibitor group (mean age, 77.3 years; n = 43) and the warfarin group (mean age, 73.2 years; n = 20) were significantly older than the non-user group (mean age, 63.7 years; n = 121; P <= 0.001). In the platelet inhibitor group 74% and in the warfarin group, 85% were injured by falls, Platelet inhibitors were not significantly associated with clinical or radiologic neuroworsening (P = 0.37-1.00), whereas warfarin increased the frequency of worsening in GCS score (P = 0.001-0.028) and Rotterdam CT score (P = 0.004), In-hospital mortality was higher in the platelet inhibitor group (28%; P = 0.030) and the warfarin group (50%; P < 0.001) compared with the nonuser group (13%). Platelet inhibitors did not predict mortality or worse outcome after adjustment for age, preinjury disability, GCS score, and Rotterdam CT score, whereas warfarin predicted both mortality and worse outcome. CONCLUSIONS: In this study of patients with moderate and severe TBI, preinjury platelet inhibitors did not cause neuroworsening or predict higher mortality or worse outcome. hi contrast, preinjury warfarin caused neuroworsening and was an independent risk factor for mortality and worse outcome at 6 months. Hence, fall prevention and liberal use of computed tomography examinations is important in this patient group.	[Tollefsen, Marie Hexeberg; Vik, Anne; Skandsen, Toril; Rao, Vidar; Moen, Kent Goran] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Vik, Anne; Rao, Vidar] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Skandsen, Toril] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Sandrod, Oddrun] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Anesthesiol & Intens Care Med, Trondheim, Norway; [Deane, Susan Frances] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Moen, Kent Goran] Nord Trondelag Hosp Trust, Levanger Hosp, Dept Med Imaging, Levanger, Norway		Moen, KG (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway.; Moen, KG (corresponding author), Nord Trondelag Hosp Trust, Levanger Hosp, Dept Med Imaging, Levanger, Norway.	kent.g.moen@ntnu.no					Allison RZ, 2017, NEUROCRIT CARE, V26, P80, DOI 10.1007/s12028-016-0303-5; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Batchelor JS, 2013, BRIT J NEUROSURG, V27, P12, DOI 10.3109/02688697.2012.705361; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Choi R, 2014, NEUROLOGY S, V82; Cull JD, 2015, AM SURGEON, V81, P128; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Joseph B, 2014, J SURG RES, V186, P287, DOI 10.1016/j.jss.2013.08.009; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Norwegian Institute of Public Health, 2012, NORW PRESCR DAT 2007; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203	24	13	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2018	114						E209	E217		10.1016/j.wneu.2018.02.167			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8PI	WOS:000432959600023	29524716	hybrid, Green Submitted			2022-02-06	
J	Liu, ZK; Ng, CF; Shiu, HT; Wong, HL; Chin, WC; Zhang, JF; Lam, PK; Poon, WS; Lau, CBS; Leung, PC; Ko, CH				Liu, Zhi-Ke; Ng, Chun-Fai; Shiu, Hoi-Ting; Wong, Hing-Lok; Chin, Wai-Ching; Zhang, Jin-Fang; Lam, Ping-Kuen; Poon, Wai-Sang; Lau, Clara Bik-San; Leung, Ping-Chung; Ko, Chun-Hay			Neuroprotective effect of Da Chuanxiong Formula against cognitive and motor deficits in a rat controlled cortical impact model of traumatic brain injury	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						Chuanxiong Rhizoma; Gastrodiae Rhizoma; Da Chuanxiong Formula; Neuroprotective effect; Traumatic brain injury	GASTRODIA-ELATA BLUME; NEURAL STEM-CELLS; Z-LIGUSTILIDE; INFLAMMATORY RESPONSE; MICE; PATHWAY; PROLIFERATION; NEUROTOXICITY; EPIDEMIOLOGY; INVOLVEMENT	Ethnopharmacological relevance: Da Chuanxiong Formula (DCXF) is one of the famous herb pairs that contains dried rhizomes of Ligusticum chuanxiong Hort. and Gastrodia elan BI. in the mass ratio of 4:1. This classic representative traditional Chinese medicine has been widely used to treat brain diseases like headache and migraine caused by blood stasis and wind pathogen. However, the therapeutic effect of DCXF on traumatic brain injury (TBI) has not been reported yet. Aim of study: The present study was performed to investigate the neuroprotective effects of DCXF and its underlying mechanisms in the controlled cortical impact (CCI)-induced TBI rat model. Materials and methods: Male Sprague-Dawley rats were divided into four groups: Sham, TBI control, 1x DCXF (520.6 mg/kg) and 5X DCXF (2603.0 mg/kg). Two treatment groups (1X and 5X DCXF) were intragastrically administered daily for 7 days before CO-induced TBI and then DCXF treatments were continued post-TBI until the animal behavioral tests, including Morris water maze test, acceleration rotarod motor test and CatWalk quantitative gait analysis test, were done. The brain water content and blood brain barrier (BBB) integrity were measured by wet-dry weight method and Evans blue method, respectively. The number of neuron cells, neural stem cells (NSCs), GFAP positive cells (astrocyte) as well as Iba-1 positive cells (microglia) were determined by histology and immunohistochemistry. Results: Treatment with DCXF significantly improved the learning ability and memory retention in Morris water maze test, and remarkably enhanced motor performances in acceleration rotarod motor test and catwalk quantitative gait analysis test after TBI. Moreover, DCXF treatment was able to reduce BBB permeability, brain edema, microglia and astrocyte activation, improve the proliferation of NSCs and decrease neurons loss in the brain with TBI. Conclusions: The present study demonstrated that DCXF treatment could decrease BBB leakage and brain edema, reduce neuron loss, microglia and astrocyte activation, and increase NSCs proliferation, which may contribute to the cognitive and motor protection of DCXF in the TBI rats. It is the first time to provide potentially underlying mechanisms of the neuroprotective effect of DCXF on TBI-induced brain damage and functional outcomes.	[Liu, Zhi-Ke; Ng, Chun-Fai; Shiu, Hoi-Ting; Wong, Hing-Lok; Lau, Clara Bik-San; Leung, Ping-Chung; Ko, Chun-Hay] Chinese Univ Hong Kong, Inst Chinese Med, Shatin, Hong Kong, Peoples R China; [Liu, Zhi-Ke; Ng, Chun-Fai; Shiu, Hoi-Ting; Wong, Hing-Lok; Lau, Clara Bik-San; Leung, Ping-Chung; Ko, Chun-Hay] Chinese Univ Hong Kong, State Key Lab Phytochem & Plant Resources West Ch, Shatin, Hong Kong, Peoples R China; [Lau, Clara Bik-San; Leung, Ping-Chung; Ko, Chun-Hay] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518057, Peoples R China; [Zhang, Jin-Fang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China; [Chin, Wai-Ching; Lam, Ping-Kuen; Poon, Wai-Sang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China		Ko, CH (corresponding author), Chinese Univ Hong Kong, Inst Chinese Med, Shatin, Hong Kong, Peoples R China.	liuzhikebee@163.com; ncf0000@hotmail.com; hoitingshiu@gmail.com; vhlwong@cuhk.edu.hk; donchin@surgery.cuhk.edu.hk; zhangjf06@gmail.com; lampingkuen@yahoo.com.hk; wpoon@surgery.cuhk.edu.hk; claralau@cuhk.edu.hk; pingcleung@cuhk.edu.hk; gohey@yahoo.com	Lau, Clara Bik-San/AAF-3989-2020; Poon, Wai Sang/F-1558-2011	Lau, Clara Bik-San/0000-0002-7409-1270; 	Food and Health Bureau, Hong Kong, Special Administration Region, Health and Medical Research Fund [12134111]	This study was financially supported by the Food and Health Bureau, Hong Kong, Special Administration Region, Health and Medical Research Fund (no. 12134111).	Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Barzegar-Fallah N, 2016, BRAIN INJURY, V30, P926, DOI 10.3109/02699052.2016.1144083; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Chen D, 2011, J PHARMACOL EXP THER, V337, P663, DOI 10.1124/jpet.110.177055; Dai JN, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021891, 10.1371/journal.pone.0028903]; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Elovic EP, 2008, ARCH PHYS MED REHAB, V89, pS21, DOI 10.1016/j.apmr.2007.12.012; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Feng ZB, 2012, J ETHNOPHARMACOL, V144, P313, DOI 10.1016/j.jep.2012.09.014; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Ghosh S, 2017, FOOD CHEM TOXICOL, V103, P41, DOI 10.1016/j.fct.2017.02.028; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kao TK, 2013, EXP NEUROL, V247, P188, DOI 10.1016/j.expneurol.2013.04.010; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Lam PK, 2016, ACTA NEUROCHIR SUPPL, V122, P21, DOI 10.1007/978-3-319-22533-3_4; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leo P, 2016, TRANSLATIONAL RES TR; Li JJ, 2015, BRAIN RES, V1595, P19, DOI 10.1016/j.brainres.2014.10.012; Liu BY, 2015, CHIN J TRAUMATOL, V18, P135, DOI 10.1016/j.cjtee.2015.04.002; Liu ZK, 2017, J ETHNOPHARMACOL, V196, P20, DOI 10.1016/j.jep.2016.12.014; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Mishra SK, 2017, MOL CELL NEUROSCI, V78, P25, DOI 10.1016/j.mcn.2016.11.008; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Ng C. F., 2013, EVID-BASED COMPL ALT, V2013, P1; Ng CF, 2016, J ETHNOPHARMACOL, V185, P87, DOI 10.1016/j.jep.2016.03.018; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Pu QH, 2015, LIFE SCI, V121, P46, DOI 10.1016/j.lfs.2014.11.016; Ran X, 2011, PHARM BIOL, V49, P1180, DOI 10.3109/13880209.2011.576346; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Tian YM, 2010, NEUROSCI LETT, V474, P26, DOI 10.1016/j.neulet.2010.02.066; van Donkelaar P, 2006, EXERC SPORT SCI REV, V34, P77, DOI 10.1249/00003677-200604000-00007; Wang HN, 2014, BEHAV BRAIN RES, V266, P153, DOI 10.1016/j.bbr.2014.02.046; Wang Lin, 2013, ScientificWorldJournal, V2013, P270249, DOI 10.1155/2013/270249; Wang XL, 2014, LIFE SCI, V114, P77, DOI 10.1016/j.lfs.2014.08.004; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Xu W, 2016, NEUROCHEM INT, V100, P44, DOI 10.1016/j.neuint.2016.08.012; Yamamoto S, 2006, J SURG RES, V134, P307, DOI 10.1016/j.jss.2005.11.588; Yang B, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1076-2; Zhan HD, 2016, J ETHNOPHARMACOL, V189, P361, DOI 10.1016/j.jep.2016.06.057; Zhu MD, 2014, BRAIN RES BULL, V109, P54, DOI 10.1016/j.brainresbull.2014.10.002; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	51	13	13	4	39	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741			J ETHNOPHARMACOL	J. Ethnopharmacol.	MAY 10	2018	217						11	22		10.1016/j.jep.2018.02.004			12	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	GB9KO	WOS:000429392900003	29425850				2022-02-06	
J	Jin, MF; Ni, H; Li, LL				Jin, Mei-fang; Ni, Hong; Li, Li-li			Leptin Maintained Zinc Homeostasis Against Glutamate-Induced Excitotoxicity by Preventing Mitophagy-Mediated Mitochondrial Activation in HT22 Hippocampal Neuronal Cells	FRONTIERS IN NEUROLOGY			English	Article						leptin; zinc homeostasis; mitochondria; mitophagy; glutamate; HT22	RECURRENT NEONATAL SEIZURES; TRAUMATIC BRAIN-INJURY; KETOGENIC DIET; GENE-EXPRESSION; KAINIC ACID; RAT MODEL; AUTOPHAGY; EPILEPTICUS; INHIBITION; METABOLISM	Developmental seizure-induced long-term neuronal hyperexcitation is partially mediated by regenerative mossy fiber sprouting in hippocampus. Yet, there are no effective drugs available to block this pathological process Recently, leptin has been shown to prevent the sprouting of hippocampal mossy fibers and abnormalities in the neurobehavioral parameters. However, their underlying molecular mechanisms are largely unknown. The purpose of this study was to determine the effect of glutamate on the parameters of zinc homeostasis, mitochondrial functions, and mitophagy regulating factors, as well as to investigate the protective effects of leptin against cytotoxicity of glutamate in murine HT22 hippocampal neuronal cells. Cells were assigned to one of the four groups as follows: control group, leptin alone group, glutamate injury group, and leptin pretreatment group Our results demonstrated that glutamate induced a decrease in superoxide dismutase, GSH (glutathione), and mitochondrial membrane potential and an increase in GSSG (oxidized glutathione), mitochondrial reactive oxygen species, and supplementation of leptin blocked the toxic effect of glutamate on cell survival The glutamate-induced cytotoxicity was associated with an increase in mitophagy and intracellular zinc ion levels. Furthermore, glutamate activated the mitophagy markers PINK1, Parkin, and the ratio of LC3-II/LC3-I, as well as increased the expression of zinc transporter 3 (ZnT3) Leptin corrected these glutamate-caused alterations. Finally, the mitophagy inhibitor, CsA, significantly reduced intracellular zinc ion content and ZnT3 expression. These results suggest that mitophagy-mediated zinc dyshomeostasis and mitochondrial activation contributed to glutamate-induced HT22 neuronal cell injury and that leptin treatment could counteract these detrimental effects, thus highlighting mitophagy-mediated zinc homeostasis via mitochondrial activation as a potential strategy to counteract neuroexcitotoxicity.	[Jin, Mei-fang; Ni, Hong; Li, Li-li] Soochow Univ, Childrens Hosp, Inst Pediat Res, Neurol Lab, Suzhou, Peoples R China		Ni, H (corresponding author), Soochow Univ, Childrens Hosp, Inst Pediat Res, Neurol Lab, Suzhou, Peoples R China.	nyr2000@yeah.net			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471337, 81271458]	This work was supported by the National Natural Science Foundation of China (81471337, 81271458).	Lopez-Rodriguez AB, 2016, EXP NEUROL, V279, P274, DOI 10.1016/j.expneurol.2016.03.018; Deng ZH, 2014, CELL MOL NEUROBIOL, V34, P871, DOI 10.1007/s10571-014-0066-5; Erbayat-Altay E, 2008, NEUROSCI LETT, V433, P82, DOI 10.1016/j.neulet.2007.12.051; Fu DY, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00603; Gao JJ, 2016, ONCOTARGET, V7, P26966, DOI 10.18632/oncotarget.9034; Gavello D, 2016, CHANNELS, V10, P282, DOI 10.1080/19336950.2016.1164373; Guo CX, 2016, INT J NANOMED, V11, P5257, DOI 10.2147/IJN.S112030; Guo ZH, 2008, J BIOL CHEM, V283, P1754, DOI 10.1074/jbc.M703753200; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Ho PWL, 2010, NEUROTOX RES, V17, P332, DOI 10.1007/s12640-009-9109-y; Iyyathurai J, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0093-9; Jayaram B, 2013, J MOL NEUROSCI, V49, P523, DOI 10.1007/s12031-012-9924-0; Jeong HJ, 2010, YONSEI MED J, V51, P653, DOI 10.3349/ymj.2010.51.5.653; Kumari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039382; Kumari S, 2015, J BIOL CHEM, V290, P12290, DOI 10.1074/jbc.M114.615948; Lee M, 2016, INVEST OPHTH VIS SCI, V57, P1553, DOI 10.1167/iovs.15-18551; Li X, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00042; Linkous DH, 2008, J HISTOCHEM CYTOCHEM, V56, P3, DOI 10.1369/jhc.6A7035.2007; Macrea MM, 2010, MED HYPOTHESES, V74, P1036, DOI 10.1016/j.mehy.2009.12.033; Malekizadeh Y, 2017, CEREB CORTEX, V27, P4769, DOI 10.1093/cercor/bhw272; Morrison CD, 2009, BBA-MOL BASIS DIS, V1792, P401, DOI 10.1016/j.bbadis.2008.12.004; Munzberg H, 2015, METABOLISM, V64, P13, DOI 10.1016/j.metabol.2014.09.010; Nakashima AS, 2009, BRAIN RES REV, V59, P347, DOI 10.1016/j.brainresrev.2008.10.003; Ni H, 2018, EPILEPSY RES, V139, P164, DOI 10.1016/j.eplepsyres.2017.12.009; Ni H, 2016, EPILEPSY RES, V120, P13, DOI 10.1016/j.eplepsyres.2015.11.021; Ni H, 2015, PHARMACOL BIOCHEM BE, V133, P25, DOI 10.1016/j.pbb.2015.03.012; Ni H, 2013, TOXICOL LETT, V217, P162, DOI 10.1016/j.toxlet.2012.12.010; Ni H, 2012, NEUROCHEM RES, V37, P31, DOI 10.1007/s11064-011-0578-z; Ni H, 2011, BIOL TRACE ELEM RES, V143, P320, DOI 10.1007/s12011-010-8836-5; Nuutinen T, 2010, NEUROSCI LETT, V475, P64, DOI 10.1016/j.neulet.2010.03.041; Obeid M, 2010, EPILEPSY BEHAV, V19, P278, DOI 10.1016/j.yebeh.2010.07.023; Platt TL, 2016, NEUROSCIENCE, V315, P162, DOI 10.1016/j.neuroscience.2015.12.011; Signore AP, 2008, J NEUROCHEM, V106, P1977, DOI 10.1111/j.1471-4159.2008.05457.x; Sun LQ, 2014, MOL MED REP, V9, P77, DOI 10.3892/mmr.2013.1787; Tan DX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122124; Tian T, 2015, BIOL TRACE ELEM RES, V167, P251, DOI 10.1007/s12011-015-0285-8; Vergnano AM, 2014, NEURON, V82, P1101, DOI 10.1016/j.neuron.2014.04.034; Wei LM, 2017, INT J NANOMED, V12, P1891, DOI 10.2147/IJN.S129375; Wong BX, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00091; Yang YF, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00059; Zhang JY, 2013, J CEREBR BLOOD F MET, V33, P567, DOI 10.1038/jcbfm.2012.202	41	13	14	2	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 9	2018	9								e322	10.3389/fneur.2018.00322			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GF2OX	WOS:000431780600001	29867731	Green Published, gold			2022-02-06	
J	Adelson, SL; Chounthirath, T; Hodges, NL; Collins, CL; Smith, GA				Adelson, Sarah L.; Chounthirath, Thitphalak; Hodges, Nichole L.; Collins, Christy L.; Smith, Gary A.			Pediatric Playground-Related Injuries Treated in Hospital Emergency Departments in the United States	CLINICAL PEDIATRICS			English	Article						playground; injury; fall; pediatric; emergency department	HEALTHY CHILD-DEVELOPMENT; PHYSICAL-ACTIVITY; EQUIPMENT INJURIES; ARM FRACTURE; RISK-FACTORS; PLAY; FALLS; SEVERITY; QUALITY; PROGRAM	This study analyzed pediatric playground-related injuries data from the National Electronic Injury Surveillance System. An estimated 5025440 children <18 years were treated in US emergency departments for playground-related injuries during 1990-2012, averaging 218497 children annually. The average patient age was 6.5 years. The overall annual injury rate declined during 1990-2007 (P < .001) and then increased during 2007-2012 (P < .001). The climbing equipment-related injury rate remained constant during 1990-2009 and then increased during 2007-2012 (P = .014). The concussion/closed head injury rate increased during 1990-2008 (P < .002) with the rate almost doubling from 2008-2012 (P < .001). Falls accounted for 76.7% of all injuries and 87.7% of injuries to the upper extremities. Injuries resulted in hospitalization for 4.3% of patients. Despite current playground safety standards and guidelines, a large number of playground-related injuries continue to occur. Revised impact attenuation criteria for playground surfacing materials should be implemented and evaluated to more adequately prevent fall-related upper extremity fractures.	[Adelson, Sarah L.; Chounthirath, Thitphalak; Hodges, Nichole L.; Smith, Gary A.] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Columbus, OH USA; [Adelson, Sarah L.; Hodges, Nichole L.; Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Collins, Christy L.] Datalys Ctr Sports Injury & Prevent Inc, Indianapolis, IN USA; [Smith, Gary A.] Child Injury Prevent Alliance, Columbus, OH USA		Smith, GA (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	gary.smith@nationwidechildrens.org	Michaels, Nichole/AAJ-5943-2021; Kehoe, Clare/ABC-7984-2020	Michaels, Nichole/0000-0003-2618-6440	Medical Student Research Scholarship Program at The Ohio State University College of Medicine	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Author Sarah Adelson received a research scholarship stipend from the Medical Student Research Scholarship Program at The Ohio State University College of Medicine while she worked on this study.	Allen EM, 2013, PEDIATRICS, V131, P233, DOI 10.1542/peds.2012-0643; [Anonymous], INT EST US RES POP A; ASTM International, F195114 ASTM INT; ASTM International, F148711 ASTM INT; ASTM International, F129213 ASTM INT; Bundy AC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-680; Cheng TA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2721; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24; Fiissel D, 2005, INJURY PREV, V11, P337, DOI 10.1136/ip.2005.009167; Ginsburg KR, 2007, PEDIATRICS, V119, P182, DOI 10.1542/peds.2006-2697; Huchcroft SA, 2013, CHRON DIS INJ CAN, V33, P175; Janssen M, 2015, BRIT J SPORT MED, V49, P259, DOI 10.1136/bjsports-2012-091517; Keays G, 2012, INJURY PREV, V18, P138, DOI 10.1136/injuryprev-2011-040240; Laforest S, 2001, Inj Prev, V7, P35, DOI 10.1136/ip.7.1.35; Loder RT, 2008, J PEDIATR SURG, V43, P691, DOI 10.1016/j.jpedsurg.2007.12.061; Mack M G, 1997, Inj Prev, V3, P100, DOI 10.1136/ip.3.2.100; Mack M G, 2000, Inj Prev, V6, P141, DOI 10.1136/ip.6.2.141; McCambridge TM, 2006, PEDIATRICS, V117, P1834, DOI 10.1542/peds.2006-0472; Milteer RM, 2012, PEDIATRICS, V129, pE204, DOI 10.1542/peds.2011-2953; Murray R, 2013, PEDIATRICS, V131, P183, DOI 10.1542/peds.2012-2993; Nelson MC, 2006, PEDIATRICS, V117, P1281, DOI 10.1542/peds.2005-1692; Norton C, 2004, ARCH DIS CHILD, V89, P103, DOI 10.1136/adc.2002.013045; Potwarka LR, 2008, J COMMUN HEALTH, V33, P344, DOI 10.1007/s10900-008-9104-x; Schmalz DL, 2007, J ADOLESCENT HEALTH, V41, P559, DOI 10.1016/j.jadohealth.2007.07.001; Schroeder T., NEISS SAMPLE DESIGN; Sherker S, 2005, INJURY PREV, V11, P120, DOI 10.1136/ip.2004.007310; Sherker S, 2004, MED J AUSTRALIA, V180, P562, DOI 10.5694/j.1326-5377.2004.tb06092.x; Sherker S, 2003, INJURY PREV, V9, P279, DOI 10.1136/ip.9.3.279; Singh A, 2012, ARCH PEDIAT ADOL MED, V166, P49, DOI 10.1001/archpediatrics.2011.716; US Census Bureau, NAT INT TABL 2000 20; US Census Bureau, ANN EST RES POP SING ANN EST RES POP SING; US Consumer Product Safety Commission, PUBL PLAYGR SAF HDB; Vollman D, 2009, CLIN PEDIATR, V48, P66, DOI 10.1177/0009922808321898	34	13	13	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	MAY	2018	57	5					584	592		10.1177/0009922817732144			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	GC4TA	WOS:000429776500011	28937299				2022-02-06	
J	Grande, LJ; Robinson, ME; Radigan, LJ; Levin, LK; Fortier, CB; Milberg, WP; McGlinchey, RE				Grande, Laura J.; Robinson, Meghan E.; Radigan, Lauren J.; Levin, Laura K.; Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.			Verbal Memory Deficits in OEF/OIF/OND Veterans Exposed to Blasts at Close Range	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Blast; Memory; Returning Veterans; Concussion; mTBI; PTSD	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; POSTTRAUMATIC-STRESS-DISORDER; SYMPTOM VALIDITY TEST; IRAQI FREEDOM; CLINICAL CHARACTERISTICS; FUNCTIONAL CONNECTIVITY; COGNITIVE PERFORMANCE; MILITARY PERSONNEL; ENDURING FREEDOM	Objectives: This study investigated the relationship between close proximity to detonated blast munitions and cognitive functioning in OEF/OIF/OND Veterans. Methods: A total of 333 participants completed a comprehensive evaluation that included assessment of neuropsychological functions, psychiatric diagnoses and history of military and non-military brain injury. Participants were assigned to a Close-Range Blast Exposure (CBE) or Non-Close-Range Blast Exposure (nonCBE) group based on whether they had reported being exposed to at least one blast within 10 meters. Results: Groups were compared on principal component scores representing the domains of memory, verbal fluency, and complex attention (empirically derived from a battery of standardized cognitive tests), after adjusting for age, education, PTSD diagnosis, sleep quality, substance abuse disorder, and pain. The CBE group showed poorer performance on the memory component. Rates of clinical impairment were significantly higher in the CBE group on select CVLT-II indices. Exploratory analyses examined the effects of concussion and multiple blasts on test performance and revealed that number of lifetime concussions did not contribute to memory performance. However, accumulating blast exposures at distances greater than 10 meters did contribute to poorer performance. Conclusions: Close proximity to detonated blast munitions may impact memory, and Veterans exposed to close-range blast are more likely to demonstrate clinically meaningful deficits. These findings were observed after statistically adjusting for comorbid factors. Results suggest that proximity to blast should be considered when assessing for memory deficits in returning Veterans. Comorbid psychiatric factors may not entirely account for cognitive difficulties.	[Grande, Laura J.] VA Boston Healthcare Syst, Psychol Serv, Boston, MA USA; [Grande, Laura J.; Robinson, Meghan E.; Radigan, Lauren J.; Levin, Laura K.; Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Grande, Laura J.; Robinson, Meghan E.; Radigan, Lauren J.; Levin, Laura K.; Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, GRECC, Boston, MA USA; [Grande, Laura J.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Robinson, Meghan E.] VA Boston Healthcare Syst, Neuroimaging Res Vet NeRVe Ctr, Boston, MA USA; [Robinson, Meghan E.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Radigan, Lauren J.] Wayne State Univ, Dept Psychol, Detroit, MA USA; [Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA USA		Grande, LJ (corresponding author), Psychol Serv 116B, 150 South Huntington Ave, Boston, MA 02132 USA.	laura.grande@va.gov	Fortier, Catherine/AAS-2163-2021	Fortier, Catherine/0000-0002-8953-9904	CSRD VA [I01 CX001327] Funding Source: Medline; Veterans AffairsUS Department of Veterans Affairs [I50RX003001, I01CX001327] Funding Source: NIH RePORTER		Alosco ML, 2016, J HEAD TRAUMA REHAB, V31, P360, DOI 10.1097/HTR.0000000000000201; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Armstrong T, 2011, BEHAV RES THER, V49, P756, DOI 10.1016/j.brat.2011.08.003; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Blake D, 2006, J TRAUMA STRESS, V8, P75; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Clark US, 2007, NEUROPSYCHOLOGY, V21, P346, DOI 10.1037/0894-4105.21.3.346; Cooper DB, 2014, J REHABIL RES DEV, V51, P1023, DOI [10.1682/JRRD.2013.05.0104, 10.1682/JRRD.2013.05.0140]; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Delis D.C., 1999, CALIFORNIA VERBAL LE, VSecond; Delis DC., 2001, DELIS KAPLAN EXECUTI; First M.B., 1996, STRUCTURED CLIN INTE; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; GOLINKOFF M, 1989, J AFFECT DISORDERS, V17, P105, DOI 10.1016/0165-0327(89)90032-3; Green P., 2004, MED SYMPTOM VALIDITY; GREENBERG LM, 1993, J CHILD PSYCHOL PSYC, V34, P1019, DOI 10.1111/j.1469-7610.1993.tb01105.x; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Heaton R. K., 2004, REVISED COMPREHENSIV; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Iudicello JE, 2011, CLIN NEUROPSYCHOL, V25, P269, DOI 10.1080/13854046.2010.546812; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kim JS, 2015, NEURODEGENER DIS, V15, P294, DOI 10.1159/000430953; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; MacNamara A, 2014, J ABNORM PSYCHOL, V123, P557, DOI 10.1037/a0036997; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Miller MA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00224; Montgomery C, 2012, HUM PSYCHOPHARM CLIN, V27, P217, DOI 10.1002/hup.1273; Neipert L, 2014, BRAIN INJURY, V28, P1667, DOI 10.3109/02699052.2014.947623; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Piechatzek M, 2009, HUM PSYCHOPHARM CLIN, V24, P650, DOI 10.1002/hup.1069; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Rourke S. B., 2009, NEUROPSYCHOLOGICAL A, P398; Soble JR, 2013, J CLIN EXP NEUROPSYC, V35, P551, DOI 10.1080/13803395.2013.798398; Solowij Nadia, 2008, Curr Drug Abuse Rev, V1, P81; Stevens S. S, 2002, APPL MULTIVARIATE ST; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Stricker NH, 2017, J CLIN EXP NEUROPSYC, V39, P768, DOI 10.1080/13803395.2016.1264575; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Wong YC, 2014, J NEUROTRAUM, V31, pA25	68	13	13	1	7	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2018	24	5					466	475		10.1017/S1355617717001242			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	GD5LH	WOS:000430548000006	29362020				2022-02-06	
J	Jahan-Abad, AJ; Alizadeh, L; Negah, SS; Barati, P; Ghadiri, MK; Meuth, SG; Kovac, S; Gorji, A				Jahan-Abad, Ali Jahanbazi; Alizadeh, Leila; Negah, Sajad Sahab; Barati, Parastoo; Ghadiri, Maryam Khaleghi; Meuth, Sven G.; Kovac, Stjepana; Gorji, Ali			Apoptosis Following Cortical Spreading Depression in Juvenile Rats	MOLECULAR NEUROBIOLOGY			English	Article						Spreading depolarization; Cell injury; Developing brain; Migraine; Stroke; Epilepsy	AUTOSOMAL-DOMINANT ARTERIOPATHY; TRAUMATIC BRAIN-INJURY; SUBCORTICAL INFARCTS; EVENTS RESULT; CELL-DAMAGE; DEATH; CYTOTOXICITY; HIPPOCAMPUS; INHIBITION; MECHANISMS	Repetitive cortical spreading depression (CSD) can lead to cell death in immature brain tissue. Caspases are involved in neuronal cell death in several CSD-related neurological disorders, such as stroke and epilepsy. Yet, whether repetitive CSD itself can induce caspase activation in adult or juvenile tissue remains unknown. Inducing repetitive CSD in somatosensory cortices of juvenile and adult rats in vivo, we thus aimed to investigate the effect of repetitive CSD on the expression caspase-3, caspase-8, caspase-9, and caspase-12 in different brain regions using immunohistochemistry and western blotting techniques. Higher numbers of dark neurons and TUNEL-positive cells were observed in the hippocampal CA1 and CA3 regions as well as in the entorhinal and somatosensory cortices after CSD in juvenile rats. This was accompanied by higher expressions of caspase-3, caspase-8, and caspase-9. Caspase-12 levels remained unchanged after CSD, suggesting that endoplasmic reticulum stress is not involved in CSD-triggered apoptosis. Changes in caspase expression were paralleled by a decrease of procaspase-3, procaspase-8, and procaspase-9 in juvenile rat brain tissue subjected to CSD. In contrast, repetitive CSD in adult rats did not result in the upregulation of caspase signaling. Our data points to a maturation-dependent vulnerability of brain tissue to repetitive CSD with a higher degree of apoptotic damage and caspase upregulation observed in juvenile tissue. Findings suggest a key role of caspase signaling in CSD-induced cell death in the immature brain. This implies that anti-apoptotic treatment may prevent CSD-related functional deficits in the immature brain.	[Jahan-Abad, Ali Jahanbazi; Alizadeh, Leila; Barati, Parastoo; Gorji, Ali] Khatam Alanbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran; [Negah, Sajad Sahab; Gorji, Ali] Mashhad Univ Med Sci, Dept Neurosci, Mashhad, Iran; [Ghadiri, Maryam Khaleghi; Gorji, Ali] Westfalische Wilhelms Univ Munster, Dept Neurosurg, Munster, Germany; [Meuth, Sven G.; Kovac, Stjepana; Gorji, Ali] Westfalische Wilhelms Univ Munster, Dept Neurol, Munster, Germany; [Gorji, Ali] Westfalische Wilhelms Univ Munster, Epilepsy Res Ctr, Robert Koch Str 45, D-48149 Munster, Germany		Gorji, A (corresponding author), Khatam Alanbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran.; Gorji, A (corresponding author), Mashhad Univ Med Sci, Dept Neurosci, Mashhad, Iran.; Gorji, A (corresponding author), Westfalische Wilhelms Univ Munster, Dept Neurosurg, Munster, Germany.; Gorji, A (corresponding author), Westfalische Wilhelms Univ Munster, Dept Neurol, Munster, Germany.; Gorji, A (corresponding author), Westfalische Wilhelms Univ Munster, Epilepsy Res Ctr, Robert Koch Str 45, D-48149 Munster, Germany.	gorjial@uni-muenster.de	Jahan-Abad, Ali Jahanbazi/AAW-3641-2021; Negah, Sajad Sahab/AAQ-5852-2020	Jahan-Abad, Ali Jahanbazi/0000-0001-8629-7762; Gorji, Ali/0000-0002-4557-3270; naseri, shahrokh/0000-0001-8974-2120	Iran National Science Foundation (INSF)Iran National Science Foundation (INSF)	This study was supported by the Iran National Science Foundation (INSF) to AG.	Akpan N, 2011, J NEUROSCI, V31, P8894, DOI 10.1523/JNEUROSCI.0698-11.2011; Lopez-Ramirez MA, 2012, J IMMUNOL, V189, P3130, DOI 10.4049/jimmunol.1103460; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bures J, 1974, MECH APPL LEAOS SPRE; Eikermann-Haerter K, 2011, ANN NEUROL, V69, P413, DOI 10.1002/ana.22281; Formichi P, 2009, J CELL PHYSIOL, V219, P494, DOI 10.1002/jcp.21695; Fukuda H, 2004, CELL DEATH DIFFER, V11, P1166, DOI 10.1038/sj.cdd.4401472; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Ghaemi A, 2017, CEPHALALGIA; Ghaemi A, 2016, MOL NEUROBIOL, V53, P143, DOI 10.1007/s12035-014-8995-z; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; Gray F, 2007, J NEUROPATH EXP NEUR, V66, P597, DOI 10.1097/nen.0b013e318093e574; HABLITZ JJ, 1989, DEV BRAIN RES, V46, P243, DOI 10.1016/0165-3806(89)90288-5; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; HERRERAS O, 1993, BRAIN RES, V610, P283, DOI 10.1016/0006-8993(93)91412-L; Jafarian M, 2010, NEUROSCIENCE, V169, P388, DOI 10.1016/j.neuroscience.2010.04.062; JANIGRO D, 1987, BRAIN RES, V404, P189, DOI 10.1016/0006-8993(87)91370-9; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Kimura H, 2003, BRAIN RES, V990, P148, DOI 10.1016/S0006-8993(03)03450-4; Kovac S, 2013, NEUROPHARMACOLOGY, V69, P96, DOI 10.1016/j.neuropharm.2012.05.012; KRAIG RP, 1991, J NEUROSCI, V11, P2187; Kramer DR, 2016, J CLIN NEUROSCI, V24, P22, DOI 10.1016/j.jocn.2015.08.004; Kunkler PE, J CEREB BLOOD FLOW M, V24, P829; Lambert C, 2016, MOL NEUROBIOL, V53, P2297, DOI 10.1007/s12035-015-9138-x; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; Ooigawa H, 2006, ACTA NEUROPATHOL, V112, P471, DOI 10.1007/s00401-006-0108-2; Pomper JK, 2006, J NEUROPHYSIOL, V95, P355, DOI 10.1152/jn.00186.2005; Reed JC, 1999, CANC DRUG DISC DEV, V5, P99; Robertson GS, 2000, BRAIN PATHOL, V10, P283, DOI 10.1111/j.1750-3639.2000.tb00262.x; Sadeghian H, 2012, EXP NEUROL, V233, P438, DOI 10.1016/j.expneurol.2011.11.017; Schierle GS, 1999, NAT MED, V5, P97, DOI 10.1038/4785; Schwarz JM, 2012, HORM BEHAV, V62, P243, DOI 10.1016/j.yhbeh.2012.02.018; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shabanzadeh AP, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.272; Shen Y, 2012, J NEUROSCI RES, V90, P105, DOI 10.1002/jnr.22722; Somjen GG, 2006, J NEUROPHYSIOL, V95, P16, DOI 10.1152/jn.01008.2005; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Yu YF, 2012, P NATL ACAD SCI USA, V109, P2585, DOI 10.1073/pnas.1121111109	44	13	13	1	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	MAY	2018	55	5					4225	4239		10.1007/s12035-017-0642-z			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB7EY	WOS:000429238900048	28612259				2022-02-06	
J	Kappy, NS; Chang, SH; Harris, WM; Plastini, M; Ortiz, T; Zhang, P; Hazelton, JP; Carpenter, JP; Brown, SA				Kappy, Nikolas S.; Chang, Shaohua; Harris, William M.; Plastini, Michael; Ortiz, Telisha; Zhang, Ping; Hazelton, Joshua P.; Carpenter, Jeffrey P.; Brown, Spencer A.			Human adipose-derived stem cell treatment modulates cellular protection in both in vitro and in vivo traumatic brain injury models	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Adipose-derived stem cells; cytokines; inflammation; traumatic brain injury	NECROSIS-FACTOR-ALPHA; RATS; SECRETOME	BACKGROUND Traumatic brain injury (TBI) is a common cause of morbidity and mortality in the civilian population. The purpose of this study was to examine the effect(s) of adipose-derived stem cell (ASC) treatment on cellular and functional recovery in TBI via both in vitro and in vivo methods. METHODS Cultured neuroblastoma cells, SH-SY5Y, were scratched to mimic TBI in an in vitro model. The effect of ASC-conditioned medium (CM) on cell death, mitochondrial function, and expression of inflammatory cytokines (tumor necrosis factor [TNF-], interleukin 1 [IL-1], and IL-6), as well as apoptosis marker FAS, was measured. In our in vivo model, Sprague-Dawley rats underwent TBI via a frontal, closed-head injury model. Animals randomly received either intravenous human-derived ASCs or intravenous saline within 3 hours of injury and were compared with a sham group. Functional recovery was evaluated via accelerating Rotarod method. On post-TBI Day 3, brain tissue was harvested and assessed for cellular damage via enzyme-linked immunosorbent assay for TNF-, as well as immunohistochemical staining for -amyloid precursor protein (-APP). RESULTS Our in vitro data show that ASC treatment imparted reduced cell death (ratio to control: 1.21 0.066 vs. 1.01 +/- 0.056, p = 0.017), increased cell viability (ratio to control: 0.86 +/- 0.009 vs. 1.09 +/- 0.01, p = 0.0001), increased mitochondrial function (percentage of control: 78 +/- 6% vs. 68 +/- 3%), and significantly decreased levels of inflammatory cytokine IL-1. In our in vivo study, compared with TBI alone, ASC-treated animals showed no difference in functional recovery, lower levels of expressed TNF- (ratio to total protein, 0.47 +/- 0.01 vs. 0.67 +/- 0.04; p < 0.01), and lower levels of -amyloid precursor protein (fluorescence ratio, 0.43 +/- 0.05 vs. 0.69 +/- 0.03; p < 0.01). CONCLUSIONS Adipose-derived stem cell treatment results in improved cell survival, decreased inflammatory marker release, and decreased evidence of neural injury. No difference in functional recovery was seen. These data suggest the potential for ASC treatment to aid in cellular protection and recovery in neural cells following TBI.	[Kappy, Nikolas S.; Chang, Shaohua; Harris, William M.; Plastini, Michael; Ortiz, Telisha; Zhang, Ping; Carpenter, Jeffrey P.; Brown, Spencer A.] Cooper Univ Hosp, Dept Surg, Camden, NJ USA; [Hazelton, Joshua P.] Cooper Univ Hosp, Div Trauma, Camden, NJ USA		Kappy, NS (corresponding author), 3 Cooper Plaza,Suite 411, Camden, NJ 08103 USA.	Kappy-Nikolas@CooperHealth.edu					Anbari F, 2014, NEURAL REGEN RES, V9, P919, DOI 10.4103/1673-5374.133133; Bird SM, 2016, NEUROSCI BIOBEHAV R, V64, P215, DOI 10.1016/j.neubiorev.2016.01.004; Chuang TJ, 2012, J TRAUMA ACUTE CARE, V73, P1161, DOI 10.1097/TA.0b013e318265d128; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Dekmak A, 2016, BEHAV BRAIN RES; Kapur SK, 2013, BIOCHIMIE, V95, P2222, DOI 10.1016/j.biochi.2013.06.001; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Kishimoto Y, 2016, DATA BRIEF, V9, P62, DOI 10.1016/j.dib.2016.08.041; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mert T, 2015, INFLAMMATION, V38, P1302, DOI 10.1007/s10753-014-0101-1; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; Post AF, 2013, TRAUMA; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; Selianina N V, 2013, Zh Vopr Neirokhir Im N N Burdenko, V77, P22; Selianina N.V., 2013, ZHURNAL VOPROSY NEIR, V77, P27; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Trembovler V, 1999, J INTERF CYTOK RES, V19, P791, DOI 10.1089/107999099313640; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	22	13	14	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2018	84	5					745	751		10.1097/TA.0000000000001770			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	GE7LT	WOS:000431415300008	29251705				2022-02-06	
J	Li, L; Ma, XY; Pandey, S; Deng, XY; Chen, SY; Cui, DM; Gao, L				Li, Lei; Ma, Xiaoye; Pandey, Sajan; Deng, Xianyu; Chen, Songyu; Cui, Daming; Gao, Liang			The Most-Cited Works in Severe Traumatic Brain Injury: A Bibliometric Analysis of the 100 Most Cited Articles	WORLD NEUROSURGERY			English	Article						Bibliometric analysis; Citation classics; Severe traumatic brain injury	IMPACT; JOURNALS; PATTERNS	BACKGROUND: There is an abundance of works published on severe traumatic brain injury (sTBI). Bibliometric analyses aim to provide a macroscopic view of research activities regarding sTBI and are helpful in determining the most impactful studies within this field. METHODS: We performed a generalized search using the database of Web of Science, organized the references by the number of citations, and reviewed full length-articles for the top-100 most-cited articles on sTBI. The articles were classified according to focus. RESULTS: The top-100 articles were cited on average 326.4 times per paper. The Journal of Neurosurgery published the greatest number of top-100 cited articles (9 of 100). Authors from the United States published the majority (67%) of the most-cited articles. The most popular categories were "reviews and guidelines" and "etiology and epidemiology." CONCLUSIONS: The present study provides a cross-sectional summary of the 100 most-cited articles on sTBI, highlighting areas of research needing further investigation and development.	[Li, Lei; Pandey, Sajan; Deng, Xianyu; Chen, Songyu; Cui, Daming; Gao, Liang] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Neurosurg, Shanghai, Peoples R China; [Ma, Xiaoye] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Neurol, Shanghai, Peoples R China		Cui, DM (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Neurosurg, Shanghai, Peoples R China.	damingcui@hotmail.com			Health and Family Planning Commission [03.02.16.001]	This work was supported by Health and Family Planning Commission Grant 03.02.16.001, to Liang Gao. The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Alotaibi NM, 2016, WORLD NEUROSURG, V89, P587, DOI 10.1016/j.wneu.2015.11.072; Arunachalam L, 2017, ANN SURG, V265, P1141, DOI 10.1097/SLA.0000000000001795; Carter CS, 2015, BIOL PSYCHIAT, V78, P434, DOI 10.1016/j.biopsych.2015.08.004; Charleswell C, 2015, J EPIDEMIOL COMMUN H, V69, P290, DOI 10.1136/jech-2014-204239; Coller BS, 2015, BLOOD, V126, P2548, DOI 10.1182/blood-2015-09-659581; Gal D, 2017, EUR HEART J, V38, P1249, DOI 10.1093/eurheartj/ehw459; GARFIELD E, 1987, JAMA-J AM MED ASSOC, V257, P52, DOI 10.1001/jama.257.1.52; Hirshman BR, 2016, ANN NEUROL, V79, P169, DOI 10.1002/ana.24569; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kim HJ, 2016, NEUROIMAGE, V139, P149, DOI 10.1016/j.neuroimage.2016.06.029; Leng ZK, 2013, NEURAL REGEN RES, V8, P1286, DOI 10.3969/j.issn.1673-5374.2013.14.005; Leopold S, 2015, CLIN ORTHOP RELAT R, V473, P3695, DOI 10.1007/s11999-015-4516-2; Lin C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13442; Loomes DE, 2013, GASTROENTEROLOGY, V144, P673, DOI 10.1053/j.gastro.2013.02.013; Maas AIR, 2012, LANCET NEUROL, V11, P12, DOI 10.1016/S1474-4422(11)70267-8; Mimouni M, 2016, OPHTHALMOLOGY, V123, P1824, DOI 10.1016/j.ophtha.2016.04.034; Pagel PS, 2015, ANESTHESIOLOGY, V123, P683, DOI 10.1097/ALN.0000000000000737; Parikh LI, 2017, OBSTET GYNECOL, V129, P243, DOI 10.1097/AOG.0000000000001852; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Raheja A, 2016, J NEUROSURG, V125, P631, DOI 10.3171/2015.6.JNS15674; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sardanelli F, 2014, RADIOLOGY, V272, P533, DOI 10.1148/radiol.14131730; Sharma B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00879; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Sweileh WM, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0476-7	26	13	13	2	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2018	113						E82	E87		10.1016/j.wneu.2018.01.164			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8JD	WOS:000432942700011	29409928				2022-02-06	
J	Schwartz, JA; Connolly, EJ; Valgardson, BA				Schwartz, Joseph A.; Connolly, Eric J.; Valgardson, Bradon A.			An evaluation of the directional relationship between head injuries and subsequent changes in impulse control and delinquency in a sample of previously adjudicated males	JOURNAL OF CRIMINAL JUSTICE			English	Article						Head injury; Impulse control; Delinquency; Life-course criminology	TRAUMATIC BRAIN-INJURY; LOW SELF-CONTROL; GENETICALLY INFORMED TEST; ANTISOCIAL-BEHAVIOR; RISK-TAKING; ENVIRONMENTAL-INFLUENCES; PARENTAL SOCIALIZATION; EXECUTIVE FUNCTIONS; SENSATION SEEKING; DECISION-MAKING	Research over the past decade has found that head injuries are associated with negative outcomes including lower levels of self-control and a greater prevalence of delinquent behavior. Despite this pattern of findings, previous research remains unclear as to whether head injuries influence subsequent levels of self-control and delinquency, or whether lower levels of self-control increase the likelihood of sustaining a head injury. The current study begins to address this gap in the literature by analyzing longitudinal data spanning from childhood to young adulthood on adolescent offenders from the Pathways to Desistance study. A series of cross-lagged autoregressive path models were estimated to examine the prospective associations between head injuries, changes in impulse control (a dimension of self-control), and delinquency while controlling for stability in all three constructs. Findings indicate: 1) impulse control and delinquency displayed significant levels of stability across the study period; 2) head injuries appear to occur prior to decreases in impulse control; 3) decreases in impulse control do not appear to systematically increase the odds of sustaining future head injuries; and 4) head injuries did not appear to result in systematic increases in delinquent behavior across the life course.	[Schwartz, Joseph A.; Valgardson, Bradon A.] Univ Nebraska, Sch Criminol & Criminal Justice, 218 CPACS,6001 Dodge St, Omaha, NE 68182 USA; [Connolly, Eric J.] Sam Houston State Univ, Coll Criminal Justice, Huntsville, TX 77340 USA		Schwartz, JA (corresponding author), Univ Nebraska, Sch Criminol & Criminal Justice, 218 CPACS,6001 Dodge St, Omaha, NE 68182 USA.	jaschwartz@unomaha.edu		Connolly, Eric/0000-0003-4714-6739	Office of Juvenile Justice and Delinquency Prevention [2007-MU-FX-0002]; National Institute of Justice [2008-IJ-CX-0023]; John D. and Catherine T. MacArthur Foundation; William T. Grant Foundation; Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF); William Penn Foundation; Center for Disease Control, National Institute on Drug Abuse [R01DA019697]; Pennsylvania Commission on Crime and Delinquency; Arizona Governor's Justice Commission	The authors would like to thank Jon Brauer for thoughtful comments on previous drafts of this study. We would also like to thank Ryan Meldrum and the anonymous reviewers for their suggestions and comments, which have certainly strengthened this study. The content of the article is the authors' sole responsibility and any errors or omissions are solely ours. The project described was supported by funds from the following: Office of Juvenile Justice and Delinquency Prevention (2007-MU-FX-0002), National Institute of Justice (2008-IJ-CX-0023), John D. and Catherine T. MacArthur Foundation, William T. Grant Foundation, Robert Wood Johnson Foundation, William Penn Foundation, Center for Disease Control, National Institute on Drug Abuse (R01DA019697), Pennsylvania Commission on Crime and Delinquency, and the Arizona Governor's Justice Commission. We are grateful for their support. The content of this paper, however, is solely the responsibility of the authors and does not necessarily represent the official views of these agencies.	Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Barnes JC, 2017, J QUANT CRIMINOL, V33, P319, DOI 10.1007/s10940-016-9298-5; Barnfield TV, 1998, BRAIN INJURY, V12, P951, DOI 10.1080/026990598122007; Beaver KM, 2007, CRIM JUSTICE BEHAV, V34, P1345, DOI 10.1177/0093854807302049; Beaver KM, 2013, J CRIM JUST, V41, P300, DOI 10.1016/j.jcrimjus.2013.07.003; Beaver KM, 2009, CRIM JUSTICE BEHAV, V36, P41, DOI 10.1177/0093854808326992; Behnken M. P., 2015, ROUDEDGE INT HDB BIO; Boals A, 2011, PSYCHOL HEALTH, V26, P1049, DOI 10.1080/08870446.2010.529139; Boutwell BB, 2010, J RES CRIME DELINQ, V47, P174, DOI 10.1177/0022427809357715; Brame Robert, 2004, Youth Violence Juv Justice, V2, P256, DOI 10.1177/1541204004265877; Brauer JR, 2017, J RES ADOLESCENCE, V27, P452, DOI 10.1111/jora.12283; Burt CH, 2006, CRIMINOLOGY, V44, P353, DOI 10.1111/j.1745-9125.2006.00052.x; Cauffman E, 2005, CRIMINOLOGY, V43, P133, DOI 10.1111/j.0011-1348.2005.00005.x; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Connolly EJ, 2014, J INTERPERS VIOLENCE, V29, P707, DOI 10.1177/0886260513505209; Cristofori I, 2016, J NEUROSCI, V36, P2757, DOI 10.1523/JNEUROSCI.2975-15.2016; de Ridder DTD, 2012, PERS SOC PSYCHOL REV, V16, P76, DOI 10.1177/1088868311418749; DelBello MP, 1999, PSYCHIAT RES, V89, P281, DOI 10.1016/S0165-1781(99)00112-2; DeLisi M., 2014, NURTURE VERSUS BIOSO, P172, DOI [10.4135/9781483349114.n11, DOI 10.4135/9781483349114.N11]; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fishbein D, 2016, INT J OFFENDER THER, V60, P575, DOI 10.1177/0306624X14554778; Forth A. E., 2003, HARE PSYCHOPATHY CHE; Franken A, 2016, J YOUTH ADOLESCENCE, V45, P1800, DOI 10.1007/s10964-015-0287-z; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Gibson CL, 2010, J RES CRIME DELINQ, V47, P31, DOI 10.1177/0022427809348903; Gottfredson M. R., 1990, GEN THEORY CRIME; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Harden KP, 2012, DEVELOPMENTAL SCI, V15, P150, DOI 10.1111/j.1467-7687.2011.01115.x; Harden KP, 2011, DEV PSYCHOL, V47, P739, DOI 10.1037/a0023279; Hay C, 2001, CRIMINOLOGY, V39, P707, DOI 10.1111/j.1745-9125.2001.tb00938.x; Hay C., 2016, SELF CONTROL CRIME L; Hay C, 2006, CRIMINOLOGY, V44, P739, DOI 10.1111/j.1745-9125.2006.00062.x; HOLLINGSHEAD AB, 1971, SOC FORCES, V49, P563, DOI 10.2307/2576737; Holtfreter K, 2008, CRIMINOLOGY, V46, P189, DOI 10.1111/j.1745-9125.2008.00101.x; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; HUIZINGA D, 1991, J CRIM LAW CRIM, V82, P83, DOI 10.2307/1143790; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jennings WG, 2010, J INTERPERS VIOLENCE, V25, P2147, DOI 10.1177/0886260509354888; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; Knight George P, 2004, Youth Violence Juv Justice, V2, P273, DOI 10.1177/1541204004265878; Langevin R, 2006, BRAIN COGNITION, V60, P206; Lauritsen J. L., 2007, CRIME PREVENTION STU, V22, P55; LAURITSEN JL, 1991, CRIMINOLOGY, V29, P265, DOI 10.1111/j.1745-9125.1991.tb01067.x; Lauterbach MD, 2015, NEUROPSYCH DIS TREAT, V11, P1601, DOI 10.2147/NDT.S80457; Loughran TA, 2011, CRIMINOLOGY, V49, P1029, DOI 10.1111/j.1745-9125.2011.00251.x; May G, 2013, ANN CLIN PSYCHIATRY, V25, P289; McDonald BC, 2017, NEUROPSYCHOPHARMACOL, V42, P1766, DOI 10.1038/npp.2016.261; Meldrum RC, 2018, INT J OFFENDER THER, V62, P935, DOI 10.1177/0306624X16662921; Meldrum RC, 2015, CRIM JUSTICE BEHAV, V42, P1183, DOI 10.1177/0093854815595662; Meldrum RC, 2012, J CRIM JUST, V40, P452, DOI 10.1016/j.jcrimjus.2012.07.002; Meldrum RC, 2012, J YOUTH ADOLESCENCE, V41, P691, DOI 10.1007/s10964-011-9692-0; Miller HV, 2011, AM J HEALTH BEHAV, V35, P15; Moffitt T., 2001, SEX DIFFERENCES ANTI; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Monahan KC, 2013, DEV PSYCHOPATHOL, V25, P1093, DOI 10.1017/S0954579413000394; Mulvey E.P., DOI 10.3886/ICPSR29961.v2; Mulvey Edward P, 2004, Youth Violence Juv Justice, V2, P213, DOI 10.1177/1541204004265864; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Nedelec JL, 2014, J CRIM JUST, V42, P288, DOI 10.1016/j.jcrimjus.2014.02.002; Nofziger S, 2008, J RES CRIME DELINQ, V45, P191, DOI 10.1177/0022427807313708; Perron B. E., 2015, INT HDB BIOSOCIAL CR; Piquero AR, 2017, YOUTH VIOLENCE JUV J, V15, P359, DOI 10.1177/1541204016657396; Piquero AR, 2016, J EXP CRIMINOL, V12, P249, DOI 10.1007/s11292-016-9257-z; Piquero AR, 2013, CRIME DELINQUENCY, V59, P738, DOI 10.1177/0011128712459491; Polito MZ, 2010, J AM ACAD NURSE PRAC, V22, P504, DOI 10.1111/j.1745-7599.2010.00540.x; Pratt TC, 2000, CRIMINOLOGY, V38, P931, DOI 10.1111/j.1745-9125.2000.tb00911.x; Pratt TC, 2004, J RES CRIME DELINQ, V41, P219, DOI 10.1177/0022427803260270; Pratt TC, 2016, EUR J CRIMINOL, V13, P129, DOI 10.1177/1477370815587771; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Ray B, 2017, CRIM JUSTICE BEHAV, V44, P472, DOI 10.1177/0093854816686631; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Romer D, 2010, PREV SCI, V11, P319, DOI 10.1007/s11121-010-0171-8; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schubert Carol A, 2004, Youth Violence Juv Justice, V2, P237, DOI 10.1177/1541204004265875; Schwartz J. A., 2017, J RES CRIME DELINQUE; Schwartz JA, 2014, J AFFECT DISORDERS, V164, P139, DOI 10.1016/j.jad.2014.04.015; Selner-O'Hagan MB, 1998, J CHILD PSYCHOL PSYC, V39, P215, DOI 10.1017/S002196309700187X; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Shulman EP, 2017, CHILD DEV, V88, P16, DOI 10.1111/cdev.12684; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2007, CURR DIR PSYCHOL SCI, V16, P55, DOI 10.1111/j.1467-8721.2007.00475.x; Steinberg L, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12532; Sullivan CJ, 2014, J QUANT CRIMINOL, V30, P709, DOI 10.1007/s10940-014-9220-y; Sweeten G, 2012, J QUANT CRIMINOL, V28, P533, DOI 10.1007/s10940-011-9160-8; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Teasdale B, 2009, SOC PROBL, V56, P205, DOI 10.1525/sp.2009.56.1.205; Turner MG, 2005, J CRIM JUST, V33, P327, DOI 10.1016/j.jcrimjus.2005.04.003; Vazsonyi AT, 2017, J CRIM JUST, V48, P48, DOI 10.1016/j.jcrimjus.2016.10.001; Walters GD, 2014, AGGRESSIVE BEHAV, V40, P238, DOI 10.1002/ab.21514; Wechsler D., 2011, WECHSLER ABBREVIATED; WEINBERGER DA, 1990, J PERS, V58, P381, DOI 10.1111/j.1467-6494.1990.tb00235.x; Wright JP, 2005, CRIMINOLOGY, V43, P1169, DOI 10.1111/j.1745-9125.2005.00036.x; Yuan P, 2014, NEUROSCI BIOBEHAV R, V42, P180, DOI 10.1016/j.neubiorev.2014.02.005	98	13	13	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0047-2352	1873-6203		J CRIM JUST	J. Crim. Justice	MAY-JUN	2018	56				SI		70	80		10.1016/j.jcrimjus.2017.08.004			11	Criminology & Penology	Social Science Citation Index (SSCI)	Criminology & Penology	GH4UM	WOS:000433400300009					2022-02-06	
J	Townsend, JM; Zabel, TA; Feng, Y; Wang, J; Andrews, BT; Nudo, RJ; Berkland, CJ; Detamore, MS				Townsend, Jakob M.; Zabel, Taylor A.; Feng, Yi; Wang, Jinxi; Andrews, Brian T.; Nudo, Randolph J.; Berkland, Cory J.; Detamore, Michael S.			Effects of tissue processing on bioactivity of cartilage matrix-based hydrogels encapsulating osteoconductive particles	BIOMEDICAL MATERIALS			English	Article						hydrogel; traumatic brain injury; syndrome of the trephined; decellularized; cartilage; calvarial bone; photocrosslinking	DEMINERALIZED BONE-MATRIX; DECOMPRESSIVE CRANIECTOMY; SCAFFOLDS; GELATIN; GROWTH; BIOMATERIALS; REGENERATION; INJURY; REPAIR; GELS	In the treatment of severe traumatic brain injury (TBI), decompressive craniectomy is commonly used to remove a large portion of calvarial bone to allow unimpeded brain swelling. Hydrogels have the potential to revolutionize TBI treatment by permitting a single-surgical intervention, remaining pliable during brain swelling, and tuned to regenerate bone after swelling has subsided. With this motivation, our goal is to present a pliable material capable of regenerating calvarial bone across a critical size defect. We therefore proposed the use of a methacrylated solubilized decellularized cartilage (MeSDCC) hydrogel encapsulating synthetic osteogenic particles of hydroxyapatite nanofibers, bioglass microparticles, or added rat bone marrow-derived mesenchymal stem cells (rMSCs) for bone regeneration in critical-size rat calvarial defects. Fibrin hydrogels were employed as a control material for the study. MeSDCC hydrogels exhibited sufficient rheological performance for material placement before crosslinking (tau(y) > 500 Pa), and sufficient compressive moduli post-crosslinking (E > 150 kPa). In vitro experiments suggested increased calcium deposition for cells seeded on the MeSDCC material; however, in vivo bone regeneration was minimal in both MeSDCC and fibrin groups, even with colloidal materials or added rMSCs. Minimal bone regeneration in the MeSDCC test groups may potentially be attributed to cartilage solubilization after decellularization, in which material signals may have degraded from enzymatic treatment. Looking to the future, an improvement in the bioactivity of the material will be crucial to the success of bone regeneration strategies for TBI treatment.	[Townsend, Jakob M.; Detamore, Michael S.] Univ Oklahoma, Stephenson Sch Biomed Engn, Norman, OK 73019 USA; [Zabel, Taylor A.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66047 USA; [Feng, Yi; Wang, Jinxi] Univ Kansas, Med Ctr, Dept Orthoped Surg, Kansas City, KS 66160 USA; [Andrews, Brian T.] Univ Kansas, Med Ctr, Dept Plast Surg, Kansas City, KS 66160 USA; [Nudo, Randolph J.] Univ Kansas, Med Ctr, Dept Rehabil Med, Kansas City, KS 66160 USA; [Berkland, Cory J.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA		Townsend, JM (corresponding author), Univ Oklahoma, Stephenson Sch Biomed Engn, Norman, OK 73019 USA.		Townsend, Jakob/AAH-9637-2019	Detamore, Michael/0000-0002-7525-8132; Andrews, Brian/0000-0003-3994-6808	Kansas Bioscience Authority Rising Star Award; Stephenson Graduate Fellowship; National Institute of Dental and Craniofacial Research of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01 DE022472]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01DE022472] Funding Source: NIH RePORTER	The authors would like to thank Nanova Biomaterials, Inc. and MO-SCI, Corp. for generously providing the hydroxyapatite nanofibers and bioglass microparticles, respectively. We would like to recognize funding from the Kansas Bioscience Authority Rising Star Award and the Stephenson Graduate Fellowship. Research reported in this publication was supported by the National Institute of Dental and Craniofacial Research of the National Institutes of Health under Award Number R01 DE022472. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beck EC, 2016, ACTA BIOMATER, V38, P94, DOI 10.1016/j.actbio.2016.04.019; Beck EC, 2016, ANN BIOMED ENG, V44, P1863, DOI 10.1007/s10439-015-1547-5; Beck EC, 2016, TISSUE ENG PT A, V22, P665, DOI [10.1089/ten.tea.2015.0546, 10.1089/ten.TEA.2015.0546]; Beck EC, 2015, ANN BIOMED ENG, V43, P2569, DOI 10.1007/s10439-015-1277-8; Buckley MJ, 2010, ORAL MAXIL SURG CLIN, V22, P195, DOI 10.1016/j.coms.2009.10.008; Choy DKS, 2013, TISSUE ENG PT A, V19, P2382, DOI [10.1089/ten.TEA.2012.0733, 10.1089/ten.tea.2012.0733]; Converse GL, 2012, ACTA BIOMATER, V8, P2722, DOI 10.1016/j.actbio.2012.03.047; Cunniffe GM, 2017, EUR CELLS MATER, V33, P130, DOI 10.22203/eCM.v033a10; Cunniffe GM, 2015, EUR POLYM J, V72, P464, DOI 10.1016/j.eurpolymj.2015.07.021; Cunniffe GM, 2015, ACTA BIOMATER, V23, P82, DOI 10.1016/j.actbio.2015.05.031; Cushing H, 1905, ESTABLISHMENT CEREBR; Dennis SC, 2015, TISSUE ENG PART B-RE, V21, P247, DOI [10.1089/ten.teb.2014.0419, 10.1089/ten.TEB.2014.0419]; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Eberle APR, 2008, IND ENG CHEM RES, V47, P3470, DOI 10.1021/ie070800j; Gawlitta D, 2015, TISSUE ENG PT A, V21, P694, DOI [10.1089/ten.tea.2014.0117, 10.1089/ten.TEA.2014.0117]; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; Khader BA, 2016, MAT SCI ENG C-MATER, V66, P315, DOI 10.1016/j.msec.2016.04.101; Kretlow JD, 2009, ADV MATER, V21, P3368, DOI 10.1002/adma.200802009; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030; NaPier Z, 2016, SEMIN SPINE SURG, V28, P196; O'Reilly EB, 2015, J PLAST RECONSTR AES, V68, P329, DOI 10.1016/j.bjps.2014.11.001; Oladunjoye AO, 2013, J NEUROSURG, V118, P776, DOI 10.3171/2013.1.JNS121475; Rennerfeldt DA, 2013, BIOMATERIALS, V34, P8241, DOI 10.1016/j.biomaterials.2013.07.052; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Samaniuk JR, 2014, AICHE J, V60, P1523, DOI 10.1002/aic.14329; Schallenberger MA, 2014, J CRANIOFAC SURG, V25, P657, DOI 10.1097/SCS.0000000000000610; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Spotnitz William D, 2014, ISRN Surg, V2014, P203943, DOI 10.1155/2014/203943; Spotnitz WD, 2010, WORLD J SURG, V34, P632, DOI 10.1007/s00268-009-0252-7; Sutherland AJ, 2015, MACROMOL BIOSCI, V15, P979, DOI 10.1002/mabi.201400472; Sutherland AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121966; Sutherland AJ, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400165; Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Townsend JM, 2017, AAPS J, V19, P703, DOI 10.1208/s12248-017-0045-0; Visser J, 2015, BIOMATERIALS, V37, P174, DOI 10.1016/j.biomaterials.2014.10.020; Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yeung CYC, 2016, WOUND REPAIR REGEN, V24, P1089, DOI 10.1111/wrr.12481; Zhang T, 2007, J BIOACT COMPAT POL, V22, P19, DOI 10.1177/0883911506074025	43	13	13	1	35	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1748-6041	1748-605X		BIOMED MATER	Biomed. Mater.	MAY	2018	13	3							034108	10.1088/1748-605X/aaad77			11	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	FZ6OU	WOS:000427719700002	29411714	Green Accepted			2022-02-06	
J	Abou El Fadl, MH; O'Phelan, KH				Abou El Fadl, Mohamed H.; O'Phelan, Kristine H.			Management of Traumatic Brain Injury: An Update	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						TBI; ICP; Sedation; PSH; Monitors; Multimodality; Informatics	PAROXYSMAL SYMPATHETIC HYPERACTIVITY; RAISED INTRACRANIAL-PRESSURE; DECOMPRESSIVE CRANIECTOMY; DIAGNOSTIC-CRITERIA; NEUROCRITICAL CARE; HYPERTONIC SALINE; METAANALYSIS; TRIAL; HYPERTENSION; HYPOTHERMIA	The care of patients with traumatic brain injury can be one of the most challenging and rewarding aspects of clinical neurocritical care. This article reviews the approach to unique aspects specific to the care of this patient population. These aspects include appropriate use of sedation and analgesia, and the principles and the clinical use of intracranial monitors. Common clinical challenges encountered in these patients are also discussed, including the treatment of intracranial hypertension, temperature management, and control of sympathetic hyperactivity.	[Abou El Fadl, Mohamed H.; O'Phelan, Kristine H.] Univ Miami, Neurocrit Care, Dept Neurol, Miller Sch Med, 1120 Northwest 14th St,Suite 1356, Miami, FL 33136 USA		O'Phelan, KH (corresponding author), Univ Miami, Neurocrit Care, Dept Neurol, Miller Sch Med, 1120 Northwest 14th St,Suite 1356, Miami, FL 33136 USA.	KOPhelan@med.miami.edu					Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Ayodele M, PITTSBURGH IN PRESS; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Carney N, 2016, MANAGEMENT SEVERE TR; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Citerio G, 2015, CURR OPIN CRIT CARE, V21, P113, DOI 10.1097/MCC.0000000000000179; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cooper DJ, 2011, NEW ENGL J MED, V365, P2040; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Farahvar A, 2011, J NEUROSURG, V115, P191, DOI 10.3171/2011.4.JNS101116a; Fernandez-Ortega JF, 2017, J NEUROTRAUM, V34, P109, DOI 10.1089/neu.2015.4364; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kramer CL, 2014, NEUROCRIT CARE, V21, P309, DOI 10.1007/s12028-014-9988-5; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Lyden P, 2016, STROKE, V47, P2888, DOI 10.1161/STROKEAHA.116.014200; Makarenko S, 2016, J CLIN NEUROSCI, V26, P8, DOI 10.1016/j.jocn.2015.05.065; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; Mathew MJ, 2016, ACTA NEUROCHIR, V158, P2047, DOI 10.1007/s00701-016-2934-x; Melhem S, 2014, CRIT CARE, V18, DOI 10.1186/cc13713; O'Phelan Kristine H, 2015, World J Crit Care Med, V4, P296, DOI 10.5492/wjccm.v4.i4.296; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Ohle R, 2015, J ULTRAS MED, V34, P1285, DOI 10.7863/ultra.34.7.1285; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Rickard AC, 2014, EMERG MED J, V31, P679, DOI 10.1136/emermed-2013-202679; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a; Shutter LA, 2016, NEW ENGL J MED, V375, P1183, DOI 10.1056/NEJMe1609722; Sivaganesan A, 2014, NEUROCRIT CARE, V20, P132, DOI 10.1007/s12028-013-9872-8; SYDENHAM E, 2009, COCHRANE DATABASE SY; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9	43	13	13	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	APR	2018	29	2					213	+		10.1016/j.nec.2017.11.002			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GB6MJ	WOS:000429183000003	29502712				2022-02-06	
J	Chudy, D; Deletis, V; Almahariq, F; Marcinkovic, P; Skrlin, J; Paradzik, V				Chudy, Darko; Deletis, Vedran; Almahariq, Fadi; Marcinkovic, Petar; Skrlin, Jasenka; Paradzik, Veronika			Deep brain stimulation for the early treatment of the minimally conscious state and vegetative state: experience in 14 patients	JOURNAL OF NEUROSURGERY			English	Article						minimally conscious state; vegetative state; deep brain stimulation; centromedian-parafascicular nucleus; functional neurosurgery	COMA; AROUSAL; SYSTEM	OBJECTIVE An effective treatment of patients in a minimally conscious state (MCS) or vegetative state (VS) caused by hypoxic encephalopathy or traumatic brain injury (TBI) is not yet available. Deep brain stimulation (DBS) of the thalamic reticular nuclei has been attempted as a therapeutic procedure mainly in patients with TBI. The purpose of this study was to investigate the therapeutic use of DBS for patients in VS or MCS. METHODS Fourteen of 49 patients in VS or MCS qualified for inclusion in this study and underwent DBS. Of these 14 patients, 4 were in MCS and 10 were in VS. The etiology of VS or MCS was TBI in 4 cases and hypoxic encephalopathy due to cardiac arrest in 10. The selection criteria for DBS, evaluating the status of the cerebral cortex and thalamocortical reticular formation, included: neurological evaluation, electrophysiological evaluation, and the results of positron emission tomography (PET) and MRI examinations. The target for DBS was the centromedian-parafascicular (CM-pf) complex. The duration of follow-up ranged from 38 to 60 months. RESULTS Two MCS patients regained consciousness and regained their ability to walk, speak fluently, and live independently. One MCS patient reached the level of consciousness, but was still in a wheelchair at the time the article was written. One VS patient (who had suffered a cerebral ischemic lesion) improved to the level of consciousness and currently responds to simple commands. Three VS patients died of respiratory infection, sepsis, or cerebrovascular insult (1 of each). The other 7 patients remained without substantial improvement of consciousness. CONCLUSIONS Spontaneous recovery from MCS/VS to the level of consciousness with no or minimal need for assistance in everyday life is very rare. Therefore, if a patient in VS or MCS fulfills the selection criteria (presence of somatosensory evoked potentials from upper extremities, motor and brainstem auditory evoked potentials, with cerebral glucose metabolism affected not more than the level of hypometabolism, which is judged using PET), DBS could be a treatment option.	[Chudy, Darko; Almahariq, Fadi; Marcinkovic, Petar] Univ Hosp Dubrava, Dept Neurosurg, Avenija Gojka Suska 6, Zagreb 10000, Croatia; [Skrlin, Jasenka] Univ Hosp Dubrava, Ctr Clin Microbiol & Hosp Infect, Zagreb, Croatia; [Paradzik, Veronika] Univ Hosp Dubrava, Ctr Phys Med & Rehabil, Zagreb, Croatia; [Chudy, Darko] Univ Zagreb, Croatian Inst Brain Res, Sch Med, Zagreb, Croatia; [Deletis, Vedran] Univ Split, Sch Med, Split, Croatia; [Deletis, Vedran] Albert Einstein Coll Med, New York, NY USA		Chudy, D (corresponding author), Univ Hosp Dubrava, Dept Neurosurg, Avenija Gojka Suska 6, Zagreb 10000, Croatia.	darko.chudy@gmail.com					ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1995, NEW ENGL J MED, V333, P130, DOI 10.1056/NEJM199507133330216; Bejjani BP, 2002, NEUROLOGY, V59, P1425, DOI 10.1212/01.WNL.0000031428.31861.23; COHADON F, 1993, NEUROCHIRURGIE, V39, P281; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; HASSLER R, 1969, ELECTROEN CLIN NEURO, V27, P306, DOI 10.1016/0013-4694(69)90060-1; JENNETT B, 1972, LANCET, V1, P734; Magrassi L, 2016, J NEUROSURG, V125, P972, DOI 10.3171/2015.7.JNS15700; MCLARDY T, 1969, CONFIN NEUROL, V31, P219; Miloushev Vesselin Z, 2016, Top Magn Reson Imaging, V25, P31, DOI 10.1097/RMR.0000000000000076; Moll CKE, 2009, PROG BRAIN RES, V177, P125, DOI 10.1016/S0079-6123(09)17710-5; Patuzzo S, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/641213; Rappaport M, 2005, NEUROPSYCHOL REHABIL, V15, P442, DOI 10.1080/09602010443000335; ROSS DT, 1993, J CEREBR BLOOD F MET, V13, P558, DOI 10.1038/jcbfm.1993.73; Schiff ND, 2008, NATURE, V452, P120, DOI 10.1038/nature06818; STURM V, 1979, ACTA NEUROCHIR, V47, P235, DOI 10.1007/BF01406406; Tsubokawa T, 1990, Brain Inj, V4, P315; Yamamoto T, 2005, ACTA NEUROCHIR SUPPL, V93, P101; Yamamoto T, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.04.010; Yamamoto T, 2010, EUR J NEUROSCI, V32, P1145, DOI 10.1111/j.1460-9568.2010.07412.x	20	13	14	1	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2018	128	4					1189	1198					10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GB4QJ	WOS:000429045500263					2022-02-06	
J	Meinert, E; Bell, MJ; Buttram, S; Kochanek, PM; Balasubramani, GK; Wisniewski, SR; Adelson, PD				Meinert, Elizabeth; Bell, Michael J.; Buttram, Sandra; Kochanek, Patrick M.; Balasubramani, Goundappa K.; Wisniewski, Stephen R.; Adelson, P. David		Pediat Traumatic Brain Injury Cons	Initiating Nutritional Support Before 72 Hours Is Associated With Favorable Outcome After Severe Traumatic Brain Injury in Children: A Secondary Analysis of a Randomized, Controlled Trial of Therapeutic Hypothermia	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						functional outcome; hypothermia; mortality; nutritional support; severe traumatic brain injury	MEASURED ENERGY-EXPENDITURE; HEAD-INJURY; UNITED-STATES; HYPERGLYCEMIA; DISCHARGE	Objectives: To understand the relationship between the timing of initiation of nutritional support in children with severe traumatic brain injury and outcomes. Design: Secondary analysis of a randomized, controlled trial of therapeutic hypothermia (Pediatric Traumatic Brain Injury Consortium: Hypothermia, also known as "the Cool Kids Trial" (NCT 00222742). Settings: Fifteen clinical sites in the United States, Australia, and New Zealand. Subjects: Inclusion criteria included 1) age less than 18 years, 2) postresuscitation Glasgow Coma Scale less than or equal to 8, 3) Glasgow Coma Scale motor score less than 6, and 4) available to be randomized within 6 hours after injury. Exclusion criteria included normal head CT, Glasgow Coma Scale equals to 3, hypotension for greater than 10 minutes (< fifth percentile for age), uncorrectable coagulopathy, hypoxia (arterial oxygen saturation < 90% for > 30 min), pregnancy, penetrating injury, and unavailability of a parent or guardian to consent at centers without emergency waiver of consent. Interventions: Therapeutic hypothermia (32-33 degrees C for 48 hr) followed by slow rewarming for the primary study. For this analysis, the only intervention was the extraction of data regarding nutritional support from the existing database. Measurements and Main Results: Timing of initiation of nutritional support was determined and patients stratified into four groups (group 1-no nutritional support over first 7 d; group 2-nutritional support initiated < 48 hr after injury; group 3-nutritional support initiated 48 to < 72 hr after injury; group 4-nutritional support initiated 72-168 hr after injury). Outcomes were also stratified (mortality and Glasgow Outcomes Scale-Extended for Pediatrics; 1-4, 5-7, 8) at 6 and 12 months. Mixed-effects models were performed to define the relationship between nutrition and outcome. Children (n = 90, 77 randomized, 13 run-in) were enrolled (mean Glasgow Coma Scale = 5.8); the mortality rate was 13.3%. 57.8% of subjects received hypothermia Initiation of nutrition before 72 hours was associated with survival (p = 0.01), favorable 6 months Glasgow Outcomes Scale-Extended for Pediatrics (p = 0.03), and favorable 12 months Glasgow Outcomes Scale-Extended for Pediatrics (p = 0.04). Specifically, groups 2 and 3 had favorable outcomes versus group 1. Conclusions: Initiation of nutritional support before 72 hours after traumatic brain injury was associated with decreased mortality and favorable outcome in this secondary analysis. Although this provides a rationale to initiate nutritional support early after traumatic brain injury, definitive studies that control for important covariates (severity of injury, clinical site, calories delivered, parenteral/enteral routes, and other factors) are needed to provide definitive evidence on the optimization of the timing of nutritional support after severe traumatic brain injury in children.	[Meinert, Elizabeth; Bell, Michael J.; Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Bell, Michael J.; Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Buttram, Sandra; Adelson, P. David] Barrow Neurol Inst, Dept Neurol Surg, Phoenix, AZ 85013 USA; [Buttram, Sandra; Adelson, P. David] Phoenix Childrens, Phoenix, AZ USA; [Balasubramani, Goundappa K.; Wisniewski, Stephen R.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA		Bell, MJ (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA.; Bell, MJ (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA.; Bell, MJ (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.	bellmj4@upmc.edu	Adelson, David/W-2083-2019	Goundappa K, Balasubramani/0000-0001-7221-1825; Meinert, Elizabeth/0000-0002-3350-6169	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS052478, NCT 00222742]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Society of Critical Care Medicine (SCCM); NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Patient-Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI; SCCM; Codman Neuro; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); Adelson Medical Consulting; Thieme Publishing; Phoenix Children's Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS052478, U01NS081041] Funding Source: NIH RePORTER	The Pediatric Traumatic Brain Injury Consortium: Hypothermia was funded by National Institute of Neurological Disorders and Stroke (NS052478; NCT 00222742).; Dr. Meinert's institution received funding from the National Institute of Neurological Disorders and Stroke (NINDS), and she received funding from Society of Critical Care Medicine (SCCM) (travel grant). Dr. Bell's institution received funding from NINDS, and he received support for article research from the National Institutes of Health (NIH). Dr. Buttram's institution received funding from the National Institute of Child Health and Human Development; she received support for article research from the NIH; and she disclosed that she is a Data Safety Monitoring Board member for study evaluating Early Rehabilitation after Acute Brain Injury at the University of Pittsburgh funded by Patient-Centered Outcomes Research Institute. Dr. Kochanek received funding from SCCM via an editor stipend for his services as Editor-in-Chief for Pediatric Critical Care Medicine. Dr. Wisniewski's institution received funding from the NIH, and he received support for article research from the NIH. Dr. Adelson's institution received funding from the NIH, Codman Neuro, and the National Center for Advancing Translational Sciences; he received funding from Phoenix Children's Hospital, Adelson Medical Consulting, and Thieme Publishing; and he received support for article research from the NIH. Dr. Balasubramani disclosed that he does not have any potential conflicts of interest.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Briassoulis G, 2006, PEDIATR CRIT CARE ME, V7, P56, DOI 10.1097/01.PCC.0000192339.44871.26; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DEUTSCHMAN CS, 1986, J NEUROSURG, V64, P89, DOI 10.3171/jns.1986.64.1.0089; Fivez T, 2016, NEW ENGL J MED, V374, P1111, DOI 10.1056/NEJMoa1514762; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Malakouti A, 2012, PEDIATR CRIT CARE ME, V13, pE18, DOI 10.1097/PCC.0b013e31820aba1f; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; MOORE R, 1989, J TRAUMA, V29, P1633, DOI 10.1097/00005373-198912000-00007; PHILLIPS R, 1987, J NEUROSURG, V67, P846, DOI 10.3171/jns.1987.67.6.0846; Taha AA, 2011, J NEUROSCI NURS, V43, P291, DOI 10.1097/JNN.0b013e318234e9b2; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	22	13	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	APR	2018	19	4					345	352		10.1097/PCC.0000000000001471			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	GK1CA	WOS:000435849300014	29370008	Green Accepted			2022-02-06	
J	Oliver, J; Avraham, J; Frangos, S; Tomita, S; DiMaggio, C				Oliver, Jamie; Avraham, Jacob; Frangos, Spiros; Tomita, Sandra; DiMaggio, Charles			The epidemiology of inpatient pediatric trauma in United States hospitals 2000 to 2011	JOURNAL OF PEDIATRIC SURGERY			English	Article						Trauma; Injury; Epidemiology; Pediatric; Public health	ELECTRONIC HEALTH RECORDS; INJURY SEVERITY SCORE; DATA-BANK; BRAIN-INJURY; RISK-FACTORS; CENTER CARE; MORTALITY; CENTERS; CHILDREN; ASSOCIATION	Background: This study provides important updates to the epidemiology of pediatric trauma in the United States. Methods: Age-specific epidemiologic analysis of the Healthcare Cost and Utilization Project's Nationwide Inpatient Sample, representing 2.4 million pediatric traumatic injury discharges in the US from 2000 to 2011. We present yearly data with overlying loess smoothing lines, proportions of common injuries and surgical procedures, and survey-adjusted logistic regression analysis. Results: From 2000 to 2011 there was a 21.7% decline in US pediatric trauma injury inpatient discharges from 273.2 to 213.7 admissions per 100,000. Inpatient case-fatality decreased 5.5% from 1.26% (95% CI 1.05-1.47) to 1.19% (95% CI 1.01-1.38). Severe injuries accounted for 26.5% (se = 0.11) of all discharges in 2000 increasing to 31.3% (se = 0.13) in 2011. The most common injury mechanism across all age groups was motor vehicle crashes (MVCs), followed by assaults (15-19 years), sports (10-14), falls (5-9) and burns (<5). The total injury-related, inflation-adjusted cost was $21.7 billion, increasing 56% during the study period. Conclusions: The overall rate of inpatient pediatric injury discharges across the United States has been declining. While injury severity is increasing in hospitalized patients, case-fatality rates are decreasing. MVCs remain a common source of all pediatric trauma. (c) 2017 Elsevier Inc. All rights reserved.	[Oliver, Jamie] NYU, Sch Med, 550 1st Ave, New York, NY 10016 USA; [Avraham, Jacob; Frangos, Spiros; DiMaggio, Charles] NYU, Sch Med, Dept Surg, Div Trauma & Acute Care Surg, 550 1st Ave, New York, NY 10016 USA; [Tomita, Sandra] NYU, Sch Med, Dept Pediat Surg, 550 1st Ave, New York, NY 10016 USA; [DiMaggio, Charles] NYU, Sch Med, Dept Populat Hlth, 550 1st Ave, New York, NY 10016 USA		DiMaggio, C (corresponding author), NYU, Bellevue Hosp Ctr, Dept Surg, Div Trauma & Acute Care Surg, 15th Fl,462 1st Ave, New York, NY 10016 USA.	Charles.DiMaggio@nyumc.org		, Sandra/0000-0002-5472-9361; DiMaggio, Charles/0000-0003-2356-6659; Frangos, Spiros/0000-0003-2860-8969; Oliver, Jamie/0000-0002-2664-7756	National Institute of Child Health and Human Development at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01-HD087460]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD087460] Funding Source: NIH RePORTER	This study was funded in part by the National Institute of Child Health and Human Development at the National Institutes of Health, grant number R01-HD087460.	Agency for Healthcare Research and Quality, HEALTHC COST UT PROJ; American Medical Association Hospital, 2005, INT CLASS DIS; [Anonymous], 2015, CONS PRIC IND DET RE; [Anonymous], HCUP METH SER SPEC S; Aziz H, 2015, J TRAUMA ACUTE CARE, V79, P463, DOI 10.1097/TA.0000000000000777; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bressan S, 2014, EMERG MED J, V31, P425, DOI 10.1136/emermed-2012-201957; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Centers for Disease Control and Prevention, COND TREND AN YRBS D COND TREND AN YRBS D; Chan KH, 2016, LARYNGOSCOPE, V126, P485, DOI 10.1002/lary.25457; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coorevits P, 2013, J INTERN MED, V274, P547, DOI 10.1111/joim.12119; DiMaggio C, 2016, INJURY, V47, P1393, DOI 10.1016/j.injury.2016.04.002; DiMaggio C, 2016, ANN EPIDEMIOL, V26, P412, DOI 10.1016/j.annepidem.2016.04.002; Dreyfus J, 2016, J PEDIATR SURG, V51, P1693, DOI 10.1016/j.jpedsurg.2016.04.005; Englum BR, 2016, J PEDIATR SURG, V51, P1526, DOI 10.1016/j.jpedsurg.2016.05.003; Faul M, 2010, TRAUMATIC BRAIN INJU; Fingerhut LA, 2002, INJ PREV, V8, P259, DOI 10.1136/ip.8.3.259; Firth GB, 2012, SPINE, V37, pE599, DOI 10.1097/BRS.0b013e31824079ea; Gedeborg R., 2009, JOINT M INT COLL EFF; Gholve PA, 2007, NELSONS TXB PEDIAT, P682; Gilchrist Julie, 2012, Morbidity and Mortality Weekly Report, V61, P270; Glance LG, 2012, ARCH SURG-CHICAGO, V147, P732, DOI 10.1001/archsurg.2012.1138; Haider AH, 2004, J AM COLL SURGEONS, V198, P906, DOI 10.1016/j.jamcollsurg.2004.02.013; Hirshon JM, 2009, ACAD EMERG MED, V16, P1103, DOI 10.1111/j.1553-2712.2009.00554.x; Hulka F, 1997, J TRAUMA, V42, P514, DOI 10.1097/00005373-199703000-00020; Insurance Institute for Highway Safety, 2016, GEN STAT YEARL SNAPS; Insurance Institute for Highway Safety, 2015, 50 IIHS, V50, P1; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Jansson B, 2006, J PUBLIC HEALTH POL, V27, P146, DOI 10.1057/palgrave.jphp.3200076; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Kamboj A, 2016, CLIN PEDIAT PHILA; Lang DT, 2014, RJSONIO SERIALIZE R; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI DOI 10.18637/JSS.V009.I08; Maarouf AM, 2015, AFR J UROL, V21, P44, DOI 10.1016/j.afju.2014.11.006; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6; Myers SR, 2016, PEDIAT EMERG CARE, V1; Namachivayam P, 2010, PEDIATR CRIT CARE ME, V11, P549, DOI 10.1097/PCC.0b013e3181ce7427; Naranje SM, 2016, J PEDIATR ORTHOPED, V36, pE45, DOI 10.1097/BPO.0000000000000595; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Oyetunji TA, 2014, AM SURGEON, V80, P366; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; Patrice EM, 2012, FRACTURE MANAGEMENT; Pickrell TM, 2016, 812243 DOT HS; Pracht EE, 2008, J PEDIATR SURG, V43, P212, DOI 10.1016/j.jpedsurg.2007.09.047; Rotundo MF, 2014, RESOURCES OPTIMAL CA; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Sathya C, 2015, JAMA SURG, V150, P874, DOI 10.1001/jamasurg.2015.1121; Segui-Gomez M., 2012, INJURY RES, P291; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Society AT, 2015, FIND YOUR LOC TRAUM; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Stone ME, 2016, J TRAUMA ACUTE CARE, V80, P604, DOI 10.1097/TA.0000000000000976; UNICEF, 2001, LEAG TABL CHILD DEAT; Vavilala MS, 2004, J TRAUMA, V57, P119, DOI 10.1097/01.TA.0000105882.89291.5B; Wang NE, 2013, J TRAUMA ACUTE CARE, V75, P704, DOI 10.1097/TA.0b013e31829a0a65; Watson JA, 2017, J PEDIATR SURG, V52, P136, DOI 10.1016/j.jpedsurg.2016.10.042; Webman RB, 2016, JAMA PEDIATR, V170, P780, DOI 10.1001/jamapediatrics.2016.0805; World Health Organisation, 2008, WORLD REPORT CHILD I; Yue JK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15612	65	13	13	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	APR	2018	53	4					758	764		10.1016/j.jpedsurg.2017.04.014			7	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	GB8CF	WOS:000429301400034	28506480	Green Accepted			2022-02-06	
J	Reneker, JC; Cheruvu, VK; Yang, JZ; James, MA; Cook, CE				Reneker, Jennifer C.; Cheruvu, Vinay K.; Yang, Jingzhen; James, Mark A.; Cook, Chad E.			Physical examination of dizziness in athletes after a concussion: A descriptive study	MUSCULOSKELETAL SCIENCE AND PRACTICE			English	Article						Concussion; Dizziness; Physical examination; Differential diagnosis	SPORTS-RELATED CONCUSSION; NECK PAIN; CERVICOGENIC DIZZINESS; PROFESSIONAL FOOTBALL; VISUAL DISTURBANCES; DIAGNOSTIC-VALUE; WHIPLASH INJURY; CLINICAL-TESTS; EYE-MOVEMENTS; REHABILITATION	Background: Dizziness is commonly reported after concussion. With the forces experienced at the time of the injury, several anatomical locations may have been altered, causing dizziness. Objective: Describe an objective examination and the types of impairment/dysfunction implicated by the results of clinical examination tests in subjects with dizziness after a concussion. Design: Cross-Sectional. Methods: Athletes between ages 10-23 were enrolled with a diagnosis of concussion. An examination was completed to identify areas potentially contributing to dizziness, including tests of oculomotor control, the vestibular system, neuromotor control, and musculoskeletal components of the cervical spine. Descriptive analyses were completed to define the anatomical areas/types of dysfunction identified by positive findings of the examination tests. Results: All (n = 41; 100%) subjects had examination findings consistent with central dysfunction. Of these, 36 (97.8%) had oculomotor control deficits; 29 (70.7%) demonstrated motion sensitivity; and 6 (15%) had central vestibular deficits. Nineteen (46.3%) had peripheral dysfunction, including 18 (43.9%) with unilateral hypofunction, and 2 (4.9%) with Benign Paroxysmal Positional Vertigo. Thirty-four (82.9%) had cervical dysfunction, with 11 (26.8%) presenting with cervicogenic dizziness, and 31 (75.6%) with altered neuromotor control. Conclusions: Functional injury to centrally-mediated pathways, specifically oculomotor control, and afferent and efferent pathways in the cervical spine are commonly identified through clinical examination tests in individuals with a complaint of dizziness post-concussion. According to results presented here, a high majority (90%) of the participants demonstrated dizziness that appeared to be multifactorial in nature and was not attributable to one main type of dysfunction. The common pathways between the systems make it difficult to isolate only one anatomical area as a contributor to dizziness.	[Reneker, Jennifer C.; Cheruvu, Vinay K.; James, Mark A.] Kent State Univ, Dept Biostat Environm Hlth Sci & Epidemiol, Coll Publ Hlth, Kent, OH 44242 USA; [Reneker, Jennifer C.] Univ Mississippi, Med Ctr, Dept Phys Therapy, Sch Hlth Related Profess, 2500 North State St, Jackson, MS 39216 USA; [Reneker, Jennifer C.] Univ Mississippi, Med Ctr, Dept Neurosurg, Sch Med, Jackson, MS 39216 USA; [Yang, Jingzhen] Ohio State Univ, Dept Pediat, Coll Med, Ctr Injury Res & Policy,Res Inst Nationwide Child, Columbus, OH 43210 USA; [Cook, Chad E.] Duke Univ, Dept Orthopaed, Div Phys Therapy, Durham, NC USA		Reneker, JC (corresponding author), Univ Mississippi, Med Ctr, Dept Phys Therapy, Sch Hlth Related Profess, 2500 North State St, Jackson, MS 39216 USA.	jreneker@umc.edu	Reneker, Jennifer/N-2038-2016	Reneker, Jennifer/0000-0003-3617-5681			Akin FW, 2003, J REHABIL RES DEV, V40, P415, DOI 10.1682/JRRD.2003.09.0415; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; BOTZEL K, 1993, BRAIN, V116, P337, DOI 10.1093/brain/116.2.337; Brandt T, 1993, J Vestib Res, V3, P373; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; BUTTNER U, 1995, J NEUROL, V242, P384, DOI 10.1007/BF00868394; Chan Y, 2009, CURR OPIN OTOLARYNGO, V17, P200, DOI 10.1097/MOO.0b013e32832b2594; Chiu TTW, 2005, J ORTHOP SPORT PHYS, V35, P567; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Fife Terry D, 2012, Continuum (Minneap Minn), V18, P1060, DOI 10.1212/01.CON.0000418376.80099.24; Gimse R, 1996, J CLIN EXP NEUROPSYC, V18, P178, DOI 10.1080/01688639608408273; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grip H, 2009, J CLIN MONIT COMPUT, V23, P31, DOI 10.1007/s10877-009-9160-5; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Heikkila HV, 1998, ARCH PHYS MED REHAB, V79, P1089, DOI 10.1016/S0003-9993(98)90176-9; Herdman SJ, 2014, VESTIBULAR REHABILIT; Howell D R, 2017, CLIN J SPORT MED; Hulse M, 2000, HNO, V48, P295, DOI 10.1007/s001060050569; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; Jeon EJ, 2013, AM J OTOLARYNG, V34, P471, DOI 10.1016/j.amjoto.2013.04.005; JURGENS R, 1989, EXP BRAIN RES, V77, P381, DOI 10.1007/BF00274995; Landel R., 2010, COMB SEC M SAN DEIG; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Malmstrom EM, 2007, DISABIL REHABIL, V29, P1193, DOI 10.1080/09638280600948383; Mergner T, 1998, EXP BRAIN RES, V120, P450, DOI 10.1007/s002210050418; Michiels S, 2015, PHYS THER, V95, P1529, DOI 10.2522/ptj.20140457; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Newman-Toker DE, 2007, MAYO CLIN PROC, V82, P1329, DOI 10.4065/82.11.1329; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Quatman-Yates CC, 2012, BRIT J SPORT MED, V46, P649, DOI 10.1136/bjsm.2010.079616; Reiley A. S., 2017, ARCH PHYSIOTHER, V7, P12, DOI DOI 10.1180/S40945-017-0040-X; Reneker J., 2015, INJ EPIDEMIOL, V2; Reneker JC, 2017, SCAND J MED SCI SPOR, V27, P2009, DOI 10.1111/sms.12827; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; Semple BD, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00069; Serra A, 2002, J NEUROL NEUROSUR PS, V73, P615, DOI 10.1136/jnnp.73.6.615; Takemori S, 1983, Adv Otorhinolaryngol, V29, P102; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2008, ARCH PHYS MED REHAB, V89, P522, DOI 10.1016/j.apmr.2007.11.002; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; Treleaven J, 2014, MANUAL THER, V19, P203, DOI 10.1016/j.math.2014.01.005; Treleaven J, 2011, MANUAL THER, V16, P252, DOI 10.1016/j.math.2010.11.002; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Wrisley DM, 2000, J ORTHOP SPORT PHYS, V30, P755, DOI 10.2519/jospt.2000.30.12.755; Zainun Zuraida, 2012, Med J Malaysia, V67, P386; Zito G, 2006, MANUAL THER, V11, P118, DOI 10.1016/j.math.2005.04.007	49	13	13	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2468-7812			MUSCULOSKEL SCI PRAC	Musculoskelet. Sci. Pract.	APR	2018	34						8	13		10.1016/j.msksp.2017.11.012			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	FZ6ZG	WOS:000427748500003	29197811				2022-02-06	
J	Schranz, AL; Manning, KY; Dekaban, GA; Fischer, L; Jevremovic, T; Blackney, K; Barreira, C; Doherty, TJ; Fraser, DD; Brown, A; Holmes, J; Menon, RS; Bartha, R				Schranz, Amy L.; Manning, Kathryn Y.; Dekaban, Gregory A.; Fischer, Lisa; Jevremovic, Tatiana; Blackney, Kevin; Barreira, Christy; Doherty, Timothy J.; Fraser, Douglas D.; Brown, Arthur; Holmes, Jeff; Menon, Ravi S.; Bartha, Robert			Reduced brain glutamine in female varsity rugby athletes after concussion and in non-concussed athletes after a season of play	HUMAN BRAIN MAPPING			English	Article						athlete brain; concussion; creatine; diffusion tensor imaging; female; glutamine; magnetic resonance imaging; magnetic resonance spectroscopy; white matter; rugby	PROFESSIONAL SOCCER PLAYERS; SPORTS-RELATED CONCUSSION; TEMPORAL WINDOW; WHITE-MATTER; INJURY; RECOVERY; IMPACT; VULNERABILITY; MYOINOSITOL; METABOLISM	The purpose of this study was to use non-invasive proton magnetic resonance spectroscopy (MRS) and diffusion tensor imaging (DTI) to monitor changes in prefrontal white matter metabolite levels and tissue microstructure in female rugby players with and without concussion (ages 18-23, n = 64). Evaluations including clinical tests and 3 T MRI were performed at the beginning of a season (in-season) and followed up at the end of the season (off-season). Concussed athletes were additionally evaluated 24-72 hr (n = 14), three months (n = 11), and six months (n = 8) post-concussion. Reduced glutamine at 24-72 hr and three months post-concussion, and reduced glutamine/creatine at three months post-concussion were observed. In non-concussed athletes (n = 46) both glutamine and glutamine/creatine were lower in the off-season compared to in-season. Within the MRS voxel, an increase in fractional anisotropy (FA) and decrease in radial diffusivity (RD) were also observed in the non-concussed athletes, and correlated with changes in glutamine and glutamine/creatine. Decreases in glutamine and glutamine/creatine suggest reduced oxidative metabolism. Changes in FA and RD may indicate neuroinflammation or re-myelination. The observed changes did not correlate with clinical test scores suggesting these imaging metrics may be more sensitive to brain injury and could aid in assessing recovery of brain injury from concussion.	[Schranz, Amy L.; Manning, Kathryn Y.; Menon, Ravi S.; Bartha, Robert] Univ Western Ontario, Ctr Funct & Metab Mapping, Robarts Res Inst, 1151 Richmond St North, London, ON N6A 5B7, Canada; [Schranz, Amy L.; Manning, Kathryn Y.; Menon, Ravi S.; Bartha, Robert] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med Biophys, 1151 Richmond St North,Med Sci Bldg, London, ON N6A 5C1, Canada; [Dekaban, Gregory A.; Blackney, Kevin; Barreira, Christy; Brown, Arthur] Univ Western Ontario, Robarts Res Inst, Mol Med Res Labs, 1151 Richmond St North, London, ON N6A 5B7, Canada; [Dekaban, Gregory A.; Blackney, Kevin] Univ Western Ontario, Schulich Sch Med & Dent, Dept Microbiol & Immunol, 1151 Richmond St North,Dent Sci Bldg, London, ON N6A 3K7, Canada; [Fischer, Lisa; Jevremovic, Tatiana] Univ Western Ontario, Ctr 3M, Dept Family Med, 1151 Richmond St North, London, ON N6A 3K7, Canada; [Fischer, Lisa; Jevremovic, Tatiana] Univ Western Ontario, Ctr 3M, Fowler Kennedy Sport Med Clin, 1151 Richmond St North, London, ON N6A 3K7, Canada; [Doherty, Timothy J.] Univ Western Ontario, Parkwood Inst, Schulich Sch Med & Dent, Dept Phys Med & Rehabil, 550 Wellington Rd,Hobbins Bldg, London, ON N6C 0A7, Canada; [Fraser, Douglas D.] Childrens Hosp, London Hlth Sci Ctr, Paediat Crit Care Med, 800 Commissioners Rd East, London, ON N6A 5W9, Canada; [Brown, Arthur] Univ Western Ontario, Dept Anat & Cell Biol, 1151 Richmond St North,Med Sci Bldg, London, ON N6A 3K7, Canada; [Holmes, Jeff] Univ Western Ontario, Elborn Coll, Sch Occupat Therapy, 1201 Western Rd, London, ON N6A 1H1, Canada		Bartha, R (corresponding author), Univ Western Ontario, Robarts Res Inst, 1151 Richmond St, London, ON N6A 5B7, Canada.	rbartha@robarts.ca	Menon, Ravi S/K-5500-2013; Bartha, Robert/K-3611-2013; Dekaban, Gregory/L-1987-2013; Brown, Arthur/K-8328-2013; Fischer, Lisa K/H-3999-2015	Menon, Ravi S/0000-0002-7916-0263; Bartha, Robert/0000-0002-7118-9096; Dekaban, Gregory/0000-0002-3087-4660; Brown, Arthur/0000-0002-8725-3195; Fischer, Lisa K/0000-0001-5992-0176	Schulich School of Medicine and Dentistry, Western University; Brain Canada; Canada First Research Excellence Fund	Schulich School of Medicine and Dentistry, Western University; Brain Canada; Canada First Research Excellence Fund	[Anonymous], 2013, BRIT J SPORT MED, V47, P259; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Bartha R, 1999, NMR BIOMED, V12, P205, DOI 10.1002/(SICI)1099-1492(199906)12:4<205::AID-NBM558>3.0.CO;2-1; Bartha R, 2000, MAGN RESON MED, V44, P641, DOI 10.1002/1522-2594(200010)44:4<641::AID-MRM19>3.0.CO;2-G; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bey T, 2009, WEST J EMERG MED, V10, P6; Brook EM, 2016, PHYSICIAN SPORTSMED, V44, P20, DOI 10.1080/00913847.2016.1142834; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; DAVIE CA, 1995, J NEUROL NEUROSUR PS, V58, P688, DOI 10.1136/jnnp.58.6.688; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Echemendia R., 2015, MAGNETIC RESONANCE S; Gao R. A. D., 2017, INT J PATHOLOGY CLIN, V3; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goncalves S, 2016, J NEUROSURG-SPINE, V25, P436, DOI 10.3171/2016.2.SPINE15944; Harris AD, 2017, MAGN RESON MED, V77, P1377, DOI 10.1002/mrm.26619; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hertz L, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010017; Hirrlinger J, 2014, GLIA, V62, P1749, DOI 10.1002/glia.22737; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Kreis R, 2016, MAGN RESON MED, V75, P15, DOI 10.1002/mrm.25568; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P., 2017, BRIT J SPORTS MED; Moreau WJ, 2015, J CHIROPR MED, V14, P169, DOI 10.1016/j.jcm.2015.08.003; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tator CH, 2014, BRIT J SPORT MED, V48, P81, DOI 10.1136/bjsports-2013-093040; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	51	13	14	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	APR	2018	39	4					1489	1499		10.1002/hbm.23919			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FY8LW	WOS:000427117300002	29271016	Green Published			2022-02-06	
J	Brodsky, JR; Lipson, S; Wilber, J; Zhou, GW				Brodsky, Jacob R.; Lipson, Sophie; Wilber, Jared; Zhou, Guangwei			Benign Paroxysmal Positional Vertigo (BPPV) in Children and Adolescents: Clinical Features and Response to Therapy in 110 Pediatric Patients	OTOLOGY & NEUROTOLOGY			English	Article						Benign paroxysmal positional vertigo; BPPV; Pediatric vertigo	VITAMIN-D; MIGRAINE; EPIDEMIOLOGY; NYSTAGMUS; DIAGNOSIS	Objective:This study aimed to characterize the clinical features and outcomes of benign paroxysmal positional vertigo (BPPV) in the pediatric population.Study Design:Retrospective case review.Setting:Tertiary care center.Patients:One hundred ten patients, aged 5 to 19 years old, diagnosed with BPPV.Main Outcome Measures:Patient demographics, comorbidities, canal involvement, response to treatment, and incidence of recurrence.Results:BPPV was diagnosed in 19.8% of patients seen for dizziness during the study period. Patient age ranged 5 to 19 years old (mean=13.43.4 yr). Female:male ratio was 3:2. The most prevalent comorbidities were concussion (n=42, 38.2%) and migraine disorders (n=33, 30.0%). Average time to diagnosis from symptom onset was 178.2 +/- 190.8 days. The posterior canal was most frequently affected (n=80, 72.7%), followed by the lateral canal (n=37, 33.6%) and superior canal (n=21, 19.1%), and 36.4% (n=40) of patients had multiple canals affected. Treatment requiring more than or equal to five maneuvers to achieve resolution was observed in 11.8% of cases (n=13). Recurrence was observed in 18.2% of cases. A logistic regression analysis demonstrated that patients with vestibular migraine or benign paroxysmal vertigo of childhood had five times higher odds of recurrence of BPPV, p=0.003, 95% [1.735, 15.342], than those who did not have either.Conclusions:BPPV is a relatively common cause of dizziness in the pediatric population. Children and adolescents with BPPV can be successfully treated with repositioning maneuvers but may be at risk for treatment resistance and recurrence. Increased awareness of BPPV in pediatric patients may reduce delays in identification and treatment.	[Brodsky, Jacob R.; Lipson, Sophie; Wilber, Jared; Zhou, Guangwei] Boston Childrens Hosp, Dept Otolaryngol & Commun Enhancement, Boston, MA USA; [Brodsky, Jacob R.; Zhou, Guangwei] Harvard Med Sch, Dept Otol & Laryngol, Boston, MA USA; [Wilber, Jared] Emory Univ, Atlanta, GA 30322 USA		Brodsky, JR (corresponding author), Dept Otolaryngol & Commun Enhancement, 300 Longwood Ave, Boston, MA 02115 USA.	jacob.brodsky@childrens.harvard.edu		Lipson, Sophie/0000-0001-5609-8156; Brodsky, Jacob/0000-0001-9656-5855	Department of Otolaryngology and Communication Enhancement at Boston Children's Hospital	All financial support for this study was provided by the Department of Otolaryngology and Communication Enhancement at Boston Children's Hospital.	Aksoy Songul, 2007, Kulak Burun Bogaz Ihtis Derg, V17, P307; Anagnostou E, 2015, J CLIN NEUROL, V11, P262, DOI 10.3988/jcn.2015.11.3.262; Bachor E, 2002, LARYNGOSCOPE, V112, P147, DOI 10.1097/00005537-200201000-00026; Balatsouras DG, 2007, INT J PEDIATR OTORHI, V71, P487, DOI 10.1016/j.ijporl.2006.11.024; Balatsouras DG, 2017, ANN OTO RHINOL LARYN, V126, P54, DOI 10.1177/0003489416674961; BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, pS1, DOI 10.1177/0194599816689667; Caruso G, 2005, AUDIOL MED, V3, P7, DOI DOI 10.1080/16513860510028310; Chu CH, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0547-z; D'Agostino R, 2003, INT J PEDIATR OTORHI, V67, P549, DOI 10.1016/S0165-5876(03)00009-0; Dieterich M, 2017, CURR OPIN NEUROL, V30, P107, DOI 10.1097/WCO.0000000000000417; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Faralli M, 2014, B-ENT, V10, P133; Fay JL, 2016, PEDIATR PHYS THER, V28, P355, DOI 10.1097/PEP.0000000000000249; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Hamilton SS, 2015, INT J PEDIATR OTORHI, V79, P1283, DOI 10.1016/j.ijporl.2015.05.033; Hilton MP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003162.pub3; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Holick MF, 2017, REV ENDOCR METAB DIS, V18, P153, DOI 10.1007/s11154-017-9424-1; Hunt WT, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008675.pub2; Kim JS, 2014, NEW ENGL J MED, V370, P1138, DOI 10.1056/NEJMcp1309481; Koo JW, 2006, CEPHALALGIA, V26, P1310, DOI 10.1111/j.1468-2982.2006.01208.x; Lee JD, 2017, INT J PEDIATR OTORHI, V94, P36, DOI 10.1016/j.ijporl.2017.01.012; Marcelli V, 2006, BRAIN DEV-JPN, V28, P80, DOI 10.1016/j.braindev.2005.05.003; Naganuma H, 1996, ACTA OTO-LARYNGOL, P9; O'Reilly RC, 2011, OTOLARYNG HEAD NECK, V144, P142, DOI 10.1177/0194599810393679; Okumura T, 2016, INT J PEDIATR OTORHI, V88, P89, DOI 10.1016/j.ijporl.2016.06.046; PARNES LS, 1992, LARYNGOSCOPE, V102, P988; Rhim GI, 2016, LARYNSCOPE INVESTIG, V1, P150, DOI 10.1002/lio2.35; Saka N, 2013, INT J PEDIATR OTORHI, V77, P233, DOI 10.1016/j.ijporl.2012.11.003; Schuknecht H F, 1973, Adv Otorhinolaryngol, V20, P434; Shetye Anuradha, 2012, Cochlear Implants Int, V13, P177, DOI 10.1179/1754762811Y.0000000011; Silva C, 2015, ACTA OTORRINOLAR ESP, V66, P205, DOI 10.1016/j.otorri.2014.09.003; Skatvedt Olav, 2009, Tidsskr Nor Laegeforen, V129, P634, DOI 10.4045/tidsskr.09.33787; Song JJ, 2012, ACTA OTO-LARYNGOL, V132, pS109, DOI 10.3109/00016489.2012.662714; Steenerson RL, 2005, LARYNGOSCOPE, V115, P226, DOI 10.1097/01.mlg.0000154723.55044.b5; Teixido M, 2017, J LARYNGOL OTOL, V131, P508, DOI 10.1017/S0022215117000536; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; Yetiser Sertac, 2015, Int Tinnitus J, V19, P64, DOI 10.5935/0946-5448.20150011	40	13	15	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	MAR	2018	39	3					344	350		10.1097/MAO.0000000000001673			7	Clinical Neurology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology	HK2WC	WOS:000457772600023	29287036				2022-02-06	
J	Chapman, EB; Nasypany, A; May, J; Henry, T; Hummel, C; Jun, HP				Chapman, Erin B.; Nasypany, Alan; May, Jim; Henry, Timothy; Hummel, Chris; Jun, Hyung-pil			Investigation of the Rosenbaum Concussion Knowledge and Attitudes Survey in Collegiate Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						extensive psychometric analysis; NCAA concussion guidelines; outcome measure	SCHOOL; CONSENSUS; EDUCATION; PLAYERS; SPORTS	Objective: The purpose of this study is to determine whether the Rosenbaum Concussion Knowledge and Attitudes Survey (RoCKAS) is an appropriate outcome measure to assess knowledge and attitudes toward concussion in collegiate student-athletes as determined through validity and reliability testing. Study Design: Convenience study. Setting: The researcher recruited all athletic teams at a Division III National Collegiate Athletic Association institution. Participants: Four hundred thirty-three collegiate student-athletes, 18 years of age or older, from a variety of sports took part in this study. As the validity of RoCKAS has never been established for the target population, this study randomly split respondents into 2 studies. Interventions: Participants in this study completed the RoCKAS during preseason meetings before concussion education. The primary researcher was not present during the completion of the survey to allow participants to answer honestly without concern of coercion. Main Outcome Measures: A paper-based Rosenbaum Concussion Knowledge and Attitudes Survey. Results: The Concussion Knowledge Index (CKI) was distributed in 2 cluster constructs and identified variables of low and high difficulty. Multivariate statistical analysis of the Concussion Attitude Index (CAI) explains 68.79% of the total variance. The Confirmatory Factor Analysis did not confirm the hypothesis that similar constructs can be found between data sets (X-49(2)- 207.902; consistent akaike information criterion - 391.550; root mean square error of approximation = 0.125, and goodness of fit index = 0.868). Conclusions: The CKI is a valid and reliable measure in collegiate student-athletes. However, the results of the Confirmatory Factor Analysis indicated a poor model fit and improper correlations between attitude items. Therefore, the CAI may not be a sound outcome measure of collegiate studentathlete's attitudes toward concussions.	[Chapman, Erin B.; Henry, Timothy] Coll Brockport, 350 New Campus Dr, Brockport, NY 14420 USA; [Chapman, Erin B.; Nasypany, Alan; May, Jim; Jun, Hyung-pil] Univ Idaho, Moscow, ID 83843 USA; [Hummel, Chris] Ithaca Coll, Ithaca, NY 14850 USA		Chapman, EB (corresponding author), Coll Brockport, 350 New Campus Dr, Brockport, NY 14420 USA.	echapman@brockport.edu					Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Cudeck R., 2000, HDB APPL MULTIVARIAT, P265, DOI DOI 10.1016/B978-012691360-6/50011-2; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Hoyle R.H., 1995, STRUCTURAL EQUATION; Hoyle R.H., 2000, HDB APPL MULTIVARIAT, P465, DOI [10.1016/B978-012691360-6/50017-3, DOI 10.1016/B978-012691360-6/50017-3]; Kaufman L., 2009, FINDING GROUPS DATA, V344; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Nelson PRC, 1996, CHEMOMETR INTELL LAB, V35, P45, DOI 10.1016/S0169-7439(96)00007-X; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sefton J, 2003, THESIS; Simonds CB, 2004, THESIS; Stevens JP, 2012, APPL MULTIVARIATE ST; Stratford PW, 1996, PHYS THER, V76, P1109, DOI 10.1093/ptj/76.10.1109; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tabachnick B.G., 2001, USING MULTIVARIATE S; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Vela LI, 2010, J ATHL TRAINING, V45, P630, DOI 10.4085/1062-6050-45.6.630; Yong AG, 2013, TUTOR QUANT METHODS, V9, P79, DOI 10.20982/tqmp.09.2.p079; [No title captured]; [No title captured]; [No title captured]	27	13	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2018	28	2					117	124		10.1097/JSM.0000000000000421			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	GP1HC	WOS:000440564900006	28644159				2022-02-06	
J	Cooper, DB; Curtiss, G; Armistead-Jehle, P; Belanger, HG; Tate, DF; Reid, M; Bowles, AO; Velez, CS; Kennedy, JE; Vanderploeg, RD				Cooper, Douglas B.; Curtiss, Glenn; Armistead-Jehle, Patrick; Belanger, Heather G.; Tate, David F.; Reid, Matthew; Bowles, Amy O.; Velez, Carmen S.; Kennedy, Jan E.; Vanderploeg, Rodney D.			Neuropsychological Performance and Subjective Symptom Reporting in Military Service Members With a History of Multiple Concussions: Comparison With a Single Concussion, Posttraumatic Stress Disorder, and Orthopedic Trauma	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						blast injuries; cognitive functioning; concussion; mild TBI; multiple concussions; postconcussive syndrome; posttraumatic stress disorder; traumatic brain injury	BRAIN-INJURY; FOOTBALL PLAYERS; MILD; VETERANS; METAANALYSIS; SEVERITY; FATIGUE; SCALE; COMPLAINTS; ADVERSITY	Objective: To examine differences in objective neurocognitive performance and subjective cognitive symptoms in individuals with a history of a single concussion, multiple concussions, orthopedic injuries, and posttraumatic stress disorder (PTSD). Method: Participants included 116 military service members who sustained a mild traumatic brain injury (mTBI) during combat deployment. Subjects were subdivided into groups based on concussion frequency: a single concussion (n= 42), 2 concussions (n= 21), and 3 or more concussions (n= 53). Eighty-one subjects sustained an orthopedic injury (n= 60) during deployment or were diagnosed with PTSD (n= 21), but had no history of mTBI. Subjects completed a battery of neuropsychological tests and self-report measures of postconcussive symptoms, PTSD symptoms, and psychopathology. Results: No differences were found among the concussion groups on a composite neuropsychological measure. The PTSD group had the highest number of symptom complaints, with the 2-concussion and 3-plus-concussion groups being most similar to the PTSD group. The concussion groups showed a nonsignificant pattern of increasing distress with increasing number of concussions. Conclusions: The current findings are consistent with meta-analytic results showing no differential effect on neuropsychological functioning due to multiple concussions. Results also support the burden of adversity hypothesis suggesting increasing symptom levels with increasing psychological or physically traumatic exposures.	[Cooper, Douglas B.; Curtiss, Glenn; Belanger, Heather G.; Reid, Matthew; Kennedy, Jan E.; Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Cooper, Douglas B.; Reid, Matthew; Kennedy, Jan E.] San Antonio Mil Med Ctr, Dept Neurol, Ft Sam Houston, TX USA; [Bowles, Amy O.] San Antonio Mil Med Ctr, Dept Rehabil, Ft Sam Houston, TX USA; [Cooper, Douglas B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Curtiss, Glenn; Belanger, Heather G.] Univ S Florida, Dept Psychol, Tampa, FL USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL USA; [Curtiss, Glenn; Belanger, Heather G.; Vanderploeg, Rodney D.] James A Haley VA Med Ctr, Tampa, FL USA; [Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Concuss Clin, Ft Leavenworth, KS USA; [Tate, David F.; Velez, Carmen S.] Univ Missouri St Louis, Missouri Inst Mental Hlth, Berkeley, MO USA; [Tate, David F.; Velez, Carmen S.] Univ Missouri, Dept Psychiat, St Louis, MO 63121 USA; [Bowles, Amy O.] Uniformed Serv Univ Hlth Sci, Dept Phys Med & Rehabil, Bethesda, MD 20814 USA		Cooper, DB (corresponding author), MCHE MDU DVBIC, Def & Vet Brain Injury Ctr, San Antonio Mil Med Ctr, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.	douglas.b.cooper.ctr@mail.mil	Curtiss, Glenn/ABB-5566-2020; Tate, David F/I-3963-2013; Armistead-Jehle, Patrick/AAU-5741-2020	Tate, David F/0000-0003-0213-1920; Armistead-Jehle, Patrick/0000-0002-6784-1432	TATRC research grant (ERMS) [12286030]	This work is the result of work supported with resources and the use of the facilities at Brooke Army Medical Center (BAMC),Joint Base San Antonio. Research staff and resources were provided in part by the Defense and Veterans Brain Injury Center (DVBIC) and the Telemedicine and Advanced Technology Research Center. Data management was supported by TATRC research grant (ERMS#12286030) to David Tate.	Belanger HG, 2016, CLIN NEUROPSYCHOL, V30, P1063, DOI 10.1080/13854046.2016.1193632; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bell BD, 1999, ARCH CLIN NEUROPSYCH, V14, P389, DOI 10.1016/S0887-6177(98)00020-1; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Derogatis L. R., 1996, SCL 90 R SYMPTOM CHE; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Edmed SL, 2015, J CLIN EXP NEUROPSYC, V37, P641, DOI 10.1080/13803395.2015.1038984; Edmed SL, 2014, BRAIN INJURY, V28, P1277, DOI 10.3109/02699052.2014.915988; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Heaton R. K., 2004, REVISED COMPREHENSIV; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; MacGregor AJ, 2011, J REHABIL RES DEV, V48, P1269, DOI 10.1682/JRRD.2011.01.0013; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; ORand AM, 1996, GERONTOLOGIST, V36, P230, DOI 10.1093/geront/36.2.230; Orme DR, 2004, REHABIL PSYCHOL, V49, P250, DOI 10.1037/0090-5550.49.3.250; Price RK, 2004, DRUG ALCOHOL DEPEN, V76, pS31, DOI 10.1016/j.drugalcdep.2004.08.005; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Seguin M, 2007, PSYCHOL MED, V37, P1575, DOI 10.1017/S0033291707000955; Sherman EMS, 2000, BRAIN INJURY, V14, P621; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Tate DF, STUDY COGNITIVE REHA; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Van Patten R, 2016, J CLIN EXP NEUROPSYC, V38, P12, DOI 10.1080/13803395.2015.1091064; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Weathers F.W., 1991, PTSD CHECKLIST MILIT; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilkinson G.S., 2006, WRAT 4 WIDE RANGE AC; Woodson J., 2015, TRAUMATIC BRAIN INJU; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	54	13	13	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2018	33	2					81	90		10.1097/HTR.0000000000000375			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GN6AI	WOS:000439152200009	29517589				2022-02-06	
J	Kerr, ZY; Kroshus, E; Lee, JGL; Yeargin, SW; Dompier, TP				Kerr, Zachary Y.; Kroshus, Emily; Lee, Joseph G. L.; Yeargin, Susan W.; Dompier, Thomas P.			Coaches' Implementation of the USA Football "Heads Up Football" Educational Program	HEALTH PROMOTION PRACTICE			English	Article						process evaluation; program planning and evaluation; injury prevention; safety; unintentional injury	TRAIN-THE-TRAINER; SPORTS-RELATED INJURIES; FOR-DISEASE-CONTROL; HIGH-SCHOOL SPORTS; RECURRENT CONCUSSION; UNITED-STATES; OPINION LEADERS; NCAA CONCUSSION; PLAYERS; RISK	An integral part of the Heads Up Football (HUF) educational program is the Player Safety Coach (PSC), who is responsible for teaching other coaches within a youth football league about safer blocking/tackling and injury prevention. This study examines the association between youth football coaches' interactions with the PSC (i.e., attending the PSC clinic at the beginning of the season and seeing the PSC on-field during practices) and their subsequent implementation of the HUF educational program. Data were collected via online questionnaire completed by 1,316 youth football coaches from HUF leagues. Data were analyzed with frequencies and logistic regression. Nearly half of coaches (44.8%) did not attend the PSC clinic; 25.9% reported not seeing their league's PSC on the field on a regular basis. The lack of PSC on-site presence was significantly associated with worse implementation for concussion recognition and response, heat preparedness and hydration, and sudden cardiac event preparedness. PSC clinic attendance was not associated with implementation. Opportunities exist for improvement in the HUF educational program as there appears to be inconsistent implementation. Further research is warranted to understand how to optimize the role of the PSC in the youth sports context.	[Kerr, Zachary Y.] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Kroshus, Emily] Univ Washington, Seattle, WA 98195 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Seattle, WA USA; [Lee, Joseph G. L.] East Carolina Univ, Greenville, NC USA; [Yeargin, Susan W.] Univ South Carolina, Columbia, SC USA; [Dompier, Thomas P.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA		Kerr, ZY (corresponding author), Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu					Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bailey R, 2006, J SCHOOL HEALTH, V76, P397, DOI 10.1111/j.1746-1561.2006.00132.x; Bergeron MF, 2005, MED SCI SPORT EXER, V37, P1421, DOI 10.1249/01.mss.0000174891.46893.82; Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Corelli RL, 2007, AM J PHARM EDUC, V71, DOI 10.5688/aj7106109; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Finch CF, 2015, OSTEOARTHR CARTILAGE, V23, P1138, DOI 10.1016/j.joca.2015.02.165; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; KELLY JA, 1991, AM J PUBLIC HEALTH, V81, P168, DOI 10.2105/AJPH.81.2.168; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116648441; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115603979; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kreck Carol, 2014, STATES ADDRESS CONCU; Li L, 2013, AIDS EDUC PREV, V25, P327, DOI 10.1521/aeap.2013.25.4.327; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McKeon PO, 2013, SPORTS MED, V43, P385, DOI [10.1007/s40279-013-0043-z, DOI 10.1007/s40279-013-0043-z]; Mearns Bryony M, 2011, Nat Rev Cardiol, V8, P244, DOI 10.1038/nrcardio.2011.57; National Council of Youth Sports, 2008, REP TRENDS PART ORG; Orfaly RA, 2005, J PUBLIC HEALTH MAN, pS123; Pop Warner Football, 2012, RUL CHANG REG PRACT; Powell JW, 2004, J ATHL TRAINING, V39, P56; Rogers E., 2010, DIFFUSION INNOVATION, V4th; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Simon JE, 2016, J ATHL TRAINING, V51, P205, DOI 10.4085/1062-6050-51.4.05; Toresdahl BG, 2013, J ATHL TRAINING, V48, P242, DOI 10.4085/1062-6050-48.1.20; Trabeau M, 2008, AM J IND MED, V51, P130, DOI 10.1002/ajim.20499; Valente TW, 2007, HEALTH EDUC BEHAV, V34, P881, DOI 10.1177/1090198106297855	37	13	13	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1524-8399	1552-6372		HEALTH PROMOT PRACT	Health Promot. Pract.	MAR	2018	19	2					184	193		10.1177/1524839917700398			10	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	GC5FA	WOS:000429809900005	28351166				2022-02-06	
J	Albrecht, JS; Afshar, M; Stein, DM; Smith, GS				Albrecht, Jennifer S.; Afshar, Majid; Stein, Deborah M.; Smith, Gordon S.			Association of Alcohol With Mortality After Traumatic Brain Injury	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						alcohol; mortality; traumatic brain injury	SUBSTANCE-ABUSE; HEAD-INJURY; ETHANOL; INTOXICATION; OUTCOMES; MODERATE; LEVEL; SCALE; RISK; COMA	Although alcohol exposure results in reducedmortality after traumatic brain injury (TBI) in animal models, clinical trials based on proposed mechanisms have been disappointing and have reported conflicting results. Methodological issues common to many of these clinical studies may have contributed to the spurious results. Our objective was to evaluate the association between blood alcohol concentration (BAC) and in-hospitalmortality after TBI, and overcome methodological problems of prior studies. We conducted a retrospective cohort study on individuals treated for isolated TBI (n = 1,084) at the R Adams Cowley Shock Trauma Center (Baltimore, Maryland) from 1997 to 2012. We excluded individuals with injury to other body regions and examined multiple cutpoints of BAC. Our primary outcome was in-hospital mortality. In adjusted logistic regression models, the upper level of each blood alcohol categorization from 0.10 g/dL (odds ratio = 0.63, 95% confidence interval: 0.40, 0.97) through 0.30 g/dL (odds ratio = 0.25, 95% confidence interval: 0.08, 0.84) was associated with reduced risk of mortality after TBI compared with individuals with undetectable BAC. In sensitivity analyses among individuals without penetrating brain injuries (95% firearm-related) (n = 899), the protective association was eliminated. This study provides evidence that the observed protective association between BAC and in-hospitalmortality after TBI resulted from bias introduced by inclusion of penetrating injuries.	[Albrecht, Jennifer S.; Smith, Gordon S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Afshar, Majid] Loyola Univ, Dept Publ Hlth Sci, Chicago, IL 60611 USA; [Stein, Deborah M.] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Dept Surg,Div Surg Crit Care, Baltimore, MD 21201 USA; [Smith, Gordon S.] Univ Maryland, Natl Study Ctr Trauma & Emergency Med Serv, Shock Trauma & Anesthesiol Res STAR Organized Res, Baltimore, MD 21201 USA		Albrecht, JS (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Med Sch Teaching Facil 334C, 10 South Pine St, Baltimore, MD 21201 USA.	jalbrecht@som.umaryland.edu	Afshar, Majid/AAD-8365-2019	Afshar, Majid/0000-0002-6368-4652; Albrecht, Jennifer/0000-0003-4838-2274; Stein, Deborah/0000-0003-3683-3963; Smith, Gordon/0000-0002-2911-3071	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12HD43489, K23AA024503, R01AA18707]; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1K01HS024560]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD043489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA018707, K23AA024503] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (grants K12HD43489 (to J.S.A.), K23AA024503 (to M.A.), and R01AA18707 (to G.S.S.)) and the Agency for Healthcare Research and Quality (grant 1K01HS024560 (to J.S.A.)).	Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Berry C, 2011, AM SURGEON, V77, P1416; Berry C, 2010, AM SURGEON, V76, P1067; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Branas CC, 2016, EPIDEMIOL REV, V38, P32, DOI 10.1093/epirev/mxv010; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1375, DOI 10.1016/j.jocn.2015.02.030; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Committee on Medical Aspect of Automotive Safety, 1971, JAMA-J AM MED ASSOC, V215, P277; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kim H, 2008, J TRAUMA, V65, P1287, DOI 10.1097/TA.0b013e31817196f5; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Lash, MODERN EPIDEMIOLOGY; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Marr A., 2004, CENTRAL NERVOUS SYST; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Pruitt BA, 2001, J TRAUMA, V51, pS1, DOI 10.1097/00005373-200108001-00001; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ., 1995, GUIDELINES SURVEILLA; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willis C, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003986.PUB2; Yurkewicz L, 2005, J NEUROTRAUM, V22, P1428, DOI 10.1089/neu.2005.22.1428; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275	40	13	13	1	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0002-9262	1476-6256		AM J EPIDEMIOL	Am. J. Epidemiol.	FEB	2018	187	2					233	241		10.1093/aje/kwx254			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FU4KD	WOS:000423821100007	28641392	Green Published, Bronze			2022-02-06	
J	Czapski, GA; Cieslik, M; Wencel, PL; Wojtowicz, S; Strosznajder, RP; Strosznajder, JB				Czapski, Grzegorz A.; Cieslik, Magdalena; Wencel, Przemyslaw L.; Wojtowicz, Sylwia; Strosznajder, Robert P.; Strosznajder, Joanna B.			Inhibition of poly(ADP-ribose) polymerase-1 alters expression of mitochondria-related genes in PC12 cells: relevance to mitochondrial homeostasis in neurodegenerative disorders	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Poly(ADP-ribose) polymerase-1; Amyloid beta; Mitochondria; Gene expression; Fission/fusion; Oxidation	COPPER-DEPENDENT INHIBITION; TRAUMATIC BRAIN-INJURY; AMYLOID-BETA FORMATION; CYTOCHROME-C-OXIDASE; ALZHEIMERS-DISEASE; A-BETA; SYSTEMIC INFLAMMATION; CASCADE HYPOTHESIS; NAD(+) DEPLETION; OXIDATIVE STRESS	Alzheimer's disease (AD) is characterized by the release of amyloid beta peptides (A beta) in the form of monomers/oligomers which may lead to oxidative stress, mitochondria dysfunction, synaptic loss, neuroinflammation and, in consequence, to overactivation of poly(ADP-ribose) polymerase-1 (PARP-1). However, A beta peptides are also released in the brain ischemia, traumatic injury and in inflammatory response. PARP-1 is suggested to be a promising target in therapy of neurodegenerative disorders. We investigated the impact of PARP-1 inhibition on transcription of mitochondria-related genes in PC12 cells. Moreover, the effect of PARP-1 inhibitor (PJ34) on cells subjected to A beta oligomers (A beta O) - evoked stress was analyzed. Our data demonstrated that inhibition of PARP-1 in PC12 cells enhanced the transcription of genes for antioxidative enzymes (Sod1, Gpx1, Gpx4), activated genes regulating mitochondrial fission/fusion (Mfn1, Mfn2, Dnm1l, Opa1, Fis1), subunits of ETC complexes (mt-Nd1, Sdha, mt-Cytb) and modulated expression of several TFs, enhanced Foxol and decreased Nrf1, Stat6, Nfkb1. A beta O elevated free radicals concentration, decreased mitochondria membrane potential (MMP) and cell viability after 24 h. Gene transcription was not affected by A beta O after 24 h, but was significantly downregulated after 96 h. In A beta O stress, PJ34 exerted stimulatory effect on expression of several genes (Gpx1, Gpx4, Opa1, Mfn2, Fis1 and Sdha), decreased transcription of numerous TFs (Nrf1, Tfam, Stat3, Stat6, Trp53, Nfkb1) and prevented oxidative stress. Our results indicated that PARP-1 inhibition significantly enhanced transcription of genes involved in antioxidative defense and in regulation of mitochondria function, but was not able to ameliorate cells viability affected by A beta.	[Czapski, Grzegorz A.; Cieslik, Magdalena; Wojtowicz, Sylwia; Strosznajder, Joanna B.] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Cellular Signalling, Pawinskiego 5, PL-02106 Warsaw, Poland; [Wencel, Przemyslaw L.; Strosznajder, Robert P.] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurosurg, Lab Preclin Res & Environm Agents, Pawinskiego 5, PL-02106 Warsaw, Poland		Czapski, GA; Strosznajder, JB (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Dept Cellular Signalling, Pawinskiego 5, PL-02106 Warsaw, Poland.	gczapski@imdik.pan.pl; mcieslik@imdik.pan.pl; pwencel@imdik.pan.pl; swojtowicz@imdik.pan.pl; rstrosznajder@imdik.pan.pl; jstrosznajder@imdik.pan.pl		Czapski, Grzegorz/0000-0002-7541-1571; Cieslik, Magdalena/0000-0002-7604-4371; Strosznajder, Robert/0000-0002-1922-0295; Strosznajder, Joanna/0000-0002-6213-1212	National Science CentreNational Science Centre, Poland [2013/09/B/NZ3/01350]	This work was supported by The National Science Centre (http://www.ncn.gov.pl) [Grant 2013/09/B/NZ3/01350].	Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002; ALTHAUS FR, 1982, J BIOL CHEM, V257, P5528; Bai P, 2015, TRENDS ENDOCRIN MET, V26, P75, DOI 10.1016/j.tem.2014.11.003; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Basello DA, 2015, MITOCHONDRION, V24, P56, DOI 10.1016/j.mito.2015.07.005; Berger N.A., 2017, BR J PHARM; Brunyanszki A, 2016, FREE RADICAL BIO MED, V100, P257, DOI 10.1016/j.freeradbiomed.2016.02.024; Burkle A, 2013, MOL ASPECTS MED, V34, P1046, DOI 10.1016/j.mam.2012.12.010; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; Cieslik M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137193; Cieslik M, 2013, NEUROCHEM INT, V62, P626, DOI 10.1016/j.neuint.2013.02.016; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Crouch PJ, 2006, J NEUROCHEM, V99, P226, DOI 10.1111/j.1471-4159.2006.04050.x; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; Czapski GA, 2006, NEUROCHEM INT, V49, P751, DOI 10.1016/j.neuint.2006.06.006; Czapski GA, 2013, NEUROCHEM INT, V62, P664, DOI 10.1016/j.neuint.2013.01.020; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; EDWARDS MJ, 1980, NATURE, V287, P745, DOI 10.1038/287745a0; Felici R, 2015, MOL PHARMACOL, V87, P965, DOI 10.1124/mol.114.097204; Felici R, 2014, NEUROTHERAPEUTICS, V11, P651, DOI 10.1007/s13311-014-0285-y; Gillardon F, 2007, PROTEOMICS, V7, P605, DOI 10.1002/pmic.200600728; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Jacewicz M, 2009, FOLIA NEUROPATHOL, V47, P321; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kauppinen TM, 2013, BBA-MOL CELL RES, V1833, P1985, DOI 10.1016/j.bbamcr.2013.04.005; Kocki J., DYSREGULATION AMYLOI; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krstic D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-151; Lai Y, 2008, J NEUROCHEM, V104, P1700, DOI 10.1111/j.1471-4159.2007.05114.x; Lapucci A, 2011, MOL PHARMACOL, V79, P932, DOI 10.1124/mol.110.070110; Lee HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028033, 10.1371/journal.pone.0050296, 10.1371/journal.pone.0044670, 10.1186/1747-597X-7-11]; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Leuner K, 2012, MOL NEUROBIOL, V46, P186, DOI 10.1007/s12035-012-8307-4; Leuner K, 2012, ANTIOXID REDOX SIGN, V16, P1421, DOI 10.1089/ars.2011.4173; Martire S, 2016, J ALZHEIMERS DIS, V54, P307, DOI 10.3233/JAD-151040; Martire S, 2015, MECH AGEING DEV, V146, P53, DOI 10.1016/j.mad.2015.04.001; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; Modis K, 2012, BIOCHEM PHARMACOL, V83, P633, DOI 10.1016/j.bcp.2011.12.014; Oei SL, 2001, BIOCHEM BIOPH RES CO, V285, P27, DOI 10.1006/bbrc.2001.5115; Pankotai E, 2009, MITOCHONDRION, V9, P159, DOI 10.1016/j.mito.2009.01.013; Pedros I, 2014, BBA-MOL BASIS DIS, V1842, P1556, DOI 10.1016/j.bbadis.2014.05.025; Pieper AA, 2000, P NATL ACAD SCI USA, V97, P1845, DOI 10.1073/pnas.97.4.1845; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; Schmitt K, 2012, ANTIOXID REDOX SIGN, V16, P1456, DOI 10.1089/ars.2011.4400; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sriram CS, 2015, NEURAL REGEN RES, V10, P49, DOI 10.4103/1673-5374.150653; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Strosznajder JB, 2000, ACTA BIOCHIM POL, V47, P847, DOI 10.18388/abp.2000_4003; Strosznajder JB, 2000, ACTA BIOCHIM POL, V47, P331, DOI 10.18388/abp.2000_4012; Strosznajder JB, 2012, MOL NEUROBIOL, V46, P78, DOI 10.1007/s12035-012-8258-9; Strosznajder JB, 2011, NEUROCHEM RES, V36, P839, DOI 10.1007/s11064-011-0412-7; Strosznajder RP, 2010, MOL NEUROBIOL, V41, P187, DOI 10.1007/s12035-010-8124-6; Strosznajder RP, 2005, MOL NEUROBIOL, V31, P149, DOI 10.1385/MN:31:1-3:149; Strosznajder RP, 2003, J MOL NEUROSCI, V20, P61, DOI 10.1385/JMN:20:1:61; Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010; Szczesny B, 2014, NUCLEIC ACIDS RES, V42, P13161, DOI 10.1093/nar/gku1089; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Vida A, 2017, SEMIN CELL DEV BIOL, V63, P135, DOI 10.1016/j.semcdb.2016.12.009; Walsh DM, 2016, NAT REV NEUROSCI, V17, P251, DOI 10.1038/nrn.2016.13; Watson D, 2005, NEUROL RES, V27, P869, DOI 10.1179/016164105X49436; Wencel P.L., 2016, FOLIA NEUROPATHOL, V54, P348; Wencel P. L., 2017, MOL NEUROBIOL; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201	67	13	14	4	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	FEB	2018	1865	2					281	288		10.1016/j.bbamcr.2017.11.003			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FU5LB	WOS:000423893100006	29128369	Bronze			2022-02-06	
J	Davis, GA; Ellenbogen, RG; Bailes, J; Cantu, RC; Johnston, KM; Manley, GT; Nagahiro, S; Sills, A; Tator, CH; McCrory, P				Davis, Gavin A.; Ellenbogen, Richard G.; Bailes, Julian; Cantu, Robert C.; Johnston, Karen M.; Manley, Geoffrey T.; Nagahiro, Shinji; Sills, Allen; Tator, Charles H.; McCrory, Paul			The Berlin International Consensus Meeting on Concussion in Sport	NEUROSURGERY			English	Article						Concussion; Sport	STATEMENT; ZURICH	The Fifth International Conference on Concussion in Sport was held in Berlin in October 2016. A series of 12 questions and subquestions was developed and the expert panel members were required to perform a systematic review to answer each question. Following presentation at the Berlin meeting of the systematic review, poster abstracts and audience discussion, the summary Consensus Statement was produced. Further, a series of tools for the management of sport-related concussion was developed, including the Sport Concussion Assessment Tool Fifth edition (SCAT5),the Child SCAT5, and the Concussion Recognition Tool Fifth edition. This paper elaborates on this process, the outcomes, and explores the implications for neurosurgeons in the management of sportrelated concussion.	[Davis, Gavin A.; McCrory, Paul] Florey Inst Neurosci & Mental Hlth, Melbourne Brain Ctr, Austin Campus, Heidelberg, Australia; [Davis, Gavin A.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Davis, Gavin A.] Cabrini Med Ctr, Malvern, Vic, Australia; [Davis, Gavin A.] Austin Hlth, Heidelberg, Vic, Australia; [Ellenbogen, Richard G.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Bailes, Julian] North Shore Univ Hlth Syst, Dept Neurosurg, Evanston, IL USA; [Cantu, Robert C.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Boston, MA 02118 USA; [Johnston, Karen M.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Johnston, Karen M.] Concuss Management Program AESM, Toronto, ON, Canada; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA; [Nagahiro, Shinji] Tokushima Univ Hosp, Dept Neurosurg, Tokushima, Japan; [Sills, Allen] Vanderbilt Univ, Med Ctr, Dept Neurosurg, Nashville, TN USA; [Tator, Charles H.] Toronto Western Hosp, Div Neurosurg, Toronto, ON, Canada; [Tator, Charles H.] Toronto Western Hosp, Canadian Concuss Ctr, Toronto, ON, Canada; [Tator, Charles H.] Univ Toronto, Toronto, ON, Canada		Davis, GA (corresponding author), Cabrini Med Ctr, Dept Neurosurg, Suite 53 Neurosurg, Malvern, Vic 3144, Australia.	gavin.davis@me.com	McCrory, Paul/Q-8688-2019	McCrory, Paul/0000-0003-4850-0568	General Electric companyGeneral Electric; IOC; CogState Inc.; Axon Sports (US); The Australian Football League funds research at the Florey Institute	GAD is an honorary member of the Australian Football League Concussion Working Group and has attended meetings organized by sporting organizations including the National Football League (NFL; USA), National Rugby League (Australia), and FIFA (Switzerland); however, he has not received any payment, research funding, or other monies from these groups other than for travel costs. RGE is a volunteer cochairman of the NFL Head Neck and Spine Medical Committee. JB is a member of the NFL Players' Association Health and Safety Committee, Chairman of Medical Advisory Committee of Pop Warner Football, but does not receive compensation or research funding. RCC is Senior Advisor NFL Head Neck and Spine Committee, VP NOCSAE and Chair Scientific Advisory Committee, Medical Director and Director of Clinical Research, Dr. Robert Cantu Concussion Center, Emerson Hospital, Co-Founder, Medical Director Concussion Legacy Foundation, Royalties Houghton Mifflin Harcourt, Legal Expert Opinion (NCAA, NHL etc.). GTM has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild TBI at meetings, scientific conferences, and symposiums. He serves as an unaffiliated neurotrauma consultant for the NFL. He has received funding from General Electric company, acting through its GE Healthymagination unit. Dr. Manley is also a subcontract PI on the NCAA-DOD Grand Alliance Concussion Assessment, Research and Education Consortium. He did not receive any form of financial support directly related to this manuscript. AS is an unaffiliated neurotrauma consultant to the NFL and a member of the medical committee of the International Equestrian Foundation. He also serves as unpaid consultant to the Nashville Predators (NHL) hockey team. PMcC is a coinvestigator, collaborator, or consultant on grants relating to mild TBI funded by several governmental organizations. He is directly employed by the National Health & Medical Research Council of Australia and is based at the Florey Institute of Neuroscience and Mental Health. He is Cochair of the Australian Centre for Research into Sports Injury and its Prevention, which is one of the International University Research Centres for Prevention of Injury and Protection of Athlete Health supported by the IOC. He is cochair of the International Concussion in Sport Group and is a member of the scientific advisory boards of the International Concussion & Head Injury Research Foundation (London, UK) and the Sports Surgery Clinic (Dublin, Ireland). He has a clinical and consulting practice in general and sports neurology. He receives book royalties from McGraw-Hill and was employed in an editorial capacity by the British Medical Journal Publishing Group from 2001 to 2008. He has been reimbursed by the government, professional scientific bodies, and sporting bodies for travel costs related to presenting research on mild TBI and sport-related concussion at meetings, scientific conferences, and symposiums. He received consultancy fees in 2010 from Axon Sports (US) for the development of educational material (which was not renewed) and has received research funding since 2001 from CogState Inc. The Australian Football League funds research at the Florey Institute under a legal memorandum and Dr. McCrory does not receive any money from this industry funded research. Dr.; McCrory is a cofounder and shareholder in 2 biomedical companies (involved in eHealth and compression garment technologies) but does not hold any individual shares in any company related to concussion or brain injury assessment or technology. He did not receive any form of financial support directly related to this manuscript. The other authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meeuwisse WH, 2017, BRIT J SPORT MED, V51, P873, DOI 10.1136/bjsports-2017-097569	10	13	13	1	21	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	FEB	2018	82	2					232	236		10.1093/neuros/nyx344			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FV0DJ	WOS:000424225800041	29106653				2022-02-06	
J	Jackson, TC; Kotermanski, SE; Jackson, EK; Kochanek, PM				Jackson, Travis C.; Kotermanski, Shawn E.; Jackson, Edwin K.; Kochanek, Patrick M.			BrainPhys (R) increases neurofilament levels in CNS cultures, and facilitates investigation of axonal damage after a mechanical stretch-injury in vitro	EXPERIMENTAL NEUROLOGY			English	Article						Mechanical stretch-injury; BrainPhys (R); Neurofilaments; TBI; RBM5	TRAUMATIC BRAIN-INJURY; CORTICAL-NEURONS; MILD; ACTIVATION; PROTEIN; CELLS; ASTROCYTES; MODEL; CREB; TAU	Neurobasal (R)/B27 is a gold standard culture media used to study primary neurons in vitro. An alternative media (BrainPhys (R)/SM1) was recently developed which robustly enhances neuronal activity vs. Neurobasal (R) or DMEM. To the best of our knowledge BrainPhys (R) has not been explored in the setting of neuronal injury. Here we characterized the utility of BrainPhys (R) in a model of in vitro mechanical-stretch injury. Methods/results: Primary rat cortical neurons were maintained in classic Neurobasal (R), or sequentially maintained in Neurocult (R) followed by BrainPhys (R) (hereafter simply referred to as "BrainPhys (R) maintained neurons"). The levels of axonal markers and proteins involved in neurotransmission were compared on day in vitro 10 (DIV10). BrainPhys (R) maintained neurons had higher levels of GluN2B, GluR1, Neurofilament light/heavy chain (NF-L & NF-H), and protein phosphatase 2 A (PP2A) vs. neurons in Neurobasal (R). Mechanical stretch-injury (50 ms/54% biaxial stretch) to BrainPhys (R) maintained neurons modestly (albeit significantly) increased 24 h lactate dehydrogenase (LDH) levels but markedly decreased axonal NF-L levels post-injury vs. uninjured controls or neurons given a milder 38% stretch-injury. Furthermore, two 54% stretch-injuries (in tandem) exacerbated 24 h LDH release, increased alpha-spectrin breakdown products (SBDPs), and decreased Tau levels. Also, BrainPhys (R) maintained cultures had decreased markers of cell damage 24 h after a single 54% stretch-injury vs. neurons in Neurobasal (R). Finally, we tested the hypothesis that lentivirus mediated overexpression of the pro-death protein RBM5 exacerbates neuronal and/or axonal injury in primary CNS cultures. RBM5 overexpression vs. empty-vector controls increased 24 h LDH release, and SBDP levels, after a single 54% stretch-injury but did not affect NF-L levels or Tau. Conclusion: BrainPhys (R) is a promising new reagent which facilities the investigation of molecular targets involved in axonal and/or neuronal injury in vitro.	[Jackson, Travis C.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Childrens Hosp Pittsburgh,UPMC,John G Rangos Res, 6th Floor,4401 Penn Ave, Pittsburgh, PA 15224 USA; [Jackson, Travis C.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Scaife Hall,3550 Terrace St, Pittsburgh, PA USA; [Kotermanski, Shawn E.; Jackson, Edwin K.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Bridgeside Point Bldg 1,100 Technol Dr, Pittsburgh, PA USA		Jackson, TC (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Childrens Hosp Pittsburgh,UPMC,John G Rangos Res, 6th Floor,4401 Penn Ave, Pittsburgh, PA 15224 USA.	jacksontc@upmc.edu		Jackson, Edwin/0000-0002-8101-6009	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS088145];  [R21NS098057]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS088145, R21NS098057] Funding Source: NIH RePORTER	This work was supported by NIH/NINDS grant R21NS088145 to TCJ and by grant R21NS098057 to TCJ.	Ahmed SM, 2002, J NEUROTRAUM, V19, P1619, DOI 10.1089/089771502762300274; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Al Nimer F., 2015, PLOS ONE, V10; Amin N, 1997, NEUROCHEM INT, V30, P271, DOI 10.1016/S0197-0186(96)00092-7; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Bahrami Farideh, 2013, Iranian Biomedical Journal, V17, P101, DOI 10.6091/ibj.11242.2013; Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112; Bergman J., 2016, NEUROL NEUROIMMUNOL, V3; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cavalcanti-Adam EA, 2002, J BONE MINER RES, V17, P2130, DOI 10.1359/jbmr.2002.17.12.2130; Cheng P, 2015, J NEUROL SCI, V359, P48, DOI 10.1016/j.jns.2015.10.025; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Ellis EF, 2007, J NEUROCHEM, V101, P1463, DOI 10.1111/j.1471-4159.2007.04515.x; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Ferrario CR, 2013, J NEUROPHYSIOL, V110, P131, DOI 10.1152/jn.01011.2012; Geranmayeh M. H., 2015, Iranian Journal of Veterinary Medicine, V9, P163; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Guo GJ, 2016, CELL REP, V14, P956, DOI 10.1016/j.celrep.2015.12.089; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Harrill JA, 2015, IN VITRO CELL DEV-AN, V51, P612, DOI 10.1007/s11626-015-9873-3; Hogins J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025633; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Jackson TC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.187; Jackson TC, 2015, J CEREBR BLOOD F MET, V35, P655, DOI 10.1038/jcbfm.2014.242; Kevenaar JT, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00044; Kobayashi T, 2011, INT J CANCER, V128, P304, DOI 10.1002/ijc.25345; KOSIK KS, 1987, J NEUROSCI, V7, P3142; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Loiselle JJ, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00204; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marx V, 2013, NATURE, V496, P253, DOI [10.1038/496253a, 10.1038/498255a]; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; Petry FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094251; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Ren Ping, 2007, Fen Zi Xi Bao Sheng Wu Xue Bao, V40, P79; Rintala-Maki ND, 2004, APOPTOSIS, V9, P475, DOI 10.1023/B:APPT.0000031455.79352.57; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shao C, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-123; Shao C, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-160; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Smith M, 2016, EXP NEUROL, V286, P107, DOI 10.1016/j.expneurol.2016.10.002; Su ZZ, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0815-7; Sun Y, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0029-7; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Tauskela JS, 2008, J BIOL CHEM, V283, P34667, DOI 10.1074/jbc.M805624200; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632, DOI 10.1152/jn.1997.77.2.632; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; Thomson CE, 2006, J NEUROSCI RES, V84, P1703, DOI 10.1002/jnr.21084; Tzekov R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153608; Valor LM, 2010, CELL DEATH DIFFER, V17, P1636, DOI 10.1038/cdd.2010.40; Wang CC, 2011, NEURON, V72, P789, DOI 10.1016/j.neuron.2011.09.023; Wang Ke, 2012, J Cell Death, V5, P1, DOI 10.4137/JCD.S9073; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Yang WJ, 2017, ACTA NEUROL SCAND, V135, P622, DOI 10.1111/ane.12644; Ye ZC, 1998, GLIA, V22, P237, DOI 10.1002/(SICI)1098-1136(199803)22:3<237::AID-GLIA3>3.0.CO;2-2; Yuan A, 2015, MOL PSYCHIATR, V20, P986, DOI [10.1038/mp.2015.45, 10.1038/mp.2015.99]; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang JL, 2015, INT J BIOCHEM CELL B, V60, P43, DOI 10.1016/j.biocel.2014.12.020; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	75	13	13	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2018	300						232	246		10.1016/j.expneurol.2017.11.013			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT1JZ	WOS:000422893300022	29199132	hybrid, Green Accepted			2022-02-06	
J	Kirov, II; Whitlow, CT; Zamora, C				Kirov, Ivan I.; Whitlow, Christopher T.; Zamora, Carlos			Susceptibility-Weighted Imaging and Magnetic Resonance Spectroscopy in Concussion	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article						Magnetic resonance spectroscopy (MRS); Mild traumatic brain injury (mTBI); Concussion; SWI; Susceptibility-weighted imaging	TRAUMATIC BRAIN-INJURY; PROTON MR SPECTROSCOPY; DIFFUSE AXONAL INJURY; SPORTS-RELATED CONCUSSION; N-ACETYLASPARTATE; CORPUS-CALLOSUM; TEMPORAL WINDOW; IN-VIVO; MILD; CHILDREN	Although susceptibility-weighted imaging (SWI) studies have suggested an increased number of microhemorrhages in concussion, most show no significant differences compared with controls. There have been mixed results on using SWI to predict neurologic outcomes. Drawbacks include inability to time microhemorrhages and difficulty in attributing them to the concussion. Magnetic resonance spectroscopy (MRS) in concussion can identify metabolic abnormalities, with many studies showing correlations with clinical outcome. Applications in individual patients are impeded by conflicting data and lack of consensus on an optimal protocol. Therefore, currently MRS has most utility in group-level comparisons designed to reveal the pathophysiology of concussion.	[Kirov, Ivan I.] NYU, Sch Med, Bernard & Irene Schwartz Ctr Biomed Imaging, Ctr Adv Imaging Innovat & Res CAI2R,Dept Radiol, 660 First Ave,421, New York, NY 10016 USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Clin Translat Sci Inst, Dept Radiol, Div Neuroradiol, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Clin Translat Sci Inst, Dept Biomed Engn, 1 Med Ctr Blvd, Winston Salem, NC 27106 USA; [Zamora, Carlos] Univ N Carolina, Sch Med, Dept Radiol, Div Neuroradiol, CB 7510,3327 Old Infirm, Chapel Hill, NC 27599 USA		Zamora, C (corresponding author), Univ N Carolina, Sch Med, Dept Radiol, Div Neuroradiol, CB 7510,3327 Old Infirm, Chapel Hill, NC 27599 USA.	carlos_zamora@med.unc.edu	Kirov, Ivan/I-2792-2019; Zamora, Carlos/J-5249-2019	Kirov, Ivan/0000-0001-5641-8578; Zamora, Carlos/0000-0001-8532-9646			Aaen GS, 2010, PEDIATRICS, V125, P295, DOI 10.1542/peds.2008-3312; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Barker P, 2010, PULSE SEQUENCES PROT; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Belli A, 2006, J NEUROCHEM, V96, P861, DOI 10.1111/j.1471-4159.2005.03602.x; Benarroch EE, 2008, NEUROLOGY, V70, P1353, DOI 10.1212/01.wnl.0000311267.63292.6c; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; Blanke ML, 2009, FRONT NEUROSCI, P283; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chang K, 2014, AM J NEURORADIOL, V35, P1091, DOI 10.3174/ajnr.A3818; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Choe MC, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0573-9; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Danielsen ER, 2003, NEURORADIOLOGY, V45, P722, DOI 10.1007/s00234-003-1068-z; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; DeGraaf RA, 2007, IN VIVO NMR SPECTROS, P61; Denk C, 2010, J MAGN RESON IMAGING, V31, P185, DOI 10.1002/jmri.21995; Dhandapani S, 2014, J CLIN NEUROSCI, V21, P745, DOI 10.1016/j.jocn.2013.07.038; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Faul M, TRAUMATIC BRAIN INJU; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goos JDC, 2011, STROKE, V42, P1894, DOI 10.1161/STROKEAHA.110.599837; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Gujar SK, 2005, J NEURO-OPHTHALMOL, V25, P217, DOI 10.1097/01.wno.0000177307.21081.81; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Hoch SE, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3710; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Kirov I, 2007, BRAIN INJURY, V21, P1147, DOI 10.1080/02699050701630383; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lyeth BG, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00217; Maudsley AA, 2015, J NEUROTRAUM, V32, P1056, DOI 10.1089/neu.2014.3505; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Mountford CE, 2010, CHEM REV, V110, P3060, DOI 10.1021/cr900250y; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Ong BC, 2010, J MED IMAG RADIAT ON, V54, P435, DOI 10.1111/j.1754-9485.2010.02208.x; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Prost RW, 1997, MAGN RESON MED, V37, P615, DOI 10.1002/mrm.1910370422; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Sarmento E, 2009, HEADACHE, V49, P1345, DOI 10.1111/j.1526-4610.2009.01494.x; Shams S, 2015, AM J NEURORADIOL, V36, P1089, DOI 10.3174/ajnr.A4248; Shin SS, 2017, BRAIN IMAGING BEHAV, V11, P591, DOI 10.1007/s11682-017-9684-0; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; SIMMONS ML, 1991, NEUROSCIENCE, V45, P37, DOI 10.1016/0306-4522(91)90101-S; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Sivak S, 2014, BRAIN INJURY, V28, P341, DOI 10.3109/02699052.2013.865270; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P550, DOI 10.1007/s11682-015-9424-2; Tao JJ, 2015, NEURAL REGEN RES, V10, P1879, DOI 10.4103/1673-5374.170322; TEASDALE G, 1974, LANCET, V2, P81; Thomas B, 2008, NEURORADIOLOGY, V50, P105, DOI 10.1007/s00234-007-0316-z; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wang X, 2014, NEUROL SCI, V35, P1533, DOI 10.1007/s10072-014-1788-3; Widerstrom-Noga E, 2016, J NEUROTRAUM, V33, P1380, DOI 10.1089/neu.2015.4098; Wintermark M, 2015, AM J NEURORADIOL, V36, pE12, DOI 10.3174/ajnr.A4254; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Yang Z, 2012, J NEUROTRAUM, V29, P2124, DOI 10.1089/neu.2012.2395; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	109	13	15	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	FEB	2018	28	1					91	+		10.1016/j.nic.2017.09.007			17	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FR3UA	WOS:000418990900010	29157856				2022-02-06	
J	Lee, HC; Chong, S; Lee, JY; Cheon, JE; Phi, JH; Kim, SK; Kim, IO; Wang, KC				Lee, Hee Chang; Chong, Sangjoon; Lee, Ji Yeoun; Cheon, Jung-Eun; Phi, Ji Hoon; Kim, Seung-Ki; Kim, In-One; Wang, Kyu-Chang			Benign extracerebral fluid collection complicated by subdural hematoma and fluid collection: clinical characteristics and management	CHILDS NERVOUS SYSTEM			English	Article						Benign extracerebral fluid collection in infancy; Subdural hematoma; Subdural fluid collection; Trauma history	TERM-FOLLOW-UP; EXTERNAL HYDROCEPHALUS; SUBARACHNOID SPACES; INFANTS; ENLARGEMENT	Introduction Benign extracerebral fluid collection (bECFC) can be complicated by subdural hematoma (SDH) or subdural fluid collection (SDFC). The etiology, natural history, and management strategy for SDH/SDFC in bECFC are not fully understood. We retrospectively reviewed the cases of bECFC patients complicated with SDH/SDFC and tried (1) to confirm the fact that bECFC children are vulnerable to SDH/SDFC, (2) to investigate the clinical significance of 'trauma history' witnessed by a caregiver, and (3) to determine optimal management for them. Method Among 213 bECFC patients identified from January 2000 to August 2015, 20 patients (male:female = 14:6; median age, 6.5 months; range 1-16 months) complicated by SDH/SDFC documented with brain imaging were evaluated for their clinical manifestations, radiologic features, and management outcomes. The median follow-up period was 9.5 months. They were divided into two groups (traumatic group versus non-traumatic group) according to whether objective radiologic evidence of head injury was present or not, and the two groups were analyzed for any clinical differences between them. We also evaluated the clinical significance of witnessed traumatic events by caregivers as an additional independent variable in the analysis. Results The incidence of SDH/SDFC in bECFC patients was 9.4% (20/213) in our data. In a comparative analysis, the traumatic group is more likely to have 'acute' stage SDH, whereas the non-traumatic group is more likely to have 'chronic' stage SDH. The trauma history witnessed by caregivers did not show clinical significance in the data analysis when included as an independent variable. The prognosis of SDH/SDFC in bECFC patients was favorable without surgery in most of patients regardless of whether the patient has evidence of head trauma or not. Conclusion Benign ECFC is vulnerable to SDH/SDFC development. For the bECFC patients complicated by SDH/SDFC, the trauma history witnessed by a caregiver did not show any clinical significance. A 'wait and watch' strategy is sufficient for the management of SDH/SDFC in bECFC patients.	[Lee, Hee Chang; Chong, Sangjoon; Lee, Ji Yeoun; Phi, Ji Hoon; Kim, Seung-Ki; Wang, Kyu-Chang] Seoul Natl Univ, Childrens Hosp, Div Pediat Neurosurg, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea; [Cheon, Jung-Eun; Kim, In-One] Seoul Natl Univ, Childrens Hosp, Div Pediat Radiol, Coll Med, Seoul, South Korea		Wang, KC (corresponding author), Seoul Natl Univ, Childrens Hosp, Div Pediat Neurosurg, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea.	kcwang@snu.ac.kr		Lee, Hee Chang/0000-0001-7657-712X	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education [2015R1D1A1A01059605]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education (2015R1D1A1A01059605).	AZAIS M, 1992, ANN PEDIATR-PARIS, V39, P550; BODE H, 1987, KLIN PADIATR, V199, P399, DOI 10.1055/s-2008-1026830; Ghosh PS, 2011, CLIN PEDIATR, V50, P897, DOI 10.1177/0009922811406435; Hellbusch LC, 2007, J NEUROSURG, V107, P119, DOI 10.3171/PED-07/08/119; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; IKEDA A, 1987, CHILD NERV SYST, V3, P19, DOI 10.1007/BF00707188; KAPILA A, 1982, RADIOLOGY, V142, P669, DOI 10.1148/radiology.142.3.6977789; McNeely PD, 2006, AM J NEURORADIOL, V27, P1725; MENT LR, 1981, J NEUROSURG, V54, P504, DOI 10.3171/jns.1981.54.4.0504; MORI K, 1993, CHILD NERV SYST, V9, P282, DOI 10.1007/BF00306274; Nishimura K, 1996, ACTA NEUROCHIR, V138, P179, DOI 10.1007/BF01411358; ODITA JC, 1992, CHILD NERV SYST, V8, P36, DOI 10.1007/BF00316560; Papasian NC, 2000, PEDIATR NEUROSURG, V33, P188, DOI 10.1159/000055951; Ravid S, 2003, PEDIATR NEUROL, V28, P139, DOI 10.1016/S0887-8994(02)00500-3; Vinchon M, 2010, CHILD NERV SYST, V26, P1485, DOI 10.1007/s00381-010-1233-8; Yew AY, 2011, PEDIATR NEUROSURG, V47, P1, DOI 10.1159/000322357	16	13	13	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2018	34	2					235	245		10.1007/s00381-017-3583-y			11	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FT8IA	WOS:000423394800014	28889182				2022-02-06	
J	Song, H; Fang, SH; Gao, J; Wang, JX; Can, ZZ; Guo, ZY; Huang, QP; Qu, YQ; Zhou, H; Yu, JY				Song, Hai; Fang, Shanhua; Gao, Jing; Wang, Jiaxong; Can, Zhenzhen; Guo, Zeyun; Huang, Qiongping; Qu, Yongqang; Zhou, Hu; Yu, Jianyun			Quantitative Proteomic Study Reveals Up-Regulation of cAMP Signaling Pathway-Related Proteins in Mild Traumatic Brain Injury	JOURNAL OF PROTEOME RESEARCH			English	Article						mTBI; iTRAQ; proteomic analysis; cAMP signal process; Pde10a; Gnal	ITRAQ; PHOSPHODIESTERASE; EXPRESSION; PDE10A; PHOSPHORYLATION; CHROMATOGRAPHY; MECHANISMS; RECEPTORS; STRESS; SILAC	Traumatic brain injury (TBI), as a neurological injury, becomes a leading cause of disability and mortality due to lacking effective therapy. About 75% of TBI is mild traumatic brain injury (mTBI). However, the complex molecular mechanisms underlying mTBI pathophysiology remains to be elucidated. In this study, iTRAQ-based quantitative proteomic approach was employed to measure temporal-global proteome changes of rat brain tissues from different time points (1 day, 7 day and 6 months) post single mTBI (smTBI) and repetitive mTBI (rmTBI). A total of 5169 proteins were identified, of which, 237 proteins were significantly changed between control rats and mTBI model rats. Fuzzy c-means (FCM) clustering analysis classified these 237 proteins into six clusters according to their temporal pattern of protein abundance. Functional bioinformatics analysis and protein-protein interaction (PPI) network mapping of these FCM clusters showed that phosphodiesterase 10A (Pde10a) and guanine nucleotide-binding protein G (olf) subunit alpha (Gnal) were the node proteins in the cAMP signaling pathway. Other biological processes, such as cell adhesion, autophagy, myelination, microtubule depolymerization and brain development, were also over-represented in FCM clusters. Further Western Blot experiments confirmed that Pde10a and Gnal were acutely up-regulated in severity-dependent manner by mTBI, but these two proteins could not be down-regulated to basal level at the time point of 6 months post repetitive mTBI. Our study demonstrated that different severity of mTBI cause significant temporal profiling change at the proteomic level and pointed out the cAMP signaling pathway-related proteins, Pde10a and Gnal, may play important roles in the pathogenesis and recovery of mTBI.	[Song, Hai; Wang, Jiaxong; Qu, Yongqang; Yu, Jianyun] Kunming Med Univ, Dept Forens Med, Kunming 650032, Yunnan, Peoples R China; [Can, Zhenzhen; Guo, Zeyun] Kunming Med Univ, Dept Anat & Histol, Kunming 650032, Yunnan, Peoples R China; [Fang, Shanhua; Zhou, Hu] Shanghai Univ Tradit Chinese Med, E Inst Shanghai Municipal Educ Comm, 1200 Cai Lun Rd, Shanghai 201203, Peoples R China; [Gao, Jing; Huang, Qiongping; Zhou, Hu] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Analyt Chem, Shanghai 201203, Peoples R China; [Gao, Jing; Huang, Qiongping; Zhou, Hu] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Song, Hai; Wang, Jiaxong] Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg, Kunming 650032, Yunnan, Peoples R China		Yu, JY (corresponding author), Kunming Med Univ, Dept Forens Med, Kunming 650032, Yunnan, Peoples R China.; Zhou, H (corresponding author), Shanghai Univ Tradit Chinese Med, E Inst Shanghai Municipal Educ Comm, 1200 Cai Lun Rd, Shanghai 201203, Peoples R China.; Zhou, H (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Dept Analyt Chem, Shanghai 201203, Peoples R China.; Zhou, H (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China.	zhouhu@simm.ac.cn; jianyunyu@sina.com			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81360467, 21375138]; Key Project of Application and Basis Research of Yunnan Province, China [2013FB104]; Chinese Academy of SciencesChinese Academy of Sciences; Chinese Academy of SciencesChinese Academy of Sciences [XDA12030203]	This research was supported by the National Nature Science Foundation of China (No. 81360467 and No. 21375138); the Key Project of Application and Basis Research of Yunnan Province, China (No. 2013FB104); the "one hundred talent program" of the Chinese Academy of Sciences and the Strategic Priority Research Program (No. XDA12030203) of the Chinese Academy of Sciences.	Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Butler D, 2006, AUTOPHAGY, V2, P234, DOI 10.4161/auto.2729; Chen ZG, 2017, ADDICT BIOL, V22, P1731, DOI 10.1111/adb.12435; Corvol JC, 2001, J NEUROCHEM, V76, P1585, DOI 10.1046/j.1471-4159.2001.00201.x; Coskran TM, 2006, J HISTOCHEM CYTOCHEM, V54, P1205, DOI 10.1369/JHC.6A6930.2006; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Deschamps C, 2009, EXP NEUROL, V219, P466, DOI 10.1016/j.expneurol.2009.06.020; DeSouza L, 2005, J PROTEOME RES, V4, P377, DOI 10.1021/pr049821j; Evans Teresa M, 2014, Transl Proteom, V3, P10; Fuchs T, 2013, NAT GENET, V45, P88, DOI 10.1038/ng.2496; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Geiger T, 2010, NAT METHODS, V7, P383, DOI 10.1038/nmeth.1446; Giorgi M, 2011, NEUROBIOL DIS, V43, P293, DOI 10.1016/j.nbd.2011.04.006; Girault JA, 2012, ADV EXP MED BIOL, V970, P407, DOI 10.1007/978-3-7091-0932-8_18; Gonsalvez D, 2016, NEUROPHARMACOLOGY, V110, P586, DOI 10.1016/j.neuropharm.2015.04.024; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Himanen JP, 2003, INT J BIOCHEM CELL B, V35, P130, DOI 10.1016/S1357-2725(02)00096-1; Imanishi T, 1997, EUR J PHARMACOL, V321, P273, DOI 10.1016/S0014-2999(96)00969-7; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; KEYNES R, 1995, CELL, V83, P161, DOI 10.1016/0092-8674(95)90157-4; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lakshmanan R, 2010, NEUROCRIT CARE, V12, P324, DOI 10.1007/s12028-010-9342-5; Lizhnyak P. N., 2015, BRAIN NEUROTRAUMA MO; Lizhnyak PN, 2015, EXPERT REV PROTEOMIC, V12, P75, DOI 10.1586/14789450.2015.1000869; Lv L, 2017, J PROTEOMICS, V160, P74, DOI 10.1016/j.jprot.2017.03.012; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; Nakamura K, 2006, J CHROMATOGR A, V1106, P181, DOI 10.1016/j.chroma.2005.12.068; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; Niccolini F, 2015, BRAIN, V138, P3016, DOI 10.1093/brain/awv214; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; Oliva AA, 2012, J NEUROCHEM, V123, P1019, DOI 10.1111/jnc.12049; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ottens AK, 2006, MASS SPECTROM REV, V25, P380, DOI 10.1002/mas.20073; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Rodriguez-Collazo PR, 2008, EXP CELL RES, V314, P1, DOI 10.1016/j.yexcr.2007.09.011; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Scheiermann C, 2007, SCIENCE, V318, P1472, DOI 10.1126/science.1149276; Schmidt C, 2014, RNA, V20, P406, DOI 10.1261/rna.041244.113; Song H, 2016, NEUROSCI LETT, V622, P95, DOI 10.1016/j.neulet.2016.04.048; Song XM, 2008, J PROTEOME RES, V7, P2952, DOI 10.1021/pr800072x; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tao YM, 2013, PROTEOMICS, V13, P1314, DOI 10.1002/pmic.201200437; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tzekov R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153608; Vemula SR, 2013, HUM MOL GENET, V22, P2510, DOI 10.1093/hmg/ddt102; Vuoristo JT, 2000, MOL PSYCHIATR, V5, P495, DOI 10.1038/sj.mp.4000758; Wang HX, 2012, J PROTEOME RES, V11, P487, DOI 10.1021/pr2008225; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Yu CL, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00635; Zupanc GKH, 2007, PROTEOM CLIN APPL, V1, P1362, DOI 10.1002/prca.200700420	56	13	14	4	12	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	FEB	2018	17	2					858	869		10.1021/acs.jproteome.7b00618			12	Biochemical Research Methods	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV6ZK	WOS:000424730700010	29215295	hybrid			2022-02-06	
J	Strollo, BP; Bennett, GJ; Chopko, MS; Guo, WA				Strollo, Brian P.; Bennett, Gregory J.; Chopko, Michael S.; Guo, Weidun Alan			Timing of venous thromboembolism chemoprophylaxis after traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article							INTRACRANIAL HEMORRHAGE; RESPONSE RATES; GUIDELINES; PROPHYLAXIS; PREVENTION; MANAGEMENT; RISK	Objectives: Currently no national standard exists on optimal timing to initiate VTE chemoprophylaxis after traumatic brain injury (TBI). We designed this survey to assess current practice regarding the timing of VTE chemoprophylaxis after TBI. Methods: All the EAST members were surveyed online. Participants reported demographics, and responses to questions regarding VTE chemoprophylaxis in TBI and timing of chemoprophylaxis in 2 hypothetical clinical scenarios of TBI. Results: Three hundred and ninety-one full responses were collected (response rate 30.9%). Most respondents (75%) reported the decision to initiate VTE chemoprophylaxis with a consensus between the neurosurgery and trauma/critical care services. While 76% of respondents reported experience of seeing pulmonary embolism without chemoprophylaxis, 44% witnessed progression of TBI after VTE chemoprophylaxis. Approximately 50% considered their practice of VTE chemoprophylaxis in TBI patients to be conservative. Almost 50% reported no standardized protocol in their institutions. While 1/3 of the members believed guidelines exist, another 1/3 believed no guidelines available. Responses to two clinical scenarios showed various approaches regarding the timing of VTE chemoprophylaxis. Conclusions: Currently there is a wide variability in the practice patterns regarding the timing of VTE chemoprophylaxis in TBI patients. This survey reinforces the need for further investigation to guide clinical practice. (C) 2017 Elsevier Inc. All rights reserved.	[Strollo, Brian P.; Bennett, Gregory J.; Chopko, Michael S.; Guo, Weidun Alan] Univ Buffalo SUNY, Dept Surg, Buffalo, NY 14260 USA; [Bennett, Gregory J.] Erie Cty Med Ctr & Labs, Dept Neurosurg, Buffalo, NY USA; [Strollo, Brian P.] Univ Louisville, Dept Surg, Louisville, KY 40292 USA		Guo, WA (corresponding author), Univ Buffalo SUNY, Dept Surg, Buffalo, NY 14260 USA.	waguo@buffalo.edu					Abdel-Aziz H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0814-z; ACS/ TQIP, 2016, BEST PRACT MAN TRAUM; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons, 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2007.9991; Carney N., 2016, GUIDELINES MANAGEMEN, V4th; CZAJA R, 1994, ANN INTERN MED, V120, P602, DOI 10.7326/0003-4819-120-7-199404010-00012; Depew AJ, 2008, AM SURGEON, V74, P906; Dillman DA., 2000, MAIL INTERNET SURVEY; Faul M, 2010, TRAUMATIC BRAIN INJU; Gabbay J, 2004, BRIT MED J, V329, P1013, DOI 10.1136/bmj.329.7473.1013; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Grabo D, US ARMY I SURG RES J; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Jamjoom AAB, 2016, BRIT J NEUROSURG, V30, P240, DOI 10.3109/02688697.2016.1161170; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Kshettry VR, 2014, J CLIN NEUROSCI, V21, P282, DOI 10.1016/j.jocn.2013.07.003; Mesa-Galan LA, 2016, J TRAUMA ACUTE CARE; Meyer RM, 2017, J NEUROSURG, V126, P1047, DOI 10.3171/2016.4.JNS16101; Robertson J, 2005, PHARMACOEPIDEM DR S, V14, P571, DOI 10.1002/pds.1126; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Salottolo K, 2011, J TRAUMA, V70, P19, DOI 10.1097/TA.0b013e318207c54d; SCHWARTZ JS, 1991, ANN INTERN MED, V114, P46, DOI 10.7326/0003-4819-114-1-46; Sheehan K. B., 2001, J COMPUT-MEDIAT COMM, V6, DOI [10.1111/j.1083-6101.2001.tb00117.x, DOI 10.1111/J.1083-6101.2001.TB00117.X]; Valle EJ, 2014, J TRAUMA ACUTE CARE, V77, P243, DOI 10.1097/TA.0000000000000307; Zachariah J, 2016, NEUROCRIT CARE	25	13	13	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2018	43						75	80		10.1016/j.jcrc.2017.08.012			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ7DK	WOS:000418522800014	28850931				2022-02-06	
J	Titus, DJ; Wilson, NM; Alcazar, O; Calixte, DA; Dietrich, WD; Gurney, ME; Atkins, CM				Titus, David J.; Wilson, Nicole M.; Alcazar, Oscar; Calixte, Dale A.; Dietrich, W. Dalton; Gurney, Mark E.; Atkins, Coleen M.			A negative allosteric modulator of PDE4D enhances learning after traumatic brain injury	NEUROBIOLOGY OF LEARNING AND MEMORY			English	Article						Cognition; Fluid Percussion Injury; Hippocampus; Memory; Phosphodiesterase; Traumatic brain injury	LONG-TERM POTENTIATION; KNOCK-DOWN; PHOSPHODIESTERASE 4B; HIPPOCAMPAL NEUROGENESIS; RECOGNITION MEMORY; ALZHEIMERS-DISEASE; IMPROVES MEMORY; SPLICE VARIANTS; MICE DEFICIENT; UNITED-STATES	Traumatic brain injury (TBI) significantly decreases cyclic AMP (cAMP) signaling which produces long-term synaptic plasticity deficits and chronic learning and memory impairments. Phosphodiesterase 4 (PDE4) is a major family of cAMP hydrolyzing enzymes in the brain and of the four PDE4 subtypes, PDE4D in particular has been found to be involved in memory formation. Although most PDE4 inhibitors target all PDE4 subtypes, PDE4D can be targeted with a selective, negative allosteric modulator, D159687. In this study, we hypothesized that treating animals with D159687 could reverse the cognitive deficits caused by TBI. To test this hypothesis, adult male Sprague Dawley rats received sham surgery or moderate parasagittal fluid-percussion brain injury. After 3 months of recovery, animals were treated with D159687 (0.3 mg/kg, intraperitoneally) at 30 min prior to cue and contextual fear conditioning, acquisition in the water maze or during a spatial working memory task. Treatment with D159687 had no significant effect on these behavioral tasks in non-injured, sham animals, but did reverse the learning and memory deficits in chronic TBI animals. Assessment of hippocampal slices at 3 months post-TBI revealed that D159687 reversed both the depression in basal synaptic transmission in area CA1 as well as the late-phase of long-term potentiation. These results demonstrate that a negative allosteric modulator of PDE4D may be a potential therapeutic to improve chronic cognitive dysfunction following TBI.	[Titus, David J.; Wilson, Nicole M.; Alcazar, Oscar; Calixte, Dale A.; Dietrich, W. Dalton; Atkins, Coleen M.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, 1095 NW 14 Terrace, Miami, FL 33136 USA; [Gurney, Mark E.] Tetra Discovery Partners Inc, 38 Fulton St West,Suite 303, Grand Rapids, MI 49503 USA		Atkins, CM (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, 1095 NW 14 Terrace, Miami, FL 33136 USA.	catkins@med.miami.edu			National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS069721, R01 NS056072, R44 MH091791]; Miami Project to Cure Paralysis; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R44MH091791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069721, R01NS056072] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD023579] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (R01 NS069721 to C.M.A., R01 NS056072 to C.M.A. and W.D.D. and R44 MH091791 to M.E.G.) and The Miami Project to Cure Paralysis. We thank Concepcion Furones, Jonathan Mendoza, Rosmery Santos and Kevin Sikah for technical support.	Atkins C.M., 2010, EUR J NEUROSCI, V28, P35; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brullo C, 2016, EUR J MED CHEM, V124, P82, DOI 10.1016/j.ejmech.2016.08.018; Bruno O, 2011, BRIT J PHARMACOL, V164, P2054, DOI 10.1111/j.1476-5381.2011.01524.x; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; BUTLER MG, 1988, AM J MED GENET, V30, P971, DOI 10.1002/ajmg.1320300416; Cherry JA, 1999, J COMP NEUROL, V407, P287; Chong J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002309.pub4; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Del Rosso James Q, 2016, J Clin Aesthet Dermatol, V9, P43; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dlaboga D, 2006, BRAIN RES, V1096, P104, DOI 10.1016/j.brainres.2006.04.032; Faul M, 2010, TRAUMATIC BRAIN INJU; Frieden T.R., 2015, REPORT C TRAUMATIC B; Giralt A, 2011, HUM MOL GENET, V20, P4232, DOI 10.1093/hmg/ddr351; Gurney ME, 2015, NEUROTHERAPEUTICS, V12, P49, DOI 10.1007/s13311-014-0309-7; Gurney ME, 2011, HANDB EXP PHARMACOL, V204, P167, DOI 10.1007/978-3-642-17969-3_7; Hansen RT, 2015, CURR PHARM DESIGN, V21, P291; He Z, 2011, ACS CHEM NEUROSCI, V2, P600, DOI 10.1021/cn2000487; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kalgutkar AS, 2004, XENOBIOTICA, V34, P755, DOI 10.1080/00498250400005682; Kaname T, 2014, CELL SIGNAL, V26, P2446, DOI 10.1016/j.cellsig.2014.07.025; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee H, 2012, AM J HUM GENET, V90, P746, DOI 10.1016/j.ajhg.2012.03.004; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; Lindstrand A, 2014, J MED GENET, V51, P45, DOI 10.1136/jmedgenet-2013-101937; Linglart A, 2012, J CLIN ENDOCR METAB, V97, pE2328, DOI 10.1210/jc.2012-2326; Lynch DC, 2013, HUM MUTAT, V34, P97, DOI 10.1002/humu.22222; Maren S, 1997, NEUROBIOL LEARN MEM, V67, P142, DOI 10.1006/nlme.1996.3752; Michot C, 2012, AM J HUM GENET, V90, P740, DOI 10.1016/j.ajhg.2012.03.003; Miro X, 2002, SYNAPSE, V45, P259, DOI 10.1002/syn.10100; Mori F, 2010, J CHEM NEUROANAT, V40, P36, DOI 10.1016/j.jchemneu.2010.03.004; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Oliva AA, 2012, J NEUROCHEM, V123, P1019, DOI 10.1111/jnc.12049; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Press NJ, 2009, PROGR MED CHEM, V47, P37, DOI 10.1016/S0079-6468(08)00202-6; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rampersad SN, 2010, J BIOL CHEM, V285, P33614, DOI 10.1074/jbc.M110.140004; Ricciarelli R, 2017, SCI REP-UK, V7, DOI 10.1038/srep46320; Richter W, 2005, BIOCHEM J, V388, P803, DOI 10.1042/BJ20050030; Robichaud A, 2001, NEUROPHARMACOLOGY, V40, P262, DOI 10.1016/S0028-3908(00)00142-8; Rutten K, 2008, PSYCHOPHARMACOLOGY, V196, P643, DOI 10.1007/s00213-007-0999-1; Rutten K, 2008, EUR J NEUROSCI, V28, P625, DOI 10.1111/j.1460-9568.2008.06349.x; Rutten K, 2009, NEUROPSYCHOPHARMACOL, V34, P1914, DOI 10.1038/npp.2009.24; Schaefer TL, 2012, GENES BRAIN BEHAV, V11, P614, DOI 10.1111/j.1601-183X.2012.00796.x; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sierksma ASR, 2014, NEUROPHARMACOLOGY, V77, P120, DOI 10.1016/j.neuropharm.2013.09.015; Siuciak JA, 2008, PSYCHOPHARMACOLOGY, V197, P115, DOI 10.1007/s00213-007-1014-6; Tilley DG, 2005, MOL PHARMACOL, V68, P596, DOI 10.1124/mol.105.014126; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Wang ZZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11332; Wang ZZ, 2013, BRIT J PHARMACOL, V168, P1001, DOI 10.1111/j.1476-5381.2012.02225.x; Wilson NM, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00005; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang C, 2017, SCI REP-UK, V7, DOI 10.1038/srep40115; Zhang C, 2014, J ALZHEIMERS DIS, V38, P269, DOI 10.3233/JAD-122236; Zhang HT, 2008, NEUROPSYCHOPHARMACOL, V33, P1611, DOI 10.1038/sj.npp.1301537; Zhang HT, 2009, CURR PHARM DESIGN, V15, P1688, DOI 10.2174/138161209788168092	69	13	13	1	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1074-7427	1095-9564		NEUROBIOL LEARN MEM	Neurobiol. Learn. Mem.	FEB	2018	148						38	49		10.1016/j.nlm.2017.12.008			12	Behavioral Sciences; Neurosciences; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	FZ9ED	WOS:000427911500006	29294383	Bronze, Green Accepted			2022-02-06	
J	Wade, SL; Taylor, HG; Yeates, KO; Kirkwood, M; Zang, HY; McNally, K; Stacin, T; Zhang, NH				Wade, Shari L.; Taylor, Hudson Gerry; Yeates, Keith Owen; Kirkwood, Michael; Zang, Huaiyu; McNally, Kelly; Stacin, Terry; Zhang, Nanhua			Online Problem Solving for Adolescent Brain Injury: A Randomized Trial of 2 Approaches	JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS			English	Article						brain injury; problem solving; adolescence; randomized clinical trial	EXECUTIVE DYSFUNCTION; SOCIAL COMPETENCE; BEHAVIOR PROBLEMS; INTERVENTION; CHILDREN; TEEN; OUTCOMES; EFFICACY; DEFICITS; THERAPY	Objective: Adolescent traumatic brain injury (TBI) contributes to deficits in executive functioning and behavior, but few evidence-based treatments exist. We conducted a randomized clinical trial comparing Teen Online Problem Solving with Family (TOPS-Family) with Teen Online Problem Solving with Teen Only (TOPS-TO) or the access to Internet Resources Comparison (IRC) group. Methods: Children, aged 11 to 18 years, who sustained a complicated mild-to-severe TBI in the previous 18 months were randomly assigned to the TOPS-Family (49), TOPS-TO (51), or IRC group (52). Parent and self-report measures of externalizing behaviors and executive functioning were completed before treatment and 6 months later. Treatment effects were examined using linear regression models, adjusting for baseline symptom levels. Age, maternal education, and family stresses were examined as moderators. Results: The TOPS-Family group had lower levels of parent-reported executive dysfunction at follow-up than the TOPS-TO group, and differences between the TOPS-Family and IRC groups approached significance. Maternal education moderated improvements in parent-reported externalizing behaviors, with less educated parents in the TOPS-Family group reporting fewer symptoms. On the self-report Behavior Rating Inventory of Executive Functions, treatment efficacy varied with the level of parental stresses. The TOPS-Family group reported greater improvements at low stress levels, whereas the TOPS-TO group reported greater improvement at high-stress levels. The TOPS-TO group did not have significantly lower symptoms than the IRC group on any comparison. Conclusion: Findings support the efficacy of online family problem solving to address executive dysfunction and improve externalizing behaviors among youth with TBI from less advantaged households. Treatment with the teen alone may be indicated in high-stress families.	[Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; [Taylor, Hudson Gerry] Case Western Univ, Dept Pediat, Cleveland, OH USA; [Taylor, Hudson Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Pediat & Clin Neurosci, Calgary, AB, Canada; [Kirkwood, Michael] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael] Univ Colorado, Sch Med, Aurora, CO USA; [Zang, Huaiyu; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Zang, Huaiyu; Zhang, Nanhua] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [McNally, Kelly] Nationwide Childrens Hosp, Sect Pediat Psychol & Neuropsychol, Columbus, OH USA; [Stacin, Terry] Metrohlth Med Ctr, Dept Pediat, Cleveland, OH USA; [Stacin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Zang, Huaiyu/AAY-6603-2021; Yeates, Keith/AAJ-4223-2020	Zhang, Nanhua/0000-0001-5796-3404; Yeates, Keith/0000-0001-7680-2892; McNally, Kelly/0000-0001-9278-9413	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133B090010]	This study was supported by the National Institute on Disability, Independent Living, and Rehabilitation Research, formerly known as the National Institute on Disability and Rehabilitation Research (Grant No. H133B090010).	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Achenbach TM, 1991, MANUAL SELF REPORT A; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CDC, 2010, WEB BAS INJ STAT QUE; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gan C, 2010, BRAIN INJURY, V24, P651, DOI 10.3109/02699051003692142; Gioia G.A., 2000, BRIEF BEHAV RATING I; Isquith PK, 2004, BRIEF SR BEHAV RATIN; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kurowski BG, 2014, JAMA PEDIATR, V168, P523, DOI 10.1001/jamapediatrics.2013.5070; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Kurowski BG, 2013, ARCH PHYS MED REHAB, V94, P543, DOI 10.1016/j.apmr.2012.10.029; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Luna B, 2009, ADV CHILD DEV BEHAV, V37, P233, DOI 10.1016/S0065-2407(09)03706-9; Moos RH, 1994, LIFE STRESSORS SOCIA; Narad ME, 2015, J DEV BEHAV PEDIATR, V36, P700, DOI 10.1097/DBP.0000000000000208; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; TEASDALE G, 1974, LANCET, V2, P81; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2017, REHABIL PSYCHOL, V62, P290, DOI 10.1037/rep0000160; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d	30	13	13	2	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-206X	1536-7312		J DEV BEHAV PEDIATR	J. Dev. Behav. Pediatr.	FEB-MAR	2018	39	2					154	162		10.1097/DBP.0000000000000519			9	Behavioral Sciences; Psychology, Developmental; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Psychology; Pediatrics	GB9DU	WOS:000429375100082	29076889				2022-02-06	
J	Arun, P; Rittase, WB; Wilder, DM; Wang, Y; Gist, ID; Long, JB				Arun, Peethambaran; Rittase, William B.; Wilder, Donna M.; Wang, Ying; Gist, Irene D.; Long, Joseph B.			Defective methionine metabolism in the brain after repeated blast exposures might contribute to increased oxidative stress	NEUROCHEMISTRY INTERNATIONAL			English	Article						Blast exposure; Traumatic brain injury; Oxidative stress; Antioxidants; Methionine; Cysteine; Glutathione; Ascorbic acid	N-ACETYLCYSTEINE; ASCORBIC-ACID; ANTIOXIDANT DEFENSE; RAT MODEL; INJURY; OVERPRESSURE; INFLAMMATION; MECHANISMS; EXPRESSION; INDUCTION	Blast-induced traumatic brain injury (bTBI) is one of the major disabilities in Service Members returning from recent military operations. The neurobiological underpinnings of bTBI, which are associated with acute and chronic neuropathological and neurobehavioral deficits, are uncertain. Increased oxidative stress in the brain is reported to play a significant role promoting neuronal damage associated with both brain injury and neurodegenerative disorders. In this study, brains of rats exposed to repeated blasts in a shock tube underwent untargeted profiling of primary metabolism by automatic linear exchange/cold injection GC-TOF mass spectrometry and revealed acute and sub-acute disruptions in the metabolism of the essential amino acid methionine and associated antioxidants. Methionine sulfoxide, the oxidized metabolite of methionine, showed a sustained increase in the brain after blast exposure which Was associated with a significant decrease in cysteine, the amino acid derived from methionine. Glutathione, the antioxidant synthesized from cysteine, also concomitantly decreased as did the antioxidant ascorbic acid. Reductions in ascorbic acid were accompanied by increased levels of its oxidized metabolite, dehydroascorbic acid and other metabolites such as threonic acid, isothreonic acid, glycolic acid and oxalic acid. Fluorometric analysis of the brains showed acute and sub-acute increase in total reactive oxygen species. In view of the fundamental importance of glutathione in the brain as an antioxidant, including its role in the reduction of dehydroascorbic acid to ascorbic acid, the disruptions in methionine metabolism elicited by blast exposure might prominently contribute to neuronal injury by promoting increased and sustained oxidative stress. (C) 2017 Elsevier Ltd. All rights reserved.	[Arun, Peethambaran; Rittase, William B.; Wilder, Donna M.; Wang, Ying; Gist, Irene D.; Long, Joseph B.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA		Arun, P; Long, JB (corresponding author), Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	peethambaran.arun.ctr@mail.mil; joseph.b.long.civ@mail.mil			Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0018, W81XWH-11-2-0127]	This work was supported by Congressionally Directed Medical Research Program [award numbers W81XWH-08-2-0018 and W81XWH-11-2-0127].	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Costa MZ, 2013, MOL CELL BIOCHEM, V384, P21, DOI 10.1007/s11010-013-1777-5; Dash PK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00036; Deutsch JC, 2000, J CHROMATOGR A, V881, P299, DOI 10.1016/S0021-9673(00)00166-7; Du XP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4159357; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; GAMBARDELLA RL, 1977, BIOCHIM BIOPHYS ACTA, V499, P156, DOI 10.1016/0304-4165(77)90238-0; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Jansson PJ, 2004, FREE RADICAL RES, V38, P855, DOI 10.1080/10715760410001700497; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Li X, 2001, ANTIOXID REDOX SIGN, V3, P1089, DOI 10.1089/152308601317203594; Ling G, 2015, Handb Clin Neurol, V127, P173, DOI 10.1016/B978-0-444-52892-6.00011-8; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lucke-Wold BP, 2015, TRANSL RES, V166, P509, DOI 10.1016/j.trsl.2015.08.005; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; MEISTER A, 1994, J BIOL CHEM, V269, P9397; Melkani GC, 2006, BIOCHEM BIOPH RES CO, V347, P534, DOI 10.1016/j.bbrc.2006.06.136; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Paul BD, 2014, NATURE, V509, P96, DOI 10.1038/nature13136; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Shahripour RB, 2014, BRAIN BEHAV, V4, P108, DOI 10.1002/brb3.208; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Yi JH, 2006, J NEUROTRAUM, V23, P86, DOI 10.1089/neu.2006.23.86; Yi JH, 2005, BRAIN RES, V1033, P13, DOI 10.1016/j.brainres.2004.10.055; Zhang MY, 2013, J MOL NEUROSCI, V51, P57, DOI 10.1007/s12031-012-9948-5	41	13	13	3	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JAN	2018	112						234	238		10.1016/j.neuint.2017.07.014			5	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FU1ZZ	WOS:000423649300024	28774719				2022-02-06	
J	Bland, ML; Zuby, DS; Mueller, BC; Rowson, S				Bland, Megan L.; Zuby, David S.; Mueller, Becky C.; Rowson, Steven			Differences in the protective capabilities of bicycle helmets in real-world and standard-specified impact scenarios	TRAFFIC INJURY PREVENTION			English	Article						Cycling; concussion; injury risk; impact attenuation; acceleration; biomechanics	HEAD ACCELERATION; BRAIN-INJURY; CONCUSSION; FOOTBALL; ACCIDENTS; DAMAGE; RISK	Objective: The purpose of this study was to investigate relative differences in impact attenuation capabilities of bicycle helmets under real-world impact conditions and safety standard-specified conditions using a standard rig.Methods: A Consumer Product Safety Commission (CPSC) test rig was used to impact 10 helmet models of varied design. Impact configurations included 2 locations and 2 velocities. A frontal rim location (inferior to the standard-defined test area) and a temporal location were selected to reflect common cyclist impacts. An impact velocity of 3.4m/s, an average normal impact velocity in cyclist accidents, was selected, as well as the CPSC standard velocity of 6.2m/s. Four samples per helmet model were subjected to each of the 4 impact configurations once (randomized test order per sample), resulting in 160 drop tests. Peak linear acceleration (PLA) and head injury criterion (HIC)-based Abbreviated Injury Scale (AIS) 4 brain injury risk were determined and compared across helmets and impact configurations using analysis of variance. Other impact characteristics such as duration, effective liner stiffness, and energy dissipated were also calculated from acceleration data.Results: Helmet performance varied significantly between models. PLA ranged from 78 to 169 g at 3.4m/s (0-2% AIS 4 brain injury risk) and 165-432 g (10-100% risk) at 6.2m/s. Temporal impacts resulted in higher PLAs than frontal impacts, likely due to increased effective liner stiffness. However, 2 helmets exceeded the CPSC pass-fail threshold (300 g) at the frontal rim location, producing >70% risk. Force-displacement curves suggest that bottoming-out occurred in these impacts. Aside from bottoming-out cases, helmets that performed worse in one impact configuration tended to perform worse in others, with non-road-style helmets among the worst.Conclusions: The 10 bicycle helmets tested produced considerable differences in their protective capabilities under both real-world and standard-specified conditions on the CPSC rig. Risk of severe brain injury varied widely between helmets at the standard impact velocity, whereas the common, lower severity impacts produced PLAs associated with concussion. Helmets of a nonroad style generally performed worse across configuration. The temporal location produced higher risks for most helmets, although some helmets were found to offer inadequate protection at the helmet rim. Because this is a commonly impacted location in cyclist accidents, there may be benefit to expanding the testable area in standards to include the rim. Results from this study demonstrate the value in testing nonstandard conditions and can be used to inform standards testing and helmet design.	[Bland, Megan L.; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA; [Zuby, David S.; Mueller, Becky C.] Insurance Inst Highway Safety, Ruckersville, VA USA		Bland, ML (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	mbland27@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596			Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; American Association of Neurological Surgeons, 2014, SPORTS REL HEAD INJ; Bourdet N, 2012, P I MECH ENG P-J SPO, V226, P282, DOI 10.1177/1754337112442326; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Ching RP, 1997, ACCIDENT ANAL PREV, V29, P555, DOI 10.1016/S0001-4575(97)00008-0; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Elvik R, 2013, ACCIDENT ANAL PREV, V60, P245, DOI 10.1016/j.aap.2012.12.003; Gennarelli TA, 1971, 15 STAPP CAR CRASH C; Gennarelli TA, 1972, 720970 SAE; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hansen K, 2013, ACCIDENT ANAL PREV, V59, P109, DOI 10.1016/j.aap.2013.05.019; Klug C, 2015, IRCOBI C 2015 LYON F; McIntosh A, 1998, ACCIDENT ANAL PREV, V30, P161, DOI 10.1016/S0001-4575(97)00089-4; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; Mertz Harold J, 2003, Stapp Car Crash J, V47, P155; Mills NJ, 2008, INT J IMPACT ENG, V35, P1075, DOI 10.1016/j.ijimpeng.2007.05.005; Mills N J, 1990, Br J Sports Med, V24, P55; Milne G, 2014, INT J CRASHWORTHINES, V19, P323, DOI 10.1080/13588265.2013.859470; Ommaya A.K., 1985, BIOMECHANICS TRAUMA, P245; Otte D, 1989, 33 STAPP CAR CRASH C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; SACKS JJ, 1991, JAMA-J AM MED ASSOC, V266, P3016, DOI 10.1001/jama.266.21.3016; Schulman J, 2002, INJ PREV, V8, P47, DOI 10.1136/ip.8.1.47; SMITH TA, 1994, ACCIDENT ANAL PREV, V26, P795, DOI 10.1016/0001-4575(94)90055-8; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1974, DOI 10.1001/jama.276.24.1974; WILLIAMS M, 1991, ACCIDENT ANAL PREV, V23, P119, DOI 10.1016/0001-4575(91)90043-5	28	13	13	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2018	19			1			S158	S163		10.1080/15389588.2017.1388915			6	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	GA9TD	WOS:000428682800024	29584492				2022-02-06	
J	Dams-O'Connor, K; Landau, A; Hoffman, J; St De Lore, J				Dams-O'Connor, Kristen; Landau, Alexandra; Hoffman, Jeanne; St De Lore, Jef			Patient perspectives on quality and access to healthcare after brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; acquired brain injury; chronic health; qualitative research	LONG-TERM DISABILITY; UNITED-STATES; SELF-MANAGEMENT; CHRONIC ILLNESS; POPULATION; OUTCOMES; HOSPITALIZATION; REHABILITATION; COMMUNICATION; PROFESSIONALS	Primary objective: To gather information about brain injury (BI) survivors' long-term healthcare needs, quality, barriers and facilitators.Research design: Qualitative content analysis of data gathered in focus groups using semi-structured interviews.Methods: Forty-four community-dwelling adults participated at two clinical research centres in Seattle, Washington and New York, New York. Participants were asked open-ended questions about their experiences with healthcare in the community with regard to care needs, utilization, access, barriers and facilitators to health management.Results: Central themes emerged across three categories: 1) barriers to healthcare access/utilization, 2) facilitators to healthcare access/utilization, and 3) suggestions for improving healthcare after BI. The importance of communication as both a facilitator and barrier to care was mentioned by most participants. Compensatory strategies and external tools were identified as key facilitators of medical self-management. Finally, improving clinicians' knowledge about BI emerged as a potential solution to address health needs of individuals with chronic BI.Conclusions: Additional efforts need to be made to improve access to appropriate healthcare and increase the ability for individuals to successfully navigate the healthcare system. Findings suggest several specific, low-cost modifications to healthcare delivery and strategies for improving medical self-management that can maximize long-term health maintenance for BI survivors.	[Dams-O'Connor, Kristen; Landau, Alexandra] Icahn Sch Med Mt Sinai, Dept Rehabil Med, One Gustave Levy Pl,Box 1163, New York, NY 10029 USA; [Hoffman, Jeanne] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [St De Lore, Jef] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA		Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, One Gustave Levy Pl,Box 1163, New York, NY 10029 USA.	kristen.dams-oconnor@mountsinai.org			National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DP0038-02-00, 90DP0031-01-00]; National Institutes of Health, National Institute of Child Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS) [K01HD074651-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD074651] Funding Source: NIH RePORTER	This work was supported by Grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (Grant Numbers 90DP0038-02-00 and 90DP0031-01-00), and by a Grant from the National Institutes of Health, National Institute of Child Health and Development (Grant Number K01HD074651-01A1).	[Anonymous], 2014, WEB APPL MAN AN PRES; Bayliss EA, 2015, ANN FAM MED, V13, P123, DOI 10.1370/afm.1739; Bellinger JD, 2010, INT J ENV RES PUB HE, V7, P975, DOI 10.3390/ijerph7030975; Bowers B, 2003, DISABIL SOC, V18, P443, DOI 10.1080/0968759032000080995; Brain Injury Association of America, 2015, BRAIN INJ STAT; Breed S, 2008, J HEAD TRAUMA REHAB, V23, P149, DOI 10.1097/01.HTR.0000319931.76966.ff; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Cabana MD, 2004, J FAM PRACTICE, V53, P974; Coleman MT, 2005, AM FAM PHYSICIAN, V72, P1503; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Coulter A, 2007, BMJ-BRIT MED J, V335, P24, DOI 10.1136/bmj.39246.581169.80; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; DeJong Gerben, 2002, NATL REHABILITATION, V1, P9; Flanagan S, 2005, BRAIN INJURY PROFESS, V2, P22; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Flanagan SR, 2006, CLIN GERIATR MED, V22, P449, DOI 10.1016/j.cger.2005.12.011; Giles GM, 2006, J HEAD TRAUMA REHAB, V21, P168, DOI 10.1097/00001199-200603000-00009; Hannerz H, 2001, STROKE, V32, P1739, DOI 10.1161/01.STR.32.8.1739; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Kelley JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094207; Kroll Thilo, 2003, Manag Care Q, V11, P11; Malec JF, 2013, J HEAD TRAUMA REHAB, V28, P476, DOI 10.1097/HTR.0000000000000003; Masel BE, 2015, J NEUROTRAUM, V32, P1833, DOI 10.1089/neu.2015.29004.bm; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McClure J, 2008, BRAIN INJURY, V22, P639, DOI 10.1080/02699050802255585; McClure J, 2006, BRAIN INJURY, V20, P1029, DOI 10.1080/02699050600909870; Morris MA, 2015, DISABIL HEALTH J, V8, P208, DOI 10.1016/j.dhjo.2014.09.007; O'Callaghan AM, 2010, INT J SPEECH-LANG PA, V12, P107, DOI 10.3109/17549500903431774; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Quinn C, 2016, J APPL GERONTOL, V35, P1154, DOI 10.1177/0733464814566852; Quinn C, 2016, INT PSYCHOGERIATR, V28, P787, DOI 10.1017/S1041610215002094; Redpath SJ, 2010, BRAIN INJURY, V24, P802, DOI 10.3109/02699051003709623; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Schulman-Green D, 2012, J NURS SCHOLARSHIP, V44, P136, DOI 10.1111/j.1547-5069.2012.01444.x; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Toor GK, 2016, ARCH PHYS MED REHAB, V97, pS54, DOI 10.1016/j.apmr.2015.02.010; Turner S, 2004, AGE AGEING, V33, P461, DOI 10.1093/ageing/afh140; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wittink MN, 2016, CONT CLIN TRIAL COMM, V4, P214, DOI 10.1016/j.conctc.2016.10.002; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	46	13	13	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	4					431	441		10.1080/02699052.2018.1429024			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FV9WZ	WOS:000424942400006	29388840				2022-02-06	
J	Ortiz, OHH; Garcia, HIG; Ramirez, FM; Florez, JSC; Valencia, BAG; Mantilla, SEM; Ochoa, MJM; Ochoa, JES; Jaimes, F				Hernandez Ortiz, Olga Helena; Garcia Garcia, Hector Ivan; Munoz Ramirez, Fabian; Cardona Florez, Juan Sebastian; Gil Valencia, Bladimir Alejandro; Medina Mantilla, Salvador Ernesto; Moreno Ochoa, Maria Juliana; Sara Ochoa, Jorge Eliecer; Jaimes, Fabian			Development of a prediction rule for diagnosing postoperative meningitis: a cross-sectional study	JOURNAL OF NEUROSURGERY			English	Article						postoperative meningitis; nosocomial meningitis; prediction rule; lactate; infection	CEREBROSPINAL-FLUID LACTATE; NEUROSURGICAL BACTERIAL-MENINGITIS; C-REACTIVE PROTEIN; RISK-FACTORS; DIFFERENTIAL-DIAGNOSIS; SERUM PROCALCITONIN; METHODOLOGICAL STANDARDS; SUBARACHNOID HEMORRHAGE; ANTIBIOTIC-PROPHYLAXIS; ASEPTIC-MENINGITIS	OBJECTIVE Diagnosing nosocomial meningitis (NM) in neurosurgical patients is difficult. The standard CSF test is not optimal and when it is obtained, CSF cultures are negative in as many as 70% of cases. The goal of this study was to develop a diagnostic prediction rule for postoperative meningitis using a combination of clinical, laboratory, and CSF variables, as well as risk factors (RFs) for CNS infection. METHODS A cross-sectional study was performed in 4 intensive care units in Medellin, Colombia. Patients with a history of neurosurgical procedures were selected at the onset of febrile symptoms and/or after an increase in acute-phase reactants. Their CSF was studied for suspicion of infection and a bivariate analysis was performed between the dependent variable (confirmed/probable NM) and the identified independent variables. Those variables with a p value <= 0.2 were fitted in a multiple logistic regression analysis with the same dependent variable. After determining the best model according to its discrimination and calibration, the beta coefficient for each selected dichotomized variable obtained from the logistic regression model was used to construct the score for the prediction rule. RESULTS Among 320 patients recruited for the study, 154 had confirmed or probable NM. Using bivariate analysis, 15 variables had statistical associations with the outcome: aneurysmal subarachnoid hemorrhage (aSAH), traumatic brain injury, CSF leak, positioning of external ventricular drains (EVDs), daily CSF draining via EVDs, intraventricular hemorrhage, neurological deterioration, age >= 50 years, surgical duration >= 220 minutes, blood loss during surgery >= 200 ml, C-reactive protein (CRP) >= 6 mg/dl, CSF/serum glucose ratio <= 0.4 mmol/L, CSF lactate >= 4 mmol/L, CSF leukocytes >= 250 cells, and CSF polymorphonuclear (PMN) neutrophils >= 50%. The multivariate analysis fitted a final model with 6 variables for the prediction rule (aSAH diagnosis: 1 point; CRP >= 6 mg/dl: 1 point; CSF/serum glucose ratio <= 0.4 mmol/L: 1 point; CSF leak: 1.5 points; CSF PMN neutrophils >= 50%: 1.5 points; and CSF lactate <= 4 mmol/L: 4 points) with good calibration (Hosmer-Lemeshow goodness of fit = 0.71) and discrimination (area under the receiver operating characteristic curve = 0.94). CONCLUSIONS The prediction rule for diagnosing NM improves the diagnostic accuracy in neurosurgical patients with suspicion of infection. A score >= 6 points suggests a high probability of neuroinfection, for which antibiotic treatment should be considered. An independent validation of the rule in a different group of patients is warranted. https://thejns.org/doi/abs/10.3171/2016.10.JNS16379	[Hernandez Ortiz, Olga Helena; Garcia Garcia, Hector Ivan; Jaimes, Fabian] Univ Antioquia, Sch Med, Acad Grp Clin Epidemiol GRAEPIC, Medellin, Colombia; [Hernandez Ortiz, Olga Helena; Medina Mantilla, Salvador Ernesto; Moreno Ochoa, Maria Juliana] Inst Neurol Colombia, Medellin, Colombia; [Hernandez Ortiz, Olga Helena; Gil Valencia, Bladimir Alejandro; Sara Ochoa, Jorge Eliecer] Clin Medellin, Medellin, Colombia; [Munoz Ramirez, Fabian; Cardona Florez, Juan Sebastian; Gil Valencia, Bladimir Alejandro] Univ Pontificia Bolivariana, Medellin, Colombia; [Munoz Ramirez, Fabian] Hosp Pablo Tobon Uribe, Medellin, Colombia; [Cardona Florez, Juan Sebastian; Gil Valencia, Bladimir Alejandro] Clin Las Amer, Medellin, Colombia; [Medina Mantilla, Salvador Ernesto; Moreno Ochoa, Maria Juliana] Univ CES, Medellin, Colombia		Ortiz, OHH (corresponding author), Neurol Inst Colombia, Intens Care, St 51D 62-29, Medellin 050012, Colombia.	olgahdezo@gmail.com	Jaimes, Fabian/AAE-4109-2020; Jaimes, Fabian/R-4258-2016	Jaimes, Fabian/0000-0002-7315-5367; Jaimes, Fabian/0000-0002-7315-5367; Hernandez Ortiz, Olga Helena/0000-0002-9738-0489; Garcia Garcia, Hector Ivan/0000-0002-3549-1263	"Sustainability Strategy Clinical Epidemiology Academic Group", University of Antioquia ("Estrategia de Sostenibilidad Grupo Academico de Epidemiologia Clinica [GRAEPIC]," Universidad de Antioquia)	We would like to thank Clinica las Americas, Hospital Pablo Tobon Uribe, Clinica Medellin, and Instituto Neurologico de Colombia. We would also like to thank Julian Fernando Arango and Jhon Bayron Velasquez for their continuous technical, administrative, and personal support. Financial support for this study was received from the "Sustainability Strategy 2013-2014 Clinical Epidemiology Academic Group", University of Antioquia ("Estrategia de Sostenibilidad 2013-2014 Grupo Academico de Epidemiologia Clinica [GRAEPIC]," Universidad de Antioquia).	BALCH RE, 1967, J NEUROSURG, V26, P41, DOI 10.3171/jns.1967.26.1part1.0041; Berger C, 2002, CRIT CARE MED, V30, P1778, DOI 10.1097/00003246-200208000-00017; BLOMSTEDT GC, 1985, ACTA NEUROCHIR, V78, P81, DOI 10.1007/BF01808684; Brouwer MC, 2012, LANCET, V380, P1684, DOI 10.1016/S0140-6736(12)61185-4; BUSSE O, 1983, STROKE, V14, P960, DOI 10.1161/01.STR.14.6.960; CARMEL PW, 1993, PEDIATR NEUROSURG, V19, P276, DOI 10.1159/000120744; Chiang HY, 2014, J NEUROSURG, V120, P509, DOI 10.3171/2013.9.JNS13843; Choi SH, 2013, INFECT CHEMOTHER, V45, P308, DOI 10.3947/ic.2013.45.3.308; Commichau C, 2003, NEUROLOGY, V60, P837, DOI 10.1212/01.WNL.0000047344.28843.EB; Conen A, 2008, CLIN INFECT DIS, V47, P73, DOI 10.1086/588298; CURTIS GDW, 1981, J INFECTION, V3, P159, DOI 10.1016/S0163-4453(81)91336-0; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Federico G, 2001, SCAND J INFECT DIS, V33, P533, DOI 10.1080/00365540110026557; Fernandez A, 2007, NEUROLOGY, V68, P1013, DOI 10.1212/01.wnl.0000258543.45879.f5; Forgacs P, 2001, CLIN INFECT DIS, V32, P179, DOI 10.1086/318471; Frontera JA, 2008, NEUROSURGERY, V62, P80, DOI 10.1227/01.NEU.0000311064.18368.EA; FUJISHIMA M, 1975, STROKE, V6, P707, DOI 10.1161/01.STR.6.6.707; Gerdes LU, 1998, SCAND J CLIN LAB INV, V58, P383, DOI 10.1080/00365519850186364; Grille P, 2012, NEUROCIRUGIA, V23, P131, DOI 10.1016/j.neucir.2011.11.005; Kadane JB, 2004, J AM STAT ASSOC, V99, P279, DOI 10.1198/016214504000000269; Korinek AM, 2005, BRIT J NEUROSURG, V19, P155, DOI 10.1080/02688690500145639; Korinek AM, 2006, NEUROSURGERY, V59, P126, DOI 10.1227/01.NEU.0000220477.47323.92; Kourbeti IS, 2015, J NEUROSURG, V122, P1113, DOI 10.3171/2014.8.JNS132557; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Leib SL, 1999, CLIN INFECT DIS, V29, P69, DOI 10.1086/520184; Li YR, 2015, CLIN BIOCHEM, V48, P50, DOI 10.1016/j.clinbiochem.2014.10.007; Lopez-Cortes LF, 2000, CRIT CARE MED, V28, P215, DOI 10.1097/00003246-200001000-00035; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Martinez R, 2002, INTENS CARE MED, V28, P208, DOI 10.1007/s00134-001-1176-3; McClelland S, 2007, CLIN INFECT DIS, V45, P55, DOI 10.1086/518580; MOLLMAN HD, 1986, J NEUROSURG, V64, P902, DOI 10.3171/jns.1986.64.6.0902; Maskin LP, 2013, CLIN NEUROL NEUROSUR, V115, P1820, DOI 10.1016/j.clineuro.2013.05.034; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Reichert MCF, 2002, AM J INFECT CONTROL, V30, P158, DOI 10.1067/mic.2002.119925; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; ROLAND PS, 1989, OTOLARYNG HEAD NECK, V101, P445, DOI 10.1177/019459988910100407; ROSS D, 1988, J NEUROSURG, V69, P669, DOI 10.3171/jns.1988.69.5.0669; Scaravilli V, 2011, NEUROCRIT CARE, V15, P287, DOI 10.1007/s12028-011-9588-6; Shimetani N, 2001, SCAND J CLIN LAB INV, V61, P567; SIMPSON H, 1977, ARCH DIS CHILD, V52, P844, DOI 10.1136/adc.52.11.844; SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700; Steyerberg E., 2010, CLIN PREDICTION MODE; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Tavares WM, 2006, ARQ NEURO-PSIQUIAT, V64, P592, DOI 10.1590/S0004-282X2006000400012; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; vanAken MO, 1997, CLIN INFECT DIS, V25, P852, DOI 10.1086/515533; Viallon A, 2011, CRIT CARE, V15, DOI 10.1186/cc10254; Wang KW, 2005, J CLIN NEUROSCI, V12, P647, DOI 10.1016/j.jocn.2004.09.017; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; Wong GK, 2008, J CLIN NEUROSCI, V15, P654, DOI 10.1016/j.jocn.2007.03.011; YAO H, 1989, J NEUROL NEUROSUR PS, V52, P372, DOI 10.1136/jnnp.52.3.372	54	13	14	1	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2018	128	1					262	271		10.3171/2016.10.JNS16379			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FR3AW	WOS:000418939300032	28298047				2022-02-06	
J	Mahadewa, TGB; Golden, N; Saputra, A; Ryalino, C				Mahadewa, Tjokorda Gde Bagus; Golden, Nyoman; Saputra, Anne; Ryalino, Christopher			Modified Revised Trauma-Marshall score as a proposed tool in predicting the outcome of moderate and severe traumatic brain injury	OPEN ACCESS EMERGENCY MEDICINE			English	Article						head injury; CT scan; revised score; prognostic score	MINOR HEAD-INJURY; CLASSIFICATION; EPIDEMIOLOGY; TOMOGRAPHY; MANAGEMENT; HEMORRHAGE; IMPACT; SCALE; CT	Background: Traumatic brain injury (TBI) is a common healthcare problem related to disability. An easy-to-use trauma scoring system informs physicians about the severity of trauma and helps to decide the course of management. The purpose of this study is to use the combination of both physiological and anatomical assessment tools that predict the outcome and develop a new modified prognostic scoring system in TBIs. Patients and methods: A total of 181 subjects admitted to the emergency department (ED) of Sanglah General Hospital were documented for both Marshall CT scan classification score (MCTC) and Revised Trauma Score (RTS) upon admission. Glasgow Outcome Scale (GOS) was then documented at six months after brain injury. A new Modified Revised Trauma-Marshall score (m-RTS) was developed using statistical analytic methods. Results: The total sample enrolled for this study was 181 patients. The mean RTS upon admission was 10.2 +/- 1.2. Of the 181 subjects, 110 (60.8%) were found to have favorable GOS (GOS score >3). Best Youden's index results were obtained with any of the RTS of <= 10 with area under receiver operating characteristic (ROC) curve of 0.2542 and with risk ratio of 2.9 (95% CI=1.98-4.28; P=0.001); and Marshall score <= 2 with area under R(X; curve of 0.2249 with risk ratio of 3.9 (95% CI=2.52-5.89; P=0.001). The RTS-Marshall combination has higher sensitivity with risk ratio of 4.5 (Cl 952.55-8.0; P.001) for screening tools of unfavorable outcome. The Pearson's correlation between RTS and Marshall classification is 0.464 (P<0.001). Conclusion: Combination of physiological and anatomical score improves the prognostic of outcome in moderate and severe TBI patients, formulated in this accurate, simple, applicable and reliable m-RTS prognostic score model.	[Mahadewa, Tjokorda Gde Bagus; Golden, Nyoman; Saputra, Anne] Udayana Univ, Fac Med, Dept Surg, Div Neurosurg, Denpasar, Bali, Indonesia; [Ryalino, Christopher] Udayana Univ, Fac Med, Dept Anesthesiol & Intens Care, Denpasar, Bali, Indonesia		Mahadewa, TGB (corresponding author), Udayana Univ, Sanglah Gen Hosp, Dept Surg, Denpasar 80113, Bali, Indonesia.	tjokbagusmahadewa@gmail.com	Ryalino, Christopher/K-1673-2019; Tjokorda, Mahadewa/K-3792-2016	Ryalino, Christopher/0000-0001-9618-6230; Saputra, Anne/0000-0003-3199-2957; Tjokorda, Mahadewa/0000-0002-4445-4085			Azian AA, 2001, ACTA NEUROCHIR, V143, P711, DOI 10.1007/s007010170051; Castellan N. J, 1988, NONPARAMETRIC STAT B; Chesnut R M, 1995, New Horiz, V3, P366; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Hsiang John N K, 2005, J Long Term Eff Med Implants, V15, P153, DOI 10.1615/JLongTermEffMedImplants.v15.i2.40; Kondo Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10348; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lefering R, 2009, EUR J TRAUMA EMERG S, V35, P437, DOI 10.1007/s00068-009-9122-0; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Mizraji R, 2009, TRANSPL P, V41, P3489, DOI 10.1016/j.transproceed.2009.09.008; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Saini NS, 2012, INDIAN J NEUROTRAUM, V9, P45, DOI 10.1016/j.ijnt.2012.04.009; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; TEASDALE G, 1992, J NEUROTRAUM, V9, pS249; Ting HW, 2010, J CHIN MED ASSOC, V73, P139, DOI 10.1016/S1726-4901(10)70028-9; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402; [No title captured]	24	13	13	1	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1500			OPEN ACCESS EMERG M	Open Access Emerg. Med.		2018	10						135	139		10.2147/OAEM.S179090			5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	GX1JF	WOS:000447471600001	30349408	gold, Green Published, Green Submitted			2022-02-06	
J	Mantua, J; Helms, SM; Weymann, KB; Capaldi, VF; Lim, MM				Mantua, Janna; Helms, Steven M.; Weymann, Kris B.; Capaldi, Vincent F., II; Lim, Miranda M.			Sleep Quality and Emotion Regulation Interact to Predict Anxiety in Veterans with PTSD	BEHAVIOURAL NEUROLOGY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; COMBAT VETERANS; OF-LIFE; INSOMNIA; IRAQ; AFGHANISTAN; PREVALENCE; DEPRESSION; QUESTIONNAIRE	Posttraumatic stress disorder (PTSD) is a debilitating and common consequence of military service. PTSD is associated with increased incidence of mood disturbances (e.g., anxiety). Additionally, veterans with PTSD often have poor-quality sleep and poor emotion regulation ability. We sought to assess whether such sleep and emotion regulation deficits contribute to mood disturbances. In 144 veterans, using a double moderation model, we tested the relationship between PTSD and anxiety and examined whether sleep quality and emotion regulation interact to moderate this relationship. We found that PTSD predicts higher anxiety in veterans with poor and average sleep quality who utilize maladaptive emotion regulation strategies. However, there was no relationship between PTSD and anxiety in individuals with good sleep quality, regardless of emotion regulation. Similarly, there was no relationship between PTSD and anxiety in individuals with better emotion regulation, regardless of sleep quality. Results were unchanged when controlling for history of traumatic brain injury (TBI), despite the fact that those with both PTSD and TBI had the poorest emotion regulation overall. Taken together, these results suggest that good-quality sleep may be protective against poor emotion regulation in veterans with PTSD. Sleep may therefore be a target for therapeutic intervention in veterans with PTSD and heightened anxiety.	[Mantua, Janna] Univ Massachusetts, Neurosci & Behav Program, Amherst, MA 01003 USA; [Mantua, Janna; Capaldi, Vincent F., II] Walter Reed Army Inst Res, Behav Biol Branch, Silver Spring, MD 20910 USA; [Helms, Steven M.; Weymann, Kris B.; Lim, Miranda M.] VA Portland Hlth Care Syst, Portland, OR 97239 USA; [Helms, Steven M.; Weymann, Kris B.; Lim, Miranda M.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA		Lim, MM (corresponding author), VA Portland Hlth Care Syst, Portland, OR 97239 USA.; Lim, MM (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97239 USA.	lmir@ohsu.edu			Sleep Research Society Mentor-Mentee Program award; VA Portland Health Care System, VA Career Development Award [IK2 BX002712]; NIH EXITOUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1GM118964]; Portland VA Research Foundation; VA OAA Post-doctoral Nursing Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [UL1GM118964] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2BX002712] Funding Source: NIH RePORTER	The authors would like to express their sincere appreciation and gratitude for the participation of all subjects, to the staff at the VA Portland Health Care System Sleep Disorders Clinic. Specific acknowledgements go to Ryan A. Opel for assistance with data curation and Alexander Q. Chau and Matthew R. Gieger for assistance with chart review. This work was supported by the Sleep Research Society Mentor-Mentee Program award, awarded to Janna Mantua. This work was also supported with resources and the use of facilities at the VA Portland Health Care System, VA Career Development Award no. IK2 BX002712, NIH EXITO Institutional Core, no. UL1GM118964, the Portland VA Research Foundation to Miranda M. Lim, and VA OAA Post-doctoral Nursing Research Fellowship to Kris B. Weymann.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Berking M, 2008, BEHAV RES THER, V46, P1230, DOI 10.1016/j.brat.2008.08.005; Boden MT, 2013, J SOC CLIN PSYCHOL, V32, P296, DOI 10.1521/jscp.2013.32.3.296; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Broderick Joan E, 2013, EGEMS (Wash DC), V1, P1015, DOI 10.13063/2327-9214.1015; Chasens ER, 2009, SLEEP, V32, P915, DOI 10.1093/sleep/32.7.915; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; DAVIDSON JRT, 1991, PSYCHOL MED, V21, P713, DOI 10.1017/S0033291700022352; den Hollander-Gijsman ME, 2010, EUR PSYCHIAT, V25, P197, DOI 10.1016/j.eurpsy.2009.09.005; DiCiccio TJ, 1996, STAT SCI, V11, P189; Dursa EK, 2014, J TRAUMA STRESS, V27, P542, DOI 10.1002/jts.21956; Fernandez-Mendoza J, 2010, PSYCHOSOM MED, V72, P397, DOI 10.1097/PSY.0b013e3181d75319; Ginzburg K, 2010, J AFFECT DISORDERS, V123, P249, DOI 10.1016/j.jad.2009.08.006; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI [DOI 10.1037/1089-2680.2.3.271, 10.1037/1089-2680.2.3.271]; Hayes A.F., 2012, PROCESS VERSATILE CO; Kompier MAJ, 2012, SCAND J WORK ENV HEA, V38, P238, DOI 10.5271/sjweh.3263; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Maguen S, 2012, WOMEN HEALTH ISS, V22, pE61, DOI 10.1016/j.whi.2011.07.010; Mantua J., 2018, SLEEP MED REV; Margolies SO, 2013, J CLIN PSYCHOL, V69, P1026, DOI 10.1002/jclp.21970; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; Motomura Y, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx133; Motomura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056578; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Sheppes G, 2008, EMOTION, V8, P870, DOI 10.1037/a0013711; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Street AE, 2015, PSYCHOL MED, V45, P717, DOI 10.1017/S003329171400258X; Swanson LM, 2009, J TRAUMA STRESS, V22, P639, DOI 10.1002/jts.20468; Tamanna S, 2014, J CLIN SLEEP MED, V10, P631, DOI 10.5664/jcsm.3786; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Ulmer CS, 2011, J CLIN SLEEP MED, V7, P57; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vantieghem I, 2016, PSYCHOL HEALTH, V31, P1064, DOI 10.1080/08870446.2016.1171866; WARSHAW MG, 1993, AM J PSYCHIAT, V150, P1512; Weathers F.W., 1993, 9 ANN C ISTSS; Wright KM, 2011, J CLIN PSYCHOL, V67, P1240, DOI 10.1002/jclp.20845; Zatzick DF, 1997, AM J PSYCHIAT, V154, P1690, DOI 10.1176/ajp.154.12.1690	45	13	14	3	11	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2018	2018								7940832	10.1155/2018/7940832			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GK1QY	WOS:000435894700001	29971139	Green Published, gold, Green Submitted			2022-02-06	
J	Merritt, VC; Clark, AL; Sorg, SF; Evangelista, ND; Werhane, ML; Bondi, MW; Schiehser, DM; Delano-Wood, L				Merritt, Victoria C.; Clark, Alexandra L.; Sorg, Scott F.; Evangelista, Nicole D.; Werhane, Madeleine L.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa			Apolipoprotein E (APOE) epsilon 4 genotype is associated with reduced neuropsychological performance in military veterans with a history of mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Apolipoprotein E gene; cognitive functioning; mild traumatic brain injury; military Veterans; neuropsychological assessment	POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; HEAD-INJURY; RECOVERY; MODERATE; SYMPTOMS; ALLELE; MEMORY	Introduction: The purpose of this study was to investigate the effect of the apolipoprotein E (APOE) epsilon 4 allele on neuropsychological functioning in military Veterans with a remote history of mild traumatic brain injury (mTBI).Method: This cross-sectional study included 99 Veterans (mTBI=53; military controls, MC=46) who underwent neuropsychological assessment and APOE genotyping. Three neurocognitive composite scoresmemory (=.84), speed (=.85), and executive functioning (=.76)were computed from 24 norm-referenced variables, and the total number of impaired scores (>1.5 SDs below mean) for each participant was calculated.Results: Analyses of covariance adjusting for ethnicity and posttraumatic stress disorder (PTSD) symptoms revealed that although no significant differences were observed between mTBI epsilon 4 allele groups on the executive functioning composite (p>.05), mTBI epsilon 4+Veterans performed more poorly than epsilon 4- Veterans on the memory (p=.045, (2)(p)=.083) and speed (p=.023, (2)(p)=.106) composites. Furthermore, Mann-Whitney U tests showed that epsilon 4+mTBI Veterans displayed a significantly greater number of impaired scores than did epsilon 4- mTBI Veterans (p=.010, r=.355). In contrast, there were no significant differences across any of the cognitive variables between epsilon 4+and epsilon 4- MCs (all p>.05).Conclusions: Results suggest that APOE epsilon 4 genotype is related to reduced memory and processingspeed performance, as well as overall cognitive impairment, in those with a history of mTBI, but does not appear to have the same negative effects on cognition in the absence of neurotrauma. Although results are preliminary, the present study advances understanding of genetic influences on cognitive functioning in Veterans with remote mTBIs. Future longitudinal work is needed to elucidate the underlying brain-based mechanisms of epsilon 4 allelic effects on cognitive and clinical outcomes following TBI.	[Merritt, Victoria C.; Sorg, Scott F.; Evangelista, Nicole D.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa] VASDHS, San Diego, CA USA; [Clark, Alexandra L.; Werhane, Madeleine L.] SDSU UCSD, Joint Doctoral Program Clin Psychol, San Diego, CA USA; [Sorg, Scott F.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Schiehser, Dawn M.; Delano-Wood, Lisa] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA		Delano-Wood, L (corresponding author), Univ Calif San Diego, VASDHS, Ctr Excellence Stress & Mental Hlth, Dept Psychiat, 3350 La Jolla Village Dr,MC 151B, San Diego, CA 92161 USA.	ldelano@ucsd.edu		Merritt, Victoria/0000-0001-5683-4168	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24AG026431] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24 AG026431] Funding Source: Medline		Alexopoulos P, 2011, J ALZHEIMERS DIS, V26, P207, DOI 10.3233/JAD-2011-110356; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P139, DOI 10.1097/01.HTR.0000319930.69343.64; Belanger H. G., 2014, HDB NEUROPSYCHOLOGY; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boosman H, 2017, NEUROPSYCHOL REHABIL, V27, P581, DOI 10.1080/09602011.2015.1113996; Brooks BL, 2008, J INT NEUROPSYCH SOC, V14, P463, DOI 10.1017/S1355617708080521; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Clark AL, 2016, BRAIN INJURY, V30, P864, DOI 10.3109/02699052.2016.1144894; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cooper DB, 2014, J REHABIL RES DEV, V51, P1023, DOI [10.1682/JRRD.2013.05.0104, 10.1682/JRRD.2013.05.0140]; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Heaton R.K., 1981, WISCONSIN CARD SORTI; Hodgkinson A, 2009, BRAIN IMPAIR, V10, P162, DOI 10.1375/brim.10.2.162; Holtzman DM, 2000, ANN NEUROL, V47, P739, DOI 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.3.CO;2-#; Hong Eun Pyo, 2012, Genomics & Informatics, V10, P117, DOI 10.5808/GI.2012.10.2.117; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P923, DOI 10.1007/978-0-387-76978-3_32; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Leclercq PD, 2005, J NEUROL NEUROSUR PS, V76, P229, DOI 10.1136/jnnp.2003.025528; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Liu Y, 2016, MOL NEUROBIOL, V53, P4539, DOI 10.1007/s12035-015-9388-7; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mahley RW, 1996, ANN NY ACAD SCI, V777, P139, DOI 10.1111/j.1749-6632.1996.tb34412.x; Martindale SL, 2016, REHABIL PSYCHOL, V61, P231, DOI 10.1037/rep0000076; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McAllister T. W., 2011, TXB TRAUMATIC BRAIN, P37; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; Meyers JE., 1995, REY COMPLEX FIGURE T; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048895; Padgett CR, 2016, NEUROPSYCHOLOGY, V30, P775, DOI 10.1037/neu0000270; Padgett CR, 2016, J CLIN EXP NEUROPSYC, V38, P551, DOI 10.1080/13803395.2015.1137557; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shadli RM, 2011, BRAIN INJURY, V25, P596, DOI 10.3109/02699052.2011.572947; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Small BJ, 2004, PSYCHOL AGING, V19, P592, DOI 10.1037/0882-7974.19.4.592; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; Sorg SF, 2016, J HEAD TRAUMA REHAB, V31, P297, DOI 10.1097/HTR.0000000000000189; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; Tanielian T., 2008, INVISIBLE WOUNDS WAR; The Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Weathers F. W., 1991, HE PTSD CHECKLIST MI; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wilson M, 2007, BRIT J ANAESTH, V99, P43, DOI 10.1093/bja/aem142; Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003	88	13	13	1	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2018	40	10					1050	1061		10.1080/13803395.2018.1508555			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GT7JS	WOS:000444703700009	30124361				2022-02-06	
J	O'Hern, S; Oxley, J				O'Hern, Steve; Oxley, Jennie			Fatal cyclist crashes in Australia	TRAFFIC INJURY PREVENTION			English	Article						Cyclists; fatalities; road safety; injury mechanism	BICYCLING INJURIES; RISK-TAKING; VICTORIA; HELMETS; SAFETY	Objectives: The number of casualty road crashes in Australia has steadily reduced over the past few decades; however, a concurrent reduction has not been achieved for crashes involving cyclists. This has resulted in a disproportionate overrepresentation of cyclists in fatal injury statistics. This article explores the contributing factors and injury mechanisms among coronial reported fatal cyclist crashes in Australia. Methods: The National Coronial Information System (NCIS) is a remote data entry and retrieval system containing detailed coronial information managed by the Victorian Department of Justice and Regulation. All coroner-reported closed cases involving a cyclist fatality in Australia from 2006 to 2015 were extracted from the database. In total, 336 cases in the NCIS database involving a cyclist fatality that occurred within the road reserve throughout Australia were identified and extracted for analysis. Variables in the analyses included age, gender, mechanism of injury, medical cause of death, time of incident, modes of transport involved, speed limit, road geometry, police narratives, and toxicology reports. The NCIS data were supplemented with spatial information using the geographic coordinates of the crash. Geographic information was utilized to gather information regarding various location characteristics such as speed limits and road geometry. Descriptive analysis techniques were performed on the data to examine key variables. Analyses also included cross-tabulation and Pearson's chi-squared tests (chi(2)) for comparison of variables collected. All analyses were undertaken at a level of significance (alpha) of .05. Effect size was assessed using Cramer's V statistic (phi(c)). Results: The majority of fatal outcome crashes occurred in New South Wales (27.4%), followed by Victoria (25.9%) and Queensland (22.0%), and the majority involved male cyclists aged between 35 and 64 years. Those aged between 18 and 34 years were the next most frequent group of fatally injured cyclists. Helmet use was reported in 62.2% of cases. When reported, 19.6% of cyclists were not wearing a helmet at the time of the incident. The presence of alcohol was detected in 14.6% of postmortem examinations and illicit drugs including tetrahydrocannabinol, opioids, and methamphetamine were identified in 17.6% of cases. Analysis of the road characteristics identified a relatively even split between crashes that occurred in low speed environments (60 km/h and below; 51.2%) and higher speed environments (48.8%). Crash counterparts commonly involved light vehicles (31.3%) and heavy vehicles (38.4%), with approximately one quarter (23.8%) being single-vehicle crashes (i.e., bicycle only). Analyses of injury information identified that cyclists most commonly sustained multiple injuries (38.8%). Injuries to the head (31.3%), chest (4.8%), neck (3.4%), and brain (2.0%) were also commonly reported. Conclusions: The findings provide insight into key contributing factors and injury characteristics of fatal cyclist crashes in Australia and can inform and guide the development of effective infrastructure designs and strategies to reduce cyclist trauma.	[O'Hern, Steve; Oxley, Jennie] Monash Univ, Accid Res Ctr, 21 Alliance Way, Clayton, Vic 3800, Australia		O'Hern, S (corresponding author), Monash Univ, Accid Res Ctr, 21 Alliance Way, Clayton, Vic 3800, Australia.	steve.ohern@monash.edu	O'Hern, Steve/AAX-1624-2020	O'Hern, Steve/0000-0002-7961-3875; Oxley, Jennie/0000-0002-7519-1994	Australian Research CouncilAustralian Research Council [LP130100380]	This project was supported by the Australian Research Council Grant Number: LP130100380. The project is a collaborative partnership between Monash University, University of Melbourne, Curtin University, Main Roads WA, VicRoads, The Transport Accident Commission (TAC), The Cycling Promotion Fund, and the Amy Gillett Foundation.	Andersson AL, 2002, INJURY, V33, P467, DOI 10.1016/S0020-1383(02)00028-1; [Anonymous], 2013, FOC CYCL COP GUID DE; Australian Bicycle Council, 2010, AUSTR NAT CYCL STRAT; Australian Bureau of Statistics, 2011, AUSTR STAT GEOGR STA, V5; Bauman A. E., 2008, CYCLING GETTING AUST; Biegler P., 2012, MACCS MONASH ALFRED; Boufous S, 2013, INJURY PREV, V49, P404; Boufous S, 2016, INJURY PREV, V22, P284, DOI 10.1136/injuryprev-2015-041681; Boufous S, 2012, ACCIDENT ANAL PREV, V49, P404, DOI 10.1016/j.aap.2012.03.011; Bureau of Infrastructure Transport and Regional Economics, 2016, ROAD TRAUM AUSTR 201; CAMERON MH, 1994, ACCIDENT ANAL PREV, V26, P325, DOI 10.1016/0001-4575(94)90006-X; City of Portland Bureau of Transportation, 2010, PORTL BIC PLAN 2030; Cobey KD, 2013, EVOL PSYCHOL-US, V11, P350, DOI 10.1177/147470491301100206; Corben B, 2000, INJURY REDUCTION MEA; Curnow WJ, 2003, ACCIDENT ANAL PREV, V35, P287, DOI 10.1016/S0001-4575(02)00012-X; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; Fishman E, 2012, J AUSTRALAS COLL ROA, V23, P19; Garrard J, 2010, J AUSTRALAS COLL ROA, V21, P37; Garrard J., 2009, ACTIVE TRANSPORT ADU; Greater London Authority, 2013, MAYORS VIS CYCL LOND; Heesch KC, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-106; Heesch KC, 2011, ACCIDENT ANAL PREV, V43, P2085, DOI 10.1016/j.aap.2011.05.031; Hillman M., 1992, CYCLING HLTH SAFETY; Infrastructure Australia, 2009, CYCL INFR AUSTR CIT; Institute for Road Safety Research, 2017, CYCL SWOV FACT SHEET; Kugelberg FC, 2007, FORENSIC SCI INT, V165, P10, DOI 10.1016/j.forsciint.2006.05.004; Mitra B, 2017, EMERG MED AUSTRALAS, V29, P96, DOI 10.1111/1742-6723.12682; O'Hern S, 2015, J TRANSP HEALTH, V2, P79, DOI 10.1016/j.jth.2014.09.016; Pai CW, 2014, ACCIDENT ANAL PREV, V62, P191, DOI 10.1016/j.aap.2013.09.008; Prati G, 2018, TRANSPORT REV, V38, P184, DOI 10.1080/01441647.2017.1314391; Schepers P, 2014, ACCIDENT ANAL PREV, V62, P331, DOI 10.1016/j.aap.2013.03.032; Sikic M, 2009, MED J AUSTRALIA, V190, P353, DOI 10.5694/j.1326-5377.2009.tb02446.x; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; Victorian Government, 2012, CYCL FUT 2013 2023 V; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1	36	13	13	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2018	19			2			S27	S31		10.1080/15389588.2018.1497166			5	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	HQ5UO	WOS:000462478300005	30335520				2022-02-06	
J	Teutsch, P; Jones, CE; Kaiser, ME; Gardner, NA; Lim, MM				Teutsch, Peyton; Jones, Carolyn E.; Kaiser, Mara E.; Gardner, Natasha Avalon; Lim, Miranda M.			Gait and Conditioned Fear Impairments in Mouse Model of Comorbid TBI and PTSD	BEHAVIOURAL NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; PREPULSE INHIBITION; STRESS; IMPACT; DEFICITS; MILD	Study Objectives. Traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) commonly cooccur. Approaches to research and treatment of these disorders have been segregated, despite overlapping symptomology. We and others have hypothesized that comorbid TBI + PTSD generates worse symptoms than either condition alone. We present a mouse model of comorbid TBI + PTSD to further explore this condition. Methods. A mouse model of TBI + PTSD was generated using the single prolonged stress (SPS) protocol in combination with the controlled cortical impact (CCI) protocol. This resulted in four experimental groups: control, TBI, PTSD, and TBI + PTSD. Behavioral phenotyping included gait analysis, contextual fear conditioning, acoustic startle response, and prepulse inhibition. Results. Mice in the TBI + PTSD group showed a significantly impaired gait compared to their counterparts with TBI alone as well as control mice. Mice in the TBI + PTSD group showed significantly impaired contextual fear recall compared to controls. Prepulse inhibition testing revealed intact acoustic startle and auditory sensory gating. Conclusions. These results indicate that SPS paired with CCI in mice produces unique behavioral impairments in gait and fear recall that are not present in either condition alone. Further studies are underway to examine additional behavioral, physiological, and pathological phenotypes in this combined model of TBI + PTSD.	[Teutsch, Peyton; Jones, Carolyn E.; Kaiser, Mara E.; Gardner, Natasha Avalon; Lim, Miranda M.] VA Portland Hlth Care Syst, Portland, OR 97239 USA; [Jones, Carolyn E.; Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Gardner, Natasha Avalon] Portland State Univ, Portland, OR 97207 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Med, Oregon Inst Occupat Hlth Sci, Dept Neurol,Div Pulm & Crit Care Med, Portland, OR 97201 USA		Lim, MM (corresponding author), VA Portland Hlth Care Syst, Portland, OR 97239 USA.; Lim, MM (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.; Lim, MM (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Oregon Inst Occupat Hlth Sci, Dept Neurol,Div Pulm & Crit Care Med, Portland, OR 97201 USA.	lmir@ohsu.edu		Kaiser, Mara/0000-0002-6116-9753	VA Career Development Award [IK2 BX002712]; NIH EXITO Institutional CoreUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1GM118964]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32AA007468-29, 5T32HL083808-10]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL083808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [UL1GM118964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32AA007468] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2BX002712] Funding Source: NIH RePORTER	The authors would like to express their sincere appreciation and gratitude to Dr. Charles K. Meshul and Madeline L. Churchill for the use of the DigiGait apparatus, Delvin J. Akins for his input early on in establishing the combined TBI + PTSD protocol, Chau Nguyen for the assistance in video scoring, Ryan A. Opel for the surgical training, and the animal care staff in the Portland VA Veterinary Medical Unit. This material is the result of work supported with resources and the use of facilities at the VA Portland Health Care System, VA Career Development Award no. IK2 BX002712, NIH EXITO Institutional Core, no. UL1GM118964, the Oregon Medical Research Foundation New Investigator Award, and the Portland VA Research Foundation to Miranda M. Lim and NIH 5T32AA007468-29 and NIH 5T32HL083808-10 to Carolyn E. Jones.	Aikins DE, 2017, NEUROSCI LETT, V639, P162, DOI 10.1016/j.neulet.2016.12.056; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arai A, 2016, BEHAV BRAIN RES, V315, P83, DOI 10.1016/j.bbr.2016.08.022; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Garfinkel SN, 2014, J NEUROSCI, V34, P13435, DOI 10.1523/JNEUROSCI.4287-13.2014; Grillon C, 1996, PSYCHIAT RES, V64, P169, DOI 10.1016/S0165-1781(96)02942-3; Gupta MA, 2013, INT REV PSYCHIATR, V25, P86, DOI 10.3109/09540261.2012.736367; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Kaczkurkin AN, 2017, AM J PSYCHIAT, V174, P125, DOI 10.1176/appi.ajp.2016.15121549; Kohl S, 2013, J PSYCHIATR RES, V47, P445, DOI 10.1016/j.jpsychires.2012.11.018; Lisieski MJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00196; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Morey RA, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.196; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Orr SP, 2002, PSYCHIAT CLIN N AM, V25, P271, DOI 10.1016/S0193-953X(01)00007-7; Osier N. D., 2015, BRAIN NEUROTRAUMA MO; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Perez-Garcia G, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0357-17.2018; Perrine SA, 2016, BEHAV BRAIN RES, V303, P228, DOI 10.1016/j.bbr.2016.01.056; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Souza RR, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00615; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tanielian T, 2008, PSYCHOL COGNITIVE IN; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Wortzel HS, 2014, NEUROREHABILITATION, V34, P613, DOI 10.3233/NRE-141086; Yamamoto S, 2009, DEPRESS ANXIETY, V26, P1110, DOI 10.1002/da.20629; Yehuda R, 2002, PSYCHIAT CLIN N AM, V25, pxi, DOI 10.1016/S0193-953X(02)00027-8; Yu HR, 2013, STRESS, V16, P564, DOI 10.3109/10253890.2013.806908; Zuckerman A, 2017, J NEUROTRAUM, V34, P145, DOI 10.1089/neu.2015.4310	35	13	13	2	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2018	2018								6037015	10.1155/2018/6037015			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GV4LW	WOS:000446071900001	30327687	Green Published, gold, Green Submitted			2022-02-06	
J	Thomas, DG; Bradley, L; Servi, A; Reilly, S; Apps, JN; McCrea, M; Hammeke, T				Thomas, Danny George; Bradley, Lia; Servi, Ashley; Reilly, Suzanne; Apps, Jennifer Niskala; McCrea, Michael; Hammeke, Thomas			PARENTAL KNOWLEDGE AND RECALL OF CONCUSSION DISCHARGE INSTRUCTIONS	JOURNAL OF EMERGENCY NURSING			English	Article						Concussion; Adolescents; Parents Discharge instructions; Emergency department	EMERGENCY-DEPARTMENT; ADVICE; INJURY; VISITS	Introduction: Children increasingly are being seen in the emergency department for a concussion, or mild traumatic brain injury (mTBI). A key aim of the ED visit is to provide discharge advice that can help parents to identify an evolving neurosurgical crisis, facilitate recovery, and prevent reinjury. The present study examined parents' knowledge of symptoms and recall of discharge instructions after their adolescent's mTBI and the effect of supplementing written discharge instructions with verbal instruction and reinforcement. Methods: We performed a nested observational study of parents/caregivers of patients who participated in a larger mTBI study. After their adolescent's mTBI, parents were given verbal and standardized written instructions. The ED discharge process was observed using a structured checklist, and parents were surveyed 3 days after discharge on knowledge and recall of discharge instructions. Results: Ninety-three parents completed the postsurvey. Nearly 1 in 5 parents were confused about when to return to the emergency department after evaluation for head injury. Up to 1 in 4 parents could not recall specific discharge advice related to concussion. Parents who received verbal reinforcement of written discharge instructions were more likely to recall them. Conclusion: Emergency nurses and clinicians should strive to utilize both verbal and written discharge instructions with families to help increase understanding.	[Thomas, Danny George] Med Coll Wisconsin, Childrens Hosp Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Bradley, Lia; Servi, Ashley; Reilly, Suzanne] ENA Milwaukee Area Chapter Reg, Milwaukee, WI USA; [Bradley, Lia; Servi, Ashley; Reilly, Suzanne] Childrens Hosp Wisconsin, Emergency Dept, Trauma Ctr, Milwaukee, WI 53201 USA; [Apps, Jennifer Niskala] Med Coll Wisconsin, Dept Psychiat & Behav Med, Milwaukee, WI 53226 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Brain Injury Res, Milwaukee, WI 53226 USA; [Hammeke, Thomas] Zablocki VA Med Ctr, Dept Psychiat & Behav Med, Milwaukee, WI USA; [Hammeke, Thomas] Med Coll Wisconsin, Milwaukee, WI 53226 USA		Thomas, DG (corresponding author), Childrens Corp Ctr, Pediat Emergency Med, 999 N 92nd St, Milwaukee, WI 53226 USA.	dthomas@mcw.edu		Thomas, Danny/0000-0002-7470-9835	Injury Research Center Seed Grant, Injury Research Center, Medical College of Wisconsin; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8UL1TR000055]	Research funded by the 2010 Injury Research Center Seed Grant, Injury Research Center, Medical College of Wisconsin.r This publication was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through grant No. 8UL1TR000055. Its contents are the sole responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.	AUSTIN PE, 1995, ANN EMERG MED, V25, P317, DOI 10.1016/S0196-0644(95)70286-5; Bloch SA, 2013, PEDIATR EMERG CARE, V29, P699, DOI 10.1097/PEC.0b013e3182955480; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; DeMatteo C, 2015, CLIN PEDIATR, V54, P152, DOI 10.1177/0009922814558256; Engel KG, 2009, ANN EMERG MED, V53, P454, DOI 10.1016/j.annemergmed.2008.05.016; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Gignon M, 2014, J EMERG NURS, V40, P51, DOI 10.1016/j.jen.2012.10.004; Greenwald J., HOSP DISCHARGE READM; Hwang V, 2014, J TRAUMA ACUTE CARE, V77, P117, DOI 10.1097/TA.0000000000000275; Kempe CB, 2014, BRAIN INJURY, V28, P1551, DOI 10.3109/02699052.2014.937360; Langlois J., HEADS BRAIN INJURY Y; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McMillan TM, 2009, BRAIN INJURY, V23, P509, DOI 10.1080/02699050902970729; Patel B, 2009, PEDIATR EMERG CARE, V25, P558, DOI 10.1097/PEC.0b013e3181b4f495; Samuels-Kalow ME, 2012, ANN EMERG MED, V60, P152, DOI 10.1016/j.annemergmed.2011.10.023; Thomas D, 2015, PEDIATRICS, V135; Vashi A, 2011, ANN EMERG MED, V57, P315, DOI 10.1016/j.annemergmed.2010.08.024; Zavala S, 2011, J EMERG NURS, V37, P138, DOI 10.1016/j.jen.2009.11.008; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	21	13	13	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0099-1767	1527-2966		J EMERG NURS	J. Emerg. Nurs.	JAN	2018	44	1					52	56		10.1016/j.jen.2017.04.012			5	Emergency Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Nursing	FR8HG	WOS:000419314900011	28527643				2022-02-06	
J	Yu, NZ; Hu, S; Hao, Z				Yu, Nianzu; Hu, Si; Hao, Zheng			BENIFICIAL EFFECT OF STACHYDRINE ON THE TRAUMATIC BRAIN INJURY INDUCED NEURODEGENERATION BY ATTENUATING THE EXPRESSIONS OF AKT/MTOR/PI3K AND TLR4/NF kappa-B PATHWAY	TRANSLATIONAL NEUROSCIENCE			English	Article						Stachydrine; Traumatic brain injury; Apoptosis; Inflammation; TLR-4	OXIDATIVE STRESS	Present investigation aims to explore the protective effect of stachydrine against traumatic brain injury (TBI) and also investigate the molecular mechanism of its action. TBI was induced by the fall a hammer (450 g) from the height of 1.5 m. and later stachydrine was administered for 2 weeks starting 2 hr after the induction of TBI. Effect of stachydrine was determined by estimating modified neurological severity score (mNSS), percentage of water content in the brain and cognitive dysfunction in TBI rats. Moreover western blot assay, histopathology and enzyme linked immunosorbent assay (ELISA) tests were used to determine the effect of stachydrine on TBI injured rats. Result of the report suggests that stachydrine reduces the mNSS and percentage of water content in the brain and also attenuates the cognitive dysfunction in TBI injured rats. However data of western blot assay reports that stachydrine reduces the expression of PI3K/m-TOR/Akt pathway in the brain tissues of TBI rats. Concentration of interleukin (IL-1 beta), tumor necrosis factor-alpha (TNF-alpha) and interferon gamma (INF-gamma)was reduces in stachydrine treated group than TBI group. Moreover expression of Nuclear factor-kappa B/Toll-like receptor 4 (NF-kappa B/TLR-4) protein was also decreased in stachydrine treated group than TBI group. Histopathology study on brain tissue reveals that the percentage of apoptotic cells was also reduced in stachydrine treated group than TBI group. Data of this investigation concludes that stachydrine protects the neuronal injury by attenuating the phosphatidylinositide 3-kinases/mammalian target of rapamycin/Protein kinase B (PI3K/m-TOR/Akt) and NF-kappa B/TLR-4 pathway in TBI injured rats.	[Yu, Nianzu; Hu, Si; Hao, Zheng] Nanchang Univ, Affiliated Hosp 1, Dept Neurosurg, Nanchang 330006, Jiangxi, Peoples R China		Hao, Z (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Neurosurg, Nanchang 330006, Jiangxi, Peoples R China.	Holdsworthmope@yahoo.com					Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Chen HH, 2017, AM J TRANSL RES, V9, P4250; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; He HF, 2018, DRUG DES DEV THER, V12, P629, DOI 10.2147/DDDT.S158313; Hu YY, 2016, MICROB PATHOGENESIS, V99, P51, DOI 10.1016/j.micpath.2016.08.006; Jellusova J, 2016, CRIT REV BIOCHEM MOL, V51, P359, DOI 10.1080/10409238.2016.1215288; Kitagishi Yasuko, 2012, Depress Res Treat, V2012, P752563, DOI 10.1155/2012/752563; Li XF, 2018, INT J MOL MED, V42, P1917, DOI 10.3892/ijmm.2018.3794; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Mikhed Y, 2015, INT J MOL SCI, V16, P15918, DOI 10.3390/ijms160715918; Popescu C, 2015, J Med Life, V8, P272; Rathee P, 2012, NAT PROD RES, V26, P1737, DOI 10.1080/14786419.2011.608673; Saji M, 2010, MOL CELL ENDOCRINOL, V321, P20, DOI 10.1016/j.mce.2009.10.016; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Zhang Chen, 2014, BMC Complement Altern Med, V14, P474, DOI 10.1186/1472-6882-14-474; Zhang RH, 2018, PHYTOCHEMISTRY, V147, P167, DOI 10.1016/j.phytochem.2017.12.016; Zhao LL, 2017, INT IMMUNOPHARMACOL, V48, P102, DOI 10.1016/j.intimp.2017.05.002	20	13	14	0	3	DE GRUYTER POLAND SP ZOO	WARSAW	BOGUMILA ZUGA 32A STR., 01-811 WARSAW, POLAND	2081-3856	2081-6936		TRANSL NEUROSCI	Transl. Neurosci.	JAN	2018	9	1					175	182		10.1515/tnsci-2018-0026			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK4KV	WOS:000457903200001	30687544	gold, Green Published			2022-02-06	
J	DeMaster, D; Johnson, C; Juranek, J; Ewing-Cobbs, L				DeMaster, Dana; Johnson, Chad; Juranek, Jenifer; Ewing-Cobbs, Linda			Memory and the hippocampal formation following pediatric traumatic brain injury	BRAIN AND BEHAVIOR			English	Article						hippocampal development; memory; traumatic brain injury	CLOSED-HEAD-INJURY; DEVELOPMENTAL DIFFERENCES; ACADEMIC-ACHIEVEMENT; EPISODIC MEMORY; NEUROCOGNITIVE OUTCOMES; CORTICAL CONTRIBUTIONS; COGNITIVE PREDICTORS; AEROBIC FITNESS; EARLY-CHILDHOOD; TEMPORAL-LOBE	IntroductionPrevious research indicates disruption of learning and memory in children who have experienced traumatic brain injury (TBI). ObjectiveThis research evaluates the impact of pediatric TBI on volumetric differences along the long axis of the hippocampus, a region of the brain that is critical for explicit memory. MethodsStructural brain data and behavioral measures were collected 6weeks following TBI or extracranial injury (EI), in children aged 8-15years and from a group of age matched typically developing controls (TDC). Total hippocampal volume and hippocampal subregion volumes corresponding to hippocampal head, body, and tail were compared across groups and were examined in relation to verbal and visual memory. ResultsGroup differences were evident such that hippocampal body volume was found to be smaller for TBI and EI groups compared to the TDC group. Analysis restricted to the TBI group indicated that hippocampal head volume was associated with severity of injury. The relation between severity of injury and hippocampal head volume is particularly important considering results from our investigation of hippocampal volume-to-memory performance relations indicating positive correlations between hippocampal head volume and performance on memory measures for both the TBI group and the TDC group. Significant negative correlations between hippocampal body volume and memory were evident for the TBI group but not EI or TDC groups. Correlations between memory performance and hippocampal tail volume were not significant for the TBI or TDC groups, although for the EI group, a positive correlation was found between hippocampal tail volume and memory. ConclusionTogether these results underscore an important relation between hippocampal structure and memory function during the subacute stage of recovery from pediatric TBI.	[DeMaster, Dana; Johnson, Chad; Juranek, Jenifer; Ewing-Cobbs, Linda] Univ Texas Houston, Childrens Leaning Inst, Dept Pediat, McGovern Med Sch, Houston, TX 77004 USA		DeMaster, D (corresponding author), Univ Texas Houston, Childrens Leaning Inst, Dept Pediat, McGovern Med Sch, Houston, TX 77004 USA.	Dana.M.Demaster@uth.tmc.edu		DeMaster, Dana/0000-0002-8655-7517	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS43608]	National Institutes of Health, Grant/Award Number: R01 NS43608	Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Arroyos-Jurado E., 2006, EXCEPTIONALITY, V14, P125, DOI [10.1207/s15327035ex1403_2, DOI 10.1207/S15327035EX1403_2]; Avants B, 2008, ACAD RADIOL, V15, P1360, DOI 10.1016/j.acra.2008.07.007; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; Chaddock L, 2010, DEV NEUROSCI-BASEL, V32, P249, DOI 10.1159/000316648; Daugherty AM, 2016, HIPPOCAMPUS, V26, P220, DOI 10.1002/hipo.22517; DeMaster D, 2014, CEREB CORTEX, V24, P3036, DOI 10.1093/cercor/bht160; DeMaster D, 2013, NEUROPSYCHOLOGIA, V51, P2415, DOI 10.1016/j.neuropsychologia.2013.05.026; DeMaster DM, 2013, CORTEX, V49, P1482, DOI 10.1016/j.cortex.2012.08.004; Dennis EL, 2016, J NEUROTRAUM, V33, P840, DOI 10.1089/neu.2015.4012; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Duvernoy H. M., 2013, HUMAN HIPPOCAMPUS FU; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; EWINGCOBBS L, 1985, J CLIN EXP NEUROPSYC, V7, P612; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; Farmer JE, 1999, DEV NEUROPSYCHOL, V15, P269, DOI 10.1080/87565649909540749; Farovik A, 2010, LEARN MEMORY, V17, P801, DOI 10.1101/lm.1616209; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Ghetti S, 2010, J NEUROSCI, V30, P9548, DOI 10.1523/JNEUROSCI.3500-09.2010; Giedd JN, 1996, J COMP NEUROL, V366, P223, DOI 10.1002/(SICI)1096-9861(19960304)366:2<223::AID-CNE3>3.0.CO;2-7; Gogtay N, 2006, HIPPOCAMPUS, V16, P664, DOI 10.1002/hipo.20193; Hassevoort KM, 2016, MIND BRAIN EDUC, V10, P162, DOI 10.1111/mbe.12108; Herting MM, 2012, BEHAV BRAIN RES, V233, P517, DOI 10.1016/j.bbr.2012.05.012; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Insausti R, 2010, ADV ANAT EMBRYOL CEL, V206, P71; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Knight RG, 2009, J CLIN EXP NEUROPSYC, V31, P575, DOI 10.1080/13803390802363710; Lee JK, 2014, NEUROIMAGE, V94, P162, DOI 10.1016/j.neuroimage.2014.03.019; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; Luby JL, 2016, P NATL ACAD SCI USA, V113, P5742, DOI 10.1073/pnas.1601443113; Maguire EA, 2006, HIPPOCAMPUS, V16, P1091, DOI 10.1002/hipo.20233; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; Ofen N, 2012, NEUROSCI BIOBEHAV R, V36, P1708, DOI 10.1016/j.neubiorev.2012.02.016; Ofen N, 2012, J NEUROSCI, V32, P10012, DOI 10.1523/JNEUROSCI.1082-11.2012; Ostby Y, 2012, CEREB CORTEX, V22, P381, DOI 10.1093/cercor/bhr116; Ostby Y, 2009, J NEUROSCI, V29, P11772, DOI 10.1523/JNEUROSCI.1242-09.2009; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Phillipou A, 2014, DEV MED CHILD NEUROL, V56, P337, DOI 10.1111/dmcn.12345; Poppenk J, 2011, NEURON, V72, P931, DOI 10.1016/j.neuron.2011.10.014; Rao U, 2010, BIOL PSYCHIAT, V67, P357, DOI 10.1016/j.biopsych.2009.10.017; Reynolds C., 2007, J PSYCHOEDUCATIONAL, V27, P157; Riggins T, 2015, CHILD DEV, V86, P1710, DOI 10.1111/cdev.12445; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Rushby JA, 2016, NEUROIMAGE-CLIN, V12, P607, DOI 10.1016/j.nicl.2016.09.017; Schlichting ML, 2017, J COGNITIVE NEUROSCI, V29, P37, DOI 10.1162/jocn_a_01028; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Staff RT, 2012, ANN NEUROL, V71, P653, DOI 10.1002/ana.22631; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; TEASDALE G, 1974, LANCET, V2, P81; Thaler NS, 2011, APPL NEUROPSYCHOL, V18, P168, DOI 10.1080/09084282.2011.595443; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Yurgelun-Todd DA, 2003, PERCEPT MOTOR SKILL, V96, P3, DOI 10.2466/pms.2003.96.1.3; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831	67	13	13	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	DEC	2017	7	12							e00832	10.1002/brb3.832			12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	FR1UP	WOS:000418853300002	29299377	Green Published, gold			2022-02-06	
J	Ichkova, A; Rodriguez-Grande, B; Bar, C; Villega, F; Konsman, JP; Badaut, J				Ichkova, Aleksandra; Rodriguez-Grande, Beatriz; Bar, Claire; Villega, Frederic; Konsman, Jan Pieter; Badaut, Jerome			Vascular impairment as a pathological mechanism underlying long-lasting cognitive dysfunction after pediatric traumatic brain injury	NEUROCHEMISTRY INTERNATIONAL			English	Article						Traumatic brain injury; Pediatric; Development; Cerebrovascular dysfunction; Neurovascular unit	CONTROLLED CORTICAL IMPACT; CENTRAL-NERVOUS-SYSTEM; BETA FIBRIL FORMATION; OF-THE-LITERATURE; CEREBRAL AUTOREGULATION; BARRIER PERMEABILITY; ALZHEIMERS-DISEASE; P-GLYCOPROTEIN; HEAD-INJURY; FUNCTIONAL RECOVERY	Traumatic brain injury (TBI) is the leading cause of death and disability in children. Indeed, the acute mechanical injury often evolves to a chronic brain disorder with long-term cognitive, emotional and social dysfunction even in the case of mild TBI. Contrary to the commonly held idea that children show better recovery from injuries than adults, pediatric TBI patients actually have worse outcome than adults for the same injury severity. Acute trauma to the young brain likely interferes with the fine-tuned developmental processes and may give rise to long-lasting consequences on brain's function. This review will focus on cerebrovascular dysfunction as an important early event that may lead to long-term phenotypic changes in the brain after pediatric TBI. These, in turn may be associated with accelerated brain aging and cognitive dysfunction. Finally, since no effective treatments are currently available, understanding the unique pathophysiological mechanisms of pediatric TBI is crucial for the development of new therapeutic options. (C) 2017 Elsevier Ltd. All rights reserved.	[Ichkova, Aleksandra; Rodriguez-Grande, Beatriz; Bar, Claire; Konsman, Jan Pieter; Badaut, Jerome] Univ Bordeaux, CNRS UMR 5287, INCIA, Bordeaux, France; [Bar, Claire; Villega, Frederic] Univ Childrens Hosp Bordeaux, Dept Pediat Neurol, Bordeaux, France; [Badaut, Jerome] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA USA		Badaut, J (corresponding author), Bordeaux Univ, CNRS UMR 5287, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	jerome.badaut@u-bordeaux.fr	; Rodriguez-Grande, Beatriz/I-5397-2015	Konsman, Jan Pieter/0000-0001-7247-0472; VILLEGA, frederic/0000-0002-5423-3171; Rodriguez-Grande, Beatriz/0000-0002-4638-7576	ANR-TRAIL Vasc-TBIFrench National Research Agency (ANR); CNRSCentre National de la Recherche Scientifique (CNRS)European Commission; Fondation des gueules cassees; ERA-NET NEURON JTC CnsA-flame	The authors wish to acknowledge the following funding: Fondation des gueules cassees (JB), ERA-NET NEURON JTC2014 CnsA-flame (JB), ANR-TRAIL Vasc-TBI (JB) and CNRS support.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Ajao D., 2011, SOC NEUROSCI ABSTR V, V41; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Armstead WM, 2011, NEUROL RES, V33, P133, DOI 10.1179/016164111X12881719352174; Armstead WM, 2011, NEUROL RES, V33, P127, DOI 10.1179/016164111X12881719352138; Armstead WM, 2011, J NEUROTRAUM, V28, P451, DOI 10.1089/neu.2010.1659; Armstead WM, 1999, EXP TOXICOL PATHOL, V51, P137, DOI 10.1016/S0940-2993(99)80087-6; Armstead WM, 2004, EXP TOXICOL PATHOL, V56, P75, DOI 10.1016/j.etp.2004.04.003; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1999, J NEUROTRAUM, V16, P391, DOI 10.1089/neu.1999.16.391; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Badaut J, 2015, NEUROSCIENCE, V285, P215, DOI 10.1016/j.neuroscience.2014.10.035; Badaut J, 2014, TRANSL STROKE RES, V5, P394, DOI 10.1007/s12975-013-0304-z; Badaut J, 2014, BBA-GEN SUBJECTS, V1840, P1554, DOI 10.1016/j.bbagen.2013.10.032; Bakker MJ, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-43; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P171; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Biagi L, 2007, J MAGN RESON IMAGING, V25, P696, DOI 10.1002/jmri.20839; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Bundgaard M, 2008, GLIA, V56, P699, DOI 10.1002/glia.20642; Castillo GM, 1997, J NEUROCHEM, V69, P2452; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chevignard M, 2016, ANN PHYS REHABIL MED, V59, pe133; Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247; Cotman SL, 2000, MOL CELL NEUROSCI, V15, P183, DOI 10.1006/mcne.1999.0816; CSERR HF, 1984, AM J PHYSIOL, V246, pR277, DOI 10.1152/ajpregu.1984.246.3.R277; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; De Bock M, 2016, GLIA, V64, P1097, DOI 10.1002/glia.22960; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Garcia D, 2015, J PEDIATR PSYCHOL, V40, P391, DOI 10.1093/jpepsy/jsu093; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Greco T, 2016, J CEREBR BLOOD F MET, V36, P1603, DOI 10.1177/0271678X15610584; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Hanlon LA, 2016, J NEUROPATH EXP NEUR, V75, P214, DOI 10.1093/jnen/nlv021; Harati R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-273; Hawkes CA, 2014, NEURODEGENER DIS, V13, P17, DOI 10.1159/000351096; Hawkes CA, 2013, AGING CELL, V12, P224, DOI 10.1111/acel.12045; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jernigan TL, 2011, PROG BRAIN RES, V189, P77, DOI 10.1016/B978-0-444-53884-0.00019-1; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Jodoin J, 2003, J NEUROCHEM, V87, P1010, DOI 10.1046/j.1471-4159.2003.02081.x; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Jullienne A, 2014, J CEREBR BLOOD F MET, V34, P1637, DOI 10.1038/jcbfm.2014.124; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kasemsri T, 1997, AM J PHYSIOL-HEART C, V273, pH2639; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Leung J, 2016, J PHYSIOL-LONDON, V594, P2681, DOI 10.1113/JP271056; Maa T, 2016, J NEUROSURG-PEDIATR, V18, P73, DOI 10.3171/2016.1.PEDS15564; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mannix R, 2014, J NEUROSURG, V121, P1337, DOI 10.3171/2014.8.JNS14715; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; McCaffrey G, 2007, J NEUROCHEM, V103, P2540, DOI 10.1111/j.1471-4159.2007.04943.x; McCaffrey G, 2012, J NEUROCHEM, V122, P962, DOI 10.1111/j.1471-4159.2012.07831.x; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mhanna MJ, 2015, J NEUROSURG PEDIAT, V16, P1; Muramatsu K, 1997, STROKE, V28, P2281, DOI 10.1161/01.STR.28.11.2281; Nagel C, 2016, ACTA NEUROCHIR SUPPL, V122, P239, DOI 10.1007/978-3-319-22533-3_48; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Philip S, 2009, J TRAUMA, V67, pS128, DOI 10.1097/TA.0b013e3181ad32c7; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Prins ML, 2006, DEV NEUROSCI-BASEL, V28, P447, DOI 10.1159/000094170; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Quintard H, 2016, J NEUROTRAUM, V33, P681, DOI 10.1089/neu.2015.4057; Raz L, 2016, J CEREBR BLOOD F MET, V36, P172, DOI 10.1038/jcbfm.2015.164; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Robertson CL, 2015, J BIOENERG BIOMEMBR, V47, P43, DOI 10.1007/s10863-014-9585-5; ROBERTSON PL, 1985, DEV BRAIN RES, V23, P219, DOI 10.1016/0165-3806(85)90044-6; Rossi JL, 2015, J NEUROTRAUM, V32, P1101, DOI 10.1089/neu.2014.3611; Roumeliotis N, 2016, CHILD NERV SYST, V32, P2363, DOI 10.1007/s00381-016-3231-y; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stonestreet BS, 2000, AM J PHYSIOL-REG I, V279, pR468, DOI 10.1152/ajpregu.2000.279.2.R468; Sysyn GD, 2001, AM J PHYSIOL-REG I, V280, pR547, DOI 10.1152/ajpregu.2001.280.2.R547; Taylor ZE, 2013, DEV PSYCHOBIOL, V55, P869, DOI 10.1002/dev.21079; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala MS, 2008, NEUROCRIT CARE, V9, P45, DOI 10.1007/s12028-007-9036-9; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vavilala MS, 2003, J NEUROSURG ANESTH, V15, P307, DOI 10.1097/00008506-200310000-00003; Vavilala MS, 2002, ACTA ANAESTH SCAND, V46, P393, DOI 10.1034/j.1399-6576.2002.460411.x; Wang ML, 2016, J NEUROL SCI, V370, P244, DOI 10.1016/j.jns.2016.09.049; Wei ZZ, 2016, CELL TRANSPLANT, V25, P797, DOI 10.3727/096368916X690403; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Zhang BF, 2015, WORLD NEUROSURG, V83, P567, DOI 10.1016/j.wneu.2014.12.010; Zhang JH, 2012, NAT REV NEUROL, V8, P711, DOI 10.1038/nrneurol.2012.210	121	13	14	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	DEC	2017	111				SI		93	102		10.1016/j.neuint.2017.03.022			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FR3OS	WOS:000418976600010	28377126				2022-02-06	
J	Rolland, JS				Rolland, John S.			Neurocognitive Impairment: Addressing Couple and Family Challenges	FAMILY PROCESS			English	Article						Neurocognitive Impairment; Dementia; Family Caregivers; Biopsychosocial	TRAUMATIC BRAIN-INJURY; CONTROLLED-TRIAL; DEMENTIA; INTERVENTIONS; METAANALYSIS; CAREGIVERS; DISEASE	Conditions involving neurocognitive impairment pose enormous challenges to couples and families. However, research and practice tend to focus narrowly on immediate issues for individual caregivers and their dyadic relationship with the affected member. A broad family systems approach with attention to family processes over time is needed in training, practice, and research. In this paper, Rolland's Family Systems Illness model provides a guiding framework to consider the interaction of different psychosocial types of neurocognitive conditions and their evolution over time with individual, couple, and family life-course development. Discussion addresses key family and couple issues with mild-to-severe cognitive impairment and progressive dementias, including: communication, multigenerational legacies, threatened future neurocognitive disability, ambiguous loss, decisional capacity, reaching limits, placement decisions, issues for adult children and spousal caregivers, and the transformation of intimate bonds. Principles and guidelines are offered to help couples and families master complex challenges, deepen bonds, and forge positive pathways ahead.	[Rolland, John S.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Rolland, John S.] Chicago Ctr Family Hlth, 20 N Wacker Dr,1442, Chicago, IL 60606 USA		Rolland, JS (corresponding author), Chicago Ctr Family Hlth, 20 N Wacker Dr,1442, Chicago, IL 60606 USA.	john.rolland@northwestern.edu					Ablitt A, 2009, AGING MENT HEALTH, V13, P497, DOI 10.1080/13607860902774436; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Batsch NL, 2012, WORLD ALZHEIMER REPO; Belle SH, 2006, ANN INTERN MED, V145, P727, DOI 10.7326/0003-4819-145-10-200611210-00005; Benbow SM, 2014, INT PSYCHOGERIATR, V26, P2037, DOI 10.1017/S1041610214001343; Boss P., 2011, LOVING SOMEONE WHO H; Boss P, 2010, PASTOR PSYCHOL, V59, P137, DOI 10.1007/s11089-009-0264-0; Carr D, 2010, J MARRIAGE FAM, V72, P743, DOI 10.1111/j.1741-3737.2010.00728.x; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; DANIELS KJ, 2007, FAMILIES, V25, P162; Dassel KB, 2017, GERONTOLOGIST, V57, P319, DOI 10.1093/geront/gnv148; FISHER L, 1994, FAM PROCESS, V33, P305, DOI 10.1111/j.1545-5300.1994.00305.x; Garcia Preto, 2016, EXPANDING FAMILY LIF, P339; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Hartmann M, 2010, PSYCHOTHER PSYCHOSOM, V79, P136, DOI 10.1159/000286958; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Imber-Black E., 2012, NORMAL FAMILY PROCES, P483; Joling KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030936; Kasper J., 2016, DISABILITY CARE NEED; Kazak AE, 2006, FAM SYST HEALTH, V24, P381, DOI DOI 10.1037/1091-7527.24.4.381; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI [10.1037/1091-7527.26.1.69, DOI 10.1037/1091-7527.26.1.69]; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Lum TY, 2008, HEALTH CARE FINANC R, V30, P35; Martire LM, 2010, ANN BEHAV MED, V40, P325, DOI 10.1007/s12160-010-9216-2; McDaniel SH., 2014, MED FAMILY THERAPY I, V2nd Ed.; Mittelman MS, 2008, AM J GERIAT PSYCHIAT, V16, P893, DOI 10.1097/JGP.0b013e3181898095; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Peek CJ, 2015, FAM SYST HEALTH, V33, P86, DOI 10.1037/fsh0000128; Rolland, 2006, INDIVIDUALS FAMILIES, P139; Rolland J. S., 2016, EXPANDING FAMILY LIF, P430; Rolland J. S., HELPING COU IN PRESS; Rolland JS, 2017, FAM SYST HEALTH, V35, P7, DOI 10.1037/fsh0000250; ROLLAND JS, 1990, FAM PROCESS, V29, P229, DOI 10.1111/j.1545-5300.1990.00229.x; Rolland JS, 1994, FAMILIES ILLNESS DIS; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Shields CG, 2012, J MARITAL FAM THER, V38, P265, DOI 10.1111/j.1752-0606.2011.00269.x; Smith G. E., 2013, CAREGIVING ALZHEIMER, P3; Talley, 2013, CAREGIVING ALZHEIMER, P17, DOI DOI 10.1007/978-1-4614-5335-2_2; The CDC NIH DoD and VA Leadership Panel, 2013, C TRAUM BRAIN INJ US; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Walsh F., 2016, STRENGTHENING FAMILY; Weihs K, 2002, FAM SYST HEALTH, V20, P7, DOI [10.1037/h0089481, DOI 10.1037/H0089481]; Weingarten K, 2012, FAM PROCESS, V51, P440, DOI 10.1111/j.1545-5300.2012.01412.x; Weingarten K, 2010, FAM PROCESS, V49, P5, DOI 10.1111/j.1545-5300.2010.01305.x; Werner Perla, 2013, Alzheimers Dement, V9, pe74, DOI 10.1016/j.jalz.2012.02.006; Wood BL, 2008, FAM PROCESS, V47, P21, DOI 10.1111/j.1545-5300.2008.00237.x; WRIGHT L. M., 2009, BELIEFS ILLNESS MODE; Zarit S., 2013, CARING ALZHEIMERS DI; Zuelsdorff M., 2017, LIFETIME STRESSFUL E	52	13	13	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-7370	1545-5300		FAM PROCESS	Fam. Process	DEC	2017	56	4					799	818		10.1111/famp.12316			20	Psychology, Clinical; Family Studies	Social Science Citation Index (SSCI)	Psychology; Family Studies	FP0GG	WOS:000417276800002	28887888				2022-02-06	
J	Roy-O'Reilly, M; Ritzel, RM; Conway, SE; Staff, I; Fortunato, G; McCullough, LD				Roy-O'Reilly, Meaghan; Ritzel, Rodney M.; Conway, Sarah E.; Staff, Ilene; Fortunato, Gilbert; McCullough, Louise D.			CCL11 (Eotaxin-1) Levels Predict Long-Term Functional Outcomes in Patients Following Ischemic Stroke	TRANSLATIONAL STROKE RESEARCH			English	Article						Stroke; Eotaxin; CCLL1; Inflammation; Neuroinflammation; Ischemia	RECEPTOR CCR3; EXPRESSION; CHEMOKINE; BRAIN; CELLS	Circulating levels of the pro-inflammatory cytokine C-C motif chemokine 11 (CCL11, also known as eotaxin-1) are increased in several animal models of neuroinflammation, including traumatic brain injury and Alzheimer's disease. Increased levels of CCL11 have also been linked to decreased neurogenesis in mice. We hypothesized that circulating CCL11 levels would increase following ischemic stroke in mice and humans, and that higher CCL11 levels would correlate with poor long-term recovery in patients. As predicted, circulating levels of CCL11 in both young and aged mice increased significantly 24 h after experimental stroke. However, ischemic stroke patients showed decreased CCL11 levels compared to controls 24 h after stroke. Interestingly, lower post-stroke CCL11 levels were predictive of increased stroke severity and independently predictive of poorer functional outcomes in patients 12 months after ischemic stroke. These results illustrate important differences in the peripheral inflammatory response to ischemic stroke between mice and human patients. In addition, it suggests CCL11 as a candidate biomarker for the prediction of acute and long-term functional outcomes in ischemic stroke patients.	[Roy-O'Reilly, Meaghan; McCullough, Louise D.] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA; [Ritzel, Rodney M.] Univ Connecticut, Hlth Ctr, Dept Neurosci, Farmington, CT 06032 USA; [Conway, Sarah E.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Conway, Sarah E.; Staff, Ilene; Fortunato, Gilbert; McCullough, Louise D.] Hartford Hosp, 80 Seymour St, Hartford, CT 06106 USA		McCullough, LD (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA.; McCullough, LD (corresponding author), Hartford Hosp, 80 Seymour St, Hartford, CT 06106 USA.	Louise.D.McCullough@uth.tmc.edu	McCullough, Louise/R-2824-2019	Roy-O'Reilly, Meaghan/0000-0002-6824-885X; Ritzel, Rodney/0000-0002-0160-2930	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS094543, NS076293, 1F30NS098628]; Hartford Hospital Research Department; Russell and Diana Hawkins Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS076293, F30NS098628, R01NS094543] Funding Source: NIH RePORTER	This study was funded by the National Institutes of Health NS094543 and NS076293 (to LDM) and the Hartford Hospital Research Department, and the Russell and Diana Hawkins Family Foundation Discovery Fellowships to the Graduate School at UTHealth (to MAR) and the National Institutes of Health 1F30NS098628 (to MAR).	Adar T, 2014, CLIN IMMUNOL, V153, P199, DOI 10.1016/j.clim.2014.04.012; Chung KF, 1999, BRIT J PHARMACOL, V127, P1145, DOI 10.1038/sj.bjp.0702660; de Paulis A, 2001, INT ARCH ALLERGY IMM, V124, P146, DOI 10.1159/000053694; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Emanuele E, 2006, ATHEROSCLEROSIS, V186, P140, DOI 10.1016/j.atherosclerosis.2005.07.002; Erickson MA, 2014, J PHARMACOL EXP THER, V349, P497, DOI 10.1124/jpet.114.213074; Flurkey K, 2007, MOUSE BIOMEDICAL RES, V2, P637; Fryer AD, 2006, J CLIN INVEST, V116, P228, DOI 10.1172/JCI25423; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Gerber BO, 1997, CURR BIOL, V7, P836, DOI 10.1016/S0960-9822(06)00371-X; Huber A. K., 2016, CLIN IMMUNOL; Kitaura M, 1996, J BIOL CHEM, V271, P7725, DOI 10.1074/jbc.271.13.7725; Manwani B, 2014, STROKE, V45, P571, DOI 10.1161/STROKEAHA.113.002944; Manwani B, 2011, BRAIN BEHAV IMMUN, V25, P1689, DOI 10.1016/j.bbi.2011.06.015; Menzies-Gow A, 2002, J IMMUNOL, V169, P2712, DOI 10.4049/jimmunol.169.5.2712; Mir A, 2002, AM J GASTROENTEROL, V97, P1452, DOI 10.1016/S0002-9270(02)04043-1; Miyamasu M, 2000, INT ARCH ALLERGY IMM, V122, P54, DOI 10.1159/000053634; Parajuli B, 2015, GLIA, V63, P2274, DOI 10.1002/glia.22892; Rothenberg ME, 1997, J EXP MED, V185, P785, DOI 10.1084/jem.185.4.785; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Targowski T, 2005, J INVEST ALLERG CLIN, V15, P277; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Xia MQ, 1998, AM J PATHOL, V153, P31, DOI 10.1016/S0002-9440(10)65542-3; Zschaler J, 2014, CRIT REV IMMUNOL, V34, P433	25	13	13	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	DEC	2017	8	6					578	584		10.1007/s12975-017-0545-3			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FK1JM	WOS:000413236900007	28634890	Green Accepted			2022-02-06	
J	Schmitt, T; Thornton, AE; Rawtaer, I; Barr, AM; Gicas, KM; Lang, DJ; Vertinsky, AT; Rauscher, A; Procyshyn, RM; Buchanan, T; Cheng, A; MacKay, S; Leonova, O; Langheimer, V; Field, TS; Heran, MK; Vila-Rodriguez, F; O'Connor, TA; MacEwan, GW; Honer, WG; Panenka, WJ				Schmitt, Toby; Thornton, Allen E.; Rawtaer, Iris; Barr, Alasdair M.; Gicas, Kristina M.; Lang, Donna J.; Vertinsky, A. Talia; Rauscher, Alexander; Procyshyn, Ric M.; Buchanan, Tari; Cheng, Alex; MacKay, Sarah; Leonova, Olga; Langheimer, Verena; Field, Thalia S.; Heran, Manraj K.; Vila-Rodriguez, Fidel; O'Connor, Tiffany A.; MacEwan, G. William; Honer, William G.; Panenka, William J.			Traumatic Brain Injury in a Community-Based Cohort of Homeless and Vulnerably Housed Individuals	JOURNAL OF NEUROTRAUMA			English	Article						concussion; diffusion tensor imaging; gray matter volume; homeless; traumatic brain injury	HEAD-INJURY; DISORDERS; HEALTH; MILD; DEPRESSION; SEQUELAE; HISTORY; ADULTS; RISK; FORM	We characterized traumatic brain injury (TBI) and studied its associations with mental and physical health in a community cohort of homeless and vulnerably housed individuals. Detailed mental and physical health structured interviews, neuropsychological testing, and multimodal magnetic resonance imaging (MRI) were performed on 283 participants. Two TBI participant groups were defined for primary analyses: those with a self-reported history of TBI and those with MRI confirmation of TBI. By self-report, 174 participants (61.5%) reported a previous serious head or face injury (symptomatic or asymptomatic), with 100 (35.3%) experiencing symptoms consistent with TBI (any post-injury loss of consciousness, confusion, or memory loss). Persons self-reporting TBI had poorer current mental and physical health, more ongoing neurological symptoms, and a higher rate of mood disorders, compared to those with no TBI. The presence of a mood disorder, a TBI history, and an interaction between these factors contributed to lower mental health. There was evidence of TBI in 20 participants (6.9%) on clinical MRI sequences. These participants had globally lower cortical gray matter volumes and lower white matter fractional anisotropy (FA) values. Neurocognitive test scores positively correlated with both FA and cortical gray matter volumes in participants with MRI evidence of trauma. Previous TBI is associated with poorer mental and physical health in homeless and vulnerably housed individuals and interacts with mood disorders to exacerbate poor mental health. Focal traumatic lesions evident on MRI are associated with diffusely lower gray matter volumes and white matter integrity, which predict cognitive functioning.	[Schmitt, Toby; Rawtaer, Iris; Procyshyn, Ric M.; Buchanan, Tari; Cheng, Alex; MacKay, Sarah; Leonova, Olga; Langheimer, Verena; Vila-Rodriguez, Fidel; MacEwan, G. William; Honer, William G.; Panenka, William J.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Barr, Alasdair M.] Univ British Columbia, Dept Pharmacol, Vancouver, BC, Canada; [Lang, Donna J.; Vertinsky, A. Talia; Rauscher, Alexander; Heran, Manraj K.] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Field, Thalia S.] Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC, Canada; [Panenka, William J.] Simon Fraser Univ, British Columbia Neuropsychiat Program, Burnaby, BC, Canada; [Thornton, Allen E.; Gicas, Kristina M.; O'Connor, Tiffany A.] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada		Panenka, WJ (corresponding author), British Columbia Childrens Hosp, Res Bldg,3rd Floor,Room A3-123,938 West 28th Ave, Vancouver, BC B5Z 4H4, Canada.	wpanenka@mail.ubc.ca	Field, Thalia/G-8477-2019; Vila, Fidel/L-3463-2019; Field, Thalia/P-4103-2019; Procyshyn, Ric/AAE-5499-2019	Field, Thalia/0000-0002-1176-0633; Vila, Fidel/0000-0002-8273-8820; Field, Thalia/0000-0002-1176-0633; Panenka, William/0000-0001-7143-6512; Barr, Alasdair/0000-0002-3407-1574; Procyshyn, Ric/0000-0002-4348-0855; Rawtaer, Iris/0000-0002-8214-6454; Lang, Donna/0000-0001-9373-1555	Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) [CBG-101827, MOP-137103]; British Columbia Mental Health and Substance Use Services (an Agency of the Provincial Health Services Authority); Jack Bell Chair in Schizophrenia	The authors thank the many Research Assistants and Volunteers that have been an integral part of this study since the beginning. This study was funded by the Canadian Institutes for Health Research (CBG-101827, MOP-137103), and the British Columbia Mental Health and Substance Use Services (an Agency of the Provincial Health Services Authority). William Honer was supported by the Jack Bell Chair in Schizophrenia.	BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chaudhry S, 2005, MED CARE, V43, P607, DOI 10.1097/01.mlr.0000163658.65008.ec; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fray PJ, 1996, INT J GERIATR PSYCH, V11, P329; Goforth HW, 2010, NEUROL CLIN, V28, P199, DOI 10.1016/j.ncl.2009.09.010; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Gonzalez EA, 2001, J NERV MENT DIS, V189, P176, DOI 10.1097/00005053-200103000-00006; Holdnack H.A., 2001, WECHSLER TEST ADULT; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Jones AA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008876; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, P1986, DOI 10.2105/AJPH.2014.302087; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Pluck G, 2011, BRIT J CLIN PSYCHOL, V50, P33, DOI 10.1348/014466510X490253; Roebuck-Spencer T., 2014, HDB NEUROPSYCHOLOGY, P16; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Solliday-McRoy C, 2004, J NERV MENT DIS, V192, P471, DOI 10.1097/01.nmd.0000131962.30547.26; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Svoboda T, 2014, EMERG MED J, V31, P571, DOI 10.1136/emermed-2012-201761; To MJ, 2015, J HEAD TRAUMA REHAB, V30, P270, DOI 10.1097/HTR.0000000000000044; Topolovec-Vranic J., 2014, CMAJ OPEN, V2, P69; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; Vila-Rodriguez F, 2013, AM J PSYCHIAT, V170, P1413, DOI 10.1176/appi.ajp.2013.12111439; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060	42	13	13	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2017	34	23					3301	3310		10.1089/neu.2017.5076			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FN9HM	WOS:000416341700012	28741437				2022-02-06	
J	Su, SH; Wu, YF; Lin, Q; Hai, J				Su, Shao-Hua; Wu, Yi-Fang; Lin, Qi; Hai, Jian			Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-kappa B pathways	NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY			English	Article						Endocannabinoid system; Chronic cerebral hypoperfusion; Neuroinflammation; NF-kappa B pathway	TRAUMATIC BRAIN-INJURY; INFLAMMATORY RESPONSE; COGNITIVE DYSFUNCTION; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; ISCHEMIC-STROKE; CELL-DEATH; RAT MODEL; ACTIVATION; MECHANISMS	The present study explored the protective effects of cannabinoid receptor agonist WIN55,212-2 (WIN) and fatty acid amide hydrolase inhibitor URB597 (URB) against neuroinflammation in rats with chronic cerebral hypoperfusion (CCH). Activated microglia, astrocytes, and nuclear factor kappa B (NF-kappa B) p65-positive cells were measured by immunofluorescence. Reactive oxygen species (ROS) was assessed by dihydroethidium staining. The protein levels of cluster of differentiation molecule 11b (OX-42), glial fibrillary acidic protein (GFAP), NF-kappa B p65, inhibitor of kappa B alpha (I kappa B-a), I kappa B kinase a/beta (IKK a/beta), phosphorylated IKK a/beta (p-IKK a/beta), cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), tumor necrosis factor (TNF)-alpha, and interleukin-1 beta (IL-1 beta) were examined by western blotting or enzyme-linked immunosorbent assay. All the protein levels of OX-42, GFAP, TNF-a, IL-1 beta, COX-2, and iNOS are increased in CCH rats. WIN and URB downregulated the levels of OX-42, GFAP, TNF-alpha, IL-1 beta, COX-2 and iNOS and inhibited CCH-induced ROS accumulation in CCH rats, indicating that WIN and URB might exert their neuroprotective effects by inhibiting the neuroinflammatory response. In addition, the NF-kappa B signaling pathway was activated by CCH in frontal cortex and hippocampus, while the aforementioned changes were reversed by WIN and URB treatment. These findings suggest that WIN and URB treatment ameliorated CCH-induced neuroinflammation through inhibition of the classical pathway of NF-kappa B activation, resulting in mitigation of chronic ischemic injury.	[Su, Shao-Hua; Wu, Yi-Fang; Hai, Jian] Tongji Univ, Tongji Hosp, Dept Neurosurg, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China; [Lin, Qi] Shanghai Jiao Tong Univ, Inst Med Sci, Dept Pharm, Sch Med, Shanghai 200025, Peoples R China		Hai, J (corresponding author), Tongji Univ, Tongji Hosp, Dept Neurosurg, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China.	haijiando@163.com		Su, Shao-Hua/0000-0001-7911-5406	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271212, 81601146]	This work was supported by the National Natural Science Foundation of China (grant no.: 81271212 to J. Hai and no.: 81601146 to S.H. Su)	Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004; Baek JH, 2009, NEUROSCI LETT, V464, P71, DOI 10.1016/j.neulet.2009.08.008; Batti L, 2010, J NEUROIMMUNOL, V218, P21, DOI 10.1016/j.jneuroim.2009.11.002; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Bond WS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00523; Bosier B, 2010, BIOCHEM PHARMACOL, V80, P1, DOI 10.1016/j.bcp.2010.02.013; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Demuth DG, 2006, LIFE SCI, V78, P549, DOI 10.1016/j.lfs.2005.05.055; Denes A, 2011, CEREBROVASC DIS, V32, P517, DOI 10.1159/000332205; Farkas E, 2006, BRAIN RES, V1087, P168, DOI 10.1016/j.brainres.2006.02.134; Farkas E, 2007, BRAIN RES REV, V54, P162, DOI 10.1016/j.brainresrev.2007.01.003; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Fu XB, 2014, PHARMACOL BIOCHEM BE, V126, P122, DOI 10.1016/j.pbb.2014.09.005; Geng XK, 2015, STROKE, V46, P492, DOI 10.1161/STROKEAHA.114.006994; Gross ER, 2003, AM J PHYSIOL-HEART C, V284, pH1552, DOI 10.1152/ajpheart.01013.2002; Hai J, 2013, NEUROL RES, V35, P734, DOI 10.1179/1743132812Y.0000000154; Hai J, 2009, BRAIN RES, V1301, P80, DOI 10.1016/j.brainres.2009.09.001; Hainsworth AH, 2008, J CEREBR BLOOD F MET, V28, P1877, DOI 10.1038/jcbfm.2008.91; Hasumi T, 2007, INTERNAL MED, V46, P1311, DOI 10.2169/internalmedicine.46.0262; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hill MN, 2010, J NEUROSCI, V30, P14980, DOI 10.1523/JNEUROSCI.4283-10.2010; Hovens IB, 2015, NEUROBIOL LEARN MEM, V118, P74, DOI 10.1016/j.nlm.2014.11.009; Hwang J, 2010, LIFE SCI, V86, P615, DOI 10.1016/j.lfs.2009.06.003; Janero DR, 2009, EXPERT OPIN EMERG DR, V14, P43, DOI [10.1517/14728210902736568, 10.1517/14728210902736568 ]; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Kaushal V, 2008, J NEUROSCI, V28, P2221, DOI 10.1523/JNEUROSCI.5643-07.2008; Khan MM, 2012, STROKE, V43, P1376, DOI 10.1161/STROKEAHA.111.635516; Kim DH, 2009, FOOD CHEM TOXICOL, V47, P1473, DOI 10.1016/j.fct.2009.03.028; Kuhad A, 2009, PHARMACOL BIOCHEM BE, V92, P251, DOI 10.1016/j.pbb.2008.12.012; Kwak PA, 2012, J CLIN NEUROL, V8, P284, DOI 10.3988/jcn.2012.8.4.284; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; Lee JE, 2014, TOXICOL APPL PHARM, V278, P159, DOI 10.1016/j.taap.2014.04.021; Lin Q, 2010, BRAIN RES, V1325, P183, DOI 10.1016/j.brainres.2010.02.037; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu J, 2011, BRAIN BEHAV IMMUN, V25, P1658, DOI 10.1016/j.bbi.2011.06.009; Lu J, 2010, CEREB CORTEX, V20, P2540, DOI 10.1093/cercor/bhq002; Macchi B, 2015, CNS NEUROL DISORD-DR, V14, P313, DOI 10.2174/1871527314666150225124928; Martin-Moreno AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-8; Naidu PS, 2010, J PHARMACOL EXP THER, V334, P182, DOI 10.1124/jpet.109.164806; NI JW, 1994, BRAIN RES, V653, P231, DOI 10.1016/0006-8993(94)90394-8; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Pizzi M, 2009, FEBS J, V276, P27, DOI 10.1111/j.1742-4658.2008.06767.x; Poulet R, 2006, J CEREBR BLOOD F MET, V26, P253, DOI 10.1038/sj.jcbfm.9600188; Rezende RM, 2012, PHARMACOLOGY, V89, P127, DOI 10.1159/000336346; Slusar JE, 2013, NEUROPHARMACOLOGY, V72, P116, DOI 10.1016/j.neuropharm.2013.04.018; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Su SH, 2015, NEUROSCIENCE, V301, P563, DOI 10.1016/j.neuroscience.2015.03.021; Su SH, 2013, EUR J NEUROL, V20, P1081, DOI 10.1111/ene.12138; Su SH, 2016, BEHAV BRAIN RES, V313, P334, DOI 10.1016/j.bbr.2016.07.009; Su SH, 2014, J CLIN NEUROSCI, V21, P1734, DOI 10.1016/j.jocn.2013.12.032; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Tagliaferro P, 2006, BRAIN RES, V1085, P163, DOI 10.1016/j.brainres.2005.12.089; Tusi SK, 2010, APOPTOSIS, V15, P738, DOI 10.1007/s10495-010-0496-6; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang TG, 2004, J NEUROCHEM, V88, P939, DOI 10.1046/j.1471-4159.2003.02242.x; Ye M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.494	61	13	13	1	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-1298	1432-1912		N-S ARCH PHARMACOL	Naunyn-Schmiedebergs Arch. Pharmacol.	DEC	2017	390	12					1189	1200		10.1007/s00210-017-1417-9			12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FM4VV	WOS:000415026600002	28825114				2022-02-06	
J	Terpstra, AR; Girard, TA; Colella, B; Green, REA				Terpstra, Alex R.; Girard, Todd A.; Colella, Brenda; Green, Robin E. A.			Higher Anxiety Symptoms Predict Progressive Hippocampal Atrophy in the Chronic Stages of Moderate to Severe Traumatic Brain Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury; hippocampal atrophy; anxiety; neurodegeneration; rehabilitation	POSTTRAUMATIC-STRESS-DISORDER; MILD COGNITIVE IMPAIRMENT; ADNI HARMONIZED PROTOCOL; MAGNETIC-RESONANCE; PSYCHOMETRIC PROPERTIES; DIFFUSION-TENSOR; DEPRESSION; VOLUME; HEAD; SEGMENTATION	Background. In the chronic stages of moderate-severe traumatic brain injury (TBI), progressive hippocampal volume loss-continuing well after acute neurological insults have resolvedhas now been well documented. Previous research in other populations suggests that elevated anxiety symptoms are associated with compromise to the medial temporal lobes. Objective. To examine whether higher anxiety symptoms predict greater hippocampal volume loss in moderate-severe TBI. Methods. We conducted an analysis of prospectively collected, longitudinal behavioral and magnetic resonance imaging (MRI) data from 5 to 12 to 30 months post-injury. Eighty participants were included in the study, with anxiety symptom and MRI data collected at a minimum of 2 time points. Correlational and bivariate latent difference score (with imputation) analyses were used to examine the relationship of Beck Anxiety Inventory scores with hippocampal volume loss, while controlling for depressive symptoms and total brain volume. Results. Analyses revealed that higher anxiety symptoms at 5 and at 12 months following moderate-severe TBI predicted significant later volume loss in the right hippocampal complex and the right hippocampal head. Right hippocampal volume and volume change did not predict subsequent anxiety scores or anxiety change scores. Conclusions. These novel findings implicate anxiety symptoms as a possible predictor of progressive hippocampal volume loss in the chronic stages of moderate-severe TBI.	[Terpstra, Alex R.; Colella, Brenda; Green, Robin E. A.] Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G2A2, Canada; [Terpstra, Alex R.; Green, Robin E. A.] Univ Toronto, Toronto, ON, Canada; [Girard, Todd A.] Ryerson Univ, Toronto, ON, Canada		Green, REA (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G2A2, Canada.	robin.green@uhn.ca	Girard, Todd/I-1961-2019	Girard, Todd/0000-0002-7204-5684; Green, Robin/0000-0001-9451-3963	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Toronto Rehabilitation Institute Student Scholarship; Margaret and Howard Gamble Research Grant through University of Toronto	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by a Canada Research Chair in Traumatic Brain Injury grant from the Canadian Institutes of Health Research, a Toronto Rehabilitation Institute Student Scholarship, and a Margaret and Howard Gamble Research Grant through the University of Toronto.	Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Apostolova LG, 2015, ALZHEIMERS DEMENT, V11, P139, DOI 10.1016/j.jalz.2015.01.001; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Barnes J, 2010, NEUROIMAGE, V53, P1244, DOI 10.1016/j.neuroimage.2010.06.025; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bekker MHJ, 2007, GENDER MED, V4, pS178, DOI 10.1016/S1550-8579(07)80057-X; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bertisch HC, 2013, REHABIL PSYCHOL, V58, P429, DOI 10.1037/a0034554; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P126, DOI 10.1016/j.jalz.2014.02.009; Brosschot JF, 2006, J PSYCHOSOM RES, V60, P113, DOI 10.1016/j.jpsychores.2005.06.074; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Duvernoy HM, 1988, HUMAN HIPPOCAMPUS AT, P61; Engin E, 2007, BEHAV PHARMACOL, V18, P365, DOI 10.1097/FBP.0b013e3282de7929; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Fox LC, 2016, BEHAV BRAIN RES, V312, P362, DOI 10.1016/j.bbr.2016.06.048; Frisoni GB, 2015, ALZHEIMERS DEMENT, V11, P111, DOI 10.1016/j.jalz.2014.05.1756; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Grynberg D, 2010, PERS INDIV DIFFER, V49, P845, DOI 10.1016/j.paid.2010.07.013; Hawk ST, 2013, J PERS ASSESS, V95, P96, DOI 10.1080/00223891.2012.696080; Hoofien D, 2005, APPL NEUROPSYCHOL, V12, P30, DOI 10.1207/s15324826an1201_6; Irle E, 2010, J PSYCHIATR NEUROSCI, V35, P126, DOI 10.1503/jpn.090041; Ising M, 2008, EUR J NEUROSCI, V28, P389, DOI 10.1111/j.1460-9568.2008.06332.x; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Joireman J.A., 2002, N AM J PSYCHOL, V4, P63; Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Kit KA, 2007, REHABIL PSYCHOL, V52, P25, DOI 10.1037/0090-5550.52.1.25; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mah L, 2015, AM J GERIAT PSYCHIAT, V23, P466, DOI 10.1016/j.jagp.2014.10.005; Maller JJ, 2007, HIPPOCAMPUS, V17, P1023, DOI 10.1002/hipo.20339; Maller JJ, 2006, HIPPOCAMPUS, V16, P80, DOI 10.1002/hipo.20133; Maller JJ, 2016, HANDBOOK OF STRUCTUR; Martin EI, 2009, PSYCHIAT CLIN N AM, V32, P549, DOI 10.1016/j.psc.2009.05.004; McArdle J.J., 2012, HDB DEV RES METHODS, P385; McArdle JJ, 2004, J GERONTOL B-PSYCHOL, V59, pP294, DOI 10.1093/geronb/59.6.P294; Murray F, 2008, EUR J PHARMACOL, V583, P115, DOI 10.1016/j.ejphar.2008.01.014; Oler JA, 2010, NATURE, V466, P864, DOI 10.1038/nature09282; Pavic L, 2007, PSYCHIAT RES-NEUROIM, V154, P191, DOI 10.1016/j.pscychresns.2006.08.005; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rauch SL, 2003, ANN NY ACAD SCI, V985, P389; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Sorrells SF, 2014, NEUROENDOCRINOLOGY, V100, P129, DOI 10.1159/000367849; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Sturm VE, 2013, P NATL ACAD SCI USA, V110, P9944, DOI 10.1073/pnas.1301119110; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; TEASDALE G, 1974, LANCET, V2, P81; Terpstra AR, 2015, ANXIETY CHRONIC MODE; Toffanin T, 2011, EUR PSYCHIAT, V26, P64, DOI 10.1016/j.eurpsy.2010.09.003; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Vythilingam M, 2005, PSYCHIAT RES-NEUROIM, V139, P89, DOI 10.1016/j.pscychresns.2005.04.003; WATSON C, 1992, NEUROLOGY, V42, P1743, DOI 10.1212/WNL.42.9.1743; Watson C, 1997, ARCH NEUROL-CHICAGO, V54, P1521, DOI 10.1001/archneur.1997.00550240071015; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Wood RL, 2013, J HEAD TRAUMA REHAB, V28, P98, DOI 10.1097/HTR.0b013e3182426029	67	13	14	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	DEC	2017	31	12					1063	1071		10.1177/1545968317736817			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ5BW	WOS:000418374500007	29153039	Bronze			2022-02-06	
J	Uozumi, Y; Mizobe, T; Miyamoto, H; Ashida, N; Katsube, T; Tatsumi, S; Nakamura, M; Kohmura, E				Uozumi, Yoichi; Mizobe, Takashi; Miyamoto, Hirohito; Ashida, Noriaki; Katsube, Tsuyoshi; Tatsumi, Shotaro; Nakamura, Mitsugu; Kohmura, Eiji			Decreased serum sodium levels predict symptomatic vasospasm in patients with subarachnoid hemorrhage	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Subarachnoid hemorrhage; Cerebral vasospasm; Hyponatremia	DELAYED CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; SALT WASTING SYNDROME; NEUROSURGICAL PATIENTS; HYPONATREMIA; INFARCTION; OUTCOMES; SCALE	Background: Symptomatic vasospasm is a major cause of morbidity and mortality in subarachnoid, hemorrhage patients. Hyponatremia and dehydration due to natriuresis after subarachnoid hemorrhage are related to symptomatic vasospasm. Therefore, most institutions are currently targeting euvolemia and eunatremia in subarachnoid hemorrhage patients to avoid complications. We retrospectively investigated the predictors of symptomatic vasospasm with respect to water and sodium homeostasis, while maintaining euvolemia and eunatremia after subarachnoid hemorrhage. Methods: We monitored changes in serum sodium levels, serum osmolarity, daily sodium intake, daily urine volume, and daily water balance for 14 days after subarachnoid hemorrhage. Outcomes were assessed using the modified Rankin scale at 1 month after subarachnoid hemorrhage. Results: Among 97 patients, 27 (27.8%) had symptomatic vasospasm. Patients with symptomatic vasospasm were older than those without symptomatic vasospasm; the occurrence of symptomatic vasospasm affected outcomes. Serum sodium levels were sequentially significantly decreased, but within the normal range from 1 day before the occurrence of symptomatic vasospasm. Serum osmolarity of the spasm group was lower than that of the non-spasm group. Conclusions: Symptomatic vasospasm occurs more often in older patients and affects outcomes. A decrease in serum sodium levels occurs a day before symptomatic vasospasm. This observation may help predict symptomatic vasospasm. (C) 2017 Elsevier Ltd. All rights reserved.	[Uozumi, Yoichi; Miyamoto, Hirohito; Katsube, Tsuyoshi; Tatsumi, Shotaro] Steel Mem Hirohata Hosp, Dept Neurosurg, Himeji, Hyogo, Japan; [Mizobe, Takashi; Ashida, Noriaki; Nakamura, Mitsugu] Hyogo Brain & Heart Ctr, Dept Neurosurg, Himeji, Hyogo, Japan; [Uozumi, Yoichi; Kohmura, Eiji] Kobe Univ Hosp, Dept Neurosurg, Kobe, Hyogo, Japan		Uozumi, Y (corresponding author), Steel Mem Hirohata Hosp, Dept Neurosurg, Hirohata Ku, 3-1 Yumesaki Cho, Himeji, Hyogo 6711122, Japan.	uozumiyowichi@gmail.com		Uozumi, Yoichi/0000-0002-5985-2764; Mizobe, Takashi/0000-0002-8315-6419; Nakamura, Mitsugu/0000-0001-9487-5200			Al-Rawi PG, 2010, STROKE, V41, P122, DOI 10.1161/STROKEAHA.109.560698; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Berendes E, 1997, LANCET, V349, P245, DOI 10.1016/S0140-6736(96)08093-2; Brown RJ, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0446-6; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Chandy D, 2006, NEUROL INDIA, V54, P273, DOI 10.4103/0028-3886.27151; de Rooij NK, 2013, STROKE, V44, P43, DOI 10.1161/STROKEAHA.112.674291; Ellison DH, 2007, NEW ENGL J MED, V356, P2064, DOI 10.1056/NEJMcp066837; Epstein M, 1996, J AM SOC NEPHROL, V7, P1106; Fergusen S, 2007, NEUROSURGERY, V60, P658, DOI 10.1227/01.NEU.0000255396.23280.31; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Hannon MJ, 2012, J CLIN ENDOCR METAB, V97, P1423, DOI 10.1210/jc.2011-3201; Harrigan MR, 1996, NEUROSURGERY, V38, P152, DOI 10.1097/00006123-199601000-00035; Harrod CG, 2005, NEUROSURGERY, V56, P633, DOI 10.1227/01.NEU.0000156644.45384.92; HASAN D, 1989, STROKE, V20, P1511, DOI 10.1161/01.STR.20.11.1511; Heavens KR, 2014, AM J CLIN NUTR, V100, P1252, DOI 10.3945/ajcn.114.091009; Igarashi T, 2007, NEUROL RES, V29, P835, DOI 10.1179/016164107X228624; Kao L, 2009, PITUITARY, V12, P347, DOI 10.1007/s11102-009-0188-9; Katayama Y, 2007, STROKE, V38, P2373, DOI 10.1161/STROKEAHA.106.480038; Kissoon NR, 2015, J STROKE CEREBROVASC, V24, P2245, DOI 10.1016/j.jstrokecerebrovasdis.2015.05.027; Kurokawa Y, 1996, SURG NEUROL, V46, P500, DOI 10.1016/S0090-3019(96)00034-1; Lanterna LA, 2013, J STROKE CEREBROVASC, V22, pE189, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.002; Nakagawa I, 2013, CEREBROVASC DIS, V35, P131, DOI 10.1159/000346586; Palmer BF, 2003, TRENDS ENDOCRIN MET, V14, P182, DOI 10.1016/S1043-2760(03)00048-1; PETERS JP, 1950, T ASSOC AM PHYSICIAN, V63, P57; Qureshi AI, 2002, NEUROSURGERY, V50, P749, DOI 10.1097/00006123-200204000-00012; Rabinstein AA, 2004, STROKE, V35, P1862, DOI 10.1161/01.STR.0000133132.76983.8e; Rahman M, 2009, NEUROSURGERY, V65, P925, DOI 10.1227/01.NEU.0000358954.62182.B3; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; See AP, 2016, J CLIN NEUROSCI, V32, P115, DOI 10.1016/j.jocn.2016.04.006; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; Suzuki Y, 2007, SURG NEUROL, V68, P126, DOI 10.1016/j.surneu.2006.10.037; WIJDICKS EFM, 1985, ANN NEUROL, V17, P137, DOI 10.1002/ana.410170206; Zheng B, 2011, J NEUROL NEUROSUR PS, V82, P213, DOI 10.1136/jnnp.2009.180349	35	13	13	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2017	46						118	123		10.1016/j.jocn.2017.08.037			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM9CM	WOS:000415391600025	28887070	Green Published			2022-02-06	
J	Zeiler, FA; Lo, BWY; Akoth, E; Silvaggio, J; Kaufmann, AM; Teitelbaum, J; West, M				Zeiler, F. A.; Lo, B. W. Y.; Akoth, E.; Silvaggio, J.; Kaufmann, A. M.; Teitelbaum, J.; West, M.			Predicting Outcome in Subarachnoid Hemorrhage (SAH) Utilizing the Full Outline of UnResponsiveness (FOUR) Score	NEUROCRITICAL CARE			English	Article						Full Outline of UnResponsiveness; SAH; Aneurysm; Subarachnoid hemorrhage; Outcome prediction	TRAUMATIC BRAIN-INJURY; COMA SCALE; NEUROSURGICAL PATIENTS; VALIDATION	Existing scoring systems for aneurysmal subarachnoid hemorrhage (SAH) patients fail to accurately predict patient outcome. Our goal was to prospectively study the Full Outline of UnResponsiveness (FOUR) score as applied to newly admitted aneurysmal SAH patients. All adult patients presenting to Health Sciences Center in Winnipeg from January 2013 to July 2015 (2.5 year period) with aneurysmal SAH were prospectively enrolled in this study. All patients were followed up to 6 months. FOUR score was calculated upon admission, with repeat calculation at 7 and 14 days. The primary outcomes were: mortality, as well as dichotomized 1- and 6-month Glasgow Outcome Scale (GOS) and modified Rankin Scale (mRS) values. Sixty-four patients were included, with a mean age of 54.2 years (range 26-85 years). The mean FOUR score upon admission pre- and post-external ventricular drain (EVD) was 10.3 (range 0-16) and 11.1 (range 3-16), respectively. There was a statistically significant association between pre-EVD FOUR score (total, eye, respiratory and motor sub-scores) with mortality, 1-month GOS, and 6-month GOS/mRS (p < 0.05 in all). The day 7 total, eye, respiratory, and motor FOUR scores were associated with mortality, 1-month GOS/mRS, and 6-month GOS/mRS (p < 0.05 in all). The day 14 total, eye, respiratory, and motor FOUR scores were associated with 6-month GOS (p < 0.05 in all). The day 7 cumulative FOUR score was associated with the development of clinical vasospasm (p < 0.05). The FOUR score at admission and day 7 post-SAH is associated with mortality, 1-month GOS/mRS, and 6-month GOS/mRS. The FOUR score at day 14 post-SAH is associated with 6-month GOS. The brainstem sub-score was not associated with 1- or 6-month primary outcomes.	[Zeiler, F. A.; Akoth, E.; Silvaggio, J.; Kaufmann, A. M.; West, M.] Univ Manitoba, Hlth Sci Ctr, Dept Surg, Sect Neurosurg, GB-1,820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada; [Zeiler, F. A.] Univ Manitoba, Clinician Investigator Program, Winnipeg, MB, Canada; [Zeiler, F. A.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Lo, B. W. Y.] McGill Univ, Montreal Neurol Inst, Sect Neurosurg & Neurocrit Care, Montreal, PQ, Canada; [Lo, B. W. Y.; Teitelbaum, J.] Montreal Neurol Inst, Sect Neurocrit Care, Montreal, PQ, Canada		Zeiler, FA (corresponding author), Univ Manitoba, Hlth Sci Ctr, Dept Surg, Sect Neurosurg, GB-1,820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Clinician Investigator Program, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England.	umzeiler@myumanitoba.ca; Benjamin.lo@mcgill.ca; eakoth@exchange.hsc.mb.ca; JSilvaggio@exchange.hsc.mb.ca; akaufmann@exchange.hsc.mb.ca; jteitelbaum@hotmail.com; MWest@exchange.hsc.mb.ca		Zeiler, Frederick/0000-0003-1737-0510; Teitelbaum, Jeanne/0000-0002-9834-3882	Cambridge Commonwealth Trust Scholarship; Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery; University of Manitoba Clinician Investigator Program; R. Samuel McLaughlin Research and Education Award; Manitoba Medical Service Foundation; University of Manitoba Faculty of Medicine Dean's Fellowship Fund	This work was made possible through salary support through the Cambridge Commonwealth Trust Scholarship, the Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery, the University of Manitoba Clinician Investigator Program, R. Samuel McLaughlin Research and Education Award, the Manitoba Medical Service Foundation, and the University of Manitoba Faculty of Medicine Dean's Fellowship Fund.	Akavipat P, 2011, ACTA MED OKAYAMA, V65, P205; Bruno MA, 2011, NEUROCRIT CARE, V15, P447, DOI 10.1007/s12028-011-9547-2; Chen BX, 2013, ACTA NEUROCHIR, V155, P2133, DOI 10.1007/s00701-013-1854-2; DRAKE CG, 1988, J NEUROSURG, V68, P985; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Kramer AA, 2012, CRIT CARE MED, V40, P2671, DOI 10.1097/CCM.0b013e318258fd88; Okasha AS, 2014, NEUROCRIT CARE, V21, P496, DOI 10.1007/s12028-014-9995-6; Oshiro EM, 1997, NEUROSURGERY, V41, P140, DOI 10.1097/00006123-199707000-00029; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	12	13	14	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2017	27	3					381	391		10.1007/s12028-017-0396-5			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FN7DT	WOS:000416179300011	28382509				2022-02-06	
J	Espana, LY; Lee, RM; Ling, JM; Jeromin, A; Mayer, AR; Meier, TB				Espana, Lezlie Y.; Lee, Ryan M.; Ling, Josef M.; Jeromin, Andreas; Mayer, Andrew R.; Meier, Timothy B.			Serial Assessment of Gray Matter Abnormalities after Sport-Related Concussion	JOURNAL OF NEUROTRAUMA			English	Article						concussion; diffusion; GFAP; fractional anisotropy; mTBI	TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; TENSOR IMAGING FINDINGS; COLLEGIATE FOOTBALL PLAYERS; C-TERMINAL HYDROLASE-L1; LONGITUDINAL ASSESSMENT; COORDINATE SYSTEM; SERUM BIOMARKERS; CORTICAL SURFACE; PLASMA-LEVELS	There is an urgent need to characterize the acute physiological effects of sport-related concussion (SRC). We investigated the effects of SRC on gray matter structure and diffusion metrics in collegiate athletes at 1.64 (T1; n = 33), 8.33 (T2; n = 30), and 32.15 days (T3; n = 36) post-concussion, with healthy collegiate contact-sport athletes serving as controls (HA; n = 46). Plasma levels of glial fibrillary acidic protein (GFAP) were assessed in a subset of athletes. We hypothesized that acute SRC would be associated with increased fractional anisotropy (FA), decreased mean diffusivity (MD), and increased GFAP relative to noninjured HA, without acute differences in gray matter volume or cortical thickness. Further, we hypothesized that neither diffusion nor structure would show longitudinal changes across the first month post-SRC. Finally, we hypothesized that gray matter diffusion metrics would correlate with plasma GFAP levels, as indicated by preclinical literature. Consistent with our hypothesis, acute SRC was associated with decreased MD in the left pallidum, increased FA in the right amygdala, and a significantly greater number and volume of subject-specific clusters with increased FA compared to HA. No differences in gray matter volume, cortical thickness, or GFAP were observed between groups. There were no longitudinal changes in any measure across the first month post-SRC. Finally, FA in the right amygdala was inversely correlated with GFAP at T2. These results suggest that gray matter diffusion metrics may be useful in determining the physiological effects of SRC.	[Espana, Lezlie Y.; Lee, Ryan M.; Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Ling, Josef M.; Mayer, Andrew R.] Lovelace Biomed & Environm Res Inst, Mind Res Network, Albuquerque, NM USA; [Jeromin, Andreas] Quanterix Corp, Lexington, MA USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Laureate Inst Brain Res, Tulsa, OK USA		Meier, TB (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	tmeier@mcw.edu		Espana, Lezlie/0000-0002-6466-4653	Laureate Institute for Brain Research - William K. Warren Foundation; Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin	This research was conducted using internal funds from the Laureate Institute for Brain Research, which is supported by The William K. Warren Foundation. Dr. Meier received support for this work through a project funded through the Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin. The authors thank the psychiatric assessment team and MRI technicians at the Laureate Institute for Brain Research, Dr. Rashmi Singh and Dr. Patrick Bellgowan for their assistance with data collection, Christopher Nerio, David Polanski, Dr. Thomas Allen, and Dr. Lamont Cavanagh for athlete referral and injury oversight, and Dr. Kent Teague and Ashlee Taylor at the University of Oklahoma Integrative Immunology Center for assistance with blood processing and storage.	Albaugh MD, 2015, J PEDIATR-US, V166, P394, DOI 10.1016/j.jpeds.2014.10.016; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chen G, 2014, NEUROIMAGE, V99, P571, DOI 10.1016/j.neuroimage.2014.06.027; Chen G, 2013, NEUROIMAGE, V73, P176, DOI 10.1016/j.neuroimage.2013.01.047; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leh SE, 2017, J NEUROTRAUM, V34, P1402, DOI 10.1089/neu.2016.4591; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Mannix R, 2014, J NEUROTRAUM, V31, P1072, DOI 10.1089/neu.2013.3265; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2016, J NEUROTRAUM, V33, P1349, DOI 10.1089/neu.2015.4118; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Rhine T, 2016, BRAIN INJURY, V30, P1231, DOI 10.1080/02699052.2016.1178396; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Saad ZS, 2012, NEUROIMAGE, V62, P768, DOI 10.1016/j.neuroimage.2011.09.016; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; Vallez Garcia D, 2016, J NEUROTRAUM, V33, P1855, DOI 10.1089/neu.2015.4230; Wilson DH, 2016, JALA-J LAB AUTOM, V21, P533, DOI 10.1177/2211068215589580; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zhu Y., 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/548392; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	67	13	13	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2017	34	22					3143	3152		10.1089/neu.2017.5002			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FL9GC	WOS:000414560000010	28665173				2022-02-06	
J	Xu, B; Sandrini, M; Levy, S; Volochayev, R; Awosika, O; Butman, JA; Pham, DL; Cohen, LG				Xu, Benjamin; Sandrini, Marco; Levy, Sarah; Volochayev, Rita; Awosika, Oluwole; Butman, John A.; Pham, Dzung L.; Cohen, Leonardo G.			Lasting deficit in inhibitory control with mild traumatic brain injury	SCIENTIFIC REPORTS			English	Article							INFERIOR FRONTAL-CORTEX; RESPONSE-INHIBITION; STOP-SIGNAL; SUSTAINED ATTENTION; COGNITIVE CONTROL; ERROR-AWARENESS; HUMANS; MRI; CONNECTIVITY; ACTIVATIONS	Being able to focus on a complex task and inhibit unwanted actions or interfering information (i.e., inhibitory control) are essential human cognitive abilities. However, it remains unknown the extent to which mild traumatic brain injury (mTBI) may impact these critical functions. In this study, seventeen patients and age-matched healthy controls (HC) performed a variant of the Stroop task and attention-demanding 4-choice response tasks (4CRT) with identical stimuli but two contexts: one required only routine responses and the other with occasional response conflicts. The results showed that mTBI patients performed equally well as the HC when the 4CRT required only routine responses. However, when the task conditions included occasional response conflicts, mTBI patients with even a single concussion showed a significant slow-down in all responses and higher error rates relative to the HC. Results from event-related functional magnetic resonance imaging (efMRI) revealed altered neural activity in the mTBI patients in the cerebellum-thalamo-cortical and the fronto-basal-ganglia networks regulating inhibitory control. These results suggest that even without apparent difficulties in performing complex attention-demanding but routine tasks, patients with mTBI may experience long-lasting deficits in regulating inhibitory control when situations call for rapid conflict resolutions.	[Xu, Benjamin; Sandrini, Marco; Volochayev, Rita; Awosika, Oluwole; Cohen, Leonardo G.] NINDS, Human Cort Physiol & Neurorehabil Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Xu, Benjamin; Sandrini, Marco; Levy, Sarah; Butman, John A.; Pham, Dzung L.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Butman, John A.] NIH, Radiol & Imaging Sci, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA		Xu, B (corresponding author), NINDS, Human Cort Physiol & Neurorehabil Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.; Xu, B (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA.	benxu1@mail.nih.gov	Pham, Dzung/AAR-8263-2020; Butman, John A/A-2694-2008; Sandrini, Marco/J-2276-2014; Butman, John/J-2780-2013	Sandrini, Marco/0000-0002-1664-5722; Butman, John/0000-0002-1547-9195; Levy, Sarah/0000-0002-8254-2553	Department of Defense through the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [G189AN, G189BK]; National Institute of Neurological Disorders and Stroke, at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003030] Funding Source: NIH RePORTER	This work was supported by the Department of Defense through the Center for Neuroscience and Regenerative Medicine (G189AN and G189BK) and by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, at the National Institutes of Health.	Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2016, J NEUROSCI, V36, P11489, DOI 10.1523/JNEUROSCI.2348-16.2016; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Brunia CHM, 1999, ACTA PSYCHOL, V101, P213, DOI 10.1016/S0001-6918(99)00006-2; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; DeHaan A, 2007, NEUROPSYCHOLOGIA, V45, P406, DOI 10.1016/j.neuropsychologia.2006.06.008; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Hermans L., 2016, NEUROREHABIL NEURAL; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jahfari S, 2010, J COGNITIVE NEUROSCI, V22, P1479, DOI 10.1162/jocn.2009.21307; Kenner NM, 2010, J NEUROSCI, V30, P8512, DOI 10.1523/JNEUROSCI.1096-10.2010; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Lepage C, 2017, BRAIN IMAGING BEHAV; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Leunissen I, 2013, HUM BRAIN MAPP, V34, P1254, DOI 10.1002/hbm.21508; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Nachev P, 2007, NEUROIMAGE, V36, pT155, DOI 10.1016/j.neuroimage.2007.03.034; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Niemann H, 1996, NEUROPSYCHOL REV, V6, P11, DOI 10.1007/BF01875418; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Portas CM, 1998, J NEUROSCI, V18, P8979; Prevosto V, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00056; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Stewart JAL, 1999, BRAIN COGNITION, V41, P411, DOI 10.1006/brcg.1999.1141; Sumner P, 2007, NEURON, V54, P697, DOI 10.1016/j.neuron.2007.05.016; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vascak M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00157; Vascak M, 2018, CEREB CORTEX, V28, P1625, DOI 10.1093/cercor/bhx058; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00595; Xu BJM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00034; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	56	13	14	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 2	2017	7								14902	10.1038/s41598-017-14867-y			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL5GR	WOS:000414261500019	29097755	gold, Green Published			2022-02-06	
J	Meisel, JE; Chang, M				Meisel, Jayda E.; Chang, Mayland			Selective small-molecule inhibitors as chemical tools to define the roles of matrix metalloproteinases in disease	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Matrix metalloproteinases; Gelatinases; Thiiranes; ND-322; ND-336; MMP roles	BLOOD-BRAIN-BARRIER; LONG-TERM PROGNOSIS; GELATINASE INHIBITOR; INFLAMMATORY ARTHRITIS; FUNCTIONAL RECOVERY; TISSUE INHIBITOR; MICE DEFICIENT; TETHERED RESIN; FOOT ULCERS; CANCER	The focus of this article is to highlight novel inhibitors and current examples where the use of selective small molecule inhibitors has been critical in defining the roles of matrix metalloproteinases (MMPs) in disease. Selective small-molecule inhibitors are surgical chemical tools that can inhibit the targeted enzyme; they are the method of choice to ascertain the roles of MMPs and complement studies with knockout animals. This strategy can identify targets for therapeutic development as exemplified by the use of selective small-molecule MMP inhibitors in diabetic wound healing, spinal cord injury, stroke, traumatic brain injury, cancer metastasis, and viral infection. This article is part of a Special Issue entitled: Matrix Metalloproteinases edited by Rafael Fridman.	[Meisel, Jayda E.; Chang, Mayland] Univ Notre Dame, 354C McCourtney Hall, Notre Dame, IN 46556 USA		Chang, M (corresponding author), Univ Notre Dame, 354C McCourtney Hall, Notre Dame, IN 46556 USA.	mchang@nd.edu			American Diabetes AssociationAmerican Diabetes Association [1-15-ACN-06]	This work was supported by the American Diabetes Association Pathway to Stop Diabetes grant 1-15-ACN-06.	[Anonymous], 2011, J Spinal Cord Med, V34, P620, DOI 10.1179/204577211X13218754005537; APELQVIST J, 1993, J INTERN MED, V233, P485, DOI 10.1111/j.1365-2796.1993.tb01003.x; Armstrong David G, 2007, Int Wound J, V4, P286; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Aureli L, 2008, CURR MED CHEM, V15, P2192, DOI 10.2174/092986708785747490; Baranger K, 2016, CELL MOL LIFE SCI, V73, P217, DOI 10.1007/s00018-015-1992-1; BAUER EA, 1985, P NATL ACAD SCI USA, V82, P4132, DOI 10.1073/pnas.82.12.4132; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Biswas MHU, 2016, STEM CELL REP, V7, P316, DOI 10.1016/j.stemcr.2016.08.006; Bode W, 1999, CELL MOL LIFE SCI, V55, P639, DOI 10.1007/s000180050320; Bonfil RD, 2007, AM J PATHOL, V170, P2100, DOI 10.2353/ajpath.2007.060720; Bonfil RD, 2006, INT J CANCER, V118, P2721, DOI 10.1002/ijc.21645; Bracken MB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001046.pub2; Brown S, 2000, J AM CHEM SOC, V122, P6799, DOI 10.1021/ja001461n; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Castro-Castro A., 2016, ANN REV CELL DEV BIO, V32; CDC C.f.D.C.a.P. National Center for Health Statistics, 2015, UND CAUS DEATH 1999; CDC NCHS, 2011, FACT FACTS DIAB; Celenza G, 2008, CHEM BIOL DRUG DES, V71, P187, DOI 10.1111/j.1747-0277.2008.00632.x; Chen YC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002672; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cox JH, 2010, ARTHRITIS RHEUM-US, V62, P3645, DOI 10.1002/art.27757; Cui JK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-21; Devel L, 2006, J BIOL CHEM, V281, P11152, DOI 10.1074/jbc.M600222200; Devel L, 2010, J BIOL CHEM, V285, P35900, DOI 10.1074/jbc.M110.139634; Ding DR, 2014, MEDCHEMCOMM, V5, P1381, DOI 10.1039/c4md00172a; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Donnan GA, 2011, NAT REV NEUROL, V7, P400, DOI 10.1038/nrneurol.2011.89; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Faul M, 2010, TRAUMATIC BRAIN INJU, P891, DOI [10.1016/B978-0-444-52910-7.00011-8, DOI 10.1016/B978-0-444-52910-7.00011-8]; Feldinger K, 2014, ONCOTARGET, V5, P6633, DOI 10.18632/oncotarget.1955; Fisher JF, 2010, METHODS MOL BIOL, V622, P471, DOI 10.1007/978-1-60327-299-5_27; Forbes C, 2009, CHEM BIOL DRUG DES, V74, P527, DOI 10.1111/j.1747-0285.2009.00881.x; Gao M, 2016, ACS CHEM NEUROSCI, V7, P1482, DOI 10.1021/acschemneuro.6b00217; Gao M, 2015, P NATL ACAD SCI USA, V112, P15226, DOI 10.1073/pnas.1517847112; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Gooyit M., 2015, SCAFFOLDS MED CHEM, P262; Gooyit M.D., 2013, GELATINASE INHIBITIO; Gooyit M, 2014, ACS CHEM BIOL, V9, P105, DOI 10.1021/cb4005468; Gooyit M, 2013, J MED CHEM, V56, P8139, DOI 10.1021/jm401217d; Gooyit M, 2012, ACS CHEM NEUROSCI, V3, P730, DOI 10.1021/cn300062w; Gooyit M, 2011, J MED CHEM, V54, P6676, DOI 10.1021/jm200566e; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Guo JL, 2012, ONCOL REP, V28, P1709, DOI 10.3892/or.2012.2003; Guo ZD, 2010, NEUROL RES, V32, P715, DOI 10.1179/016164109X12478302362491; Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; He ZJ, 2009, CHINESE MED J-PEKING, V122, P2346, DOI 10.3760/cma.j.issn.0366-6999.2009.19.029; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hesek D, 2006, CHEM BIOL, V13, P379, DOI 10.1016/j.chembiol.2006.01.012; Hesek D, 2006, J ORG CHEM, V71, P5848, DOI 10.1021/jo060058h; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Ikejiri M, 2005, J BIOL CHEM, V280, P33992, DOI 10.1074/jbc.M504303200; Ikejiri M, 2005, J ORG CHEM, V70, P5709, DOI 10.1021/jo050339+; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, P528, DOI 10.1161/ATVBAHA.110.219147; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kaneko K, 2016, ARTHRITIS RHEUMATOL, V68, P521, DOI 10.1002/art.39414; Kawahara R, 2017, J PROTEOMICS, V151, P53, DOI 10.1016/j.jprot.2016.08.017; Kehrli P, 1999, NEUROCHIRURGIE, V45, P357; Kruger A, 2005, CANCER RES, V65, P3523, DOI 10.1158/0008-5472.CAN-04-3570; Lafleur MA, 2001, BIOCHEM J, V357, P107, DOI 10.1042/0264-6021:3570107; Lazaro JL, 2016, J WOUND CARE, V25, P277, DOI 10.12968/jowc.2016.25.5.277; Lee M, 2007, CHEM BIOL DRUG DES, V70, P371, DOI 10.1111/j.1747-0285.2007.00577.x; Lee M, 2015, ACS CHEM NEUROSCI, V6, P1658, DOI 10.1021/acschemneuro.5b00140; Lee M, 2012, ACS MED CHEM LETT, V3, P490, DOI 10.1021/ml300050b; Lee M, 2009, CHEM BIOL DRUG DES, V73, P189, DOI 10.1111/j.1747-0285.2008.00750.x; Liu Y, 2009, DIABETES CARE, V32, P117, DOI [10.2337/dc08-0763, 10.2337/dc09-1394]; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8; Luplerdlop N, 2006, EMBO REP, V7, P1176, DOI 10.1038/sj.embor.7400814; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Martin MD, 2008, CANCER RES, V68, P6251, DOI 10.1158/0008-5472.CAN-08-0537; Marusak C, 2016, PHARMACOL RES, V113, P515, DOI 10.1016/j.phrs.2016.09.033; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Mohan V., 2016, MEDICINE, V3, P31, DOI [DOI 10.2147/MNM.S65143, 10.2147/mnm.s65143]; Mohanan V, 2013, CLIN EXP METASTAS, V30, P507, DOI 10.1007/s10585-012-9555-4; Morbach S, 2012, DIABETES CARE, V35, P2021, DOI 10.2337/dc12-0200; Mozaffarian D, 2015, HEART DIS STROKE STA; Mullooly M, 2015, BRIT J CANCER, V113, P945, DOI 10.1038/bjc.2015.288; Nayak L, 2012, CURR ONCOL REP, V14, P48, DOI 10.1007/s11912-011-0203-y; Nguyen M, 2000, J BIOL CHEM, V275, P9095, DOI 10.1074/jbc.275.13.9095; Nieder C, 2011, CANCER-AM CANCER SOC, V117, P2505, DOI 10.1002/cncr.25707; Noble LJ, 2002, J NEUROSCI, V22, P7526; Nuti E, 2007, CURR PHARM DESIGN, V13, P2087; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Ota R, 2009, J CEREBR BLOOD F MET, V29, P1547, DOI 10.1038/jcbfm.2009.77; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Pirila E., WOUND REPAIR; Pochetti G, 2009, J MED CHEM, V52, P1040, DOI 10.1021/jm801166j; Rice JB, 2014, DIABETES CARE, V37, P651, DOI 10.2337/dc13-2176; Rocks N, 2008, BIOCHIMIE, V90, P369, DOI 10.1016/j.biochi.2007.08.008; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Semple BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143386; Shaverdashvili K, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12201; Shibui S, 1999, JPN J CLIN ONCOL, V29, P243, DOI 10.1093/jjco/29.5.243; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Skiles JW, 2004, CURR MED CHEM, V11, P2911, DOI 10.2174/0929867043364018; Song W, 2013, ACS CHEM NEUROSCI, V4, P1168, DOI 10.1021/cn400077d; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; Tang JP, 2004, J CEREBR BLOOD F MET, V24, P1133, DOI 10.1097/01.WCB.0000135593.05952.DE; Testero SA, 2011, ACS MED CHEM LETT, V2, P177, DOI 10.1021/ml100254e; Dinh T, 2012, DIABETES, V61, P2937, DOI 10.2337/db12-0227; Toth M, 2000, J BIOL CHEM, V275, P41415, DOI 10.1074/jbc.M006871200; Trivedi A., 2005, INT J NEUROPROTECT N, V2, P30; Vafadari B, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13415; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wilhelm I, 2013, INT J MOL SCI, V14, P1383, DOI 10.3390/ijms14011383; World Health Organization, 2014, WORLD CANC REPORT 20; Xie TX, 2006, CANCER RES, V66, P3188, DOI 10.1158/0008-5472.CAN-05-2674; Yan YG, 2015, BIOORGAN MED CHEM, V23, P6632, DOI 10.1016/j.bmc.2015.09.013; Yang Y, 2015, BRAIN RES, V1623, P30, DOI 10.1016/j.brainres.2015.04.024; Yu F, 2008, J NEUROTRAUM, V25, P184, DOI 10.1089/neu.2007.0438; Zhang HQ, 2011, NEUROTHERAPEUTICS, V8, P206, DOI 10.1007/s13311-011-0038-0; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197; Ziyadeh N, 2011, ADV SKIN WOUND CARE, V24, P31, DOI 10.1097/01.ASW.0000392922.30229.b3; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	131	13	13	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	1879-2596		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	NOV	2017	1864	11	A		SI		2001	2014		10.1016/j.bbamcr.2017.04.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FK6JN	WOS:000413610100008	28435009	Bronze			2022-02-06	
J	Shibahashi, K; Sugiyama, K; Okura, Y; Hoda, H; Hamabe, Y				Shibahashi, Keita; Sugiyama, Kazuhiro; Okura, Yoshihiro; Hoda, Hidenori; Hamabe, Yuichi			Multicenter Retrospective Cohort Study of " Talk and Die" After Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Mortality; Risk factor; Skull fracture; Subdural hematoma; Talk and die; Traumatic brain injury	HEAD-INJURY; PROGESTERONE; DETERIORATE; PERIOD; DEATH; COMA	BACKGROUND: Patients who "talk and die" after traumatic brain injury (TBI) are potentially salvageable. The reported incidences and risk factors for the "talk and die" phenomenon are conflicting and do not take into account recent improvements in trauma care. The aim of this study was to determine the incidences of "talk and die" after TBI in a modern trauma care system, as well as associated risk factors. METHODS: We identified patients who experienced TBI (abbreviated injury scale 3-5) between 2004 and 2015 who talked on admission (i.e., their verbal component on the Glasgow Coma Scale was >= 3 on admission) using a nationwide trauma registry (the Japan Trauma Data Bank). The end point was in-hospital mortality. We compared patients who talked and died with those who talked and survived. RESULTS: During the study period, 236,698 patients were registered in the database. Of the 24,833 patients who were eligible for analysis, 956 (4.0%) patients subsequently died in the hospital. The in-hospital mortality rate significantly decreased over the past 12 years. Older age; male sex; a higher injury severity score; a lower Glasgow Coma Scale score; comorbidities (congestive heart failure, chronic kidney disease, liver cirrhosis, and hematologic disorders); hypotension on arrival; subdural hemorrhage; contusion; and vault fracture were independently associated with higher in-hospital mortality. CONCLUSION: Even in modern trauma care systems, some patients still talk and die after TBI. We identified certain risk factors in patients with TBI that elicit the requirement for close observation, even if these patients talk after TBI.	[Shibahashi, Keita] Tokyo Metropolitan Bokutoh Hosp, Dept Emergency, Tokyo, Japan; Tokyo Metropolitan Bokutoh Hosp, Intens Care Ctr, Tokyo, Japan		Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Dept Emergency, Tokyo, Japan.	kshibahashi@yahoo.co.jp		Sugiyama, Kazuhiro/0000-0003-4543-3064; Hoda, Hidenori/0000-0002-4283-4412			BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Davis DP, 2007, J TRAUMA, V62, P277, DOI 10.1097/TA.0b013e31802ef4a3; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dunn LT, 2003, J TRAUMA, V54, P497, DOI 10.1097/01.TA.0000030627.71453.CD; GALBRAITH S, 1976, BMJ-BRIT MED J, V1, P1438, DOI 10.1136/bmj.1.6023.1438; Goldschlager T, 2007, J CLIN NEUROSCI, V14, P618, DOI 10.1016/j.jocn.2006.02.018; Hlatky R, 2004, NEUROSURGERY, V55, P1318, DOI 10.1227/01.NEU.0000143029.42638.2C; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; RATANALERT S, 1990, SURG NEUROL, V34, P27, DOI 10.1016/0090-3019(90)90168-O; REILLY PL, 1975, LANCET, V2, P375; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165	21	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2017	107						82	86		10.1016/J.WNEU.2017.07.117			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN2XV	WOS:000415860500013	28765023				2022-02-06	
J	Wilson, SL; Gangathimmaiah, V				Wilson, Stephanie Laura; Gangathimmaiah, Vinay			Does prehospital management by doctors affect outcome in major trauma? A systematic review	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	33rd Annual Meeting of the Australasian-College-of-Emergency-Medicine	NOV 20-24, 2016	Queenstown, NEW ZEALAND	Australasian Coll Emergency Med		Prehospital; trauma; physician; mortality; disability	RAPID-SEQUENCE INTUBATION; SEVERELY INJURED PATIENTS; EMERGENCY MEDICAL-SERVICES; QUALITY-OF-LIFE; BRAIN-INJURY; ENDOTRACHEAL INTUBATION; SEVERITY SCORE; BLUNT TRAUMA; CARE; PHYSICIAN	BACKGROUND: There is substantial variation worldwide in prehospital management of trauma and the role of doctors is controversial. The objective of this review was to determine whether prehospital management by doctors affects outcomes in major trauma, including the prespecified subgroup of severe traumatic brain injuries when compared with management by other advanced life support providers. METHODS: EMBASE, MEDLINE(R), PubMed, SciELO, Trip, Web of Science, and Zetoc were searched for published articles. HSRProj, OpenGrey, and the World Health Organization International Clinical Trials Registry Platform were searched for unpublished data. Relevant reference lists were hand-searched. There were no limits on publication year, but articles were limited to the English language. Authors were contacted for further information as required. Quality was assessed using the Downs and Black criteria. Mortality was the primary outcome, and disability was the secondary outcome of interest. Studies were subjected to a descriptive analysis alone without a meta-analysis due to significant study heterogeneity. All searches, quality assessment, data abstraction, and data analysis was performed by two reviewers independently. RESULTS: Two thousand thirty-seven articles were identified, 49 full-text articles assessed and eight studies included. The included studies consisted of one randomized controlled trial with 375 participants and seven observational studies with over 4,451 participants. All included studies were at a moderate to high risk of bias. Six of the eight included studies showed an improved outcome with prehospital management by doctors, five in terms of mortality and one in terms of disability. Two studies found no significant difference. CONCLUSION: There appears to be an association between prehospital management by doctors and improved survival in major trauma. There may also be an association with improved survival and better functional outcomes in severe traumatic brain injury. Further high-quality evidence is needed to confirm these findings. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.	[Wilson, Stephanie Laura] Townsville Hosp, Emergency Dept, Townsville Base, Qld, Australia; [Gangathimmaiah, Vinay] Lifeflight Retrieval Med, Townsville Base, Qld, Australia		Wilson, SL (corresponding author), Townsville Hosp, Emergency Dept, Townsville Base, Qld, Australia.	stephanielaurawilson@gmail.com		Wilson, Stephanie/0000-0002-9559-9276			Anke AGW, 2003, CLIN REHABIL, V17, P431, DOI 10.1191/0269215503cr629oa; Apodaca A, 2013, J TRAUMA ACUTE CARE, V75, pS157, DOI 10.1097/TA.0b013e318299da3e; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; BAXT WG, 1987, JAMA-J AM MED ASSOC, V257, P3246, DOI 10.1001/jama.257.23.3246; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bieler D, 2017, INJURY, V48, P32, DOI 10.1016/j.injury.2016.08.015; Botker MT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-12; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; CHAMPION HR, 1995, J TRAUMA, V38, P94, DOI 10.1097/00005373-199501000-00024; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Chesters A, 2016, TRAUMA, V18, P124, DOI 10.1177/1460408615619197; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Clinical Quality and Patient Safety Unit Queensland Ambulance Service, 2016, CLIN PRACT GUID TRAU; Crewdson K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1603-7; Curtis KA, 2012, MED J AUSTRALIA, V197, P233, DOI 10.5694/mja11.11351; Davies GE, 2011, J TRAUMA, V70, pE75, DOI 10.1097/TA.0b013e3181f6f72f; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Ellis DY, 2007, EMERG MED J, V24, P139, DOI 10.1136/emj.2006.040428; Evans SA, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-8; Frankema SPG, 2004, BRIT J SURG, V91, P1520, DOI 10.1002/bjs.4756; Franschman G, 2013, INJURY, V44, P1232, DOI 10.1016/j.injury.2013.06.002; Franschman G, 2012, INJURY, V43, P1838, DOI 10.1016/j.injury.2012.05.020; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Galvagno SM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009228.pub3; Garner A, 1999, AUST NZ J SURG, V69, P697, DOI 10.1046/j.1440-1622.1999.01688.x; Garner Alan A, 2004, Emerg Med Australas, V16, P318, DOI 10.1111/j.1742-6723.2004.00636.x; Garner AA, 2015, EMERG MED J, V32, P869, DOI 10.1136/emermed-2014-204390; Halcomb Elizabeth, 2005, Aust Crit Care, V18, P17, DOI 10.1016/S1036-7314(05)80020-7; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P377, DOI 10.3109/10903121003790173; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JENNETT B, 1975, LANCET, V1, P480; Lossius HM, 2012, CRIT CARE, V16, DOI 10.1186/cc11189; MacDonald Russell D, 2015, Air Med J, V34, P134, DOI 10.1016/j.amj.2015.02.004; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Morris S, 2000, J TRAUMA, V49, P461, DOI 10.1097/00005373-200009000-00013; Open Grey, SYST INF GREY LIT EU; Oppe S, 2001, ACCIDENT ANAL PREV, V33, P129, DOI 10.1016/S0001-4575(00)00023-3; Pakkanen T, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0256-x; Post RB, 2006, DISABIL REHABIL, V28, P1399, DOI 10.1080/09638280600641392; Potter D, 2013, J R Nav Med Serv, V99, P16; Rinburg AN, 2009, BRIT J SURG, V96, P1365, DOI 10.1002/bjs.6720; Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Roudsari BS, 2007, INJURY, V38, P993, DOI 10.1016/j.injury.2007.03.028; Roudsari BS, 2007, INJURY, V38, P1001, DOI 10.1016/j.injury.2007.04.008; Royal Australasian College of Surgeons NZ Trauma Committee, 2012, GUID STRUCT APPR PRO; South Western Ambulance Service, 2014, TRAUM CAR ACC TRAUM; Strote J, 2009, AM J EMERG MED, V27, P1142, DOI 10.1016/j.ajem.2008.08.011; US National Library of Medicine, HLTH SERV RES PROJ P; Varghese M., 2005, PREHOSPITAL TRAUMA C; Wang Henry E, 2005, Prehosp Emerg Care, V9, P156; Warner KJ, 2010, PREHOSP EMERG CARE, V14, P103, DOI 10.3109/10903120903144858; WHO, INT CLIN TRIALS REG; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, GLOB STAT REP ROAD S	60	13	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2017	83	5					965	974		10.1097/TA.0000000000001559			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	FP2IO	WOS:000417440900033	28590350				2022-02-06	
J	Grant, DA; Serpa, R; Moattari, CR; Brown, A; Greco, T; Prins, ML; Teng, E				Grant, Daya A.; Serpa, Rebecka; Moattari, Cameron R.; Brown, Ari; Greco, Tiffany; Prins, Mayumi L.; Teng, Edmond			Repeat Mild Traumatic Brain Injury in Adolescent Rats Increases Subsequent beta-Amyloid Pathogenesis	JOURNAL OF NEUROTRAUMA			English	Article						adolescence; Alzheimer's disease; amyloid; mild traumatic brain injury; transgenic rat	ALZHEIMERS-DISEASE; TRANSGENIC RAT; HEAD-INJURY; TEMPORAL WINDOW; MOUSE MODEL; COGNITIVE IMPAIRMENT; RECURRENT CONCUSSION; PROTEIN DEPOSITION; FOOTBALL PLAYERS; PLAQUE LOAD	Single moderate-to-severe traumatic brain injuries (TBIs) may increase subsequent risk for neurodegenerative disease by facilitating beta-amyloid (A beta) deposition. However, the chronic effects on A beta pathogenesis of repetitive mild TBIs (rTBI), which are common in adolescents and young adults, remain uncertain. We examined the effects of rTBI sustained during adolescence on subsequent deposition of A beta pathology in a transgenic APP/PS1 rat model. Transgenic rats received sham or four individual mild TBIs (rTBIs) separated by either 24- or 72-h intervals at post-natal day 35 (before A beta plaque deposition). Animals were euthanized at 12 months of age and underwent immunohistochemical analyses of A beta plaque deposition. Significantly greater hippocampal A beta plaque deposition was observed after rTBI separated by 24h relative to rTBI separated by 72h or sham injuries. These increases in hippocampal A beta plaque load were driven by increases in both plaque number and size. Similar, though less-pronounced, effects were observed in extrahippocampal regions. Increases in A beta plaque deposition were observed both ipsilaterally and contralaterally to the injury site and in both males and females. rTBIs sustained in adolescence can increase subsequent deposition of A beta pathology, and these effects are critically dependent on interinjury interval.	[Grant, Daya A.; Serpa, Rebecka; Brown, Ari; Greco, Tiffany; Prins, Mayumi L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Teng, Edmond] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Grant, Daya A.; Moattari, Cameron R.] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA USA; [Teng, Edmond] Vet Affairs Greater Angeles Healthcare Syst, Los Angeles, CA USA		Prins, ML (corresponding author), 300 Stein Plaza,Suite 532, Los Angeles, CA 90095 USA.	mprins@mednet.ucla.edu	Greco, Tiffany/ABA-3519-2021	Serpa, Rebecka/0000-0001-5232-9172; Moattari, Cameron/0000-0003-0197-6008	NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K08 AG34628]; NIA - American Federation for Aging Research [K08 AG34628]; NIA - John A. Hartford Foundation [K08 AG34628]; NIA - Atlantic Philanthropies [K08 AG34628]; NIA - Starr Foundation [K08 AG34628]; UCLA Brain Injury Research Center	This work was supported by the NIA (K08 AG34628 [jointly sponsored by the NIA, the American Federation for Aging Research, the John A. Hartford Foundation, the Atlantic Philanthropies, the Starr Foundation, and an anonymous donor] to E.T.) and the UCLA Brain Injury Research Center.	ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; Bird SM, 2016, NEUROSCI BIOBEHAV R, V64, P215, DOI 10.1016/j.neubiorev.2016.01.004; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Callaway JK, 2016, BEHAV BRAIN RES, V303, P44, DOI 10.1016/j.bbr.2016.01.032; Carroll JC, 2010, BRAIN RES, V1366, P233, DOI 10.1016/j.brainres.2010.10.009; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Costa T, 2010, J NEUROSCI RES, V88, P1329, DOI 10.1002/jnr.22300; Counotte DS, 2010, EUR J NEUROSCI, V32, P1452, DOI 10.1111/j.1460-9568.2010.07404.x; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Flood DG, 2009, NEUROBIOL AGING, V30, P1078, DOI 10.1016/j.neurobiolaging.2007.10.006; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gardner RC, 2014, ANN NEUROL, V75, P339, DOI 10.1002/ana.24121; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Greco T, 2015, DEV NEUROBIOL, V75, P193, DOI 10.1002/dneu.22218; Greco T, 2013, J NEUROTRAUM, V30, P1983, DOI 10.1089/neu.2013.2990; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hall AM, 2012, BRAIN RES BULL, V88, P3, DOI 10.1016/j.brainresbull.2011.11.017; Heggland I, 2015, EUR J NEUROSCI, V41, P1245, DOI 10.1111/ejn.12876; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lesne S, 2008, NEUROSCIENCE, V151, P745, DOI 10.1016/j.neuroscience.2007.10.054; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewis EM, 2002, DRUG CHEM TOXICOL, V25, P437, DOI 10.1081/DCT-120014794; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Liu L, 2008, NEUROBIOL DIS, V31, P46, DOI 10.1016/j.nbd.2008.03.005; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Mielke MM, 2014, CLIN EPIDEMIOL, V6, P37, DOI 10.2147/CLEP.S37929; Mitew S, 2013, NEUROBIOL AGING, V34, P2341, DOI 10.1016/j.neurobiolaging.2013.04.010; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nakagawa Y, 2000, EXP NEUROL, V163, P244, DOI 10.1006/exnr.2000.7375; NEHLIG A, 1988, J NEUROSCI, V8, P2321; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Sturchler-Pierrat C, 2000, ANN NY ACAD SCI, V920, P134; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Teng E, 2011, NEUROBIOL DIS, V43, P565, DOI 10.1016/j.nbd.2011.05.003; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; VanItallie TB, 2015, METABOLISM, V64, pS51, DOI 10.1016/j.metabol.2014.10.033; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016	76	13	13	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2018	35	1					94	104		10.1089/neu.2017.5042		OCT 2017	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FS1WO	WOS:000414457000001	28728464	Green Published			2022-02-06	
J	Albalawi, T; Hamner, JW; Lapointe, M; Meehan, WP; Tan, CO				Albalawi, Tamadher; Hamner, Jason W.; Lapointe, Matthew; Meehan, William P., III; Tan, Can Ozan			The Relationship between Cerebral Vasoreactivity and Post-Concussive Symptom Severity	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; cognitive function; headache; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBROVASCULAR REACTIVITY IMPAIRMENT; BLOOD-FLOW-VELOCITY; INTERNATIONAL-CONFERENCE; TRANSCRANIAL DOPPLER; ARTERY DIAMETER; CARBON-DIOXIDE; EXERCISE; SPORT; AUTOREGULATION	While pathophysiology underlying post-concussion symptom burden is unknown, data suggest that cerebrovascular dysfunction may be among the culprits. We sought to determine whether the degree of impairment in the ability of cerebrovasculature to buffer against changes in arterial gases (vasoreactivity) is associated with concussion symptoms. In 15 participants (19 +/- 5 years, 1 week to 1 year post-injury) diagnosed with concussion, we assessed vasoreactivity from the slope of the linear relationship of beat-by-beat middle cerebral artery blood flow velocity (transcranial Doppler ultrasound) to end-tidal CO2 during progressive increases in end-tidal CO2 (air rebreathing). Symptom burden was assessed using the Post-Concussion Symptom Scale. Subsequently, we explored the relationship between vasoreactivity and the severity of post-concussion headache and cognitive difficulties by linear models. During rebreathing, CO2 increased from 32.6 +/- 1.6 to 46.8 +/- 1.8mmHg and cerebrovascular conductance (i.e., flow velocity over pressure) increased from 0.48 +/- 0.04 to 0.74 +/- 0.06 cms(-1) mmHg(-1). There was a strong linear relationship between the increase in CO2 and in conductance (R-2 = 0.81 +/- 0.05; p < 0.05). On average, cerebral vasoreactivity was 0.018 +/- 0.003 cm(-1) s(-1) mmHg CO2-1. Although vasoreactivity tended to be somewhat higher in the asymptotic participants (0.019 +/- 0.003 vs. 0.015 +/- 0.005 cm(-1) s(-1) mmHg CO2-1), this difference was not statistically significant (p = 0.48). Higher vasoreactivity was strongly associated with more severe headaches (R-2 = 0.57; p < 0.01) and worse cognitive symptoms (R-2 = 0.71; p < 0.01). Thus, cerebral vasoreactivity relates strongly to post-concussive headache and cognitive symptom burden. This has significant implications for understanding the pathophysiology underlying post-concussive symptom burden and for devising effective treatment options.	[Albalawi, Tamadher; Hamner, Jason W.; Lapointe, Matthew; Tan, Can Ozan] Spaulding Rehabil Hosp, Cerebrovasc Res Lab, Boston, MA USA; [Albalawi, Tamadher; Tan, Can Ozan] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Micheli Ctr Sports Injury Prevent, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat & Orthoped, Boston, MA USA		Tan, CO (corresponding author), Spaulding Hosp Cambridge, 1575 Cambridge St, Cambridge, MA 02138 USA.	cotan@mgh.harvard.edu	Hamner, J. W./B-4607-2017; Tan, Can Ozan/E-2598-2016	Hamner, J. W./0000-0002-5819-2362; Tan, Can Ozan/0000-0001-9673-9907	Neuroscience Center at King Fahad Specialist Hospital, Dammam, Saudi Arabia	Dr. Albalawi is supported by a scholarship from The Neuroscience Center at King Fahad Specialist Hospital, Dammam, Saudi Arabia.	Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; BENSCHOP RJ, 1994, CIRCULATION, V89, P762, DOI 10.1161/01.CIR.89.2.762; Brys M, 2003, AM J PHYSIOL-HEART C, V285, pH1048, DOI 10.1152/ajpheart.00062.2003; Chan ST, 2009, BRAIN RES, V1291, P53, DOI 10.1016/j.brainres.2009.07.057; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Guiney H, 2015, NEUROPSYCHOLOGY, V29, P1, DOI 10.1037/neu0000124; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; HARPER AM, 1965, J NEUROL NEUROSUR PS, V28, P449, DOI 10.1136/jnnp.28.5.449; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; IONESCUTIRGOVISTE C, 1990, ARCH INT PHYSIOL BIO, V98, P111, DOI 10.3109/13813459009115744; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jordan J, 2000, HYPERTENSION, V36, P383, DOI 10.1161/01.HYP.36.3.383; JORGENSEN LG, 1992, J APPL PHYSIOL, V72, P1123, DOI 10.1152/jappl.1992.72.3.1123; KAWAI Y, 1993, J APPL PHYSIOL, V74, P3046, DOI 10.1152/jappl.1993.74.6.3046; Kim DI, 2018, AUTON NEUROSCI-BASIC, V209, P43, DOI 10.1016/j.autneu.2017.04.001; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; LEHRER PM, 1989, PSYCHOPHYSIOLOGY, V26, P668, DOI 10.1111/j.1469-8986.1989.tb03169.x; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; MORAINE JJ, 1993, EUR J APPL PHYSIOL O, V67, P35, DOI 10.1007/BF00377701; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SAITO N, 1990, ACT NEUR S, V51, P186; Serrador JM, 2006, AM J PHYSIOL-REG I, V290, pR1087, DOI 10.1152/ajpregu.00446.2005; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Smith JJ, 1997, ANESTH ANALG, V84, P363, DOI 10.1097/00000539-199702000-00023; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Tan CO, 2014, EXP PHYSIOL, V99, P3, DOI 10.1113/expphysiol.2013.072355; Unterberg AW, 1997, ACT NEUR S, V70, P106; Verbree J, 2014, J APPL PHYSIOL, V117, P1084, DOI 10.1152/japplphysiol.00651.2014; Vernieri F, 2008, CEPHALALGIA, V28, P689, DOI 10.1111/j.1468-2982.2008.01579.x; West T.A, 2014, J NEUROTRAUM, V31; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Zhang R, 1997, J APPL PHYSIOL, V83, P2139, DOI 10.1152/jappl.1997.83.6.2139	49	13	13	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2700	2705		10.1089/neu.2017.5060			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700004	28537493				2022-02-06	
J	Chao, LL; Raymond, MR; Leo, CK; Abadjian, LR				Chao, Linda L.; Raymond, Morgan R.; Leo, Cynthia K.; Abadjian, Linda R.			Evidence of Hippocampal Structural Alterations in Gulf War Veterans With Predicted Exposure to the Khamisiyah Plume	JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SUBJECTIVE COGNITIVE COMPLAINTS; TBI IDENTIFICATION METHOD; GENOME-WIDE ASSOCIATION; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; ALCOHOL DEPENDENCE; T2-WEIGHTED MRI; APO E4; VOLUME	Objectives: To replicate and expand our previous findings of smaller hippocampal volumes in Gulf War (GW) veterans with predicted exposure to the Khamisiyah plume. Methods: Total hippocampal and hippocampal subfield volumes were quantified from 3 Tesla magnetic resonance images in 113 GW veterans, 62 of whom had predicted exposure as per the Department of Defense exposure models. Results: Veterans with predicted exposure had smaller total hippocampal and CA3/dentate gyrus volumes compared with unexposed veterans, even after accounting for potentially confounding genetic and clinical variables. Among veterans with predicted exposure, memory performance was positively correlated with hippocampal volume and negatively correlated with estimated exposure levels and self-reported memory difficulties. Conclusions: These results replicate and extend our previous finding that low-level exposure to chemical nerve agents from the Khamisiyah pit demolition has detrimental, lasting effects on brain structure and function.	[Chao, Linda L.; Raymond, Morgan R.; Leo, Cynthia K.; Abadjian, Linda R.] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Ctr Imaging Neurodegenerat Dis, San Francisco, CA USA; [Chao, Linda L.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA USA; [Chao, Linda L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA		Chao, LL (corresponding author), 4150 Clement St,114M, San Francisco, CA 94121 USA.	linda.chao@ucsf.edu		Chao, Linda/0000-0002-8593-2434	VA grant entitled "Longitudinal Assessment of Gulf War Veterans with Suspected Sarin Exposure" [CX000798]	This study was supported by VA grant No. CX000798 entitled "Longitudinal Assessment of Gulf War Veterans with Suspected Sarin Exposure."	Abdel-Rahman A, 2002, NEUROSCIENCE, V113, P721, DOI 10.1016/S0306-4522(02)00176-8; Agartz I, 1999, ARCH GEN PSYCHIAT, V56, P356, DOI 10.1001/archpsyc.56.4.356; Amariglio RE, 2012, NEUROPSYCHOLOGIA, V50, P2880, DOI 10.1016/j.neuropsychologia.2012.08.011; [Anonymous], 1991, POT EXP SAR DEM KHAM; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Binns J, 2011, FEDERAL PRACTITIONER, V28, P37; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Chao LL, 2016, J OCCUP ENVIRON MED, V58, P1014, DOI 10.1097/JOM.0000000000000851; Chao LL, 2014, NEUROTOXICOLOGY, V44, P263, DOI 10.1016/j.neuro.2014.07.003; Chao LL, 2010, NEUROTOXICOLOGY, V31, P493, DOI 10.1016/j.neuro.2010.05.006; Chao LL, 2017, MIL MED IN PRESS; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Delis D.C., 2000, CALIFORNIA VERBAL LE; den Heijer T, 2010, BRAIN, V133, P1163, DOI 10.1093/brain/awq048; Dickerson BC, 2010, NEUROPSYCHOPHARMACOL, V35, P86, DOI 10.1038/npp.2009.126; Enserink M, 2001, SCIENCE, V291, P814, DOI 10.1126/science.291.5505.814; First MB, 1995, STRUCTURED CLIN INTE; Fotuhi M, 2012, NAT REV NEUROL, V8, P189, DOI 10.1038/nrneurol.2012.27; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Hafkemeijer A, 2013, BRAIN CONNECT, V3, P353, DOI 10.1089/brain.2013.0144; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Henderson RF, 2002, TOXICOL APPL PHARM, V184, P67, DOI 10.1006/taap.2002.9495; Hohman TJ, 2011, NEUROPSYCHOLOGY, V25, P125, DOI 10.1037/a0020859; Institute of Medicine, 2010, GULF WAR HLTH; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Jessen F, 2006, NEUROBIOL AGING, V27, P1751, DOI 10.1016/j.neurobiolaging.2005.10.010; Joseph SC, 1997, MIL MED, V162, P149; Kang HK, 1996, NEW ENGL J MED, V335, P1498, DOI 10.1056/NEJM199611143352006; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee J, 2016, PSYCHIAT RES-NEUROIM, V258, P16, DOI 10.1016/j.pscychresns.2016.10.009; LEHTOVIRTA M, 1995, NEUROSCIENCE, V67, P65, DOI 10.1016/0306-4522(95)00014-A; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; Malykhin NV, 2010, J PSYCHIATR NEUROSCI, V35, P337, DOI 10.1503/jpn.100002; Mueller SG, 2008, NEUROIMAGE, V42, P42, DOI 10.1016/j.neuroimage.2008.04.174; Mueller SG, 2009, HIPPOCAMPUS, V19, P558, DOI 10.1002/hipo.20614; Murphy FM, 1999, MIL MED, V164, P327, DOI 10.1093/milmed/164.5.327; Norman MA, 2000, J CLIN EXP NEUROPSYC, V22, P80, DOI 10.1076/1380-3395(200002)22:1;1-8;FT080; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048895; Pazdernik TL, 2001, J APPL TOXICOL, V21, pS87, DOI 10.1002/jat.818; Perrotin A, 2012, ARCH NEUROL-CHICAGO, V69, P223, DOI 10.1001/archneurol.2011.666; Pluta J, 2012, J ALZHEIMERS DIS, V31, P85, DOI 10.3233/JAD-2012-111931; Pohlack ST, 2014, BRAIN STRUCT FUNCT, V219, P255, DOI 10.1007/s00429-012-0497-z; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; Rodda J, 2010, EUR PSYCHIAT, V25, P123, DOI 10.1016/j.eurpsy.2009.07.011; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Schultz Stephanie A, 2015, Alzheimers Dement (Amst), V1, P33; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Steffens DC, 2002, AM J GERIAT PSYCHIAT, V10, P62, DOI 10.1176/appi.ajgp.10.1.62; Vasterling JJ, 2006, PHILOS T R SOC B, V361, P593, DOI 10.1098/rstb.2006.1819; VERONESI B, 1990, TOXICOL APPL PHARM, V104, P440, DOI 10.1016/0041-008X(90)90166-R; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; White RKS, 2011, FED PRACT, P13; Wolfe J, 1996, INSTRUMENTATION STRE, P144; Wrench JM, 2009, J NEUROL NEUROSUR PS, V80, P539, DOI 10.1136/jnnp.2008.152165; Yamasue H, 2007, ANN NEUROL, V61, P37, DOI 10.1002/ana.21024; Yehuda R, 2004, BIOL PSYCHIAT, V55, P291, DOI 10.1016/S0006-3223(03)00641-3; Yushkevich PA, 2010, NEUROIMAGE, V53, P1208, DOI 10.1016/j.neuroimage.2010.06.040; Zou K, 2010, BIOL PSYCHIAT, V67, P186, DOI 10.1016/j.biopsych.2009.09.014	67	13	13	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-2752	1536-5948		J OCCUP ENVIRON MED	J. Occup. Environ. Med.	OCT	2017	59	10					923	929		10.1097/JOM.0000000000001082			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FJ2FM	WOS:000412539800009	28692012				2022-02-06	
J	Davies, DJ; Clancy, M; Lighter, D; Balanos, GM; Lucas, SJE; Dehghani, H; Su, ZJ; Forcione, M; Belli, A				Davies, David James; Clancy, Michael; Lighter, Daniel; Balanos, George M.; Lucas, Samuel John Edwin; Dehghani, Hamid; Su, Zhangjie; Forcione, Mario; Belli, Antonio			Frequency-domain vs continuous-wave near-infrared spectroscopy devices: a comparison of clinically viable monitors in controlled hypoxia	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Head injury; Cerebral blood flow; Frequency-domain near-infrared spectroscopy; Continuous-wave near-infrared spectroscopy	TRAUMATIC BRAIN-INJURY; DIFFUSE OPTICAL TOMOGRAPHY; CEREBRAL OXYGENATION; SURGERY; ACTIVATION; SATURATION; FMRI	The Near-infrared spectroscopy (NIRS) has not been adopted as a mainstream monitoring modality in acute neurosurgical care due to concerns about its reliability and consistency. However, improvements in NIRS parameter recovery techniques are now available that may improve the quantitative accuracy of NIRS for this clinical context. Therefore, the aim of this study was to compare the abilities of a continuous-wave (CW) NIRS device with a similarly clinically viable NIRS device utilising a frequency-domain (FD) parameter recovery technique in detecting changes in cerebral tissue saturation during stepwise increases of experimentally induced hypoxia. Nine healthy individuals (6M/3F) underwent a dynamic end-tidal forced manipulation of their expiratory gases to induce a stepwise induced hypoxia. The minimum end-tidal oxygen partial pressure (EtO2) achieved was 40 mm Hg. Simultaneous neurological and extra-cranial tissue NIRS reading were obtained during this protocol by both tested devices. Both devices detected significant changes in cerebral tissue saturation during the induction of hypoxia (CW 9.8 +/- 2.3 %; FD 7.0 +/- 3.4 %; Wilcoxon signed rank test P < 0.01 for both devices). No significant difference was observed between the saturation changes observed by either device (P = 0.625). An observably greater degree of noise was noticed in parameters recovered by the FD device, and both demonstrated equally variable baseline readings (Coefficient of variance 8.4 and 9.7 % for the CW and FD devices, respectively) between individuals tested. No advantageous difference was observed in parameters recovered from the FD device compared with those detected by CW.	[Davies, David James; Su, Zhangjie; Belli, Antonio] Univ Hosp Birmingham NHS Fdn Trust, NIHR SRMRC, Heritage Bldg Old Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England; [Davies, David James; Forcione, Mario; Belli, Antonio] Univ Hosp Birmingham NHS Fdn Trust, Dept Neurosurg, Birmingham, W Midlands, England; [Clancy, Michael; Dehghani, Hamid] Univ Birmingham, PSIBS Doctoral Training Ctr, Birmingham, W Midlands, England; [Lighter, Daniel] Univ Birmingham, Sch Chem, Birmingham, W Midlands, England; [Balanos, George M.; Lucas, Samuel John Edwin] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England; [Su, Zhangjie; Belli, Antonio] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England		Davies, DJ (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, NIHR SRMRC, Heritage Bldg Old Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England.; Davies, DJ (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Dept Neurosurg, Birmingham, W Midlands, England.	David.Davies@uhb.nhs.uk	Lucas, Samuel/J-4124-2014; Belli, Antonio/I-3799-2015; Lucas, Samuel/AAR-8980-2021; Forcione, Mario/K-2852-2018	Lucas, Samuel/0000-0002-8713-2457; Belli, Antonio/0000-0002-3211-9933; Lucas, Samuel/0000-0002-8713-2457; Balanos, George/0000-0002-8971-6691; Forcione, Mario/0000-0002-4045-8011; Dehghani, Hamid/0000-0003-4117-0412			Calderon-Arnulphi M, 2007, J NEUROSURG, V106, P283, DOI 10.3171/jns.2007.106.2.283; Clancy M, 2015, EUR C BIOM OPT INT S; Contini D, 2007, PROC SPIE, V6629, DOI 10.1117/12.728104; Cooper RJ, 2012, NEUROIMAGE, V62, P1999, DOI 10.1016/j.neuroimage.2012.05.031; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Eggebrecht AT, 2012, NEUROIMAGE, V61, P1120, DOI 10.1016/j.neuroimage.2012.01.124; Fantini S, 1999, PHYS MED BIOL, V44, P1543, DOI 10.1088/0031-9155/44/6/308; Franceschini MA, 2007, PEDIATR RES, V61, P546, DOI 10.1203/pdr.0b013e318045be99; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Lucas SJE, 2011, J PHYSIOL-LONDON, V589, P741, DOI 10.1113/jphysiol.2010.192534; Maas AIR, 2010, INTENS CARE MED, V36, P1283, DOI 10.1007/s00134-010-1921-6; MATCHER SJ, 1995, ANAL BIOCHEM, V227, P54, DOI 10.1006/abio.1995.1252; Murkin JM, 2007, ANESTH ANALG, V104, P51, DOI 10.1213/01.ane.0000246814.29362.f4; Pogue BW, 2001, RADIOLOGY, V218, P261, DOI 10.1148/radiology.218.1.r01ja51261; Rothschild Ryan Mark, 2010, Front Neuroeng, V3, P112, DOI 10.3389/fneng.2010.00112; Sato H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1960907; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Suzuki S, 1999, P SOC PHOTO-OPT INS, V3597, P582, DOI 10.1117/12.356862; Toronov V, 2001, OPT EXPRESS, V9, P417, DOI 10.1364/OE.9.000417; Tyburski JG, 2003, J TRAUMA, V55, P892, DOI 10.1097/01.TA.0000097827.51916.7E; Vohra Hunaid A, 2009, Interact Cardiovasc Thorac Surg, V9, P318, DOI 10.1510/icvts.2009.206367; Wise RG, 2007, J CEREBR BLOOD F MET, V27, P1521, DOI 10.1038/sj.jcbfm.9600465; Wolf M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804899	25	13	13	1	5	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	OCT	2017	31	5					967	974		10.1007/s10877-016-9942-5			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	FG9PL	WOS:000410771300012	27778208	Green Published, hybrid			2022-02-06	
J	Ewing-Cobbs, L; Prasad, MR; Cox, CS; Granger, DA; Duque, G; Swank, PR				Ewing-Cobbs, Linda; Prasad, Mary R.; Cox, Charles S., Jr.; Granger, Douglas A.; Duque, Gerardo; Swank, Paul R.			Altered stress system reactivity after pediatric injury: Relation with post traumatic stress symptoms	PSYCHONEUROENDOCRINOLOGY			English	Article						Hypothalamic pituitary adrenal; Autonomic nervous system; Cortisol; Salivary alpha amylase; Injury; Post-traumatic stress	SALIVARY ALPHA-AMYLASE; PTSD SYMPTOMS; CORTISOL CONCENTRATIONS; PSYCHOSOCIAL STRESS; DISORDER; CHILDREN; BRAIN; HISTORY; HEALTH; YOUTH	Injury is the leading cause of death and disability in childhood. Injured children are at high risk for developing alterations in stress response systems and post-traumatic stress symptoms (PTSS) that may compromise longterm physical and psychological health. In a prospective, observational cohort study, we examined individual differences in, and correlates of, stress-reactivity of the hypothalamic-pituitary-adrenal axis (HPA; salivary cortisol) and autonomic nervous system (ANS; salivary alpha amylase, sAA) following pediatric injury. Participants were 8-15 years of age and hospitalized for traumatic brain injury (TBI; n = 55; M age = 13.9 yrs; 40 males) or extracranial injury (EI; n = 29; M age 12.3 yrs, 20 males) following vehicular accidents. Six months post-injury, saliva was collected before and after the Trier Social Stress Test and later assayed for cortisol and sAA. Relative to a healthy non-injured comparison group (n = 33; M age = 12.5 yrs, 16 males), injured children (ages 8-12 years), but not adolescents (ages 13-15 yrs), had higher cortisol levels; regardless of age, injured participants showed dampened cortisol reactivity to social evaluative threat. Compared to participants with EI, children with TBI had elevated cortisol and adolescents had elevated sAA. With respect to PTSS, individual differences in sAA were negatively correlated with avoidance in the TBI group and positively correlated with emotional numbing within the EI group. Importantly, psychological and neurobiological sequelae were weakly related to injury severity. Given the high prevalence of pediatric injury, these sequelae affect many children and represent a significant public health concern. Consequently, surveillance of post-traumatic sequelae should in dude the full spectrum of injury severity. Monitoring the activity, reactivity, and regulation of biological systems sensitive to environmental insults may advance our understanding of individual differences in sequelae and adaptation following traumatic pediatric injury.	[Ewing-Cobbs, Linda; Prasad, Mary R.; Duque, Gerardo] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA; [Ewing-Cobbs, Linda; Prasad, Mary R.; Duque, Gerardo] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Houston, TX 77030 USA; [Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA; [Swank, Paul R.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Granger, Douglas A.] Univ Calif Irvine, Dept Psychol & Social Behav Pediat & Publ Hlth, Irvine, CA USA; [Granger, Douglas A.] Univ Calif Irvine, Inst Interdisciplinary Salivary Biosci, Irvine, CA USA; [Granger, Douglas A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Sch Nursing, Baltimore, MD 21218 USA; [Granger, Douglas A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA		Ewing-Cobbs, L (corresponding author), Dept Pediat, 7000 Fannin St,Suite 2401, Houston, TX 77030 USA.	Linda.ewing-cobbs@uth.tmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS046308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046308] Funding Source: NIH RePORTER	This work was funded in part by National Institutes of HealthR01 NS046308. The content is solely the responsibility of the authors and does not necessarily represent the official views of the granting institute.	Abelson JL, 2014, PSYCHONEUROENDOCRINO, V44, P60, DOI 10.1016/j.psyneuen.2014.02.016; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Allwood MA, 2011, J CLIN CHILD ADOLESC, V40, P659, DOI 10.1080/15374416.2011.597081; Allwood MA, 2011, BIOL PSYCHOL, V88, P57, DOI 10.1016/j.biopsycho.2011.06.008; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Bae YJ, 2015, J PSYCHIATR RES, V71, P78, DOI 10.1016/j.jpsychires.2015.09.013; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Biederman J, 2002, AM J PSYCHIAT, V159, P1556, DOI 10.1176/appi.ajp.159.9.1556; BuskeKirschbaum A, 1997, PSYCHOSOM MED, V59, P419, DOI 10.1097/00006842-199707000-00012; Carrion VG, 2002, BIOL PSYCHIAT, V51, P575, DOI 10.1016/S0006-3223(01)01310-5; Centers for Disease Control and Prevention, 2016, NCFIPAC; De Bellis MD, 2014, CHILD ADOL PSYCH CL, V23, P185, DOI 10.1016/j.chc.2014.01.002; Delahanty DL, 2005, PSYCHONEUROENDOCRINO, V30, P121, DOI 10.1016/j.psyneuen.2004.06.004; Delahanty DL, 2006, ANN NY ACAD SCI, V1071, P27, DOI 10.1196/annals.1364.003; Doom JR, 2015, PSYCHONEUROENDOCRINO, V59, P102, DOI 10.1016/j.psyneuen.2015.04.024; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Frewen PA, 2012, J CLIN PSYCHIAT, V73, P431, DOI 10.4088/JCP.10m06477; Gandubert C, 2016, NEUROBIOL STRESS, V3, P61, DOI 10.1016/j.ynstr.2016.02.002; Gordis EB, 2008, HORM BEHAV, V53, P96, DOI 10.1016/j.yhbeh.2007.09.002; Granger DA, 2007, ANN NY ACAD SCI, V1098, P122, DOI 10.1196/annals.1384.008; Granger DA, 2009, PSYCHONEUROENDOCRINO, V34, P1437, DOI 10.1016/j.psyneuen.2009.06.017; Gunnar MR, 2001, DEV PSYCHOPATHOL, V13, P515, DOI 10.1017/S0954579401003066; Hendrickson RC, 2016, EXP NEUROL, V284, P181, DOI 10.1016/j.expneurol.2016.05.014; Hopper JW, 2007, J TRAUMA STRESS, V20, P713, DOI 10.1002/jts.20284; Juranek J, 2012, BRAIN IMAGING BEHAV, V6, P36, DOI 10.1007/s11682-011-9140-5; Kassam-Adams N, 2010, J AM ACAD CHILD PSY, V49, P616, DOI 10.1016/j.jaac.2010.02.011; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Keeshin BR, 2015, J CHILD ADOL PSYCHOP, V25, P344, DOI 10.1089/cap.2014.0034; Khoury JE, 2015, NEUROBIOL STRESS, V2, P34, DOI 10.1016/j.ynstr.2015.04.002; Koss KJ, 2016, PSYCHONEUROENDOCRINO, V66, P31, DOI 10.1016/j.psyneuen.2015.12.018; Kuras YI, 2017, DEV PSYCHOBIOL, V59, P91, DOI 10.1002/dev.21470; Laflamme L, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/819687; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Max JE, 2015, J PEDIATR REHAB MED, V8, P345, DOI 10.3233/PRM-150352; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; McEwen BS, 2015, NEUROBIOL STRESS, V1, P1, DOI 10.1016/j.ynstr.2014.09.001; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McFarlane AC, 2011, PSYCHONEUROENDOCRINO, V36, P720, DOI 10.1016/j.psyneuen.2010.10.007; Pacella ML, 2017, SOC SCI MED, V175, P228, DOI 10.1016/j.socscimed.2016.12.046; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Payne L. A., 2014, J CHILD ADOLESC BEHA, V2; Peckins MK, 2015, DEV PSYCHOPATHOL, V27, P1461, DOI 10.1017/S0954579415000875; Pervanidou P, 2007, BIOL PSYCHIAT, V62, P1095, DOI 10.1016/j.biopsych.2007.02.008; Price J, 2016, J PEDIATR PSYCHOL, V41, P86, DOI 10.1093/jpepsy/jsv074; Reifschneider K, 2015, J CLIN MED, V4, P1536, DOI 10.3390/jcm4081536; Schreier H, 2005, J TRAUMA, V58, P353, DOI 10.1097/01.TA.0000152537.15672.B7; Shirtcliff EA, 2008, DEV PSYCHOBIOL, V50, P690, DOI 10.1002/dev.20336; TEASDALE G, 1974, LANCET, V2, P81; Trickett PK, 2014, CHILD MALTREATMENT, V19, P27, DOI 10.1177/1077559513520466; Trickett PK, 2010, DEV PSYCHOPATHOL, V22, P165, DOI 10.1017/S0954579409990332; Weems CF, 2007, J TRAUMA STRESS, V20, P903, DOI 10.1002/jts.20251; Weems CF, 2003, J CLIN CHILD ADOLESC, V32, P166, DOI 10.1207/15374420360533158; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Yehuda R, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.57; Yehuda R, 2010, PSYCHOPHARMACOLOGY, V212, P405, DOI 10.1007/s00213-010-1969-6; Yim IS, 2015, PSYCHONEUROENDOCRINO, V57, P61, DOI 10.1016/j.psyneuen.2015.03.021; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	59	13	13	0	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4530			PSYCHONEUROENDOCRINO	Psychoneuroendocrinology	OCT	2017	84						66	75		10.1016/j.psyneuen.2017.06.003			10	Endocrinology & Metabolism; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism; Neurosciences & Neurology; Psychiatry	FF3IQ	WOS:000408789100008	28667938	Green Accepted			2022-02-06	
J	Human, T; Cook, AM; Anger, B; Bledsoe, K; Castle, A; Deen, D; Gibbs, H; Lesch, C; Liang, N; McAllen, K; Morrison, C; Parker, D; Rowe, AS; Rhoney, D; Sangha, K; Santayana, E; Taylor, S; Tesoro, E; Brophy, G				Human, Theresa; Cook, Aaron M.; Anger, Brian; Bledsoe, Kathleen; Castle, Amber; Deen, David; Gibbs, Haley; Lesch, Christine; Liang, Norah; McAllen, Karen; Morrison, Christopher; Parker, Dennis, Jr.; Rowe, A. Shaun; Rhoney, Denise; Sangha, Kiranpal; Santayana, Elena; Taylor, Scott; Tesoro, Eljim; Brophy, Gretchen			Treatment of Hyponatremia in Patients with Acute Neurological Injury	NEUROCRITICAL CARE			English	Article						Hyponatremia; Neurocritical care; Intensive care unit; Subarachnoid hemorrhage; Intracerebral hemorrhage; Traumatic brain injury; Intracranial tumor	ANEURYSMAL SUBARACHNOID HEMORRHAGE; SEVERE HEAD-INJURY; TRANSSPHENOIDAL SURGERY; ANTIDIURETIC-HORMONE; WATER	Little data exist regarding the practice of sodium management in acute neurologically injured patients. This study describes the practice variations, thresholds for treatment, and effectiveness of treatment in this population. This retrospective, multicenter, observational study identified 400 ICU patients, from 17 centers, admitted for >= 48 h with subarachnoid hemorrhage (SAH), traumatic brain injury (TBI), intraparenchymal hemorrhage, or intracranial tumors between January 1, 2011 and July 31, 2012. Data collection included demographics, APACHE II, Glascow Coma Score (GCS), serum sodium (Na+), fluid rate and tonicity, use of sodium-altering therapies, intensive care unit (ICU) and hospital length of stay, and modified Rankin score upon discharge. Data were collected for the first 21 days of ICU admission or ICU discharge, whichever came first. Sodium trigger for treatment defined as the Na+ value prior to treatment with response defined as an increase of >= 4 mEq/L at 24 h. Sodium-altering therapy was initiated in 34 % (137/400) of patients with 23 % (32/137) having Na+ > 135 mEq/L at time of treatment initiation. The most common indications for treatment were declining serum Na+ (68/116, 59 %) and cerebral edema with mental status changes (21/116, 18 %). Median Na+ treatment trigger was 133 mEq/L (IQR 129-139) with no difference between diagnoses. Incidence and treatment of hyponatremia was more common in SAH and TBI [SAH (49/106, 46 %), TBI (39/97, 40 %), ICH (27/102, 26 %), tumor (22/95, 23 %); p = 0.001]. The most common initial treatment was hypertonic saline (85/137, 62 %), followed by oral sodium chloride tablets (42/137, 31 %) and fluid restriction (15/137, 11 %). Among treated patients, 60 % had a response at 24 h. Treated patients had lower admission GCS (12 vs. 14, p = 0.02) and higher APACHE II scores (12 vs. 10, p = 0.001). There was no statistically significant difference in outcome when comparing treated and untreated patients. Sodium-altering therapy is commonly employed among neurologically injured patients. Hypertonic saline infusions were used first line in more than half of treated patients with the majority having a positive response at 24 h. Further studies are needed to evaluate the impact of various treatments on patient outcomes.	[Human, Theresa] Washington Univ, Barnes Jewish Hosp, St Louis, MO USA; [Cook, Aaron M.] Univ Kentucky, Lexington, KY USA; [Anger, Brian] St Louis Univ Hosp, St Louis, MO USA; [Bledsoe, Kathleen] Univ Virginia Hlth Syst, Charlottesville, VA USA; [Castle, Amber] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA; [Deen, David] Mem Univ Ctr, Savannah, GA USA; [Gibbs, Haley] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; [Lesch, Christine] New York Presbyterian Hosp, New York, NY USA; [Liang, Norah] Hartford Hosp, Hartford, CT 06115 USA; [McAllen, Karen] Spectrum Hlth, Grand Rapids, MI USA; [Morrison, Christopher] Jackson Mem Hosp, Miami, FL 33136 USA; [Parker, Dennis, Jr.] Detroit Receiving Hosp & Univ Hlth Ctr, Detroit, MI USA; [Rowe, A. Shaun] Univ Tennessee, Knoxville, TN USA; [Rhoney, Denise] Univ N Carolina, Chapel Hill, NC USA; [Sangha, Kiranpal] Univ Cincinnati, Univ Hosp, Cincinnati, OH USA; [Santayana, Elena] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Taylor, Scott] Via Cristi, Wichita, KS USA; [Tesoro, Eljim] Univ Illinois, Chicago, IL USA; [Brophy, Gretchen] Virginia Commonwealth, Med Coll Virginia, Richmond, VA 23284 USA		Brophy, G (corresponding author), Virginia Commonwealth, Med Coll Virginia, Richmond, VA 23284 USA.	gbrophy@vcu.edu		Brophy, Gretchen/0000-0002-4749-2693; Cook, Aaron/0000-0001-8539-902X			ARIEFF AI, 1976, MEDICINE, V55, P121, DOI 10.1097/00005792-197603000-00002; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Cole Chad D, 2004, Neurosurg Focus, V16, pE9; Ellison DH, 2007, NEW ENGL J MED, V356, P2064, DOI 10.1056/NEJMcp066837; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HASAN D, 1990, ANN NEUROL, V27, P106, DOI 10.1002/ana.410270118; Hensen J, 1999, CLIN ENDOCRINOL, V50, P431, DOI 10.1046/j.1365-2265.1999.00666.x; Qureshi AI, 2002, NEUROSURGERY, V50, P749, DOI 10.1097/00006123-200204000-00012; Rabinstein AA, 2003, NEUROLOGIST, V9, P290, DOI 10.1097/01.nrl.0000095258.07720.89; SANE T, 1994, J CLIN ENDOCR METAB, V79, P1395, DOI 10.1210/jc.79.5.1395; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; Verbalis JG, 2003, BEST PRACT RES CL EN, V17, P471, DOI 10.1016/S1521-690X(03)00049-6; Vermeij FH, 1998, STROKE, V29, P924, DOI 10.1161/01.STR.29.5.924; Waikar SS, 2009, AM J MED, V122, P857, DOI 10.1016/j.amjmed.2009.01.027; Wei Tao, 2003, Chin Med Sci J, V18, P120; WEINAND ME, 1989, NEUROSURGERY, V25, P781, DOI 10.1227/00006123-198911000-00014	16	13	13	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2017	27	2					242	248		10.1007/s12028-016-0343-x			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FJ4VC	WOS:000412739900013	28054290				2022-02-06	
J	Neidecker, JM; Gealt, DB; Luksch, JR; Weaver, MD				Neidecker, John M.; Gealt, David B.; Luksch, John R.; Weaver, Martin D.			First-Time Sports-Related Concussion Recovery: The Role of Sex, Age, and Sport	JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION			English	Article						athlete; concussion; head injury; sports	HIGH-SCHOOL; GENDER-DIFFERENCES; UNITED-STATES; TRAJECTORIES; MODIFIERS; SYMPTOMS; ANXIETY	Background: Concussion is one of the most common injuries in athletes. Current concussion consensus statements propose that female sex may be a modifying factor in concussion management and recovery. Objective: To determine whether female athletes in middle school and high school with a first-time, sports-related concussion remained symptomatic longer than their male counterparts. Methods: A retrospective medical record analysis was performed among athletes who sustained a concussion between 2011 and 2013. Inclusion criteria consisted of age between 11 and 18 years and diagnosis of first-time concussion sustained while playing organized sports. Using the documented notes in the medical record, length of time that each athlete was symptomatic from his or her concussion was calculated. Results: A total of 110 male and 102 female athletes (N=212) met the eligibility criteria for the study. A significant difference was found in the median number of days female athletes remained symptomatic (28 days) when compared with male athletes (11 days) (P<.001). No statistically significant difference was found in symptom duration between age groups. When matched for sex, no statistically significant differences were found in symptom duration between the type of sports played. Conclusion: Female athletes aged 11 to 18 years with first-time, sports-related concussions remained symptomatic for a longer period when compared with male athletes of similar age, regardless of sport played. The mechanism behind this difference needs to be further elucidated.	[Neidecker, John M.] Orthopaed Specialists North Carolina, 11200 Governor Manly Way,Ste 309, Raleigh, NC 27614 USA; [Gealt, David B.; Weaver, Martin D.] Cooper Univ Hosp, Cooper Bone & Joint Inst, Camden, NJ USA; [Luksch, John R.] Rothman Inst, Philadelphia, PA USA		Neidecker, JM (corresponding author), Orthopaed Specialists North Carolina, 11200 Governor Manly Way,Ste 309, Raleigh, NC 27614 USA.	neidy13@yahoo.com	Weaver, Martin/AAK-7062-2020	Weaver, Martin/0000-0001-8969-2186			Altemus M, 2014, FRONT NEUROENDOCRIN, V35, P320, DOI 10.1016/j.yfrne.2014.05.004; ANDREASON PJ, 1994, PSYCHIAT RES, V51, P175, DOI 10.1016/0165-1781(94)90037-X; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bernstein A, 2006, BEHAV RES THER, V44, P679, DOI 10.1016/j.brat.2005.03.011; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Cassidy D., 2016, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-097699, DOI 10.1136/BJSPORTS-2017-097699]; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Finocchi C, 2014, NEUROL SCI, V35, pS207, DOI 10.1007/s10072-014-1772-y; GE XJ, 1994, DEV PSYCHOL, V30, P467, DOI 10.1037/0012-1649.30.4.467; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist J., 2011, MMWR-MORBID MORTAL W, V60, P1337; Hankin BL, 2009, J CLIN CHILD ADOLESC, V38, P460, DOI 10.1080/15374410902976288; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Lee YM, 2013, J NEUROSURG-PEDIATR, V12, P537, DOI 10.3171/2013.7.PEDS12572; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	31	13	13	0	4	AMER OSTEOPATHIC ASSN	CHICAGO	142 EAST ONTARIO STREET, CHICAGO, IL 60611-2864 USA	0098-6151	1945-1997		J AM OSTEOPATH ASSOC	J. Am. Osteopath. Assoc.	OCT	2017	117	10					635	642		10.7556/jaoa.2017.120			8	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	FO3UX	WOS:000416761800005	28973180				2022-02-06	
J	Omar, M; Moore, L; Lauzier, F; Tardif, PA; Dufresne, P; Boutin, A; Lessard-Bonaventure, P; Paquet, J; Clement, J; Turgeon, AF				Omar, Madiba; Moore, Lynne; Lauzier, Francois; Tardif, Pier-Alexandre; Dufresne, Philippe; Boutin, Amelie; Lessard-Bonaventure, Paule; Paquet, Jerome; Clement, Julien; Turgeon, Alexis F.			Complications following hospital admission for traumatic brain injury: A multicenter cohort study	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; Complications; Quality of care; Trauma system	LENGTH-OF-STAY; HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; EXTRACRANIAL COMPLICATIONS; MULTIPLE IMPUTATION; MORTALITY; CARE; TRANSFUSION; ANEMIA; SYSTEM	Purpose: To evaluate the incidence, determinants and impact on outcome of in-hospital complications in adults with traumatic brain injury (TBI). Materials and methods: We conducted a multicenter cohort study of TBI patients admitted between 2007 and 2012 in an inclusive Canadian trauma system. Risk ratios of complications, odds ratios of mortality and geometric mean ratios of length of stay (LOS) were calculated using generalized linear models with adjustment for prognostic indicators and hospital cluster effects. Results: Of 12,887 patients, 3.2% had at least one neurological complication and 22.6% a non-neurological complication. Mechanical ventilation, head injury severity, blood transfusion and neurosurgical intervention had the strongest correlation with neurological complications. Mechanical ventilation, the Glasgow Coma Scale, blood transfusion and concomitant injuries had the strongest correlation with non-neurological complications. Neurological and non-neurological complications were associated with a 85% and 53% increase in the odds of mortality, and a 60% and two-fold increases in LOS, respectively. Conclusions: More than 20% of patients with TBI developed a complication. Many of these complications were associated with increased mortality and LOS. Results highlight the importance of prevention strategies adapted to treatment decisions and underline the need to improve knowledge on the underuse and overuse of clinical interventions. (C) 2017 Elsevier Inc. All rights reserved.	[Omar, Madiba; Moore, Lynne; Tardif, Pier-Alexandre; Dufresne, Philippe; Boutin, Amelie; Turgeon, Alexis F.] Univ Laval, Dept Social & Preventat Med, Quebec City, PQ, Canada; [Omar, Madiba; Moore, Lynne; Lauzier, Francois; Tardif, Pier-Alexandre; Dufresne, Philippe; Boutin, Amelie; Lessard-Bonaventure, Paule; Turgeon, Alexis F.] Univ Laval, Populat Hlth & Optimal Hlth Practices Unit, Trauma Emergency Crit Care Med,Axe Sante Populat, Ctr Rech,CHU Quebec,Hop Enfant Jesus,Traumatol Ur, Quebec City, PQ, Canada; [Lauzier, Francois] Univ Laval, Dept Internal Med, Quebec City, PQ, Canada; [Lessard-Bonaventure, Paule; Paquet, Jerome] Univ Laval, Div Neurosurg, Dept Neurol Sci, Quebec City, PQ, Canada; [Clement, Julien] Inst Natl Excellence Sante & Serv Sociaux, Montreal, PQ, Canada; [Clement, Julien] Univ Laval, Dept Surg, Quebec City, PQ, Canada; [Turgeon, Alexis F.] Univ Laval, Dept Anesthesiol & Crit Care Med, Quebec City, PQ, Canada		Moore, L (corresponding author), Univ Laval, Axe Sante Populat & Prat Optimales Sante, Traumatol Urgence Soins Intensifs,Populat Hlth Pr, Ctr Rech,CHU Quebec,Trauma Emergency Critical Car, 1401,18 Rue,Local H-012a, Quebec City, PQ G1J 1Z4, Canada.	lynne.moore@fmed.ulaval.ca	; Lauzier, Francois/B-9237-2015	Boutin, Amelie/0000-0003-1907-2920; Tardif, Pier-Alexandre/0000-0003-3003-2399; Dufresne, Philippe/0000-0002-4847-0525; Lauzier, Francois/0000-0002-6530-5513	Canadian Institutes of Health Research: New Investigator AwardCanadian Institutes of Health Research (CIHR) [110996]; Fonds de la Recherche du Quebec - Sante: clinician-scientist award	Canadian Institutes of Health Research: New Investigator Award (AFT and LM) and research grant (LM; #110996); Fonds de la Recherche du Quebec - Sante: clinician-scientist award (FL). None of the funding sources had any role in the study design; the collection, analysis and interpretation of data; the writing of the report; or in the decision to submit the article for publication.	[Anonymous], 2013, INT IN TRAUM BRAIN I; Arthur M, 2009, J RURAL HEALTH, V25, P182, DOI 10.1111/j.1748-0361.2009.00215.x; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Bontke C. F., 1993, J HEAD TRAUMA REHAB, V8, P34; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P27, DOI 10.4103/2229-5151.79279; Dinh P, 2013, PHARM STAT, V12, P260, DOI 10.1002/pst.1579; DuBose JJ, 2008, ARCH SURG, V143; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Ewig S, 1999, AM J RESP CRIT CARE, V159, P188, DOI 10.1164/ajrccm.159.1.9803097; Faul M, 2010, TRAUMATIC BRAIN INJU; Gagne MLG, 2008, ETUDE COMP GRAVITE B; Hemmila MR, 2008, SURGERY, V144, P307, DOI 10.1016/j.surg.2008.05.003; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Ingraham AM, 2010, ANN SURG, V252, P358, DOI 10.1097/SLA.0b013e3181e623bf; Kennedy RE, 2006, J HEAD TRAUMA REHAB, V21, P260, DOI 10.1097/00001199-200605000-00006; Kuimi BLB, 2015, INJURY, V46, P595, DOI 10.1016/j.injury.2015.01.006; Lagoe RJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-200; Lee K, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/207247; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Linnemann M, 2014, NEUROREHABILITATION, V35, P755, DOI 10.3233/NRE-141160; Llanos-Méndez Aurora, 2004, Gac Sanit, V18, P190, DOI 10.1157/13063095; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Moore L, 2005, J TRAUMA, V59, P698, DOI 10.1097/01.ta.0000177700.54943.ee; Moore LLF, 2014, ANN SURG UNPUB; Moore L, 2014, ANN SURG, V260, P1121, DOI 10.1097/SLA.0000000000000648; Moore L, 2014, J TRAUMA ACUTE CARE, V77, P322, DOI 10.1097/TA.0000000000000366; Moore L, 2012, CRIT CARE, V16, DOI 10.1186/cc11680; Muehlschlegel S, 2013, NEUROCRIT CARE, V18, P318, DOI 10.1007/s12028-013-9817-2; O'Reilly GM, 2010, ACAD EMERG MED, V17, P1122, DOI 10.1111/j.1553-2712.2010.00887.x; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; sociaux Indeesees, 2012, SOC IND CAR HIST IMP, P85; sociaux MdlSedS, 2014, CADR NORM SYST INF R; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; TBI Statistics. Brain Trauma Foundation, 2014, TBI STAT; Tonidandel S, 2010, ORGAN RES METHODS, V13, P767, DOI 10.1177/1094428109341993; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Wanzel KR, 2000, CAN J SURG, V43, P113; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	46	13	15	2	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	OCT	2017	41						1	8		10.1016/j.jcrc.2017.04.031			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FM6YO	WOS:000415210400002	28477507				2022-02-06	
J	Samuelson, KW; Abadjian, L; Jordan, JT; Bartel, A; Vasterling, J; Seal, K				Samuelson, Kristin W.; Abadjian, Linda; Jordan, Joshua T.; Bartel, Alisa; Vasterling, Jennifer; Seal, Karen			The Association Between PTSD and Functional Outcome Is Mediated by Perception of Cognitive Problems Rather Than Objective Neuropsychological Test Performance	JOURNAL OF TRAUMATIC STRESS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; CROSS-VALIDATION; COMBAT VETERANS; SOCIAL SUPPORT; HEART-DISEASE; HEALTH SURVEY; SYMPTOMS; DEFICITS; SEVERITY	Posttraumatic stress disorder (PTSD) has been consistently linked to poorer functional outcomes, including quality of life, health problems, and social and occupational functioning. Less is known about the potential mechanisms by which PTSD leads to poorer functional outcomes. We hypothesized that neurocognitive functioning and perception of cognitive problems would both mediate the relationship between PTSD diagnosis and functioning. In a sample of 140 veterans of the recent wars and conflicts in Iraq and Afghanistan, we assessed PTSD symptoms, history of traumatic brain injury (TBI), depression, self-report measures of quality of life, social and occupational functioning, and reintegration to civilian life, as well as perception of cognitive problems. Veterans also completed a comprehensive neuropsychological battery of tests. Structural equation modeling revealed that perception of cognitive problems, but not objective neuropsychological performance, mediated the relationship between PTSD diagnosis and functional outcomes after controlling for TBI, depression, education, and a premorbid IQ estimate, b = -6.29, 95% bias-corrected bootstrapped confidence interval [-11.03, -2.88], showing a large effect size. These results highlight the importance of addressing appraisals of posttrauma cognitive functioning in treatment as a means of improving functional outcomes.	[Samuelson, Kristin W.; Bartel, Alisa] Univ Colorado, Dept Psychol, Colorado Springs, CO 80933 USA; [Abadjian, Linda; Seal, Karen] San Francisco VA Hlth Care Syst, Dept Mental Hlth, San Francisco, CA USA; [Jordan, Joshua T.] Alliant Int Univ, Dept Clin Psychol, San Francisco, CA USA; [Vasterling, Jennifer] VA Boston Hlth Care Syst, Natl Ctr PTSD, Boston, MA USA; [Vasterling, Jennifer] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Seal, Karen] Univ Calif San Francisco, Dept Med & Psychiat, San Francisco, CA 94143 USA		Samuelson, KW (corresponding author), Univ Colorado, 1420 Austin Bluffs Pkwy, Colorado Springs, CO 80918 USA.	ksamuel3@uccs.edu		Jordan, Joshua/0000-0001-7007-8098	Veterans Administration Health Services Research and Development Service ProgramUS Department of Veterans Affairs [SDR-08-408]	This work was supported by the Veterans Administration Health Services Research and Development Service Program (SDR-08-408).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Beckham JC, 1998, AM J PSYCHIAT, V155, P1565, DOI 10.1176/ajp.155.11.1565; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008; Binder LM, 1999, ARCH CLIN NEUROPSYCH, V14, P531, DOI 10.1016/S0887-6177(98)00047-X; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BLANCHARD EB, 1994, BEHAV RES THER, V32, P283, DOI 10.1016/0005-7967(94)90123-6; Boscarino JA, 2008, PSYCHOSOM MED, V70, P668, DOI 10.1097/PSY.0b013e31817bccaf; Brancu M, 2016, PSYCHOL TRAUMA-US, V8, P222, DOI 10.1037/tra0000078; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Buist-Bouwman MA, 2008, ACTA PSYCHIAT SCAND, V118, P451, DOI 10.1111/j.1600-0447.2008.01285.x; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Davis LW, 2016, PSYCHIAT RES, V237, P182, DOI 10.1016/j.psychres.2016.01.045; Delis DC., 2001, DELIS KAPLAN EXECUTI; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Department of Veterans Affairs Department of Defense, 2016, VADOD CLIN PRACTICE; Department of Veterans Affairs Department of Defense American Heart Association/American Stroke Association, 2010, VA DOD CLIN PRACT GU; Dobie DJ, 2004, ARCH INTERN MED, V164, P394, DOI 10.1001/archinte.164.4.394; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; First M., 1997, STRUCTURED CLIN INTE; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Geuze E, 2009, DEPRESS ANXIETY, V26, P7, DOI 10.1002/da.20476; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Holowka D. W., 2012, OXFORD HDB TRAUMATIC, P315; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ivanova JI, 2011, AM J MANAG CARE, V17, pE314; King PR, 2012, J CLIN PSYCHOL MED S, V19, P376, DOI 10.1007/s10880-012-9345-9; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P109, DOI 10.1001/archpsyc.64.1.109; Lee RSC, 2012, J AFFECT DISORDERS, V140, P113, DOI 10.1016/j.jad.2011.10.023; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Li J, 2015, PSYCHO-ONCOLOGY, V24, P676, DOI 10.1002/pon.3710; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; McCall WV, 2003, PSYCHIAT RES, V121, P179, DOI 10.1016/j.psychres.2003.09.003; McGarity S, 2017, J HEAD TRAUMA REHAB, V32, P34, DOI 10.1097/HTR.0000000000000242; McIntyre RS, 2013, DEPRESS ANXIETY, V30, P515, DOI 10.1002/da.22063; MCNALLY RJ, 1995, AM J PSYCHIAT, V152, P936; Norman SB, 2007, J NERV MENT DIS, V195, P48, DOI 10.1097/01.nmd.0000252135.25114.02; Pietrzak RH, 2009, DEPRESS ANXIETY, V26, P745, DOI 10.1002/da.20558; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Reitan RM, 1992, TRAIL MAKING TEST MA; Rey A., 1944, REY OSTERRIETH COMPL; Robinaugh DJ, 2011, J ANXIETY DISORD, V25, P1072, DOI 10.1016/j.janxdis.2011.07.004; Rodriguez P, 2012, J REHABIL RES DEV, V49, P649, DOI 10.1682/JRRD.2011.09.0162; RONALD MG, 1995, ARCH INTERN MED, V155, P262; Samuelson K., 2016, PSYCHOL TRAUMA-US, V5, P537; Samuelson KW, 2006, NEUROPSYCHOLOGY, V20, P716, DOI 10.1037/0894-4105.20.6.716; Sayer NA, 2014, SOC ISS POLICY REV, V8, P33, DOI 10.1111/sipr.12001; Sayer NA, 2011, J TRAUMA STRESS, V24, P660, DOI 10.1002/jts.20706; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stata Corporation, 2015, STAT STAT SOFTW REL STAT STAT SOFTW REL; Stein MB, 1997, AM J PSYCHIAT, V154, P1114; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tremont G, 1998, CLIN NEUROPSYCHOL, V12, P560, DOI 10.1076/clin.12.4.560.7238; Twamley EW, 2002, AM J PSYCHIAT, V159, P2013, DOI 10.1176/appi.ajp.159.12.2013; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vasterling JJ, 2008, J REHABIL RES DEV, V45, P347, DOI 10.1682/JRRD.2007.05.0077; Wechsler D., 2008, WAIS 4 WECHSLER ADUL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wolfe JW KR, 1996, MEASUREMENT STRESS T, P198; Wrocklage KM, 2016, J INT NEUROPSYCH SOC, V22, P399, DOI 10.1017/S1355617716000059	73	13	13	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	OCT	2017	30	5					521	530		10.1002/jts.22223			10	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	FL0RY	WOS:000413919700009	29030878				2022-02-06	
J	Warren, M; Subramani, K; Schwartz, R; Raju, R				Warren, Marie; Subramani, Kumar; Schwartz, Richard; Raju, Raghavan			Mitochondrial dysfunction in rat splenocytes following hemorrhagic shock	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Trauma; Hemorrhage; Shock; Mitochondrial function	TRAUMATIC BRAIN-INJURY; ACUTE LUNG INJURY; NF-KAPPA-B; INFLAMMATORY RESPONSE; STERILE INFLAMMATION; IMMUNE-RESPONSE; HYPOXIA; ACTIVATION; CELLS; HMGB1	The regulation of mitochondrial function is critical in cellular homeostasis following hemorrhagic shock. Hemorrhagic shock results in fluid loss and reduced availability of oxygen and nutrients to tissues. The spleen is a secondary lymphoid organ playing a key role in 'filtering the blood' and in the innate and adaptive immune responses. To understand the molecular basis of hemorrhagic shock, we investigated the changes in splenocyte mitochondrial respiration, and concomitant immune and metabolic alterations. The hemorrhagic injury (HI) in our rat model was induced by bleeding 60% of the total blood volume followed by resuscitation with Ringers lactate. Another group of animals was subjected to hemorrhage, but did not receive fluid resuscitation. Oxygen consumption rate of splenocytes were determined using a Seahorse analyzer. We found a significantly reduced oxygen consumption rate in splenocytes following HI compared to sham operated rats. The mitochondrial stress test revealed a decreased basal oxygen consumption rate, ATP production, maximal respiration and spare respiratory capacity. The mitochondrial membrane potential, and citrate synthase activity, were also reduced in the splenocytes following HI. Hypoxic response in the splenocyte was confirmed by increased gene expression of Hif1 alpha. Elevated level of mitochondrial stress protein, hsp60 and induction of high mobility group box1 protein (HMGB1) were observed in splenocytes following HI. An increased inflammatory response was demonstrated by significantly increased expression of IL-6, IFN-beta, Mip-1 alpha, IL-10 and NF kappa bp65. In summary, we conclude that splenocyte oxidative phosphorylation and metabolism were severely compromised following HI.	[Warren, Marie; Subramani, Kumar; Schwartz, Richard; Raju, Raghavan] Augusta Univ, CB 2601,Sanders Bldg,1460 Laney Walker Blvd, Augusta, GA 30912 USA		Raju, R (corresponding author), Augusta Univ, CB 2601,Sanders Bldg,1460 Laney Walker Blvd, Augusta, GA 30912 USA.	rraju@augusta.edu	Subramani, Kumar/AAM-6765-2020	Subramani, Kumar/0000-0002-8478-3625; Raju, Raghavan/0000-0002-4516-8654	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 GM101927, R01 GM122059]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM122059, R01GM101927] Funding Source: NIH RePORTER	Authors acknowledge the assistance of Sumin Lu in ATP and lactate determination. RR acknowledges the support of the National Institutes of Health (R01 GM101927 and R01 GM122059) and laboratory start up assistance from the Augusta University, Augusta, GA, USA.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Angele MK, 1999, AM J PHYSIOL-CELL PH, V276, pC145, DOI 10.1152/ajpcell.1999.276.1.C145; Antonelli M, 2007, CRIT CARE, V11, DOI 10.1186/cc6132; Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Ayala A, 2002, AM J PATHOL, V161, P2283, DOI 10.1016/S0002-9440(10)64504-X; AYALA A, 1991, AM J PHYSIOL, V260, pR167, DOI 10.1152/ajpregu.1991.260.1.R167; Ayub A, 2015, MOL MED, V21, P305, DOI 10.2119/molmed.2015.00013; Baker TA, 2012, CRIT CARE MED, V40, P876, DOI 10.1097/CCM.0b013e318232e314; Bakovic D, 2003, J APPL PHYSIOL, V95, P1460, DOI 10.1152/japplphysiol.00221.2003; Bartels K, 2013, P NATL ACAD SCI USA, V110, P18351, DOI 10.1073/pnas.1318345110; Betensley A, 2017, J CLIN MED, V6, DOI 10.3390/jcm6010002; Bhandari T, 2014, INFECT DIS THER, V3, P159, DOI 10.1007/s40121-014-0030-1; Bierly AL, 2008, J IMMUNOL, V181, P8485, DOI 10.4049/jimmunol.181.12.8485; Bursa F, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-11; Chen KB, 2012, J TRAUMA ACUTE CARE, V72, P660, DOI 10.1097/TA.0b013e3182318551; Choudhry MA, 2005, SHOCK, V24, P101, DOI 10.1097/01.shk.0000191341.31530.5e; Colgan SP, 2016, ANNU REV PATHOL-MECH, V11, P77, DOI 10.1146/annurev-pathol-012615-044231; Dobson GP, 2015, FRONT SURG, V2, DOI 10.3389/fsurg.2015.00043; Ham P.B., 2016, PROG NEUROBIOL; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hsieh CH, 2009, AM J PATHOL, V175, P1504, DOI 10.2353/ajpath.2009.081174; Hsieh YC, 2006, J MOL CELL CARDIOL, V41, P511, DOI 10.1016/j.yjmcc.2006.06.001; Hubbard WJ, 2004, SHOCK, V22, P395, DOI 10.1097/01.shk.0000143407.90473.cc; Jaffer U, 2010, HEART LUNG VESSEL, V2, P161; Jian BX, 2014, MOL MED, V20, P10, DOI 10.2119/molmed.2013.00077; Jian BX, 2008, BBA-MOL BASIS DIS, V1782, P621, DOI 10.1016/j.bbadis.2008.08.007; Kan WH, 2008, J APPL PHYSIOL, V105, P595, DOI 10.1152/japplphysiol.00012.2008; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Li YQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/523481; Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Lu SM, 2016, CYTOKINE, V81, P35, DOI 10.1016/j.cyto.2016.01.022; Luciano JA, 2015, SHOCK, V44, P149, DOI 10.1097/SHK.0000000000000412; McNamee EN, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf4630; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Molina PE, 2015, ALCOHOL RES-CURR REV, V37, P263; Molina PE, 2013, SHOCK, V39, P240, DOI 10.1097/SHK.0b013e318285b86d; Mommsen P, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/186709; Neeland IJ, 2017, METABOLISM, V67, P80, DOI 10.1016/j.metabol.2016.11.008; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Poulose N, 2014, AGING DIS, V5, P101, DOI 10.14336/AD.2014.0500101; Raymond S. L., 2017, BIOCH BIOPHYS ACTA; Rio D.C., 2010, COLD SPRING HARB PRO, V2010, ppdb.prot5439, DOI [10.1101/pdb.prot5439, DOI 10.1101/PDB.PROT5439]; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Shenkar R, 1996, AM J PHYSIOL-LUNG C, V270, pL729, DOI 10.1152/ajplung.1996.270.5.L729; Shoemaker W. C., 1988, CRIT CARE MED, V16; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sodhi CP, 2015, J IMMUNOL, V194, P4931, DOI 10.4049/jimmunol.1402490; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Subramani K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02495-5; Thiessen S. E., 2017, BIOCH BIOPHYS ACTA; Villarroel J. P., J TRAUMA ACUTE CARE, V75; Wang HC, 2014, EXPERT OPIN THER TAR, V18, P257, DOI 10.1517/14728222.2014.863876; Wang H, 2015, SHOCK, V44, P173, DOI 10.1097/SHK.0000000000000390; Wu RQ, 2006, CRIT CARE MED, V34, P1273, DOI 10.1097/01.CCM.0000208437.93725.18; Xu Lin, 2016, Med Sci Monit, V22, P2561; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907	60	13	16	1	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	1879-260X		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	OCT	2017	1863	10	B		SI		2526	2533		10.1016/j.bbadis.2017.08.024			8	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FN1VK	WOS:000415779100002	28844961	Green Accepted, Bronze			2022-02-06	
J	Ziebell, JM; Ray-Jones, H; Lifshitz, J				Ziebell, Jenna M.; Ray-Jones, Helen; Lifshitz, Jonathan			NOGO PRESENCE IS INVERSELY ASSOCIATED WITH SHIFTS IN CORTICAL MICROGLIAL MORPHOLOGY FOLLOWING EXPERIMENTAL DIFFUSE BRAIN INJURY	NEUROSCIENCE			English	Article						microglia; Nogo; traumatic brain injury; myelin; oligodendrocytes	AXONAL REGENERATION; IN-VITRO; RECEPTOR; CNS; DEGENERATION; MACROPHAGES; ACTIVATION; MICE; INFLAMMATION; INHIBITION	Diffuse traumatic brain injury (TBI) initiates secondary pathology, including inflammation and reduced myelination. Considering these injury-related pathologies, the many states of activated microglia as demonstrated by differing morphologies would form, migrate, and function in and through fields of growth-inhibitory myelin byproduct, specifically Nogo. Here we evaluate the relationship between inflammation and reduced myelin antigenicity in the wake of diffuse TBI and present the hypothesis that the Nogo-66 receptor antagonist peptide NEP(1-40) would reverse the injury-induced shift in distribution of microglia morphologies by limiting myelin-based inhibition. Adult male rats were subjected to midline fluid percussion sham or brain injury. At 2 h, 6 h, 1 d, 2 d, 7 d, and 21 d post injury, immunohistochemical staining was analyzed in sensory cortex (S1BF) for myelin antigens (myelin basic protein; MBP and CNPase), microglia morphology (ionized calcium-binding adapter protein; lba1), Nogo receptor and Nogo. Pronounced reduction in myelin antigenicity was evident transiently at 1 d post-injury, as evidenced by decreased MBP and CNPase staining, as well as loss of white matter organization, compared to sham and later injury time points. Concomitant with reduced myelin antigenicity, injury shifted microglia morphology from the predominantly ramified morphology observed in sham-injured cortex to hyper-ramified, activated, fully activated, or rod. Changes in microglial morphology were evident as early as 2 h post-injury, and remained at least until day 21. Additional cohorts of uninjured and brain-injured animals received vehicle or drug (NEP(1-40), i.p., 15 min and 19 h post-injury) and brains were collected at 2 h, 6 h, 1 d, 2 d, or 7 d post-injury. NEP(1-40) administration further shifted distributions of microglia away from an injury-induced activated morphology toward greater proportions of rod and macrophage-like morphologies compared to vehicle-treated. By 7 d post-injury, no differences in the distributions of microglia were noted between vehicle and NEP(1-40). This study begins to link secondary pathologies of white matter damage and inflammation after diffuse TBI. In the injured brain, secondary pathologies co-occur and likely interact, with consequences for neuronal circuit disruption leading to neurological symptoms. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.	[Ziebell, Jenna M.; Ray-Jones, Helen; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Ziebell, Jenna M.; Ray-Jones, Helen; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Lifshitz, Jonathan] VA Healthcare Syst, Phoenix, AZ USA; [Lifshitz, Jonathan] Arizona State Univ, Psychol, Tempe, AZ USA; [Ray-Jones, Helen] Univ Bath, Dept Biol & Biochem, Bath, Avon, England		Ziebell, JM (corresponding author), Univ Tasmania, Wicking Dementia Res & Educ Ctr, Private Bag 143, Hobart, Tas 7001, Australia.	Jenna.ziebell@gmail.com	Ziebell, Jenna/Y-4496-2019	Ziebell, Jenna/0000-0003-2497-4347	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065052]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065052] Funding Source: NIH RePORTER	The authors would like to thank Megan Evilsizor and Daniel Griffiths for surgical preparation of animals and tissue collection for this study, Anika Perdok for assistance with cell counts, Rachel K. Rowe, Ph.D. and Dr. M. Cristina Morganti-Kossmann for critical analysis of the manuscript. Research for this report was supported, in part, by National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01NS065052 and Mission Support from Phoenix Children's Hospital.	Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Batchelor PE, 1999, J NEUROSCI, V19, P1708; BROADWELL RD, 1982, SCIENCE, V217, P164, DOI 10.1126/science.7089551; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; David S, 2008, TRENDS NEUROSCI, V31, P221, DOI 10.1016/j.tins.2008.02.002; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Fry EJ, 2007, NEURON, V53, P649, DOI 10.1016/j.neuron.2007.02.009; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Hanisch UK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00065; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nissl F., 1899, ARCH PSYCHIAT, V32, P656; Pernet V, 2008, J NEUROSCI, V28, P7435, DOI 10.1523/JNEUROSCI.0727-08.2008; Perry VH, 2010, ASN NEURO, V2, P281, DOI 10.1042/AN20100024; Satoh JI, 2005, J NEUROPATH EXP NEUR, V64, P129, DOI 10.1093/jnen/64.2.129; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Tanaka T, 2009, J BIOL CHEM, V284, P21626, DOI 10.1074/jbc.M109.005603; Taylor SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097096; Tong J, 2013, J NEUROTRAUM, V30, P247, DOI 10.1089/neu.2012.2493; Tremblay ME, 2011, NEURON GLIA BIOL, V7, P67, DOI 10.1017/S1740925X12000038; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Tremblay Marie-Eve, 2011, Commun Integr Biol, V4, P220, DOI 10.4161/cib.4.2.14506; Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007; Wang F, 2012, BRAIN RES, V1469, P153, DOI 10.1016/j.brainres.2012.06.040; Wierzba-Bobrowicz T, 2002, FOLIA NEUROPATHOL, V40, P125; WILLIAMS K, 1994, J NEUROSCI RES, V38, P433, DOI 10.1002/jnr.490380409; Yan J, 2012, J NEUROCHEM, V120, P721, DOI 10.1111/j.1471-4159.2011.07619.x; Ziebell JM, 2015, METAB BRAIN DIS, V30, P393, DOI 10.1007/s11011-014-9539-y; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	47	13	13	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	SEP 17	2017	359						209	223		10.1016/j.neuroscience.2017.07.027			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FE7QD	WOS:000408401100019	28736137	Green Accepted			2022-02-06	
J	Liang, DY; Shi, XY; Liu, P; Sun, Y; Sahbaie, P; Li, WW; Yeomans, DC; Clark, JD				Liang, De-Yong; Shi, Xiaoyou; Liu, Peng; Sun, Yuan; Sahbaie, Peyman; Li, Wen-Wu; Yeomans, David C.; Clark, J. David			The Chemokine Receptor CXCR2 Supports Nociceptive Sensitization after Traumatic Brain Injury	MOLECULAR PAIN			English	Article						Traumatic Brain Injury; CXCR2; Histone acetyltransferase; Anarcardic acid; Chronic pain	SPINAL-CORD ASTROCYTES; BONE CANCER PAIN; NEUROPATHIC PAIN; UP-REGULATION; EPIGENETIC REGULATION; INFLAMMATORY PAIN; NERVE INJURY; RAT MODEL; CXCL1; MICE	Chronic pain after traumatic brain injury (TBI) is very common, but the mechanisms linking TBI to pain and the pain-related interactions of TBI with peripheral injuries are poorly understood. Chemokine receptors play an important role in both pain and brain injury. In the current work we pursued the hypothesis that the epigenetically-regulated CXC chemokine receptor 2 (CXCR2) is a crucial modulator of nociceptive sensitization induced by TBI. For these studies we used the rat lateral fluid percussion model of TBI. Histone actyltransferase activity was blocked using anacardic acid beginning immediately following injury, or delayed for 7 days prior to administration. The selective CXCR2 antagonist SCH527123 administered systemically or intrathecally was used to probe the role of chemokine signaling on mechanical hindpaw sensitization after TBI. The expression of the CXCR2 receptor was accomplished using real-time PCR, immunohistochemistry and Western blotting, while epigenetic regulation was assessed using chromatin immunoprecipitation assay. The spinal levels of several pain-related mediators including CXCL1, an endogenous ligand for CXCR2, as well as BDNF and PDYN were measured by ELISA. We observed that anacardic acid potently blocked and reversed mechanical hindpaw sensitization after TBI. The same drug was able to prevent the up-regulation of CXCR2 after TBI, but did not affect the spinal expression of other pain mediators. On the other hand, both systemically and intrathecally administered SCH527123 reversed hindpaw allodynia after TBI. Most of the spinal CXCR2 appeared to be expressed by spinal cord neurons. Chromatin immunoprecipitation experiments demonstrated TBI-enhanced association of the CXCR2 promoter with acetylated-H3K9 histone protein that was also reversible using anacardic acid. Taken together, our findings suggested that TBI causes the up-regulation of spinal CXCR2 through an epigenetic mechanism ultimately supporting nociceptive sensitization. The use of CXCR2 antagonists may, therefore, be useful in pain resulting from TBI.	[Liang, De-Yong; Sun, Yuan; Sahbaie, Peyman; Clark, J. David] Vet Affairs Palo Alto Hlth Care Syst, Dept Anesthesiol, Palo Alto, CA USA; [Liang, De-Yong; Shi, Xiaoyou; Liu, Peng; Sun, Yuan; Sahbaie, Peyman; Li, Wen-Wu; Yeomans, David C.; Clark, J. David] Stanford Univ, Dept Anesthesiol Pain & Perioperat Med, Sch Med, Stanford, CA 94305 USA; [Liang, De-Yong; Clark, J. David] Stanford Univ, Sch Med, Stanford, CA 94305 USA		Liang, DY (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.				DOD CDMRP award [MR130295]; VA Merit Review GrantUS Department of Veterans Affairs [1I01RX001776]; Veterans AffairsUS Department of Veterans Affairs [I01RX001776] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the DOD CDMRP award MR130295 and VA Merit Review Grant 1I01RX001776 to JDC.	Bose P, 2013, J NEUROTRAUM, V30, P1177, DOI 10.1089/neu.2012.2740; Boyer N, 2014, PAIN, V155, P1196, DOI 10.1016/j.pain.2014.03.001; Cao DL, 2016, BRAIN RES BULL, V127, P219, DOI 10.1016/j.brainresbull.2016.09.016; Cao DL, 2014, EXP NEUROL, V261, P328, DOI 10.1016/j.expneurol.2014.05.014; Chen G, 2014, BRAIN, V137, P2193, DOI 10.1093/brain/awu140; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; De Felice M, 2016, PAIN MANAG, V6, P111, DOI 10.2217/pmt.15.63; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Guo TZ, 2004, PAIN, V108, P95, DOI 10.1016/j.pain.2003.12.010; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Holz O, 2010, EUR RESPIR J, V35, P564, DOI 10.1183/09031936.00048509; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004017; Kiguchi N, 2013, CYTOKINE, V64, P666, DOI 10.1016/j.cyto.2013.09.019; Kiguchi N, 2012, J PHARMACOL EXP THER, V340, P577, DOI 10.1124/jpet.111.187724; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liang DY, 2017, IBRO REP, V2, P14, DOI 10.1016/j.ibror.2016.12.001; Liang DY, 2013, J PAIN, V14, P36, DOI 10.1016/j.jpain.2012.10.005; Ling G.S., 2004, CURR PROTOC NEUROSCI, V9, pUnit; Luo Y, 2000, J IMMUNOL, V165, P4015, DOI 10.4049/jimmunol.165.7.4015; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ning Y, 2012, MOL CANCER THER, V11, P1353, DOI 10.1158/1535-7163.MCT-11-0915; OSSIPOV MH, 1985, BRAIN RES, V341, P320, DOI 10.1016/0006-8993(85)91071-6; Otto VI, 2001, NEUROREPORT, V12, P2059, DOI 10.1097/00001756-200107030-00053; Poree LR, 1998, ANESTH ANALG, V87, P941, DOI 10.1097/00000539-199810000-00037; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Strigo IA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.116; Sun Y, 2014, J PAIN, V15, P856, DOI 10.1016/j.jpain.2014.05.003; Sun Y, 2013, ANESTHESIOLOGY, V119, P1198, DOI 10.1097/ALN.0b013e31829ce340; Ucal M, 2017, J NEUROTRAUM, V34, P475, DOI 10.1089/neu.2016.4411; Valles A, 2006, NEUROBIOL DIS, V22, P312, DOI 10.1016/j.nbd.2005.11.015; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; Xu J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-38; Yang LH, 2016, NEUROSCI LETT, V626, P135, DOI 10.1016/j.neulet.2015.12.044; Zhang ZJ, 2013, PAIN, V154, P2185, DOI 10.1016/j.pain.2013.07.002; Zhou XR, 2007, IMMUNOLOGY, V122, P476, DOI 10.1111/j.1365-2567.2007.02674.x; Zhou YQ, 2015, CURR PHARM DESIGN, V21, P5029, DOI 10.2174/1381612821666150831141931	46	13	13	1	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1744-8069			MOL PAIN	Mol. Pain	SEP 8	2017	13								1744806917730212	10.1177/1744806917730212			37	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FF0RO	WOS:000408609000001	28845733	Green Published, gold			2022-02-06	
J	Dalise, S; Cavalli, L; Ghuman, H; Wahlberg, B; Gerwig, M; Chisari, C; Ambrosio, F; Modo, M				Dalise, Stefania; Cavalli, Loredana; Ghuman, Harmanvir; Wahlberg, Brendon; Gerwig, Madeline; Chisari, Carmelo; Ambrosio, Fabrisia; Modo, Michel			Biological effects of dosing aerobic exercise and neuromuscular electrical stimulation in rats	SCIENTIFIC REPORTS			English	Article							GROWTH-FACTOR-I; TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; PHYSICAL-EXERCISE; CLINICAL-PRACTICE; CHRONIC STROKE; ANIMAL-MODELS; KLOTHO; REHABILITATION; PERSPECTIVES	Aerobic exercise (AE) and non-aerobic neuromuscular electric stimulation (NMES) are common interventions used in physical therapy. We explored the dose-dependency (low, medium, high) of these interventions on biochemical factors, such as brain derived neurotrophic growth factor (BDNF), vascular endothelial growth factor-A (VEGF-A), insulin-like growth factor-1 (IGF-1) and Klotho, in the blood and brain of normal rats, as well as a treadmill-based maximum capacity test (MCT). A medium dose of AE produced the most improvement in MCT with dose-dependent changes in Klotho in the blood. A dose-dependent increase of BDNF was evident following completion of an NMES protocol, but there was no improvement in MCT performance. Gene expression in the hippocampus was increased after both AE and NMES, with IGF-1 being a signaling molecule that correlated with MCT performance in the AE conditions, but also highly correlated with VEGF-A and Klotho. Blood Klotho levels can serve as a biomarker of therapeutic dosing of AE, whereas IGF-1 is a key molecule coupled to gene expression of other molecules in the hippocampus. This approach provides a translatable paradigm to investigate the mode and mechanism of action of interventions employed in physical therapy that can improve our understanding of how these factors change under pathological conditions.	[Dalise, Stefania; Cavalli, Loredana; Ghuman, Harmanvir; Ambrosio, Fabrisia; Modo, Michel] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15261 USA; [Ghuman, Harmanvir; Ambrosio, Fabrisia; Modo, Michel] Dept Bioengn, Pittsburgh, PA USA; [Wahlberg, Brendon; Modo, Michel] Dept Radiol, Pittsburgh, PA USA; [Gerwig, Madeline] Dept Neurosci, Pittsburgh, PA USA; [Ambrosio, Fabrisia] Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Dalise, Stefania; Cavalli, Loredana; Chisari, Carmelo] Univ Hosp Pisa, Dept Neurosci, Unit Neurorehabil, Pisa, Italy		Modo, M (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15261 USA.; Modo, M (corresponding author), Dept Bioengn, Pittsburgh, PA USA.; Modo, M (corresponding author), Dept Radiol, Pittsburgh, PA USA.	mmm154@pitt.edu	Dalise, Stefania/K-8940-2016	Ghuman, Harmanvir/0000-0002-9123-7796; Dalise, Stefania/0000-0002-1422-1539; Cavalli, Loredana/0000-0003-4075-933X; Modo, Michel/0000-0003-4436-735X	Alliance for Regenerative Rehabilitation Research & Training (AR3T); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health; National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health; National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P2CHD086843, R56AG052978]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P2CHD086843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R56AG052978] Funding Source: NIH RePORTER	This research received funding from the Alliance for Regenerative Rehabilitation Research & Training (AR3T), which is supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Neurological Disorders and Stroke (NINDS), and National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health under Award Number P2CHD086843 and R56AG052978. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AMBROSIO F, 2012, JOVE J VIS EXP MAY, DOI DOI 10.3791/3914; Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Avin KG, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00189; Banerjee P, 2005, J APPL PHYSIOL, V99, P2307, DOI 10.1152/japplphysiol.00891.2004; Banja JD, 2013, ARCH PHYS MED REHAB, V94, pS55, DOI 10.1016/j.apmr.2012.08.218; Barha CK, 2017, FRONT NEUROENDOCRIN, V46, P86, DOI 10.1016/j.yfrne.2017.06.001; Beck W, 2013, ACTA PHYSIOL HUNG, V100, P427, DOI 10.1556/APhysiol.100.2013.013; Bedrosian TA, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.262; Bertani S, 2010, IN VIVO, V24, P827; Bian A, 2015, CLIN INTERV AGING, V10, P1233, DOI 10.2147/CIA.S84978; Brito VWH, 2014, BRAZ J BIOL, V74, P444, DOI 10.1590/1519-6984.07912; BRUCE RA, 1949, J CLIN INVEST, V28, P1423, DOI 10.1172/JCI102207; Carpenter TO, 2010, J CLIN ENDOCR METAB, V95, pE352, DOI 10.1210/jc.2010-0589; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; Cauraugh JH, 2003, J NEUROL NEUROSUR PS, V74, P1562, DOI 10.1136/jnnp.74.11.1562; Cotman CW, 2007, ALZHEIMERS DEMENT, V3, pS30, DOI 10.1016/j.jalz.2007.01.013; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Crognale D, 2013, J STRENGTH COND RES, V27, P208, DOI 10.1519/JSC.0b013e318252f5e5; Crowe Louis, 2011, BMJ Case Rep, V2011, DOI 10.1136/bcr.06.2011.4343; Dijkers M. P. J. M, 2011, FOCUS TECHNICAL BRIE, V33, P1; Distefano G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054922; Dobkin BH, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0331-y; English AW, 2011, ANN ANAT, V193, P354, DOI 10.1016/j.aanat.2011.02.013; FARRELL PA, 1979, MED SCI SPORT EXER, V11, P338; Foster Philip P, 2011, Front Neurol, V2, P28, DOI 10.3389/fneur.2011.00028; Fujiwara T., 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/2350137; Gappmaier Eduard, 2012, Cardiopulm Phys Ther J, V23, P19; Gordon T, 2016, EUR J NEUROSCI, V43, P336, DOI 10.1111/ejn.13005; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; Gregory SM, 2013, MED SCI SPORT EXER, V45, P420, DOI 10.1249/MSS.0b013e3182750bd4; Hasan SMM, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2961573; Hiatt WR, 2014, CIRCULATION, V130, P69, DOI 10.1161/CIRCULATIONAHA.113.007003; Ho CH, 2014, PHYS MED REH CLIN N, V25, P631, DOI 10.1016/j.pmr.2014.05.001; Jensen CS, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00187; Jones AM, 2017, SPORTS MED, V47, pS65, DOI 10.1007/s40279-017-0688-0; Kanchiku T, 2008, J NEUROSCI METH, V167, P317, DOI 10.1016/j.jneumeth.2007.08.002; Kaplan SL, 2013, PEDIATR PHYS THER, V25, P257, DOI 10.1097/PEP.0b013e31829491c5; Kozlowski DA, 2013, COMPR PHYSIOL, V3, P121, DOI 10.1002/cphy.c110005; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Leclerc K, 2017, CLEV CLIN J MED, V84, P161, DOI 10.3949/ccjm.84a.15013; Lou JWH, 2017, MUSCLE NERVE, V55, P179, DOI 10.1002/mus.25224; Maass A, 2016, NEUROIMAGE, V131, P142, DOI 10.1016/j.neuroimage.2015.10.084; MacLellan CL, 2011, NEUROREHAB NEURAL RE, V25, P740, DOI 10.1177/1545968311407517; Machado FSM, 2015, PHYSIOL BEHAV, V140, P8, DOI 10.1016/j.physbeh.2014.11.069; Margonis K, 2007, FREE RADICAL BIO MED, V43, P901, DOI 10.1016/j.freeradbiomed.2007.05.022; Matsubara T, 2014, AM J PHYSIOL-HEART C, V306, pH348, DOI 10.1152/ajpheart.00429.2013; Mostafidi E., 2016, NEPHROUROL MON, V8, DOI [10.5812/numonthly.30245, DOI 10.5812/NUMONTHLY]; Noble GK, 2007, J ANIM SCI, V85, P163, DOI 10.2527/jas.2006-210; Oborn E, 2012, CURR OPIN NEUROL, V25, P676, DOI 10.1097/WCO.0b013e32835a35f2; Palacios G, 2015, NUTR HOSP, V31, P237, DOI 10.3305/nh.2015.31.sup3.8771; Pereira S, 2012, TOP STROKE REHABIL, V19, P491, DOI 10.1310/tsr1906-491; Peterson AB, 2014, PSYCHOPHARMACOLOGY, V231, P2661, DOI 10.1007/s00213-014-3437-1; Rodrigues B, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-38; Roedel A, 2006, LAB ANIM-UK, V40, P371, DOI 10.1258/002367706778476343; Santos-Dias A, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-096139; Sarma S, 2016, CARDIOL CLIN, V34, P603, DOI 10.1016/j.ccl.2016.06.009; Smith EJ, 2012, STEM CELLS, V30, P785, DOI 10.1002/stem.1024; Stein C, 2015, STROKE, V46, P2197, DOI 10.1161/STROKEAHA.115.009633; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Teilmann AC, 2014, LAB ANIM-UK, V48, P278, DOI 10.1177/0023677214541438; Thomas AG, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00086; Toft MF, 2006, LAB ANIM-UK, V40, P261, DOI 10.1258/002367706777611433; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; Villeda SA, 2013, AUTOIMMUN REV, V12, P674, DOI 10.1016/j.autrev.2012.10.014; Wasfy MM, 2016, CIRCULATION, V133, P2297, DOI 10.1161/CIRCULATIONAHA.116.018093; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Zoladz JA, 2010, J PHYSIOL PHARMACOL, V61, P533	67	13	14	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 7	2017	7								10830	10.1038/s41598-017-11260-7			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG1NC	WOS:000409561800081	28883534	Green Published, gold			2022-02-06	
J	El-Dessouki, AM; Galal, MA; Awad, AS; Zaki, HF				El-Dessouki, Ahmed M.; Galal, Mai A.; Awad, Azza S.; Zaki, Hala F.			Neuroprotective Effects of Simvastatin and Cilostazol in L-Methionine-Induced Vascular Dementia in Rats	MOLECULAR NEUROBIOLOGY			English	Article						Vascular dementia; L-methionine; Simvastatin; Cilostazol; Oxidative stress; Acetylcholinesterase	FOCAL CEREBRAL-ISCHEMIA; NF-KAPPA-B; TRAUMATIC BRAIN-INJURY; SMOOTH-MUSCLE-CELLS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; BLOOD-FLOW; CEREBROVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; CEREBROSPINAL-FLUID	Vascular dementia (VaD) is a degenerative cerebrovascular disorder that leads to progressive decline in cognitive abilities and memory. Several reports demonstrated that oxidative stress and endothelial dysfunction are principal pathogenic factors in VaD. The present study was constructed to determine the possible neuroprotective effects of simvastatin in comparison with cilostazol in VaD induced by l-methionine in rats. Male Wistar rats were divided into four groups. Group I (control group), group II received l-methionine (1.7 g/kg, p.o.) for 32 days. The remaining two groups received simvastatin (50 mg/kg, p.o.) and cilostazol (100 mg/kg, p.o.), respectively, for 32 days after induction of VaD by l-methionine. Subsequently, rats were tested for cognitive performance using Morris water maze test then sacrificed for biochemical and histopathological assays. l-methionine induced VaD reflected by alterations in rats' behavior as well as the estimated neurotransmitters, acetylcholinesterase activity as well as increased brain oxidative stress and inflammation parallel to histopathological changes in brain tissue. Treatment of rats with simvastatin ameliorated l-methionine-induced behavioral, neurochemical, and histological changes in a manner comparable to cilostazol. Simvastatin may be regarded as a potential therapeutic strategy for the treatment of VaD. To the best of our knowledge, this is the first study to reveal the neuroprotective effects of simvastatin or cilostazol in l-methionine-induced VaD.	[Galal, Mai A.; Zaki, Hala F.] Cairo Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo 11562, Egypt; [El-Dessouki, Ahmed M.; Awad, Azza S.] Ahram Canadian Univ, Dept Pharmacol & Toxicol, Fac Pharm, 6 October,4th Ind Area, Giza 12566, Egypt		El-Dessouki, AM; Awad, AS (corresponding author), Ahram Canadian Univ, Dept Pharmacol & Toxicol, Fac Pharm, 6 October,4th Ind Area, Giza 12566, Egypt.	a_desoky88@yahoo.com; azza_mohie@hotmail.com; halafzaki@gmail.com		Zaki, Hala/0000-0001-9026-4015			Abbas AM, 2013, J PHYSIOL BIOCHEM, V69, P737, DOI 10.1007/s13105-013-0250-y; Akyol S, 2014, REDOX REP, V19, P180, DOI 10.1179/1351000214Y.0000000094; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Allard P, 1999, DEMENT GERIATR COGN, V10, P77, DOI 10.1159/000017105; Arai H, 2009, AM J GERIAT PSYCHIAT, V17, P353, DOI 10.1097/JGP.0b013e31819431ea; ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43; Association AD, 2014, PER ART DIS PEOPL DI; Aviles H, 2005, NEUROIMMUNOMODULAT, V12, P173, DOI 10.1159/000084850; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Burn DJ, 2014, NONMOTOR SYMPTOMS PA, V158; Cervellati C, 2014, J NEUROL SCI, V337, P156, DOI 10.1016/j.jns.2013.11.041; Chen CT, 2014, J CEREBR BLOOD F MET, V34, P376, DOI 10.1038/jcbfm.2013.221; Chen F, 1999, CLIN CHEM, V45, P7; Choi JM, 2002, J PHARMACOL EXP THER, V300, P787, DOI 10.1124/jpet.300.3.787; Cimino A, 2005, NEUROTOXICOLOGY, V26, P929, DOI 10.1016/j.neuro.2005.03.009; Cui X, 2009, NEUROSCIENCE, V159, P744, DOI 10.1016/j.neuroscience.2008.12.055; Dai XM, 2010, CIRC RES, V106, P1870, DOI 10.1161/CIRCRESAHA.109.212746; DENBLAAUWEN DH, 1983, J CLIN CHEM CLIN BIO, V21, P381; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Duron E, 2008, VASC HEALTH RISK MAN, V4, P363; Elliott MS, 2009, BRAIN; Elrod R, 1997, AM J PSYCHIAT, V154, P25; Eskdale J, 1997, IMMUNOGENETICS, V46, P120, DOI 10.1007/s002510050250; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Frick M, 2003, ATHEROSCLEROSIS, V170, P229, DOI 10.1016/S0021-9150(03)00299-5; Frisardi V, 2010, AGEING RES REV, V9, P399, DOI 10.1016/j.arr.2010.04.007; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Gupta S, 2014, EUR J PHARMACOL, V723, P80, DOI 10.1016/j.ejphar.2013.12.003; Hase Y, 2012, EXP NEUROL, V233, P523, DOI 10.1016/j.expneurol.2011.11.038; Hiramatsu M, 2010, BRIT J PHARMACOL, V161, P1899, DOI 10.1111/j.1476-5381.2010.01014.x; Ho PI, 2001, J NEUROCHEM, V78, P249, DOI 10.1046/j.1471-4159.2001.00384.x; Honda F, 2006, STROKE, V37, P223, DOI 10.1161/01.STR.0000196977.76702.6d; Jasinska M, 2007, PHARMACOL REP, V59, P483; Jefferies H, 2003, ANZ J SURG, V73, P517, DOI 10.1046/j.1445-1433.2003.02682.x; Jeynes B, 2009, NEUROSCI LETT, V463, P244, DOI 10.1016/j.neulet.2009.07.091; Keil U, 2004, POL J PHARMACOL, V56, P631; Kepe V, 2006, P NATL ACAD SCI USA, V103, P702, DOI 10.1073/pnas.0510237103; Kim KY, 2002, J PHARMACOL EXP THER, V300, P709, DOI 10.1124/jpet.300.2.709; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Kou JH, 2010, BRAIN RES, V1356, P102, DOI 10.1016/j.brainres.2010.07.102; Lee JH, 2006, BRAIN RES, V1082, P182, DOI 10.1016/j.brainres.2006.01.088; Lee JH, 2003, BRAIN RES, V994, P91, DOI 10.1016/j.brainres.2003.09.021; Leeson CPM, 2002, CIRC RES, V90, P1153, DOI 10.1161/01.RES.0000020562.07492.D4; Margaritis M, 2014, ANTIOXID REDOX SIGN, V20, P1198, DOI 10.1089/ars.2013.5430; Mathew JS, 2001, J VET DIAGN INVEST, V13, P17, DOI 10.1177/104063870101300104; McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903; Mendoza-Oliva A, 2013, CNS NEUROL DISORD-DR, V12, P842, DOI 10.2174/18715273113129990083; Moreira ELG, 2015, DIET NUTR DEMENTIA C, P743; Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088; Parle M., 2004, Asia Pacific Journal of Pharmacology, V16, P101; Perna AF, 2003, AMINO ACIDS, V25, P409, DOI 10.1007/s00726-003-0026-8; Qi XF, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.44; Rauch BJ, 2014, MOL MICROBIOL, V94, P1330, DOI 10.1111/mmi.12832; Reischl S, 2014, INHIBITION HIF PROLY; Saito S, 2014, HEPATOL RES, V44, P460, DOI 10.1111/hepr.12140; Sakurai H, 2013, GERIATR GERONTOL INT, V13, P90, DOI 10.1111/j.1447-0594.2012.00866.x; Sato A, 2004, NEUROSCI LETT, V361, P90, DOI 10.1016/j.neulet.2004.01.004; Sato A, 2001, INT J DEV NEUROSCI, V19, P327, DOI 10.1016/S0736-5748(01)00017-X; Shabanzadeh AP, 2005, BRAIN RES, V1042, P1, DOI 10.1016/j.brainres.2005.01.105; Sharma B, 2012, PROG NEURO-PSYCHOPH, V38, P207, DOI 10.1016/j.pnpbp.2012.03.013; Simard M, 2015, J NEUROPSYCHIATRY CL; Song GH, 2005, NEUROGASTROENT MOTIL, V17, P744, DOI 10.1111/j.1365-2982.2005.00653.x; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tan XL, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0020-0; Toda Y, 2014, NEUROL RES, V36, P1011, DOI 10.1179/1743132814Y.0000000389; TOHGI H, 1992, J NEURAL TRANSM-PARK, V4, P69, DOI 10.1007/BF02257623; Tong XK, 2015, J CEREBR BLOOD F MET, V35, P512, DOI 10.1038/jcbfm.2014.226; Tramontina AC, 2011, J NEURAL TRANSM, V118, P1641, DOI 10.1007/s00702-011-0680-z; Ullrich C, 2010, MOL CELL NEUROSCI, V45, P408, DOI 10.1016/j.mcn.2010.08.001; Ungureanu Didona, 2003, Rev Med Chir Soc Med Nat Iasi, V107, P66; Venihaki M, 2001, J CLIN INVEST, V108, P1159, DOI 10.1172/JCI12869; Wang KW, 2014, ANN CLIN LAB SCI, V44, P145; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Wang X, 2012, J MOL CELL CARDIOL, V52, P753, DOI 10.1016/j.yjmcc.2011.12.009; Yuzawa Izumi, 2008, J Stroke Cerebrovasc Dis, V17, P281, DOI 10.1016/j.jstrokecerebrovasdis.2008.03.007; Zhang L, 2006, CELL BIOL INT, V30, P592, DOI 10.1016/j.cellbi.2006.03.007	77	13	13	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	SEP	2017	54	7					5074	5084		10.1007/s12035-016-0051-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC0BO	WOS:000406503500019	27544235				2022-02-06	
J	Fuentes, MM; Thompson, L; Quistberg, A; Haaland, WL; Rhodes, K; Kartin, D; Kerfeld, C; Apkon, S; Rowhani-Rahbar, A; Rivara, FP				Fuentes, Molly M.; Thompson, Leah; Quistberg, Alex; Haaland, Wren L.; Rhodes, Karin; Kartin, Deborah; Kerfeld, Cheryl.; Apkon, Susan; Rowhani-Rahbar, Ali; Rivara, Frederick P.			Auditing Access to Outpatient Rehabilitation Services for Children With Traumatic Brain Injury and Public Insurance in Washington State	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Disabled children; Health equity; Health services accessibility; Health services for persons with disabilities; Rehabilitation	SPECIALTY CARE; OUTCOMES	Objective: To identify insurance-based disparities in access to outpatient pediatric neurorehabilitation services. Design: Audit study with paired calls, where callers posed as a mother seeking services for a simulated child with history of severe traumatic brain injury and public or private insurance. Setting: Outpatient rehabilitation clinics. Participants: Sample of rehabilitation clinics (N = 287): 195 physical therapy (PT) clinics, 109 occupational therapy (OT) clinics, 102 speech therapy (ST) clinics, and 11 rehabilitation medicine clinics. Interventions: Not applicable. Main Outcome Measures: Acceptance of public insurance and the number of business days until the next available appointment. Results: Therapy clinics were more likely to accept private insurance than public insurance (relative risk [RR] for PT clinics, 1.33; 95% confidence interval [CI], 1.22-1.44; RR for OT clinics, 1.40; 95% CI, 1.24-1.57; and RR for ST clinics, 1.42; 95% CI, 1.25-1.62), with no significant difference for rehabilitation medicine clinics (RR, 1.10; 95% CI, 0.90-1.34). The difference in median wait time between clinics that accepted public insurance and those accepting only private insurance was 4 business days for PT clinics and 15 days for ST clinics (P <=.001), but the median wait time was not significantly different for OT clinics or rehabilitation medicine clinics. When adjusting for urban and multidisciplinary clinic statuses, the wait time at clinics accepting public insurance was 59% longer for PT (95% CI, 39%-81%), 18% longer for OT (95% CI, 7%-30%), and 107% longer for ST (95% CI, 87%-130%) than that at clinics accepting only private insurance. Distance to clinics varied by discipline and area within the state. Conclusions: Therapy clinics were less likely to accept public insurance than private insurance. Therapy clinics accepting public insurance had longer wait times than did clinics that accepted only private insurance. Rehabilitation professionals should attempt to implement policy and practice changes to promote equitable access to care. (C) 2017 by the American Congress of Rehabilitation Medicine.	[Fuentes, Molly M.; Kartin, Deborah; Kerfeld, Cheryl.; Apkon, Susan] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; [Fuentes, Molly M.; Thompson, Leah; Haaland, Wren L.; Rivara, Frederick P.] Seattle Childrens Res Inst, POB 5371,M-S CW8, Seattle, WA 98145 USA; [Fuentes, Molly M.; Quistberg, Alex; Rowhani-Rahbar, Ali; Rivara, Frederick P.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Rhodes, Karin] Hofstra Northwell Sch Med, Off Populat Hlth, Great Neck, NY USA; [Rowhani-Rahbar, Ali; Rivara, Frederick P.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA		Fuentes, MM (corresponding author), Seattle Childrens Res Inst, POB 5371,M-S CW8, Seattle, WA 98145 USA.	molly.fuentes@seattlechildrens.org		Quistberg, Alex/0000-0001-9730-2686; Rowhani-Rahbar, Ali/0000-0002-2705-4485; Fuentes, Molly/0000-0001-8971-228X	Seattle Sports Concussion Research Collaborative; Satterberg Foundation; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5T32HD057822-05]; National Center For Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL I TR000423]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822, K12HD001097] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000423, UL1TR002319] Funding Source: NIH RePORTER	Supported by the Seattle Sports Concussion Research Collaborative, the Satterberg Foundation, the National Institute of Child Health and Human Development (grant no. 5T32HD057822-05), and the National Center For Advancing Translational Sciences of the National Institutes of Health (grant no. UL I TR000423). The funding agencies had no involvement in any phase of study conduct. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2010, EXC PART MICR OFF PR; Bisgaier J, 2012, ARCH PEDIAT ADOL MED, V166, P304, DOI 10.1001/archpediatrics.2011.1158; Bisgaier J, 2011, NEW ENGL J MED, V364, P2324, DOI 10.1056/NEJMsa1013285; Chaudhry SB, 2013, J AM ACAD DERMATOL, V68, P738, DOI 10.1016/j.jaad.2012.10.034; Faul M, 2010, TRAUMATIC BRAIN INJU; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Kaiser Family Foundation, STAT HLTH FACTS HLTH; Medicaid and CHIP Payment and Access Commission, 2015, CHILD ENR CHIP MED S; Medicaid and CHIP Payment and Access Commission, 2016, MED CHIP INC EL LEV; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; Penn EB, 2012, INT J PEDIATR OTORHI, V76, P1671, DOI 10.1016/j.ijporl.2012.08.002; Schiraldi M, 2015, J NEUROL SURG PART A, V76, P224, DOI 10.1055/s-0034-1543958; Schneider A., GPS VISUALIZERS ADDR; Skinner AC, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-194; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; U.S. Census Bureau, TIGER LIN SHAP TIGER; United States Department of Agriculture Economic Research Service, URB INFL COD; Washington State Department of Transportation, WSDOT GEODATA DISTR; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	19	13	13	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2017	98	9					1763	1770		10.1016/j.apmr.2016.12.013			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	FG8XB	WOS:000410720000005	28126353	Green Accepted			2022-02-06	
J	Hahn-Markowitz, J; Berger, I; Manor, I; Maeir, A				Hahn-Markowitz, Jeri; Berger, Itai; Manor, Iris; Maeir, Adina			Impact of the Cognitive-Functional (Cog-Fun) Intervention on Executive Functions and Participation Among Children With Attention Deficit Hyperactivity Disorder: A Randomized Controlled Trial	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article							TRAUMATIC BRAIN-INJURY; DEFICIT/HYPERACTIVITY DISORDER; ADHD; ADULTS	OBJECTIVE. We examined the effect of the Cognitive-Functional (Cog-Fun) occupational therapy intervention on executive functions and participation among children with attention deficit hyperactivity disorder (ADHD). METHOD. We used a randomized, controlled study with a crossover design. One hundred and seven children age 7-10 yr diagnosed with ADHD were allocated to treatment or wait-list control group. The control group received treatment after a 3-mo wait. Outcome measures included the Behavior Rating Inventory of Executive Function (BRIEF) and the Canadian Occupational Performance Measure (COPM). RESULTS. Significant improvements were found on both the BRIEF and COPM after intervention with large treatment effects. Before crossover, significant Time x Group interactions were found on the BRIEF. CONCLUSION. This study supports the effectiveness of the Cog-Fun intervention in improving executive functions and participation among children with ADHD.	[Hahn-Markowitz, Jeri] Hadassah & Hebrew Univ Jerusalem, Sch Occupat Therapy, Cognit Funct Rehabil Lab, Jerusalem, Israel; [Berger, Itai] Hadassah Hebrew Univ, Paediat Neurol Unit, Neurocognit Ctr, Med Ctr, Jerusalem, Israel; [Manor, Iris] Geha Mental Hlth Ctr, Attent Deficit Hyperact Disorder Clin, Petah Tiqwa, Israel; [Maeir, Adina] Hadassah & Hebrew Univ Jerusalem, Sch Occupat Therapy, Grad Studies, Jerusalem, Israel		Hahn-Markowitz, J (corresponding author), Hadassah & Hebrew Univ Jerusalem, Sch Occupat Therapy, Cognit Funct Rehabil Lab, Jerusalem, Israel.	jerihahnmarkowitz@gmail.com	Berger, Itai/D-9729-2017	Berger, Itai/0000-0002-7577-4444; Maeir, Adina/0000-0002-3356-5847	Milton Rosenbaum Endowment Fund for Research in Psychiatric Sciences; Martin Levin Institute for Child Development; Rama Shoval Foundation	For help with funding for this research, we thank the Milton Rosenbaum Endowment Fund for Research in Psychiatric Sciences, the Martin Levin Institute for Child Development, and the Rama Shoval Foundation. This study has been registered at ClinicalTrials.gov (NCT01792921).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Antshel KM, 2014, HDB EXECUTIVE FUNCTI, P107, DOI DOI 10.1007/978-1-4614-8106-5_7; Barkley RA., 2012, EXECUTIVE FUNCTIONS; Biederman J, 2004, J CONSULT CLIN PSYCH, V72, P757, DOI 10.1037/0022-006X.72.5.757; Brown T.E., 2013, NEW UNDERSTANDING AD; Cermak SA, 2011, COGNITION OCCUPATION, P249; Dawson DR, 2013, ARCH PHYS MED REHAB, V94, P1959, DOI 10.1016/j.apmr.2013.05.021; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; de Schipper E, 2015, EUR CHILD ADOLES PSY, V24, P1509, DOI 10.1007/s00787-015-0778-1; Dunn W, 2012, AM J OCCUP THER, V66, P520, DOI 10.5014/ajot.2012.004119; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Gharebaghy S, 2015, PHYS OCCUP THER PEDI, V35, P13, DOI 10.3109/01942638.2014.957428; Gioia GA IP, 2000, BEHAV RATING INVENTO; Hahn-Markowitz J, 2020, J ATTEN DISORD, V24, P655, DOI 10.1177/1087054716666955; Hahn-Markowitz J, 2011, AM J OCCUP THER, V65, P384, DOI 10.5014/ajot.2011.000901; Halperin JM, 2013, J ATTEN DISORD, V17, P711, DOI 10.1177/1087054711435681; Katz N, 2011, COGNITION OCCUPATION; Maeir A., 2014, ADHD TRANSPARENT IMP, P81; Maeir A., 2012, COGNITIVE FUNCTIONAL; Maeir A, 2014, AM J OCCUP THER, V68, P260, DOI 10.5014/ajot.2014.011700; Mahone EM, 2002, ARCH CLIN NEUROPSYCH, V17, P643, DOI 10.1016/S0887-6177(01)00168-8; Mandich, 2004, ENABLING OCCUPATION; Martin AJ, 2016, LEARN INDIVID DIFFER, V45, P222, DOI 10.1016/j.lindif.2015.12.014; McCandless Stephen, 2007, J Atten Disord, V10, P381, DOI 10.1177/1087054706292115; Piskur B, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-177; Polatajko HJ, 2011, COGNITION OCCUPATION, P299; Pollock N., 2005, CANADIAN OCCUPATIONA; Tamm L, 2014, J ATTEN DISORD, V18, P551, DOI 10.1177/1087054712445782; Toglia J.P., 2011, COGNITION OCCUPATION, P116; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Tseng WL, 2013, J CHILD PSYCHOL PSYC, V54, P996, DOI 10.1111/jcpp.12072; World Health Organization, 2007, INT CLASS FUNCT DIS	33	13	13	1	9	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	SEP-OCT	2017	71	5							7105220010	10.5014/ajot.2017.022053			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	GM6DI	WOS:000438249400001	28809658				2022-02-06	
J	Hernandez, MC; Thiels, CA; Aho, JM; Habermann, EB; Zielinski, MD; Stubbs, JA; Jenkins, DH; Zietlow, SP				Hernandez, Matthew C.; Thiels, Cornelius A.; Aho, Johnathon M.; Habermann, Elizabeth B.; Zielinski, Martin D.; Stubbs, James A.; Jenkins, Donald H.; Zietlow, Scott P.			Prehospital plasma resuscitation associated with improved neurologic outcomes after traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; GOSE; prehospital; resuscitation; blood product	FRESH-FROZEN PLASMA; LARGE ANIMAL-MODEL; UNITED-STATES; BLOOD-TRANSFUSIONS; COAGULOPATHY; EXPERIENCE; RATIONALE; PLATELETS; FIELD; SHOCK	BACKGROUND: Trauma-related hypotension and coagulopathy worsen secondary brain injury in patients with traumatic brain injuries (TBIs). Early damage control resuscitation with blood products may mitigate hypotension and coagulopathy. Preliminary data suggest resuscitation with plasma in large animals improves neurologic function after TBI; however, data in humans are lacking. METHODS: We retrospectively identified all patients with multiple injuries age > 15 years with head injuries undergoing prehospital resuscitation with blood products at a single Level I trauma center from January 2002 to December 2013. Inclusion criteria were prehospital resuscitation with either packed red blood cells (pRBCs) or thawed plasma as sole colloid resuscitation. Patients who died in hospital and those using anticoagulants were excluded. Primary outcomes were Glasgow Outcomes Score Extended (GOSE) and Disability Rating Score (DRS) at dismissal and during follow-up. RESULTS: Of 76 patients meeting inclusion criteria, 53% (n = 40) received prehospital pRBCs and 47%(n = 36) received thawed plasma. Age, gender, injury severity or TBI severity, arrival laboratory values, and number of prehospital units were similar (all p > 0.05). Patients who received thawed plasma had an improved neurologic outcome compared to those receiving pRBCs (median GOSE 7 [7-8] vs. 5.5 [3-7], p < 0.001). Additionally, patients who received thawed plasma had improved functionality compared to pRBCs (median DRS 2 [1-3.5] vs. 9 [3-13], p < 0.001). Calculated GOSE and DRS scores during follow-up, median 6 [5-7] months, demonstrated increased function in those resuscitated with thawed plasma compared to pRBCs by both median GOSE (8 [7-8] vs. 6 [6-7], p < 0.001) and DRS (0 [0-1] vs. 4 [2-8], p < 0.001). CONCLUSION: In critically injured trauma patients with TBI, early resuscitation with thawed plasma is associated with improved neurologic and functional outcomes at discharge and during follow-up compared to pRBCs alone. These preliminary data support the further investigation and use of plasma in the resuscitation of critically injured TBI patients. (Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.)	[Hernandez, Matthew C.; Aho, Johnathon M.; Zielinski, Martin D.; Jenkins, Donald H.; Zietlow, Scott P.] Mayo Clin, Dept Surg, Rochester, MN 55905 USA; [Thiels, Cornelius A.; Habermann, Elizabeth B.] Mayo Clin, Div Trauma Crit Care & Gen Surg, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA; [Stubbs, James A.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA		Hernandez, MC (corresponding author), Mayo Clin, Div Trauma Crit Care & Gen Surg, Dept Surg, 200 First St SW, Rochester, MN 55905 USA.	hernandez.matthew@mayo.edu		Habermann, Elizabeth/0000-0002-1140-003X	Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; CTSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR000136]; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32 HL105355]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000136] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL105355] Funding Source: NIH RePORTER	Support provided by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery (C.A.T. and E.B.H.), CTSA grant KL2 TR000136 (M.D.Z.), and by the National Heart, Lung, and Blood Institute T32 HL105355 (J.M.A.).	Bhangu A, 2013, INJURY, V44, P1693, DOI 10.1016/j.injury.2012.07.193; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brown JB, 2015, PREHOSP EMERG CARE, V19, P343, DOI 10.3109/10903127.2014.995851; Chapman MP, 2015, SHOCK, V44, P63, DOI 10.1097/SHK.0000000000000376; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; del Junco DJ, 2013, J TRAUMA ACUTE CARE, V75, pS24, DOI 10.1097/TA.0b013e31828fa3b9; DITUNNO JF, 1992, J NEUROTRAUM, V9, pS301; Epstein DS, 2015, BRIT J NEUROSURG, V29, P118, DOI 10.3109/02688697.2014.950632; Epstein DS, 2016, J CLIN NEUROSCI, V29, P64, DOI 10.1016/j.jocn.2015.11.024; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Higgins GL, 2012, PREHOSP DISASTER MED, V27, P231, DOI 10.1017/S1049023X12000659; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Jenkins D, 2014, SHOCK, V41, P84, DOI 10.1097/SHK.0000000000000133; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Maegele M, 2010, WORLD J EMERG MED, V1, P12; Mitra B, 2010, INJURY, V41, P35, DOI 10.1016/j.injury.2009.09.029; Moore HB, 2015, J AM COLL SURGEONS, V220, P872, DOI 10.1016/j.jamcollsurg.2015.01.026; Novak DJ, 2015, TRANSFUSION, V55, P1331, DOI 10.1111/trf.13098; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Riskin DJ, 2009, J AM COLL SURGEONS, V209, P198, DOI 10.1016/j.jamcollsurg.2009.04.016; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Savage SA, 2015, J TRAUMA ACUTE CARE, V78, P224, DOI 10.1097/TA.0000000000000502; Schrieber M, 2007, J TRAUMA, V63, P1261; Sillesen M, 2017, J AM COLL SURGEONS, V224, P49, DOI 10.1016/j.jamcollsurg.2016.09.015; Sillesen M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0046-2; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Thiels CA, 2016, WORLD J SURG, V40, P2297, DOI 10.1007/s00268-016-3572-4; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204	35	13	13	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2017	83	3					398	405		10.1097/TA.0000000000001581			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	FF0ET	WOS:000408575700008	28538641	Green Accepted			2022-02-06	
J	Hinson, HE; Schreiber, MA; Laurie, AL; Baguley, IJ; Bourdette, D; Ling, GSF				Hinson, Holly E.; Schreiber, Martin A.; Laurie, Amber L.; Baguley, Ian J.; Bourdette, Dennis; Ling, Geoffrey S. F.			Early Fever As a Predictor of Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						autonomic instability; fever; paroxysmal sympathetic hyperactivity; sympathetic storms; traumatic brain injury	DIAGNOSTIC-CRITERIA; DYSAUTONOMIA; STROKE; IMPACT	Objective: Paroxysmal sympathetic hyperactivity (PSH) is characterized by episodic, hyperadrenergic alterations in vital signs after traumatic brain injury (TBI). We sought to apply an objective scale to the vital sign alterations of PSH in order to determine whether 1 element might be predictive of developing PSH. Setting/Participants/Design: We conducted an observational study of consecutive TBI patients (Glasgow Coma Scale score <= 12) and monitored the cohort for clinical evidence of PSH. PSH was defined as a paroxysm of 3 or more of the following characteristics: (1) tachycardia, (2) tachypnea, (3) hypertension, (4) fever, (5) dystonia (rigidity or decerebrate posturing), and (6) diaphoresis, with no other obvious causation (ie, alcohol withdrawal, sepsis). Main Measures: TheModified Clinical Feature Severity Scale (mCFSS) was applied to each participant once daily for the first 5 days of hospitalization. Results: Nineteen (11%) of the 167 patients met criteria for PSH. Patients with PSH had a higher 5-day cumulative mCFSS score than those without PSH (median [interquartile range] = 36 [29-42] vs 29 [22-35], P = .01). Of the 4 components of the mCFSS, elevated temperature appeared to be most predictive of the development of PSH, especially during the first 24 hours (odds ratio = 1.95; 95% confidence interval, 1.12-3.40). Conclusion: Early fever after TBI may signal impending autonomic dysfunction.	[Hinson, Holly E.; Bourdette, Dennis] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,CR-127, Portland, OR 97239 USA; [Hinson, Holly E.; Laurie, Amber L.] Oregon Hlth & Sci Univ, Dept Emergency Med, 3181 SW Sam Jackson Pk Rd,CR-127, Portland, OR 97239 USA; [Schreiber, Martin A.] Oregon Hlth & Sci Univ, Dept Trauma Crit Care & Acute Surg, Portland, OR 97201 USA; [Baguley, Ian J.] Westmead Hosp, Brain Injury Rehabil Serv, Sydney, NSW, Australia; [Ling, Geoffrey S. F.] Def Adv Res Projects Agcy, Biol Technol Off, Bethesda, MD USA		Hinson, HE (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,CR-127, Portland, OR 97239 USA.; Hinson, HE (corresponding author), Oregon Hlth & Sci Univ, Dept Emergency Med, 3181 SW Sam Jackson Pk Rd,CR-127, Portland, OR 97239 USA.	hinson@ohsu.edu	Hinson, Holly/Q-2268-2019; Baguley, Ian/AAM-5828-2021	Hinson, Holly/0000-0003-1598-9782; 	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5K12HL108974-03]; Oregon Clinical and Translational Research Institute from the National Center for Advancing Translational Sciences at the National Institutes of Health (NIH) [UL1TR000128]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL108974] Funding Source: NIH RePORTER	The project described was supported in part by award no. 5K12HL108974-03 from the National Heart, Lung, and Blood Institute. This publication was supported by Oregon Clinical and Translational Research Institute, grant no. UL1TR000128, from the National Center for Advancing Translational Sciences at the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the NIH.	Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Lv LQ, 2011, J TRAUMA, V71, P538, DOI 10.1097/TA.0b013e31820ebee1; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; MILHOLLAND AV, 1973, NEW ENGL J MED, V288, P1272, DOI 10.1056/NEJM197306142882405; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; Saxena M, 2015, INTENS CARE MED, V41, P823, DOI 10.1007/s00134-015-3676-6	11	13	14	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2017	32	5					E50	E54		10.1097/HTR.0000000000000271			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FG2DW	WOS:000409893800006	28060200	Green Accepted			2022-02-06	
J	Lau, LA; Noubary, F; Wang, DQ; Dulla, CG				Lau, Lauren A.; Noubary, Farzad; Wang, Dongqing; Dulla, Chris G.			alpha 2 delta 1 Signaling Drives Cell Death, Synaptogenesis, Circuit Reorganization, and Gabapentin-Mediated Neuroprotection in a Model of Insult-Induced Cortical Malformation	ENEURO			English	Article						a2d-1; cell death; cortex; gabapentin; malformation; polymicrogyriax	CALCIUM-CHANNEL; NEUROPATHIC PAIN; CEREBRAL-CORTEX; RAT MODEL; ALPHA(2)DELTA SUBUNIT; GLUTAMATE UPTAKE; FREEZE-LESION; BRAIN-INJURY; THROMBOSPONDIN-1; DYSPLASIA	Developmental cortical malformations (DCMs) result from pre- and perinatal insults, as well as genetic mutations. Hypoxia, viral infection, and traumatic injury are the most common environmental causes of DCMs, and are associated with the subsyndromes focal polymicrogyria and focal cortical dysplasia (FCD) Type IIId, both of which have a high incidence of epilepsy. Understanding the molecular signals that lead to the formation of a hyperexcitable network in DCMs is critical to devising novel treatment strategies. In a previous study using the freeze-lesion (FL) murine model of DCM, we found that levels of thrombospondin (TSP) and the calcium channel auxiliary subunit alpha 2 delta-1 were elevated. TSP binds to alpha 2 delta-1 to drive the formation of excitatory synapses during development, suggesting that overactivation of this pathway may lead to exuberant excitatory synaptogenesis and network hyperexcitability seen in DCMs. In that study, antagonizing TSP/alpha 2 delta-1 signaling using the drug gabapentin (GBP) reduced many FL-induced pathologies. Here, we used mice with a genetic deletion of alpha 2 delta-1 to determine how alpha 2 delta-1 contributes to cell death, elevated excitatory synapse number, and in vitro network function after FL and to examine the molecular specificity of GBP's effects. We identified a critical role for alpha 2 delta-1 in FL-induced pathologies and in mediating the neuroprotective effects of GBP. Interestingly, genetic deletion of alpha 2 delta-1 did not eliminate GBP's effects on synaptogenesis, suggesting that GBP can have alpha 2 delta-1-independent effects. Taken together these studies suggests that inhibiting alpha 2 delta-1 signaling may have therapeutic promise to reduce cell death and network reorganization associated with insult-induced DCMs.	[Lau, Lauren A.; Dulla, Chris G.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Lau, Lauren A.] Tufts Sackler Sch Biomed Sci, Neurosci Program, Boston, MA 02111 USA; [Noubary, Farzad] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Noubary, Farzad] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Wang, Dongqing] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA		Dulla, CG (corresponding author), Tufts Univ, Dept Neurosci, 136 Harrison Ave,SC203, Boston, MA 02111 USA.	chris.dulla@tufts.edu		Dulla, Chris/0000-0002-6560-6535; Lau, Lauren/0000-0003-3312-183X	Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke Grant [R01- NS076885]; Sackler School Deans Fellowship; Tufts Center for Neuroscience Research Grant [P30 NS047243]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS047243, R56NS076885, R01NS076885] Funding Source: NIH RePORTER	This work was supported by the Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke Grant R01- NS076885 (to C.G.D.), the Sackler School Deans Fellowship (L.A.L.), and the Tufts Center for Neuroscience Research Grant P30 NS047243.	Andresen L, 2014, NEUROBIOL DIS, V71, P305, DOI 10.1016/j.nbd.2014.08.022; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Armbruster M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00277; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Bordey A, 2001, J NEUROPHYSIOL, V85, P1719, DOI 10.1152/jn.2001.85.4.1719; Boroujerdi A, 2008, PAIN, V139, P358, DOI 10.1016/j.pain.2008.05.004; Campbell SL, 2008, NEUROBIOL DIS, V32, P254, DOI 10.1016/j.nbd.2008.07.003; Campbell SL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00425; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cole RL, 2005, J COMP NEUROL, V491, P246, DOI 10.1002/cne.20693; Crino PB, 2005, J CHILD NEUROL, V20, P330, DOI 10.1177/08830738050200041101; Dulla CG, 2013, NEUROBIOL DIS, V49, P232, DOI 10.1016/j.nbd.2012.09.001; DVORAK K, 1977, ACTA NEUROPATHOL, V38, P203; Emmez H, 2010, WORLD NEUROSURG, V73, P729, DOI 10.1016/j.wneu.2010.04.008; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Faria LC, 2017, NEUROBIOL DIS, V102, P70, DOI 10.1016/j.nbd.2017.01.009; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Fuller-Bicer GA, 2009, AM J PHYSIOL-HEART C, V297, pH117, DOI 10.1152/ajpheart.00122.2009; Gee NS, 1996, J BIOL CHEM, V271, P5768, DOI 10.1074/jbc.271.10.5768; Hanson E, 2016, NEUROBIOL DIS, V89, P157, DOI 10.1016/j.nbd.2016.02.012; Hendrich J, 2008, P NATL ACAD SCI USA, V105, P3628, DOI 10.1073/pnas.0708930105; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Insolera R, 2014, NAT NEUROSCI, V17, P1528, DOI 10.1038/nn.3831; Ippolito DM, 2010, J VIS EXP; Jacobs KM, 1999, EPILEPSY RES, V36, P165, DOI 10.1016/S0920-1211(99)00050-9; Jacobs KM, 1996, CEREB CORTEX, V6, P514, DOI 10.1093/cercor/6.3.514; Kale A, 2011, J NEUROSURG-SPINE, V15, P228, DOI 10.3171/2011.4.SPINE10583; Kim YK, 2010, KOREAN J ANESTHESIOL, V58, P184, DOI 10.4097/kjae.2010.58.2.184; Kim YS, 2009, J PHARMACOL SCI, V109, P144, DOI 10.1254/jphs.08067SC; Kurshan PT, 2009, NAT NEUROSCI, V12, P1415, DOI 10.1038/nn.2417; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Leventer Richard J, 2008, Dialogues Clin Neurosci, V10, P47; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; Li KW, 2014, J BIOL CHEM, V289, P7025, DOI 10.1074/jbc.M114.548990; Li N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009894; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lin TN, 2003, STROKE, V34, P177, DOI 10.1161/01.STR.0000047100.84604.BA; Luhmann H J, 1996, Epilepsy Res Suppl, V12, P119; Luhmann HJ, 2016, J NEUROSCI METH, V260, P62, DOI 10.1016/j.jneumeth.2015.03.034; Maneuf YP, 2001, BRIT J PHARMACOL, V134, P237, DOI 10.1038/sj.bjp.0704227; Mastrolia V, 2017, DIABETES, V66, P897, DOI 10.2337/db16-0336; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nieto-Rostro M, 2014, NEUROSCIENCE, V283, P124, DOI 10.1016/j.neuroscience.2014.03.013; Ning MM, 2011, STROKE, V42, P37, DOI 10.1161/STROKEAHA.110.585703; Patel R, 2013, J NEUROSCI, V33, P16412, DOI 10.1523/JNEUROSCI.1026-13.2013; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Santolini I, 2017, EPILEPSIA, V58, P1993, DOI 10.1111/epi.13898; Sun QQ, 2016, EPILEPSIA, V57, P1581, DOI 10.1111/epi.13501; Takahashi DK, 2017, CEREB CORTEX, P1; Takano T, 2006, PEDIATR NEUROL, V35, P38, DOI 10.1016/j.pediatrneurol.2005.11.007; Traa BS, 2008, PEDIATR RES, V64, P81, DOI 10.1203/PDR.0b013e318174e70e; Vergult S, 2015, EUR J HUM GENET, V23, P628, DOI 10.1038/ejhg.2014.141; Wang JL, 2016, ACTA NEUROL SCAND, V134, P189, DOI 10.1111/ane.12528; Watanabe M, 2002, MICROSC MICROANAL, V8, P375, DOI 10.1017/S1431927602010346; Williams AJ, 2006, J PHARMACOL EXP THER, V318, P947, DOI 10.1124/jpet.106.105999; Williams AJ, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00093; Yang RH, 2009, PAIN, V143, P48, DOI 10.1016/j.pain.2009.01.020; Yeh Chin-Yi, 2011, Acta Anaesthesiol Taiwan, V49, P144, DOI 10.1016/j.aat.2011.11.006; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]	60	13	13	0	0	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	SEP-OCT	2017	4	5							UNSP e0316-17.2017	10.1523/ENEURO.0316-17.2017			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FS1FJ	WOS:000419519800044	29109971	gold, Green Published			2022-02-06	
J	Mirshekar, MA; Fanaei, H; Keikhaei, F; Javan, FS				Mirshekar, Mohammad Ali; Fanaei, Hamed; Keikhaei, Fereshteh; Javan, Fatemeh Sargolzaee			Diosmin improved cognitive deficit and amplified brain electrical activity in the rat model of traumatic brain injury	BIOMEDICINE & PHARMACOTHERAPY			English	Article							LONG-TERM POTENTIATION; NF-KAPPA-B; TNF-ALPHA; INFLAMMATORY CYTOKINES; ISCHEMIA/REPERFUSION INJURY; INTRACRANIAL-PRESSURE; NITRIC-OXIDE; GALLIC ACID; PROTECTS; INVOLVEMENT	Objective: Traumatic brain injury (TBI) is one of the main causes of intellectual and cognitive disabilities in humans. Clinically, it is essential to limit the progress of cognitive impairment after TBI. It is reported that diosmin has a neuroprotective effect that can limit the progress of the impairment. The aim of this study was to evaluate the effects of diosmin on neurological score, memory, tumor necrosis factor-alpha (TNF-alpha) level and long-term potentiation in hippocampal dentate gyrus after the injury. Methods: A total of ninety six adult male Wistar rats were used as test subjects in this study. The animals were randomly assigned into one of the following three groups (n = 32/group): Sham, TBI and diosmin (100 mg/kg, p.o for seven consecutive days before TBI induction). TBI was induced into the animals by Marmarou's method. Briefly, a 200 g weight was dropped from a 1 m height through a free-falling tube onto the head of the anesthetized rats. Results: The veterinary coma scale scores, memory and long-term potentiation in TBI group showed significant decrease at different times after the onset of TBI when compared with Sham (p < 0.001). The TNF-alpha level in the hippocampus of the TBI group of animals was significantly higher than that found in the test subjects from the Sham group (p < 0.001). The pre-treatment of the TBI group with diosmin significantly improved their neurological scores, memory and long-term potentiation (p < 0.001) when compared with the TBI group. The TNF-alpha level in hippocampus of the diosmin group was significantly lower than the TBI group (p < 0.001). Conclusion: Based on the results of the present study, pre-treatment with diosmin has protective effects against TBI-induced memory and long-term potentiation impairment. The effects of diosmin may be mediated through a decrement in the TNF-alpha concentration of hippocampus as a pro-inflammatory cytokine. (C) 2017 Elsevier Masson SAS. All rights reserved.	[Mirshekar, Mohammad Ali; Fanaei, Hamed; Keikhaei, Fereshteh; Javan, Fatemeh Sargolzaee] Zahedan Univ Med Sci, Sch Med, Dept Physiol, Zahedan, Iran; [Fanaei, Hamed] Zahedan Univ Med Sci, Pregnancy Hlth Res Ctr, Zahedan, Iran		Fanaei, H (corresponding author), Zahedan Univ Med Sci, Dept Physiol, Persian Gulf Highway, Zahedan, Iran.	fanaeih@yahoo.com	Mirshekar, Mohammad Ali/S-4167-2017; Fanaei, Hamed/S-3308-2017	Mirshekar, Mohammad Ali/0000-0002-0449-6440; Fanaei, Hamed/0000-0002-1345-2052	Zahedan University of Medical Sciences, Deputy of research and technology [7602]	This project was supported financially by Zahedan University of Medical Sciences, Deputy of research and technology (grant no. 7602).	Abdullah Z, 2015, MOL CELL NEUROSCI, V69, P65, DOI 10.1016/j.mcn.2015.11.003; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adouani I, 2013, CHROMATOGRAPHIA, V76, P499, DOI 10.1007/s10337-013-2404-z; Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Albensi BC, 2001, J NEUROSCI RES, V65, P279, DOI 10.1002/jnr.1151; Albensi BC, 2000, SYNAPSE, V35, P151; Campanero MA, 2010, J PHARMACEUT BIOMED, V51, P875, DOI 10.1016/j.jpba.2009.09.012; Arabmoazzen S, 2015, IRAN J BASIC MED SCI, V18, P745; Arisi GM, 2014, EPILEPSY BEHAV, V38, P43, DOI 10.1016/j.yebeh.2014.01.017; Barreca D, 2013, BIOCHIMIE, V95, P2042, DOI 10.1016/j.biochi.2013.07.014; Benavente-Garcia O, 2008, J AGR FOOD CHEM, V56, P6185, DOI 10.1021/jf8006568; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Carballo-Villalobos AI, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8263463; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; COVA D, 1992, INT J CLIN PHARM TH, V30, P29; Deadwyler SA, 1996, J NEUROSCI, V16, P354; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; del Zoppo GJ, 2000, THROMB RES, V98, pV73; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; DeVries HE, 1997, PHARMACOL REV, V49, P143; Dubal DB, 2001, ENDOCRINOLOGY, V142, P43, DOI 10.1210/en.142.1.43; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Friesenecker B, 1995, INT J MICROCIRC, V15, P17, DOI 10.1159/000179090; Gesuete R, 2014, J NEUROPATH EXP NEUR, V73, P378, DOI 10.1097/NEN.0000000000000068; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Imam F, 2015, PHARMACOL RES, V102, P1, DOI 10.1016/j.phrs.2015.09.001; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lindqvist D, 2017, PSYCHONEUROENDOCRINO, V76, P197, DOI 10.1016/j.psyneuen.2016.11.031; Liu X, 2014, NEUROSCIENCE, V268, P318, DOI 10.1016/j.neuroscience.2014.03.032; Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Luo CL, 2013, BRAIN RES, V1502, P1, DOI 10.1016/j.brainres.2013.01.037; McDaniel JC, 2013, WOUND REPAIR REGEN, V21, P339, DOI 10.1111/wrr.12036; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Mirshekar M, 2011, IRAN J PHARM RES, V10, P569; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Morais MCC, 2010, NAT PROD RES, V24, P1758, DOI 10.1080/14786410903335232; Mottahedin A, 2017, J CEREBR BLOOD F MET, V37, P1192, DOI 10.1177/0271678X17691292; Neniskyte U, 2014, FEBS LETT, V588, P2952, DOI 10.1016/j.febslet.2014.05.046; Noorbakhshnia M, 2017, PHYSIOL BEHAV, V169, P69, DOI 10.1016/j.physbeh.2016.11.027; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Ozen L. J., 2011, ARCH CLIN NEUROPSYCH, V27; Parhiz H, 2015, PHYTOTHER RES, V29, P323, DOI 10.1002/ptr.5256; Paxinos G, 2006, RAT BRAIN STEREOTAXI; Pei HF, 2015, FREE RADICAL BIO MED, V82, P114, DOI 10.1016/j.freeradbiomed.2015.02.002; Ramnath D., 2017, SEMINARS CELL DEV BI; Rehman MU, 2013, BRIT J NUTR, V110, P699, DOI 10.1017/S0007114512005752; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Roohbakhsh A, 2007, CLIN EXP PHARMACOL P, V34, P223, DOI 10.1111/j.1440-1681.2007.04576.x; Rostworowski M, 1997, J NEUROSCI, V17, P3664; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Sarkaki A, 2015, CAN J PHYSIOL PHARM, V93, P687, DOI 10.1139/cjpp-2014-0546; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; Silachev DN, 2015, B EXP BIOL MED+, V159, P528, DOI 10.1007/s10517-015-3009-3; Silambarasan T, 2012, EUR J PHARMACOL, V679, P81, DOI 10.1016/j.ejphar.2011.12.040; Simsek T, 2014, TURK J SURG, V30, P153, DOI 10.5152/UCD.2014.2653; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Tahir M, 2013, ALCOHOL, V47, P131, DOI 10.1016/j.alcohol.2012.12.010; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wang Shan-Shan, 2014, Shengli Xuebao, V66, P463; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Wu XH, 2015, NEUROCHEM RES, V40, P1882, DOI 10.1007/s11064-015-1683-1; Zelova H, 2013, INFLAMM RES, V62, P641, DOI 10.1007/s00011-013-0633-0; Zhang M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109589, 10.1371/journal.pone.0105994]; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhu H, 2013, BRAIN RES, V1541, P69, DOI 10.1016/j.brainres.2013.10.002	82	13	13	0	2	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	SEP	2017	93						1220	1229		10.1016/j.biopha.2017.07.014			10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	FE0PU	WOS:000407923000133	28738538				2022-02-06	
J	Pluta, A; Gawron, N; Sobanska, M; Wojcik, AD; Lojek, E				Pluta, Agnieszka; Gawron, Natalia; Sobanska, Marta; Wojcik, Adrian Dominik; Lojek, Emilia			The Nature of the Relationship Between Neurocognition and Theory of Mind Impairments in Stroke Patients	NEUROPSYCHOLOGY			English	Article						theory of mind; stroke; cognitive and affective components of theory of mind; cognitive function	CARD SORTING TEST; VENTROMEDIAL PREFRONTAL CORTEX; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; FRONTAL-LOBE; COGNITIVE THEORY; WORKING-MEMORY; ADULTS; TRAIL; SCHIZOPHRENIA	Objective: Theory of mind (ToM) is a complex, high-level cognitive function that allows people to infer the cognitive and affective mental states of others. Previous studies have produced limited and frequently contradictory findings on the neuropsychological underpinnings of ToM performance in patients with stroke. The aim of the present study is to investigate neuropsychological mechanisms of cognitive and affective theory of mind dysfunctions in patients with stroke. Method: Fifty-eight patients with stroke and 22 healthy controls matched in age, gender, and education level underwent robust neuropsychological examination of their pragmatic abilities, executive functions, attention, memory, psychomotor speed, and visuospatial abilities as well as a cognitive and affective ToM assessment. Results: Patients with stroke demonstrated impaired performance in all ToM tasks. While pragmatic competence and, to a lesser degree, executive functions had the strongest contribution to ToM impairments, attention and general cognitive functioning did not directly affect mentalizing abilities, as demonstrated by a path analysis. Our study reveals the different roles of cognitive functions in cognitive and affective components of ToM. Executive functions contributed only to the cognitive components of ToM. Conclusion: Deficits in cognitive aspects of ToM are best explained by impairment of pragmatic competence and executive functions. In contrast, executive dysfunction does not affect the ability to understand the affective mental states of others.	[Pluta, Agnieszka; Gawron, Natalia; Sobanska, Marta; Lojek, Emilia] Univ Warsaw, Fac Psychol, Warsaw, Poland; [Wojcik, Adrian Dominik] Nicolaus Copernicus Univ, Fac Humanities, Torun, Poland		Pluta, A (corresponding author), Stawki 5-7, Warsaw, Poland.	apluta@psych.uw.edu.pl	Gawron, Natalia/AAW-9718-2020; Wojcik, Adrian Dominik/I-5593-2019; Sobanska, Marta/ABE-1807-2020; Gawron, Natalia/H-4831-2013	Wojcik, Adrian Dominik/0000-0002-7073-6019; Sobanska, Marta/0000-0003-4242-308X; Gawron, Natalia/0000-0002-6052-1946; Pluta, Agnieszka/0000-0002-4684-1919	START Scholarship - Foundation for the Polish Science; Faculty of Psychology, University of Warsaw [BST 171203/2014, 174403/2015]; National Science Centre, PolandNational Science Centre, Poland [DEC-2014/15/B/HS6/03738]	Agnieszka Pluta was supported by the START Scholarship awarded by the Foundation for the Polish Science. Emilia Lojek was supported by Faculty of Psychology, University of Warsaw (BST 171203/2014 and 174403/2015). Adrian Dominik Wojcik was supported by the National Science Centre, Poland (Grant DEC-2014/15/B/HS6/03738).	Aboulafia-Brakha T, 2011, J NEUROPSYCHOL, V5, P39, DOI 10.1348/174866410X533660; Angeleri R, 2014, CAN J EXP PSYCHOL, V68, P133, DOI 10.1037/cep0000011; Apperly IA, 2006, SOC NEUROSCI-UK, V1, P334, DOI 10.1080/17470910601038693; Apperly IA, 2009, DEV PSYCHOL, V45, P190, DOI 10.1037/a0014098; Baez S, 2015, J NEUROPSYCHOL, V9, P203, DOI 10.1111/jnp.12046; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bejanin A, 2017, SOC NEUROSCI-UK, V12, P287, DOI 10.1080/17470919.2016.1168314; Bentler PM, 1999, MULTIVAR BEHAV RES, V34, P181, DOI 10.1207/S15327906Mb340203; BERMAN KF, 1995, NEUROPSYCHOLOGIA, V33, P1027, DOI 10.1016/0028-3932(95)00035-2; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; Brzezinski J., 2004, WECHSLER ADULT INTEL; Carlson SM, 2002, INFANT CHILD DEV, V11, P73, DOI 10.1002/icd.298; Champagne-Lavau M, 2009, J NEUROLINGUIST, V22, P413, DOI 10.1016/j.jneuroling.2009.02.002; Charlton RA, 2009, PSYCHOL AGING, V24, P338, DOI 10.1037/a0015225; Colle L, 2008, J AUTISM DEV DISORD, V38, P28, DOI 10.1007/s10803-007-0357-5; Corradi-Dell'Acqua C, 2014, SOC COGN AFFECT NEUR, V9, P1175, DOI 10.1093/scan/nst097; Couture SM, 2011, SCHIZOPHR RES, V125, P152, DOI 10.1016/j.schres.2010.09.020; Cummings L, 2011, PRAGMAT SOC, V2, P17, DOI 10.1075/ps.2.1.02cum; De Mulder H., 2015, J CHILD LANG, V42, P1; de Villiers JG, 2002, COGNITIVE DEV, V17, P1037, DOI 10.1016/S0885-2014(02)00073-4; de Villiers J, 2007, LINGUA, V117, P1858, DOI 10.1016/j.lingua.2006.11.006; Edwards JR, 2007, PSYCHOL METHODS, V12, P1, DOI 10.1037/1082-989X.12.1.1; Fernandez C, 2013, FIRST LANG, V33, P20, DOI 10.1177/0142723711422633; Fine C, 2001, BRAIN, V124, P287, DOI 10.1093/brain/124.2.287; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Frank C Kobayashi, 2010, Open Neuroimag J, V4, P37, DOI 10.2174/1874440001004020037; Goodglass H, 1983, ASSESSMENT APHASIA R; Gordon ACL, 1998, J EXP CHILD PSYCHOL, V68, P70, DOI 10.1006/jecp.1997.2423; Greve KW, 1998, ARCH CLIN NEUROPSYCH, V13, P597; Guariglia P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099700; Hale CM, 2003, DEVELOPMENTAL SCI, V6, P346, DOI 10.1111/1467-7687.00289; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Jaworowska A, 2002, WISCONSIN CARD SORTI; Kalbe E, 2010, CORTEX, V46, P769, DOI 10.1016/j.cortex.2009.07.010; Karpinski J, 1990, CAUSALITY SOCIOLOGIC; KAWASAKI Y, 1993, SCHIZOPHR RES, V10, P109, DOI 10.1016/0920-9964(93)90045-K; Leopold A, 2012, SOC COGN AFFECT NEUR, V7, P871, DOI 10.1093/scan/nsr071; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Li XM, 2013, INT J PSYCHOL, V48, P715, DOI 10.1080/00207594.2012.673724; Lojek E, 2009, INTERDISCIPLINARY CO, V1, P1; Lojek E., 2007, RIGHT HEMISPHERE LAN; Lojek E., 2012, COLOUR TRAIL MAKING; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; Marcovitch S, 2015, COGNITIVE DEV, V33, P40, DOI 10.1016/j.cogdev.2014.07.001; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; Mohammadzadeh A, 2016, ADHD-ATTEND DEFICIT, V8, P73, DOI 10.1007/s12402-015-0187-9; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Newton AM, 2007, PSYCHOL SCI, V18, P574, DOI 10.1111/j.1467-9280.2007.01942.x; Oosterman JM, 2010, CLIN NEUROPSYCHOL, V24, P203, DOI 10.1080/13854040903482848; Orellana Gricel, 2013, Front Psychiatry, V4, P35, DOI 10.3389/fpsyt.2013.00035; Perner J, 1999, TRENDS COGN SCI, V3, P337, DOI 10.1016/S1364-6613(99)01362-5; Poletti M, 2012, NEUROSCI BIOBEHAV R, V36, P2147, DOI 10.1016/j.neubiorev.2012.07.004; Poletti M, 2011, BEHAV BRAIN RES, V219, P342, DOI 10.1016/j.bbr.2011.01.010; Polgar P, 2010, SCHIZOPHR RES, V122, P85, DOI 10.1016/j.schres.2010.06.007; Rouder JN, 2016, PSYCHOL METHODS; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Sabbagh MA, 2006, PSYCHOL SCI, V17, P74, DOI 10.1111/j.1467-9280.2005.01667.x; Salthouse TA, 2011, INTELLIGENCE, V39, P222, DOI 10.1016/j.intell.2011.03.001; Samson D, 2009, J NEUROPSYCHOL, V3, P3, DOI 10.1348/174866408X377883; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Saxe R, 2006, BRAIN RES, V1079, P57, DOI 10.1016/j.brainres.2006.01.001; Saxe R., 2009, ENCY CONSCIOUSNESS, P401, DOI [10.1016/B978-012373873-8.00078-5, DOI 10.1016/B978-012373873-8.00078-5]; Schlaffke L, 2015, HUM BRAIN MAPP, V36, P29, DOI 10.1002/hbm.22610; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Shamay-Tsoory SG, 2006, SOC NEUROSCI-UK, V1, P149, DOI 10.1080/17470910600985589; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Thoemmes F, 2015, BASIC APPL SOC PSYCH, V37, P226, DOI 10.1080/01973533.2015.1049351; Varley R, 2000, CURR BIOL, V10, P723, DOI 10.1016/S0960-9822(00)00538-8; Volz HP, 1997, PSYCHIAT RES-NEUROIM, V75, P145, DOI 10.1016/S0925-4927(97)00053-X; Wang ZW, 2013, PSYCHOL AGING, V28, P284, DOI 10.1037/a0030876; Wetzels R, 2012, AM STAT, V66, P104, DOI 10.1080/00031305.2012.695956; Xi CH, 2011, BEHAV BRAIN RES, V221, P587, DOI 10.1016/j.bbr.2010.09.031; Yeh ZT, 2014, PSYCHIAT CLIN NEUROS, V68, P612, DOI 10.1111/pcn.12173; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013	78	13	13	1	13	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	SEP	2017	31	6					666	681		10.1037/neu0000379			16	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FT3IZ	WOS:000423042100008	28459255				2022-02-06	
J	Yun, BJ; White, BA; Harvey, HB; Prabhakar, AM; Sonis, JD; Glover, M; Vallillo, E; Choi, S; Borczuk, P; Raja, AS				Yun, Brian J.; White, Benjamin A.; Harvey, H. Benjamin; Prabhakar, Anand M.; Sonis, Jonathan D.; Glover, McKinley; Vallillo, Emily; Choi, Sun; Borczuk, Pierre; Raja, Ali S.			Opportunity to reduce transfer of patients with mild traumatic brain injury and intracranial hemorrhage to a Level 1 trauma center	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Intracranial hemorrhages; Traumatic brain hemorrhage; Traumatic subdural hematoma; Traumatic brain injuries; Traumatic subarachnoid hemorrhage; Brain concussion; Traumatic cerebral hemorrhage; Neurosurgery; Patient transfer	HEAD COMPUTED-TOMOGRAPHY; CARE-UNIT ADMISSION; NEUROSURGICAL INTERVENTION; SUBARACHNOID HEMORRHAGE; PROTOCOL; CT; OUTCOMES; STATES	Objective: Current guidelines do not address the disposition of patients with mild traumatic brain injury (TBI) and resultant intracranial hemorrhage (ICH). Emergency medicine clinicians working in hospitals without neurosurgery coverage typically transfer patients with both to a trauma center with neurosurgery capability. Evidence is accruing which demonstrates that the risk of neurologic decompensation depends on the type of ICH and as a result, not every patient may need to be transferred. The purpose of this study was to identify risk factors for admission among patients with mild TBI and ICH who were transferred from a community hospital to the emergency department (ED) of a Level 1 trauma center. Methods: Study subjects were patients >= 18 years of age who were transferred from a community hospital to the ED of an urban, academic Level 1 trauma center between April 1, 2015 and March 31, 2016, and with an isolated traumatic ICH. Patients who had an epidural hematoma, were deemed to require a trauma center's level of service, were found to have non-traumatic ICHs, or had a Glasgow Coma Scale of < 13 were excluded. Using a multivariable logistic regression model, we sought to determine patient factors and Computed Tomography (CT) findings which were associated with admission (to the floor, intensive care unit, or operating room with neurosurgery) of the Level 1 trauma center. Results: 644 transferred patients were identified; 205 remained eligible after exclusion criteria. Presence of warfarin (odds ratio [OR] 4.09, 95% Confidence Interval [CI] 1.64, 10.25, p = 0.0026) and a subdural hematoma (SDH) >= 1 cm(OR 6.28, 95% CI 1.24, 31.71, p = 0.0263) were independently statistically significant factors predicting admission. Age, sex, GCS, presence of neurologic deficit, aspirin use, clopidogrel use, SDH < 1 cm, IPH, and SAH were each independently not significant predictive factors of an admission. Conclusions: After controlling for factors, transferred patients with mild TBI with a SDH >= 1 cm or on warfarin have a higher odds ratio of requiring inpatient admission to a Level 1 trauma center. While these patients may require admission, there may be opportunities to develop and study a low risk traumatic intracranial hemorrhage protocol, which keeps a subgroup of patients with a mild TBI and resultant ICH at community hospitals with access to a nearby Level 1 trauma center. (C) 2017 Elsevier Inc. All rights reserved.	[Yun, Brian J.; White, Benjamin A.; Sonis, Jonathan D.; Borczuk, Pierre; Raja, Ali S.] Massachusetts Gen Hosp, Harvard Med Sch, Dept Emergency Med, 55 Fruit St, Boston, MA 02114 USA; [Yun, Brian J.; White, Benjamin A.; Prabhakar, Anand M.; Sonis, Jonathan D.; Glover, McKinley; Raja, Ali S.] Massachusetts Gen Hosp, CREDO, Dept Emergency Med, 55 Fruit St, Boston, MA 02114 USA; [Harvey, H. Benjamin; Prabhakar, Anand M.; Glover, McKinley; Vallillo, Emily; Choi, Sun] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, 55 Fruit St, Boston, MA 02114 USA; [Prabhakar, Anand M.] Massachusetts Gen Hosp, Dept Radiol, Div Emergency Imaging, 55 Fruit St, Boston, MA 02114 USA; [Sonis, Jonathan D.] Harvard Affiliated Emergency Med Residency Progra, 5 Emerson Pl,Suite 101, Boston, MA 02114 USA; [Glover, McKinley] Massachusetts Gen Physicians Org, 55 Fruit St, Boston, MA 02114 USA		Yun, BJ (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, 0 Emerson Pl,Suite 3B, Boston, MA 02114 USA.	byun@partners.org	Raja, Ali S./AAE-5103-2019	Yun, Brian/0000-0002-3842-420X			AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Albertine P, 2016, AM J EMERG MED, V34, P521, DOI 10.1016/j.ajem.2015.12.035; Ashkenazi I, 2007, EMERG MED J, V24, P550, DOI 10.1136/emj.2006.044461; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Bir SC, 2015, CLIN NEUROL NEUROSUR, V138, P99, DOI 10.1016/j.clineuro.2015.07.021; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P1180, DOI 10.1136/jnnp.2007.135178; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kreitzer N, 2014, ACAD EMERG MED, V21, P1084, DOI 10.1111/acem.12479; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Nayak NV, 2013, J TRAUMA ACUTE CARE, V75, P273, DOI 10.1097/TA.0b013e3182905eb4; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; SAS Institute Inc, 2012, SAS WIND REL 9 4; Schaller B, 2010, EMERG MED J, V27, P537, DOI 10.1136/emj.2009.073031; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	22	13	13	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	SEP	2017	35	9					1281	1284		10.1016/j.ajem.2017.03.071			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FE0XI	WOS:000407942600014	28385479				2022-02-06	
J	Antonakakis, M; Dimitriadis, SI; Zervakis, M; Papanicolaou, AC; Zouridakis, G				Antonakakis, Marios; Dimitriadis, Stavros I.; Zervakis, Michalis; Papanicolaou, Andrew C.; Zouridakis, George			Altered Rich-Club and Frequency-Dependent Subnetwork Organization in Mild Traumatic Brain Injury: A MEG Resting-State Study	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						magnetoencephalography (MEG); mild traumatic brain injury; network resilience; cross-frequency coupling; intrinsic networks	FUNCTIONAL CONNECTIVITY; DYNAMICS; MAGNETOENCEPHALOGRAPHY; NETWORKS; EEG; REORGANIZATION; FLUCTUATIONS; RECOVERY; MODELS	Functional brain connectivity networks exhibit "small-world" characteristics and some of these networks follow a "rich-club" organization, whereby a few nodes of high connectivity (hubs) tend to connect more densely among themselves than to nodes of lower connectivity. The Current study followed an "attack strategy" to compare the rich-club and small-world network organization models using Magnetoencephalographic (MEG) recordings from mild traumatic brain injury (mTBI) patients and neurologically healthy controls to identify the topology that describes the underlying intrinsic brain network organization. We hypothesized that the reduction in global efficiency caused by an attack targeting a model's hubs would reveal the "true" underlying topological organization. Connectivity networks were estimated using mutual information as the basis for cross-frequency coupling. Our results revealed a prominent rich-club network organization for both groups. In particular, mTBI patients demonstrated hypersynchronization among rich-club hubs compared to controls in the delta band and the delta-gamma(1), theta-gamma(1), and beta-gamma(2) frequency pairs. Moreover, rich-club hubs in mTBI patients were overrepresented in right frontal brain areas, from theta to gamma(1) frequencies, and underrepresented in left occipital regions in the delta-beta, delta-gamma(1), theta-beta, and beta-gamma(2) frequency pairs. These findings indicate that the rich-club organization of resting-state MEG, considering its role in information integration and its vulnerability to various disorders like mTBI, may have a significant predictive value in the development of reliable biomarkers to help the validation of the recovery frommTBI. Furthermore, the proposed approachmight be used as a validation tool to assess patient recovery.	[Antonakakis, Marios] Westfalian Wilhelms Univ Muenster, Inst Biomagnetism & Biosignal Anal, Munster, Germany; [Antonakakis, Marios; Zervakis, Michalis] Tech Univ Crete, Sch Elect & Comp Engn, Digital Image & Signal Proc Lab, Khania, Greece; [Dimitriadis, Stavros I.] Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, Cardiff, S Glam, Wales; [Dimitriadis, Stavros I.] Cardiff Univ, Sch Psychol, CUBRIC, Cardiff, S Glam, Wales; [Dimitriadis, Stavros I.] Cardiff Univ, Sch Psychol, CUBRIC, Neuroinformat Grp, Cardiff, S Glam, Wales; [Dimitriadis, Stavros I.] Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales; [Papanicolaou, Andrew C.] Univ Tennessee, Le Bonheur Childrens Hosp, Dept Pediat, Neurosci Inst,Hlth Sci Ctr, Memphis, TN USA; [Papanicolaou, Andrew C.] Univ Tennessee, Le Bonheur Childrens Hosp, Dept Anat & Neurobiol, Neurosci Inst,Hlth Sci Ctr, Memphis, TN USA; [Zouridakis, George] Univ Houston, Biomed Imaging Lab, Dept Engn Technol, Houston, TX USA; [Zouridakis, George] Univ Houston, Dept Comp Sci, Biomed Imaging Lab, Houston, TX 77204 USA; [Zouridakis, George] Univ Houston, Dept Biomed Engn, Biomed Imaging Lab, Houston, TX USA; [Zouridakis, George] Univ Houston, Dept Elect & Comp Engn, Biomed Imaging Lab, Houston, TX USA		Antonakakis, M (corresponding author), Westfalian Wilhelms Univ Muenster, Inst Biomagnetism & Biosignal Anal, Munster, Germany.; Antonakakis, M (corresponding author), Tech Univ Crete, Sch Elect & Comp Engn, Digital Image & Signal Proc Lab, Khania, Greece.	marios.antonakakis@uni-muenster.de	DIMITRIADIS, STAVROS I/AAN-8992-2020; Antonakakis, Marios/ABD-8218-2020; Zouridakis, George/R-8876-2019	DIMITRIADIS, STAVROS I/0000-0002-0000-5392; Antonakakis, Marios/0000-0003-1173-7895; Zouridakis, George/0000-0002-7770-9857	Department of Defense Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0135]; MRC grantUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K004360/1]; Marie Curie COFUND EU-UK Research Fellowship; National Centre for Mental Health (NCMH) at Cardiff University	The current study is part of a larger project, the Integrated Clinical Protocol, conducted by the Investigators and staff of The Mission Connect Mild Traumatic Brain Injury Translational Research Consortium and supported by the Department of Defense Congressionally Directed Medical Research Program W81XWH-08-2-0135. SD was supported by MRC grant MR/K004360/1 (Behavioral and Neurophysiological Effects of Schizophrenia Risk Genes: A Multi-locus, Pathway Based Approach) and Marie Curie COFUND EU-UK Research Fellowship. This study was supported by the National Centre for Mental Health (NCMH) at Cardiff University. We would like to acknowledge Cardiff RCUK funding scheme.	Alhourani A, 2016, J NEUROPHYSIOL, V116, P1840, DOI 10.1152/jn.00513.2016; Antonakakis M, 2016, INT J PSYCHOPHYSIOL, V102, P1, DOI 10.1016/j.ijpsycho.2016.02.002; Antonakakis M, 2015, IEEE ENG MED BIO, P7426, DOI 10.1109/EMBC.2015.7320108; Athanasiou A, 2018, NEUROSCIENCE, V378, P54, DOI 10.1016/j.neuroscience.2016.05.044; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betzel RF, 2016, NEUROIMAGE, V124, P1054, DOI 10.1016/j.neuroimage.2015.09.041; Bharath RD, 2016, EUR J NEUROL, V23, P1729, DOI 10.1111/ene.13104; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Buzsaki Gyorgy, 2012, Dialogues Clin Neurosci, V14, P345; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Crossley NA, 2016, SCHIZOPHRENIA BULL, V42, P434, DOI 10.1093/schbul/sbv146; da Costa L, 2015, J NEUROL NEUROSUR PS, V86, P1008, DOI 10.1136/jnnp-2014-308571; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; Dimitriadis SI, 2015, COGN NEURODYNAMICS, V9, P371, DOI 10.1007/s11571-015-9330-8; Dimitriadis SI, 2013, NEUROIMAGE, V83, P307, DOI 10.1016/j.neuroimage.2013.06.036; Dimitriadis SI, 2013, BRAIN TOPOGR, V26, P397, DOI 10.1007/s10548-013-0276-z; Dimitriadis S. I., 2014, 13 MED C MED BIOL EN, P1710; Dimitriadis S, 2016, IEEE T NEUR SYS REH, V24, P1017, DOI 10.1109/TNSRE.2016.2516107; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Dimitriadis SI, 2015, ANN BIOMED ENG, V43, P977, DOI 10.1007/s10439-014-1143-0; Dimitriadis SI, 2012, NONLIN DYNAM PSYCHOL, V16, P5; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Florin E, 2015, NEUROIMAGE, V111, P26, DOI 10.1016/j.neuroimage.2015.01.054; Hansen ECA, 2015, NEUROIMAGE, V105, P525, DOI 10.1016/j.neuroimage.2014.11.001; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Levin H. S., 2009, MISSION CONNECT MILD, DOI 10.21236/ADA550012; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Li LY, 2017, BRAIN INJURY, V31, P965; Li LY, 2015, IEEE ENG MED BIO, P6963, DOI 10.1109/EMBC.2015.7319994; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Luo Q, 2013, J NEUROTRAUM, V30, P1702, DOI 10.1089/neu.2012.2679; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Misic B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003427; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Palva JM, 2011, PROG BRAIN RES, V193, P335, DOI 10.1016/B978-0-444-53839-0.00022-3; Pang EW, 2016, ANN CLIN TRANSL NEUR, V3, P124, DOI 10.1002/acn3.280; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schroeter MS, 2015, J NEUROSCI, V35, P5459, DOI 10.1523/JNEUROSCI.4259-14.2015; Senden M, 2014, NEUROIMAGE, V96, P174, DOI 10.1016/j.neuroimage.2014.03.066; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Tewarie P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069318; Tsiaras V, 2011, COMPUT BIOL MED, V41, P1166, DOI 10.1016/j.compbiomed.2011.04.004; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vertes PE, 2015, J CHILD PSYCHOL PSYC, V56, P299, DOI 10.1111/jcpp.12365; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Watanabe T, 2015, SCI REP-UK, V5, DOI 10.1038/srep16152; Zhan J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00027; Zouridakis G., 2016, 20 INT C BIOM BIOMAG; Zouridakis G, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412400064	59	13	13	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	AUG 30	2017	11								416	10.3389/fnhum.2017.00416			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	FF4GA	WOS:000408893900001	28912698	Green Accepted, Green Published, gold			2022-02-06	
J	Zhao, WY; Chen, SB; Wang, JJ; Xu, C; Zhao, ML; Dong, HJ; Liang, HQ; Li, XH; Tu, Y; Zhang, S; Chen, C; Sun, HT				Zhao, Wan-Yong; Chen, Shao-Bo; Wang, Jing-Jing; Xu, Chao; Zhao, Ming-Liang; Dong, Hua-Jiang; Liang, Hai-Qian; Li, Xiao-Hong; Tu, Yue; Zhang, Sai; Chen, Chong; Sun, Hong-Tao			Establishment of an ideal time window model in hypothermic-targeted temperature management after traumatic brain injury in rats	BRAIN RESEARCH			English	Article						Hypothermic-targeted temperature management; Traumatic brain injury; Time window; Effect	MILD HYPOTHERMIA; MODERATE HYPOTHERMIA; POSTTRAUMATIC HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; NEURON APOPTOSIS; CARDIAC-ARREST; DENTATE GYRUS; ADULT MICE; EXPRESSION; PROTEIN	Although hypothermic-targeted temperature management (HTTM) holds great potential for the treatment of traumatic brain injury (TBI), translation of the efficacy of hypothermia from animal models to TBI patients has no entire consistency. This study aimed to find an ideal time window model in experimental rats which was more in accordance with clinical practice through the delayed HTTM intervention. Sprague-Dawley rats were subjected to unilateral cortical contusion injury and received therapeutic hypothermia at 15 mins, 2 h, 4 h respectively after TBI. The neurological function was evaluated with the modified neurological severity score and Morris water maze test. The brain edema and morphological changes were measured with the water content and H&E staining. Brain sections were immunostained with antibodies against DCX (a neuroblast marker) and GFAP (an astrocyte marker). The apoptosis levels in the ipsilateral hippocampi and cortex were examined with antibodies against the apoptotic proteins Bcl-2, Bax, and cleaved caspase-3 by the immunofluorescence and western blotting. The results indicated that each hypothermia therapy group could improve neurobehavioral and cognitive function, alleviate brain edema and reduce inflammation. Furthermore, we observed that therapeutic hypothermia increased DCX expression, decreased GFAP expression, upregulated Bcl-2 expression and downregulated Bax and cleaved Caspase-3 expression. The above results suggested that HTTM at 2 h or even at 4 h post injury revealed beneficial brain protection similarly, despite the best effect at 15 min post-injury. These findings may provide relatively ideal time window models, further making the following experimental results more credible and persuasive. (C) 2017 Elsevier B.V. All rights reserved.	[Zhao, Wan-Yong; Wang, Jing-Jing; Xu, Chao; Zhao, Ming-Liang; Liang, Hai-Qian; Li, Xiao-Hong; Tu, Yue; Zhang, Sai; Chen, Chong; Sun, Hong-Tao] Logist Univ PAPF, Pingjin Hosp, Tianjin Key Lab Neurotrauma Repair, Brain Ctr, Tianjin 300162, Peoples R China; [Chen, Shao-Bo] Logist Univ PAPF, Pingjin Hosp, Heart Ctr, Tianjin Key Lab Cardiovasc Remodeling & Target Or, Tianjin 300162, Peoples R China; [Dong, Hua-Jiang] Tianjin Univ, State Key Lab Precis Measurement Technol & Instru, Tianjin 300072, Peoples R China		Chen, C; Sun, HT (corresponding author), Logist Univ PAPF, Pingjin Hosp, Tianjin Key Lab Neurotrauma Repair, Brain Ctr, Tianjin 300162, Peoples R China.	chongchen12@hotmail.com; chenmo333@163.com		, Dong/0000-0002-4141-3077	National Nature Scientific Fund of China [81471275, 81401067, 81301050]; National Nature Scientific Fund of Tianjin [14JCQNJC10200, 15JCQNJC11100, 15JCYBJC28100, 16JCYBJC27600]	This work was supported by the National Nature Scientific Fund of China (81471275, 81401067, 81301050) and the National Nature Scientific Fund of Tianjin (14JCQNJC10200, 15JCQNJC11100, 15JCYBJC28100, 16JCYBJC27600).	Atkins CM, 2007, EUR J NEUROSCI, V26, P810, DOI 10.1111/j.1460-9568.2007.05720.x; Bramlett HM, 2012, THER HYPOTHERMIA TEM, V2, P14, DOI 10.1089/ther.2012.0002; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Chen C, 2016, NEUROSCIENCE, V335, P114, DOI 10.1016/j.neuroscience.2016.08.038; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Feng JF, 2010, NEUROSURGERY, V67, P730, DOI 10.1227/01.NEU.0000378023.81727.6E; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Guo C, 2016, NEUROSCI LETT, V635, P17, DOI 10.1016/j.neulet.2016.10.031; Hifumi T, 2016, J NEUROTRAUM, V33, P1047, DOI 10.1089/neu.2015.4033; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jia F, 2014, J NEUROTRAUM, V31, P387, DOI 10.1089/neu.2008.0814; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Kwak M, 2015, DEV NEUROSCI-BASEL, V37, P428, DOI 10.1159/000430862; Lee JH, 2017, NEURAL REGEN RES, V12, P341, DOI 10.4103/1673-5374.202915; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mao WF, 2014, INT J NEUROSCI, V124, P281, DOI 10.3109/00207454.2013.838236; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Pilchova I, 2015, CELL MOL NEUROBIOL, V35, P23, DOI 10.1007/s10571-014-0104-3; Polderman KH, 2015, THER HYPOTHERMIA TEM, V5, P73, DOI 10.1089/ther.2014.0031; Radabaugh HL, 2016, EXP NEUROL, V286, P61, DOI 10.1016/j.expneurol.2016.09.015; Robertson CL, 2000, CRIT CARE MED, V28, P3218, DOI 10.1097/00003246-200009000-00017; Schober ME, 2016, J NEUROTRAUM, V33, P390, DOI 10.1089/neu.2015.3945; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; Stocchetti N, 2014, LANCET NEUROL, V13, P14, DOI 10.1016/S1474-4422(13)70280-1; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun HT, 2016, NEUROPSYCH DIS TREAT, V12, DOI 10.2147/NDT.S106915; Tado M, 2014, J NEUROTRAUM, V31, P691, DOI 10.1089/neu.2013.2940; Wang G, 2016, NEURAL REGEN RES, V11, P771, DOI 10.4103/1673-5374.182704; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; Yokobori S, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0137-4; Yokobori Shoji, 2013, Acta Neurochir Suppl, V118, P77, DOI 10.1007/978-3-7091-1434-6_13; Zheng SG, 2015, EUR J PHARMACOL, V750, P52, DOI 10.1016/j.ejphar.2015.01.031	41	13	17	3	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 15	2017	1669						141	149		10.1016/j.brainres.2017.06.006			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC3HM	WOS:000406729700017	28629741				2022-02-06	
J	Dong, XQ; Yu, WH; Du, Q; Wang, H; Zhu, Q; Yang, DB; Che, ZH; Shen, YF; Jiang, L				Dong, Xiao-Qiao; Yu, Wen-Hua; Du, Quan; Wang, Hao; Zhu, Qiang; Yang, Ding-Bo; Che, Zhi-Hao; Shen, Yong-Feng; Jiang, Li			Serum periostin concentrations and outcomes after severe traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Periostin; Severity; Mortality; Outcome; Prognosis; Biomarker	PROGNOSTIC VALUE; MORTALITY; EXPRESSION; CANCER; RISK; PERFORMANCE; MECHANISMS; HEMORRHAGE; PREDICTION; INFARCTION	Background: Periostin, a neurite outgrowth-promoting factor, is increasingly expressed in rat brain tissues after cerebral ischemia or subarachnoid hemorrhage. However, periostin concentrations are undetermined in peripheral blood from patients with traumatic brain injury (TBI). Methods: In this prospective, observational study, serum periostin concentrations were measured in 130 controls and 130 severe TBI patients. We investigated its association with trauma severity reflected by Glasgow Coma Scale (GCS) score and prognosis (i.e., 30-day mortality and 30-day overall survival). Results: As compared with the controls, serum periostin concentrations were significantly increased in the patients [(median, 246.5 ng/ml; interquartile range, 164.5-328.6 ng/ml) vs. (median, 61.8 ng/ml; interquartile range, 37.9-77.9 ng/ml), P < 0.001]. Periostin concentrations independently correlated with GCS scores (t = -6.199, P < 0.001). Serum periostin concentrations higher than 308.2 ng/ml predicted 30-day mortality with a sensitivity of 72.4% and a specificity of 78.2% [area under curve, 815; 95% confidence interval (CI), 0.737-0.878]. Periostin concentrations higher than 246.5 ng/ml were independently related to 30-day mortality and 30-day overall survival with odds ratio value of 3.829 (95% CI, 1.104-13.281) and hazard ratio value of 5.667 (95% CI, 1.953-16.443) respectively. Conclusions: Increased serum periostin concentrations clearly reflect trauma severity and mortality following TBI.	[Dong, Xiao-Qiao; Yu, Wen-Hua; Du, Quan; Wang, Hao; Zhu, Qiang; Yang, Ding-Bo; Che, Zhi-Hao; Shen, Yong-Feng; Jiang, Li] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China		Yu, WH (corresponding author), Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	hzwenhuayu@163.com			Zhejiang Province Medical and Health Project [2014KYA177, 2016RCB016]; Hangzhou Medical Research Fund Project [2014Z06, 2016Z10]	We thank all staffs in Department of Neurosurgery, The Hangzhou First People's Hospital (Hangzhou, China) for their technical support. This study was supported financially by Zhejiang Province Medical and Health Project ( 2014KYA177, 2016RCB016) and Hangzhou Medical Research Fund Project (2014Z06, 2016Z10).	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Amoroso T, 2017, J NERV MENT DIS, V205, P318, DOI 10.1097/NMD.0000000000000621; Andrews PJD, 2017, CRIT CARE MED, V45, P883, DOI 10.1097/CCM.0000000000002376; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Azar S, 2017, METHODS MOL BIOL, V1598, P45, DOI 10.1007/978-1-4939-6952-4_3; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Gorska K, 2016, POL ARCH MED WEWN, V126, P124, DOI 10.20452/pamw.3299; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Guo XF, 2016, ONCOTARGET, V7, P80521, DOI 10.18632/oncotarget.11825; Katsuragi N, 2004, CIRCULATION, V110, P1806, DOI 10.1161/01.CIR.0000142607.33398.54; Kou K, 2014, BRIT J DERMATOL, V171, P283, DOI 10.1111/bjd.12943; Ling L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088755; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Liu L, 2017, STROKE, V48, P1108, DOI 10.1161/STROKEAHA.117.016629; Ma SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113130; Majdan M, 2017, J NEUROSCI RURAL PRA, V8, P20, DOI 10.4103/0976-3147.193543; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Matsunaga E, 2015, DEV GROWTH DIFFER, V57, P200, DOI 10.1111/dgd.12194; Mikheev AM, 2015, NEURO-ONCOLOGY, V17, P372, DOI 10.1093/neuonc/nou161; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; Moniuszko T, 2016, ONCOL LETT, V12, P783, DOI 10.3892/ol.2016.4692; Morita H, 2016, HYPERTENSION, V67, P504, DOI 10.1161/HYPERTENSIONAHA.115.06449; Nuzzo PV, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2139-y; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Oku E, 2008, INT J HEMATOL, V88, P57, DOI 10.1007/s12185-008-0095-2; Ozyurt E, 2015, TURK NEUROSURG, V25, P877, DOI 10.5137/1019-5149.JTN.9181-13.0; Qin JB, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0126-x; Qiu F, 2013, J BIOCHEM MOL TOXIC, V27, P364, DOI 10.1002/jbt.21498; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Semprini R, 2017, J ALLERGY CLIN IMMUN, V139, P1687, DOI 10.1016/j.jaci.2016.11.041; Shen LJ, 2014, CLIN CHIM ACTA, V427, P37, DOI 10.1016/j.cca.2013.09.047; Shi HY, 2014, J NEUROSURG, V121, P1323, DOI 10.3171/2014.8.JNS131526; Shimamura M, 2012, STROKE, V43, P1108, DOI 10.1161/STROKEAHA.111.636662; Tajiri M, 2015, RESPIR INVESTIG, V53, P73, DOI 10.1016/j.resinv.2014.12.003; Taniyama Y, 2016, HYPERTENSION, V67, P356, DOI 10.1161/HYPERTENSIONAHA.115.06265; Tian BX, 2014, TUMOR BIOL, V35, P5877, DOI 10.1007/s13277-014-1778-3; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Xu CH, 2017, ONCOTARGET, V8, P18746, DOI 10.18632/oncotarget.13004; Zhang ZY, 2014, PEPTIDES, V60, P13, DOI 10.1016/j.peptides.2014.07.016	42	13	13	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	AUG	2017	471						298	303		10.1016/j.cca.2017.06.020			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	FD2ZK	WOS:000407403100049	28668564				2022-02-06	
J	Hakimizadeh, E; Shamsizadeh, A; Roohbakhsh, A; Arababadi, MK; Hajizadeh, MR; Shariati, M; Rahmani, MR; Allahtavakoli, M				Hakimizadeh, Elham; Shamsizadeh, Ali; Roohbakhsh, Ali; Arababadi, Mohammad Kazemi; Hajizadeh, Mohammad R.; Shariati, Mehdi; Rahmani, Mohammad R.; Allahtavakoli, Mohammad			Inhibition of transient receptor potential vanilloid-1 confers neuroprotection, reduces tumor necrosis factor-alpha, and increases IL-10 in a rat stroke model	FUNDAMENTAL & CLINICAL PHARMACOLOGY			English	Article						cerebral ischemia; IL-10; neuroprotection; transient receptor potential vanilloid-1; tumor necrosis factor-alpha	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; TNF-ALPHA; ANTIINFLAMMATORY CYTOKINES; INDUCED HYPOTHERMIA; EMBOLIC STROKE; INFARCT VOLUME; INFLAMMATION; TRPV1; MICE	Stroke is a major cause of mortality and long-term disability in adults. Transient receptor potential vanilloid-1 (TRPV1) plays a crucial role in neuroinflammation. In this study, the effects of TRPV1 agonist (capsaicin) and antagonist (AMG9810) on cerebral ischemia were investigated. Forty male Wistar rats were assigned to the following experimental groups: sham, vehicle) ischemic), AMG9810 (selective TRPV1 antagonist, 0.5 mg/kg; 3 h after stroke), and capsaicin (1 mg/kg; 3 h after stroke). Stroke was induced by permanent middle cerebral artery occlusion and neurological deficits were evaluated 1, 3, and 7 days after stroke. Then, infarct volume, brain edema, body temperature, mRNA expression of TRPV1, and serum concentrations of tumor necrosis factor-alpha (TNF-) and IL-10 were measured. Compared to the vehicle group, AMG9810 significantly decreased the infarct volume (P < 0.01). Latency for the removal of sticky labels from the forepaw and the hanging time were significantly decreased and increased, respectively, following administration of AMG9810 (P < 0.01 and P < 0.001 vs. vehicle) 3 and 7 days after stroke. Compared to the sham group, the mRNA expression of TRPV1 was significantly increased in vehicle group (P < 0.01). Administration of AMG9810 significantly increased the anti-inflammatory cytokine IL-10 and decreased the inflammatory cytokine TNF- (P < 0.05). Moreover, our results indicate that AMG9810 might a promising candidate for the hypothermic treatment of stroke. The findings also suggest a key role for AMG9810 in reducing inflammation after stroke and imply that TRPV1 could be a potential target for the treatment of ischemic stroke.	[Hakimizadeh, Elham] Rafsanjan Univ Med Sci, Physiol Pharmacol Res Ctr, Emam Ali Blvd, Rafsanjan 7717933777, Iran; [Shamsizadeh, Ali; Rahmani, Mohammad R.; Allahtavakoli, Mohammad] Rafsanjan Univ Med Sci, Sch Med, Dept Physiol & Pharmacol, Emam Ali Blvd, Rafsanjan 7717933777, Iran; [Roohbakhsh, Ali] Mashhad Univ Med Sci, Pharmaceut Res Ctr, Univ St, Mashhad 1394491388, Iran; [Arababadi, Mohammad Kazemi] Rafsanjan Univ Med Sci, Fac Paramed, Dept Lab Sci, Emam Ali Blvd, Rafsanjan 7717933777, Iran; [Hajizadeh, Mohammad R.] Rafsanjan Univ Med Sci, Mol Med Res Ctr, Dept Biochem, Emam Ali Blvd, Rafsanjan 7717933777, Iran; [Shariati, Mehdi] Rafsanjan Univ Med Sci, Sch Med, Dept Anat, Emam Ali Blvd, Rafsanjan 7717933777, Iran		Allahtavakoli, M (corresponding author), Rafsanjan Univ Med Sci, Sch Med, Dept Physiol & Pharmacol, Emam Ali Blvd, Rafsanjan 7717933777, Iran.	mohammadatir@yahoo.com	Roohbakhsh, Ali/H-4060-2017; Shamsizadeh, Ali/D-3807-2017; Rahmani, Mohammadreza/M-6533-2017; Kazemi Arababadi, Mohammad/H-5282-2017; Hakimizadeh, Elham/N-5810-2018	Roohbakhsh, Ali/0000-0001-5032-4263; Shamsizadeh, Ali/0000-0001-8329-9156; Rahmani, Mohammadreza/0000-0001-7395-5770; Kazemi Arababadi, Mohammad/0000-0002-4829-1586; Kazemi Arababadi, Mohammad/0000-0002-4315-8153; Mirzaei, Mohammad Reza/0000-0001-9799-7377; Hakimizadeh, Elham/0000-0002-2811-7716	Rafsanjan University of Medical Sciences, Iran [9/20/794]	This study was financially supported by the Grant no 9/20/794 from the Research Vice Chancellor of the Rafsanjan University of Medical Sciences, Iran.	Allahtavakoli M, 2007, BASIC CLIN PHARMACOL, V101, P309, DOI 10.1111/j.1742-7843.2007.00127.x; Allahtavakoli M, 2011, BRAIN RES BULL, V85, P219, DOI 10.1016/j.brainresbull.2011.03.019; Borghi SM, 2013, J NAT PROD, V76, P1141, DOI 10.1021/np400222v; Cao ZJ, 2014, AM J PHYSIOL-REG I, V306, pR149, DOI 10.1152/ajpregu.00329.2013; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109842; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fu J, 2012, NAT NEUROSCI, V15, P64, DOI 10.1038/nn.2986; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hattori K, 2000, STROKE, V31, P1939, DOI 10.1161/01.STR.31.8.1939; Hernandez-Guillamon M, 2015, J BIOL CHEM, V290, P15078, DOI 10.1074/jbc.M114.610931; Institute for Laboratory Animal Resources, 1996, GUIDE CARE USE LAB A; John T, 2007, CYTOKINE, V40, P226, DOI 10.1016/j.cyto.2007.10.002; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Keeble J, 2005, ARTHRITIS RHEUM, V52, P3248, DOI 10.1002/art.21297; Khatibi NH, 2011, ACTA NEUROCHIR SUPPL, V111, P225, DOI 10.1007/978-3-7091-0693-8_38; Kuroda S, 1997, CLIN NEUROSCI, V4, P199; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lapointe TK, 2011, CHANNELS, V5, P525, DOI 10.4161/chan.5.6.18016; Lehto SG, 2008, J PHARMACOL EXP THER, V326, P218, DOI 10.1124/jpet.107.132233; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Liu N, 2009, CELL MOL IMMUNOL, V6, P207, DOI 10.1038/cmi.2009.28; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Miyanohara J, 2015, BIOCHEM BIOPH RES CO, V467, P478, DOI 10.1016/j.bbrc.2015.10.027; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Muzzi M, 2012, J CEREBR BLOOD F MET, V32, P978, DOI 10.1038/jcbfm.2012.36; Ooboshi H, 2005, CIRCULATION, V111, P913, DOI 10.1161/01.CIR.0000155622.68580.DC; Ouk T, 2014, FUND CLIN PHARMACOL, V28, P294, DOI 10.1111/fcp.12035; Pegorini S, 2005, BRIT J PHARMACOL, V144, P727, DOI 10.1038/sj.bjp.0706115; Petrault M., 2016, FUND CLIN PHARM, V30, P12246; Pinto A, 2008, METABOLISM, V57, P676, DOI 10.1016/j.metabol.2008.01.004; Planells-Cases R, 2011, ADV EXP MED BIOL, V704, P491, DOI 10.1007/978-94-007-0265-3_27; RENNICK D, 1995, CLIN IMMUNOL IMMUNOP, V76, pS174, DOI 10.1016/S0090-1229(95)90144-2; Schomacher M, 2008, BRAIN RES, V1240, P213, DOI 10.1016/j.brainres.2008.09.019; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; Tarkowski E, 1997, CLIN EXP IMMUNOL, V110, P492, DOI 10.1046/j.1365-2249.1997.4621483.x; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; vansExel E, 2002, STROKE, V33, P1135; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Xing BZ, 2008, STROKE, V39, P2362, DOI 10.1161/STROKEAHA.107.507939; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Zheng Z, 2004, NEUROL RES, V26, P884, DOI 10.1179/016164104X2357; Zielinska M, 2015, INFLAMM BOWEL DIS, V21, P419, DOI 10.1097/MIB.0000000000000234	46	13	17	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0767-3981	1472-8206		FUND CLIN PHARMACOL	Fundam. Clin. Pharmacol.	AUG	2017	31	4					420	428		10.1111/fcp.12279			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	EZ7EY	WOS:000404885500006	28199737				2022-02-06	
J	Howrey, BT; Graham, JE; Pappadis, MR; Granger, CV; Ottenbacher, KJ				Howrey, Bret T.; Graham, James E.; Pappadis, Monique R.; Granger, Carl V.; Ottenbacher, Kenneth J.			Trajectories of Functional Change After Inpatient Rehabilitation for Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Recovery of function; Rehabilitation; Traumatic brain injury	INDEPENDENCE MEASURE; ETHNIC DISPARITIES; MINORITY STATUS; OUTCOMES; DISCHARGE; RECOVERY; CARE; VALIDITY; MODERATE; SYSTEM	Objective: To examine trajectories of functional recovery after rehabilitation for traumatic brain injury (TBI). Design: Prospective study. Setting: Inpatient rehabilitation hospitals in the Uniform Data System for Medical Rehabilitation. Participants: A subset of individuals receiving inpatient rehabilitation services for TBI from 2002 to 2010 who also had postdischarge measurement of functional independence (N=16,583). Interventions: Inpatient rehabilitation. Main Outcomes Measures: Admission, discharge, and follow-up data were obtained from the Uniform Data System for Medical Rehabilitation. We used latent class mixture models to examine recovery trajectories for both cognitive and motor functioning as measured by the FIM instrument. Results: Latent class models identified 3 trajectories (low, medium, high) for both cognitive and motor FIM subscales. Factors associated with membership in the low cognition trajectory group included younger age, male sex, racial/ethnic minority, Medicare or Medicaid (vs commercial or other insurance), comorbid conditions, and greater duration from injury date to rehabilitation admission date. Factors associated with membership in the low motor trajectory group included older age, racial/ethnic minority, Medicare or Medicaid coverage, comorbid conditions, open head injury, and greater duration to admission. Conclusions: Standard approaches to assessing recovery patterns after TBI obscure differences between subgroups with trajectories that differ from the overall mean. Select demographic and clinical characteristics can help classify patients with TBI into distinct functional recovery trajectories, which can enhance both patient-centered care and quality improvement efforts. (C) 2017 Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Howrey, Bret T.] Univ Texas Med Branch, Dept Family Med, 301 Univ Blvd, Galveston, TX 77555 USA; [Graham, James E.; Pappadis, Monique R.; Ottenbacher, Kenneth J.] Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX 77555 USA; [Granger, Carl V.] Univ Buffalo, Sch Med & Biomed Sci, Dept Neurol, Buffalo, NY USA		Howrey, BT (corresponding author), Univ Texas Med Branch, Dept Family Med, 301 Univ Blvd, Galveston, TX 77555 USA.	bthowrey@utmb.edu		Ottenbacher, Kenneth/0000-0001-5990-3982; Pappadis, Monique R./0000-0003-4742-4380	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD069443, R24 HD065702]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069443, R24HD065702] Funding Source: NIH RePORTER	Supported in part by the National Institutes of Health (grant nos. R01 HD069443 and R24 HD065702).	Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Buntin MB, 2005, HEALTH SERV RES, V40, P413, DOI 10.1111/j.1475-6773.2005.0i366.x; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Dahdah MN, 2016, ARCH PHYS MED REHAB, V97, P1821, DOI 10.1016/j.apmr.2016.05.005; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Freburger JK, 2011, ARCH PHYS MED REHAB, V92, P1220, DOI 10.1016/j.apmr.2011.03.019; Graham JE, 2014, AM J PHYS MED REHAB, V93, P231, DOI 10.1097/PHM.0b013e3182a92c58; Graham JE, 2010, PHYS THER, V90, P1591, DOI 10.2522/ptj.20100018; Hart T, 2007, J HEAD TRAUMA REHAB, V22, P122, DOI 10.1097/01.HTR.0000265100.37059.44; Hart T, 2014, ARCH PHYS MED REHAB, V95, P2103, DOI 10.1016/j.apmr.2014.07.001; Heinemann Allen W, 1994, Top Stroke Rehabil, V1, P1; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2013, SOCIOL METHOD RES, V42, P608, DOI 10.1177/0049124113503141; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lequerica A, 2015, BRAIN INJURY, V29, P1445, DOI 10.3109/02699052.2015.1075144; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Muthen B, 1999, BIOMETRICS, V55, P463, DOI 10.1111/j.0006-341X.1999.00463.x; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Newhouse JP, 2013, JAMA-J AM MED ASSOC, V310, P1227, DOI 10.1001/jama.2013.278139; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Sirois MJ, 2004, ARCH PHYS MED REHAB, V85, P184, DOI 10.1016/j.apmr.2003.06.009; Smith PM, 1996, ARCH PHYS MED REHAB, V77, P431, DOI 10.1016/S0003-9993(96)90029-5; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; TEASDALE G, 1974, LANCET, V2, P81; Wasserman L, 2000, J MATH PSYCHOL, V44, P92, DOI 10.1006/jmps.1999.1278; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0	48	13	13	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2017	98	8					1606	1613		10.1016/j.apmr.2017.03.009			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FD1OF	WOS:000407305900013	28392325	Green Accepted			2022-02-06	
J	Bernier, RA; Roy, A; Venkatesan, UM; Grossner, EC; Brenner, EK; Hillary, FG				Bernier, Rachel Anne; Roy, Arnab; Venkatesan, Umesh Meyyappan; Grossner, Emily C.; Brenner, Einat K.; Hillary, Frank Gerard			Dedifferentiation Does not account for hyperconnectivity after Traumatic Brain injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; TBI; functional connectivity; dedifferentiation; graph theory	STATE FUNCTIONAL CONNECTIVITY; TRANSCRANIAL MAGNETIC STIMULATION; WORKING-MEMORY; DEFAULT MODE; NEURAL SPECIALIZATION; GRAPH ANALYSIS; OLDER-ADULTS; NETWORK; ATTENTION; AGE	Objective: Changes in functional network connectivity following traumatic brain injury (TBI) have received increasing attention in recent neuroimaging literature. This study sought to understand how disrupted systems adapt to injury during resting and goal-directed brain states. Hyperconnectivity has been a common finding, and dedifferentiation (or loss of segregation of networks) is one possible explanation for this finding. We hypothesized that individuals with TBI would show dedifferentiation of networks (as noted in other clinical populations) and these effects would be associated with cognitive dysfunction. Methods: Graph theory was implemented to examine functional connectivity during periods of task and rest in 19 individuals with moderate/severe TBI and 14 healthy controls (HCs). Using a functional brain atlas derived from 83 functional imaging studies, graph theory was used to examine network dynamics and determine whether dedifferentiation accounts for changes in connectivity. Regions of interest were assigned to one of three groups: task-positive, default mode, or other networks. Relationships between these metrics were then compared with performance on neuropsychological tests. Results: Hyperconnectivity in TBI was most commonly observed as increased within-network connectivity. Network strengths within networks that showed differences between TBI and HCs were correlated with performance on five neuropsychological tests typically sensitive to deficits commonly reported in TBI. Hyperconnectivity within the default mode network (DMN) during task was associated with better performance on Digit Span Backward, a measure of working memory [R-2(18) = 0.28, p = 0.02]. In other words, increased differentiation of networks during task was associated with better working memory. Hyperconnectivity within the task-positive network during rest was not associated with behavior. Negative correlation weights were not associated with behavior. Csonclusion: The primary hypothesis that hyperconnectivity occurs through increased segregation of networks, rather than dedifferentiation, was not supported. Instead, enhanced connectivity post injury was observed within network. Results suggest that the relationship between increased connectivity and cognitive functioning may be both state (rest or task) and network dependent. High-cost network hubs were identical for both rest and task, and cost was negatively associated with performance on measures of psychomotor speed and set-shifting.	[Bernier, Rachel Anne; Roy, Arnab; Venkatesan, Umesh Meyyappan; Grossner, Emily C.; Brenner, Einat K.; Hillary, Frank Gerard] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Bernier, Rachel Anne; Roy, Arnab; Venkatesan, Umesh Meyyappan; Grossner, Emily C.; Brenner, Einat K.; Hillary, Frank Gerard] Social Life & Engn Sci Imaging Ctr, University Pk, PA 16802 USA; [Hillary, Frank Gerard] Hershey Med Ctr, Dept Neurol, Hershey, PA USA		Bernier, RA (corresponding author), Penn State Univ, Dept Psychol, University Pk, PA 16802 USA.; Bernier, RA (corresponding author), Social Life & Engn Sci Imaging Ctr, University Pk, PA 16802 USA.	rub221@psu.edu	Hillary, Frank/AAN-8622-2021	Bernier, Rachel/0000-0002-2759-9186	Social Sciences Research Institute, in University Park, PA, USA; Penn State CTSI Grant from National Center for Advancing Translational Sciences, National Institutes of Health [UL Tr000127]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002014, UL1TR000127] Funding Source: NIH RePORTER	This project was supported by the Social Sciences Research Institute, in University Park, PA, USA and the Penn State CTSI Grant (UL Tr000127) from the National Center for Advancing Translational Sciences, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Anticevic A, 2012, P NATL ACAD SCI USA, V109, P16720, DOI 10.1073/pnas.1208494109; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Berlingeri M, 2013, EXP BRAIN RES, V224, P393, DOI 10.1007/s00221-012-3319-x; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Carp J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029411; Daselaar SM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.013.2009; Dennis Nancy A, 2011, Neurobiol Aging, V32, DOI 10.1016/j.neurobiolaging.2010.04.004; Dobryakova E, 2015, BRAIN CONNECT, V5, P433, DOI 10.1089/brain.2014.0283; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2012, NEUROIMAGE, V62, P2232, DOI 10.1016/j.neuroimage.2012.03.035; Goh JOS, 2011, AGING DIS, V2, P30; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mazaika P. K., 2009, NEUROLMAGE S1, V47, pS58, DOI DOI 10.1016/S1053-8119(09)70238-1; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Parente F, 2018, BRAIN IMAGING BEHAV, V12, P467, DOI 10.1007/s11682-017-9715-x; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Payer D, 2006, NEUROREPORT, V17, P487, DOI 10.1097/01.wnr.0000209005.40481.31; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; R Core Team, 2014, R LANG ENV STAT COMP; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170541; Roy A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00146; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sours C, 2018, BRAIN IMAGING BEHAV, V12, P697, DOI 10.1007/s11682-017-9724-9; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; TEASDALE G, 1974, LANCET, V2, P81; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	49	13	13	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 17	2017	8								297	10.3389/fneur.2017.00297			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FB9TK	WOS:000406481700001	28769858	gold, Green Published			2022-02-06	
J	Boccia, M; Marin, D; D'Antuono, G; Ciurli, P; Incoccia, C; Antonucci, G; Guariglia, C; Piccardi, L				Boccia, Maddalena; Marin, Dario; D'Antuono, Giovanni; Ciurli, Paola; Incoccia, Chiara; Antonucci, Gabriella; Guariglia, Cecilia; Piccardi, Laura			The Tower of London (ToL) in Italy: standardization of the ToL test in an Italian population	NEUROLOGICAL SCIENCES			English	Article						Tower of London; Executive deficit; Planning; Problem-solving; Frontal lobe; Normative data	EXECUTIVE FUNCTION DEFICITS; MILD COGNITIVE IMPAIRMENT; FLUID INTELLIGENCE; TASK; PERFORMANCE; ABILITIES; ADULTS; METAANALYSIS; PREDICTORS; DEMENTIA	Deficit in planning and problem-solving, affecting a wide range of neuropsychological patients, has been widely investigated using the Tower of London (ToL) test, as developed by Shallice (Philos Trans R Soc Lond Ser B Biol Sci 298:199-209, 1). The ToL taps on several executive functions (EF), such as planning, time for planning or rule breaks, which may be usefully indexed by different ToL measurements. However, in its original version, the different aspects involved in ToL are not evaluated in a specific way. Here, we report the standardization of the ToL, on 896 individuals aged 15-86 years, taking in account individual factors (i.e. gender, age, years of education) which may affect performances on ToL. We computed several indexes on the ToL including score, planning and execution times, perseverations, rule breaks and self-monitoring. We found that these indexes were affected by individual factors such as gender, age and education. Present results not only provide extensive normative data according to gender, as well as different age and education ranges, but also represent a very useful instrument for a more fine-grained diagnosis of EF deficits in a wide range of neuropsychological patients, including traumatic brain injury and brain-damaged patients, as well as Alzheimer's disease and Parkinson's disease patients.	[Boccia, Maddalena; D'Antuono, Giovanni; Antonucci, Gabriella; Guariglia, Cecilia] Sapienza Univ Rome, Dept Psychol, Rome, Italy; [Boccia, Maddalena; Ciurli, Paola; Incoccia, Chiara; Antonucci, Gabriella; Guariglia, Cecilia; Piccardi, Laura] IRCCS Fdn Santa Lucia Rome, Neuropsychol Unit, Rome, Italy; [Marin, Dario] IMFR Gervasutta Hosp, Udine, Italy; [Piccardi, Laura] Aquila Univ, Dept Life Hlth & Environm Sci, Laquila, Italy		Boccia, M (corresponding author), Sapienza Univ Rome, Dept Psychol, Rome, Italy.; Boccia, M (corresponding author), IRCCS Fdn Santa Lucia Rome, Neuropsychol Unit, Rome, Italy.	maddalena.boccia@uniroma1.it	D'Antuono, Giovanni/AAF-1130-2021; ANTONUCCI, GABRIELLA/F-3827-2011; Piccardi, laura/AAC-7587-2022; Boccia, Maddalena/I-4575-2018	ANTONUCCI, GABRIELLA/0000-0003-0253-9029; Boccia, Maddalena/0000-0002-2044-8326; Incoccia, Chiara/0000-0003-4068-6548; guariglia, cecilia/0000-0001-7474-6030; Piccardi, Laura/0000-0002-1322-5538			Andres P, 2000, J GERONTOL B-PSYCHOL, V55, pP373, DOI 10.1093/geronb/55.6.P373; Andrews G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01032; [Anonymous], 1987, Ital J Neurol Sci, VSuppl 8, P1; Basso A, 1987, Funct Neurol, V2, P189; Bianchi A, 2008, NEUROL SCI, V29, P209, DOI 10.1007/s10072-008-0970-x; Boghi A, 2006, NEUROIMAGE, V33, P999, DOI 10.1016/j.neuroimage.2006.07.022; Bugg JM, 2006, BRAIN COGNITION, V62, P9, DOI 10.1016/j.bandc.2006.02.006; Carder HP, 2004, Q J EXP PSYCHOL-A, V57, P1459, DOI 10.1080/02724980343000864; Carlin D, 2000, NEUROPSYCHOLOGIA, V38, P655, DOI 10.1016/S0028-3932(99)00102-5; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P1; Culbertson WC, 2004, ASSESSMENT, V11, P27, DOI 10.1177/1073191103258590; D'Antuono G, 2016, APPL NEUROPSYCH-ADUL, V20, P1; KRIKORIAN R, 1994, J CLIN EXP NEUROPSYC, V16, P840, DOI 10.1080/01688639408402697; Lam BYH, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-138; Nitschke K, 2017, HUM BRAIN MAPP, V38, P396, DOI 10.1002/hbm.23368; Paolucci S, 2012, EUR J PHYS REHAB MED, V48, P455; Phillips LH, 1999, MEMORY, V7, P209, DOI 10.1080/741944066; Phillips LH, 2002, EMOTION, V2, P263, DOI 10.1037/1528-3542.2.3.263; Rabbitt P, 2000, PSYCHOL RES-PSYCH FO, V63, P308, DOI 10.1007/s004269900009; Rainville C, 2002, ARCH CLIN NEUROPSYCH, V17, P513, DOI 10.1016/S0887-6177(01)00132-9; Rainville C, 2012, J CLIN EXP NEUROPSYC, V34, P306, DOI 10.1080/13803395.2011.639298; Raven J. C., 1938, STANDARD PROGR MATRI; Riccio CA, 2004, ARCH CLIN NEUROPSYCH, V19, P661, DOI 10.1016/j.acn.2003.09.001; Sanchez-Benavides G, 2010, J INT NEUROPSYCH SOC, V16, P836, DOI 10.1017/S135561771000069X; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sullivan JR, 2009, APPL NEUROPSYCHOL, V16, P62, DOI 10.1080/09084280802644243; Unterrainer JM, 2004, J CLIN EXP NEUROPSYC, V26, P846, DOI 10.1080/13803390490509574; Unterrainer JM, 2006, J PHYSIOL-PARIS, V99, P308, DOI 10.1016/j.jphysparis.2006.03.014; Zook N, 2006, AGING NEUROPSYCHOL C, V13, P1, DOI 10.1080/13825580490904183; Zook NA, 2004, BRAIN COGNITION, V56, P286, DOI 10.1016/j.bandc.2004.07.003	30	13	14	0	10	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JUL	2017	38	7					1263	1270		10.1007/s10072-017-2957-y			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EZ3KT	WOS:000404610500013	28432516	Green Published			2022-02-06	
J	Lee, JK; Wu, J; Banks, S; Bernick, C; Massand, MG; Modic, MT; Ruggieri, P; Jones, SE				Lee, J. K.; Wu, J.; Banks, S.; Bernick, C.; Massand, M. G.; Modic, M. T.; Ruggieri, P.; Jones, S. E.			Prevalence of Traumatic Findings on Routine MRI in a Large Cohort of Professional Fighters	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							CAVUM SEPTI PELLUCIDI; BRAIN-INJURY; WHITE-MATTER; CEREBRAL MICROHEMORRHAGES; FOOTBALL PLAYERS; AMATEUR BOXERS; ABNORMALITIES; DEMENTIA; HEALTH; VERGAE	BACKGROUND AND PURPOSE: Previous studies investigating MR imaging abnormalities among fighters have had small sample sizes. This investigation assessed a large number of fighters using the same conventional sequences on the same scanner. MATERIALS AND METHODS: Conventional 3T MR imaging was used to assess 499 fighters (boxers, mixed martial artists, and martial artists) and 62 controls for nonspecific WM changes, cerebral microhemorrhage, cavum septum pellucidum, and cavum vergae. The lengths of the cavum septum pellucidum and cavum vergae and the ratio of cavum septum pellucidum to the septum pellucidum lengths were assessed. RESULTS: The prevalence of nonspecific WM changes was similar between groups. Fighters had a prevalence of cerebral microhemorrhage (4.2% versus 0% for controls, P = .152). Fighters had a higher prevalence of cavum septum pellucidum versus controls (53.1% versus 17.7%, P < .001) and cavum vergae versus controls (14.4% versus 0%, P < .001). The lengths of the cavum septum pellucidum plus the cavum vergae (P < .001), cavum septum pellucidum (P = .025), and cavum septum pellucidum to the septum pellucidum length ratio (P = .009) were higher in fighters than in controls. The number of fights slightly correlated with cavum septum pellucidum plus cavum vergae length (R= 0.306, P < .001) and cavum septum pellucidum length (R = 0.278, P < .001). When fighters were subdivided into boxers, mixed martial artists, and martial artists, results were similar to those in the whole-group analysis. CONCLUSIONS: This study assessed MR imaging findings in a large cohort demonstrating a significantly increased prevalence of cavum septum pellucidum among fighters. Although cerebral microhemorrhages were higher in fighters than in controls, this finding was not statistically significant, possibly partially due to underpowering of the study.	[Lee, J. K.; Wu, J.; Massand, M. G.; Modic, M. T.; Ruggieri, P.; Jones, S. E.] Cleveland Clin, Imaging Inst, 9500 Euclid Ave,L10, Cleveland, OH 44195 USA; [Banks, S.; Bernick, C.] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Cleveland, OH 44106 USA		Lee, JK (corresponding author), Cleveland Clin, Imaging Inst, 9500 Euclid Ave,L10, Cleveland, OH 44195 USA.	leej13@ccf.org		Banks, Sarah/0000-0001-7536-2370; Ruggieri, Paul/0000-0002-9723-561X	HBO; Lincy Foundation; Ultimate Fighting Championship; Spike TV/Bellator MMA; Top Rank Promotions; Golden Boy Promotions; August Rapone Family Foundation; Haymon Boxing	This work was supported by HBO, the Lincy Foundation, Ultimate Fighting Championship, Spike TV/Bellator MMA, Top Rank Promotions, Golden Boy Promotions, the August Rapone Family Foundation, and Haymon Boxing.	Aviv RI, 2010, CAN ASSOC RADIOL J, V61, P29, DOI 10.1016/j.carj.2009.09.002; Banks SJ, 2014, J NEUROPSYCH CLIN N, V26, P44, DOI 10.1176/appi.neuropsych.12070185; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bernick C, 2013, AM J EPIDEMIOL, V178, P280, DOI 10.1093/aje/kws456; Bodensteiner JB, 1997, SPORTS MED, V24, P361, DOI 10.2165/00007256-199724060-00002; Born CM, 2004, EUR ARCH PSY CLIN N, V254, P295, DOI 10.1007/s00406-004-0496-z; Cassasa CB, 1924, P NEW YORK PATH SOC, P101; Casson Ira R, 2006, Neurosurgery, V58, pE1003, DOI 10.1227/01.NEY.0000217313.15590.C5; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Clark AL, 2016, BRAIN INJURY, V30, P864, DOI 10.3109/02699052.2016.1144894; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P297; Hahnel S, 2008, AM J NEURORADIOL, V29, P388, DOI 10.3174/ajnr.A0799; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; LEVIN HS, 1987, J NEUROSURG, V67, P657, DOI 10.3171/jns.1987.67.5.0657; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; OTERUELO FT, 1986, ANAT ANZEIGER, V162, P271; Pauling KJ, 1998, PEDIATR NEUROL, V19, P195, DOI 10.1016/S0887-8994(98)00040-X; Pittella JEH, 2005, SURG NEUROL, V63, P30, DOI 10.1016/j.surneu.2004.09.012; Qureshi AI, 2015, J STROKE CEREBROVASC, V24, P1217, DOI 10.1016/j.jstrokecerebrovasdis.2015.01.020; SCHWIDDE JT, 1952, AMA ARCH NEUROL PSY, V67, P625, DOI 10.1001/archneurpsyc.1952.02320170043006; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Silk T, 2013, PSYCHIAT RES-NEUROIM, V213, P186, DOI 10.1016/j.pscychresns.2013.03.001; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Zhang L, 2006, AM J NEURORADIOL, V27, P2000	37	13	13	0	3	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	JUL	2017	38	7					1303	1310		10.3174/ajnr.A5175			8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FA6PB	WOS:000405565100008	28473342	hybrid, Green Published			2022-02-06	
J	Nelson, LD; Loman, MM; LaRoche, AA; Furger, RE; McCrea, MA				Nelson, Lindsay D.; Loman, Michelle M.; LaRoche, Ashley A.; Furger, Robyn E.; McCrea, Michael A.			Baseline Performance and Psychometric Properties of the Child Sport Concussion Assessment Tool 3 (Child-SCAT3) in 5-to 13-year-old Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						children; youth; concussion; assessment; normative data; child sport concussion assessment tool	TRAUMATIC BRAIN-INJURY; ERROR SCORING SYSTEM; HEAD-INJURY; ADOLESCENTS; MANAGEMENT; QUESTIONS; STATEMENT; IMPACT; ADULT; SCAT2	Objective: To determine the normative, baseline performance and psychometric properties of the Child Sport Concussion Assessment Tool 3 (Child-SCAT3) in 5- to 13-year-old athletes. Design: Cross-sectional study. Setting: Practice fields. Participants: Contact sport athletes (N = 155) 5 to 13 years old. Independent Variables: Age, gender, verbal intellectual functioning (receptive vocabulary). Main Outcome Measures: Child-SCAT3: self-reported and parent-reported symptoms, cognitive performance (child form of the Standardized Assessment of Concussion; SAC-C), and balance ( modified Balance Error Scoring System, mBESS-C; tandem gait). A subset of the sample repeated the Child-SCAT3 at another date. Some subjects also completed the Adult-SCAT3 version of the symptom checklist and mBESS. Results: Small-to-medium-sized effects of age were observed on all Child-SCAT3 components. Effects of gender and receptive vocabulary were observed on select components of the SCAT3. Younger age and lower receptive vocabulary were independently associated with greater symptom endorsement, yet parents rated higher symptom burden for older children. Internal consistency reliability and stability of symptom ratings was good to excellent. Stability was more modest for SAC-C and tandem gait scores and very poor for mBESS-C scores, perhaps due to restricted variance. Inter-rater reliability (self-rated vs parent-rated symptoms) was fair. Conclusions: The Child-SCAT3 self-report symptom checklist may be inappropriate to administer to younger school-aged children. Some of the age effects observed warrant use of demographically appropriate norms in Child-SCAT3 interpretation. The findings can provide guidance for clinicians assessing children of varying ages and point to directions for further development of refined approaches for pediatric concussion assessment.	[Nelson, Lindsay D.; LaRoche, Ashley A.; Furger, Robyn E.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.; Loman, Michelle M.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA		Nelson, LD (corresponding author), 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	linelson@mcw.edu		LaRoche, Ashley/0000-0003-0197-0853	Charles D. Jacobus Family Foundation; Clinical and Translational Science Institute grant [1UL1-RR031973 (-01)]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8UL1TR000055]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436, UL1TR000055] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR031973] Funding Source: NIH RePORTER	Supported by the Charles D. Jacobus Family Foundation and the students of Norway Middle School in Muskego, WI. The REDCap electronic database service used in the study was supported by the Clinical and Translational Science Institute grant 1UL1-RR031973 (-01) and by the National Center for Advancing Translational Sciences, National Institutes of Health grant 8UL1TR000055. The manuscript's contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Bell NL, 2001, J CLIN PSYCHOL, V57, P417, DOI 10.1002/jclp.1024; Brady MS, 1999, APPL DEV SCI, V3; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brubacher SR, 2015, DEV REV, V36, P15, DOI 10.1016/j.dr.2015.01.001; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Dunn L. M., 2007, PPVT 4 PEABODY PICTU; Fritzley VH, 2013, CHILD DEV, V84, P711, DOI 10.1111/cdev.12006; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Harris JF, 1990, J COGN DEV, V5, P223; Herring SA, 2011, MED SCI SPORTS EXERC, V43, P2412; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Mehrani MB, 2011, FIRST LANG, V31, P214, DOI 10.1177/0142723710391886; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Peterson C, 2001, CAN J BEHAV SCI, V33, P118, DOI 10.1037/h0087134; PICKLES W, 1950, NEW ENGL J MED, V242, P607, DOI 10.1056/NEJM195004202421602; Pratt, 1990, FIRST LANG, V10, P167, DOI [10.1177/014272379001002905, DOI 10.1177/014272379001002905]; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Susco TM, 2004, J ATHL TRAINING, V39, P241; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732; Wandrey L, 2012, PSYCHOL PUBLIC POL L, V18, P79, DOI 10.1037/a0024812	34	13	13	1	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2017	27	4					381	387		10.1097/JSM.0000000000000369			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	EZ4EA	WOS:000404663800013	27428682	Green Accepted			2022-02-06	
J	Sekhon, MS; Gooderham, P; Toyota, B; Kherzi, N; Hu, V; Dhingra, VK; Hameed, MS; Chittock, DR; Griesdale, DE				Sekhon, Mypinder S.; Gooderham, Peter; Toyota, Brian; Kherzi, Navid; Hu, Vivien; Dhingra, Vinay K.; Hameed, Morad S.; Chittock, Dean R.; Griesdale, Donald E.			Implementation of Neurocritical Care Is Associated With Improved Outcomes in Traumatic Brain Injury	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Neurocritical care; Intracranial pressure; Cerebral autoregulation; Brain tissue oxygen	UNITED-STATES; IMPACT; NEUROINTENSIVIST; EPIDEMIOLOGY; PROGRAM	Background: Traditionally, the delivery of dedicated neurocritical care (NCC) occurs in distinct NCC units and is associated with improved outcomes. Institution-specific logistical challenges pose barriers to the development of distinct NCC units; therefore, we developed a consultancy NCC service coupled with the implementation of invasive multimodal neuromonitoring, within a medical-surgical intensive care unit. Our objective was to evaluate the effect of a consultancy NCC program on neurologic outcomes in severe traumatic brain injury patients. Methods: We conducted a single-center quasi-experimental uncontrolled pre- and post-NCC study in severe traumatic brain injury patients (Glasgow Coma Scale <= 8). The NCC program includes consultation with a neurointensivist and neurosurgeon and multimodal neuromonitoring. Demographic, injury severity metrics, neurophysiologic data, and therapeutic interventions were collected. Glasgow Outcome Scale (GOS) at 6 months was the primary outcome. Multivariable ordinal logistic regression was used to model the association between NCC implementation and GOS at 6 months. Results: A total of 113 patients were identified: 76 pre-NCC and 37 post-NCC. Mean age was 39 years (standard deviation [SD], 2) and 87 of 113 (77%) patients were male. Median admission motor score was 3 (interquartile ratio, 1-4). Daily mean arterial pressure was higher (95 mmHg [SD, 10]) versus (88 mmHg [SD, 10], p < 0.001) and daily mean core body temperature was lower (36.6 degrees C [SD, 0.90]) versus (37.2 degrees C [SD, 1.0], p = 0.001) post-NCC compared with pre-NCC, respectively. Multivariable regression modelling revealed the NCC program was associated with a 2.5 increased odds (odds ratios, 2.5; 95% confidence interval, 1.1-5.3; p = 0.022) of improved 6-month GOS. Conclusions: Implementation of a NCC program is associated with improved 6 month GOS in severe TBI patients.	[Sekhon, Mypinder S.; Dhingra, Vinay K.; Hameed, Morad S.; Chittock, Dean R.; Griesdale, Donald E.] Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Vancouver, BC, Canada; [Sekhon, Mypinder S.; Gooderham, Peter; Toyota, Brian; Kherzi, Navid] Univ British Columbia, Vancouver Gen Hosp, Div Neurosurg, Dept Surg, Vancouver, BC, Canada; [Hu, Vivien] Univ British Columbia, Vancouver Gen Hosp, Fac Med, Vancouver, BC, Canada; [Sekhon, Mypinder S.] Univ British Columbia, Vancouver Gen Hosp, Dept Surg, Div Trauma Surg, Vancouver, BC, Canada; [Griesdale, Donald E.] Univ British Columbia, Vancouver Gen Hosp, Dept Anaesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [Griesdale, Donald E.] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada		Sekhon, MS (corresponding author), Vancouver Gen Hosp, Crit Care Med, Room 2438,Jim Pattison Pavil,2nd Floor, Vancouver, BC V5Z 1M9, Canada.	mypindersekhon@gmail.com	Griesdale, Donald/AAT-7762-2021	Griesdale, Donald/0000-0001-5985-8624			Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Buis ML, 2010, STATA J, V10, P11, DOI 10.1177/1536867X1001000104; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Diaz-Arrastia R., BRAIN TISSUE OXYGEN; Dings J, 1998, NEUROL RES, V20, pS71; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Grieve R, 2016, BRIT J NEUROSURG, P1; Grimshaw J, 2000, FAM PRACT, V17, pS11, DOI 10.1093/fampra/17.suppl_1.S11; Josephson SA, 2010, J NEUROSURG, V112, P626, DOI 10.3171/2009.8.JNS09441; Korbakis G, 2014, CRIT CARE CLIN, V30, P657, DOI 10.1016/j.ccc.2014.06.001; Kramer AH, 2014, CURR OPIN CRIT CARE, V20, P174, DOI 10.1097/MCC.0000000000000076; Kramer AH, 2011, NEUROCRIT CARE, V14, P329, DOI 10.1007/s12028-011-9530-y; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Lerch C, 2006, NEUROCRIT CARE, V5, P85, DOI 10.1385/NCC:5:2:85; Lott JP, 2009, AM J RESP CRIT CARE, V179, P676, DOI 10.1164/rccm.200808-1281OC; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Samuels O, 2011, NEUROCRIT CARE, V14, P334, DOI 10.1007/s12028-011-9505-z; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Smielewski P, 2012, EUR J ANAESTH, V29, pA34; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Varelas PN, 2008, NEUROCRIT CARE, V9, P293, DOI 10.1007/s12028-008-9050-6; Varelas PN, 2006, J NEUROSURG, V104, P713, DOI 10.3171/jns.2006.104.5.713; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; WARME PE, 1991, ACTA NEUROCHIR, V110, P57, DOI 10.1007/BF01402049; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	41	13	13	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	JUL	2017	44	4					350	357		10.1017/cjn.2017.25			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FD3WX	WOS:000407464200003	28343456	Bronze			2022-02-06	
J	Smith, S; Devine, M; Taddeo, J; McAlister, VC				Smith, Shane; Devine, Melissa; Taddeo, Joseph; McAlister, Vivian Charles			Injury profile suffered by targets of antipersonnel improvised explosive devices: prospective cohort study	BMJ OPEN			English	Article							INTERNATIONAL-COMMITTEE; RED-CROSS; AFGHANISTAN; EXPERIENCE; BASTION; MINES	Objective To describe pattern 1 injuries caused by the antipersonnel improvised explosive device (AP-IED) in comparison to those previously described for antipersonnel mines (APM). Design Prospective cohort study of 100 consecutive pedestrian victims of an AP-IED, with traumatic amputation without regard for gender, nationality or military status. Setting Multinational Medical Unit at Kandahar Air Field, Afghanistan. Participants One hundred consecutive patients, all male, 6-44 years old. Main outcome measures The details of injuries were recorded to describe the pattern and characterise the injuries suffered by the target of AP-IEDs. The level of amputation, the level of soft tissue injury, the fracture pattern (including pelvic fractures) as well as perineal, gluteal, genital and other injuries were recorded. Results Victims of AP-IED were more likely, compared with APM victims, to have multiple amputations (70.0% vs 10.4%; p<0.001) or genital injury (26% vs 13%; p=0.007). Multiple amputations occurred in 70 patients: 5 quadruple amputations, 27 triple amputations and 38 double amputations. Pelvic fracture occurred in 21 victims, all but one of whom had multiple amputations. Severe perineal, gluteal or genital injuries were present in 46 patients. Severe soft tissue injury was universal, with injection of contaminated soil along tissue planes well above entry sites. There were 13 facial injuries, 9 skull fractures and 3 traumatic brain injuries. Eleven eye injuries were seen; none of the victims with eye injuries were wearing eye protection. The casualty fatality rate was at least 19%. The presence of more than one amputation was associated with a higher rate of pelvic fracture (28.6% vs 3.3%; p=0.005) and perineal-gluteal injury (32.6% vs 11.1%; p=0.009). Conclusion The injury pattern suffered by the target of the AP-IED is markedly worse than that of conventional APM. Pelvic binders and tourniquets should be applied at the point of injury to patients with multiple amputations or perineal injuries.	[Smith, Shane; McAlister, Vivian Charles] Royal Canadian Med Serv, London, ON, Canada; [Smith, Shane; McAlister, Vivian Charles] Univ Western Ontario, Div Gen Surg, London, ON, Canada; [Devine, Melissa] Royal Canadian Med Serv, Halifax, NS, Canada; [Taddeo, Joseph] Maine Vet Affairs Med Ctr, Dept Surg, Augusta, MD USA		McAlister, VC (corresponding author), Royal Canadian Med Serv, London, ON, Canada.; McAlister, VC (corresponding author), Univ Western Ontario, Div Gen Surg, London, ON, Canada.	vmcalist@uwo.ca	McAlister, Vivian/B-9881-2008	McAlister, Vivian/0000-0002-2479-6862			Beckett A, 2012, INJURY, V43, P2072, DOI 10.1016/j.injury.2012.01.005; Brisebois R, 2011, CAN J SURG, V54, pS20, DOI 10.1503/cjs.024811; Bryusov PG, 1996, COMBAT INJURIES EXTR; COUPLAND RM, 1989, ANN ROY COLL SURG, V71, P404; COUPLAND RM, 1991, BMJ-BRIT MED J, V303, P1509, DOI 10.1136/bmj.303.6816.1509; Giannou C., 2013, WAR SURG WORKING LTD, V2; Jacobs N, 2014, INJURY, V45, P1422, DOI 10.1016/j.injury.2012.05.001; Jacobs N, 2012, INJURY, V43, P1037, DOI 10.1016/j.injury.2011.12.017; Korver AJH, 1996, INJURY, V27, P477, DOI 10.1016/0020-1383(96)00066-6; Morrison JJ, 2012, BRIT J SURG, V99, P362, DOI 10.1002/bjs.7765; Nations U, 1999, UN TREATY SERIES, V2056, P211; O'Shea MK, 2012, INT J ANTIMICROB AG, V39, P363, DOI 10.1016/j.ijantimicag.2012.01.018; Penn-Barwell JG, 2014, INJURY, V45, P1105, DOI 10.1016/j.injury.2014.01.025; Soroush Ahmadreza, 2008, Arch Iran Med, V11, P595; Taddeo Joseph, 2015, Can J Surg, V58, pS104, DOI 10.1503/cjs.013114	15	13	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JUL	2017	7	7							e014697	10.1136/bmjopen-2016-014697			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG4HQ	WOS:000410203700053	28835410	Green Published, gold			2022-02-06	
J	Vezzani, A; Pascente, R; Ravizza, T				Vezzani, Annamaria; Pascente, Rosaria; Ravizza, Teresa			Biomarkers of Epileptogenesis: The Focus on Glia and Cognitive Dysfunctions	NEUROCHEMICAL RESEARCH			English	Article						Epilepsy; Biomarker; Imaging; Inflammation; Astrocytes; Co-morbidity	TEMPORAL-LOBE EPILEPSY; LITHIUM-PILOCARPINE MODEL; TRAUMATIC BRAIN-INJURY; TOLL-LIKE RECEPTOR; MOBILITY GROUP BOX-1; MAGNETIC-RESONANCE-SPECTROSCOPY; C-11 DEUTERIUM-DEPRENYL; GLYCATION END-PRODUCTS; STATUS EPILEPTICUS; IN-VIVO	The need to find measures that reliably predict the onset of epilepsy after injurious events or how the patient will respond to anti-seizure drugs led to intensive pre-clinical and clinical research to discover non-invasive biomarkers that could increase the sensitivity of existing clinical indicators. The use of experimental models of epileptogenesis and of drug-resistance is instrumental to select the most promising approaches to explore such biomarkers in the pre-clinical setting for further clinical validation. The approaches most frequently used to find clinically useful biomarkers of epileptogenesis include molecular brain imaging, EEG signal analysis and the measure of soluble molecules in biofluids which may reflect brain intrinsic events involved in epilepsy development. Among those, we focused our attention on proton magnetic resonance imaging (H-1-MRS)-based analysis of astrocytic activation, and related blood biomarkers, since this cell population appears to be pivotally involved in various epileptogenesis processes triggered by differing insults. Moreover, we also investigated behavioral biomarkers by focusing on cognitive dysfunctions since this deficit represents a typical co-morbidity in epilepsy which may manifest even before the onset of spontaneous seizures. In this review article, we will report our recently published evidence supporting the utility of measuring astrocyte activation, the soluble molecules they release, and the associated cognitive deficits during epileptogenesis for early stratification of animals developing epilepsy. We will discuss the potential clinical translation of our findings for enriching the patient population in preventive clinical trials designed to study anti-epileptogenic treatments.	[Vezzani, Annamaria; Pascente, Rosaria; Ravizza, Teresa] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Via G La Masa 19, I-20156 Milan, Italy		Vezzani, A (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Via G La Masa 19, I-20156 Milan, Italy.	annamaria.vezzani@marionegri.it	Vezzani, Annamaria/AAB-1882-2020; Ravizza, Teresa/AAB-1440-2020	Vezzani, Annamaria/0000-0003-0573-6175; Ravizza, Teresa/0000-0002-9578-018X	European Union's Seventh Framework Programme (FP7) [602102 (EPITARGET)]; Citizen United for Research in Epilepsy (CURE)	We acknowledge the grant support by the European Union's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement No. 602102 (EPITARGET), and Citizen United for Research in Epilepsy (CURE).	Achour SB, 2010, NEUROCHEM INT, V57, P440, DOI 10.1016/j.neuint.2010.02.013; Amhaoul H, 2015, NEUROBIOL DIS, V82, P526, DOI 10.1016/j.nbd.2015.09.004; Aronica E, 2012, GLIA, V60, P1258, DOI 10.1002/glia.22312; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Austin JK, 2001, PEDIATRICS, V107, P115, DOI 10.1542/peds.107.1.115; Balosso S, 2014, ANTIOXID REDOX SIGN, V21, P1726, DOI 10.1089/ars.2013.5349; Barkas L, 2012, BRAIN, V135, P2358, DOI 10.1093/brain/aws176; Berg AT, 2005, DEV MED CHILD NEUROL, V47, P749, DOI 10.1017/S001216220500157X; Blank T, 2013, GLIA, V61, P62, DOI 10.1002/glia.22372; Boer K, 2006, J NEUROIMMUNOL, V173, P188, DOI 10.1016/j.jneuroim.2006.01.002; Boison D, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00109; Brackhan M, 2016, J NUCL MED, V57, P1302, DOI 10.2967/jnumed.116.172494; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Broer S, 2015, EPILEPSY BEHAV, V53, P98, DOI 10.1016/j.yebeh.2015.09.028; Bronisz E, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7369020; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Butler T, 2016, EPILEPSIA, V57, pE191, DOI 10.1111/epi.13457; Chauviere L, 2009, J NEUROSCI, V29, P5402, DOI 10.1523/JNEUROSCI.4699-08.2009; Cilio MR, 2003, EPILEPSIA, V44, P518, DOI 10.1046/j.1528-1157.2003.48802.x; Cleary RA, 2013, EPILEPSY RES, V106, P264, DOI 10.1016/j.eplepsyres.2013.03.015; de Araujo GM, 2012, SEIZURE-EUR J EPILEP, V21, P619, DOI 10.1016/j.seizure.2012.07.002; Depaulis A, 2016, J NEUROSCI METH, V260, P159, DOI 10.1016/j.jneumeth.2015.05.022; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Dube C, 2001, EXP NEUROL, V167, P227, DOI 10.1006/exnr.2000.7561; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Filibian M, 2012, EPILEPSIA, V53, P1907, DOI 10.1111/j.1528-1167.2012.03685.x; Friedman A, 2012, JASPERS BASIC MECH; Friedman A, 2009, EPILEPSY RES, V85, P142, DOI 10.1016/j.eplepsyres.2009.03.005; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gastens AM, 2008, EPILEPSIA, V49, P1759, DOI 10.1111/j.1528-1167.2008.01659.x; GERLAI R, 1995, LEARN MEMORY, V2, P26, DOI 10.1101/lm.2.1.26; Gershen LD, 2015, JAMA NEUROL, V72, P882, DOI 10.1001/jamaneurol.2015.0941; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Haik S, 2008, ARCH NEUROL-CHICAGO, V65, P545, DOI 10.1001/archneur.65.4.545; Hammen T, 2008, NMR BIOMED, V21, P545, DOI 10.1002/nbm.1222; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Henshall DC, 2016, LANCET NEUROL, V15, P1368, DOI 10.1016/S1474-4422(16)30246-0; Hermann B, 2006, BRAIN, V129, P2609, DOI 10.1093/brain/awl196; Hirvonen J, 2012, J NUCL MED, V53, P234, DOI 10.2967/jnumed.111.091694; Hitiris N, 2007, EPILEPSY RES, V75, P192, DOI 10.1016/j.eplepsyres.2007.06.003; Hort J, 2000, BEHAV BRAIN RES, V112, P77, DOI 10.1016/S0166-4328(00)00163-7; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Iori V, 2013, NEUROBIOL DIS, V58, P102, DOI 10.1016/j.nbd.2013.03.006; Ito S, 2013, NEUROBIOL DIS, V49, P29, DOI 10.1016/j.nbd.2012.08.003; Kanner AM, 2009, NEUROLOGY, V72, P793, DOI 10.1212/01.wnl.0000343850.85763.9c; Kleen JK, 2012, JASPERS BASIC MECH; Klitgaard H, 2002, EPILEPSY RES, V51, P93, DOI 10.1016/S0920-1211(02)00099-2; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Kubova H, 2004, EUR J NEUROSCI, V19, P3255, DOI 10.1111/j.0953-816X.2004.03410.x; KUMLIEN E, 1992, EPILEPSIA, V33, P610, DOI 10.1111/j.1528-1157.1992.tb02336.x; Kumlien E, 2001, ACTA NEUROL SCAND, V103, P360, DOI 10.1034/j.1600-0404.2001.103006360.x; KUMLIEN E, 1995, EPILEPSIA, V36, P712, DOI 10.1111/j.1528-1157.1995.tb01051.x; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Leroy C, 2011, NEUROBIOL DIS, V43, P588, DOI 10.1016/j.nbd.2011.05.007; LIU Z, 1994, EPILEPSY RES, V19, P191, DOI 10.1016/0920-1211(94)90062-0; Loscher W, 2011, SEIZURE-EUR J EPILEP, V20, P359, DOI 10.1016/j.seizure.2011.01.003; Mader I, 2008, EUR J RADIOL, V67, P250, DOI 10.1016/j.ejrad.2008.02.033; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Marques-Carneiro JE, 2016, NEUROSCIENCE, V316, P389, DOI 10.1016/j.neuroscience.2015.12.048; Mazarati A, 2011, EXP NEUROL, V232, P143, DOI 10.1016/j.expneurol.2011.08.012; Mizuno S, 2000, ACTA NEUROL SCAND, V102, P175, DOI 10.1034/j.1600-0404.2000.102003175.x; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Morquette P, 2015, NAT NEUROSCI, V18, P844, DOI 10.1038/nn.4013; Morris GP, 2013, NEUROBIOL LEARN MEM, V105, P40, DOI 10.1016/j.nlm.2013.07.002; Nishiyama H, 2002, P NATL ACAD SCI USA, V99, P4037, DOI 10.1073/pnas.052020999; Oakley JC, 2011, EPILEPSIA, V52, P59, DOI 10.1111/j.1528-1167.2011.03004.x; Oostrom KJ, 2003, PEDIATRICS, V112, P1338, DOI 10.1542/peds.112.6.1338; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Ota Y, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/185463; Pascente R, 2016, NEUROBIOL DIS, V93, P146, DOI 10.1016/j.nbd.2016.05.001; Pauletti A, 2017, BRAIN IN PRESS; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2016, LANCET NEUROL, V15, P185, DOI 10.1016/S1474-4422(15)00248-3; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P231, DOI 10.1007/s13311-014-0257-2; Pitkanen A, 2011, BIOMARK MED, V5, P629, DOI [10.2217/BMM.11.67, 10.2217/bmm.11.67]; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Ravizza T, 2006, NEUROBIOL DIS, V24, P128, DOI 10.1016/j.nbd.2006.06.003; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Roch C, 2002, EPILEPSIA, V43, P325, DOI 10.1046/j.1528-1157.2002.11301.x; Sakatani S, 2008, J NEUROSCI, V28, P10928, DOI 10.1523/JNEUROSCI.3693-08.2008; Sankar R, 2000, ANN NEUROL, V48, P580, DOI 10.1002/1531-8249(200010)48:4<580::AID-ANA4>3.3.CO;2-2; Sayin U, 2004, EPILEPSIA, V45, P1539, DOI 10.1111/j.0013-9580.2004.54903.x; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shapiro LA, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01491.x; Snitker S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066277; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Todd KJ, 2006, J PHYSIOLOGY-PARIS, V99, P75, DOI 10.1016/j.jphysparis.2005.12.002; Turkdogan-Sozuer D, 2000, EUR RADIOL, V10, P962, DOI 10.1007/s003300051045; van Vliet EA, 2017, EPILEPSIA, V58, P315, DOI 10.1111/epi.13621; Wagner S, 2006, CURR MED CHEM, V13, P2819, DOI 10.2174/092986706778522002; Walker LE, 2017, J CLIN INV IN PRESS; Wang N, 2015, NEUROSCIENCE, V287, P144, DOI 10.1016/j.neuroscience.2014.12.021; Weissberg I, 2015, NEUROBIOL DIS, V78, P115, DOI 10.1016/j.nbd.2015.02.029; Witt JA, 2015, SEIZURE-EUR J EPILEP, V26, P65, DOI 10.1016/j.seizure.2015.01.018; Worrell GA, 2004, BRAIN, V127, P1496, DOI 10.1093/brain/awh149; Wu YJ, 2015, J CEREBR BLOOD F MET, V35, P1862, DOI 10.1038/jcbfm.2015.145; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Zucker S, 2004, ADV CLIN CHEM, V38, P37, DOI 10.1016/S0065-2423(04)38002-9; Zurolo E, 2011, BRAIN, V134, P1015, DOI 10.1093/brain/awr032	105	13	15	0	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUL	2017	42	7			SI		2089	2098		10.1007/s11064-017-2271-3			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FA3GA	WOS:000405329600026	28434163				2022-02-06	
J	West, A; Jennum, P; Simonsen, SA; Sander, B; Pavlova, M; Iversen, HK				West, Anders; Jennum, Poul; Simonsen, Sofie Amalie; Sander, Birgit; Pavlova, Milena; Iversen, Helle K.			Impact of naturalistic lighting on hospitalized stroke patients in a rehabilitation unit: Design and measurement	CHRONOBIOLOGY INTERNATIONAL			English	Article						Anxiety; circadian rhythm; cognition; depression; hospitalization; intervention; light; method description; sleep; stroke	TRAUMATIC BRAIN-INJURY; ACUTE-PHASE; COGNITIVE IMPAIRMENT; SLEEP QUALITY; DISTURBANCES; INDEX; SENSITIVITY; DEPRESSION; DISORDERS; ROOMS	Introduction and rationale: Stroke is a major cause of acquired cerebral disability among adults, frequently accompanied by depression, anxiety, cognitive impairment, disrupted sleep and fatigue. New ways of intervention to prevent these complications are therefore needed. The major circadian regulator, the suprachiasmatic nucleus, is mainly controlled by natural daylight, and the blue spectrum is considered the most powerful. During stroke rehabilitation, patients typically are mostly indoors and therefore not exposed to the natural daytime variation in light intensity. Furthermore, several rehabilitation hospitals may be exposed to powerful light in the blue spectrum, but at a time that is adversely related to their endogenous circadian phase, for example in the late evening instead of the daytime. Hypothesis: Naturalistic light that mimics the natural daytime spectrum variation will have a positive impact on the health of poststroke patients admitted to rehabilitation. We test specifically for improved sleep and less fatigue (questionnaires, polysomnography, Actiwatch), improved well-being (questionnaires), lessen anxiety and depression (questionnaires), improved cognition (tests), stabilizing of the autonomous nervous system (ECG/HR, blood pressure, temperature) and stabilizing of the diurnal biochemistry (blood markers). Study design: The study is a prospective parallel longitudinal randomized controlled study (quasi randomization). Stroke patients in need of rehabilitation will be included at the acute stroke unit and randomized to either the intervention unit (naturalistic lighting) or the control unit (CU) (standard lighting). The naturalistic light is installed in the entire IU (Cromaviso, Denmark). Conclusion: This study aims to elucidate the influence of naturalistic light on patients during long-term hospitalization in a real hospital setting. The hypotheses are based on preclinical research, as studies using naturalistic light have never been performed before. Investigating the effects of naturalistic light in a clinical setting is therefore much needed.	[West, Anders; Simonsen, Sofie Amalie; Iversen, Helle K.] Univ Copenhagen, Rigshosp, Clin Stroke Res Unit, Dept Neurol,Fac Hlth Sci, Glostrup, Denmark; [Jennum, Poul] Univ Copenhagen, Rigshosp, Danish Ctr Sleep Med, Dept Neurophysiol,Fac Hlth Sci, Glostrup, Denmark; [Sander, Birgit] Copenhagen Univ Hosp, Rigshosp, Dept Ophthalmol, Glostrup, Denmark; [Pavlova, Milena] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Div Epilepsy Neurophysiol & Sleep, Boston, MA USA		West, A (corresponding author), Univ Copenhagen, Rigshosp, Clin Stroke Res Unit, Dept Neurol,Fac Hlth Sci, Glostrup, Denmark.	anders.sode.west@regionh.dk	Iversen, Helle Klingenberg/P-5726-2019; Pavlova, Milena/AAK-1844-2020	Iversen, Helle Klingenberg/0000-0002-5880-6352; Simonsen, Sofie Amalie/0000-0002-1987-7318	Market Development Foundation; Capital Region of Copenhagen and Service Center Rigshospitalet Glostrup and traveling grant from the University of Copenhagen	This study has received research grant support from The Market Development Foundation, the Capital Region of Copenhagen and Service Center Rigshospitalet Glostrup and traveling grant from the University of Copenhagen.d	Aben I, 2002, PSYCHOSOMATICS, V43, P386, DOI 10.1176/appi.psy.43.5.386; Allgaier AK, 2013, INT J GERIATR PSYCH, V28, P1197, DOI 10.1002/gps.3944; Andersen M, 2012, LIGHTING RES TECHNOL, V44, P37, DOI 10.1177/1477153511435961; BASKETT JJ, 1991, AGE AGEING, V20, P430, DOI 10.1093/ageing/20.6.430; Beauchemin KM, 1996, J AFFECT DISORDERS, V40, P49, DOI 10.1016/0165-0327(96)00040-7; Bech P, 2001, J AFFECT DISORDERS, V66, P159, DOI 10.1016/S0165-0327(00)00309-8; Benedetti F, 2001, J AFFECT DISORDERS, V62, P221, DOI 10.1016/S0165-0327(00)00149-X; Bernhofer EI, 2014, J ADV NURS, V70, P1164, DOI 10.1111/jan.12282; Borbely AA, 2009, J SLEEP RES, V18, P1, DOI 10.1111/j.1365-2869.2009.00750.x; Burkhalter H, 2014, T INT, V28, P59; Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cavalcanti P, 2012, CHRONOBIOL INT, V29, P1267, DOI 10.3109/07420528.2012.719960; Cho JR, 2013, SLEEP MED, V14, P1422, DOI 10.1016/j.sleep.2013.09.007; Chong MS, 2013, CLIN INTERV AGING, V8, P565, DOI 10.2147/CIA.S44926; Cornelissen G, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-16; CZEISLER CA, 1980, SCIENCE, V210, P1264, DOI 10.1126/science.7434029; De Rui M, 2015, NEUROCHEM RES, V40, P284, DOI 10.1007/s11064-014-1414-z; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P230, DOI 10.1159/000441106; Gooley JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000741; Hermann DM, 2009, NEUROLOGY, V73, P1313, DOI 10.1212/WNL.0b013e3181bd137c; Jennum P, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1100-0; Kamper JE, 2016, J HEAD TRAUMA REHAB, V31, P117, DOI 10.1097/HTR.0000000000000215; Lin Jin-Mann S, 2009, Popul Health Metr, V7, P18, DOI 10.1186/1478-7954-7-18; Lucas RJ, 2012, ROD CONE MELANOPSIN; McFadden E, 2014, AM J EPIDEMIOL, V180, P245, DOI 10.1093/aje/kwu117; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Obayashi K, 2014, CHRONOBIOL INT, V32, P310; Paradee CV, 2005, CLIN NEUROPSYCHOL, V19, P55, DOI 10.1080/13854040490524173; Pendlebury ST, 2012, CEREBROVASC DIS, V34, P48, DOI 10.1159/000338905; Pendlebury ST, 2012, STROKE, V43, P464, DOI 10.1161/STROKEAHA.111.633586; Ponsaing LB, 2016, SLEEP BREATH, V23, P1159; RIEMERSMA-VAN DER LEK R. F., 2008, JAMA-J AM MED ASSOC, V299, P2642, DOI DOI 10.1001/JAMA.299.22.2642; Sarkis RA, 2016, CLIN NEUROPHYSIOL, V127, P2785, DOI 10.1016/j.clinph.2016.05.275; Schmidt TM, 2011, J NEUROSCI, V31, P16094, DOI 10.1523/JNEUROSCI.4132-11.2011; Stickgold R, 2013, CURR OPIN NEUROBIOL, V23, P847, DOI 10.1016/j.conb.2013.04.002; Takekawa H, 2007, AUTON NEUROSCI-BASIC, V131, P131, DOI 10.1016/j.autneu.2006.08.008; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Tranah GJ, 2011, ANN NEUROL, V70, P722, DOI 10.1002/ana.22468; Van Someren EJW, 2000, EXP GERONTOL, V35, P1229, DOI 10.1016/S0531-5565(00)00191-1; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716; Venkateshiah SB, 2012, CHEST, V141, P1337, DOI 10.1378/chest.11-2591; Wakamura Tomoko, 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P345, DOI 10.2114/jpa.20.345; Wiseman-Hakes C, 2016, NEUROREHAB NEURAL RE, V30, P713, DOI 10.1177/1545968315619697; Wright KP, 2006, J COGNITIVE NEUROSCI, V18, P508, DOI 10.1162/jocn.2006.18.4.508; Wunsch H, 2011, CRIT CARE, V15, DOI 10.1186/cc10075	49	13	13	0	14	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.	JUL	2017	34	6					687	697		10.1080/07420528.2017.1314300			11	Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Life Sciences & Biomedicine - Other Topics; Physiology	FA4DF	WOS:000405393300002	28430522				2022-02-06	
J	Xia, Z; Peng, WJ; Cheng, SH; Zhong, BW; Sheng, CX; Zhang, CH; Gong, W; Cheng, S; Li, J; Wang, Z				Xia, Zian; Peng, Weijun; Cheng, Shunhua; Zhong, Bingwu; Sheng, Chenxia; Zhang, Chunhu; Gong, Wei; Cheng, Shuai; Li, Jun; Wang, Zhe			Naoling decoction restores cognitive function by inhibiting the neuroinflammatory network in a rat model of Alzheimer's disease	ONCOTARGET			English	Article						Alzheimer's disease; Naoling decoction; amyloid-beta (A beta) deposits; neuroinflammatory network; Chromogranin A	TRAUMATIC BRAIN-INJURY; MOUSE MODEL; KAPPA-B; INTERLEUKIN-1-BETA PRODUCTION; MICROGLIAL ACTIVATION; NLRP3 INFLAMMASOME; TRANSGENIC MICE; CHROMOGRANIN-A; AMYLOID-BETA; IMPAIRMENT	Neuroinflammation is central to the pathogenesis of Alzheimer's disease (AD). We previously showed that Naoling decoction (NLD), a traditional Chinese medicine, was effective against AD, acting by inhibiting expression of IL-1 beta and IL-6. In the present study, we generated the rat model of AD by injecting A beta(1-42) peptide intracerebroventricularly and evaluated the dose- dependent effects of NLD treatment. The NLD-treated rats exhibited significant improvements in cognitive function as evaluated by the Morris water maze test. Golgi-Cox staining revealed that NLD treatment dose- dependently increased dendritic spines in the CA1 region, which were diminished in vehicle-treated rats. Further, NLD treatment normalized hippocampal Chromogranin A levels, which were elevated by A beta(1-42) induction. NLD also attenuated activation of microglia and astrocytes induced by A beta(1-2.) Subsequently, NLD dose-dependently reduced levels TNF-alpha, IL-1 beta and IL-6 by inhibiting the NF-B-K signaling pathway and the ASC-dependent inflammasome in the hippocampus. These findings reveal that NLD is a promising therapeutic agent that exerts inhibitory effects at multiple sites within the neuroinflammatory network induced in AD.	[Xia, Zian; Peng, Weijun; Cheng, Shunhua; Zhong, Bingwu; Sheng, Chenxia; Gong, Wei; Cheng, Shuai; Wang, Zhe] Cent S Univ, Dept Integrated Tradit Chinese & Western Med, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Xia, Zian; Zhang, Chunhu] Cent S Univ, Dept Integrated Tradit Chinese & Western Med, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Cheng, Shunhua] Cent S Univ, Dept Urol, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Gong, Wei] Liuyang Hosp Tradit Chinese Med, Dept Neurol, Liuyang 4103002, Hunan, Peoples R China; [Li, Jun] Cent S Univ, Xiangya Sch Med, Canc Hosp, Thyroid Tumour Internal Med Dept, Changsha 410013, Hunan, Peoples R China		Wang, Z (corresponding author), Cent S Univ, Dept Integrated Tradit Chinese & Western Med, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China.	ericwangzhe@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81373705, 81603670]; Hunan Provincial Natural Science Foundation of ChinaNatural Science Foundation of Hunan Province	This work was financially supported by the National Natural Science Foundation of China (No. 81373705, 81603670), and Hunan Provincial Natural Science Foundation of China.	Baek H, 2016, ONCOTARGET, V7, P69347, DOI 10.18632/oncotarget.12469; Bordt EA, 2014, FREE RADICAL BIO MED, V76, P34, DOI 10.1016/j.freeradbiomed.2014.07.033; Braidy N, 2016, ONCOTARGET, V7, P64589, DOI 10.18632/oncotarget.10905; Calsolaro V, 2016, ALZHEIMERS DEMENT, V12, P719, DOI 10.1016/j.jalz.2016.02.010; Couturier J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0477-y; Delcambre GH, 2016, PEERJ, V4, DOI 10.7717/peerj.1601; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Guo JT, 2002, J NEUROSCI, V22, P5900; Hoarau JJ, 2011, CNS NEUROL DISORD-DR, V10, P25, DOI 10.2174/187152711794488601; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Kaushal V, 2015, CELL DEATH DIFFER, V22, P1676, DOI 10.1038/cdd.2015.16; Kong LW, 2015, INT IMMUNOPHARMACOL, V29, P401, DOI 10.1016/j.intimp.2015.10.023; Lai J, 2014, NEUROCHEM INT, V75, P26, DOI 10.1016/j.neuint.2014.05.006; Lechner T, 2004, EXP GERONTOL, V39, P101, DOI 10.1016/j.exger.2003.09.018; Li X, 2010, PRACTICAL PREVENTIVE, V17, P959, DOI [10.3969/j.issn.1006-3110.2010.05.051, DOI 10.3969/J.ISSN.1006-3110.2010.05.051]; Lin LF, 2015, J ETHNOPHARMACOL, V159, P158, DOI 10.1016/j.jep.2014.11.009; Liu B, 2015, NEUROSCIENCE, V294, P193, DOI 10.1016/j.neuroscience.2015.02.053; Liu L, 2014, NEUROBIOL AGING, V35, P309, DOI 10.1016/j.neurobiolaging.2013.08.016; Loh YP, 2012, J MOL NEUROSCI, V48, P347, DOI 10.1007/s12031-012-9728-2; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Lyman M, 2014, NEUROSCI RES, V79, P1, DOI 10.1016/j.neures.2013.10.004; Mattsson N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.69; Medeiros R, 2013, EXP NEUROL, V239, P133, DOI 10.1016/j.expneurol.2012.10.007; Morales I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00112; Perez-Gonzalez R, 2013, NEUROBIOL AGING, V34, P2133, DOI 10.1016/j.neurobiolaging.2013.03.011; Ritchie CW, 2016, LANCET PSYCHIAT, V3, P179, DOI 10.1016/S2215-0366(15)00454-X; Ryu J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.30; Sastre M, 2003, J NEUROSCI, V23, P9796; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Shao AW, 2016, MOL NEUROBIOL, V53, P18, DOI 10.1007/s12035-014-8986-0; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Shi JQ, 2013, CNS NEUROSCI THER, V19, P262, DOI 10.1111/cns.12066; Shi S, 2016, EUR J IMMUNOL, V46, P665, DOI 10.1002/eji.201545855; Spangenberg EE, 2017, BRAIN BEHAV IMMUN, V61, P1, DOI 10.1016/j.bbi.2016.07.003; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Wang Zhe, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P113, DOI 10.3969/j.issn.1672-7347.2013.02.001; Wildsmith KR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-22; Wu Z, 2013, NEUROBIOL AGING, V34, P2715, DOI 10.1016/j.neurobiolaging.2013.05.018; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Xuan AG, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-202; Yang B, 2017, MOL NEUROBIOL, V54, P4833, DOI 10.1007/s12035-016-0038-5; Yasuno F, 2012, PSYCHIAT RES-NEUROIM, V203, P67, DOI 10.1016/j.pscychresns.2011.08.013; Zendedel A, 2016, MOL NEUROBIOL, V53, P3063, DOI 10.1007/s12035-015-9203-5; Zeng KW, 2010, INT IMMUNOPHARMACOL, V10, P668, DOI 10.1016/j.intimp.2010.03.010; Zhong Bingwu, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P910, DOI 10.3969/j.issn.1672-7347.2010.09.002; Zhong Bingwu, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P431, DOI 10.3969/j.issn.1672-7347.2010.05.005; Zhu D, 2016, J ALZHEIMERS DIS, V52, P483, DOI 10.3233/JAD-151090	50	13	16	1	12	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA		1949-2553		ONCOTARGET	Oncotarget	JUN 27	2017	8	26					42648	42663		10.18632/oncotarget.17337			16	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	FA5OQ	WOS:000405493400074	28487495	Green Published, Green Submitted, gold			2022-02-06	
J	Kawoos, U; McCarron, RM; Chavko, M				Kawoos, Usmah; McCarron, Richard M.; Chavko, Mikulas			Protective Effect of N-Acetylcysteine Amide on Blast-Induced Increase in Intracranial Pressure in Rats	FRONTIERS IN NEUROLOGY			English	Article						blast overpressure; traumatic brain injury; intracranial pressure; oxidative stress; N-acetylcysteine amide	TRAUMATIC BRAIN-INJURY; ATTENUATES EDEMA FORMATION; ANTIOXIDANT THERAPY; CORTICAL CONTUSION; OXIDATIVE STRESS; MITOCHONDRIAL BIOENERGETICS; FUNCTIONAL RECOVERY; NEUROPROTECTION; OPC-14117; PATHOPHYSIOLOGY	Blast-induced traumatic brain injury is associated with acute and possibly chronic elevation of intracranial pressure (ICP). The outcome after TBI is dependent on the progression of complex processes which are mediated by oxidative stress. So far, no effective pharmacological protection against TBI exists. In this study, rats were exposed to a single or repetitive blast overpressure (BOP) at moderate intensities of 72 or 110 kPa in a compressed air-driven shock tube. The degree and duration of the increase in ICP were proportional to the intensity and frequency of the blast exposure(s). In most cases, a single dose of antioxidant N-acetylcysteine amide (NACA) (500 mg/kg) administered intravenously 2 h after exposure to BOP significantly attenuated blast-induced increase in ICP. A single dose of NACA was not effective in improving the outcome in the group of animals that were subjected to repetitive blast exposures at 110 kPa on the same day. In this group, two treatments with NACA at 2 and 4 h post-BOP exposure resulted in significant attenuation of elevated ICP. Treatment with NACA prior to BOP exposure completely prevented the elevation of ICP. The findings indicate that oxidative stress plays an important role in blast-induced elevated ICP as treatment with NACA-ameliorated ICP increase, which is frequently related to poor functional recovery after TBI.	[Kawoos, Usmah; McCarron, Richard M.; Chavko, Mikulas] Naval Med Res Ctr, Dept Neurotrauma, Silver Spring, MD 20910 USA; [McCarron, Richard M.] Uniformed Serv Univ Hlth Sci, Dept Surg, Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA		Kawoos, U (corresponding author), Naval Med Res Ctr, Dept Neurotrauma, Silver Spring, MD 20910 USA.	usmah.kawoos.ctr@mail.mil			Office of Naval Research (ONR) Work UnitOffice of Naval Research [601152N.0000.001.A1308]	This work was supported by Office of Naval Research (ONR) Work Unit 601152N.0000.001.A1308.	Aoyama N, 2002, BRAIN RES, V934, P117, DOI 10.1016/S0006-8993(02)02366-1; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dalle Lucca Jurandir J, 2012, J Neurol Sci, V318, P146, DOI 10.1016/j.jns.2012.02.002; Deepmala, 2015, NEUROSCI BIOBEHAV R, V55, P294, DOI 10.1016/j.neubiorev.2015.04.015; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dodd S, 2008, EXPERT OPIN BIOL TH, V8, P1955, DOI [10.1517/14728220802517901, 10.1517/14728220802517901 ]; Du XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080138; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Grinberg L, 2005, FREE RADICAL BIO MED, V38, P136, DOI 10.1016/j.freeradbiomed.2004.09.025; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Guild SJ, 2015, J APPL PHYSIOL, V119, P576, DOI 10.1152/japplphysiol.00165.2015; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Gunther M, 2015, J CLIN NEUROSCI, V22, P1477, DOI 10.1016/j.jocn.2015.03.025; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Kawamata T, 1997, ACT NEUR S, V70, P191; Kawoos U, 2008, IEEE T MICROW THEORY, V56, P2356, DOI 10.1109/TMTT.2008.2004253; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146; Kawoos U, 2014, IEEE T BIO-MED ENG, V61, P841, DOI 10.1109/TBME.2013.2291239; Kaynar MY, 1998, NEUROSURG REV, V21, P260, DOI 10.1007/BF01105782; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kucherov Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4765727; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mori T, 1998, ACT NEUR S, V71, P120; National Academies Press, 2014, GULF WAR AND HLTH; OLSSON B, 1988, EUR J CLIN PHARMACOL, V34, P77, DOI 10.1007/BF01061422; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Penugonda S, 2011, TOXICOL LETT, V201, P1, DOI 10.1016/j.toxlet.2010.11.013; PHILLIPS YY, 1991, TXB MILITARY MED 1, V5, P295; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reed TT, 2009, J NEUROSCI RES, V87, P408, DOI 10.1002/jnr.21872; Romner B, 2013, NAT REV NEUROL, V9, P185, DOI 10.1038/nrneurol.2013.37; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Sarker KP, 1999, THROMB HAEMOSTASIS, V82, P1071, DOI 10.1055/s-0037-1614331; Semple BD, 2014, EXP NEUROL, V261, P291, DOI 10.1016/j.expneurol.2014.07.013; Shahripour RB, 2014, BRAIN BEHAV, V4, P108, DOI 10.1002/brb3.208; Shen QH, 2016, WORLDV EVID-BASED NU, V13, P380, DOI 10.1111/wvn.12167; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Stein M, 1999, SURG CLIN N AM, V79, P1537, DOI 10.1016/S0039-6109(05)70091-8; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Sunitha K, 2013, FREE RADICAL RES, V47, P357, DOI 10.3109/10715762.2013.781595; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Tobwala S, 2013, FREE RADICAL RES, V47, P740, DOI 10.3109/10715762.2013.819974; Toklu H.Z., 2015, BRAIN NEUROTRAUMA MO, P43, DOI [10.1201/b18126, DOI 10.1201/B18126]; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Yi JH, 2005, BRAIN RES, V1033, P13, DOI 10.1016/j.brainres.2004.10.055; YONUTAS HM, 2016, BRAIN RES, V1640, DOI DOI 10.1016/BRAINRES.2016.02.007; Zhang XS, 2009, BRAIN RES, V1275, P87, DOI 10.1016/j.brainres.2009.04.008	71	13	13	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 6	2017	8								219	10.3389/fneur.2017.00219			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EX6YH	WOS:000403387700001	28634463	Green Published, gold			2022-02-06	
J	Carelli, S; Giallongo, T; Viaggi, C; Latorre, E; Gombalova, Z; Raspa, A; Mazza, M; Vaglini, F; Di Giulio, AM; Gorio, A				Carelli, Stephana; Giallongo, Toniella; Viaggi, Cristina; Latorre, Elisa; Gombalova, Zuzana; Raspa, Andrea; Mazza, Massimiliano; Vaglini, Francesca; Di Giulio, Anna Maria; Gorio, Alfredo			Recovery from experimental parkinsonism by intrastriatal application of erythropoietin or EPO-releasing neural precursors	NEUROPHARMACOLOGY			English	Article						Erythropoietin; Parkinson's disease; Adult stem cells; Cell therapy; Regenerative medicine; MPTP	RECOMBINANT-HUMAN-ERYTHROPOIETIN; TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; DOPAMINE NEURONS; MOUSE MODEL; CYTOCHROME-P450 2E1; FUNCTIONAL RECOVERY; PRIMATE MODEL; IN-VITRO; DISEASE	An extensive literature has shown a powerful neuroprotective action of Erythropoietin (EPO) both in vivo and in vitro. This study shows that EPO, whether ectopically administered or released by neural precursors, does reverse MPTP-induced parkinsonism in mice. Unilateral stereotaxic injection of 2.5 x 10(5) erythropoietin-releasing neural precursor cells (Er-NPCs) rescued degenerating striatal dopaminergic neurons and promoted behavioral recovery as shown by three independent behavioral tests. These effects were replicated through direct intrastriatal administration of recombinant human EPO. At the end of the observational period, most of the transplanted Er-NPCs were vital and migrated via the striatum to reach Substantia Nigra. The restorative effects appear to be mediated by EPO since co-injection of anti-EPO or anti-EPOR antibodies antagonized the positive outcomes. Furthermore, this report supports the neuroprotective action of EPO, which may also be achieved via administration of EPO-releasing cells such as Er-NPCs. (C) 2017 Elsevier Ltd. All right's reserved.	[Carelli, Stephana; Giallongo, Toniella; Latorre, Elisa; Gombalova, Zuzana; Raspa, Andrea; Di Giulio, Anna Maria; Gorio, Alfredo] Univ Milan, Dept Hlth Sci, Labs Pharmacol, Milan, Italy; [Viaggi, Cristina; Vaglini, Francesca] Univ Pisa, Dipartimento Ric Traslaz & Nuove Tecnol Med & Chi, Pisa, Italy; [Mazza, Massimiliano] European Inst Oncol, Expt Oncol Dept, Via Adamello 16, I-20139 Milan, Italy		Carelli, S (corresponding author), Univ Milan, Lab Pharmacol, Dept Hlth Sci, Via A Rudini 8, I-20142 Milan, Italy.	stephana.carelli@guest.unimi.it; alfredo.gorio@unimi.it	Carelli, Stephana/AAB-2365-2021; Mazza, Massimiliano/AAA-4420-2021; raspa, andrea/J-9909-2016	Carelli, Stephana/0000-0003-4603-396X; Mazza, Massimiliano/0000-0001-9053-5743; Di Giulio, Anna Maria/0000-0002-5702-4623; raspa, andrea/0000-0003-2599-2424; Latorre, Elisa/0000-0002-8297-1219	"Neurogel-en-Marche" Foundation (France); AUS Niguarda Onlus (Italy); Fondazione "Romeo and Enrica Invernizzi"	The authors acknowledge the economic support of the "Neurogel-en-Marche" Foundation (France) and AUS Niguarda Onlus (Italy) to AG, and Fondazione "Romeo and Enrica Invernizzi" to AMDG.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Barker RA, 2014, CELL STEM CELL, V15, P539, DOI 10.1016/j.stem.2014.09.016; Barker RA, 2013, PROG NEUROBIOL, V110, P63, DOI 10.1016/j.pneurobio.2013.04.003; Barker RA, 2013, LANCET NEUROL, V12, P84, DOI 10.1016/S1474-4422(12)70295-8; Barzilay R, 2009, STEM CELLS DEV, V18, P591, DOI 10.1089/scd.2008.0138; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brundin P, 2012, PROG BRAIN RES, V200, P221, DOI 10.1016/B978-0-444-59575-1.00010-7; Cai JL, 2009, STEM CELLS, V27, P220, DOI 10.1634/stemcells.2008-0734; Carelli S, 2015, CELL TRANSPLANT, V24, P703, DOI 10.3727/096368914X685140; Carelli S, 2014, JOVE-J VIS EXP, DOI 10.3791/52141; Chandra G, 2016, J BIOL CHEM, V291, P15267, DOI 10.1074/jbc.M116.714824; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; CORSINI GU, 1985, EUR J PHARMACOL, V119, P127, DOI 10.1016/0014-2999(85)90331-0; Cui YF, 2010, BRAIN, V133, P189, DOI 10.1093/brain/awp290; Dhanushkodi A, 2013, GENES BRAIN BEHAV, V12, P224, DOI 10.1111/gbb.12001; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Doi D, 2014, STEM CELL REP, V2, P337, DOI 10.1016/j.stemcr.2014.01.013; Erbas O, 2015, NEUROPEPTIDES, V49, P1, DOI 10.1016/j.npep.2014.10.003; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Gao H. M., 2003, OFFICIAL PUBLICATION, V13, P1957, DOI DOI 10.1096/FJ.03-0203FJE; Goldberg NRS, 2011, NEUROSCIENCE, V180, P256, DOI 10.1016/j.neuroscience.2011.02.027; Gorio A, 2005, P NATL ACAD SCI USA, V102, P16379, DOI 10.1073/pnas.0508479102; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Hallett PJ, 2015, CELL STEM CELL, V16, P269, DOI 10.1016/j.stem.2015.01.018; Hallett PJ, 2014, CELL REP, V7, P1755, DOI 10.1016/j.celrep.2014.05.027; HANTRAYE P, 1992, NEUROREPORT, V3, P265, DOI 10.1097/00001756-199203000-00013; Haque NSK, 1997, CELL TRANSPLANT, V6, P239, DOI 10.1016/S0963-6897(97)86921-7; Heikal L, 2016, HYPOXIA, V4, P121, DOI 10.2147/HP.S104377; Jang W, 2016, MOL NEUROBIOL, V53, P3812, DOI 10.1007/s12035-015-9316-x; Jang W, 2014, J NEUROL SCI, V337, P47, DOI 10.1016/j.jns.2013.11.015; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jia Y, 2014, J MOL NEUROSCI, V53, P117, DOI 10.1007/s12031-013-0208-0; Kanaan NM, 2006, BRAIN RES, V1068, P221, DOI 10.1016/j.brainres.2005.10.078; Kefalopoulou Z, 2014, JAMA NEUROL, V71, P83, DOI 10.1001/jamaneurol.2013.4749; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kim ST, 2010, BRAIN RES, V1306, P176, DOI 10.1016/j.brainres.2009.09.103; KONISHI Y, 1993, BRAIN RES, V609, P29, DOI 10.1016/0006-8993(93)90850-M; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Latorre E., 2014, J STEM CELL RES TRAN, V1, P1008; Li ZM, 2016, CLIN NEUROL NEUROSUR, V150, P80, DOI 10.1016/j.clineuro.2016.09.001; Liang CL, 2004, J COMP NEUROL, V473, P97, DOI 10.1002/cne.20098; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Marfia G, 2011, NEUROBIOL DIS, V43, P86, DOI 10.1016/j.nbd.2011.02.004; Marti HH, 2004, J EXP BIOL, V207, P3233, DOI 10.1242/jeb.01049; Martinez-Cerdeno V, 2010, CELL STEM CELL, V6, P238, DOI 10.1016/j.stem.2010.01.004; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; MORSE JK, 1993, J NEUROSCI, V13, P4146; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Pedroso I, 2012, MEDICC REV, V14, P11, DOI 10.37757/MR2012V14.N1.4; Petroske E, 2001, NEUROSCIENCE, V106, P589, DOI 10.1016/S0306-4522(01)00295-0; Phani S, 2010, BRAIN RES, V1343, P1, DOI 10.1016/j.brainres.2010.04.061; Puskovic V, 2006, MOL THER, V14, P710, DOI 10.1016/j.ymthe.2006.07.004; Romeo S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01395; Schintu N, 2009, NEUROTOX RES, V16, P127, DOI 10.1007/s12640-009-9061-x; SCHULTZBERG M, 1984, NEUROSCIENCE, V12, P17, DOI 10.1016/0306-4522(84)90134-9; Sekiyama K, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/271732; Shen Y, 2010, TRANSPL P, V42, P1595, DOI 10.1016/j.transproceed.2009.11.050; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Signore AP, 2006, J NEUROCHEM, V96, P428, DOI 10.1111/j.1471-4159.2005.03587.x; Sundberg M, 2013, STEM CELLS, V31, P1548, DOI 10.1002/stem.1415; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tayra JT, 2013, BRAIN RES, V1502, P55, DOI 10.1016/j.brainres.2013.01.042; Tillerson JL, 2003, J NEUROSCI METH, V123, P189, DOI 10.1016/S0165-0270(02)00360-6; Tsui A., 2001, J NEUROL, V258, P1393; Vaglini F, 2004, J NEUROCHEM, V91, P285, DOI 10.1111/j.1471-4159.2004.02720.x; Viaggi C, 2009, NEUROPHARMACOLOGY, V56, P1075, DOI 10.1016/j.neuropharm.2009.03.003; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	78	13	15	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	JUN	2017	119						76	90		10.1016/j.neuropharm.2017.03.035			15	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	EX8PX	WOS:000403513800007	28373075				2022-02-06	
J	Cikajlo, I; Staba, UC; Vrhovac, S; Larkin, F; Roddy, M				Cikajlo, Imre; Staba, Ursa Cizman; Vrhovac, Suzana; Larkin, Frances; Roddy, Mark			A Cloud-Based Virtual Reality App for a Novel Telemindfulness Service: Rationale, Design and Feasibility Evaluation	JMIR RESEARCH PROTOCOLS			English	Article						Virtual reality; headset; Samsung; psychology; mindfulness; telepsychology; telehealth technology; telemedicine	MINDFULNESS MEDITATION; FOCUSED ATTENTION; THERAPY; INTERVENTION; IMPACT; LIFE	Background: Worldwide, there has been a marked increase in stress and anxiety, also among patients with traumatic brain injury (TBI). Access to psychology services is limited, with some estimates suggesting that over 50% of sufferers are not accessing the existing services available to them for reasons such as inconvenience, embarrassment, or stigmatization concerns around mental health. Health service providers have increasingly been turning to drug-free therapies, such as mindfulness programs, as complementary treatments. Objective: Virtual reality (VR) as a new delivery method for meditation-based stress and anxiety reduction therapy offers configurable environments and privacy protection. Our objective was to design a serious learning-meditation environment and to test the feasibility of the developed telemindfulness approach based on cloud technologies. Methods: We developed a cloud-based system, which consisted of a Web interface for the mindfulness instructor and remote clients, who had 3D VR headsets. The mindfulness instructor could communicate over the Web interface with the participants using the headset. Additionally, the Web app enabled group sessions in virtual rooms, 360-degree videos, and real interactions or standalone meditation. The mindfulness program was designed as an 8-week Mindfulness-Based Stress Reduction course specifically for the developed virtual environments. The program was tested with four employees and four patients with TBI. The effects were measured with psychometric tests, the Mindful Attention Awareness Scale (MAAS) and the Satisfaction With Life Scale (SWLS). Patients also carried out the Mini-Mental State Examination (MMSE). An additional objective evaluation has also been carried out by tracking head motion. Additionally, the power spectrum analyses of similar tasks between sessions were tested. Results: The patients achieved a higher level of life satisfaction during the study (SWLS: mean 23.0, SD 1.8 vs mean 18.3, SD 3.9) and a slight increase of the MAAS score (mean 3.4, SD 0.6 vs mean 3.3, SD 0.4). Particular insight into the MAAS items revealed that one patient had a lower MAAS score (mean 2.3). Employees showed high MAAS scores (mean 4.3, SD 0.7) and although their SWLS dropped to mean 26, their SWLS was still high (mean 27.3, SD 2.8). The power spectrum showed that the employees had a considerable reduction in high-frequency movements less than 0.34 Hz, particularly with the 360-degree video. As expected, the patients demonstrated a gradual decrease of high-frequency movements while sitting during the mindfulness practices in the virtual environment. Conclusions: With such a small sample size, it is too early to make any specific conclusions, but the presented results may accelerate the use of innovative technologies and challenge new ideas in research and development in the field of mindfulness/telemindfulness.	[Cikajlo, Imre; Staba, Ursa Cizman; Vrhovac, Suzana] Univ Rehabil Inst, Linhartova C 51, Ljubljana 1000, Slovenia; [Larkin, Frances; Roddy, Mark] Mind Myths Ltd, Off 9, Sligo Enterprise & Technol Ctr, Strandhill, Sligo, Ireland		Cikajlo, I (corresponding author), Univ Rehabil Inst, Linhartova C 51, Ljubljana 1000, Slovenia.	imre.cikajlo@ir-rs.si	Cikajlo, Imre/AAD-5189-2019	Cikajlo, Imre/0000-0002-8428-7621; Roddy, Mark/0000-0001-7600-7266; Vrhovac, Suzana/0000-0002-8349-0353	FICHe (Future Internet CHallenge for eHealth) under European Commission	The authors would like to acknowledge the coordination and management support from MindMyths Ltd, technical support from PlaySign Ltd, and financial support from FICHe (Future Internet CHallenge for eHealth) under the European Commission Fifth Framework Programme (FP7).	Baer RA, 2012, J CLIN PSYCHOL, V68, P755, DOI 10.1002/jclp.21865; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bedard M, 2005, J COGN REHABIL, V23, P8, DOI DOI 10.1080/0963828031000090489; Boggs JM, 2014, J MED INTERNET RES, V16, P332, DOI 10.2196/jmir.3129; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Creavin ST, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011145.pub2; de Bruin E, 2011, MINDFULNESS, V2, P211; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Hughes NH, 2011, QUATERNION EULER ANG; Jennett C, 2008, INT J HUM-COMPUT ST, V66, P641, DOI 10.1016/j.ijhcs.2008.04.004; Kabat-Zinn J., 1994, THERE YOU ARE MINDFU; Kabat-Zinn J., 2014, MBSR 8 WEEK IT WORKS; KABATZINN J, 1992, AM J PSYCHIAT, V149, P936; Khoury B, 2013, CLIN PSYCHOL REV, V33, P763, DOI 10.1016/j.cpr.2013.05.005; Kim MK, 2016, PSYCHIAT INVEST, V13, P196, DOI 10.4306/pi.2016.13.2.196; Koshino H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05954; Lutz A, 2009, J NEUROSCI, V29, P13418, DOI 10.1523/JNEUROSCI.1614-09.2009; Lutz J, 2014, SOC COGN AFFECT NEUR, V9, P776, DOI 10.1093/scan/nst043; Manna A, 2010, BRAIN RES BULL, V82, P46, DOI 10.1016/j.brainresbull.2010.03.001; Rappaport L., 2013, MINDFULNESS ARTS THE; Reddit, 2015, OV SURV; Rizzo A, 2015, J CONTEMP PSYCHOTHER, V45, P255, DOI 10.1007/s10879-015-9306-3; Rizzo AA, 2008, STUD HEALTH TECHNOL, V132, P420; Roggero M., 2009, 7 HOT MAR S MATH GEO, DOI [10.1007/978-3-642-22078-4, DOI 10.1007/978-3-642-22078-4]; Russell TA, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00282; Tabaj A, 2015, REHABIL COUNS BULL, V58, P113, DOI 10.1177/0034355214537383; Taylor VA, 2011, NEUROIMAGE, V57, P1524, DOI 10.1016/j.neuroimage.2011.06.001; Travis F, 2010, CONSCIOUS COGN, V19, P1110, DOI 10.1016/j.concog.2010.01.007; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Zeidan F, 2011, J NEUROSCI, V31, P5540, DOI 10.1523/JNEUROSCI.5791-10.2011	33	13	15	2	28	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	JUN	2017	6	6							e108	10.2196/resprot.6849			16	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	EX3QQ	WOS:000403147500008	28583904	Green Published, gold			2022-02-06	
J	Heron-Delaney, M; Warren, J; Kenardy, JA				Heron-Delaney, Michelle; Warren, Jacelle; Kenardy, Justin A.			Predictors of non-return to work 2 years post-injury in road traffic crash survivors: Results from the UQ SuPPORT study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Motor vehicles; Traffic accidents; Return to work; Mental health; Health	RETURN-TO-WORK; POSTTRAUMATIC-STRESS-DISORDER; LOW-BACK-PAIN; TRAUMATIC BRAIN-INJURY; RECOVERY EXPECTATIONS; CLINICAL-IMPLICATIONS; MULTIPLE INJURIES; DEPRESSION SCALE; HOSPITAL ANXIETY; SEVERITY SCORE	Purpose: Individuals who have sustained an injury from a road traffic crash (RTC) are at increased risk for long lasting health problems and non-return to work (NRTW). Determining the predictors of NRTW is necessary to develop screening tools to identify at-risk individuals and to provide early targeted intervention for successful return to work (RTW). The aim of this study was to identify factors that can predict which individuals will not RTW following minor or moderate injuries sustained from a RTC. Method: Participants were 194 claimants (63.4% female) within a common-law "fault-based" system from the UQ SuPPORT cohort who were working prior to their RTC. Participants were assessed at 6 months on a variety of physical and mental health measures and RTW status was determined at 2 years post-RTC. RTW rate was 78.4%. Results: Univariate predictors of NRTW included being the driver or passenger, having a prior psychiatric diagnosis, high disability level, low mental or physical quality of life, predicted non-recovery, high pain, low function, high expectations of pain persistency, low expectations about RTW, having a psychiatric diagnosis, elevated depression or anxiety. The final multivariable logistic regression model included only two variables: disability level and expectations about RTW. Seventy-five percent of individuals who will not RTW by 2 years can be identified accurately at an early stage, using only these two predictors. Conclusion: The results are promising, because they suggest that having information about two factors, which are easily obtainable, can predict with accuracy those who will require additional support to facilitate RTW. (C) 2017 Elsevier Ltd. All rights reserved.	[Heron-Delaney, Michelle] Australian Catholic Univ, Sch Psychol, 1100 Nudgee Rd, Brisbane, Qld 4014, Australia; [Warren, Jacelle; Kenardy, Justin A.] Univ Queensland, Recover Injury Res Ctr, Brisbane, Qld, Australia; [Kenardy, Justin A.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia		Heron-Delaney, M (corresponding author), Australian Catholic Univ, Sch Psychol, 1100 Nudgee Rd, Brisbane, Qld 4014, Australia.	michelle.delaney@acu.edu.au	Warren, Jacelle/G-2125-2010; Kenardy, Justin A/H-6603-2014; Kenardy, Justin/F-2085-2010; Heron-Delaney, Michelle/M-7540-2014	Warren, Jacelle/0000-0002-2273-1846; Kenardy, Justin A/0000-0001-9475-8450; Heron-Delaney, Michelle/0000-0003-1332-9385	Motor Accident Insurance Commission (MAIC)	We acknowledge the Policy and Research Team at the Motor Accident Insurance Commission (MAIC) for its input at various stages of the project and four anonymous reviewers. This research was funded by the Motor Accident Insurance Commission (MAIC), however, the views in this paper do not necessarily reflect those of the funder.	ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Association for the Advancement of Automotive Medicine, 2005, ABBR INJ SCAL AIS; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barnes Jo, 2006, Annu Proc Assoc Adv Automot Med, V50, P253; Berecki-Gisolf J, 2012, J OCCUP REHABIL, V22, P283, DOI 10.1007/s10926-011-9344-y; BITRE, 2009, 118 BITRE; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Blackwell TL, 2003, REHABIL COUNS BULL, V46, P108, DOI 10.1177/00343552030460020501; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Bureau of Transport Economics, 2000, ROAD CRASH COSTS AUS; Carriere JS, 2015, J OCCUP REHABIL, V25, P348, DOI 10.1007/s10926-014-9543-4; Clay FJ, 2012, J OCCUP REHABIL, V22, P363, DOI 10.1007/s10926-012-9354-4; Clay FJ, 2010, INJURY, V41, P787, DOI 10.1016/j.injury.2010.04.005; Cole DC, 2002, CAN MED ASSOC J, V166, P749; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Du Bois M, 2008, EUR SPINE J, V17, P380, DOI 10.1007/s00586-007-0567-8; Ebrahim S, 2015, J OCCUP REHABIL, V25, P240, DOI 10.1007/s10926-014-9535-4; Fadyl J, 2008, J OCCUP REHABIL, V18, P362, DOI 10.1007/s10926-008-9153-0; Fitzharris M, 2010, AUST NZ J PUBL HEAL, V34, P153, DOI 10.1111/j.1753-6405.2010.00500.x; Fort E, 2011, J REHABIL MED, V43, P283, DOI 10.2340/16501977-0670; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Gabbe BJ, 2007, MED J AUSTRALIA, V187, P14, DOI 10.5694/j.1326-5377.2007.tb01108.x; Garrelfs SF, 2015, BRAIN INJURY, V29, P550, DOI 10.3109/02699052.2014.995227; Gopinath B, 2015, EUR J PAIN, V19, P1111, DOI 10.1002/ejp.634; Grafarend E.W., 2006, LINEAR NONLINEAR MOD; Harrison Kate, 2003, Work, V21, P141; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; He YH, 2010, J OCCUP REHABIL, V20, P378, DOI 10.1007/s10926-010-9232-x; Heijbel B, 2006, J OCCUP REHABIL, V16, P173, DOI 10.1007/s10926-006-9016-5; Hours M, 2013, ACCIDENT ANAL PREV, V50, P92, DOI 10.1016/j.aap.2012.03.037; Huijs JJJM, 2012, J OCCUP REHABIL, V22, P301, DOI 10.1007/s10926-011-9351-z; Iakova M, 2012, J OCCUP REHABIL, V22, P532, DOI 10.1007/s10926-012-9369-x; Iles RA, 2009, J OCCUP REHABIL, V19, P25, DOI 10.1007/s10926-008-9161-0; Kenardy J, EUR J PSYCHOTRAUMATO; Kenardy J, 2015, INJURY, V46, P883, DOI 10.1016/j.injury.2014.11.006; Kenardy J, 2015, ARCH PHYS MED REHAB, V96, P410, DOI 10.1016/j.apmr.2014.10.007; Kessler Ronald C., 1998, INT J METH PSYCH RES, V7, P171, DOI [DOI 10.1002/MPR.47, 10.1002/mpr.47]; Kuijer W, 2006, J OCCUP REHABIL, V16, P439, DOI 10.1007/s10926-006-9021-8; Kuijpers PMJC, 2003, PSYCHOSOMATICS, V44, P329, DOI 10.1176/appi.psy.44.4.329; Kvam L, 2015, J OCCUP REHABIL, V25, P368, DOI 10.1007/s10926-014-9545-2; Lackner JM, 1996, J CONSULT CLIN PSYCH, V64, P212, DOI 10.1037/0022-006X.64.1.212; Lange C, 2007, J OCCUP REHABIL, V17, P1, DOI 10.1007/s10926-006-9039-y; Lilley R, 2012, BMJ, V2; Lin KH, 2013, J OCCUP REHABIL, V23, P55, DOI 10.1007/s10926-012-9381-1; Linton SJ, 2003, CLIN J PAIN, V19, P80, DOI 10.1097/00002508-200303000-00002; Littleton SM, 2012, INJURY, V43, P1586, DOI 10.1016/j.injury.2011.03.002; Lloyd C, 2008, AUST OCCUP THER J, V55, P23, DOI 10.1111/j.1440-1630.2006.00624.x; Matthews LR, 2005, BEHAV RES THER, V43, P475, DOI 10.1016/j.brat.2004.03.008; Mayou R, 2001, BRIT J PSYCHIAT, V179, P528, DOI 10.1192/bjp.179.6.528; Motor Accident Insurance Commission, 2015, STAT INF 1 JUL 31 DE; O'Donnell ML, 2009, MED J AUSTRALIA, V190, pS71; Ottomanelli L, 2009, J SPINAL CORD MED, V32, P503, DOI 10.1080/10790268.2009.11754553; Peters L, 1996, INT J METHOD PSYCH, V6, P167, DOI 10.1002/(SICI)1234-988X(199610)6:3<167::AID-MPR159>3.3.CO;2-Z; Read KM, 2004, J TRAUMA, V57, P815, DOI 10.1097/01.TA.0000136289.15303.44; Schnyder U, 2003, AM J PSYCHIAT, V160, P2025, DOI 10.1176/appi.ajp.160.11.2025; Smith B, 2007, COUNS PSYCHOL Q, V20, P149, DOI 10.1080/09515070701403679; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Soo CA, 2007, BRAIN IMPAIR, V8, P101, DOI DOI 10.1375/BRIM.8.2.101; Stiers W, 2012, OXFORD HDB REHABILIT, P417; Street TD, 2015, WORK, V51, P373, DOI 10.3233/WOR-141980; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Turner JA, 2006, SPINE, V31, P682, DOI 10.1097/01.brs.0000202762.88787.af; Ustin TB, 2010, MEASURING HLTH DISAB; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Ware J., 2000, SCORE VERSION 2 SF 3; Weiss D, 1997, ASSESSING PSYCHOL TR, P399, DOI DOI 10.1037/T12199-000; World Health Organization, 2009, GLOB STAT REP ROAD S; Zampolini M, 2007, DISABIL REHABIL, V29, P1377, DOI 10.1080/09638280701314980; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	72	13	13	1	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JUN	2017	48	6					1120	1128		10.1016/j.injury.2017.03.012			9	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EW4QO	WOS:000402486200005	28343652	Green Accepted			2022-02-06	
J	Mann, A; Tator, CH; Carson, JD				Mann, Aneetinder; Tator, Charles H.; Carson, James D.			Concussion diagnosis and management Knowledge and attitudes of family medicine residents	CANADIAN FAMILY PHYSICIAN			English	Article							EMERGENCY-DEPARTMENT; ATHLETIC TRAINERS; SPORT; COACHES; GUIDELINES; PLAYERS; RETURN	Objective To assess the knowledge of, attitudes toward, and learning needs for concussion diagnosis and management among family medicine residents. Design E-mail survey. Setting University of Toronto in Ontario. Participants Family medicine residents (N = 348). Main outcome measures To describe relationships between awareness of concussion management and lifestyle, education background, and residency placement, t tests and x(2) tests were used as appropriate. Linear regression was used to compare self-reported concussion knowledge with knowledge scores. Thematic analysis was used to interpret answers to the qualitative question asking residents to describe challenges they foresee physicians facing when diagnosing and managing concussion. Results The residents who responded (n = 73, response rate 21%) correctly answered an average of 5.2 questions out of 9 (58%) regarding the diagnosis and management of concussion. Postgraduate year, sex, personal history of concussion, and clinical exposure to concussion were not significant factors in predicting the number of correct answers. Several misconceptions and knowledge gaps were revealed. Of residents who responded, 71% did not recognize chronic traumatic encephalopathy and only 63% recognized second-impact syndrome as consequences of repetitive concussions. Moreover, 32% of residents did not think that every individual with a concussion should see a physician as part of management. Knowledge scores did not predict self-reported concussion knowledge. Thematic analysis revealed 4 themes related to the challenges of concussion diagnosis and management: the nonspecificity and vagueness of symptoms, lack of formal diagnostic criteria, patient compliance with management, and counseling patients with respect to return to play, work, or learning. Conclusion We found substantial gaps in knowledge surrounding concussion diagnosis and management among family medicine residents. This lack of knowledge should be addressed at both the undergraduate medical education level and the residency training level to improve concussion-related care and patient outcomes.	[Mann, Aneetinder] Univ Toronto, Fac Med, Toronto, ON, Canada; [Tator, Charles H.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Tator, Charles H.] Toronto Western Hosp, Canadian Concuss Ctr, Toronto, ON, Canada; [Tator, Charles H.] Krembil Res Inst, Toronto, ON, Canada; [Tator, Charles H.] Parachute Canada, Toronto, ON, Canada; [Carson, James D.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Carson, James D.] Markham Stouffville Hosp, Markham, ON, Canada; [Carson, James D.] Scarborough & Rouge Hosp, Scarborough, ON, Canada		Mann, A (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.	aneet.mann@mail.utoronto.ca					Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Boggild M, 2012, CAN J NEUROL SCI, V39, P361, DOI 10.1017/S0317167100013524; Burke MJ, 2012, CAN J NEUROL SCI, V39, P763, DOI 10.1017/S0317167100015584; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Echlin PS, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12286; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Fraas MR, 2015, IRISH J MED SCI, V184, P425, DOI 10.1007/s11845-014-1137-9; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; LaBond Virginia, 2014, NASN Sch Nurse, V29, P194; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Murphy A, 2012, PM&R, V4, P419, DOI 10.1016/j.pmrj.2012.03.013; Naftel KG, 2014, SOUTH MED J, V107, P418, DOI 10.14423/SMJ.0000000000000136; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Radhakrishna R, 2008, J EXT, V46; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; *STAT CAN, 2010, GEN SOC SURV 2010 CY; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	28	13	13	0	7	COLL FAMILY PHYSICIANS CANADA	MISSISSAUGA	2630 SKYMARK AVE, MISSISSAUGA, ONTARIO L4W 5A4, CANADA	0008-350X	1715-5258		CAN FAM PHYSICIAN	Can. Fam. Phys.	JUN	2017	63	6					460	466					7	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3FP	WOS:000405328300014	28615399				2022-02-06	
J	Mioni, G; Bertucci, E; Rosato, A; Terrett, G; Rendell, PG; Zamuner, M; Stablum, F				Mioni, Giovanna; Bertucci, Erica; Rosato, Antonella; Terrett, Gill; Rendell, Peter G.; Zamuner, Massimo; Stablum, Franca			Improving prospective memory performance with future event simulation in traumatic brain injury patients	BRITISH JOURNAL OF CLINICAL PSYCHOLOGY			English	Article						prospective memory; traumatic brain injury; future event simulation; Virtual Week	IMPLEMENTATION INTENTIONS; VIRTUAL WEEK; ADULTS; INVOLVEMENT; THINKING; ALCOHOL; DEMANDS; TASK	ObjectivePrevious studies have shown that traumatic brain injury (TBI) patients have difficulties with prospective memory (PM). Considering that PM is closely linked to independent living it is of primary interest to develop strategies that can improve PM performance in TBI patients. MethodThis study employed Virtual Week task as a measure of PM, and we included future event simulation to boost PM performance. Study 1 evaluated the efficacy of the strategy and investigated possible practice effects. Twenty-four healthy participants performed Virtual Week in a no strategy condition, and 24 healthy participants performed it in a mixed condition (no strategy - future event simulation). In Study 2, 18 TBI patients completed the mixed condition of Virtual Week and were compared with the 24 healthy controls who undertook the mixed condition of Virtual Week in Study 1. All participants also completed a neuropsychological evaluation to characterize the groups on level of cognitive functioning. ResultsStudy 1 showed that participants in the future event simulation condition outperformed participants in the no strategy condition, and these results were not attributable to practice effects. Results of Study 2 showed that TBI patients performed PM tasks less accurately than controls, but that future event simulation can substantially reduce TBI-related deficits in PM performance. The future event simulation strategy also improved the controls' PM performance. ConclusionsThese studies showed the value of future event simulation strategy in improving PM performance in healthy participants as well as in TBI patients. Practitioner points TBI patients performed PM tasks less accurately than controls, confirming prospective memory impairment in these patients. Participants in the future event simulation condition out-performed participants in the no strategy condition. Future event simulation can substantially reduce TBI-related deficits in PM performance. Future event simulation strategy also improved the controls' PM performance.	[Mioni, Giovanna; Stablum, Franca] Univ Padua, Dept Gen Psychol, Via Venezia 12, I-35131 Padua, Italy; [Bertucci, Erica; Rosato, Antonella; Zamuner, Massimo] Assoc Rieduc Ente Privato AREP Onlus, Treviso, Italy; [Terrett, Gill; Rendell, Peter G.] Australian Catholic Univ, Sch Psychol, Melbourne, Vic, Australia		Mioni, G (corresponding author), Univ Padua, Dept Gen Psychol, Via Venezia 12, I-35131 Padua, Italy.	mioni.giovanna@gmail.com	Rendell, Peter/E-7539-2010; Terrett, Gill/D-7165-2019	Rendell, Peter/0000-0002-4829-4322; Terrett, Gill/0000-0003-2500-6428; mioni, Giovanna/0000-0002-1212-4591			[Anonymous], 1987, Ital J Neurol Sci, VSuppl 8, P1; Burgess P, 2005, CURR ISS THINK REASO, P199; Chasteen AL, 2001, PSYCHOL SCI, V12, P457, DOI 10.1111/1467-9280.00385; Cohen J., 2013, STAT POWER ANAL BEHA; Coste C, 2015, NEUROPSYCHOLOGIA, V71, P133, DOI 10.1016/j.neuropsychologia.2015.03.014; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Foster ER, 2013, NEUROPSYCHOLOGY, V27, P170, DOI 10.1037/a0031946; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Gollwitzer PM, 1997, J PERS SOC PSYCHOL, V73, P186, DOI 10.1037/0022-3514.73.1.186; Griffiths A, 2012, ADDICTION, V107, P1809, DOI 10.1111/j.1360-0443.2012.03941.x; Howell DC., 1997, STAT METHODS PSYCHOL, V4th ed; Kardiasmenos KS, 2008, NEUROPSYCHOLOGY, V22, P746, DOI 10.1037/a0013211; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M., 2008, PROSPECTIVE MEMORY C; Leitz JR, 2009, PSYCHOPHARMACOLOGY, V205, P379, DOI 10.1007/s00213-009-1546-z; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; McDaniel M.A., 1996, PROSPECT MEM THEORY, P115; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA., 1996, PROSPECTIVE MEMORY T, P1; McDaniel MA, 2008, MEM COGNITION, V36, P716, DOI 10.3758/MC.36.4.716; McDaniel MA, 2010, MEM COGNITION, V38, P221, DOI 10.3758/MC.38.2.221; McFarland CP, 2009, NEUROPSYCHOLOGIA, V47, P1660, DOI 10.1016/j.neuropsychologia.2009.02.023; Mioni G., 2014, TRAUMATIC BRAIN INJU, P401, DOI [10.5772/5730, DOI 10.5772/57307]; Mioni G, 2017, NEUROPSYCHOL REHABIL, V27, P486, DOI 10.1080/09602011.2015.1103758; Mioni G, 2015, J INT NEUROPSYCH SOC, V21, P305, DOI 10.1017/S1355617715000211; Mioni G, 2015, NEUROPSYCHOL REHABIL, V25, P419, DOI 10.1080/09602011.2014.941295; Mioni G, 2013, J CLIN EXP NEUROPSYC, V35, P617, DOI 10.1080/13803395.2013.804036; Neroni MA, 2014, CONSCIOUS COGN, V23, P53, DOI 10.1016/j.concog.2013.12.001; Paraskevaides T, 2010, PSYCHOPHARMACOLOGY, V208, P301, DOI 10.1007/s00213-009-1731-0; Platt B, 2016, PSYCHOPHARMACOLOGY, V233, P499, DOI 10.1007/s00213-015-4145-1; Rasmussen KW, 2014, J NEUROPSYCHOL, V8, P34, DOI 10.1111/jnp.12003; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Schnitzspahn KM, 2009, EUR J AGEING, V6, P147, DOI 10.1007/s10433-009-0116-x; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; TEASDALE G, 1974, LANCET, V2, P81; Terrett G, 2016, Q J EXP PSYCHOL, V69, P310, DOI 10.1080/17470218.2015.1054294; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; Webb TL, 2007, J EXP SOC PSYCHOL, V43, P295, DOI 10.1016/j.jesp.2006.02.001; [No title captured]	41	13	13	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0144-6657	2044-8260		BRIT J CLIN PSYCHOL	Br. J. Clin. Psychol.	JUN	2017	56	2					130	148		10.1111/bjc.12126			19	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	EU1NG	WOS:000400786500002	28093771				2022-02-06	
J	Solmaz, B; Tunc, B; Parker, D; Whyte, J; Hart, T; Rabinowitz, A; Rohrbach, M; Kim, J; Verma, R				Solmaz, Berkan; Tunc, Birkan; Parker, Drew; Whyte, John; Hart, Tessa; Rabinowitz, Amanda; Rohrbach, Morgan; Kim, Junghoon; Verma, Ragini			Assessing Connectivity Related Injury Burden in Diffuse Traumatic Brain Injury	HUMAN BRAIN MAPPING			English	Article						diffuse axonal injury; brain network; structural connectivity; diffusion; behavior; cognition	WHITE-MATTER INTEGRITY; AXONAL INJURY; STRUCTURAL CONNECTIVITY; COGNITIVE IMPAIRMENT; NETWORK CONNECTIVITY; MILD; CLASSIFICATION; TRACTOGRAPHY; SCALE; ORIENTATION	Many of the clinical and behavioral manifestations of traumatic brain injury (TBI) are thought to arise from disruption to the structural network of the brain due to diffuse axonal injury (DAI). However, a principled way of summarizing diffuse connectivity alterations to quantify injury burden is lacking. In this study, we developed a connectome injury score, Disruption Index of the Structural Connectome (DISC), which summarizes the cumulative effects of TBI-induced connectivity abnormalities across the entire brain. Forty patients with moderate-to-severe TBI examined at 3 months postinjury and 35 uninjured healthy controls underwent magnetic resonance imaging with diffusion tensor imaging, and completed behavioral assessment including global clinical outcome measures and neuropsychological tests. TBI patients were selected to maximize the likelihood of DAI in the absence of large focal brain lesions. We found that hub-like regions, with high betweenness centrality, were most likely to be impaired as a result of diffuse TBI. Clustering of participants revealed a subgroup of TBI patients with similar connectivity abnormality profiles who exhibited relatively poor cognitive performance. Among TBI patients, DISC was significantly correlated with post-traumatic amnesia, verbal learning, executive function, and processing speed. Our experiments jointly demonstrated that assessing structural connectivity alterations may be useful in development of patient-oriented diagnostic and prognostic tools. (C) 2017 Wiley Periodicals, Inc.	[Solmaz, Berkan; Tunc, Birkan; Parker, Drew; Verma, Ragini] Univ Penn, Perelman Sch Med, Dept Radiol, Ctr Biomed Image Comp & Analyt, Philadelphia, PA 19104 USA; [Whyte, John; Hart, Tessa; Rabinowitz, Amanda; Rohrbach, Morgan; Kim, Junghoon] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Kim, Junghoon] CUNY, Sch Med, City Coll New York, New York, NY 10031 USA		Kim, J (corresponding author), Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA.; Kim, J (corresponding author), CUNY, Sch Med, City Coll New York, New York, NY 10031 USA.	jkim@med.cuny.edu	Kim, Junghoon John/I-6702-2019	Kim, Junghoon John/0000-0001-5729-8993	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS065980, R01-NS096606, R01-MH092862]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH092862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065980, R01NS096606] Funding Source: NIH RePORTER	Contract grant sponsor: National Institutes of Health (NIH), Contract grant number: R01-NS065980, R01-NS096606, and R01-MH092862	Aerts H, 2016, BRAIN, V139, P3063, DOI 10.1093/brain/aww194; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Benton AL, 1994, MULTILINGUAL APHASIA; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Cote MA, 2013, MED IMAGE ANAL, V17, P844, DOI 10.1016/j.media.2013.03.009; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fillard P, 2011, NEUROIMAGE, V56, P220, DOI 10.1016/j.neuroimage.2011.01.032; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuceyeski A, 2011, NEUROIMAGE, V58, P109, DOI 10.1016/j.neuroimage.2011.05.087; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; McIntosh TK, 1996, LAB INVEST, V74, P315; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Pal D, 2012, CLIN NEUROL NEUROSUR, V114, P564, DOI 10.1016/j.clineuro.2011.12.002; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan R., 1985, HALSTEAD REITAN NEUR; Rey A, 1958, EXAMEN CLIN PSYCHOL; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; Senbabaoglu Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06207; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tuch D.S., 1999, MAGN RESON MED, V7, P321; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Warren DE, 2014, P NATL ACAD SCI USA, V111, P14247, DOI 10.1073/pnas.1322173111; Watanabe T, 2016, MED IMAGE COMPUTING; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; White T, 2009, PSYCHIAT RES-NEUROIM, V174, P110, DOI 10.1016/j.pscychresns.2009.04.014; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664	72	13	13	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	JUN	2017	38	6					2913	2922		10.1002/hbm.23561			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	EZ7XV	WOS:000404939900009	28294464	Green Published, Green Accepted			2022-02-06	
J	Spurlock, MS; Ahmed, AI; Rivera, KN; Yokobori, S; Lee, SW; Sam, PN; Shear, DA; Hefferan, MP; Hazel, TG; Johe, KK; Gajavelli, S; Tortella, FC; Bullock, RM				Spurlock, Markus S.; Ahmed, Aminul I.; Rivera, Karla N.; Yokobori, Shoji; Lee, Stephanie W.; Sam, Pingdewinde N.; Shear, Deborah A.; Hefferan, Michael P.; Hazel, Thomas G.; Johe, Karl K.; Gajavelli, Shyam; Tortella, Frank C.; Bullock, Ross M.			Amelioration of Penetrating Ballistic-Like Brain Injury Induced Cognitive Deficits after Neuronal Differentiation of Transplanted Human Neural Stem Cells	JOURNAL OF NEUROTRAUMA			English	Article						behavior deficit; cell transplantation; hNSC; neuronal differentiation; PBBI; TBI	AMYOTROPHIC-LATERAL-SCLEROSIS; PHASE-I TRIAL; RAT MODEL; FUNCTIONAL RECOVERY; STEM/PROGENITOR CELLS; PROGENITOR CELLS; SYNAPTIC PROTEIN; GUNSHOT WOUNDS; STROMAL CELLS; RODENT MODEL	Penetrating traumatic brain injury (PTBI) is one of the major cause of death and disability worldwide. Previous studies with penetrating ballistic-like brain injury (PBBI), a PTBI rat model revealed widespread perilesional neurodegeneration, similar to that seen in humans following gunshot wound to the head, which is unmitigated by any available therapies to date. Therefore, we evaluated human neural stem cell (hNSC) engraftment to putatively exploit the potential of cell therapy that has been seen in other central nervous system injury models. Toward this objective, green fluorescent protein (GFP) labeled hNSC (400,000 per animal) were transplanted in immunosuppressed Sprague-Dawley (SD), Fisher, and athymic (ATN) PBBI rats 1 week after injury. Tacrolimus (3 mg/kg 2 days prior to transplantation, then 1 mg/kg/day), methylprednisolone (10 mg/kg on the day of transplant, 1 mg/kg/week thereafter), and mycophenolate mofetil (30 mg/kg/day) for 7 days following transplantation were used to confer immunosuppression. Engraftment in SD and ATN was comparable at 8 weeks post-transplantation. Evaluation of hNSC differentiation and distribution revealed increased neuronal differentiation of transplanted cells with time. At 16 weeks post-transplantation, neither cell proliferation nor glial lineage markers were detected. Transplanted cell morphology was similar to that of neighboring host neurons, and there was relatively little migration of cells from the peritransplant site. By 16 weeks, GF-positive processes extended both rostrocaudally and bilaterally into parenchyma, spreading along host white matter tracts, traversing the internal capsule, and extending similar to 13mm caudally from transplantation site reaching into the brainstem. In a Morris water maze test at 8 weeks post-transplantation, animals with transplants had shorter latency to platform than vehicle-treated animals. However, weak injury-induced cognitive deficits in the control group at the delayed time point confounded benefits of durable engraftment and neuronal differentiation. Therefore, these results justify further studies to progress towards clinical translation of hNSC therapy for PTBI.	[Spurlock, Markus S.; Ahmed, Aminul I.; Rivera, Karla N.; Yokobori, Shoji; Lee, Stephanie W.; Sam, Pingdewinde N.; Gajavelli, Shyam; Bullock, Ross M.] Miami Project Cure Paralysis, 1095 NW 14th Terrace, Miami, FL 33136 USA; [Shear, Deborah A.; Tortella, Frank C.] Walter Reed Army Inst Res, Branch Brain Trauma Neuroprotect & Neurorestorat, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA; [Hefferan, Michael P.; Hazel, Thomas G.; Johe, Karl K.] Neuralstem Inc, Germantown, MD USA		Gajavelli, S (corresponding author), Miami Project Cure Paralysis, 1095 NW 14th Terrace, Miami, FL 33136 USA.	shyam@miami.edu	Gajavelli, Shyam/AAI-1374-2019	Gajavelli, Shyam/0000-0002-5947-6973; Ahmed, Aminul/0000-0001-6670-0438	Department of Health State of Florida General Revenue Funds; NIH Morehouse College Minority Biomedical Research Support - Research Initiative for Scientific Enhancement (MBRS-RISE) Fellowship; NIH Summer Student Fellowship;  [W81XWH-16-2-0008-BAA-150111]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS083064] Funding Source: NIH RePORTER; Academy of Medical Sciences (AMS)Academy of Medical Sciences (AMS) [AMS-SGCL9-Ahmed] Funding Source: researchfish	These studies were supported in part by W81XWH-16-2-0008-BAA-150111 to R.M.B. and by the Department of Health State of Florida General Revenue Funds to The Miami Project to Cure Paralysis. P.N.S., a student volunteer from San Francisco State University (SFSU), was supported by an NIH Morehouse College Minority Biomedical Research Support - Research Initiative for Scientific Enhancement (MBRS-RISE) Fellowship and in part by an NIH Summer Student Fellowship. The authors thank Dr. Khadil Hosein, Dr. Meghan O Blaya, Dr. Lai Yee Leung, Dr. Ying Deng-Bryant, Dr. Stanislava Jergova, Dr. Melissa Carballosa-Gautam, Dr. Guobin Zhang, Dr. Adaikkalasamy David (Titus), Dr. Philip Ruiz, Dr. Alex Marcillo, Dr. Donna Avison, David Joel Sequeira, Yoelvis Hernandez, Jessica Monterrosa Mena, Nuan Song, Matthew Aguirre, and Julia Janecki for technical contributions to this study, and Nathan Bryant Schoen, Dr. Meghan O Blaya, and Maria Muniz for proofreading the manuscript.	Ahmed AI, 2016, J ROY ARMY MED CORPS, V162, P98, DOI 10.1136/jramc-2015-000475; Al Nimer F, 2004, NEUROREPORT, V15, P1871, DOI 10.1097/00001756-200408260-00007; Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; Bailey AM, 2014, NAT BIOTECHNOL, V32, P721, DOI 10.1038/nbt.2971; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Bonaventura G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140790; Boutte AM, 2012, ELECTROPHORESIS, V33, P3693, DOI 10.1002/elps.201200196; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Chang J, 2015, EXP NEUROL, V273, P225, DOI 10.1016/j.expneurol.2015.08.020; Chen ZY, 2011, BRAIN RES, V1368, P71, DOI 10.1016/j.brainres.2010.10.028; Chen ZY, 2009, J NEUROTRAUM, V26, P1987, DOI 10.1089/neu.2008.0863; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Defense and Veterans Brain Injury Center, 2016, DOD WORLDW NUMB TBI; Deng-Bryant Y, 2015, RESTOR NEUROL NEUROS, V33, P189, DOI 10.3233/RNN-140455; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; Elias PZ, 2015, J TISSUE ENG REGEN M, V9, P137, DOI 10.1002/term.1621; Elias PZ, 2012, J NEUROSCI METH, V209, P199, DOI 10.1016/j.jneumeth.2012.06.003; Faul M, 2010, TRAUMATIC BRAIN INJU; Feldman EL, 2014, ANN NEUROL, V75, P363, DOI 10.1002/ana.24113; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Gajavelli S, 2015, J CEREBR BLOOD F MET, V35, P773, DOI 10.1038/jcbfm.2014.243; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gao JL, 2016, CELL TRANSPLANT, V25, P1863, DOI 10.3727/096368916X691150; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Giusto E, 2014, EXP NEUROL, V260, P19, DOI 10.1016/j.expneurol.2013.03.009; Glass JD, 2012, STEM CELLS, V30, P1144, DOI 10.1002/stem.1079; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Guevara AB, 2016, J HEAD TRAUMA REHAB, V31, pE48, DOI 10.1097/HTR.0000000000000151; Guo XF, 2010, J TISSUE ENG REGEN M, V4, P181, DOI 10.1002/term.223; Hagan M, 2003, NEUROSCI LETT, V351, P149, DOI 10.1016/j.neulet.2003.07.021; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Hefferan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042614; Hefferan MP, 2011, CELL TRANSPLANT, V20, P1153, DOI 10.3727/096368910X564553; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; Jena AB, 2014, J GEN INTERN MED, V29, P1065, DOI 10.1007/s11606-014-2779-z; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Khan MB, 2014, WORLD NEUROSURG, V82, P14, DOI 10.1016/j.wneu.2013.01.026; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee DH, 2013, CHILD NERV SYST, V29, P403, DOI 10.1007/s00381-012-1969-4; Lee GQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099000; Leong WK, 2013, STEM CELLS, V31, P1040, DOI 10.1002/stem.1348; Lin DJ., 2012, SURG NEUROL INT, V3, P98, DOI [DOI 10.4103/2152-7806, 10.4103/2152-7806.100187, DOI 10.4103/2152-7806.100187]; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Lu X.C., 2015, J NEUROTRAUMA; Lundberg J, 2012, CELL TRANSPLANT, V21, P333, DOI 10.3727/096368911X576036; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Oehmichen Manfred, 2009, Leg Med (Tokyo), V11 Suppl 1, pS50, DOI 10.1016/j.legalmed.2009.01.113; Office of Cellular Tissue and Gene Therapy (OCTGT), 2013, GUID IND PRECL ASS I; Pendharkar AV, 2010, STROKE, V41, P2064, DOI 10.1161/STROKEAHA.109.575993; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; Pruitt BA, 2001, J TRAUMA, V51, pS1, DOI 10.1097/00005373-200108001-00001; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Riley J, 2014, NEUROSURGERY, V74, P77, DOI 10.1227/NEU.0000000000000156; Riley J, 2012, NEUROSURGERY, V71, P405, DOI 10.1227/NEU.0b013e31825ca05f; Rolfe A., 2015, BRAIN NEUROTRAUMA MO, P587; Rosenfeld JV, 2015, WORLD J SURG, V39, P1352, DOI 10.1007/s00268-014-2874-7; Roshal LM, 2009, B EXP BIOL MED+, V148, P140, DOI 10.1007/s10517-009-0642-8; Shear DA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00073; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Skardelly M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00318; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Steinbeck JA, 2015, NEURON, V86, P187, DOI 10.1016/j.neuron.2015.03.002; Streib E, 2016, J TRAUMA ACUTE CARE, V80, P849, DOI 10.1097/TA.0000000000001090; Tadesse T, 2014, ANN CLIN TRANSL NEUR, V1, P900, DOI 10.1002/acn3.134; Tajiri N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091408; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Tasigiorgos S, 2015, J AM COLL SURGEONS, V221, P1005, DOI 10.1016/j.jamcollsurg.2015.08.430; Tennstaedt A, 2015, BIOMATERIALS, V44, P143, DOI 10.1016/j.biomaterials.2014.12.038; Tsyb AF, 2009, B EXP BIOL MED+, V147, P132, DOI 10.1007/s10517-009-0432-3; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang EY, 2012, J NEUROTRAUM, V29, P295, DOI 10.1089/neu.2011.2043; Wei HH, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-19; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Wennersten A, 2006, EXP NEUROL, V199, P339, DOI 10.1016/j.expneurol.2005.12.035; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Winn H.R, 2011, YOUMANS NEUROLOGICAL, V4; Wu P, 2002, GENE THER, V9, P245, DOI 10.1038/sj.gt.3301646; Xiong Y, 2010, DISCOV MED, V10, P434; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Yan J, 2006, STEM CELLS, V24, P1976, DOI 10.1634/stemcells.2005-0518; Yan ZJ, 2013, NEUROCHEM RES, V38, P1022, DOI 10.1007/s11064-013-1012-5; Yavagal DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093735; Young NH, 2008, PLOS MED, V5, P1186, DOI 10.1371/journal.pmed.0050168; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770	96	13	13	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2017	34	11					1981	1995		10.1089/neu.2016.4602			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EV4KD	WOS:000401727500008	28249550	Green Published			2022-02-06	
J	Tang, CH; Bao, Y; Qi, M; Zhou, LZ; Liu, F; Mao, J; Lei, QM; Qi, ST; Qiu, BH				Tang, Chunhai; Bao, Yun; Qi, Min; Zhou, Lizhi; Liu, Fan; Mao, Jian; Lei, Qingmei; Qi, Songtao; Qiu, Binghui			Mild induced hypothermia for patients with severe traumatic brain injury after decompressive craniectomy	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; Hypothermia; Craniectomy; Intracranial pressure; Outcome	THERAPEUTIC HYPOTHERMIA; INTRACRANIAL-PRESSURE; MODERATE HYPOTHERMIA; OUTCOMES; HYPERTENSION; IMPACT	Purpose: To evaluate the efficacy and safety of mild induced hypothermia for intracranial hypertension in patients with traumatic brain injury after decompressive craniectomy. Methods: A total of 60 adults with intracranial pressure (ICP) of more than 20 mm Hg after decompressive craniectomy were randomly assigned to standard care (control group) or hypothermia (32 degrees C-35 degrees C) plus standard care. Then, ICP, cerebral perfusion pressure, Glasgow Outcome Scale score, and complications were assessed. Results: There was a significant difference in ICP and cerebral perfusion pressure between the 2 groups. Favorable outcomes occurred in 12 (40.0%) and 7 (36.5%) patients in the hypothermia and control groups, respectively (P =.267). Kaplan-Meier curves revealed a marked difference in survival between the hypothermia and control groups (P =.032). There were significant differences in pulmonary infection and electrolyte disorders between the hypothermia and control groups (P =.038 and.033, respectively). Conclusion: Mild induced hypothermia can reduce intracranial hypertension after decompressive craniectomy, decreasing patient mortality. Hypothermia should be considered one of the main treatments for intracranial hypertension after decompressive craniectomy in patients with traumatic brain injury. (C) 2016 Elsevier Inc. All rights reserved.	[Tang, Chunhai; Bao, Yun; Qi, Min; Zhou, Lizhi; Liu, Fan; Mao, Jian; Lei, Qingmei; Qi, Songtao; Qiu, Binghui] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Tang, Chunhai] Guangxi Med Univ, Affiliated Hosp 10, Dept Neurosurg, Nanning, Guangdong, Peoples R China; [Qi, Min] Southern Med Univ, Coll Clin Med 1, Guangzhou, Guangdong, Peoples R China; [Zhou, Lizhi] Southern Med Univ, Sch Biostat, Dept Biostat, Guangzhou, Guangdong, Peoples R China; [Lei, Qingmei] Southern Med Univ, Nanfang Hosp, Dept Nursing, Guangzhou, Guangdong, Peoples R China		Qi, ST; Qiu, BH (corresponding author), Guangzhou Dadao Bei St 1838, Guangzhou, Guangdong, Peoples R China.	qisongtaonfyy@126.com			key Clinical Specialty Discipline Construction Program, President Foundation of Nanfang Hospital, Southern Medical University [2015C028]; Science and Technology Planning Project of Guangdong Province, China [2012B091100463, 2013B021800304]	This study was supported by key Clinical Specialty Discipline Construction Program, President Foundation of Nanfang Hospital, Southern Medical University (2015C028). Science and Technology Planning Project of Guangdong Province, China (2012B091100463, 2013B021800304).	Andrews PJD, 2016, NEW ENGL J MED, V374, P1385, DOI 10.1056/NEJMc1600339; Burger R, 2004, NEUROSURGERY, V54, P701, DOI 10.1227/01.NEU.0000108784.80585.EE; Carney NA, 2007, METHODS J NEUROTR S1, V24, pS3; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; Georgoff P, 2010, WORLD NEUROSURG, V74, P331, DOI 10.1016/j.wneu.2010.03.025; Han JS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002827; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Kahveci FS, 2001, SURG NEUROL, V56, P206, DOI 10.1016/S0090-3019(01)00555-9; Kelts EA, 2010, NEUROREHABILITATION, V27, P223, DOI 10.3233/NRE-2010-0601; Konstantinidis A, 2011, J TRAUMA, V71, P1627, DOI 10.1097/TA.0b013e3182159e31; Kramer C, 2012, NEUROLOGIST, V18, P173, DOI 10.1097/NRL.0b013e318253f8ef; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Popugaev KA, 2014, J NEUROL SURG REP, V75, pE224, DOI 10.1055/s-0034-1387188; Sandestig A, 2014, THER HYPOTHERMIA TEM, V4, P10, DOI 10.1089/ther.2013.0024; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Tang A, 2015, J SURG RES, V194, P565, DOI 10.1016/j.jss.2014.11.017; Wang JW, 2016, J CLIN NEUROSCI, V27, P1, DOI 10.1016/j.jocn.2015.06.037; Wang R, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001733	20	13	13	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	JUN	2017	39						267	270		10.1016/j.jcrc.2016.12.012			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW4KR	WOS:000402470900045	28069320				2022-02-06	
J	Charry, JD; Tejada, JH; Pinzon, MA; Tejada, WA; Ochoa, JD; Falla, M; Tovar, JH; Cuellar-Bahamon, AM; Solano, JP				Charry, Jose D.; Tejada, Jorman H.; Pinzon, Miguel A.; Tejada, Wilson A.; Ochoa, Juan D.; Falla, Manuel; Tovar, Jesus H.; Cuellar-Bahamon, Ana M.; Solano, Juan P.			Predicted Unfavorable Neurologic Outcome Is Overestimated by the Marshall Computed Tomography Score, Corticosteroid Randomization After Significant Head Injury (CRASH), and International Mission for Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury (IMPACT) Models in Patients with Severe Traumatic Brain Injury Managed with Early Decompressive Craniectomy	WORLD NEUROSURGERY			English	Article						Neurologic outcome; Prognosis models; Traumatic brain injury	MORTALITY; PROTOCOL; ADULTS; CARE	INTRODUCTION: Traumatic brain injury (TBI) is of public health interest and produces significant mortality and disability in Colombia. Calculators and prognostic models have been developed to establish neurologic outcomes. We tested prognostic models (the Marshall computed tomography [CT] score, International Mission for Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury (IMPACT), and Corticosteroid Randomization After Significant Head Injury) for 14-day mortality, 6-month mortality, and 6-month outcome in patients with TBI at a university hospital in Colombia. METHODS: A 127-patient cohort with TBI was treated in a regional trauma center in Colombia over 2 years and bivariate and multivariate analyses were used. Discriminatory power of the models, their accuracy, and precision was assessed by both logistic regression and area under the receiver operating characteristic curve (AUC). Shapiro-Wilk, chi(2), and Wilcoxon test were used to compare real outcomes in the cohort against predicted outcomes. RESULTS: The group's median age was 33 years, and 84.25% were male. The injury severity score median was 25, and median Glasgow Coma Scale motor score was 3. Six-month mortality was 29.13%. Six-month unfavorable outcome was 37%. Mortality prediction by Marshall CT score was 52.8%, P=0.104 (AUC 0.585; 95% confidence interval [CI] 0 0.489-0.681), the mortality prediction by CRASH prognosis calculator was 59.9%, P < 0.001 (AUC 0.706; 95% CI 0.590-0.821), and the unfavorable outcome prediction by IMPACT was 77%, P < 0.048 (AUC 0.670; 95% CI 0.575-0.763). CONCLUSIONS: In a university hospital in Colombia, the Marshall CT score, IMPACT, and Corticosteroid Randomization After Significant Head Injury models overestimated the adverse neurologic outcome in patients with severe head trauma.	[Charry, Jose D.] Fdn Univ Navarra Uninavarra, Dept Med, Neiva, Colombia; [Charry, Jose D.] Univ Jaen, Jaen, Spain; [Tejada, Jorman H.; Pinzon, Miguel A.; Tovar, Jesus H.] Univ Surcolombiana, Dept Anesthesiol & Resuscitat, Neiva, Colombia; [Tejada, Wilson A.; Ochoa, Juan D.; Falla, Manuel; Cuellar-Bahamon, Ana M.] Univ Surcolombiana, Dept Med, Neiva, Colombia; [Solano, Juan P.] Neiva Univ Hosp, Dept Neurosurg, Neiva, Colombia		Charry, JD (corresponding author), Fdn Univ Navarra Uninavarra, Dept Med, Neiva, Colombia.; Charry, JD (corresponding author), Univ Jaen, Jaen, Spain.	danielcharry06@gmail.com		Charry, Jose D./0000-0002-8789-7281; Pinzon Pinzon, Miguel Angel/0000-0001-5828-9212			Byass P, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001477; Charry JD, 2016, BRIT J NEUROSURG, V30, P235, DOI 10.3109/02688697.2015.1096905; Charry JD, 2016, J NEUROSCI RURAL PRA, V7, P7, DOI 10.4103/0976-3147.172151; Coughlan MD, 2003, CHILD NERV SYST, V19, P348, DOI 10.1007/s00381-003-0736-y; De la Hoz GA, 2013, FORENSIS, P79; Edwards P, 2005, LANCET, V365, P1957; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Honeybul S, 2014, J NEUROSURG, V120, P1131, DOI 10.3171/2014.1.JNS131559; Honeybul S, 2011, J NEUROTRAUM, V28, P2199, DOI 10.1089/neu.2011.1907; Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3; Hutchinson PJ, 2011, BRIT J NEUROSURG, V25, P441, DOI 10.3109/02688697.2011.583366; Kesinger MR, 2014, INJURY, V45, P1350, DOI 10.1016/j.injury.2014.04.037; Kesinger MR, 2014, WORLD J SURG, V38, P1869, DOI 10.1007/s00268-014-2534-y; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; TIMMONS SD, 2011, NEW ENGL J MED, V365, P373	20	13	14	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2017	101						554	558		10.1016/j.wneu.2017.02.051			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EV7CR	WOS:000401932500072	28223249				2022-02-06	
J	Hanninen, T; Parkkari, J; Tuominen, M; Iverson, GL; Ohman, J; Vartiainen, M; Luoto, TM				Hanninen, Timo; Parkkari, Jari; Tuominen, Markku; Iverson, Grant L.; Ohman, Juha; Vartiainen, Matti; Luoto, Teemu M.			Interpreting change on the SCAT3 in professional ice hockey players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain concussion; Head injuries; Baseline survey; Ice hockey	CONCUSSION; SPORT; STATEMENT; INJURIES	Objectives: To examine test-retest reliability of the. SCAT3 for two consecutive seasons using a large sample of professional male ice hockey players, and to make recommendations for interpreting change on the test. Design: A cross-sectional descriptive study. Methods: Preseason baseline testing was administered in the beginning of the seasons 2013-2014 and 2014-2015 to 179 professional male hockey players in rink side settings. Results: The test-retest reliabilities of the SCAT3 components were uniformly low. However, the majority of athletes remained grossly within their own individual performance range when two pre-season SCAT3 baseline scores were compared to published normative reference values. Being tested by the same person or a different person did not influence the results. It was uncommon for the Symptom score to worsen by >= 3 points, the Symptom Severity score to worsen by >= 5 points, SAC total score to worsen by >= 3 points, M-BESS total error points to increase by >= 3, or the time to complete Tandem Gait to increase by >= 4s; each occurred in less than 10% of the sample. Conclusions: The SCAT3 has low test-retest reliability. Change scores should be interpreted with caution, and more research is needed to determine the clinical usefulness of the SCAT3 for diagnosing concussion and monitoring recovery. Careful examination of the natural distributions of difference scores provides clinicians with useful information on how to interpret change on the test. (C) 2016 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Hanninen, Timo; Parkkari, Jari] Tampere Res Ctr Sports Med, UKK Inst Hlth Promot Res, Tampere, Finland; IIHF, Zurich, Switzerland; Liiga Finnish Ice Hockey Assoc, Tampere, Finland; Medisport Ltd, Tampere, Finland; Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; MassGen Hosp Children Sport Concuss Program, Boston, MA USA; Home Base, Boston, MA USA; Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; Univ Helsinki, Div Cognit Psychol & Neuropsychol, Inst Behav Sci, Helsinki, Finland		Hanninen, T (corresponding author), Tampere Res Ctr Sports Med, UKK Inst Hlth Promot Res, Tampere, Finland.	timo.hanninen@fimnet.fi	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284; Iverson, Grant/0000-0001-7348-9570	Finnish Ice Hockey Association (FIHA); Finnish Hockey Player Association (FHPA); Finnish Ministry of Education and Culture; Finnish Medical Foundation; Maire Taponen Foundation; Finnish Hockey League; Mooney-Reed Charitable Foundation; ImPACT Applications, Inc.	We greatly appreciate the cooperation of all the team physicians and physiotherapists (Davies Paul, Helenius Petri, Huttunen Jussi, Hyde Jacob, Hamalainen Jari, Ikonen Juhani, Isotupa Juha, Kivela Mika, Kuosmanen Mika, Kuutamoinen Ville, Lahtinen Teppo, Lampinen Juha, Lehtonen Petri, Lukkari Janne, Mali Hero, Mustapaa Sampo, Nakari Juha, Nissila M., Partanen Joonas, Piekkola Ville, Pihkoluoma Tomi, Pohjonen Veli-Matti, Puustinen Vesa, Ruokkeinen Mikko, Suomalainen Ville, Tikanto Jukka, Toivanen Tero, Tahkapaa Mikko, Uotila Toni, Vahtera Ville, Virtala Mika, Vaisanen Jonne, Yrttiaho Harri) who volunteered their time to collect the data for this project. We sincerely thank Mr. Kari Tokola, M.Sc., for the statistical advice, Ms. Birgitta Jarvinen, M.Sc for help in conducting literature searches, and research assistant Anne Simi for her contribution to data collection. We would like to thank the Finnish Hockey League, Finnish Ice Hockey Association (FIHA), and Finnish Hockey Player Association (FHPA) for all their support. This study was financially supported by the Finnish Ministry of Education and Culture, The Finnish Medical Foundation; Maire Taponen Foundation, and the Finnish Hockey League. GLI acknowledges support from the Mooney-Reed Charitable Foundation and ImPACT Applications, Inc.	Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; MANN AH, 1985, EUR J CLIN PHARMACOL, V28, P31, DOI 10.1007/BF00543707; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McKay CD, 2014, BRIT J SPORT MED, V48, P57, DOI 10.1136/bjsports-2013-092860; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Tuominen M, 2015, BRIT J SPORT MED, V49, P30, DOI 10.1136/bjsports-2014-093688; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756	10	13	13	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAY	2017	20	5					424	431		10.1016/j.jsams.2016.09.009			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EU3TE	WOS:000400953100003	27707536	Green Published, Green Accepted			2022-02-06	
J	Kononenko, O; Galatenko, V; Andersson, M; Bazov, I; Watanabe, H; Zhou, XW; Iatsyshyna, A; Mityakina, I; Yakovleva, T; Sarkisyan, D; Ponomarev, I; Krishtal, O; Marklund, N; Tonevitsky, A; Adkins, DL; Bakalkin, G				Kononenko, Olga; Galatenko, Vladimir; Andersson, Malin; Bazov, Igor; Watanabe, Hiroyuki; Zhou, Xing Wu; Iatsyshyna, Anna; Mityakina, Irina; Yakovleva, Tatiana; Sarkisyan, Daniil; Ponomarev, Igor; Krishtal, Oleg; Marklund, Niklas; Tonevitsky, Alex; Adkins, DeAnna L.; Bakalkin, Georgy			Intra- and interregional coregulation of opioid genes: broken symmetry in spinal circuits	FASEB JOURNAL			English	Article						neuropeptides; spinal cord; lateralization	CONTROLLED CORTICAL IMPACT; TRAUMATIC BRAIN-INJURY; DROPLET DIGITAL PCR; COEXPRESSION NETWORKS; POSTURAL ASYMMETRY; INDUCED ARTHRITIS; NEURAL CIRCUITS; RECEPTOR GENE; RAT; EXPRESSION	Regulation of the formation and rewiring of neural circuits by neuropeptides may require coordinated production of these signaling molecules and their receptors that may be established at the transcriptional level. Here, we address this hypothesis by comparing absolute expression levels of opioid peptides with their receptors, the largest neuropeptide family, and by characterizing coexpression (transcriptionally coordinated) patterns of these genes. We demonstrated that expression patterns of opioid genes highly correlate within and across functionally and anatomically different areas. Opioid peptide genes, compared with their receptor genes, are transcribed at much greater absolute levels, which suggests formation of a neuropeptide cloud that covers the receptor-expressed circuits. Surprisingly, we found that both expression levels and the proportion of opioid receptors are strongly lateralized in the spinal cord, interregional coexpression patterns are side specific, and intraregional coexpression profiles are affected differently by left-and right-side unilateral body injury. We propose that opioid genes are regulated as interconnected components of the same molecular system distributed between distinct anatomic regions. The striking feature of this system is its asymmetric coexpression patterns, which suggest side-specific regulation of selective neural circuits by opioid neurohormones.-Kononenko, O., Galatenko, V., Andersson, M., Bazov, I., Watanabe, H., Zhou, X. W., Iatsyshyna, A., Mityakina, I., Yakovleva, T., Sarkisyan, D., Ponomarev, I., Krishtal, O., Marklund, N., Tonevitsky, A., Adkins, D. L., Bakalkin, G. Intra-and interregional coregulation of opioid genes: broken symmetry in spinal circuits.	[Kononenko, Olga; Andersson, Malin; Bazov, Igor; Watanabe, Hiroyuki; Zhou, Xing Wu; Iatsyshyna, Anna; Yakovleva, Tatiana; Sarkisyan, Daniil; Bakalkin, Georgy] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Kononenko, Olga; Krishtal, Oleg] Bogomoletz Inst Physiol, Key State Lab, Kiev, Ukraine; [Galatenko, Vladimir; Mityakina, Irina; Tonevitsky, Alex] Moscow MV Lomonosov State Univ, Moscow, Russia; [Iatsyshyna, Anna] Inst Mol Biol & Genet, Dept Human Genet, Kiev, Ukraine; [Ponomarev, Igor] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Ponomarev, Igor] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Marklund, Niklas] Uppsala Univ Hosp, Sect Neurosurg, Dept Neurosci, Uppsala, Sweden; [Adkins, DeAnna L.] Med Univ South Carolina, Coll Hlth Profess, Dept Neurosci, Coll Med, Charleston, SC USA; [Adkins, DeAnna L.] Med Univ South Carolina, Coll Hlth Profess, Dept Hlth Sci & Res, Charleston, SC USA		Bazov, I (corresponding author), Uppsala Univ, Div Biol Res Drug Dependence, Dept Pharmaceut Biosci, Husargatan 3,Box 591, S-75124 Uppsala, Sweden.	igor.bazov@farmbio.uu.se	Galatenko, Vladimir V./E-5139-2014; Tonevitsky, Alexander/R-5596-2019; Andersson, Malin/A-9930-2009; Galatenko, Vladimir/ABB-7514-2020; Iatsyshyna, Anna/M-3648-2015	Galatenko, Vladimir V./0000-0003-3029-3628; Andersson, Malin/0000-0002-1450-8046; Galatenko, Vladimir/0000-0003-3029-3628; Bakalkin, Georgy/0000-0002-8074-9833; Adkins, DeAnna L/0000-0002-3063-5731; Marklund, Niklas/0000-0002-9797-5626; Bazov, Igor/0000-0003-4388-1656; Iatsyshyna, Anna/0000-0002-8175-6955	Swedish Science Research Council (VR)Swedish Research Council; Swedish Council for Working Life and Social Research (FORTE); Swedish Research Council FormasSwedish Research CouncilSwedish Research Council Formas; Swedish Institute (Visby Program); European Union, Swedish Brain Foundation; Uppsala University Hospital Research Fund (ALF); U. S. National Institutes of Health National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS065866]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R28AA012725] Funding Source: NIH RePORTER	This work was supported, in part, by grants from the Swedish Science Research Council (VR), the Swedish Council for Working Life and Social Research (FORTE), and the Swedish Research Council Formas (to G. B.); the Swedish Institute (Visby Program; to O. K. and G. B.); the European Union, Swedish Brain Foundation, and Uppsala University Hospital Research Fund (ALF; to N. M.); and U. S. National Institutes of Health National Institute of Neurological Disorders and Stroke Grant NS065866 (to D. L. A.). The authors thank Prof. Olga Korosteleva (Statistics at California State University, Long Beach, Long Beach, CA, USA) for discussion and correction of the manuscript. The authors declare no conflicts of interest.	BAKALKIN GJ, 1980, DOKL AKAD NAUK SSSR+, V252, P762; BAKALKIN GY, 1989, BRAIN RES, V480, P268, DOI 10.1016/0006-8993(89)90192-3; BAKALKIN GY, 1986, PEPTIDES, V7, P551, DOI 10.1016/0196-9781(86)90025-2; BAKALKIN GY, 1989, BRAIN RES, V480, P277, DOI 10.1016/0006-8993(89)90193-5; Bardoni R, 2014, NEURON, V81, P1312, DOI 10.1016/j.neuron.2014.01.044; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Barrios A, 2012, NAT NEUROSCI, V15, P1675, DOI 10.1038/nn.3253; CHAMBERLAIN TJ, 1963, J NEUROPHYSIOL, V26, P662, DOI 10.1152/jn.1963.26.4.662; Chavkin C, 2013, MOL PHARMACOL, V83, P729, DOI 10.1124/mol.112.083337; CHAZOV EI, 1981, EXPERIENTIA, V37, P887, DOI 10.1007/BF01985696; Clarke RW, 2004, BRAIN RES REV, V46, P163, DOI 10.1016/j.brainresrev.2004.07.005; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Combs HL, 2016, J NEUROTRAUM, V33, P741, DOI 10.1089/neu.2015.4136; Concha ML, 2012, NAT REV NEUROSCI, V13, P832, DOI 10.1038/nrn3371; DiGiorgio AM, 1929, ARCH FISIOL, V27, P518; DiGiorgio AM, 1942, ARCH FISIOL, V42, P25; Drake CT, 2007, PROG BRAIN RES, V163, P245, DOI 10.1016/S0079-6123(07)63015-5; Duan B, 2014, CELL, V159, P1417, DOI 10.1016/j.cell.2014.11.003; Duboc V, 2015, ANNU REV GENET, V49, P647, DOI 10.1146/annurev-genet-112414-055322; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Francks C, 2015, ANN NY ACAD SCI, V1359, P1, DOI 10.1111/nyas.12770; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Gaiteri C, 2014, GENES BRAIN BEHAV, V13, P13, DOI 10.1111/gbb.12106; Gao CJ, 2012, NEUROSCIENCE, V202, P352, DOI 10.1016/j.neuroscience.2011.11.060; Georganta EM, 2010, NEUROPHARMACOLOGY, V59, P139, DOI 10.1016/j.neuropharm.2010.04.010; Grange P, 2014, P NATL ACAD SCI USA, V111, P5397, DOI 10.1073/pnas.1312098111; Hauser KF, 2005, FRONT BIOSCI-LANDMRK, V10, P216, DOI 10.2741/1522; Hausmann M, 2013, NEUROPSYCHOLOGIA, V51, P1734, DOI 10.1016/j.neuropsychologia.2013.05.017; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; HERKENHAM M, 1987, NEUROSCIENCE, V23, P1, DOI 10.1016/0306-4522(87)90268-5; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Hong S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086851; Hu Zhenjun, 2014, Curr Protoc Bioinformatics, V45, DOI 10.1002/0471250953.bi0808s45; Hu ZJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-17; Hussain ZM, 2012, J NEUROTRAUM, V29, P1785, DOI 10.1089/neu.2011.2286; Jefferson SC, 2016, NEUROREHAB NEURAL RE, V30, P155, DOI 10.1177/1545968315600274; JENNRICH RI, 1970, J AM STAT ASSOC, V65, P904, DOI 10.2307/2284596; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kim KI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-114; Kraus J, 2001, J BIOL CHEM, V276, P43901, DOI 10.1074/jbc.M107543200; Kuzmin A, 2000, J PHARMACOL EXP THER, V295, P1031; Leinwand Sarah G, 2014, Worm, V3, pe27730, DOI 10.4161/worm.27730; LEVIN BE, 1995, BRAIN RES, V674, P307, DOI 10.1016/0006-8993(95)00032-L; Li Q, 2003, MOL BRAIN RES, V114, P46, DOI 10.1016/S0169-328X(03)00131-1; Li YP, 2015, G3-GENES GENOM GENET, V5, P1075, DOI 10.1534/g3.115.018127; Lopez-Kleine L, 2013, BRIEF FUNCT GENOMICS, V12, P457, DOI 10.1093/bfgp/elt003; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; MacNeilage PF, 2009, SCI AM, V301, P60, DOI 10.1038/scientificamerican0709-60; Madsen KS, 2012, NEUROIMAGE, V63, P95, DOI 10.1016/j.neuroimage.2012.06.071; Marcoli M, 2015, REV NEUROSCIENCE, V26, P489, DOI 10.1515/revneuro-2015-0007; Marlin BJ, 2015, NATURE, V520, P499, DOI 10.1038/nature14402; MATTHEWS SG, 1995, DEV BRAIN RES, V86, P259, DOI 10.1016/0165-3806(95)00032-9; McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n; MORROW L, 1981, NEUROPSYCHOLOGIA, V19, P65, DOI 10.1016/0028-3932(81)90045-2; Park SW, 2008, NEUROSCIENCE, V151, P1034, DOI 10.1016/j.neuroscience.2007.12.015; PEARLSON GD, 1981, BRAIN RES, V218, P233, DOI 10.1016/0006-8993(81)91303-2; PERSSON S, 1994, NEUROSCIENCE, V63, P313, DOI 10.1016/0306-4522(94)90026-4; Remage-Healey L, 2014, HORM BEHAV, V66, P552, DOI 10.1016/j.yhbeh.2014.07.014; Reznikov K, 1999, EUR J NEUROSCI, V11, P2711, DOI 10.1046/j.1460-9568.1999.00680.x; Schaefer SY, 2009, NEUROPSYCHOLOGIA, V47, P2953, DOI 10.1016/j.neuropsychologia.2009.06.025; Schweickert A, 2008, DEV DYNAM, V237, P3557, DOI 10.1002/dvdy.21638; Steffens H, 2011, NEUROSCI RES, V70, P44, DOI 10.1016/j.neures.2011.01.011; Stoop R, 2012, NEURON, V76, P142, DOI 10.1016/j.neuron.2012.09.025; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; THAI L, 1992, MOL BRAIN RES, V16, P150, DOI 10.1016/0169-328X(92)90205-P; Nguyen TV, 2013, CEREB CORTEX, V23, P1424, DOI 10.1093/cercor/bhs125; Ulrich JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.365197; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Watanabe H, 2015, CEREB CORTEX, V25, P97, DOI 10.1093/cercor/bht204; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Wu YX, 2014, NEUROSCI LETT, V580, P7, DOI 10.1016/j.neulet.2013.11.055; Yuen JWF, 2004, NEUROREPORT, V15, P1431, DOI 10.1097/01.wnr.0000130433.90962.6e; Zaringhalam J, 2008, CLIN EXP PHARMACOL P, V35, P1309, DOI 10.1111/j.1440-1681.2008.05009.x; Zink CF, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.2	76	13	13	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1953	1963		10.1096/fj.201601039R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	WOS:000399195500017	28122917	Green Published			2022-02-06	
J	Lu, X; Bao, XJ; Li, JT; Zhang, GH; Guan, J; Gao, YZ; Wu, PL; Zhu, ZH; Huo, XL; Wang, RZ				Lu, Xia; Bao, Xinjie; Li, Jiantao; Zhang, Guanghao; Guan, Jian; Gao, Yunzhou; Wu, Peilin; Zhu, Zhaohui; Huo, Xiaolin; Wang, Renzhi			High-frequency repetitive transcranial magnetic stimulation for treating moderate traumatic brain injury in rats: A pilot study	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						traumatic brain injury; transcranial magnetic stimulation; neuromodulation; neural stem cell; neurogenesis	CEREBRAL-BLOOD-FLOW; DORSOLATERAL PREFRONTAL CORTEX; HUMAN MOTOR CORTEX; NEUROGENESIS; MODEL; NEUROPLASTICITY; PERFORMANCE; DEPRESSION; RESPONSES; RECOVERY	Transcranial magnetic stimulation (TMS) is a method of noninvasive brain stimulation that causes neuromodulation by activating neurons or changing excitability in a certain brain area. Considering the known effects of TMS and the pathophysiology of traumatic brain injury (TBI), TMS was proposed to have potential for treating this condition. Moderate TBI was induced in adult male Sprague Dawley rats using Feeney's weight-dropping method. Injured rats were divided into a TMS group and a control group. Repetitive TMS (rTMS) was administered to rats in the TMS group from post-TBI day 2. At post-TBI days 7, 14 and 28, three or four of the rats were sacrificed, and harvested brains were embedded in paraffin and sectioned. Sections were then treated with hematoxylin and eosin and immunohistochemical staining. Three rats from each group underwent fludeoxyglucose F 18 micro-positron emission tomography scanning on post-TBI day 2 and 13. The unexpected mortality rate after injury was lower in the TMS group than in the control group. The modified neurological severity score of the TMS group was lower compared with the control group at post-TBI day 14. According to the results of hematoxylin eosin staining, relative cerebral parenchyma loss was lower at post-TBI day 28 in the TMS group compared with the control group. However, the aforementioned differences were not found to be statistically significant. There was also no significant difference in glucose metabolism between the two groups. According to immunohistochemical staining, the TMS group showed a significantly higher level of proliferation (indicated by bromodeoxyuridine) in the subventricular zone, as compared with the control group (P< 0.05). A significantly higher rate of neuron survival at day 28 (P< 0.05; indicated by NeuN) and a significantly reduced rate of apoptosis at days 7 and 14 (P< 0.05; indicated by caspase-3) were observed in the perilesional zone of the TMS group, as compared with the control group. The current findings suggest that high-frequency rTMS may promote neurogenesis and provide a basis for further studies in this area.	[Lu, Xia; Bao, Xinjie; Li, Jiantao; Guan, Jian; Wang, Renzhi] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurosurg, 1 Shuaifuyuan, Beijing 100005, Peoples R China; [Lu, Xia; Bao, Xinjie; Li, Jiantao; Guan, Jian; Wu, Peilin; Zhu, Zhaohui; Wang, Renzhi] Peking Union Med Coll, 1 Shuaifuyuan, Beijing 100005, Peoples R China; [Zhang, Guanghao; Huo, Xiaolin] Chinese Acad Sci, Inst Elect Engn, Lab Bioelectromagnet, Beijing 100190, Peoples R China; [Gao, Yunzhou] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Histol & Anat, Beijing 100005, Peoples R China; [Wu, Peilin; Zhu, Zhaohui] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100005, Peoples R China		Wang, RZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurosurg, 1 Shuaifuyuan, Beijing 100005, Peoples R China.; Wang, RZ (corresponding author), Peking Union Med Coll, 1 Shuaifuyuan, Beijing 100005, Peoples R China.	wangrz@126.com			National High Technology Research and Development Program of ChinaNational High Technology Research and Development Program of China [2014AA020513]; National Basic Research Program of ChinaNational Basic Research Program of China [2014CB541603]; CAMS Initiative for Innovative Medicine (CAMS-12M) [2016-12M-017]	This research was supported by the National High Technology Research and Development Program of China (2014AA020513), the National Basic Research Program of China (grant no. 2014CB541603), and CAMS Initiative for Innovative Medicine (CAMS-12M) (2016-12M-017).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Arias-Carrion O, 2004, J NEUROSCI RES, V78, P16, DOI 10.1002/jnr.20235; Bao XJ, 2011, EUR J NEUROSCI, V34, P87, DOI 10.1111/j.1460-9568.2011.07733.x; BARKER AT, 1985, LANCET, V1, P1106; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Cho SS, 2012, BRAIN STIMUL, V5, P116, DOI 10.1016/j.brs.2012.03.007; Constantinescu CC, 2009, PHYS MED BIOL, V54, P2885, DOI 10.1088/0031-9155/54/9/020; Cuccurazzu B, 2010, EXP NEUROL, V226, P173, DOI 10.1016/j.expneurol.2010.08.022; Dayan E, 2013, NAT NEUROSCI, V16, P838, DOI 10.1038/nn.3422; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gao Y, 2004, ZHE JIANG CHUANG SHA, V9, P283; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Guan J, 2012, BIOMATERIALS, V33, P1386, DOI 10.1016/j.biomaterials.2011.10.073; Hirata T, 2008, NEUROGASTROENT MOTIL, V20, P557, DOI 10.1111/j.1365-2982.2007.01069.x; Kito S, 2008, NEUROPSYCHOBIOLOGY, V58, P29, DOI 10.1159/000154477; Orosz A, 2012, NEUROIMAGE, V61, P599, DOI 10.1016/j.neuroimage.2012.03.084; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Rodger J, 2015, NEURAL REGEN RES, V10, P357, DOI 10.4103/1673-5374.153676; Rueger MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043776; Schallert T, 1997, ADV NEUROL, V73, P229; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Speer AM, 2000, BIOL PSYCHIAT, V48, P1133, DOI 10.1016/S0006-3223(00)01065-9; Sun W, 2011, CLIN EEG NEUROSCI, V42, P40, DOI 10.1177/155005941104200109; Sung WH, 2013, STROKE, V44, P1375, DOI 10.1161/STROKEAHA.111.000522; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tasset I, 2013, BRAIN STIMUL, V6, P84, DOI 10.1016/j.brs.2012.03.015; Tasset I, 2010, NEUROCHEM RES, V35, P1182, DOI 10.1007/s11064-010-0172-9; Teyssier JR, 2013, J PSYCHIATR RES, V47, P935, DOI 10.1016/j.jpsychires.2013.03.002; Tunez I, 2006, NEUROSCI RES, V56, P91, DOI 10.1016/j.neures.2006.05.012; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Visnyei K, 2006, EXP NEUROL, V197, P465, DOI 10.1016/j.expneurol.2005.10.023; Wang HY, 2011, J NEUROSCI, V31, P11044, DOI 10.1523/JNEUROSCI.2125-11.2011; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yoon YS, 2012, ANN REHABIL MED-ARM, V36, P596, DOI 10.5535/arm.2012.36.5.596; Yue L, 2009, BRAIN RES, V1260, P94, DOI 10.1016/j.brainres.2009.01.009	37	13	14	1	11	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	MAY	2017	13	5					2247	2254		10.3892/etm.2017.4283			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EU5NG	WOS:000401078200085	28565833	Green Published, gold, Green Submitted			2022-02-06	
J	Odgaard, L; Johnsen, SP; Pedersen, AR; Nielsen, JF				Odgaard, Lene; Johnsen, Soren Paaske; Pedersen, Asger Roer; Nielsen, Jorgen Feldbaek			Return to Work After Severe Traumatic Brain Injury: A Nationwide Follow-up Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						craniocerebral trauma; employment; health benefits; injury outcomes; matched-pair analysis; population-based; prevalence; register; rehabilitation	POPULATION; EMPLOYMENT; EPIDEMIOLOGY; UNEMPLOYMENT; PREDICTORS; COHORT	Objective: To determine return to work (RTW) after severe traumatic brain injury (TBI) and to compare long-term labor market attachment (LMA) with the general population. Participants: All persons aged 18 to 64 years who received highly specialized neurorehabilitation after severe TBI between 2004 and 2012 (n = 637) were matched to general population controls on age, sex, preinjury employment status, educational level, and residence (n = 2497). Design: Nationwide follow-up study using weekly records on public assistance benefits. Main Measures: Both RTW and LMA were defined as having no public assistance benefits except education grants/leave. Stable LMA was defined as weeks with LMA of 75% or more. LMA among persons with severe TBI and controls was compared using multivariable conditional logistic regression. Results: RTW mainly occurred within first 2 years after severe TBI, with 30% of the people attempting RTW and 16% achieving stable LMA within 2 years. The prevalence of people with LMA decreased to 11% from 21/2 years to 5 years postinjury. Adjusted odds ratios were 0.01 for LMA up to 2 years postinjury and 0.05 for stable LMA for persons with severe TBI compared with the general population. Conclusion: Both RTW and long-term LMA after severe TBI were low in Denmark when compared with the general population and other countries.	[Odgaard, Lene; Pedersen, Asger Roer; Nielsen, Jorgen Feldbaek] Aarhus Univ, Hammel Neurorehabil Ctr, Res Dept, Voldbyvej 15, DK-8450 Hammel, Denmark; [Odgaard, Lene; Pedersen, Asger Roer; Nielsen, Jorgen Feldbaek] Aarhus Univ, Univ Res Clin, Voldbyvej 15, DK-8450 Hammel, Denmark; [Johnsen, Soren Paaske] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark		Odgaard, L (corresponding author), Aarhus Univ, Hammel Neurorehabil Ctr, Res Dept, Voldbyvej 15, DK-8450 Hammel, Denmark.; Odgaard, L (corresponding author), Aarhus Univ, Univ Res Clin, Voldbyvej 15, DK-8450 Hammel, Denmark.	lenehell@rm.dk	Nielsen, Jorgen Feldbak/AAR-6384-2021; Odgaard, Lene/AAF-1909-2020	Nielsen, Jorgen Feldbak/0000-0001-5339-171X; Odgaard, Lene/0000-0002-9830-3282			Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Annoni J M, 1992, Disabil Rehabil, V14, P23; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Biering K, 2013, J OCCUP REHABIL, V23, P400, DOI 10.1007/s10926-012-9405-x; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Economics A., 2009, EC COST SPINAL CORD, P31; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; Engberg AW, 2007, J HEAD TRAUMA REHAB, V22, P221, DOI 10.1097/01.HTR.0000281837.62226.54; European Action Service, 2013, EUR AR BANK LEND SUR, P5; European Commission, 2015, PERS DIS EMPL SOC AF; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Hart T, 2014, ARCH PHYS MED REHAB, V95, P2103, DOI 10.1016/j.apmr.2014.07.001; Hjollund NH, 2007, SCAND J PUBLIC HEALT, V35, P497, DOI 10.1080/14034940701271882; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2016, J HEAD TRAUMA REHAB, V31, pE42, DOI 10.1097/HTR.0000000000000147; Ketchum JM, 2012, NEUROREHABILITATION, V30, P13, DOI 10.3233/NRE-2011-0723; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Ministry of Employment, UN INS DENM; Ministry of Employment, ACT LAB MARK POL; Odgaard L, 2015, CLIN EPIDEMIOL, V7, P225, DOI 10.2147/CLEP.S78141; OECD, 2010, SECURITY SYSTEM REFO, P9; OECD, 2010, SICKN DIS WORK BREAK, P49; OECD, 2008, SICKN DIS WORK BREAK, V3, P52; Office of Special Education and Rehabilitative Services Department of Education, 2013, Fed Regist, V78, P27036; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Sjolander A, 2013, STAT MED, V32, P4696, DOI 10.1002/sim.5879; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956	38	13	13	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2017	32	3					E57	E64		10.1097/HTR.0000000000000239			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EV4GM	WOS:000401716900013	27323216				2022-02-06	
J	Walker, WC; Franke, LM; Sima, AP; Cifu, DX				Walker, William C.; Franke, Laura M.; Sima, Adam P.; Cifu, David X.			Symptom Trajectories After Military Blast Exposure and the Influence of Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; concussion; diagnosis; explosive blast; longitudinal studies; military injury; military personnel; postconcussion symptoms; symptom assessment; veterans	POSTTRAUMATIC-STRESS-DISORDER; SPORTS-RELATED CONCUSSION; OPERATION ENDURING FREEDOM; IRAQI FREEDOM; COMBAT VETERANS; SOLDIERS; QUESTIONNAIRE; RELIABILITY; PERSONNEL; ACCURACY	Background: Blast-related mild traumatic brain injury (blast mTBI) is a signature wound of recent US military conflicts in the Middle East, but the relatedness of postconcussive symptoms (PCS) to the blast mTBI is unclear, and longitudinal symptom data are sparse. Objectives: To characterize postdeployment symptom levels and trajectories and to determine relationship to blast mTBI. Methods: A total of 216 participants within 2 years of blast exposure during deployment underwent structured interviews or algorithmic questionnaires for blast mTBI. Detailed symptom inventories for PCS, pain, posttraumatic stress disorder, and depression were taken serially at enrollment, 6 months, and 12 months later. Repeated-measure analysis of variance models were built. Results: Up to 50% of participants had at least 1 high-grade blast mTBI (with posttraumatic amnesia), 31% had low-grade only, and 19% had neither. Within the entire cohort, all 4 composite symptom scores started high and stayed unchanged. Between blast mTBI groups, symptom scores differed at every time point with some evidence of convergence over time. The PCS groups, different by definition to start, diverged further over time with those initially more symptomatic becoming relatively more so. Conclusions: History of blast mTBI accompanied by posttraumatic amnesia is associated with greater nonspecific symptoms after deployment, and prognosis for improvement when symptoms are prominent is poor.	[Walker, William C.; Franke, Laura M.; Cifu, David X.] Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Walker, William C.; Franke, Laura M.] Def & Vet Brain Injury Ctr, Richmond, VA USA; [Walker, William C.; Franke, Laura M.; Cifu, David X.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Sima, Adam P.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA		Walker, WC (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil, Richmond, VA 23298 USA.	wwalker@mcvh-vcu.edu	; Franke, Lude/P-7036-2016	Cifu, David/0000-0003-1600-9387; Franke, Lude/0000-0002-5159-8802; Sima, Adam/0000-0001-8426-9987	Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command; US Army Medical Research & Material Command, Congressionally Directed Medical Research Program (CDMRP) grant [W91ZSQ8118N6200001]	This material is based upon work supported with resources and the use of facilities at the Hunter Holmes McGuire Veterans Affairs Medical Center in Richmond, Virginia; and is based upon work supported in part by the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command.; This study was supported by a grant from US Army Medical Research & Material Command, Congressionally Directed Medical Research Program (CDMRP) grant# W91ZSQ8118N6200001; Epidemiological Study of Mild Traumatic Brain Injury Sequelae Caused by Blast Exposure during Operations Iraq Freedom and Enduring Freedom.	Andrikopoulos J, 2014, JAMA NEUROL, V71, P654, DOI 10.1001/jamaneurol.2013.6408; [Anonymous], DOD WORLDW NUMB TBI; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Betthauser LM, 2012, NEUROPSYCHOL REV, V22, P35, DOI 10.1007/s11065-012-9191-4; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Centers for Disease Control and Prevention, DOD VA COD PROP DOD; Cifu D, 2011, OVERCOMING POSTDEPLO; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Cripps A, 2013, J SPORT REHABIL, V22, P67, DOI 10.1123/jsr.22.1.67; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Dretsch MN, 2015, J NEUROTRAUM, V32, P1217, DOI 10.1089/neu.2014.3637; Edwards LJ, 2008, STAT MED, V27, P6137, DOI 10.1002/sim.3429; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fitzmaurice GM., 2012, APPL LONGITUDINAL AN; Harvey AG, 2002, PSYCHOL BULL, V128, P886, DOI 10.1037//0033-2909.128.6.886; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kelley CL, 2014, PSYCHOL SERV, V11, P229, DOI 10.1037/a0034892; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pigeon WR, 2013, J PSYCHOSOM RES, V75, P546, DOI 10.1016/j.jpsychores.2013.09.004; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reijnen A, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.05.003; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Silver JM, 2014, PSYCHIAT CLIN N AM, V37, P91, DOI 10.1016/j.psc.2013.11.001; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Walker WC, 2014, J REHABIL RES DEV, V51, P1203, DOI 10.1682/JRRD.2013.12.0271; Walker WC, 2013, J HEAD TRAUMA REHAB, V28, P68, DOI 10.1097/HTR.0b013e318255dfd0; Wares JR, 2015, J REHABIL RES DEV, V52, P591, DOI 10.1682/JRRD.2014.08.0197; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298	47	13	13	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2017	32	3					E16	E26		10.1097/HTR.0000000000000251			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EV4GM	WOS:000401716900009	27603760				2022-02-06	
J	Bai, RJ; Gao, HB; Han, ZL; Ge, XT; Huang, S; Chen, FL; Lei, P				Bai, Ruojing; Gao, Huabin; Han, Zhaoli; Ge, Xintong; Huang, Shan; Chen, Fanglian; Lei, Ping			Long-Term Kinetics of Immunologic Components and Neurological Deficits in Rats Following Repetitive Mild Traumatic Brain Injury	MEDICAL SCIENCE MONITOR			English	Article						Brain Injuries; Immunity Cellular; Nervous System Diseases	BEHAVIORAL DEFICITS; INFLAMMATION; MACROPHAGES; SUBSETS	Background: Despite growing awareness of repetitive mild traumatic brain injury (rmTBI), understanding of the involvement of long-term kinetics of immunologic components in the central and peripheral immune system took part remains incomplete. The present study aimed to provide a quantitative assay for certain immune system parameters in rmTBI rats. Material/Methods: Neurological functions were assessed by modified Neurological Severity Score (mNSS) and Morris Water Maze (MWM), immunologic components from brain and peripheral blood were analyzed by flow cytometry (FCM), and concentrations of inflammatory cytokines, including tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, and IL-10 were measure by enzyme-linked immunosorbent assay (ELISA). Results: Neurological functions of rmTBI rats were seriously impaired. In the brain, T cells were up-regulated and peaked at week 1. The percentage of CD4(+) T cells decreased from week 1 to week 4, while CD8(+) T cells notably decreased at week 1, then increased until week 4. The infiltration proportion of Treg cells was reduced at week 1 and peaked at week 2. CD86(+)/CD11b(+) M1 peaked at week 4 and CD206(+)/CD11b(+) M2 rose at week 1. IL-6/IL-10 showed a similar pattern, whose rise corresponded to the decrease in TNF-alpha at week 2 after rmTBI. FCM demonstrated peripheral immune dysfunction after rmTBI. Conclusions: mNSS and MWM demonstrated neuronal deficits in rmTBI rats, and central and peripheral immune systems were implicated in the pathophysiological processes of rmTBI. Long-term immune response may play dual roles in injury and repair of rmTBI.	[Bai, Ruojing; Gao, Huabin; Han, Zhaoli; Huang, Shan; Lei, Ping] Tianjin Med Univ, Gen Hosp, Tianjin Geriatr Inst, Dept Geriatr, Tianjin, Peoples R China; [Bai, Ruojing; Gao, Huabin; Huang, Shan; Lei, Ping] Tianjin Geriatr Inst, Lab Neurotrauma & Neurodegenerat Disorders, Tianjin, Peoples R China; [Bai, Ruojing; Gao, Huabin; Ge, Xintong; Huang, Shan; Chen, Fanglian] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Bai, Ruojing; Gao, Huabin; Ge, Xintong; Huang, Shan; Chen, Fanglian] Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin, Peoples R China; [Bai, Ruojing; Gao, Huabin; Ge, Xintong; Huang, Shan; Chen, Fanglian] Tianjin Neurol Inst, Lab Neurotrauma, Tianjin, Peoples R China; [Ge, Xintong] Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China		Lei, P (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Geriatr Inst, Dept Geriatr, Tianjin, Peoples R China.; Lei, P (corresponding author), Tianjin Geriatr Inst, Lab Neurotrauma & Neurodegenerat Disorders, Tianjin, Peoples R China.	leiping1974@163.com	Ge, Xintong/X-4889-2019	Ge, Xintong/0000-0001-7153-952X			Alves OL, 2001, BRAIN INJURY, V1; An CR, 2014, PROG NEUROBIOL, V115, P6, DOI 10.1016/j.pneurobio.2013.12.002; Carli P, 2004, LANCET, V363, P584, DOI 10.1016/S0140-6736(04)15626-2; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Collins C., 2002, OCCUPATIONAL THERAPY, P395; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; FORD AL, 1995, J IMMUNOL, V154, P4309; GERSHON RK, 1972, J IMMUNOL, V108, P586; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Linfert Douglas, 2009, Transplant Rev (Orlando), V23, P1, DOI 10.1016/j.trre.2008.08.003; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Monahan R, 2015, IMMUNOL RES, V63, P3, DOI 10.1007/s12026-015-8698-1; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Ren XF, 2011, J NEUROSCI, V31, P8556, DOI 10.1523/JNEUROSCI.1623-11.2011; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Stankovic ND, 2016, ACTA NEUROPATHOL, V131, P347, DOI 10.1007/s00401-015-1524-y; van Rossum D, 2004, METAB BRAIN DIS, V19, P393, DOI 10.1023/B:MEBR.0000043984.73063.d8; Walsh JT, 2015, J CLIN INVEST, V125, P2547, DOI 10.1172/JCI82458; Wu G, 2016, MED SCI MONITOR, V22, P2161, DOI 10.12659/MSM.896568; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067	32	13	13	1	7	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	APR 8	2017	23						1707	1718		10.12659/MSM.901124			12	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	ES1KD	WOS:000399285600002	28390198	Green Published			2022-02-06	
J	Swartz, RH; Cayley, ML; Lanctot, KL; Murray, BJ; Cohen, A; Thorpe, KE; Sicard, MN; Lien, K; Sahlas, DJ; Herrmann, N				Swartz, Richard H.; Cayley, Megan L.; Lanctot, Krista L.; Murray, Brian J.; Cohen, Ashley; Thorpe, Kevin E.; Sicard, Michelle N.; Lien, Karen; Sahlas, Demetrios J.; Herrmann, Nathan			The "DOC" screen: Feasible and valid screening for depression, Obstructive Sleep Apnea (OSA) and cognitive impairment in stroke prevention clinics	PLOS ONE			English	Article							MAJOR DEPRESSION; POSTSTROKE; QUESTIONNAIRE; RECOVERY; MOCA; TOOL	Background Post-stroke Depression, Obstructive sleep apnea (OSA) and Cognitive impairment ("DOC") are associated with greater mortality, worse recovery and poorer quality of life. Best practice recommendations endorse routine screening for each condition; yet, all are underassessed, diagnosed and treated. We seek to determine the feasibility and validity of an integrated tool ("DOC" screen) to identify stroke clinic patients at high-risk of depression, OSA, and cognitive impairment. Methods All consecutive new referrals to a regional Stroke Prevention Clinic who were Englishspeaking and non-aphasic were eligible to be screened. Time for screen completion was logged. DOC screen results were compared to the neuropsychological battery and polysomnogram assessments using a modified receiver operator characteristic and area under the curve analysis. Data is reported to conform to STARD guidelines. Findings 1503 people were screened over 2 years. 89% of eligible patients completed the screen in 5 minutes or less (mean 4.2 minutes), less than half the time it takes to complete the Montreal Cognitive Assessment (MoCA). 437 people consented to detailed testing. Of those, 421 completed the Structured Clinical Interview for Depression within 3 months of screening, 387 completed detailed neuropsychological testing within 3 months, and 88 had overnight polysomnograms. Screening scores combined with demographic variables (age, sex, education, body mass index), had excellent validity compared to gold standard diagnoses: DOC-Mood AUC 0.90; DOC-Apnea AUC 0.80; DOC-Cog AUC 0.81. DOC screen scores can reliably categorize patients in to low-, intermediate-or high-risk groups for further action and can do so with comparable accuracy to more time-consuming screens. Conclusions Systematic screening of depression, obstructive sleep apnea, and cognitive impairment in 5 minutes or less is feasible and valid in a high volume stroke clinic using the DOC screen. The DOC screen may facilitate improved identification and treatment of these comorbidities to improve function in patients after stroke and in those with other neurological diseases that share these comorbid conditions (e.g. Alzheimer's disease/mild cognitive impairment, Parkinson's disease, Traumatic Brain Injury, multiple sclerosis).	[Swartz, Richard H.; Lanctot, Krista L.; Murray, Brian J.; Thorpe, Kevin E.; Herrmann, Nathan] Univ Toronto, Toronto, ON, Canada; [Swartz, Richard H.; Cayley, Megan L.; Murray, Brian J.; Sicard, Michelle N.; Lien, Karen] Sunnybrook Hlth Sci Ctr, Dept Med Neurol, Toronto, ON, Canada; [Swartz, Richard H.; Lanctot, Krista L.; Murray, Brian J.; Herrmann, Nathan] Hurvitz Brain Sci Res Program, Toronto, ON, Canada; [Swartz, Richard H.] Heart & Stroke Fdn Canadian Partnership Stroke Re, Toronto, ON, Canada; [Swartz, Richard H.] Univ Toronto, Stroke Program, Toronto, ON, Canada; [Lanctot, Krista L.; Herrmann, Nathan] Sunnybrook Hlth Sci Ctr, Dept Psychiat, Toronto, ON, Canada; [Cohen, Ashley; Thorpe, Kevin E.] St Michaels Hosp, Appl Hlth Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Thorpe, Kevin E.] Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Sahlas, Demetrios J.] McMaster Univ, Hamilton, ON, Canada; [Sahlas, Demetrios J.] Hamilton Hlth Sci, Dept Med Neurol, Hamilton, ON, Canada; [Sahlas, Demetrios J.] Hamilton Gen Hosp, Toronto, ON, Canada		Swartz, RH (corresponding author), Univ Toronto, Toronto, ON, Canada.; Swartz, RH (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Med Neurol, Toronto, ON, Canada.; Swartz, RH (corresponding author), Hurvitz Brain Sci Res Program, Toronto, ON, Canada.; Swartz, RH (corresponding author), Heart & Stroke Fdn Canadian Partnership Stroke Re, Toronto, ON, Canada.; Swartz, RH (corresponding author), Univ Toronto, Stroke Program, Toronto, ON, Canada.	rick.swartz@sunnybrook.ca	Lanctot, Krista L./AAY-4820-2020; Murray, Brian/E-6786-2016	Lanctot, Krista L./0000-0001-7024-6637; Swartz, Rick/0000-0001-6571-5531; Thorpe, Kevin/0000-0002-7586-3893; Murray, Brian/0000-0001-5085-0909	HSF Ontario [000392]; CIHRCanadian Institutes of Health Research (CIHR) [1012404]; HSF Canada; Canadian Partnership for Stroke Recovery; Department of Medicine (Sunnybrook HSC); Department of Medicine (University of Toronto)University of Toronto; Brill Chair in Neurology Sunnybrook HSC	This study was supported by HSF Ontario (Grant No.000392) and the CIHR (Grant No.1012404). RHS receives salary support from a New Investigator Award and the HJ Barnett Award from the HSF Canada, the Canadian Partnership for Stroke Recovery, the Department of Medicine (Sunnybrook HSC and University of Toronto), and the Brill Chair in Neurology Sunnybrook HSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Bossuyt PM, 2015, RADIOLOGY, V277, P826, DOI 10.1148/radiol.2015151516; Boyle LL, 2011, INT J GERIATR PSYCH, V26, P952, DOI 10.1002/gps.2632; Chemerinski E, 2001, STROKE, V32, P113, DOI 10.1161/01.STR.32.1.113; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Coutts SB, 2015, INT J STROKE, V10, P282, DOI 10.1111/ijs.12439; Darvesh S, 2005, CAN J NEUROL SCI, V32, P167, DOI 10.1017/S0317167100003930; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dong YH, 2010, J NEUROL SCI, V299, P15, DOI 10.1016/j.jns.2010.08.051; Eskes GA, 2015, INT J STROKE, V10, P1130, DOI 10.1111/ijs.12557; First MB, 1996, STRUCTURED CLIN INTE, P32; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Hall R, 2013, ONTARIO STROKE EVALU; Hermann DM, 2016, NEUROLOGY, V87, P1407, DOI 10.1212/WNL.0000000000003037; Herrmann N, 1998, STROKE, V29, P618, DOI 10.1161/01.STR.29.3.618; Johnson KG, 2010, J CLIN SLEEP MED, V6, P131; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Leach L., 2000, KAPLAN BAYCREST NEUR; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Mai LM, 2013, CAN J NEUROL SCI, V40, P192, DOI 10.1017/S031716710001372X; MORRIS PLP, 1992, MED J AUSTRALIA, V157, P239, DOI 10.5694/j.1326-5377.1992.tb137126.x; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; NICE guidelines: Stroke Quality Standards 9, 2010, NICE GUID STROK QUAL; Paul SL, 2006, STROKE, V37, P2854, DOI 10.1161/01.STR.0000244806.05099.52; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Swartz RH, VALIDATING PRAGMATIC; Swartz RH, 2016, INT J STROKE, V11, P509, DOI 10.1177/1747493016641968; Thombs BD, 2008, J GEN INTERN MED, V23, P2014, DOI 10.1007/s11606-008-0802-y; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wells KB, 1989, JAMA-J AM MED ASSOC, V262, P924	33	13	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174451	10.1371/journal.pone.0174451			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2IO	WOS:000399352000007	28376127	Green Published, Green Submitted, gold			2022-02-06	
J	Adams, RS; Corrigan, JD; Mohr, BA; Williams, TV; Larson, MJ				Adams, Rachel Sayko; Corrigan, John D.; Mohr, Beth A.; Williams, Thomas V.; Larson, Mary Jo			Traumatic Brain Injury and Post-Deployment Binge Drinking among Male and Female Army Active Duty Service Members Returning from Operation Enduring Freedom/Operation Iraqi Freedom	JOURNAL OF NEUROTRAUMA			English	Article						binge drinking; gender; post-deployment; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; SUBSTANCE USE; MILITARY PERSONNEL; GENDER-DIFFERENCES; ALCOHOL MISUSE; MENTAL-HEALTH; PRIMARY-CARE; COMBAT; AFGHANISTAN; SYMPTOMS	This study examines whether the relationship between traumatic brain injury (TBI) and post-deployment binge drinking is independent of screening positive for mental health problems among male and female service members. Data are from the Substance Use and Psychological Injury Combat Study of Army members returning from deployment to Afghanistan or Iraq in fiscal years 2008-2011. The sample consists of 240,694 male and 26,406 female active duty members who completed initial and follow-up questionnaires. The initial questionnaire, completed at the end of deployment, included screens for TBI and mental health problems (post-traumatic stress disorder, depression, harmful thoughts). The dependent variable, frequent binge drinking (six or more drinks on one occasion, at least monthly), was assessed on the follow-up questionnaire on average 3-9 months post-deployment. More than 21% of males and 7% of females reported frequent binge drinking. Male members were more likely to screen positive for TBI, compared with females (7.5% vs. 4.4%). Females with both TBI and mental health positive screens had more than double the risk of frequent binge drinking, compared with those without either problem (15.8% vs. 6.6%), and males with both problems had almost double the risk, compared with males with neither problem (33.6% vs. 19.7%). In multivariable logistic regression models, having a TBI and a comorbid positive mental health screen was associated with increased odds of frequent binge drinking among both males and females (adjusted odds ratio [AOR] = 1.59, CI: 1.50-1.69, and AOR= 2.11, CI: 1.57-2.83, respectively), compared with those with neither condition. More research is needed on the interaction of gender and binge drinking, especially when TBI and mental health problems co-exist.	[Adams, Rachel Sayko; Mohr, Beth A.; Larson, Mary Jo] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Williams, Thomas V.] US Dept Def, Falls Church, VA USA		Adams, RS (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St, Waltham, MA 02453 USA.	radams@brandeis.edu	Corrigan, John D./E-2921-2011; Adams, Rachel/AAH-4653-2020		National Institute of Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01DA030150]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA030150] Funding Source: NIH RePORTER	This study was funded by National Institute of Drug Abuse (NIDA) grant R01DA030150. We acknowledge Kennell and Associates, Inc. for compiling the data files used in these analyses, as well as Dr. Thomas V. Williams, the Defense Health Agency's (DHA) DoD data sponsor. The DHA's Privacy and Civil Liberties Office, and the U.S. Army Medical Department's Patient Administration Systems and Biostatistics Activity of the U.S. DoD provided access to these data.	Adams RS, 2016, J HEAD TRAUMA REHAB, V31, P13, DOI 10.1097/HTR.0000000000000082; Adams RS, 2013, SUBST USE MISUSE, V48, P821, DOI 10.3109/10826084.2013.797995; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Barlas F. M., 2013, 2011 DEP DEFENSE HLT; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bliese P., 2005, POSTDEPLOYMENT PSYCH, V3; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bliese PD, 2011, DEPLOYMENT PSYCHOL E, P175; Bray R, 2009, DEP DEFENSE SURVEY H; Bray RM, 2013, SUBST USE MISUSE, V48, P799, DOI 10.3109/10826084.2013.796990; Bray RM, 2010, MIL MED, V175, P390, DOI 10.7205/MILMED-D-09-00132; Brown JM, 2010, MIL MED, V175, P101, DOI 10.7205/MILMED-D-09-00080; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Calhoun PS, 2010, PSYCHIAT RES, V178, P330, DOI 10.1016/j.psychres.2009.11.009; Casement MD, 2015, SOC COGN AFFECT NEUR, V10, P416, DOI 10.1093/scan/nsu061; Chase S, 2012, HEALTH CARE WOMEN IN, V33, P631, DOI 10.1080/07399332.2012.673652; Conard PL, 2014, NURS FORUM, V49, P1, DOI 10.1111/nuf.12049; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Forbes EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094640; Golub A, 2014, ADDICT BEHAV, V39, P449, DOI 10.1016/j.addbeh.2013.06.020; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine, 2012, TREATM POSTTR STRESS; Jakupcak M, 2010, ADDICT BEHAV, V35, P840, DOI 10.1016/j.addbeh.2010.03.023; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Larson MJ, 2012, J SOC WORK PRACT ADD, V12, P6, DOI 10.1080/1533256X.2012.647586; Larson MJ, 2014, AM J PUBLIC HEALTH, V104, P1402, DOI 10.2105/AJPH.2014.301901; Larson MJ, 2013, SUBST USE MISUSE, V48, P863, DOI 10.3109/10826084.2013.794840; Maguen S, 2012, J PSYCHIATR RES, V46, P311, DOI 10.1016/j.jpsychires.2011.11.007; Mattiko MJ, 2011, ADDICT BEHAV, V36, P608, DOI 10.1016/j.addbeh.2011.01.023; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; National Institute on Alcohol Abuse and Alcoholism, 2005, HELP PAT WHO DRINK T; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; OBrien C. P., 2013, SUBSTANCE USE DISORD; Pietrzak RH, 2011, J PSYCHIATR RES, V45, P1579, DOI 10.1016/j.jpsychires.2011.07.010; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Ramchand R, 2011, MIL PSYCHOL, V23, P6, DOI 10.1080/08995605.2011.534407; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Santiago PN, 2010, PSYCHIAT SERV, V61, P575, DOI 10.1176/ps.2010.61.6.575; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sellitto M, 2010, J NEUROSCI, V30, P16429, DOI 10.1523/JNEUROSCI.2516-10.2010; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Spera C, 2011, J STUD ALCOHOL DRUGS, V72, P5, DOI 10.15288/jsad.2011.72.5; Stahre MA, 2009, AM J PREV MED, V36, P208, DOI 10.1016/j.amepre.2008.10.017; Stein M. B., 2016, J NEUROTRAUMA; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; US Department of Defense, 2013, EL 1994 DIR GROUND C; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006	56	13	13	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1457	1465		10.1089/neu.2016.4693			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600015	27762655	Green Published			2022-02-06	
J	Al-Mufti, F; Mayer, SA				Al-Mufti, Fawaz; Mayer, Stephan A.			Neurocritical Care of Acute Subdural Hemorrhage	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Acute subdural hematoma; Acute subdural hemorrhage; Traumatic brain injury; Advanced Trauma Life Support protocol	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; PROLONGED MECHANICAL VENTILATION; RAPID-SEQUENCE INTUBATION; VENOUS OXYGEN-SATURATION; END-EXPIRATORY PRESSURE; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; TISSUE OXYGEN	Although urgent surgical hematoma evacuation is necessary for most patients with subdural hematoma (SDH), well-orchestrated, evidenced-based, multidisciplinary, postoperative critical care is essential to achieve the best possible outcome. Acute SDH complicates approximately 11% of mild to moderate traumatic brain injuries (TB's) that require hospitalization, and approximately 20% of severe TBIs. Acute SDH usually is related to a clear traumatic event, but in some cases can occur spontaneously. Management of SDH in the setting of TBI typically conforms to the Advanced Trauma Life Support protocol with airway taking priority, and management breathing and circulation occurring in parallel rather than sequence.	[Al-Mufti, Fawaz] Rutgers State Univ, New Jersey Med Sch, Endovasc Surg Neuroradiol Program, Newark, NJ USA; [Mayer, Stephan A.] Henry Ford Hlth Syst, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA		Mayer, SA (corresponding author), Henry Ford Hlth Syst, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA.	stephanamayer@gmail.com	Al-Mufti, Fawaz/AAZ-3360-2020	Al-Mufti, Fawaz/0000-0003-4461-7005			Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Andre C, 2007, EUR J NEUROL, V14, P21, DOI 10.1111/j.1468-1331.2006.01536.x; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Badjatia N, 2014, NEUROCRIT CARE, V21, P159, DOI 10.1007/s12028-014-0036-2; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bateman NT, 1998, BRIT MED J, V317, P798, DOI 10.1136/bmj.317.7161.798; Beck J, 2014, J NEUROSURG, V121, P1380, DOI 10.3171/2014.6.JNS14550; BERGMANN M, 1992, CLIN NEUROL NEUROSUR, V94, P235, DOI 10.1016/0303-8467(92)90095-K; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Bratton S, 2007, J NEUROTRAUM, V24, P59, DOI DOI 10.1089/neu.2007.9987; Bruder EA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010225.pub2; Busl KM, 2015, J NEUROSURG ANESTH, V27, P31, DOI 10.1097/ANA.0000000000000085; Busl KM, 2013, NEUROCRIT CARE, V19, P176, DOI 10.1007/s12028-013-9864-8; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Cohen L, 2015, ANN EMERG MED, V65, P43, DOI 10.1016/j.annemergmed.2014.06.018; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P308, DOI 10.1001/jama.275.4.308; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Cruz J, 2001, NEUROSURGERY, V49, P864; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; Edwards P, 2005, LANCET, V365, P1957; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; ERSAHIN Y, 1993, PEDIATR NEUROSURG, V19, P31, DOI 10.1159/000120697; Ertmer C, 2014, CRIT CARE, V18, DOI 10.1186/cc13764; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Garber ST, 2012, J NEUROSURG, V116, P1093, DOI 10.3171/2012.2.JNS112132; GARDNER AE, 1972, ANESTH ANAL CURR RES, V51, P741; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Gu JW, 2014, J CRIT CARE, V29, P287, DOI 10.1016/j.jcrc.2013.10.021; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hodzovic I, 2012, ACTA CLIN CROAT, V51, P525; Hutchinson P, 2014, NEUROCRIT CARE, V21, P148, DOI 10.1007/s12028-014-0035-3; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Inamasu J, 2002, RESUSCITATION, V52, P71, DOI 10.1016/S0300-9572(01)00433-6; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kam PCA, 2007, ANAESTHESIA, V62, P690, DOI 10.1111/j.1365-2044.2007.05055.x; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Lasky MR, 1998, J TRAUMA, V44, P527, DOI 10.1097/00005373-199803000-00020; Lewis Philip M, 2012, Acta Neurochir Suppl, V114, P147, DOI 10.1007/978-3-7091-0956-4_27; Li J, 1999, AM J EMERG MED, V17, P141, DOI 10.1016/S0735-6757(99)90046-3; Lowe GJ, 2006, CURR OPIN CRIT CARE, V12, P3, DOI 10.1097/01.ccx.0000198055.29600.4b; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; MANNUCCI PM, 1983, NEW ENGL J MED, V308, P8, DOI 10.1056/NEJM198301063080102; Marion DW, 2006, NEUROSURGERY, V58, P655; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; MATTLE H, 1989, J NEUROL NEUROSUR PS, V52, P829, DOI 10.1136/jnnp.52.7.829; Maxeiner H, 2002, NEUROSURGERY, V50, P503, DOI 10.1097/00006123-200203000-00013; Mayer SA, 2002, J INTENSIVE CARE MED, V17, P55, DOI 10.1046/j.1525-1489.2002.17201.x; McGuire G, 1997, CRIT CARE MED, V25, P1059, DOI 10.1097/00003246-199706000-00025; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Misra UK, 2003, J NEUROL SCI, V208, P25, DOI 10.1016/S0022-510X(02)00415-X; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Naidech AM, 2014, STROKE, V45, P2451, DOI 10.1161/STROKEAHA.114.006061; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; National Clinical Guideline C, 2014, NAT I HLTH CLIN EXC; Nemer SN, 2015, J CRIT CARE, V30, P1263, DOI 10.1016/j.jcrc.2015.07.019; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Okuno S, 1999, SURG NEUROL, V52, P180, DOI 10.1016/S0090-3019(97)00028-1; Pajoumand M, 2016, J TRAUMA ACUTE CARE, V81, P345, DOI 10.1097/TA.0000000000001069; Peltoniemi MA, 2016, CLIN PHARMACOKINET, V55, P1059, DOI 10.1007/s40262-016-0383-6; Pennings FA, 2008, J NEUROTRAUM, V25, P1173, DOI 10.1089/neu.2007.0402; Rabinstein AA, 2010, J NEUROSURG, V112, P455, DOI 10.3171/2009.7.JNS09392; Radic JAE, 2014, NEUROCRIT CARE, V21, P228, DOI 10.1007/s12028-013-9951-x; RENGACHARY SS, 1981, NEUROSURGERY, V8, P166, DOI 10.1227/00006123-198102000-00005; REYMOND MA, 1992, NEUROSURG REV, V15, P21, DOI 10.1007/BF02352062; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; SABO RA, 1995, SURG NEUROL, V43, P579, DOI 10.1016/0090-3019(95)00155-7; SALVANT JB, 1993, NEUROSURGERY, V33, P387; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Shafer A, 1998, CRIT CARE MED, V26, P947, DOI 10.1097/00003246-199805000-00034; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Tayal VS, 1999, ACAD EMERG MED, V6, P31, DOI 10.1111/j.1553-2712.1999.tb00091.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; TOMMASINO C, 1988, CRIT CARE MED, V16, P862, DOI 10.1097/00003246-198809000-00009; TRYBA M, 1991, J CLIN GASTROENTEROL, V13, pS44; Venn RM, 2003, INTENS CARE MED, V29, P201, DOI 10.1007/s00134-002-1579-9; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569; Veshchev Igor, 2002, Med Sci Monit, V8, pCS98; WINTZEN AR, 1982, ARCH NEUROL-CHICAGO, V39, P69, DOI 10.1001/archneur.1982.00510140003001; Zarbock SD, 2008, NEUROCRIT CARE, V9, P210, DOI 10.1007/s12028-008-9120-9	113	13	13	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	APR	2017	28	2					267	+		10.1016/j.nec.2016.11.009			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ES1AJ	WOS:000399260000010	28325461				2022-02-06	
J	Arshad, Q; Roberts, RE; Ahmad, H; Lobo, R; Patel, M; Ham, T; Sharp, DJ; Seemungal, BM				Arshad, Q.; Roberts, R. E.; Ahmad, H.; Lobo, R.; Patel, M.; Ham, T.; Sharp, D. J.; Seemungal, B. M.			Patients with chronic dizziness following traumatic head injury typically have multiple diagnoses involving combined peripheral and central vestibular dysfunction	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Vestibular dysfunction; Traumatic head injury; Chronic dizziness		Objective: We hypothesised that chronic vestibular symptoms (CVS) of imbalance and dizziness post-traumatic head injury (THI) may relate to: (i) the occurrence of multiple simultaneous vestibular diagnoses including both peripheral and central vestibular dysfunction in individual patients increasing the chance of missed diagnoses and suboptimal treatment; (ii) an impaired response to vestibular rehabilitation since the central mechanisms that mediate rehabilitation related brain plasticity may themselves be disrupted. Methods: We report the results of a retrospective analysis of both the comprehensive clinical and vestibular laboratory testing of 20 consecutive THI patients with prominent and persisting vestibular symptoms still present at least 6 months post THI. Results: Individual THI patients typically had multiple vestibular diagnoses and unique to this group of vestibular patients, often displayed both peripheral and central vestibular dysfunction. Despite expert neuro-otological management, at two years 20% of patients still had persisting vestibular symptoms. Conclusion: In summary, chronic vestibular dysfunction in THI could relate to: (i) the presence of multiple vestibular diagnoses, increasing the risk of 'missed' vestibular diagnoses leading to persisting symptoms; (ii) the impact of brain trauma which may impair brain plasticity mediated repair mechanisms. Apart from alerting physicians to the potential for multiple vestibular diagnoses in THI, future work to identify the specific deficits in brain function mediating poor recovery from post-THI vestibular dysfunction could provide the rationale for developing new therapy for head injury patients whose vestibular symptoms are resistant to treatment. (C) 2017 Published by Elsevier B.V.	[Arshad, Q.; Roberts, R. E.; Ahmad, H.; Lobo, R.; Patel, M.; Seemungal, B. M.] Imperial Coll, Charing Cross Hosp Campus, Acad Dept Neurootol, Div Brain Sci, Fulham Palace Rd, London W6 8RF, England; [Ham, T.; Sharp, D. J.] Imperial Coll London, Hammersmith Hosp, Computat Cognit & Clin Neuroimaging Lab, London W12 0NN, England		Seemungal, BM (corresponding author), Imperial Coll, Charing Cross Hosp Campus, Acad Dept Neurootol, Div Brain Sci, Fulham Palace Rd, London W6 8RF, England.	b.seemungal@imperial.ac.uk	Sharp, David J/A-2119-2013	Patel, Mitesh/0000-0002-3594-5448; Patel, Mitesh/0000-0001-6926-941X; Seemungal, Barry/0000-0002-6578-0904	Health Foundation and Academy of Medical Sciences Clinician Scientist Fellowship; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; NIHR Imperial BRC; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/P006493/1] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-011-048] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/P006493/1] Funding Source: UKRI	The authors would like to thank the patients for participating in this study. This work was supported by a Health Foundation and Academy of Medical Sciences Clinician Scientist Fellowship (B.M.S.); the Medical Research Council (B.M.S., D.J.S., H.A., R.E.R., T.H.) and the NIHR Imperial BRC.	BERMAN JM, 1978, J OTOLARYNGOL, V7, P237; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Fife TD, 2009, SEMIN NEUROL, V29, P500, DOI 10.1055/s-0029-1241041; Fotuhi M, 2009, J NEUROL, V256, P711, DOI 10.1007/s00415-009-5050-5; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Maskell F., 2006, BRAIN INJ, V20; Nigmatullina Y, 2015, CEREB CORTEX, V25, P554, DOI 10.1093/cercor/bht266; Ochi K, 2003, OTOLARYNG HEAD NECK, V129, P655, DOI 10.1016/S0194-5998(03)01578-X	10	13	14	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	APR	2017	155						17	19		10.1016/j.clineuro.2017.01.021			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ER4FD	WOS:000398753600005	28212927	Green Accepted			2022-02-06	
J	Bagwe, S; Chung, LK; Lagman, C; Voth, BL; Barnette, NE; Elhajjmoussa, L; Yang, I				Bagwe, Shefali; Chung, Lawrance K.; Lagman, Carlito; Voth, Brittany L.; Barnette, Natalie E.; Elhajjmoussa, Lekaa; Yang, Isaac			Blood transfusion indications in neurosurgical patients: A systematic review	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Blood transfusion; Cerebral neoplasm; Intracranial aneurysm; Neurosurgery; Subarachnoid hemorrhage; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; INTRAOPERATIVE AUTOLOGOUS BLOOD; CELL TRANSFUSION; CEREBRAL OXYGENATION; HEAD-INJURY; CLINICAL-PRACTICE; CRITICAL-CARE; ANEMIA; HEMOGLOBIN	Neurosurgical procedures can be complicated by significant blood losses that have the potential to decrease tissue perfusion to critical brain tissue. Red blood cell transfusion is used in a variety of capacities both inside, and outside, of the operating room to prevent untoward neurologic damage. However, evidence-based guidelines concerning thresholds and indications for transfusion in neurosurgery remain limited. Consequently, transfusion practices in neurosurgical patients are highly variable and based on institutional experiences. Recently, a paradigm shift has occurred in neurocritical intensive care units, whereby restrictive transfusion is increasingly favored over liberal transfusion but the ideal strategy remains in clinical equipoise. The authors of this study perform a systematic review of the literature with the objective of capturing the changing landscape of blood transfusion indications in neurosurgical patients. (C) 2017 Elsevier B.V. All rights reserved.	[Bagwe, Shefali; Chung, Lawrance K.; Lagman, Carlito; Voth, Brittany L.; Barnette, Natalie E.; Elhajjmoussa, Lekaa; Yang, Isaac] Univ Calif Los Angeles, Dept Neurosurg, 300 Stein Plaza,Suite 562,5th Floor Wasserman Bld, Los Angeles, CA 90095 USA; [Yang, Isaac] Univ Calif Los Angeles, Radiat Oncol, Los Angeles, CA USA; [Yang, Isaac] Univ Calif Los Angeles, Head & Neck Surg, Los Angeles, CA USA; [Yang, Isaac] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA		Yang, I (corresponding author), Univ Calif Los Angeles, Dept Neurosurg, 300 Stein Plaza,Suite 562,5th Floor Wasserman Bld, Los Angeles, CA 90095 USA.	iyang@mednet.ucla.edu	Yang, Isaac/AAT-5897-2020	Yang, Isaac/0000-0002-5176-5615	AMA Foundation Seed Grant; Gurtin Skull Base Research Fellowship; Visionary Fund Grant; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research UCLA Scholars in Translational Medicine Program Award; UCLA Honberger Endowment Brain Tumor Research Seed Grant; ASIA Carolyn L. Kuckein Student Research Fellowship; Stop Cancer (US) Research Career Development Award; Jason Dess el Memorial Seed Grant	Lawrance K. Chung is supported by an AMA Foundation Seed Grant and an ASIA Carolyn L. Kuckein Student Research Fellowship. Carlito Lagman is supported by a Gurtin Skull Base Research Fellowship. Isaac Yang is partially supported by a Visionary Fund Grant, an Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research UCLA Scholars in Translational Medicine Program Award, the Jason Dess el Memorial Seed Grant, the UCLA Honberger Endowment Brain Tumor Research Seed Grant and the Stop Cancer (US) Research Career Development Award. The remaining authors have no disclosures or conflicts of interest.	Acker SN, 2014, J TRAUMA ACUTE CARE, V76, P1082, DOI 10.1097/TA.0000000000000095; Al-Dorzi H. M., 2015, CRIT CARE RES PRACT, V2015; Almeida KJ, 2016, ARQ NEURO-PSIQUIAT, V74, P644, DOI 10.1590/0004-282X20160093; Awada WN, 2015, J CLIN MONIT COMPUT, V29, P733, DOI 10.1007/s10877-015-9660-4; Bejjani GK, 1999, SURG NEUROL, V52, P577, DOI 10.1016/S0090-3019(99)00108-1; Bellapart J, 2012, J TRAUMA ACUTE CARE, V73, P997, DOI 10.1097/TA.0b013e318265cede; Blajchman MA, 2001, TRANSFUS CLIN BIOL, V8, P207, DOI 10.1016/S1246-7820(01)00136-7; BORGSTROM L, 1975, ACTA PHYSIOL SCAND, V93, P505, DOI 10.1111/j.1748-1716.1975.tb05842.x; Broessner G, 2009, CRIT CARE MED, V37, P1886, DOI 10.1097/CCM.0b013e31819ffd7f; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Carson JL, 2002, TRANSFUS MED REV, V16, P187, DOI 10.1053/tmrv.2002.33461; Cataldi S, 1997, NEUROSURGERY, V40, P765, DOI 10.1097/00006123-199704000-00021; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Couture DE, 2002, STROKE, V33, P994, DOI 10.1161/hs0402.105296; Dhar R, 2012, J NEUROSURG, V116, P648, DOI 10.3171/2011.9.JNS11691; Duane TM, 2008, J SURG RES, V147, P163, DOI 10.1016/j.jss.2008.02.044; Durak MA, 2016, BIOMED RES-INDIA, V27, P849; Ekelund A, 2002, ACTA NEUROCHIR, V144, P703, DOI 10.1007/s00701-002-0959-9; Festic E, 2013, NEUROCRIT CARE, V18, P209, DOI 10.1007/s12028-012-9777-y; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Kleinert K., 2009, HSSJ, V6, P190; Kramer AH, 2008, CRIT CARE MED, V36, P2070, DOI 10.1097/CCM.0b013e31817c1095; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Kudo H, 2004, SURG NEUROL, V62, P195, DOI 10.1016/j.surneu.2003.10.044; Kumar MA, 2014, NEUROCRIT CARE, V20, P84, DOI 10.1007/s12028-013-9819-0; Kurtz P, 2016, NEUROCRIT CARE, V24, P118, DOI 10.1007/s12028-015-0180-3; Le Roux PD, 2001, NEUROSURGERY, V49, P1068, DOI 10.1097/00006123-200111000-00009; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; Lelubre C, 2016, MINERVA ANESTESIOL, V82, P112; Levine J, 2010, NEUROSURGERY, V66, P312, DOI 10.1227/01.NEU.0000363747.47587.6C; Liang H, 2009, SURG NEUROL, V71, P74, DOI 10.1016/j.surneu.2007.11.015; Linsler S, 2012, ACTA NEUROCHIR, V154, P1303, DOI 10.1007/s00701-012-1373-6; Luostarinen T, 2015, WORLD NEUROSURG, V84, P446, DOI 10.1016/j.wneu.2015.03.053; McEwen J, 2009, CURR OPIN ANESTHESIO, V22, P566, DOI 10.1097/ACO.0b013e32832ff4a2; McGirr A, 2014, CAN J NEUROL SCI, V41, P583, DOI 10.1017/cjn.2014.14; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; McLaren AT, 2007, AM J PHYSIOL-REG I, V292, pR403, DOI 10.1152/ajpregu.00403.2006; Mebel D, 2016, ANESTH ANALG, V122, P503, DOI 10.1213/ANE.0000000000001065; Naidech AM, 2011, TRANSFUSION MED, V21, P130, DOI 10.1111/j.1365-3148.2010.01048.x; Naidech AM, 2008, NEUROCRIT CARE, V9, P198, DOI 10.1007/s12028-008-9113-8; Naidech AM, 2007, CRIT CARE MED, V35, P2383, DOI 10.1097/01.CCM.0000284516.17580.2C; Naidech AM, 2010, NEUROCRIT CARE, V13, P313, DOI 10.1007/s12028-010-9424-4; Napolitano Lena M, 2004, Curr Opin Crit Care, V10, P311; Napolitano LM, 2009, J TRAUMA, V67, P1439, DOI 10.1097/TA.0b013e3181ba7074; Naqash Imtiaz A, 2011, J Anaesthesiol Clin Pharmacol, V27, P54; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; Pasternak JJ, 2008, J NEUROSURG ANESTH, V20, P15, DOI 10.1097/ANA.0b013e318155b1c4; Peerdeman SM, 2000, INTENS CARE MED, V26, P662, DOI 10.1007/s001340051230; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Seicean A, 2015, J NEUROSURG, V123, P91, DOI 10.3171/2014.10.JNS14551; Sekhon MS, 2015, NEUROCRIT CARE, V23, P210, DOI 10.1007/s12028-015-0141-x; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Shander A., 2011, BR J ANAESTH S1, V107, pi49; SHIMADA N, 1989, J CEREBR BLOOD F MET, V9, P603, DOI 10.1038/jcbfm.1989.86; Smith MJ, 2004, J NEUROSURG, V101, P1, DOI 10.3171/jns.2004.101.1.0001; Springer MV, 2009, NEUROSURGERY, V65, P1043, DOI 10.1227/01.NEU.0000359317.15269.20; Stehling LC, 1996, ANESTHESIOLOGY, V84, P732; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Treggiari MM, 2009, CURR OPIN CRIT CARE, V15, P83, DOI 10.1097/MCC.0b013e32832922d1; Utter GH, 2011, J NEUROTRAUM, V28, P155, DOI 10.1089/neu.2010.1451; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Vassal O, 2016, PEDIATR ANESTH, V26, P199, DOI 10.1111/pan.12810; Vedantam A, 2016, J NEUROSURG, V125, P1229, DOI 10.3171/2015.11.JNS151515; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Wei NL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144551; Yamal JM, 2015, J TRAUMA ACUTE CARE, V79, P843, DOI 10.1097/TA.0000000000000834; Yee JN, 2017, J CLIN ANESTH, V36, P164, DOI 10.1016/j.jclinane.2016.10.031; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	76	13	14	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	APR	2017	155						83	89		10.1016/j.clineuro.2017.02.006			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ER4FD	WOS:000398753600016	28282628				2022-02-06	
J	Cheng, K; Bassil, R; Carandang, R; Hall, W; Muehlschlegel, S				Cheng, Katarina; Bassil, Ribal; Carandang, Raphael; Hall, Wiley; Muehlschlegel, Susanne			The Estimated Verbal GCS Subscore in Intubated Traumatic Brain Injury Patients: Is it Really Better?	JOURNAL OF NEUROTRAUMA			English	Article						estimated verbal GCS; Glasgow Coma Scale; motor GCS; outcome prognostication; traumatic brain injury	GLASGOW COMA SCALE; INTRACEREBRAL HEMORRHAGE; MOTOR COMPONENT; TRIAL RATIONALE; INTENSIVE-CARE; PREDICTION; SCORES; IMPACT	The Glasgow Coma Scale (GCS) has limited utility in intubated patients due to the inability to assign verbal subscores. The verbal subscore can be derived from the eye and motor subscores using a mathematical model, but the advantage of this method and its use in outcome prognostication in traumatic brain injury (TBI) patients remains unknown. We compared the validated "Core+CT''-IMPACT-model performance in 251 intubated TBI patients prospectively enrolled in the longitudinal OPTIMISM study between November 2009 and May 2015 when substituting the original motor GCS (mGCS) with the total estimated GCS (teGCS; with estimated verbal subscore). We hypothesized that model performance would improve with teGCS. Glasgow Outcome Scale (GOS) scores were assessed at 3 and 12 months by trained interviewers. In the complete case analysis, there was no statistically or clinically significant difference in the discrimination (C-statistic) at either time-point using the mGCS versus the teGCS (3 months: 0.893 vs. 0.871; 12 months: 0.926 vs. 0.92). At 3 months, IMPACT-model calibration was excellent with mGCS and teGCS (Hosmer-Lemeshow "goodness-offit'' chi square p value 0.9293 and 0.9934, respectively); it was adequate at 12 months with teGCS (0.5893) but low with mGCS (0.0158), possibly related to diminished power at 12 months. At both time-points, motor GCS contributed more to the variability of outcome (Nagelkerke DR 2) than teGCS (3 months: 5.8% vs. 0.4%; 12 months: 5% vs. 2.6%). The sensitivity analysis with imputed missing outcomes yielded similar results, with improved calibration for both GCS variants. In our cohort of intubated TBI patients, there was no statistically or clinically meaningful improvement in the IMPACT-model performance by substituting the original mGCS with teGCS.	[Cheng, Katarina; Bassil, Ribal; Carandang, Raphael; Hall, Wiley; Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Carandang, Raphael; Hall, Wiley; Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Surg, Worcester, MA USA; [Carandang, Raphael; Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Anesthesiol Crit Care, Worcester, MA USA		Muehlschlegel, S (corresponding author), Univ Massachusetts, Sch Med, 55 Lake Ave North,s-5, Worcester, MA 01655 USA.	Susanne.Muehlschlegel@umassmemorial.org			NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD080971]; University of Massachusetts Medical School Center for Clinical and Translational Science; NIH Clinical and Translational Science AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1TR000161]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD080971] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001453, UL1TR000161] Funding Source: NIH RePORTER	This project was in part funded by NIH/NICHD grant K23HD080971 (to S.M.) and supported by the University of Massachusetts Medical School Center for Clinical and Translational Science, funded by the NIH Clinical and Translational Science Award to the University of Massachusetts Medical School (UL1TR000161).	Beskind DL, 2014, PREHOSP EMERG CARE, V18, P68, DOI 10.3109/10903127.2013.844870; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHAMPION HR, 1981, CRIT CARE MED, V9, P672, DOI 10.1097/00003246-198109000-00015; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Ellison P., 2013, WHY I DONT TRUST HOS; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Muehlschlegel S, 2013, NEUROCRIT CARE, V18, P318, DOI 10.1007/s12028-013-9817-2; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; NISKANEN M, 1991, CRIT CARE MED, V19, P1465, DOI 10.1097/00003246-199112000-00005; Qureshi AI, 2011, NEUROCRIT CARE, V15, P559, DOI 10.1007/s12028-011-9538-3; Qureshi AI, 2007, NEUROCRIT CARE, V6, P56, DOI 10.1385/NCC:6:1:56; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Rost NS, 2008, STROKE, V39, P2304, DOI 10.1161/STROKEAHA.107.512202; Rutledge R, 1996, J TRAUMA, V41, P514, DOI 10.1097/00005373-199609000-00022; Sheth KN, 2016, NEUROCRIT CARE, V24, P132, DOI 10.1007/s12028-015-0189-7; STARMARK JE, 1988, J NEUROSURG, V69, P692, DOI 10.3171/jns.1988.69.5.0692; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yeatts SD, 2013, NEUROCRIT CARE, V19, P257, DOI 10.1007/s12028-013-9861-y	29	13	13	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1603	1609		10.1089/neu.2016.4657			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500012	27774844	Green Published			2022-02-06	
J	Dobrachinski, F; Gerbatin, RD; Sartori, G; Marques, NF; Zemolin, AP; Silva, LFA; Franco, JL; Royes, LFF; Fighera, MR; Soares, FAA				Dobrachinski, Fernando; Gerbatin, Rogerio da Rosa; Sartori, Glaubia; Marques, Naiani Ferreira; Zemolin, Ana Paula; Almeida Silva, Luiz Fernando; Franco, Jeferson Luis; Freire Royes, Luiz Fernando; Fighera, Michele Rechia; Antunes Soares, Felix Alexandre			Regulation of Mitochondrial Function and Glutamatergic System Are the Target of Guanosine Effect in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						fluid percussion injury; glutamate; glutamate transporters; mitochondria redox system; purinergic nucleoside	HIPPOCAMPAL SLICES; NITRIC-OXIDE; CELL-DEATH; OXIDATIVE STRESS; OXYGEN/GLUCOSE DEPRIVATION; SUPEROXIDE-DISMUTASE; PATHWAY ACTIVATION; NEURONAL INJURY; DYSFUNCTION; RATS	Traumatic brain injury (TBI) is a highly complex multi-factorial disorder. Experimental trauma involves primary and secondary injury cascades that underlie delayed neuronal dysfunction and death. Mitochondrial dysfunction and gluta-matergic excitotoxicity are the hallmark mechanisms of damage. Accordingly, a successful pharmacological intervention requires a multi-faceted approach. Guanosine (GUO) is known for its neuromodulator effects in various models of brain pathology, specifically those that involve the glutamatergic system. The aim of the study was to investigate the GUO effects against mitochondrial damage in hippocampus and cortex of rats subjected to TBI, as well as the relationship of this effect with the glutamatergic system. Adult male Wistar rats were subjected to a unilateral moderate fluid percussion brain injury (FPI) and treated 15 min later with GUO (7.5 mg/kg) or vehicle (saline 0.9%). Analyses were performed in hippocampus and cortex 3 h post-trauma and revealed significant mitochondrial dysfunction, characterized by a disrupted membrane potential, unbalanced redox system, decreased mitochondrial viability, and complex I inhibition. Further, disruption of Ca2+ homeostasis and increased mitochondrial swelling was also noted. Our results showed that mitochondrial dysfunction contributed to decreased glutamate uptake and levels of glial glutamate transporters (glutamate transporter 1 and glutamate aspartate transporter), which leads to excitotoxicity. GUO treatment ameliorated mitochondrial damage and glutamatergic dyshomeostasis. Thus, GUO might provide a new efficacious strategy for the treatment acute physiological alterations secondary to TBI.	[Dobrachinski, Fernando; Gerbatin, Rogerio da Rosa; Sartori, Glaubia; Marques, Naiani Ferreira; Zemolin, Ana Paula; Almeida Silva, Luiz Fernando; Franco, Jeferson Luis; Freire Royes, Luiz Fernando; Fighera, Michele Rechia; Antunes Soares, Felix Alexandre] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Dept Bioquim & Biol Mol, Campus UFSM, BR-97105900 Santa Maria, RS, Brazil; [Gerbatin, Rogerio da Rosa; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Lab Bioquim Exercicio, Santa Maria, RS, Brazil; [Fighera, Michele Rechia] Univ Fed Santa Maria, Ctr Ciencias Saude, Dept Neuropsiquiatria, Santa Maria, RS, Brazil; [Franco, Jeferson Luis] Univ Fed Pampa, Programa Posgrad Ciencias Biol, Campus Sao Gabriel, Sao Gabriel, RS, Brazil; [Dobrachinski, Fernando] Univ Coimbra, Fac Med, CNC Ctr Neurociencias & Biol Celular, Coimbra, Portugal		Soares, FAA (corresponding author), Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Dept Bioquim & Biol Mol, Campus UFSM, BR-97105900 Santa Maria, RS, Brazil.	felix@ufsm.br	Fighera, Michele R/J-9576-2014; Soares, Felix/AAE-6251-2020; Dobrachinski, Fernando/C-4316-2014; Franco, Jeferson Luis/F-7797-2012; Soares, Felix AA/K-7611-2012; SARTORI, GLAUBIA/J-3435-2014	Soares, Felix/0000-0002-6453-7902; Dobrachinski, Fernando/0000-0002-3948-1273; Franco, Jeferson Luis/0000-0002-3874-8618; Soares, Felix AA/0000-0002-6453-7902; SARTORI, GLAUBIA/0000-0002-1088-8731; Almeida Silva, Luiz Fernando/0000-0002-7621-4836	INCT for excitotoxicity and neuroprotection-MCT/CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); CAPESCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FAPERGS/PRONEMFundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS) [11/2029-1]	This study was supported by INCT for excitotoxicity and neuroprotection-MCT/CNPq. J.L.F., L.F.R., M.R.F., and F.A.A.S. received a fellowship by CNPq; F.D., R.R.G., G.S.S., and N.F.M received a fellowship by CAPES. Additional support was given by FAPERGS/PRONEM 11/2029-1.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Arundine M, 2003, J NEUROTRAUM, V20, P1377, DOI 10.1089/089771503322686166; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Bettio LEB, 2016, PURINERG SIGNAL, V12, P411, DOI 10.1007/s11302-016-9509-4; Boison D, 2010, CELL DEATH DIFFER, V17, P1071, DOI 10.1038/cdd.2009.131; Bottje W, 2002, POULTRY SCI, V81, P546, DOI 10.1093/ps/81.4.546; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bringold U, 2000, FREE RADICAL BIO MED, V29, P343, DOI 10.1016/S0891-5849(00)00318-X; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Ciruela F, 2013, J NEUROCHEM, V126, P425, DOI 10.1111/jnc.12328; Clark RSB, 2007, J CEREBR BLOOD F MET, V27, P316, DOI 10.1038/sj.jcbfm.9600338; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Dal-Cim T, 2011, NEUROSCIENCE, V183, P212, DOI 10.1016/j.neuroscience.2011.03.022; Dal-Cim T, 2016, NEUROTOX RES, V29, P460, DOI 10.1007/s12640-015-9595-z; Dal-Cim T, 2013, J NEUROCHEM, V126, P437, DOI 10.1111/jnc.12324; Dal-Cim T, 2012, NEUROCHEM INT, V61, P397, DOI 10.1016/j.neuint.2012.05.021; Danbolt NC, 2016, NEUROCHEM INT, V98, P29, DOI 10.1016/j.neuint.2016.05.009; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dobrachinski F, 2012, NEUROCHEM RES, V37, P1993, DOI 10.1007/s11064-012-0820-3; Finkel E, 2001, SCIENCE, V292, P624, DOI 10.1126/science.292.5517.624; FISCHER JC, 1985, CLIN CHIM ACTA, V153, P23, DOI 10.1016/0009-8981(85)90135-4; Franco JL, 2010, TOXICOL SCI, V113, P150, DOI 10.1093/toxsci/kfp245; Frizzo MED, 2002, CELL MOL NEUROBIOL, V22, P353; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Jackson EK, 2013, AM J PHYSIOL-CELL PH, V304, pC406, DOI 10.1152/ajpcell.00212.2012; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jiang SC, 2007, PURINERG SIGNAL, V3, P411, DOI 10.1007/s11302-007-9079-6; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Li LB, 2006, J NEUROCHEM, V97, P759, DOI 10.1111/j.1471-4159.2006.03743.x; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Molz S, 2011, J NEUROSCI RES, V89, P1400, DOI 10.1002/jnr.22681; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Rathbone MP, 2011, BRAIN RES, V1407, P79, DOI 10.1016/j.brainres.2011.06.027; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; Schmidt AP, 2007, PHARMACOL THERAPEUT, V116, P401, DOI 10.1016/j.pharmthera.2007.07.004; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Soares FA, 2004, BRAIN RES, V1005, P182, DOI 10.1016/j.brainres.2004.01.053; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Votyakova TV, 2005, J NEUROCHEM, V93, P526, DOI 10.1111/j.1471-4159.2005.03042.x; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wang GJ, 2002, J NEUROPHYSIOL, V87, P740, DOI 10.1152/jn.00345.2001; White RJ, 1996, J NEUROSCI, V16, P5688; Xiong Y, 2005, J NEUROCHEM, V95, P732, DOI 10.1111/j.1471-4159.2005.03412.x; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	67	13	14	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1318	1328		10.1089/neu.2016.4563			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600003	27931151				2022-02-06	
J	Faried, A; Bachani, AM; Sendjaja, AN; Hung, YW; Arifin, MZ				Faried, Ahmad; Bachani, Abdulgafoor M.; Sendjaja, Andi N.; Hung, Yuen W.; Arifin, Muhammad Z.			Characteristics of Moderate and Severe Traumatic Brain Injury of Motorcycle Crashes in Bandung, Indonesia	WORLD NEUROSURGERY			English	Article						Characteristics of traumatic brain injury; Mortality; Motorcycle	EPIDEMIOLOGY; NEUROTRAUMA; MORTALITY; IMPACT; CARE	BACKGROUND: Traumatic brain injury (TBI) constitutes a critical public health and socioeconomic problem. As one of the leading causes of mortality and disability from road traffic crashes, the incidence of TBIs is increasing with increasing motor vehicle usage. Understanding the prevalence and describing the characteristics of TBI are crucial for successful implementation of prevention and treatment efforts to reduce the mortality and morbidity caused by TBIs. METHODS: We studied cases of moderate and severe TBI resulting from motorcycle crashes from January 1, 2013 to June 30, 2014. Variables studied included sex, age, time interval (from crash to arrival at the emergency department), alcohol consumption, helmet use, severity of TBI, choice of treatment, and the outcome. RESULTS: A total of 2108 head injury cases were seen at the emergency department during this period, 1324 (62.8%) of which resulted from motorcycle crashes. Of those cases, 30.7% (407 cases) were categorized as moderate or severe TBI with 29.2% mortality. Most of the patients were male (80.8%), <60 years old (96.1%), and did not wear a helmet (71.2%). More than half of the cases (56.7%) arrived at the emergency department within 6 hours, 14.0% of the cases were under alcohol intoxication, and 37.8% of the cases were operated on. CONCLUSIONS: This preliminary analysis highlights the need to address road safety, especially with respect to helmet use and drink driving, to reduce the burden of TBIs in Bandung.	[Faried, Ahmad; Sendjaja, Andi N.; Arifin, Muhammad Z.] Univ Padjadjarane, Dept Neurosurg, Dr Hasan Sadikin Hosp, Fac Med, Bandung, West Java, Indonesia; [Bachani, Abdulgafoor M.; Hung, Yuen W.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Johns Hopkins Int Injury Res Unit, Baltimore, MD USA		Faried, A (corresponding author), Univ Padjadjarane, Dept Neurosurg, Dr Hasan Sadikin Hosp, Fac Med, Bandung, West Java, Indonesia.	faried.fkup@gmail.com			Injury Working Group, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia	This study was supported by Grants-in-Aid to A.F. from the Injury Working Group, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.	Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Brain Trauma Foundation, 2007, J NEUROTRAUMA S, V24, pS1; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Faul M, 2010, TRAUMATIC BRAIN INJU; Hazen A, 2006, J NATL MED ASSOC, V98, P73; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Sitsapesan HA, 2013, WORLD NEUROSURG, V79, P568, DOI 10.1016/j.wneu.2012.09.018; Stata Corporation, 2015, STAT STAT SOFTW REL STAT STAT SOFTW REL; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Stocchetti N, 2014, LANCET NEUROL, V13, P14, DOI 10.1016/S1474-4422(13)70280-1; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tjahjadi M, 2013, INDIAN J NEUROTRAUM, V10, P3, DOI 10.1016/j.ijnt.2013.04.007; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Umerani MS, 2014, TURK NEUROSURG, V24, P19, DOI 10.5137/1019-5149.JTN.7080-12.1; World Health Organization, 2013, GLOB STAT REP ROAD S; World Health Organization, 2015, GLOB STAT REP ROAD S	26	13	13	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2017	100						195	200		10.1016/j.wneu.2016.12.133			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EV7BT	WOS:000401930000025	28087431				2022-02-06	
J	Gutierrez-de la Iglesia, D; Perez-Lopez, LM; Cabrera-Gonzalez, M; Knorr-Gimenez, J				Gutierrez-de la Iglesia, Diego; Perez-Lopez, Laura M.; Cabrera-Gonzalez, Marisa; Knorr-Gimenez, Jorge			Surgical Techniques for Displaced Radial Neck Fractures: Predictive Factors of Functional Results	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						radius fractures; child; surgical procedures; open surgery; treatment outcome	PERCUTANEOUS REDUCTION; CHILDREN; FIXATION; MANAGEMENT; METAIZEAU	Background: Fractures of the radial neck represent about 1% of all childhood fractures and 5% to 10% of childhood traumatic lesions involving the elbow. Management of these fractures in children is still controversial. Intramedullary percutaneous nail reduction (Metaizeau technique) is considered the most effective surgical technique because of its excellent results and easy learning curve. Complications may arise, however, especially in Bohler technique, in which a percutaneous pin is placed over the radial head. When this technique does not provide correct reduction, open reduction must be performed. Because open reduction is traditionally associated with a high risk of complications, however, its use is restricted to severely displaced fractures and only when the percutaneous techniques have failed or their application contraindicated because of associated injuries to the distal radius. Methods: In this retrospective study, we evaluated 51 children between the ages of 6 and 15 years who presented to our institution from 1996 to 2012 with Metaizeau-modified Judet grades 3, 4a, and 4b radial head fractures. The surgical techniques used were closed reduction and casting under general anesthesia (n = 7), closed reduction and intramedullary nailing using Metaizeau technique (n = 27), and Metaizeau technique and open reduction with intramedullary nailing (n = 17). Functional results of the 3 surgical techniques were evaluated using the Mayo Elbow Performance Score (MEPS) and compared by modified Judet classification using chi(2) analysis. Results: No statistic significant association was found between type of surgery and final MEPS was observed (P = 0.110). However, a significant association was found between initial modified Judet grade and final MEPS. Conclusions: In the present study, final functional outcome seems to be not affected by open reduction but was significantly associated with initial modified Judet grade. Level of Evidence: Level III-retrospective study comparing closed and open reduction techniques, performed at the same institution.	[Gutierrez-de la Iglesia, Diego; Perez-Lopez, Laura M.; Cabrera-Gonzalez, Marisa; Knorr-Gimenez, Jorge] Univ Barcelona, Pediat Upper Limb Unit, Pediat Orthopaed Surg Dept, St Joan de Deu Childrens Hosp, Passeig St Joan de Deu 2, Barcelona 08950, Spain		Gutierrez-de la Iglesia, D (corresponding author), Univ Barcelona, Pediat Upper Limb Unit, Pediat Orthopaed Surg Dept, St Joan de Deu Childrens Hosp, Passeig St Joan de Deu 2, Barcelona 08950, Spain.	dgutierrez@hsjdbcn.org		Perez-Lopez, Laura M./0000-0002-3881-4048; Perez-Lopez, Laura M./0000-0001-8261-3297			Basmajian HG, 2014, J PEDIATR ORTHOP B, V23, P369, DOI 10.1097/BPB.0000000000000057; BERNSTEIN SM, 1993, J PEDIATR ORTHOPED, V13, P85, DOI 10.1097/01241398-199301000-00017; Bither Nitin, 2015, Eur J Orthop Surg Traumatol, V25, P99, DOI 10.1007/s00590-014-1452-x; Brandao GF, 2010, J PEDIATR ORTHOPED, V30, P110, DOI 10.1097/BPO.0b013e3181cf118a; Cha SM, 2012, INT ORTHOP, V36, P803, DOI 10.1007/s00264-011-1387-3; Colovic H, 2008, VOJNOSANIT PREGL, V65, P27, DOI 10.2298/VSP0801027C; Cornwall Roger, 2013, J Bone Joint Surg Am, V95, pe157, DOI 10.2106/JBJS.M.01063; DSOUZA S, 1993, J PEDIATR ORTHOPED, V13, P232; Eberl R, 2010, CHIRURG, V81, P915, DOI 10.1007/s00104-010-1915-5; Falciglia F, 2014, J PEDIATR ORTHOPED, V34, P756, DOI 10.1097/BPO.0000000000000299; Fuentes-Salguero L, 2012, Rev Esp Cir Ortop Traumatol, V56, P300, DOI 10.1016/j.recot.2012.01.002; Garcia-Alvarez F, 2001, Chir Organi Mov, V86, P211; GonzalezHerranz P, 1997, J PEDIATR ORTHOPED, V17, P325, DOI 10.1097/00004694-199705000-00011; Klitscher D, 2009, J PEDIATR ORTHOPED, V29, P698, DOI 10.1097/BPO.0b013e3181b76895; Matuszewski Lukasz, 2012, Ortop Traumatol Rehabil, V14, P261, DOI 10.5604/15093492.1002260; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; Monson R, 2009, J PEDIATR ORTHOPED, V29, P243, DOI 10.1097/BPO.0b013e3181990745; Pring Maya E, 2012, J Pediatr Orthop, V32 Suppl 1, pS14, DOI 10.1097/BPO.0b013e31824b251d; Radomisli TE, 1998, CLIN ORTHOP RELAT R, P30; Schmittenbecher PP, 2005, J PEDIATR ORTHOPED, V25, P45; Song KS, 2015, J PEDIATR ORTHOPED, V35, pE26, DOI 10.1097/BPO.0000000000000305; Sun Jianhua, 2012, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V26, P661; Tan Bryan Hsi Ming, 2011, J Orthop Surg (Hong Kong), V19, P209; Tarallo L, 2013, J ORTHOP TRAUMATOL, V14, P291, DOI 10.1007/s10195-013-0252-0; TIBONE JE, 1981, J BONE JOINT SURG AM, V63, P100, DOI 10.2106/00004623-198163010-00013; Ugutmen E, 2010, J PEDIATR ORTHOP B, V19, P289, DOI 10.1097/BPB.0b013e32833918a0; Ursei Monica, 2006, Acta Orthop Belg, V72, P131; Wang J, 2013, J PEDIATR ORTHOP B, V22, P127, DOI 10.1097/BPB.0b013e32835b5700; Wilkins K, 1991, FRACTURES CHILDREN, P728; Zimmerman RM, 2013, J BONE JOINT SURG AM, V95A, P1825, DOI 10.2106/JBJS.L.01130	30	13	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	APR-MAY	2017	37	3					159	165		10.1097/BPO.0000000000000617			7	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	EN3XS	WOS:000395941800016	26296224				2022-02-06	
J	Jamnia, N; Urban, JH; Stutzmann, GE; Chiren, SG; Reisenbigler, E; Marr, R; Peterson, DA; Kozlowski, DA				Jamnia, Naseem; Urban, Janice H.; Stutzmann, Grace E.; Chiren, Sarah G.; Reisenbigler, Emily; Marr, Robert; Peterson, Daniel A.; Kozlowski, Dorothy A.			A Clinically Relevant Closed-Head Model of Single and Repeat Concussive Injury in the Adult Rat Using a Controlled Cortical Impact Device	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; learning and memory; locomotor function; models of brain injury; rat	TRAUMATIC BRAIN-INJURY; MOUSE MODEL; SHORT-TERM; COGNITIVE IMPAIRMENT; ANIMAL-MODEL; HIGH-SCHOOL; PITUITARY; MOTOR; MEMORY; ENCEPHALOPATHY	Repeat concussions (RC) can result in significant long-term neurological consequences and increased risk for neurodegenerative disease compared with single concussion (SC). Mechanisms underlying this difference are poorly understood and best elucidated using an animal model. To the best of our knowledge, there is no closed-head model in the adult rat using a commercially available device. We developed a novel and clinically relevant closed-head injury (CHI) model of both SC and RC in the adult rat using a controlled cortical impact (CCI) device. Adult rats received either a single or repeat CHI (three injuries, 48 h apart), and acute deficits in sensorimotor and locomotor function (foot fault; open field), memory (novel object), and anxiety (open field; corticosterone [CORT]) were measured. Assessment of cellular pathology was also conducted. Within the first week post-CHI, rats with SC or RC showed similar deficits in motor coordination, decreased locomotion, and higher resting CORT levels. Rats with an SC had memory deficits post-injury day (PID) 3 that recovered to sham levels by PID 7; however, rats with RC continued to show memory deficits. No obvious gross pathology was observed on the cortical surface or in coronal sections. Further examination showed thinning of the cortex and corpus callosum in RC animals compared with shams and increased axonal pathology in the corpus callosum of both SC and RC animals. Our data present a model of CHI that results in clinically relevant markers of concussion and an early differentiation between SC and RC.	[Jamnia, Naseem; Kozlowski, Dorothy A.] Depaul Univ, Dept Biol Sci, 2325 N Clifton Ave, Chicago, IL 60614 USA; [Urban, Janice H.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Physiol & Biophys, N Chicago, IL USA; [Stutzmann, Grace E.; Chiren, Sarah G.; Reisenbigler, Emily; Marr, Robert; Peterson, Daniel A.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Ctr Stem Cell & Regenerat Med, N Chicago, IL USA; [Stutzmann, Grace E.; Chiren, Sarah G.; Reisenbigler, Emily; Marr, Robert; Peterson, Daniel A.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Neurosci, N Chicago, IL USA		Kozlowski, DA (corresponding author), Depaul Univ, Dept Biol Sci, 2325 N Clifton Ave, Chicago, IL 60614 USA.	dkozlows@depaul.edu		Jamnia, Naseem/0000-0003-4825-7764	DePaul-RFUMS Research Pilot Grant; DePaul University Research Council	The authors wish to acknowledge Sarah Scheinman, Gina DeJoseph, and Nic Kapecki for their technical support. Funding was provided by the DePaul-RFUMS Research Pilot Grant (JHU, GES, RM, DAP, DAK) and the DePaul University Research Council (NJ, DAK).	Adkins DL, 2015, NEUROREHAB NEURAL RE, V29, P989, DOI 10.1177/1545968315576577; Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; CARROLL BJ, 1976, ARCH GEN PSYCHIAT, V33, P1039; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Dimitrov EL, 2007, ENDOCRINOLOGY, V148, P3666, DOI 10.1210/en.2006-1730; Doulames VM, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015.00369, 10.3389/fnbeh.2015.00275]; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 2006, BEHAV BRAIN RES, V171, P26, DOI 10.1016/j.bbr.2006.03.016; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greco T, 2013, J NEUROTRAUM, V30, P1983, DOI 10.1089/neu.2013.2990; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Karaca Z, 2016, PROG MOL BIOL TRANSL, V138, P167, DOI 10.1016/bs.pmbts.2015.10.010; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Ma HP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004205; Maldonado MA, 2008, NEUROREHAB NEURAL RE, V22, P250, DOI 10.1177/1545968307308551; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; Markel A L, 1989, Neurosci Behav Physiol, V19, P279, DOI 10.1007/BF01236015; Masel BE, 2015, J NEUROTRAUM, V32, P1902, DOI 10.1089/neu.2014.3526; Mathiasen J.R., 2010, CURR PROTOC PHARM, V49, DOI [10.1002/0471141755.ph0559s49, DOI 10.1002/0471141755.PH0559S49]; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meziane H, 2007, GENES BRAIN BEHAV, V6, P192, DOI 10.1111/j.1601-183X.2006.00249.x; Miyauchi T, 2013, J NEUROTRAUM, V30, P1664, DOI 10.1089/neu.2013.2995; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Namjoshi DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053529; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pearce N, 2014, LANCET NEUROL, V13, P969, DOI 10.1016/S1474-4422(14)70146-2; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Sousa JC, 2004, J NEUROCHEM, V88, P1052, DOI 10.1046/j.1471-4159.2003.02309.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yu HR, 2014, BRAIN INJURY, V28, P244, DOI 10.3109/02699052.2013.859735	67	13	14	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1351	1363		10.1089/neu.2016.4517			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600006	27762651				2022-02-06	
J	Shepherd, SM; Ogloff, JRP; Shea, D; Pfeifer, JE; Paradies, Y				Shepherd, S. M.; Ogloff, J. R. P.; Shea, D.; Pfeifer, J. E.; Paradies, Y.			Aboriginal prisoners and cognitive impairment: the impact of dual disadvantage on Social and Emotional Wellbeing	JOURNAL OF INTELLECTUAL DISABILITY RESEARCH			English	Article						Aboriginal; cognitive impairment; prisoner health; Social and Emotional Wellbeing	TRAUMATIC BRAIN-INJURY; CRIMINAL-JUSTICE SYSTEM; NEW-SOUTH-WALES; INTELLECTUAL DISABILITY; INDIGENOUS AUSTRALIANS; JUVENILE-OFFENDERS; MENTAL-ILLNESS; SUBSTANCE USE; YOUNG-PEOPLE; PREVALENCE	BackgroundNegligible information is available regarding the Social and Emotional Wellbeing (SEWB) needs of Aboriginal Australian individuals in custody with cognitive impairment. This is problematic given that Aboriginal people with cognitive impairment often experience dual disadvantage in the context of the justice system. This study sought to ascertain the relationship between cognitive impairment and mental health/cultural needs (SEWB) Aboriginal and Torres Strait Islander people in custody. MethodA sample of 122 Aboriginal and Torres Strait Islander people were administered a culturally themed semi-structured questionnaire in custodial settings in Victoria, Australia. The questionnaire included measures of cognitive impairment, SEWB and forensic needs. Analyses were performed to determine differences in the presence of SEWB and unmet custodial needs by level of cognitive impairment. ResultsFindings revealed a diminished level of wellbeing for cognitively impaired participants across several factors. Cognitive impairment was associated with poorer coping mechanisms, additional experiences of racism, difficulties handling emotions, discomfort around non-Aboriginal people and reduced access to meaningful activities in custody. All participants regardless of their level of impairment recognised the importance of cultural engagement; however, cognitively impaired participants had greater difficulty accessing/practicing cultural activities. ConclusionsCulturally responsive disability assistance should be available at all phases of the justice system for Indigenous people with cognitive impairment to ensure that equitable care is accessible and needs are addressed.	[Shepherd, S. M.; Pfeifer, J. E.] Swinburne Univ Technol, Ctr Forens Behav Sci, 505 Hoddle St, Clifton Hills, Vic 3068, Australia; [Ogloff, J. R. P.; Shea, D.] Swinburne Univ Technol, Victorian Inst Forens Mental Hlth Forensicare, Ctr Forens Behav Sci, Clifton Hills, Vic, Australia; [Paradies, Y.] Deakin Univ, Alfred Deakin Res Inst Citizenship & Globalisat, Geelong, Vic 3217, Australia		Shepherd, SM (corresponding author), Swinburne Univ Technol, Ctr Forens Behav Sci, 505 Hoddle St, Clifton Hills, Vic 3068, Australia.; Shepherd, SM (corresponding author), Forensicare, 505 Hoddle St, Clifton Hills, Vic 3068, Australia.	sshepherd@swin.edu.au	Pfeifer, Jeffrey/AAF-7507-2021; Shea, Daniel E./U-1860-2019	Pfeifer, Jeffrey/0000-0001-8793-9261; Ogloff, James/0000-0002-3137-5556; Shea, Daniel/0000-0003-2962-3853			AIHW & AIFS, 2013, STRAT PRACT PROM SOC; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; Australian Bureau of Statistics, 2007, AUSTR SOC TRENDS; Australian Bureau of Statistics, 2015, PRIS AUSTR 2015; Australian Bureau of Statistics, 2014, AB TORR STRAIT ISL P; Australian Bureau of Statistics, 2014, INT DIS; Australian Human Rights Commission, 2014, EQ LAW DIS JUST STRA; Australian Human Rights Commission, 2008, PREV CRIM PROM RIGHT; Australian Institute of Health and Welfare, 2009, MEAS SOC EM WELLB AB; Australian Institute of Health and Welfare, 2007, AUSTR I HLTH WELF B; Baldry E., 2012, PEOPLE INTELLECTUAL; Baldry E, 2013, J POLICY PRACT INTEL, V10, P222, DOI 10.1111/jppi.12039; Bhandari A, 2015, J INTELL DISABIL RES, V59, P571, DOI 10.1111/jir.12162; Bohanna I, 2013, ASSESSMENT ACQUIRED; Closing the Gap Clearinghouse (AIHW & AIFS), 2014, FET ALC SPECTR DIS R; Cockram J., 2000, THESIS; Cockram J., 2005, PSYCHIAT PSYCHOL LAW, V12, P163, DOI DOI 10.1375/PPLT.2005.12.1.163; Commonwealth of Australia, 2015, ALC HURT PEOPL HARM; Day A, 2006, INT J OFFENDER THER, V50, P520, DOI 10.1177/0306624X06286971; Department of Health Ageing, 2004, SOC HLTH EM WELL BEI; Dias S, 2013, AUST NZ J PSYCHIAT, V47, P938, DOI 10.1177/0004867413492220; Dingwall K, 2014, BMC PSYCHOL, V2, DOI [DOI 10.1186/2050-7283-2-13, 10.1186/2050-7283-2-13]; Dingwall KM, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-42; Dingwall KM, 2010, AUST NZ J PSYCHIAT, V44, P20, DOI 10.3109/00048670903393670; Dowse L., 2011, PEOPLE MENTAL HLTH D; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Frize M, 2008, J INTELL DISABIL RES, V52, P510, DOI 10.1111/j.1365-2788.2008.01058.x; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Glaser W, 1999, INT J OFFENDER THER, V43, P338, DOI 10.1177/0306624X99433007; Glasson EJ, 2005, J INTELL DISABIL RES, V49, P626, DOI 10.1111/j.1365-2788.2005.00722.x; Gray A., 2009, COGNITIVE IMPAIRMENT, V10; Hayes S., 2000, HAYES ABILITY SCREEN; Haysom L, 2014, J INTELL DISABIL RES, V58, P1004, DOI 10.1111/jir.12109; Hobson B., 2008, OPEN CRIMINOLOGY J, V1, P12; Holland S., 2007, INTELLECTUAL DISABIL; Holland S, 2011, PSYCHOL CRIME LAW, V17, P25, DOI 10.1080/10683160903392285; Holland T, 2002, J INTELL DISABIL RES, V46, P6, DOI 10.1046/j.1365-2788.2002.00001.x; Hollinsworth D, 2013, DISABIL SOC, V28, P601, DOI 10.1080/09687599.2012.717879; Indig D, 2011, 2009 NSW YOUNG PEOPL; Jackson M., 2011, CORRECTIONS RES PAPE, V4; Kelly G., 2012, ISSUES INEQUITIES FA; Klimecki MR, 1994, AUSTR NZ J DEV DISAB, V19, P204; LoGiudice D, 2006, INT PSYCHOGERIATR, V18, P269, DOI 10.1017/S1041610205002681; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, P1986, DOI 10.2105/AJPH.2014.302087; Maxwell Y, 2013, INT J PRISON HEALTH, V9, P57, DOI 10.1108/17449201311326934; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Murphy G., 2015, J APPL RES INTELLECT, DOI 10.1111/jar.12224; Murphy G. H., 2012, CLIN PSYCHOL PEOPLE, P235; NAAJA (North Australian Aboriginal Justice Agency), 2013, N AUSTR AB JUST AG R; Paradies Y, 2009, ETHNIC RACIAL STUD, V32, P548, DOI 10.1080/01419870802065234; Productivity Commission, 2011, DIS CAR SUPP DRAFT R, V1; Riches VC, 2006, INT J LAW PSYCHIAT, V29, P386, DOI 10.1016/j.ijlp.2005.10.003; Rushworth, 2011, OUT SIGHT OUT MIND P; Sattler J.M., 2001, ASSESSMENT CHILDREN; Shepherd S. M., 2016, TRENDS ISSU IN PRESS; Shepherd SM, 2014, PSYCHOL PUBLIC POL L, V20, P31, DOI 10.1037/a0033972; Sherwood J, 2013, CONTEMP NURSE, V46, P28, DOI 10.5172/conu.2013.46.1.28; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Simpson J., 2013, PARTICIPANTS JUST PO; Simpson Jim, 2004, CRIMINAL JUSTICE IND; Slade M., 2003, CANFOR CAMBERWELL AS; Sotiri M., 2006, CURR ISS CRIM JUSTIC, V17, P431, DOI [10.1080/10345329.2006.12036369, DOI 10.1080/10345329.2006.12036369]; Sotiri M., 2012, NO END SIGHT IMPRISO; The Psychological Corporation, 1999, WECHSLER ABBREVIATED; Trofimovs J, 2014, INT J LAW PSYCHIAT, V37, P390, DOI 10.1016/j.ijlp.2014.02.010; VALS (Victorian Aboriginal Legal Service Co-operative Limited), 2011, ACC JUST PEOPL COGN; Vanny KA, 2009, J INTELL DISABIL RES, V53, P289, DOI 10.1111/j.1365-2788.2008.01148.x; Vanny K, 2008, PSYCHIAT PSYCHOL LAW, V15, P261, DOI 10.1080/13218710802014535; Villamanta Disability Rights Legal Service Inc, 2012, PEOPL WHO HAV INT DI; Walker, 2010, WORKING TOGETHER ABO; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697	71	13	14	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0964-2633	1365-2788		J INTELL DISABIL RES	J. Intell. Disabil. Res.	APR	2017	61	4					385	397		10.1111/jir.12357			13	Education, Special; Genetics & Heredity; Clinical Neurology; Psychiatry; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Genetics & Heredity; Neurosciences & Neurology; Psychiatry; Rehabilitation	EM8FK	WOS:000395546600007	28054417	Green Published			2022-02-06	
J	Rochefort, C; Walters-Stewart, C; Aglipay, M; Barrowman, N; Zemek, R; Sveistrup, H				Rochefort, Coralie; Walters-Stewart, Coren; Aglipay, Mary; Barrowman, Nick; Zemek, Roger; Sveistrup, Heidi			Balance Markers in Adolescents at 1 Month Postconcussion	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; balance; adolescents; center of pressure; dual task	TRAUMATIC BRAIN-INJURY; ERROR SCORING SYSTEM; POSTURAL STABILITY; PEDIATRIC CONCUSSION; FORCE PLATFORM; HEAD-INJURY; BOARD; INTERFERENCE; FREQUENCY; SYMPTOMS	Background: The Balance Error Scoring System (BESS) shows that balance tends to recover within days after a concussion, whereas measures of the movement of the center of pressure (COP) show that balance deficits can persist up to 1 month after concussion. While approximately 30% of adolescents suffering concussion have functional consequences including balance deficits, evidence of the use of different balance assessments for concussion is limited within this population. Purpose: To compare performance on a series of balance assessments between adolescents with a diagnosed concussion at 1 month postinjury and noninjured control participants within the same age distribution. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Thirty-three adolescents 1 month postconcussion and 33 control participants completed the BESS followed by two, 2-minute trials standing on a Nintendo Wii Balance Board (WBB), during which the COP under their feet was recorded using 2 testing protocols: (1) double-leg stance, eyes open (EO) and (2) double-leg stance, eyes closed (EC). Participants then completed a dual-task condition (DT) with eyes open combining a double-leg stance and a Stroop color and word test while standing on the WBB. Three commonly used COP variables, anterior-posterior (A/P) and mediolateral (M/L) velocity and 95% ellipse, were computed for each condition performed on the WBB. Results: Participants postconcussion swayed over a significantly larger ellipse area compared with the control group in the EO (P = .008), EC (P = .002), and DT (P = .003) conditions and also performed the DT condition with faster COP velocity in the M/L direction (P = .007). No significant group difference was identified for BESS total score. Conclusion: At 1 month postconcussion, participants continued to demonstrate balance deficits in COP control despite scoring similar to controls on the BESS. Simple COP measures of balance may identify subtle impairments not captured by the BESS.	[Sveistrup, Heidi] Univ Ottawa, Sch Rehabil Sci, Fac Hlth Sci, 200 Lees Ave A-121, Ottawa, ON K1N 6N5, Canada; [Rochefort, Coralie; Walters-Stewart, Coren; Sveistrup, Heidi] Univ Ottawa, Sch Human Kinet, Fac Hlth Sci, 200 Lees Ave A-121, Ottawa, ON, Canada; [Aglipay, Mary; Barrowman, Nick; Zemek, Roger] Eastern Ontario Res Inst, Childrens Hosp, Ottawa, ON, Canada; [Zemek, Roger] Univ Ottawa, Dept Pediat, Fac Med, Ottawa, ON, Canada; [Zemek, Roger] Univ Ottawa, Dept Emergency Med, Fac Med, Ottawa, ON, Canada		Sveistrup, H (corresponding author), Univ Ottawa, Sch Rehabil Sci, Fac Hlth Sci, 200 Lees Ave A-121, Ottawa, ON K1N 6N5, Canada.	heidi.sveistrup@uottawa.ca	Zemek, Roger/H-1039-2018; Barrowman, Nick/AAL-3166-2020	Barrowman, Nick/0000-0002-4704-9595			Bartlett HL, 2014, GAIT POSTURE, V39, P224, DOI 10.1016/j.gaitpost.2013.07.010; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2005, MED SCI SPORT EXER, V37, P689, DOI 10.1249/01.MSS.0000159019.14919.09; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Huurnink A, 2013, J BIOMECH, V46, P1392, DOI 10.1016/j.jbiomech.2013.02.018; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; Pavan P, 2015, EUR J SPORT SCI, V15, P600, DOI 10.1080/17461391.2014.956801; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Piirtola M, 2006, GERONTOLOGY, V52, P1, DOI 10.1159/000089820; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Quatman-Yates CC, 2015, PEDIATR PHYS THER, V27, P316, DOI 10.1097/PEP.0000000000000193; Rhine T, 2017, J HEAD TRAUMA REHAB, V32, pE18, DOI 10.1097/HTR.0000000000000192; Rhine TD, 2016, CLIN J SPORT MED, V26, P221, DOI 10.1097/JSM.0000000000000234; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Scoppa F, 2013, GAIT POSTURE, V37, P290, DOI 10.1016/j.gaitpost.2012.07.009; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Thiagarajan P, 2014, BRAIN INJURY, V28, P930, DOI 10.3109/02699052.2014.888761; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	31	13	13	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	MAR 17	2017	5	3							2325967117695507	10.1177/2325967117695507			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	ET4XB	WOS:000400287300001	28451603	Green Published, gold			2022-02-06	
J	Zhao, S; Yu, ZY; Liu, Y; Bai, Y; Jiang, YH; van Leyen, K; Yang, YG; Lok, JM; Whalen, MJ; Lo, EH; Wang, XY				Zhao, Song; Yu, Zhanyang; Liu, Yu; Bai, Yang; Jiang, Yinghua; van Leyen, Klaus; Yang, Yong-Guang; Lok, Josephine M.; Whalen, Michael J.; Lo, Eng H.; Wang, Xiaoying			CD47 deficiency improves neurological outcomes of traumatic brain injury in mice	NEUROSCIENCE LETTERS			English	Article						CD47; Traumatic brain injury (TBI); Controlled cortical impact (CCI); Neutrophil infiltration; Vessel density; Vascular endothelial growth factor (VEGF); Angiopoietin 1 (Ang-1); Neurological severity score (NSS)	CELL-DEATH; HISTOPATHOLOGY; MIGRATION	CD47 is a receptor for signal -regulatory protein alpha (SIRPcs) in self -recognition by the innate immune system, and a receptor of thrombospondin-1 (TSP-1) contributing to vascular impairment in response to stress. However, the roles of CD47 in traumatic brain injury (TBI) have not been investigated. In this study we aimed to test our hypothesis that CD47 mediates early neutrophil brain infiltration and late brain vascular remodeling after TBI. Mice were subjected to TBI using a controlled cortical impact (CCI) device. We examined early phase neutrophil infiltration, and late phase brain vessel density, pro-angiogenic markers VEGF and Ang-1 protein expression, neurological function deficits and lesion volumes for up to three weeks after TBI. Our results show that mice deficient in CD47 (CD47 Knockout) had significantly less brain neutrophil infiltration at 24 h, upregulated VEGF expression in peri-lesion cortex at 7 and 14 days, and increased blood vessel density at 21 days after TBI, compared to wild type (WT) mice. CD47 knockout also significantly decreased sensorimotor function deficits and reduced brain lesion volume at 21 days after TBI. We conclude that CD47 may play pathological roles in brain neutrophil infiltration, progression of brain tissue damage, impairment of cerebrovascular remodeling and functional recovery after TBI. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Zhao, Song; Bai, Yang] Jilin Univ, Dept Orthoped, Bethune Hosp 1, Changchun, Jilin, Peoples R China; [Zhao, Song; Bai, Yang] Jilin Univ, Dept Neurosurg, Bethune Hosp 1, Changchun, Jilin, Peoples R China; [Zhao, Song; Yu, Zhanyang; Liu, Yu; Jiang, Yinghua; van Leyen, Klaus; Lok, Josephine M.; Lo, Eng H.; Wang, Xiaoying] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Lab, 149 13th St,Room 2401, Charlestown, MA 02129 USA; [Zhao, Song; Yu, Zhanyang; Liu, Yu; Jiang, Yinghua; van Leyen, Klaus; Lok, Josephine M.; Lo, Eng H.; Wang, Xiaoying] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, 149 13th St,Room 2401, Charlestown, MA 02129 USA; [Liu, Yu] Harbin Med Univ, Affiliated Hosp 2, Dept Neurol, Harbin, Heilongjiang, Peoples R China; [Yang, Yong-Guang] Columbia Univ Coll Phys & Surg, Dept Med, Columbia Ctr Translat Immunol, New York, NY USA; [Lok, Josephine M.; Whalen, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Pediat Crit Care Med, Charlestown, MA USA		Wang, XY (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, 149 13th St,Room 2401, Charlestown, MA 02129 USA.; Wang, XY (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, 149 13th St,Room 2401, Charlestown, MA 02129 USA.	33528276@qq.com; Yu.Zhanyang@mgh.harvard.edu; liuyuly1982@163.com; 1295915645@qq.com; yjiang6@mgh.harvard.edu; kvanleyen@mgh.harvard.edu; yy2324@columbia.edu; JLOK1@mgh.harvard.edu; mwhalen@mgh.harvard.edu; lo@helix.mgh.harvard.edu; wangxi@helix.mgh.harvard.edu	van Leyen, Klaus/C-9126-2013	van Leyen, Klaus/0000-0003-1032-3754	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R37-NS37074]; China Nature Science Foundation [81301035]	This study was in part supported by NIH grant R37-NS37074, and China Nature Science Foundation grant 81301035.	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Colak T, 2012, INJURY, V43, P1264, DOI 10.1016/j.injury.2012.01.021; Isenberg JS, 2009, NITRIC OXIDE-BIOL CH, V21, P52, DOI 10.1016/j.niox.2009.05.005; Jin G, 2009, EXP NEUROL, V217, P165, DOI 10.1016/j.expneurol.2009.02.004; Jones RS, 2013, J NEUROIMMUNE PHARM, V8, P301, DOI 10.1007/s11481-012-9427-3; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Krasovsky A, 2014, J NEUROSCI, V34, P15446, DOI 10.1523/JNEUROSCI.5435-13.2014; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Manna PP, 2005, J BIOL CHEM, V280, P29637, DOI 10.1074/jbc.M500922200; Martinelli R, 2013, ARTERIOSCL THROM VAS, V33, P2566, DOI 10.1161/ATVBAHA.113.301903; Mbye LH, 2012, J CEREBR BLOOD F MET, V32, P515, DOI 10.1038/jcbfm.2011.158; Myers SA, 2011, NEUROBIOL DIS, V42, P21, DOI 10.1016/j.nbd.2010.12.010; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Thickbroom GW, 2001, ANN NEUROL, V49, P320, DOI 10.1002/ana.68; Wang XS, 2014, STROKE, V45, P619, DOI 10.1161/STROKEAHA.113.003823; Xing CH, 2009, J NEUROSCI RES, V87, P2571, DOI 10.1002/jnr.22076; Xing CH, 2009, J NEUROCHEM, V108, P430, DOI 10.1111/j.1471-4159.2008.05777.x; Zhang HY, 2015, BRAIN RES, V1623, P74, DOI 10.1016/j.brainres.2015.03.012; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhao S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-67	21	13	14	1	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 16	2017	643						125	130		10.1016/j.neulet.2016.12.006			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EO8UN	WOS:000396966100020	27931776				2022-02-06	
J	Drijkoningen, D; Chalavi, S; Sunaert, S; Duysens, J; Swinnen, SP; Caeyenberghs, K				Drijkoningen, David; Chalavi, Sima; Sunaert, Stefan; Duysens, Jacques; Swinnen, Stephan P.; Caeyenberghs, Karen			Regional Gray Matter Volume Loss Is Associated with Gait Impairments in Young Brain-Injured Individuals	JOURNAL OF NEUROTRAUMA			English	Article						gait impairments; gray matter atrophy; neural control of gait; traumatic brain injury; volumetric analysis	DIFFUSE AXONAL INJURY; HUMAN CEREBRAL-CORTEX; MAGNETIC-RESONANCE IMAGES; CLOSED-HEAD TRAUMA; OLDER-ADULTS; TREADMILL WALKING; GEOMETRICALLY ACCURATE; SURFACE RECONSTRUCTION; LONGITUDINAL CHANGES; CORTICAL THICKNESS	Traumatic brain injury (TBI) often leads to impairments in gait performance. However, the underlying neurostructural pathology of these gait deficits is poorly understood. We aimed to investigate regional gray matter (GM) volume in young moderate-to-severe TBI participants (n=19; age 13 years 11 months +/- 3 years 1 month), compared with typically developing (TD) participants (n=30; 14 years 10 months +/- 2 years 2 months), and assess whether reduced volume was related to impaired gait performance in TBI participants. Cortical and subcortical GM structures involved in the neural control of gait were selected as regions of interest (ROIs) and their volume was extracted using Freesurfer. Moreover, established spatiotemporal markers of gait impairments in TBI participants, including step length asymmetry, step length variability, and double support time, were obtained using an electronic walkway. Compared with TD participants, TBI participants showed increased double support time, step length asymmetry, and step length variability, suggesting a reduced gait control. Secondly, in TBI participants, reduced volumes were demonstrated in overall subcortical GM and individual subcortical ROIs, including the hippocampus, cerebellar cortex, putamen, and thalamus. Moreover, in the TBI group, volume losses in subcortical ROIs were highly inter-correlated, indicating that atrophy tends to occur in combined subcortical structures. Finally, it was demonstrated, for the first time, that gait abnormalities in TBI subjects were associated with reduced volume in specific GM structures, including the hippocampus, thalamus, and the cerebellar, superior frontal, paracentral, posterior cingulate, and superior parietal cortices. The present study is an important first step in the understanding of the neurostructural pathology underlying impaired gait in TBI patients.	[Drijkoningen, David] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Drijkoningen, David; Chalavi, Sima; Duysens, Jacques; Swinnen, Stephan P.; Caeyenberghs, Karen] Grp Biomed Sci, Movement Control & Neuroplast Res Grp, Leuven, Belgium; [Sunaert, Stefan] Univ Hosp, Dept Radiol, Leuven, Belgium; [Swinnen, Stephan P.] Leuven Res Inst Neurosci & Dis, Leuven, Belgium; [Caeyenberghs, Karen] Australian Catholic Univ, Melbourne, Vic, Australia		Drijkoningen, D (corresponding author), Univ Med Ctr Utrecht, Dept Biomed Sci, Hijmans van den Bergh Bldg,Univ Weg 98, NL-3584 CG Utrecht, Netherlands.	d.m.t.drijkoningen@umcutrecht.nl		Caeyenberghs, Karen/0000-0001-7009-6843; Duysens, Jacques/0000-0002-0043-8817; Chalavi, Sima/0000-0002-2339-8168	Research Program of the Research Foundation-Flanders (FWO)FWO [G.A114.11, G.0721.12, G.0708.14]; Research Fund KU LeuvenKU Leuven [OT/11/071]; Interuniversity Attraction Poles program of the Belgian federal governmentBelgian Federal Science Policy Office [P7/11]	This work was supported by a grant from the Research Program of the Research Foundation-Flanders (FWO; Levenslijn G.A114.11 and G.0721.12, G.0708.14). Additional support was provided by the Research Fund KU Leuven (OT/11/071) and the Interuniversity Attraction Poles program of the Belgian federal government [P7/11].	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ai JL, 2007, EXP BRAIN RES, V177, P95, DOI 10.1007/s00221-006-0654-9; Alexander LD, 2009, STROKE, V40, P537, DOI 10.1161/STROKEAHA.108.527374; Allali G, 2014, J GERONTOL A-BIOL, V69, P1389, DOI 10.1093/gerona/glt207; Amboni M, 2013, MOVEMENT DISORD, V28, P1520, DOI 10.1002/mds.25674; Annweiler C, 2013, BRAIN, V136, P859, DOI 10.1093/brain/aws373; Atabaki SM, 2007, PEDIATR REV, V28, P215, DOI 10.1542/pir.28-6-215; Bakker M, 2007, J NEURAL TRANSM, V114, P1323, DOI 10.1007/s00702-007-0783-8; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beauchet O, 2014, BRAIN TOPOGR, V27, P293, DOI 10.1007/s10548-013-0293-y; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; Bruijn SM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00104; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Callisaya ML, 2013, J AM GERIATR SOC, V61, P1074, DOI 10.1111/jgs.12331; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Drew T, 2004, PROG BRAIN RES, V143, P251, DOI 10.1016/S0079-6123(03)43025-2; Drew T, 2015, CURR OPIN NEUROBIOL, V33, P25, DOI 10.1016/j.conb.2015.01.011; Drijkoningen D, 2015, J NEUROTRAUM, V32, P1324, DOI 10.1089/neu.2014.3787; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Duysens J, 2013, CLIN NEUROPHYSIOL, V124, P217, DOI 10.1016/j.clinph.2012.09.004; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Fearing MA, 2008, J CHILD NEUROL, V23, P729, DOI 10.1177/0883073808314159; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gooijers J, 2016, NEUROREHAB NEURAL RE, V30, P603, DOI 10.1177/1545968315613448; Gwin JT, 2011, NEUROIMAGE, V54, P1289, DOI 10.1016/j.neuroimage.2010.08.066; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hausdorff JM, 1997, ARCH PHYS MED REHAB, V78, P278, DOI 10.1016/S0003-9993(97)90034-4; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Ilg W, 2008, BRAIN, V131, P2913, DOI 10.1093/brain/awn246; Jahn K, 2004, NEUROIMAGE, V22, P1722, DOI 10.1016/j.neuroimage.2004.05.017; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Katz-Leurer M, 2010, DEV NEUROREHABIL, V13, P170, DOI 10.3109/17518420903512873; Katz-Leurer M, 2009, GAIT POSTURE, V29, P154, DOI 10.1016/j.gaitpost.2008.06.013; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Koenraadt KLM, 2014, NEUROIMAGE, V85, P415, DOI 10.1016/j.neuroimage.2013.04.070; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; la Fougere C, 2010, NEUROIMAGE, V50, P1589, DOI 10.1016/j.neuroimage.2009.12.060; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Miyai I, 1999, STROKE, V30, P1380, DOI 10.1161/01.STR.30.7.1380; Miyai I, 2002, ANN NEUROL, V52, P188, DOI 10.1002/ana.10274; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Nutt JG, 2011, MOVEMENT DISORD, V26, P1166, DOI 10.1002/mds.23588; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Oddie SD, 1996, J NEUROSCI, V16, P1948; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Paylor R, 2001, PHYSIOL BEHAV, V73, P781, DOI 10.1016/S0031-9384(01)00515-7; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rivas J, 1996, EXP BRAIN RES, V108, P113; Rosano C, 2007, J GERONTOL A-BIOL, V62, P1048, DOI 10.1093/gerona/62.9.1048; Rosano C, 2012, AGE AGEING, V41, P58, DOI 10.1093/ageing/afr113; Rosano C, 2008, J GERONTOL A-BIOL, V63, P1380, DOI 10.1093/gerona/63.12.1380; Rosso AL, 2014, GAIT POSTURE, V40, P225, DOI 10.1016/j.gaitpost.2014.03.192; SAHUQUILLO J, 1989, ACTA NEUROCHIR, V101, P149, DOI 10.1007/BF01410531; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shimada H, 2013, GAIT POSTURE, V38, P203, DOI 10.1016/j.gaitpost.2012.11.008; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Srikanth V, 2009, STROKE, V40, P175, DOI 10.1161/STROKEAHA.108.524355; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Suzuki M, 2008, NEUROIMAGE, V39, P600, DOI 10.1016/j.neuroimage.2007.08.044; Takayanagi Y, 2013, J NEUROPSYCH CLIN N, V25, P292, DOI 10.1176/appi.neuropsych.12040093; Taylor DL, 2006, BRAIN PATHOL, V16, P195, DOI 10.1111/j.1750-3639.2006.00017.x; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wai YY, 2012, PARKINSONISM RELAT D, V18, P537, DOI 10.1016/j.parkreldis.2012.02.004; Wang CH, 2008, J NEURAL TRANSM, V115, P1149, DOI 10.1007/s00702-008-0058-z; Wang JJ, 2009, J NEURAL TRANSM, V116, P1087, DOI 10.1007/s00702-009-0269-y; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wen L, 2014, NEURAL REGEN RES, V9, P1902, DOI 10.4103/1673-5374.145358; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Yogev G, 2007, EXP BRAIN RES, V177, P336, DOI 10.1007/s00221-006-0676-3; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zimmerman ME, 2009, BRAIN RES, V1291, P73, DOI 10.1016/j.brainres.2009.07.043	108	13	13	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					1022	1034		10.1089/neu.2016.4500			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200007	27673741				2022-02-06	
J	Olsson, M; Nilsson, M; Fugl-Meyer, K; Petersson, LM; Wennman-Larsen, A; Kjeldgard, L; Alexanderson, K				Olsson, Mariann; Nilsson, Marie; Fugl-Meyer, Kerstin; Petersson, Lena-Marie; Wennman-Larsen, Agneta; Kjeldgard, Linnea; Alexanderson, Kristina			Life satisfaction of women of working age shortly after breast cancer surgery	QUALITY OF LIFE RESEARCH			English	Article						Breast cancer; Quality of life; Life satisfaction; Social support	QUALITY-OF-LIFE; 18-TO 64-YEAR-OLD SWEDES; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; SOCIAL SUPPORT; SICKNESS ABSENCE; SURVIVORS; ADJUSTMENT; REHABILITATION; POPULATION	To explore, among women of working age, satisfaction with life as a whole and with different life domains, and its associations with social and health variables, shortly after breast cancer surgery. This cross-sectional study included 605 women, aged 20-63 years, who had had breast cancer surgery with no distant metastasis, pre-surgical chemotherapy, or previous breast cancer. Associations between LiSat-11 and demographic and social factors as well as health- and treatment-related variables were analysed by multivariable logistic regression. Compared with Swedish reference levels, the women were, after breast cancer surgery, less satisfied with life, particularly sexual life. Women working shortly after breast cancer surgery were more often satisfied with life in provision domains compared with the reference population. Although most included variables showed associations with satisfaction, after adjustment for all significantly associated variables, only six variables-having children, being in work, having emotional and informational social support, and having good physical and emotional functioning-were positively associated with satisfaction with life as a whole. The odds ratios for satisfaction were higher in most life domains if the woman had social support and good emotional and cognitive functioning. One month after breast cancer surgery, satisfaction with different life domains was associated primarily with social support and health-related functioning. However, this soon after surgery, treatment-related variables showed no significant associations with life satisfaction. These results are useful for planning interventions to enhance e.g. social support and emotional as well as cognitive functioning.	[Olsson, Mariann; Nilsson, Marie; Fugl-Meyer, Kerstin] Karolinska Inst, Div Social Work, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Nilsson, Marie; Fugl-Meyer, Kerstin] Karolinska Univ Hosp, Dept Social Work, Stockholm, Sweden; [Nilsson, Marie; Petersson, Lena-Marie; Wennman-Larsen, Agneta; Kjeldgard, Linnea; Alexanderson, Kristina] Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden; [Wennman-Larsen, Agneta] Sophiahemmet Univ, Stockholm, Sweden		Olsson, M (corresponding author), Karolinska Inst, Div Social Work, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	mariann.olsson@ki.se	Wennman-Larsen, Agneta/A-8432-2015	Wennman-Larsen, Agneta/0000-0002-3457-4737; Olsson, Mariann/0000-0003-3759-3981; Kjeldgard, Linnea/0000-0002-4575-7483; Sjogren Fugl-Meyer, Kerstin/0000-0003-4794-0959; Nilsson, Marie/0000-0002-9938-2509	Swedish Research CouncilSwedish Research CouncilEuropean Commission [521-2009-2315]; Swedish Cancer SocietySwedish Cancer Society [08-257]; Swedish Council for Working Life and Social ResearchSwedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte) [2006-0920]	This study was financially supported by the Swedish Research Council (521-2009-2315), the Swedish Cancer Society (08-257) and the Swedish Council for Working Life and Social Research (2006-0920).	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Anke AGW, 2003, CLIN REHABIL, V17, P431, DOI 10.1191/0269215503cr629oa; Anke A, 2013, J REHABIL MED, V45, P277, DOI 10.2340/16501977-1102; [Anonymous], 2005, 1 NAT I WORK LIF; Bai AL, 2016, CANCER MED-US, V5, P111, DOI 10.1002/cam4.565; Boosman H, 2011, CLIN REHABIL, V25, P460, DOI 10.1177/0269215510388314; Brandao T, 2017, PSYCHO-ONCOLOGY, V26, P917, DOI 10.1002/pon.4230; Breckenridge LM, 2012, PSYCHO-ONCOLOGY, V21, P43, DOI 10.1002/pon.1860; Calvio L, 2010, J OCCUP ENVIRON MED, V52, P219, DOI 10.1097/JOM.0b013e3181d0bef7; Campbell A., 1976, QUALITY AM LIFE; Cicero V, 2009, PSYCHO-ONCOLOGY, V18, P1045, DOI 10.1002/pon.1390; Derogar M, 2012, ACTA ONCOL, V51, P10, DOI 10.3109/0284186X.2011.614636; Eberhard J, 2009, J SEX MED, V6, P1979, DOI 10.1111/j.1743-6109.2009.01298.x; *EORTC, 2001, EORTC C30 SCOR MAN; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Fallbjork U, 2012, CANCER NURS, V35, pE41, DOI 10.1097/NCC.0b013e31823528fb; Fiszer C, 2014, PSYCHO-ONCOLOGY, V23, P361, DOI 10.1002/pon.3432; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Fugl-Meyer KS, 2016, J REHABIL MED, V48, P758, DOI 10.2340/16501977-2146; Geyh S, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-94; GYLLENSKOLD K, 1982, BREAST CANC PSYCHOL; Hansen Annie, 2005, Work, V25, P231; Howard-Anderson J, 2012, JNCI-J NATL CANCER I, V104, P386, DOI 10.1093/jnci/djr541; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; Johansson G, 2004, SOC SCI MED, V58, P1857, DOI 10.1016/S0277-9536(03)00407-6; Johnsson A, 2011, WORK, V38, P337, DOI 10.3233/WOR-2011-1137; Kanatas A, 2012, TUMORI, V98, P678, DOI 10.1700/1217.13489; Karabulut N, 2009, J PSYCHOSOC ONCOL, V27, P332, DOI 10.1080/07347330902979101; Karlsson Berit, 2006, Scand J Occup Ther, V13, P193; Laurent K., 2011, Annals of Physical and Rehabilitation Medicine, V54, P376, DOI 10.1016/j.rehab.2011.06.002; Mehnert A, 2013, CANCER-AM CANCER SOC, V119, P2151, DOI 10.1002/cncr.28067; Melin R, 2003, J REHABIL MED, V35, P84, DOI 10.1080/16501970306119; Merrick D, 2012, J REHABIL MED, V44, P764, DOI 10.2340/16501977-1022; Moons P, 2006, INT J NURS STUD, V43, P891, DOI 10.1016/j.ijnurstu.2006.03.015; Muller R, 2012, SPINAL CORD, V50, P94, DOI 10.1038/sc.2011.116; Nilsson MI, 2013, PSYCHO-ONCOLOGY, V22, P1639, DOI 10.1002/pon.3192; Nilsson M, 2011, EUR J ONCOL NURS, V15, P267, DOI 10.1016/j.ejon.2011.03.005; Nilsson MI, 2016, J CANCER SURVIV, V10, P564, DOI 10.1007/s11764-015-0502-7; Nilsson MI, 2013, PSYCHO-ONCOLOGY, V22, P2755, DOI 10.1002/pon.3341; Oberg K, 2005, J SEX MED, V2, P169, DOI 10.1111/j.1743-6109.2005.20226.x; Petersson LM, 2013, J OCCUP REHABIL, V23, P391, DOI 10.1007/s10926-012-9402-0; Petersson LM, 2011, ACTA ONCOL, V50, P282, DOI 10.3109/0284186X.2010.533191; Rizalar S, 2014, ASIAN PAC J CANCER P, V15, P3429, DOI 10.7314/APJCP.2014.15.8.3429; Skeppner E, 2008, EUR UROL, V54, P631, DOI 10.1016/j.eururo.2007.10.028; Spagnola Sarah, 2003, Breast J, V9, P463, DOI 10.1046/j.1524-4741.2003.09603.x; Thors C L, 2001, Cancer Control, V8, P442; UNDEN AL, 1989, SOC SCI MED, V29, P1387, DOI 10.1016/0277-9536(89)90240-2; von Wright G.H., 1963, VARIETIES GOODNESS; Wennman-Larsen A, 2016, EUR J ONCOL NURS, V22, P1, DOI 10.1016/j.ejon.2016.02.010	49	13	14	1	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	MAR	2017	26	3					673	684		10.1007/s11136-016-1479-z			12	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	EL1DX	WOS:000394361800014	28070803	Green Published, hybrid			2022-02-06	
J	Ratiu, I; Azuma, T				Ratiu, Ileana; Azuma, Tamiko			Language control in bilingual adults with and without history of mild traumatic brain injury	BRAIN AND LANGUAGE			English	Article						Traumatic brain injury; Bilingualism; Executive function; Language control	WORKING-MEMORY; EXECUTIVE FUNCTIONS; COGNITIVE CONTROL; EYE-MOVEMENTS; BIMODAL BILINGUALS; STRESS-DISORDER; TASK; REPRESENTATION; 2ND-LANGUAGE; ATTENTION	Adults with a history of traumatic brain injury often show deficits in executive functioning (EF), including the ability to inhibit, switch, and attend to tasks. These abilities are critical for language processing in bilinguals. This study examined the effect of mild traumatic brain injury (mTBI) on EF and language processing in bilinguals using behavioral and eye-tracking measures. Twenty-two bilinguals with a history of mTBI and twenty healthy control bilinguals were administered executive function and language processing tasks. Bilinguals with a history of mTBI showed deficits in specific EFs and had higher rates of language processing errors than healthy control bilinguals. Additionally, individuals with a history of mTBI have different patterns of eye movements during reading than healthy control bilinguals. These data suggest that language processing deficits are related to underlying EF abilities. The findings provide important information regarding specific EF and language control deficits in bilinguals with a history mTBI. (C) 2016 Elsevier Inc. All rights reserved.	[Ratiu, Ileana; Azuma, Tamiko] Arizona State Univ, Tempe, AZ 85287 USA; [Ratiu, Ileana] Midwestern Univ, Glendale, AZ USA; [Azuma, Tamiko] Arizona State Univ, Dept Speech & Hearing Sci, POB 870102, Tempe, AZ 85287 USA		Ratiu, I (corresponding author), Midwestern Univ, Dept Speech Language Pathol, 19555 N 59th Ave, Glendale, AZ 85308 USA.	iratiu@midwestern.edu; azuma@asu.edu			American Speech Language-Hearing Foundation; Graduate and Professional Student Association of Arizona State University	This research was supported in part by the American Speech Language-Hearing Foundation and the Graduate and Professional Student Association of Arizona State University.	Abutalebi J, 2008, ACTA PSYCHOL, V128, P466, DOI 10.1016/j.actpsy.2008.03.014; Abutalebi J, 2008, CEREB CORTEX, V18, P1496, DOI 10.1093/cercor/bhm182; Altarriba J, 1996, MEM COGNITION, V24, P477, DOI 10.3758/BF03200936; Anderson TM, 2010, J CLIN EXP NEUROPSYC, V32, P1074, DOI 10.1080/13803391003733560; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Betthauser LM, 2012, NEUROPSYCHOL REV, V22, P35, DOI 10.1007/s11065-012-9191-4; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Cooper J. D., 1993, NEUROEPIDEMIOLOGY, V2, P70; Corsi P. M., 1972, THESIS MCGILL U MONT; Crinion J, 2006, SCIENCE, V312, P1537, DOI 10.1126/science.1127761; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dijkstra T, 2002, BILINGUALISM LANGUAG, V5; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Dunabeitia JA, 2010, EXP PSYCHOL, V57, P98, DOI 10.1027/1618-3169/a000013; Dunn L.M., 1997, PEABODY PICTURE VOCA, V3rd Edition; Emmorey K, 2008, PSYCHOL SCI, V19, P1201, DOI 10.1111/j.1467-9280.2008.02224.x; ESLINGER PJ, 1995, NEUROREHABILITATION, V5, P161, DOI 10.3233/NRE-1995-5206; Fabbro F, 2001, BRAIN LANG, V79, P211, DOI 10.1006/brln.2001.2481; Faul M, 2010, TRAUMATIC BRAIN INJU; Garbin G, 2010, NEUROIMAGE, V53, P1272, DOI 10.1016/j.neuroimage.2010.05.078; Garner JK, 2009, J PSYCHOL, V143, P405, DOI 10.3200/JRLP.143.4.405-426; GILHOOLY KJ, 1980, BEHAV RES METH INSTR, V12, P395, DOI 10.3758/BF03201693; Gollan TH, 2014, PSYCHOL SCI, V25, P585, DOI 10.1177/0956797613512661; Gollan TH, 2011, PSYCHOL SCI, V22, P1155, DOI 10.1177/0956797611417002; Green D.W., 1998, BILING-LANG COGN, V1, P67, DOI [10.1017/S1366728998000133, DOI 10.1017/S1366728998000133]; Green DW, 2013, J COGN PSYCHOL, V25, P515, DOI 10.1080/20445911.2013.796377; Hernandez AE, 2009, BRAIN LANG, V109, P133, DOI 10.1016/j.bandl.2008.12.005; Hunt AW, 2013, NEUROPSYCHOL REHABIL, V23, P914, DOI 10.1080/09602011.2013.835739; Illes J, 1999, BRAIN LANG, V70, P347, DOI 10.1006/brln.1999.2186; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kuera H., 1967, COMPUTATIONAL ANAL P; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lehtonen MH, 2005, NEUROREPORT, V16, P607, DOI 10.1097/00001756-200504250-00018; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Libben MR, 2009, J EXP PSYCHOL LEARN, V35, P381, DOI 10.1037/a0014875; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lorenzen B, 2008, AM J SPEECH-LANG PAT, V17, P299, DOI 10.1044/1058-0360(2008/026); Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marian V, 2003, BRAIN LANG, V86, P70, DOI 10.1016/S0093-934X(02)00535-7; Marian V., 2003, BILING-LANG COGN, V6, P97, DOI 10.1017/S1366728903001068; Marien P, 2005, NEUROCASE, V11, P385, DOI 10.1080/13554790500212880; Marion V, 2007, J SPEECH LANG HEAR R, V50, P940, DOI 10.1044/1092-4388(2007/067); Marrero MZ, 2002, CLIN PSYCHOL REV, V22, P463, DOI 10.1016/S0272-7358(01)00109-X; Martin N. A., 2012, RECEPTIVE ONE WORD P; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Ozen LJ, 2010, J INT NEUROPSYCH SOC, V16, P556, DOI 10.1017/S1355617710000202; Paap KR, 2013, COGNITIVE PSYCHOL, V66, P232, DOI 10.1016/j.cogpsych.2012.12.002; Pavio A., 1968, J EXPT PSYCHOL M 2 S, V76; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; Prior A, 2011, J INT NEUROPSYCH SOC, V17, P682, DOI 10.1017/S1355617711000580; Raven J, 1998, MANUAL RAVENS PROGR; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1986, MEM COGNITION, V14, P191, DOI 10.3758/BF03197692; RAYNER K, 1979, PERCEPTION, V8, P21, DOI 10.1068/p080021; Rayner K., 2011, OXFORD HDB EYE MOVEM, P751, DOI [10.1093/oxfordhb/9780199539789.013.0041, DOI 10.1093/OXFORDHB/9780199539789.013.0041]; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Schneider W., 2002, E PRIME VERSION 1 0; Sebastian-Galles N., 2000, LEXESP LEXICO INFORM; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Spivey MJ, 1999, PSYCHOL SCI, V10, P281, DOI 10.1111/1467-9280.00151; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Unsworth N, 2007, PSYCHOL BULL, V133, P1038, DOI 10.1037/0033-2909.133.6.1038; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zou LJ, 2012, NEUROIMAGE, V62, P1367, DOI 10.1016/j.neuroimage.2012.05.062	80	13	13	2	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	MAR	2017	166						29	39		10.1016/j.bandl.2016.12.004			11	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	EL4AH	WOS:000394561800003	28039735				2022-02-06	
J	Sherer, M; Nick, TG; Sander, AM; Melguizo, M; Hanks, R; Novack, TA; Tulsky, D; Kisala, P; Luo, CQ; Tang, XY				Sherer, Mark; Nick, Todd G.; Sander, Angelle M.; Melguizo, Maria; Hanks, Robin; Novack, Thomas A.; Tulsky, David; Kisala, Pamela; Luo, Chunqiao; Tang, Xinyu			Groupings of Persons With Traumatic Brain Injury: A New Approach to Classifying Traumatic Brain Injury in the Post-Acute Period	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						classification; environment; outcome; quality of life; traumatic brain injury; treatment	CLOSED-HEAD-INJURY; REHABILITATION; CLUSTERS; NUMBER; LIFE	Objective: To (1) identify groups of persons with traumatic brain injury (TBI) who differ on 12 dimensions of cognitive function: cognitive, emotional, and physical symptoms; personal strengths; physical functioning; environmental supports; and performance validity; and (2) describe patterns of differences among the groups on these dimensions and on participation outcome. Setting: Three centers for rehabilitation of persons with TBI. Participants: A total of 504 persons with TBI living in the community who were an average (standard deviation) of 6.3 (6.8) years postinjury and who had capacity to give consent, could be interviewed and tested in English, and were able to participate in an assessment lasting up to 4 hours. Design: Observational study of a convenience sample of persons with TBI. Main Measures: Selected scales from the Traumatic Brain Injury Quality of Life measures, Neurobehavioral Symptom Inventory, Economic Quality of Life Scale, Family Assessment Device General Functioning Scale, measures of cognitive function, Word Memory Test, and Participation Assessment with Recombined Tools-Objective (PART-O) scale. Results: Cluster analysis identified 5 groups of persons with TBI who differed in clinically meaningful ways on the 12 dimension scores and the PART-O scale. Conclusion: Cluster groupings identified in this study could assist clinicians with case conceptualization and treatment planning.	[Sherer, Mark; Sander, Angelle M.] TIRR Mem Hermann, 1333 Moursund St, Houston, TX 77030 USA; [Sherer, Mark; Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Nick, Todd G.; Melguizo, Maria; Luo, Chunqiao; Tang, Xinyu] Univ Arkansas Med Sci, Dept Pediat & Biostat, Little Rock, AR 72205 USA; [Sander, Angelle M.] Harris Hlth Syst, Ctr Trauma Rehabil, Dept Phys Med & Rehabil, Houston, TX USA; [Hanks, Robin] Wayne State Univ, Sch Med, Rehabil Inst Michigan, Dept Phys Med & Rehabil, Detroit, MI USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Tulsky, David; Kisala, Pamela] Univ Delaware, Coll Hlth Sci, Dept Phys Therapy, Newark, DE 19716 USA; [Tulsky, David] Kessler Fdn, W Orange, NJ USA		Sherer, M (corresponding author), TIRR Mem Hermann, 1333 Moursund St, Houston, TX 77030 USA.	Mark.Sherer@memorialhermann.org		Tulsky, David/0000-0002-4335-4509	US Department of Education National Institute on Disability and Rehabilitation Research grants [H133B090023, H133A120020]	This research was supported by US Department of Education National Institute on Disability and Rehabilitation Research grants H133B090023 and H133A120020.	BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; BenYishay Y, 1996, NEUROPSYCHOL REHABIL, V6, P327, DOI 10.1080/713755514; Bergquist T.F., 2014, HDB NEUROPSYCHOLOGY, P77; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Calinski TT., 1974, COMMUN STAT, V3, P1, DOI 10.1080/03610927408827101; Charrad M, 2014, J STAT SOFTW, V61, P1; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Dams-O'Connor K, 2013, BRAIN IMPAIR, V14, P51, DOI 10.1017/BrImp.2013.9; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Green P., 1996, WORD MEMORY TEST USE; Marion DW, 2006, NEUROSURGERY, V58, P655; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; R Core Team, 2018, R LANGUAGE ENV STAT; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A, 1958, EXAMIN CLIN PSYCHOL; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Sherer M, 2003, DEMONSTRATING UTILIT, P39; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; TEASDALE G, 1974, LANCET, V2, P81; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Tulsky DS, 2015, ARCH PHYS MED REHAB, V96, P604, DOI 10.1016/j.apmr.2014.02.030; Wechsler D., 2008, WECHSLER ADULT INTEL; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002	27	13	13	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2017	32	2					125	133		10.1097/HTR.0000000000000207			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EN3YU	WOS:000395944700014	26709583				2022-02-06	
J	Zhang, MY; Shan, HY; Chang, P; Ma, L; Chu, Y; Shen, X; Wu, Q; Wang, ZF; Luo, CL; Wang, T; Chen, XP; Tao, LY				Zhang, Mingyang; Shan, Haiyan; Chang, Pan; Ma, Lu; Chu, Yang; Shen, Xi; Wu, Qiong; Wang, Zufeng; Luo, Chengliang; Wang, Tao; Chen, Xiping; Tao, Luyang			Upregulation of 3-MST Relates to Neuronal Autophagy After Traumatic Brain Injury in Mice	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						3-mercaptopyruvate sulfurtransferase; Traumatic brain injury; Autophagic cell death; Mice	CONTROLLED CORTICAL IMPACT; MERCAPTOPYRUVATE SULFURTRANSFERASE; HYDROGEN-SULFIDE; CELL-DEATH; NEURODEGENERATIVE DISEASE; OXIDATIVE STRESS; APOPTOSIS; THERAPY; PATHOPHYSIOLOGY; INTERMEDIATE	3-mercaptopyruvate sulfurtransferase (3-MST) was a novel hydrogen sulfide (H2S)-synthesizing enzyme that may be involved in cyanide degradation and in thiosulfate biosynthesis. Over recent years, considerable attention has been focused on the biochemistry and molecular biology of H2S-synthesizing enzyme. In contrast, there have been few concerted attempts to investigate the changes in the expression of the H2S-synthesizing enzymes with disease states. To investigate the changes of 3-MST after traumatic brain injury (TBI) and its possible role, mice TBI model was established by controlled cortical impact system, and the expression and cellular localization of 3-MST after TBI was investigated in the present study. Western blot analysis revealed that 3-MST was present in normal mice brain cortex. It gradually increased, reached a peak on the first day after TBI, and then reached a valley on the third day. Importantly, 3-MST was colocalized with neuron. In addition, Western blot detection showed that the first day post injury was also the autophagic peak indicated by the elevated expression of LC3. Importantly, immunohistochemistry analysis revealed that injury-induced expression of 3-MST was partly colabeled by LC3. However, there was no colocalization of 3-MST with propidium iodide (cell death marker) and LC3 positive cells were partly colocalized with propidium iodide. These data suggested that 3-MST was mainly located in living neurons and may be implicated in the autophagy of neuron and involved in the pathophysiology of brain after TBI.	[Zhang, Mingyang; Ma, Lu; Chu, Yang; Shen, Xi; Wu, Qiong; Wang, Zufeng; Luo, Chengliang; Wang, Tao; Chen, Xiping; Tao, Luyang] Soochow Univ, Inst Forens Sci, Suzhou 215123, Jiangsu, Peoples R China; [Zhang, Mingyang] Minist Justice, Shanghai Key Lab Forens Med, Inst Forens Sci, Shanghai 200063, Peoples R China; [Shan, Haiyan] North Dist Suzhou Municipal Hosp, Dept Obstet & Gynecol, Suzhou 215008, Jiangsu, Peoples R China; [Chang, Pan] Xian Med Coll, Affiliated Hosp 2, Cent Lab, Xian 710038, Peoples R China		Zhang, MY; Tao, LY (corresponding author), Soochow Univ, Inst Forens Sci, Suzhou 215123, Jiangsu, Peoples R China.; Zhang, MY (corresponding author), Minist Justice, Shanghai Key Lab Forens Med, Inst Forens Sci, Shanghai 200063, Peoples R China.	mingyangzhang@suda.edu.cn; taoluyang@suda.edu.cn	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Shen, Xi/0000-0001-7568-7335; Zhang, Mingyang/0000-0003-1612-0763	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81172911, 81271379, 81301039, 81530062]; National High Technology Research and Development Program of China (863 Program)National High Technology Research and Development Program of China [2015AA020503]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015M570476]; Shanghai Key Lab of Forensic Medicine [KF1502]; Suzhou Science and Technology Development Project [SYSD2015119]	This work was supported by the National Natural Science Foundation of China (No. 81172911, No. 81271379, No. 81301039, No. 81530062); National High Technology Research and Development Program of China (863 Program, No. 2015AA020503); The Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); China Postdoctoral Science Foundation funded project (No. 2015M570476); Shanghai Key Lab of Forensic Medicine (KF1502); Suzhou Science and Technology Development Project (SYSD2015119).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Fayaz SM, 2014, CNS NEUROL DISORD-DR, V13, P42, DOI 10.2174/18715273113126660189; Frasdorf B, 2014, J BIOL CHEM, V289, P34543, DOI 10.1074/jbc.M114.605733; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Giordano S, 2014, REDOX BIOL, V2, P82, DOI 10.1016/j.redox.2013.12.013; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Jeruc J, 2006, AM J KIDNEY DIS, V48, P410, DOI 10.1053/j.ajkd.2006.05.019; Jiang T, 2015, FREE RADICAL BIO MED, V88, P199, DOI 10.1016/j.freeradbiomed.2015.06.014; Kimura H, 2015, HANDB EXP PHARMACOL, V230, P61, DOI 10.1007/978-3-319-18144-8_3; Kimura H, 2014, MOLECULES, V19, P16146, DOI 10.3390/molecules191016146; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Moon HE, 2015, EXP NEUROBIOL, V24, P103, DOI 10.5607/en.2015.24.2.103; Nagahara N, 1996, SEIKAGAKU, V68, P197; Nagahara N, 1998, HISTOCHEM CELL BIOL, V110, P243, DOI 10.1007/s004180050286; Nagahara N, 1999, HISTOL HISTOPATHOL, V14, P1277, DOI 10.14670/HH-14.1277; Nagahara Noriyuki, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P198, DOI 10.2174/1568008033340162; Nagahara N, 2013, ANTIOXID REDOX SIGN, V19, P1792, DOI 10.1089/ars.2012.5031; Nagahara N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01986; Nagahara N, 2012, ANTIOXID REDOX SIGN, V16, P747, DOI 10.1089/ars.2011.4468; Navarro-Yepes J, 2014, PHARMACOL THERAPEUT, V142, P206, DOI 10.1016/j.pharmthera.2013.12.007; Ozacmak VH, 2016, NUTR NEUROSCI, V19, P176, DOI 10.1179/1476830515Y.0000000027; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Park Y, 2015, J NEUROTRAUM, V32, P1449, DOI 10.1089/neu.2014.3694; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Wang HC, 2016, WORLD NEUROSURG, V87, P463, DOI 10.1016/j.wneu.2015.10.010; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Xiong N, 2011, NEUROSCIENCE, V199, P292, DOI 10.1016/j.neuroscience.2011.10.031; Zhang L, 2015, FREE RADICAL BIO MED, V89, P452, DOI 10.1016/j.freeradbiomed.2015.08.030; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang MY, 2013, J MOL NEUROSCI, V51, P57, DOI 10.1007/s12031-012-9948-5; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4; Zhao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067322	49	13	13	2	11	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAR	2017	37	2					291	302		10.1007/s10571-016-0369-9			12	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	EL2EB	WOS:000394431800009	27038311				2022-02-06	
J	Zhu, Y				Zhu, Yong			Design and Validation of a Low-Cost Portable Device to Quantify Postural Stability	SENSORS			English	Article						human balance; postural stability; approximate entropy (ApEn); center-of-pressure (COP); portable device; low-cost assessment device	APPROXIMATE ENTROPY; CEREBRAL CONCUSSION; HUMAN BALANCE; SWAY; REGULARITY	Measurement of the displacement of the center-of-pressure (COP) is an important tool used in biomechanics to assess postural stability and human balance. The goal of this research was to design and validate a low-cost portable device that can offer a quick indication of the state of postural stability and human balance related conditions. Approximate entropy (ApEn) values reflecting the amount of irregularity hiding in COP oscillations were used to calculate the index. The prototype adopted a portable design using the measurements of the load cells located at the four corners of a low-cost force platform. The test subject was asked to stand on the device in a quiet, normal, upright stance for 30 s with eyes open and subsequently for 30 s with eyes closed. Based on the COP displacement signals, the ApEn values were calculated. The results indicated that the prototype device was capable of capturing the increase in regularity of postural control in the visual-deprivation conditions. It was also able to decipher the subtle postural control differences along anterior-posterior and medial-lateral directions. The data analysis demonstrated that the prototype would enable the quantification of postural stability and thus provide a low-cost portable device to assess many conditions related to postural stability and human balance such as aging and pathologies.	[Zhu, Yong] Wilkes Univ, Dept Mech Engn, Wilkes Barre, PA 18766 USA		Zhu, Y (corresponding author), Wilkes Univ, Dept Mech Engn, Wilkes Barre, PA 18766 USA.	yong.zhu@wilkes.edu			Wilkes University	This research was partly supported by the Wilkes University mentoring project fund. Funds are received from Wilkes University for covering the costs to publish in open access. The author would like to thank the anonymous reviewers for their careful reading of the manuscript and their many insightful comments and suggestions.	Abrahamova D, 2008, PHYSIOL RES, V57, P957, DOI 10.33549/physiolres.931238; Garcia RB, 2012, ACTA OTORRINOLAR ESP, V63, P332, DOI 10.1016/j.otorri.2012.03.006; Balasubramaniam R, 2000, GAIT POSTURE, V11, P12, DOI 10.1016/S0966-6362(99)00051-X; Bartlett R, 2010, ENCY INT SPORTS STUD; Borg FG, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-38; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chon KH, 2009, IEEE ENG MED BIOL, V28, P18, DOI 10.1109/MEMB.2009.934629; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Gaerlan M.G., 2010, THESIS U NEVADA LAS; Ghomashchi H, 2011, INT J BIFURCAT CHAOS, V21, P1163, DOI 10.1142/S021812741102891X; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; HASAN SS, 1990, J BIOMECH, V23, P783, DOI 10.1016/0021-9290(90)90025-X; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Huang CW, 2013, SENSORS-BASEL, V13, P10151, DOI 10.3390/s130810151; Jauregui-Renaud K., 2013, POSTURAL BALANCE PER; Johnson M. L., 2004, NUMERICAL COMPUTER M, V384; Lamoth CJC, 2009, GAIT POSTURE, V29, P546, DOI 10.1016/j.gaitpost.2008.12.006; Lizama LEC, 2016, J NEUROPHYSIOL, V115, P907, DOI 10.1152/jn.00103.2014; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Roerdink M, 2011, HUM MOVEMENT SCI, V30, P203, DOI 10.1016/j.humov.2010.04.005; Stins JF, 2011, HUM MOVEMENT SCI, V30, P190, DOI 10.1016/j.humov.2010.05.013; Strang A. J., 2010, PROFESS SAF, V55, P27; Valle MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep37040; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3	31	13	13	2	9	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	MAR	2017	17	3								10.3390/s17030619			12	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	ER5CJ	WOS:000398818700192	28335461	Green Published, gold, Green Submitted			2022-02-06	
J	Zupan, B; Babbage, D; Neumann, D; Willer, B				Zupan, Barbra; Babbage, Duncan; Neumann, Dawn; Willer, Barry			Sex Differences in Emotion Recognition and Emotional Inferencing Following Severe Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						Emotion recognition; emotional inferencing; sex; traumatic brain injury	FACIAL AFFECT RECOGNITION; GENDER-DIFFERENCES; PERCEPTION DEFICITS; FEMALE ADVANTAGE; VOCAL AFFECT; EXPRESSIONS; MIND; IMPAIRMENTS; INTENSITY; RESPONSES	The primary objective of the current study was to determine if men and women with traumatic brain injury (TBI) differ in their emotion recognition and emotional inferencing abilities. In addition to overall accuracy, we explored whether differences were contingent upon the target emotion for each task, or upon high-and low-intensity facial and vocal emotion expressions. A total of 160 participants (116 men) with severe TBI completed three tasks - a task measuring facial emotion recognition (DANVA-Faces), vocal emotion recognition (DANVA-Voices) and one measuring emotional inferencing (emotional inference from stories test (EIST)). Results showed that women with TBI were significantly more accurate in their recognition of vocal emotion expressions and also for emotional inferencing. Further analyses of task performance showed that women were significantly better than men at recognising fearful facial expressions and also facial emotion expressions high in intensity. Women also displayed increased response accuracy for sad vocal expressions and low-intensity vocal emotion expressions. Analysis of the EIST task showed that women were more accurate than men at emotional inferencing in sad and fearful stories. A similar proportion of women and men with TBI were impaired (>= 2 SDs when compared to normative means) at facial emotion perception,x(2) = 1.45, p = 0.228, but a larger proportion of men was impaired at vocal emotion recognition, x(2) = 7.13, p = 0.008, and emotional inferencing, x(2) = 7.51, p = 0.006.	[Zupan, Barbra] Brock Univ, Dept Appl Linguist, St Catharines, ON L2S 3A1, Canada; [Babbage, Duncan] Auckland Univ Technol, Ctr Person Ctr Res, Auckland, New Zealand; [Babbage, Duncan] Auckland Univ Technol, Ctr EHealth, Auckland, New Zealand; [Neumann, Dawn] Indiana Univ, Rehabil Hosp Indiana, Sch Med, Dept Phys Med & Rehabil, Bloomington, IN 47405 USA; [Willer, Barry] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA		Zupan, B (corresponding author), Brock Univ, Dept Appl Linguist, St Catharines, ON L2S 3A1, Canada.	bzupan@brocku.ca		Babbage, Duncan/0000-0002-9259-9246; Barbra, Zupan/0000-0002-4603-333X	National Institute on Disability and Rehabilitation Research [H133G080043]	This work was supported by the National Institute on Disability and Rehabilitation Research (grant no. H133G080043).	Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Barrett LF, 2011, CURR DIR PSYCHOL SCI, V20, P286, DOI 10.1177/0963721411422522; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bonebright TL, 1996, SEX ROLES, V34, P429, DOI 10.1007/BF01547811; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Camarata S, 2006, INTELLIGENCE, V34, P231, DOI 10.1016/j.intell.2005.12.001; Campanella S, 2004, NEUROSCI LETT, V367, P14, DOI 10.1016/j.neulet.2004.05.097; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Collignon O, 2010, NEUROPSYCHOLOGIA, V48, P220, DOI 10.1016/j.neuropsychologia.2009.09.007; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Cunningham DW, 2009, J VISION, V9, DOI 10.1167/9.13.7; Duke M.P., 2008, MANUAL RECEPTIVE TES; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferstl EC, 2005, J COGNITIVE NEUROSCI, V17, P724, DOI 10.1162/0898929053747658; Frank MG, 2001, J PERS SOC PSYCHOL, V80, P75, DOI 10.1037/0022-3514.80.1.75; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Hampson E, 2006, EVOL HUM BEHAV, V27, P401, DOI 10.1016/j.evolhumbehav.2006.05.002; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Johnstone T, 2000, HDB EMOTIONS, P220, DOI DOI 10.1016/J.JML.2007.11.007; Keltner D., 2000, HDB EMOTIONS; Kessels RPC, 2014, J NEUROPSYCHOL, V8, P75, DOI 10.1111/jnp.12009; Killgore WDS, 2001, NEUROREPORT, V12, P427, DOI 10.1097/00001756-200102120-00047; Krach S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-9; LaBar KS, 2003, CEREB CORTEX, V13, P1023, DOI 10.1093/cercor/13.10.1023; Lee TMC, 2002, NEUROSCI LETT, V333, P13, DOI 10.1016/S0304-3940(02)00965-5; Li H, 2008, NEUROIMAGE, V40, P1921, DOI 10.1016/j.neuroimage.2008.01.033; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; Nalder E., 2016, ARCH PHYS MED REHA S, V2, P546; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Nowicki S, 1998, GENET SOC GEN PSYCH, V124, P39; NOWICKI S, 1993, J SOC PSYCHOL, V133, P749, DOI 10.1080/00224545.1993.9713934; NOWICKI S, 1994, THE JOURNAL OF GENET, V153, P385; Phillips ML, 2003, BRIT J PSYCHIAT, V182, P190, DOI 10.1192/bjp.182.3.190; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Rosip JC, 2004, J NONVERBAL BEHAV, V28, P267, DOI 10.1007/s10919-004-4159-6; Russell JA, 2003, ANNU REV PSYCHOL, V54, P329, DOI 10.1146/annurev.psych.54.101601.145102; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; Schirmer A, 2002, COGNITIVE BRAIN RES, V14, P228, DOI 10.1016/S0926-6410(02)00108-8; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Schultz J, 2009, EXP BRAIN RES, V194, P465, DOI 10.1007/s00221-009-1721-9; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Thayer JF, 2000, SCAND J PSYCHOL, V41, P243, DOI 10.1111/1467-9450.00193; Thompson AE, 2014, COGNITION EMOTION, V28, P1164, DOI 10.1080/02699931.2013.875889; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; WALLBOTT HG, 1986, J PERS SOC PSYCHOL, V51, P690, DOI 10.1037/0022-3514.51.4.690; Wildgruber D, 2002, NEUROIMAGE, V15, P856, DOI 10.1006/nimg.2001.0998; Yim J, 2013, BRAIN INJURY, V27, P1155, DOI 10.3109/02699052.2013.804203; Zupan B, 2015, BRAIN INJURY, V29, P877, DOI 10.3109/02699052.2015.1011233; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6; Zupan B, 2014, BRAIN INJURY, V28, P1087, DOI 10.3109/02699052.2014.901560; Zupan B, 2009, J COMMUN DISORD, V42, P1, DOI 10.1016/j.jcomdis.2008.06.001	64	13	13	0	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAR	2017	18	1					36	48		10.1017/BrImp.2016.22			13	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	EQ3SZ	WOS:000397994400004		Bronze, Green Submitted			2022-02-06	
J	Spitz, G; Alway, Y; Gould, KR; Ponsford, JL				Spitz, Gershon; Alway, Yvette; Gould, Kate Rachel; Ponsford, Jennie L.			Disrupted White Matter Microstructure and Mood Disorders after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						depression; DTI; mood; MRI; traumatic brain injury	PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; MRI FINDINGS; DIAGNOSIS; ANXIETY; ATLAS	Traumatic brain injury (TBI) is associated with an elevated frequency of mood disorders that may, in part, be explained by changes in white-matter microstructure. This study is the first to examine the relationship between mood disorders and white-matter pathology in a sample of patients with mild to severe TBI using a standardized psychiatric interview. This study reports on a sub-sample of 29 individuals recruited from a large prospective study that examined the evolution of psychiatric disorders following complicated, mild to severe TBI. Individuals with TBI were also compared with 23 healthy control participants. Individuals were invited to complete the Structured Clinical Interview for DSM-IV Disorders (SCID) to diagnose psychiatric disorders. Participants who developed a mood disorder within the first 3 years were categorized into a TBI-Mood group. Diffusion tensor tractography assessed white matter microstructure using atlas-based tractaveraged and along-tract approaches. Fractional anisotropy (FA) was used as the measure of white-matter microstructure. TBI participants with and without a mood disorder did not differ in regard to injury severity and other background factors. Nevertheless, TBI participants diagnosed with a mood disorder displayed significantly lower tract-averaged FA values for the right arcuate fasciculus (p = 0.011), right inferior longitudinal fasciculus (p = 0.009), and anterior segments I (p = 0.0004) and II (p = 0.007) of the corpus callosum, as well as the left (p = 0.014) and right (p = 0.015) fronto-occipital longitudinal fasciculi. The pattern of white matter disruption identified in the current study provides further support for a neurobiological basis of post-TBI mood disorders. Greater understanding of individuals' underlying neuropathology may enable better characterization and prediction of mood disorders. Integration of neuropathology may also inform the potential efficacy of pharmacological and psychological interventions.	[Spitz, Gershon] Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic 3168, Australia; Epworth HealthCare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Spitz, G (corresponding author), Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic 3168, Australia.	Gershon.Spitz@monash.edu	Gould, Kate Rachel/AAA-5511-2020; Spitz, Gershon/H-7755-2014	Gould, Kate Rachel/0000-0002-3564-7408; Spitz, Gershon/0000-0002-7810-1480			aan het Rot M, 2009, CAN MED ASSOC J, V180, P305, DOI 10.1503/cmaj.080697; Alway Y., 2016, PSYCHOL MED, P1; Alway Y, 2012, NEUROPSYCHOL REHABIL, V22, P374, DOI 10.1080/09602011.2011.648757; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Beck AT, 1979, COGNITIVE THERAPY EM; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Colby JB, 2012, NEUROIMAGE, V59, P3227, DOI 10.1016/j.neuroimage.2011.11.004; Deprez S, 2013, BRAIN IMAGING BEHAV, V7, P409, DOI 10.1007/s11682-012-9220-1; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Gibbon M., 1997, USERS GUIDE STRUCTUR; Godsil BP, 2013, EUR NEUROPSYCHOPHARM, V23, P1165, DOI 10.1016/j.euroneuro.2012.10.018; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Han K, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00231; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koponen S, 2006, PSYCHIAT RES-NEUROIM, V146, P263, DOI 10.1016/j.pscychresns.2005.05.015; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lee Bruce, 2005, NeuroRx, V2, P372; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Maller JJ, 2014, BEHAV BRAIN RES, V271, P147, DOI 10.1016/j.bbr.2014.05.047; Maller JJ, 2014, HUM BRAIN MAPP, V35, P227, DOI 10.1002/hbm.22171; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Rao V, 2012, J NEUROPSYCH CLIN N, V24, P309, DOI 10.1176/appi.neuropsych.11080188; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Schonberger M, 2011, BRAIN INJURY, V25, P543, DOI 10.3109/02699052.2011.565013; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; StataCorp, 2015, STAT STAT SOFTW REL; Tax CMW, 2014, NEUROIMAGE, V86, P67, DOI 10.1016/j.neuroimage.2013.07.067; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	59	13	13	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					807	815		10.1089/neu.2016.4527			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200007	27550509				2022-02-06	
J	Wang, Y; Wei, YL; Oguntayo, S; Wilder, D; Tong, L; Su, Y; Gist, I; Arun, P; Long, JB				Wang, Ying; Wei, Yanling; Oguntayo, Samuel; Wilder, Donna; Tong, Lawrence; Su, Yan; Gist, Irene; Arun, Peethambaran; Long, Joseph B.			Cerebrospinal Fluid Chemokine (C-C Motif) Ligand 2 Is an Early-Response Biomarker for Blast-Overpressure-Wave-Induced Neurotrauma in Rats	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; blast-induced neurotrauma; CCL2; cerebrospinal fluid; chemokines	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; SERVICE MEMBERS; INFLAMMATION; CCL2; PROTEIN; EXPRESSION; MODEL; MCP-1; PAIN	Chemokines and their receptors are of great interest within the milieu of immune responses elicited in the central nervous system in response to trauma. Chemokine (C-C motif)) ligand 2 (CCL2), which is also known as monocyte chemotactic protein-1, has been implicated in the pathogenesis of traumatic brain injury (TBI), brain ischemia, Alzheimer's disease, and other neurodegenerative diseases. In this study, we investigated the time course of CCL2 accumulation in cerebrospinal fluid (CSF) after exposures to single and repeated blast overpressures of varied intensities along with the neuropathological changes and motor deficits resulting from these blast conditions. Significantly increased concentrations of CCL2 in CSF were evident by 1 h of blast exposure and persisted over 24 h with peak levels measured at 6 h post-injury. The increased levels of CCL2 in CSF corresponded with both the number and intensities of blast overpressure and were also commensurate with the extent of neuromotor impairment and neuropathological abnormalities resulting from these exposures. CCL2 levels in CSF and plasma were tightly correlated with levels of CCL2 messenger RNA in cerebellum, the brain region most consistently neuropathologically disrupted by blast. In view of the roles of CCL2 that have been implicated in multiple neurodegenerative disorders, it is likely that the sustained high levels of CCL2 and the increased expression of its main receptor, CCR2, in the brain after blast may similarly contribute to neurodegenerative processes after blast exposure. In addition, the markedly elevated concentration of CCL2 in CSF might be a candidate early-response biomarker for diagnosis and prognosis of blast-induced TBI.	[Wang, Ying; Wei, Yanling; Oguntayo, Samuel; Wilder, Donna; Tong, Lawrence; Su, Yan; Gist, Irene; Arun, Peethambaran; Long, Joseph B.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA		Wang, Y (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	ying.wang5.ctr@mail.mil; joseph.b.long.civ@mail.mil			Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-11-2-0127, W81-XWH-08-2-0018, W81XWH-08-2-0017]	We thank Dr. James DeMar for useful manuscript corrections and comments and Dr. Yuanzhang Li for valuable suggestions regarding data analysis. Technical guidance and assistance from Stephen VanAlbert and Andrea Edwards are also gratefully acknowledged. This work was supported by Congressionally Directed Medical Research Program awards W81XWH-11-2-0127, W81-XWH-08-2-0018, and W81XWH-08-2-0017. The contents, opinions, and assertions contained herein are private views of the authors and are not to be construed as official or reflecting the views of the Department of the Army or the Department of Defense.	Agoston D.V., 2015, BRAIN NEUROTRAUMA MO; Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Chabok SY, 2012, J TRAUMA ACUTE CARE, V72, P1654, DOI 10.1097/TA.0b013e318246887e; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Czaja AJ, 2014, ALIMENT PHARM THER, V40, P261, DOI 10.1111/apt.12825; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Di Pietro V, 2015, NEUROCHEM RES, V40, P991, DOI 10.1007/s11064-015-1554-9; Fabene PF, 2010, J NEUROIMMUNOL, V224, P22, DOI 10.1016/j.jneuroim.2010.05.016; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Graber DJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0298-4; Hackel D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063564; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Ho L, 2012, J ALZHEIMERS DIS, V31, P301, DOI 10.3233/JAD-2012-120598; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kiyota T, 2013, NEUROBIOL AGING, V34, P1060, DOI 10.1016/j.neurobiolaging.2012.08.009; Kiyota T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006197; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Locatelli D, 2012, J BIOL CHEM, V287, P25782, DOI 10.1074/jbc.M112.362830; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Madrigal JLM, 2014, ADV EXP MED BIOL, V824, P209, DOI 10.1007/978-3-319-07320-0_15; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Obermuller N, 2014, INT UROL NEPHROL, V46, P1, DOI 10.1007/s11255-013-0448-5; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Proudfoot AEI, 2008, J NEUROIMMUNOL, V198, P27, DOI 10.1016/j.jneuroim.2008.04.007; Quick ML, 2012, AM J PHYSIOL-REG I, V303, pR580, DOI 10.1152/ajpregu.00240.2012; Rhodes JKJ, 2009, J NEUROTRAUM, V26, P507, DOI 10.1089/neu.2008.0686; Rosito M, 2012, J NEUROSCI, V32, P3154, DOI 10.1523/JNEUROSCI.4046-11.2012; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; SOZZANI S, 1994, J IMMUNOL, V152, P3615; Stratton KJ, 2014, J PAIN, V15, P1023, DOI 10.1016/j.jpain.2014.07.002; Tanuma N, 2006, ACTA NEUROPATHOL, V112, P195, DOI 10.1007/s00401-006-0083-7; Toyama Yoshihiro, 2005, Radiat Med, V23, P309; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Van Steenwinckel J, 2011, J NEUROSCI, V31, P5865, DOI 10.1523/JNEUROSCI.5986-10.2011; Wang Y, 2014, J NEUROTRAUM, V31, P498, DOI [10.1089/NEU.2013.3074, 10.1089/neu.2013.3074]; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Yamamoto M, 2005, AM J PATHOL, V166, P1475, DOI 10.1016/S0002-9440(10)62364-4; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	64	13	13	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					952	962		10.1089/neu.2016.4465			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200023	27487732				2022-02-06	
J	Hogeveen, J; Hauner, KK; Chau, A; Krueger, F; Grafman, J				Hogeveen, Jeremy; Hauner, Katherina K.; Chau, Aileen; Krueger, Frank; Grafman, Jordan			Impaired Valuation Leads to Increased Apathy Following Ventromedial Prefrontal Cortex Damage	CEREBRAL CORTEX			English	Article						apathy; stimulus valuation; traumatic brain injury; ventromedial prefrontal cortex; voxel-based lesion-symptom mapping	TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE DAMAGE; ORBITOFRONTAL CORTEX; DECISION-MAKING; CHOICE; HUMANS; INTELLIGENCE; MODULATION; CONFIDENCE; JUDGMENT	Apathy is defined by reduced goal-directed behavior, and is common in patients with damage to the ventromedial prefrontal cortex (vmPFC). Separately, in neuroeconomics research, the vmPFC has been shown to play a role in reward processingnamely, in "stimulus valuation," or the computation of the subjective reward value of a stimulus. Here, we used a sample of patients with focal brain lesions (N = 93) and matched healthy controls (N = 21) to determine whether the association between vmPFC damage and increased apathy is driven by impaired valuation. An auction task was used to measure valuation, and apathy was assessed via caregiver ratings of patients' day-to-day behavior. Lesion-symptom mapping identified the locus of impaired valuation in the vmPFC, and patients with damage to this region demonstrated increased apathy relative to patients with damage to dorsomedial prefrontal cortex (dmPFC), patients with damage to other brain regions, and healthy controls. Critically, the association between vmPFC damage and apathywas mediated by impaired valuation, with no effect as a function of dmPFC damage. Our results implicate a valuation-based mechanism underlying the relationship between vmPFC integrity and apathy, bridging findings from both the clinical literature and neuroeconomics research.	[Hogeveen, Jeremy; Hauner, Katherina K.; Chau, Aileen; Grafman, Jordan] Rehabil Inst Chicago, Cognit Neurosci Lab, 345 East Super St, Chicago, IL 60611 USA; [Hogeveen, Jeremy; Hauner, Katherina K.; Grafman, Jordan] George Mason Univ, Dept Phys Med & Rehabil, Fairfax, VA 22030 USA; [Hauner, Katherina K.; Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA		Hogeveen, J (corresponding author), Rehabil Inst Chicago, Cognit Neurosci Lab, 345 East Super St, Chicago, IL 60611 USA.	jeremy.hogeveen@northwestern.edu		Hogeveen, Jeremy/0000-0001-9612-2085	Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12 HS023011]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS023011] Funding Source: NIH RePORTER	K.K.H. is supported by the Agency for Healthcare Research and Quality (K12 HS023011).	Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Camille N, 2011, J NEUROSCI, V31, P15048, DOI 10.1523/JNEUROSCI.3164-11.2011; Camille N, 2011, J NEUROSCI, V31, P7527, DOI 10.1523/JNEUROSCI.6527-10.2011; Camus M, 2009, EUR J NEUROSCI, V30, P1980, DOI 10.1111/j.1460-9568.2009.06991.x; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Clithero JA, 2014, SOC COGN AFFECT NEUR, V9, P1289, DOI 10.1093/scan/nst106; Coussons-Read ME, 2012, BRAIN BEHAV IMMUN, V26, P650, DOI 10.1016/j.bbi.2012.02.009; De Coster L, 2013, COGN AFFECT BEHAV NE, V13, P519, DOI 10.3758/s13415-013-0168-4; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176; Fellows LK, 2011, ANN NY ACAD SCI, V1239, P51, DOI 10.1111/j.1749-6632.2011.06229.x; Fellows LK, 2005, NEUROPSYCHOLOGIA, V43, P1214, DOI 10.1016/j.neuropsychologia.2004.07.018; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; Glimcher PW, 2005, GAME ECON BEHAV, V52, P213, DOI 10.1016/j.geb.2004.06.011; Grace J, 2001, FRSBE FRONTAL SYSTEM; Gray J.M, 1994, CLIN REHABIL, V8, P188, DOI [10.1177/026921559400800302, DOI 10.1177/026921559400800302, DOI 10.1080/09602010902949207]; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hayes A. F., 2008, INTRO MEDIATION MODE; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Hayes AF, 2013, PSYCHOL SCI, V24, P1918, DOI 10.1177/0956797613480187; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kirk U, 2011, P NATL ACAD SCI USA, V108, P10332, DOI 10.1073/pnas.1019332108; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Koenigs M, 2008, J NEUROSCI, V28, P12341, DOI 10.1523/JNEUROSCI.2324-08.2008; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Krueger F, 2009, P NATL ACAD SCI USA, V106, P22486, DOI 10.1073/pnas.0912568106; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lawrence AD, 2011, SOC NEUROSCI-UK, V6, P653, DOI 10.1080/17470919.2011.556821; Leopold A, 2012, SOC COGN AFFECT NEUR, V7, P871, DOI 10.1093/scan/nsr071; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Markus HR, 2010, J CONSUM RES, V37, P344, DOI 10.1086/651242; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Murphy KJ., 2000, NEUROPSYCHOLOGY EMOT, P340; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Pardini M, 2010, NEUROLOGY, V74, P749, DOI 10.1212/WNL.0b013e3181d25b6b; Peters F, 2006, DEMENT GERIATR COGN, V21, P373, DOI 10.1159/000091898; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Rangel A., 2014, NEUROECONOMICS, P125, DOI [10.1016/B978-0-12-416008-8.00008-5, DOI 10.1016/B978-0-12-416008-8.00008-5, 10 .1016/B978-0-12-416008-8.00008-5]; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Regenwetter M, 2011, PSYCHOL REV, V118, P42, DOI 10.1037/a0021150; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vorauer JD, 2009, PSYCHOL SCI, V20, P838, DOI 10.1111/j.1467-9280.2009.02369.x; Wunderlich K, 2010, P NATL ACAD SCI USA, V107, P15005, DOI 10.1073/pnas.1002258107	53	13	13	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	FEB	2017	27	2					1401	1408		10.1093/cercor/bhv317			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EP3BN	WOS:000397257600040	26740488	Bronze			2022-02-06	
J	Ilie, G; Mann, RE; Boak, A; Hamilton, HA; Rehm, J; Cusimano, MD				Ilie, Gabriela; Mann, Robert E.; Boak, Angela; Hamilton, Hayley A.; Rehm, Juergen; Cusimano, Michael D.			Possession of weapon and school violence among adolescents and their association with history of traumatic brain injury, substance use and mental health issues	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article							CLASSIFICATION; SYSTEM	Purpose: Assessment of the association between illegal possession of weapon and assault on school property among adolescents with and without a history of traumatic brain injury (TBI) while assessing risk factors for these outcomes. Methods: Data were derived from the Centre for Addiction and Mental Health's 2013 Ontario Student Drug Use and Health Survey completed by students in grades 7-12 (ages 11-20). Results: In this sample of 5478 adolescents, 6.1% (95% CI: 5.0, 7.4) reported carrying a weapon (e. g., gun or knife) on school property, 10.8% (95% CI: 9.5, 12.3) were engaged in a physical fight and 6.4% (95% CI: 5.4, 7.6) reported having beat up or hurt someone on purpose at school, during last year. Youth who reported carrying a weapon, who were engaged in a physical fight and those who assaulted peers on school property during last year had statistically significantly higher odds of reporting a history of TBIs, being male, in first years of high-school, scored positive for elevated psychological distress, and were current regular alcohol (weapon possession only) and cannabis users. Conclusion: Previously it was thought that alcohol and drugs were the main contributors to school violence. Here we show that history of TBIs is yet another significant predictor of violence at school among adolescents. The results suggest that school vigilance and combined violence and TBI prevention, treatment and rehabilitation programs in this population are warranted. (C) 2016 Elsevier Ltd. All rights reserved.	[Ilie, Gabriela] Dalhousie Univ, Fac Med, 5790 Univ Ave, Halifax, NS, Canada; [Ilie, Gabriela; Mann, Robert E.; Boak, Angela; Hamilton, Hayley A.; Rehm, Juergen] Social & Epidemiol Res Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Mann, Robert E.; Hamilton, Hayley A.; Rehm, Juergen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cusimano, Michael D.] St Michaels Hosp, Dept Neurosurg, Toronto, ON, Canada		Ilie, G (corresponding author), Dalhousie Univ, Fac Med, 5790 Univ Ave, Halifax, NS, Canada.	Gabriela.Ilie@dal.ca	Cusimano, Michael/X-4059-2019; Ilie, Gabriela/AAM-9122-2021		STAIR Team Grant from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation; Natural Sciences and Engineering Research CouncilNatural Sciences and Engineering Research Council of Canada (NSERC); Social Sciences and Humanities Research CouncilSocial Sciences and Humanities Research Council of Canada (SSHRC); Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario; Industry Canada;  [AUTO21]	This work was financially supported by a STAIR Team Grant from the Canadian Institutes of Health Research (#TIR-103946) and by the Ontario Neurotrauma Foundation. Additional funding was obtained from a grant from AUTO21, a member of the Networks of Centres of Excellence program that is administered and funded by the Natural Sciences and Engineering Research Council, the Social Sciences and Humanities Research Council, in partnership with Industry Canada, and ongoing funding support from the Ontario Ministry of Health and Long-Term Care.	[Anonymous], 2001, MMWR-MORBID MORTAL W, V60, P1337; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Benedict A., 2013, COMMUNICATION; Boak A, 2013, CAMH RES DOCUMENT SE, V38; Butterworth P, 2004, J CLIN EPIDEMIOL, V57, P742, DOI 10.1016/j.jclinepi.2003.10.015; Cantu RC, 2001, J ATHL TRAINING, V36, P244; CDC, 2014, 1991 2013 HIGH SCH Y; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Courser MW, 2009, EVALUATION REV, V33, P370, DOI 10.1177/0193841X09337228; Dicker BG, 1989, HEAD TRAUMA REHABIL, V4, P73; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Frances A, DSM 4 CLASSIFICATION; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hux D, 1998, BRAIN INJURY, V12, P667; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Korn E.L., 1999, ANAL HLTH SURVEYS; Kuipers P, 2000, J HEAD TRAUMA REHAB, V15, P1275, DOI 10.1097/00001199-200012000-00007; Lowry R, 1999, J SCHOOL HEALTH, V69, P347, DOI 10.1111/j.1746-1561.1999.tb06427.x; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mitka M, 2012, JAMA-J AM MED ASSOC, V308, P2327, DOI 10.1001/jama.2012.111345; Office of National Drug Control Policy, 2007, TEENS DRUGS VIOL SPE; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Paglia-Boak A, 2013, CAMH RES DOCUMENT SE, V36; Reid Robert J, 2006, J Prim Prev, V27, P281, DOI 10.1007/s10935-006-0035-y; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; West BT, 2008, STATA J, V8, P520, DOI 10.1177/1536867X0800800404	35	13	13	0	17	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	FEB	2017	48	2					285	292		10.1016/j.injury.2016.09.030			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EO8BO	WOS:000396914100012	27955825				2022-02-06	
J	Mihalik, JP; Lynall, RC; Wasserman, EB; Guskiewicz, KM; Marshall, SW				Mihalik, Jason P.; Lynall, Robert C.; Wasserman, Erin B.; Guskiewicz, Kevin M.; Marshall, Stephen W.			Evaluating the "Threshold Theory": Can Head Impact Indicators Help?	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						BIOMECHANICS; BRAIN INJURY; CONCUSSION; SPORT INJURY	COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL FOOTBALL; TRAUMATIC BRAIN-INJURY; YOUTH ICE HOCKEY; CONCUSSION; BIOMECHANICS; SEVERITY; VALIDATION; EXPOSURE; HELMETS	Purpose: This study aimed to determine the clinical utility of biomechanical head impact indicators by measuring the sensitivity, specificity, positive predictive value (PV+), and negative predictive value (PV-) of multiple thresholds. Methods: Head impact biomechanics (n = 283,348) from 185 football players in one Division I program were collected. A multidisciplinary clinical team independently made concussion diagnoses (n = 24). We dichotomized each impact using diagnosis (yes = 24, no = 283,324) and across a range of plausible impact indicator thresholds (10g increments beginning with a resultant linear head acceleration of 50g and ending with 120g). Results: Some thresholds had adequate sensitivity, specificity, and PV-. All thresholds had low PV+, with the best recorded PV+ less than 0.4% when accounting for all head impacts sustained by our sample. Even when conservatively adjusting the frequency of diagnosed concussions by a factor of 5 to account for unreported/undiagnosed injuries, the PV+ of head impact indicators at any threshold was no greater than 1.94%. Conclusions: Although specificity and PV- appear high, the low PV+ would generate many unnecessary evaluations if these indicators were the sole diagnostic criteria. The clinical diagnostic value of head impact indicators is considerably questioned by these data. Notwithstanding, valid sensor technologies continue to offer objective data that have been used to improve player safety and reduce injury risk.	[Mihalik, Jason P.; Lynall, Robert C.; Wasserman, Erin B.; Guskiewicz, Kevin M.; Marshall, Stephen W.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Mihalik, Jason P.; Lynall, Robert C.; Guskiewicz, Kevin M.] Univ N Carolina, Curriculum Human Movement Sci, Dept Allied Hlth Sci, Sch Med, Chapel Hill, NC USA; [Mihalik, Jason P.; Guskiewicz, Kevin M.; Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Lynall, Robert C.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Wasserman, Erin B.] Datalys Ctr, Indianapolis, IN USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA		Mihalik, JP (corresponding author), 2201 Stallings Evans Sports Med Complex, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640; Wasserman, Erin/0000-0001-5957-5878	National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (Atlanta, GA)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000196]; National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000196] Funding Source: NIH RePORTER	Funding was provided in part by the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (Atlanta, GA; R49/CE000196) and the National Operating Committee on Standards for Athletic Equipment (Overland Park, KS). The results and opinions expressed herein are those of the authors and do not constitute endorsement by the American College of Sports Medicine, the Centers for Disease Control and Prevention, or the National Operating Committee on Standards for Athletic Equipment.	Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Mihalik JP, 2008, P I MECH ENG P-J SPO, V222, P45, DOI 10.1243/17543371JSET4; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2014, AM SOC TEST MATER, V1552, P41, DOI 10.1520/STP155220120108; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Portney LG, 2000, FDN CLIN RES APPL PR, Vxiv, P752; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Rothman KJ, 2012, EPIDEMIOLOGY INTRO, P282; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	31	13	13	0	27	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	FEB	2017	49	2					247	253		10.1249/MSS.0000000000001089			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EI3SN	WOS:000392411700004	27580157				2022-02-06	
J	Moreno-Lopez, L; Manktelow, AE; Sahakian, BJ; Menon, DK; Stamatakis, EA				Moreno-Lopez, Laura; Manktelow, Anne E.; Sahakian, Barbara J.; Menon, David K.; Stamatakis, Emmanuel A.			Anything goes? Regulation of the neural processes underlying response inhibition in TBI patients	EUROPEAN NEUROPSYCHOPHARMACOLOGY			English	Article						Traumatic brain injury; Response inhibition; Functional connectivity; Methylphenidate	TRAUMATIC BRAIN-INJURY; DEFAULT MODE NETWORK; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; STATE FUNCTIONAL CONNECTIVITY; STRUCTURAL CONNECTIVITY; PATTERN-CLASSIFICATION; SALIENCE NETWORK; WORKING-MEMORY; RESTING BRAIN; METHYLPHENIDATE	Despite evidence for beneficial use of methylphenidate in response inhibition, no studies so far have investigated the effects of this drug in the neurobiology of inhibitory control in traumatic brain injury (TBI), even though impulsive behaviours are frequently reported in this patient group. We investigated the neural basis of response inhibition in a group of TBI patients using functional magnetic resonance imaging and a stop-signal paradigm. In a randomised double blinded crossover study, the patients received either a single 30 mg dose of methylphenidate or placebo and performed the stop-signal task. Activation in the right inferior frontal gyrus (RIFG), an area associated with response inhibition, was significantly lower in patients compared to healthy controls. Poor response inhibition in this group was associated with greater connectivity between the RIFG and a set of regions considered to be part of the default mode network (DMN), a finding that suggests the interplay between DMN and frontal executive networks maybe compromised. A single dose of methylphenidate rendered activity and connectivity profiles of the patients RIFG near normal. The results of this study indicate that the neural circuitry involved in response inhibition in TBI patients may be partially restored with methylphenidate. Given the known mechanisms of action of methylphenidate, the effect we observed may be due to increased dopamine and noradrenaline levels. (C) 2016 Elsevier B.V. and ECNP. All rights reserved.	[Moreno-Lopez, Laura; Manktelow, Anne E.; Menon, David K.; Stamatakis, Emmanuel A.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Box 93,Hills Rd, Cambridge CB2 0QQ, England; [Sahakian, Barbara J.] Univ Cambridge, Dept Psychiat, Herchel Smith Bldg Brain & Mind Sci,Forvie Site, Cambridge CB2 0SZ, England; [Sahakian, Barbara J.] Univ Cambridge, MRC Wellcome Trust Behav, Cambridge CB2 3EB, England; [Sahakian, Barbara J.] Univ Cambridge, Clin Neurosci Inst, Cambridge CB2 3EB, England		Moreno-Lopez, L (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Box 93,Hills Rd, Cambridge CB2 0QQ, England.	lm618@cam.ac.uk	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601	Evelyn Trust [06/20]; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish	The study was funded by the Evelyn Trust - Grant no. 06/20. The Evelyn Trust had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	An L, 2013, NEUROPSYCHOPHARMACOL, V38, P1287, DOI 10.1038/npp.2013.27; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Aron AR, 2003, BIOL PSYCHIAT, V54, P1465, DOI 10.1016/S0006-3223(03)00609-7; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chamberlain SR, 2007, BIOL PSYCHIAT, V62, P977, DOI 10.1016/j.biopsych.2007.03.003; Chamberlain SR, 2011, J ALZHEIMERS DIS, V24, P125, DOI 10.3233/JAD-2010-100450; Chamberlain SR, 2009, BIOL PSYCHIAT, V65, P550, DOI 10.1016/j.biopsych.2008.10.014; Chen AC, 2013, P NATL ACAD SCI USA, V110, P19944, DOI 10.1073/pnas.1311772110; Costa A, 2013, CEREB CORTEX, V23, P1179, DOI 10.1093/cercor/bhs107; FARAJ BA, 1974, J PHARMACOL EXP THER, V191, P535; Fassbender C, 2009, BRAIN RES, V1273, P114, DOI 10.1016/j.brainres.2009.02.070; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gao W, 2012, HUM BRAIN MAPP, V33, P192, DOI 10.1002/hbm.21204; Gardani M, 2015, ARCH PHYS MED REHAB, V96, P1691, DOI 10.1016/j.apmr.2015.05.006; Ghahremani DG, 2012, J NEUROSCI, V32, P7316, DOI 10.1523/JNEUROSCI.4284-11.2012; Gilbert DL, 2006, NEUROPSYCHOPHARMACOL, V31, P442, DOI 10.1038/sj.npp.1300806; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Liddle EB, 2011, J CHILD PSYCHOL PSYC, V52, P761, DOI 10.1111/j.1469-7610.2010.02333.x; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; Marquand AF, 2011, NEUROPSYCHOPHARMACOL, V36, P1237, DOI 10.1038/npp.2011.9; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Pauls AM, 2012, BIOL PSYCHIAT, V72, P142, DOI 10.1016/j.biopsych.2012.03.028; Peterson BS, 2009, AM J PSYCHIAT, V166, P1286, DOI 10.1176/appi.ajp.2009.08050724; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Rubia K, 2007, HUM BRAIN MAPP, V28, P1163, DOI 10.1002/hbm.20347; Rubia K, 2014, BIOL PSYCHIAT, V76, P616, DOI 10.1016/j.biopsych.2013.10.016; Sagaspe P, 2007, J SLEEP RES, V16, P381, DOI 10.1111/j.1365-2869.2007.00607.x; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Silk T. J., 2016, BRAIN IMAGI IN PRESS; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sripada CS, 2013, NEUROIMAGE, V81, P213, DOI 10.1016/j.neuroimage.2013.05.016; Stamatakis EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014496; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; TEASDALE G, 1974, LANCET, V2, P81; Tomasi D, 2011, NEUROIMAGE, V54, P3101, DOI 10.1016/j.neuroimage.2010.10.060; van Rooij D, 2015, NEUROIMAGE-CLIN, V7, P325, DOI 10.1016/j.nicl.2015.01.004; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Vink M, 2005, HUM BRAIN MAPP, V25, P336, DOI 10.1002/hbm.20111; Ward B. D., 2000, SIMULTANEOUS INFEREN; Wen XT, 2013, J NEUROSCI, V33, P6444, DOI 10.1523/JNEUROSCI.4939-12.2013; Zhang S, 2012, HUM BRAIN MAPP, V33, P89, DOI 10.1002/hbm.21197	62	13	13	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-977X	1873-7862		EUR NEUROPSYCHOPHARM	Eur. Neuropsychopharmacol.	FEB	2017	27	2					159	169		10.1016/j.euroneuro.2016.12.002			11	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	EL1RU	WOS:000394399500006	28012706	Green Submitted			2022-02-06	
J	Zaninotto, AL; Vicentini, JE; Solla, DJF; Silva, TT; Guirado, VMD; Feltrin, F; de Lucia, MCS; Teixeira, MJ; Paiva, WS				Zaninotto, Ana Luiza; Vicentini, Jessica Elias; Fontoura Solla, Davi Jorge; Silva, Tatiana Tateishi; de Paula Guirado, Vinicius Monteiro; Feltrin, Fabricio; Souza de Lucia, Mara Cristina; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva			Visuospatial memory improvement in patients with diffuse axonal injury (DAI): a 1-year follow-up study	ACTA NEUROPSYCHIATRICA			English	Article						cognition; improvement; progmostic; traumatic brain injury; visuospatial memory	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; CLOSED-HEAD INJURY; REHABILITATION; MODERATE; DISABILITY; TBI; CONSEQUENCES; PERFORMANCE; DEPRESSION	Objective Diffuse axonal injury (DAI) is prevalent in traumatic brain injury (TBI), and is often associated with poor outcomes and cognitive impairment, including memory deficits. Few studies have explored visual memory after TBI and its relationship to executive functioning. Executive functioning is crucial for remembering an object's location, operating devices, driving, and route finding. We compared visual memory performance via the Rey-Osterrieth Complex Figure (ROCF) test 6 and 12 months after DAI. Method In total, 40 patients (mean age 28.7 years; 87.5% male) with moderate-to-severe DAI following a road traffic accident completed the 1-year follow-up. There was a three-phase prospective assessment. In phase 1 (1-3 months after trauma), patients completed the Beck Depression Inventory (BDI) and State-Trait Anxiety Inventory (STAI). In phases 2 (6 months) and 3 (12 months), they completed the BDI, STAI, and a neuropsychological battery [ROCF copy and recall, digit span forward/backward, Grooved Pegboard test, intelligence quotient (IQ) by Wechsler Adult Intelligence Scale-III (WAIS-III)]. Results There was an improvement in ROCF recall over time (p=0.013), but not ROCF copy (p=0.657).There was no change in executive function (Savage scores) copy (p=0.230) or recall (p=0.155). Age, years of education, severity of the trauma, and IQ did not influence ROCF recall improvement. Conclusion There are time-dependent improvements in visual memory in patients with DAI. Neuroplasticity in the 1st months after trauma provides an opportunity for visuospatial memory learning. The present findings may be useful to formulate management plans for long-term TBI rehabilitation.	[Zaninotto, Ana Luiza; Vicentini, Jessica Elias; Silva, Tatiana Tateishi; Souza de Lucia, Mara Cristina] Univ Sao Paulo, Div Psychol, Clin Hosp, Sch Med, Sao Paulo, Brazil; [Zaninotto, Ana Luiza; Fontoura Solla, Davi Jorge; de Paula Guirado, Vinicius Monteiro; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Div Neurosurg, Clin Hosp, Sch Med, Sao Paulo, Brazil; [Feltrin, Fabricio] Univ Sao Paulo, Inst Radiol, Clin Hosp, Sch Med, Sao Paulo, Brazil		Paiva, WS (corresponding author), 255 Eneas de Carvalho Aguiar St,Off 4079, BR-05403010 Sao Paulo, SP, Brazil.	wellingsonpaiva@yahoo.com.br	Zaninotto, Ana Luiza C./I-4095-2016; de Paula Guirado, Vinicius Monteiro/AAG-7299-2019; Vicentini, Jessica/E-5692-2014; Paiva, Wellingson S/G-5517-2013; Solla, Davi/E-6988-2013	Zaninotto, Ana Luiza C./0000-0003-0639-0612; de Paula Guirado, Vinicius Monteiro/0000-0002-7782-3609; Paiva, Wellingson S/0000-0002-5165-7040; Solla, Davi/0000-0002-5092-6595			Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Andrade L., 1998, REV PSIQUIATRIA CLIN, V25, P245; Ariza M, 2006, BRAIN INJURY, V20, P1053, DOI 10.1080/02699050600909862; Ashton VL, 2005, J CLIN EXP NEUROPSYC, V27, P55, DOI 10.1080/138033990513636; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Costa TL, 2015, NEUROPSYCHOLOGIA, V78, P142, DOI 10.1016/j.neuropsychologia.2015.10.008; Coutinho ACAM, 2010, AVAL PSICOL, V9, P25; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Gorenstein C, 1996, BRAZ J MED BIOL RES, V29, P453; Greenwald BD, 2015, J NEUROTRAUM, V32, P1883, DOI 10.1089/neu.2014.3454; Herrera-Melero MC, 2015, BRAIN INJURY, V29, P1439, DOI 10.3109/02699052.2015.1071428; Imai M F, 1996, Rev Esc Enferm USP, V30, P116; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Kraus J F, 1993, EPIDEMIOLOGY HEAD IN; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Lee JH, 2003, J CLIN EXP NEUROPSYC, V25, P594, DOI 10.1076/jcen.25.5.594.14582; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Levine AJ, 2004, CLIN NEUROPSYCHOL, V18, P373, DOI 10.1080/1385404049052420; MAPOU R, 2013, HDB HEAD TRAUMA EARL; Matthews CG., 1964, INSTRUCTION MANUAL A; McArthur DL, 2004, BRAIN PATHOL, V14, P185, DOI 10.1111/j.1750-3639.2004.tb00052.x; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; OSTERRIETH P, 1944, ARCH PSYCHOL, V1, P1021; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Pappert E.J., 1999, TXB CLIN NEUROLOGY; REY A, 2010, FIGURASCOMPLEXAS REY; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Ringe WK, 2002, ASSESSMENT, V9, P254, DOI 10.1177/1073191102009003004; Savage CR, 1999, BIOL PSYCHIAT, V45, P905, DOI 10.1016/S0006-3223(98)00278-9; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Shum DHK, 2000, J CLIN EXP NEUROPSYC, V22, P25, DOI 10.1076/1380-3395(200002)22:1;1-8;FT025; Sozda CN, 2014, NEUROPSYCHOLOGY, V28, P347, DOI 10.1037/neu0000043; SPIELBERG CD, 1970, TESTMANUAL STATE TRA; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; TOMBAUGH TN, 1992, J CLIN EXP NEUROPSYC, V14, P647, DOI 10.1080/01688639208402853; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Weschler D., 1997, WESCHLER ADULT INTEL; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; ZANINOTTO AL, CLIN TRIAL TRAUMATIC; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	51	13	14	0	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1601-5215			ACTA NEUROPSYCHIATR	Acta Neuropsychiatr.	FEB	2017	29	1					35	42		10.1017/neu.2016.29			8	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	EK1AC	WOS:000393657200004	27725006				2022-02-06	
J	Yin, XJ; Chen, ZY; Zhu, XN; Hu, JJ				Yin, Xiang-Jie; Chen, Zhen-Yan; Zhu, Xiao-Na; Hu, Jin-Jia			Loss of PAFR prevents neuroinflammation and brain dysfunction after traumatic brain injury	SCIENTIFIC REPORTS			English	Article							PLATELET-ACTIVATING-FACTOR; DENDRITIC SPINES; COGNITIVE IMPAIRMENT; RECEPTOR ANTAGONISM; MEMORY; INFLAMMATION; INHIBITION; PLASTICITY; RAT; PATHOPHYSIOLOGY	Traumatic brain injury (TBI) is a principal cause of death and disability worldwide, which is a major public health problem. Death caused by TBI accounts for a third of all damage related illnesses, which 75% TBI occurred in low and middle income countries. With the increasing use of motor vehicles, the incidence of TBI has been at a high level. The abnormal brain functions of TBI patients often show the acute and long-term neurological dysfunction, which mainly associated with the pathological process of malignant brain edema and neuroinflammation in the brain. Owing to the neuroinflammation lasts for months or even years after TBI, which is a pivotal causative factor that give rise to neurodegenerative disease at late stage of TBI. Studies have shown that platelet activating factor (PAF) inducing inflammatory reaction after TBI could not be ignored. The morphological and behavioral abnormalities after TBI in wild type mice are rescued by general knockout of PAFR gene that neuroinflammation responses and cognitive ability are improved. Our results thus define a key inflammatory molecule PAF that participates in the neuroinflammation and helps bring about cerebral dysfunction during the TBI acute phase.	[Yin, Xiang-Jie; Chen, Zhen-Yan; Zhu, Xiao-Na; Hu, Jin-Jia] Shanghai Jiao Tong Univ, Sch Med, Dept Anat Histol & Embryol, Shanghai, Peoples R China; [Zhu, Xiao-Na] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang 110016, Peoples R China		Hu, JJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Anat Histol & Embryol, Shanghai, Peoples R China.	jjhu2609@126.com					Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Alvarez MI, 2015, GLIA, V63, P287, DOI 10.1002/glia.22751; Andres AL, 2013, J NEUROSCI, V 33, P16945, DOI 10.1523/JNEUROSCI.1445-13.2013; Bate C, 2006, NEUROPHARMACOLOGY, V51, P173, DOI 10.1016/j.neuropharm.2006.02.015; Belayev L, 2009, BRAIN RES, V1253, P184, DOI 10.1016/j.brainres.2008.11.074; Belayev L, 2008, EXP NEUROL, V214, P253, DOI 10.1016/j.expneurol.2008.08.009; Bellizzi MJ, 2016, J NEUROSCI, V36, P1336, DOI 10.1523/JNEUROSCI.1171-15.2016; Bellizzi MJ, 2005, J CLIN INVEST, V115, P3185, DOI 10.1172/JCI25444; Bencsik N, 2015, J CELL BIOL, V210, P771, DOI 10.1083/jcb.201501114; Birch AM, 2013, HIPPOCAMPUS, V23, P437, DOI 10.1002/hipo.22103; Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Christakis DA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00546; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fahlenkamp AV, 2011, INFLAMM RES, V60, P379, DOI 10.1007/s00011-010-0281-6; Gao Y, 2015, J NEUROCHEM, V134, P340, DOI 10.1111/jnc.13123; Gonzalez-Burgos I, 2015, NEUROSCIENCE, V298, P74, DOI 10.1016/j.neuroscience.2015.04.019; Guerrero AT, 2013, N-S ARCH PHARMACOL, V386, P51, DOI 10.1007/s00210-012-0813-4; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Jing J., 2015, EVID-BASED COMPL ALT, V2015, P1, DOI DOI 10.1155/2015/142129; Karver CL, 2014, CHILD NEUROPSYCHOL, V20, P343, DOI 10.1080/09297049.2013.796918; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klevanski M, 2015, J NEUROSCI, V35, P16018, DOI 10.1523/JNEUROSCI.2009-15.2015; Kolko M, 2003, NEUROSCI LETT, V338, P164, DOI 10.1016/S0304-3940(02)01385-X; LASZLO F, 1994, BRIT J PHARMACOL, V113, P1131, DOI 10.1111/j.1476-5381.1994.tb17114.x; Lewis KM, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/578480; Li GH, 2015, TOXICOL LETT, V233, P102, DOI 10.1016/j.toxlet.2014.11.026; Li J, 2008, CELL MOL NEUROBIOL, V28, P125, DOI 10.1007/s10571-007-9190-9; Li J, 2009, CELL MOL NEUROBIOL, V29, P589, DOI 10.1007/s10571-009-9351-0; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mann AP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11980; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Musto AE, 2011, EPILEPSIA, V52, P551, DOI 10.1111/j.1528-1167.2010.02920.x; Ogden F, 1998, J NEUROSCI RES, V53, P677, DOI 10.1002/(SICI)1097-4547(19980915)53:6<677::AID-JNR6>3.0.CO;2-2; Pei HX, 2015, PHARMACOLOGY, V96, P233, DOI 10.1159/000438945; Plotkowski MC, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv046; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Sato S, 2014, ARTHRITIS RHEUMATOL, V66, P3436, DOI 10.1002/art.38818; Shen X, 2013, ANESTHESIOLOGY, V118, P502, DOI 10.1097/ALN.0b013e3182834d77; SQUADRITO F, 1993, J LIPID MEDIATOR, V8, P53; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Umemura A, 1997, J Stroke Cerebrovasc Dis, V6, P394, DOI 10.1016/S1052-3057(97)80040-7; Viswanath M, 2000, PEDIATR RES, V48, P109, DOI 10.1203/00006450-200007000-00019; Wang X, 2014, J NEUROSCI RES, V92, P232, DOI 10.1002/jnr.23306; Wang YM, 2015, ACS APPL MATER INTER, V7, P8437, DOI 10.1021/acsami.5b00215; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xia XW, 2012, WORLD NEUROSURG, V78, P689, DOI 10.1016/j.wneu.2011.07.042; Yu WH, 2012, PHYTOTHER RES, V26, P1838, DOI 10.1002/ptr.4662; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhu XN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11096; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	57	13	14	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JAN 17	2017	7								40614	10.1038/srep40614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3KM	WOS:000392389600001	28094295	Green Published, gold			2022-02-06	
J	Belanger, HG; Silva, MA; Donnell, AJ; McKenzie-Hartman, T; Lamberty, GJ; Vanderploeg, RD				Belanger, Heather G.; Silva, Marc A.; Donnell, Alison J.; McKenzie-Hartman, Tamara; Lamberty, Greg J.; Vanderploeg, Rodney D.			Utility of the Neurobehavioral Symptom Inventory As an Outcome Measure: A VA TBI Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; mild TBI; neurobehavioral; outcome; postconcussion; postconcussive syndrome; postdeployment; rehabilitation; TBI; traumatic brain injury; Veteran	TRAUMATIC BRAIN-INJURY; DISABILITY RATING-SCALE; POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; PARTICIPATION ASSESSMENT; PREDICTIVE-VALIDITY; VETERANS; RELIABILITY; REHABILITATION	Objective: To examine the utility of the Neurobehavioral Symptom Inventory (NSI)-a measure of postconcussion symptoms used within the Veterans Health Administration-as an index of rehabilitation outcome. Setting: Veterans Administration Polytrauma Rehabilitation Centers Traumatic Brain Injury (TBI) Model Systems program. Participants: A total of 159 Veterans (14% with mild TBI; 86% with moderate-severe TBI). Main Measures: Disability Rating Scale; Functional Independence Measure; Glasgow Outcome Scale-Extended; NSI; Participation Assessment with Recombined Tools-Objective; Posttraumatic Stress Disorder Checklist-Civilian Version; Satisfaction With Life Scale; Supervision Rating Scale. Analyses: Correlations and exploratory factor analyses examined the interrelations among outcome measures. Hierarchical regression analyses were utilized to determine if the NSI predicted rehabilitation outcome measures after controlling for demographic variables, TBI severity, and time since injury. NSI reliable changes from pretreatment to 1-year follow-up were examined. Receiver operating characteristics curve analyses were conducted to evaluate the ability of changes in the NSI to predict meaningful change in functioning and employment status. Results: The NSI correlated with psychological distress measures. The NSI administered prior to brain injury rehabilitation had limited predictive utility beyond satisfaction with life. A minority of patients (32%) demonstrated reliable changes on the NSI from baseline to 1-year follow-up. Changes on the NSI were not predictive of meaningful change in employment or functioning. Conclusion: The NSI was not useful for assessing meaningful change in a sample of mixed severity TBI patients.	[Belanger, Heather G.; Silva, Marc A.; Donnell, Alison J.; McKenzie-Hartman, Tamara; Vanderploeg, Rodney D.] James A Haley VAMC, Dept Mental Hlth & Behav Sci, Tampa, FL USA; [Belanger, Heather G.; Silva, Marc A.; McKenzie-Hartman, Tamara; Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL USA; [Belanger, Heather G.; Donnell, Alison J.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL USA; [Lamberty, Greg J.] Minneapolis VA Hlth Care Syst, Hlth Serv Line, Minneapolis, MN USA; [Lamberty, Greg J.] Univ Minnesota, Sch Med, Dept Psychiat, Minneapolis, MN 55455 USA		Belanger, HG (corresponding author), James A Haley Vet Hosp, 13000 Bruce B Downs Blvd,MHBS 116B, Tampa, FL 33612 USA.	Heather.Belanger@va.gov	Silva, Marc A./J-1874-2019	Silva, Marc A./0000-0002-3879-6054	Veterans Health Administration Central Office VA TBI Model Systems Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center [W91YTZ-13-C-0015]; US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); US Department of Veterans AffairsUS Department of Veterans Affairs [1 I50 HX001233-01, W81XWH-13-2-0095]; US Department of Defense Congressionally Directed Medical Research Programs; Chronic Effects of Neurotrauma Consortium [VA CSRD W81XWH-13-2-0095]	This material is the result of work supported with resources and the use of facilities at the James A. Haley Veterans' Hospital and the Minneapolis VA Health Care System, and supported in part by the Veterans Health Administration Central Office VA TBI Model Systems Program of Research, and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command, US Department of Veterans Affairs grants (1 I50 HX001233-01, W81XWH-13-2-0095), and US Department of Defense Congressionally Directed Medical Research Programs, and Chronic Effects of Neurotrauma Consortium (VA CSRD W81XWH-13-2-0095).	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; de Vet HCW, 2007, QUAL LIFE RES, V16, P131, DOI 10.1007/s11136-006-9109-9; Department of Veterans Affairs and Department of Defense, 2010, VA DOD CLIN PRACT GU; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Dretsch M, 2016, J HEAD TRAUMA REHAB, V31, P23, DOI 10.1097/HTR.0000000000000109; ELIASON MR, 1984, PHYS THER, V64, P1357, DOI 10.1093/ptj/64.9.1357; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall K M, 1994, NeuroRehabilitation, V4, P76, DOI 10.3233/NRE-1994-4204; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lakens D., 2008, FRONT PSYCHOL, V26, P1; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P1603, DOI 10.1016/j.apmr.2012.04.003; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Silva MA, 2013, CLIN NEUROPSYCHOL, V27, P601; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Waldron-Perrine B, 2012, MIL MED, V177, P1293, DOI 10.7205/MILMED-D-12-00169; Weathers FW, 1991, PCL C FOR DSM 4; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204	47	13	13	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2017	32	1					46	54		10.1097/HTR.0000000000000208			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EI2GH	WOS:000392304400005	26709585				2022-02-06	
J	Chai, C; Guo, R; Zuo, C; Fan, LL; Liu, SF; Qian, TY; Haacke, EM; Xia, S; Shen, W				Chai, Chao; Guo, Rui; Zuo, Chao; Fan, Linlin; Liu, Saifeng; Qian, Tianyi; Haacke, E. Mark; Xia, Shuang; Shen, Wen			Decreased susceptibility of major veins in mild traumatic brain injury is correlated with post-concussive symptoms: A quantitative susceptibility mapping study	NEUROIMAGE-CLINICAL			English	Article						Mild traumatic brain injury; Axonal injury; Regional cerebral venous oxygen saturation; Susceptibility weighted imaging; Quantitative susceptibility mapping; Post-concussive symptom	DIFFUSE AXONAL INJURY; IN-VIVO MEASUREMENT; OXYGEN-SATURATION; TISSUE-DAMAGE; HEAD-INJURY; QUESTIONNAIRE; PREDICTION; DIAGNOSIS; MODERATE	Cerebral venous oxygen saturation (SvO(2)) is an important biomarker of brain function. In this study, we aimed to explore the relative changes of regional cerebral SvO(2) among axonal injury (AI) patients, non-AI patients and healthy controls (HCs) using quantitative susceptibility mapping (QSM). 48 patients and 32 HCs were enrolled. The patients were divided into two groups depending on the imaging based evidence of AI. QSM was used to measure the susceptibility of major cerebral veins. Nonparametric testing was performed for susceptibility differences among the non-AI patient group, AI patient group and healthy control group. Correlation was performed between the susceptibility of major cerebral veins, elapsed time post trauma (ETPT) and post-concussive symptom scores. The ROC analysis was performed for the diagnostic efficiency of susceptibility to discriminate mTBI patients from HCs. The susceptibility of the straight sinus in non-AI and AI patients was significantly lower than that in HCs (P < 0.001, P= 0.004, respectively, Bonferroni corrected), which may indicate an increased regional cerebral SvO(2) in patients. The susceptibility of the straight sinus in non-AI patients positively correlated with ETPT (r = 0.573, P = 0.003, FDR corrected) while that in AI patients negatively correlated with the Rivermead Post Concussion Symptoms Questionnaire scores (r =-0.582, P= 0.018, FDR corrected). The sensitivity, specificity and AUC values of susceptibility for the discrimination between mTBI patients and HCs were 88%, 69% and 0.84. In conclusion, the susceptibility of the straight sinus can be used as a biomarker to monitor the progress of mild TBI and to differentiate mTBI patients from healthy controls.	[Chai, Chao; Xia, Shuang; Shen, Wen] Tianjin First Cent Hosp, Dept Radiol, Tianjin 300192, Peoples R China; [Guo, Rui] Tianjin First Cent Hosp, Dept Neurosurg, Tianjin 300192, Peoples R China; [Zuo, Chao] Cangzhou Cent Hosp, Dept Nucl Med, Cangzhou 061001, Hebei, Peoples R China; [Fan, Linlin] Tianjin First Cent Hosp, Dept Prophylact Inoculat & Stat, Tianjin 300192, Peoples R China; [Liu, Saifeng] MRI Inst Biomed Res, Waterloo, ON N9A6T2, Canada; [Qian, Tianyi] Siemens Healthcare, MR Collaborat, Beijing 100102, Peoples R China; [Haacke, E. Mark] Wayne State Univ, Dept Radiol, Detroit, MI 48202 USA		Xia, S; Shen, W (corresponding author), Tianjin First Cent Hosp, Dept Radiol, Tianjin 300192, Peoples R China.	xiashuang77@163.com; shenwen66happy@163.com	chai, chao/M-6698-2019; Liu, Saifeng/I-1242-2019	Xia, Shuang/0000-0003-1626-6383	Natural Scientific Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81501457]; Tianjin Health Bureau of Science and Technology [14KG103]	This work was supported by the Natural Scientific Foundation of China (grant number 81501457 to Shuang Xia) and the Tianjin Health Bureau of Science and Technology (grant number 14KG103 to Shuang Xia).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Barnes SRS, 2009, MAGN RESON IMAGING C, V17, P47, DOI 10.1016/j.mric.2008.12.002; Buch S, 2016, J CEREB BLOOD FLOW M; Chen SF, 2004, J CEREBR BLOOD F MET, V24, P1025, DOI 10.1097/01.WCB.0000129415.34520.47; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Davceva N, 2015, AM J FOREN MED PATH, V36, P127, DOI 10.1097/PAF.0000000000000168; Davies DJ, 2015, J NEUROTRAUM, V32, P1; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Fan AP, 2014, MAGN RESON MED, V72, P149, DOI 10.1002/mrm.24918; Fan AP, 2012, MAGN RESON MED, V67, P669, DOI 10.1002/mrm.23050; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Haacke EM, 2015, MAGN RESON IMAGING, V33, P1, DOI 10.1016/j.mri.2014.09.004; Haacke EM, 1997, HUM BRAIN MAPP, V5, P341, DOI 10.1002/(SICI)1097-0193(1997)5:5<341::AID-HBM2>3.0.CO;2-3; Harris NG, 2012, J NEUROTRAUM, V29, P1469, DOI 10.1089/neu.2011.2161; He X, 2009, P NATL ACAD SCI USA, V106, P13558, DOI 10.1073/pnas.0904899106; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Hsieh MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149602; Iraji A, 2016, NEUROIMAGE-CLIN, V12, P100, DOI 10.1016/j.nicl.2016.06.012; Jain V, 2013, MAGN RESON MED, V70, P785, DOI 10.1002/mrm.24519; Jain V, 2010, J CEREBR BLOOD F MET, V30, P1598, DOI 10.1038/jcbfm.2010.49; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Krishnamurthy LC, 2014, MAGN RESON MED, V71, P978, DOI 10.1002/mrm.24750; Liu SF, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3552; Liu T, 2011, NMR BIOMED, V24, P1129, DOI 10.1002/nbm.1670; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCredie VA, 2017, NEUROCRIT CARE, V26, P247, DOI 10.1007/s12028-016-0310-6; McDaniel P, 2017, MAGN RESON MED, V77, P1713, DOI 10.1002/mrm.26227; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Pearl M, 2011, SEMIN ULTRASOUND CT, V32, P252, DOI 10.1053/j.sult.2011.02.001; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sun HT, 2016, NEUROPSYCH DIS TREAT, V12, P2125, DOI 10.2147/NDT.S102929; Takahata Keisuke, 2016, Brain Nerve, V68, P849, DOI 10.11477/mf.1416200517; Tang J, 2013, MAGN RESON MED, V69, P1396, DOI 10.1002/mrm.24384; Xia S, 2014, MAGN RESON IMAGING, V32, P1272, DOI 10.1016/j.mri.2014.08.012; Xu B, 2014, MAGN RESON MED, V72, P438, DOI 10.1002/mrm.24937	48	13	13	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	15						625	632		10.1016/j.nicl.2017.06.008			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FG3MN	WOS:000410067200065	28664033	gold, Green Published			2022-02-06	
J	Chen, YH; Zhang, X; Zhang, BD; He, GD; Zhou, LF; Xie, YB				Chen, Yanhua; Zhang, Xu; Zhang, Bingdong; He, Guodong; Zhou, Lifang; Xie, Yubo			Dexmedetomidine reduces the neuronal apoptosis related to cardiopulmonary bypass by inhibiting activation of the JAK2-STAT3 pathway	DRUG DESIGN DEVELOPMENT AND THERAPY			English	Article						apoptosis; cardiopulmonary bypass; dexmedetomidine; neuroprotective effect; JAK2; STAT3	ISCHEMIA-REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; CARDIAC-SURGERY; ISCHEMIA/REPERFUSION INJURY; JAK2/STAT3 PATHWAY; CEREBRAL-ISCHEMIA; NEONATAL-RATS; INFLAMMATORY RESPONSE; SIGNALING PATHWAY; ORGAN DAMAGE	Cardiopulmonary bypass (CPB) constitutes one of the primary methodologies pertaining to cardiac surgery. However, this form of surgery can cause damage to the body. Many studies have reported that dexmedetomidine confers cerebral protection. In this study, we aimed to investigate the effect and mechanism of dexmedetomidine on neuronal apoptosis caused by CPB. Here, rats were treated with different doses of dexmedetomidine by intravenous infusion 2 hours after CPB. We observed that dexmedetomidine treatment to rats reduces the S100 beta, NSE levels in plasma, and neuronal apoptosis following CPB in a dose-dependent manner. Furthermore, we observed that the beneficial effect of dexmedetomidine treatment following CPB was associated with a reduction in IL6, an inflammatory cytokine in plasma and cortex. Our results suggest that dexmedetomidine provides neuroprotective effects by inhibiting inflammation and reducing neuronal apoptosis. There was a correlation between the protective effect on the brain and the dose of dexmedetomidine. In addition, dexmedetomidine administration inhibits phosphorylation of JAK2 and STAT3 proteins in the hippocampus of rats 2 hours after CPB. Therefore, we speculate that the JAK2-STAT3 pathway plays an important role in the neuroprotective effects of dexmedetomidine following brain injury induced by CPB.	[Chen, Yanhua; Zhang, Bingdong] Guangxi Med Univ, Affiliated Hosp 1, Cardiovasc Inst, Dept Anesthesiol, Nanning, Peoples R China; [Zhang, Xu; He, Guodong; Zhou, Lifang; Xie, Yubo] Guangxi Med Univ, Affiliated Hosp 1, Dept Anesthesiol, 6 Shuangyong Rd, Nanning 530021, Guangxi, Peoples R China		Xie, YB (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Anesthesiol, 6 Shuangyong Rd, Nanning 530021, Guangxi, Peoples R China.	xybdoctor@163.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81373498]; Science Study and Technology Development Program of Guangxi [1355005-4-2]; Natural Science Foundation of GuangxiNational Natural Science Foundation of Guangxi Province [2015GXNS-FBA139139]; Youth Science Foundation of Guangxi Medical University [GXMUYSF2014041]; Department of Education Scientific Research Subject of Guangxi, China [KY2016YB079]	This work was supported by the Natural Science Foundation of China (81373498), Science Study and Technology Development Program of Guangxi (1355005-4-2), Natural Science Foundation of Guangxi (2015GXNS-FBA139139), Youth Science Foundation of Guangxi Medical University (GXMUYSF2014041) and the Department of Education Scientific Research Subject of Guangxi (KY2016YB079), China.	Bulow NMH, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20154646; Caputo M, 2014, J THORAC CARDIOV SUR, V148, P792, DOI 10.1016/j.jtcvs.2014.06.001; Cheng XY, 2016, MOL MED REP, V14, P797, DOI 10.3892/mmr.2016.5345; de Jong PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035070; Deng HL, 2015, MOL MED REP, V11, P3659, DOI 10.3892/mmr.2015.3170; Fujii Y, 2013, ARTIF ORGANS, V37, P136, DOI 10.1111/j.1525-1594.2012.01535.x; HATASHITA S, 1988, J CEREBR BLOOD F MET, V8, P552, DOI 10.1038/jcbfm.1988.96; Homi HM, 2010, J THORAC CARDIOV SUR, V140, P660, DOI 10.1016/j.jtcvs.2009.10.063; Hori D, 2015, ANESTH ANALG, V121, P1187, DOI 10.1213/ANE.0000000000000930; Howell KW, 2016, J SURG RES, V201, P76, DOI 10.1016/j.jss.2015.10.016; Hristova M, 2016, J NEUROCHEM, V136, P981, DOI 10.1111/jnc.13490; Hwang L, 2013, INT J MOL MED, V31, P1047, DOI 10.3892/ijmm.2013.1301; Jia LL, 2017, BRAIN RES, V1657, P202, DOI 10.1016/j.brainres.2016.12.015; Jongman RM, 2014, SHOCK, V42, P121, DOI 10.1097/SHK.0000000000000190; Kim HC, 2017, J NEUROSURG ANESTH, V29, P37, DOI 10.1097/ANA.0000000000000331; Kim J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112012; Kim YR, 2013, INT J MOL MED, V32, P1303, DOI 10.3892/ijmm.2013.1511; Komine-Kobayashi M, 2006, J CEREBR BLOOD F MET, V26, P402, DOI 10.1038/sj.jcbfm.9600195; Kunisawa T, 2011, J ANESTH, V25, P818, DOI 10.1007/s00540-011-1215-3; Li LL, 2015, INT J CLIN EXP MED, V8, P14985; Liao ZX, 2014, BRAIN RES BULL, V107, P69, DOI 10.1016/j.brainresbull.2014.07.001; Liu X, 2014, NEUROSCIENCE, V268, P318, DOI 10.1016/j.neuroscience.2014.03.032; Luo XH, 2016, CLIN NEUROL NEUROSUR, V146, P105, DOI 10.1016/j.clineuro.2016.05.004; Lv J, 2017, ENVIRON TOXICOL PHAR, V52, P121, DOI 10.1016/j.etap.2017.03.017; Matata BM, 2015, J CARDIOTHOR VASC AN, V29, P1236, DOI 10.1053/j.jvca.2015.02.020; McDonagh DL, 2014, LANCET NEUROL, V13, P490, DOI 10.1016/S1474-4422(14)70004-3; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Ouk T, 2016, VASC PHARMACOL, V80, P59, DOI 10.1016/j.vph.2015.12.005; Owais K, 2015, ANN THORAC SURG, V100, P1636, DOI 10.1016/j.athoracsur.2015.05.013; Pan WY, 2016, CELL MOL NEUROBIOL, V36, P1179, DOI 10.1007/s10571-015-0315-2; Patel N, 2015, CARDIOVASC PSYCHIAT, V2015, P370612, DOI DOI 10.1155/2015/370612; Podgoreanu MV, 2006, CIRCULATION, V114, pI275, DOI 10.1161/CIRCULATIONAHA.105.001032; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Si YN, 2014, EUR REV MED PHARMACO, V18, P1843; Si YN, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-141; Sifringer M, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/530371; Steinbrenner H, 2016, INFLAMMATION, V39, P1363, DOI 10.1007/s10753-016-0368-5; Sugita S, 2013, J NIPPON MED SCH, V80, P131, DOI 10.1272/jnms.80.131; Tao Z, 2015, INT J CLIN EXP PATHO, V8, P6732; Trop S, 2014, J SURG RES, V187, P43, DOI 10.1016/j.jss.2013.09.035; Wang YJ, 2016, MOL MED REP, V14, P769, DOI 10.3892/mmr.2016.5321; Zeng XZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151620; Zhang WW, 2016, EXP BIOL MED, V241, P1819, DOI 10.1177/1535370216648804; Zhang XK, 2015, IRAN J BASIC MED SCI, V18, P604; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018; Zhu YJ, 2016, BRAIN RES, V1644, P1, DOI 10.1016/j.brainres.2016.04.074	47	13	15	0	3	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1177-8881			DRUG DES DEV THER	Drug Des. Dev. Ther.		2017	11						2787	2799		10.2147/DDDT.S140644			13	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	GP1IW	WOS:000440570000001	29033541	gold, Green Published, Green Submitted			2022-02-06	
J	Coutinho, V; Camara-Costa, H; Kemlin, I; de Villemeur, TB; Rodriguez, D; Dellatolas, G				Coutinho, V.; Camara-Costa, H.; Kemlin, I.; de Villemeur, T. Billette; Rodriguez, D.; Dellatolas, G.			The Discrepancy between Performance-Based Measures and Questionnaires when Assessing Clinical Outcomes and Quality of Life in Pediatric Patients with Neurological Disorders	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Assessment; neurofibromatosis type 1; neuropsychological tests; outcome; parental reports	TRAUMATIC BRAIN-INJURY; NEUROFIBROMATOSIS TYPE-1; COGNITIVE DYSFUNCTION; EXECUTIVE FUNCTION; CHILDREN; COMPLAINTS; ATTENTION; SYMPTOMS; BEHAVIOR; RATINGS	In clinical outcome assessment, the relation between performance-based measures and questionnaire ratings of the same domain is weak, but correlations between questionnaires proposed for the evaluation of different domains are strong. The present study aims to illustrate these phenomena in a group of patients with neurofibromatosis type 1 (NF1) and to propose an explanatory hypothesis. A single neuropsychologist interviewed the parents about the child's situation and current difficulties and then assessed this parental view as overall positive or overall negative. The same assessor then administered the Wechsler Intelligence Scales and neuropsychological tests to 78 children and adolescents with NF1 (5-18 years). Parents then completed the Child Behavioral Checklist (CBCL), the Conners' Parent Rating Scale, the Behavior Rating Inventory of Executive Function (BRIEF), as well as questionnaires assessing quality of life, impact of the medical disorder, and their own difficulties. All questionnaires were inter-correlated (r=0.29 - 0.84) and associated with the overall positive or negative parental view of the child's progress (effect size=0.41-1.46). Conversely, questionnaires were weakly or not significantly related to intelligence, cognitive measures, or clinical severity. In conclusion, the parental view of the child's progress was related to the answers to questionnaires assessing quality of life or strengths and difficulties of patients with a neurological disorder. This factor should be assessed independently and taken into account when assessing clinical outcome.	[Coutinho, V.; Kemlin, I.; de Villemeur, T. Billette; Rodriguez, D.] Trousseau Hosp, AP HP, Pediat Neurol Unit, GHUEP, Paris, France; [Coutinho, V.; Kemlin, I.; Rodriguez, D.] Neurofibromatosis Referral Ctr, Paris, France; [Coutinho, V.; Camara-Costa, H.; Dellatolas, G.] Natl Inst Hlth & Med Res, INSERM CESP1018, Villejuif, France; [Coutinho, V.] Paris Descartes Univ, Paris, France; [de Villemeur, T. Billette; Rodriguez, D.] Sorbonne Univ, UPMC, Paris, France; [de Villemeur, T. Billette; Rodriguez, D.] Natl Inst Hlth & Med Res, INSERM U1141, Paris, France		Coutinho, V (corresponding author), Hop Trousseau, Serv Neuropediat, 26 Ave Docteur Arnold Netter, F-75012 Paris, France.	virginie.coutinho@trs.aphp.fr	Dellatolas, Georges/AAW-1377-2021	Camara-Costa, Hugo/0000-0002-3739-7190			Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Biglia N, 2012, EUR J CANCER CARE, V21, P485, DOI 10.1111/j.1365-2354.2011.01320.x; Chevignard MP, 2012, BRAIN INJURY, V26, P1033, DOI 10.3109/02699052.2012.666366; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA; Cortese S, 2007, J PSYCHOSOM RES, V63, P587, DOI 10.1016/j.jpsychores.2007.08.005; Coutinho V, 2016, RES DEV DISABIL, V48, P220, DOI 10.1016/j.ridd.2015.11.010; Cutting LE, 2010, CHILD NEUROPSYCHOL, V16, P417, DOI 10.1080/09297041003761985; Descheemaeker MJ, 2005, J INTELL DISABIL RES, V49, P33, DOI 10.1111/j.1365-2788.2005.00660.x; Dirven L, 2015, NEURO-ONCOL PRACT, V2, P2, DOI 10.1093/nop/npv002; Ferner Rosalie E, 2010, Pract Neurol, V10, P82, DOI 10.1136/jnnp.2010.206532; Frol AB, 2013, ALLERGY ASTHMA PROC, V34, P170, DOI 10.2500/aap.2013.34.3642; Gehring K, 2015, NEURO-ONCOL PRACT, V2, P20, DOI 10.1093/nop/npu035; Gioa G. A., 2000, INVENTAIRE EVALUATIO; GOYETTE CH, 1978, J ABNORM CHILD PSYCH, V6, P221, DOI 10.1007/BF00919127; Hermelink K, 2010, PSYCHO-ONCOLOGY, V19, P1321, DOI 10.1002/pon.1695; Hooper L, 2007, NEUROPSYCHOL REHABIL, V17, P621, DOI 10.1080/09602010601137054; Isenberg JC, 2013, J CHILD NEUROL, V28, P45, DOI 10.1177/0883073812439435; Kennedy C, 2014, INT J RADIAT ONCOL, V88, P292, DOI 10.1016/j.ijrobp.2013.09.046; Lehtonen A, 2013, DEV MED CHILD NEUROL, V55, P111, DOI 10.1111/j.1469-8749.2012.04399.x; Liemburg GB, 2015, MOL GENET METAB, V114, P425, DOI 10.1016/j.ymgme.2014.12.302; Mahone EM, 2007, CLIN NEUROPSYCHOL, V21, P569, DOI 10.1080/13854040600762724; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Moore LH, 1997, J NEUROPSYCH CLIN N, V9, P37; Mora PA, 2007, ANN BEHAV MED, V34, P77, DOI 10.1007/BF02879923; National Institutes of Health (NIH), 1988, CONS DEV C STAT NEUR, V6, P1; Payne JM, 2011, CHILD NEUROPSYCHOL, V17, P313, DOI 10.1080/09297049.2010.542746; Pullens MJJ, 2010, PSYCHO-ONCOLOGY, V19, P1127, DOI 10.1002/pon.1673; Soria Carmen, 2007, Dev Neurorehabil, V10, P213, DOI 10.1080/13638490601111129; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Wechsler D., 2004, ECHELLE INTELLIGENCE; Wechsler D., 2005, ECHELLE INTELLIGENCE	33	13	13	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2017	6	4					255	261		10.1080/21622965.2016.1146141			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FK7SD	WOS:000413706600002	27182681				2022-02-06	
J	Dillard, C; Ditchman, N; Nersessova, K; Foster, N; Wehman, P; West, M; Riedlinger, B; Monasterio, E; Shaw, B; Neblett, J				Dillard, Charles; Ditchman, Nicole; Nersessova, Karine; Foster, Nicola; Wehman, Paul; West, Michael; Riedlinger, Brendalin; Monasterio, Eugenio; Shaw, Bill; Neblett, Julie			Post-concussion symptoms in mild traumatic brain injury: findings from a paediatric outpatient clinic	DISABILITY AND REHABILITATION			English	Article						Adolescent; brain concussion; brain injuries; child; paediatric hospitals; post-concussion syndrome	SPORTS-RELATED CONCUSSION; STATES HIGH-SCHOOL; SEX-DIFFERENCES; HEAD-INJURY; BASE-LINE; NEUROPSYCHOLOGICAL FUNCTION; RISK-FACTORS; TASK-FORCE; CHILDREN; SCALE	Purpose Mild traumatic brain injury (mTBI) is common among children and is associated with a range of symptomatology and clinical presentations. This study uses data from a paediatric outpatient TBI clinic to (1) investigate characteristics associated with more severe post-concussive symptoms and (2) examine differences in the proportion of individuals endorsing specific post-concussion symptoms based on group (e.g., sex, type of injury, and psychiatric history). Methods Data from the Children's Hospital of Richmond's TBI outpatient programme were analysed (N=157). Results Gender and sports injury were associated with severity of symptoms. In addition, females endorsed a greater number of overall symptoms than males. A number of specific symptoms were found to be endorsed to a greater extent based on psychiatric history and type of injury; however, overall total number of symptoms endorsed did not differ based on these characteristics. Conclusions Findings from this study provide further evidence that mTBI affects a wide range of youth and that associated symptomatology can indeed be varied. Moreover, results revealed differences in endorsement of specific symptoms and symptom severity based on patient and injury characteristics which have implications for concussion assessment and treatment.	[Dillard, Charles; Nersessova, Karine; Foster, Nicola; Riedlinger, Brendalin; Shaw, Bill; Neblett, Julie] Virginia Commonwealth Univ, Childrens Hosp Richmond, Pediat TBI Program, Richmond, VA 23284 USA; [Dillard, Charles; Wehman, Paul; Monasterio, Eugenio] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Ditchman, Nicole] IIT, Dept Psychol, Chicago, IL 60616 USA; [Wehman, Paul; West, Michael] Virginia Commonwealth Univ Richmond, Rehabil Res & Training Ctr, Richmond, VA USA		Dillard, C (corresponding author), Virginia Commonwealth Univ, Childrens Hosp Richmond, Pediat TBI Program, Richmond, VA 23284 USA.	cdillard2@mcvh-vcu.edu					Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Clayton GH, 2013, CURR PHYS MED REHABI, V1, P88; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; DeMatteo C, 2015, DISABIL REHABIL, V37, P1107, DOI 10.3109/09638288.2014.952452; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; IBM Corp. Released, 2012, IBM SPSS STAT WIND V; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lee YM, 2013, J NEUROSURG-PEDIATR, V12, P537, DOI 10.3171/2013.7.PEDS12572; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1999, SPORTS-RELATED CONCUSSION, P200; Lovell MR, 2002, NEUROLOGIC ATHLETIC, P32; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	47	13	13	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2017	39	6					544	550		10.3109/09638288.2016.1152602			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EK4AR	WOS:000393870000003	26971917				2022-02-06	
J	Dodick, D; Starling, AJ; Wethe, J; Pang, Y; Messner, LV; Smith, C; Master, CL; Halker-Singh, RB; Vargas, BB; Bogle, JM; Mandrekar, J; Talaber, A; Leong, D				Dodick, David; Starling, Amaal J.; Wethe, Jennifer; Pang, Yi; Messner, Leonard V.; Smith, Craig; Master, Christina L.; Halker-Singh, Rashmi B.; Vargas, Bert B.; Bogle, Jamie M.; Mandrekar, Jay; Talaber, Alexandra; Leong, Danielle			The Effect of In-School Saccadic Training on Reading Fluency and Comprehension in First and Second Grade Students: A Randomized Controlled Trial	JOURNAL OF CHILD NEUROLOGY			English	Article						reading; eye movements; saccadic training; intervention; randomized controlled trial	BRAIN-INJURY MTBI; EYE-MOVEMENTS; KING-DEVICK; CHILDREN; ASSOCIATIONS; CONCUSSION; TRACKING; HYPOXIA; DISEASE; TESTS	Efficient eye movements provide a physical foundation for proficient reading skills. We investigated the effect of in-school saccadic training on reading performance. In this cross-over design, study participants (n = 327, 165 males; mean age [SD]: 7 y 6 mo [1y 1 mo]) were randomized into treatment and control groups, who then underwent eighteen 20-minute training sessions over 5 weeks using King-Devick Reading Acceleration Program Software. Pre-and posttreatment reading assessments included fluency, comprehension, and rapid number naming performance. The treatment group had significantly greater improvement than the control group in fluency (6.2% vs 3.6%, P =.0277) and comprehension (7.5% vs 1.5%, P =.0002). The high-needs student group significantly improved in fluency (P <.001) and comprehension (P <.001). We hypothesize these improvements to be attributed to the repetitive practice of reading-related eye movements, shifting visuospatial attention, and visual processing. Consideration should be given to teaching the physical act of reading within the early education curriculum.	[Dodick, David; Starling, Amaal J.; Wethe, Jennifer; Halker-Singh, Rashmi B.; Vargas, Bert B.; Bogle, Jamie M.] Mayo Clin, Dept Neurol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA; [Pang, Yi; Messner, Leonard V.; Leong, Danielle] Illinois Eye Inst, Chicago, IL USA; [Smith, Craig] Bill & Melinda Gates Fdn, Seattle, WA USA; [Master, Christina L.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Mandrekar, Jay] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Talaber, Alexandra; Leong, Danielle] King Devick Test Inc, Oak Brook Terrace, IL USA		Dodick, D (corresponding author), Mayo Clin, Dept Neurol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA.	dodick.david@mayo.edu		Master, Christina/0000-0002-6717-4270	King-Devick Test, Inc.	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by King-Devick Test, Inc.	Allen M, 2012, M AM OPT ASS OPT CHI; [Anonymous], 2015, KING DEV TEST READ T; [Anonymous], 2013, EARL READ PROF US, P1; [Anonymous], 2013, NATL ASSESSMENT ED P; Ayaz H, 2014, J NEUROSCI NEUROENGI, V3, P1; Balcer LJ, 2015, BRAIN, V138, P11, DOI 10.1093/brain/awu335; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Biscaldi M, 1998, NEUROPSYCHOLOGIA, V36, P1189, DOI 10.1016/S0028-3932(97)00170-X; Chetwood ASA, 2012, SURG ENDOSC, V26, P2003, DOI 10.1007/s00464-011-2143-x; Convergence insufficiency treatment trial investigator group, 2009, ARCH OPHTHALMOL-CHIC, V126, P1336; Davies EC, 2012, NEUROLOGY, V78, pE103, DOI 10.1212/WNL.0b013e318251833d; Denton CA, 2011, SCI STUD ST BONAVENT, V15; Dore-Mazars K, 2004, PSYCHOL RES-PSYCH FO, V69, P67, DOI 10.1007/s00426-003-0166-1; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; Feder KP, 2007, DEV MED CHILD NEUROL, V49, P312, DOI 10.1111/j.1469-8749.2007.00312.x; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fernandez G, 2013, INVEST OPHTH VIS SCI, V54, P8345, DOI 10.1167/iovs.13-12877; FIORAVANTI F, 1995, VISION RES, V35, P3217, DOI 10.1016/0042-6989(95)00152-5; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Hosp MK, 2005, SCHOOL PSYCHOL REV, V34, P9; Leong DF, 2014, CLIN PEDIATR, V53, P858, DOI 10.1177/0009922814532520; Lesnick J, 2010, LONGITUDINAL ANAL 3, P1; Lin TP, 2014, PARKINSONISM RELAT D, V20, P226, DOI 10.1016/j.parkreldis.2013.10.009; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; Miles SB, 2006, CHILD DEV, V77, P103, DOI 10.1111/j.1467-8624.2006.00859.x; Moster S, 2014, J NEUROL SCI, V343, P105, DOI 10.1016/j.jns.2014.05.047; Peltsch A, 2014, EUR J NEUROSCI, V39, P2000, DOI 10.1111/ejn.12617; Quaid P, 2013, GRAEF ARCH CLIN EXP, V251, P169, DOI 10.1007/s00417-012-2135-0; Seassau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070261; Stepanek J, 2014, AVIAT SPACE ENVIR MD, V85, P700, DOI 10.3357/ASEM.3645.2014; Stepanek J, 2013, AVIAT SPACE ENVIR MD, V84, P1017, DOI 10.3357/ASEM.3616.2013; Thiagarajan P, 2014, BRAIN INJURY, V28, P930, DOI 10.3109/02699052.2014.888761; Thiagarajan P, 2014, NEUROREHABILITATION, V34, P129, DOI 10.3233/NRE-131025; van Wyk A, 2014, NEUROREHAB NEURAL RE, V28, P856, DOI 10.1177/1545968314526306; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Wethe J, 2012, VIS DEV REHABIL	37	13	13	1	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2017	32	1					104	111		10.1177/0883073816668704			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	EP2KX	WOS:000397213000014	28257277				2022-02-06	
J	Drapeau, J; Gosselin, N; Peretz, I; McKerral, M				Drapeau, Joanie; Gosselin, Nathalie; Peretz, Isabelle; McKerral, Michelle			Emotional recognition from dynamic facial, vocal and musical expressions following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; mild; complicated mild; moderate; severe; emotions; faces; non-linguistic vocalizations; music	IMPAIRED RECOGNITION; MILD; DEFICITS; PERCEPTION; DAMAGE; CONCUSSION; RECOVERY; MODERATE; PEOPLE; SCARY	Objectives: To assess emotion recognition from dynamic facial, vocal and musical expressions in sub-groups of adults with traumatic brain injuries (TBI) of different severities and identify possible common underlying mechanisms across domains.Methods: Forty-one adults participated in this study: 10 with moderate-severe TBI, nine with complicated mild TBI, 11 with uncomplicated mild TBI and 11 healthy controls, who were administered experimental (emotional recognition, valence-arousal) and control tasks (emotional and structural discrimination) for each domain.Results: Recognition of fearful faces was significantly impaired in moderate-severe and in complicated mild TBI sub-groups, as compared to those with uncomplicated mild TBI and controls. Effect sizes were medium-large. Participants with lower GCS scores performed more poorly when recognizing fearful dynamic facial expressions. Emotion recognition from auditory domains was preserved following TBI, irrespective of severity. All groups performed equally on control tasks, indicating no perceptual disorders. Although emotional recognition from vocal and musical expressions was preserved, no correlation was found across auditory domains.Conclusions: This preliminary study may contribute to improving comprehension of emotional recognition following TBI. Future studies of larger samples could usefully include measures of functional impacts of recognition deficits for fearful facial expressions. These could help refine interventions for emotional recognition following a brain injury.	[Drapeau, Joanie; McKerral, Michelle] CRLB, CRIR, 2275 Ave Laurier Est, Montreal, PQ H2N 2N8, Canada; [Drapeau, Joanie; Gosselin, Nathalie; McKerral, Michelle] Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada; [Drapeau, Joanie; Gosselin, Nathalie; Peretz, Isabelle] CRBLM, Montreal, PQ, Canada; [Drapeau, Joanie; Gosselin, Nathalie; Peretz, Isabelle] Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada; [Drapeau, Joanie; Gosselin, Nathalie; Peretz, Isabelle; McKerral, Michelle] Univ Montreal, Dept Psychol, Montreal, PQ, Canada		McKerral, M (corresponding author), CRLB, CRIR, 2275 Ave Laurier Est, Montreal, PQ H2N 2N8, Canada.	michelle.mckerral@umontreal.ca			National Science and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC); Centre de readaptation Lucie-Bruneau; Canada Research ChairNatural Resources CanadaCanadian Forest ServiceCanada Research Chairs; Fonds de recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec; Faculte des etudes superieures et postdoctorales de l'Universite de Montreal	This study was supported by the National Science and Engineering Research Council of Canada and the Centre de readaptation Lucie-Bruneau (grants to M.M.), a Canada Research Chair (to I.P.), the Fonds de recherche du Quebec-Sante and the Faculte des etudes superieures et postdoctorales de l'Universite de Montreal (scholarships to J.D.). The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs R., 2000, NEUROPSYCHOLOGY EMOT, P194; Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; Arlinghaus K, 2011, TXB TRAUMATIC BRAIN, P55; Arnal LH, 2015, CURR BIOL, V25, P2051, DOI 10.1016/j.cub.2015.06.043; Aube W, 2015, SOC COGN AFFECT NEUR, V10, P399, DOI 10.1093/scan/nsu067; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beck AT, 2013, MANUAL BECK DEPRESSI; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531; Bigler E.D., 2011, TXB TRAUMATIC BRAIN, P73, DOI DOI 10.1177/1753193410381840; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Callahan BL, 2011, BRAIN COGNITION, V77, P412, DOI 10.1016/j.bandc.2011.08.017; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Dellacherie D, 2011, NEUROPSYCHOLOGIA, V49, P618, DOI 10.1016/j.neuropsychologia.2010.11.008; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P1; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Gosselin N, 2005, BRAIN, V128, P628, DOI 10.1093/brain/awh420; Gosselin N, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12253; Gosselin N, 2007, NEUROPSYCHOLOGIA, V45, P236, DOI 10.1016/j.neuropsychologia.2006.07.012; Gosselin N, 2011, CORTEX, V47, P1116, DOI 10.1016/j.cortex.2011.05.012; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hawk ST, 2009, EMOTION, V9, P293, DOI 10.1037/a0015178; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Iverson GL, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P43; Juslin Patrik, 2011, HDB MUSIC EMOTION TH; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Koelsch S, 2014, NAT REV NEUROSCI, V15, P170, DOI 10.1038/nrn3666; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2011, BRAIN IMPAIR, V12, P165; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Neumann D, 2016, BRAIN IMAGING BEHAV, V10, P569, DOI 10.1007/s11682-015-9415-3; Peretz I., 2010, HDB MUSIC EMOTION TH; Peretz I, 2013, EVOLUTION EMOTIONAL, P277; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Roy S, STOIC DATABASE DYNAM; Rymarczyk K, 2011, INT J PSYCHOPHYSIOL, V79, P330, DOI 10.1016/j.ijpsycho.2010.11.001; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Sarkamo T, 2012, ANN NY ACAD SCI, V1252, P266, DOI 10.1111/j.1749-6632.2011.06405.x; Sarkamo T, 2010, J COGNITIVE NEUROSCI, V22, P2716, DOI 10.1162/jocn.2009.21376; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Trautmann SA, 2009, BRAIN RES, V1284, P100, DOI 10.1016/j.brainres.2009.05.075; Vandekerckhove M, 2014, NEUROPSYCHOLOGY, V28, P605, DOI 10.1037/neu0000057; VieIllard S, 2008, COGNITION EMOTION, V22, P720, DOI 10.1080/02699930701503567; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Zupan B, 2014, BRAIN INJURY, V28, P1087, DOI 10.3109/02699052.2014.901560	66	13	13	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	2					221	229		10.1080/02699052.2016.1208846			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EM2RO	WOS:000395163500010	28067551				2022-02-06	
J	Gooden, JR; Ponsford, JL; Charlton, JL; Ross, PE; Marshall, S; Gagnon, S; Bedard, M; Stolwyk, RJ				Gooden, James R.; Ponsford, Jennie L.; Charlton, Judith L.; Ross, Pamela E.; Marshall, Shawn; Gagnon, Sylvain; Bedard, Michel; Stolwyk, Renerus J.			Self-Awareness and Self-Ratings of On-Road Driving Performance After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						driving; rehabilitation; self-awareness; traumatic brain injury	FOLLOW-UP; COMMUNITY INTEGRATION; ACCIDENT RATE; PREDICTORS; DEFICITS; RETURN; MODERATE; DRIVERS; AGE	Objective: To examine self-rated, clinician-rated, and self-awareness of on-road driving performance in individuals with traumatic brain injury (TBI) deemed fit and unfit to resume driving and healthy controls, and to explore their associations with demographic, injury, cognitive, and mood variables. Methods: Participants included 37 individuals with moderate to severe TBI, and 49 healthy age, sex, and education-matched controls from Australia and Canada. Participants completed an on-road assessment, the Brain Injury Driving Self-Awareness Measure (BIDSAM), and a comprehensive neuropsychological assessment. Results: Awareness scores on the BIDSAM were significantly different between groups, F(2, 83) = 28.44 (P < .001; eta(2) = 0.41), with post hoc tests indicating TBI participants who failed the on-road assessment had worse scores compared with those who passed and controls. Poor self-awareness was significantly correlated with reduced psychomotor speed (r(s) = -0.37; P < .01) and attentional switching (r(s) = 0.28; P < .01). Worse self-ratings of driving were associated with depression (r(s) = 0.42; P < .01) and anxiety (r(s) = 0.38; P < .01). Conclusions: Individuals with TBI who failed an on-road assessment significantly overestimated their driving ability. Impaired cognitive function was associated with reduced self-awareness of driving. These findings suggest impaired awareness of driving may need to be addressed as part of driver rehabilitation programs.	[Gooden, James R.; Ponsford, Jennie L.; Stolwyk, Renerus J.] Monash Univ, Sch Psychol Sci, 18 Innovat Walk,Clayton Campus, Clayton, Vic 3800, Australia; [Ponsford, Jennie L.] Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Charlton, Judith L.] Monash Univ, Accid Res Ctr, Clayton, Vic, Australia; [Ross, Pamela E.] Epworth Rehabil, Richmond, Vic, Australia; [Marshall, Shawn] Univ Ottawa, Dept ofMedicine, Ottawa, ON, Canada; [Gagnon, Sylvain] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada; [Bedard, Michel] Lakehead Univ, Ctr Res & Safe Driving, Thunder Bay, ON, Canada		Stolwyk, RJ (corresponding author), Monash Univ, Sch Psychol Sci, 18 Innovat Walk,Clayton Campus, Clayton, Vic 3800, Australia.	rene.stolwyk@monash.edu		Gooden, James/0000-0001-6835-9528; Charlton, Judith/0000-0002-5990-2151	Transport Accident Commission (Victoria, Australia); Ontario Neurotrauma Foundation (Ontario, Canada); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL108974] Funding Source: NIH RePORTER	This research project was jointly funded by the Transport Accident Commission (Victoria, Australia) and the Ontario Neurotrauma Foundation (Ontario, Canada).	Ackerman ML, 2010, TRANSPORT RES F-TRAF, V13, P307, DOI 10.1016/j.trf.2010.06.003; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1997, HAYLING BRIXTON TEST; Charlton JL, 2006, TRANSPORT RES F-TRAF, V9, P363, DOI 10.1016/j.trf.2006.06.006; Clare L, 2010, AGING MENT HEALTH, V14, P20, DOI 10.1080/13607860903421029; Colarusso R.P., 2003, MOTOR FREE VISUAL PE; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Gooden JR, 2015, DEV BRAIN INJU UNPUB; Grice KO, 2003, AM J OCCUP THER, V57, P570; Griffen JA, 2011, CLIN NEUROPSYCHOL, V25, P1158, DOI 10.1080/13854046.2011.609841; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Jones SJ., 2008, BRIT J OCCUP THER, V71, P44, DOI DOI 10.1177/030802260807100202; Labbe DR, 2014, J HEAD TRAUMA REHAB, V29, P185, DOI 10.1097/HTR.0b013e3182795211; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; McBrinn J, 2008, BRAIN INJURY, V22, P765, DOI 10.1080/02699050802372208; Meng A, 2015, J APPL GERONTOL, V34, pNP62, DOI 10.1177/0733464812463433; Molnar LJ, 2013, TRANSPORT RES F-TRAF, V20, P29, DOI 10.1016/j.trf.2013.05.001; Morton N, 2010, J INT NEUROPSYCH SOC, V16, P1089, DOI 10.1017/S1355617710000925; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Preece MHW, 2011, J NEUROL NEUROSUR PS, V82, P447, DOI 10.1136/jnnp.2010.215228; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Reitan R, 1988, HALSTEAD REITAN NEUR; Richardson C, 2015, J HEAD TRAUMA REHAB, V30, pE43, DOI 10.1097/HTR.0000000000000048; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Smith A., 1991, SYMBOL DIGIT MODALIT; Tabachnick B. G., 2006, USING MULTIVARIATE S, V5th; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tuokko H, 2013, ACCIDENT ANAL PREV, V61, P267, DOI 10.1016/j.aap.2013.02.036; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Vlahodimitrakou Z, 2013, ACCIDENT ANAL PREV, V61, P253, DOI 10.1016/j.aap.2013.03.027; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	53	13	13	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2017	32	1					E50	E59		10.1097/HTR.0000000000000212			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EI2GH	WOS:000392304400013	26828715				2022-02-06	
J	Halstrom, A; MacDonald, E; Neil, C; Arendts, G; Fatovich, D; Fitzgerald, M				Halstrom, Alison; MacDonald, Ellen; Neil, Claire; Arendts, Glenn; Fatovich, Daniel; Fitzgerald, Melinda			Elevation of oxidative stress indicators in a pilot study of plasma following traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Biomarkers; Traumatic brain injury; Oxidative stress; Hydroxynonenal	S100B	Traumatic brain injury (TBI) encompasses a broad range of injury mechanisms and severity. A detailed determination of TBI severity can be a complex challenge, with current clinical tools sometimes insufficient to tailor a clinical response to a spectrum of patient needs. Blood biomarkers of TBI may supplement clinical assessments but currently available biomarkers have limited sensitivity and specificity. While oxidative stress is known to feature in damage mechanisms following TBI, investigation of blood biomarkers of oxidative stress has been limited. This exploratory pilot study of a subset of 18 trauma patients with TBI of varying severity, quantifies circulating concentrations of the structural damage indicators S100b, and myelin basic protein (MBP), and the biomarkers of oxidative stress hydroxynonenal (HNE), malondialdehyde (MDA), carboxy-methyl-lysine (CML), and 8-hydroxy-2'-deoxy-guanosine (8-OHDG). Significant increases in circulating S100b, MBP, and HNE were observed in TBI patient samples compared to 8 uninjured controls, and there was a significant decrease in CML. This small exploratory study supports the current literature on S100b and MBP elevation in TBI, and reveals potential for the use of peripheral oxidative stress markers to assist in determination of TBI severity. Further investigation is required to validate results and confirm trends. (C) 2016 Elsevier Ltd. All rights reserved.	[Halstrom, Alison; Fitzgerald, Melinda] Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Perth, WA 6009, Australia; [MacDonald, Ellen; Arendts, Glenn] Univ Western Australia, Royal Perth Hosp, Emergency Med, Perth, WA, Australia; [MacDonald, Ellen; Neil, Claire; Arendts, Glenn; Fatovich, Daniel] Harry Perkins Inst Med Res, Ctr Clin Res Emergency Med, Perth, WA, Australia		Fitzgerald, M (corresponding author), Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Perth, WA 6009, Australia.	20947223@student.uwa.edu.au; ellen.macdonald@uwa.edu.au; claire.neil@uwa.edu.au; glenn.arendts@uwa.edu.au; daniel.fatovich@health.wa.gov.au; lindy.fitzgerald@uwa.edu.au	Fitzgerald, Melinda/C-4235-2011; Fatovich, Daniel/J-5510-2013	Fitzgerald, Melinda/0000-0002-4823-8179; Arendts, Glenn/0000-0001-7830-7756; Fatovich, Daniel/0000-0001-9414-6905	National Health and Medical Research Council, AustraliaNational Health and Medical Research Council of Australia [APP1087114]	MF is supported by a National Health and Medical Research Council, Australia, Career Development Fellowship (APP1087114).	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Arendts G, 2012, EMERG MED AUSTRALAS, V24, P31, DOI 10.1111/j.1742-6723.2011.01500.x; Bar B, 2011, STROKE, V42, P2944, DOI 10.1161/STROKEAHA.111.617639; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Boehm BO, 2004, DIABETOLOGIA, V47, P1376, DOI 10.1007/s00125-004-1455-y; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bruce ED, 2015, MOL CELL NEUROSCI, V66, P103, DOI 10.1016/j.mcn.2015.03.017; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Helps Y, 2008, INJ RES STAT SER, V45; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Lee WC, 2012, BIOCHEM BIOPH RES CO, V425, P842, DOI 10.1016/j.bbrc.2012.08.002; Mendez DR, 2004, J TRAUMA, V56, P1235, DOI 10.1097/01.TA.0000130759.62286.0E; Nielsen F, 1997, CLIN CHEM, V43, P1209; Ohrt-Nissen S, 2011, EMERG MED J, V28, P941, DOI 10.1136/emj.2010.091363; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; Siman R, 2014, J NEUROTRAUM, V32, P1; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Teasdale G, 1971, LANCET, V3; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	23	13	14	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JAN	2017	35						104	108		10.1016/j.jocn.2016.09.006			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EI2YS	WOS:000392356700023	27697434	Green Submitted			2022-02-06	
J	Kikinis, Z; Muehlmann, M; Pasternak, O; Peled, S; Kulkarni, P; Ferris, C; Bouix, S; Rathi, Y; Koerte, IK; Pieper, S; Yarmarkovich, A; Porter, CL; Kristal, BS; Shenton, ME				Kikinis, Zora; Muehlmann, Marc; Pasternak, Ofer; Peled, Sharon; Kulkarni, Praveen; Ferris, Craig; Bouix, Sylvain; Rathi, Yogesh; Koerte, Inga K.; Pieper, Steve; Yarmarkovich, Alexander; Porter, Caryn L.; Kristal, Bruce S.; Shenton, Martha E.			Diffusion imaging of mild traumatic brain injury in the impact accelerated rodent model: A pilot study	BRAIN INJURY			English	Article						Animal model; mild traumatic brain injury (mTBI); diffusion tensor magnetic resonance imaging (dMRI); fractional anisotropy (FA); impact acceleration injury	AXONAL INJURY; HEAD-INJURY; RATS; DYSFUNCTION; EDEMA	Primary Objective: There is a need to understand pathologic processes of the brain following mild traumatic brain injury (mTBI). Previous studies report axonal injury and oedema in the first week after injury in a rodent model. This study aims to investigate the processes occurring 1 week after injury at the time of regeneration and degeneration using diffusion tensor imaging (DTI) in the impact acceleration rat mTBI model.Research Design: Eighteen rats were subjected to impact acceleration injury, and three rats served as sham controls. Seven days post injury, DTI was acquired from fixed rat brains using a 7T scanner. Group comparison of Fractional Anisotropy (FA) values between traumatized and sham animals was performed using Tract-Based Spatial Statistics (TBSS), a method that we adapted for rats.Main Outcomes and Results: TBSS revealed white matter regions of the brain with increased FA values in the traumatized versus sham rats, localized mainly to the contrecoup region. Regions of increased FA included the pyramidal tract, the cerebral peduncle, the superior cerebellar peduncle and to a lesser extent the fibre tracts of the corpus callosum, the anterior commissure, the fimbria of the hippocampus, the fornix, the medial forebrain bundle and the optic chiasm.Conclusion: Seven days post injury, during the period of tissue reparation in the impact acceleration rat model of mTBI, microstructural changes to white matter can be detected using DTI.	[Kikinis, Zora; Muehlmann, Marc; Pasternak, Ofer; Bouix, Sylvain; Rathi, Yogesh; Koerte, Inga K.; Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, Boston, MA USA; [Muehlmann, Marc; Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Pasternak, Ofer; Peled, Sharon; Bouix, Sylvain; Rathi, Yogesh; Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA; [Kulkarni, Praveen; Ferris, Craig] Northeastern Univ, Dept Psychol, Ctr Translat NeuroImaging, Boston, MA 02115 USA; [Pieper, Steve; Yarmarkovich, Alexander] Isomics Inc, Cambridge, MA USA; [Porter, Caryn L.; Kristal, Bruce S.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA USA; [Shenton, Martha E.] Harvard Med Sch, VA Boston Healthcare Syst, Dept Psychiat, Boston, MA USA		Kikinis, Z (corresponding author), Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, 1249 Boylston St, Boston, MA 02115 USA.	zora@bwh.harvard.edu	Peled, Sharon/ABD-7732-2021; Koerte, Inga Katharina/AAW-3031-2021; Shenton, Martha/V-8780-2019	Kulkarni, Praveen/0000-0002-8876-4544	NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41 EB015902] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD090641] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD090641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015902] Funding Source: NIH RePORTER		Angoa-Perez M, 2014, J NEUROCHEM, V129, P916, DOI 10.1111/jnc.12690; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beauchamp MH, 2011, BRAIN INJURY, V25, P950, DOI 10.3109/02699052.2011.589791; Bigler ED, 2014, BRAIN INJURY, P1; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Cai Yu, 2011, Front Psychiatry, V2, P54, DOI 10.3389/fpsyt.2011.00054; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chang EY, 2014, J MAGN RESON IMAGING, V40, P496, DOI 10.1002/jmri.24360; Cook GA, 2014, MIL MED, V179, P1083, DOI 10.7205/MILMED-D-13-00435; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Drew LB, 2004, NEUROCRIT CARE, V1, P385, DOI 10.1385/NCC:1:3:385; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Faul M, 2010, TRAUMATIC BRAIN INJU; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Guilfoyle DN, 2003, NMR BIOMED, V16, P77, DOI 10.1002/nbm.814; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Laalo JP, 2014, BRAIN INJURY, V28, P66, DOI 10.3109/02699052.2013.857791; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Miller KL, 2011, NEUROIMAGE, V57, P167, DOI 10.1016/j.neuroimage.2011.03.070; Morrison AL, 1998, AM J FOREN MED PATH, V19, P109, DOI 10.1097/00000433-199806000-00002; National Institute for Health and Clinical Excellence, 2014, HEAD INJ TRIAG ASS I; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Sun SW, 2003, MAGN RESON MED, V50, P743, DOI 10.1002/mrm.10605; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; van de Looij Y, 2012, NMR BIOMED, V25, P93, DOI 10.1002/nbm.1721; Vik Anne, 2006, Tidsskr Nor Laegeforen, V126, P2940	40	13	14	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	10					1376	1381		10.1080/02699052.2017.1318450			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GH	WOS:000415961800016	28627942	Green Accepted			2022-02-06	
J	Kolarova, M; Sengupta, U; Bartos, A; Ricny, J; Kayed, R				Kolarova, Michala; Sengupta, Urmi; Bartos, Ales; Ricny, Jan; Kayed, Rakez			Tau Oligomers in Sera of Patients with Alzheimer's Disease and Aged Controls	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; oligomers; serum; tau protein	CEREBROSPINAL FLUID SYSTEM; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; CHOROID-PLEXUS; NEUROFIBRILLARY TANGLES; MOUSE MODEL; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; NEURONAL-ACTIVITY	Although tau protein was long regarded as an intracellular protein with several functions inside the cell, new evidence has shown tau secretion into the extracellular space. The active secretion of tau could be a physiological response of neurons to increased intracellular amounts of tau during the progression of tau pathology. We looked for potential differences in the serum levels of toxic tau oligomers in regards to cognitive impairment of subjects. We detected tau oligomers in the serum of Alzheimer's disease (AD) patients, but they were also present to some extent in the serum of healthy older subjects where the levels positively correlated with aging (Spearman r = 0.26, p = 0.016). On the contrary, we found lower levels of tau oligomers in the serum of mild cognitive impairment (MCI) (p = 0.033) and MCI-AD (p = 0.006) patients. These results could suggest that clearance of extracellular tau proteins takes place, in part, in the periphery. In the case of MCI patients, the lower levels of tau oligomers could be the result of impaired clearance of tau protein from interstitium to blood and consequent accumulation of tau aggregates in the brain.	[Kolarova, Michala; Bartos, Ales; Ricny, Jan] Natl Inst Mental Hlth, Klecany, Czech Republic; [Kolarova, Michala] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Sengupta, Urmi; Kayed, Rakez] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA; [Sengupta, Urmi; Kayed, Rakez] Univ Texas Med Branch, Dept Neurol & Neurosci & Cell Biol, Galveston, TX 77555 USA		Kayed, R (corresponding author), 301 Univ Blvd,Route 1045, Galveston, TX 77555 USA.; Kolarova, M (corresponding author), Topolova 748, Klecany 25067, Czech Republic.	michala.kolarova@nudz.cz; rakayed@utmb.edu	Kolarova, Michala/P-3369-2016; Ricny, Jan/V-1662-2018; Bartos, Ales/C-4353-2019	Kolarova, Michala/0000-0002-5679-540X; Ricny, Jan/0000-0003-2625-057X; Bartos, Ales/0000-0002-8020-8252	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1AG054025, RO1NS094557, LO1611]; MEYS under the NPU I program [GACR 13-26601S, PROGRES Q35]; Alzheimer Foundation Czech Republic (AVASTipendium for the human brain); grant Mobility of Charles University in Prague; Mitchell Center for Neurodegenerative Diseases; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG054025] Funding Source: NIH RePORTER	This study was supported by the grants from National Institute of Health RO1AG054025, RO1NS094557 project Nr. LO1611 with a financial support from the MEYS under the NPU I program, GACR 13-26601S, PROGRES Q35, The Alzheimer Foundation Czech Republic (AVASTipendium for the human brain), grant Mobility of Charles University in Prague and the Mitchell Center for Neurodegenerative Diseases.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Bartos A, 2007, J NEUROL, V254, P20, DOI 10.1007/s00415-006-0185-0; Bartos A, 2012, J NEUROIMMUNOL, V252, P100, DOI 10.1016/j.jneuroim.2012.08.001; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Bitsch A, 2002, EUR NEUROL, V47, P45, DOI 10.1159/000047946; Brion JP, 2001, BIOCHEM SOC SYMP, V67, P81; Brkic M, 2015, J NEUROSCI, V35, P12766, DOI 10.1523/JNEUROSCI.0006-15.2015; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; Castillo-Carranza DL, 2014, J NEUROSCI, V34, P4260, DOI 10.1523/JNEUROSCI.3192-13.2014; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; Cowan CM, 2012, BIOCHEM SOC T, V40, P693, DOI 10.1042/BST20120135; Crossgrove JS, 2005, EXP BIOL MED, V230, P771, DOI 10.1177/153537020523001011; Deisenhammer F, 2006, EUR J NEUROL, V13, P913, DOI 10.1111/j.1468-1331.2006.01493.x; Emerich DF, 2005, BIOESSAYS, V27, P262, DOI 10.1002/bies.20193; Farias G, 2012, J ALZHEIMERS DIS, V31, P65, DOI 10.3233/JAD-2012-120304; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fritschi SK, 2014, BRAIN, V137, P2909, DOI 10.1093/brain/awu255; Holtzman DM, 2011, NEUROBIOL AGING, V32, pS4, DOI 10.1016/j.neurobiolaging.2011.09.003; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Kolarova M., 2012, INT J ALZHEIMERS DIS, V2012, DOI [10.1155/2012/731526, DOI 10.1155/2012/731526]; Krzyzanowska A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00075; Lasagna-Reeves CA, 2011, CURR ALZHEIMER RES, V8, P659; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Liu TL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5686; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; Marques F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-38; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Neumann K, 2011, J ALZHEIMERS DIS, V25, P103, DOI 10.3233/JAD-2011-101641; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Preston JE, 2001, MICROSC RES TECHNIQ, V52, P31, DOI 10.1002/1097-0029(20010101)52:1<31::AID-JEMT5>3.3.CO;2-K; Redzic ZB, 2005, CURR TOP DEV BIOL, V71, P1, DOI 10.1016/S0070-2153(05)71001-2; Sagripanti A, 1998, EXP GERONTOL, V33, P891, DOI 10.1016/S0531-5565(98)00047-3; Saman S, 2014, J ALZHEIMERS DIS, V40, pS47, DOI 10.3233/JAD-132135; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Scheltens P, 1992, Ned Tijdschr Geneeskd, V136, P2459; Sengupta U, 2017, ANN CLIN TRANSL NEUR, V4, P226, DOI 10.1002/acn3.382; Serot JM, 2012, J ALZHEIMERS DIS, V30, P17, DOI 10.3233/JAD-2012-111964; Serot JM, 2003, FRONT BIOSCI-LANDMRK, V8, pS515, DOI 10.2741/1085; Serot JM, 2000, ACTA NEUROPATHOL, V99, P105, DOI 10.1007/PL00007412; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Sparks D Larry, 2012, Am J Neurodegener Dis, V1, P99; Spector R, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-28; Spires-Jones TL, 2011, J MOL NEUROSCI, V45, P438, DOI 10.1007/s12031-011-9566-7; Sui XJ, 2014, NEUROSCI BULL, V30, P233, DOI 10.1007/s12264-013-1412-1; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163	53	13	14	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2017	58	2					471	478		10.3233/JAD-170048			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EX1OP	WOS:000402994400015	28453485				2022-02-06	
J	Li, J; Gao, L; Xie, K; Zhan, J; Luo, XP; Wang, HF; Zhang, HF; Zhao, J; Zhou, FQ; Zeng, XJ; He, LC; He, YL; Gong, HH				Li, Jian; Gao, Lei; Xie, Kai; Zhan, Jie; Luo, Xiaoping; Wang, Huifang; Zhang, Huifang; Zhao, Jing; Zhou, Fuqing; Zeng, Xianjun; He, Laichang; He, Yulin; Gong, Honghan			Detection of Functional Homotopy in Traumatic Axonal Injury	EUROPEAN RADIOLOGY			English	Article						Traumatic axonal injury; Homotopy; Interhemispheric connection; Brain; Resting-state fMRI	BRAIN-INJURY; DIFFUSION-TENSOR; CORPUS-CALLOSUM; WORKING-MEMORY; RATING-SCALE; CONNECTIVITY; STATE; MILD; INTEGRITY; NETWORKS	This study aimed to explore the interhemispheric intrinsic connectivity in traumatic axonal injury (TAI) patients. Twenty-one patients with TAI (14 males, seven females; mean age, 38.71 +/- 15.25 years) and 22 well-matched healthy controls (16 males, six females; mean age, 38.50 +/- 13.82 years) were recruited, and from them we obtained resting-state fMRI data. Interhemispheric coordination was examined using voxel-mirrored homotopic connectivity (VMHC) and seed-based functional connectivity analysis was performed. We observed significantly decreased VMHC in a number of regions in TAI patients, including the prefrontal, temporal, occipital, parietal, and posterior cingulate cortices, thalami and cerebellar posterior lobes. Subsequent seed-based functional connectivity analysis revealed widely disrupted functional connectivity between the regions of local homotopic connectivity deficits and other areas of the brain, particularly the areas subserving the default, salience, integrative, and executive systems. The lower VMHC of the inferior frontal gyrus and basal ganglia, thalamus, and caudate were significant correlated with the Beck Depression Inventory score, Clinical Dementia Rating score, and Mini-Mental State Examination score, respectively. TAI is associated with regionally decreased interhemispheric interactions and extensively disrupted seed-based functional connectivity, generating further evidence of diffuse disconnection being associated with clinical symptoms in TAI patients. aEuro cent Traumatic axonal injury is associated with decreased interhemispheric connectivity aEuro cent Traumatic axonal injury couples with widely disrupted functional connectivity aEuro cent These alterations support the default, salience, integrative, and executive functions.	[Li, Jian; Gao, Lei; Xie, Kai; Zhan, Jie; Luo, Xiaoping; Wang, Huifang; Zhang, Huifang; Zhao, Jing; Zhou, Fuqing; Zeng, Xianjun; He, Laichang; He, Yulin; Gong, Honghan] Nanchang Univ, Affiliated Hosp 1, Dept Radiol, 17 Yongwai Zheng St, Nanchang City 330006, Jiangxi, Peoples R China		Gao, L (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Radiol, 17 Yongwai Zheng St, Nanchang City 330006, Jiangxi, Peoples R China.	ncu6096@126.com; honghan_gong@sina.com		Gao, Lei/0000-0002-0081-0172	National Natural Science Foundations of ChinaNational Natural Science Foundation of China (NSFC) [81260217, 81460263]	The scientific guarantor of this publication is Honghan Gong. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. This study has received funding by the National Natural Science Foundations of China (81260217 and 81460263). One of the authors (Lei Gao) has significant statistical expertise. Institutional Review Board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. Methodology: retrospective, cross sectional study, performed at one institution.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Arenivas A, 2014, BRAIN IMAGING BEHAV, V8, P407, DOI 10.1007/s11682-012-9191-2; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Dal Monte O, 2014, CORTEX, V58, P9, DOI 10.1016/j.cortex.2014.05.002; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hubbard NA, 2015, J CEREB BLOOD FLOW M; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones DT, 2011, ARCH NEUROL-CHICAGO, V68, P242, DOI 10.1001/archneurol.2010.259; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Marchand WR, 2012, NEUROSCI LETT, V514, P86, DOI 10.1016/j.neulet.2012.02.063; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nouri F. M., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Quigley M, 2003, AM J NEURORADIOL, V24, P208; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Saindane AM, 2007, AM J NEURORADIOL, V28, P767; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; SPARROW SS, 1985, J PEDIATR PSYCHOL, V10, P215, DOI 10.1093/jpepsy/10.2.215; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stark DE, 2008, REGIONAL VARIATION I, P13754; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Tyszka JM, 2011, J NEUROSCI, V31, P15154, DOI 10.1523/JNEUROSCI.1453-11.2011; Uddin LQ, 2008, NEUROREPORT, V19, P703, DOI 10.1097/WNR.0b013e3282fb8203; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	64	13	13	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	JAN	2017	27	1					325	335		10.1007/s00330-016-4302-x			11	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Radiology, Nuclear Medicine & Medical Imaging	EE1NX	WOS:000389350100037	27048533				2022-02-06	
J	Li, ZZ; Wang, Y; Zeng, G; Zheng, XW; Wang, WB; Ling, Y; Tang, HM; Zhang, JF				Li, Zhengzhao; Wang, Yong; Zeng, Guang; Zheng, Xiaowen; Wang, Wenbo; Ling, Yun; Tang, Huamin; Zhang, Jianfeng			Increased miR-155 and heme oxygenase-1 expression is involved in the protective effects of formononetin in traumatic brain injury in rats	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Formononetin; phytoestrogen; traumatic brain injury (TBI); miR-155; heme oxygenase-1 (HO-1); BACH1	NRF2-ARE SIGNALING PATHWAY; OXIDATIVE STRESS; CANCER CELLS; DOWN-REGULATION; ACTIVATION; APOPTOSIS; NEUROPROTECTION; MECHANISM; MODELS; BACH1	Oxidative stress has been considered a major contributing factor to traumatic brain injury (TBI). Formononetin, a phytoestrogen that belongs to the flavonoid family, is extracted from plants and herbs such as the red clover. Growing evidence demonstrates that formononetin has antioxidant properties. Therefore, formononetin has potential use in treating oxidative stress injuries in TBI. In this study, the neuroprotective and antioxidant effects of formononetin against TBI, as well as the related probable mechanisms, were investigated. The TBI model was produced in male Wistar rats through Feeney's weight-drop model. At 1 day after TBI, the neurological function score and brain water content were assessed. TUNEL assay was used to determine neuronal apoptosis. The expression levels of miR-155, HO-1, and BACH1 were measured by RT-PCR and western blotting. Consequently, our findings showed that formononetin pretreatment for 5 days significantly improved the neurological scores, reduced brain edema and inhibited neuronal apoptosis in rats after TBI. MiR-155 was substantially decreased and BACH1 expression was significantly increased in the TBI model, while pretreatment with formononetin dramatically up-regulated the expression levels of miR-155 and HO-1 and down-regulated the protein expression of BACH1 in rats after TBI. In summary, formononetin has been shown to have neuroprotective effects, and the mechanisms of this effect may be associated with its inhibition of oxidative stress and activation of Nrf2-dependent antioxidant pathways in TBI.	[Li, Zhengzhao; Zeng, Guang; Zheng, Xiaowen; Ling, Yun; Tang, Huamin; Zhang, Jianfeng] Guangxi Med Univ, Dept Emergency, Affiliated Hosp 2, Nanning 530007, Peoples R China; [Wang, Yong] Guilin Med Univ, Dept Physiol, Guilin 541004, Peoples R China; [Wang, Wenbo] Guilin Med Univ, Dept Neurosurg, Affiliated Hosp, Guilin 541001, Peoples R China		Zhang, JF (corresponding author), Guangxi Med Univ, Dept Emergency, Affiliated Hosp 2, Nanning 530007, Peoples R China.	jianfeng_zhang888@126.com		Zhang, Jianfeng/0000-0003-4213-9310	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [8146-0211, 81560378]; Guangxi Emergency and Medical Rescue Talent Highland [GXJZ-201506]	This work was supported by the National Natural Science Foundation of China (8146-0211, 81560378) and the Guangxi Emergency and Medical Rescue Talent Highland (GXJZ-201506).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Chen J, 2012, HORM METAB RES, V44, P943, DOI 10.1055/s-0032-1321818; Chen J, 2015, FOOD FUNCT, V6, P3091, DOI [10.1039/c5fo00374a, 10.1039/C5FO00374A]; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050957, 10.1371/journal.pone.0051246]; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cheng XH, 2013, FREE RADICAL BIO MED, V64, P4, DOI 10.1016/j.freeradbiomed.2013.07.025; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Engler-Chiurazzi EB, 2017, PROG NEUROBIOL, V157, P188, DOI 10.1016/j.pneurobio.2015.12.008; Li ZZ, 2014, J NEUROL SCI, V338, P112, DOI 10.1016/j.jns.2013.12.027; Liu L, 2014, ADV DIFFER EQU, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0103948; Liu ZW, 2017, NEUROCHEM RES, V42, P1375, DOI 10.1007/s11064-017-2186-z; Lou J, 2016, NEUROCHEM RES, V41, P1291, DOI 10.1007/s11064-016-1826-z; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Pulkkinen KH, 2011, FREE RADICAL BIO MED, V51, P2124, DOI 10.1016/j.freeradbiomed.2011.09.014; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Shu LF, 2016, NEUROSCI LETT, V611, P74, DOI 10.1016/j.neulet.2015.11.012; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Wan C, 2016, TOXICOL APPL PHARM, V295, P85, DOI 10.1016/j.taap.2016.01.023; Wang P, 2016, NEUROCHEM RES, V41, P2627, DOI 10.1007/s11064-016-1975-0; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang T, 2016, J NEUROCHEM, V137, P122, DOI 10.1111/jnc.13534; Yang YQ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00580; Zhang L, 2017, MOL NEUROBIOL; Zhang X, 2014, NUTR CANCER, V66, P656, DOI 10.1080/01635581.2014.894098; Zhou Y, 2016, CLIN REV ALLERG IMMU, V50, P345, DOI 10.1007/s12016-016-8538-7	29	13	14	1	4	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2017	9	12					5653	5661					9	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	FR6YN	WOS:000419213500042	29312517				2022-02-06	
J	McGarity, S; Barnett, SD; Lamberty, G; Kretzmer, T; Powell-Cope, G; Patel, N; Nakase-Richardson, R				McGarity, Suzanne; Barnett, Scott D.; Lamberty, Greg; Kretzmer, Tracy; Powell-Cope, Gail; Patel, Nitin; Nakase-Richardson, Risa			Community Reintegration Problems Among Veterans and Active Duty Service Members With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						community reintegration; driving; employment; Model Systems; mTBI; NIDRR; OEF/OIF; polytrauma; TBIMS; traumatic brain injury; VA; veterans	GENERALIZED ANXIETY DISORDER; PARTICIPATION ASSESSMENT; MAJOR DEPRESSION; RATING-SCALE; INTEGRATION; HEALTH; SOLDIERS; RETURN; PEOPLE; VALIDATION	Objectives: To examine community reintegration problems among Veterans and military service members with mild or moderate/severe traumatic brain injury (TBI) at 1 year postinjury and to identify unique predictors that may contribute to these difficulties. Setting: VA Polytrauma Rehabilitation Centers. Participants: Participants were 154 inpatients enrolled in the VA TBI Model Systems Program with available injury severity data (mild = 28.6%; moderate/severe = 71.4%) and 1-year postinjury outcome data. Design: Prospective, longitudinal cohort. Main Measures: Community reintegration outcomes included independent driving, employability, and general community participation. Additional measures assessed depression, posttraumatic stress, and cognitive and motor functioning. Results: In the mild TBI (mTBI) group, posttraumatic stress disorder and depressive symptoms were associated with lower levels of various community reintegration outcomes. In the moderate/severe TBI group, cognition and motor skills were significantly associated with lower levels of community participation, independent driving, and employability. Conclusion: Community reintegration is problematic for Veterans and active duty service members with a history of TBI. Unique comorbidities across injury severity groups inhibit full reintegration into the community. These findings highlight the ongoing rehabilitation needs of persons with TBI, specifically evidence-based mental healthcare, in comprehensive rehabilitation programs consistent with a chronic disease management model.	[McGarity, Suzanne; Barnett, Scott D.; Lamberty, Greg; Kretzmer, Tracy; Powell-Cope, Gail; Patel, Nitin; Nakase-Richardson, Risa] Univ S Florida, James A Haley Vet Hosp, Dept Med, Tampa, FL USA		McGarity, S (corresponding author), James A Haley Vet Hosp, 13000 Bruce B Downs Blvd,MC 116 B, Tampa, FL 33612 USA.	Suzanne.McGarity@va.gov			VHA Central Office Division of Rehabilitation Medicine Health Services Research and Development [HSRD SDR 13-228]; VA TBI Model System Program of Research; General Dynamics Information Technology from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC) [W91YTZ-13-C-0015]; Department of Veterans Affairs, National Institute on Disability, Independent Living, and Rehabilitation Research; Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research	This research is sponsored by VHA Central Office Division of Rehabilitation Medicine Health Services Research and Development (HSRD SDR 13-228), VA TBI Model System Program of Research, and Subcontract from General Dynamics Information Technology (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC). The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research. The authors acknowledge DVBIC personnel for their contribution to this study including collection of follow-up data and ongoing collaborative efforts at improving data collection efficiency in TBIMS. These individuals include Katherine Levie; Jennifer Boyce, RN; Adam Haskin; Joyce Chung, MPH; and Tiffany Amos. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Department of Defense position or any other federal agency, policy, or decision unless so designated by other official documentation.	Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1749, DOI 10.1016/j.apmr.2004.07.348; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; Brenner LA, 2015, REHABIL PSYCHOL, V60, P277, DOI 10.1037/rep0000048; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Bushnik T, 2008, ARCH PHYS MED REHAB, V89, P894, DOI 10.1016/j.apmr.2008.03.001; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Classen S, 2011, AM J OCCUP THER, V65, P419, DOI 10.5014/ajot.2011.000893; Coleman Bryer R, 2005, DRIVER REHABILITATIO, P165; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dobie DJ, 2002, GEN HOSP PSYCHIAT, V24, P367, DOI 10.1016/S0163-8343(02)00207-4; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Graves DE, 2008, J SPINAL CORD MED, V31, P177, DOI 10.1080/10790268.2008.11760709; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hannold EM, 2013, J REHABIL RES DEV, V50, P1315, DOI 10.1682/JRRD.2013.04.0084; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hundt Natalie E, 2015, Psychol Trauma, V7, P539, DOI 10.1037/tra0000035; Institute of Medicine (IOM), 2008, GULF WAR HLTH, V7; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kang HK, 1996, NEW ENGL J MED, V335, P1498, DOI 10.1056/NEJM199611143352006; Kelley AM, 2012, J PSYCHIATR RES, V46, P582, DOI 10.1016/j.jpsychires.2012.01.017; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Lew HL, 2010, NEUROREHABILITATION, V26, P271, DOI 10.3233/NRE-2010-0562; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Rauch SAM, 2009, DEPRESS ANXIETY, V26, P732, DOI 10.1002/da.20518; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Smith TC, 2007, ANN EPIDEMIOL, V17, P525, DOI 10.1016/j.annepidem.2006.12.002; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; U.S. Department of Veterans Affairs & Department of Defense, 2010, VA DOD CLIN PRACT GU; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Weathers F.W., 1993, ANN CONV INT SOC TRA; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002	70	13	13	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2017	32	1					34	45		10.1097/HTR.0000000000000242			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EI2GH	WOS:000392304400004	27323217				2022-02-06	
J	Milakara, D; Grozea, C; Dahlem, M; Major, S; Winkler, MKL; Luckl, J; Scheel, M; Kola, V; Schoknecht, K; Lublinsky, S; Friedman, A; Martus, P; Hartings, JA; Woitzik, J; Dreier, JP				Milakara, Denny; Grozea, Cristian; Dahlem, Markus; Major, Sebastian; Winkler, Maren K. L.; Lueckl, Janos; Scheel, Michael; Kola, Vasilis; Schoknecht, Karl; Lublinsky, Svetlana; Friedman, Alon; Martus, Peter; Hartings, Jed A.; Woitzik, Johannes; Dreier, Jens P.			Simulation of spreading depolarization trajectories in cerebral cortex: Correlation of velocity and susceptibility in patients with aneurysmal subarachnoid hemorrhage	NEUROIMAGE-CLINICAL			English	Article						Cytotoxic edema; Ischemia; Spreading depression; Stroke; Subarachnoid hemorrhage; Traumatic brain injury	BLOOD-FLOW; HEMODYNAMIC-RESPONSES; ANOXIC DEPOLARIZATION; DEPRESSION WAVES; ISCHEMIC DAMAGE; IMAGING REVEALS; NMDA-RECEPTOR; MIGRAINE AURA; NITRIC-OXIDE; PROPAGATION	In many cerebral grey matter structures including the neocortex, spreading depolarization (SD) is the principal mechanism of the near-complete breakdown of the transcellular ion gradients with abrupt water influx into neurons. Accordingly, SDs are abundantly recorded in patients with traumatic brain injury, spontaneous intracerebral hemorrhage, aneurysmal subarachnoid hemorrhage (aSAH) and malignant hemispheric stroke using subdural electrode strips. SD is observed as a large slow potential change, spreading in the cortex at velocities between 2 and 9 mm/min. Velocity and SD susceptibility typically correlate positively in various animal models. In patients monitored in neurocritical care, the Co-Operative Studies on Brain Injury Depolarizations (COSBID) recommends several variables to quantify SD occurrence and susceptibility, although accurate measures of SD velocity have not been possible. Therefore, we developed an algorithm to estimate SD velocities based on reconstructing SD trajectories of the wave-front's curvature center from magnetic resonance imaging scans and time-of-SD-arrival-differences between subdural electrode pairs. We then correlated variables indicating SD susceptibility with algorithm-estimated SD velocities in twelve aSAH patients. Highly significant correlations supported the algorithm's validity. The trajectory search failed significantly more often for SDs recorded directly over emerging focal brain lesions suggesting in humans similar to animals that the complexity of SD propagation paths increase in tissue undergoing injury.	[Milakara, Denny; Major, Sebastian; Winkler, Maren K. L.; Lueckl, Janos; Kola, Vasilis; Schoknecht, Karl; Dreier, Jens P.] Humboldt Univ, Charite Univ Med Berlin, Ctr Stroke Res, Freie Univ Berlin, Charite Campus Mitte,Charitepl 1, D-10117 Berlin, Germany; [Milakara, Denny; Major, Sebastian; Winkler, Maren K. L.; Lueckl, Janos; Scheel, Michael; Kola, Vasilis; Schoknecht, Karl; Woitzik, Johannes; Dreier, Jens P.] Berlin Inst Hlth, Charitepl 1, D-10117 Berlin, Germany; [Grozea, Cristian] VISCOM Visual Comp Fraunhofer Inst Open Commun Sy, Berlin, Germany; [Dahlem, Markus] Humboldt Univ, Dept Phys, Berlin, Germany; [Major, Sebastian; Dreier, Jens P.] Humboldt Univ, Charite Univ Med Berlin, Dept Neurol, Freie Univ Berlin, Berlin, Germany; [Major, Sebastian; Schoknecht, Karl; Dreier, Jens P.] Humboldt Univ, Charite Univ Med Berlin, Dept Expt Neurol, Freie Univ Berlin, Berlin, Germany; [Scheel, Michael] Humboldt Univ, Charite Univ Med Berlin, Dept Neuroradiol, Freie Univ Berlin, Berlin, Germany; [Lublinsky, Svetlana; Friedman, Alon] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Neurobiol, Beer Sheva, Israel; [Lublinsky, Svetlana; Friedman, Alon] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel; [Friedman, Alon] Dalhousie Univ, Fac Med, Dept Med Neurosci, Halifax, NS, Canada; [Martus, Peter] Univ Tubingen, Inst Clin Epidemiol & Appl Biometry, Tubingen, Germany; [Hartings, Jed A.] Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA; [Woitzik, Johannes] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Neurosurg, Berlin, Germany		Dreier, JP (corresponding author), Humboldt Univ, Charite Univ Med Berlin, Ctr Stroke Res, Freie Univ Berlin, Charite Campus Mitte,Charitepl 1, D-10117 Berlin, Germany.; Dreier, JP (corresponding author), Berlin Inst Hlth, Charitepl 1, D-10117 Berlin, Germany.	jens.dreier@charite.de	Scheel, Michael/M-2350-2019; Luckl, Janos/ABF-7183-2021; Milakara, Denny/AAL-8129-2021; Major, Sebastian/I-1838-2019	Luckl, Janos/0000-0001-8094-771X; Milakara, Denny/0000-0003-3148-6122; Major, Sebastian/0000-0003-0970-1308; , Alon/0000-0003-4780-8456; Hartings, Jed/0000-0001-8583-3471; Scheel, Michael/0000-0002-3505-2914; Woitzik, Johannes/0000-0002-1865-4606	Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin)Federal Ministry of Education & Research (BMBF) [01 EO 0801, BCCN 01GQ1001C B2]; NeuroCure SESAH [EXC 257/2]; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [DR 323/5-1]; Mayfield Education and Research Foundation	This work was supported by the Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin, 01 EO 0801; BCCN 01GQ1001C B2) and NeuroCure SESAH (EXC 257/2) to Dr. Dreier JP and Deutsche Forschungsgemeinschaft (DFG DR 323/5-1) to Drs. Dreier JP, Martus P, and Woitzik J and Mayfield Education and Research Foundation to Dr. Hartings JA.	Aitken PG, 1998, J NEUROPHYSIOL, V80, P1514, DOI 10.1152/jn.1998.80.3.1514; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BACK T, 1994, J CEREBR BLOOD F MET, V14, P12, DOI 10.1038/jcbfm.1994.3; Basarsky TA, 1998, J NEUROSCI, V18, P7189; Bere Z, 2014, NEUROSCIENCE, V260, P217, DOI 10.1016/j.neuroscience.2013.12.032; Bere Z, 2014, J CEREBR BLOOD F MET, V34, P1695, DOI 10.1038/jcbfm.2014.136; Bogdanov VB, 2011, NEUROBIOL DIS, V41, P430, DOI 10.1016/j.nbd.2010.10.014; Bosche B, 2010, ANN NEUROL, V67, P607, DOI 10.1002/ana.21943; Bowyer SM, 2001, ANN NEUROL, V50, P582, DOI 10.1002/ana.1293; Bruce DA, 2000, CHILD NERV SYST, V16, P724, DOI 10.1007/s003810000336; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Cain SM, 2017, P NATL ACAD SCI USA, V114, P2401, DOI 10.1073/pnas.1614447114; Chen SB, 2006, NEUROSCI LETT, V396, P132, DOI 10.1016/j.neulet.2005.11.025; Dahlem MA, 2004, ANN PHYS-BERLIN, V13, P442, DOI 10.1002/andp.200410087; Dahlem MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005007; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Crespigny A, 1998, J CEREBR BLOOD F MET, V18, P1008, DOI 10.1097/00004647-199809000-00010; de Crespigny AJ, 1999, STROKE, V30, P2212, DOI 10.1161/01.STR.30.10.2212; Desbrun M, 1999, COMP GRAPH, P317; Dhir A, 2012, NEUROSCI LETT, V514, P67, DOI 10.1016/j.neulet.2012.02.058; Dijkhuizen RM, 1999, BRAIN RES, V840, P194, DOI 10.1016/S0006-8993(99)01769-2; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2017, P NATL ACAD SCI USA, V114, P2112, DOI 10.1073/pnas.1700760114; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2013, NEUROSCIENTIST, V19, P25, DOI 10.1177/1073858412453340; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Drenckhahn C, 2016, J CLIN NEUROPHYSIOL, V33, P250, DOI 10.1097/WNP.0000000000000274; Eikermann-Haerter K, 2009, J CLIN INVEST, V119, P99, DOI 10.1172/JCI36059; Eiselt M, 2004, BRAIN RES, V1028, P83, DOI 10.1016/j.brainres.2004.09.002; Eross L, 2009, J NEUROSURG, V110, P327, DOI 10.3171/2008.6.JNS17611; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Farkas E, 2010, NEUROIMAGE, V51, P734, DOI 10.1016/j.neuroimage.2010.02.055; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fujita S, 2016, CEREB CORTEX, V26, P1580, DOI 10.1093/cercor/bhu336; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P308, DOI 10.1152/jn.1956.19.4.308; HABLITZ JJ, 1989, DEV BRAIN RES, V46, P243, DOI 10.1016/0165-3806(89)90288-5; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; HAGLUND MM, 1985, BRAIN RES, V343, P198, DOI 10.1016/0006-8993(85)91180-1; HAGLUND MM, 1990, J NEUROPHYSIOL, V63, P225, DOI 10.1152/jn.1990.63.2.225; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1857, DOI 10.1177/0271678X16653135; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Helbok R, 2017, J CEREBR BLOOD F MET, V37, P1871, DOI 10.1177/0271678X16651269; HERRERAS O, 1993, BRAIN RES, V610, P276, DOI 10.1016/0006-8993(93)91411-K; Hinzman JM, 2015, EXP NEUROL, V267, P243, DOI 10.1016/j.expneurol.2015.03.014; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; James MF, 1999, J PHYSIOL-LONDON, V519, P415, DOI 10.1111/j.1469-7793.1999.0415m.x; Jarvis CR, 2001, CEREB CORTEX, V11, P249, DOI 10.1093/cercor/11.3.249; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Kaufmann D, 2017, J CEREBR BLOOD F MET, V37, P1748, DOI 10.1177/0271678X16659496; Kneer F, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/5/053010; KOROLEVA VI, 1979, BRAIN RES, V173, P209, DOI 10.1016/0006-8993(79)90622-X; Koroleva VI, 1996, P NATL ACAD SCI USA, V93, P3710, DOI 10.1073/pnas.93.8.3710; Kudo C, 2008, EXP NEUROL, V212, P201, DOI 10.1016/j.expneurol.2008.03.026; LAURITZEN M, 1983, ANN NEUROL, V13, P633, DOI 10.1002/ana.410130609; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; LEAO AAP, 1945, J NEUROPHYSIOL, V8, P33; Lindquist BE, 2017, J CEREBR BLOOD F MET, V37, P1656, DOI 10.1177/0271678X16650696; Major S, 2017, J CEREBR BLOOD F MET, V37, P1687, DOI 10.1177/0271678X16639059; Makarova J, 2010, J NEUROPHYSIOL, V103, P2446, DOI 10.1152/jn.01045.2009; MARRANNES R, 1988, BRAIN RES, V457, P226, DOI 10.1016/0006-8993(88)90690-7; MARSHALL WH, 1959, PHYSIOL REV, V39, P239, DOI 10.1152/physrev.1959.39.2.239; MARTINSFERREIRA H, 1974, J NEUROPHYSIOL, V37, P773, DOI 10.1152/jn.1974.37.4.773; Maslarova A, 2011, STROKE, V42, P2917, DOI 10.1161/STROKEAHA.111.621581; Mazel T, 2002, PHYSIOL RES, V51, pS85; Menyhart A, 2015, NEUROBIOL AGING, V36, P3269, DOI 10.1016/j.neurobiolaging.2015.08.014; Merkler D, 2009, ANN NEUROL, V66, P355, DOI 10.1002/ana.21746; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; Nallet H, 1999, BRAIN RES, V842, P148, DOI 10.1016/S0006-8993(99)01859-4; Obeidat AS, 2000, J CEREBR BLOOD F MET, V20, P412, DOI 10.1097/00004647-200002000-00024; OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406; Oliveira-Ferreira AI, 2010, J CEREBR BLOOD F MET, V30, P1504, DOI 10.1038/jcbfm.2010.40; PEREZPINON MA, 1995, J NEUROPHYSIOL, V74, P565, DOI 10.1152/jn.1995.74.2.565; Petzold GC, 2008, STROKE, V39, P1292, DOI 10.1161/STROKEAHA.107.500710; Petzold GC, 2005, STROKE, V36, P1270, DOI 10.1161/01.STR.0000166023.51307.e0; Pluta RM, 2009, NEUROL RES, V31, P151, DOI 10.1179/174313209X393564; RICHTER F, 1993, NEUROSCI LETT, V152, P65, DOI 10.1016/0304-3940(93)90484-3; Rungta RL, 2015, CELL, V161, P610, DOI 10.1016/j.cell.2015.03.029; Santos E, 2017, J CEREBR BLOOD F MET, V37, P2639, DOI 10.1177/0271678X16689801; Santos E, 2014, NEUROIMAGE, V99, P244, DOI 10.1016/j.neuroimage.2014.05.021; Sawant-Pokam PM, 2017, CEREB CORTEX, V27, P1311, DOI 10.1093/cercor/bhv328; Scholl MJ, 2017, J CEREBR BLOOD F MET, V37, P1706, DOI 10.1177/0271678X16668988; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; SHIBATA M, 1972, J NEUROPHYSIOL, V35, P381, DOI 10.1152/jn.1972.35.3.381; Shirman L. A., 1990, CONSTRUCTION SMOOTH; Steffensen AB, 2015, J NEUROSCI, V35, P12172, DOI 10.1523/JNEUROSCI.0400-15.2015; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Sukhotinsky I, 2011, CEPHALALGIA, V31, P1601, DOI 10.1177/0333102411425865; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Theis M, 2003, J NEUROSCI, V23, P766; ULMER HJ, 1995, BRAIN RES, V691, P239, DOI 10.1016/0006-8993(95)00737-B; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; Van Harreveld A., 1967, Journal of Neurophysiology, V30, P911; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; Winkler MKL, 2017, J CEREBR BLOOD F MET, V37, P1841, DOI 10.1177/0271678X16641424; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932; WOODS RP, 1994, NEW ENGL J MED, V331, P1689, DOI 10.1056/NEJM199412223312505; Zandt BJ, 2013, J NEUROSCI, V33, P5915, DOI 10.1523/JNEUROSCI.5115-12.2013	110	13	13	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	16						524	538		10.1016/j.nicl.2017.09.005			15	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FK1IU	WOS:000413235100056	28948141	gold, Green Published			2022-02-06	
J	Parrott, DJ; Swartout, KM; Eckhardt, CI; Subramani, OS				Parrott, Dominic J.; Swartout, Kevin M.; Eckhardt, Christopher I.; Subramani, Olivia S.			Deconstructing the associations between executive functioning, problematic alcohol use and intimate partner aggression: A dyadic analysis	DRUG AND ALCOHOL REVIEW			English	Article						intimate partner violence; heavy drinking; domestic violence; emotion regulation; actor-partner interdependence model	BEHAVIOR RATING INVENTORY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CONFIRMATORY FACTOR-ANALYSIS; TRAUMATIC BRAIN-INJURY; FUNCTION-ADULT VERSION; NEUROPSYCHOLOGICAL MEASURES; CONCEPTUAL-FRAMEWORK; ANTISOCIAL-BEHAVIOR; PHYSICAL AGGRESSION; DOMESTIC VIOLENCE	Introduction and AimsProblematic drinking and executive functioning deficits are two known risk factors for intimate partner aggression (IPA). However, executive functioning is a multifaceted construct, and it is not clear whether deficits in specific components of executive functioning are differentially associated with IPA perpetration generally and within the context of problematic alcohol use. To address this question, the present study investigated the effects of problematic drinking and components of executive functioning on physical IPA perpetration within a dyadic framework. Design and MethodsParticipants were 582 heavy drinking couples (total n=1164) with a recent history of psychological and/or physical IPA recruited from two metropolitan cities in the USA. Multilevel models were used to examine effects within an actor-partner interdependence framework. ResultsThe highest levels of physical IPA were observed among actors who reported everyday consequences of executive functioning deficits related to emotional dysregulation whose partners were problematic drinkers. However, the association between executive functioning deficits related to emotional dysregulation and IPA was stronger towards partners who were non-problematic drinkers relative to partners who were problematic drinkers. No such effect was found for executive functioning deficits related to behavioural regulation. Discussion and ConclusionsResults provide insight into how problematic drinking and specific executive functioning deficits interact dyadically in relation to physical IPA perpetration. [Parrott DJ, Swartout KM, Eckhardt CI, Subramani OS. Deconstructing the associations between executive functioning, problematic alcohol use and intimate partner aggression: A dyadic analysis. Drug Alcohol Rev 2017;36:88-96]	[Parrott, Dominic J.; Swartout, Kevin M.; Subramani, Olivia S.] Georgia State Univ, Dept Psychol, POB 5010, Atlanta, GA 30302 USA; [Eckhardt, Christopher I.] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA		Parrott, DJ (corresponding author), Georgia State Univ, Dept Psychol, POB 5010, Atlanta, GA 30302 USA.	parrott@gsu.edu		Eckhardt, Christopher/0000-0001-6118-3611	National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01-AA-020578]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA020578] Funding Source: NIH RePORTER	This research was supported by grant R01-AA-020578 from the National Institute on Alcohol Abuse and Alcoholism awarded to the 1st and 3rd authors.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson V., 2008, EXECUTIVE FUNCTIONS; Babor TF, 2001, AUDIT ALCOHOL USE DI; Birkley EL, 2015, CLIN PSYCHOL REV, V37, P40, DOI 10.1016/j.cpr.2015.01.002; Black M C., 2011, NATL INTIMATE PARTNE; Bueso-Izquierdo N, 2015, AGGRESS VIOLENT BEH, V25, P243, DOI 10.1016/j.avb.2015.09.009; Chang WP, 2009, J PSYCHOPHYSIOL, V23, P113, DOI 10.1027/0269-8803.23.3.113; Cook WL, 2005, INT J BEHAV DEV, V29, P101, DOI 10.1080/01650250444000405; Corvo K, 2014, PARTN ABUSE, V5, P342, DOI 10.1891/1946-6560.5.3.342; Corvo K, 2013, AGGRESS VIOLENT BEH, V18, P175, DOI 10.1016/j.avb.2012.11.017; Crane CA, 2014, AGGRESSIVE BEHAV, V40, P440, DOI 10.1002/ab.21533; Deaux K., 2012, OXFORD HDB PERSONALI, P209, DOI DOI 10.1093/OXFORDHB/9780195398991.013.0009; Denckla MB, 2002, CHILD NEUROPSYCHOL, V8, P304, DOI 10.1076/chin.8.4.304.13512; Devries KM, 2014, ADDICTION, V109, P379, DOI 10.1111/add.12393; DeWall CN, 2011, PSYCHOL VIOLENCE, V1, P245, DOI 10.1037/a0023842; Donders J, 2016, ARCH CLIN NEUROPSYCH, V31, P29, DOI 10.1093/arclin/acv048; Eckhardt CI, 2007, J CONSULT CLIN PSYCH, V75, P61, DOI 10.1037/0022-006X.75.1.61; Eckhardt CI, 2015, VIOLENCE AGAINST WOM, V21, P939, DOI 10.1177/1077801215589376; Egeland J, 2010, CHILD NEUROPSYCHOL, V16, P326, DOI 10.1080/09297041003601462; Ellis ML, 2009, J ABNORM CHILD PSYCH, V37, P945, DOI 10.1007/s10802-009-9321-5; Finkel E.J., 2013, OXFORD HDB CLOSE REL, P452, DOI [10.1093/OXFORDHB/9780195398694.013.0020, DOI 10.1093/OXFORDHB/9780195398694.013.0020]; Finkel EJ, 2007, REV GEN PSYCHOL, V11, P193, DOI 10.1037/1089-2680.11.2.193; Fishbein D, 2000, CRIM JUSTICE BEHAV, V27, P139, DOI 10.1177/0093854800027002001; Foran HM, 2008, J FAM VIOLENCE, V23, P141, DOI 10.1007/s10896-007-9136-5; Giancola PR, 2006, ADDICT BEHAV, V31, P2169, DOI 10.1016/j.addbeh.2006.02.019; Giancola PR, 2012, PSYCHOL ADDICT BEHAV, V26, P201, DOI 10.1037/a0025207; Giancola PR, 2000, EXP CLIN PSYCHOPHARM, V8, P576, DOI 10.1037//1064-1297.8.4.576; Giancola PR, 2004, J ABNORM PSYCHOL, V113, P541, DOI 10.1037/0021-843X.113.4.541; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Goldberg E., 2002, EXECUTIVE BRAIN FRON; Harper FWK, 2005, J INTERPERS VIOLENCE, V20, P1648, DOI 10.1177/0886260505278717; Hoaken PNS, 1998, J STUD ALCOHOL, V59, P599, DOI 10.15288/jsa.1998.59.599; Jarvis, 2006, DIRECTRT VERSION 200; Kenny DA, 1999, PERS RELATIONSHIP, V6, P433, DOI 10.1111/j.1475-6811.1999.tb00202.x; Leonard KE, 2005, ADDICTION, V100, P422, DOI 10.1111/j.1360-0443.2005.00994.x; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; MOFFITT TE, 1993, DEV PSYCHOPATHOL, V5, P135, DOI 10.1017/S0954579400004302; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Parrott DJ, 2017, DRUG ALCOHOL REV, V36, P88, DOI 10.1111/dar.12454; Pinto LA, 2010, AGGRESS VIOLENT BEH, V15, P387, DOI 10.1016/j.avb.2010.07.001; Rabin LA, 2011, J CLIN EXP NEUROPSYC, V33, P344, DOI 10.1080/13803395.2010.518597; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Shorey RC, 2015, PREV SCI, V16, P873, DOI 10.1007/s11121-015-0568-5; Shorey RC, 2012, AGGRESS VIOLENT BEH, V17, P289, DOI 10.1016/j.avb.2012.03.001; Shorey RC, 2011, J INTERPERS VIOLENCE, V26, P2681, DOI 10.1177/0886260510388289; Slep AMS, 2005, J CONSULT CLIN PSYCH, V73, P435, DOI 10.1037/0022-006X.73.3.435; Stanford MS, 1997, PERS INDIV DIFFER, V23, P961, DOI 10.1016/S0191-8869(97)00120-7; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Swartout KM, 2015, PSYCHOL VIOLENCE, V5, P305, DOI 10.1037/a0038316; Testa M, 2014, PSYCHOL ADDICT BEHAV, V28, P127, DOI 10.1037/a0032988; Testa M, 2012, J STUD ALCOHOL DRUGS, V73, P268, DOI 10.15288/jsad.2012.73.268; Watkins LE, 2015, PSYCHOL ADDICT BEHAV, V29, P653, DOI 10.1037/adb0000074; Watkins LE, 2014, AGGRESSIVE BEHAV, V40, P369, DOI 10.1002/ab.21528; West S. G., 1991, MULTIPLE REGRESSION; Woodin EM, 2014, ADDICT BEHAV, V39, P1890, DOI 10.1016/j.addbeh.2014.07.033; [No title captured]	58	13	13	1	12	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0959-5236	1465-3362		DRUG ALCOHOL REV	Drug Alcohol Rev.	JAN	2017	36	1					88	96		10.1111/dar.12454			9	Substance Abuse	Social Science Citation Index (SSCI)	Substance Abuse	EK5PB	WOS:000393977200013	28116760	Green Accepted			2022-02-06	
J	Parry, PV; Choi, PA; Bauer, JS; Panczykowski, DM; Puccio, AM; Okonkwo, DO				Parry, Phillip V.; Choi, Phillip A.; Bauer, Joshua S.; Panczykowski, David M.; Puccio, Ava M.; Okonkwo, David O.			Utility of the Aspirin and P2Y12 Response Assays to Determine the Effect of Antiplatelet Agents on Platelet Reactivity in Traumatic Brain Injury	NEUROSURGERY			English	Article						Aspirin; Aspirin response unit; Clopidogrel; Platelet dysfunction; P2Y12 response unit; Traumatic brain injury	PERCUTANEOUS CORONARY INTERVENTION; COMPLEX CONCENTRATE BERIPLEX; INTRACRANIAL HEMORRHAGE; ELDERLY-PATIENTS; CLOPIDOGREL; ANTICOAGULATION; RESISTANCE; REVERSAL; WARFARIN; RESPONSIVENESS	BACKGROUND: Premorbid antithrombotic medicationmayworsen intracranial injury and outcome after traumatic brain injury (TBI). Routine laboratory tests are insufficient to evaluate platelet activity. OBJECTIVE: To profile the spectrum of platelet inhibition, as measured by aspirin and P2Y12 response unit assays, in a TBI population on antiplatelet therapy. METHODS: This single-center, prospective cohort study included patients presenting to our institution between November 2010 and January 2015 with a clinical history of TBI. Serum platelet reactivity levels were determined immediately on admission and analyzed using the aspirin and P2Y12 response unit assays; test results were reported as aspirin response units and P2Y12 response units. We report congruence between assay results and clinical history as well as differences in assay results between types of antiplatelet therapy. RESULTS: A sample of 317 patients was available for analysis, of which 87% had experiencedmild TBI, 7% moderate, and 6% severe; themean agewas 71.5 years. Themean aspirin response units in patients with a history of any aspirin use was 456 +/- 67 (range, 350-659), with 88% demonstrating therapeutic platelet inhibition. For clopidogrel, the mean P2Y12 response unit was 191 +/- 70 (range, 51-351); 77% showed therapeutic response. CONCLUSION: Rapid measurement of antiplatelet function using the aspirin and P2Y12 response assays indicated asmany as one fourth of patients on antiplatelet therapy do not have platelet dysfunction. Further research is required to develop guidelines for the use of these assays to guide platelet transfusion in the setting of TBI.	[Parry, Phillip V.; Bauer, Joshua S.; Panczykowski, David M.; Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA; [Choi, Phillip A.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Bauer, Joshua S.] St Georges Univ, Sch Med, St Georges, Grenada		Okonkwo, DO (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol Surg, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA.	okonkwodo@upmc.edu			Walter L. Copeland Fund of The Pittsburgh Foundation; University of Pittsburgh Clinical Scientist Training Program (CSTP); Clinical and Translational Science Institute [UL1 TL1TR000005]	Support for this research was provided by the Walter L. Copeland Fund of The Pittsburgh Foundation, the University of Pittsburgh Clinical Scientist Training Program (CSTP), and the Clinical and Translational Science Institute (UL1 TL1TR000005). The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Abaci A, 2005, THROMB RES, V116, P465, DOI 10.1016/j.thromres.2005.02.005; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Blais N, 2009, THROMB HAEMOSTASIS, V102, P404, DOI 10.1160/TH09-02-0126; Breet NJ, 2010, J THROMB HAEMOST, V8, P2140, DOI 10.1111/j.1538-7836.2010.04017.x; Briggs A, 2015, J SURG RES, V193, P802, DOI 10.1016/j.jss.2014.08.016; Bruce D, 2008, CRIT CARE, V12, DOI 10.1186/cc6987; Chen WH, 2007, AM J MED, V120, P631, DOI 10.1016/j.amjmed.2006.10.021; Chen WH, 2004, J AM COLL CARDIOL, V43, P1122, DOI 10.1016/j.jacc.2003.12.034; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gum PA, 2003, J AM COLL CARDIOL, V41, P961, DOI 10.1016/S0735-1097(02)03014-0; Hankey GJ, 2006, LANCET, V367, P606, DOI 10.1016/S0140-6736(06)68040-9; Hovens MMC, 2007, AM HEART J, V153, P175, DOI 10.1016/j.ahj.2006.10.040; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Kakouros N, 2013, J THROMB HAEMOST, V11, P1814, DOI 10.1111/jth.12376; Lankiewicz MW, 2006, J THROMB HAEMOST, V4, P967, DOI 10.1111/j.1538-7836.2006.01815.x; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Lee PY, 2005, AM J MED, V118, P723, DOI 10.1016/j.amjmed.2005.03.041; Lev EI, 2006, J AM COLL CARDIOL, V47, P27, DOI 10.1016/j.jacc.2005.08.058; Malinin A, 2006, METHOD FIND EXP CLIN, V28, P315, DOI 10.1358/mf.2006.28.5.990205; Malinin A, 2007, THROMB RES, V119, P277, DOI 10.1016/j.thromres.2006.01.019; Marcucci R, 2009, CIRCULATION, V119, P237, DOI 10.1161/CIRCULATIONAHA.108.812636; Mayer SA, 2009, STROKE, V40, P833, DOI 10.1161/STROKEAHA.108.524470; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Michelson AD, 2009, AM J CARDIOL, V103, p20A, DOI 10.1016/j.amjcard.2008.11.019; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Nielsen HL, 2008, THROMB RES, V123, P267, DOI 10.1016/j.thromres.2008.03.023; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Pabinger I, 2008, J THROMB HAEMOST, V6, P622, DOI 10.1111/j.1538-7836.2008.02904.x; PARETI FI, 1980, AM J MED, V69, P235, DOI 10.1016/0002-9343(80)90383-6; Patti G, 2008, J AM COLL CARDIOL, V52, P1128, DOI 10.1016/j.jacc.2008.06.038; Preston FE, 2002, BRIT J HAEMATOL, V116, P619, DOI 10.1046/j.0007-1048.2001.03295.x; Price MJ, 2011, CIRCULATION, V124, P1132, DOI 10.1161/CIRCULATIONAHA.111.029165; Price MJ, 2009, CIRCULATION, V119, P2625, DOI 10.1161/CIRCULATIONAHA.107.696732; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Snoep JD, 2007, AM HEART J, V154, P221, DOI 10.1016/j.ahj.2007.04.014; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661	38	13	13	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JAN	2017	80	1					92	96		10.1227/NEU.0000000000001406			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EZ1ZT	WOS:000404510000016	28362884	Bronze, Green Published			2022-02-06	
J	Peters, ME; Rao, V; Bechtold, KT; Roy, D; Sair, HI; Leoutsakos, JM; Diaz-Arrastia, R; Stevens, RD; Batty, DS; Falk, H; Fernandez, C; Ofoche, U; Vassila, A; Hall, AJ; Anderson, B; Bessman, E; Lyketsos, CG; Everett, AD; Van Eyk, J; Korley, FK				Peters, Matthew E.; Rao, Vani; Bechtold, Kathleen T.; Roy, Durga; Sair, Haris I.; Leoutsakos, Jeannie-Marie; Diaz-Arrastia, Ramon; Stevens, Robert D.; Batty, D. Scott, Jr.; Falk, Hayley; Fernandez, Christopher; Ofoche, Uju; Vassila, Alexandra; Hall, Anna J.; Anderson, Braden; Bessman, Edward; Lyketsos, Constantine G.; Everett, Allen D.; Van Eyk, Jennifer; Korley, Frederick K.			Head injury serum markers for assessing response to trauma: Design of the HeadSMART study	BRAIN INJURY			English	Article						Traumatic brain injury; TBI; blunt head trauma; biomarkers	COMMON DATA ELEMENTS; BRAIN-INJURY; RATING SCALE; BIOMARKERS; RELIABILITY; DIAGNOSIS; VALIDITY; METALLOTHIONEIN; QUESTIONNAIRE; PROTEIN	Background: Accurate diagnosis and risk stratification of traumatic brain injury (TBI) at time of presentation remains a clinical challenge. The Head Injury Serum Markers for Assessing Response to Trauma study (HeadSMART) aims to examine blood-based biomarkers for diagnosing and determining prognosis in TBI. Methods: HeadSMART is a 6-month prospective cohort study comparing emergency department patients evaluated for TBI (exposure group) to (1) emergency department patients evaluated for traumatic injury without head trauma and (2) healthy persons. Study methods and characteristics of the first 300 exposure participants are discussed. Results: Of the first 300 participants in the exposure arm, 70% met the American Congress of Rehabilitation Medicine criteria for TBI, with the majority (80.1%) classified as mild TBI. The majority of subjects in the exposure arm had Glasgow Coma Scale scores of 13-15 (98.9%), normal head computed tomography (81.3%) and no prior history of concussion (71.7%). Conclusion: With systematic phenotyping, HeadSMART will facilitate diagnosis and risk-stratification of the heterogeneous group of individuals currently diagnosed with TBI.	[Peters, Matthew E.; Rao, Vani; Bechtold, Kathleen T.; Roy, Durga; Sair, Haris I.; Leoutsakos, Jeannie-Marie; Stevens, Robert D.; Falk, Hayley; Fernandez, Christopher; Ofoche, Uju; Vassila, Alexandra; Hall, Anna J.; Anderson, Braden; Bessman, Edward; Lyketsos, Constantine G.; Everett, Allen D.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Batty, D. Scott, Jr.] ImmunArray, Richmond, VA USA; [Van Eyk, Jennifer] Cedars Sinai, Dept Med, Inst Heart, Los Angeles, CA USA; [Korley, Frederick K.] Univ Michigan Hlth Syst, North Campus Res Bldg,Bldg 026-333N, Ann Arbor, MI 48105 USA		Korley, FK (corresponding author), Univ Michigan Hlth Syst, North Campus Res Bldg,Bldg 026-333N, Ann Arbor, MI 48105 USA.	korley@med.umich.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594	Harold Amos Medical Faculty Development Award from the Robert Wood Johnson Foundation; ImmunArray; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG027668] Funding Source: NIH RePORTER	Frederick Korley, M.D., Ph.D. was supported by the Harold Amos Medical Faculty Development Award from the Robert Wood Johnson Foundation. HeadSMART was funded by ImmunArray. ImmunArray has licensed patents to biomarkers described in this article. Under a licensing agreement between ImmunArray and the Johns Hopkins University, Drs Everett, Van Eyk and Korley are entitled to royalties on biomarkers described in this article. Dr Batty is an officer, shareholder, and employee of ImmunArray.	Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Arnould A, 2015, ANN PHYS REHABIL MED; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Buonora JE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00068; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics, 2010, 2010 NAT HOSP AMB ME; Chou SHY, 2014, NEUROCRIT CARE, V21, P187, DOI 10.1007/s12028-014-0039-z; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Failla MD, 2015, BRAIN DERIVED NEUROT; Golden C.J., 1978, STROOP COLOR WORD TE, P1; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heaton R.K., 1981, WISCONSIN CARD SORTI; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Holdnack H.A., 2001, WECHSLER TEST ADULT; Hornik K, PACKAGE RWEKA; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; JENNETT B, 1975, LANCET, V1, P480; Kansagara D., 2013, COMPLICATIONS MILD T; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korley F.K., 2015, J NEUROTRAUMA; Korley FK, 2015, J HEAD TRAUMA REHABI; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Lyketsos CG, 1999, J AM GERIATR SOC, V47, P487, DOI 10.1111/j.1532-5415.1999.tb07245.x; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; PALMITER RD, 1992, P NATL ACAD SCI USA, V89, P6333, DOI 10.1073/pnas.89.14.6333; Quinlan JR, 1993, J R C4 5 PROGRAMS MA; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Schretlen D, 1996, CLIN NEUROPSYCHOL, V10, P80, DOI 10.1080/13854049608406666; SPITZER RL, 1983, COMPR PSYCHIAT, V24, P399, DOI 10.1016/0010-440X(83)90032-9; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; STARR LB, 1983, EXP AGING RES, V9, P101, DOI 10.1080/03610738308258434; Surgucheva I, 2014, MOL CELL NEUROSCI, V63, P114, DOI 10.1016/j.mcn.2014.10.005; Yang J, 2015, CLIN BIOCH; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	51	13	13	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					370	378		10.1080/02699052.2016.1231344			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900014	28140672	Green Accepted			2022-02-06	
J	Pillai, C; Gittinger, JW				Pillai, Cinthi; Gittinger, John W., Jr.			Vision Testing in the Evaluation of Concussion	SEMINARS IN OPHTHALMOLOGY			English	Article						Brain; injury; neurology; neuro-ophthalmology; technology; traumatic	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; TEST-RETEST RELIABILITY; VISUAL SCREENING TOOL; BASE-LINE; KING-DEVICK; OCULOMOTOR REHABILITATION; FOOTBALL PLAYERS; TEST-PERFORMANCE; SMOOTH-PURSUIT	Traumatic brain injury results from an acute impact to the head causing brain dysfunction. Concussion is a form of mild traumatic brain injury. There are significant short- and long-term sequelae of concussion, and early diagnosis and management are key to recovery. Visual system symptoms and signs are common following concussion and have been shown to be a useful feature of concussion testing. Neuro-ophthalmic findings include abnormalities in the pupillary light reflex, accommodation, convergence, extraocular motility, steroacuity, as well as pursuit and saccades. Concussion generally occurs out of the medical setting, and access to a trained examiner or equipment to assist in diagnosis is limited. For this reason, much research is focused on developing a concussion test that is practical and reliable, and technology is likely to play an important role in this. Ultimately, no single test is a substitute for clinical judgment and multifaceted testing.	[Pillai, Cinthi; Gittinger, John W., Jr.] Harvard Med Sch, Massachusetts Eye & Ear Infirm, 243 Charles St, Boston, MA 02114 USA		Pillai, C (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear Infirm, 243 Charles St, Boston, MA 02114 USA.	cpillaimd@gmail.com		Pillai, Cinthi/0000-0002-7662-443X			Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; [Anonymous], 2013, BRIT J SPORT MED, V47, P259; [Anonymous], 2013, ARM FORC VIS TEST; Armato E, 2001, Acta Otorrinolaringol Esp, V52, P567; Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Barker J. M., 2007, Journal of Medical Engineering & Technology, V31, P161, DOI 10.1080/03091900500272781; Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Capo-Aponte J.E., 2013, J SPINE, V4, DOI [10.4172/2165-7939.S4-004, DOI 10.4172/2165-7939.S4-004]; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; De Monte VE, 2010, J CLIN EXP NEUROPSYC, V32, P28, DOI 10.1080/13803390902806519; DeHaan A, 2007, NEUROPSYCHOLOGIA, V45, P406, DOI 10.1016/j.neuropsychologia.2006.06.008; Dhaliwal A, 2006, J NEURO-OPHTHALMOL, V26, P4, DOI 10.1097/01.wno.0000204661.48806.1d; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Doble JE, 2010, PM&R, V2, P244, DOI 10.1016/j.pmrj.2010.01.011; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Du T, 2005, BRAIN INJURY, V19, P1125, DOI 10.1080/02699050500149817; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fischer TD, 2015, J NEUROTRAUMA; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goia G, CONCUSSION THERES AP; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Han SJ, 2010, OPHTHAL PHYSL OPT, V30, P95, DOI 10.1111/j.1475-1313.2009.00681.x; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Hang B, 2015, PEDIATR EMERG CARE, V31, P688, DOI 10.1097/PEC.0000000000000438; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Jones NS, 2014, CLIN J SPORT MED, V24, P284, DOI 10.1097/JSM.0000000000000031; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lee H, 2015, BRIT J SPORT MED, V49, P500, DOI 10.1136/bjsports-2013-092930; Liu GT, 2010, NEUROOPHTHALMOLOGY D, P551; London Richard, 2003, Optometry, V74, P111; Lovell M, 2000, IMPACT IMMEDIATE POS; Luoto TM, 2014, J NEUROTRAUM, V31, P728, DOI 10.1089/neu.2013.3174; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; Mayers LB, 2011, J CLIN EXP NEUROPSYC, V33, P532, DOI 10.1080/13803395.2010.535506; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Miller LJ, 1999, ARCH CLIN NEUROPSYCH, V14, P537; Nacci A, 2011, ACTA OTORHINOLARYNGO, V31, P378; Naftel KG, 2014, SOUTH MED J, V107, P418, DOI 10.14423/SMJ.0000000000000136; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; NASHOLD BS, 1972, ARCH OPHTHALMOL-CHIC, V88, P245; Padula WV, 2009, BRAIN INJURY, V23, P566, DOI 10.1080/02699050902926283; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Sarno S, 2000, VISION RES, V40, P3029, DOI 10.1016/S0042-6989(00)00137-1; Sarno S, 2003, BRAIN INJURY, V17, P413, DOI 10.1080/0269905031000070161; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schneiders AG, 2012, SCAND J MED SCI SPOR, V22, P85, DOI 10.1111/j.1600-0838.2010.01141.x; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Singman EL, 2013, MED INSTRUMENTATION; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; Thiagarajan P, 2015, BRAIN INJURY, V29, P1420, DOI 10.3109/02699052.2015.1045029; Thiagarajan P, 2014, J REHABIL RES DEV, V51, P175, DOI 10.1682/JRRD.2013.01.0027; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235; Thie J, 2012, DOC OPHTHALMOL, V125, P149, DOI 10.1007/s10633-012-9345-y; Ting W, 2015, CANADIAN J NEUROLOGI, V42, pS40; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Tsirka V, 2010, INT J NEUROSCI, V120, P184, DOI 10.3109/00207450903585308; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Wilkins SA, 2014, J NEUROSURG-PEDIATR, V13, P82, DOI 10.3171/2013.10.PEDS13241; Williams IM, 1997, J CLIN NEUROSCI, V4, P186, DOI 10.1016/S0967-5868(97)90072-2; Wroblewski D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/206082; Xu GQ, 2010, BRAIN RES, V1322, P153, DOI 10.1016/j.brainres.2010.01.072; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	103	13	13	0	23	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0882-0538	1744-5205		SEMIN OPHTHALMOL	Semin. Ophthalmol.		2017	32	1			SI		144	152		10.1080/08820538.2016.1228412			9	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Ophthalmology	EJ6HS	WOS:000393320700021	27805468				2022-02-06	
J	Rigon, J; Burro, R; Guariglia, C; Maini, M; Marin, D; Ciurli, P; Bivona, U; Formisano, R				Rigon, Jessica; Burro, Roberto; Guariglia, Cecilia; Maini, Manuela; Marin, Dario; Ciurli, Paola; Bivona, Umberto; Formisano, Rita			Self-awareness rehabilitation after Traumatic Brain Injury: A pilot study to compare two group therapies	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Self-awareness disorders; traumatic brain injury; group therapy; rehabilitation; GLMMs	DISABILITY RATING-SCALE; REJECTIVE MULTIPLE TEST; FALSE DISCOVERY RATE; IMPAIRED AWARENESS; BONFERRONI PROCEDURE; EXECUTIVE FUNCTION; HEAD-INJURY; DEFICITS; RELIABILITY; RECOVERY	Background and Purpose: Deficits of self-awareness (SA) are very common after severe acquired brain injury (sABI), especially in traumatic brain injury (TBI), playing an important role in the efficacy of the rehabilitation process. This pilot study provides information regarding two structured group therapies for disorders of SA. Methods: Nine patients with severe TBI were consecutively recruited and randomly assigned to one SA group therapy programme, according either to the model proposed by Ben-Yishay & Lakin (1989) (B&L Group), or by Sohlberg & Mateer (1989) (S&M Group). Neuropsychological tests and self-awareness questionnaires were administered before and after a 10 weeks group therapy. Results: Results showed that both SA and neuropsychological functioning significantly improved in both groups. Conclusion: It is important to investigate and treat self-awareness, also to improve the outcome of neuropsychological disorders. The two group therapies proposed seem to be specific for impulsivity and emotional dyscontrol and for cognitive disorders.	[Rigon, Jessica] Osped San Camillo, IRCCS Fdn, Via Alberoni 70, I-30126 Venezia Lido, Italy; [Burro, Roberto] Univ Verona, Dipartimento Sci Umane, Verona, Italy; [Guariglia, Cecilia; Ciurli, Paola; Bivona, Umberto; Formisano, Rita] IRCCS Santa Lucia, Rome, Italy; [Maini, Manuela] CRA Nucleo Speciale Gravissime Disabil Virginia G, Bologna, Italy; [Marin, Dario] IRCCS E Medea, Pordenone, Italy		Rigon, J (corresponding author), Osped San Camillo, IRCCS Fdn, Via Alberoni 70, I-30126 Venezia Lido, Italy.	jessica.rigon@ospedalesancamillo.net		guariglia, cecilia/0000-0001-7474-6030			ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Basso A, 1987, Funct Neurol, V2, P189; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Ben-Yishay Y., 1989, NEUROPSYCHOLOGICAL T, V1, P271; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson D.F., 1986, FRONTAL LOBES; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; Bianchi I, 2014, ACTA PSYCHOL, V151, P117, DOI 10.1016/j.actpsy.2014.06.003; Bianchi I, 2013, ACTA PSYCHOL, V144, P121, DOI 10.1016/j.actpsy.2013.05.005; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bivona U, 2015, RESTOR NEUROL NEUROS, V33, P335, DOI 10.3233/RNN-140484; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Branchini E, 2015, THINK REASONING, V21, P397, DOI 10.1080/13546783.2014.994035; Carbery H, 1983, COGNITIVE REHABILITA, V1, P5; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; CICERONE KD, 1991, J HEAD TRAUMA REHAB, V6, P30, DOI DOI 10.1097/00001199-199112000-00007; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Fisher JE, 2004, J RES PERS, V38, P24, DOI 10.1016/j.jrp.2003.09.014; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Freeland J, 1996, MAGAZINE, V4, P32; FRYER LJ, 1987, J HEAD TRAUMA REHAB, V2, P51, DOI DOI 10.1097/00001199-198709000-00007; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Hagen C., 1972, LEVELS COGNITIVE FUN; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; HOLM S, 1979, SCAND J STAT, V6, P65; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; JENNETT B, 1975, LANCET, V1, P480; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KRIKORIAN R, 1994, J CLIN EXP NEUROPSYC, V16, P840, DOI 10.1080/01688639408402697; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lundqvist A, 2010, BRAIN INJURY, V24, P823, DOI 10.3109/02699051003724986; Markova IS, 2006, NEUROPSYCHOL REHABIL, V16, P439, DOI 10.1080/09602010500373396; Mazzucchi A., 1997, RIABILITAZIONE NEURO, P75; McDonald JH., 2014, HDB BIOL STAT; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; NOVACK DH, 1992, ARCH INTERN MED, V152, P1814, DOI 10.1001/archinte.152.9.1814; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Orsini A., 2003, B PSICOL APPL, V239, P73; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; R Core Team, 2018, R LANGUAGE ENV STAT; Rappaport M, 2005, NEUROPSYCHOL REHABIL, V15, P442, DOI 10.1080/09602010443000335; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Raven J. C., 1954, STANDARD PROGR MATRI; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Sherer M, 1998, NEUROREHABILITATION, V10, P25, DOI 10.3233/NRE-1998-10104; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Simmond M, 2003, BRAIN INJURY, V17, P325, DOI 10.1080/0269905021000013219; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Sohlberg MM, 1998, J HEAD TRAUMA REHAB, V13, P62, DOI 10.1097/00001199-199810000-00008; Spencer E. A., 1993, WILLARD SPACKMANS OC; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Warner M., 1991, HERDERS WARRIORS TRA, P3, DOI DOI 10.4095/134069; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Zimmerman P., 1992, TEST BATTERIE AUFMER	74	13	13	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2017	35	1					115	127		10.3233/RNN-150538			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EM5CG	WOS:000395328900008	28059799	Green Published, Green Submitted, Bronze			2022-02-06	
J	Snow, PC; Woodward, MN				Snow, Pamela C.; Woodward, Mary N.			Intervening to address communication difficulties in incarcerated youth: A Phase 1 clinical trial	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						Youth justice; language; intervention	ORAL LANGUAGE COMPETENCE; TRAUMATIC BRAIN-INJURY; JUVENILE-OFFENDERS; YOUNG OFFENDERS; CHILD MALTREATMENT; SPEECH; QUESTIONNAIRE; BEHAVIORS; PATHOLOGY; ABILITY	Purpose: Although a number of studies have described high rates of wide-ranging language difficulties in youth offender samples, minimal intervention research has been conducted with this population. The aim of this study was to implement a small-scale speech-language pathology (SLP) intervention study in a secure youth justice facility and to identify key practical challenges associated with conducting SLP interventions in youth custodial settings. Method: Six young males were recruited and underwent assessment via a range of standardised and self-report communication measures. Measures of nonverbal IQ and of therapeutic engagement were also employed, and participants' own goals concerning communication competence were incorporated into treatment. Participants completed seven to 16 weeks' of 1:1 SLP intervention, once or twice per week. Result: Therapeutic engagement was generally strong. All participants made gains and responded favourably regarding the usefulness of the intervention. Many practical issues conspired to make this a challenging SLP intervention setting. Conclusion: Youth custodial sentences represent an important opportunity for high-risk youths with compromised communication skills to receive specialist SLP therapeutic services to reduce the impact of their communication difficulties post-release into the community.	[Snow, Pamela C.] La Trobe Univ, Coll Sci Hlth & Engn, La Trobe Rural Hlth Sch, POB 199, Bendigo, Vic 3552, Australia; [Woodward, Mary N.] Speak Your Mind Serv, Sydney, NSW, Australia		Snow, PC (corresponding author), La Trobe Univ, Coll Sci Hlth & Engn, La Trobe Rural Hlth Sch, POB 199, Bendigo, Vic 3552, Australia.	p.snow@latrobe.edu.au		Snow, Pamela/0000-0002-2426-8349	New South Wales Department of the Attorney General (Juvenile Justice)	We are grateful to the New South Wales Department of the Attorney General (Juvenile Justice) for funding this project and to NSW JJ staff for assisting with its implementation.	Australian Bureau of Statistics, 2012, CULT DIV AUSTR; Australian Institute of Health and Welfare, 2014, JUV JUST SER, V16; BELL N, 1986, VISUALIZING VERBALIZ; Blanton DJ, 2007, LANG SPEECH HEAR SER, V38, P309, DOI 10.1044/0161-1461(2007/033); Bryan K, 2004, INT J LANG COMM DIS, V39, P391, DOI 10.1080/13682820410001666376; Bryan K, 2007, INT J LANG COMM DIS, V42, P505, DOI 10.1080/13682820601053977; Bryan K, 2013, CHILD LANG TEACH THE, V29, P359, DOI 10.1177/0265659013482930; Caire L., 2013, SPEECH PATHOLOGY YOU; Cohen N, 2001, LANGUAGE IMPAIRMENT; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Enderby P., 1983, FRENCHAY DYSARTHIA A; GRAY C, 1994, COMIC STRIP CONVERSA; Gregory J, 2011, INT J LANG COMM DIS, V46, P202, DOI 10.3109/13682822.2010.490573; Jeffries J. H., 2001, AUDITORY PROCESSING; Joffe V., 2012, VOCABULARY ENRICHMEN; Jones C., 2001, J MENTAL HLTH, V10, P457, DOI [DOI 10.1080/09638230120041227, 10.1080/09638230124439]; Kaufman NL, 2004, KAUFMAN BRIEF INTELL; Kelly A., 2009, TALKABOUT TEENAGERS; LaVigne M, 2013, CUNY LAW REV U WISCO; Law J, 2004, J SPEECH LANG HEAR R, V47, P924, DOI 10.1044/1092-4388(2004/069); National Health and Medical Research Council (NHMRC), 2009, NHMRC LEV EV GRAD RE; Royal College of Speech Language Therapists, YOUNG OFF CRIM JUST; Ryan EP, 2004, PSYCHIAT SERV, V55, P1397, DOI 10.1176/appi.ps.55.12.1397; Sanger D, 2003, J COMMUN DISORD, V36, P465, DOI 10.1016/S0021-9924(03)00034-0; Sanger D., 2001, COMMUN DISORD Q, V23, P17, DOI [10.1177/152574010102300104., DOI 10.1177/152574010102300104, 10.1177/152574010102300104]; Sanger DD, 2000, J COMMUN DISORD, V33, P31, DOI 10.1016/S0021-9924(99)00024-6; Semel E., 2003, CLIN EVALUATION LANG; Sloan S., 2006, COMMUNICATE CONFIDEN; SNOW P. C., 2011, TRENDS ISSUES CRIME, V435, P1; Snow PC, 2008, CHILD SOC, V22, P16, DOI 10.1111/j.1099-0860.2006.00076.x; Snow PC, 2016, INT J SPEECH-LANG PA, V18, P216, DOI 10.3109/17549507.2015.1112837; Snow PC, 2016, INT J SPEECH-LANG PA, V18, P20, DOI 10.3109/17549507.2015.1081291; Snow PC, 2015, INT J LANG COMM DIS, V50, P1, DOI 10.1111/1460-6984.12117; Snow PC, 2011, INT J SPEECH-LANG PA, V13, P480, DOI 10.3109/17549507.2011.578661; Snow PC, 2009, INT J SPEECH-LANG PA, V11, P95, DOI 10.1080/17549500802415712; Snow PC, 2005, PSYCHOL CRIME LAW, V11, P239, DOI 10.1080/1068316042000209323; Speechmark, 2002, SKILLS DIAL LIV SOC; Stewart A, 2008, CHILD ABUSE NEGLECT, V32, P51, DOI 10.1016/j.chiabu.2007.04.011; Tomlin K., 1994, SOURCE APRAXIA THERA; Wiig E. H., 1989, TEST LANGUAGE COMPET; [No title captured]	43	13	13	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1754-9507	1754-9515		INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.		2017	19	4					392	406		10.1080/17549507.2016.1216600			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	FB6FF	WOS:000406236100005	27712123				2022-02-06	
J	Stepanichev, M; Onufriev, M; Aniol, V; Freiman, S; Brandstaetter, H; Winter, S; Lazareva, N; Guekht, A; Gulyaeva, N				Stepanichev, Mikhail; Onufriev, Mikhail; Aniol, Viktor; Freiman, Sofia; Brandstaetter, Hemma; Winter, Stefan; Lazareva, Natalia; Guekht, Alla; Gulyaeva, Natalia			Effects of cerebrolysin on nerve growth factor system in the aging rat brain	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Aging; brain; Cerebrolysin; neurotrophin; NGF; BDNF; TrkA; TrkB; p75NTR; neocortex; hippocampus; memory; rat	NEUROTROPHIC TREATMENT; DOUBLE-BLIND; RECEPTOR; BDNF; EXPRESSION; RECOVERY; YOUNG; NGF; PROTEINS; STROKE	Background: Aging is associated with some cognitive decline and enhanced risk of development of neurodegenerative diseases. It is assumed that altered metabolism and functions of neurotrophin systems may underlie these age-related functional and structural modifications. Cerebrolysin(TM) (CBL) is a neuropeptide mixture with neurotrophic effects, which is widely used for the treatment of stroke and traumatic brain injury patients. It is also evident that CBL has an overall beneficial effect and a favorable benefit-risk ratio in patients with dementia. However, the effects of CBL on cognition and brain neurotrophin system in normal aging remain obscure. Objective: The aim of the present study was to examine the age-related modifications of endogenous neurotrophin systems in the brain of male Wistar rats and the effects of CBL on learning and memory as well as the levels neurotrophins and their receptors. Methods: Old (23-24 months) and young (2-3 months) male Wistar rats were used for the study. A half of animals were subjected to CBL course (2.5 ml/kg, 20 i.p. injections). Behavior of rats was studied using the open field test and simple water maze training. The contents of NGF and BDNF were studied using enzyme-linked immunosorbent assay; the expression of neurotrophin receptors was estimated by Western-blot analysis. Results: CBL treatment did not affect general status, age-related weight changes, general locomotor activity as well as general brain histology. In a water maze task, a minor effect of CBL was observed in old rats at the start of training and no effect on memory retention was found. Aging induced a decrease in neurotrophin receptors TrkA, TrkB, and p75NTR in the neocortex. CBL counteracted effects of aging on neocortical TrkA and p75NTR receptors and decreased expression of proNGF without influencing overall NGF levels. BDNF system was not significantly affected by CBL. Conclusion: The pro-neuroplastic "antiaging" effects of CBL in the neocortex of old animals were generally related to the NGF rather than the BDNF system.	[Stepanichev, Mikhail; Onufriev, Mikhail; Aniol, Viktor; Freiman, Sofia; Lazareva, Natalia; Gulyaeva, Natalia] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, 5A Butlerov Str, Moscow 117485, Russia; [Onufriev, Mikhail; Freiman, Sofia; Guekht, Alla; Gulyaeva, Natalia] Moscow Res & Clin Ctr Neuropsychiat, Healthcare Dept Moscow, Moscow State Budgetary Hlth Inst, Moscow, Russia; [Brandstaetter, Hemma; Winter, Stefan] EVER Neuro Pharma GmbH, Dept Res & Med, Unterach, Austria		Gulyaeva, N (corresponding author), Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, 5A Butlerov Str, Moscow 117485, Russia.	nata_gul@yahoo.com	Freiman, Sofia/F-1284-2019; Gulyaeva, Natalia V/R-7959-2016; Guekht, Alla/N-3422-2019; Aniol, Victor/AAO-3220-2020; Guekht, Alla B./Y-6725-2018; Stepanichev, Mikhail/J-8022-2018	Freiman, Sofia/0000-0002-8759-9719; Guekht, Alla/0000-0002-1170-6127; Stepanichev, Mikhail/0000-0001-8109-8692; Onufriev, Mikhail/0000-0003-2533-1263	EVER Neuro Pharma GmbH; Russian Science FoundationRussian Science Foundation (RSF) [14-25-00136]; Russian Science FoundationRussian Science Foundation (RSF) [17-25-00013] Funding Source: Russian Science Foundation	This work was partly funded by EVER Neuro Pharma GmbH and Russian Science Foundation (grant #14-25-00136; studies on receptors of neurotrophins).	Bimonte-Nelson HA, 2008, EXP AGING RES, V34, P13, DOI 10.1080/03610730701761908; Bornstein N, 2012, DRUG TODAY, V48, P43, DOI 10.1358/dot.2012.48(Suppl.A).1739723; Bothwell M, 2014, Handb Exp Pharmacol, V220, P3, DOI 10.1007/978-3-642-45106-5_1; Bucci C, 2014, MEMBRANES, V4, P642, DOI 10.3390/membranes4040642; Budni J, 2015, AGING DIS, V6, P331, DOI 10.14336/AD.2015.0825; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chen CC, 2013, BRIT J NEUROSURG, V27, P803, DOI 10.3109/02688697.2013.793287; Chen N., 2013, COCHRANE DB SYST REV, V1, P1; CRUTCHER KA, 1991, NEUROBIOL AGING, V12, P449, DOI 10.1016/0197-4580(91)90072-R; Cuello AC, 2007, CURR ALZHEIMER RES, V4, P351, DOI 10.2174/156720507781788774; Eder P, 2001, HISTOCHEM J, V33, P605, DOI 10.1023/A:1016394031947; Gschanes A, 2000, HISTOCHEM J, V32, P71, DOI 10.1023/A:1004003008683; Gschanes A, 1998, J NEURAL TRANSM-SUPP, P313; HutterPaier B, 1996, ARZNEIMITTELFORSCH, V46, P237; Kelley A.E., 1993, BEHAV NEUROSCIENCE P, VVol.II, P1; Kraemer B R, 2014, Handb Exp Pharmacol, V220, P121, DOI 10.1007/978-3-642-45106-5_6; LAPCHAK PA, 1993, NEUROBIOL AGING, V14, P121, DOI 10.1016/0197-4580(93)90087-R; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; Masliah E, 2012, DRUG TODAY, V48, P3, DOI 10.1358/dot.2012.48(Suppl.A).1739716; Maurice T, 1996, BRAIN RES, V706, P181, DOI 10.1016/0006-8993(95)01032-7; Meeker RB, 2015, NEURAL REGEN RES, V10, P721, DOI 10.4103/1673-5374.156967; Muresanu DF, 2016, STROKE, V47, P151, DOI 10.1161/STROKEAHA.115.009416; Muresanu DF, 2015, CNS NEUROL DISORD-DR, V14, P587, DOI 10.2174/1871527314666150430162531; Niewiadomska G, 2011, BEHAV BRAIN RES, V221, P515, DOI 10.1016/j.bbr.2010.02.024; Perovic M, 2013, AGE, V35, P2057, DOI 10.1007/s11357-012-9495-6; Reinprecht I, 1999, HISTOCHEM J, V31, P394; Shi SS, 2010, YONSEI MED J, V51, P661, DOI 10.3349/ymj.2010.51.5.661; Terry AV, 2011, PHYSIOL BEHAV, V102, P149, DOI 10.1016/j.physbeh.2010.11.005; Ubhi K, 2013, J NEUROSCI RES, V91, P167, DOI 10.1002/jnr.23142; Ukraintseva SV, 2004, ANN NY ACAD SCI, V1019, P64, DOI 10.1196/annals.1297.014; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4	32	13	18	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2017	35	6					571	581		10.3233/RNN-170724			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FN6RY	WOS:000416144800002	29172008	Green Submitted, Green Published, Bronze			2022-02-06	
J	Stricker, NH; Lippa, SM; Green, DL; McGlynn, SM; Grande, LJ; Milberg, WP; McGlinchey, RE				Stricker, Nikki H.; Lippa, Sara M.; Green, Deborah L.; McGlynn, Susan M.; Grande, Laura J.; Milberg, William P.; McGlinchey, Regina E.			Elevated rates of memory impairment in military service-members and veterans with posttraumatic stress disorder	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Memory; Military personnel; Neuropsychological tests; Posttraumatic stress disorder; Veterans	TRAUMATIC-BRAIN-INJURY; STRUCTURED CLINICAL INTERVIEW; NEUROPSYCHOLOGICAL OUTCOMES; COGNITIVE IMPAIRMENT; PERFORMANCE VALIDITY; POSTCONCUSSIVE SYMPTOMS; COMBAT VETERANS; NEUROCOGNITIVE FUNCTION; PSYCHOMETRIC PROPERTIES; PSYCHOLOGICAL SYMPTOMS	Introduction: Studies investigating the neurocognitive effects of posttraumatic stress disorder (PTSD) routinely find deficits in various cognitive domains. However, the rate of cognitive impairment in individuals with PTSD remains unclear, as studies have focused on null hypothesis testing (NHT) and inferring patterns of impairment rather than empirically determining the rate of cognitive impairment in this sample. Method: This study examined rates of cognitive impairment using a domain-specific approach in non-treatment-seeking Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn service members and veterans with (n=92) and without (n=79) PTSD and without substance abuse/dependence who passed a performance validity measure and were matched on age, education, estimated IQ, and ethnicity. Chi-square analyses were used to compare the rate of cognitive impairment across groups based on normative scores using three cutoffs (-1, -1.5, and -2SDs). NHT was also used to compare performances across groups. Results: Individuals with PTSD showed higher rates of impairment in memory (-1-SD cutoff) than controls, but equivalent rates of impairment in attention, processing speed, and executive functioning; no significant differences were found on NHT. Impairment in any domain was also more prevalent in PTSD (-1-, -1.5-, and -2-SD cutoffs). No differences were found on NHT or rates of impairment in individuals with PTSD with (n=34) and without (n=58) depression. Conclusions: Patients with PTSD were more likely to meet criteria for memory impairment and to show impairment in any domain than controls. Patients with PTSD and comorbid depression were no more likely to be impaired in any cognitive domain or to have lower scores on individual cognitive tasks than patients with PTSD alone. Clinicians noting cognitive impairment in individuals with PTSD should exercise caution before ascribing that impairment to another etiology if deficits are limited to memory.	[Stricker, Nikki H.; Green, Deborah L.; McGlynn, Susan M.] VA Boston Healthcare Syst, Boston, MA USA; [Stricker, Nikki H.; McGlynn, Susan M.; Grande, Laura J.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Stricker, Nikki H.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Lippa, Sara M.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Milberg, William P.; McGlinchey, Regina E.] Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Milberg, William P.; McGlinchey, Regina E.] GRECC, Boston, MA USA; [Milberg, William P.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA USA		Stricker, NH (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	stricker.nikki@mayo.edu		Stricker, Nikki/0000-0001-9034-1252	Translational Research Center for TBI and Stress Disorders (TRACTS); VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B9254-C]; Department of Veterans Affairs, Veterans Health Administration, VISN 1 Career Development AwardUS Department of Veterans Affairs	This work was supported by the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [grant number B9254-C]; and a Department of Veterans Affairs, Veterans Health Administration, VISN 1 Career Development Award to Nikki Stricker.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Aupperle RL, 2002, MULT SCLER J, V8, P382, DOI 10.1191/1352458502ms832oa; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benedict R., 1997, BRIEF VISUOSPATIAL M; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; Brandes D, 2002, PSYCHIAT RES, V110, P231, DOI 10.1016/S0165-1781(02)00125-7; BREMNER JD, 1993, AM J PSYCHIAT, V150, P1015; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Brooks BL, 2007, J INT NEUROPSYCH SOC, V13, P490, DOI 10.1017/D1355617707070531; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Bustamante V, 2001, J TRAUMA STRESS, V14, P791, DOI 10.1023/A:1013050423901; Cambridge Cognition Ltd, 2013, NEUORPS TEST AUT BAT; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P850, DOI 10.1080/13854046.2012.686631; DeGutis J, 2015, J INT NEUROPSYCH SOC, V21, P342, DOI 10.1017/S1355617715000235; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Department of Defense and Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; Esterman M, 2013, J INT NEUROPSYCH SOC, V19, P835, DOI 10.1017/S135561771300057X; First M.B., 1996, STRUCTURED CLIN INTE; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Franklin CL, 2001, J NERV MENT DIS, V189, P548, DOI 10.1097/00005053-200108000-00008; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gil T., 1990, J TRAUMA STRESS, V3, P29, DOI DOI 10.1002/JTS.2490030104; Gilbertson MW, 2006, J ABNORM PSYCHOL, V115, P484, DOI 10.1037/0021-843X.115.3.484; Gilbertson MW, 2001, J TRAUMA STRESS, V14, P413, DOI 10.1023/A:1011181305501; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 2004, GREENS MED SYMPTOM V; Gualtieri CT, 2008, J CLIN PSYCHIAT, V69, P1122, DOI 10.4088/JCP.v69n0712; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hudetz JA, 2010, J CARDIOTHOR VASC AN, V24, P964, DOI 10.1053/j.jvca.2010.02.019; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P923, DOI 10.1007/978-0-387-76978-3_32; Jak AJ, 2009, AM J GERIAT PSYCHIAT, V17, P368, DOI 10.1097/JGP.0b013e31819431d5; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Jelinek L, 2006, J CLIN EXP NEUROPSYC, V28, P940, DOI 10.1080/13803390591004347; Jenkins MA, 2000, CLIN NEUROPSYCHOL, V14, P7, DOI 10.1076/1385-4046(200002)14:1;1-8;FT007; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Johnsen GE, 2008, J ANXIETY DISORD, V22, P464, DOI 10.1016/j.janxdis.2007.04.007; Kane KD, 2014, AM J ALZHEIMERS DIS, V29, P601, DOI 10.1177/1533317514524812; Koenen KC, 2001, BRAIN COGNITION, V45, P64, DOI 10.1006/brcg.2000.1256; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Leark R. A., 2011, TEST VARIABLES ATTEN; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lippa SM, 2014, ARCH CLIN NEUROPSYCH, V29, P236, DOI 10.1093/arclin/acu002; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; Marx BP, 2009, J INT NEUROPSYCH SOC, V15, P840, DOI 10.1017/S1355617709990488; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; Nijdam MJ, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.19979; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Shucard JL, 2008, BIOL PSYCHOL, V79, P223, DOI 10.1016/j.biopsycho.2008.05.005; Soble JR, 2013, J CLIN EXP NEUROPSYC, V35, P551, DOI 10.1080/13803395.2013.798398; Stricker NH, 2015, J TRAUMA STRESS, V28, P102, DOI 10.1002/jts.22000; Stuss DT, 1988, CLIN NEUROPSYCHOL, V2, P246, DOI [DOI 10.1080/13854048808520107, 10.1080/13854048808520107]; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Weber R, 2012, COMMUN METHODS MEAS, V6, P190, DOI 10.1080/19312458.2012.703834; Wechsler D., 2008, WECHSLER ADULT INTEL; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Wisdom NM, 2014, CLIN NEUROPSYCHOL, V28, P128, DOI 10.1080/13854046.2013.863977; Yehuda R, 2005, J CLIN EXP NEUROPSYC, V27, P504, DOI 10.1080/138033990520223	99	13	13	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2017	39	8					768	785		10.1080/13803395.2016.1264575			18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FA7HI	WOS:000405616100004	27976973				2022-02-06	
J	Wright, WG; McDevitt, J; Tierney, R; Haran, FJ; Appiah-Kubi, KO; Dumont, A				Wright, W. Geoffrey; McDevitt, Jane; Tierney, Ryan; Haran, F. Jay; Appiah-Kubi, Kwadwo Osei; Dumont, Alex			Assessing subacute mild traumatic brain injury with a portable virtual reality balance device	DISABILITY AND REHABILITATION			English	Article						Visual-vestibular processing; virtual reality; concussion; posture; sensory organization test	TEST-RETEST RELIABILITY; POSTURAL STABILITY; HEAD-INJURY; VESTIBULAR REHABILITATION; CONCUSSION ASSESSMENT; FOOTBALL PLAYERS; RECOVERY; DEFICITS; ENVIRONMENT; RESPONSES	Purpose: Balance impairment is a common sensorimotor symptom in mild traumatic brain injury (mTBI). We designed an affordable, portable virtual reality (VR)-based balance screening device (Virtual Environment TBI Screen [VETS]), which will be validated relative to the Neurocom Sensory Organization Test (SOT) to determine if it can replace commonly used postural assessments. Methods: This preliminary study examines healthy adults (n=56) and adults with mTBI (n=11). Participants performed six upright postural tasks on the VETS and the SOT. Analysis of variance was used to determine between-group differences. Pearson's correlations were used to establish construct validity. Known-groups approach was used to establish classification accuracy. Results: The mTBI cohort performed significantly worse than the healthy cohort on the new device (p=0.001). The new device has 91.0% accuracy and an ROC curve with a significant area-under-the-curve (AUC=0.865, p<0.001). Conditions with dynamic visual stimulation were the most sensitive to health status. The SOT had an 84.8% accuracy and AUC =0.703 (p=0.034). Conclusions: The new VR-based device is a valid measure for detecting balance impairment following mTBI and can potentially replace more expensive and cumbersome equipment. Assessments that test visual-vestibular processing, such as VETS, increase sensitivity to mTBI-related balance deficits, which can be used to guide rehabilitation. Implications for rehabilitation Emerging technology using virtual reality can be economically integrated into the clinical setting for easy testing of postural control in neurologically impaired populations. Tailoring postural assessments to include tasks that rely on visual and vestibular integration will increase the accuracy of detecting balance impairment following mild traumatic brain injury.	[Wright, W. Geoffrey; Appiah-Kubi, Kwadwo Osei] Temple Univ, Dept Phys Therapy, Philadelphia, PA 19122 USA; [McDevitt, Jane] East Stroudsburg Univ, Dept Athlet Training, East Stroudsburg, PA USA; [McDevitt, Jane; Tierney, Ryan] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [Haran, F. Jay] Univ North Carolina Greensboro, Dept Kinesiol, Greensboro, NC USA; [Wright, W. Geoffrey; Dumont, Alex] Temple Univ, Dept Bioengn, Philadelphia, PA 19122 USA		Wright, WG (corresponding author), Temple Univ, Dept Phys Therapy, Philadelphia, PA 19122 USA.	wrightw@temple.edu	Appiah-Kubi, Kwadwo/ABF-9527-2020	Appiah-Kubi, Kwadwo/0000-0001-6566-9758	Congressionally Directed Medical Research ProgramsUnited States Department of Defense [W81XWH-13-C-0189]	This work was supported, in part, by the Congressionally Directed Medical Research Programs [W81XWH-13-C-0189].	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Baker C.S., 2014, PHYSL REP, V2, P1; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Brandt T, 1999, ANN NY ACAD SCI, V871, P293, DOI 10.1111/j.1749-6632.1999.tb09193.x; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Field A., 1998, BRIT PSYCHOL SOC MAT, V6, P13; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Haran FJ, 2016, J NEUROTRAUM, V33, P705, DOI 10.1089/neu.2015.4060; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Jacobs SM, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0389-5; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kaufman DR, 2014, PHYS THER SPORT, V15, P181, DOI 10.1016/j.ptsp.2013.10.002; Keshner EA, 2000, J VESTIBUL RES-EQUIL, V10, P207; Kirsch V, 2016, BRAIN STRUCT FUNCT, V221, P1291, DOI 10.1007/s00429-014-0971-x; LISHMAN JR, 1973, PERCEPTION, V2, P287, DOI 10.1068/p020287; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; NeuroCom, DIV NAT SETT STAND B; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Ruhe A, 2014, SPORTS HEALTH, V6, P427, DOI 10.1177/1941738114541238; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Teel EF, 2015, CLIN J SPORT MED, V25, P144, DOI 10.1097/JSM.0000000000000109; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wright WG, 2015, 2015 INTERNATIONAL CONFERENCE ON VIRTUAL REHABILITATION PROCEEDINGS (ICVR), P72, DOI 10.1109/ICVR.2015.7358591; Young W, 2011, GAIT POSTURE, V33, P303, DOI 10.1016/j.gaitpost.2010.10.089	42	13	14	1	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2017	39	15					1564	1572		10.1080/09638288.2016.1226432			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EU3KS	WOS:000400929200014	27718642				2022-02-06	
J	Yue, JK; Winkler, EA; Sharma, S; Vassar, MJ; Ratcliff, JJ; Korley, FK; Seabury, SA; Ferguson, AR; Lingsma, HF; Deng, HS; Meeuws, S; Adeoye, OM; Rick, JW; Robinson, CK; Duarte, SM; Yuh, EL; Mukherjee, P; Dikmen, SS; McAllister, TW; Diaz-Arrastia, R; Valadka, AB; Gordon, WA; Okonkwo, DO; Manley, GT				Yue, John K.; Winkler, Ethan A.; Sharma, Sourabh; Vassar, Mary J.; Ratcliff, Jonathan J.; Korley, Frederick K.; Seabury, Seth A.; Ferguson, Adam R.; Lingsma, Hester F.; Deng, Hansen; Meeuws, Sacha; Adeoye, Opeolu M.; Rick, Jonathan W.; Robinson, Caitlin K.; Duarte, Siena M.; Yuh, Esther L.; Mukherjee, Pratik; Dikmen, Sureyya S.; McAllister, Thomas W.; Diaz-Arrastia, Ramon; Valadka, Alex B.; Gordon, Wayne A.; Okonkwo, David O.; Manley, Geoffrey T.		TRACK-TBI Investigators	Temporal profile of care following mild traumatic brain injury: predictors of hospital admission, follow-up referral and six-month outcome	BRAIN INJURY			English	Article						Clinical evaluation; follow-up care; outcome assessment; rehabilitation; traumatic brain injury	COMMON DATA ELEMENTS; GLASGOW COMA SCALE; COMPLICATED MILD; DECISION-MAKING; 1ST YEAR; TRANSFORMING RESEARCH; CLINICAL KNOWLEDGE; UNCOMPLICATED MILD; SEVERITY SCORE; UNITED-STATES	Objective: To Investigate the clinical management and medical follow-up of patients with mild traumatic brain injury (mTBI) presenting to emergency departments (EDs). Methods: Overall, 168 aduit patients with mTBI from the prospective, multicentre Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) Pilot study with Glasgow Coma Scale (GCS) 13-15, no polytrauma and alive at six months were included. Predictors for hospital admission, three-month follow-up referral and six-month functional disability (Glasgow Outcome Scale-Extended (GOSE) <= 6) were analysed using multivariable regression. Results: Overall, 48% were admitted to hospital, 22% received three-month referral and 27% reported six-month functional disability. Intracranial pathology on ED head computed tomography (multivariable odds ratio (OR) = 81.08,95% confidence interval (Cl) [10.28-639.36]) and amnesia (>30-minutes: OR = 5.27 [1.75-15.87]; unknown duration: OR = 4.43 [1.26-15.62]) predicted hospital admission. Older age (per-year OR = 1.03 [1.01-1.05]) predicted three-month referral, while part-time/unemployment predicted lack of referral (OR = 0.17 [0.06-0.50]). GCS < 15 (OR = 2.46 [1.05-5.78]) and prior history of seizures (OR = 3.62 [1.21-10.89]) predicted six-month functional disability, while increased education (per-year OR = 0.86 [0.76-0.97]) was protective. Conclusions: Clinical factors modulate triage to admission, while demographic/socioeconomic elements modulate follow-up care acquisition; six-month functional disability associates with both clinical and demographic/socioeconomic variables. Improving triage to acute and outpatient care requires further investigation to optimize resource allocation and outcome after mTBI.	[Yue, John K.; Winkler, Ethan A.; Sharma, Sourabh; Vassar, Mary J.; Ferguson, Adam R.; Deng, Hansen; Rick, Jonathan W.; Robinson, Caitlin K.; Duarte, Siena M.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA; [Yue, John K.; Winkler, Ethan A.; Sharma, Sourabh; Vassar, Mary J.; Ferguson, Adam R.; Deng, Hansen; Rick, Jonathan W.; Robinson, Caitlin K.; Duarte, Siena M.; Yuh, Esther L.; Mukherjee, Pratik; Manley, Geoffrey T.] San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [Ratcliff, Jonathan J.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; [Ratcliff, Jonathan J.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Korley, Frederick K.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Seabury, Seth A.] Univ Southern Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA; [Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Meeuws, Sacha] Univ Hosp Antwerp, Dept Neurol Surg, Edegem, Belgium; [Adeoye, Opeolu M.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA; [Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94110 USA; [Dikmen, Sureyya S.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [McAllister, Thomas W.] Indiana Univ, Dept Psychiat, Indianapolis, IN 46204 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Diaz-Arrastia, Ramon] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Valadka, Alex B.] Seton Brain & Spine Inst, Austin, TX USA; [Gordon, Wayne A.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA		Manley, GT (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.	manleyg@neurosurg.ucsf.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722; Ferguson, Adam/0000-0001-7102-1608	 [NINDS 1RC2NS069409-01];  [3RC2NS069409-02S1];  [5RC2NS069409-02];  [1U01NS086090-01];  [3U0 IN S086090-02S1];  [3U01NS086090-02S2];  [3U01NS086090-03S1];  [5U0INS086090-02];  [5U01NS086090-03];  [US DOD W81XWH-13-1-0441];  [US DOD W81XWH-14-2-0176]	This work was supported by the following grants: NINDS 1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01,3U0 IN S086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1,5U0INS086090-02, 5U01NS086090-03; US DOD W81XWH-13-1-0441, US DOD W81XWH-14-2-0176.	American College of Surgeons, 2014, RES OPT CAR INJ PAT; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; Dagher JH, 2013, BRAIN INJURY, V27, P189, DOI 10.3109/02699052.2012.729288; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Finkelstein E., 2006, INCIDENCE EC BURDEN; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Freeman M., 2014, J INT NEUROPSYCHOL S, V5, P1; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Glasgow RE, 2012, AM J PUBLIC HEALTH, V102, P1274, DOI 10.2105/AJPH.2012.300755; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Howell D. C., 2012, STAT METHODS PSYCHOL, V8 th; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; MARSHALL LF, 1995, J NEUROTRAUM, V12, P929, DOI 10.1089/neu.1995.12.929; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Russo J, 2013, GEN HOSP PSYCHIAT, V35, P485, DOI 10.1016/j.genhosppsych.2013.04.016; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Schwab W, 2000, J TRAUMA, V48, P30; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Shah SM, 2003, PRINCIPLES PRACTICE; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; US Department of Health & Human Services; Centers for Disease Control (CDC), REP C MILD TRAUM BRA; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wenden FJ, 1998, CLIN REHABIL, V12, P53, DOI 10.1191/026921598675567949; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	66	13	13	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1820	1829		10.1080/02699052.2017.1351000			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500014	29166203				2022-02-06	
J	Renfro, M; Bainbridge, DB; Smith, ML				Renfro, Mindy; Bainbridge, Donna B.; Smith, Matthew Lee			Validation of Evidence-Based Fall Prevention Programs for Adults with Intellectual and/or Developmental Disorders: A Modified Otago Exercise Program	FRONTIERS IN PUBLIC HEALTH			English	Article						falls; fall prevention; intellectual and/or developmental disorders; older adults; evidence-based program; Otago Exercise Program; functional performance	2-MINUTE WALK TEST; OLDER-ADULTS; PHYSICAL-ACTIVITY; YOUNG-ADULTS; PRIMARY-CARE; HEALTH; DISABILITY; RISK; ASSOCIATION; RELIABILITY	Introduction: Evidence-based fall prevention (EBFP) programs significantly decrease fall risk, falls, and fall-related injuries in community-dwelling older adults. To date, EBFP programs are only validated for use among people with normal cognition and, therefore, are not evidence-based for adults with intellectual and/or developmental disorders (IDD) such as Alzheimers disease and related dementias, cerebral vascular accident, or traumatic brain injury. Background: Adults with IDD experience not only a higher rate of falls than their community-dwelling, cognitively intact peers but also higher rates and earlier onset of chronic diseases, also known to increase fall risk. Adults with IDD experience many barriers to health care and health promotion programs. As the lifespan for people with IDD continues to increase, issues of aging (including falls with associated injury) are on the rise and require effective and efficient prevention. Methods: A modified group-based version of the Otago Exercise Program (OEP) was developed and implemented at a worksite employing adults with IDD in Montana. Participants were tested pre- and post-intervention using the Center for Disease Control and Preventions (CDC) Stopping Elderly Accidents Deaths and Injuries (STEADI) tool kit. Participants participated in progressive once weekly, 1-h group exercise classes and home programs over a 7-week period. Discharge planning with consumers and caregivers included home exercise, walking, and an optional home assessment. Results: Despite the limited number of participants (n = 15) and short length of participation, improvements were observed in the 30-s Chair Stand Test, 4-Stage Balance Test, and 2-Minute Walk Test. Additionally, three individuals experienced an improvement in ambulation independence. Participants reported no falls during the study period. Discussion: Promising results of this preliminary project underline the need for further study of this modified OEP among adults with IDD. Future multicenter study should include more participants in diverse geographic regions with longer lengths of participation and follow-up.	[Renfro, Mindy; Bainbridge, Donna B.] Univ Montana, MonTECH Rural Inst, Missoula, MT 59812 USA; [Smith, Matthew Lee] Univ Georgia, Inst Gerontol, Coll Publ Hlth, Athens, GA 30602 USA; [Smith, Matthew Lee] Texas A&M Sch Publ Hlth, College Stn, TX USA		Renfro, M (corresponding author), Univ Montana, MonTECH Rural Inst, Missoula, MT 59812 USA.	mindy.renfro@mso.umt.edu	Renfro, Mindy/X-7984-2019				ALEXANDER BH, 1992, AM J PUBLIC HEALTH, V82, P1020, DOI 10.2105/AJPH.82.7.1020; American Association on Intellectual and Developmental Disabilities, 2013, DEF INT DIS; Anderson L, 2013, AM PUBLIC HLTH ASS A; Anderson LL, 2013, INTELLECT DEV DISAB, V51, P385, DOI 10.1352/1934-9556-51.5.385; Bishop KM, 2013, J PSYCHOSOC NURS MEN, V51, P15, DOI 10.3928/02793695-20121218-02; Bohannon Richard W, 2014, BMC Res Notes, V7, P269, DOI 10.1186/1756-0500-7-269; Campbell A. J., 2003, OTAGO EXERCISE PROGR; Campbell AJ, 1999, AGE AGEING, V28, P513, DOI 10.1093/ageing/28.6.513; Carande-Kulis V, 2015, J SAFETY RES, V52, P65, DOI 10.1016/j.jsr.2014.12.007; Carmeli E, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00031; Carter K, 2014, ACSMS HEALTH FIT J, V18, P37; Connelly DM, 2009, PHYSIOTH CAN, V61, P78, DOI 10.3138/physio.61.2.78; Copeland S.R., 2002, TEACH EXCEPT CHILDRE, V35, P16, DOI [10.1177/004005990203500103, DOI 10.1177/004005990203500103]; Esbensen AJ, 2010, INT REV RES MENT RET, V39, P107, DOI 10.1016/S0074-7750(10)39004-5; Farrell RJ, 2004, ADAPT PHYS ACT Q, V21, P153, DOI 10.1123/apaq.21.2.153; Focht-New G, 2012, INTELLECT DEV DISAB, V50, P129, DOI 10.1352/1934-9556-50.02.129; Ford JA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010652; Gardner MM, 2001, AGE AGEING, V30, P77, DOI 10.1093/ageing/30.1.77; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Grenier S, 2014, INT PSYCHOGERIATR, V26, P1511, DOI 10.1017/S104161021400074X; Hale LA, 2016, DISABIL REHABIL, V38, P36, DOI 10.3109/09638288.2015.1017613; Hallum A, 1995, Curr Probl Pediatr, V25, P12, DOI 10.1016/S0045-9380(06)80013-7; Hosking FJ, 2016, AM J PUBLIC HEALTH, V106, P1483, DOI 10.2105/AJPH.2016.303240; Hutzler Y, 2010, J INTELL DISABIL RES, V54, P767, DOI 10.1111/j.1365-2788.2010.01313.x; Irvin DJ, 2004, GERIATR NURS, V25, P99, DOI 10.1016/j.gerinurse.2003.10.022; Iwarsson S, 2009, CLIN REHABIL, V23, P558, DOI 10.1177/0269215508101740; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Jones David, 2011, Nurs Stand, V25, P50; Kamer Angela R, 2016, Alzheimers Dement (Amst), V2, P49, DOI 10.1016/j.dadm.2016.01.001; Kojima G, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0039-7; Kojima T, 2011, GERIATR GERONTOL INT, V11, P438, DOI 10.1111/j.1447-0594.2011.00703.x; Kraemer BR, 2003, MENT RETARD, V41, P250, DOI 10.1352/0047-6765(2003)41<250:QOLFYA>2.0.CO;2; McCarron M, 2013, RES DEV DISABIL, V34, P521, DOI 10.1016/j.ridd.2012.07.029; McCarthy EK, 2004, J GERONTOL A-BIOL, V59, P1207, DOI 10.1093/gerona/59.11.1207; Mertz KJ, 2010, AM J PREV MED, V39, P15, DOI 10.1016/j.amepre.2010.03.013; Moran JA, 2013, MAYO CLIN PROC, V88, P831, DOI 10.1016/j.mayocp.2013.04.024; National Council on Aging, 2012, HIGH TIER EV BAS HLT; Neece CL, 2009, INTELLECT DEV DISAB, V47, P31, DOI 10.1352/2009.47:31-43; Noonan RK, 2011, J SAFETY RES, V42, P427, DOI 10.1016/j.jsr.2010.12.002; Phelan EA, 2015, MED CLIN N AM, V99, P281, DOI 10.1016/j.mcna.2014.11.004; Raad J, 2013, REHAB MEASURES; Renfro M, 2015, FALLPAIDD SURVEY; Rimmer JH, 2014, INTRO ACHIEVING BENE; Robertson MC, 2001, BRIT MED J, V322, P697, DOI 10.1136/bmj.322.7288.697; ROSSITERFORNOFF JE, 1995, J GERONTOL A-BIOL, V50, pM291, DOI 10.1093/gerona/50A.6.M291; Salb J, 2015, J INTELL DISABIL RES, V59, P1121, DOI 10.1111/jir.12216; Selman JPR, 2014, RESP CARE, V59, P525, DOI 10.4187/respcare.02649; Shaw BH, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0168-z; Sherrington Catherine, 2011, N S W Public Health Bull, V22, P78, DOI 10.1071/NB10056; Shubert TE, 2016, J APPL GERO IN PRESS; Shubert TE, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00152; Smith E, 2016, GAIT POSTURE, V43, P239, DOI 10.1016/j.gaitpost.2015.10.004; Smith WN, 2010, CLIN INTERV AGING, V5, P173; Smulders E, 2013, J INTELL DISABIL RES, V57, P1173, DOI 10.1111/j.1365-2788.2012.01643.x; Stevens JA, 2013, HEALTH PROMOT PRACT, V14, P706, DOI 10.1177/1524839912463576; Stevens Judy A., 2000, Morbidity and Mortality Weekly Report, V49, P3; Timar B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154654; UNC School of Medicine, 2016, REF; van Schijndel-Speet M, 2014, INTELLECT DEV DISAB, V52, P175, DOI 10.1352/1934-9556-52.3.175; Waters DL, 2011, ARCH PHYS MED REHAB, V92, P1581, DOI 10.1016/j.apmr.2011.05.014; Wilkinson JE, 2008, J AM BOARD FAM MED, V21, P215, DOI 10.3122/jabfm.2008.03.070197; Zia A, 2015, POSTGRAD MED, V127, P186, DOI 10.1080/00325481.2015.996505	62	13	13	0	31	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-2565		FRONT PUBLIC HEALTH	Front. Public Health	DEC 6	2016	4								261	10.3389/fpubh.2016.00261			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FE9CS	WOS:000408502400001	27999771	Green Published, gold, Green Submitted			2022-02-06	
J	Childers, C; Hux, K				Childers, Carrie; Hux, Karen			Invisible Injuries: The Experiences of College Students with Histories of Mild Traumatic Brain Injury	JOURNAL OF POSTSECONDARY EDUCATION AND DISABILITY			English	Article						Mild traumatic brain injury; college experiences; academic accommodations; support services; self-advocacy		This qualitative study explored the college life phenomenon as experienced by students with mild traumatic brain injury (MTBI). Previous research about such students has focused on topics including study strategy use, access of support services, and insights from caregivers or instructors. However, little attention has been paid to the perceptions of postsecondary students, and available data stems almost exclusively from structured survey items and quantitative research studies. The lack of direct input from students with MTBI means professionals have limited insight into perceptions about students' challenges and successes associated with college experiences. To address this research gap, we asked five college students with MTBI to discuss their college experiences, factors mediating those experiences, and perceived similarities and differences between themselves and other college students with and without disabilities. Each interview lasted approximately one hour and used a semi-structured interview protocol. Data were analyzed using established phenomenological methods. Results suggested that the students experienced cognitive, physical, and social-emotional changes that altered their academic experiences, necessitated academic accommodations, and required self-advocacy skills. In addition, family and teacher support, self-determination, and academic accommodations positively affected students' college experiences, whereas factors such as injury invisibility, coursework difficulty, and teacher misconceptions or lack of support had negative effects. The findings highlight the need for additional education and support for college students with MTBI and the educators who serve them.	[Childers, Carrie] Marshall Univ, Commun Disorders Dept, Huntington, WV 25755 USA; [Hux, Karen] Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE 68583 USA		Childers, C (corresponding author), Marshall Univ, Commun Disorders Dept, Huntington, WV 25755 USA.	childersca@marshall.edu; khux1@unl.edu	Hux, Karen/AAQ-2078-2020				[Anonymous], 2012, INJ PREV CONTR TRAUM; Beamon K., 2002, RACE SOC, V5, P179, DOI DOI 10.1016/J.RACSOC.2004.01.006; BEERS SR, 1994, J LEARN DISABIL, V27, P315, DOI 10.1177/002221949402700508; Blanchet S, 2009, BRAIN INJURY, V23, P111, DOI 10.1080/02699050802649688; Brain Injury Association of America, MILD BRAIN INJ CONC; Brown C, 2000, J VOCAT BEHAV, V56, P53, DOI 10.1006/jvbe.1999.1691; Brown J., 2015, M AM SPEECH LANG HEA; Bush E, 2011, J POSTSECOND EDUC DI, V24, P231; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Church TE, 2009, J POSTSECOND EDUC DI, V22, P43; Creswell J.W ., 2007, QUAL INQ; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Grossman PD, 2009, J POSTSECOND EDUC DI, V22, P4; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Haag H. K. L., 2009, THESIS; Harris JR, 1997, J HEAD TRAUMA REHAB, V12, P67, DOI 10.1097/00001199-199704000-00007; Hux K, 2010, BRAIN INJURY, V24, P13, DOI 10.3109/02699050903446823; Kennedy MRT, 2011, J HEAD TRAUMA REHAB, V26, P212, DOI 10.1097/HTR.0b013e318218dd0e; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Klein F. C., 1982, WALL STREET J, P1; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Krause M, 2014, BRAIN INJURY, V28, P1301, DOI 10.3109/02699052.2014.916416; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Laforce R, 2001, PERCEPT MOTOR SKILL, V93, P281, DOI 10.2466/PMS.93.5.281-288; Lally PS, 2005, RES Q EXERCISE SPORT, V76, P275; Lincoln Y., 2011, SAGE HDB QUALITATIVE, P43; MacLennan DL, 2008, NEUROREHABILITATION, V23, P521; Madaus JW, 2009, J POSTSECOND EDUC DI, V22, P10; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; McBain L., 2012, SOLDIER STUDENT 2 AS; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moustakas C.E., 1994, PHENOMENOLOGICAL RES; Ochoa T., 2005, AMERICAN SECONDARY E, V33, P6; Potter DD, 2001, NEUROPSYCHOLOGIA, V39, P1464, DOI 10.1016/S0028-3932(01)00057-4; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; Raue K., 2011, 2011018 NCES US GOVT; Rodset M, 2008, SCAND J DISABIL RES, V10, P90, DOI 10.1080/15017410801927807; Ryan L M, 1996, Appl Neuropsychol, V3, P49, DOI 10.1207/s15324826an0302_1; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schutz LE, 2010, INT J SPEC EDUC, V25, P55; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Tincani M., 2004, COLL TEACHING, V52, P128, DOI [10.3200/CTCH.52.4.128-133, DOI 10.3200/CTCH.52.4.128-133]; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Triplett G, 1996, PERCEPT MOTOR SKILL, V83, P1344, DOI 10.2466/pms.1996.83.3f.1344; U.S. Department of Education National Center for Education Statistics, 2016, DIG ED STAT 2015; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wolf LE, 2001, ANN NY ACAD SCI, V931, P385; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU; Zoroya G., 2005, US TODAY, P3	55	13	13	0	1	ASSOC HIGHER EDUCATION & DISABILITY-AHEAD	COLUMBUS	ASSOC HIGHER EDUCATION & DISABILITY-AHEAD, COLUMBUS, OH 00000 USA	2379-7762	2328-3343		J POSTSECOND EDUC DI	J. Postsecond. Educ. Disabil.	WIN	2016	29	4					389	405					17	Education, Special	Emerging Sources Citation Index (ESCI)	Education & Educational Research	VE7HS	WOS:000440163900007					2022-02-06	
J	Joseph, B; Khalil, M; Harrison, C; Swartz, T; Kulvatunyou, N; Haider, AA; Jokar, TO; Burk, D; Mahmoud, A; Latifi, R; Rhee, P				Joseph, Bellal; Khalil, Mazhar; Harrison, Caitlyn; Swartz, Tianyi; Kulvatunyou, Narong; Haider, Ansab A.; Jokar, Tahereh O.; Burk, David; Mahmoud, Ali; Latifi, Rifat; Rhee, Peter			Assessing the Efficacy of Prothrombin Complex Concentrate in Multiply Injured Patients With High-Energy Pelvic and Extremity Fractures	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						extremity fractures; PCC; traumatic coagulopathy; prothrombin complex; coagulopathy reversal	FRESH-FROZEN PLASMA; TRAUMATIC BRAIN-INJURY; EMERGENCY ANTICOAGULATION REVERSAL; EARLY COAGULOPATHY; FACTOR-VIIA; ASSOCIATION; MANAGEMENT; WARFARIN; SURGERY	Objectives: Prothrombin complex concentrate (PCC) is being increasingly used for reversing induced coagulopathy of trauma. However, the use of PCC for reversing coagulopathy in multiply injured patients with pelvic and/or lower extremity fractures remains unclear. The aim of our study was to assess the efficacy of PCC for reversing coagulopathy in this group of patients. Design: Two-year retrospective analysis. Setting: Our level I trauma center. Patients/Participants: All coagulopathic [International normalized ratio (INR) >= 1.5] trauma patients. Patients with femur, tibia, or pelvic fracture were included. Patients were divided into 2 groups: PCC (single dose) and fresh frozen plasma (FFP). Patients in the 2 groups were matched using propensity score matching. Main Outcome Measurements: Time to correction of INR, time to intervention, development of thromboembolic complications, mortality, and cost of therapy. Results: A total of 81 patients (PCC: 27, FFP: 54) were included. Patients who received PCC had faster correction of INR and shorter time to surgical intervention in comparison to patients who received FFP. PCC therapy was also associated with lower overall blood product requirement (P = 0.02) and lower transfusion costs (P = 0.0001). Conclusions: In a matched cohort of multiply injured patients with pelvic and/or lower extremity fractures, administration of a single dose of PCC significantly reduced the time to correction of INR and time to intervention compared with patients who received FFP therapy. This may allow orthopaedic surgeons to more safely proceed with early, definitive fixation strategies.	[Joseph, Bellal; Khalil, Mazhar; Harrison, Caitlyn; Swartz, Tianyi; Kulvatunyou, Narong; Haider, Ansab A.; Jokar, Tahereh O.; Burk, David; Mahmoud, Ali; Latifi, Rifat; Rhee, Peter] Univ Arizona, Dept Surg, Div Trauma Crit Care Burns & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care Burns & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu		Latifi, Rifat/0000-0003-1091-3682			Beck KH, 2000, INFUS THER TRANSFUS, V27, P144; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Cullinane DC, 2011, J TRAUMA, V71, P1850, DOI 10.1097/TA.0b013e31823dca9a; Davis JW, 2008, J TRAUMA, V65, P1012, DOI 10.1097/TA.0b013e318189a836; Demeyere R, 2010, VOX SANG, V99, P251, DOI 10.1111/j.1423-0410.2010.01339.x; Dickneite G, 2009, BRIT J ANAESTH, V102, P345, DOI 10.1093/bja/aen391; Dickneite G, 2010, J TRAUMA, V68, P1151, DOI 10.1097/TA.0b013e3181b06364; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Eastridge BJ, 2002, J TRAUMA, V53, P446, DOI 10.1097/00005373-200209000-00009; Guest JF, 2010, CLIN THER, V32, P2478, DOI 10.1016/j.clinthera.2011.01.011; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holland LL, 2006, AM J CLIN PATHOL, V126, P133, DOI 10.1309/NQXHUG7HND78LFFK; Joseph B, 2015, NEUROSURGERY, V76, P601, DOI 10.1227/NEU.0000000000000685; Joseph B, 2014, WORLD J SURG, V38, P1875, DOI 10.1007/s00268-014-2631-y; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Joseph B, 2013, J TRAUMA ACUTE CARE, V74, P248, DOI 10.1097/TA.0b013e3182788a40; Joseph B, 2012, J TRAUMA ACUTE CARE, V72, P828, DOI 10.1097/TA.0b013e318247c944; Lankiewicz MW, 2006, J THROMB HAEMOST, V4, P967, DOI 10.1111/j.1538-7836.2006.01815.x; Lubetsky A, 2004, THROMB RES, V113, P371, DOI 10.1016/j.thromres.2004.04.004; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Magnussen RA, 2007, J ORTHOP TRAUMA, V21, P603, DOI 10.1097/BOT.0b013e3181599c27; Makris M, 2011, BLOOD TRANSFUS-ITALY, V9, P117, DOI 10.2450/2011.0111-10; Pabinger I, 2008, J THROMB HAEMOST, V6, P622, DOI 10.1111/j.1538-7836.2008.02904.x; Pandit V, 2015, J AM COLL SURGEONS, V221, pE23, DOI 10.1016/j.jamcollsurg.2015.08.358; Purmonen T, 2015, DRUGS R&D, V15, P155, DOI 10.1007/s40268-015-0088-6; Schurr MJ, 2004, J TRAUMA, V57, P718; Stein DM, 2008, INJURY, V39, P1054, DOI 10.1016/j.injury.2008.03.032; Tieu BH, 2007, WORLD J SURG, V31, P1055, DOI 10.1007/s00268-006-0653-9; White NJ, 2013, HEMATOL-AM SOC HEMAT, P660, DOI 10.1182/asheducation-2013.1.660; Yang L, 2012, TRANSFUSION, V52, P1673, DOI 10.1111/j.1537-2995.2011.03515.x	31	13	13	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	DEC	2016	30	12					653	658		10.1097/BOT.0000000000000665			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	ED6CG	WOS:000388941600010	27875491				2022-02-06	
J	Sener, S; Van Hecke, W; Feyen, BFE; Van der Steen, G; Pullens, P; Van de Hauwe, L; Menovsky, T; Parizel, PM; Jorens, PG; Maas, AIR				Sener, Suleyman; Van Hecke, Wim; Feyen, Bart F. E.; Van der Steen, Gregory; Pullens, Pim; Van de Hauwe, Luc; Menovsky, Tomas; Parizel, Paul M.; Jorens, Philippe G.; Maas, Andrew I. R.			Diffusion Tensor Imaging: A Possible Biomarker in Severe Traumatic Brain Injury and Aneurysmal Subarachnoid Hemorrhage?	NEUROSURGERY			English	Article						Aneurysmal subarachnoid hemorrhage; Biomarker; Diffusion tensor imaging; Outcome; Prognosis; Traumatic brain injury	WHITE-MATTER INJURY; OUTCOME PREDICTION; AXONAL INJURY; VASOSPASM; MODERATE; ABNORMALITIES; INTEGRITY	BACKGROUND: A great need exists in traumatic brain injury (TBI) and aneurysmal subarachnoid hemorrhage (aSAH) for objective biomarkers to better characterize the disease process and to serve as early endpoints in clinical studies. Diffusion tensor imaging (DTI) has shown promise in TBI, but much less is known about aSAH. OBJECTIVE: To explore the use of whole-brain DTI tractography in TBI and aSAH as a biomarker and early endpoint. METHODS: Of a cohort of 43 patients with severe TBI (n = 20) or aSAH (n = 23) enrolled in a prospective, observational, multimodality monitoring study, DTI data were acquired at approximately day 12 (median, 12 days; interquartile range, 12-14 days) after injury in 22 patients (TBI, n = 12; aSAH, n = 10). Whole-brain DTI tractography was performed, and the following parameters quantified: average fractional anisotropy, mean diffusivity, tract length, and the total number of reconstructed fiber tracts. These were compared between TBI and aSAH patients and correlated with mortality and functional outcome assessed at 6 months by the Glasgow Outcome Scale Extended. RESULTS: Significant differences were found for fractional anisotropy values (P = .01), total number of tracts (P = .03), and average tract length (P = .002) between survivors and nonsurvivors. A sensitivity analysis showed consistency of results between the TBI and aSAH patients for the various DTI measures. CONCLUSION: DTI parameters, assessed at approximately day 12 after injury, correlated with mortality at 6 months in patients with severe TBI or aSAH. Similar patterns were found for both TBI and aSAH patients. This supports a potential role of DTI as early endpoint for clinical studies and a predictor of late mortality.	[Sener, Suleyman; Feyen, Bart F. E.; Van der Steen, Gregory; Menovsky, Tomas; Maas, Andrew I. R.] Univ Antwerp Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium; [Van Hecke, Wim; Pullens, Pim; Van de Hauwe, Luc; Parizel, Paul M.] Univ Antwerp Hosp, Dept Radiol, Edegem, Belgium; [Jorens, Philippe G.] Univ Antwerp Hosp, Dept Intens Care, Edegem, Belgium; [Sener, Suleyman; Feyen, Bart F. E.; Menovsky, Tomas; Parizel, Paul M.; Jorens, Philippe G.; Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium		Sener, S (corresponding author), Univ Antwerp Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium.	suleyman.sener@uza.be		Parizel, Paul M./0000-0002-0221-2854; Pullens, Pim/0000-0003-2014-7248	IWT-the Flemish Agency for Innovation by Science and Technology	Andrew I. R. Maas received financial support from IWT-the Flemish Agency for Innovation by Science and Technology. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Bullock AR, 2006, NEUROSURGERY, V58, pVI; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Hadeishi H, 2002, NEUROSURGERY, V50, P741, DOI 10.1097/00006123-200204000-00010; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jang SH, 2014, MBJ OPEN, V4; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kochunov P, 2007, NEUROIMAGE, V35, P478, DOI 10.1016/j.neuroimage.2006.12.021; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2014, MYMENSINGH MED J, V4, P223; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Kummer TT, 2015, BRAIN, V138, P2608, DOI 10.1093/brain/awv180; Lee JW, 2006, J HEAD TRAUMA REHAB, V21, P272, DOI 10.1097/00001199-200605000-00007; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Macdonald RL, 2010, NEUROCRIT CARE, V13, P416, DOI 10.1007/s12028-010-9433-3; Mukherjee P, 2006, NEUROIMAG CLIN N AM, V16, P19, DOI 10.1016/j.nic.2005.11.004; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Parmentier-Decrucq E, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-10; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Rordorf G, 1999, STROKE, V30, P599, DOI 10.1161/01.STR.30.3.599; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Schweizer TA, 2012, CLIN NEUROL NEUROSUR, V114, P798, DOI 10.1016/j.clineuro.2011.12.045; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shinohara Y, 2011, J STROKE CEREBROVASC, V20, pS100, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.011; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wouters A, 2015, J CEREBR BLOOD F MET, V35, P1681, DOI 10.1038/jcbfm.2015.108; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yeo SS, 2012, STROKE, V43, P2239, DOI 10.1161/STROKEAHA.112.661116; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	41	13	13	0	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	DEC	2016	79	6					786	793		10.1227/NEU.0000000000001325			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EI6OH	WOS:000392614700018	27352277				2022-02-06	
J	Yeh, TS; Huang, YP; Wang, HI; Pan, SL				Yeh, T-S; Huang, Y-P; Wang, H-I; Pan, S-L			Spinal cord injury and Parkinson's disease: a population-based, propensity score-matched, longitudinal follow-up study	SPINAL CORD			English	Article							TRAUMATIC BRAIN-INJURY; ALPHA-SYNUCLEIN; TNF-ALPHA; AUTOANTIBODIES; CYTOKINES; MICROGLIA	Objectives: To investigate whether patients with spinal cord injury (SCI) are at an increased risk of developing Parkinson's disease (PD). Study design: A population-based, propensity score-matched, longitudinal follow-up cohort study. Setting: The study was conducted using the National Health Insurance (NHI) Research Database. Methods: A total of 10 125 patients with at least 2 ambulatory visits with a diagnosis of SCI in 2001 were enrolled in the SCI group. The non-SCI group comprised 10 125 propensity score-matched patients without SCI. The propensity scores were computed using a logistic regression model that included age, sex, comorbidities and socioeconomic status. The PD-free survival rates of the two groups were estimated using the Kaplan-Meier method. Stratified Cox proportional hazard regression was used to estimate the effect of SCI on subsequent occurrence of PD. Results: During the 3-year follow-up period, 99 subjects in the SCI group and 59 in the non-SCI group developed PD. The hazard ratio of PD for the SCI group compared with the non-SCI group was 1.65 (95% confidence interval 1.16-2.33, P=0.0049). The PD-free survival rate for the SCI group was lower than that for the non-SCI group (P=0.0017). Conclusions: This study shows that SCI is associated with a subsequent increased risk of PD. Further studies are needed to elucidate the mechanism underlying this association.	[Yeh, T-S; Huang, Y-P] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Phys Med & Rehabil, Touliu, Yunlin, Taiwan; [Wang, H-I; Pan, S-L] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, 7 Chung Shan S Rd, Taipei 100, Taiwan; [Pan, S-L] Natl Taiwan Univ, Coll Med, Dept Phys Med & Rehabil, Taipei, Taiwan		Pan, SL (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, 7 Chung Shan S Rd, Taipei 100, Taiwan.; Pan, SL (corresponding author), Natl Taiwan Univ, Coll Med, 7 Chung Shan S Rd, Taipei 100, Taiwan.	panslcb@gmail.com		PAN, SHIN-LIANG/0000-0001-6451-4666	Department of Health (DOH), Executive Yuan, Republic of China [DOH93-TD-M-113-030, DOH94-TD-M-113-004, DOH95-TD-M-113-002]	This study was supported by grants DOH93-TD-M-113-030, DOH94-TD-M-113-004 and DOH95-TD-M-113-002 from the Department of Health (DOH), Executive Yuan, Republic of China. This study used the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health. The conclusions in our study do not necessarily represent those of the Department of Health, Executive Yuan, Republic of China.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Biglari B, 2015, SPINAL CORD, V53, P510, DOI 10.1038/sc.2015.28; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Busch DJ, 2012, J COMP NEUROL, V520, P1751, DOI 10.1002/cne.23011; Chen CC, 2009, NEUROEPIDEMIOLOGY, V33, P350, DOI 10.1159/000254572; Corrigan F, 2015, BRIT J PHARMACOL, V173, P703; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; David Samuel, 2012, Handb Clin Neurol, V109, P485, DOI 10.1016/B978-0-444-52137-8.00030-9; Davies AL, 2007, ARCH PHYS MED REHAB, V88, P1384, DOI 10.1016/j.apmr.2007.08.004; Fischer R, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/610813; Gallegos S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00059; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; Huang YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068314; Huse DM, 2005, MOVEMENT DISORD, V20, P1449, DOI 10.1002/mds.20609; Lee HJ, 2014, NAT REV NEUROL, V10, P92, DOI 10.1038/nrneurol.2013.275; Liu CY, 2006, J HEALTHC MANAG, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Pan WH, 2008, CURR PHARM DESIGN, V14, P1620, DOI 10.2174/138161208784705450; Pan WH, 2003, J NEUROIMMUNOL, V134, P111, DOI 10.1016/S0165-5728(02)00426-5; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Parsons LS, 2004, PERFORMING 1 N CASE; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Sakurai M, 2009, J CEREBR BLOOD F MET, V29, P752, DOI 10.1038/jcbfm.2008.167; Sanchez-Guajardo V, 2015, NEUROSCIENCE, V302, P47, DOI 10.1016/j.neuroscience.2015.02.008; Stojkovska I, 2015, EXP BIOL MED, V240, P1387, DOI 10.1177/1535370215576313; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004	30	13	13	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	DEC	2016	54	12					1215	1219		10.1038/sc.2016.74			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	EF9IY	WOS:000390645100023	27241446	Bronze			2022-02-06	
J	Visser-Keizer, AC; Westerhof-Evers, HJ; Gerritsen, MJJ; van der Naalt, J; Spikman, JM				Visser-Keizer, Annemarie C.; Westerhof-Evers, Herma J.; Gerritsen, Marleen J. J.; van der Naalt, Joukje; Spikman, Jacoba M.			To Fear Is to Gain? The Role of Fear Recognition in Risky Decision Making in TBI Patients and Healthy Controls	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; IOWA GAMBLING TASK; FACIAL EMOTION RECOGNITION; PREFRONTAL CORTEX; SEX-DIFFERENCES; SOCIAL COGNITION; DEFICITS; DAMAGE; LESIONS; METAANALYSIS	Fear is an important emotional reaction that guides decision making in situations of ambiguity or uncertainty. Both recognition of facial expressions of fear and decision making ability can be impaired after traumatic brain injury (TBI), in particular when the frontal lobe is damaged. So far, it has not been investigated how recognition of fear influences risk behavior in healthy subjects and TBI patients. The ability to recognize fear is thought to be related to the ability to experience fear and to use it as a warning signal to guide decision making. We hypothesized that a better ability to recognize fear would be related to a better regulation of risk behavior, with healthy controls outperforming TBI patients. To investigate this, 59 healthy subjects and 49 TBI patients were assessed with a test for emotion recognition (Facial Expression of Emotion: Stimuli and Tests) and a gambling task (Iowa Gambling Task (IGT)). The results showed that, regardless of post traumatic amnesia duration or the presence of frontal lesions, patients were more impaired than healthy controls on both fear recognition and decision making. In both groups, a significant relationship was found between better fear recognition, the development of an advantageous strategy across the IGT and less risk behavior in the last blocks of the IGT. Educational level moderated this relationship in the final block of the IGT. This study has important clinical implications, indicating that impaired decision making and risk behavior after TBI can be preceded by deficits in the processing of fear.	[Visser-Keizer, Annemarie C.; Gerritsen, Marleen J. J.; van der Naalt, Joukje; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Westerhof-Evers, Herma J.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Groningen, Netherlands; [Westerhof-Evers, Herma J.; Spikman, Jacoba M.] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands		Visser-Keizer, AC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	a.c.visser@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763; van der Naalt, Joukje/0000-0001-9873-2418	Dutch Brain Foundation [F2008-1-18]	This study was funded by the Dutch Brain Foundation, grant number F2008-1-18 ww.hersenstichting.nl. JMS HJWE JN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Aite A, 2013, EMOTION, V13, P177, DOI 10.1037/a0031345; Arrais KC, 2010, J PSYCHIATR RES, V44, P535, DOI 10.1016/j.jpsychires.2009.11.003; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Balconi M, 2011, NEUROSCI RES, V71, P251, DOI 10.1016/j.neures.2011.07.1833; Bastiaansen JACJ, 2009, PHILOS T R SOC B, V364, P2391, DOI 10.1098/rstb.2009.0058; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Beitz KM, 2014, J EXP PSYCHOL GEN, V143, P1677, DOI 10.1037/a0035823; Bonatti E, 2008, COGN BEHAV NEUROL, V21, P164, DOI 10.1097/WNN.0b013e318184e688; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Brand M, 2007, J CLIN EXP NEUROPSYC, V29, P86, DOI 10.1080/13803390500507196; Buchanan TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010640; Bull PN, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00391; Cotrena C, 2014, BRAIN INJURY, V28, P1070, DOI 10.3109/02699052.2014.896943; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; Doty TJ, 2014, COGN AFFECT BEHAV NE, V14, P1438, DOI 10.3758/s13415-014-0290-y; Duffau H, 2012, CORTEX, V48, P120, DOI 10.1016/j.cortex.2011.04.029; Dunn BD, 2010, PSYCHOL SCI, V21, P1835, DOI 10.1177/0956797610389191; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Evans JSBT, 2011, DEV REV, V31, P86, DOI 10.1016/j.dr.2011.07.007; Evans KL, 2015, BRAIN COGNITION, V93, P42, DOI 10.1016/j.bandc.2014.11.006; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Heilman RM, 2010, EMOTION, V10, P257, DOI 10.1037/a0018489; Higgins, 1990, HDB MOTIVATION COGNI, P527, DOI DOI 10.2307/2072281; Ibarretxe-Bilbao N, 2009, EUR J NEUROSCI, V30, P1162, DOI 10.1111/j.1460-9568.2009.06892.x; Jenkins LM, 2014, PSYCHIAT RES-NEUROIM, V224, P192, DOI 10.1016/j.pscychresns.2014.08.007; Keltner D, 1999, COGNITION EMOTION, V13, P505, DOI 10.1080/026999399379168; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Letswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148; Levenson RW, 1999, COGNITION EMOTION, V13, P481, DOI 10.1080/026999399379159; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; LUNDQVIST LO, 1995, SCAND J PSYCHOL, V36, P130, DOI 10.1111/j.1467-9450.1995.tb00974.x; MacPherson SE, 2009, CLIN NEUROPSYCHOL, V23, P510, DOI 10.1080/13854040802396586; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Marsh AA, 2011, J CHILD PSYCHOL PSYC, V52, P834, DOI 10.1111/j.1469-7610.2010.02353.x; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; Moody EJ, 2007, EMOTION, V7, P447, DOI 10.1037/1528-3542.7.2.447; Neumann D, 2014, J HEAD TRAUMA REHABI; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Oberman LM, 2007, SOC NEUROSCI-UK, V2, P167, DOI 10.1080/17470910701391943; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Overman WH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00935; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Rosenberg H, 2015, NEUROPSYCHOLOGY, V29, P509, DOI 10.1037/neu0000171; Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001; Seo MG, 2007, ACAD MANAGE J, V50, P923, DOI 10.2307/20159897; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Surcinelli P, 2006, J ANXIETY DISORD, V20, P110, DOI 10.1016/j.janxdis.2004.11.010; Terasawa Y, 2014, COGNITION EMOTION, V28, P1435, DOI 10.1080/02699931.2014.888988; Thompson AE, 2014, COGNITION EMOTION, V28, P1164, DOI 10.1080/02699931.2013.875889; van den Bos R, 2013, BEHAV BRAIN RES, V238, P95, DOI 10.1016/j.bbr.2012.10.002; Van Kleef GA, 2010, SOC PERSONAL PSYCHOL, V4, P331, DOI 10.1111/j.1751-9004.2010.00262.x; Vandekerckhove M, 2014, NEUROPSYCHOLOGY, V28, P605, DOI 10.1037/neu0000057; Verdejo-Garcia A, 2007, DRUG ALCOHOL DEPEN, V86, P139, DOI 10.1016/j.drugalcdep.2006.05.024; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Werner NS, 2009, PSYCHOPHYSIOLOGY, V46, P1123, DOI 10.1111/j.1469-8986.2009.00855.x; Yasuno F, 2014, BRAIN COGNITION, V84, P63, DOI 10.1016/j.bandc.2013.11.005; Yechiam E, 2005, PSYCHOL SCI, V16, P973, DOI 10.1111/j.1467-9280.2005.01646.x; Young A.W., 2002, FACIAL EXPRESSIONS E, P3595, DOI [10.1016/j.neuropsychologia.2010.08.008, DOI 10.1016/J.NEUROPSYCHOLOGIA.2010.08.008]; Zeelenberg M, 2008, JUDGM DECIS MAK, V3, P18	77	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166995	10.1371/journal.pone.0166995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED4UE	WOS:000388846400053	27870900	gold, Green Submitted, Green Published			2022-02-06	
J	Walsh, DV; Capo-Aponte, JE; Beltran, T; Cole, WR; Ballard, A; Dumayas, JY				Walsh, David V.; Capo-Aponte, Jose E.; Beltran, Thomas; Cole, Wesley R.; Ballard, Ashley; Dumayas, Joseph Y.			Assessment of the King-Devick (R) (KD) test for screening acute mTBI/concussion in warfighters	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						King-Devick (KD) test; Saccades; Mild traumatic brain injury (mTBI); Military	TRAUMATIC BRAIN-INJURY; KING-DEVICK TEST; RUGBY LEAGUE; RECOVERY; REHABILITATION; CONCUSSION; SYMPTOMS; IRAQ	Objectives: The Department of Defense reported that 344,030 cases of traumatic brain injury (TBI) were clinically confirmed from 2000 to 2015, with mild TBI (mTBI) accounting for 82.3% of all cases. Unfortunately, warfighters with TBI are often identified only when moderate or severe head injuries have occurred, leaving more subtle mTBI cases undiagnosed. This study aims to identify and validate an eye-movement visual test for screening acute mTBI. Methods: Two-hundred active duty military personnel were recruited to perform the King-Devick (R) (KD) test. Subjects were equally divided into two groups: those with diagnosed acute mTBI (<= 72 h) and age-matched controls. The KD test was administered twice for test-retest reliability, and the outcome measure was total cumulative time to complete each test. Results: The mTBI group had approximately 36% mean slower performance time with significant differences between the groups (p < 0.001) in both tests. There were significant differences between the two KD test administrations in each group, however, a strong correlation was observed between each test administration. Conclusions: Significant differences in KD test performance were seen between the acute mTBI and control groups. The results suggest the KD test can be utilized for screening acute mTBI. A validated and rapidly administered mTBI screening test with results that are easily interpreted by providers is essential in making return-to duty decisions in the injured warfighter. Published by Elsevier B.V.	[Walsh, David V.] US Army Aeromed Res Lab, Vis Protect & Performance Div, 6901 Farrel Rd, Ft Rucker, AL 36362 USA; [Capo-Aponte, Jose E.; Ballard, Ashley; Dumayas, Joseph Y.] Womack Army Med Ctr, Dept Optometry, 2817 Reilly Rd,Stop A, Ft Bragg, NC 28310 USA; [Beltran, Thomas] Womack Army Med Ctr, Dept Clin Invest, 2817 Reilly Rd,Stop A, Ft Bragg, NC 28310 USA; [Cole, Wesley R.] Womack Army Med Ctr, Def & Vet Brain Injury Ctr, Dept Brain Injury Med, 2817 Reilly Rd,Stop A, Ft Bragg, NC 28310 USA		Walsh, DV (corresponding author), US Army Aeromed Res Lab, Vis Protect & Performance Div, 6901 Farrel Rd, Ft Rucker, AL 36362 USA.	david.v.walsh.mil@mail.mil		Beltran, Thomas/0000-0001-8971-1201	Military Operational Medicine Research Program of the U.S. Army Medical Research and Materiel Command (USAMRMC); Department of Defense Army Rapid Innovation Fund Research Program of the Office of the Congressionally Directed Medical Research Programs (CDMRP) [W81XWH-14-C-0048]; Geneva Foundation; Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs	This research was funded by the Military Operational Medicine Research Program of the U.S. Army Medical Research and Materiel Command (USAMRMC), and FY13 Department of Defense Army Rapid Innovation Fund Research Program of the Office of the Congressionally Directed Medical Research Programs (CDMRP) under contract No. W81XWH-14-C-0048. This research was conducted with support from the Geneva Foundation as well as the Defense and Veterans Brain Injury Center (DVBIC) and staffing support from General Dynamics Information Technology.	[Anonymous], DOD WORLDW NUMB TBI; [Anonymous], 2004, VISUAL NEUROSCIENCES, V1, P507; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Capo-Aponte JE, 2012, J REHABIL RES DEV, V49, P1377, DOI 10.1682/JRRD.2011.07.0128; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iaccarino Mary Alexis, 2015, Handb Clin Neurol, V127, P411, DOI 10.1016/B978-0-444-52892-6.00026-X; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; Lin TP, 2014, PARKINSONISM RELAT D, V20, P226, DOI 10.1016/j.parkreldis.2013.10.009; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Moster S, 2014, J NEUROL SCI, V343, P105, DOI 10.1016/j.jns.2014.05.047; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Schmid Kara E, 2012, Front Neurol, V3, P90, DOI 10.3389/fneur.2012.00090; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Vandiver VL, 2003, J HEAD TRAUMA REHAB, V18, P457, DOI 10.1097/00001199-200309000-00007; VanEssen DC, 1997, J NEUROSCI, V17, P7079	25	13	13	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	NOV 15	2016	370						305	309		10.1016/j.jns.2016.09.014			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EB8FV	WOS:000387627800063	27646958	hybrid			2022-02-06	
J	Bilotta, F; Robba, C; Santoro, A; Delfini, R; Rosa, G; Agati, L				Bilotta, Federico; Robba, Chiara; Santoro, Antonio; Delfini, Roberto; Rosa, Giovanni; Agati, Luciano			CONTRAST-ENHANCED ULTRASOUND IMAGING IN DETECTION OF CHANGES IN CEREBRAL PERFUSION	ULTRASOUND IN MEDICINE AND BIOLOGY			English	Article						Contrast ultrasound imaging; Decompressive craniectomy; Brain perfusion; Intra-cranial pressure	TRAUMATIC BRAIN-INJURY; BLOOD-VOLUME; INTRACRANIAL HYPERTENSION; DECOMPRESSIVE CRANIECTOMY; MECHANICAL VENTILATION; PULMONARY TRANSIT; ARTERIAL FRACTION; ECHOCARDIOGRAPHY; HEMICRANIECTOMY; ASSOCIATION	Contrast-enhanced ultrasonography (CEU) is a non-invasive imaging technique that provides real-time, bedside information on changes in global and segmental organ perfusion. Currently, there is a lack of data concerning changes in the distribution of segmental brain perfusion in acute ischemic stroke treated by decompressive craniectomy. The aim of our case series was to assess the role of CEU after decompressive craniectomy in patients with acute ischemic stroke. CEU was performed in 12 patients at baseline and after any one of the following interventions was performed as dictated by the patient's clinical condition: vasoactive drug administration (in order to achieve cerebral perfusion pressure >= 70 mm Hg and mean arterial pressure,100 mm Hg for management of arterial blood pressure) and mild hyperventilation (carbon dioxide arterial pressure 5 3035 mm Hg). CEU was able to detect a significant variation in cerebral contrast distribution in both normal and pathologic hemispheres after induced hyperventilation (difference in time to peak [dTTP] = -38.4%), vasodilation (dTTP = -6.6%) and vasoconstriction (dTTP = +31.2%) (p < 0.05). CEU can be useful in assessing real-time cerebral perfusion changes in neurocritical care patients. (C) 2016 World Federation for Ultrasound in Medicine & Biology.	[Bilotta, Federico; Rosa, Giovanni] Univ Rome Sapienza, Dept Anesthesiol, Rome, Italy; [Robba, Chiara] Addenbrookes Hosp, Neurocrit Care Unit, Cambridge, England; [Santoro, Antonio; Delfini, Roberto] Univ Rome Sapienza, Dept Neurosurg, Rome, Italy; [Agati, Luciano] Univ Rome Sapienza, Dept Cardiol, Rome, Italy		Robba, C (corresponding author), Cambridge Univ Hosp Trust, Addenbrookes Hosp, Neurocrit Care Unit, Hills Rd, Cambridge CB2 0QQ, England.	kiarobba@gmail.com	Robba, Chiara/AAS-7421-2020	agati, luciano/0000-0003-3186-1797			Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; [Anonymous], 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2007.9997; [Anonymous], 2004, T AM CLIN CLIMAT ASS, V115, P137; Bilotta F, 2005, ECHOCARDIOGR-J CARD, V22, P395, DOI 10.1111/j.1540-8175.2005.04084.x; Bilotta F, 1999, ANESTH ANALG, V89, P273; Bilotta F, 2013, NEUROL RES, V35, P149, DOI 10.1179/1743132812Y.0000000155; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Brain Trauma Foundation, 2003, PEDIATR CRIT CARE ME, V4, P45; Ciccone MM, 2012, CURR NEUROVASC RES, V9, P120; Curry R, 2008, PEDIATR CRIT CARE ME, V9, P141, DOI 10.1097/PCC.0B013e318166870e; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; FORTUNE JB, 1995, J TRAUMA, V39, P463; Galiuto L, 2008, J AM COLL CARDIOL, V51, P552, DOI 10.1016/j.jacc.2007.09.051; Gover A, 2011, ISR MED ASSOC J, V13, P9; HARRINGTON T, 1973, NEUROLOGY, V23, P294, DOI 10.1212/WNL.23.3.294; He W, 2008, CLIN IMAG, V32, P419, DOI 10.1016/j.clinimag.2008.05.006; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; Hofmeijer J, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-29; Ito H, 2005, J CEREBR BLOOD F MET, V25, P852, DOI 10.1038/sj.jcbfm.9600076; Ito H, 2001, ANN NUCL MED, V15, P111, DOI 10.1007/BF02988600; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kern R, 2004, STROKE, V35, P1665, DOI 10.1161/01.STR.0000129332.10721.7e; Li X, 2016, CLIN CARDIOL, V39, P453, DOI 10.1002/clc.22548; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Neumann JO, 2008, INTENS CARE MED, V34, P1676, DOI 10.1007/s00134-008-1123-7; Orlacchio A, 2011, ULTRASOUND MED BIOL, V37, P1, DOI 10.1016/j.ultrasmedbio.2010.10.012; Rim SJ, 2001, CIRCULATION, V104, P2582, DOI 10.1161/hc4601.099400; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Senior R, 2009, EUR J ECHOCARDIOGR, V10, P194, DOI 10.1093/ejechocard/jep005; Strebel SP, 1998, ANESTHESIOLOGY, V89, P67, DOI 10.1097/00000542-199807000-00012; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Unsgaard G, 2002, NEUROSURGERY, V51, P402, DOI 10.1097/00006123-200208000-00019; VOCI P, 1995, CIRCULATION, V91, P1714, DOI 10.1161/01.CIR.91.6.1714; Voci P, 1994, J Am Soc Echocardiogr, V7, P337; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; Yang C, 2015, MED PHYS, V42, P4762, DOI 10.1118/1.4926550	39	13	13	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0301-5629	1879-291X		ULTRASOUND MED BIOL	Ultrasound Med. Biol.	NOV	2016	42	11					2708	2716		10.1016/j.ultrasmedbio.2016.06.007			9	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	EE3QR	WOS:000389511000020	27475927				2022-02-06	
J	Dienel, GA; Rothman, DL; Nordstrom, CH				Dienel, Gerald A.; Rothman, Douglas L.; Nordstroem, Carl-Henrik			Microdialysate concentration changes do not provide sufficient information to evaluate metabolic effects of lactate supplementation in brain-injured patients	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Cerebral microdialysis; brain metabolism; glucose; lactate supplementation; traumatic brain injury	CEREBRAL GLUCOSE-UTILIZATION; HUMAN VISUAL-CORTEX; INTRACRANIAL HYPERTENSIVE EPISODES; POSITRON-EMISSION-TOMOGRAPHY; NUCLEAR-MAGNETIC-RESONANCE; PENTOSE-PHOSPHATE PATHWAY; ENERGY-METABOLISM; RAT-BRAIN; AEROBIC GLYCOLYSIS; WHITE-MATTER	Cerebral microdialysis is a widely used clinical tool for monitoring extracellular concentrations of selected metabolites after brain injury and to guide neurocritical care. Extracellular glucose levels and lactate/pyruvate ratios have high diagnostic value because they can detect hypoglycemia and deficits in oxidative metabolism, respectively. In addition, patterns of metabolite concentrations can distinguish between ischemia and mitochondrial dysfunction, and are helpful to choose and evaluate therapy. Increased intracranial pressure can be life-threatening after brain injury, and hypertonic solutions are commonly used for pressure reduction. Recent reports have advocated use of hypertonic sodium lactate, based on claims that it is glucose sparing and provides an oxidative fuel for injured brain. However, changes in extracellular concentrations in microdialysate are not evidence that a rise in extracellular glucose level is beneficial or that lactate is metabolized and improves neuroenergetics. The increase in glucose concentration may reflect inhibition of glycolysis, glycogenolysis, and pentose phosphate shunt pathway fluxes by lactate flooding in patients with mitochondrial dysfunction. In such cases, lactate will not be metabolizable and lactate flooding may be harmful. More rigorous approaches are required to evaluate metabolic and physiological effects of administration of hypertonic sodium lactate to brain-injured patients.	[Dienel, Gerald A.] Univ Arkansas Med Sci, Dept Neurol, Little Rock, AR 72205 USA; [Dienel, Gerald A.] Univ New Mexico, Dept Cell Biol & Physiol, Albuquerque, NM USA; [Rothman, Douglas L.] Yale Univ Sch Med, Dept Radiol & Biomed Imaging, Magnet Resonance Res Ctr, New Haven, CT USA; [Nordstroem, Carl-Henrik] Univ Lund Hosp, Dept Neurosurg, Lund, Sweden; [Nordstroem, Carl-Henrik] Odense Univ Hosp, Dept Neurosurg, Odense, Denmark		Dienel, GA (corresponding author), Univ Arkansas Med Sci, Dept Neurol, Little Rock, AR 72205 USA.	gadienel@uams.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS087568A]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001863] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: GD and C-HN received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. DLR was supported by the National Institutes of Health (grant number R01NS087568A).	ADACHI K, 1995, J CEREBR BLOOD F MET, V15, P97, DOI 10.1038/jcbfm.1995.11; AGARDH CD, 1978, J NEUROCHEM, V31, P1135, DOI 10.1111/j.1471-4159.1978.tb06236.x; Amer-Wahlin I, 2010, J MATERN-FETAL NEO M, V23, P158, DOI 10.3109/14767050903067360; Bak LK, 2012, ASN NEURO, V4, DOI 10.1042/AN20120004; Ball KK, 2010, J CEREBR BLOOD F MET, V30, P162, DOI 10.1038/jcbfm.2009.206; BORGSTROM L, 1976, J NEUROCHEM, V27, P971, DOI 10.1111/j.1471-4159.1976.tb05165.x; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Bozzo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071721; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; CAVAZZUTI M, 1991, BRIT J ANAESTH, V66, P490, DOI 10.1093/bja/66.4.490; CHAPMAN AG, 1977, J NEUROCHEM, V28, P1025, DOI 10.1111/j.1471-4159.1977.tb10665.x; CHEN W, 1993, P NATL ACAD SCI USA, V90, P9896, DOI 10.1073/pnas.90.21.9896; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; CHUGANI HT, 1991, J CEREBR BLOOD F MET, V11, P35, DOI 10.1038/jcbfm.1991.4; COX DWG, 1988, EXP BRAIN RES, V69, P368; Cruz NF, 1999, J CEREBR BLOOD F MET, V19, P380, DOI 10.1097/00004647-199904000-00004; DAHLGREN N, 1980, BRAIN RES, V184, P143, DOI 10.1016/0006-8993(80)90593-4; DAM M, 1990, ANESTHESIOLOGY, V73, P499, DOI 10.1097/00000542-199009000-00021; de Graaf RA, 2001, J CEREBR BLOOD F MET, V21, P483, DOI 10.1097/00004647-200105000-00002; DIENEL GA, 1991, J CEREBR BLOOD F MET, V11, P25, DOI 10.1038/jcbfm.1991.3; Dienel GA, 2007, J NEUROCHEM, V102, P466, DOI 10.1111/j.1471-4159.2007.04595.x; Dienel GA, 2016, J NEUROCHEM, V138, P14, DOI 10.1111/jnc.13630; Dienel GA, 2014, J CEREBR BLOOD F MET, V34, P1736, DOI 10.1038/jcbfm.2014.153; Dienel GA, 2012, ASN NEURO, V4, P267, DOI 10.1042/AN20120021; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; DiNuzzo M, 2010, J CEREBR BLOOD F MET, V30, P586, DOI 10.1038/jcbfm.2009.232; Diringer MN, 2013, CURR OPIN CRIT CARE, V19, P77, DOI 10.1097/MCC.0b013e32835eba30; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Ederoth P, 2004, BRIT J CLIN PHARMACO, V57, P427, DOI 10.1046/j.1365-2125.2003.02032.x; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Feuerstein D, 2016, J CEREBR BLOOD F MET, V36, P1965, DOI 10.1177/0271678X15612779; FOLBERGR.J, 1970, J NEUROCHEM, V17, P1155, DOI 10.1111/j.1471-4159.1970.tb03363.x; FOLBERGROVA J, 1969, J NEUROCHEM, V16, P191, DOI 10.1111/j.1471-4159.1969.tb05937.x; Frahm J, 1996, MAGNET RESON MED, V35, P143, DOI 10.1002/mrm.1910350202; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Galow Lukas V, 2014, Front Neurosci, V8, P398, DOI 10.3389/fnins.2014.00398; GATFIELD PD, 1966, J NEUROCHEM, V13, P185, DOI 10.1111/j.1471-4159.1966.tb07512.x; Gilbert E, 2006, BRAIN RES, V1117, P213, DOI 10.1016/j.brainres.2006.07.107; GJEDDE A, 1983, J CEREBR BLOOD F MET, V3, P303, DOI 10.1038/jcbfm.1983.45; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Glenn TC, 2015, J NEUROTRAUM, V32, P811, DOI 10.1089/neu.2014.3482; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; HALPERIN ML, 1969, J BIOL CHEM, V244, P384; Hein TW, 2006, INVEST OPHTH VIS SCI, V47, P693, DOI 10.1167/iovs.05-1224; HEISS WD, 1984, J CEREBR BLOOD F MET, V4, P212, DOI 10.1038/jcbfm.1984.30; Helbok R, 2011, J NEUROL NEUROSUR PS, V82, P378, DOI 10.1136/jnnp.2009.198754; Hertz L, 2015, METAB BRAIN DIS, V30, P317, DOI 10.1007/s11011-014-9536-1; HOLDEN JE, 1991, J CEREBR BLOOD F MET, V11, P171, DOI 10.1038/jcbfm.1991.50; Hu YB, 1997, J NEUROCHEM, V68, P1745; Hu YB, 1997, J NEUROCHEM, V69, P1484; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hutchinson P, 2009, ACTA NEUROCHIR, V151, P51, DOI 10.1007/s00701-008-0169-1; Hyder F, 2016, J CEREBR BLOOD F MET, V36, P903, DOI 10.1177/0271678X15625349; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Ivanov AI, 2014, J CEREBR BLOOD F MET, V34, P397, DOI 10.1038/jcbfm.2013.222; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Lauritzen KH, 2014, CEREB CORTEX, V24, P2784, DOI 10.1093/cercor/bht136; LEHMENKUHLER A, 1993, NEUROSCIENCE, V55, P339, DOI 10.1016/0306-4522(93)90503-8; Leloup C, 2015, J NEUROCHEM, V135, P639, DOI 10.1111/jnc.13276; Li BW, 2015, J NEUROCHEM, V135, P742, DOI 10.1111/jnc.13143; Madsen PL, 1999, J CEREBR BLOOD F MET, V19, P393, DOI 10.1097/00004647-199904000-00005; Madsen PL, 1998, J CEREBR BLOOD F MET, V18, P742, DOI 10.1097/00004647-199807000-00005; Mangia S, 2007, J CEREBR BLOOD F MET, V27, P1055, DOI 10.1038/sj.jcbfm.9600401; Mangia S, 2011, J CEREBR BLOOD F MET, V31, P1346, DOI 10.1038/jcbfm.2011.29; Mangia S, 2009, J NEUROCHEM, V109, P55, DOI 10.1111/j.1471-4159.2009.06003.x; Marko NF, 2012, CRIT CARE, V16, DOI 10.1186/cc11182; Mintun MA, 2002, NEUROIMAGE, V16, P531, DOI 10.1006/nimg.2002.1114; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Muller MS, 2014, BIOCHEM SOC T, V42, P1311, DOI 10.1042/BST20140157; Nakanishi H, 1996, J CEREBR BLOOD F MET, V16, P439, DOI 10.1097/00004647-199605000-00010; NEDERGAARD M, 1993, AM J PHYSIOL, V265, pR282, DOI 10.1152/ajpregu.1993.265.2.R282; Nielsen TH, 2014, NEUROCRIT CARE, V21, P35, DOI 10.1007/s12028-013-9875-5; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P793, DOI 10.1111/aas.12092; Nordstrom CH, 2014, J NEUROTRAUM, V31, P1528, DOI 10.1089/neu.2013.3229; Nordstrom CH, 2014, INTENS CARE MED, V40, P919, DOI 10.1007/s00134-014-3297-5; Nordstrom CH, 2013, J REHABIL MED, V45, P710, DOI 10.2340/16501977-1157; Nordstrom CH, 2010, CHILD NERV SYST, V26, P465, DOI 10.1007/s00381-009-1035-z; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Okada Y, 2007, BRAIN ENERGETICS INT, P17, DOI [10.1007/978-0-387-30411-3_2, DOI 10.1007/978-0-387-30411-3_2]; Osborne DM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00164; Patel AB, 2014, P NATL ACAD SCI USA, V111, P5385, DOI 10.1073/pnas.1403576111; Patet C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0638-5; Patet C, 2015, J NEUROTRAUM, V32, P1560, DOI 10.1089/neu.2014.3781; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PRICHARD J, 1991, P NATL ACAD SCI USA, V88, P5829, DOI 10.1073/pnas.88.13.5829; Quintard H, 2016, J NEUROTRAUM, V33, P681, DOI 10.1089/neu.2015.4057; Quistorff B, 2008, FASEB J, V22, P3443, DOI 10.1096/fj.08-106104; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Reinstrup P, 2011, NEUROCRIT CARE, V14, P441, DOI 10.1007/s12028-010-9486-3; Rothman DL, 2011, NMR BIOMED, V24, P943, DOI 10.1002/nbm.1772; Schaller B, 2014, NEUROIMAGE, V93, P138, DOI 10.1016/j.neuroimage.2014.02.016; Seifert T, 2011, PROG NEUROBIOL, V95, P406, DOI 10.1016/j.pneurobio.2011.09.008; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Tang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4284; Tholance Y, 2011, CLIN CHIM ACTA, V412, P647, DOI 10.1016/j.cca.2010.12.025; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; TRIVEDI B, 1966, J BIOL CHEM, V241, P4110; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; VEECH RL, 1991, NMR BIOMED, V4, P53, DOI 10.1002/nbm.1940040204; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Winkler U, 2015, NEUROCHEM RES, V40, P2394, DOI 10.1007/s11064-015-1526-0; WISE BL, 1962, J NEUROSURG, V19, P1038, DOI 10.3171/jns.1962.19.12.1038; Yamanishi S, 2006, AM J PHYSIOL-HEART C, V290, pH925, DOI 10.1152/ajpheart.01012.2005	110	13	13	1	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2016	36	11					1844	1864		10.1177/0271678X16666552			21	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	EB3KL	WOS:000387263300002	27604313	Bronze, Green Published			2022-02-06	
J	Hart, T; Novack, TA; Temkin, N; Barber, J; Dikmen, SS; Diaz-Arrastia, R; Ricker, J; Hesdorffer, DC; Jallo, J; Hsu, NH; Zafonte, R				Hart, Tessa; Novack, Thomas A.; Temkin, Nancy; Barber, Jason; Dikmen, Sureyya S.; Diaz-Arrastia, Ramon; Ricker, Joseph; Hesdorffer, Dale C.; Jallo, Jack; Hsu, Nancy H.; Zafonte, Ross			Duration of Posttraumatic Amnesia Predicts Neuropsychological and Global Outcome in Complicated Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive function; outcome measures; posttraumatic amnesia; traumatic brain injury	WORD-ASSOCIATION TEST; GLASGOW COMA SCALE; MINOR HEAD-INJURY; UNCOMPLICATED MILD; STRUCTURED INTERVIEWS; UNITED-STATES; RECOVERY; TRIAL; RELIABILITY; SYMPTOMS	Objectives: Examine the effects of posttraumatic amnesia (PTA) duration on neuropsychological and global recovery from 1 to 6 months after complicated mild traumatic brain injury (cmTBI). Participants: A total of 330 persons with cmTBI defined as Glasgow Coma Scale score of 13 to 15 in emergency department, with well-defined abnormalities on neuroimaging. Methods: Enrollment within 24 hours of injury with follow-up at 1, 3, and 6 months. Measures: Glasgow Outcome Scale-Extended, California Verbal Learning Test II, and Controlled Oral Word Association Test. Duration of PTA was retrospectively measured with structured interview at 30 days postinjury. Results: Despite all having a Glasgow Coma Scale Score of 13 to 15, a quarter of the sample had a PTA duration of greater than 7 days; half had PTA duration of 1 of 7 days. Both cognitive performance and Extended Glasgow Outcome Scale outcomes were strongly associated with time since injury and PTA duration, with those with PTA duration of greater than 1 week showing residual moderate disability at 6-month assessment. Conclusions: Findings reinforce importance of careful measurement of duration of PTA to refine outcome prediction and allocation of resources to those with cmTBI. Future research would benefit from standardization in computed tomographic criteria and use of severity indices beyond Glasgow Coma Scale to characterize cmTBI.	[Hart, Tessa] Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Temkin, Nancy] Univ Washington, Neurol Surg & Biostat, Seattle, WA 98195 USA; [Barber, Jason] Univ Washington, Neurol Surg, Seattle, WA 98195 USA; [Dikmen, Sureyya S.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Ricker, Joseph] NYU, Sch Med, Dept Rehabil Med, New York, NY USA; [Hesdorffer, Dale C.] Columbia Univ, GH Sergievsky Ctr, New York, NY USA; [Hesdorffer, Dale C.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Jallo, Jack] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA; [Hsu, Nancy H.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Zafonte, Ross] Brigham & Womens Hosp, Massachusetts Gen Hosp, Spaulding Rehabil Hosp, 75 Francis St, Boston, MA 02115 USA; [Zafonte, Ross] Harvard Med Sch, Boston, MA USA		Hart, T (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	thart@einstein.edu		Ricker, Joseph/0000-0003-3415-991X; Jallo, Jack/0000-0002-5512-1729; Diaz-Arrastia, Ramon/0000-0001-6051-3594	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01 HD042738, U01 HD042687] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042687, U01HD042738] Funding Source: NIH RePORTER		Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benton AL, 1994, MULTILINGUAL APHASIA; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Delis D.C., 2000, MANUAL CALIFORNIA VE; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2015, ARCH PHYS MED REHAB, V96, P956, DOI 10.1016/j.apmr.2014.12.014; Novack TA, 2000, BRAIN INJURY, V14, P987; NOVACK TA, 1995, CLIN NEUROPSYCHOL, V9, P38; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ross TP, 2006, CLIN NEUROPSYCHOL, V20, P414, DOI 10.1080/13854040590967153; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Vaccaro M, 2007, DISABIL REHABIL-ASSI, V2, P85, DOI 10.1080/17483100601167586; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	40	13	13	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2016	31	6					E1	E9		10.1097/HTR.0000000000000210			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EC0IW	WOS:000387784800001	26828710	Green Accepted, Green Submitted			2022-02-06	
J	O'Sullivan, DM; Fife, GP				O'Sullivan, David M.; Fife, Gabriel P.			Impact attenuation of protective boxing and taekwondo headgear	EUROPEAN JOURNAL OF SPORT SCIENCE			English	Article						Headgear; biomechanics; boxing; taekwondo; head injury; concussion	PERFORMANCE; INJURY; FOOTBALL; HELMETS	This study aimed to compare the impact attenuation performance of boxing and taekwondo headgear in terms of peak linear and rotational acceleration. To measure the impact attenuation of headgear, a standardized (American Society for Testing and Materials (ASTM) F-2397) martial arts headgear striker was used to impart impacts to a 50th Percentile Male Hybrid III Crash Test Dummy head and neck complex. Two boxing (Adidas and Greenhill) and two taekwondo (Adidas and Nike) headgear, approved by the Association Internationale de Boxe Amateur and the World Taekwondo Federation (WTF), were selected. Each of the selected headgear was fitted to the Hybrid III head and subsequently subjected to five impacts at the front and side with a maximum impact interim time of 60 seconds by the rotating striker at 8 +/- 0.3m/s. Linear and rotational acceleration were recorded at 10,000Hz. There were significant interactions of the impact location and brand on the rotational acceleration, F(3,40)=6.7, p<.05. There were significant main effects of both impact location F(1,40)=9.07, p<.05 and headgear brand F(3,40)=9.9, p<.05 on the linear acceleration. Pairwise comparisons show significant differences between the front and side for both linear and rotational acceleration. The headgear tested failed the ASTM high impact test requirement to reduce the linear acceleration to below a threshold of 150g. Further development of headgear to reduce impact linear and rotational acceleration magnitudes should be called for by the relevant sport governing bodies and initiated by headgear manufactures.	[O'Sullivan, David M.] Pusan Natl Univ, Div Sport Sci, Pusan, South Korea; [Fife, Gabriel P.] Texas State Univ, Hlth & Human Performance, San Marcos, TX USA		Fife, GP (corresponding author), Texas State Univ, San Marcos, TX 78666 USA.	gabefife@txstate.edu			National Research Foundation of Korea - Korean GovernmentNational Research Foundation of KoreaKorean Government [NRF-2013S1A5A8022563]	This work was supported by the National Research Foundation of Korea grant funded by the Korean Government [NRF-2013S1A5A8022563].	Aare M, 2004, INT J CRASHWORTHINES, V9, P15, DOI 10.1533/ijcr.2004.0268; Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; Ashker S. E., 2011, INT J PERF ANAL SPOR, V11, P171; Baird LC, 2010, NEUROSURGERY, V67, P1444, DOI 10.1227/NEU.0b013e3181e5e2cd; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Batterham AM, 2005, SPORTSCIENCE, V9, P6; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Caserta GD, 2011, COMPOS STRUCT, V93, P2748, DOI 10.1016/j.compstruct.2011.05.029; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Fife GP, 2013, BRIT J SPORT MED, V47, P1161, DOI 10.1136/bjsports-2012-090979; Kis M, 2013, CLIN J SPORT MED, V23, P470, DOI 10.1097/JSM.0b013e318295a80f; Koh JO, 2002, J SPORT MED PHYS FIT, V42, P348; Kulkarni SG, 2013, COMPOS STRUCT, V101, P313, DOI 10.1016/j.compstruct.2013.02.014; LOWENHIELM P, 1975, J BIOMECH, V8, P351, DOI 10.1016/0021-9290(75)90069-X; McIntosh A, 2004, BRIT J SPORT MED, V38, P46, DOI 10.1136/bjsm.2002.003103; McIntosh AS, 2015, BRIT J SPORT MED, V49, P1108, DOI 10.1136/bjsports-2015-095094; O'Sullivan D, 2014, BRIT J SPORT MED, V48, P648, DOI DOI 10.1136/BJSPORTS-2014-093494.233; O'Sullivan D, 2009, J SPORT SCI MED, V8, P13; O'Sullivan DM, 2013, BRIT J SPORT MED, V47, P447, DOI 10.1136/bjsports-2012-091416; Pieter W, 2014, BRIT J SPORT MED, V48, P652, DOI DOI 10.1136/BJSPORTS-2014-093494.246; Pieter W, 2012, BRIT J SPORT MED, V46, P485, DOI 10.1136/bjsports-2012-091011; Robinson MB, 2011, PROCEDIA ENGINEER, V13, P415, DOI 10.1016/j.proeng.2011.05.107; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; SAE, 1995, INSTR IMP TEST 1; Sanami M, 2014, PROCEDIA ENGINEER, V72, P453, DOI 10.1016/j.proeng.2014.06.079; Stojsih S, 2010, BRIT J SPORT MED, V44, P725, DOI 10.1136/bjsm.2008.052845; Zazryn TR, 2003, BRIT J SPORT MED, V37, P321, DOI 10.1136/bjsm.37.4.321; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	29	13	13	0	27	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1746-1391	1536-7290		EUR J SPORT SCI	Eur. J. Sport Sci.	NOV	2016	16	8					1219	1225		10.1080/17461391.2016.1161073			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DV4JG	WOS:000382891300042	26999564				2022-02-06	
J	Young, AMH; Guilfoyle, MR; Fernandes, H; Garnett, MR; Agrawal, S; Hutchinson, PJ				Young, Adam M. H.; Guilfoyle, Mathew R.; Fernandes, Helen; Garnett, Matthew R.; Agrawal, Shruti; Hutchinson, Peter J.			The application of adult traumatic brain injury models in a pediatric cohort	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						brain; injury; acute; prediction; trauma	MINOR HEAD-INJURY; PROGNOSTIC MODELS; PATIENT; IMPACT; RULE; AGE	OBJECTIVE There is increasing interest in the use of predictive models of outcome in adult head injury. Two international models have been identified to be reliable modalities for predicting outcome: the Corticosteroid Randomisation After Significant Head Injury (CRASH) model, and the International Mission on Prognosis and Analysis of randomized Controlled Trials in TBI (IMPACT) model. However, these models are designed only to identify outcomes in adult populations. METHODS A retrospective analysis was performed on pediatric patients with severe traumatic brain injury (TBI) admitted to the pediatric intensive care unit (PICU) of Addenbrooke's Hospital between January 2009 and December 2013. The individual risk of 14-day mortality was calculated using the CRASH-Basic and -CT models, and the risk of 6-month mortality calculated using the IMPACT-Core and-Extended (including CT findings) models. Model accuracy was determined by standardized mortality ratio (SMtR; observed/expected deaths), discrimination was evaluated as the area under the receiver operating curve (AUROC), and calibration assessed using the Hosmer-Lemeshow chi(2) test. RESULTS Ninety-four patients with an average age of 7.3 years were admitted to the PICU with a TBI. The mortality rate was 12.7% at 14 days and at 6 months. For the CRASH-Basic model, the SMtR was 1.42 and both calibration (chi(2) = 6.1, p = 0.64) and discrimination (AUROC = 0.92) were good. For the IMPACT-Core model, the SMtR was 1.03 and the model was also well calibrated (chi(2) = 8.99, p = 0.34) and had good discrimination (AUROC = 0.85). Poor outcome was observed in 17% of the cohort and identified with the CRASH-Basic and IMPACT-Core models to varying degrees: standardized morbidity ratio = 0.89 vs 0.67, respectively; calibration = 6.5 (chi(2)) and 0.59 (p value) versus 8.52 (chi(2)) and 0.38 (p value), respectively; and discrimination (AUROC) = 0.92 versus 0.83, respectively. CONCLUSIONS Adult head injury models may be applied with sufficient accuracy to identify predictors of morbidity and mortality in pediatric TBI.	[Young, Adam M. H.; Guilfoyle, Mathew R.; Fernandes, Helen; Garnett, Matthew R.; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Acad Neurosurg, Cambridge, England; [Agrawal, Shruti] Univ Cambridge, Addenbrookes Hosp, Dept Paediat Intens Care, Cambridge, England		Young, AMH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Acad Neurosurg, Cambridge, England.	ay276@cam.ac.uk			Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986 ID79068, G1002277 ID98489]; National Institute for Health Research Biomedical Research Centre Cambridge (Neuroscience Theme, and Brain Injury and Repair Theme); NIHR Research Professorship; Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2014-14-005, NIHR-RP-R3-12-013] Funding Source: researchfish	We gratefully acknowledge financial support as follows. Research support was provided by the Medical Research Council (grant nos. G0600986 ID79068 and G1002277 ID98489) and the National Institute for Health Research Biomedical Research Centre Cambridge (Neuroscience Theme, and Brain Injury and Repair Theme). Dr. Hutchinson is supported by an NIHR Research Professorship and an Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS9; Bouras T, 2007, J NEUROTRAUM, V24, P1355, DOI 10.1089/neu.2005.370; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Faul M, 2010, TRAUMATIC BRAIN INJU; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; LINGSMA HF, 2010, NED TIJDSCHR GENEES, V154, P107; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Mitra B, 2008, ANZ J SURG, V78, P588, DOI 10.1111/j.1445-2197.2008.04579.x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	20	13	13	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2016	18	5					558	564		10.3171/2016.5.PEDS15427			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DZ8FL	WOS:000386106200006	27564785	Bronze			2022-02-06	
J	Bartels, AN; Johnson, C; Lewis, J; Clevenger, JW; Barnes, SL; Hammer, RD; Ahmad, S				Bartels, Ashley N.; Johnson, Cory; Lewis, Julie; Clevenger, James W.; Barnes, Stephen L.; Hammer, Richard D.; Ahmad, Salman			Platelet adenosine diphosphate inhibition in trauma patients by thromboelastography correlates with paradoxical increase in platelet dense granule content by flow cytometry	SURGERY			English	Article							BRAIN-INJURY; INDUCED COAGULOPATHY; DYSFUNCTION; RELEASE; ASSAY	Background. The mechanism of platelet dysfunction in acute traumatic coagulopathy is unknown. Traumatic brain injury is hypothesized as a cause, while some investigators presume platelets become "exhausted." We hypothesized that platelet hyperstimulation and consumption resulting from trauma leads to decreased platelet function secondary to depletion of platelet granules. Methods. Twenty-five trauma patients were divided into traumatic brain injury and no traumatic brain injury groups. Healthy volunteers served as controls. All had thromboelastography with platelet mapping and flow cytometric assays of mepacrine performed. Mepacrine uptake in unstimulated platelets was used for quantification of platelet content of dense granules. Results. Twelve patients with traumatic brain injury and 13 patients without traumatic brain injury were enrolled. Twenty-one trauma patients showed adenosine diphosphate inhibition (>30%) on thromboelastography with platelet mapping compared with the healthy volunteers who served as controls (P < .01). Mepacrine assay showed a difference in mean fluorescent intensity for all trauma patients of 4,259 +/- 1,341 compared with controls of 3,143 +/- 709 (P = .044), correlating with greater quantities of dense granules. Neither adenosine diphosphate inhibition nor average difference in mean fluorescent intensity between traumatic brain injury and no traumatic brain injury groups were significant (P = .2). Conclusion. Trauma patients maintain their dense granule, contradicting the theory of platelet granule exhaustion as the etiology for platelet dysfunction in traumatic brain injury.	Univ Missouri, Hosp & Clin, Dept Surg, Div Acute Care Surg, Columbia, MO USA; Univ Missouri, Hosp & Clin, Dept Pathol & Anat Sci, Columbia, MO USA		Bartels, AN (corresponding author), One Hosp Dr,McHaney Hall 404, Columbia, MO 65212 USA.	bartelsan@health.missouri.edu		Hammer, Richard D./0000-0002-7173-9414; Ahmad, Salman/0000-0003-3862-0937; Barnes, Stephen/0000-0001-6186-1435	internal department of surgery grant	Supported by an internal department of surgery grant. The testing equipment for thromboelastography in controls was donated by Haeomoscope Corporation.	Briggs A, 2015, J SURG RES, V193, P802, DOI 10.1016/j.jss.2014.08.016; Cap A, 2015, ANAESTHESIA, V70, DOI 10.1111/anae.12914; Cardenas JC, 2014, CURR OPIN HEMATOL, V21, P404, DOI 10.1097/MOH.0000000000000063; Chapman M, 2016, AC SURG C 2016 JACKS; Chen LQ, 2004, J THORAC CARDIOV SUR, V128, P425, DOI 10.1016/j.jtcvs.2004.02.019; Cohen MJ, 2014, THROMB RES, V133, pS25, DOI 10.1016/j.thromres.2014.03.013; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Hammer RD, 2016, MODERN PATH IN PRESS; Kornblith LZ, 2014, J TRAUMA ACUTE CARE, V76, P255, DOI 10.1097/TA.0000000000000108; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; McCully SP, 2013, SEMIN THROMB HEMOST, V39, P896, DOI 10.1055/s-0033-1357484; Michelson AD, 1996, BLOOD, V87, P4925, DOI 10.1182/blood.V87.12.4925.bloodjournal87124925; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Noel P, 2013, SEMIN HEMATOL, V50, P259, DOI 10.1053/j.seminhematol.2013.06.009; PARETI FI, 1980, AM J MED, V69, P235, DOI 10.1016/0002-9343(80)90383-6; Ramstrom AS, 1999, PLATELETS, V10, P153, DOI 10.1080/09537109976239; WALL JE, 1995, BRIT J HAEMATOL, V89, P380, DOI 10.1111/j.1365-2141.1995.tb03315.x; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050	22	13	13	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	OCT	2016	160	4					954	958		10.1016/j.surg.2016.07.012			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DW6CG	WOS:000383733400028	27531317				2022-02-06	
J	Chen, W; Guo, YJ; Yang, WJ; Zheng, P; Zeng, JS; Tong, WS				Chen, Wei; Guo, Yijun; Yang, Wenjin; Zheng, Ping; Zeng, Jinsong; Tong, Wusong			Involvement of Connexin40 in the Protective Effects of Ginsenoside Rb1 Against Traumatic Brain Injury	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						TBI; Connexin40; Ginsenoside Rb1; Neuroprotective activity	ENDOTHELIAL-CELLS; GAP-JUNCTIONS; ISCHEMIA; INFLAMMATION; LIPOPOLYSACCHARIDE; ACTIVATION; BLOCKADE; INCREASE; LEPTIN; DEATH	Ginsenosides are the major active components of ginseng, which have been proven to be effective in therapies for neurodegenerative diseases. Ginsenoside Rb1 (GS-Rb1) is the most abundant among all the identified ginsenosides and has been shown to exert neuroprotective effects, although the underlying molecular mechanisms remain unclear. Connexins are a family of transmembrane proteins that form gap junctions, which are important for diffusion of cytosolic factors such as ions and second messenger signaling molecules. Previous studies have shown that a subset of connexin proteins is involved in neuroprotection. We investigated the protective effects of GS-Rb1 against traumatic brain injury (TBI) and the potential mechanism using TBI mouse model. We discovered that TBI-induced brain injury and up-regulation of connexin40 (Cx40) protein expression as early as 6 h post-TBI, which was reversed by administration of GS-Rb1. In addition, we found that the protective effects of GS-Rb1 are dose and time dependent and are partially mediated through phosphorylation of ERK1/2 signaling pathway, as evidenced by the abolishment of GS-Rb1-mediated elevation of p-ERK1/2 expression and inhibition of Cx40 expressions when ERK inhibitor U0126 was used. Our study provides evidence that Cx40 is implicated in TBI-induced brain injuries, and GS-Rb1 exerts neuroprotective activity against TBI involving down-regulation of Cx40 expression.	[Chen, Wei; Guo, Yijun; Yang, Wenjin; Zheng, Ping; Zeng, Jinsong; Tong, Wusong] Peoples Hosp, Pu Dong New Area, 490 South Chuanhuan Rd, Shanghai 201299, Peoples R China		Tong, WS (corresponding author), Peoples Hosp, Pu Dong New Area, 490 South Chuanhuan Rd, Shanghai 201299, Peoples R China.	wstong3@sina.com		Tong, Wusong/0000-0003-1072-7310; Chen, Wei/0000-0001-7438-3241	Health Planning Commission Project of Pu Dong New Area, Shanghai [PKJ2012-Y3]; Health Planning Commission Project of Pu Dong New Area [PWZz-2013-13]	This work was supported by the Health Planning Commission Project of Pu Dong New Area, Shanghai (No. PKJ2012-Y3) and the Health Planning Commission Project of Pu Dong New Area (No. PWZz-2013-13).	Bolon ML, 2007, J CELL PHYSIOL, V211, P159, DOI 10.1002/jcp.20928; Chaldoupi SM, 2009, EUR J CARDIOV PREV R, V16, P616, DOI 10.1097/HJR.0b013e32832da03a; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chen ZY, 2010, NEUROSCI LETT, V482, P264, DOI 10.1016/j.neulet.2010.07.052; Cheng WD, 2013, INT ORTHOP, V37, P2065, DOI 10.1007/s00264-013-1990-6; Cheng Y, 2005, ACTA PHARMACOL SIN, V26, P143, DOI 10.1111/j.1745-7254.2005.00034.x; Cho IH, 2012, J GINSENG RES, V36, P342, DOI 10.5142/jgr.2012.36.4.342; Cho YL, 2015, J BIOL CHEM, V290, P467, DOI 10.1074/jbc.M114.603142; Christensen LP, 2009, ADV FOOD NUTR RES, V55, P1, DOI 10.1016/S1043-4526(08)00401-4; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; Davidson JO, 2013, EXP NEUROL, V248, P301, DOI 10.1016/j.expneurol.2013.06.026; Deng ZH, 2014, CELL MOL NEUROBIOL, V34, P871, DOI 10.1007/s10571-014-0066-5; Fang JS, 2012, J VASC RES, V49, P2, DOI 10.1159/000329616; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; Gao XQ, 2010, J ETHNOPHARMACOL, V132, P393, DOI 10.1016/j.jep.2010.07.033; Hashimoto R, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/693717; HATASHITA S, 1988, J CEREBR BLOOD F MET, V8, P552, DOI 10.1038/jcbfm.1988.96; Hung TH, 2006, PLACENTA, V27, P996, DOI 10.1016/j.placenta.2005.11.002; JARA PI, 1995, P NATL ACAD SCI USA, V92, P7011, DOI 10.1073/pnas.92.15.7011; Kim KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062409; Kimura Y, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/946242; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Li Z, 2005, AM J CHINESE MED, V33, P923, DOI 10.1142/S0192415X05003430; Mook-Jung I, 2001, J NEUROSCI RES, V63, P509, DOI 10.1002/jnr.1045; Morel S, 2012, CURR PHARM BIOTECHNO, V13, P17, DOI 10.2174/138920112798868638; Ni N, 2014, MOLECULES, V19, P3012, DOI 10.3390/molecules19033012; NISHIYAMA N, 1994, BIOL PHARM BULL, V17, P509, DOI 10.1248/bpb.17.509; Park HJ, 2012, J GINSENG RES, V36, P225, DOI 10.5142/jgr.2012.36.3.225; Radad K, 2004, BRAIN RES, V1021, P41, DOI 10.1016/j.brainres.2004.06.030; Rawanduzy A, 1997, J NEUROSURG, V87, P916, DOI 10.3171/jns.1997.87.6.0916; Schulz R, 2015, PHARMACOL THERAPEUT, V153, P90, DOI 10.1016/j.pharmthera.2015.06.005; Smyth JW, 2014, TRAFFIC, V15, P684, DOI 10.1111/tra.12169; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Wang K, 2015, NEUROSCI LETT, V591, P53, DOI 10.1016/j.neulet.2015.02.016; Wang YL, 2011, NEUROSCI LETT, V487, P70, DOI 10.1016/j.neulet.2010.09.076; Weng Z, 2007, J BIOL CHEM, V282, P34479, DOI 10.1074/jbc.M705426200; Wu YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092618; Zhu J, 2012, NEUROSCIENCE, V202, P342, DOI 10.1016/j.neuroscience.2011.11.070	43	13	13	0	20	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	OCT	2016	36	7					1057	1065		10.1007/s10571-015-0299-y			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DS3KA	WOS:000380680500004	26645822				2022-02-06	
J	Fischer-Baum, S; Miozzo, M; Laiacona, M; Capitani, E				Fischer-Baum, Simon; Miozzo, Michele; Laiacona, Marcella; Capitani, Erminio			Perseveration During Verbal Fluency in Traumatic Brain Injury Reflects Impairments in Working Memory	NEUROPSYCHOLOGY			English	Article						perseveration; traumatic brain injury; verbal fluency	ALZHEIMERS-DISEASE; INHIBITORY CONTROL; CATEGORY FLUENCY; COGNITIVE IMPAIRMENT; HUNTINGTONS-DISEASE; SEMANTIC FLUENCY; DEFICITS; PERFORMANCE; APHASIA; MILD	Objective: Previous studies of verbal fluency have reported higher rates of perseverative responses in both Alzheimer's disease (AD) and traumatic brain injury (TBI) relative to control groups. These perseverations could arise from a number of impairments-for example, failures in working memory, inhibitory control, or word retrieval-and different clinical populations may show an increase in perseveration because of different underlying deficits. The objective of the current report is to investigate the cause of perseveration in verbal fluency in individuals with TBI and compare those results to a recent study of individuals with AD. Method: In a previous study, conducted by Miozzo, Fischer-Baum, and Caccappolo-van Vliet (2013), perseveration errors produced by individuals with AD were shown to have long lags between the 1st occurrence of a word and its repetition in verbal fluency, suggesting that perseverations were caused by a failure of the working memory mechanisms that control response monitoring. In the present investigation, we applied the same analysis to the perseveration errors produced during 197 administrations of the verbal fluency task with 143 individuals with TBI. Results: The perseverations of individuals with TBI showed a lag distribution similar to that of the AD population, with the lag between the 1st occurrence of a word and its repetition systematically longer than would be expected by chance. Conclusions: These results suggest that the perseverations produced during verbal fluency in individuals with TBI stem from the same working memory mechanism proposed in AD, rather than inhibitory control or word retrieval deficits.	[Fischer-Baum, Simon] Rice Univ, Dept Psychol, MS 25,POB 1892, Houston, TX 77251 USA; [Miozzo, Michele] New Sch, Dept Psychol, New York, NY USA; [Laiacona, Marcella] Veruno Sci Inst, IRCCS, S Maugeri Fdn, Veruno, Italy; [Capitani, Erminio] Univ Milan, Dept Hlth Sci, I-20122 Milan, Italy		Fischer-Baum, S (corresponding author), Rice Univ, Dept Psychol, MS 25,POB 1892, Houston, TX 77251 USA.	simon.j.fischer-baum@rice.edu					Ackerman T, 2007, APHASIOLOGY, V21, P1018, DOI 10.1080/02687030701198361; ALBERT ML, 1986, CORTEX, V22, P103, DOI 10.1016/S0010-9452(86)80035-1; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baldo JV, 1998, NEUROPSYCHOLOGY, V12, P259, DOI 10.1037/0894-4105.12.2.259; BAYLES KA, 1993, J CLIN EXP NEUROPSYC, V15, P547, DOI 10.1080/01688639308402578; Bayles Kathryn A., 2004, Seminars in Speech and Language, V25, P335, DOI 10.1055/s-2004-837246; Belleville S, 2007, NEUROPSYCHOLOGY, V21, P458, DOI 10.1037/0894-4105.21.4.458; Bittner RM, 2006, BRAIN INJURY, V20, P971, DOI 10.1080/02699050600909763; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; BURGESS PW, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P110; Caccappolo-van Vliet E, 2003, NEUROCASE, V9, P297; Capitani E, 2009, NEUROPSYCHOLOGIA, V47, P423, DOI 10.1016/j.neuropsychologia.2008.09.016; Cohen L, 1998, BRAIN, V121, P1641, DOI 10.1093/brain/121.9.1641; Collette F, 1997, HUM BRAIN MAPP, V5, P110, DOI 10.1002/(SICI)1097-0193(1997)5:2<110::AID-HBM4>3.0.CO;2-6; Cossa FM, 1999, BRAIN INJURY, V13, P583; Crawford TJ, 2005, BIOL PSYCHIAT, V57, P1052, DOI 10.1016/j.biopsych.2005.01.017; Crawford TJ, 2013, AGE, V35, P1637, DOI 10.1007/s11357-012-9466-y; Croot K, 2000, BRAIN LANG, V75, P277, DOI 10.1006/brln.2000.2357; CUMMINGS JL, 1985, NEUROLOGY, V35, P394, DOI 10.1212/WNL.35.3.394; Dell GS, 1997, PSYCHOL REV, V104, P123, DOI 10.1037/0033-295X.104.1.123; Duncan J, 1997, COGNITIVE NEUROPSYCH, V14, P713, DOI 10.1080/026432997381420; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Fischer-Baum S, 2012, NEUROPSYCHOLOGIA, V50, P305, DOI 10.1016/j.neuropsychologia.2011.12.001; Foldi NS, 2003, AGING NEUROPSYCHOL C, V10, P268, DOI 10.1076/anec.10.4.268.28970; Frankel T, 2007, APHASIOLOGY, V21, P1039, DOI 10.1080/02687030701198395; Hauser MD, 1999, CURR OPIN NEUROBIOL, V9, P214, DOI 10.1016/S0959-4388(99)80030-0; HELMICK JW, 1976, J COMMUN DISORD, V9, P143, DOI 10.1016/0021-9924(76)90006-X; Henry JD, 2005, NEUROPSYCHOLOGY, V19, P243, DOI 10.1037/0894-4105.19.2.243; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Henry JD, 2006, AGING NEUROPSYCHOL C, V13, P529, DOI 10.1080/138255890969537; Henry Julie D, 2005, Cogn Neuropsychiatry, V10, P1, DOI 10.1080/13546800344000309; HOTZ G, 1995, BRAIN INJURY, V9, P151, DOI 10.3109/02699059509008188; Hsiao EY, 2009, BRAIN LANG, V108, P133, DOI 10.1016/j.bandl.2008.11.003; HUFF FJ, 1986, BRAIN LANG, V28, P235, DOI 10.1016/0093-934X(86)90103-3; Huntley JD, 2010, INT J GERIATR PSYCH, V25, P121, DOI 10.1002/gps.2314; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; Konrad KN, 2000, BRAIN INJURY, V14, P859; KOZORA E, 1995, CLIN NEUROPSYCHOL, V9, P313, DOI 10.1080/13854049508400495; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Marczinski CA, 2006, BRAIN LANG, V97, P258, DOI 10.1016/j.bandl.2005.11.001; Martin N, 1998, APHASIOLOGY, V12, P319, DOI 10.1080/02687039808249536; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P53, DOI 10.1111/j.2044-8260.1984.tb00626.x; Miozzo M, 2013, CORTEX, V49, P2028, DOI 10.1016/j.cortex.2012.10.016; Pekkala S, 2008, DEMENT GERIATR COGN, V25, P109, DOI 10.1159/000112476; Peters F, 2007, J CLIN EXP NEUROPSYC, V29, P405, DOI 10.1080/13803390600733064; Pettit LD, 2013, BRAIN, V136, P3290, DOI 10.1093/brain/awt243; PRICE BH, 1993, ARCH NEUROL-CHICAGO, V50, P931, DOI 10.1001/archneur.1993.00540090038008; Ramage A, 1999, BRAIN LANG, V66, P329, DOI 10.1006/brln.1999.2032; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Reverberi C, 2006, NEUROPSYCHOLOGIA, V44, P469, DOI 10.1016/j.neuropsychologia.2005.05.011; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; SANDSON J, 1984, NEUROPSYCHOLOGIA, V22, P715, DOI 10.1016/0028-3932(84)90098-8; Schwartz S, 2003, BRAIN LANG, V87, P400, DOI 10.1016/S0093-934X(03)00141-X; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; SHINDLER AG, 1984, BRAIN LANG, V23, P148, DOI 10.1016/0093-934X(84)90013-0; Stopford CL, 2012, CORTEX, V48, P429, DOI 10.1016/j.cortex.2010.12.002; Suhr JA, 1998, ARCH CLIN NEUROPSYCH, V13, P447, DOI 10.1016/S0887-6177(97)00040-1; TROSTER AI, 1989, BRAIN LANG, V37, P500, DOI 10.1016/0093-934X(89)90032-1; Unsworth N, 2011, Q J EXP PSYCHOL, V64, P447, DOI 10.1080/17470218.2010.505292; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Zhao QH, 2013, NEUROSCI BULL, V29, P75, DOI 10.1007/s12264-013-1301-7	67	13	13	0	15	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	2016	30	7					791	799		10.1037/neu0000286			9	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DY9FX	WOS:000385440400002	27054439				2022-02-06	
J	Jang, SH; Kim, SY				Jang, Sung Ho; Kim, Sung Yup			Injury of the Corticospinal Tract in Patients with Mild Traumatic Brain Injury: A Diffusion Tensor Tractography Study	JOURNAL OF NEUROTRAUMA			English	Article						corticospinal tract; diffusion tensor imaging; hand function; mild traumatic brain injury; motor weakness	AXONAL INJURY; WHITE-MATTER; MAGNETIC STIMULATION; CLINICAL-APPLICATION; IMAGING FINDINGS; MOTOR WEAKNESS; REHABILITATION; EPIDEMIOLOGY; MULTICENTER; IMPAIRMENT	Motor weakness is an important sequela after traumatic brain injury (TBI). Although the majority of cases of TBI are classified as mild TBI, little is known about motor weakness in mild TBI. In this study, we attempted to investigate injury of the corticospinal tract (CST), an important neural tract for motor function, in patients with mild TBI, using diffusion tensor tractography (DTT). There were 53 patients with mild TBI and 36 control subjects who were recruited. The patients were assigned to two groups according to the presence of abnormality of the right (dominant) hand function in terms of fine motor activity and grip strength: group A-abnormal hand function, group B-normal hand function. The left CST was reconstructed, and DTT parameters (fractional anisotropy [FA] and fiber number) and configuration were estimated. There were 35 (66%) patients who had an abnormal function of the right hand. The values of FA and fiber number of patient group A were significantly lower than those of patient group B and the control group (p < 0.001). On configurational analysis of DTT for the left CST in patient group A, 80% showed partial tearing at the subcortical white matter and 20% showed narrowing. We found that in terms of DTT parameters and configuration, a significant portion of patients with mild TBI showed injury of the CST. These results suggest that DTT could provide useful information in detecting injury of the CST, and evaluation of the CST using DTT would be necessary for patients who complain of hand weakness after mild TBI.	[Jang, Sung Ho; Kim, Sung Yup] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea		Kim, SY (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	yup331@hanmail.net					ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bonnard M, 2007, EUR J NEUROSCI, V25, P872, DOI 10.1111/j.1460-9568.2007.05320.x; Brown AW, 2007, BRAIN INJURY, V21, P673, DOI 10.1080/02699050701468925; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cho HK, 2011, BRAIN INJURY, V25, P1005, DOI 10.3109/02699052.2011.605095; Choi GS, 2012, ARCH NEUROL-CHICAGO, V69, P363, DOI 10.1001/archneurol.2011.1930; Compston A, 2010, BRAIN, V133, P2835, DOI 10.1093/brain/awq274; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DAVIDOFF RA, 1990, NEUROLOGY, V40, P332; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Jang SH, 2014, NEUROSCI LETT, V572, P1, DOI 10.1016/j.neulet.2014.04.044; Jang SH, 2014, J REHABIL MED, V46, P193, DOI 10.2340/16501977-1782; Jang SH, 2011, NEUROREHABILITATION, V29, P339, DOI 10.3233/NRE-2011-0710; Jang SH, 2011, YONSEI MED J, V52, P553, DOI 10.3349/ymj.2011.52.4.553; Jang SH, 2009, NEUROREHABILITATION, V25, P229, DOI 10.3233/NRE-2009-0519; Jang SH, 2009, NEUROREHABILITATION, V24, P285, DOI 10.3233/NRE-2009-0480; Jang SH, 2009, NEUROREHABILITATION, V24, P273, DOI 10.3233/NRE-2009-0478; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kim DG, 2007, NEUROREHABILITATION, V22, P273; Kim YT, 1994, J KOREAN ACAD REHAB, V18, P780; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Lee AY, 2012, NEUROSCI LETT, V528, P16, DOI 10.1016/j.neulet.2012.08.053; Lee JW, 2006, J HEAD TRAUMA REHAB, V21, P272, DOI 10.1097/00001199-200605000-00007; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Pagani E, 2008, NEUROIMAGE, V41, P657, DOI 10.1016/j.neuroimage.2008.03.021; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Seo JP, 2015, BRAIN INJURY, V29, P110, DOI 10.3109/02699052.2014.973447; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Skoglund TS, 2008, ACTA RADIOL, V49, P98, DOI 10.1080/02841850701561372; SMITH RO, 1985, AM J OCCUP THER, V39, P531, DOI 10.5014/ajot.39.8.531; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Yasokawa YT, 2007, J NEUROTRAUM, V24, P163, DOI 10.1089/neu.2006.0073; Yoo JS, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-121; YORK DH, 1987, NEUROSURGERY, V20, P70	45	13	14	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2016	33	19					1790	1795		10.1089/neu.2015.4298			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DY8KP	WOS:000385379100008	26756272				2022-02-06	
J	Khalili, H; Sadraei, N; Niakan, A; Ghaffarpasand, F; Sadraei, A				Khalili, Hosseinali; Sadraei, Nazanin; Niakan, Amin; Ghaffarpasand, Fariborz; Sadraei, Amin			Role of Intracranial Pressure Monitoring in Management of Patients with Severe Traumatic Brain Injury: Results of a Large Level I Trauma Center in Southern Iran	WORLD NEUROSURGERY			English	Article						Cerebral perfusion pressure; Intracranial pressure monitoring; Prognosis; Traumatic brain injury; Ventriculostomy	PREDICTION; OUTCOMES	OBJECTIVE: To determine the role of intracranial pressure (ICP) monitoring in management of patients with severe traumatic brain injury (TBI) admitted to a large level I trauma center in Southern Iran. METHODS: This was a cohort study performed during a 2-year period in a level I trauma center in Southern Iran including all adult patients (> 16 years) with severe TBI (Glasgow Coma Scale [GCS] score, 3-8) who underwent ICP monitoring through ventriculostomy. The management was based on the recorded ICP values with threshold of 20 mm Hg. Decompressive craniectomy was performed in patients with intractable intracranial hypertension (persistent ICP >= 25 mm Hg). In unresponsive patients, barbiturate coma was induced. Patients were followed for 6 months and Glasgow Outcome Scale Extended was recorded. The determinants of favorable and unfavorable outcome were also determined. RESULTS: Overall, we included 248 patients with mean age of 34.6 +/- 16.6 years, among whom there were 216 men (87.1%) and 32 women (12.9%). Eighty-five patients (34.2%) had favorable and 163 (65.8%) unfavorable outcomes. Those with favorable outcome had significantly lower age (P = 0.004), higher GCS score on admission (P < 0.001), lower Rotterdam score (P=0.035), fewer episodes of intracranial hypertension (P < 0.001), and lower maximum recorded ICP (P=0.041). These factors remained statistically significant after elimination of confounders by multivariate logistic regression model. CONCLUSIONS: Age, GCS score on admission, Rotterdam score, intracranial hypertension, and maximum recorded ICP are important determinants of outcome in patients with severe TBI. ICP monitoring assisted us in targeted therapy and management of patients with severe TBI.	[Khalili, Hosseinali] Shiraz Univ Med Sci, Dept Neurosurg, Trauma Res Ctr, Shiraz, Iran; [Sadraei, Nazanin; Sadraei, Amin] Shiraz Univ Med Sci, Neurosci Res Ctr, Shiraz, Iran; [Niakan, Amin; Ghaffarpasand, Fariborz; Sadraei, Amin] Shiraz Univ Med Sci, Dept Neurosurg, Student Res Comm, Shiraz, Iran		Ghaffarpasand, F (corresponding author), Shiraz Univ Med Sci, Dept Neurosurg, Student Res Comm, Shiraz, Iran.	fariborz.ghaffarpasand@gmail.com	Ghaffarpasand, Fariborz/I-4204-2019; Khalili, Hosseinali/I-1087-2016; niakan, amin/A-6818-2019	Ghaffarpasand, Fariborz/0000-0002-1721-9987; Khalili, Hosseinali/0000-0002-3390-4212; niakan, amin/0000-0003-2644-8543	 [91-01-55-5320]	The authors wish to thank all the patients and their families who participated in the study. This research project is a result of a thesis project for partial fulfillment of a medical doctorate degree by Nazanin Sadraei (no. 91-01-55-5320), supported by the vice-chancellor of research of Shiraz University of Medical Sciences. We would like to acknowledge Mr. Arya Zamiri and Miss Sedigheh Hoosmandi, who assisted us with data collection.	Abbasi Hamid Reza, 2013, Bull Emerg Trauma, V1, P81; Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; DiRusso S, 2001, J TRAUMA, V51, P294, DOI 10.1097/00005373-200108000-00011; Ferreira Cesar Biselli, 2015, Rev Bras Ter Intensiva, V27, P315, DOI 10.5935/0103-507X.20150055; Forsyth RJ, 2015, COCHRANE DB SYST REV, V11; Georgoff P, 2010, WORLD NEUROSURG, V74, P331, DOI 10.1016/j.wneu.2010.03.025; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Han JS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002827; Heydari ST, 2013, PUBLIC HEALTH, V127, P704, DOI 10.1016/j.puhe.2013.05.003; Kavosi Z, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.22594; Kim JH, 2012, WORLD NEUROSURG, V77, P135, DOI 10.1016/j.wneu.2011.04.017; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Lozier AP, 2008, NEUROSURGERY, V62, P688, DOI [10.1227/01.neu.0000316273.35833.7c, 10.1227/01.NEU.0000017465.78245.6C]; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Mani Arash, 2015, Bull Emerg Trauma, V3, P93; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Paydar Shahram, 2013, Bull Emerg Trauma, V1, P38; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rahmanian Abdolkarim, 2014, Bull Emerg Trauma, V2, P151; Reilly P., 2005, HEAD INJURY PATHOPHY, P331; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Taghipour M, 2006, J RES MED SCI, V11, P248; Wright K, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS12271; Yuan Q, 2016, NEUROSURGERY, V78, P361, DOI 10.1227/NEU.0000000000001050; Yuan Q, 2015, CRIT CARE MED, V43, P1405, DOI 10.1097/CCM.0000000000000965	32	13	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2016	94						120	125		10.1016/j.wneu.2016.06.122			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EF5EJ	WOS:000390353200017	27392896				2022-02-06	
J	Kuhn, EN; Warmus, BA; Davis, MC; Oster, RA; Guthrie, BL				Kuhn, Elizabeth N.; Warmus, Brian A.; Davis, Matthew C.; Oster, Robert A.; Guthrie, Barton L.			Identification and Cost of Potentially Avoidable Transfers to a Tertiary Care Neurosurgery Service: A Pilot Study	NEUROSURGERY			English	Article						Healthcare utilization; Medical economics; Patient transfer	EMERGENCY MEDICAL-TREATMENT; TRAUMATIC BRAIN-INJURY; TELEMEDICINE; LEGAL; STRATEGIES; GUIDELINES; MANAGEMENT; CENTERS; ISSUES; ACCESS	BACKGROUND: Thousands of neurosurgical emergencies are transferred yearly to tertiary care facilities to assume a higher level of care. Several studies have examined how neurosurgical transfers influence patient outcomes, but characteristics of potentially avoidable transfers have yet to be investigated. OBJECTIVE: To identify whether potentially avoidable transfers represent a significant portion of transfers to a tertiary neurosurgical facility. METHODS: In this cohort study, we evaluated 916 neurosurgical patients transferred to a tertiary care facility over a 2-year period. Transfers were classified as potentially avoidable when no neurosurgical diagnostic test, intervention, or intensive monitoring was deemed necessary (n = 180). The remaining transfers were classified as justifiable (n = 736). The main outcomes and measures were age, sex, diagnosis, insurance status, intervention, distance of transfer, length of hospital and intensive care unit stay, mortality, discharge disposition, and cost. RESULTS: Nearly 20% of transfers were identified as being potentially avoidable. Although some of these patients had suffered devastating, irrecoverable neurological insults, many had innocuous conditions that did not require transfer to a higher level of care. Justifiable transfers tend to involve patients with nontraumatic intracranial hemorrhage and cranial neoplasm. Both groups were admitted to the intensive care unit at the same rate (approximately 70% of patients). Finally, the direct transportation cost of potentially avoidable transfers was $1.46 million over 2 years. CONCLUSION: This study identified the frequency and expense of potentially avoidable transfers. There is a need for closer examination of the clinical and financial implications of potentially avoidable transfers.	[Kuhn, Elizabeth N.; Warmus, Brian A.; Davis, Matthew C.; Guthrie, Barton L.] Univ Alabama Birmingham, Dept Neurol Surg, Birmingham, AL USA; [Warmus, Brian A.] Univ Alabama Birmingham, Med Scientist Training Program, Birmingham, AL USA; [Oster, Robert A.] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA		Kuhn, EN (corresponding author), Univ Alabama Birmingham, Dept Neurosurg, 1720 Second Ave S,FOT 1062, Birmingham, AL 35294 USA.	ekuhn@uabmc.edu	Alford, Elizabeth/W-1666-2019	Alford, Elizabeth/0000-0003-1779-089X; Oster, Robert/0000-0002-2247-8596	Kaul Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F30AG046088]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR00165]; UAB Medical Scientist Training Program [T32GM008361]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001417, UL1TR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F30AG046088] Funding Source: NIH RePORTER	This work was supported by the Kaul Foundation, National Institutes of Health grant F30AG046088, the National Center for Advancing Translational Sciences (UL1TR00165), and the UAB Medical Scientist Training Program (T32GM008361). The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Britt LD, 2007, J TRAUMA, V62, P67; Byrne RW, 2008, NEUROSURGERY, V62, P709, DOI 10.1227/01.neu.0000317320.79106.7e; Davis MC, 2016, WORLD NEUROSURG, V86, P103, DOI 10.1016/j.wneu.2015.08.053; Fell M J, 1996, Spec Law Dig Health Care Law, P9; Hall JL, 2014, HEALTH AFFAIR, V33, P216, DOI 10.1377/hlthaff.2013.0997; Holland CM, 2015, NEUROSURGERY, V77, P200, DOI 10.1227/NEU.0000000000000752; Itrat A, 2016, JAMA NEUROL, V73, P162, DOI 10.1001/jamaneurol.2015.3849; Joosse P, 2012, J TRAUMA ACUTE CARE, V72, P487, DOI 10.1097/TA.0b013e318226ed59; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Lind CRP, 2005, ANZ J SURG, V75, P858, DOI 10.1111/j.1445-2197.2005.03574.x; Lyerly MJ, 2016, J TELEMED TELECARE, V22, P114, DOI 10.1177/1357633X15589534; Peth HA, 2004, EMERG MED CLIN N AM, V22, P225, DOI 10.1016/s0733-8627(03)00123-8; Rasmussen MB, 2014, HEART, V100, P711, DOI 10.1136/heartjnl-2013-304576; Sanders KA, 2016, J STROKE CEREBROVASC, V25, P288, DOI 10.1016/j.jstrokecerebrovasdis.2015.09.030; Shenai MB, 2011, NEUROSURGERY, V68, DOI 10.1227/NEU.0b013e3182077efd; Spain DA, 2007, J TRAUMA, V62, P63, DOI 10.1097/TA.0b013e31802d9716; Stanberry B, 2001, COMPUT METH PROG BIO, V64, P225, DOI 10.1016/S0169-2607(00)00142-5; Stowens JC, 2015, WEST J EMERG MED, V16, P472, DOI 10.5811/westjem.2015.4.24248; Szalados JE, 2009, INT ANESTHESIOL CLIN, V47, P105, DOI 10.1097/AIA.0b013e31819342f9; Tanguay A, 2015, J EMERG MED, V49, P657, DOI 10.1016/j.jemermed.2015.05.009; Walcott BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026216; Wallace S, 1999, J TELEMED TELECARE, V5, P8, DOI 10.1258/1357633991932748; Yang YT, 2014, HEALTH AFFAIR, V33, P222, DOI 10.1377/hlthaff.2013.0958	23	13	13	0	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	OCT	2016	79	4					541	548		10.1227/NEU.0000000000001378			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DX5RK	WOS:000384439200029	27489167	Green Accepted			2022-02-06	
J	Ohsawa, M; Ishikura, K; Mutoh, J; Hisa, H				Ohsawa, Masahiro; Ishikura, Kei-ichiro; Mutoh, Junpei; Hisa, Hiroaki			INVOLVEMENT OF INHIBITION OF RhoA/Rho KINASE SIGNALING IN SIMVASTATIN-INDUCED AMELIORATION OF NEUROPATHIC PAIN	NEUROSCIENCE			English	Article						Rho kinase (ROCK); RhoA; myristoylated alanine-rich protein kinase C substrate (MARCKS); astrocyte; neuropathic pain; simvastatin	SPINAL-CORD ASTROCYTES; TRAUMATIC BRAIN-INJURY; SCIATIC-NERVE LIGATION; PROTEIN-KINASE; RHO-KINASE; SUBSTRATE PHOSPHORYLATION; NOCICEPTIVE TRANSMISSION; REDUCTASE INHIBITORS; THERMAL HYPERALGESIA; RAT MODEL	Small molecular G-protein plays a key role in several diseases. This study was designed to reveal the role of RhoA signaling in the pathophysiology of neuropathic pain in mice. Partial sciatic nerve injury caused thermal hyperalgesia, mechanical allodynia, and increased plasma membrane translocation of RhoA in the lumber spinal cord. GFAP-immunoreactivity (ir), Iba-1-ir, and Rho kinase 2 (ROCK2-ir) was also increased in the ipsilateral spinal dorsal horn of nerve-ligated mice. Moreover, partial nerve ligation increased the expression of phosphorylated myristoylated alanine-rich protein kinase C substrate (MARCKS)-ir in the ipsilateral spinal dorsal horn. Daily intrathecal administration of simvastatin, beginning 3 days before nerve injury, completely blocked all these changes in nerve-ligated mice. Pharmacological inhibition of ROCK also attenuated the increased expression of GFAP-ir and phosphorylated MARCKS-ir. Together, it is suggested that astrogliosis initiated by the activation of RhoA/ROCK signaling results in MARCKS phosphorylation in nerve terminals, which leads to hyperalgesia in neuropathic pain. Furthermore, simvastatin exerts antihyperalgesic and antiallodynic effects through the inhibition of spinal RhoA activation. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Ohsawa, Masahiro; Mutoh, Junpei; Hisa, Hiroaki] Kyushu Univ Hlth & Welf, Sch Pharmaceut Sci, Dept Pharmacol 2, 1714-1 Yoshino Machi, Nobeoka, Miyazaki 8828508, Japan; [Ohsawa, Masahiro; Ishikura, Kei-ichiro] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Neuropharmacol, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan		Ohsawa, M (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Neuropharmacol, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	ohsawa@phar.nagoya-cu.ac.jp			Ministry of Education, Science, Sports and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [25460724, 18790187, 23790646]; Nakatomi Foundation	This study was supported by a Grant-in-Aid for Scientific Research (C) Grant Number 25460724 (MO) and a Grant-in-Aid for Young Scientist (B) Grant Numbers 18790187 (MO) and 23790646 (MO) from the Ministry of Education, Science, Sports and Culture of Japan and the Nakatomi Foundation to M. O. We express our appreciation to Ms. Mari Oji, Ms. Aki Kihara, and Ms. Eiko Uematsu for their technical assistance.	Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Barsante MM, 2005, EUR J PHARMACOL, V516, P282, DOI 10.1016/j.ejphar.2005.05.005; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; Bubb MR, 1999, J BIOL CHEM, V274, P36472, DOI 10.1074/jbc.274.51.36472; Buyukafsar K, 2006, EUR J PHARMACOL, V541, P49, DOI 10.1016/j.ejphar.2006.04.042; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen XY, 2013, J PAIN, V14, P1310, DOI 10.1016/j.jpain.2013.05.011; Deyts C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008287; Ding J, 2010, J NEUROCHEM, V114, P1619, DOI 10.1111/j.1471-4159.2010.06876.x; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Narita M, 2004, EUR J NEUROSCI, V19, P479, DOI 10.1111/j.0953-816X.2003.03119.x; Ohkawara H, 2005, J BIOL CHEM, V280, P10182, DOI 10.1074/jbc.M409547200; Ohsawa M, 2000, EUR J PHARMACOL, V403, P81, DOI 10.1016/S0014-2999(00)00571-9; Ohsawa M, 2002, PAIN, V100, P27, DOI 10.1016/S0304-3959(02)00207-5; Ohsawa M, 2008, PAIN, V134, P285, DOI 10.1016/j.pain.2007.04.031; Ohsawa M, 2014, NEUROSCI LETT, V564, P27, DOI 10.1016/j.neulet.2014.01.039; Ohsawa M, 2012, J PHARMACOL SCI, V119, P102, DOI 10.1254/jphs.12007SC; Ohsawa M, 2011, PAIN, V152, P114, DOI 10.1016/j.pain.2010.10.005; Ohsawa M, 2010, EUR J PHARMACOL, V644, P1, DOI 10.1016/j.ejphar.2010.07.007; Piao C, 2015, EXP NEUROL, V273, P288, DOI 10.1016/j.expneurol.2015.09.009; Raghavendra V, 2003, PAIN, V104, P655, DOI 10.1016/S0304-3959(03)00138-6; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Ramer LM, 2004, J NEUROSCI, V24, P10796, DOI 10.1523/JNEUROSCI.3337-04.2004; Rose SD, 2001, J BIOL CHEM, V276, P36757, DOI 10.1074/jbc.M006518200; Santodomingo-Garzon T, 2006, BRIT J PHARMACOL, V149, P14, DOI 10.1038/sj.bjp.0706836; Sasaki Y, 2003, J PHARMACOL SCI, V93, P35, DOI 10.1254/jphs.93.35; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Shi XQ, 2011, PAIN, V152, P1033, DOI 10.1016/j.pain.2011.01.006; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Tatsumi S, 2005, NEUROSCIENCE, V131, P491, DOI 10.1016/j.neuroscience.2004.10.022; Willey JZ, 2010, ARCH NEUROL-CHICAGO, V67, P1062, DOI 10.1001/archneurol.2010.199; Xu M, 2007, J NEUROSCI, V27, P2570, DOI 10.1523/JNEUROSCI.3728-06.2007; Yang H, 2002, HYPERTENSION, V39, P567, DOI 10.1161/hy0202.103052; Zhang ZR, 2008, ACTA NEUROPATHOL, V115, P335, DOI 10.1007/s00401-007-0301-y	41	13	13	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	OCT 1	2016	333						204	213		10.1016/j.neuroscience.2016.07.029			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU1BU	WOS:000381942000019	27457035				2022-02-06	
J	Perez, EJ; Cepero, ML; Perez, SU; Coyle, JT; Sick, TJ; Liebl, DJ				Perez, Enmanuel J.; Cepero, Maria L.; Perez, Sebastian U.; Coyle, Joseph T.; Sick, Thomas J.; Liebl, Daniel J.			EphB3 signaling propagates synaptic dysfunction in the traumatic injured brain	NEUROBIOLOGY OF DISEASE			English	Article						EphB3 receptors; D-serine; Synapse damage; Synaptic plasticity; Traumatic brain injury	METHYL-D-ASPARTATE; CONTROLLED CORTICAL IMPACT; TRANSIENT CEREBRAL-ISCHEMIA; D-SERINE; SELECTIVE VULNERABILITY; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; COMMISSURAL AXONS; NMDA RECEPTORS; DENTATE GYRUS	Traumatic brain injury (TBI), ranging from mild concussion to severe penetrating wounds, can involve brain regions that contain damaged or lost synapses in the absence of neuronal death. These affected regions significantly contribute to sensory, motor and/or cognitive deficits. Thus, studying the mechanisms responsible for synaptic instability and dysfunction is important for protecting the nervous system from the consequences of progressive TBI. Our controlled cortical impact (CCI) injury produces similar to 20% loss of synapses and mild changes in synaptic protein levels in the CA3-CA1 hippocampus without neuronal losses. These synaptic changes are associated with functional deficits, indicated by >50% loss in synaptic plasticity and impaired learning behavior. We show that the receptor tyrosine kinase EphB3 participates in CCI injury-induced synaptic damage, where EphB3(-/-) mice show preserved long-term potentiation and hippocampal-dependent learning behavior as compared with wild type (WT) injured mice. Improved synaptic function in the absence of EphB3 results from attenuation in CCI injury -induced synaptic losses and reduced D-serine levels compared with WT injured mice. Together, these findings suggest that EphB3 signaling plays a deleterious role in synaptic stability and plasticity after TBI. (C) 2016 The Authors. Published by Elsevier Inc.	[Perez, Enmanuel J.; Cepero, Maria L.; Perez, Sebastian U.; Liebl, Daniel J.] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Sick, Thomas J.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Coyle, Joseph T.] Harvard Med Sch, McLean Hosp, Dept Psychiat, Boston, MA 02115 USA		Liebl, DJ (corresponding author), Univ Miami, Miami Project Cure Paralysis, 1095 NW 14th Terrace,R-48, Miami, FL 33136 USA.	dliebl@miami.edu			Miami Project to Cure Paralysis; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS049545, NS30291, F31NS089335]; Lois Pope Life fellowship; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH051290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS098740, P50NS030291, F31NS089335, R01NS049545] Funding Source: NIH RePORTER	We thank Peggy Bates in the electron microscopy core facilities at the Miami Project to Cure Paralysis and Jessica Landau for assisting in our synaptic analyses. We also thank Jennifer Brazill for critical reading of the manuscript and assisting with experimental revisions, as well as Jose Mier for assistance with animal husbandry. This work was supported by the Miami Project to Cure Paralysis, NIH/NINDS NS049545 (DJL), NS30291 (DJL), F31NS089335 (EJP) and the Lois Pope Life fellowship (EJP).	Adams MM, 2001, J COMP NEUROL, V432, P230, DOI 10.1002/cne.1099; Antion MD, 2010, MOL CELL NEUROSCI, V45, P378, DOI 10.1016/j.mcn.2010.07.011; Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Assis-Nascimento P, 2016, J NEUROSCI METH, V263, P57, DOI 10.1016/j.jneumeth.2016.01.025; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Balu DT, 2014, CELL MOL NEUROBIOL, V34, P419, DOI 10.1007/s10571-014-0027-z; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brown KM, 2004, DEV BRAIN RES, V152, P61, DOI 10.1016/j.devbrainres.2004.06.001; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Carlson S. W., 2015, J NEUROTRAUMA; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; DeFelipe J, 1999, CEREB CORTEX, V9, P722, DOI 10.1093/cercor/9.7.722; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gambrill AC, 2011, P NATL ACAD SCI USA, V108, P5855, DOI 10.1073/pnas.1012676108; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; GUALTIERI T, 1991, Brain Injury, V5, P219, DOI 10.3109/02699059109008093; Gundersen V, 2015, PHYSIOL REV, V95, P695, DOI 10.1152/physrev.00024.2014; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hama Y, 2006, NEUROSCI RES, V56, P279, DOI 10.1016/j.neures.2006.07.008; Han H., 2015, PHARM BIOCH BEHAV; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hruska M., 2015, NAT NEUROSCI; Hsu JC, 1998, J CEREBR BLOOD F MET, V18, P768, DOI 10.1097/00004647-199807000-00008; Hunt DL, 2012, CURR OPIN NEUROBIOL, V22, P496, DOI 10.1016/j.conb.2012.01.007; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Irie F, 2005, NAT CELL BIOL, V7, P501, DOI 10.1038/ncb1252; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Katsuki H, 2004, J PHARMACOL EXP THER, V311, P836, DOI 10.1124/jpet.104.070912; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lin CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132204; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Marrone DF, 2004, BRAIN RES, V996, P19, DOI 10.1016/j.brainres.2003.09.073; Martone ME, 1999, J NEUROSCI, V19, P1988; Mayhew TM, 1996, J NEUROCYTOL, V25, P793, DOI 10.1007/BF02284842; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; Moon JY, 2015, PHARMACOL RES, V100, P353, DOI 10.1016/j.phrs.2015.08.019; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Osier N. D., 2015, BRAIN NEUROTRAUMA MO; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pena A, 2005, ACT NEUR S, V95, P333; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Rodenas-Ruano A, 2006, DEV BIOL, V292, P34, DOI 10.1016/j.ydbio.2006.01.004; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Small DL, 1997, NEUROSCI LETT, V232, P87, DOI 10.1016/S0304-3940(97)00592-2; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Spaethling J, 2012, NEUROBIOL DIS, V46, P646, DOI 10.1016/j.nbd.2012.03.003; Theus MH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.165; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zhu YJ, 2015, J NEUROSCI METH, V254, P73, DOI 10.1016/j.jneumeth.2015.07.022; Zhuang ZY, 2010, J NEUROSCI, V30, P16015, DOI 10.1523/JNEUROSCI.0481-10.2010	87	13	13	0	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	OCT	2016	94						73	84		10.1016/j.nbd.2016.06.007			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DT9QF	WOS:000381836700008	27317833	Green Published, hybrid, Green Accepted			2022-02-06	
J	Truong, JQ; Ciuffreda, KJ				Truong, James Q.; Ciuffreda, Kenneth J.			Objective Pupillary Correlates of Photosensitivity in the Normal and Mild Traumatic Brain Injury Populations	MILITARY MEDICINE			English	Article							GANGLION-CELLS; MELANOPSIN; LIGHT; RESPONSES; ADAPTATION	Objective: No objective vision biomarker for photosensitivity currently exists. The present study sought to uncover potential biomarkers for photosensitivity within the pupillary light reflex. Methods: The pupillary light reflex was evaluated in those with mild traumatic brain injury (mTBI) and in normal individuals, with and without photosensitivity, under a range of test conditions. The Neuroptics DP-2000, infrared, binocular pupillometer was used for both binocular stimulation and recording. Twelve pupil parameters and 6 stimulus conditions were quantitatively assessed in 32 adults with mTBI and compared to 40 normal adult controls. Results: Normal subjects with photosensitivity exhibited four significant differences (p < 0.05) as compared with their nonphotosensitive cohort: larger constriction amplitude, faster average constriction velocity, faster peak constriction velocity, and slower recovery time. mTBI subjects with photosensitivity manifested six significant differences (p < 0.05) as compared with their nonphotosensitive cohort: larger baseline diameter, larger minimum diameter, faster peak dilation velocity, faster T50 and T75 recovery times, and a larger pupil diameter at 6 seconds poststimulus. Discussion: Several pupillometry parameters were significantly different in those with and without photosensitivity in both populations tested. These specific parameters could serve as potential, objectively based biomarkers for photosensitivity in these specific populations.	[Truong, James Q.; Ciuffreda, Kenneth J.] SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA		Truong, JQ (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.						Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Cap?-Aponte JE., 2013, SPINE, V4, P1; Capo-Aponte J. E., 2012, MIL MED, V177, P804; Cudeiro J, 2006, TRENDS NEUROSCI, V29, P298, DOI 10.1016/j.tins.2006.05.002; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Do MTH, 2013, P NATL ACAD SCI USA, V110, P7470, DOI 10.1073/pnas.1304039110; Du T, 2005, BRAIN INJURY, V19, P1125, DOI 10.1080/02699050500149817; GOVE A, 1995, VISUAL NEUROSCI, V12, P1027, DOI 10.1017/S0952523800006702; Green D.M., 1966, SOCIETY; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kaufman PL., 2011, ADLERS PHYSL EYE, V11; KLEIN DC, 1991, SUPRACHIASMATIC NUCL; Kuburas A, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14784; Lok C, 2011, NATURE, V469, P284, DOI 10.1038/469284a; Markwell EL, 2010, CLIN EXP OPTOM, V93, P137, DOI 10.1111/j.1444-0938.2010.00479.x; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Park JC, 2011, INVEST OPHTH VIS SCI, V52, P6624, DOI 10.1167/iovs.11-7586; Phillips S, 2015, PRIMARY CARE, V42, P243, DOI 10.1016/j.pop.2015.01.010; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Stark L, 1968, NEUROLOGICAL CONTROL; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Suter PS, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P1, DOI 10.1201/b10524; Thiagarajan P, 2015, BRAIN INJURY, V29, P1420, DOI 10.3109/02699052.2015.1045029; Truong JQ, 2014, BRAIN INJURY, V28, P1283, DOI 10.3109/02699052.2014.915989; Zasler N. D., 2012, BRAIN INJURY MED PRI	32	13	13	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	OCT	2016	181	10					1382	1390		10.7205/MILMED-D-15-00587			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL3DB	WOS:000394498700040	27753579				2022-02-06	
J	Woo, PYM; Wong, HT; Pu, JKS; Wong, WK; Wong, LYW; Lee, MW; Yam, KY; Lui, WM; Poon, WS				Woo, Peter Y. M.; Wong, H. T.; Pu, Jenny K. S.; Wong, W. K.; Wong, Larry Y. W.; Lee, Michael W. Y.; Yam, K. Y.; Lui, W. M.; Poon, W. S.		Working Grp Neurosurgical Outcomes	Primary ventriculoperitoneal shunting outcomes: a multicentre clinical audit for shunt infection and its risk factors	HONG KONG MEDICAL JOURNAL			English	Article							CEREBROSPINAL-FLUID SHUNT; SURGICAL SITE INFECTIONS; RED MAN SYNDROME; VENTRICULAR SHUNTS; PEDIATRIC-PATIENTS; UNITED-STATES; HYDROCEPHALUS; VANCOMYCIN; PROPHYLAXIS; CATHETERS	Objectives: To determine the frequency of primary ventriculoperitoneal shunt infection among patients treated at neurosurgical centres of the Hospital Authority and to identify underlying risk factors. Methods: This multicentre historical cohort study included consecutive patients who underwent primary ventriculoperitoneal shunting at a Hospital Authority neurosurgery centre from 1 January 2009 to 31 December 2011. The primary endpoint was shunt infection, defined as: (1) the presence of cerebrospinal fluid or shunt hardware culture that yielded the pathogenic micro-organism with associated compatible symptoms and signs of central nervous system infection or shunt malfunction; or (2) surgical incision site infection requiring shunt reinsertion (even in the absence of positive culture); or (3) intraperitoneal pseudocyst formation (even in the absence of positive culture). Secondary endpoints were shunt malfunction, defined as unsatisfactory cerebrospinal fluid drainage that required shunt reinsertion, and 30-day mortality. Results: A. primary ventriculoperitoneal shunt was inserted in 538 patients during the study period. The mean age of patients was 48 years (range, 13-88 years) with a male-to-female ratio of 1:1. Aneurysmal subarachnoid haemorrhage was the most common aetiology (n=169, 31%) followed by intracranial tumour (n=164, 30%), central nervous system infection (n=42, 8%), and traumatic brain injury (n=27, 5%). The mean operating time was 75 (standard deviation, 29) minutes. Shunt reinsertion and infection rates were 16% (n=87) and 7% (n=36), respectively. The most common cause for shunt reinsertion was malfunction followed by shunt infection. Independent predictors for shunt infection were: traumatic brain injury (adjusted odds ratio=6.2; 95% confidence interval, 2.3-16.8), emergency shunting (2.3; 1.0-5.1), and prophylactic vancomycin as the sole antibiotic (3.4; 1.1-11.0). The 30-day all-cause mortality was 6% and none were directly procedure-related. Conclusions: This is the first Hong Kong territory wide review of infection in primary ventriculoperitoneal shunts. Although the ventriculoperitoneal shunt infection rate met international standards, there are areas of improvement such as vancomycin administration and the avoidance of scheduling the procedure as an emergency.	[Woo, Peter Y. M.; Wong, H. T.] Kwong Wah Hosp, Dept Neurosurg, Yaumatei, Hong Kong, Peoples R China; [Pu, Jenny K. S.; Lui, W. M.] Queen Mary Hosp, Dept Surg, Div Neurosurg, Pokfulam, Hong Kong, Peoples R China; [Wong, W. K.] Princess Margaret Hosp, Dept Neurosurg, Laichikok, Hong Kong, Peoples R China; [Wong, Larry Y. W.] Queen Elizabeth Hosp, Dept Neurosurg, Jordan, Hong Kong, Peoples R China; [Lee, Michael W. Y.] Pamela Youde Nethersole Eastern Hosp, Dept Neurosurg, Chaiwan, Hong Kong, Peoples R China; [Yam, K. Y.] Tuen Mun Hosp, Dept Neurosurg, Tuen Mun, Hong Kong, Peoples R China; [Poon, W. S.] Prince Wales Hosp, Dept Surg, Div Neurosurg, Shatin, Hong Kong, Peoples R China		Woo, PYM (corresponding author), Kwong Wah Hosp, Dept Neurosurg, Yaumatei, Hong Kong, Peoples R China.	wym307@ha.org.hk	Poon, Wai Sang/F-1558-2011		Tung Wah Group of Hospitals Neuroscience Research Fund	We would like to thank members of the Hospital Authority Head Office (HAHO) Co-ordinating Committee (Neurosurgery), the Clinical Effectiveness & Technology Management Department, the Division of Quality and Safety, and the Clinical Data Analysis and Reporting System Team, HAHO IT Service for their administrative advice and data collection. We also wish to thank Drs Chris YW Liu, Alphon HY Ip, and Claudia Law for their contributions in data collection and entry. This study was supported by the Tung Wah Group of Hospitals Neuroscience Research Fund.	Abdullah KG, 2015, J NEUROSURG, V123, P1600, DOI 10.3171/2014.12.JNS142092; Albanese J, 2000, ANTIMICROB AGENTS CH, V44, P1356, DOI 10.1128/AAC.44.5.1356-1358.2000; BAYSTON R, 1974, DEV MED CHILD NEUROL, V16, P16; Birjandi A, 2012, NEUROSURG QUART, V22, P145, DOI 10.1097/WNQ.0b013e318202bb83; BORGBJERG BM, 1995, ACTA NEUROCHIR, V136, P1, DOI 10.1007/BF01411427; Choksey MS, 2004, J NEUROL NEUROSUR PS, V75, P87; CHOUX M, 1992, J NEUROSURG, V77, P875, DOI 10.3171/jns.1992.77.6.0875; Cochrane DD, 2003, PEDIATR NEUROSURG, V38, P295, DOI 10.1159/000070413; Davis SE, 1999, PEDIATR NEUROSURG, V30, P253, DOI 10.1159/000028806; DUHAIME AC, 1991, CHILD NERV SYST, V7, P211; FAILLACE WJ, 1995, SURG NEUROL, V43, P344, DOI 10.1016/0090-3019(95)80060-T; FANHAVARD P, 1990, CHEMOTHERAPY, V36, P103, DOI 10.1159/000238755; HEALY DP, 1990, ANTIMICROB AGENTS CH, V34, P550, DOI 10.1128/AAC.34.4.550; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Jeelani NUO, 2009, J NEUROS-PEDIATR, V4, P166, DOI 10.3171/2009.3.PEDS08458; Kausch W., 1908, ARCH KILN CHIR, V87, P709; Keong NCH, 2012, NEUROSURGERY, V71, P394, DOI 10.1227/NEU.0b013e318257bebb; Kestle JRW, 2011, J NEUROSURG-PEDIATR, V8, P22, DOI 10.3171/2011.4.PEDS10551; Konstantelias AA, 2015, J NEUROSURG, V122, P1096, DOI 10.3171/2014.12.JNS14908; Korinek AM, 2011, NEUROSURGERY, V68, P985, DOI 10.1227/NEU.0b013e318208f360; ODIO C, 1984, AM J DIS CHILD, V138, P1103, DOI 10.1001/archpedi.1984.02140500009004; ODIO C, 1984, AM J DIS CHILD, V138, P17, DOI 10.1001/archpedi.1984.02140390009004; Overturf Gary D, 2005, Pediatr Crit Care Med, V6, pS14, DOI 10.1097/01.PCC.0000161933.42822.86; Parker Scott L, 2011, Clin Neurosurg, V58, P122; Parker SL, 2015, WORLD NEUROSURG, V83, P382, DOI 10.1016/j.wneu.2014.06.010; Patwardhan RV, 2005, NEUROSURGERY, V56, P139, DOI 10.1227/01.NEU.0000146206.40375.41; Pirotte BJM, 2007, CHILD NERV SYST, V23, P1251, DOI 10.1007/s00381-007-0415-5; PONS VG, 1993, NEUROSURGERY, V33, P416; Ragel BT, 2006, J NEUROSURG, V105, P242, DOI 10.3171/jns.2006.105.2.242; Ratilal B, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.Cd005365.pub2; SCHOENBAUM SC, 1975, J INFECT DIS, V131, P543, DOI 10.1093/infdis/131.5.543; Sciubba DM, 2005, J NEUROSURG, V103, P131, DOI 10.3171/ped.2005.103.2.0131; Shannon CN, 2011, J NEUROSURG-PEDIATR, V8, P593, DOI 10.3171/2011.9.PEDS11192; Simon TD, 2008, J NEUROS-PEDIATR, V1, P131, DOI 10.3171/PED/2008/1/2/131; Sivagnanam S, 2003, CRIT CARE, V7, P119, DOI 10.1186/cc1871; Stevens DL, 2006, CLIN INFECT DIS, V42, pS51, DOI 10.1086/491714; Thomas R, 2012, BRIT J NEUROSURG, V26, P175, DOI 10.3109/02688697.2011.603856; Tuli S, 2000, J NEUROSURG, V92, P31, DOI 10.3171/jns.2000.92.1.0031; Tulipan N, 2006, J NEUROSURG, V104, P5, DOI 10.3171/ped.2006.104.1.5; Vanaclocha V, 1996, ACTA NEUROCHIR, V138, P829, DOI 10.1007/BF01411261; Wang KW, 2004, JPN J INFECT DIS, V57, P44; Wong JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12179; World Health Organization and Department of Health Hong Kong, 2012, HONG KONG CHIN HLTH	44	13	13	0	4	HONG KONG ACAD MEDICINE PRESS	HONG KONG	9/F/, ROOM 901, 99 WONG CHUK HANG RD, ABERDEEN, HONG KONG, 00000, PEOPLES R CHINA	1024-2708			HONG KONG MED J	Hong Kong Med. J.	OCT	2016	22	5					410	419		10.12809/hkmj154735			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY2ZJ	WOS:000384960300002	27562986	Green Submitted, gold			2022-02-06	
J	Grin'kina, NM; Li, Y; Haber, M; Sangobowale, M; Nikulina, E; Le'Pre, C; El Sehamy, AM; Dugue, R; Ho, JS; Bergold, PJ				Grin'kina, Natalia M.; Li, Yang; Haber, Margalit; Sangobowale, Michael; Nikulina, Elena; Le'Pre, Charm; El Sehamy, Alexander M.; Dugue, Rachelle; Ho, Johnson S.; Bergold, Peter J.			Righting Reflex Predicts Long-Term Histological and Behavioral Outcomes in a Closed Head Model of Traumatic Brain Injury	PLOS ONE			English	Article								Blunt impact produces a heterogeneous brain injury in people and in animal models of traumatic brain injury. We report that a single closed head impact to adult C57/BL6 mice produced two injury syndromes (CHI-1 and CHI-2). CHI-1 mice spontaneously reinitiated breathing after injury while CHI-2 mice had prolonged apnea and regained breathing only after cardiopulmonary resuscitation and supplementation of 100% O-2. The CHI-1 group significantly regained righting reflex more rapidly than the CHI-2 group. At 7 days postinjury, CHI-1, but not CHI-2 mice, acquired but had no long-term retention of an active place avoidance task. The behavioral deficits of CHI-1 and CHI-2 mice were retained one-month after the injury. CHI-1 mice had loss of hippocampal neurons and localized white matter injury at one month after injury. CHI-2 had a larger loss of hippocampal neurons and more widespread loss of myelin and axons. High-speed videos made during the injury were followed by assessment of breathing and righting reflex. These videos show that CHI-2 mice experienced a larger vertical g-force than CHI-1 mice. Time to regain righting reflex in CHI-2 mice significantly correlated with vertical g-force. Thus, physiological responses occurring immediately after injury can be valuable surrogate markers of subsequent behavioral and histological deficits.	[Haber, Margalit; Sangobowale, Michael; Le'Pre, Charm; Dugue, Rachelle; Bergold, Peter J.] Suny Downstate Med Ctr, Program Neural & Behav Sci, Brooklyn, NY 11203 USA; [Grin'kina, Natalia M.; Li, Yang; Haber, Margalit; Nikulina, Elena; El Sehamy, Alexander M.; Ho, Johnson S.; Bergold, Peter J.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural Sci, Brooklyn, NY 11203 USA; [Grin'kina, Natalia M.; Nikulina, Elena; Bergold, Peter J.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA; [Li, Yang] New York Psychiat Inst, 1051 Riverside Dr,Kolb Annex 669, New York, NY 10032 USA; [Haber, Margalit] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Rm 227,12725 Twinbrook Pkwy, Rockville, MD USA		Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Program Neural & Behav Sci, Brooklyn, NY 11203 USA.; Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural Sci, Brooklyn, NY 11203 USA.; Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	pbergold@downstate.edu		Bergold, Peter/0000-0002-6335-1380	United States Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-10-2-0171]	This study was supported by the award number: W81XWH-10-2-0171, http://mrmc.amedd.army.mil/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the invaluable assistance of Mr. Polaris and Hilarion Banks in assisting with the high-speed video recordings of the head movements and Ms. Kristen Whitney for critically reading the manuscript. This work was funded by an award from the United States Army Medical Research and Material Command (W81XWH-10-2-0171) to P.J.B.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Ding GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061241; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Huh JW, 2011, J NEUROTRAUM, V28, P245, DOI 10.1089/neu.2010.1639; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kubik S, 2005, J NEUROSCI, V25, P9205, DOI 10.1523/JNEUROSCI.1707-05.2005; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Shinohara Y, 2012, HIPPOCAMPUS, V22, P117, DOI 10.1002/hipo.20886; Skelton RW, 1998, BEHAV BRAIN RES, V96, P13, DOI 10.1016/S0166-4328(97)00199-X; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Young N, 2010, CURR OPIN CRIT CARE, V16, P45, DOI 10.1097/MCC.0b013e32833546fa	24	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0161053	10.1371/journal.pone.0161053			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	WOS:000383893200004	27657499	gold, Green Published, Green Submitted			2022-02-06	
J	Gooijers, J; Beets, IAM; Albouy, G; Beeckmans, K; Michiels, K; Sunaert, S; Swinnen, SP				Gooijers, Jolien; Beets, Iseult A. M.; Albouy, Genevieve; Beeckmans, Kurt; Michiels, Karla; Sunaert, Stefan; Swinnen, Stephan P.			Movement preparation and execution: differential functional activation patterns after traumatic brain injury	BRAIN			English	Article						fMRI; traumatic brain injury; bimanual motor control; movement preparation; visual feedback	WHITE-MATTER INTEGRITY; DIFFUSE AXONAL INJURY; WORKING-MEMORY LOAD; BIMANUAL COORDINATION; CORPUS-CALLOSUM; BEHAVIOR RELATIONSHIPS; PREFRONTAL CORTEX; MOTOR-PERFORMANCE; COGNITIVE CONTROL; POSTURAL CONTROL	Years following the insult, patients with traumatic brain injury often experience persistent motor control problems, including bimanual coordination deficits. Previous studies revealed that such deficits are related to brain structural white and grey matter abnormalities. Here, we assessed, for the first time, cerebral functional activation patterns during bimanual movement preparation and performance in patients with traumatic brain injury, using functional magnetic resonance imaging. Eighteen patients with moderate-to-severe traumatic brain injury (10 females; aged 26.3 years, standard deviation = 5.2; age range: 18.4-34.6 years) and 26 healthy young adults (15 females; aged 23.6 years, standard deviation = 3.8; age range: 19.5-33 years) performed a complex bimanual tracking task, divided into a preparation (2 s) and execution (9 s) phase, and executed either in the presence or absence of augmented visual feedback. Performance on the bimanual tracking task, expressed as the average target error, was impaired for patients as compared to controls (P < 0.001) and for trials in the absence as compared to the presence of augmented visual feedback (P < 0.001). At the cerebral level, movement preparation was characterized by reduced neural activation in the patient group relative to the control group in frontal (bilateral superior frontal gyrus, right dorsolateral prefrontal cortex), parietal (left inferior parietal lobe) and occipital (right striate and extrastriate visual cortex) areas (P's < 0.05). During the execution phase, however, the opposite pattern emerged, i.e. traumatic brain injury patients showed enhanced activations compared with controls in frontal (left dorsolateral prefrontal cortex, left lateral anterior prefrontal cortex, and left orbitofrontal cortex), parietal (bilateral inferior parietal lobe, bilateral superior parietal lobe, right precuneus, right primary somatosensory cortex), occipital (right striate and extrastriate visual cortices), and subcortical (left cerebellum crus II) areas (P's < 0.05). Moreover, a significant interaction effect between Feedback Condition and Group in the primary motor area (bilaterally) (ZP < 0.001), the cerebellum (left) (P < 0.001) and caudate (left) (P < 0.05), revealed that controls showed less overlap of activation patterns accompanying the two feedback conditions than patients with traumatic brain injury (i.e. decreased neural differentiation). In sum, our findings point towards poorer predictive control in traumatic brain injury patients in comparison to controls. Moreover, irrespective of the feedback condition, overactivations were observed in traumatically brain injured patients during movement execution, pointing to more controlled processing of motor task performance.	[Gooijers, Jolien; Beets, Iseult A. M.; Albouy, Genevieve; Swinnen, Stephan P.] Katholieke Univ Leuven, Grp Biomed Sci, Movement Control & Neuroplast Res Grp, B-3001 Leuven, Belgium; [Beets, Iseult A. M.] Lilid Bvba, BrainCTR, Diest, Belgium; [Beeckmans, Kurt] Ctr Epilepsy & Acquired Brain Injury CEPOS, Duffel, Belgium; [Michiels, Karla] Univ Hosp, Dept Phys Med & Rehabil, Leuven Campus Pellenberg, Lubbeek, Belgium; [Sunaert, Stefan] Katholieke Univ Leuven, Med Imaging Ctr, Grp Biomed Sci, B-3000 Leuven, Belgium		Gooijers, J (corresponding author), Movement Control & Neuroplast Res Grp, Tervuursevest 101 Bus 1501, B-3001 Leuven, Belgium.	Jolien.Gooijers@kuleuven.be	ALBOUY, Genevieve/P-4723-2019; Gooijers, Jolien/AAH-9202-2020; ALBOUY, Genevieve/K-5350-2015	ALBOUY, Genevieve/0000-0002-5437-023X; ALBOUY, Genevieve/0000-0002-5437-023X; Gooijers, Jolien/0000-0002-7569-7223	Interuniversity Attraction Poles program of the Belgian federal governmentBelgian Federal Science Policy Office [P7/11]; Research Fund KU LeuvenKU Leuven [C16/15/070]; FWO VlaanderenFWO [G.0721.12, G0708.14]; Research Foundation - Flanders (FWO)FWO	This work was supported by the Interuniversity Attraction Poles program of the Belgian federal government (P7/11). Additional support was provided by the Research Fund KU Leuven (C16/15/070) and FWO Vlaanderen (G.0721.12, G0708.14). J.G. is funded by a fellowship of the Research Foundation - Flanders (FWO).	Amedi A, 2005, EXP BRAIN RES, V166, P559, DOI 10.1007/s00221-005-2396-5; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Beets IAM, 2015, CEREB CORTEX, V25, P1958, DOI 10.1093/cercor/bhu005; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Brownsett SLE, 2014, BRAIN, V137, P242, DOI 10.1093/brain/awt289; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Caeyenberghs K, 2009, BRAIN COGNITION, V69, P154, DOI 10.1016/j.bandc.2008.07.001; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; Chen TL, 2008, NEUROIMAGE, V40, P1765, DOI 10.1016/j.neuroimage.2008.01.020; Choi GS, 2012, ARCH NEUROL-CHICAGO, V69, P363, DOI 10.1001/archneurol.2011.1930; Choi WH, 2013, PSYCHIAT INVEST, V10, P47, DOI 10.4306/pi.2013.10.1.47; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cieslik EC, 2013, CEREB CORTEX, V23, P2677, DOI 10.1093/cercor/bhs256; de Haan EHF, 2011, TRENDS COGN SCI, V15, P460, DOI 10.1016/j.tics.2011.08.005; Debaere F, 2004, NEUROPSYCHOLOGIA, V42, P855, DOI 10.1016/j.neuropsychologia.2003.12.010; DESROSIERS J, 1995, DISABIL REHABIL, V17, P217, DOI 10.3109/09638289509166638; Desrosiers J, 1993, CAN J OCCUP THER, V60, P9, DOI DOI 10.1177/000841749306000104; Di Russo F, 2005, J NEUROTRAUM, V22, P297; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gooijers J, 2016, NEUROREHAB NEURAL RE, V30, P603, DOI 10.1177/1545968315613448; Gooijers J, 2013, HUM BRAIN MAPP, V34, P241, DOI 10.1002/hbm.21429; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; Gray C, 1998, BRAIN INJURY, V12, P429, DOI 10.1080/026990598122548; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hardwick RM, 2013, NEUROIMAGE, V67, P283, DOI 10.1016/j.neuroimage.2012.11.020; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Hoshi E, 2007, CURR OPIN NEUROBIOL, V17, P234, DOI 10.1016/j.conb.2007.02.003; Irimia A, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S79174; Jang SH, 2011, NEUROREHABILITATION, V29, P339, DOI 10.3233/NRE-2011-0710; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Li W, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/452439; Lima FPS, 2011, NEUROL SCI, V32, P633, DOI 10.1007/s10072-011-0604-6; Lotze M, 2006, NEUROREHAB NEURAL RE, V20, P14, DOI 10.1177/1545968305282919; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mani TM, 2007, BRAIN INJURY, V21, P1155, DOI 10.1080/02699050701687367; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Moen KG, 2014, J NEUROTRAUM, V31, P56, DOI 10.1089/neu.2013.3000; Mumford J.A., 2007, GUIDE CALCULAT UNPUB; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostra KM, 2012, ARCH PHYS MED REHAB, V93, P828, DOI 10.1016/j.apmr.2011.11.018; Penta M, 1998, ARCH PHYS MED REHAB, V79, P1038, DOI 10.1016/S0003-9993(98)90167-8; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Pochon JB, 2001, CEREB CORTEX, V11, P260, DOI 10.1093/cercor/11.3.260; Prigatano GP, 2004, BRAIN INJURY, V18, P661, DOI 10.1080/02699050310001646170; Puopolo C, 2013, NEUROSCI BIOBEHAV R, V37, P2638, DOI 10.1016/j.neubiorev.2013.08.013; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; Ronsse R, 2011, CEREB CORTEX, V21, P1283, DOI 10.1093/cercor/bhq209; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Shin SS, 2012, J NEUROSURG, V116, P1062, DOI 10.3171/2012.1.JNS111282; Sinopoli KJ, 2014, J NEUROTRAUM, V31, P1843, DOI 10.1089/neu.2014.3326; Sisti HM, 2012, LEARN MEMORY, V19, P351, DOI 10.1101/lm.026534.112; Sisti HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023619; Steenbergen B, 2007, NEUROPSYCHOLOGIA, V45, P3324, DOI 10.1016/j.neuropsychologia.2007.07.002; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; Tricomi E, 2006, J COGNITIVE NEUROSCI, V18, P1029, DOI 10.1162/jocn.2006.18.6.1029; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P2677, DOI 10.1016/j.clinph.2004.06.015; Wiese H, 2006, NEUROIMAGE, V30, P1292, DOI 10.1016/j.neuroimage.2005.11.012	79	13	13	2	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	SEP	2016	139		9				2469	2485		10.1093/brain/aww177			17	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DW5WX	WOS:000383719500021	27435093	Green Accepted, Bronze			2022-02-06	
J	Herweh, C; Hess, K; Meyding-Lamade, U; Bartsch, AJ; Stippich, C; Jost, J; Friedmann-Bette, B; Heiland, S; Bendszus, M; Hahnel, S				Herweh, Christian; Hess, Klaus; Meyding-Lamade, Uta; Bartsch, Andreas J.; Stippich, Christoph; Jost, Joachim; Friedmann-Bette, Birgit; Heiland, Sabine; Bendszus, Martin; Haehnel, Stefan			Reduced white matter integrity in amateur boxers	NEURORADIOLOGY			English	Article						Diffusion tensor imaging; Traumatic brain injury; White matter disturbance; Olympic boxing; Neuropsychology	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; SPORTS-RELATED CONCUSSION; PROFESSIONAL BOXERS; CEREBRAL MICROHEMORRHAGES; MICROSTRUCTURAL DAMAGE; NERVOUS-SYSTEM; HEAD-INJURY; MRI; MICROBLEEDS	Professional boxing can lead to chronic traumatic encephalopathy, a variant of traumatic brain injury (TBI). Its occurrence in amateur boxers is a matter of debate since amateur boxing is considered to be less harmful due to more strict regulations. However, several studies using different methodological approaches have revealed subtle signs of TBI even in amateurs. Diffusion tensor imaging (DTI) is sensitive to microscopic white matter changes and has been proven useful in TBI when routine MR imaging often is unrevealing. DTI, with tract-based spatial statistics (TBSS) together with neuropsychological examination of executive functions and memory, was used to investigate a collective of 31 male amateur boxers and 31 age-matched controls as well as a subgroup of 19 individuals, respectively, who were additionally matched for intellectual performance (IQ). All participants had normal findings in neurological examination and conventional MR. Amateur boxers did not show deficits in neuropsychological tests when their IQ was taken into account. Fractional anisotropy was significantly reduced, while diffusivity measures were increased along central white matter tracts in the boxers group. These changes were in part associated with the number of fights. TBSS revealed widespread white matter disturbance partially related to the individual fighting history in amateur boxers. These findings closely resemble those in patients with accidental TBI and indicate similar histological changes in amateur boxers.	[Herweh, Christian; Bartsch, Andreas J.; Heiland, Sabine; Bendszus, Martin; Haehnel, Stefan] Heidelberg Univ, Dept Neuroradiol, Sch Med, Neuenheimer Feld 400, D-69120 Heidelberg, Germany; [Hess, Klaus] Heidelberg Univ, Dept Neurol, Sch Med, Heidelberg, Germany; [Meyding-Lamade, Uta] Krankenhaus NW Frankfurt, Dept Neurol, Frankfurt, Germany; [Stippich, Christoph] Univ Basel Hosp, Dept Neuroradiol, Basel, Switzerland; [Jost, Joachim] Natl Training Ctr Boxing, Heidelberg, Germany; [Friedmann-Bette, Birgit] Heidelberg Univ, Dept Sports Med, Sch Med, Heidelberg, Germany		Herweh, C (corresponding author), Heidelberg Univ, Dept Neuroradiol, Sch Med, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	christian.herweh@med.uni-heidelberg.de	Friedmann-Bette, Birgit/AAF-7772-2020				Adamson C, 2013, BRAIN INJURY, V27, P454, DOI 10.3109/02699052.2012.750756; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bender A.R., 2015, NEUROIMAGE; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; BROOKS N, 1987, J NEUROL NEUROSUR PS, V50, P997, DOI 10.1136/jnnp.50.8.997; BUTLER RJ, 1993, J NEUROL NEUROSUR PS, V56, P1055, DOI 10.1136/jnnp.56.10.1055; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; Chamard E, 2015, J NEUROTRAUMA; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Chappell MH, 2008, MAGN RESON IMAGING, V26, P1398, DOI 10.1016/j.mri.2008.04.004; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Chiang MC, 2011, NEUROIMAGE, V55, P448, DOI 10.1016/j.neuroimage.2010.12.053; CORSELLIS JAN, 1959, J MENT SCI, V105, P714, DOI 10.1192/bjp.105.440.714; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; DREW RH, 1986, J CLIN PSYCHOL, V42, P520, DOI 10.1002/1097-4679(198605)42:3<520::AID-JCLP2270420319>3.0.CO;2-6; Forstl H, 2010, DTSCH ARZTEBL INT, V107, P835, DOI 10.3238/arztebl.2010.0835; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Guo LF, 2013, CLIN NEURORADIOL, V23, P121, DOI 10.1007/s00062-012-0185-7; Hahnel S, 2008, AM J NEURORADIOL, V29, P388, DOI 10.3174/ajnr.A0799; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; HEILBRONNER RL, 1991, AM J SPORT MED, V19, P376, DOI 10.1177/036354659101900409; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Helmstaedter C., 2001, VERBALER LERN MERKFA; HOLZGRAEFE M, 1992, INT J SPORTS MED, V13, P616, DOI 10.1055/s-2007-1024576; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jako P, 2002, BRIT J SPORT MED, V36, P394, DOI 10.1136/bjsm.36.6.394; JORDAN BD, 1988, ARCH NEUROL-CHICAGO, V45, P1207, DOI 10.1001/archneur.1988.00520350045014; KASTE M, 1982, LANCET, V2, P1186; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Koenis MMG, 2015, HUM BRAIN MAPP, V36, P4938, DOI 10.1002/hbm.22988; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Kourtidou P, 2013, J HEAD TRAUMA REHAB, V28, P433, DOI 10.1097/HTR.0b013e3182585d06; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Liu GB, 2015, ACTA RADIOL, V56, P1256, DOI 10.1177/0284185114552883; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCLATCHIE G, 1987, J NEUROL NEUROSUR PS, V50, P96, DOI 10.1136/jnnp.50.1.96; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Moriarity J, 2004, NEUROLOGY, V62, P1497, DOI 10.1212/WNL.62.9.1497; Moriarity JM, 2012, BRIT J SPORT MED, V46, P1011, DOI 10.1136/bjsports-2011-090893; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Navas-Sanchez FJ, 2014, HUM BRAIN MAPP, V35, P2619, DOI 10.1002/hbm.22355; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Shams S, 2015, AM J NEURORADIOL, V36, P1089, DOI 10.3174/ajnr.A4248; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; STEWART WF, 1994, AM J EPIDEMIOL, V139, P573, DOI 10.1093/oxfordjournals.aje.a117047; Stiller JW, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00069; Stojsih S, 2010, BRIT J SPORT MED, V44, P725, DOI 10.1136/bjsm.2008.052845; Tewes U, 1994, HAWIE R HAMBURG WECH; Wilde EA, 2015, J NEUROTRAUMA; Wolf D, 2014, HUM BRAIN MAPP, V35, P309, DOI 10.1002/hbm.22177; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52; Zimmermann P, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P110	75	13	13	0	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	SEP	2016	58	9					911	920		10.1007/s00234-016-1705-y			10	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DY4JP	WOS:000385065100009	27230917				2022-02-06	
J	Moattari, M; Shirazi, FA; Sharifi, N; Zareh, N				Moattari, Marzieh; Shirazi, Fatemeh Alizadeh; Sharifi, Nasrin; Zareh, Najaf			Effects of a Sensory Stimulation by Nurses and Families on Level of Cognitive Function, and Basic Cognitive Sensory Recovery of Comatose Patients With Severe Traumatic Brain Injury: A Randomized Control Trial	TRAUMA MONTHLY			English	Article						Coma; Sensory Stimulation; Traumatic Brain Injury; Consciousness Level; Cognitive Function	CONSCIOUSNESS LEVEL; VEGETATIVE STATE; HEAD-INJURY; OF-LIFE; TIME; CARE; RESPONSES; PROGRAM	Background: Several lines of evidence suggest that early sensory stimulation and regular family visiting programs are potential nursing interventions to improve the outcomes of head injured comatose patients. However, little is known about the impacts of family involvement in providing sensory stimulation. Objectives: To determine the effects of a sensory stimulation program conducted by nurses and families on the consciousness, level of cognitive function, and basic cognitive sensory recovery of head injury comatose patients. Patients and Methods: This was a randomized clinical trial performed at the Shiraz level I trauma center including 60 head injured comatose patients with an initial Glasgow coma score (GCS) of less than 8. Patients were randomly assigned to receive sensory stimulation by a qualified nurse (nurse group; n = 20), by the family (family group; n = 20), or usual care (control group; n = 20). The sensory stimulation program involving the nurses and patients' families was conducted, twice daily, in the morning and evening for 7 days. The level of consciousness, level of cognitive function, and basic cognitive sensory recovery of the patients were evaluated and monitored using the GCS, Rancho Los Amigos (RLA), and Western Neuro-Sensory stimulation profile (WNSSP). Data were analyzed by chi square, Kruskal-Wallis, and repeated-measures tests using SPSS. Results: All the patients were comparable regarding their baseline characteristics, level of consciousness, level of cognitive function, and basic cognitive sensory recovery determined by GCS, RLA, and WNSSP. Although the two intervention groups of the study improved, those who received the sensory stimulation program from their families had significantly higher GCS (P = 0.001), RLA (P = 0.001), and WNSSP (P = 0.001) scores after 7 days when compared to the two other groups. Conclusions: The application of sensory stimulation by families led to significant increases in the consciousness, level of cognitive function, and basic cognitive sensory recovery of comatose patients with severe injuries.	[Moattari, Marzieh; Shirazi, Fatemeh Alizadeh; Sharifi, Nasrin] Shiraz Univ Med Sci, Sch Nursing & Midwifery, Dept Med Surg Nursing, Shiraz, Iran; [Zareh, Najaf] Shiraz Univ Med Sci, Infertil Res Ctr, Dept Biostat, Shiraz, Iran		Moattari, M (corresponding author), Shiraz Univ Med Sci, Sch Nursing & Midwifery, Dept Med Surg Nursing, Shiraz, Iran.	moattari@yahoo.com	sharifi, nasrin/C-8925-2017	sharifi, nasrin/0000-0002-6849-7653			Abbasi M, 2009, JPN J NURS SCI, V6, P21, DOI 10.1111/j.1742-7924.2009.00117.x; Aghakhani N, 2013, IRAN RED CRESCENT ME, V15, P173, DOI 10.5812/ircmj.2090; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; Barker E., 2002, NEUROSCIENCE NURSING, V2nd; Berwick DM, 2004, JAMA-J AM MED ASSOC, V292, P736, DOI 10.1001/jama.292.6.736; Campbell ML, 2003, CHEST, V123, P266, DOI 10.1378/chest.123.1.266; Davis Alice E, 2003, J Neurosci Nurs, V35, P202; Fakharian E, 2015, TRAUMA MON; Gruner ML, 2000, BRAIN INJURY, V14, P585; HALL M E, 1992, Brain Injury, V6, P435, DOI 10.3109/02699059209008139; Henneman Elizabeth A, 2002, Crit Care Nurse, V22, P12; JOHNSON DA, 1993, BRAIN INJURY, V7, P491, DOI 10.3109/02699059309008176; Karma D, 2006, INDIAN PEDIATR, V43, P856; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kater K M, 1989, West J Nurs Res, V11, P20, DOI 10.1177/019394598901100103; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Lilly CM, 2000, AM J MED, V109, P469, DOI 10.1016/S0002-9343(00)00524-6; Lombardi F, 2002, COCHRANE DATABASE SY, V2; Majdzadeh R, 2008, ACCIDENT ANAL PREV, V40, P17, DOI 10.1016/j.aap.2007.03.019; Megha M, 2013, BRAIN INJURY, V27, P570, DOI 10.3109/02699052.2013.767937; MITCHELL S, 1990, Brain Injury, V4, P273, DOI 10.3109/02699059009026177; Moattari M, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-115; Momennasab Marzieh, 2012, Iran J Nurs Midwifery Res, V17, P343; Nelson JE, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.02.007; Noda R, 2004, BRAIN INJURY, V18, P509, DOI 10.1080/02699050310001645810; Oh H, 2003, J CLIN NURS, V12, P394, DOI 10.1046/j.1365-2702.2003.00750.x; Oliveira RG, 2007, REV LAT-AM ENFERM, V15, P431, DOI 10.1590/S0104-11692007000300011; Owen MA, 2007, J NUCL MED TECHNOL, V35, P39; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schneiderman LJ, 2003, JAMA-J AM MED ASSOC, V290, P1166, DOI 10.1001/jama.290.9.1166; SEGATORE M, 1992, HEART LUNG, V21, P548; Sinha S, 2013, NEUROL INDIA, V61, P501, DOI 10.4103/0028-3886.121920; TEASDALE G, 1974, LANCET, V2, P81; Toroyan T, 2009, INJURY PREV, V15, P286, DOI 10.1136/ip.2009.023697; Wijnen VJM, 2006, CLIN NEUROPHYSIOL, V117, P1794, DOI 10.1016/j.clinph.2006.03.006; Wilson SL, 1996, BRAIN INJURY, V10, P807, DOI 10.1080/026990596123927; Wood R L, 1992, Brain Inj, V6, P411, DOI 10.3109/02699059209008137	37	13	15	1	20	NATL CENTER TRAUMA RESEARCH	TEHRAN	NATL CENTER TRAUMA RESEARCH, TEHRAN, IRAN	2251-7464	2251-7472		TRAUMA MON	Trauma Mon.	SEP	2016	21	4							e23531	10.5812/traumamon.23531			10	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	ED7QK	WOS:000389063900006	28180120	Green Published, Green Submitted			2022-02-06	
J	Raina, KD; Morse, JQ; Chisholm, D; Leibold, ML; Shen, J; Whyte, E				Raina, Ketki D.; Morse, Jennifer Q.; Chisholm, Denise; Leibold, Mary Lou; Shen, Jennifer; Whyte, Ellen			Feasibility of a Cognitive Behavioral Intervention to Manage Fatigue in Individuals With Traumatic Brain Injury: A Pilot Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						behavioral; energy conservation; fatigue; problem solving; traumatic brain injury	APATHY EVALUATION SCALE; MULTIPLE-SCLEROSIS; RATING-SCALE; HEAD-INJURY; PARTICIPATION; RELIABILITY; IMPACT; VALIDITY; REHABILITATION; VALIDATION	Objective: To evaluate the feasibility of conducting a randomized clinical trial of an Internet-based manualized intervention to teach individuals with traumatic brain injury to manage their fatigue. Setting: Community dwelling. Participants: Forty-one participants randomized to Maximizing Energy (MAX) intervention group (n = 20) and Health Education group (n = 21). Intervention: The experimental group (MAX intervention) received an 8-week program that combined education and Problem-Solving Therapy to teach individuals to manage fatigue-related problems. The attention control group received health education. Measures: Primary outcome measures pertained to the feasibility of conducting the trial. Secondary outcomes were fatigue impact and fatigue severity assessed at baseline and postintervention. Results: Of the 65 participants referred, 41 were enrolled (63% recruitment rate), of which 3 withdrew (92% retention rate). Participants in the experimental and control groups completed their homework 75% and 85% of the time, respectively, and were equally engaged in the sessions. Participants in the experimental group were able to learn and implement the MAX intervention steps. Effect sizes for all measures ranged from small (-0.17) to medium (-0.58) in favor of the intervention group. Conclusion: Findings from the study suggest that the MAX intervention is feasible to administer to individuals with post-traumatic brain injury fatigue.	[Raina, Ketki D.; Chisholm, Denise; Leibold, Mary Lou] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, 5012 Forbes Tower, Pittsburgh, PA 15260 USA; [Shen, Jennifer] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Whyte, Ellen] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Morse, Jennifer Q.] Chatham Univ, Sch Hlth Sci, Dept Counseling Psychol, Pittsburgh, PA USA		Raina, KD (corresponding author), Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, 5012 Forbes Tower, Pittsburgh, PA 15260 USA.	kraina@pitt.edu			US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-10-1-0920]	The study was funded by the US Army Medical Research and Material Command (award no. W81XWH-10-1-0920).	Arciniegas DB, 2000, CURRENT TREATMENT OP, V2, P169; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Barker-Collo S., 2007, NZ MED J, V120, P1; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carpentino LJ, 1995, NURSING DIAGNOSIS AP; D'Zurilla T. J., 1997, MANUAL SOCIAL PROBLE; D'Zurilla T.J., 2007, PROBLEM SOLVING THER, V3rd ed.; D'Zurilla TJ, 1990, PROBLEM SOLVING THER; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Elovic EP, 2005, ISS CLIN COGN NEUROP, P89; Fellus J, 2007, BRAIN INJURY MED, P545; Finlayson M, 2005, NEUROREHABILITATION, V20, P267; Finlayson Marcia, 2007, Can J Occup Ther, V74, P337; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hegel MT, 2011, PSYCHO-ONCOLOGY, V20, P1092, DOI 10.1002/pon.1830; Hegel MT, 2004, FAM MED, V36, P204; Hicks E, 2007, COCHRANE DB SYST REV; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Lai JS, 2011, ARCH PHYS MED REHAB, V92, pS20, DOI 10.1016/j.apmr.2010.08.033; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; LEZAK MD, 1978, AM J PHYS MED REHAB, V57, P9; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Mathews MM, 2001, OCCUPATIONAL THERAPY, P978; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; MONTGOMERY GK, 1995, BRAIN INJURY, V9, P453, DOI 10.3109/02699059509008205; PACKER TL, 1995, 6 WEEK COURSE ENERGY; Rubenson Camilla, 2007, Scand J Occup Ther, V14, P205, DOI 10.1080/11038120601110934; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; TEASDALE G, 1974, LANCET, V2, P81; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	45	13	13	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2016	31	5					E41	E49		10.1097/HTR.0000000000000196			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX2ZY	WOS:000384243600005	26580691				2022-02-06	
J	Schneider, BL; Ghoddoussi, F; Charlton, JL; Kohler, RJ; Galloway, MP; Perrine, SA; Conti, AC				Schneider, Brandy L.; Ghoddoussi, Farhad; Charlton, Jennifer L.; Kohler, Robert J.; Galloway, Matthew P.; Perrine, Shane A.; Conti, Alana C.			Increased Cortical Gamma-Aminobutyric Acid Precedes Incomplete Extinction of Conditioned Fear and Increased Hippocampal Excitatory Tone in a Mouse Model of Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						fear conditioning; GABA; glutamate; post-traumatic stress disorder; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; MEDIAL PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; VENTRAL HIPPOCAMPUS; MEMORY RETRIEVAL; DENTATE GYRUS; RAT; NEURONS; DEFICITS; IMPAIRMENT	Mild traumatic brain injury (mTBI) contributes to development of affective disorders, including post-traumatic stress disorder (PTSD). Psychiatric symptoms typically emerge in a tardive fashion post-TBI, with negative effects on recovery. Patients with PTSD, as well as rodent models of PTSD, demonstrate structural and functional changes in brain regions mediating fear learning, including prefrontal cortex (PFC), amygdala (AMYG), and hippocampus (HC). These changes may reflect loss of top-down control by which PFC normally exhibits inhibitory influence over AMYG reactivity to fearful stimuli, with HC contribution. Considering the susceptibility of these regions to injury, we examined fear conditioning (FC) in the delayed post-injury period, using a mouse model of mTBI. Mice with mTBI displayed enhanced acquisition and delayed extinction of FC. Using proton magnetic resonance spectroscopy ex vivo, we examined PFC, AMYG, and HC levels of gamma-aminobutyric acid (GABA) and glutamate as surrogate measures of inhibitory and excitatory neurotransmission, respectively. Eight days post-injury, GABA was increased in PFC, with no significant changes in AMYG. In animals receiving FC and mTBI, glutamate trended toward an increase and the GABA/glutamate ratio decreased in ventral HC at 25 days post-injury, whereas GABA decreased and GABA/glutamate decreased in dorsal HC. These neurochemical changes are consistent with early TBI-induced PFC hypoactivation facilitating the fear learning circuit and exacerbating behavioral fear responses. The latent emergence of overall increased excitatory tone in the HC, despite distinct plasticity in dorsal and ventral HC fields, may be associated with disordered memory function, manifested as incomplete extinction and enhanced FC recall.	[Schneider, Brandy L.; Charlton, Jennifer L.; Conti, Alana C.] John D Dingell Vet Affairs Med Ctr, Res & Dev Serv, Detroit, MI USA; [Schneider, Brandy L.; Charlton, Jennifer L.; Conti, Alana C.] Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI USA; [Ghoddoussi, Farhad; Galloway, Matthew P.] Wayne State Univ, Sch Med, Dept Anesthesiol, Detroit, MI USA; [Kohler, Robert J.; Galloway, Matthew P.; Perrine, Shane A.] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI USA; [Ghoddoussi, Farhad] Wayne State Univ, Sch Med, Magnet Resonance Core, Detroit, MI USA		Conti, AC (corresponding author), John D Dingell VA Med Ctr, 4646 John R St 11R, Detroit, MI 48201 USA.	aconti@med.wayne.edu			Veterans AffairsUS Department of Veterans Affairs [I01RX001511] Funding Source: NIH RePORTER; RRD VA [I01 RX001511] Funding Source: Medline		Abela AR, 2013, CEREB CORTEX, V23, P1396, DOI 10.1093/cercor/bhs121; Beckonert O, 2010, NAT PROTOC, V5, P1019, DOI 10.1038/nprot.2010.45; Binder S, 2003, REPORT C MILD TRAUMA; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Chudasama Y, 2012, J NEUROSCI, V32, P10915, DOI 10.1523/JNEUROSCI.1463-12.2012; Conti AC, 1998, J NEUROSCI, V18, P5663; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Esmaeili B, 2013, NEUROPSYCHOPHARMACOL, V38, P1871, DOI 10.1038/npp.2013.64; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Faul M, 2010, TRAUMATIC BRAIN INJU; Franklin K., 2007, MOUSE BRAIN STEREOTA, VThird; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Ghoddoussi F, 2010, J NEUROL SCI, V290, P41, DOI 10.1016/j.jns.2009.11.013; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Higley MJ, 2014, NAT REV NEUROSCI, V15, P567, DOI 10.1038/nrn3803; Hobin JA, 2006, HIPPOCAMPUS, V16, P174, DOI 10.1002/hipo.20144; Hoffman A., 2015, IMMEDIATE PERSISTENT; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ishikawa A, 2006, J NEUROPHYSIOL, V96, P2134, DOI 10.1152/jn.00069.2006; Karl A, 2010, NEUROSCI BIOBEHAV R, V34, P7, DOI 10.1016/j.neubiorev.2009.06.008; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Knox D, 2012, NEUROSCIENCE, V223, P163, DOI 10.1016/j.neuroscience.2012.07.047; Knox D, 2010, NEUROSCI LETT, V480, P16, DOI 10.1016/j.neulet.2010.05.052; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kyd RJ, 2005, CEREB CORTEX, V15, P720, DOI 10.1093/cercor/bhh173; Lanteaume L, 2007, CEREB CORTEX, V17, P1307, DOI 10.1093/cercor/bhl041; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Maren S, 2000, BEHAV BRAIN RES, V110, P97, DOI 10.1016/S0166-4328(99)00188-6; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; Maroun M, 2013, EUR J NEUROSCI, V38, P2611, DOI 10.1111/ejn.12259; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Michels L, 2014, PSYCHIAT RES-NEUROIM, V224, P288, DOI 10.1016/j.pscychresns.2014.09.007; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Moench KM, 2015, NEUROSCI LETT, V601, P41, DOI 10.1016/j.neulet.2014.12.035; MOSER E, 1993, J NEUROSCI, V13, P3916; Norrholm SD, 2011, BIOL PSYCHIAT, V69, P556, DOI 10.1016/j.biopsych.2010.09.013; Orsini CA, 2011, J NEUROSCI, V31, P17269, DOI 10.1523/JNEUROSCI.4095-11.2011; Perrine SA, 2014, PROG NEURO-PSYCHOPH, V51, P9, DOI 10.1016/j.pnpbp.2013.11.003; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Radulovic J, 2010, REV NEUROSCIENCE, V21, P1; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Sierra-Mercado D, 2015, BRAIN RES, V1606, P133, DOI 10.1016/j.brainres.2015.02.031; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Stanley JA, 2000, BIOL PSYCHIAT, V48, P357, DOI 10.1016/S0006-3223(00)00949-5; Tang YP, 1997, J NEUROTRAUM, V14, P863, DOI 10.1089/neu.1997.14.863; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016	73	13	13	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2016	33	17					1614	1624		10.1089/neu.2015.4190			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DU6EH	WOS:000382306300007	26529240				2022-02-06	
J	Sepahvand, E; Jalali, R; Mirzaei, M; Ebrahimzadeh, F; Ahmadi, M; Amraii, E				Sepahvand, Elham; Jalali, Rostam; Mirzaei, Maryam; Ebrahimzadeh, Farzad; Ahmadi, Mahnaz; Amraii, Esmail			Glasgow Coma Scale Versus Full Outline of UnResponsiveness Scale for Prediction of Outcomes in Patients with Traumatic Brain Injury in the Intensive Care Unit	TURKISH NEUROSURGERY			English	Article						Traumatic brain injuries; coma; Full outline of unresponsiveness; Glasgow coma scale	4 SCORE; NEUROSURGICAL PATIENTS; VALIDATION; VERSION	AIM: Glasgow Coma Scale (GCS) is the most applied tool for classifying intensity of coma and predicting patient outcomes with traumatic brain injuries. The present study was conducted with the aim of comparing two criteria of Full Outline of UnResponsiveness (FOUR) scale and GCS in predicting prognosis in patients with traumatic brain injuries. MATERIAL and METHODS: In this prospective study, 198 patients with traumatic brain injuries were investigated. FOUR and GCS criteria for each patient were determined by four well-educated nurses. The area under receiver operating characteristic (ROC) curve was determined for in-hospital mortality outcomes. RESULTS: Of all patients, 65.2% survived and 34.8% died, and FOUR had correctly predicted 82% of them. FOUR had 0.76 sensitivity and GCS had a sensitivity 0.85. Mean scores for mortality and survival rates were 4.59 +/- 2.36 and 10.71 +/- 2.24 in GCS, and 3.15 +/- 3.52 and 12.77 +/- 2.43 in FOUR, respectively. The area under ROC curve was 0.961 for FOUR and 0.928 for GCS. The area under the curve was high for FOUR in scores 6 and 7, and for GCS in scores 5 and 6. CONCLUSION: FOUR score is a valuable, sensitive and specific diagnostic criterion for predicting outcomes in patients with traumatic brain injuries.	[Sepahvand, Elham] Univ Social Welf & Rehabil Sci, Nursing, Tehran, Iran; [Jalali, Rostam; Ahmadi, Mahnaz] Kermanshah Univ Med Sci, Dept Nursing, Kermanshah, Iran; [Mirzaei, Maryam] Jahrom Univ Med Sci, Dept Nursing, Jahrom, Iran; [Ebrahimzadeh, Farzad; Amraii, Esmail] Lorestan Univ Med Sci, Dept Paramed, Khorramabad, Iran		Sepahvand, E (corresponding author), Univ Social Welf & Rehabil Sci, Nursing, Tehran, Iran.	swt_f@farasa.org	Jalali, Rostam/V-5820-2017; sepahvand, elham/AAY-5107-2020	Jalali, Rostam/0000-0003-1781-9939; 			Akavipat P, 2011, ACTA MED OKAYAMA, V65, P205; Bruno MA, 2011, NEUROCRIT CARE, V15, P447, DOI 10.1007/s12028-011-9547-2; Chan MF, 2013, J NURS MANAGE, V21, P31, DOI 10.1111/j.1365-2834.2011.01344.x; Chen BX, 2013, ACTA NEUROCHIR, V155, P2133, DOI 10.1007/s00701-013-1854-2; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Fugate JE, 2010, NEUROCRIT CARE, V13, P205, DOI 10.1007/s12028-010-9407-5; Ghayeghran A, 2009, J GUILAN U MED SCI, V72, P70; Idrovo Freire L, 2012, INTERN EMERG MED, V7, P203; Idrovo L, 2010, EUR NEUROL, V63, P364, DOI 10.1159/000292498; Iyer VN, 2009, MAYO CLIN PROC, V84, P694, DOI 10.1016/S0025-6196(11)60519-3; Izadi Avanji F, 2010, J KASHAN U MED SCI, V14, P112; Jalali R, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/289803; Kevric J, 2011, EMERG MED J, V28, P486, DOI 10.1136/emj.2009.085845; Ledoux D, 2009, CRITICAL CARE, V13, P107; Marcati E, 2012, INTERN EMERG MED, V7, P145, DOI 10.1007/s11739-011-0583-x; Mercy SA, 2013, NURS MIDWIFERY RES J, V9, P63; Sacco S, 2010, EUR NEUROL, V63, P370, DOI 10.1159/000313952; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Tadrisi SD, 2012, IRAN J CRIT CARE NUR, V5, P95; Tindall S C, 1990, CLIN METHODS HIST PH, P371; Weiss N, 2012, J NEUROL, V259, P70, DOI 10.1007/s00415-011-6120-z	22	13	14	2	7	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	SEP	2016	26	5					720	724		10.5137/1019-5149.JTN.13536-14.0			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DY7VY	WOS:000385338600011	27476914	Bronze			2022-02-06	
J	Van Vleet, TM; DeGutis, JM; Merzenich, MM; Simpson, GV; Zomet, A; Dabit, S				Van Vleet, Thomas M.; DeGutis, Joseph M.; Merzenich, Michael M.; Simpson, Gregory V.; Zomet, Ativ; Dabit, Sawsan			Targeting alertness to improve cognition in older adults: A preliminary report of benefits in executive function and skill acquisition	CORTEX			English	Article						Aging; Attention; Training; Executive function; Learning	TRAUMATIC BRAIN-INJURY; AGE-RELATED-CHANGES; LOCUS-COERULEUS; VISUAL-ATTENTION; TRAINING INTERVENTIONS; SUSTAINED ATTENTION; INTRAINDIVIDUAL VARIABILITY; WORKING-MEMORY; TASK; PERFORMANCE	Efficient self-regulation of alertness declines with age exacerbating normal declines in performance across multiple cognitive domains, including learning and skill acquisition. Previous cognitive intervention studies have shown that it is possible to enhance alertness in patients with acquired brain injury and marked attention impairments, and that this benefit generalizes to improvements in more global cognitive functions. In the current preliminary studies, we sought to test whether this approach, that targets both tonic (over a period of minutes) and phasic (moment-to-moment) alertness, can improve key executive functioning declines in older adults, and enhance the rate of skill acquisition. The results of both Experiments 1 and 2 demonstrate that, compared to active control (AC) training, alertness training significantly enhanced performance in several validated executive function measures. In Experiment 2, alertness training significantly improved skill acquisition compared to AC training in a well-characterized speed of processing (SOP) task, with the largest benefits shown in the most challenging SOP blocks. The results of the current study suggest that targeting intrinsic alertness through cognitive training provides a novel approach to improve executive functions in older adults and may be a useful adjunct treatment to enhance benefits gained in other clinically validated treatments. (C) 2016 Elsevier Ltd. All rights reserved.	[Van Vleet, Thomas M.] VA Med Ctr, Dept Vet Affairs, Martinez, CA 94553 USA; [Van Vleet, Thomas M.; Merzenich, Michael M.; Simpson, Gregory V.; Zomet, Ativ; Dabit, Sawsan] Posit Sci, San Francisco, CA USA; [Merzenich, Michael M.] Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA USA; [Zomet, Ativ] Univ Calif Berkeley, Dept Vis Sci, Berkeley, CA 94720 USA; [DeGutis, Joseph M.] VA Med Ctr, Dept Vet Affairs, Boston, MA USA; [DeGutis, Joseph M.] Harvard Med Sch, Boston, MA USA		Van Vleet, TM (corresponding author), VA Med Ctr, Dept Vet Affairs, Martinez, CA 94553 USA.	tomvanvleet@gmail.com			National Institute on Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R43 AG039965]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R44AG039965, R43AG039965] Funding Source: NIH RePORTER	This research was funded by an award from the National Institute on Aging (NIA), R43 AG039965.	Acevedo A, 2007, J GERIATR PSYCH NEUR, V20, P239, DOI 10.1177/0891988707308808; Allison P, 2012, LOGISTIC REGRESSION; Anand R, 2011, INT J GERIATR PSYCH, V26, P961, DOI 10.1002/gps.2633; Andres P, 2006, NEUROPSYCHOLOGIA, V44, P2564, DOI 10.1016/j.neuropsychologia.2006.05.005; Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; ARNETT JA, 1995, PSYCHOL ASSESSMENT, V7, P220; Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Aston-Jones G, 2005, J COMP NEUROL, V493, P99, DOI 10.1002/cne.20723; Ball K, 1993, J Am Optom Assoc, V64, P71; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Ball K, 2007, J GERONTOL B-PSYCHOL, V62, P19, DOI 10.1093/geronb/62.special_issue_1.19; Ball K, 2010, J AM GERIATR SOC, V58, P2107, DOI 10.1111/j.1532-5415.2010.03138.x; BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berthier ML, 2009, ANN NEUROL, V65, P577, DOI 10.1002/ana.21597; Bherer L, 2005, PSYCHOL AGING, V20, P695, DOI 10.1037/0882-7974.20.4.695; Bherer L, 2008, EXP AGING RES, V34, P188, DOI 10.1080/03610730802070068; Burdick DJ, 2005, J GERONTOL A-BIOL, V60, P258, DOI 10.1093/gerona/60.2.258; Cahn-Weiner DA, 2000, CLIN NEUROPSYCHOL, V14, P187, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT187; Chan RCK, 2003, BRAIN INJURY, V17, P131, DOI 10.1080/0269905021000010168; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Cheyne JA, 2006, CONSCIOUS COGN, V15, P578, DOI 10.1016/j.concog.2005.11.009; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Conlon E, 2008, AGING NEUROPSYCHOL C, V15, P446, DOI 10.1080/13825580701878008; Coppin AK, 2006, AGE AGEING, V35, P619, DOI 10.1093/ageing/afl107; Craik F. I. M., 1982, AGING COGNITIVE PROC, P191, DOI [DOI 10.1007/978-1-4684-4178-9_11, 10.1007/978-1-4684-4178-9_11]; Craik FI., 1986, HUMAN MEMORY COGNITI, V5, P409; DeGutis JM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00060; Delis DC., 2001, DELIS KAPLAN EXECUTI; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Edwards JD, 2005, AGING MENT HEALTH, V9, P262, DOI 10.1080/13607860412331336788; Edwards JD, 2009, GERONTOLOGIST, V49, P485, DOI 10.1093/geront/gnp042; Elrod R, 1997, AM J PSYCHIAT, V154, P25; Esterman M., 2012, CEREBRAL CORTEX; Esterman M, 2015, NEUROIMAGE, V111, P542, DOI 10.1016/j.neuroimage.2015.01.044; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Festa-Martino E, 2004, NEUROPSYCHOLOGY, V18, P258, DOI 10.1037/0894-4105.18.2.258; Finke K, 2012, NEUROPSYCHOLOGIA, V50, P1178, DOI 10.1016/j.neuropsychologia.2012.02.008; Georgiou-Karistianis N, 2007, AGING NEUROPSYCHOL C, V14, P213, DOI 10.1080/13825580500320681; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; Hester R, 2005, MEM COGNITION, V33, P221, DOI 10.3758/BF03195311; Husain M, 2003, NAT REV NEUROSCI, V4, P26, DOI 10.1038/nrn1005; Jacoby N, 2013, PROG BRAIN RES, V207, P121, DOI 10.1016/B978-0-444-63327-9.00004-7; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jennings JM, 2007, AGING NEUROPSYCHOL C, V14, P353, DOI 10.1080/13825580600788837; Jones S, 2006, NEUROSCI BIOBEHAV R, V30, P864, DOI 10.1016/j.neubiorev.2006.06.012; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kliegel M, 2012, J APPL RES MEM COGN, V1, P58, DOI 10.1016/j.jarmac.2012.01.002; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Lahar CJ, 2001, AGING NEUROPSYCHOL C, V8, P149, DOI 10.1076/anec.8.2.149.842; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; MacDonald SWS, 2009, NEUROPSYCHOLOGIA, V47, P2299, DOI 10.1016/j.neuropsychologia.2009.01.016; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Manly T, 2005, NEUROPSYCHOLOGIA, V43, P1721, DOI 10.1016/j.neuropsychologia.2005.02.009; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Matthias E, 2010, J EXP PSYCHOL HUMAN, V36, P38, DOI 10.1037/a0017602; McAvinue LP, 2012, ATTEN PERCEPT PSYCHO, V74, P1570, DOI 10.3758/s13414-012-0352-6; McIntire A, 2006, EXP BRAIN RES, V174, P361, DOI 10.1007/s00221-006-0469-8; Milewski-Lopez A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00067; Molloy R, 1996, HUM FACTORS, V38, P311, DOI 10.1518/001872096779048093; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Nilsson LG, 2003, ACTA NEUROL SCAND, V107, P7, DOI 10.1034/j.1600-0404.107.s179.5.x; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; O'Connell RG, 2008, NEUROPSYCHOLOGIA, V46, P1379, DOI 10.1016/j.neuropsychologia.2007.12.018; OHalloran A. M., 2013, THE JOURNALS OF GERO; Owsley C, 2004, J AM GERIATR SOC, V52, P1901, DOI 10.1111/j.1532-5415.2004.52516.x; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Perona P., 2007, CALTECH 256 OBJECT C; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Posner MI, 2008, ANN NY ACAD SCI, V1129, P193, DOI 10.1196/annals.1417.011; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Rebok GW, 2014, J AM GERIATR SOC, V62, P16, DOI 10.1111/jgs.12607; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Ridderinkhof KR, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00267; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Robertson IH, 2014, NEUROBIOL AGING, V35, P1375, DOI 10.1016/j.neurobiolaging.2013.11.028; Robertson IH, 2013, NEUROBIOL AGING, V34, P298, DOI 10.1016/j.neurobiolaging.2012.05.019; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; Ross TP, 2006, CLIN NEUROPSYCHOL, V20, P414, DOI 10.1080/13854040590967153; Royall DR, 2004, J AM GERIATR SOC, V52, P346, DOI 10.1111/j.1532-5415.2004.52104.x; Ryan M, 2010, J INT NEUROPSYCH SOC, V16, P388, DOI 10.1017/S1355617709991305; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; Salthouse TA, 2003, ALZ DIS ASSOC DIS, V17, P162, DOI 10.1097/00002093-200307000-00008; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Salthouse T, 2012, ANNU REV PSYCHOL, V63, P201, DOI 10.1146/annurev-psych-120710-100328; Sara SJ, 2012, NEURON, V76, P130, DOI 10.1016/j.neuron.2012.09.011; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Schneider B. A., 2000, IMPLICATIONS OF PERC; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Semple RJ, 2010, MINDFULNESS, V1, P121, DOI [DOI 10.1007/S12671-010-0017-2, 10.1007/s12671-010-0017-2]; SHAPIRO KL, 1994, J EXP PSYCHOL HUMAN, V20, P357, DOI 10.1037/0096-1523.20.2.357; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smilek D, 2010, PSYCHOL SCI, V21, P786, DOI 10.1177/0956797610368063; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Strenziok M, 2014, NEUROIMAGE, V85, P1027, DOI 10.1016/j.neuroimage.2013.07.069; Sturm W, 1999, NEUROPSYCHOLOGIA, V37, P797, DOI 10.1016/S0028-3932(98)00141-9; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; Tang YY, 2009, TRENDS COGN SCI, V13, P222, DOI 10.1016/j.tics.2009.01.009; Thimm M, 2006, NEUROPSYCHOLOGIA, V44, P1230, DOI 10.1016/j.neuropsychologia.2005.09.008; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Treitz FH, 2007, AGING NEUROPSYCHOL C, V14, P370, DOI 10.1080/13825580600678442; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; Valenzuela M, 2011, AM J EPIDEMIOL, V173, P1004, DOI 10.1093/aje/kwq476; Van Breukelen GJP, 2006, J CLIN EPIDEMIOL, V59, P920, DOI 10.1016/j.jclinepi.2006.02.007; Van Vleet TM, 2006, J COGNITIVE NEUROSCI, V18, P1368, DOI 10.1162/jocn.2006.18.8.1368; Van Vleet TM, 2015, NEUROCASE, V21, P489, DOI 10.1080/13554794.2014.928329; Van Vleet TM, 2013, CORTEX, V49, P679, DOI 10.1016/j.cortex.2012.03.020; Van Vleet TM, 2011, NEUROPSYCHOLOGIA, V49, P352, DOI 10.1016/j.neuropsychologia.2010.11.021; Verhaeghen P, 2005, Q J EXP PSYCHOL-A, V58, P134, DOI 10.1080/02724980443000241; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Warm JS, 2008, HUM FACTORS, V50, P433, DOI 10.1518/001872008X312152; West R, 2002, J GERONTOL B-PSYCHOL, V57, pP3, DOI 10.1093/geronb/57.1.P3; Wigal SB, 2009, CNS DRUGS, V23, P21, DOI 10.2165/00023210-200923000-00004; Wolinsky F. D., 2013, RANDOMIZED CONTROLLE; Wolinsky FD, 2010, INT PSYCHOGERIATR, V22, P470, DOI 10.1017/S1041610209991281; Wolinsky FD, 2009, J GERONTOL B-PSYCHOL, V64, P577, DOI 10.1093/geronb/gbp061; Yakhno N N, 2007, Neurosci Behav Physiol, V37, P203, DOI 10.1007/s11055-007-0002-y; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Yoo SS, 2007, NAT NEUROSCI, V10, P385, DOI 10.1038/nn1851; Zacks R. T., 2000, HUMAN MEMORY; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	136	13	13	0	12	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	SEP	2016	82						100	118		10.1016/j.cortex.2016.05.015			19	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	DT5PT	WOS:000381535800009	27372902	Green Accepted			2022-02-06	
J	Yee, MK; Seichepine, DR; Janulewicz, PA; Sullivan, KA; Proctor, SP; Krengel, MH				Yee, Megan K.; Seichepine, Daniel R.; Janulewicz, Patricia A.; Sullivan, Kimberly A.; Proctor, Susan P.; Krengel, Maxine H.			Self-Reported Traumatic Brain Injury, Health and Rate of Chronic Multisymptom Illness in Veterans From the 1990-1991 Gulf War	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						chronic multisymptom illness; Gulf War; traumatic brain injury	QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; NEURON-SPECIFIC ENOLASE; US ARMY VETERANS; PSYCHIATRIC-DISORDERS; FOLLOW-UP; SERUM CONCENTRATIONS; BIOCHEMICAL MARKERS; CARE UTILIZATION; DAMAGE S-100B	Background: Traumatic brain injury (TBI) was not considered to be common in the 1990-1991 Gulf War (GW). Therefore, the relationship between TBI and chronic health symptoms experienced by GW veterans is unknown. Health symptoms reported by veterans deployed more recently to this region (Operations Enduring and Iraqi Freedom) are similar to those of GW veterans and have been primarily attributed to TBI. Objective: To examine the relationships among self-reported TBI, health symptoms, chronic multisymptom illness (CMI), and health-related quality of life among GW veterans. Participants: Participants included 1 274 GW veterans from the Devens Cohort Study, 156 of whom self-reported a history of TBI (12.2% of the sample). Design: Cross-sectional retrospective analysis of existing survey data. Main Measures: A 52-item health symptom checklist and the RAND 36-Item Health short Form Survey. Results: Self-reported TBI in GW Veterans is related to increased rates of health symptoms, CMI, and poorer health-related quality of life. Conclusions: Gulf War veterans' self-reported exposure to TBI is related to increased rates of chronic health symptoms and CMI, which interfere with everyday activities of daily living.	[Yee, Megan K.; Proctor, Susan P.] VA Boston Healthcare Syst, Res Serv, 150 S Huntington Ave,D12-87, Boston, MA 02130 USA; [Krengel, Maxine H.] VA Boston Healthcare Syst, Psychol Res, Boston, MA 02130 USA; [Yee, Megan K.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Seichepine, Daniel R.] Univ New Hampshire, Div Social Sci, Manchester, NH USA; [Janulewicz, Patricia A.; Sullivan, Kimberly A.; Proctor, Susan P.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Proctor, Susan P.] US Army, Environm Med Res Inst, Mil Performance Div, Natick, MA 01760 USA; [Krengel, Maxine H.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA		Yee, MK (corresponding author), VA Boston Healthcare Syst, Res Serv, 150 S Huntington Ave,D12-87, Boston, MA 02130 USA.	meganyee@bu.edu		Sullivan, Kimberly/0000-0001-7940-6123; Krengel, Maxine/0000-0001-7632-590X			[Anonymous], 2014, VA DOD CLIN PRACTICE; [Anonymous], 2009, J REHABIL RES DEV, V46, pCP1; Barrientos RM, 2006, NEUROBIOL AGING, V27, P723, DOI 10.1016/j.neurobiolaging.2005.03.010; Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P450, DOI 10.1016/j.bbi.2009.01.016; Chase RP, 2015, J HEAD TRAUMA REHAB, V30, pE57, DOI 10.1097/HTR.0000000000000061; Deb S, 1999, AM J PSYCHIAT, V156, P374; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; DUNN OJ, 1959, ANN MATH STAT, V30, P192, DOI 10.1214/aoms/1177706374; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Falvo MJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1124; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine, 2014, CHRON MULT ILLN GULF; Institute of Medicine, 2010, GULF WAR HLTH UPD HL; Ismail K, 2011, OCCUP MED-OXFORD, V61, P483, DOI 10.1093/occmed/kqr086; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Kang HK, 2009, J OCCUP ENVIRON MED, V51, P401, DOI 10.1097/JOM.0b013e3181a2feeb; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; Kelsall HL, 2009, AM J EPIDEMIOL, V170, P1048, DOI 10.1093/aje/kwp238; Khanna D, 2007, AM J MANAG CARE, V13, pS218; Kosinski M, 2000, ARTHRITIS RHEUM, V43, P1478, DOI 10.1002/1529-0131(200007)43:7<1478::AID-ANR10>3.0.CO;2-M; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Kraus JF, 2014, BRAIN INJURY, P1; Li B, 2011, AM J EPIDEMIOL, V174, P761, DOI 10.1093/aje/kwr154; MAIER SF, 1993, BRAIN RES, V623, P321, DOI 10.1016/0006-8993(93)91446-Y; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Ozakinci G, 2006, ENVIRON HEALTH PERSP, V114, P1553, DOI 10.1289/ehp.9251; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Proctor SP, 2001, MIL MED, V166, P510, DOI 10.1093/milmed/166.6.510; Proctor SP, 2001, J OCCUP ENVIRON MED, V43, P259, DOI 10.1097/00043764-200103000-00014; Proctor SP, 1998, INT J EPIDEMIOL, V27, P1000, DOI 10.1093/ije/27.6.1000; Proctor SP, 2006, NEUROTOXICOLOGY, V27, P931, DOI 10.1016/j.neuro.2006.08.001; Report to Congress on Mild Traumatic Brain Injury in the United States, 2003, REP C MILD TRAUM BRA; Research Advisory Committee on Gulf War Veterans Illnesses, 2013, GULF WAR ILLN HLTH G; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Salamon R, 2006, INT J EPIDEMIOL, V35, P479, DOI 10.1093/ije/dyi318; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Singh JA, 2005, J AM GERIATR SOC, V53, P108, DOI 10.1111/j.1532-5415.2005.53020.x; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Smith BN, 2013, J OCCUP ENVIRON MED, V55, P116, DOI 10.1097/JOM.0b013e318270d709; Smith TC, 2014, AM J EPIDEMIOL, V180, P1176, DOI 10.1093/aje/kwu240; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Ware J.E., 1994, SF 36 PHYS MENTAL SU; WARE JE, 1993, HLTH SURVEY MANUAL I; White RF, 2001, AM J IND MED, V40, P42, DOI 10.1002/ajim.1070; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wolfe J, 1999, PSYCHOSOM MED, V61, P532, DOI 10.1097/00006842-199907000-00018; Wolfe J, 1998, AM J IND MED, V33, P104, DOI 10.1002/(SICI)1097-0274(199802)33:2<104::AID-AJIM2>3.0.CO;2-Y; WOLFE J, 1993, J SOC ISSUES, V49, P15, DOI 10.1111/j.1540-4560.1993.tb01179.x; Wolfe J, 2002, J OCCUP ENVIRON MED, V44, P271, DOI 10.1097/00043764-200203000-00015	67	13	13	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2016	31	5					320	328		10.1097/HTR.0000000000000173			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX2ZY	WOS:000384243600010	26291628				2022-02-06	
J	Mountney, A; Boutte, AM; Gilsdorf, J; Lu, XC; Tortella, FC; Shear, DA				Mountney, Andrea; Boutte, Angela M.; Gilsdorf, Janice; Lu, Xi-Chun; Tortella, Frank C.; Shear, Deborah A.			Intravenous Administration of Simvastatin Improves Cognitive Outcome following Severe Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						antioxidants; behavioral assessments; biomarkers; penetrating ballistic-like brain injury; traumatic brain injury	FIBRILLARY ACIDIC PROTEIN; COA REDUCTASE INHIBITORS; NITRIC-OXIDE SYNTHASE; COMBINATION THERAPY; UP-REGULATION; ATORVASTATIN; INCREASE; STATINS; MODEL; NEUROINFLAMMATION	Simvastatin is a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor commonly used to reduce serum cholesterol. The beneficial effects of oral simvastatin have been reported in pre-clinical models of traumatic brain injury (TBI). The current study was designed to evaluate the potential beneficial effects of simvastatin in a model of severe penetrating TBI using an intravenous (IV) route of administration. Rats were subjected to unilateral frontal penetrating ballistic-like brain injury (PBBI), and simvastatin was delivered intravenously at 30 min and 6 h post-injury and continued once daily for either 4 or 10 days post-PBBI. Motor function was assessed on the rotarod and cognitive performance was evaluated using the Morris water maze (MWM) task. Serum levels of inflammatory cytokines and the astrocytic biomarker, glial fibrillary acidic protein (GFAP), were quantified at 1 h, 4 h, and 24 h post-injury. Histopathological damage was assessed at the terminal end-point. Rotarod testing revealed significant motor deficits in all injury groups but no significant simvastatin-induced therapeutic benefits. All PBBI-injured animals showed cognitive impairment on the MWM test; however, 10-day simvastatin treatment mitigated these effects. Animals showed significantly improved latency to platform and retention scores, whereas the 4-day treatment regimen failed to produce any significant improvements. Biomarker and cytokine analysis showed that IV simvastatin significantly reduced GFAP, interleukin (IL)-1 alpha, and IL-17 serum levels by 4.0-, 2.6-, and 7.0-fold, respectively, at 4 h post-injury. Collectively, our results demonstrate that IV simvastatin provides significant protection against injury-induced cognitive dysfunction and reduces TBI-specific biomarker levels. Further research is warranted to identify the optimal dose and therapeutic window for IV delivery of simvastatin in models of severe TBI.	[Mountney, Andrea; Boutte, Angela M.; Gilsdorf, Janice; Lu, Xi-Chun; Tortella, Frank C.; Shear, Deborah A.] Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		Mountney, A (corresponding author), Walter Reed Army Inst Res, Brain Trauma Neuroprotect Neurorestorat, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave,Room 2A40, Silver Spring, MD 20910 USA.	andrea.mountney.mil@mail.mil					Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; [Anonymous], 2015, J NEUROTRAUMA, V32, pA1; Balduini W, 2003, STROKE, V34, P2007, DOI 10.1161/01.STR.0000080677.24419.88; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Boutte A.M., 2015, J NEUROTRAUMA; Bulsara Ketan R, 2006, Neurosurg Focus, V21, pE11; Cha Hye Jin, 2016, NEUROSCI LETT, V619, P79; Chauhan NB, 2011, RESTOR NEUROL NEUROS, V29, P23, DOI 10.3233/RNN-2011-0573; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Deng-Bryant Y, 2015, RESTOR NEUROL NEUROS, V33, P189, DOI 10.3233/RNN-140455; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar A, 2012, BRAIN RES, V1471, P13, DOI 10.1016/j.brainres.2012.06.050; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Lee G, 2001, PHARMACOL REV, V53, P569; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROSURG, V101, P822, DOI 10.3171/jns.2004.101.5.0822; Lu XCM, 2009, J NEUROTRAUM, V26, P141, DOI 10.1089/neu.2008.0629; MAGNUSSON KR, 1993, BRAIN RES, V604, P334, DOI 10.1016/0006-8993(93)90386-2; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; Mahmood A, 2008, J NEUROTRAUM, V25, P1441, DOI 10.1089/neu.2007.0495; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Mountney A, 2013, J NEUROSCI METH, V212, P1, DOI 10.1016/j.jneumeth.2012.08.025; Nagasawa K, 2002, J PHARM SCI, V91, P2605, DOI 10.1002/jps.10246; Ogasawara A, 2009, DRUG METAB DISPOS, V37, P122, DOI 10.1124/dmd.108.022574; Petzold A, 2015, BRAIN RES, V1600, P17, DOI 10.1016/j.brainres.2014.12.027; Qu CS, 2005, J NEUROSURG, V103, P695, DOI 10.3171/jns.2005.103.4.0695; Vaughan CJ, 2003, AM J CARDIOL, V91, p23B, DOI 10.1016/S0002-9149(02)03270-8; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369	39	13	14	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2016	33	16					1492	+		10.1089/neu.2015.4139			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DU6ED	WOS:000382305900003	26542887				2022-02-06	
J	Wang, YQ; Wang, DF; Zhang, LZ; Ye, FY; Li, MM; Wen, K				Wang, Yuqing; Wang, Dongfei; Zhang, Lizhi; Ye, Fangyu; Li, Mengmeng; Wen, Ke			Role of JAK-STAT pathway in reducing cardiomyocytes hypoxia/reoxygenation injury induced by S1P postconditioning	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						H9c2; S1P; JAK-STAT pathway; AG490; Stattic	ISCHEMIA-REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; APOPTOSIS; DYSFUNCTION; PROTECTION; CALCIUM; CELLS; DEATH; CARDIOPROTECTION; MITOCHONDRIA	This experiment was designed to explore the protection of sphingosine1-phosphate (S1P) post conditioning on rat myocardial cells injured by hypoxia/reoxygenation acting via the Janus kinase-signal transducer and activator of transcription (JAK-STAT) signal pathway. The data showed that S1P could significantly increase cell viability, lower the rate of apoptosis, decrease the content of lactate dehydrogenase (LDH) and caspase3 activity in the culture medium, increase the activity of total superoxide dismutase (T-SOD) and manganese superoxide dismutase (Mn-SOD), reduce the loss of mitochondrial membrane potential and the fluorescence intensity of intracellular calcium, as well as increase the phosphorylation of JAK2 and STAT3 in comparison with the H/R group. When the JAK inhibitor AG490 or the STAT inhibitor stattic were added, the effects of S1P were inhibited. Our date shows that S1P protects H9c2 cells from hypoxia/reoxygenation injury and that the protection by S1P was inhibited by AG490 and stattic. Therefore S1P protects H9c2 cells against hypoxia/reoxygenation injury via the JAK-STAT pathway. (C) 2016 Elsevier B.V. All rights reserved.	[Wang, Yuqing; Wang, Dongfei; Li, Mengmeng; Wen, Ke] Tianjin Med Univ, Dept Pharmacol, Tianjin 300070, Peoples R China; [Zhang, Lizhi] Tianjin First Ctr Hosp, Dept Obstet & Gynecol, Tianjin 300192, Peoples R China; [Ye, Fangyu] Beijing Univ Chem Technol, Coll Mat Sci & Engn, Beijing 100029, Peoples R China		Wen, K (corresponding author), Tianjin Med Univ, Dept Pharmacol, Tianjin 300070, Peoples R China.	wenke@tijmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81173058, 81502419]; National Natural Science Foundation of Tianjin [10JCZDJC20900]	The authors declare no conflict of interest. This work was supported by grants from the National Natural Science Foundation of China (Nos. 81173058 and 81502419) and National Natural Science Foundation of Tianjin (No. 10JCZDJC20900).	Boengler K, 2008, CIRC RES, V102, P131, DOI 10.1161/CIRCRESAHA.107.164699; Booz GW, 2002, J MOL CELL CARDIOL, V34, P1443, DOI 10.1006/jmcc.2002.2076; Brulhart-Meynet MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119664; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Crisostomo PR, 2006, J AM COLL SURGEONS, V202, P797, DOI 10.1016/j.jamcollsurg.2005.12.002; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Das A, 2012, J MOL CELL CARDIOL, V53, P858, DOI 10.1016/j.yjmcc.2012.09.007; Dhanasekaran A, 2008, AM J PHYSIOL-HEART C, V294, pH724, DOI 10.1152/ajpheart.00979.2007; Dhar-Mascareno M, 2005, FREE RADICAL BIO MED, V38, P1311, DOI 10.1016/j.freeradbiomed.2005.01.017; Ding J, 2010, MOL CELL NEUROSCI, V43, P201, DOI 10.1016/j.mcn.2009.11.001; Faiksen LW., 2001, LEUKEMIA, V15, P787; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Fiorillo C, 2006, CELL MOL LIFE SCI, V63, P3061, DOI 10.1007/s00018-006-6345-7; Fu WG, 2013, J SURG RES, V183, P876, DOI 10.1016/j.jss.2013.01.044; Gao L, 2011, BRIT J PHARMACOL, V162, P633, DOI 10.1111/j.1476-5381.2010.01071.x; Garcia R, 1998, J BIOMED SCI, V5, P79, DOI 10.1159/000025316; Goodman MD, 2008, AM J PHYSIOL-HEART C, V295, pH1649, DOI 10.1152/ajpheart.00692.2008; Gorina R, 2005, J NEUROCHEM, V92, P505, DOI 10.1111/j.1471-4159.2004.02878.x; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Gross ER, 2006, AM J PHYSIOL-HEART C, V291, pH827, DOI 10.1152/ajpheart.00003.2006; Hattori R, 2001, J MOL CELL CARDIOL, V33, P1929, DOI 10.1006/jmcc.2001.1456; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; He Miao, 2013, Chinese Pharmacological Bulletin, V29, P1369, DOI 10.3969/j.issn.1001-1978.2013.10.010; Heim MH, 1999, J RECEPT SIGNAL TR R, V19, P75, DOI 10.3109/10799899909036638; Hou Q, 2005, AM J PHYSIOL-HEART C, V289, pH477, DOI 10.1152/ajpheart.00879.2004; IGARASHI K, 1994, J BIOL CHEM, V269, P14333; JOLLY SR, 1984, CIRC RES, V54, P277, DOI 10.1161/01.RES.54.3.277; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Li YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048115; Liu W, 2014, TOXICOL LETT, V224, P1, DOI 10.1016/j.toxlet.2013.10.009; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Ma SH, 2015, CELL CALCIUM, V58, P286, DOI 10.1016/j.ceca.2015.06.006; Mascareno E, 2001, CIRCULATION, V104, P325, DOI 10.1161/01.CIR.104.3.325; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; NICHOLLS DG, 1985, PROG BRAIN RES, V63, P97; Podewski EK, 2003, CIRCULATION, V107, P798, DOI 10.1161/01.CIR.0000057545.82749.FF; Qin J, 2014, Drug Res (Stuttg), V64, P47, DOI 10.1055/s-0033-1349101; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Somers SJ, 2012, CARDIOVASC DRUG THER, V26, P227, DOI 10.1007/s10557-012-6376-2; Sun GB, 2012, TOXICOL APPL PHARM, V265, P229, DOI 10.1016/j.taap.2012.10.002; Wang TT, 2013, FREE RADICAL BIO MED, V63, P291, DOI 10.1016/j.freeradbiomed.2013.05.043; Wang Y, 2015, ADV DIFFER EQU-NY, DOI 10.1186/s13662-015-0358-1; Wen SH, 2012, SHOCK, V38, P411, DOI 10.1097/SHK.0b013e3182662266; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Williamson CL, 2008, AM J PHYSIOL-HEART C, V294, pH249, DOI 10.1152/ajpheart.00775.2007; Woo AYH, 2008, J PHARMACOL EXP THER, V325, P226, DOI 10.1124/jpet.107.133918; Woo AYH, 2005, CARDIOVASC RES, V65, P244, DOI 10.1016/j.cardiores.2004.09.027; Xu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024036; Xuan YT, 2001, P NATL ACAD SCI USA, V98, P9050, DOI 10.1073/pnas.161283798; Yang NS, 2008, NEPHROL DIAL TRANSPL, V23, P91, DOI 10.1093/ndt/gfm509; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; Zheng X., 2014, J NANOMATER, V2014, P1, DOI DOI 10.1155/2014/751907	55	13	14	2	21	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	AUG 5	2016	784						129	136		10.1016/j.ejphar.2016.05.024			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DR1GI	WOS:000379653600014	27215146				2022-02-06	
J	Damiano, DL; Zampieri, C; Ge, J; Acevedo, A; Dsurney, J				Damiano, Diane L.; Zampieri, Cristiane; Ge, Jie; Acevedo, Ana; Dsurney, John			Effects of a rapid-resisted elliptical training program on motor, cognitive and neurobehavioral functioning in adults with chronic traumatic brain injury	EXPERIMENTAL BRAIN RESEARCH			English	Article						Coordination; Motion; Cognition; TBI; Exercise	OLDER-ADULTS; PHYSICAL-THERAPY; EXERCISE; BALANCE; INDIVIDUALS; WALKING; IMPAIRMENT; BENEFITS; MOBILITY; DEFICITS	This small clinical trial utilized a novel rehabilitation strategy, rapid-resisted elliptical training, in an effort to increase motor, and thereby cognitive, processing speed in ambulatory individuals with traumatic brain injury (TBI). As an initial step, multimodal functional abilities were quantified and compared in 12 ambulatory adults with and 12 without TBI. After the baseline assessment, the group with TBI participated in an intensive 8-week daily exercise program using an elliptical trainer and was reassessed after completion and at an 8-week follow-up. The focus of training was on achieving a fast movement speed, and once the target was reached, resistance to motion was increased in small increments to increase intensity of muscle activation. Primary outcomes were: High-Level Mobility Assessment Tool (HiMAT), instrumented balance tests, dual-task (DT) performance and neurobehavioral questionnaires. The group with TBI had poorer movement excursion during balance tests and poorer dual-task (DT) performance. After training, balance reaction times improved and were correlated with gains in the HiMAT and DT. Sleep quality also improved and was correlated with improved depression and learning. This study illustrates how brain injury can affect multiple linked aspects of functioning and provides preliminary evidence that intensive rapid-resisted training has specific positive effects on dynamic balance and more generalized effects on sleep quality in TBI.	[Damiano, Diane L.; Zampieri, Cristiane] Dept Rehabil Med, Funct & Appl Biomech Sect, 10 Ctr Dr,Room 1-1468,MSC 1604, Bethesda, MD 20892 USA; [Ge, Jie] Univ Maryland, Sch Dent, 650 West Baltimore St, Baltimore, MD 21201 USA; [Acevedo, Ana] NIH, Dept Rehabil Med, Ctr Clin, 10 Ctr Dr,Room 1-1469,MSC 1604, Bethesda, MD 20892 USA; [Dsurney, John] NIH, Dept Rehabil Med, CNRM, Ctr Clin, 10 Ctr Dr,Room 1-1468,MSC 1604, Bethesda, MD 20892 USA		Damiano, DL (corresponding author), Dept Rehabil Med, Funct & Appl Biomech Sect, 10 Ctr Dr,Room 1-1468,MSC 1604, Bethesda, MD 20892 USA.	damianod@cc.nih.gov; zampierigallac@cc.nih.gov; jie.ge@umaryland.edu; acevedoat@cc.nih.gov; john.dsurney@nih.gov			Intramural Research Program of the National Institutes of Health, Clinical Center, Rehabilitation Medicine Department [10-CC-0150]; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; CLINICAL CENTER [ZIACL060077] Funding Source: NIH RePORTER	This research was supported by the Intramural Research Program of the National Institutes of Health, Clinical Center, Rehabilitation Medicine Department (Protocol #10-CC-0150), and by the Center for Neuroscience and Regenerative Medicine.	Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bisson E, 2007, CYBERPSYCHOL BEHAV, V10, P16, DOI 10.1089/cpb.2006.9997; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Buster T, 2013, J NEUROL PHYS THER, V37, P176, DOI 10.1097/NPT.0000000000000022; Carruthers K, 2014, TRANSL NEUROSCI, V5, P227, DOI 10.2478/s13380-014-0233-7; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Cooney GM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub6; Coronado Victor G, 2010, TRAUMATIC BRAIN INJU; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Evans JJ, 2009, J INT NEUROPSYCH SOC, V15, P112, DOI 10.1017/S1355617708090152; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Hellweg S, 2008, BRAIN INJURY, V22, P365, DOI 10.1080/02699050801998250; Ingriselli JM, 2013, J SCI MED SPORT, V28, pS1440; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Katz-Leurer M, 2009, CLIN REHABIL, V23, P714, DOI 10.1177/0269215509335293; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; McNamara A, 2007, NEUROIMAGE, V35, P1211, DOI 10.1016/j.neuroimage.2007.01.009; Newman Caren L, 2007, Int J Emerg Ment Health, V9, P133; Peters DM, 2014, ARCH PHYS MED REHAB, V95, P1454, DOI 10.1016/j.apmr.2014.04.006; Silsupadol P, 2009, ARCH PHYS MED REHAB, V90, P381, DOI 10.1016/j.apmr.2008.09.559; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Tanaka K, 2009, BRAIN COGNITION, V69, P435, DOI 10.1016/j.bandc.2008.09.008; Ustinova KI, 2015, PHYSIOTHER THEOR PR, V31, P1, DOI 10.3109/09593985.2014.945674; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009	34	13	13	4	29	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	AUG	2016	234	8					2245	2252		10.1007/s00221-016-4630-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DQ5RK	WOS:000379262400013	27025506	Green Accepted			2022-02-06	
J	Hanks, RA; Rapport, LJ; Perrine, BW; Millis, SR				Hanks, Robin A.; Rapport, Lisa J.; Perrine, Brigid Waldron; Millis, Scott R.			Correlates of Resilience in the First 5 Years After Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; resilience; psychosocial; positive psychology	SPINAL-CORD-INJURY; STRESSFUL LIFE EVENTS; SCALE CD-RISC; NEGATIVE AFFECT; REHABILITATION; PERSONALITY; ADULTS; TRAJECTORIES; PREDICTORS; DISTRESS	Purpose/Objective: To examine resilience in the context of adjustment to traumatic brain injury (TBI), including the relative roles of demographic and theoretically related constructs such as coping, social support, and positive affectivity on resilience within the first 5 years postinjury. Research Method/Design: This was a cross-sectional, observational study of 67 persons with medically documented mild complicated to severe TBI. Participants completed a battery of measures including cognitive tests; questionnaires assessing self-report of emotional symptoms, perceived social support, and coping style; and a measure of resilience. Results: Approximately 60% of the sample endorsed moderate to high levels of resilience during the first 5 years postinjury. Brain injury severity, premorbid intelligence, and cognitive flexibility did not predict resilience, as measured by the Connor-Davidson Resilience Scale. By contrast, task-oriented coping and perceived social support were strong and unique covariates of resilience. Positive and negative affectivity were related to resilience but were not unique covariates of it in the presence of task-oriented coping and perceived social support. Discriminant validity of resilience as a concept and the means of assessing it was supported by findings that emotion-oriented and avoidance coping were not meaningfully related to resilience. Conclusions/Implications: Overall, the findings indicate that the majority of individuals in this sample reported high levels of resilience after brain injury and that correlates of resilience in adults with TBI is similar to that observed in adults without the history of cognitive impairment. Impact and Implications Although there has been a great deal of discussion about why people do well after brain injury during the postacute period of recovery after traumatic brain, there is a paucity of data on resilience in this population. This exploratory study is the first to examine the relationship between demographic, brain injury characteristics, and theoretically related constructs with regard to resilience after moderate to severe traumatic brain injury. The study lays the foundation for understanding resiliency in this rehabilitation population. In this report, there were high levels of resilience after brain injury, and the level of resilience in adults with TBI was similar to that in adults without cognitive impairment. In rehabilitation settings, assessment of resilience and development of positive coping strategies may be beneficial to recovery. Specifically, evaluation of scores on these measures may be useful in developing treatment plans to improve positive outcomes for persons with traumatic brain injury.	[Hanks, Robin A.; Perrine, Brigid Waldron; Millis, Scott R.] Wayne State Univ, Rehabil Inst Michigan, Dept Phys Med & Rehabil, Detroit, MI 48201 USA; [Rapport, Lisa J.] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA		Hanks, RA (corresponding author), Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, Suite 555,261 Mack Blvd, Detroit, MI 48201 USA.	rhanks@med.wayne.edu		Rapport, Lisa/0000-0001-8014-9523	U.S. Department of Education/National Institute on Disability and Rehabilitation Research Grant [H133G080064-10]	This research was supported by U.S. Department of Education/National Institute on Disability and Rehabilitation Research Grant H133G080064-10.	Beasley M, 2003, PERS INDIV DIFFER, V34, P77, DOI 10.1016/S0191-8869(02)00027-2; Bertisch H, 2014, NEUROREHABILITATION, V34, P573, DOI 10.3233/NRE-141059; Black R, 2015, J HEALTH PSYCHOL, V20, P1434, DOI 10.1177/1359105313512879; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Bonanno GA, 2012, SOC SCI MED, V74, P753, DOI 10.1016/j.socscimed.2011.11.022; Burns RA, 2010, PERS INDIV DIFFER, V48, P527, DOI 10.1016/j.paid.2009.11.026; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Catalano D, 2011, REHABIL PSYCHOL, V56, P200, DOI 10.1037/a0024571; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cutrona EC., 1987, ADV PERSONAL RELATIO, V1, P37, DOI DOI 10.1037/0882-7974.1.1.47; Daniels JK, 2012, J CLIN PSYCHIAT, V73, P327, DOI 10.4088/JCP.10m06293; Elisei S, 2013, PSYCHIAT DANUB, V25, pS263; ENDLER NS, 1990, J PERS SOC PSYCHOL, V58, P844, DOI 10.1037/0022-3514.58.5.844; Gilbert DT, 2004, PSYCHOL SCI, V15, P346, DOI 10.1111/j.0956-7976.2004.00681.x; Green KT, 2014, ADDICT BEHAV, V39, P406, DOI 10.1016/j.addbeh.2013.08.024; Hanks RA, 2004, DIFFERENTIAL DIAGNOSIS IN ADULT NEUROPSYCHOLOGICAL ASSESSMENT, P218; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hayter MR, 2014, SPINAL CORD, V52, P167, DOI 10.1038/sc.2013.152; Hjemdal O, 2012, SCAND J PSYCHOL, V53, P174, DOI 10.1111/j.1467-9450.2011.00928.x; JENNETT B, 1976, LANCET, V307, P1031; Jones TG, 2003, CLIN NEUROPSYCHOL, V17, P3, DOI 10.1076/clin.17.1.3.15626; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; KERCHER K, 1992, RES AGING, V14, P131, DOI 10.1177/0164027592142001; KOBASA SC, 1979, J PERS SOC PSYCHOL, V37, P1, DOI 10.1037/0022-3514.37.1.1; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lyons J.A., 1991, J TRAUMA STRESS, V4, P93, DOI [DOI 10.1007/BF00976011, 10.1002/jts.2490040108, DOI 10.1002/JTS.2490040108]; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McWilliams LA, 2003, J CLIN PSYCHOL, V59, P423, DOI 10.1002/jclp.10080; Monden KR, 2014, SPINAL CORD, V52, P197, DOI 10.1038/sc.2013.159; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Padesky CA, 2012, CLIN PSYCHOL PSYCHOT, V19, P283, DOI 10.1002/cpp.1795; Quale AJ, 2010, REHABIL PSYCHOL, V55, P12, DOI 10.1037/a0018415; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; Sells D, 2009, CHRONIC ILLN, V5, P92, DOI 10.1177/1742395309104166; Shin JI, 2012, ANN REHABIL MED-ARM, V36, P815, DOI 10.5535/arm.2012.36.6.815; Snyder CR, 2006, REHABIL PSYCHOL, V51, P89, DOI 10.1037/0090-5550.51.2.89; Stewart DE, 2011, PSYCHOSOMATICS, V52, P199, DOI 10.1016/j.psym.2011.01.036; The Psychological Corporation, 2001, WECHSLER TEST ADULT; Tonks J, 2011, BRAIN INJURY, V25, P870, DOI 10.3109/02699052.2011.581641; Waldron-Perrine B, 2011, REHABIL PSYCHOL, V56, P107, DOI 10.1037/a0023552; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; White JH, 2012, ANN FAM MED, V10, P435, DOI 10.1370/afm.1374; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Wingo AP, 2014, J PSYCHIATR RES, V51, P93, DOI 10.1016/j.jpsychires.2014.01.007; Wolfson, 1993, HALSTEAD REITAN NEUR; Wrenn GL, 2011, J NATL MED ASSOC, V103, P560, DOI 10.1016/S0027-9684(15)30381-3; Zannas AS, 2014, NEUROSCIENCE, V264, P157, DOI 10.1016/j.neuroscience.2013.12.003	51	13	14	0	27	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2016	61	3					269	276		10.1037/rep0000069			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	DV9HR	WOS:000383251900006	26855130				2022-02-06	
J	Jodoin, M; Rouleau, DM; Charlebois-Plante, C; Benoit, B; Leduc, S; Laflamme, GY; Gosselin, N; Larson-Dupuis, C; De Beaumont, L				Jodoin, Marianne; Rouleau, Dominique M.; Charlebois-Plante, Camille; Benoit, Benoit; Leduc, Stephane; Laflamme, G-Yves; Gosselin, Nadia; Larson-Dupuis, Camille; De Beaumont, Louis			Incidence rate of mild traumatic brain injury among patients who have suffered from an isolated limb fracture: Upper limb fracture patients are more at risk	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Mild traumatic brain injury; Orthopaedic monotrauma; Incidence rate	PERSISTENT SYMPTOMS; EPIDEMIOLOGY; CONCUSSION; DIAGNOSIS; RECOVERY; SPORTS	Objectives: This study compares the incidence rate of mild traumatic brain injury (mild TBI) detected at follow-up visits (retrospective diagnosis) in patients suffering from an isolated limb trauma, with the incidence rate held by the hospital records (prospective diagnosis) of the sampled cohort. This study also seeks to determine which types of fractures present with the highest incidence of mild TBI. Patients and methods: Retrospective assessment of mild TBI among orthopaedic monotrauma patients, randomly selected for participation in an Orthopaedic clinic of a Level I Trauma Hospital. Patients in the remission phase of a limb fracture were recruited between August 2014 and May 2015. No intervention was done (observational study). Main outcome measurements: Standardized semi-structured interviews were conducted with all patients to retrospectively assess for mild TBI at the time of the fracture. Emergency room related medical records of all patients were carefully analyzed to determine whether a prospective mild TBI diagnosis was made following the accident. Results: A total of 251 patients were recruited (54% females, Mean age = 49). Study interview revealed a 23.5% incidence rate of mild TBI compared to an incidence rate of 8.8% for prospective diagnosis (chi(2) = 78.47; p < 0.0001). Patients suffering from an upper limb monotrauma (29.6%; n = 42/142) are significantly more at risk of sustaining a mild TBI compared to lower limb fractures (15.6%; n = 17/109) (chi(2) = 6.70; p = 0.010). More specifically, patients with a proximal upper limb injury were significantly more at risk of sustaining concomitant mild TBI (40.6%; 26/64) compared to distal upper limb fractures (20.25%; 16/79) (chi(2) = 7.07; p = 0.008). Conclusions: Results suggest an important concomitance of mild TBI among orthopaedic trauma patients, the majority of which go undetected during acute care. Patients treated for an upper limb fracture are particularly at risk of sustaining concomitant mild TBI. (C) 2016 Elsevier Ltd. All rights reserved.	[Jodoin, Marianne; Gosselin, Nadia; Larson-Dupuis, Camille] Univ Montreal, Dept Psychol, Res Ctr Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada; [Jodoin, Marianne; Rouleau, Dominique M.; Benoit, Benoit; Leduc, Stephane; Laflamme, G-Yves; Gosselin, Nadia; Larson-Dupuis, Camille; De Beaumont, Louis] Montreal Sacred Heart Hosp, Res Ctr, Montreal, PQ, Canada; [De Beaumont, Louis] Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ, Canada; [Rouleau, Dominique M.; Charlebois-Plante, Camille; Benoit, Benoit; Leduc, Stephane; Laflamme, G-Yves] Univ Montreal, Dept Surg, Montreal, PQ, Canada		Rouleau, DM (corresponding author), 5400 Gouin Ouest,Suite C-2095, Montreal, PQ H4J 1C5, Canada.	dominique.rouleau@umontreal.ca			UQTR Research Chair on the Neurobiology of Mild Traumatic Brain Injury	UQTR Research Chair on the Neurobiology of Mild Traumatic Brain Injury awarded to LDB.	Andruszkow H, 2013, CLIN ORTHOP RELAT R, V471, P2899, DOI 10.1007/s11999-013-3031-6; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Court-Brown CM, 2011, OSTEOPOROSIS INT, V22, P1211, DOI 10.1007/s00198-010-1315-1; Court-Brown CM, 2012, INJURY, V43, P891, DOI 10.1016/j.injury.2011.12.007; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dhawan P, 2006, BCMJ, V9, P442; Ferree Steven, 2014, J Trauma Manag Outcomes, V8, P17, DOI 10.1186/1752-2897-8-17; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Foundation ON, 2013, GUID MILD TRAUM BRAI, P156; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mamaril Myrna Eileen, 2007, J Perianesth Nurs, V22, P184; Manara JR, 2015, J SHOULDER ELB SURG, V24, P823, DOI 10.1016/j.jse.2014.12.003; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Marshall S, 2012, CAN FAM PHYSICIAN, V58, pE128; Mkandawire NC, 2002, INJURY, V33, P111, DOI 10.1016/S0020-1383(01)00047-X; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Sobin L, 2015, JAMA FACIAL PLAST SU, P1; Stuart B, 2012, J EMERG NURS, V38, P435, DOI 10.1016/j.jen.2011.04.006; Uhl RL, 2013, J AM ACAD ORTHOP SUR, V21, P624, DOI 10.5435/JAAOS-21-10-624; Urquhart DM, 2006, ANZ J SURG, V76, P600, DOI 10.1111/j.1445-2197.2006.03785.x; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633	34	13	14	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	AUG	2016	47	8					1835	1840		10.1016/j.injury.2016.05.036			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	DS9GG	WOS:000381090300040	27291349				2022-02-06	
J	Lajunen, T				Lajunen, Timo			Barriers and facilitators of bicycle helmet use among children and their parents	TRANSPORTATION RESEARCH PART F-TRAFFIC PSYCHOLOGY AND BEHAVIOUR			English	Article						Bicycle helmet use; Barriers; Facilitators; Risk; School children; Adults	HEALTH BELIEF MODEL; HEAD-INJURY; ADOLESCENTS; ATTITUDES; RISK; LEGISLATION; TEENAGERS; EFFICACY; STUDENTS; BEHAVIOR	Despite the fact that bicycle helmet use protects against head injuries, helmet use rate is still low even in countries with high concern for traffic safety. Earlier research shows that helmet use declines with age and that helmet use is low especially among teenagers. The aim of the present study was to investigate barriers and facilitators of helmet use among primary and secondary school pupils and their parents. Identical surveys were conducted among school children (n = 235) and their parents (n =106). Children's and adults' responses concerning cycling, helmet use, helmet ownership, risk assessment and barriers and facilitators were compared and separate regression analyses conducted. Helmet use rate was lower among pupils than adults and they scored higher in most of the barrier items. The results of regression analyses showed that among children, age, gender, barriers and facilitators predicted helmet use while among adults only frequency of cycling and barriers were related to helmet use. Among children, the strongest correlates of not using a helmet were the belief of not needing a helmet and wish to use a cap or a hat instead. Having a helmet wearing as a habit and feeling safer were the strongest correlates of using helmet. Among adults, the strongest correlates of not using a helmet were "helmet looks ridiculous", "just going to short trip" and riding close to home while the strongest correlate of using a helmet was the habit of helmet use. It was concluded that targeting the barriers in helmet wearing campaigns might work better both among children and adults than emphasising the benefits at least among Norwegian child and adult cyclists. (C) 2015 Elsevier Ltd. All rights reserved.	[Lajunen, Timo] Norwegian Univ Sci & Technol NTNU, Dept Psychol, N-7491 Trondheim, Norway		Lajunen, T (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Psychol, N-7491 Trondheim, Norway.	timo.lajunen@svt.ntnu.no		Lajunen, Timo/0000-0001-5967-5254	Department of Psychology, Norwegian University for Science and Technology (NTNU)	I would like to thank Professors Tornbjorn Rundmo and Hermundur Sigmundsson for their most valuabe support for this study. This study was supported by Department of Psychology, Norwegian University for Science and Technology (NTNU). The study is part of COST Action TU1101 "Towards safer bicycling through optimization of bicycle helmets and usage".	Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Bambach MR, 2013, ACCIDENT ANAL PREV, V53, P78, DOI 10.1016/j.aap.2013.01.005; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Curnow WJ, 2003, ACCIDENT ANAL PREV, V35, P287, DOI 10.1016/S0001-4575(02)00012-X; Dellinger AM, 2010, J SAFETY RES, V41, P375, DOI 10.1016/j.jsr.2010.05.003; Elvik R, 2011, ACCIDENT ANAL PREV, V43, P1245, DOI 10.1016/j.aap.2011.01.007; Finnoff JT, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e4; Fishman E, 2012, TRANSPORT RES F-TRAF, V15, P686, DOI 10.1016/j.trf.2012.08.002; Forjuoh Samuel N, 2003, Med Sci Monit, V9, pCR436; Hagel BE, 2011, INJURY PREV, V17, P114, DOI 10.1136/ip.2010.029165; HOWLAND J, 1989, AM J DIS CHILD, V143, P741, DOI 10.1001/archpedi.1989.02150180123033; Klein KS, 2005, INJURY PREV, V11, P288, DOI 10.1136/ip.2004.007013; Lajunen T, 2004, J SAFETY RES, V35, P115, DOI 10.1016/j.jsr.2003.09.020; Lajunen T, 2001, J SAFETY RES, V32, P323, DOI 10.1016/S0022-4375(01)00056-1; Lang IA, 2007, INJURY PREV, V13, P355, DOI 10.1136/ip.2007.015941; Lastennet F, 2001, ARCH PEDIATRIE, V8, P1246; Lindsay G, 2011, AUST NZ J PUBL HEAL, V35, P54, DOI 10.1111/j.1753-6405.2010.00621.x; Loubeau PR, 2000, ACCIDENT ANAL PREV, V32, P111, DOI 10.1016/S0001-4575(99)00059-7; Muskaug R., 2009, RES BEH OBS 2008; O'Callaghan FV, 2006, J SAFETY RES, V37, P425, DOI 10.1016/j.jsr.2006.08.001; OECD, 2004, KEEP CHILDR SAF TRAF; OECD, 2014, OECD FACTB 2014 EC E; Page RM, 1996, AM J HEALTH BEHAV, V20, P33; Parkin PC, 2003, PEDIATRICS, V112, pE192, DOI 10.1542/peds.112.3.e192; Persaud N, 2012, CAN MED ASSOC J, V184, pE921, DOI 10.1503/cmaj.120988; Pierce SR, 2014, HEALTH PROMOT PRACT, V15, P406, DOI 10.1177/1524839913512329; Rezendes Jennifer L, 2006, J Pediatr Nurs, V21, P35, DOI 10.1016/j.pedn.2005.06.005; Robertson DW, 2014, ACCIDENT ANAL PREV, V70, P314, DOI 10.1016/j.aap.2014.04.011; Ross TP, 2010, J AM COLL HEALTH, V59, P29, DOI 10.1080/07448481.2010.483702; Schejbalova Z, 2013, NEURAL NETW WORLD, V23, P609, DOI 10.14311/NNW.2013.23.036; Secginli S., 2013, INT J INJURY CONTROL; Sinha CK, 2013, SURGERY UK, V31, P123; Sleet DA, 2010, ANNU REV PUBL HEALTH, V31, P195, DOI 10.1146/annurev.publhealth.012809.103616; STEVENSON T, 1992, HEALTH EDUC RES, V7, P555, DOI 10.1093/her/7.4.555; Thompson DC, 1999, COCHRANE DATABASE SY, V4; Towner P, 1992, Fam Med, V24, P156; Trygg Trafikk, 2014, SYKK; World Health Organisation, 2008, WORLD REPORT CHILD I	39	13	13	0	31	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1369-8478	1873-5517		TRANSPORT RES F-TRAF	Transp. Res. Pt. F-Traffic Psychol. Behav.	AUG	2016	41		B				294	301		10.1016/j.trf.2015.03.005			8	Psychology, Applied; Transportation	Social Science Citation Index (SSCI)	Psychology; Transportation	DU6TK	WOS:000382347300010					2022-02-06	
J	Mouilso, ER; Tuerk, PW; Schnurr, PP; Rauch, SAM				Mouilso, Emily R.; Tuerk, Peter W.; Schnurr, Paula P.; Rauch, Sheila A. M.			Addressing the Gender Gap: Prolonged Exposure for PTSD in Veterans	PSYCHOLOGICAL SERVICES			English	Article						effectiveness; female veterans; posttraumatic stress disorder; prolonged exposure therapy	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE PROCESSING THERAPY; TRAUMATIC BRAIN-INJURY; HEALTH-STATUS; SEXUAL TRAUMA; WOMEN; MILITARY; OUTCOMES; FEMALE; CARE	As the proportion of women serving in the United States military continues to increase, more female veterans are being treated for posttraumatic stress disorder (PTSD) in Department of Veterans Affairs (VA) health care settings. Prolonged Exposure (PE) therapy is an evidence-based treatment for PTSD and is often used in VA settings. However, only a few studies have investigated the effectiveness of PE specifically for female veterans with appropriate power. Results of these studies have varied, with similar effects between female and male veterans on par with civilian effects, and more recently, better outcomes for female veterans receiving PE compared with male veterans. The current study contextualizes the evidence from those studies and considers new data regarding clinical outcomes pre- and posttreatment for a large (N = 325) sample of male and female veterans treated with PE in a PTSD specialty clinic. Results indicate a large statistically significant decrease in PTSD as measured by PTSD Checklist (PCL) scores for both male and female veterans treated with PE (d = 1.33). No difference in effectiveness and no difference in treatment completion rates were found between male and female veterans. Our findings support the effectiveness of PE for the treatment of PTSD in female as well as male veterans. Results are compared and contrasted to previous findings in the literature taking into account heterogeneity in methodological and ecological factors among the studies. Emphasis is placed on context of care issues to further the empirical conversation regarding meeting the mental health needs of female veterans.	[Mouilso, Emily R.; Tuerk, Peter W.] Ralph H Johnson VA Med Ctr, Charleston, SC USA; [Mouilso, Emily R.; Tuerk, Peter W.] Med Univ South Carolina, Charleston, SC USA; [Schnurr, Paula P.] Natl Ctr PTSD, White River Jct, VT USA; [Schnurr, Paula P.] Geisel Sch Med Dartmouth, Hanover, NH USA; [Rauch, Sheila A. M.] Dept Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Rauch, Sheila A. M.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Mouilso, Emily R.] Charlie Norwood VA Med Ctr, Augusta, GA 30901 USA		Mouilso, ER (corresponding author), Charlie Norwood VA Med Ctr, Augusta, GA 30901 USA.	emilymouilso@gmail.com	Rauch, Sheila A.M./K-4450-2015		Department of Veteran Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences Research and Development	Dr. Peter W. Tuerk's contribution to this article was partially supported by a Career Development Award (CDA-2) from the Department of Veteran Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences Research and Development (PI: Peter W. Tuerk).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bean-Mayberry BA, 2003, J GEN INTERN MED, V18, P175, DOI 10.1046/j.1525-1497.2003.20512.x; BECKER BJ, 1988, BRIT J MATH STAT PSY, V41, P257, DOI 10.1111/j.2044-8317.1988.tb00901.x; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Department of Defense, 2013, 2013 DEM PROF MIL CO; Eftekhari A, 2013, JAMA PSYCHIAT, V70, P949, DOI 10.1001/jamapsychiatry.2013.36; Eisen SV, 2012, AM J PUBLIC HEALTH, V102, pS66, DOI 10.2105/AJPH.2011.300609; Feeny NC, 2009, DEPRESS ANXIETY, V26, P724, DOI 10.1002/da.20588; Foa E.B., 2007, PROLONGED EXPOSURE T; Frayne SM, 2006, J GEN INTERN MED, V21, pS40, DOI 10.1111/j.1525-1497.2006.00373.x; Goodson JT, 2013, J TRAUMA STRESS, V26, P419, DOI 10.1002/jts.21830; Gros DF, 2011, BEHAV THER, V42, P276, DOI 10.1016/j.beth.2010.07.005; Harned MS, 2012, BEHAV RES THER, V50, P381, DOI 10.1016/j.brat.2012.02.011; Himmelfarb N, 2006, J TRAUMA STRESS, V19, P837, DOI 10.1002/jts.20163; House H., 2003, J FAMILY SOCIAL WORK, V7, P15, DOI DOI 10.1300/J039V07N01_; Insightful Corporation, 2001, S PLUS 6 COMP SOFTW; Katz LS, 2014, J CONTEMP PSYCHOTHER, V44, P9, DOI 10.1007/s10879-013-9248-6; Kimerling R, 2007, AM J PUBLIC HEALTH, V97, P2160, DOI 10.2105/AJPH.2006.092999; Koola MM, 2013, J NERV MENT DIS, V201, P348, DOI 10.1097/NMD.0b013e318288e333; Kulka RA, 1990, TRAUMA VIETNAM WAR G; McLean CP, 2011, EXPERT REV NEUROTHER, V11, P1151, DOI [10.1586/ern.11.94, 10.1586/ERN.11.94]; Meyers LL, 2013, MIL MED, V178, P95, DOI 10.7205/MILMED-D-12-00302; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Nacasch N, 2007, CNS SPECTRUMS, V12, P690, DOI 10.1017/S1092852900021520; Nacasch N, 2011, J CLIN PSYCHIAT, V72, P1174, DOI 10.4088/JCP.09m05682blu; National Center for PTSD, 2014, US PTSD CHECKL DSM 4; National Center for Veterans Analysis and Statistics, 2011, AM WOM VET MIL SERV; Pereira A, 2002, MIL MED, V167, P23, DOI 10.1093/milmed/167.1.23; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Rauch SAM, 2009, J TRAUMA STRESS, V22, P60, DOI 10.1002/jts.20380; Sadler AG, 2004, J WOMENS HEALTH, V13, P799, DOI 10.1089/jwh.2004.13.799; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; SNIJDERS TAB, 1994, SOCIOL METHOD RES, V22, P342, DOI 10.1177/0049124194022003004; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Street AE, 2013, J GEN INTERN MED, V28, pS556, DOI 10.1007/s11606-013-2333-4; Thorp SR, 2012, AM J GERIAT PSYCHIAT, V20, P276, DOI 10.1097/JGP.0b013e3182435ee9; Tuerk PW, 2013, PSYCHOL SERV, V10, P401, DOI 10.1037/a0030549; Tuerk PW, 2011, J ANXIETY DISORD, V25, P397, DOI 10.1016/j.janxdis.2010.11.002; Tuerk PW, 2010, J TRAUMA STRESS, V23, P116, DOI 10.1002/jts.20494; Turchik JA, 2010, AGGRESS VIOLENT BEH, V15, P267, DOI 10.1016/j.avb.2010.01.005; United States Government Accountability Office, 2009, VA HLTH CAR PREL FIN; University of Colorado Denver, 2012, GLIMMPSE COMP SOFTW; US Department of Veterans Affairs, 2011, AM WOM VET MIL SERV; van Minnen A, 2002, BEHAV RES THER, V40, P439, DOI 10.1016/S0005-7967(01)00024-9; Weathers F.W., 1991, PTSD CHECKLIST MILIT; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f; Yano EM, 2006, WOMEN HEALTH ISS, V16, P226, DOI 10.1016/j.whi.2006.07.002; Yoder M, 2012, PSYCHOL SERV, V9, P16, DOI 10.1037/a0026279; Zatzick DF, 1997, MIL MED, V162, P661, DOI 10.1093/milmed/162.10.661; Zayfert C, 2002, J NERV MENT DIS, V190, P233, DOI 10.1097/00005053-200204000-00004	54	13	13	0	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	AUG	2016	13	3					308	316		10.1037/ser0000040			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	DV7HC	WOS:000383106000012	26121077				2022-02-06	
J	Sun, GZ; Gao, FF; Zhao, ZM; Sun, H; Xu, W; Wu, LW; He, YC				Sun, Guo-zhu; Gao, Fen-fei; Zhao, Zong-mao; Sun, Hai; Xu, Wei; Wu, Li-wei; He, Yong-chang			Endoplasmic reticulum stress-induced apoptosis in the penumbra aggravates secondary damage in rats with traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; endoplasmic reticulum stress; apoptosis; caspase-12; caspase-3; traumatic penumbra; traumatic brain injury; neural regeneration	CELL-DEATH; IN-VITRO; CASPASE-12; PATHWAY; ACTIVATION; INVOLVEMENT; INHIBITION; EXPRESSION; MANAGEMENT; CONTUSION	Neuronal apoptosis is mediated by intrinsic and extrinsic signaling pathways such as the membrane-mediated, mitochondrial, and endoplasmic reticulum stress pathways. Few studies have examined the endoplasmic reticulum-mediated apoptosis pathway in the penumbra after traumatic brain injury, and it remains unclear whether endoplasmic reticulum stress can activate the caspase-12-dependent apoptotic pathway in the traumatic penumbra. Here, we established rat models of fluid percussion-induced traumatic brain injury and found that protein expression of caspase-12, caspase-3 and the endoplasmic reticulum stress marker 78 kDa glucose-regulated protein increased in the traumatic penumbra 6 hours after injury and peaked at 24 hours. Furthermore, numbers of terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-positive cells in the traumatic penumbra also reached peak levels 24 hours after injury. These findings suggest that caspase-12-mediated endoplasmic reticulum-related apoptosis is activated in the traumatic penumbra, and may play an important role in the pathophysiology of secondary brain injury.	[Sun, Guo-zhu; Zhao, Zong-mao; Xu, Wei; Wu, Li-wei; He, Yong-chang] Hebei Med Univ, Dept Neurosurg, Hosp 2, Shijiazhuang, Hebei Province, Peoples R China; [Gao, Fen-fei] Shantou Univ, Coll Med, Dept Pharmacol, Shantou, Guangdong, Peoples R China; [Sun, Hai] St Josephs Hosp, Div Neurol Surg, Barrow Neurol Inst, Phoenix, AZ USA		Sun, GZ (corresponding author), Hebei Med Univ, Dept Neurosurg, Hosp 2, Shijiazhuang, Hebei Province, Peoples R China.	sungzh705@163.com	Gao, Fenfei/S-5331-2019	Gao, Fenfei/0000-0003-4144-8891	Natural Science Foundation of Hebei Province of ChinaNatural Science Foundation of Hebei Province [H2014206383]; Foundation for High-Level Personnel Projects in Hebei Province of China [A201401041]	This study was supported by the Natural Science Foundation of Hebei Province of China, No. H2014206383; and Foundation for High-Level Personnel Projects in Hebei Province of China, No. A201401041.	Ang BT, 2003, J NEUROSURG, V99, P125, DOI 10.3171/jns.2003.99.1.0125; Borkham-Kamphorst E, 2016, CELL SIGNAL, V28, P34, DOI 10.1016/j.cellsig.2015.10.013; Brewster JL, 2006, MOL CELL NEUROSCI, V32, P242, DOI 10.1016/j.mcn.2006.04.006; Chakrabarti S, 2016, AGING DIS, V7, P111, DOI 10.14336/AD.2016.0312; Chuang WL, 2016, MOLECULES, DOI [10.3390/mole-cules21040460, DOI 10.3390/MOLE-CULES21040460]; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; de la Cadena SC, 2014, APOPTOSIS, V19, P414, DOI 10.1007/s10495-013-0930-7; Han Y, 2015, NEUROSCI LETT, V585, P126, DOI 10.1016/j.neulet.2014.11.040; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Jin M, 2015, NEURAL REGEN RES, V10, P1830, DOI 10.4103/1673-5374.170313; Kabadi SV, 2014, NEURAL REGEN RES, V9, P1578, DOI 10.4103/1673-5374.141779; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larner SF, 2004, J NEUROCHEM, V88, P78, DOI 10.1046/j.1471-4159.2003.02141.x; Lee JY, 2014, J NEUROTRAUM, V31, P582, DOI 10.1089/neu.2013.3146; Li HF, 2015, NEURAL REGEN RES, V10, P467, DOI 10.4103/1673-5374.153698; Li L, 2016, NEURAL REGEN RES, V11, P326, DOI 10.4103/1673-5374.177742; Liu D, 2013, INT J NEUROSCI, V123, P155, DOI 10.3109/00207454.2012.746974; Liu H, 2014, WORLD J GASTROENTERO, V20, P18189, DOI 10.3748/wjg.v20.i48.18189; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Long J, 2013, NEURAL REGEN RES, V8, P1491, DOI 10.3969/j.issn.1673-5374.2013.16.006; Ma T, 2008, EUR SURG RES, V41, P219, DOI 10.1159/000135631; Martinez JA, 2010, APOPTOSIS, V15, P1480, DOI 10.1007/s10495-010-0526-4; Martinez-Pizarro A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150357; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Shah A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18929; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Stoffel M, 1997, ACT NEUR S, V70, P91; Stoffel M, 2002, NEUROSCI LETT, V324, P201, DOI 10.1016/S0304-3940(02)00196-9; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Wei XW, 2016, BRAIN RES BULL, V124, P123, DOI 10.1016/j.brainresbull.2016.04.005; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Zhang H, 2013, INT J CLIN EXP MED, V6, P546; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhao SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073665; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056	41	13	14	0	5	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	AUG	2016	11	8					1260	1266		10.4103/1673-5374.189190			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DX1RZ	WOS:000384146000021	27651773	gold, Green Published			2022-02-06	
J	Szczygielski, J; Gund, SM; Schwerdtfeger, K; Steudel, WI; Oertel, J				Szczygielski, Jacek; Gund, Sina-Maria; Schwerdtfeger, Karsten; Steudel, Wolf-Ingo; Oertel, Joachim			Factors Affecting Outcome in Treatment of Chronic Subdural Hematoma in ICU Patients: Impact of Anticoagulation	WORLD NEUROSURGERY			English	Article						Anticoagulation; Chronic subdural hematoma; Human; Intensive care; Risk factors	RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; BURR-HOLE TREPANATION; ANTITHROMBOTIC THERAPY; WARFARIN USE; CLINICAL ARTICLE; HEAD-INJURIES; RISK-FACTORS; METAANALYSIS; HEMORRHAGE	BACKGROUND: The use of anticoagulants and older age are the main risk factors for chronic subdural hematoma (CSDH). Because the age of the population and use of anticoagulants are increasing, a growing number of CSDH cases is expected. To address this issue, we analyzed the impact of anticoagulants on postsurgical outcome in patients in the intensive care unit (ICU). METHODS: Demographic data, coagulation parameters, surgical details, radiologic appearance of hematoma, Glasgow Coma Scale (GCS) score on admission, and Glasgow Outcome Scale (GOS) score on discharge were retrieved and retrospectively analyzed in 98 patients with CSDH treated in the neurosurgical ICU using correlation coefficient tests and multivariate analysis test. RESULTS: Overall outcome was good (GOS score 4 and 5) in 55.1% of patients. Overall mortality was 9.1%. There was a correlation between GCS score on admission and GOS score. There was no correlation between hematoma thickness/radiologic appearance and impaired coagulation. Disturbance in thrombocyte function (usually resulting from aspirin intake) correlated with improved outcome, whereas warfarin-related coagulopathy correlated with poor recovery. Nevertheless, patients with thrombocytopathy presented with better initial GCS scores. Neither hematoma size nor recurrence rate affected the outcome. CONCLUSIONS: The size of CSDH was not associated with poor outcome and is not necessarily determined by the use of anticoagulants. Coagulopathy does not rule out a good outcome, but the impact of anticoagulation on treatment results in CSDH varies between the main groups of drugs (warfarin vs. antiplatelet drugs). Patients in good neurologic condition on ICU admission have better chances of recovery.	[Szczygielski, Jacek] Univ Saarland, Med Ctr, Dept Neurosurg, Homburg, Saarland, Germany; Univ Saarland, Fac Med, Homburg, Saarland, Germany		Szczygielski, J (corresponding author), Univ Saarland, Med Ctr, Dept Neurosurg, Homburg, Saarland, Germany.	jacek.szczygielski@uks.eu	Szczygielski, Jacek/AAV-4791-2021; Oertel, Joachim/AAO-5012-2021	Szczygielski, Jacek/0000-0002-3157-2824; 			Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255; Amirjamshidi A, 2007, J CLIN NEUROSCI, V14, P1240, DOI 10.1016/j.jocn.2006.03.030; Andreotti F, 2015, EUR HEART J, V36, P3238, DOI 10.1093/eurheartj/ehv304; Aspegren OP, 2013, CLIN NEUROL NEUROSUR, V115, P981, DOI 10.1016/j.clineuro.2012.10.008; Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; Bellut D, 2012, WORLD NEUROSURG, V77, P111, DOI 10.1016/j.wneu.2011.05.036; Borger V, 2012, ACTA NEUROCHIR, V154, P1549, DOI 10.1007/s00701-012-1434-x; Chari A, 2015, J NEUROTRAUMA; Chari A, 2014, BRIT J NEUROSURG, V28, P2, DOI 10.3109/02688697.2013.812184; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Connolly BJ, 2014, STROKE, V45, P1672, DOI 10.1161/STROKEAHA.114.005430; Connolly BJ, 2013, J STROKE CEREBROVASC, V22, P444, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.007; Diamond T, 1988, Br J Neurosurg, V2, P351, DOI 10.3109/02688698809001006; Ducruet AF, 2012, NEUROSURG REV, V35, P155, DOI 10.1007/s10143-011-0349-y; Forster MT, 2010, J CLIN NEUROSCI, V17, P975, DOI 10.1016/j.jocn.2009.11.023; Gelabert-Gonzalez M, 2005, CLIN NEUROL NEUROSUR, V107, P223, DOI 10.1016/j.clineuro.2004.09.015; Gonugunta V, 2001, BRIT J NEUROSURG, V15, P514, DOI 10.1080/02688690120097822; Huang YH, 2011, NEUROCRIT CARE, V14, P253, DOI 10.1007/s12028-011-9509-8; Javadi A, 2011, WORLD NEUROSURG, V75, P731, DOI 10.1016/j.wneu.2010.11.042; Jukovic Mirela, 2014, Med Pregl, V67, P277; Kim Junhak, 2015, Korean J Neurotrauma, V11, P63, DOI 10.13004/kjnt.2015.11.2.63; KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Ledic Darko, 2014, Coll Antropol, V38, P1195; Lee JY, 2004, SURG NEUROL, V61, P523, DOI 10.1016/j.surneu.2003.10.026; Lega BC, 2010, J NEUROSURG, V113, P615, DOI 10.3171/2009.9.JNS08825; Leroy HA, 2015, J CLIN NEUROSCI, V22, P1895, DOI 10.1016/j.jocn.2015.03.064; Lindvall P, 2009, J CLIN NEUROSCI, V16, P1287, DOI 10.1016/j.jocn.2009.01.001; Liu WM, 2014, J NEUROSURG, V121, P665, DOI 10.3171/2014.5.JNS132715; Marshall AL, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0309-2; MATTLE H, 1989, J NEUROL NEUROSUR PS, V52, P829, DOI 10.1136/jnnp.52.7.829; Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298; Mondorf Y, 2009, BRIT J NEUROSURG, V23, P612, DOI 10.3109/02688690903370297; Mulligan P, 2013, J NEUROSCI RURAL PRA, V4, P250, DOI 10.4103/0976-3147.118760; Panczykowski DM, 2011, J NEUROSURG, V114, P47, DOI 10.3171/2010.7.JNS10446; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Ramachandran R, 2007, SURG NEUROL, V67, P367, DOI 10.1016/j.surneu.2006.07.022; Regan JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115085; REYMOND MA, 1992, NEUROSURG REV, V15, P21, DOI 10.1007/BF02352062; Rust T, 2006, J CLIN NEUROSCI, V13, P823, DOI 10.1016/j.jocn.2004.12.013; Santarius T, 2010, WORLD NEUROSURG, V73, P747, DOI 10.1016/j.wneu.2010.03.031; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Schwarz F, 2015, CLIN NEUROL NEUROSUR, V138, P66, DOI 10.1016/j.clineuro.2015.08.002; Secil Y, 2014, J STROKE CEREBROVASC, V23, P321, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.008; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; TANAKA A, 1992, NEUROSURGERY, V30, P370, DOI 10.1227/00006123-199203000-00010; Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17; Traynelis V C, 1991, Clin Geriatr Med, V7, P583; Unterhofer C, 2016, WORLD NEUROSURG, V92, P31, DOI 10.1016/j.wneu.2016.04.081; Van der Veken J, 2014, ACTA NEUROCHIR, V156, P981, DOI 10.1007/s00701-014-2042-8; Xu C, 2016, NEUROL MED-CHIR, V56, P62, DOI 10.2176/nmc.ra.2015-0013	51	13	14	2	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2016	92						426	433		10.1016/j.wneu.2016.05.049			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DX1XI	WOS:000384160300059	27241090				2022-02-06	
J	Hu, JZ; Lang, Y; Zhang, T; Ni, SF; Lu, HB				Hu, Jianzhong; Lang, Ye; Zhang, Tao; Ni, Shuangfei; Lu, Hongbin			LENTIVIRUS-MEDIATED PGC-1 alpha OVEREXPRESSION PROTECTS AGAINST TRAUMATIC SPINAL CORD INJURY IN RATS	NEUROSCIENCE			English	Article						PGC-1 alpha; spinal cord injury; lentivirus; neuronal apoptosis; axonal regeneration; RhoA-ROCK pathway	PARKINSONS-DISEASE; AXONAL REGENERATION; FUNCTIONAL RECOVERY; GENE-THERAPY; MOUSE MODEL; IN-VIVO; EXPRESSION; RHO; ACTIVATION; APOPTOSIS	Peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-alpha) is a crucial neuronal regulator in the brain. However, its role in the spinal cord and the underlying regulating mechanisms remain poorly understood. Our previous study demonstrated that PGC-1 alpha is significantly down-regulated following acute spinal cord injury (SCI) in rats. The current study aimed to explore the effects of PGC-1 alpha overexpression on the injured spinal cord by establishing a contusive SCI model in adult Sprague-Dawley rats, followed by immediate intraspinal injection of lentiviral vectors at rostral and caudal sites 3 mm from the lesion epicenter. Hindlimb motor function was monitored using the Basso-Beattie-Bresnahan Locomotor Rating Scale (BBB scores), and cords were collected. Transfection efficiency analysis showed that lentivirus successfully induced enhanced PGC-1 alpha expression. This resulted in attenuated apoptotic changes and a greater number of surviving spinal neurons, as determined by transmission electron microscopy and Nissl staining, respectively. Western blot and immunofluorescence analyses revealed increased growth-associated protein 43 and 5-hydroxytryptamine expression, two key markers of axonal regeneration. Importantly, BBB scores showed improved hindlimb motor functional recovery. Moreover, quantitative real-time polymerase chain reaction analysis demonstrated significantly inhibited RhoA, ROCK1, and ROCK2 mRNA expression, revealing a potential mechanism of PGC-1 alpha overexpression following traumatic SCI. Altogether, these results suggest that gene delivery of PGC-1 alpha exerts a significant neuroprotective effect following traumatic SCI, which could serve as a promising treatment for repair of the injured cord, and RhoA-ROCK pathway inhibition may partially underlie this neuroprotection. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Hu, Jianzhong; Lang, Ye; Ni, Shuangfei] Cent S Univ, Xiangya Hosp, Dept Spine Surg, Changsha 410008, Hunan, Peoples R China; [Zhang, Tao; Lu, Hongbin] Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China		Lu, HB (corresponding author), Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	hongbinlu@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171698, 81371956]; Specialized Research Fund for the Doctoral Program of Higher EducationSpecialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20130162110078]	This work was supported by grants from National Natural Science Foundation of China (Nos. 81171698 and 81371956), and from the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20130162110078).	Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Agrawal R, 2014, BBA-MOL BASIS DIS, V1842, P535, DOI 10.1016/j.bbadis.2013.12.004; Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; BALENTINE JD, 1978, LAB INVEST, V39, P236; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bo XN, 2011, CURR GENE THER, V11, P101, DOI 10.2174/156652311794940773; Chen CW, 2010, NEUROCHEM RES, V35, P1111, DOI 10.1007/s11064-010-0162-y; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Cho SR, 2009, CELL TRANSPLANT, V18, P1359, DOI 10.3727/096368909X475329; Conrad S, 2005, J COMP NEUROL, V487, P166, DOI 10.1002/cne.20561; David S, 2012, INT REV NEUROBIOL, V106, P127, DOI 10.1016/B978-0-12-407178-0.00006-5; Deroose CM, 2006, MOL THER, V14, P423, DOI 10.1016/j.ymthe.2006.05.007; Dougherty SE, 2014, NEUROSCIENCE, V271, P137, DOI 10.1016/j.neuroscience.2014.04.023; Duale H, 2005, EXP PHYSIOL, V90, P71, DOI 10.1113/expphysiol.2004.029173; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; Erschbamer MK, 2005, J COMP NEUROL, V484, P224, DOI 10.1002/cne.20471; Follenzi A, 2007, CURR GENE THER, V7, P306, DOI 10.2174/156652307782151515; Franz S, 2012, EXP NEUROL, V235, P62, DOI 10.1016/j.expneurol.2011.01.015; Henery S, 2008, APOPTOSIS, V13, P1054, DOI 10.1007/s10495-008-0227-4; Hu JZ, 2015, NEUROCHEM RES, V40, P1393, DOI 10.1007/s11064-015-1606-1; Ji XC, 2015, CELL MOL NEUROBIOL, V35, P881, DOI 10.1007/s10571-015-0182-x; Johri A, 2011, NEURODEGENER DIS, V8, P496, DOI 10.1159/000327910; Kang Xiaoning, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P463; Kantor B, 2014, ADV GENET, V87, P71, DOI 10.1016/B978-0-12-800149-3.00002-0; Kim JW, 2013, SPINE, V38, pE1065, DOI 10.1097/BRS.0b013e31829839fa; Koch JC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.191; Kotipatruni RR, 2011, NEUROCHEM RES, V36, P2063, DOI 10.1007/s11064-011-0530-2; Liang HY, 2011, MUSCLE NERVE, V44, P947, DOI 10.1002/mus.22217; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lou J, 1998, SPINAL CORD, V36, P683, DOI 10.1038/sj.sc.3100632; Madura T, 2004, EMBO REP, V5, P412, DOI 10.1038/sj.embor.7400117; Mudo G, 2012, CELL MOL LIFE SCI, V69, P1153, DOI 10.1007/s00018-011-0850-z; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Palfi S, 2014, LANCET, V383, P1138, DOI 10.1016/S0140-6736(13)61939-X; Qin WP, 2009, ARCH NEUROL-CHICAGO, V66, P352, DOI 10.1001/archneurol.2008.588; Saal KA, 2015, NEUROBIOL DIS, V73, P150, DOI 10.1016/j.nbd.2014.09.013; Song WJ, 2013, NEUROBIOL DIS, V51, P72, DOI 10.1016/j.nbd.2012.07.004; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; Thau N, 2012, J NEUROPATH EXP NEUR, V71, P1064, DOI 10.1097/NEN.0b013e318275df4b; Tsunemi T, 2012, PROG NEUROBIOL, V97, P142, DOI 10.1016/j.pneurobio.2011.10.004; Watzlawick R, 2014, JAMA NEUROL, V71, P91, DOI 10.1001/jamaneurol.2013.4684; Wei WJ, 2014, J HUAZHONG U SCI-MED, V34, P657, DOI 10.1007/s11596-014-1333-x; Witte ME, 2013, ACTA NEUROPATHOL, V125, P231, DOI 10.1007/s00401-012-1052-y; Wu BQ, 2013, CHINESE MED J-PEKING, V126, P3723, DOI 10.3760/cma.j.issn.0366-6999.20111068; Wu DS, 2009, MOL THER, V17, P2020, DOI 10.1038/mt.2009.168; Zolezzi JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064019	49	13	14	2	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUL 22	2016	328						40	49		10.1016/j.neuroscience.2016.04.031			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DM5JP	WOS:000376385100005	27132229				2022-02-06	
J	Pagulayan, KF; Temkin, NR; Machamer, JE; Dikmen, SS				Pagulayan, Kathleen F.; Temkin, Nancy R.; Machamer, Joan E.; Dikmen, Sureyya S.			Patterns of Alcohol Use after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						alcohol; traumatic brain	SPINAL-CORD-INJURY; SUBSTANCE-ABUSE; PSYCHIATRIC-DISORDERS; RANDOMIZED-TRIAL; HEAD-INJURY; FOLLOW-UP; DRUG-USE; AXIS-I; REHABILITATION; VALPROATE	Alcohol misuse and traumatic brain injury (TBI) frequently co-occur. The negative consequences of this interaction are well documented, but the patterns of long-term post-injury alcohol consumption are less clear. This study examined patterns of alcohol use among 170 adults with a history of complicated mild to severe TBI. Participants were recruited from a Level 1 Trauma Center at the time of their injury and completed evaluations at 1 month, 6 months, 12 months, and 3-5 years post-injury. Pre-injury alcohol use was also assessed at the time of the 1-month assessment. A modified Quantity-Frequency Index of alcohol consumption was then calculated for each time point. The results revealed high levels of pre-injury alcohol consumption, followed by a reduction in consumption at 1-month post-injury. A significant increase in consumption was noted by 6 months post-injury, followed by more gradual increases in alcohol consumption at 1 year. Post-injury alcohol consumption was comparable to the general public at 6 months, 12 months, and 3-5 years post-injury. These results suggest that the first 6 months post-injury may be the critical window of opportunity for alcohol intervention.	[Pagulayan, Kathleen F.] VA Puget Sound Mental Illness Res Educ & Clin Ctr, Seattle, WA USA; [Pagulayan, Kathleen F.; Dikmen, Sureyya S.] Univ Washington, Dept Psychiat & Behav Med, Seattle, WA 98195 USA; [Temkin, Nancy R.; Machamer, Joan E.; Dikmen, Sureyya S.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Temkin, Nancy R.; Dikmen, Sureyya S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA		Pagulayan, KF (corresponding author), VA Puget Sound Hlth Care Syst, 1660 S Columbian Way S-116-MIRECC, Seattle, WA 98108 USA.	farkat@u.washington.edu	Pagulayan, Kati/AAR-9225-2020		CSRD VA [IK2 CX000516] Funding Source: Medline; Veterans AffairsUS Department of Veterans Affairs [IK2CX000516] Funding Source: NIH RePORTER		American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Bishop Y.M., 1975, DISCRETE MULTIVARIAT; Bogner JA, 1997, J HEAD TRAUMA REHAB, V12, P57, DOI 10.1097/00001199-199710000-00006; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier CH, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P399, DOI 10.1037/10361-019; Bondi MW, 1998, J INT NEUROPSYCH SOC, V4, P319, DOI 10.1017/S1355617798003191; Calahan D, 1969, AM DRINKING PRACTICE; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Dunlop T W, 1991, J Neuropsychiatry Clin Neurosci, V3, P150; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; GRANT I, 1987, J CONSULT CLIN PSYCH, V55, P310, DOI 10.1037/0022-006X.55.3.310; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; National Center for Health Statistics, 1997, NAT HLTH INT SURV; National Institute on Alcohol Abuse and Alcoholism (NIAAA), 2007, HELP PAT WHO DRINK T; Sander AM, 2012, J HEAD TRAUMA REHAB, V27, P319, DOI 10.1097/HTR.0b013e318269838c; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Sullivan EV, 2000, NEUROPSYCHOLOGY, V14, P341, DOI 10.1037//0894-4105.14.3.341; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	41	13	13	2	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2016	33	14					1390	1396		10.1089/neu.2015.4071			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DQ5CX	WOS:000379223100011	26530335	Green Published			2022-02-06	
J	Widerstrom-Noga, E; Govind, V; Adcock, JP; Levin, BE; Maudsley, AA				Widerstrom-Noga, Eva; Govind, Varan; Adcock, James P.; Levin, Bonnie E.; Maudsley, Andrew A.			Subacute Pain after Traumatic Brain Injury Is Associated with Lower Insular N-Acetylaspartate Concentrations	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; central pain; MRI spectroscopy; N-acetylaspartate; traumatic brain injury	BECK DEPRESSION INVENTORY; CHRONIC BACK-PAIN; MAGNETIC-RESONANCE-SPECTROSCOPY; NEUROPATHIC PAIN; GRAY-MATTER; PSYCHOMETRIC PROPERTIES; WHITE-MATTER; CORTEX; ANXIETY; ABNORMALITIES	Persistent pain is experienced by more than 50% of persons who sustain a traumatic brain injury (TBI), and more than 30% experience significant pain as early as 6 weeks after injury. Although neuropathic pain is a common consequence after CNS injuries, little attention has been given to neuropathic pain symptoms after TBI. Magnetic resonance spectroscopy (MRS) studies in subjects with TBI show decreased brain concentrations of N-acetylaspartate (NAA), a marker of neuronal density and viability. Although decreased brain NAA has been associated with neuropathic pain associated with spinal cord injury (SCI) and diabetes, this relationship has not been examined after TBI. The primary purpose of this study was to test the hypothesis that lower NAA concentrations in brain areas involved in pain perception and modulation would be associated with greater severity of neuropathic pain symptoms. Participants with TBI underwent volumetric MRS, pain and psychosocial interviews. Cluster analysis of the Neuropathic Pain Symptom Inventory subscores resulted in two TBI subgroups: The Moderate Neuropathic Pain (n = 17; 37.8%), with significantly (p = 0.038) lower insular NAA than the Low or no Neuropathic Pain group (n = 28; 62.2%), or age-and sex-matched controls (n = 45; p < 0.001). A hierarchical linear regression analysis controlling for age, sex, and time post-TBI showed that pain severity was significantly (F = 11.0; p < 0.001) predicted by a combination of lower insular NAA/Creatine (p < 0.001), lower right insular gray matter fractional volume (p < 0.001), female sex (p = 0.005), and older age (p = 0.039). These findings suggest that neuronal dysfunction in brain areas involved in pain processing is associated with pain after TBI.	[Widerstrom-Noga, Eva; Adcock, James P.] Miami Project Cure Paralysis, Miami, FL USA; [Widerstrom-Noga, Eva] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Widerstrom-Noga, Eva] Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, Miami, FL 33136 USA; [Govind, Varan; Maudsley, Andrew A.] Univ Miami, Miller Sch Med, Dept Radiol, Miami, FL 33136 USA; [Levin, Bonnie E.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA		Widerstrom-Noga, E (corresponding author), Miami Project Cure Paralysis R48, 1095 NW 14th Terrace, Miami, FL 33136 USA.	EWiderstrom-Noga@med.miami.edu		Widerstrom-Noga, Eva/0000-0003-0208-3658; Maudsley, Andrew/0000-0001-7653-3063	NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01 EB016064] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS055107] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB016064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055107] Funding Source: NIH RePORTER		Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; As-Sanie S, 2012, PAIN, V153, P1006, DOI 10.1016/j.pain.2012.01.032; Baliki MN, 2009, J NEUROPHYSIOL, V101, P875, DOI 10.1152/jn.91100.2008; Baliki MN, 2006, J NEUROSCI, V26, P12165, DOI 10.1523/JNEUROSCI.3576-06.2006; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; BASBAUM AI, 1978, ANN NEUROL, V4, P451, DOI 10.1002/ana.410040511; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bittner DM, 2013, J ALZHEIMERS DIS, V36, P155, DOI 10.3233/JAD-120778; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; Brooks JCW, 2005, NEUROIMAGE, V27, P201, DOI 10.1016/j.neuroimage.2005.03.041; Burkey AR, 1999, J NEUROSCI, V19, P4169; Chang L, 1999, NEUROLOGY, V52, P100, DOI 10.1212/WNL.52.1.100; Chang LD, 2013, J NEUROIMMUNE PHARM, V8, P576, DOI 10.1007/s11481-013-9460-x; Clarke DE, 2007, INT J METH PSYCH RES, V16, P97, DOI 10.1002/mpr.207; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Davis KD, 2008, NEUROLOGY, V70, P153, DOI 10.1212/01.wnl.0000295509.30630.10; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; Dick BD, 2007, ANESTH ANALG, V104, P1223, DOI 10.1213/01.ane.0000263280.49786.f5; Folstein MF., 2010, MINIMENTAL STATE EXA; Fukui S, 2006, MAGN RESON IMAGING, V24, P75, DOI 10.1016/j.mri.2005.10.021; FYDRICH T, 1992, J ANXIETY DISORD, V6, P55, DOI 10.1016/0887-6185(92)90026-4; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Glodzik L, 2015, J ALZHEIMERS DIS, V43, P939, DOI 10.3233/JAD-140609; Gore M, 2012, SPINE, V37, pE668, DOI 10.1097/BRS.0b013e318241e5de; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Grachev ID, 2002, J NEURAL TRANSM, V109, P1309, DOI 10.1007/s00702-002-0722-7; Grachev ID, 2000, PAIN, V89, P7, DOI 10.1016/S0304-3959(00)00340-7; Gu T, 2008, NEUROL RES, V30, P229, DOI 10.1179/016164107X235473; Gustin SM, 2014, PAIN, V155, P1027, DOI 10.1016/j.pain.2014.02.008; Gustin SM, 2010, CEREB CORTEX, V20, P1409, DOI 10.1093/cercor/bhp205; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Henderson LA, 2008, NEUROIMAGE, V39, P1867, DOI 10.1016/j.neuroimage.2007.10.045; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Kashani JH, 1999, J AFFECT DISORDERS, V52, P269, DOI 10.1016/S0165-0327(98)00055-X; KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Levin BE, 2014, J NEUROIMAGING, V24, P39, DOI 10.1111/j.1552-6569.2012.00733.x; Li XY, 2010, SCIENCE, V330, P1400, DOI 10.1126/science.1191792; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lindsay WR, 2007, J APPL RES INTELLECT, V20, P401, DOI 10.1111/j.1468-3148.2007.00380.x; Lutz J, 2008, ARTHRITIS RHEUM-US, V58, P3960, DOI 10.1002/art.24070; Marin, 1996, Semin Clin Neuropsychiatry, V1, P304; Maudsley AA, 2006, NMR BIOMED, V19, P492, DOI 10.1002/nbm.1025; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Mazzola L, 2009, PAIN, V146, P99, DOI 10.1016/j.pain.2009.07.014; Mazzola L, 2012, BRAIN, V135, P631, DOI 10.1093/brain/awr265; Metz AE, 2009, P NATL ACAD SCI USA, V106, P2423, DOI 10.1073/pnas.0809897106; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mole TB, 2014, NEUROIMAGE-CLIN, V5, P28, DOI 10.1016/j.nicl.2014.05.014; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; [National Hospital Discharge Survey (NHDS) National Hospital Ambulatory Medical Care Survey (NHAMCS) National Vital Statistics System (NVSS)], 2010, ALL DAT SOURC AR MAI; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Ostrowsky K, 2002, CEREB CORTEX, V12, P376, DOI 10.1093/cercor/12.4.376; Park K, 2013, FUTUR NEUROL, V8, P555, DOI 10.2217/FNL.13.35; Pattany PM, 2002, AM J NEURORADIOL, V23, P901; Pleis John R, 2010, Vital Health Stat 10, P1; Qiu S, 2014, J NEUROSCI, V34, P13505, DOI 10.1523/JNEUROSCI.1431-14.2014; Rigotti DJ, 2012, NEUROLOGY, V78, P1383, DOI 10.1212/WNL.0b013e318253d609; ROBERTS MHT, 1991, SYMP PAIN R, P219; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Semchenko V V, 2006, Neurosci Behav Physiol, V36, P613, DOI 10.1007/s11055-006-0065-1; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Sorensen L, 2008, DIABETES CARE, V31, P980, DOI 10.2337/dc07-2088; Starr CJ, 2009, J NEUROSCI, V29, P2684, DOI 10.1523/JNEUROSCI.5173-08.2009; Steer, 1990, MANUAL BECK ANXIETY; Steer RA, 2001, PSYCHOL REP, V88, P1075, DOI 10.2466/PR0.88.4.1075-1076; Sullivan-Singh SJ, 2014, ARCH PHYS MED REHAB, V95, P1100, DOI 10.1016/j.apmr.2014.02.001; Tenovuo O, 2007, PAIN, V131, P241, DOI 10.1016/j.pain.2007.07.003; Tham SW, 2013, J PAIN, V14, P1242, DOI 10.1016/j.jpain.2013.05.007; Turk DC, 2003, PAIN, V106, P337, DOI 10.1016/j.pain.2003.08.001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Wang Y, 1998, MAGNET RESON MED, V39, P28, DOI 10.1002/mrm.1910390107; Widerstrom-Noga E, 2015, PAIN, V156, P166, DOI 10.1016/j.pain.0000000000000019; Widerstrom-Noga E, 2013, PAIN, V154, P204, DOI 10.1016/j.pain.2012.07.022; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512; Younger JW, 2010, PAIN, V149, P222, DOI 10.1016/j.pain.2010.01.006; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	100	13	15	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2016	33	14					1380	1389		10.1089/neu.2015.4098			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DQ5CX	WOS:000379223100010	26486760	Green Published			2022-02-06	
J	Cho, YE; Latour, LL; Kim, H; Turtzo, LC; Olivera, A; Livingston, WS; Wang, D; Martin, C; Lai, C; Cashion, A; Gill, J				Cho, Young-Eun; Latour, Lawrence L.; Kim, Hyungsuk; Turtzo, L. Christine; Olivera, Anlys; Livingston, Whitney S.; Wang, Dan; Martin, Christiana; Lai, Chen; Cashion, Ann; Gill, Jessica			Older Age Results in Differential Gene Expression after Mild Traumatic Brain Injury and Is Linked to Imaging Differences at Acute Follow-up	FRONTIERS IN AGING NEUROSCIENCE			English	Article						traumatic brain injury; aging; inflammation; gene expression; imaging	ACTIVATION; DISEASE; CELLS; TRANSCRIPTOME; INFLAMMATION; METAANALYSIS; MICROARRAY; PREDICTION; RECOVERY; CORTEX	Older age consistently relates to a lesser ability to fully recover from a traumatic brain injury (TBI); however, there is limited data to explicate the nature of age-related risks. This study was undertaken to determine the relationship of age on gene-activity following a TBI, and how this biomarker relates to changes in neuroimaging findings. A young group (between the ages of 19 and 35 years), and an old group (between the ages of 60 and 89 years) were compared on global gene-activity within 48 h following a TBI, and then at follow-up within 1-week. At each time-point, gene expression profiles, and imaging findings from both magnetic resonance imaging (MRI) and computed tomography were obtained and compared. The young group was found to have greater gene expression of inflammatory regulatory genes at 48 h and 1-week in genes such as basic leucine zipper transcription factor 2 (BACH2), leucine-rich repeat neuronal 3 (LRRN3), and lymphoid enhancer-binding factor 1 (LEF1) compared to the old group. In the old group, there was increased activity in genes within S100 family, including calcium binding protein P (S100P) and S100 calcium binding protein A8 (S100A8), which previous studies have linked to poor recovery from TBI. The old group also had reduced activity of the noggin (NOG) gene, which is a member of the transforming growth factorT supertamily and is linked to neurorecovery and neuroregeneration compared to the young group. We link these gene expression findings that were validated to neuroimaging, reporting that in the old group with a MRI finding of TBI-related damage, there was a lesser likelihood to then have a negative MRI finding at follow-up compared to the young group. Together, these data indicate that age impacts gene activity following a TBI, and suggest that this differential activity related to immune regulation and neurorecovery contributes to a lesser likelihood of neuronal recovery in older patients as indicated through neuroimaging.	[Cho, Young-Eun; Kim, Hyungsuk; Olivera, Anlys; Livingston, Whitney S.; Wang, Dan; Martin, Christiana; Lai, Chen; Cashion, Ann; Gill, Jessica] NINR, NIH, Bethesda, MD 20892 USA; [Latour, Lawrence L.; Turtzo, L. Christine] Natl Inst Neurol Disorders, NIH, Bethesda, MD USA		Cashion, A; Gill, J (corresponding author), NINR, NIH, Bethesda, MD 20892 USA.	ann.cashion@nih.gov; gillj@mail.nih.gov	Latour, Larry/AAH-5663-2021; Gill, Gill M/Q-2020-2017	Latour, Larry/0000-0001-6160-5263; Martin, Christiana/0000-0002-4484-6134	Intramural Research Program of National Institute of Nursing Research in NIH; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000030, ZIANR000015] Funding Source: NIH RePORTER	This research was supported by the Intramural Research Program of National Institute of Nursing Research in NIH. This research was also supported by the Center for Neuroscience and Regenerative Medicine.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Barr TL, 2011, BIOL RES NURS, V13, P140, DOI 10.1177/1099800410385671; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P627, DOI 10.1007/s004010000232; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Cao JN, 2010, AGING CELL, V9, P453, DOI 10.1111/j.1474-9726.2010.00569.x; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cekic M, 2010, NEUROTHERAPEUTICS, V7, P81, DOI 10.1016/j.nurt.2009.10.017; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Dummula K, 2011, J NEUROSCI, V31, P12068, DOI 10.1523/JNEUROSCI.0013-11.2011; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Ghorbani P, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-18; Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104; Gupta RK, 2016, MOL NEUROBIOL, V53, P3377, DOI 10.1007/s12035-015-9287-y; Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x; Heinzelmann M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00198; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hong MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003024; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lamprecht M.R., 2016, J NEUROTRAUM, DOI [10.1089/neu.2015.4.306, DOI 10.1089/NEU.2015.4.306]; Li P., 2013, IMMUNOLOGICAL MECH T, P9; Lu XCM, 2004, J NEUROSCI RES, V77, P843, DOI 10.1002/jnr.20218; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; Mellergard P, 2012, J NEUROTRAUM, V29, P112, DOI 10.1089/neu.2010.1732; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; [National Center for Injury Prevention and Control Centers for Disease Control and Prevention [CDC]], 2003, REP C MILD TRAUM BRA; Polychronakos C, 2011, NAT REV GENET, V12, P781, DOI 10.1038/nrg3069; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Remondini D, 2010, MOL BIOSYST, V6, P1983, DOI 10.1039/c004635c; Ritzel RM, 2015, NEUROBIOL AGING, V36, P2153, DOI 10.1016/j.neurobiolaging.2015.02.016; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Sabir M, 2015, BRAIN BEHAV IMMUN, V47, P118, DOI 10.1016/j.bbi.2014.12.023; Samanta J, 2010, STROKE, V41, P357, DOI 10.1161/STROKEAHA.109.565523; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Schwartz M, 2013, J NEUROSCI, V33, P17587, DOI 10.1523/JNEUROSCI.3241-13.2013; Sherer M, 2015, CLIN NEUROPSYCHOL, V29, P522, DOI 10.1080/13854046.2015.1052763; Staffa K, 2012, J NEUROTRAUM, V29, P2716, DOI 10.1089/neu.2011.2246; Stamova BS, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-49; TEASDALE G, 1974, LANCET, V2, P81; Tierney KJ, 2016, J NEUROSURG, V124, P538, DOI 10.3171/2015.4.JNS142440; Tweedie D, 2016, J NEUROSCI METH, V272, P4, DOI 10.1016/j.jneumeth.2016.02.003; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; White TE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2412-0; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yousef H, 2015, STEM CELLS, V33, P1577, DOI 10.1002/stem.1943; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zeevi N, 2010, J AM GERIATR SOC, V58, P1749, DOI 10.1111/j.1532-5415.2010.03011.x; Zhao W, 2013, J ALZHEIMERS DIS, V34, P417, DOI 10.3233/JAD-121894; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zimmer DB, 2005, CELL MOL BIOL, V51, P201, DOI 10.1170/T620	66	13	14	0	8	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	JUL 13	2016	8								168	10.3389/fnagi.2016.00168			11	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	DR6XH	WOS:000380044100001	27468266	gold, Green Published			2022-02-06	
J	van Zellem, L; Utens, EM; Madderom, M; Legerstee, JS; Aarsen, F; Tibboel, D; Buysse, C				van Zellem, Lennart; Utens, Elisabeth M.; Madderom, Marlous; Legerstee, Jeroen S.; Aarsen, Femke; Tibboel, Dick; Buysse, Corinne			Cardiac arrest in infants, children, and adolescents: long-term emotional and behavioral functioning	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						Heart arrest; Follow-up studies; Psychopathology; Pediatrics	TRAUMATIC BRAIN-INJURY; CONGENITAL HEART-DISEASE; NEONATAL ENCEPHALOPATHY; SCHOOL-AGE; PERINATAL ASPHYXIA; RESUSCITATION; ASSOCIATION; OUTCOMES; MULTICENTER	Very little is known about the psychological consequences of a cardiac arrest (CA) during childhood. Our aim was to assess long-term emotional and behavioral functioning, and its predictors, in survivors of CA in childhood. This long-term follow-up study involved all consecutive infants, children, and adolescents surviving CA in a tertiary-care university children's hospital between January 2002 and December 2011. Emotional and behavioral functioning was assessed with the Child Behavior Checklist (CBCL), Teacher's Report Form (TRF), and Youth Self-Report (YSR). Of the eligible 107 CA survivors, 52 patients, parents, and/or teachers filled out online questionnaires. Compared with normative data, parents and teachers reported significantly more attention and somatic problems (age range 6-18 years). Parents also reported more attention problems for age range 1.5-5 years. Twenty-eight percent of the children (n = 14) scored in the psychopathological range (i.e., for age range 1.5-18 years; p < 0.001) according to parent reports. Male gender, older age, and basic life support were significantly related to worse scores on the scales internalizing problems, externalizing problems, and total problems and subscale attention problems. Conclusion: Long-term deficits in attention and somatic complaints were reported. Attention problems after childhood CA can interfere with school performance. Long-term follow-up with neuropsychological assessment should be organized.	[van Zellem, Lennart; Madderom, Marlous; Aarsen, Femke; Tibboel, Dick; Buysse, Corinne] Erasmus MC Sophia Childrens Hosp, Intens Care, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [van Zellem, Lennart; Madderom, Marlous; Aarsen, Femke; Tibboel, Dick; Buysse, Corinne] Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [Utens, Elisabeth M.; Madderom, Marlous; Legerstee, Jeroen S.; Aarsen, Femke] Erasmus MC Sophia Childrens Hosp, Dept Child & Adolescent Psychiatry Psychol, NL-3015 CN Rotterdam, Netherlands		Buysse, C (corresponding author), Erasmus MC Sophia Childrens Hosp, Intens Care, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.; Buysse, C (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.	c.buysse@erasmusmc.nl					Aarsen FK, 2006, CANCER-AM CANCER SOC, V106, P396, DOI 10.1002/cncr.21612; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Biarent D, 2010, RESUSCITATION, V81, P1364, DOI 10.1016/j.resuscitation.2010.08.012; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Centraal Bureau voor de Statistiek, 2010, DUTCH STAND CLASS OC; Cohen J., 2013, STAT POWER ANAL BEHA; Donoghue AJ, 2005, ANN EMERG MED, V46, P512, DOI 10.1016/j.annemergmed.2005.05.028; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Madderom MJ, 2013, INTENS CARE MED, V39, P1584, DOI 10.1007/s00134-013-2973-1; Marino BS, 2012, CIRCULATION, V126, P1143, DOI 10.1161/CIR.0b013e318265ee8a; Marlow N, 2005, ARCH DIS CHILD-FETAL, V90, pF380, DOI 10.1136/adc.2004.067520; Maryniak A, 2008, RESUSCITATION, V77, P46, DOI 10.1016/j.resuscitation.2007.10.024; Meert KL, 2009, PEDIATR CRIT CARE ME, V10, P544, DOI 10.1097/PCC.0b013e3181a7045c; MORRIS RD, 1993, J LEARN DISABIL, V26, P46, DOI 10.1177/002221949302600105; Moster D, 2002, ARCH DIS CHILD-FETAL, V86, pF16, DOI 10.1136/fn.86.1.F16; Osorio MB, 2013, PM&R, V5, P554, DOI 10.1016/j.pmrj.2012.11.006; Shillingford AJ, 2008, PEDIATRICS, V121, pE759, DOI 10.1542/peds.2007-1066; Spijkerboer AW, 2008, INT J CARDIOL, V125, P66, DOI 10.1016/j.ijcard.2007.02.025; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tick NT, 2007, ACTA PSYCHIAT SCAND, V116, P473, DOI 10.1111/j.1600-0447.2007.01068.x; Topjian AA, 2009, CURR OPIN CRIT CARE, V15, P203, DOI 10.1097/MCC.0b013e32832931e1; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; van Handel M, 2010, J PEDIATR PSYCHOL, V35, P286, DOI 10.1093/jpepsy/jsp049; van Zellem L, 2015, INTENS CARE MED, V41, P1057, DOI 10.1007/s00134-015-3789-y; Vermunt LCAC, 2008, BRIT J CLIN PSYCHOL, V47, P251, DOI 10.1348/014466507X258868; Visconti KJ, 1999, CIRCULATION, V100, P145; Wernovsky G, 2006, CARDIOL YOUNG, V16, P92, DOI 10.1017/S1047951105002398; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446	30	13	13	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	JUL	2016	175	7					977	986		10.1007/s00431-016-2728-4			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	DP5XH	WOS:000378571000010	27177532	Green Published			2022-02-06	
J	Ping, XJ; Jin, XM				Ping, Xingjie; Jin, Xiaoming			Chronic Posttraumatic Epilepsy following Neocortical Undercut Lesion in Mice	PLOS ONE			English	Article							V PYRAMIDAL NEURONS; CONTROLLED CORTICAL IMPACT; TRAUMATIC BRAIN-INJURY; HEAD TRAUMA; EPILEPTOGENESIS; SEIZURES; HYPEREXCITABILITY; PLASTICITY; MODELS; CORTEX	Posttraumatic epilepsy (PTE) usually develops in a small percentage of patients of traumatic brain injury after a varying latent period. Modeling this chronic neurological condition in rodents is time consuming and inefficient, which constitutes a significant obstacle in studying its mechanism and discovering novel therapeutics for its prevention and treatment. Partially isolated neocortex, or undercut, is known to induce cortical hyperexcitability and epileptiform activity in vitro, and has been used extensively for studying the neurophysiological mechanism of posttraumatic epileptogenesis. However, whether the undercut lesion in rodents causes chronic epileptic seizures has not been systematically characterized. Here we used a miniature telemetry system to continuously monitor electroencephalography (EEG) in adult C57BL mice for up to 3 months after undercut surgery. We found that 50% of animals developed spontaneous seizures between 16-50 days after injury. The mean seizure duration was 8.9 +/- 3.6 seconds, and the average seizure frequency was 0.17 +/- 0.17 times per day. There was no progression in seizure frequency and duration over the recording period. Video monitoring revealed behavioral arrests and clonic limb movement during seizure attacks. A pentylenetetrazol (PTZ) test further showed increased seizure susceptibility in the undercut mice. We conclude that undercut lesion in mice is a model of chronic PTE that involves spontaneous epileptic seizures.	[Ping, Xingjie; Jin, Xiaoming] Indiana Univ Sch Med, Dept Anat & Cell Biol, Stark Neurosci Res Inst, Indiana Spinal Cord & Brain Injury Res Grp, 320 W 15th St, Indianapolis, IN 46202 USA		Jin, XM (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, Stark Neurosci Res Inst, Indiana Spinal Cord & Brain Injury Res Grp, 320 W 15th St, Indianapolis, IN 46202 USA.	xijin@iupui.edu	Jin, Xiaoming/AAH-3555-2020; Jin, Xiaoming/N-8545-2016; ping, xingjie/AAW-4597-2020	Jin, Xiaoming/0000-0002-8671-8640; 	National Institute of Health/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS057940]; Indiana Spinal Cord and Brain Injury Research Fund from the Indiana State Department of Health [A70-1-079438, A70-3-079971, A70-4-079956]; CURE Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K99NS057940, R00NS057940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA039530] Funding Source: NIH RePORTER	This work was supported by the National Institute of Health/NINDS NS057940, the Indiana Spinal Cord and Brain Injury Research Fund from the Indiana State Department of Health (A70-1-079438, A70-3-079971, and A70-4-079956), and CURE Epilepsy Foundation to XJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Avramescu S, 2009, J NEUROTRAUM, V26, P799, DOI 10.1089/neu.2008.0739; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Chauvette S, 2016, J NEUROSCI METH, V260, P185, DOI 10.1016/j.jneumeth.2015.08.030; Curia G, 2011, CEREB CORTEX, V21, P1574, DOI 10.1093/cercor/bhq218; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Graber KD, 1999, ANN NEUROL, V46, P234, DOI 10.1002/1531-8249(199908)46:2<234::AID-ANA13>3.0.CO;2-Q; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Li HF, 2005, J NEUROPHYSIOL, V93, P146, DOI 10.1152/jn.00665.2004; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Loscher W, 2004, EPILEPSY RES, V60, P77, DOI 10.1016/j.eplepsyres.2004.06.004; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; Nita DA, 2006, J NEUROPHYSIOL, V95, P902, DOI 10.1152/jn.00742.2005; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A., 2012, HEAD TRAUMA EPILEPSY; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Salin P, 1995, J NEUROSCI, V15, P8234; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; SCOVILLE WB, 1960, P ROY SOC MED, V53, P721; SHARPLESS SK, 1962, ELECTROEN CLIN NEURO, V14, P244, DOI 10.1016/0013-4694(62)90034-2; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Timofeev I, 2014, INT REV NEUROBIOL, V114, P9, DOI 10.1016/B978-0-12-418693-4.00002-9; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Topolnik L, 2003, EUR J NEUROSCI, V18, P486, DOI 10.1046/j.1460-9568.2003.02742.x; Xiong WH, 2011, JOVE-J VIS EXP, DOI 10.3791/2840; Zayachkivsky A, 2013, J NEUROPHYSIOL, V109, P900, DOI 10.1152/jn.00593.2012; Zayachkivsky A, 2015, JOVE-J VIS EXP, DOI 10.3791/52554	46	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158231	10.1371/journal.pone.0158231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	WOS:000378801200054	27348225	gold, Green Submitted, Green Published			2022-02-06	
J	Beck, B; Bray, JE; Cameron, PA; Cooper, DJ; Gabbe, BJ				Beck, Ben; Bray, Janet E.; Cameron, Peter A.; Cooper, D. James; Gabbe, Belinda J.			Trends in severe traumatic brain injury in Victoria, 2006-2014	MEDICAL JOURNAL OF AUSTRALIA			English	Article							EPIDEMIOLOGY; AUSTRALIA; MORTALITY; OUTCOMES; SCALE; RISK	Objective: To describe the incidence and causes of hospitalisation for severe traumatic brain injury (TBI) in Victoria over a 9-year period. Design, setting and participants: A retrospective review of data from the population-based Victorian State Trauma Registry for hospitalised cases of severe TBI, 2006-2014. Main outcome measures: Temporal trends in the incidence of severe TBI and in causes of injury. Results: There were 2062 patients hospitalised with severe TBI in Victoria during the 9-year study period. The incidence of severe TBI declined significantly over this period, from 5.0 to 3.2 cases per 100000 population per year, mainly because of reductions in severe TBI resulting from motor vehicle crashes (incidence rate ratio [IRR], 0.89; 95% CI, 0.86-0.92; P < 0.001), which largely involved people in the 15-34-year-old age group (64.7%). A decline was also observed in severe TBI in motorcyclists, but this was not statistically significant (IRR, 0.94; 95% CI, 0.89-1.00; P = 0.06). The incidence of severe TBI resulting from low falls, which occurred mostly in people aged 65 years or more (68.1%), increased (IRR, 1.04; 95% CI, 1.00-1.08; P = 0.03). The overall incidence of severe TBI resulting from intentional events was 0.60 cases per 100000 population, and declined over the study period (IRR, 0.95; 95% CI, 0.91e1.00; P = 0.03). Conclusions: The decline in the incidence of motor vehicle-related severe TBI suggests that road injury prevention measures have been effective. Additional targeted measures for reducing the incidence of major head injuries from falls should be explored.	[Beck, Ben; Bray, Janet E.; Cameron, Peter A.; Cooper, D. James; Gabbe, Belinda J.] Monash Univ, Melbourne, Vic, Australia; [Cameron, Peter A.] Alfred, Melbourne, Vic, Australia; [Cooper, D. James] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia		Beck, B (corresponding author), Monash Univ, Melbourne, Vic, Australia.	ben.beck@monash.edu	Cooper, D. James/G-7961-2013; Beck, Ben/ABD-5556-2020; Bray, Janet/H-7089-2014	Cooper, D. James/0000-0002-5872-9051; Beck, Ben/0000-0003-3262-5956; Cameron, Peter/0000-0002-1443-557X; Gabbe, Belinda/0000-0001-7096-7688; Bray, Janet/0000-0002-1559-5882	Victorian Department of Health and Human Services; Transport Accident Commission; National Health and Medical Research Council (NHRMC) Australian Resuscitation Outcomes Consortium (Aus-ROC) Centre of Research ExcellenceNational Health and Medical Research Council of Australia [1029983]; NHMRC-National Heart Foundation FellowshipNational Health and Medical Research Council of Australia [1069985/100136]; Practitioner FellowshipNational Health and Medical Research Council of Australia [545926]; Career Development Fellowship from the NHMRCNational Health and Medical Research Council of Australia [GNT1048731]	The Victorian State Trauma Registry (VSTR) is funded by the Victorian Department of Health and Human Services and the Transport Accident Commission. We thank the Victorian State Trauma Outcome Registry and Monitoring (VSTORM) group for providing VSTR data. We also thank Sue McLellan for her assistance with analysing the data. Ben Beck and Janet Bray received salary support from the National Health and Medical Research Council (NHRMC) Australian Resuscitation Outcomes Consortium (Aus-ROC) Centre of Research Excellence (#1029983). Janet Bray was also supported by a co-funded NHMRC-National Heart Foundation Fellowship (#1069985/100136). Peter Cameron and Belinda Gabbe were respectively supported by a Practitioner Fellowship (#545926) and a Career Development Fellowship (GNT1048731) from the NHMRC.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL 2005 U; Australian Bureau of Statistics, 2008, 3222 0 POP PROJ AUST; Australian Bureau of Statistics, 2015, 3235 0 POP AG SEX RE; Australian Institute of Health and Welfare, 2014, SUIC HOSP SELF HARM; Bambach MR, 2012, AUSTR ROAD SAF RES P; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Helps Y, 2008, INJURY RES STAT SERI, V45; Lyckegaard A, 2015, TRAFFIC INJ PREV, V16, P380, DOI 10.1080/15389588.2014.948618; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McGwin G, 2004, J TRAUMA, V56, P512, DOI 10.1097/01.TA.0000114272.37352.21; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Palmer CS, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-1; Pilgrim JL, 2014, DRUG ALCOHOL DEPEN, V135, P119, DOI 10.1016/j.drugalcdep.2013.11.019; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; State Government of Victoria Department of Health, 2015, MAPS HOSP LOC; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; TEASDALE G, 1974, LANCET, V2, P81; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	26	13	14	0	2	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	0025-729X	1326-5377		MED J AUSTRALIA	Med. J. Aust.	JUN 20	2016	204	11					407	+		10.5694/mja15.01369			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6ZZ	WOS:000410554800012	27318397				2022-02-06	
J	Baron, DM; Hochrieser, H; Metnitz, PGH; Mauritz, W				Baron, David Marek; Hochrieser, Helene; Metnitz, Philipp G. H.; Mauritz, Walter			Tracheostomy is associated with decreased hospital mortality after moderate or severe isolated traumatic brain injury	WIENER KLINISCHE WOCHENSCHRIFT			English	Article						Isolated traumatic brain injury; Tracheostomy; Hospital mortality; Outcome	INTRACRANIAL-PRESSURE; INTENSIVE-CARE; PERCUTANEOUS TRACHEOSTOMY; MECHANICAL VENTILATION; TRACHEOTOMY; IMPACT; METAANALYSIS; INTUBATION; SYSTEM; SCORE	Data regarding the impact and timing of tracheostomy in patients with isolated traumatic brain injury (TBI) are ambiguous. Our goal was to evaluate the impact of tracheostomy on hospital mortality in patients with moderate or severe isolated TBI. We performed a retrospective cohort analysis of data prospectively collected at 87 Austrian intensive care units (ICUs). All patients continuously admitted between 1998 and 2010 were evaluated for the study. In total, 4,735 patients were admitted to ICUs with isolated TBI. Of these patients, 2,156 had a moderate or severe TBI (1,603 patients were endotracheally intubated only, 553 patients underwent tracheostomy). Epidemiological data (trauma severity, treatment, and outcome) of the two groups were compared. Patients with moderate or severe isolated TBI undergoing tracheostomy had a similar Glasgow Coma Scale score, median (interquartile range): 6 (3-8) vs 6 (3-8); p = 0.90, and Simplified Acute Physiology Score II, 45 (37-54) vs 45 (35-56); p = 0.86, compared with intubated patients not undergoing tracheostomy. Furthermore, patients undergoing tracheostomy exhibited higher Abbreviated Injury Scale Head scores and had a longer ICU stay for survivors, 30 (22-42) vs 9 (3-17) days; p < 0.0001). In contrast, risk-adjusted mortality was lower in patients undergoing tracheostomy compared with patients who remained intubated, observed-to-expected mortality ratio (95 % confidence interval): 0.62 (0.53-0.72) vs 1.00 (0.95-1.05) respectively. Despite the greater severity of head injury, patients with isolated TBI who underwent tracheostomy had a lower risk-adjusted mortality than patients who remained intubated. Reasons for this difference in outcome may be multifactorial and require further investigation.	[Baron, David Marek; Metnitz, Philipp G. H.] Med Univ Vienna, Dept Anesthesiol Gen Intens Care & Pain Managemen, Vienna, Austria; [Hochrieser, Helene] Med Univ Vienna, Dept Med Stat, Vienna, Austria; [Metnitz, Philipp G. H.] Med Univ Graz, Dept Anesthesiol & Intens Care Med, Graz, Austria; [Mauritz, Walter] Trauma Hosp Lorenz Boehler, Dept Anesthesia & Crit Care Med, Vienna, Austria		Metnitz, PGH (corresponding author), Med Univ Vienna, Dept Anesthesiol Gen Intens Care & Pain Managemen, Vienna, Austria.	philipp@metnitz.biz					Ahmed Nasim, 2007, Surg Infect (Larchmt), V8, P343, DOI 10.1089/sur.2006.065; Alali AS, 2014, J TRAUMA ACUTE CARE, V76, P6; Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; DAMELIO LF, 1994, AM SURGEON, V60, P180; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Silva BNG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007271.pub2; Griffiths J, 2005, BMJ-BRIT MED J, V330, P1243, DOI 10.1136/bmj.38467.485671.E0; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Imperiale C, 2009, ANESTH ANALG, V108, P588, DOI 10.1213/ane.0b013e31818f601b; Kluger Y, 1996, Eur J Emerg Med, V3, P95, DOI 10.1097/00063110-199606000-00007; Kocaeli H, 2008, ACTA NEUROCHIR, V150, P1263, DOI 10.1007/s00701-008-0153-9; Lane PL, 2000, CAN J SURG, V43, P442; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LESNIK I, 1992, AM SURGEON, V58, P346; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Metnitz PGH, 1999, CRIT CARE MED, V27, P1486, DOI 10.1097/00003246-199908000-00014; Metnitz PGH, 1997, WIEN KLIN WOCHENSCHR, V109, P132; Milanchi S, 2008, J TRAUMA, V65, P73, DOI 10.1097/TA.0b013e31814693f2; Miranda DR, 1996, CRIT CARE MED, V24, P64, DOI 10.1097/00003246-199601000-00012; Nieszkowska A, 2005, CRIT CARE MED, V33, P2527, DOI 10.1097/01.CCM.0000186898.58709.AA; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; PLUMMER AL, 1989, CHEST, V96, P178, DOI 10.1378/chest.96.1.178; Rizk EB, 2011, NEUROCRIT CARE, V15, P481, DOI 10.1007/s12028-011-9615-7; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2000, INTENS CARE MED, V26, P1101, DOI 10.1007/s001340051324; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; TEASDALE G, 1974, LANCET, V2, P81; Teoh WHL, 2001, ANN ACAD MED SINGAP, V30, P234; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; Wang F, 2011, CHEST, V140, P1456, DOI 10.1378/chest.11-2024; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059; Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154	38	13	13	1	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0043-5325	1613-7671		WIEN KLIN WOCHENSCHR	Wien. Klin. Wochen.	JUN	2016	128	11-12					397	403		10.1007/s00508-016-1004-y			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8WY	WOS:000378779800001	27220338	Green Published, hybrid			2022-02-06	
J	Boverman, G; Kao, TJ; Wang, X; Ashe, JM; Davenport, DM; Amm, BC				Boverman, Gregory; Kao, Tzu-Jen; Wang, Xin; Ashe, Jeffrey M.; Davenport, David M.; Amm, Bruce C.			Detection of small bleeds in the brain with electrical impedance tomography	PHYSIOLOGICAL MEASUREMENT			English	Article; Proceedings Paper	16th International Conference on Biomedical Applications of Electrical Impedance Tomography (EIT)	JUN 02-05, 2015	Neuchatel, SWITZERLAND	Nano Tera ch, Bioalps, Drager, ScioSpec, SICHH, IOP Publishing, Swisstom		electrical impedance tomography; contact impedance; hemorrhagic stroke; complete electrode model; statistical detection theory	CURRENT COMPUTED-TOMOGRAPHY; DIELECTRIC-PROPERTIES; BIOLOGICAL TISSUES; ELECTRODE MODELS; BREAST; EIT	In this paper, we describe and assess feasibility of instrumentation and algorithms for detecting bleeding due to hemorrhagic strokes and traumatic brain injury using electrical impedance tomography, a novel biomedical diagnostic modality in which the body is probed noninvasively with generally imperceptible alternating currents applied in patterns to a set of electrodes placed in contact with the skin. We focus on the GENESIS instrument developed by GE Global Research and on the achievability of our goal to detect a bleed in the center of the head with a volume of several ml. Our main topic is compensation for the large changes in voltages that tend to occur when the electrodes are in contact with biological media, specifically either human subjects or with vegetable matter proxies which seem to exhibit the same 'drift' phenomenon. We show that these changes in voltages can be modeled by assuming that each electrode is attached to the body via a discrete complex impedance whose value is time-varying and describe how this discrete component value can be estimated and largely compensated-for. We compare this discrete model with changes in contact impedances estimated using the complete electrode model showing that the two models are roughly comparable in their ability to explain the data from a single human subject experiment with electrodes attached to the head. In a simulation study, we demonstrate that it is possible to detect a small bleed in the center of the head even in the case of large changes in electrode impedances, which can be treated as nuisance parameters.	[Boverman, Gregory; Kao, Tzu-Jen; Wang, Xin; Ashe, Jeffrey M.; Davenport, David M.; Amm, Bruce C.] GE Global Res Ctr, 1 Res Circle, Niskayuna, NY 12309 USA		Boverman, G (corresponding author), GE Global Res Ctr, 1 Res Circle, Niskayuna, NY 12309 USA.	boverman@ge.com		Boverman, Gregory/0000-0002-7223-3714			BARBER DC, 1984, J PHYS E SCI INSTRUM, V17, P723, DOI 10.1088/0022-3735/17/9/002; CHENG KS, 1989, IEEE T BIO-MED ENG, V36, P918, DOI 10.1109/10.35300; Cherepenin V, 2001, PHYSIOL MEAS, V22, P9, DOI 10.1088/0967-3334/22/1/302; Fabri A., 2009, P 17 ACM SIGSPATIAL, P538, DOI DOI 10.1145/1653771.1653865; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Gabriel S, 1996, PHYS MED BIOL, V41, P2271, DOI 10.1088/0031-9155/41/11/003; Gordon C.C., 1989, ANTHROPOMETRIC SURVE; ISAACSON D, 1986, IEEE T MED IMAGING, V5, P91, DOI 10.1109/TMI.1986.4307752; Kerner TE, 2002, IEEE T MED IMAGING, V21, P638, DOI 10.1109/TMI.2002.800606; Kim BS, 2007, PHYSIOL MEAS, V28, pS57, DOI 10.1088/0967-3334/28/7/S05; LEATHARD AD, 1994, PHYSIOL MEAS, V15, pA137, DOI 10.1088/0967-3334/15/2A/018; Polydorides N, 2002, MEAS SCI TECHNOL, V13, P1871, DOI 10.1088/0957-0233/13/12/310; SOMERSALO E, 1992, SIAM J APPL MATH, V52, P1023, DOI 10.1137/0152060; Soni NK, 2004, PHYSIOL MEAS, V25, P301, DOI 10.1088/0967-3334/25/1/034; Tidswell T, 2001, NEUROIMAGE, V13, P283, DOI 10.1006/nimg.2000.0698	15	13	14	2	25	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	JUN	2016	37	6					727	750		10.1088/0967-3334/37/6/727			24	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Engineering; Physiology	DM7BE	WOS:000376506600004	27203851				2022-02-06	
J	Brandstack, N; Kurki, T; Laalo, J; Kauko, T; Tenovuo, O				Brandstack, N.; Kurki, T.; Laalo, J.; Kauko, T.; Tenovuo, O.			Reproducibility of Tract-based and Region-of-Interest DTI Analysis of Long Association Tracts	CLINICAL NEURORADIOLOGY			English	Article						Reproducibility; DTI tractography; Core ROI method; Tract-based analyses	DIFFUSION-TENSOR TRACTOGRAPHY; TRAUMATIC BRAIN-INJURY; UNCINATE FASCICULUS; RELIABILITY; MR; ABNORMALITIES; DISTORTION; INTEGRITY; 3T	Reproducibility of two different methods for quantifying fiber tracts by using a diffusion tensor imaging (DTI) sequence suitable for clinical magnetic resonance imaging (MRI) protocols was evaluated. DTI of 15 subjects was used to analyze intra-rater and inter-rater reproducibility. Another 10 subjects underwent MRI twice for assessment of between-scan reliability. Ten long association tracts were defined by fiber tracking using inclusion and exclusion regions of interest (ROIs). Whole-tract analysis and tractography-based core analysis were performed, and the effect of fractional anisotropy (FA 0.15/0.30) and turning angle threshold (27A degrees/60A degrees) on reproducibility was evaluated. Additionally, ROI measurements were performed in the core of the tracts. For the tract-based methods, intra-rater and inter-rater reliabilities of FA and mean diffusivity (MD) measurements were excellent. Between-scan reproducibility was good or excellent in 127 of 130 of the measurements. There was no systematic difference in the reproducibility of the FA, MD, and volume measurements depending on the FA or turning angle threshold. For the cross-sectional ROI measurements, reliability showed large variation from poor to excellent depending on the tract. Compared with the commonly used cross-sectional core ROI method, the tract-based analyses seem to be a more robust way to identify and measure white matter tracts of interest, and provide a novel reproducible tool to perform core analysis.	[Brandstack, N.] Helsinki Univ Hosp, Dept Radiol, PL 340, Helsinki 00029, Finland; [Kurki, T.] Terveystalo Turku Pulssi Med Ctr, Dept Radiol, Turku, Finland; [Laalo, J.] Turku Univ Hosp, Dept Radiol, PL 52, Turku 20521, Finland; [Kauko, T.] Univ Turku, Dept Biostat, Turku, Finland; [Tenovuo, O.] Turku Univ Hosp, Dept Neurol, PL 52, Turku 20521, Finland		Brandstack, N (corresponding author), Helsinki Univ Hosp, Dept Radiol, PL 340, Helsinki 00029, Finland.	nina.brandstack@hus.fi		Kurki, Timo/0000-0001-5532-3534			Alexander AL, 2006, NEUROIMAG CLIN N AM, V16, P299, DOI 10.1016/j.nic.2006.02.006; Bisdas S, 2008, AM J NEURORADIOL, V29, P1128, DOI 10.3174/ajnr.A1044; Bonekamp D, 2007, NEUROIMAGE, V34, P733, DOI 10.1016/j.neuroimage.2006.09.020; Borich MR, 2012, NEUROIMAGE, V59, P2393, DOI 10.1016/j.neuroimage.2011.09.009; Brander A, 2010, ACTA RADIOL, V51, P800, DOI 10.3109/02841851.2010.495351; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Chung S, 2010, NEUROIMAGE, V49, P631, DOI 10.1016/j.neuroimage.2009.06.067; Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062; Hasan KM, 2010, BRAIN STRUCT FUNCT, V214, P361, DOI 10.1007/s00429-009-0238-0; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Hermoye L, 2006, NEUROIMAGE, V29, P493, DOI 10.1016/j.neuroimage.2005.08.017; Hong YH, 2008, J NEUROIMAGING, V18, P282, DOI 10.1111/j.1552-6569.2007.00153.x; Kanaan RA, 2006, PSYCHIAT RES-NEUROIM, V146, P73, DOI 10.1016/j.pscychresns.2005.11.002; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kurki TJI, 2013, J MAGN RESON IMAGING, V38, P46, DOI 10.1002/jmri.23901; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Ni H, 2006, AM J NEURORADIOL, V27, P1776; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Partridge SC, 2005, J MAGN RESON IMAGING, V22, P467, DOI 10.1002/jmri.20410; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Vollmar C, 2010, NEUROIMAGE, V51, P1384, DOI 10.1016/j.neuroimage.2010.03.046; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang JY, 2012, NEUROIMAGE, V60, P1127, DOI 10.1016/j.neuroimage.2011.12.062; Wang SM, 2005, ANN NY ACAD SCI, V1064, P61, DOI 10.1196/annals.1340.013; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; Yasmin H, 2008, NEURORADIOLOGY, V50, P293, DOI 10.1007/s00234-007-0353-7	35	13	14	0	9	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1869-1439	1869-1447		CLIN NEURORADIOL	Clin. Neuroradiol.	JUN	2016	26	2					199	208		10.1007/s00062-014-0349-8			10	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DQ2CO	WOS:000379009000010	25283182	Green Published			2022-02-06	
J	Callaway, L; Winkler, D; Tippett, A; Herd, N; Migliorini, C; Willer, B				Callaway, Libby; Winkler, Dianne; Tippett, Alice; Herd, Natalie; Migliorini, Christine; Willer, Barry			The Community Integration Questionnaire - Revised: Australian normative data and measurement of electronic social networking	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						community integration; social networking; social participation	TRAUMATIC-BRAIN-INJURY; EVERYDAY TECHNOLOGY USE; RESIDENTIAL AGED CARE; SPINAL-CORD-INJURY; PSYCHOMETRIC PROPERTIES; PARTICIPATION OUTCOMES; PEOPLE; INDIVIDUALS; REHABILITATION; CIQ	Background/aim: Consideration of the relationship between meaningful participation, health and wellbeing underpins occupational therapy intervention, and drives measurement of community integration following acquired brain injury (ABI). However, utility of community integration measures has been limited to date by lack of normative data against which to compare outcomes, and none examine the growing use of electronic social networking (ESN) for social participation. This research had four aims: (i) develop and pilot items assessing ESN to add to the Community Integration Questionnaire, producing the Community Integration Questionnaire-Revised (CIQ-R); (ii) examine factor structure of the CIQ-R; (iii) collect Australian CIQ-R normative data; and (iv) assess test-retest reliability of the revised measure. Methods: Setting: Australia. Participants: A convenience sample of adults without ABI (N = 124) was used to develop and pilot ESN items. A representative general population sample of adults without ABI aged 18-64 years (N = 1973) was recruited to gather normative CIQ-R data. Design: Cross-sectional survey. Main measures: Demographic items and the CIQ-R. Results: The CIQ-R demonstrated acceptable psychometric properties, with minor modification to the original scoring based on the factor analyses provided. Large representative general population CIQ-R normative data have been established, detailing contribution of a range of independent demographic variables to community integration. Conclusion: The addition of electronic social networking items to the CIQ-R offers a contemporary method of assessing community integration following ABI. Normative CIQ-R data enhance the understanding of community integration in the general population, allowing occupational therapists and other clinicians to make more meaningful comparisons between groups.	[Callaway, Libby; Migliorini, Christine] Monash Univ, Dept Occupat Therapy, POB 527, Frankston, Vic 3130, Australia; [Winkler, Dianne; Tippett, Alice] Summer Fdn Ltd, Blackburn, Vic, Australia; [Herd, Natalie] Empir Res, Melbourne, Vic, Australia; [Willer, Barry] SUNY Buffalo, Dept Psychiat Med, Buffalo, NY USA		Callaway, L (corresponding author), Monash Univ, Dept Occupat Therapy, POB 527, Frankston, Vic 3130, Australia.	libby.callaway@monash.edu		Winkler, Di/0000-0003-3899-6248; Migliorini, Christine/0000-0002-2228-9947	Transport Accident Commission (TAC) via Institute for Safety, Compensation and Recovery Research (ISCRR)	Funding for this research was provided by the Transport Accident Commission (TAC) via the Institute for Safety, Compensation and Recovery Research (ISCRR).	Arbuckle J., 2012, AMOSS 22 0 USERS GUI; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dalemans RJ, 2010, ARCH PHYS MED REHAB, V91, P395, DOI 10.1016/j.apmr.2009.10.021; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Esselman PC, 2001, J BURN CARE REHABIL, V22, P221, DOI 10.1097/00004630-200105000-00007; Farnworth L., 2003, AUST OCCUP THER J, V50, P116, DOI [DOI 10.1046/J.1440-1630.2003.00391.X, 10.1046/j.1440-1630.2003.00391.x]; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Gontkovsky ST, 2009, NEUROREHABILITATION, V24, P185, DOI 10.3233/NRE-2009-0467; Griffen JA, 2010, REHABIL PSYCHOL, V55, P292, DOI 10.1037/a0020503; Gutman S., 2000, OCCUPATIONAL THERAPY, V15, P71, DOI [10.1300/J004v15n02_05, DOI 10.1300/J004V15N02_05]; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hallgren M, 2011, J INTELL DISABIL RES, V55, P610, DOI 10.1111/j.1365-2788.2011.01419.x; Hirsh AT, 2011, ARCH PHYS MED REHAB, V92, P1602, DOI 10.1016/j.apmr.2011.05.004; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Hutchison E.D., 2011, DIMENSIONS HUMAN BEH; Kaplan CP, 2000, AM J PHYS MED REHAB, V79, P243, DOI 10.1097/00002060-200005000-00005; Kaplan CP, 2001, BRAIN INJURY, V15, P725, DOI 10.1080/02699050010005913; Kielhofner G., 2008, MODEL HUMAN OCCUPATI; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Kratz AL, 2015, J SPINAL CORD MED, V38, P446, DOI 10.1179/2045772313Y.0000000182; Lequerica AH, 2013, J HEAD TRAUMA REHAB, V28, pE14, DOI 10.1097/HTR.0b013e31826e3ca8; Linden MA, 2005, DISABIL REHABIL, V27, P1353, DOI 10.1080/09638280500164180; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Negahban H, 2013, DISABIL REHABIL, V35, P1453, DOI 10.3109/09638288.2012.741653; Parvaneh S, 2012, AUST OCCUP THER J, V59, P131, DOI 10.1111/j.1440-1630.2012.01001.x; Ritchie L, 2014, ARCH PHYS MED REHAB, V95, P163, DOI 10.1016/j.apmr.2013.08.237; Rosenberg L, 2009, OTJR-OCCUP PART HEAL, V29, P52, DOI 10.3928/15394492-20090301-05; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Seale GS, 2002, BRAIN INJURY, V16, P955, DOI 10.1080/02699050210155258; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Sloan S., 2007, BRAIN IMPAIR, V8, P251, DOI [10.1375/brim.8.3.251, DOI 10.1375/BRIM.8.3.251]; Sloan S, 2012, BRAIN IMPAIR, V13, P24, DOI 10.1017/BrImp.2012.5; Sloan S, 2009, BRAIN IMPAIR, V10, P282, DOI 10.1375/brim.10.3.282; Sloan S, 2009, BRAIN IMPAIR, V10, P295, DOI 10.1375/brim.10.3.295; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Statacorp, 2012, STAT 12 REF MAN; Stiers W, 2012, J REHABIL RES DEV, V49, P139, DOI 10.1682/JRRD.2010.07.0131; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Todis B, 2005, BRAIN INJURY, V19, P389, DOI 10.1080/02699050400003957; Tsaousides T, 2011, BRAIN INJURY, V25, P1155, DOI 10.3109/02699052.2011.613086; Vaccaro M, 2007, DISABIL REHABIL-ASSI, V2, P85, DOI 10.1080/17483100601167586; Wehman P, 2009, J REHABIL RES DEV, V46, P909, DOI 10.1682/JRRD.2008.08.0105; Wheeler S., 2005, HUMAN DEV PERFORMANC, P264; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Willis B, 1999, QUESTION APPRAISAL S; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Winkler Dianne, 2006, Aust Health Rev, V30, P100; Winkler D, 2010, BRAIN IMPAIR, V11, P313, DOI 10.1375/brim.11.3.313; Winkler D, 2010, BRAIN IMPAIR, V11, P299, DOI 10.1375/brim.11.3.299; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; Won Yin-Ling Irene, 2002, Ment Health Serv Res, V4, P13, DOI 10.1023/A:1014093008857; [No title captured]	59	13	13	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	JUN	2016	63	3					143	153		10.1111/1440-1630.12284			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	DV0BH	WOS:000382582100005	27072343	Green Published			2022-02-06	
J	Gatson, JW; Stebbins, C; Mathews, D; Harris, TS; Madden, C; Batjer, H; Diaz-Arrastia, R; Minei, JP				Gatson, Joshua W.; Stebbins, Cari; Mathews, Dana; Harris, Thomas S.; Madden, Christopher; Batjer, Hunt; Diaz-Arrastia, Ramon; Minei, Joseph P.			Evidence of increased brain amyloid in severe TBI survivors at 1, 12, and 24 months after injury: report of 2 cases	JOURNAL OF NEUROSURGERY			English	Article						amyloid; florbetapir F18; traumatic brain injury	APOLIPOPROTEIN-E EPSILON-4; ALZHEIMERS-DISEASE; HEAD-INJURY; RISK-FACTOR; BETA; ASSOCIATION; MILD; DEPOSITION; GENOTYPE; PROTEIN	Traumatic brain injury (TBI) is a major risk factor for Alzheimer's disease. With respect to amyloid deposition, there are no published serial data regarding the deposition rate of amyloid throughout the brain after TBI. The authors conducted serial F-18-AV-45 (florbetapir F18) positron emission tomography (PET) imaging in 2 patients with severe TBI at 1, 12, and 24 months after injury. A total of 12 brain regions were surveyed for changes in amyloid levels. Case 1 involved a 50-year-old man who experienced a severe TBI. Compared with the 1-month time point, of the 12 brain regions that were surveyed, a decrease in amyloid (as indicated by standard uptake value ratios) was only observed in the hippocampus (-16%, left;-12%, right) and caudate nucleus (-18%, left;-18%, right), suggesting that initial amyloid accumulation in the brain was cleared between time points 1 and 12 months after injury. Compared to the scan at 1 year, a greater increase in amyloid (+15%) was observed in the right hippocampus at the 24-month time point. The patient in Case 2 was a 37-year-old man who suffered severe trauma to the head and a subsequent stroke; he had poor cognitive/functional outcomes and underwent 1.5 years of rehabilitation. Due to a large infarct area on the injured side of the brain (right side), the authors focused primarily on brain regions affected within the left hemisphere. Compared with the 1-month scan, they only found an increase in brain amyloid within the left anterior putamen (+11%) at 12 months after injury. In contrast, decreased amyloid burden was detected in the left caudate nucleus (-48%), occipital cortex (-21%), and precuneus (-19%) brain regions at the 12-month time point, which is indicative of early accumulation and subsequent clearance. In comparison with 12-month values, more clearance was observed, since a reduction in amyloid was found at 24 months after trauma within the left anterior putamen (-12%) and occipital cortex (-15%). Also, by 24 months, most of the amyloid had been cleared and the patient demonstrated improved results on the Rivermead symptom questionnaire, Glasgow Outcome Scale-Extended, and Disability Rating Scale. With respect to APOE status, the patient in Case 1 had two epsilon 3 alleles and the patient in Case 2 had one epsilon 2 and one epsilon 3 allele. In comparison to the findings of the initial scan at 1 month after TBI, by 12 and 24 month's after injury amyloid was cleared in some brain regions and increased in others. Serial imaging conducted here suggests that florbetapir F18 PET imaging may be useful in monitoring amyloid dynamics within specific brain regions following severe TBI and may be predictive of cognitive deficits.	[Gatson, Joshua W.; Stebbins, Cari; Minei, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Gatson, Joshua W.; Madden, Christopher; Batjer, Hunt] Univ Texas SW Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA; [Mathews, Dana] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Harris, Thomas S.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Rockville, MD USA		Gatson, JW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Dept Neurosurg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joshua.gatson@utsw.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594			Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Choi SR, 2009, J NUCL MED, V50, P1887, DOI 10.2967/jnumed.109.065284; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Fleisher AS, 2011, ARCH NEUROL-CHICAGO, V68, P1404, DOI 10.1001/archneurol.2011.150; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gatson JW, 2013, J NEUROSURG, V118, P1336, DOI 10.3171/2013.2.JNS121771; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pE1, DOI [10.1016/j.jalz.2013.06.001, 10.1016/j.jalz.2013.01.002, 10.1016/j.jalz.2012.10.007]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Mattsson N, 2014, BRAIN, V137, P1550, DOI 10.1093/brain/awu043; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; REBECK GW, 1993, NEURON, V11, P575; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rodrigue KM, 2012, NEUROLOGY, V78, P387, DOI 10.1212/WNL.0b013e318245d295; ROSES AD, 1995, ANN NEUROL, V38, P6, DOI 10.1002/ana.410380105; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Simpkins JW, 2009, ALZHEIMERS DEMENT, V5, P433, DOI 10.1016/j.jalz.2009.06.004; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tiraboschi P, 2004, NEUROLOGY, V62, P1977, DOI 10.1212/01.WNL.0000128091.92139.0F; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Wu KY, 2014, EUR J NUCL MED MOL I, V41, P714, DOI 10.1007/s00259-013-2627-0	35	13	13	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2016	124	6					1646	1653		10.3171/2015.6.JNS15639			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DM6PZ	WOS:000376476200015	26613169	Bronze			2022-02-06	
J	Lyons, TW; Stack, AM; Monuteaux, MC; Parver, SL; Gordon, CR; Gordon, CD; Proctor, MR; Nigrovic, LE				Lyons, Todd W.; Stack, Anne M.; Monuteaux, Michael C.; Parver, Stephanie L.; Gordon, Catherine R.; Gordon, Caroline D.; Proctor, Mark R.; Nigrovic, Lise E.			A QI Initiative to Reduce Hospitalization for Children With Isolated Skull Fractures	PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; SKELETAL SURVEYS; HEAD-INJURIES; INFANTS; MANAGEMENT	BACKGROUND AND OBJECTIVE: Although children with isolated skull fractures rarely require acute interventions, most are hospitalized. Our aim was to safely decrease the hospitalization rate for children with isolated skull fractures. METHODS: We designed and executed this multifaceted quality improvement (QI) initiative between January 2008 and July 2015 to reduce hospitalization rates for children 21 years old with isolated skull fractures at a single tertiary care pediatric institution. We defined an isolated skull fracture as a skull fracture without intracranial injury. The QI intervention consisted of 2 steps: (1) development and implementation of an evidence-based guideline, and (2) dissemination of a provider survey designed to reinforce guideline awareness and adherence. Our primary outcome was hospitalization rate and our balancing measure was hospital readmission within 72 hours. We used standard statistical process control methodology to assess change over time. To assess for secular trends, we examined admission rates for children with an isolated skull fracture in the Pediatric Health Information System administrative database. RESULTS: We identified 321 children with an isolated skull fracture with a median age of 11 months (interquartile range 5-16 months). The baseline admission rate was 71% (179/249, 95% confidence interval, 66%-77%) and decreased to 46% (34/72, 95% confidence interval, 35%-60%) after implementation of our QI initiative. No child was readmitted after discharge. The admission rate in our secular trend control group remained unchanged at 78%. CONCLUSIONS: We safely reduced the hospitalization rate for children with isolated skull fractures without an increase in the readmissions.	[Lyons, Todd W.; Stack, Anne M.; Monuteaux, Michael C.; Parver, Stephanie L.; Gordon, Catherine R.; Gordon, Caroline D.; Nigrovic, Lise E.] Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA; [Proctor, Mark R.] Boston Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Proctor, Mark R.] Harvard Univ, Sch Med, Boston, MA USA		Lyons, TW (corresponding author), Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	todd.lyons@childrens.harvard.edu	Monuteaux, Michael C/O-5032-2018	Nigrovic, Lise/0000-0002-6369-3997; Lyons, Todd/0000-0002-7033-1070	Provider Payer Quality Initiative foundation at Boston Children's Hospital; NIH T32 Training GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32HD040128-12]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040128] Funding Source: NIH RePORTER	This project was supported by a grant from the Provider Payer Quality Initiative foundation at Boston Children's Hospital. Dr. Lyons was supported by an NIH T32 Training Grant (5T32HD040128-12). Funded by the National Institutes of Health (NIH).	Akenroye AT, 2016, EMERG MED J, V33, P109, DOI 10.1136/emermed-2014-204363; Benneyan JC, 2003, QUAL SAF HEALTH CARE, V12, P458, DOI 10.1136/qhc.12.6.458; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, TRAUM BRAIN INJ US A; Deye KP, 2013, J TRAUMA ACUTE CARE, V74, P1553, DOI 10.1097/TA.0b013e31828b7fc4; Dias MS, 2004, J NEUROSURG, V101, P38, DOI 10.3171/ped.2004.101.2.0038; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Grigg OA, 2003, STAT METHODS MED RES, V12, P147, DOI 10.1177/096228020301200205; Kittle Kory, 2002, Semin Pediatr Surg, V11, P60, DOI 10.1053/spsu.2002.29367; Laskey AL, 2013, J PEDIATR-US, V162, P86, DOI 10.1016/j.jpeds.2012.06.038; Li J, 2012, PEDIATRICS, V130, P83, DOI 10.1542/peds.2011-1819; MADGE P, 1992, LANCET, V340, P1079, DOI 10.1016/0140-6736(92)93088-5; Mannix R, 2013, ANN EMERG MED, V62, P327, DOI 10.1016/j.annemergmed.2013.02.027; Metzger RR, 2014, J PEDIATR SURG, V49, P1856, DOI 10.1016/j.jpedsurg.2014.09.038; Myhre MC, 2007, ACTA PAEDIATR, V96, P1159, DOI 10.1111/j.1651-2227.2007.00356.x; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; ROSENTHAL BW, 1989, J PEDIATR-US, V115, P346, DOI 10.1016/S0022-3476(89)80830-3; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Shira JE, 1998, PEDIATRICS, V101, P715; Walsh KE, 2008, PEDIATRICS, V121, pE421, DOI 10.1542/peds.2007-0220; Wood JN, 2009, PEDIATRICS, V123, pE247, DOI 10.1542/peds.2008-2467	28	13	13	0	0	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUN	2016	137	6							e20153370	10.1542/peds.2015-3370			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	DP5EZ	WOS:000378520100019	27244848	Green Published			2022-02-06	
J	Ruff, RM; Klopfer, J; Blank, J				Ruff, Ronald M.; Klopfer, Jasmin; Blank, Jeremy			Homogenous Base Rates for Malingering in Neuropsychological Examination of Litigants	PSYCHOLOGICAL INJURY & LAW			English	Article						Malingering; Base rates; Neuropsychological assessment	SYMPTOM VALIDITY; PSYCHOLOGICAL INJURY; PERFORMANCE VALIDITY; RESPONSE BIAS; BRAIN-INJURY; SCALES	Base rates for malingering are often obtained and averaged across multiple clinicians who apply heterogeneous methods for detection (Mittenberg et al., J Clin Exp Neuropsychol 24: 1094-1102, 2002; Young, Psychol Inj Law 8: 200-218, 2015). Our aims of obtaining homogenous base rates included the following: (a) evaluation of all our legal cases in accordance with the guidelines set forth in the position papers by both the National Academy of Neuropsychology and the Association for Psychological Advancement in Psychological Injury and Law, (b) minimal variation between our comprehensive neuropsychological examinations, and (c) determination of base rates of failed effort in 150 consecutively examined legal cases in one medical setting. To assess the various levels of volitional exaggeration, we introduced four gradations of poor effort definitions, which relied on performance validity tests (PVTs). A comparison between two consecutive samples of 75 litigants indicated less frequent poor effort with increasingly more conservative criteria. In our analysis of a subset of litigants who sustained traumatic brain injuries (N= 115), the four base rates for mild versus moderate-severe TBI groups were equivalent for the two more lenient malingering definitions but varied for the two more conservative definitions. Specifically, for the mild TBI cases investigated, the percentage of three PVT failures (or one PVT failure significantly below chance) arrived at 3.4 %. Our final aim was to compare the base rates of poor effort that were obtained with PVTs to the base rates of emotional and physical symptom endorsement, which were obtained with symptom validity tests (SVTs). No significant correlations emerged in this analysis. The discussion emphasizes the relatively lower base rates of poor effort found in the convenience sample studied in neuropsychological evaluations relative to the higher estimates in the literature (40 +/- 10%, Larrabee et al., Clin Neuropsychol 23: 841-849, 2009) but not others based on comprehensive review.	[Ruff, Ronald M.; Klopfer, Jasmin; Blank, Jeremy] Univ Calif San Francisco, San Francisco, CA 94143 USA		Ruff, RM (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	ronruff@mindspring.com					Boone K., 2002, DOT COUNTING TEST; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2004, MED SYMPTOM VALIDITY; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Haggerty KA, 2007, CLIN NEUROPSYCHOL, V21, P917, DOI 10.1080/13854040600899724; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Jamora CW, 2013, BRAIN INJURY, V27, P1134, DOI 10.3109/02699052.2013.804196; Johansson SH, 2008, BRAIN INJURY, V22, P999, DOI 10.1080/02699050802530573; Kaufmann P. M., 2013, NATL ACAD NEUROPSYCH, V27, P11; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Lees-Haley P. R., 1999, J FORENSIC NEUROPSYC, V1, P43, DOI [10.1300/J151v01n03_04, DOI 10.1300/J151V01N03_04]; Millon T., 2009, MCMI 3 MILLON CLIN M; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morey L.C., 2007, PERSONALITY ASSESSME; Murray RF, 2007, SPINAL CORD, V45, P429, DOI 10.1038/sj.sc.3102022; Rey A., 1964, CLIN EXAMINATION PSY; ROGERS R, 1988, CLIN ASSESSMENT MALI; Ruff R. M., 2003, RNBI RUFF NEUROBEHAV; Ruff R, 2009, J HEAD TRAUMA REHAB, V24, P131, DOI 10.1097/01.HTR.0000348755.42649.e9; Ruocco AC, 2008, CLIN NEUROPSYCHOL, V22, P547, DOI 10.1080/13854040701336444; Schroeder SC, 2015, Z NEUROPSYCHOL, V26, P35, DOI 10.1024/1016-264x/a000132; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Wechsler D, 2009, WAIS 4 ADM SCORING M; Wechsler D., 2009, ADV CLIN SOLUTIONS W; Whiteside DM, 2009, CLIN NEUROPSYCHOL, V23, P523, DOI 10.1080/13854040802389169; Young G, 2015, PSYCHOL INJ LAW, V8, P200, DOI 10.1007/s12207-015-9230-6; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	36	13	13	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	JUN	2016	9	2					143	153		10.1007/s12207-016-9259-1			11	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	FG6MZ	WOS:000410496200006					2022-02-06	
J	Tan, SKR; Kolmodin, L; Sekhon, MS; Qiao, L; Zou, J; Henderson, WR; Griesdale, DEG				Tan, Sean K. R.; Kolmodin, Leif; Sekhon, Mypinder S.; Qiao, Lu; Zou, Jie; Henderson, William R.; Griesdale, Donald E. G.			The effect of continuous hypertonic saline infusion and hypernatremia on mortality in patients with severe traumatic brain injury: a retrospective cohort study	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Article							INCREASED INTRACRANIAL-PRESSURE; CEREBRAL PERFUSION-PRESSURE; INTENSIVE-CARE-UNIT; HYPEROSMOLAR THERAPY; CRITICALLY-ILL; HEAD-INJURY; EPIDEMIOLOGY; HYPERTENSION; MANNITOL; EDEMA	Hypertonic saline (HTS) is used to control intracranial pressure (ICP) in patients with traumatic brain injury (TBI); however, in prior studies, the resultant hypernatremia has been associated with increased mortality. We aimed to study the effect of HTS on ICP and mortality in patients with severe TBI. We performed a retrospective cohort study of 231 patients with severe TBI (Glasgow Coma Scale [GCS] a parts per thousand currency sign 8) admitted to two neurotrauma units from 2006-2012. We recorded daily HTS, ICP, and serum sodium (Na) concentration. We used Cox proportional regression modelling for hospital mortality and incorporated the following time-dependent variables: use of HTS, hypernatremia, and desmopressin administration. The mean [standard deviation (SD)] age of patients was 34 (17) and the median (interquartile range [IQR]) GCS was 6 [3-8]. Hypertonic saline was administered as a continuous infusion in 124 of 231 (54%) patients over 788 of 2,968 (27%) patient-days. Hypernatremia (Na > 145 mmol center dot L-1) developed in 151 of 231 (65%) patients over 717 of 2,968 (24%) patients-days. In patients who developed hypernatremia, the median [IQR] Na was 146 [142-147] mmol center dot L-1. Overall hospital mortality was 26% (59 of 231 patients). After adjusting for baseline covariates, neither HTS (hazard ratio [HR], 1.07; 95% confidence interval [CI], 0.56 to 2.05; P = 0.84) nor hypernatremia (HR, 1.31; 95% CI, 0.68 to 2.55; P = 0.42) was associated with hospital mortality. There was no effect modification by either HTS or hypernatremia on each another. Patients who received HTS observed a significant decrease in ICP during their ICU stay compared with those who did not receive HTS (4 mmHg; 95% CI, 2 to 6; P < 0.001 vs 2 mmHg; 95% CI, -1 to 5; P = 0.14). Hypertonic saline and hypernatremia are not associated with hospital mortality in patients with severe TBI.	[Tan, Sean K. R.; Kolmodin, Leif; Qiao, Lu; Zou, Jie] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Sekhon, Mypinder S.; Henderson, William R.; Griesdale, Donald E. G.] Univ British Columbia, Dept Med, Div Crit Care Med, Vancouver, BC, Canada; [Griesdale, Donald E. G.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Griesdale, Donald E. G.] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Griesdale, Donald E. G.] Vancouver Gen Hosp, Crit Care Med, Room 2438,Jim Pattison Pavil,2nd Floor, Vancouver, BC V5Z 1M9, Canada		Griesdale, DEG (corresponding author), Vancouver Gen Hosp, Crit Care Med, Room 2438,Jim Pattison Pavil,2nd Floor, Vancouver, BC V5Z 1M9, Canada.	donald.griesdale@vch.ca	Griesdale, Donald/AAT-7762-2021	Griesdale, Donald/0000-0001-5985-8624	VGH & UBC Hospital Foundation Best of Health Fund	Dr. Griesdale is funded by the VGH & UBC Hospital Foundation Best of Health Fund.	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Diringer MN, 2013, CURR OPIN CRIT CARE, V19, P77, DOI 10.1097/MCC.0b013e32835eba30; Ertmer C, 2009, CRIT CARE MED, V37, P2490, DOI 10.1097/CCM.0b013e3181aee67e; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Griesdale DEG, 2013, CRIT CARE, V17, DOI 10.1186/cc11888; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kahle KT, 2013, J CLIN NEUROSCI, V20, P30, DOI 10.1016/j.jocn.2012.10.004; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kolmodin L, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-35; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Li M, 2013, INJURY, V44, P1213, DOI 10.1016/j.injury.2012.05.021; Lindner G, 2007, AM J KIDNEY DIS, V50, P952, DOI 10.1053/j.ajkd.2007.08.016; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Muizelaar JP, 2009, CRIT CARE MED, V37, P1521, DOI 10.1097/CCM.0b013e31819d3ea0; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Shehata M, 2010, CRIT CARE S1, V14, pP355; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc7162; Torre-Healy A, 2012, NEUROCRIT CARE, V17, P117, DOI 10.1007/s12028-011-9649-x; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zygun DA, 2009, CRIT CARE, V13, DOI 10.1186/cc8014	42	13	16	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	JUN	2016	63	6					664	673		10.1007/s12630-016-0633-y			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	DL6DC	WOS:000375727500004	27030131	Bronze			2022-02-06	
J	Varner, EL; Jaquins-Gerstl, A; Michael, AC				Varner, Erika L.; Jaquins-Gerstl, Andrea; Michael, Adrian C.			Enhanced Intracranial Microdialysis by Reduction of Traumatic Penetration Injury at the Probe Track	ACS CHEMICAL NEUROSCIENCE			English	Article						Microdialysis; dexamethasone; dopamine; voltammetry; penetration injury; retrodialysis	STRIATAL DOPAMINE RELEASE; NUCLEUS-ACCUMBENS SHELL; IN-VIVO; EXTRACELLULAR DOPAMINE; RAT; DEXAMETHASONE; IMPLANTATION; CORTICOSTERONE; TRANSMISSION; VOLTAMMETRY	Microdialysis provides deep insight into chemical neuroscience by enabling in vivo intracranial chemical monitoring. Nevertheless, implanting a microdialysis probe causes a traumatic penetration injury (TPI) of brain tissue at the probe track. The TPI, which is clearly documented by voltammetry and histochemical imaging, is a drawback because it perturbs the exact tissue from which the brain dialysate samples are derived. Our goal is to reduce, if not eventually eliminate, the TPI and its detrimental effects on neurochemical monitoring. Here, we demonstrate that combining a 5-day wait period after probe implantation with the continuous retrodialysis of a low-micromolar concentration of dexamethasone vastly reduces the TPI. Our approach to reducing the TPI reinstates normal evoked dopamine release activity in the tissue adjacent to the microdialysis probe, brings evoked dopamine release at the probe outlet into quantitative agreement with evoked dopamine release next to the probe, reinstates normal immunoreactivity for tyrosine hydroxylase and the dopamine transporter near the probe track, and greatly suppresses glial activation and scaring near the probe track. This reduction of the TPI and reinstatement of normal evoked dopamine release activity adjacent to the probe track appears to be due to dexamethasone's anti-inflammatory actions.	[Varner, Erika L.; Jaquins-Gerstl, Andrea; Michael, Adrian C.] Univ Pittsburgh, Dept Chem, 219 Parkman Ave, Pittsburgh, PA 15260 USA		Michael, AC (corresponding author), Univ Pittsburgh, Dept Chem, 219 Parkman Ave, Pittsburgh, PA 15260 USA.	amichael@pitt.edu		/0000-0002-0101-0249	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 081744]; NSF Graduate Research Fellowship ProgramNational Science Foundation (NSF) [1247842]	This work was funded by the NIH (NS 081744) and by the NSF Graduate Research Fellowship Program (to E.L.V.; 1247842).	Bassareo V, 2015, BEHAV BRAIN RES, V287, P200, DOI 10.1016/j.bbr.2015.03.056; BENVENISTE H, 1987, ACTA NEUROPATHOL, V74, P234, DOI 10.1007/BF00688186; Borland LM, 2005, J NEUROSCI METH, V146, P149, DOI 10.1016/j.jneumeth.2005.02.002; Bungay PM, 2003, J NEUROCHEM, V86, P932, DOI 10.1046/j.1471-4159.2003.01904.x; Clapp-Lilly KL, 1999, J NEUROSCI METH, V90, P129, DOI 10.1016/S0165-0270(99)00064-3; Davies MI, 2000, ADV DRUG DELIVER REV, V45, P169, DOI 10.1016/S0169-409X(00)00114-9; Dietrich Jorg, 2011, Expert Rev Clin Pharmacol, V4, P233, DOI 10.1586/ecp.11.1; Ferrari CC, 2004, AM J PATHOL, V165, P1827, DOI 10.1016/S0002-9440(10)63438-4; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Gasser PJ, 2006, J NEUROSCI, V26, P8758, DOI 10.1523/JNEUROSCI.0570-06.2006; GRAEBER MB, 1989, J NEUROSCI RES, V22, P103, DOI 10.1002/jnr.490220114; Groothuis J, 2014, BRAIN STIMUL, V7, P1, DOI 10.1016/j.brs.2013.07.001; Gu H, 2015, ANAL CHEM, V87, P6088, DOI 10.1021/acs.analchem.5b00633; Hascup ER, 2009, BRAIN RES, V1291, P12, DOI 10.1016/j.brainres.2009.06.084; Holson RR, 1996, BRAIN RES, V739, P301, DOI 10.1016/S0006-8993(96)00837-2; Holson RR, 1998, BRAIN RES, V808, P182, DOI 10.1016/S0006-8993(98)00816-6; Huston J. P., 1991, TECHNIQUES BEHAV NEU, V7; Iasevoli F., 2014, CURR MOL PHARM, V6, P149; Jaquins-Gerstl A, 2011, ANAL CHEM, V83, P7662, DOI 10.1021/ac200782h; Lammers CH, 1999, MOL BRAIN RES, V69, P281, DOI 10.1016/S0169-328X(99)00105-9; Lecca D, 2006, PSYCHOPHARMACOLOGY, V184, P435, DOI 10.1007/s00213-005-0280-4; Lecca D, 2007, PSYCHOPHARMACOLOGY, V191, P653, DOI 10.1007/s00213-006-0496-y; Lindley SE, 2002, BRAIN RES, V958, P414, DOI 10.1016/S0006-8993(02)03719-8; Lindley SE, 1999, NEUROPSYCHOPHARMACOL, V21, P399, DOI 10.1016/S0893-133X(98)00103-1; Lu Y, 1998, J NEUROCHEM, V70, P584; Nesbitt KM, 2015, ACS CHEM NEUROSCI, V6, P163, DOI 10.1021/cn500257x; Nesbitt KM, 2013, ANAL CHEM, V85, P8173, DOI 10.1021/ac401201x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peters JL, 1998, J NEUROCHEM, V70, P594; Qian JH, 1999, ANAL CHEM, V71, P4486, DOI 10.1021/ac990338f; ROBINSON TE, 1991, J NEUROSCI METH, V40, P211, DOI 10.1016/0165-0270(91)90070-G; SHARP T, 1986, PHARMACOL BIOCHEM BE, V24, P1755, DOI 10.1016/0091-3057(86)90516-2; Vander Weele CM, 2014, EUR J NEUROSCI, V40, P3041, DOI 10.1111/ejn.12709; Walters SH, 2015, ACS CHEM NEUROSCI, V6, P1468, DOI 10.1021/acschemneuro.5b00128; Wang YX, 2012, J NEUROSCI METH, V208, P34, DOI 10.1016/j.jneumeth.2012.04.009; Watson CJ, 2006, ANAL CHEM, V78, P1391, DOI 10.1021/ac0693722; Westerink  B. H, 2007, HDB MICRODILAYSIS ME; Yang H, 2000, ANAL CHEM, V72, P2042, DOI 10.1021/ac991186r; Yang H, 1998, J NEUROCHEM, V71, P684; Yang HY, 2013, ACS CHEM NEUROSCI, V4, P790, DOI 10.1021/cn400072f; Yang H, 2007, FRONT NEUROENG, V1, P489; Zhong YH, 2007, BRAIN RES, V1148, P15, DOI 10.1016/j.brainres.2007.02.024; Zhou F, 2001, AM J PATHOL, V158, P2145, DOI 10.1016/S0002-9440(10)64686-X	44	13	14	0	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	JUN	2016	7	6					728	736		10.1021/acschemneuro.5b00331			9	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	DP0QY	WOS:000378195500006	27003503	Green Accepted			2022-02-06	
J	Padgett, CR; Summers, MJ; Vickers, JC; McCormack, GH; Skilbeck, CE				Padgett, Christine R.; Summers, Mathew J.; Vickers, James C.; McCormack, Graeme H.; Skilbeck, Clive E.			Exploring the effect of the apolipoprotein E (APOE) gene on executive function, working memory, and processing speed during the early recovery period following traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						working memory; executive function; processing speed; traumatic brain injury; apolipoprotein E4; apolipoprotein E2; TBI	GLASGOW COMA SCALE; COMPENSATORY MECHANISM; POSTTRAUMATIC AMNESIA; HEAD-INJURY; GENOTYPE; POLYMORPHISM; SEVERITY; ALLELE; AGE; REHABILITATION	Introduction: There is evidence that the e4 allele of the apolipoprotein E (APOE) gene is detrimental to cognitive function, but results from traumatic brain injury (TBI) populations are mixed. A possible explanation is that APOEe2 carriers have routinely been incorporated into APOEe4 and non-e4 groups, despite APOEe2 being proposed to have an ameliorative effect. Our primary aim was to investigate the influence of APOEe4 on cognitive impairment during early recovery following TBI, excluding the potential confound of APOEe2 possession. A secondary objective was to explore whether APOEe4 displays more pronounced effects in moderate to severe TBI and to consider the potential postinjury protective influence of the APOEe2 allele. Method: Participants who recently sustained a TBI (posttraumatic amnesia > 5 minutes) were assessed on measures of information processing speed, executive function, and working memory upon remission of posttraumatic amnesia. APOE genotype was determined by buccal saliva DNA extraction (APOEe4 n = 37, APOEe3 n = 92, APOEe2 n = 13). Results: Stepwise multiple regressions were performed to compare APOEe4 carriers to APOEe3 homozygotes, with injury severity, age, and estimated premorbid IQ included in the first step. This model was found to significantly predict performance on all tasks, accounting for 17.3-24.3% of the variance. When APOEe4 status was added for the second step, there were no significant changes on any tasks (additional variance <1%). The effect of APOEe4 in moderate to severe TBI and the effect of APOEe2 were explored by analysis of covariance (ANCOVA), with no significant effects revealed. Conclusions: It is unlikely that APOE genotype influences cognitive function in the initial recovery period following TBI, regardless of injury severity. However, a more nuanced and long-term exploration of the effect of APOE genotype in the TBI population is warranted.	[Padgett, Christine R.; Skilbeck, Clive E.] Univ Tasmania, Sch Med, Launceston, Tas 7250, Australia; [Padgett, Christine R.; Skilbeck, Clive E.] Royal Hobart Hosp, Tasmanian Neurotrauma Register, Hobart, Tas, Australia; [Summers, Mathew J.] Univ Sunshine Coast, Sch Social Sci, Maroochydore, Qld, Australia; [Summers, Mathew J.; Vickers, James C.; McCormack, Graeme H.] Univ Tasmania, Wicking Dementia Res & Educ Ctr, Hobart, Tas, Australia		Padgett, CR (corresponding author), Univ Tasmania, Private Bag 3502, Burnie, Tas 7320, Australia.	Christine.Padgett@utas.edu.au	Summers, Mathew J/G-3168-2011; Vickers, James/J-7464-2014	Summers, Mathew J/0000-0002-3869-4920; Vickers, James/0000-0001-5671-4879			Adibhatla RM, 2007, FUTURE LIPIDOL, V2, P403, DOI 10.2217/17460875.2.4.403; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Donohoe GG, 1999, CLIN CHEM, V45, P143; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Hollows S. E., 1985, ADULT MEMORY INFORM; Horsburgh K, 2003, INT CONGR SER, V1252, P171, DOI 10.1016/S0531-5131(03)00024-4; Horsburgh K, 2002, J CEREBR BLOOD F MET, V22, P1189, DOI 10.1097/01.wcb.0000037991.07114.4e; Howell D.C., 2010, STAT METHODS PSYCHOL, V7th ed; Jochemsen HM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.016; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Mahley RW, 2006, ACTA NEUROL SCAND, V114, P8, DOI 10.1111/j.1600-0404.2006.00679.x; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Noe E, 2010, BRAIN INJURY, V24, P886, DOI 10.3109/02699051003724952; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Rusted JM, 2013, NEUROIMAGE, V65, P364, DOI 10.1016/j.neuroimage.2012.10.010; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Shadli RM, 2011, BRAIN INJURY, V25, P596, DOI 10.3109/02699052.2011.572947; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Struble RG, 2007, EXP GERONTOL, V42, P54, DOI 10.1016/j.exger.2006.05.013; Suri S, 2013, NEUROSCI BIOBEHAV R, V37, P2878, DOI 10.1016/j.neubiorev.2013.10.010; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Weaver SM, 2014, BRAIN IMAGING BEHAV, V8, P420, DOI 10.1007/s11682-012-9197-9; WECHSLER D, 1996, WECHSLER ADULT INTEL, V3; ZANNIS VI, 1981, AM J HUM GENET, V33, P11; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	50	13	14	0	18	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAY 27	2016	38	5					551	560		10.1080/13803395.2015.1137557			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DG4HN	WOS:000372033100006	26898659				2022-02-06	
J	Song, H; Xu, LC; Zhang, RP; Cao, ZZ; Zhang, H; Yang, L; Guo, ZY; Qu, YQ; Yu, JY				Song, Hai; Xu, Lincheng; Zhang, Rongping; Cao, Zhenzhen; Zhang, Huan; Yang, Li; Guo, Zeyun; Qu, Yongqiang; Yu, Jianyun			Rosemary extract improves cognitive deficits in a rats model of repetitive mild traumatic brain injury associated with reduction of astrocytosis and neuronal degeneration in hippocampus	NEUROSCIENCE LETTERS			English	Article						Rosemary extract; Mild traumatic brain injury; Cognitive deficits; Anti-oxidative; Anti-inflammatory	ROSMARINIC ACID PROTECTS; CARNOSIC ACID; CELL-DEATH; IMPAIRMENT; MEMORY; INFLAMMATION; ANTIOXIDANT; POPULATION; CONCUSSION; MECHANISMS	In this study, we investigated whether Rosemary extract (RE) improved cognitive deficits in repetitive mild Traumatic brain injury (rmTBI) rats and its potential mechanisms. The present results showed that rmTBI caused cognitive deficits, such as increased latency to find platform and decreased time spent in target quadrant in Morris water maze (MWM). These behavioral alterations were accompanying with the increased neuronal degeneration and glial fibrillary acidic protein (GFAP)-positive cells, increased Reactive oxygen species (ROS) generation, decreased activity of Superoxide Dismutase (SOD), Glutathione Peroxidase (GPx) and Catalase (CAT), elevated protein level of IL-1 beta, IL-6 and TNF-alpha in hippocampus. Treatment with RE prevented these changes above. Our findings confirmed the effect of rosemary extract on improvement of cognitive deficits and suggested its mechanisms might be mediated by anti-oxidative and anti-inflammatory. Therefore, rosemary extract may be a potential treatment to improve cognitive deficits in rmTBI patients. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Song, Hai; Xu, Lincheng; Zhang, Huan; Qu, Yongqiang; Yu, Jianyun] Kunming Med Univ, Dept Forens Med, Kunming 650500, Yunnan, Peoples R China; [Song, Hai] Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg, Kunming 650032, Yunnan, Peoples R China; [Cao, Zhenzhen] Kunming Med Univ, Basic Med Expt Teaching Ctr, Kunming 650500, Yunnan, Peoples R China; [Yang, Li; Guo, Zeyun] Kunming Med Univ, Dept Histol & Embryol, Kunming 650500, Yunnan, Peoples R China; [Zhang, Rongping] Kunming Med Univ, Pharmaceut Coll, Kunming 650500, Yunnan, Peoples R China		Yu, JY (corresponding author), Kunming Med Univ, Dept Forens Med, Kunming 650500, Yunnan, Peoples R China.	jianyunyu@sina.com			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81360467]; Key Project of Application and Basis Research of Yunnan Province, China [2013FB104]	This study was supported by a grant from the National Nature Science Foundation of China (No.81360467) and Key Project of Application and Basis Research of Yunnan Province (No.2013FB104), China.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; ARUOMA OI, 1992, XENOBIOTICA, V22, P257, DOI 10.3109/00498259209046624; Bauer J, 2012, J PHARMACOL EXP THER, V342, P169, DOI 10.1124/jpet.112.193847; Birtic S, 2015, PHYTOCHEMISTRY, V115, P9, DOI 10.1016/j.phytochem.2014.12.026; Blostein PA, 1997, J NEUROTRAUM, V14, P171, DOI 10.1089/neu.1997.14.171; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chkhikvishvili I, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/456253; Clark RE, 2005, HIPPOCAMPUS, V15, P260, DOI 10.1002/hipo.20056; Cooper C, 2013, BRIT J PSYCHIAT, V203, P255, DOI 10.1192/bjp.bp.113.127811; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Gao LP, 2005, PHARMAZIE, V60, P62; Hadad N, 2012, FREE RADICAL BIO MED, V53, P1381, DOI 10.1016/j.freeradbiomed.2012.07.078; Haran FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079595; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Jianyun Y., 2010, CHIN J NEUROSURG DIS, V9, P337; Jimbo D, 2009, PSYCHOGERIATRICS, V9, P173, DOI 10.1111/j.1479-8301.2009.00299.x; Jin X, 2013, NEUROCHEM RES, V38, P1828, DOI 10.1007/s11064-013-1088-y; Khamse S, 2015, PHARM BIOL, V53, P1818, DOI 10.3109/13880209.2015.1010738; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lee HJ, 2008, TOXICOLOGY, V250, P109, DOI 10.1016/j.tox.2008.06.010; Luan HY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-28; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Moon DO, 2010, CANCER LETT, V288, P183, DOI 10.1016/j.canlet.2009.06.033; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moss M, 2003, INT J NEUROSCI, V113, P15, DOI 10.1080/00207450390161903; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Ozarowski M, 2013, FITOTERAPIA, V91, P261, DOI 10.1016/j.fitote.2013.09.012; Ozturk H, 2014, J PAK MED ASSOC, V64, P260; Park DH, 2010, FITOTERAPIA, V81, P644, DOI 10.1016/j.fitote.2010.03.010; Pengelly A, 2012, J MED FOOD, V15, P10, DOI 10.1089/jmf.2011.0005; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Rajasekaran D, 2013, AFR J TRADIT COMPLEM, V10, P102, DOI 10.4314/ajtcam.v10i1.14; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rossi D, 2015, PROG NEUROBIOL, V130, P86, DOI 10.1016/j.pneurobio.2015.04.003; Swarup V, 2007, ANTIMICROB AGENTS CH, V51, P3367, DOI 10.1128/AAC.00041-07; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Writer BW, 2009, J NEUROPSYCH CLIN N, V21, P362, DOI 10.1176/appi.neuropsych.21.4.362; Yu Jian-Yun, 2008, Fa Yi Xue Za Zhi, V24, P8	45	13	14	1	16	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 27	2016	622						95	101		10.1016/j.neulet.2016.04.048			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DN1OC	WOS:000376834300018	27113205				2022-02-06	
J	Charry, JD; Rubiano, AM; Puyana, JC; Carney, N; Adelson, PD				Charry, Jose D.; Rubiano, Andres M.; Puyana, Juan C.; Carney, Nancy; Adelson, P. David			Damage control of civilian penetrating brain injuries in environments of low neuro-monitoring resources	BRITISH JOURNAL OF NEUROSURGERY			English	Article						cranial decompression; damage control; gunshot injuries; neurotrauma	GUNSHOT WOUNDS; HEAD-INJURY; TRAUMA CARE; EXPERIENCE; PROTOCOL; CHILDREN	Introduction. Gunshot wounds to the head are more common in military settings. Recently, a damage control (DC) approach for the management of these lesions has been used in combat areas. The aim of this study was to evaluate the results of civilian patients with penetrating gunshot wounds to the head, managed with a strategy of early cranial decompression (ECD) as a DC procedure in a university hospital with few resources for intensive care unit (ICU) neuro-monitoring in Colombia.Materials and methods. Fifty-four patients were operated according to the DC strategy (<12 h after injury), over a 4-year period. Variables were analysed and results were evaluated according to the Glasgow Outcome Scale (GOS) at 12 months post injury; a dichotomous variable was established as favourable' (GOS 4-5) or unfavourable' (GOS 1-3). A univariate analysis was performed using a (2) test.Results. Forty (74.1%) of the patients survived and 36 (90%) of them had favourable GOS. Factors associated with adverse outcomes were: Injury Severity Score (ISS) greater than 25, bi-hemispheric involvement, intra-cerebral haematoma on the first CT, closed basal cisterns and non-reactive pupils in the emergency room.Conclusion. DC for neurotrauma with ECD is an option to improve survival and favourable neurological outcomes 12 months after injury in patients with penetrating traumatic brain injury treated in a university hospital with few resources for ICU neuro-monitoring.	[Charry, Jose D.; Rubiano, Andres M.] Univ Surcolombiana, Univ Hosp, Fac Salud, Neiva, Colombia; [Rubiano, Andres M.] Fdn MEDITECH, Calle 5 11-19, Neiva, Colombia; [Puyana, Juan C.] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; [Carney, Nancy] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA		Rubiano, AM (corresponding author), Fdn MEDITECH, Calle 5 11-19, Neiva, Colombia.	rubianoam@gmail.com	RUBIANO, ANDRES M/K-6704-2012; Adelson, David/W-2083-2019	RUBIANO, ANDRES M/0000-0001-8931-3254; Charry, Jose D./0000-0002-8789-7281	NIH-FIC Grant [R21TW009332]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R21TW009332] Funding Source: NIH RePORTER	Authors are supported by the NIH-FIC Grant # R21TW009332.	Aarabi B, 2003, NEUROSURG QUART, V13, P87, DOI 10.1097/00013414-200306000-00004; Abdolvahabi RM, 2001, NEUROL RES, V23, P210, DOI 10.1179/016164101101198361; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Byass P, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001477; Coughlan MD, 2003, CHILD NERV SYST, V19, P348, DOI 10.1007/s00381-003-0736-y; De la Hoz GA, 2013, FORENSIS, V1, P79; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; GURDJIAN ES, 1974, J NEUROSURG, V40, P157, DOI 10.3171/jns.1974.40.2.0157; Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3; Karabagli H, 2005, PEDIATR NEUROSURG, V41, P148, DOI 10.1159/000085873; Kesinger MR, 2014, INJURY, V45, P1350, DOI 10.1016/j.injury.2014.04.037; Kesinger MR, 2014, WORLD J SURG, V38, P1869, DOI 10.1007/s00268-014-2534-y; Levy M L, 2000, Neurosurg Focus, V8, pe2, DOI 10.3171/foc.2000.8.1.153; Mackerle Z, 2009, CHILD NERV SYST, V25, P909, DOI 10.1007/s00381-009-0901-z; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Rubiano AM, 2007, NEUROTRAUMA NEUROINT, P231; Rubiano AM, 2009, ULUS TRAVMA ACIL CER, V15, P28; Smith JE, 2014, INJURY, V45, P874, DOI 10.1016/j.injury.2013.12.004; STONE JL, 1995, NEUROSURGERY, V37, P1104, DOI 10.1227/00006123-199512000-00010; Zafonte RD, 2001, ARCH PHYS MED REHAB, V82, P306, DOI 10.1053/apmr.2001.18226	21	13	13	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	MAY 3	2016	30	2					235	239		10.3109/02688697.2015.1096905			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DI3LK	WOS:000373399900014	26469861				2022-02-06	
J	Balasundaram, AP; Athens, J; Schneiders, AG; McCrory, P; Sullivan, SJ				Balasundaram, Arun P.; Athens, Josie; Schneiders, Anthony G.; McCrory, Paul; Sullivan, S. John			The Influence of Psychological and Lifestyle Factors on the Reporting of Postconcussion-Like Symptoms	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Total symptom score; Symptom severity score; Psychological factors; Lifestyle factors	POST-CONCUSSIVE SYMPTOMS; TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; UNIVERSITY-STUDENTS; CONSENSUS STATEMENT; HOSPITAL ANXIETY; SPORT HELD; BASE RATES; DEPRESSION; INDIVIDUALS	Self-reported symptoms are an integral part of the assessment and management of a sports-related concussion. However, postconcussion-like symptoms are reported by non-concussed individuals. Moreover, the current best practice in the reporting of symptoms does not take into account the potential influence of psychological and lifestyle factors. This study aimed to explore the influence of these factors on the reporting of postconcussion-like symptoms. University students (N = 603) completed the Sport Concussion Assessment Tool 2 postconcussion symptom scale along with other predictor variables via a cross-sectionalweb-based survey. Linear regression analyses revealed six modifiers contributing to the total symptom score with the strongest being alcohol consumption (Estimate = 2.75, p<.001). Following these findings, clinicians need to exercise caution when interpreting the symptom scores for making decisions on the return-to-play (RTP). A failure to do so may lead the health professional to either prematurely RTP or not clear the concussed athlete to resume their sport.	[Balasundaram, Arun P.; Sullivan, S. John] Univ Otago, Sch Physiotherapy, Ctr Hlth Act & Rehabil Res, Dunedin 9054, New Zealand; [Athens, Josie] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin 9054, New Zealand; [Schneiders, Anthony G.] Cent Queensland Univ, Sch Human Hlth & Social Sci, Bundaberg, Qld 4670, Australia; [McCrory, Paul] Univ Melbourne, Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3084, Australia		Sullivan, SJ (corresponding author), Univ Otago, Sch Physiotherapy, POB 56, Dunedin 9054, New Zealand.	sjohn.sullivan@otago.ac.nz	Balasundaram, Arun Prasad/D-1270-2017; McCrory, Paul/Q-8688-2019	Balasundaram, Arun Prasad/0000-0001-8256-857X; McCrory, Paul/0000-0003-4850-0568	International Olympic Committee (IOC); Axon Sports (USA)CogState Limited; CogState IncCogState Limited	P.M. is a co-investigator, collaborator, or consultant on grants relating to mild TBI funded by several governmental organisations. He is Co-Chair of the Australian Centre for Research into Sports Injury and its Prevention (ACRISP), which is one of the International Research Centres for Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee (IOC). He has a clinical and consulting practice in general and sports neurology. He receives book royalties from McGraw-Hill and was employed in an editorial capacity by the British Medical Journal Publishing Group from 2001 to 2008. He has been reimbursed by the government, professional scientific bodies, and sporting bodies for presenting research relating to mild TBI and sports-related concussion at meetings, scientific conferences, and symposiums. He received consultancy fees in 2010 from Axon Sports (USA) for the development of educational material (which was not renewed) and has received support since 2001 from CogState Inc for research costs and the development of educational material. He is a cofounder and shareholder in two biomedical companies (involved in eHealth and Compression garment technologies) but does not hold any individual shares in any company related to concussion or brain injury assessment or technology.	Alla S, 2010, J SCI MED SPORT, V13, P24, DOI 10.1016/j.jsams.2008.12.629; Balasundaram AP, 2013, PHYS THER SPORT, V14, P253, DOI 10.1016/j.ptsp.2013.06.002; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; COHEN S, 1988, CLAR SYMP, P31; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Dillman D., 2008, INTERNET MAIL MIXED; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Field A., 2009, DISCOVERING STAT USI, V3rd ed; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Gallagher R.P., 2012, NATL SURVEY COLL COU; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL., 2012, PTSD MILD TRAUMATIC; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Moreno E., 2006, SORT-STAT OPER RES T, V30, P3; Mrazik M, 2013, J ATHL TRAINING, V48, P654, DOI 10.4085/1062-6050-48.3.19; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Polak MA, 2012, DRUG ALCOHOL REV, V31, P763, DOI 10.1111/j.1465-3362.2012.00429.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Singleton RA, 2009, J STUD ALCOHOL DRUGS, V70, P355, DOI 10.15288/jsad.2009.70.355; Stallman HM, 2010, AUST PSYCHOL, V45, P249, DOI 10.1080/00050067.2010.482109; Stewart A. L., 1992, MEASURING FUNCTIONIN, P155; Sullivan KA, 2012, J HEAD TRAUMA REHAB, V27, P293, DOI 10.1097/HTR.0b013e31822123ce; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	40	13	13	0	14	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2016	31	3					197	205		10.1093/arclin/acw001			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	DL1WX	WOS:000375424900002	26891719	Bronze			2022-02-06	
J	Bye, N; Christie, KJ; Turbic, A; Basrai, HS; Turnley, AM				Bye, Nicole; Christie, Kimberly J.; Turbic, Alisa; Basrai, Harleen S.; Turnley, Ann M.			Rho kinase inhibition following traumatic brain injury in mice promotes functional improvement and acute neuron survival but has little effect on neurogenesis, glial responses or neuroinflammation	EXPERIMENTAL NEUROLOGY			English	Article						Rho GTPase; Astrocytic gliosis; Y27632; Fasudil; Microglia; Controlled cortical impact; Horizontal ladder test; NeuN	CONTROLLED CORTICAL IMPACT; NEURITE OUTGROWTH; ROCK INHIBITOR; IN-VITRO; DOPAMINERGIC-NEURONS; AXONAL REGENERATION; LESIONAL EXPRESSION; FAMILY GTPASES; MOUSE MODEL; FASUDIL	Inhibition of the Rho/Rho kinase pathway has been shown to be beneficial in a variety of neural injuries and diseases. In this manuscript we investigate the role of Rho kinase inhibition in recovery from traumatic brain injury using a controlled cortical impact model in mice. Mice subjected to a moderately severe TBI were treated for 1 or 4 weeks with the Rho kinase inhibitor Y27632, and functional outcomes and neuronal and glial cell responses were analysed at 1, 7 and 35 days post-injury. We hypothesised that Y27632-treated mice would show functional improvement, with augmented recruitment of neuroblasts from the SVZ and enhanced survival of newborn neurons in the pericontusional cortex, with protection against neuronal degeneration, neuroinflammation and modulation of astrocyte reactivity and blood-brain-barrier permeability. While Rho kinase inhibition enhanced recovery of motor function after trauma, there were no substantial increases in the recruitment of DCX+ neuroblasts or the number of BrdU(+) or EdU(+) labelled newborn neurons in the pericontusional cortex of Y27632-treated mice. Inhibition of Rho kinase significantly reduced the number of degenerating cortical neurons at 1 day post-injury compared to saline controls but had no longer term effect on neuronal degeneration, with only modest effects on astrocytic reactivity and macrophage/microglial responses. Overall, this study showed that Rho kinase contributes to acute neurodegenerative processes in the injured cortex but does not play a significant role in SVZ neural precursor cell-derived adult neurogenesis, glial responses or blood-brain barrier permeability following a moderately severe brain injury. (C) 2016 Elsevier Inc. All rights reserved.	[Bye, Nicole; Christie, Kimberly J.; Turbic, Alisa; Basrai, Harleen S.; Turnley, Ann M.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia		Turnley, AM (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Melbourne Brain Ctr, Royal Parade Genet Lane, Parkville, Vic 3052, Australia.	turnley@unimelb.edu.au		Turnley, Ann/0000-0002-8442-127X	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [1045125, 628344]; Stem Cells Australia	This work was supported by the National Health and Medical Research Council of Australia (Project grant 1045125 and Fellowship (to AMT)) 628344 and Stem Cells Australia.	Barcia C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00809; Borisoff JF, 2003, MOL CELL NEUROSCI, V22, P405, DOI 10.1016/S1044-7431(02)00032-5; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; Brown MD, 2000, J NEUROBIOL, V43, P352, DOI 10.1002/1097-4695(20000615)43:4<352::AID-NEU4>3.0.CO;2-T; Chan CCM, 2005, EXP NEUROL, V196, P352, DOI 10.1016/j.expneurol.2005.08.011; Christie KJ, 2013, NEUROSCIENCE, V247, P75, DOI 10.1016/j.neuroscience.2013.05.019; Conrad S, 2005, J COMP NEUROL, V487, P166, DOI 10.1002/cne.20561; Cui QH, 2013, NEURAL REGEN RES, V8, P1180, DOI 10.3969/j.issn.1673-5374.2013.13.003; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Dergham P, 2002, J NEUROSCI, V22, P6570; Ding J, 2010, J NEUROCHEM, V114, P1619, DOI 10.1111/j.1471-4159.2010.06876.x; Ding J, 2010, MOL CELL NEUROSCI, V43, P201, DOI 10.1016/j.mcn.2009.11.001; Dottori M, 2008, STEM CELLS, V26, P1146, DOI 10.1634/stemcells.2007-1118; Fehlings MG, 2011, J NEUROTRAUM, V28, P787, DOI 10.1089/neu.2011.1765; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fuentes EO, 2008, J BRACHIAL PLEX PERI, V3, DOI 10.1186/1749-7221-3-19; Fujii M, 2012, NEUROCHEM INT, V60, P327, DOI 10.1016/j.neuint.2011.12.014; Gibson CL, 2014, J NEUROCHEM, V129, P816, DOI 10.1111/jnc.12681; Grunwald IC, 2002, CURR OPIN NEUROBIOL, V12, P250, DOI 10.1016/S0959-4388(02)00323-9; Gunther R, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00304; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Hotta R, 2009, STEM CELLS, V27, P2896, DOI 10.1002/stem.208; Jeon BT, 2013, NEUROTOX RES, V23, P238, DOI 10.1007/s12640-012-9339-2; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Katoh H, 1998, J BIOL CHEM, V273, P2489, DOI 10.1074/jbc.273.5.2489; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kubo T, 2008, J NEUROCHEM, V105, P113, DOI 10.1111/j.1471-4159.2007.05125.x; Kubo T, 2007, CURR PHARM DESIGN, V13, P2493; Kubo Takekazu, 2008, Ther Clin Risk Manag, V4, P605; Lau CL, 2012, J CELL PHYSIOL, V227, P1199, DOI 10.1002/jcp.22838; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Lemmens R, 2013, HUM MOL GENET, V22, P2214, DOI 10.1093/hmg/ddt073; Leong SY, 2011, NEUROCHEM INT, V59, P382, DOI 10.1016/j.neuint.2010.12.024; Leong SY, 2011, STEM CELLS, V29, P332, DOI 10.1002/stem.577; Lingor P, 2008, BRAIN, V131, P250, DOI 10.1093/brain/awm284; Lingor P, 2007, J NEUROCHEM, V103, P181, DOI 10.1111/j.1471-4159.2007.04756.x; Lord-Fontaine S, 2008, J NEUROTRAUM, V25, P1309, DOI 10.1089/neu.2008.0613; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Niego B, 2012, BLOOD, V119, P4752, DOI 10.1182/blood-2011-07-369512; O'Shea RD, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00050; Postma FR, 1996, EMBO J, V15, P2388, DOI 10.1002/j.1460-2075.1996.tb00595.x; Puschmann TB, 2010, J NEUROCHEM, V113, P881, DOI 10.1111/j.1471-4159.2010.06655.x; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Satoh S, 2001, LIFE SCI, V69, P1441, DOI 10.1016/S0024-3205(01)01229-2; Satoh SI, 2008, BRAIN RES, V1193, P102, DOI 10.1016/j.brainres.2007.11.050; Satoh S, 2010, BRAIN RES BULL, V81, P191, DOI 10.1016/j.brainresbull.2009.08.021; Shibuya M, 2005, J NEUROL SCI, V238, P31, DOI 10.1016/j.jns.2005.06.003; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Tatenhorst L, 2014, J NEUROPATH EXP NEUR, V73, P770, DOI 10.1097/NEN.0000000000000095; Tonges L, 2012, BRAIN, V135, P3355, DOI 10.1093/brain/aws254; Wu JH, 2012, CELL MOL NEUROBIOL, V32, P1187, DOI 10.1007/s10571-012-9845-z; Yamashita K, 2007, BRAIN RES, V1154, P215, DOI 10.1016/j.brainres.2007.04.013; Zhang ZB, 2012, NEUROCHEM RES, V37, P948, DOI 10.1007/s11064-011-0687-8	60	13	13	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2016	279						86	95		10.1016/j.expneurol.2016.02.012			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK0OU	WOS:000374612900007	26896832				2022-02-06	
